drug_id,drug_name,target_id,target_uniprot,target_name,target_gene,action,atc_codes
DB00001,Lepirudin,,P00734,Prothrombin,F2,inhibitor,B01AE02
DB00002,Cetuximab,,P00533,Epidermal growth factor receptor,EGFR,binder,L01FE01
DB00002,Cetuximab,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,binder,L01FE01
DB00002,Cetuximab,,P02745,Complement C1q subcomponent subunit A,C1QA,binder,L01FE01
DB00002,Cetuximab,,P02746,Complement C1q subcomponent subunit B,C1QB,binder,L01FE01
DB00002,Cetuximab,,P02747,Complement C1q subcomponent subunit C,C1QC,binder,L01FE01
DB00002,Cetuximab,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,binder,L01FE01
DB00002,Cetuximab,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,binder,L01FE01
DB00002,Cetuximab,,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,binder,L01FE01
DB00003,Dornase alfa,,,DNA,,,R05CB13
DB00004,Denileukin diftitox,,P01589,Interleukin-2 receptor subunit alpha,IL2RA,binder,L01XX29
DB00004,Denileukin diftitox,,P14784,Interleukin-2 receptor subunit beta,IL2RB,agonist,L01XX29
DB00004,Denileukin diftitox,,P31785,Cytokine receptor common subunit gamma,IL2RG,,L01XX29
DB00005,Etanercept,,P01375,Tumor necrosis factor,TNF,inhibitor,L04AB01
DB00005,Etanercept,,P01375,Tumor necrosis factor,TNF,antibody,L04AB01
DB00005,Etanercept,,P01374,Lymphotoxin-alpha,LTA,antibody,L04AB01
DB00005,Etanercept,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,ligand,L04AB01
DB00005,Etanercept,,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,ligand,L04AB01
DB00005,Etanercept,,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,ligand,L04AB01
DB00005,Etanercept,,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,ligand,L04AB01
DB00005,Etanercept,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,ligand,L04AB01
DB00005,Etanercept,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,ligand,L04AB01
DB00005,Etanercept,,P02745,Complement component 1q (C1q),C1QA,ligand,L04AB01
DB00006,Bivalirudin,,P00734,Prothrombin,F2,inhibitor,B01AE06
DB00007,Leuprolide,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,agonist,L02AE51;L02AE02
DB00008,Peginterferon alfa-2a,,P48551,Interferon alpha/beta receptor 2,IFNAR2,agonist,L03AB11;L03AB61
DB00008,Peginterferon alfa-2a,,P17181,Interferon alpha/beta receptor 1,IFNAR1,agonist,L03AB11;L03AB61
DB00009,Alteplase,,P00747,Plasminogen,PLG,activator,B01AD02;S01XA13
DB00009,Alteplase,,P02671,Fibrinogen alpha chain,FGA,binder,B01AD02;S01XA13
DB00009,Alteplase,,P02679,Fibrinogen gamma chain,FGG,binder,B01AD02;S01XA13
DB00009,Alteplase,,P05121,Plasminogen activator inhibitor 1,SERPINE1,,B01AD02;S01XA13
DB00010,Sermorelin,,Q02643,Growth hormone-releasing hormone receptor,GHRHR,agonist,V04CD03;H01AC04
DB00011,Interferon alfa-n1,,P17181,Interferon alpha/beta receptor 1,IFNAR1,agonist,L03AB06
DB00011,Interferon alfa-n1,,P48551,Interferon alpha/beta receptor 2,IFNAR2,agonist,L03AB06
DB00012,Darbepoetin alfa,,P19235,Erythropoietin receptor,EPOR,agonist,B03XA02
DB00013,Urokinase,,P00747,Plasminogen,PLG,activator,B01AD04
DB00013,Urokinase,,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,inducer,B01AD04
DB00013,Urokinase,,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,modulator,B01AD04
DB00013,Urokinase,,P05121,Plasminogen activator inhibitor 1,SERPINE1,substrate,B01AD04
DB00013,Urokinase,,P05121,Plasminogen activator inhibitor 1,SERPINE1,inducer,B01AD04
DB00013,Urokinase,,P05120,Plasminogen activator inhibitor 2,SERPINB2,substrate,B01AD04
DB00013,Urokinase,,P05120,Plasminogen activator inhibitor 2,SERPINB2,inducer,B01AD04
DB00013,Urokinase,,P05154,Plasma serine protease inhibitor,SERPINA5,substrate,B01AD04
DB00013,Urokinase,,P98164,Low-density lipoprotein receptor-related protein 2,LRP2,substrate,B01AD04
DB00013,Urokinase,,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,ST14,substrate,B01AD04
DB00013,Urokinase,,P14543,Nidogen-1,NID1,ligand,B01AD04
DB00014,Goserelin,,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,agonist,L02AE03
DB00014,Goserelin,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,agonist,L02AE03
DB00015,Reteplase,,P00747,Plasminogen,PLG,activator,B01AD07
DB00015,Reteplase,,P02671,Fibrinogen alpha chain,FGA,,B01AD07
DB00015,Reteplase,,P05121,Plasminogen activator inhibitor 1,SERPINE1,,B01AD07
DB00016,Erythropoietin,,P19235,Erythropoietin receptor,EPOR,agonist,B03XA01
DB00017,Salmon calcitonin,,P30988,Calcitonin receptor,CALCR,agonist,H05BA01
DB00018,Interferon alfa-n3,,P17181,Interferon alpha/beta receptor 1,IFNAR1,agonist,
DB00018,Interferon alfa-n3,,P48551,Interferon alpha/beta receptor 2,IFNAR2,agonist,
DB00019,Pegfilgrastim,,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,agonist,L03AA13
DB00020,Sargramostim,,P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,agonist,L03AA09
DB00020,Sargramostim,,P26951,Interleukin-3 receptor subunit alpha,IL3RA,agonist,L03AA09
DB00020,Sargramostim,,P32927,Cytokine receptor common subunit beta,CSF2RB,agonist,L03AA09
DB00020,Sargramostim,,P34741,Syndecan-2,SDC2,agonist,L03AA09
DB00020,Sargramostim,,P13727,Bone marrow proteoglycan,PRG2,,L03AA09
DB00022,Peginterferon alfa-2b,,P17181,Interferon alpha/beta receptor 1,IFNAR1,agonist,L03AB10;L03AB60
DB00022,Peginterferon alfa-2b,,P48551,Interferon alpha/beta receptor 2,IFNAR2,agonist,L03AB10;L03AB60
DB00023,Asparaginase Escherichia coli,,,L-asparagine,,other/unknown,L01XX02
DB00024,Thyrotropin alfa,,P16473,Thyrotropin receptor,TSHR,agonist,H01AB01
DB00025,"Antihemophilic factor, human recombinant",,P00742,Coagulation factor X,F10,activator,B02BD02
DB00025,"Antihemophilic factor, human recombinant",,P00740,Coagulation factor IX,F9,cofactor,B02BD02
DB00025,"Antihemophilic factor, human recombinant",,P04275,von Willebrand factor,VWF,binder,B02BD02
DB00025,"Antihemophilic factor, human recombinant",,O14832,"Phytanoyl-CoA dioxygenase, peroxisomal",PHYH,antagonist,B02BD02
DB00025,"Antihemophilic factor, human recombinant",,P07307,Asialoglycoprotein receptor 2,ASGR2,binder,B02BD02
DB00025,"Antihemophilic factor, human recombinant",,P11021,78 kDa glucose-regulated protein,HSPA5,chaperone,B02BD02
DB00025,"Antihemophilic factor, human recombinant",,P27797,Calreticulin,CALR,chaperone,B02BD02
DB00025,"Antihemophilic factor, human recombinant",,P27824,Calnexin,CANX,chaperone,B02BD02
DB00025,"Antihemophilic factor, human recombinant",,P49257,Protein ERGIC-53,LMAN1,chaperone,B02BD02
DB00025,"Antihemophilic factor, human recombinant",,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,modulator,B02BD02
DB00025,"Antihemophilic factor, human recombinant",,Q8NI22,Multiple coagulation factor deficiency protein 2,MCFD2,modulator,B02BD02
DB00026,Anakinra,,P14778,Interleukin-1 receptor type 1,IL1R1,antagonist,L04AC03
DB00028,Human immunoglobulin G,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,antagonist,
DB00028,Human immunoglobulin G,,Q92637,High affinity immunoglobulin gamma Fc receptor IB,FCGR1B,antagonist,
DB00028,Human immunoglobulin G,,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,antagonist,
DB00028,Human immunoglobulin G,,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,antagonist,
DB00028,Human immunoglobulin G,,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,antagonist,
DB00028,Human immunoglobulin G,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,antagonist,
DB00028,Human immunoglobulin G,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,antagonist,
DB00028,Human immunoglobulin G,,P01024,Complement C3,C3,binder,
DB00028,Human immunoglobulin G,,P0C0L4,Complement C4-A,C4A,binder,
DB00028,Human immunoglobulin G,,P0C0L5,Complement C4-B,C4B,binder,
DB00028,Human immunoglobulin G,,P01031,Complement C5,C5,binder,
DB00029,Anistreplase,,P00747,Plasminogen,PLG,activator,B01AD03
DB00029,Anistreplase,,P02671,Fibrinogen alpha chain,FGA,,B01AD03
DB00029,Anistreplase,,P05121,Plasminogen activator inhibitor 1,SERPINE1,,B01AD03
DB00030,Insulin human,,P06213,Insulin receptor,INSR,agonist,A10AC01;A10AE01;A10AB01;A10AD01;A10AF01
DB00030,Insulin human,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,A10AC01;A10AE01;A10AB01;A10AD01;A10AF01
DB00030,Insulin human,,P16870,Carboxypeptidase E,CPE,modulator,A10AC01;A10AE01;A10AB01;A10AD01;A10AF01
DB00030,Insulin human,,P16870,Carboxypeptidase E,CPE,product of,A10AC01;A10AE01;A10AB01;A10AD01;A10AF01
DB00030,Insulin human,,P48745,Protein NOV homolog,NOV,downregulator,A10AC01;A10AE01;A10AB01;A10AD01;A10AF01
DB00030,Insulin human,,P98164,Low-density lipoprotein receptor-related protein 2,LRP2,substrate,A10AC01;A10AE01;A10AB01;A10AD01;A10AF01
DB00030,Insulin human,,Q16270,Insulin-like growth factor-binding protein 7,IGFBP7,inhibitor,A10AC01;A10AE01;A10AB01;A10AD01;A10AF01
DB00030,Insulin human,,Q16270,Insulin-like growth factor-binding protein 7,IGFBP7,binder,A10AC01;A10AE01;A10AB01;A10AD01;A10AF01
DB00031,Tenecteplase,,P00747,Plasminogen,PLG,activator,B01AD11
DB00031,Tenecteplase,,P02671,Fibrinogen alpha chain,FGA,,B01AD11
DB00031,Tenecteplase,,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,,B01AD11
DB00031,Tenecteplase,,P05121,Plasminogen activator inhibitor 1,SERPINE1,,B01AD11
DB00031,Tenecteplase,,P05120,Plasminogen activator inhibitor 2,SERPINB2,,B01AD11
DB00031,Tenecteplase,,P05452,Tetranectin,CLEC3B,,B01AD11
DB00031,Tenecteplase,,P05787,"Keratin, type II cytoskeletal 8",KRT8,,B01AD11
DB00031,Tenecteplase,,P07355,Annexin A2,ANXA2,,B01AD11
DB00031,Tenecteplase,,P27797,Calreticulin,CALR,,B01AD11
DB00031,Tenecteplase,,P27824,Calnexin,CANX,,B01AD11
DB00031,Tenecteplase,,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,,B01AD11
DB00032,Menotropins,,P23945,Follicle-stimulating hormone receptor,FSHR,binder,G03GA02;G03GA03
DB00032,Menotropins,,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,,G03GA02;G03GA03
DB00033,Interferon gamma-1b,,P15260,Interferon gamma receptor 1,IFNGR1,binder,
DB00033,Interferon gamma-1b,,P38484,Interferon gamma receptor 2,IFNGR2,binder,
DB00034,Interferon alfa-2a,,P17181,Interferon alpha/beta receptor 1,IFNAR1,,L03AB04
DB00034,Interferon alfa-2a,,P48551,Interferon alpha/beta receptor 2,IFNAR2,,L03AB04
DB00035,Desmopressin,,P30518,Vasopressin V2 receptor,AVPR2,agonist,H01BA02
DB00035,Desmopressin,,P37288,Vasopressin V1a receptor,AVPR1A,,H01BA02
DB00035,Desmopressin,,P47901,Vasopressin V1b receptor,AVPR1B,,H01BA02
DB00036,Coagulation factor VIIa Recombinant Human,,P00742,Coagulation factor X,F10,,B02BD08
DB00036,Coagulation factor VIIa Recombinant Human,,P13726,Tissue factor,F3,,B02BD08
DB00036,Coagulation factor VIIa Recombinant Human,,P10646,Tissue factor pathway inhibitor,TFPI,,B02BD08
DB00036,Coagulation factor VIIa Recombinant Human,,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,,B02BD08
DB00036,Coagulation factor VIIa Recombinant Human,,P08709,Coagulation factor VII,F7,,B02BD08
DB00038,Oprelvekin,,Q14626,Interleukin-11 receptor subunit alpha,IL11RA,agonist,L03AC02
DB00039,Palifermin,,P21802,Fibroblast growth factor receptor 2,FGFR2,agonist,V03AF08
DB00039,Palifermin,,P21802,Fibroblast growth factor receptor 2,FGFR2,binder,V03AF08
DB00039,Palifermin,,P11362,Fibroblast growth factor receptor 1,FGFR1,agonist,V03AF08
DB00039,Palifermin,,P98160,Basement membrane-specific heparan sulfate proteoglycan core protein,HSPG2,ligand,V03AF08
DB00040,Glucagon,,P47871,Glucagon receptor,GCGR,agonist,H04AA01
DB00040,Glucagon,,O95838,Glucagon-like peptide 2 receptor,GLP2R,agonist,H04AA01
DB00040,Glucagon,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,H04AA01
DB00041,Aldesleukin,,P14784,Interleukin-2 receptor subunit beta,IL2RB,agonist,L03AC01
DB00041,Aldesleukin,,P14784,Interleukin-2 receptor subunit beta,IL2RB,modulator,L03AC01
DB00041,Aldesleukin,,P01589,Interleukin-2 receptor subunit alpha,IL2RA,agonist,L03AC01
DB00041,Aldesleukin,,P01589,Interleukin-2 receptor subunit alpha,IL2RA,modulator,L03AC01
DB00041,Aldesleukin,,P31785,Cytokine receptor common subunit gamma,IL2RG,agonist,L03AC01
DB00042,Botulinum toxin type B,,P63027,Vesicle-associated membrane protein 2,VAMP2,binder,M03AX01
DB00042,Botulinum toxin type B,,P23763,Vesicle-associated membrane protein 1,VAMP1,binder,M03AX01
DB00042,Botulinum toxin type B,,Q8N9I0,Synaptotagmin-2,SYT2,,M03AX01
DB00043,Omalizumab,,P12319,High affinity immunoglobulin epsilon receptor subunit alpha,FCER1A,inhibitor,R03DX05
DB00043,Omalizumab,,Q01362,High affinity immunoglobulin epsilon receptor subunit beta,MS4A2,inhibitor,R03DX05
DB00044,Lutropin alfa,,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,agonist,G03GA07
DB00045,Lyme disease vaccine (recombinant OspA),,O60603,Toll-like receptor 2,TLR2,other/unknown,
DB00046,Insulin lispro,,P06213,Insulin receptor,INSR,agonist,A10AC04;A10AB04;A10AD04
DB00046,Insulin lispro,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,A10AC04;A10AB04;A10AD04
DB00047,Insulin glargine,,P06213,Insulin receptor,INSR,agonist,A10AE54;A10AE04
DB00047,Insulin glargine,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,A10AE54;A10AE04
DB00048,Collagenase clostridium histolyticum,,P02452,Collagen alpha-1(I) chain,COL1A1,binder,D03BA02;M09AB02;D03BA52
DB00048,Collagenase clostridium histolyticum,,P02458,Collagen alpha-1(II) chain,COL2A1,binder,D03BA02;M09AB02;D03BA52
DB00048,Collagenase clostridium histolyticum,,P02461,Collagen alpha-1(III) chain,COL3A1,binder,D03BA02;M09AB02;D03BA52
DB00049,Rasburicase,,,Uric acid,,metabolizer,V03AF07;M04AX01
DB00050,Cetrorelix,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,antagonist,H01CC02
DB00050,Cetrorelix,,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,,H01CC02
DB00051,Adalimumab,,P01375,Tumor necrosis factor,TNF,inhibitor,L04AB04
DB00051,Adalimumab,,P01375,Tumor necrosis factor,TNF,antibody,L04AB04
DB00052,Somatotropin,,P10912,Growth hormone receptor,GHR,ligand,H01AC01
DB00052,Somatotropin,,P16471,Prolactin receptor,PRLR,ligand,H01AC01
DB00053,Imiglucerase,,,Glucocerebroside,,other/unknown,A16AB02
DB00054,Abciximab,,P05106,Integrin beta-3,ITGB3,antagonist,B01AC13
DB00054,Abciximab,,P08514,Integrin alpha-IIb,ITGA2B,antagonist,B01AC13
DB00054,Abciximab,,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,,B01AC13
DB00054,Abciximab,,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,,B01AC13
DB00054,Abciximab,,P04004,Vitronectin,VTN,,B01AC13
DB00055,Drotrecogin alfa,,P00451,Coagulation factor VIII,F8,inhibitor,B01AD10
DB00055,Drotrecogin alfa,,P12259,Coagulation factor V,F5,inhibitor,B01AD10
DB00055,Drotrecogin alfa,,P05121,Plasminogen activator inhibitor 1,SERPINE1,,B01AD10
DB00055,Drotrecogin alfa,,P07204,Thrombomodulin,THBD,,B01AD10
DB00055,Drotrecogin alfa,,P07225,Vitamin K-dependent protein S,PROS1,,B01AD10
DB00055,Drotrecogin alfa,,P00734,Prothrombin,F2,,B01AD10
DB00055,Drotrecogin alfa,,P02776,Platelet factor 4,PF4,,B01AD10
DB00055,Drotrecogin alfa,,P05154,Plasma serine protease inhibitor,SERPINA5,,B01AD10
DB00055,Drotrecogin alfa,,P35237,Serpin B6,SERPINB6,,B01AD10
DB00055,Drotrecogin alfa,,Q9UNN8,Endothelial protein C receptor,PROCR,,B01AD10
DB00056,Gemtuzumab ozogamicin,,P20138,Myeloid cell surface antigen CD33,CD33,antibody,L01FX02
DB00056,Gemtuzumab ozogamicin,,P20138,Myeloid cell surface antigen CD33,CD33,regulator,L01FX02
DB00056,Gemtuzumab ozogamicin,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,,L01FX02
DB00056,Gemtuzumab ozogamicin,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,,L01FX02
DB00056,Gemtuzumab ozogamicin,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,,L01FX02
DB00057,Indium In-111 satumomab pendetide,,,Tumor-associated glycoprotein 72 (TAG-72),,other/unknown,V09IB02
DB00058,Alpha-1-proteinase inhibitor,,P08246,Neutrophil elastase,ELANE,inhibitor,B02AB02
DB00059,Pegaspargase,,,L-asparagine,,substrate,L01XX24
DB00060,Interferon beta-1a,,P17181,Interferon alpha/beta receptor 1,IFNAR1,agonist,L03AB07
DB00060,Interferon beta-1a,,P48551,Interferon alpha/beta receptor 2,IFNAR2,,L03AB07
DB00061,Pegademase,,,Adenosine,,metabolizer,L03AX04
DB00061,Pegademase,,P62993,Growth factor receptor-bound protein 2,GRB2,binder,L03AX04
DB00062,Albumin human,,,Nitric oxide,,binder,B05AA01
DB00063,Eptifibatide,,P05106,Integrin beta-3,ITGB3,,B01AC16
DB00063,Eptifibatide,,A0A024R8I1,Voltage-dependent N-type calcium channel,CACNA1B,antagonist,B01AC16
DB00065,Infliximab,,P01375,Tumor necrosis factor,TNF,inhibitor,L04AB02
DB00066,Follitropin,,P23945,Follicle-stimulating hormone receptor,FSHR,agonist,G03GA06;G03GA10;G03GA05
DB00067,Vasopressin,,P30518,Vasopressin V2 receptor,AVPR2,agonist,
DB00067,Vasopressin,,P30518,Vasopressin V2 receptor,AVPR2,regulator,
DB00067,Vasopressin,,P37288,Vasopressin V1a receptor,AVPR1A,agonist,
DB00067,Vasopressin,,P37288,Vasopressin V1a receptor,AVPR1A,regulator,
DB00067,Vasopressin,,P47901,Vasopressin V1b receptor,AVPR1B,agonist,
DB00067,Vasopressin,,P30559,Oxytocin receptor,OXTR,agonist,
DB00068,Interferon beta-1b,,P17181,Interferon alpha/beta receptor 1,IFNAR1,agonist,L03AB08
DB00068,Interferon beta-1b,,P48551,Interferon alpha/beta receptor 2,IFNAR2,agonist,L03AB08
DB00069,Interferon alfacon-1,,P17181,Interferon alpha/beta receptor 1,IFNAR1,binder,L03AB09
DB00069,Interferon alfacon-1,,P48551,Interferon alpha/beta receptor 2,IFNAR2,binder,L03AB09
DB00070,Hyaluronidase (ovine),,,Hyaluronan,,other,
DB00070,Hyaluronidase (ovine),,P01137,Transforming growth factor beta-1,TGFB1,inhibitor,
DB00071,Insulin pork,,P06213,Insulin receptor,INSR,binder,A10AC03;A10AB03;A10AE03;A10AD03
DB00071,Insulin pork,,P08069,Insulin-like growth factor 1 receptor,IGF1R,,A10AC03;A10AB03;A10AE03;A10AD03
DB00072,Trastuzumab,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,binder,L01FD01;L01XY02
DB00072,Trastuzumab,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,antibody,L01FD01;L01XY02
DB00073,Rituximab,,P11836,B-lymphocyte antigen CD20,MS4A1,antibody,L01FA01
DB00073,Rituximab,,P11836,B-lymphocyte antigen CD20,MS4A1,regulator,L01FA01
DB00074,Basiliximab,,P01589,Interleukin-2 receptor subunit alpha,IL2RA,antibody,L04AC02
DB00074,Basiliximab,,P14784,Interleukin-2 receptor subunit beta,IL2RB,antibody,L04AC02
DB00075,Muromonab,,P04234,T-cell surface glycoprotein CD3 delta chain,CD3D,,L04AA02
DB00075,Muromonab,,P07766,T-cell surface glycoprotein CD3 epsilon chain,CD3E,binder,L04AA02
DB00075,Muromonab,,P09693,T-cell surface glycoprotein CD3 gamma chain,CD3G,,L04AA02
DB00075,Muromonab,,P20963,T-cell surface glycoprotein CD3 zeta chain,CD247,,L04AA02
DB00075,Muromonab,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,,L04AA02
DB00076,Digoxin Immune Fab (Ovine),,,Digoxin,,other/unknown,V03AB24
DB00078,Ibritumomab tiuxetan,,P11836,B-lymphocyte antigen CD20,MS4A1,antibody,V10XX02
DB00078,Ibritumomab tiuxetan,,P11836,B-lymphocyte antigen CD20,MS4A1,regulator,V10XX02
DB00080,Daptomycin,,,Cytoplasmic membrane,,incorporation into and destabilization,J01XX09
DB00081,Tositumomab,,P11836,B-lymphocyte antigen CD20,MS4A1,antibody,V10XA53
DB00081,Tositumomab,,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,,V10XA53
DB00082,Pegvisomant,,P10912,Growth hormone receptor,GHR,antagonist,H01AX01
DB00083,Botulinum toxin type A,,P60880,Synaptosomal-associated protein 25,SNAP25,inhibitor,M03AX01
DB00083,Botulinum toxin type A,,P62745,Rho-related GTP-binding protein RhoB,RHOB,inhibitor,M03AX01
DB00085,Pancrelipase,,,Dietary fat,,cleavage,A09AA02
DB00085,Pancrelipase,,,Dietary protein,,cleavage,A09AA02
DB00085,Pancrelipase,,,Dietary starch,,cleavage,A09AA02
DB00086,Streptokinase,,P00747,Plasminogen,PLG,activator,B01AD01;B06AA55
DB00086,Streptokinase,,P25116,Proteinase-activated receptor 1,F2R,activator,B01AD01;B06AA55
DB00087,Alemtuzumab,,P31358,CAMPATH-1 antigen,CD52,antibody,L04AA34
DB00087,Alemtuzumab,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,binder,L04AA34
DB00087,Alemtuzumab,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,binder,L04AA34
DB00087,Alemtuzumab,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,binder,L04AA34
DB00087,Alemtuzumab,,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,binder,L04AA34
DB00087,Alemtuzumab,,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,binder,L04AA34
DB00087,Alemtuzumab,,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,binder,L04AA34
DB00088,Alglucerase,,,Glucocerebroside,,other/unknown,A16AB01
DB00089,Capromab pendetide,,Q04609,Glutamate carboxypeptidase 2,FOLH1,other/unknown,V09IB04
DB00090,Laronidase,,,Iduronic acid,,other/unknown,A16AB05
DB00091,Cyclosporine,,P49069,Calcium signal-modulating cyclophilin ligand,CAMLG,binder,L04AD01;S01XA18
DB00091,Cyclosporine,,Q96LZ3,Calcineurin subunit B type 2,PPP3R2,inhibitor,L04AD01;S01XA18
DB00091,Cyclosporine,,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,inhibitor,L04AD01;S01XA18
DB00091,Cyclosporine,,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,binder,L04AD01;S01XA18
DB00091,Cyclosporine,,P30405,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,binder,L04AD01;S01XA18
DB00092,Alefacept,,P06729,T-cell surface antigen CD2,CD2,inhibitor,L04AA15
DB00092,Alefacept,,P06729,T-cell surface antigen CD2,CD2,antibody,L04AA15
DB00092,Alefacept,,P06729,T-cell surface antigen CD2,CD2,regulator,L04AA15
DB00092,Alefacept,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,,L04AA15
DB00092,Alefacept,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,,L04AA15
DB00093,Felypressin,,P37288,Vasopressin V1a receptor,AVPR1A,agonist,
DB00094,Urofollitropin,,P23945,Follicle-stimulating hormone receptor,FSHR,agonist,G03GA04
DB00095,Efalizumab,,P20702,Integrin alpha-X,ITGAX,antibody,L04AA21
DB00095,Efalizumab,,P20701,Integrin alpha-L,ITGAL,antibody,L04AA21
DB00097,Choriogonadotropin alfa,,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,,G03GA08
DB00097,Choriogonadotropin alfa,,P23945,Follicle-stimulating hormone receptor,FSHR,binder,G03GA08
DB00098,Antithymocyte immunoglobulin (rabbit),,Q95460,Major histocompatibility complex class I-related gene protein,MR1,antagonist,L04AA04
DB00098,Antithymocyte immunoglobulin (rabbit),,P20701,Integrin alpha-L,ITGAL,,L04AA04
DB00098,Antithymocyte immunoglobulin (rabbit),,P42081,T-lymphocyte activation antigen CD86,CD86,binder,L04AA04
DB00098,Antithymocyte immunoglobulin (rabbit),,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,,L04AA04
DB00098,Antithymocyte immunoglobulin (rabbit),,P01730,T-cell surface glycoprotein CD4,CD4,,L04AA04
DB00098,Antithymocyte immunoglobulin (rabbit),,P05556,Integrin beta-1,ITGB1,,L04AA04
DB00098,Antithymocyte immunoglobulin (rabbit),,P06756,Integrin alpha-V,ITGAV,,L04AA04
DB00098,Antithymocyte immunoglobulin (rabbit),,P05106,Integrin beta-3,ITGB3,,L04AA04
DB00098,Antithymocyte immunoglobulin (rabbit),,P06126,T-cell surface glycoprotein CD1a,CD1A,inhibitor,L04AA04
DB00099,Filgrastim,,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,stimulator,L03AA02
DB00100,Coagulation Factor IX (Recombinant),,P00742,Coagulation factor X,F10,activator,
DB00100,Coagulation Factor IX (Recombinant),,P03951,Coagulation factor XI,F11,ligand,
DB00100,Coagulation Factor IX (Recombinant),,P08709,Coagulation factor VII,F7,ligand,
DB00100,Coagulation Factor IX (Recombinant),,P00451,Coagulation factor VIII,F8,cofactor,
DB00100,Coagulation Factor IX (Recombinant),,P00734,Prothrombin,F2,,
DB00100,Coagulation Factor IX (Recombinant),,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,,
DB00100,Coagulation Factor IX (Recombinant),,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,,
DB00102,Becaplermin,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,,D03AX06;A01AD08
DB00102,Becaplermin,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,,D03AX06;A01AD08
DB00102,Becaplermin,,P01023,Alpha-2-macroglobulin,A2M,,D03AX06;A01AD08
DB00103,Agalsidase beta,,,Globotriaosylceramide,,metabolizer,A16AB04
DB00103,Agalsidase beta,,,Globotriaosylceramide,,ligand,A16AB04
DB00104,Octreotide,,,Somatostatin receptor,,agonist,H01CB02
DB00105,Interferon alfa-2b,,P48551,Interferon alpha/beta receptor 2,IFNAR2,binder,L03AB05
DB00105,Interferon alfa-2b,,P17181,Interferon alpha/beta receptor 1,IFNAR1,binder,L03AB05
DB00106,Abarelix,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,antagonist,L02BX01
DB00107,Oxytocin,,P30559,Oxytocin receptor,OXTR,agonist,G02AC01;H01BB02
DB00108,Natalizumab,,P13612,Integrin alpha-4,ITGA4,antibody,L04AA23
DB00108,Natalizumab,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,ligand,L04AA23
DB00108,Natalizumab,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,ligand,L04AA23
DB00108,Natalizumab,,P05362,Intercellular adhesion molecule 1,ICAM1,ligand,L04AA23
DB00109,Enfuvirtide,,Q53I07,Envelope glycoprotein,gp41,,J05AX07
DB00110,Palivizumab,,P13843,Fusion glycoprotein F0,F,,J06BD01
DB00110,Palivizumab,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,,J06BD01
DB00110,Palivizumab,,P00736,Complement C1r subcomponent,C1R,,J06BD01
DB00110,Palivizumab,,P02745,Complement C1q subcomponent subunit A,C1QA,,J06BD01
DB00110,Palivizumab,,P02746,Complement C1q subcomponent subunit B,C1QB,,J06BD01
DB00110,Palivizumab,,P02747,Complement C1q subcomponent subunit C,C1QC,,J06BD01
DB00110,Palivizumab,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,,J06BD01
DB00110,Palivizumab,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,,J06BD01
DB00110,Palivizumab,,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,,J06BD01
DB00111,Daclizumab,,P01589,Interleukin-2 receptor subunit alpha,IL2RA,antibody,L04AC01
DB00111,Daclizumab,,P14784,Interleukin-2 receptor subunit beta,IL2RB,antibody,L04AC01
DB00111,Daclizumab,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,,L04AC01
DB00111,Daclizumab,,P00736,Complement C1r subcomponent,C1R,,L04AC01
DB00111,Daclizumab,,P02745,Complement C1q subcomponent subunit A,C1QA,,L04AC01
DB00111,Daclizumab,,P02746,Complement C1q subcomponent subunit B,C1QB,,L04AC01
DB00111,Daclizumab,,P02747,Complement C1q subcomponent subunit C,C1QC,,L04AC01
DB00111,Daclizumab,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,,L04AC01
DB00111,Daclizumab,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,,L04AC01
DB00111,Daclizumab,,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,,L04AC01
DB00111,Daclizumab,,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,,L04AC01
DB00111,Daclizumab,,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,,L04AC01
DB00112,Bevacizumab,,P15692,Vascular endothelial growth factor A,VEGFA,,L01FG01;S01LA08
DB00112,Bevacizumab,,P02745,Complement C1q subcomponent subunit A,C1QA,,L01FG01;S01LA08
DB00112,Bevacizumab,,P02746,Complement C1q subcomponent subunit B,C1QB,,L01FG01;S01LA08
DB00112,Bevacizumab,,P02747,Complement C1q subcomponent subunit C,C1QC,,L01FG01;S01LA08
DB00112,Bevacizumab,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,,L01FG01;S01LA08
DB00112,Bevacizumab,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,,L01FG01;S01LA08
DB00112,Bevacizumab,,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,,L01FG01;S01LA08
DB00112,Bevacizumab,,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,,L01FG01;S01LA08
DB00112,Bevacizumab,,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,,L01FG01;S01LA08
DB00113,Technetium Tc-99m arcitumomab,,P13688,Carcinoembryonic antigen-related cell adhesion molecule 1,CEACAM1,other/unknown,V09IA06
DB00114,Pyridoxal phosphate,,Q9BYV1,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q99259,Glutamate decarboxylase 1,GAD1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P35520,Cystathionine beta-synthase,CBS,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q16719,Kynureninase,KYNU,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q9Y697,"Cysteine desulfurase, mitochondrial",NFS1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,activator,A11HA06
DB00114,Pyridoxal phosphate,,P04181,"Ornithine aminotransferase, mitochondrial",OAT,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P11926,Ornithine decarboxylase,ODC1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q8N5Z0,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",AADAT,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,inhibitor,A11HA06
DB00114,Pyridoxal phosphate,,Q9NVS9,Pyridoxine-5'-phosphate oxidase,PNPO,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,O95470,Sphingosine-1-phosphate lyase 1,SGPL1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P17735,Tyrosine aminotransferase,TAT,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q16773,Kynurenine--oxoglutarate transaminase 1,CCBL1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,,"Glycogen phosphorylase, liver form",,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,O15270,Serine palmitoyltransferase 2,SPTLC2,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q9Y600,Cysteine sulfinic acid decarboxylase,CSAD,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P19113,Histidine decarboxylase,HDC,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q96A70,Arginine decarboxylase,AZIN2,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P20132,L-serine dehydratase/L-threonine deaminase,SDS,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,O75600,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",GCAT,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P23378,"Glycine dehydrogenase [decarboxylating], mitochondrial",GLDC,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P24298,Alanine aminotransferase 1,GPT,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q9Y617,Phosphoserine aminotransferase,PSAT1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P13196,"5-aminolevulinate synthase, nonspecific, mitochondrial",ALAS1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P21549,Serine--pyruvate aminotransferase,AGXT,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q96GD0,Pyridoxal phosphate phosphatase,PDXP,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,O15269,Serine palmitoyltransferase 1,SPTLC1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P32929,Cystathionine gamma-lyase,CTH,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,O94903,Proline synthase co-transcribed bacterial homolog protein,PROSC,binder,A11HA06
DB00114,Pyridoxal phosphate,,P00505,"Aspartate aminotransferase, mitochondrial",GOT2,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P11216,"Glycogen phosphorylase, brain form",PYGB,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P11217,"Glycogen phosphorylase, muscle form",PYGM,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P20711,Aromatic-L-amino-acid decarboxylase,DDC,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q53ET4,Serine hydroxymethyltransferase,,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q05329,Glutamate decarboxylase 2,GAD2,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q6YP21,Kynurenine--oxoglutarate transaminase 3,CCBL2,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q6ZQY3,Glutamate decarboxylase-like protein 1,GADL1,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q96I15,Selenocysteine lyase,SCLY,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q6WRI0,Immunoglobulin superfamily member 10,IGSF10,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q8IUZ5,5-phosphohydroxy-L-lysine phospho-lyase,PHYKPL,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P34897,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P22557,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",ALAS2,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q8TD30,Alanine aminotransferase 2,GPT2,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q96EN8,Molybdenum cofactor sulfurase,MOCOS,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q96GA7,Serine dehydratase-like,SDSL,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q9GZT4,Serine racemase,SRR,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q9HD40,O-phosphoseryl-tRNA(Sec) selenium transferase,SEPSECS,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q9NUV7,Serine palmitoyltransferase 3,SPTLC3,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,Q9UGI5,Glutamic acid decarboxylase,GAD65,cofactor,A11HA06
DB00114,Pyridoxal phosphate,,P17174,Aspartate aminotransferase,GOT1,cofactor,A11HA06
DB00115,Cyanocobalamin,,Q99707,Methionine synthase,MTR,cofactor,B03BA01;B03AE01;B03BA51
DB00115,Cyanocobalamin,,P22033,"Methylmalonyl-CoA mutase, mitochondrial",MUT,cofactor,B03BA01;B03AE01;B03BA51
DB00115,Cyanocobalamin,,Q9UBK8,Methionine synthase reductase,MTRR,cofactor,B03BA01;B03AE01;B03BA51
DB00115,Cyanocobalamin,,Q8IVH4,"Methylmalonic aciduria type A protein, mitochondrial",MMAA,binder,B03BA01;B03AE01;B03BA51
DB00115,Cyanocobalamin,,Q9Y4U1,Methylmalonic aciduria and homocystinuria type C protein,MMACHC,cofactor,B03BA01;B03AE01;B03BA51
DB00115,Cyanocobalamin,,P42898,Methylenetetrahydrofolate reductase,MTHFR,cofactor,B03BA01;B03AE01;B03BA51
DB00116,Tetrahydrofolic acid,,P11586,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,cofactor,
DB00116,Tetrahydrofolic acid,,P13995,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",MTHFD2,cofactor,
DB00116,Tetrahydrofolic acid,,P48728,"Aminomethyltransferase, mitochondrial",AMT,cofactor,
DB00116,Tetrahydrofolic acid,,O75891,Cytosolic 10-formyltetrahydrofolate dehydrogenase,ALDH1L1,cofactor,
DB00116,Tetrahydrofolic acid,,Q99707,Methionine synthase,MTR,cofactor,
DB00116,Tetrahydrofolic acid,,O95954,Formimidoyltransferase-cyclodeaminase,FTCD,cofactor,
DB00116,Tetrahydrofolic acid,,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,cofactor,
DB00116,Tetrahydrofolic acid,,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,cofactor,
DB00116,Tetrahydrofolic acid,,P34897,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,cofactor,
DB00116,Tetrahydrofolic acid,,P42898,Methylenetetrahydrofolate reductase,MTHFR,cofactor,
DB00116,Tetrahydrofolic acid,,Q53ET4,Serine hydroxymethyltransferase,,cofactor,
DB00116,Tetrahydrofolic acid,,Q96DP5,"Methionyl-tRNA formyltransferase, mitochondrial",MTFMT,cofactor,
DB00117,Histidine,,P19113,Histidine decarboxylase,HDC,,
DB00117,Histidine,,P12081,"Histidine--tRNA ligase, cytoplasmic",HARS,,
DB00117,Histidine,,Q99624,Sodium-coupled neutral amino acid transporter 3,SLC38A3,,
DB00117,Histidine,,P42357,Histidine ammonia-lyase,HAL,,
DB00118,Ademetionine,,P21964,Catechol O-methyltransferase,COMT,cofactor,A16AA02
DB00118,Ademetionine,,Q8N1G2,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1,CMTR1,,A16AA02
DB00118,Ademetionine,,Q9HBK9,Arsenite methyltransferase,AS3MT,,A16AA02
DB00118,Ademetionine,,Q14749,Glycine N-methyltransferase,GNMT,cofactor,A16AA02
DB00118,Ademetionine,,P17707,S-adenosylmethionine decarboxylase proenzyme,AMD1,cofactor,A16AA02
DB00118,Ademetionine,,P31153,S-adenosylmethionine synthase isoform type-2,MAT2A,cofactor,A16AA02
DB00118,Ademetionine,,P35520,Cystathionine beta-synthase,CBS,activator,A16AA02
DB00118,Ademetionine,,Q00266,S-adenosylmethionine synthase isoform type-1,MAT1A,cofactor,A16AA02
DB00119,Pyruvic acid,,O15427,Monocarboxylate transporter 4,SLC16A3,,
DB00119,Pyruvic acid,,P36021,Monocarboxylate transporter 8,SLC16A2,,
DB00119,Pyruvic acid,,Q9BYV1,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,,
DB00119,Pyruvic acid,,O15375,Monocarboxylate transporter 6,SLC16A5,,
DB00119,Pyruvic acid,,P30613,Pyruvate kinase PKLR,PKLR,,
DB00119,Pyruvic acid,,O15403,Monocarboxylate transporter 7,SLC16A6,,
DB00119,Pyruvic acid,,O60669,Monocarboxylate transporter 2,SLC16A7,,
DB00119,Pyruvic acid,,P11177,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",PDHB,,
DB00119,Pyruvic acid,,P14618,Pyruvate kinase PKM,PKM,,
DB00119,Pyruvic acid,,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,inhibitor,
DB00119,Pyruvic acid,,O15374,Monocarboxylate transporter 5,SLC16A4,,
DB00119,Pyruvic acid,,O95907,Monocarboxylate transporter 3,SLC16A8,,
DB00119,Pyruvic acid,,P53985,Monocarboxylate transporter 1,SLC16A1,,
DB00119,Pyruvic acid,,P11498,"Pyruvate carboxylase, mitochondrial",PC,,
DB00120,Phenylalanine,,P17735,Tyrosine aminotransferase,TAT,,
DB00120,Phenylalanine,,Q9UHI5,Large neutral amino acids transporter small subunit 2,SLC7A8,,
DB00120,Phenylalanine,,Q9Y285,Phenylalanine--tRNA ligase alpha subunit,FARSA,,
DB00120,Phenylalanine,,P00439,Phenylalanine-4-hydroxylase,PAH,,
DB00120,Phenylalanine,,O95363,"Phenylalanine--tRNA ligase, mitochondrial",FARS2,,
DB00120,Phenylalanine,,Q9NSD9,Phenylalanine--tRNA ligase beta subunit,FARSB,,
DB00120,Phenylalanine,,P07101,Tyrosine 3-monooxygenase,TH,binder,
DB00121,Biotin,,P05166,"Propionyl-CoA carboxylase beta chain, mitochondrial",PCCB,cofactor,A11HA05
DB00121,Biotin,,P50747,Biotin--protein ligase,HLCS,substrate,A11HA05
DB00121,Biotin,,Q9HCC0,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial",MCCC2,cofactor,A11HA05
DB00121,Biotin,,O00763,Acetyl-CoA carboxylase 2,ACACB,cofactor,A11HA05
DB00121,Biotin,,Q96RQ3,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial",MCCC1,cofactor,A11HA05
DB00121,Biotin,,P11498,"Pyruvate carboxylase, mitochondrial",PC,cofactor,A11HA05
DB00121,Biotin,,P05165,"Propionyl-CoA carboxylase alpha chain, mitochondrial",PCCA,cofactor,A11HA05
DB00121,Biotin,,Q13085,Acetyl-CoA carboxylase 1,ACACA,cofactor,A11HA05
DB00122,Choline,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,
DB00122,Choline,,Q9Y5K3,Choline-phosphate cytidylyltransferase B,PCYT1B,product of,
DB00122,Choline,,P22303,Acetylcholinesterase,ACHE,product of,
DB00122,Choline,,P49585,Choline-phosphate cytidylyltransferase A,PCYT1A,product of,
DB00122,Choline,,O14939,Phospholipase D2,PLD2,product of,
DB00122,Choline,,P06276,Cholinesterase,BCHE,product of,
DB00122,Choline,,Q13393,Phospholipase D1,PLD1,product of,
DB00122,Choline,,Q8TCT1,Phosphoethanolamine/phosphocholine phosphatase,PHOSPHO1,product of,
DB00123,Lysine,,P30825,High affinity cationic amino acid transporter 1,SLC7A1,,V03AF11;B05XB03
DB00123,Lysine,,O43246,Cationic amino acid transporter 4,SLC7A4,,V03AF11;B05XB03
DB00123,Lysine,,Q8WY07,Cationic amino acid transporter 3,SLC7A3,,V03AF11;B05XB03
DB00123,Lysine,,P52569,Low affinity cationic amino acid transporter 2,SLC7A2,,V03AF11;B05XB03
DB00123,Lysine,,Q15046,Lysine--tRNA ligase,KARS,,V03AF11;B05XB03
DB00125,Arginine,,Q8WY07,Cationic amino acid transporter 3,SLC7A3,,V03AF11;B05XB01
DB00125,Arginine,,Q96A70,Arginine decarboxylase,AZIN2,,V03AF11;B05XB01
DB00125,Arginine,,P04424,Argininosuccinate lyase,ASL,,V03AF11;B05XB01
DB00125,Arginine,,P35228,"Nitric oxide synthase, inducible",NOS2,,V03AF11;B05XB01
DB00125,Arginine,,P30825,High affinity cationic amino acid transporter 1,SLC7A1,,V03AF11;B05XB01
DB00125,Arginine,,P78540,"Arginase-2, mitochondrial",ARG2,,V03AF11;B05XB01
DB00125,Arginine,,O43246,Cationic amino acid transporter 4,SLC7A4,,V03AF11;B05XB01
DB00125,Arginine,,P00966,Argininosuccinate synthase,ASS1,,V03AF11;B05XB01
DB00125,Arginine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,V03AF11;B05XB01
DB00126,Ascorbic acid,,Q54873,Hyaluronate lyase,,inhibitor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,,DNA,,cleavage,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,P24300,Xylose isomerase,xylA,substrate,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,O00469,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",PLOD2,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,O14832,"Phytanoyl-CoA dioxygenase, peroxisomal",PHYH,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,O60568,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",PLOD3,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,O75936,Gamma-butyrobetaine dioxygenase,BBOX1,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,P09172,Dopamine beta-hydroxylase,DBH,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,P19021,Peptidyl-glycine alpha-amidating monooxygenase,PAM,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q32P28,Prolyl 3-hydroxylase 1,P3H1,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q8IVL5,Prolyl 3-hydroxylase 2,P3H2,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q8IVL6,Prolyl 3-hydroxylase 3,P3H3,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,P13674,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q8N543,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1,OGFOD1,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q6N063,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,OGFOD2,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q6NS38,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2,ALKBH2,activator,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q96Q83,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,ALKBH3,activator,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q9BY66,Lysine-specific demethylase 5D,KDM5D,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q02809,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",PLOD1,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q9NVH6,"Trimethyllysine dioxygenase, mitochondrial",TMLHE,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q9NXG6,Transmembrane prolyl 4-hydroxylase,P4HTM,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q9GZT9,Egl nine homolog 1,EGLN1,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q96KS0,Egl nine homolog 2,EGLN2,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00126,Ascorbic acid,,Q9H6Z9,Egl nine homolog 3,EGLN3,cofactor,G01AD03;A11GA01;A11GB01;S01XA15
DB00127,Spermine,,P52788,Spermine synthase,SMS,ligand,
DB00127,Spermine,,Q9NWM0,Spermine oxidase,SMOX,ligand,
DB00127,Spermine,,,DNA,,binder,
DB00127,Spermine,,P11926,Ornithine decarboxylase,ODC1,product of,
DB00127,Spermine,,P41180,Extracellular calcium-sensing receptor,CASR,,
DB00127,Spermine,,P08588,Beta-1 adrenergic receptor,ADRB1,,
DB00127,Spermine,,P07550,Beta-2 adrenergic receptor,ADRB2,,
DB00128,Aspartic acid,,Q8N142,Adenylosuccinate Synthetases,ADSSL1,substrate,
DB00128,Aspartic acid,,Q9UJS0,Calcium-binding mitochondrial carrier protein Aralar2,SLC25A13,,
DB00128,Aspartic acid,,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,,
DB00128,Aspartic acid,,P45381,Aspartoacylase,ASPA,,
DB00128,Aspartic acid,,P08243,Asparagine synthetase [glutamine-hydrolyzing],ASNS,substrate,
DB00128,Aspartic acid,,P00966,Argininosuccinate synthase,ASS1,,
DB00128,Aspartic acid,,Q03154,Aminoacylase-1,ACY1,,
DB00128,Aspartic acid,,P00505,"Aspartate aminotransferase, mitochondrial",GOT2,,
DB00128,Aspartic acid,,P14868,"Aspartate--tRNA ligase, cytoplasmic",DARS,,
DB00128,Aspartic acid,,O75746,Calcium-binding mitochondrial carrier protein Aralar1,SLC25A12,,
DB00128,Aspartic acid,,Q12797,Aspartyl/asparaginyl beta-hydroxylase,ASPH,,
DB00128,Aspartic acid,,P22234,Multifunctional protein ADE2,PAICS,substrate,
DB00128,Aspartic acid,,P30520,Adenylosuccinate synthetase isozyme 2,ADSS,,
DB00128,Aspartic acid,,P43005,Excitatory amino acid transporter 3,SLC1A1,,
DB00128,Aspartic acid,,Q6PI48,"Aspartate--tRNA ligase, mitochondrial",DARS2,,
DB00128,Aspartic acid,,Q7L266,Isoaspartyl peptidase/L-asparaginase,ASRGL1,,
DB00128,Aspartic acid,,P07998,Ribonuclease pancreatic,RNASE1,,
DB00128,Aspartic acid,,P61626,Lysozyme C,LYZ,,
DB00129,Ornithine,,P04181,"Ornithine aminotransferase, mitochondrial",OAT,,A05BA06
DB00129,Ornithine,,P00480,"Ornithine carbamoyltransferase, mitochondrial",OTC,,A05BA06
DB00129,Ornithine,,P05089,Arginase-1,ARG1,,A05BA06
DB00129,Ornithine,,P54368,Ornithine decarboxylase antizyme 1,OAZ1,,A05BA06
DB00129,Ornithine,,P30825,High affinity cationic amino acid transporter 1,SLC7A1,,A05BA06
DB00129,Ornithine,,P52569,Low affinity cationic amino acid transporter 2,SLC7A2,,A05BA06
DB00129,Ornithine,,Q9BXI2,Mitochondrial ornithine transporter 2,SLC25A2,,A05BA06
DB00129,Ornithine,,P78540,"Arginase-2, mitochondrial",ARG2,,A05BA06
DB00129,Ornithine,,Q9Y619,Mitochondrial ornithine transporter 1,SLC25A15,,A05BA06
DB00129,Ornithine,,P50440,"Glycine amidinotransferase, mitochondrial",GATM,,A05BA06
DB00130,L-Glutamine,,P17812,CTP synthase 1,CTPS1,antagonist,A16AA03
DB00130,L-Glutamine,,P17812,CTP synthase 1,CTPS1,substrate,A16AA03
DB00130,L-Glutamine,,Q06203,Amidophosphoribosyltransferase,PPAT,substrate,A16AA03
DB00130,L-Glutamine,,P15104,Glutamine synthetase,GLUL,product of,A16AA03
DB00131,Adenosine phosphate,,Q13131,5'-AMP-activated protein kinase,PRKAA1,activator,
DB00131,Adenosine phosphate,,P55263,Adenosine kinase,ADK,product of,
DB00131,Adenosine phosphate,,Q9Y478,5'-AMP-activated protein kinase subunit beta-1,PRKAB1,activator,
DB00131,Adenosine phosphate,,Q9NR19,"Acetyl-coenzyme A synthetase, cytoplasmic",ACSS2,product of,
DB00131,Adenosine phosphate,,Q13131,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,activator,
DB00131,Adenosine phosphate,,Q08828,Adenylate cyclase type 1,ADCY1,product of,
DB00131,Adenosine phosphate,,P33121,Long-chain-fatty-acid--CoA ligase 1,ACSL1,product of,
DB00131,Adenosine phosphate,,P16220,Cyclic AMP-responsive element-binding protein 1,CREB1,activator,
DB00131,Adenosine phosphate,,,DNA,,component of,
DB00131,Adenosine phosphate,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,product of,
DB00131,Adenosine phosphate,,,"Glycogen phosphorylase, liver form",,activator,
DB00131,Adenosine phosphate,,P49773,Histidine triad nucleotide-binding protein 1,HINT1,product of,
DB00131,Adenosine phosphate,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,product of,
DB00131,Adenosine phosphate,,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,antagonist,
DB00132,alpha-Linolenic acid,,O60427,Fatty acid desaturase 1,FADS1,ligand,
DB00132,alpha-Linolenic acid,,O95864,Fatty acid desaturase 2,FADS2,ligand,
DB00132,alpha-Linolenic acid,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,inhibitor,
DB00132,alpha-Linolenic acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB00132,alpha-Linolenic acid,,Q96RI1,Bile acid receptor,NR1H4,agonist,
DB00132,alpha-Linolenic acid,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB00132,alpha-Linolenic acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB00132,alpha-Linolenic acid,,P19793,Retinoic acid receptor RXR-alpha,RXRA,,
DB00132,alpha-Linolenic acid,,Q9NXB9,Elongation of very long chain fatty acids protein 2,ELOVL2,substrate,
DB00132,alpha-Linolenic acid,,Q9NYP7,Elongation of very long chain fatty acids protein 5,ELOVL5,substrate,
DB00132,alpha-Linolenic acid,,P32418,Sodium/calcium exchanger 1,SLC8A1,,
DB00133,Serine,,P35520,Cystathionine beta-synthase,CBS,,
DB00133,Serine,,P20132,L-serine dehydratase/L-threonine deaminase,SDS,,
DB00133,Serine,,Q9GZT4,Serine racemase,SRR,,
DB00133,Serine,,O15270,Serine palmitoyltransferase 2,SPTLC2,,
DB00133,Serine,,O15269,Serine palmitoyltransferase 1,SPTLC1,,
DB00133,Serine,,P49591,"Serine--tRNA ligase, cytoplasmic",SARS,,
DB00133,Serine,,P21549,Serine--pyruvate aminotransferase,AGXT,,
DB00134,Methionine,,Q9UBK8,Methionine synthase reductase,MTRR,product of,V03AB26
DB00134,Methionine,,Q99707,Methionine synthase,MTR,product of,V03AB26
DB00134,Methionine,,P50579,Methionine aminopeptidase 2,METAP2,product of,V03AB26
DB00134,Methionine,,Q93088,Betaine--homocysteine S-methyltransferase 1,BHMT,product of,V03AB26
DB00134,Methionine,,Q9H2M3,S-methylmethionine--homocysteine S-methyltransferase BHMT2,BHMT2,product of,V03AB26
DB00135,Tyrosine,,P07101,Tyrosine 3-monooxygenase,TH,binder,
DB00135,Tyrosine,,Q9Y2Z4,"Tyrosine--tRNA ligase, mitochondrial",YARS2,,
DB00135,Tyrosine,,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,,
DB00135,Tyrosine,,P17735,Tyrosine aminotransferase,TAT,,
DB00136,Calcitriol,,P11473,Vitamin D3 receptor,VDR,agonist,D05AX03;A11CC04
DB00136,Calcitriol,,P31260,Homeobox protein Hox-A10,HOXA10,,D05AX03;A11CC04
DB00138,Cystine,,Q9UPY5,Cystine/glutamate transporter,SLC7A11,,
DB00138,Cystine,,O60931,Cystinosin,CTNS,,
DB00139,Succinic acid,,P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,inhibitor,
DB00139,Succinic acid,,Q9BXA5,Succinate receptor 1,SUCNR1,,
DB00140,Riboflavin,,Q969G6,Riboflavin kinase,RFK,ligand,A11HA04;S01XA26
DB00140,Riboflavin,,P0AFU8,Riboflavin synthase,ribC,other,A11HA04;S01XA26
DB00140,Riboflavin,,P30043,Flavin reductase (NADPH),BLVRB,product of,A11HA04;S01XA26
DB00141,N-Acetylglucosamine,,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,,
DB00141,N-Acetylglucosamine,,O60513,"Beta-1,4-galactosyltransferase 4",B4GALT4,,
DB00141,N-Acetylglucosamine,,Q9UJ70,N-acetyl-D-glucosamine kinase,NAGK,,
DB00141,N-Acetylglucosamine,,Q9UK23,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,NAGPA,,
DB00141,N-Acetylglucosamine,,P54802,Alpha-N-acetylglucosaminidase,NAGLU,activator,
DB00141,N-Acetylglucosamine,,P51606,N-acylglucosamine 2-epimerase,RENBP,,
DB00142,Glutamic acid,,Q13255,Metabotropic glutamate receptor 1,GRM1,,A09AB01
DB00142,Glutamic acid,,Q14833,Metabotropic glutamate receptor 4,GRM4,,A09AB01
DB00142,Glutamic acid,,Q16099,"Glutamate receptor ionotropic, kainate 4",GRIK4,,A09AB01
DB00142,Glutamic acid,,Q16478,"Glutamate receptor ionotropic, kainate 5",GRIK5,,A09AB01
DB00142,Glutamic acid,,Q14831,Metabotropic glutamate receptor 7,GRM7,,A09AB01
DB00142,Glutamic acid,,O00222,Metabotropic glutamate receptor 8,GRM8,,A09AB01
DB00142,Glutamic acid,,O00341,Excitatory amino acid transporter 5,SLC1A7,,A09AB01
DB00142,Glutamic acid,,O14841,5-oxoprolinase,OPLAH,,A09AB01
DB00142,Glutamic acid,,O15067,Phosphoribosylformylglycinamidine synthase,PFAS,,A09AB01
DB00142,Glutamic acid,,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,,A09AB01
DB00142,Glutamic acid,,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,,A09AB01
DB00142,Glutamic acid,,O94925,"Glutaminase kidney isoform, mitochondrial",GLS,,A09AB01
DB00142,Glutamic acid,,P00505,"Aspartate aminotransferase, mitochondrial",GOT2,,A09AB01
DB00142,Glutamic acid,,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,,A09AB01
DB00142,Glutamic acid,,P08243,Asparagine synthetase [glutamine-hydrolyzing],ASNS,,A09AB01
DB00142,Glutamic acid,,P15104,Glutamine synthetase,GLUL,,A09AB01
DB00142,Glutamic acid,,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,,A09AB01
DB00142,Glutamic acid,,P17735,Tyrosine aminotransferase,TAT,,A09AB01
DB00142,Glutamic acid,,P24298,Alanine aminotransferase 1,GPT,,A09AB01
DB00142,Glutamic acid,,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,,A09AB01
DB00142,Glutamic acid,,P43003,Excitatory amino acid transporter 1,SLC1A3,,A09AB01
DB00142,Glutamic acid,,P43004,Excitatory amino acid transporter 2,SLC1A2,,A09AB01
DB00142,Glutamic acid,,P43005,Excitatory amino acid transporter 3,SLC1A1,,A09AB01
DB00142,Glutamic acid,,P48506,Glutamate--cysteine ligase catalytic subunit,GCLC,substrate,A09AB01
DB00142,Glutamic acid,,P48664,Excitatory amino acid transporter 4,SLC1A6,,A09AB01
DB00142,Glutamic acid,,P49448,"Glutamate dehydrogenase 2, mitochondrial",GLUD2,substrate,A09AB01
DB00142,Glutamic acid,,P49915,GMP synthase [glutamine-hydrolyzing],GMPS,,A09AB01
DB00142,Glutamic acid,,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,,A09AB01
DB00142,Glutamic acid,,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,,A09AB01
DB00142,Glutamic acid,,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,,A09AB01
DB00142,Glutamic acid,,Q05932,"Folylpolyglutamate synthase, mitochondrial",FPGS,,A09AB01
DB00142,Glutamic acid,,Q07075,Glutamyl aminopeptidase,ENPEP,,A09AB01
DB00142,Glutamic acid,,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,,A09AB01
DB00142,Glutamic acid,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,,A09AB01
DB00142,Glutamic acid,,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,,A09AB01
DB00142,Glutamic acid,,Q5JPH6,"Probable glutamate--tRNA ligase, mitochondrial",EARS2,,A09AB01
DB00142,Glutamic acid,,Q6IA69,Glutamine-dependent NAD(+) synthetase,NADSYN1,product of,A09AB01
DB00142,Glutamic acid,,Q8N159,"N-acetylglutamate synthase, mitochondrial",NAGS,,A09AB01
DB00142,Glutamic acid,,Q8N5Z0,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",AADAT,,A09AB01
DB00142,Glutamic acid,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,,A09AB01
DB00142,Glutamic acid,,Q8TD30,Alanine aminotransferase 2,GPT2,substrate,A09AB01
DB00142,Glutamic acid,,Q8TD30,Alanine aminotransferase 2,GPT2,product of,A09AB01
DB00142,Glutamic acid,,Q9UDR5,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,,A09AB01
DB00142,Glutamic acid,,Q9UI32,"Glutaminase liver isoform, mitochondrial",GLS2,,A09AB01
DB00142,Glutamic acid,,Q9ULA0,Aspartyl aminopeptidase,DNPEP,,A09AB01
DB00142,Glutamic acid,,Q9UPY5,Cystine/glutamate transporter,SLC7A11,,A09AB01
DB00142,Glutamic acid,,Q9Y646,Carboxypeptidase Q,CPQ,,A09AB01
DB00142,Glutamic acid,,Q9Y617,Phosphoserine aminotransferase,PSAT1,,A09AB01
DB00142,Glutamic acid,,P00367,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,,A09AB01
DB00142,Glutamic acid,,P39086,"Glutamate receptor ionotropic, kainate 1",GRIK1,,A09AB01
DB00142,Glutamic acid,,P42261,Glutamate receptor 1,GRIA1,,A09AB01
DB00142,Glutamic acid,,P48507,Glutamate--cysteine ligase regulatory subunit,GCLM,,A09AB01
DB00142,Glutamic acid,,Q04609,Glutamate carboxypeptidase 2,FOLH1,,A09AB01
DB00142,Glutamic acid,,Q05329,Glutamate decarboxylase 2,GAD2,,A09AB01
DB00142,Glutamic acid,,Q99259,Glutamate decarboxylase 1,GAD1,,A09AB01
DB00142,Glutamic acid,,O95954,Formimidoyltransferase-cyclodeaminase,FTCD,,A09AB01
DB00142,Glutamic acid,,P42262,Glutamate receptor 2,GRIA2,,A09AB01
DB00142,Glutamic acid,,P42263,Glutamate receptor 3,GRIA3,,A09AB01
DB00142,Glutamic acid,,P48058,Glutamate receptor 4,GRIA4,,A09AB01
DB00142,Glutamic acid,,P54886,Delta-1-pyrroline-5-carboxylate synthase,ALDH18A1,,A09AB01
DB00142,Glutamic acid,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,,A09AB01
DB00142,Glutamic acid,,Q13003,"Glutamate receptor ionotropic, kainate 3",GRIK3,,A09AB01
DB00142,Glutamic acid,,P17174,Aspartate aminotransferase,GOT1,substrate,A09AB01
DB00143,Glutathione,,P15121,Aldose reductase,AKR1B1,,V03AB32
DB00143,Glutathione,,P14780,Matrix metalloproteinase-9,MMP9,,V03AB32
DB00143,Glutathione,,P08684,Cytochrome P450 3A4,CYP3A4,,V03AB32
DB00143,Glutathione,,O75715,Glutathione peroxidase,GPX5,,V03AB32
DB00143,Glutathione,,P00390,"Glutathione reductase, mitochondrial",GSR,,V03AB32
DB00143,Glutathione,,P48637,Glutathione synthetase,GSS,,V03AB32
DB00143,Glutathione,,P09488,Glutathione S-transferase Mu 1,GSTM1,,V03AB32
DB00143,Glutathione,,Q9Y2Q3,Glutathione S-transferase kappa 1,GSTK1,,V03AB32
DB00143,Glutathione,,Q16772,Glutathione S-transferase A3,GSTA3,,V03AB32
DB00143,Glutathione,,P21266,Glutathione S-transferase Mu 3,GSTM3,,V03AB32
DB00143,Glutathione,,O15217,Glutathione S-transferase A4,GSTA4,,V03AB32
DB00143,Glutathione,,Q03013,Glutathione S-transferase Mu 4,GSTM4,,V03AB32
DB00143,Glutathione,,Q7RTV2,Glutathione S-transferase A5,GSTA5,,V03AB32
DB00143,Glutathione,,P09211,Glutathione S-transferase P,GSTP1,,V03AB32
DB00143,Glutathione,,P78417,Glutathione S-transferase omega-1,GSTO1,,V03AB32
DB00143,Glutathione,,P07203,Glutathione peroxidase 1,GPX1,cofactor,V03AB32
DB00143,Glutathione,,P18283,Glutathione peroxidase 2,GPX2,cofactor,V03AB32
DB00143,Glutathione,,P30711,Glutathione S-transferase theta-1,GSTT1,,V03AB32
DB00143,Glutathione,,O43708,Maleylacetoacetate isomerase,GSTZ1,,V03AB32
DB00143,Glutathione,,O75715,Epididymal secretory glutathione peroxidase,GPX5,cofactor,V03AB32
DB00143,Glutathione,,P22352,Glutathione peroxidase 3,GPX3,cofactor,V03AB32
DB00143,Glutathione,,Q04760,Lactoylglutathione lyase,GLO1,,V03AB32
DB00143,Glutathione,,Q16873,Leukotriene C4 synthase,LTC4S,,V03AB32
DB00143,Glutathione,,O14880,Microsomal glutathione S-transferase 3,MGST3,,V03AB32
DB00143,Glutathione,,O60760,Hematopoietic prostaglandin D synthase,HPGDS,,V03AB32
DB00143,Glutathione,,P08263,Glutathione S-transferase A1,GSTA1,,V03AB32
DB00143,Glutathione,,P09210,Glutathione S-transferase A2,GSTA2,,V03AB32
DB00143,Glutathione,,P10620,Microsomal glutathione S-transferase 1,MGST1,,V03AB32
DB00143,Glutathione,,P10768,S-formylglutathione hydrolase,ESD,,V03AB32
DB00143,Glutathione,,P19440,Gamma-glutamyltranspeptidase 1,GGT1,,V03AB32
DB00143,Glutathione,,P28161,Glutathione S-transferase Mu 2,GSTM2,,V03AB32
DB00143,Glutathione,,P35754,Glutaredoxin-1,GLRX,,V03AB32
DB00143,Glutathione,,P36969,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",GPX4,cofactor,V03AB32
DB00143,Glutathione,,P46439,Glutathione S-transferase Mu 5,GSTM5,,V03AB32
DB00143,Glutathione,,P59796,Glutathione peroxidase 6,GPX6,cofactor,V03AB32
DB00143,Glutathione,,Q16775,"Hydroxyacylglutathione hydrolase, mitochondrial",HAGH,,V03AB32
DB00143,Glutathione,,Q6NSD4,Glutathione peroxidase,GPX1,,V03AB32
DB00143,Glutathione,,Q96SL4,Glutathione peroxidase 7,GPX7,cofactor,V03AB32
DB00143,Glutathione,,Q99735,Microsomal glutathione S-transferase 2,MGST2,,V03AB32
DB00143,Glutathione,,Q9H4Y5,Glutathione S-transferase omega-2,GSTO2,,V03AB32
DB00143,Glutathione,,Q9NS18,"Glutaredoxin-2, mitochondrial",GLRX2,,V03AB32
DB00144,Phosphatidyl serine,,Q9UG56,Phosphatidylserine decarboxylase proenzyme,PISD,,
DB00144,Phosphatidyl serine,,Q8WTV0,Scavenger receptor class B member 1,SCARB1,,
DB00144,Phosphatidyl serine,,P17252,Protein kinase C alpha type,PRKCA,,
DB00144,Phosphatidyl serine,,P48651,Phosphatidylserine synthase 1,PTDSS1,,
DB00144,Phosphatidyl serine,,P49619,Diacylglycerol kinase gamma,DGKG,,
DB00144,Phosphatidyl serine,,Q16760,Diacylglycerol kinase delta,DGKD,,
DB00144,Phosphatidyl serine,,Q9BVG9,Phosphatidylserine synthase 2,PTDSS2,,
DB00144,Phosphatidyl serine,,Q9NXE4,Sphingomyelin phosphodiesterase 4,SMPD4,,
DB00144,Phosphatidyl serine,,Q9NY59,Sphingomyelin phosphodiesterase 3,SMPD3,,
DB00144,Phosphatidyl serine,,Q9Y2Q0,Probable phospholipid-transporting ATPase IA,ATP8A1,,
DB00145,Glycine,,O75600,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",GCAT,substrate,B05CX03
DB00145,Glycine,,P13196,"5-aminolevulinate synthase, nonspecific, mitochondrial",ALAS1,substrate,B05CX03
DB00145,Glycine,,P22557,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",ALAS2,substrate,B05CX03
DB00145,Glycine,,P41250,Glycine--tRNA ligase,GARS,substrate,B05CX03
DB00145,Glycine,,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,antagonist,B05CX03
DB00145,Glycine,,Q14032,Bile acid-CoA:amino acid N-acyltransferase,BAAT,substrate,B05CX03
DB00145,Glycine,,Q14330,N-arachidonyl glycine receptor,GPR18,substrate,B05CX03
DB00145,Glycine,,P48637,Glutathione synthetase,GSS,substrate,B05CX03
DB00145,Glycine,,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,agonist,B05CX03
DB00145,Glycine,,Q53ET4,Serine hydroxymethyltransferase,,product of,B05CX03
DB00145,Glycine,,Q6IB77,Glycine N-acyltransferase,GLYAT,substrate,B05CX03
DB00145,Glycine,,P34897,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,product of,B05CX03
DB00145,Glycine,,Q8WU03,Glycine N-acyltransferase-like protein 2,GLYATL2,substrate,B05CX03
DB00145,Glycine,,Q969I3,Glycine N-acyltransferase-like protein 1,GLYATL1,substrate,B05CX03
DB00145,Glycine,,Q9BYV1,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,product of,B05CX03
DB00145,Glycine,,Q9P0Z9,Peroxisomal sarcosine oxidase,PIPOX,product of,B05CX03
DB00145,Glycine,,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,substrate,B05CX03
DB00145,Glycine,,P23415,Glycine receptor subunit alpha-1,GLRA1,ligand,B05CX03
DB00145,Glycine,,P21549,Serine--pyruvate aminotransferase,AGXT,substrate,B05CX03
DB00145,Glycine,,P48167,Glycine receptor subunit beta,GLRB,ligand,B05CX03
DB00145,Glycine,,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,product of,B05CX03
DB00145,Glycine,,O75311,Glycine receptor subunit alpha-3,GLRA3,ligand,B05CX03
DB00145,Glycine,,P23416,Glycine receptor subunit alpha-2,GLRA2,ligand,B05CX03
DB00145,Glycine,,Q14749,Glycine N-methyltransferase,GNMT,substrate,B05CX03
DB00145,Glycine,,P50440,"Glycine amidinotransferase, mitochondrial",GATM,substrate,B05CX03
DB00146,Calcifediol,,P11473,Vitamin D3 receptor,VDR,agonist,A11CC06;H05BX05
DB00147,Pyridoxal,,O00764,Pyridoxal kinase,PDXK,,
DB00148,Creatine,,P06732,Creatine kinase M-type,CKM,ligand,
DB00148,Creatine,,P12532,"Creatine kinase U-type, mitochondrial",CKMT1A,ligand,
DB00148,Creatine,,P12277,Creatine kinase B-type,CKB,ligand,
DB00148,Creatine,,P17540,"Creatine kinase S-type, mitochondrial",CKMT2,ligand,
DB00148,Creatine,,P48029,Sodium- and chloride-dependent creatine transporter 1,SLC6A8,,
DB00148,Creatine,,Q14353,Guanidinoacetate N-methyltransferase,GAMT,product of,
DB00149,Leucine,,Q15031,"Probable leucine--tRNA ligase, mitochondrial",LARS2,,
DB00149,Leucine,,O60294,Leucine carboxyl methyltransferase 2,LCMT2,,
DB00149,Leucine,,Q9UIC8,Leucine carboxyl methyltransferase 1,LCMT1,,
DB00149,Leucine,,Q9P2J5,"Leucine--tRNA ligase, cytoplasmic",LARS,,
DB00149,Leucine,,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,,
DB00149,Leucine,,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,,
DB00150,Tryptophan,,P23381,"Tryptophan--tRNA ligase, cytoplasmic",WARS,inhibitor,N06AX02
DB00150,Tryptophan,,P00953,Tryptophan--tRNA ligase,trpS,inhibitor,N06AX02
DB00150,Tryptophan,,Q9UGM6,"Tryptophan--tRNA ligase, mitochondrial",WARS2,inhibitor,N06AX02
DB00151,Cysteine,,P48507,Glutamate--cysteine ligase regulatory subunit,GCLM,,
DB00151,Cysteine,,P48506,Glutamate--cysteine ligase catalytic subunit,GCLC,,
DB00151,Cysteine,,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,substrate,
DB00151,Cysteine,,P00505,"Aspartate aminotransferase, mitochondrial",GOT2,substrate,
DB00151,Cysteine,,P32929,Cystathionine gamma-lyase,CTH,,
DB00151,Cysteine,,P35520,Cystathionine beta-synthase,CBS,,
DB00151,Cysteine,,P49589,"Cysteine--tRNA ligase, cytoplasmic",CARS,substrate,
DB00151,Cysteine,,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,,
DB00151,Cysteine,,P48637,Glutathione synthetase,GSS,,
DB00151,Cysteine,,Q9HA77,"Probable cysteine--tRNA ligase, mitochondrial",CARS2,substrate,
DB00151,Cysteine,,Q9Y600,Cysteine sulfinic acid decarboxylase,CSAD,,
DB00151,Cysteine,,Q9Y697,"Cysteine desulfurase, mitochondrial",NFS1,,
DB00151,Cysteine,,Q16878,Cysteine dioxygenase type 1,CDO1,,
DB00152,Thiamine,,Q9H3S4,Thiamin pyrophosphokinase 1,TPK1,substrate,A11DA01
DB00153,Ergocalciferol,,P11473,Vitamin D3 receptor,VDR,agonist,A11CC01
DB00153,Ergocalciferol,,Q06432,Voltage-dependent calcium channel,CACNG1,inducer,A11CC01
DB00154,Dihomo-gamma-linolenic acid,,P35354,Prostaglandin G/H synthase 2,PTGS2,,
DB00154,Dihomo-gamma-linolenic acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB00155,Citrulline,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB00155,Citrulline,,P00966,Argininosuccinate synthase,ASS1,,
DB00155,Citrulline,,O95865,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2",DDAH2,,
DB00155,Citrulline,,O94760,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",DDAH1,,
DB00155,Citrulline,,P00480,"Ornithine carbamoyltransferase, mitochondrial",OTC,,
DB00155,Citrulline,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB00155,Citrulline,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB00155,Citrulline,,Q9UM07,Protein-arginine deiminase type-4,PADI4,,
DB00155,Citrulline,,Q6TGC4,Protein-arginine deiminase type-6,PADI6,product of,
DB00155,Citrulline,,Q9ULC6,Protein-arginine deiminase type-1,PADI1,,
DB00155,Citrulline,,Q9ULW8,Protein-arginine deiminase type-3,PADI3,,
DB00155,Citrulline,,Q9Y2J8,Protein-arginine deiminase type-2,PADI2,,
DB00156,Threonine,,P26639,"Threonine--tRNA ligase, cytoplasmic",TARS,,
DB00156,Threonine,,Q9BW92,"Threonine--tRNA ligase, mitochondrial",TARS2,,
DB00156,Threonine,,Q47066,Beta-lactamase Toho-1,bla,unknown,
DB00157,NADH,,O60701,UDP-glucose 6-dehydrogenase,UGDH,,
DB00157,NADH,,P07327,Alcohol dehydrogenase 1A,ADH1A,,
DB00157,NADH,,Q00796,Sorbitol dehydrogenase,SORD,,
DB00157,NADH,,P08319,Alcohol dehydrogenase 4,ADH4,,
DB00157,NADH,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB00157,NADH,,P00325,Alcohol dehydrogenase 1B,ADH1B,,
DB00157,NADH,,P40394,Alcohol dehydrogenase class 4 mu/sigma chain,ADH7,,
DB00157,NADH,,P21695,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",GPD1,,
DB00157,NADH,,Q6ZMR3,L-lactate dehydrogenase A-like 6A,LDHAL6A,,
DB00157,NADH,,P11766,Alcohol dehydrogenase class-3,ADH5,,
DB00157,NADH,,P15121,Aldose reductase,AKR1B1,,
DB00157,NADH,,Q99714,3-hydroxyacyl-CoA dehydrogenase type-2,HSD17B10,,
DB00157,NADH,,P40926,"Malate dehydrogenase, mitochondrial",MDH2,,
DB00157,NADH,,P00338,L-lactate dehydrogenase A chain,LDHA,,
DB00157,NADH,,P23368,"NAD-dependent malic enzyme, mitochondrial",ME2,,
DB00157,NADH,,P51659,Peroxisomal multifunctional enzyme type 2,HSD17B4,,
DB00157,NADH,,Q9BYZ2,L-lactate dehydrogenase A-like 6B,LDHAL6B,,
DB00157,NADH,,P07864,L-lactate dehydrogenase C chain,LDHC,,
DB00157,NADH,,P07195,L-lactate dehydrogenase B chain,LDHB,,
DB00157,NADH,,Q08426,Peroxisomal bifunctional enzyme,EHHADH,,
DB00157,NADH,,Q16836,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,,
DB00157,NADH,,Q16798,"NADP-dependent malic enzyme, mitochondrial",ME3,,
DB00157,NADH,,Q02338,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial",BDH1,,
DB00157,NADH,,P40925,"Malate dehydrogenase, cytoplasmic",MDH1,,
DB00157,NADH,,P31937,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",HIBADH,,
DB00157,NADH,,P37058,Testosterone 17-beta-dehydrogenase 3,HSD17B3,,
DB00157,NADH,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,,
DB00157,NADH,,P48163,NADP-dependent malic enzyme,ME1,,
DB00157,NADH,,O43175,D-3-phosphoglycerate dehydrogenase,PHGDH,,
DB00157,NADH,,P56937,3-keto-steroid reductase,HSD17B7,,
DB00157,NADH,,P51553,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",IDH3G,,
DB00157,NADH,,O43837,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial",IDH3B,,
DB00157,NADH,,P50213,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",IDH3A,,
DB00157,NADH,,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,,
DB00157,NADH,,P37059,Estradiol 17-beta-dehydrogenase 2,HSD17B2,,
DB00157,NADH,,Q92781,11-cis retinol dehydrogenase,RDH5,,
DB00157,NADH,,O95479,GDH/6PGL endoplasmic bifunctional protein,H6PD,,
DB00157,NADH,,Q92506,Estradiol 17-beta-dehydrogenase 8,HSD17B8,,
DB00157,NADH,,P17516,Aldo-keto reductase family 1 member C4,AKR1C4,,
DB00157,NADH,,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,,
DB00157,NADH,,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,,
DB00157,NADH,,P15428,15-hydroxyprostaglandin dehydrogenase [NAD(+)],HPGD,,
DB00157,NADH,,Q13630,GDP-L-fucose synthase,TSTA3,,
DB00157,NADH,,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,,
DB00157,NADH,,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB00157,NADH,,P26439,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,HSD3B2,,
DB00157,NADH,,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,,
DB00157,NADH,,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,,
DB00157,NADH,,P40939,"Trifunctional enzyme subunit alpha, mitochondrial",HADHA,,
DB00157,NADH,,P05091,"Aldehyde dehydrogenase, mitochondrial",ALDH2,,
DB00157,NADH,,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,,
DB00157,NADH,,P52895,Aldo-keto reductase family 1 member C2,AKR1C2,,
DB00157,NADH,,Q15738,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating",NSDHL,,
DB00157,NADH,,P48448,Aldehyde dehydrogenase family 3 member B2,ALDH3B2,,
DB00157,NADH,,Q02252,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial",ALDH6A1,,
DB00157,NADH,,P30838,"Aldehyde dehydrogenase, dimeric NADP-preferring",ALDH3A1,,
DB00157,NADH,,P00352,Retinal dehydrogenase 1,ALDH1A1,,
DB00157,NADH,,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,,
DB00157,NADH,,P49189,4-trimethylaminobutyraldehyde dehydrogenase,ALDH9A1,,
DB00157,NADH,,P47895,Aldehyde dehydrogenase family 1 member A3,ALDH1A3,,
DB00157,NADH,,P30837,"Aldehyde dehydrogenase X, mitochondrial",ALDH1B1,,
DB00157,NADH,,P43353,Aldehyde dehydrogenase family 3 member B1,ALDH3B1,,
DB00157,NADH,,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,,
DB00157,NADH,,O94788,Retinal dehydrogenase 2,ALDH1A2,,
DB00157,NADH,,P51648,Fatty aldehyde dehydrogenase,ALDH3A2,,
DB00157,NADH,,P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,,
DB00157,NADH,,P49419,Alpha-aminoadipic semialdehyde dehydrogenase,ALDH7A1,,
DB00157,NADH,,P30043,Flavin reductase (NADPH),BLVRB,,
DB00157,NADH,,Q96C36,Pyrroline-5-carboxylate reductase 2,PYCR2,,
DB00157,NADH,,P32322,"Pyrroline-5-carboxylate reductase 1, mitochondrial",PYCR1,,
DB00157,NADH,,P00367,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,,
DB00157,NADH,,P11177,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",PDHB,,
DB00157,NADH,,P29803,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial",PDHA2,,
DB00157,NADH,,P08559,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",PDHA1,,
DB00157,NADH,,P53004,Biliverdin reductase A,BLVRA,,
DB00157,NADH,,P16219,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADS,,
DB00157,NADH,,P00374,Dihydrofolate reductase,DHFR,,
DB00157,NADH,,Q02218,"2-oxoglutarate dehydrogenase, mitochondrial",OGDH,,
DB00157,NADH,,P49448,"Glutamate dehydrogenase 2, mitochondrial",GLUD2,,
DB00157,NADH,,Q9UBM7,7-dehydrocholesterol reductase,DHCR7,,
DB00157,NADH,,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,
DB00157,NADH,,P03891,NADH-ubiquinone oxidoreductase chain 2,MT-ND2,binder,
DB00157,NADH,,Q9UDR5,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,,
DB00157,NADH,,P03897,NADH-ubiquinone oxidoreductase chain 3,MT-ND3,binder,
DB00157,NADH,,O75251,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial",NDUFS7,,
DB00157,NADH,,P11586,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,,
DB00157,NADH,,P13995,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",MTHFD2,,
DB00157,NADH,,P30038,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial",ALDH4A1,,
DB00157,NADH,,P00387,NADH-cytochrome b5 reductase 3,CYB5R3,,
DB00157,NADH,,Q86Y39,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11,NDUFA11,,
DB00157,NADH,,P03905,NADH-ubiquinone oxidoreductase chain 4,MT-ND4,,
DB00157,NADH,,P09417,Dihydropteridine reductase,QDPR,,
DB00157,NADH,,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,binder,
DB00157,NADH,,Q13423,"NAD(P) transhydrogenase, mitochondrial",NNT,,
DB00157,NADH,,Q16718,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,NDUFA5,,
DB00157,NADH,,Q16795,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial",NDUFA9,,
DB00157,NADH,,P03901,NADH-ubiquinone oxidoreductase chain 4L,MT-ND4L,,
DB00157,NADH,,O95299,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial",NDUFA10,,
DB00157,NADH,,O95182,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7,NDUFA7,,
DB00157,NADH,,O15239,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1,NDUFA1,,
DB00157,NADH,,P03923,NADH-ubiquinone oxidoreductase chain 6,MT-ND6,,
DB00157,NADH,,P03915,NADH-ubiquinone oxidoreductase chain 5,MT-ND5,,
DB00157,NADH,,O00483,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4,NDUFA4,,
DB00157,NADH,,P56556,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6,NDUFA6,,
DB00157,NADH,,O14561,"Acyl carrier protein, mitochondrial",NDUFAB1,,
DB00157,NADH,,O43678,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2,NDUFA2,,
DB00157,NADH,,P51970,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8,NDUFA8,,
DB00157,NADH,,O95167,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3,NDUFA3,,
DB00157,NADH,,O95169,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial",NDUFB8,,
DB00157,NADH,,O95298,NADH dehydrogenase [ubiquinone] 1 subunit C2,NDUFC2,,
DB00157,NADH,,O75438,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1,NDUFB1,,
DB00157,NADH,,P28331,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial",NDUFS1,,
DB00157,NADH,,O96000,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10,NDUFB10,,
DB00157,NADH,,O95168,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,NDUFB4,,
DB00157,NADH,,O43676,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3,NDUFB3,,
DB00157,NADH,,O95178,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial",NDUFB2,,
DB00157,NADH,,P17568,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,NDUFB7,,
DB00157,NADH,,Q9Y6M9,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9,NDUFB9,,
DB00157,NADH,,O75306,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial",NDUFS2,,
DB00157,NADH,,O43674,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial",NDUFB5,,
DB00157,NADH,,O43677,"NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial",NDUFC1,,
DB00157,NADH,,O95139,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6,NDUFB6,,
DB00157,NADH,,P56181,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",NDUFV3,,
DB00157,NADH,,P09622,"Dihydrolipoyl dehydrogenase, mitochondrial",DLD,,
DB00157,NADH,,O75489,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial",NDUFS3,,
DB00157,NADH,,P00390,"Glutathione reductase, mitochondrial",GSR,,
DB00157,NADH,,Q9UI09,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12,NDUFA12,,
DB00157,NADH,,O43920,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5,NDUFS5,,
DB00157,NADH,,O43181,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial",NDUFS4,,
DB00157,NADH,,P49821,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial",NDUFV1,,
DB00157,NADH,,P19404,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial",NDUFV2,,
DB00157,NADH,,Q9P0J0,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13,NDUFA13,,
DB00157,NADH,,Q16878,Cysteine dioxygenase type 1,CDO1,,
DB00157,NADH,,O75380,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",NDUFS6,,
DB00157,NADH,,Q9NRX3,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2,NDUFA4L2,,
DB00157,NADH,,O00217,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial",NDUFS8,,
DB00157,NADH,,Q02928,Cytochrome P450 4A11,CYP4A11,,
DB00157,NADH,,P10515,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",DLAT,,
DB00157,NADH,,P48728,"Aminomethyltransferase, mitochondrial",AMT,,
DB00157,NADH,,Q15800,Methylsterol monooxygenase 1,MSMO1,,
DB00157,NADH,,P09601,Heme oxygenase 1,HMOX1,,
DB00157,NADH,,P30519,Heme oxygenase 2,HMOX2,,
DB00157,NADH,,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,,
DB00157,NADH,,P14679,Tyrosinase,TYR,,
DB00158,Folic acid,,P41439,Folate receptor gamma,FOLR3,binder,B03AE02;B03AD04;V04CX02;B03AD01;B03BB51;B03AD03;B03BB01;B03AE01;B03AD05;B03AD02
DB00158,Folic acid,,P14207,Folate receptor beta,FOLR2,binder,B03AE02;B03AD04;V04CX02;B03AD01;B03BB51;B03AD03;B03BB01;B03AE01;B03AD05;B03AD02
DB00158,Folic acid,,P15328,Folate receptor alpha,FOLR1,,B03AE02;B03AD04;V04CX02;B03AD01;B03BB51;B03AD03;B03BB01;B03AE01;B03AD05;B03AD02
DB00159,Icosapent,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB00159,Icosapent,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB00159,Icosapent,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,
DB00159,Icosapent,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,regulator,
DB00159,Icosapent,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,agonist,
DB00159,Icosapent,,O14842,Free fatty acid receptor 1,FFAR1,agonist,
DB00159,Icosapent,,P32418,Sodium/calcium exchanger 1,SLC8A1,inhibitor,
DB00159,Icosapent,,O15540,"Fatty acid-binding protein, brain",FABP7,agonist,
DB00159,Icosapent,,O60427,Fatty acid desaturase 1,FADS1,agonist,
DB00159,Icosapent,,O60488,Long-chain-fatty-acid--CoA ligase 4,ACSL4,inducer,
DB00159,Icosapent,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,inducer,
DB00159,Icosapent,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB00159,Icosapent,,P09917,Arachidonate 5-lipoxygenase,ALOX5,substrate,
DB00160,Alanine,,P21549,Serine--pyruvate aminotransferase,AGXT,,
DB00160,Alanine,,P24298,Alanine aminotransferase 1,GPT,,
DB00160,Alanine,,Q9Y697,"Cysteine desulfurase, mitochondrial",NFS1,,
DB00160,Alanine,,Q7Z2H8,Proton-coupled amino acid transporter 1,SLC36A1,,
DB00160,Alanine,,Q9UHI5,Large neutral amino acids transporter small subunit 2,SLC7A8,,
DB00160,Alanine,,Q9BYV1,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,,
DB00160,Alanine,,P49588,"Alanine--tRNA ligase, cytoplasmic",AARS,,
DB00160,Alanine,,P43007,Neutral amino acid transporter A,SLC1A4,,
DB00160,Alanine,,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,inhibitor,
DB00160,Alanine,,Q16719,Kynureninase,KYNU,,
DB00160,Alanine,,Q5JTZ9,"Alanine--tRNA ligase, mitochondrial",AARS2,,
DB00160,Alanine,,Q8IUZ5,5-phosphohydroxy-L-lysine phospho-lyase,PHYKPL,,
DB00160,Alanine,,Q8TD30,Alanine aminotransferase 2,GPT2,,
DB00161,Valine,,P05166,"Propionyl-CoA carboxylase beta chain, mitochondrial",PCCB,,
DB00161,Valine,,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,,
DB00161,Valine,,P26640,Valine--tRNA ligase,VARS,,
DB00162,Vitamin A,,P05090,Apolipoprotein D,APOD,ligand,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,P41222,Prostaglandin-H2 D-isomerase,PTGDS,ligand,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,Q96NR8,Retinol dehydrogenase 12,RDH12,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,Q92781,11-cis retinol dehydrogenase,RDH5,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,Q8NBN7,Retinol dehydrogenase 13,RDH13,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,O94788,Retinal dehydrogenase 2,ALDH1A2,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,P00352,Retinal dehydrogenase 1,ALDH1A1,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,O95237,Lecithin retinol acyltransferase,LRAT,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,O75911,Short-chain dehydrogenase/reductase 3,DHRS3,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,P47895,Aldehyde dehydrogenase family 1 member A3,ALDH1A3,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,Q6NUM9,"All-trans-retinol 13,14-reductase",RETSAT,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,Q8TC12,Retinol dehydrogenase 11,RDH11,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,Q9BTZ2,Dehydrogenase/reductase SDR family member 4,DHRS4,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,Q9HBH5,Retinol dehydrogenase 14,RDH14,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00162,Vitamin A,,Q9NYR8,Retinol dehydrogenase 8,RDH8,substrate,S01XA02;V04CB01;D10AD02;R01AX02;A11CA01
DB00163,Vitamin E,,Q9UDX3,SEC14-like protein 4,SEC14L4,,
DB00163,Vitamin E,,Q9UDX4,SEC14-like protein 3,SEC14L3,,
DB00163,Vitamin E,,O76054,SEC14-like protein 2,SEC14L2,,
DB00163,Vitamin E,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB00163,Vitamin E,,P05771,Protein kinase C beta type,PRKCB,,
DB00163,Vitamin E,,P09917,Arachidonate 5-lipoxygenase,ALOX5,,
DB00163,Vitamin E,,P17252,Protein kinase C alpha type,PRKCA,,
DB00163,Vitamin E,,P23743,Diacylglycerol kinase alpha,DGKA,,
DB00163,Vitamin E,,P62714,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform,PPP2CB,,
DB00163,Vitamin E,,P67775,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,PPP2CA,,
DB00165,Pyridoxine,,O00764,Pyridoxal kinase,PDXK,ligand,J04AM08;A11HA02
DB00166,Lipoic acid,,Q9Y234,"Lipoyltransferase 1, mitochondrial",LIPT1,,A16AX01
DB00166,Lipoic acid,,Q9Y289,Sodium-dependent multivitamin transporter,SLC5A6,,A16AX01
DB00166,Lipoic acid,,O43766,"Lipoyl synthase, mitochondrial",LIAS,,A16AX01
DB00167,Isoleucine,,P45954,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",ACADSB,,
DB00167,Isoleucine,,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,,
DB00167,Isoleucine,,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,,
DB00167,Isoleucine,,P41252,"Isoleucine--tRNA ligase, cytoplasmic",IARS,,
DB00167,Isoleucine,,Q9NSE4,"Isoleucine--tRNA ligase, mitochondrial",IARS2,,
DB00168,Aspartame,,Q7RTX0,Taste receptor type 1 member 3,TAS1R3,,
DB00168,Aspartame,,Q8TE23,Taste receptor type 1 member 2,TAS1R2,agonist,
DB00168,Aspartame,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,inducer,
DB00169,Cholecalciferol,,P11473,Vitamin D3 receptor,VDR,agonist,M05BB09;M05BX53;M05BB07;M05BB08;A11CC55;M05BB05;A11CC05;M05BB03;M05BB04
DB00170,Menadione,,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,cofactor,B02BA02
DB00170,Menadione,,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,cofactor,B02BA02
DB00170,Menadione,,Q8N0U8,Vitamin K epoxide reductase complex subunit 1-like protein 1,VKORC1L1,cofactor,B02BA02
DB00170,Menadione,,P00734,Prothrombin,F2,activator,B02BA02
DB00170,Menadione,,P00740,Coagulation factor IX,F9,activator,B02BA02
DB00170,Menadione,,P04070,Vitamin K-dependent protein C,PROC,activator,B02BA02
DB00170,Menadione,,P07225,Vitamin K-dependent protein S,PROS1,activator,B02BA02
DB00170,Menadione,,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,B02BA02
DB00170,Menadione,,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,,B02BA02
DB00170,Menadione,,P02818,Osteocalcin,BGLAP,agonist,B02BA02
DB00171,ATP,,O95255,Multidrug resistance-associated protein 6,ABCC6,,
DB00171,ATP,,O15439,Multidrug resistance-associated protein 4,ABCC4,,
DB00171,ATP,,P33527,Multidrug resistance-associated protein 1,ABCC1,,
DB00171,ATP,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,cofactor,
DB00171,ATP,,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,,
DB00171,ATP,,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB00171,ATP,,P67870,Casein kinase II subunit beta,CSNK2B,,
DB00171,ATP,,Q96G91,P2Y purinoceptor 11,P2RY11,,
DB00171,ATP,,P53041,Serine/threonine-protein phosphatase 5,PPP5C,,
DB00171,ATP,,P42684,Tyrosine-protein kinase ABL2,ABL2,inhibitor,
DB00171,ATP,,O95477,ATP-binding cassette sub-family A member 1,ABCA1,,
DB00171,ATP,,Q9NR19,"Acetyl-coenzyme A synthetase, cytoplasmic",ACSS2,,
DB00171,ATP,,Q9UM73,ALK tyrosine kinase receptor,ALK,,
DB00171,ATP,,Q13564,NEDD8-activating enzyme E1 regulatory subunit,NAE1,,
DB00171,ATP,,Q13131,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,,
DB00171,ATP,,P10398,Serine/threonine-protein kinase A-Raf,ARAF,,
DB00171,ATP,,P37023,Serine/threonine-protein kinase receptor R3,ACVRL1,,
DB00171,ATP,,P33121,Long-chain-fatty-acid--CoA ligase 1,ACSL1,,
DB00171,ATP,,P49902,Cytosolic purine 5'-nucleotidase,NT5C2,,
DB00171,ATP,,O43681,ATPase ASNA1,ASNA1,,
DB00171,ATP,,O60706,ATP-binding cassette sub-family C member 9,ABCC9,,
DB00171,ATP,,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,,
DB00171,ATP,,P25098,Beta-adrenergic receptor kinase 1,ADRBK1,,
DB00171,ATP,,O14727,Apoptotic protease-activating factor 1,APAF1,,
DB00171,ATP,,Q9NUB1,"Acetyl-coenzyme A synthetase 2-like, mitochondrial",ACSS1,,
DB00171,ATP,,P36896,Activin receptor type-1B,ACVR1B,,
DB00171,ATP,,Q04771,Activin receptor type-1,ACVR1,,
DB00171,ATP,,O95342,Bile salt export pump,ABCB11,,
DB00171,ATP,,P08243,Asparagine synthetase [glutamine-hydrolyzing],ASNS,,
DB00171,ATP,,Q96Q40,Cyclin-dependent kinase 15,CDK15,,
DB00171,ATP,,P12235,ADP/ATP translocase 1,SLC25A4,,
DB00171,ATP,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,,
DB00171,ATP,,P00966,Argininosuccinate synthase,ASS1,,
DB00171,ATP,,Q9Y4W6,AFG3-like protein 2,AFG3L2,,
DB00171,ATP,,P35626,Beta-adrenergic receptor kinase 2,ADRBK2,,
DB00171,ATP,,Q16671,Anti-Muellerian hormone type-2 receptor,AMHR2,,
DB00171,ATP,,Q07912,Activated CDC42 kinase 1,TNK2,,
DB00171,ATP,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,
DB00171,ATP,,Q08828,Adenylate cyclase type 1,ADCY1,,
DB00171,ATP,,P08183,P-glycoprotein 1,ABCB1,,
DB00171,ATP,,P45844,ATP-binding cassette sub-family G member 1,ABCG1,,
DB00171,ATP,,Q92887,Canalicular multispecific organic anion transporter 1,ABCC2,,
DB00172,Proline,,P32322,"Pyrroline-5-carboxylate reductase 1, mitochondrial",PYCR1,,
DB00172,Proline,,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,,
DB00172,Proline,,Q9UN76,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),SLC6A14,,
DB00172,Proline,,Q99884,Sodium-dependent proline transporter,SLC6A7,,
DB00172,Proline,,Q96C36,Pyrroline-5-carboxylate reductase 2,PYCR2,,
DB00172,Proline,,O15460,Prolyl 4-hydroxylase subunit alpha-2,P4HA2,,
DB00172,Proline,,O43272,"Proline dehydrogenase 1, mitochondrial",PRODH,,
DB00172,Proline,,O43447,Peptidyl-prolyl cis-trans isomerase H,PPIH,,
DB00172,Proline,,O94903,Proline synthase co-transcribed bacterial homolog protein,PROSC,,
DB00172,Proline,,P13674,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,,
DB00172,Proline,,P23284,Peptidyl-prolyl cis-trans isomerase B,PPIB,binder,
DB00172,Proline,,P30405,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,,
DB00172,Proline,,P45877,Peptidyl-prolyl cis-trans isomerase C,PPIC,,
DB00172,Proline,,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,binder,
DB00172,Proline,,Q13427,Peptidyl-prolyl cis-trans isomerase G,PPIG,,
DB00172,Proline,,Q32P28,Prolyl 3-hydroxylase 1,P3H1,,
DB00172,Proline,,Q4W8W1,Pyrroline-5-carboxylate reductase,P5CR2,,
DB00172,Proline,,Q7L3T8,"Probable proline--tRNA ligase, mitochondrial",PARS2,,
DB00172,Proline,,Q8IVL5,Prolyl 3-hydroxylase 2,P3H2,,
DB00172,Proline,,Q8IVL6,Prolyl 3-hydroxylase 3,P3H3,,
DB00172,Proline,,Q53H96,Pyrroline-5-carboxylate reductase 3,PYCRL,,
DB00172,Proline,,Q96EM0,Trans-L-3-hydroxyproline dehydratase,L3HYPDH,,
DB00173,Adenine,,P07741,Adenine phosphoribosyltransferase,APRT,,
DB00173,Adenine,,,DNA,,,
DB00173,Adenine,,Q13126,S-methyl-5'-thioadenosine phosphorylase,MTAP,,
DB00173,Adenine,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB00173,Adenine,,O00763,Acetyl-CoA carboxylase 2,ACACB,,
DB00173,Adenine,,P24666,Low molecular weight phosphotyrosine protein phosphatase,ACP1,,
DB00173,Adenine,,P0AF12,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,mtnN,,
DB00173,Adenine,,Q9BY49,Peroxisomal trans-2-enoyl-CoA reductase,PECR,,
DB00173,Adenine,,P17802,A/G-specific adenine glycosylase,mutY,,
DB00173,Adenine,,Q8RLY5,Nucleoside deoxyribosyltransferase-I,ptd,,
DB00173,Adenine,,P78362,SRSF protein kinase 2,SRPK2,,
DB00173,Adenine,,Q5SL87,Holliday junction ATP-dependent DNA helicase RuvB,ruvB,,
DB00174,Asparagine,,Q9H2H9,Sodium-coupled neutral amino acid transporters,SLC38A1,inhibitor,
DB00174,Asparagine,,Q15758,Neutral amino acid transporter B(0),SLC1A5,,
DB00174,Asparagine,,P08243,Asparagine synthetase [glutamine-hydrolyzing],ASNS,,
DB00174,Asparagine,,O43776,"Asparagine--tRNA ligase, cytoplasmic",NARS,,
DB00174,Asparagine,,Q7L266,Isoaspartyl peptidase/L-asparaginase,ASRGL1,substrate,
DB00174,Asparagine,,Q96I59,"Probable asparagine--tRNA ligase, mitochondrial",NARS2,,
DB00175,Pravastatin,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,inhibitor,C10AA03;C10BA11;C10BA03;C10BA12;C10BX02
DB00175,Pravastatin,,Q92769,Histone deacetylase 2,HDAC2,inhibitor,C10AA03;C10BA11;C10BA03;C10BA12;C10BX02
DB00176,Fluvoxamine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AB08
DB00176,Fluvoxamine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,,N06AB08
DB00177,Valsartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,C09DX05;C10BX10;C09DA03;C09CA03;C09DX02;C09DX01;C09DB08;C09DB01;C09DX04
DB00178,Ramipril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09BX03;C10BX04;C09BB05;C09AA05;C10BX18;C10BX17;C09BB07;C09BX05;C10BX06;C09BA05
DB00178,Ramipril,,P46663,B1 bradykinin receptor,BDKRB1,,C09BX03;C10BX04;C09BB05;C09AA05;C10BX18;C10BX17;C09BB07;C09BX05;C10BX06;C09BA05
DB00179,Masoprocol,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,L01XX10
DB00179,Masoprocol,,P04278,Sex hormone-binding globulin,SHBG,,L01XX10
DB00179,Masoprocol,,Q96QT4,Transient receptor potential cation channel subfamily M member 7,TRPM7,inhibitor,L01XX10
DB00180,Flunisolide,,P04150,Glucocorticoid receptor,NR3C1,agonist,R01AD04;R03BA03
DB00181,Baclofen,,O75899,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,agonist,M03BX01
DB00181,Baclofen,,P61073,C-X-C chemokine receptor type 4,CXCR4,allosteric modulator,M03BX01
DB00181,Baclofen,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,agonist,M03BX01
DB00182,Amphetamine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,N06BA01
DB00182,Amphetamine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,negative modulator,N06BA01
DB00182,Amphetamine,,Q16568,Cocaine- and amphetamine-regulated transcript protein,CARTPT,agonist,N06BA01
DB00182,Amphetamine,,Q96RJ0,Trace amine-associated receptor 1,TAAR1,agonist,N06BA01
DB00182,Amphetamine,,P21397,Monoamine oxidase,MAOA,inhibitor,N06BA01
DB00182,Amphetamine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,agonist,N06BA01
DB00182,Amphetamine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,substrate,N06BA01
DB00182,Amphetamine,,P35348,Alpha adrenergic receptor,ADRA1A,agonist,N06BA01
DB00182,Amphetamine,,P08588,Beta adrenergic receptor,ADRB1,agonist,N06BA01
DB00182,Amphetamine,,P14416,Dopamine D2 receptor,DRD2,binder,N06BA01
DB00182,Amphetamine,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,N06BA01
DB00182,Amphetamine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,binder,N06BA01
DB00183,Pentagastrin,,P32239,Gastrin/cholecystokinin type B receptor,CCKBR,agonist,V04CG04
DB00184,Nicotine,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,agonist,N07BA01
DB00184,Nicotine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,agonist,N07BA01
DB00184,Nicotine,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,agonist,N07BA01
DB00184,Nicotine,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,agonist,N07BA01
DB00184,Nicotine,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,agonist,N07BA01
DB00184,Nicotine,,P30532,Neuronal acetylcholine receptor subunit alpha-5,CHRNA5,agonist,N07BA01
DB00184,Nicotine,,Q15825,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,agonist,N07BA01
DB00184,Nicotine,,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,agonist,N07BA01
DB00184,Nicotine,,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,agonist,N07BA01
DB00184,Nicotine,,Q05901,Neuronal acetylcholine receptor subunit beta-3,CHRNB3,agonist,N07BA01
DB00184,Nicotine,,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,agonist,N07BA01
DB00184,Nicotine,,P11511,Cytochrome P450 19A1,CYP19A1,inhibitor,N07BA01
DB00184,Nicotine,,P28329,Choline O-acetyltransferase,CHAT,inhibitor,N07BA01
DB00185,Cevimeline,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,agonist,N07AX03
DB00185,Cevimeline,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,agonist,N07AX03
DB00186,Lorazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA56;N05BA06
DB00186,Lorazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA56;N05BA06
DB00187,Esmolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07AB09
DB00188,Bortezomib,,P28074,Proteasome subunit beta type-5,PSMB5,inhibitor,L01XG01
DB00188,Bortezomib,,P20618,Proteasome subunit beta type-1,PSMB1,inhibitor,L01XG01
DB00189,Ethchlorvynol,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CM08
DB00190,Carbidopa,,P20711,Aromatic-L-amino-acid decarboxylase,DDC,inhibitor,
DB00191,Phentermine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,A08AA01;A08AA51
DB00191,Phentermine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,A08AA01;A08AA51
DB00191,Phentermine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,A08AA01;A08AA51
DB00191,Phentermine,,P21397,Amine oxidase [flavin-containing] A,MAOA,antagonist,A08AA01;A08AA51
DB00191,Phentermine,,P27338,Amine oxidase [flavin-containing] B,MAOB,antagonist,A08AA01;A08AA51
DB00191,Phentermine,,P01303,Pro-neuropeptide Y,NPY,inhibitor,A08AA01;A08AA51
DB00192,Indecainide,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,
DB00193,Tramadol,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,inhibitor,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,Q05586,NMDA receptor,GRIN1,inhibitor,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P30542,Adenosine receptor A1,ADORA1,agonist,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P08913,Alpha-2 adrenergic receptors,ADRA2A,inducer,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P41143,Delta-type opioid receptor,OPRD1,agonist,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,P25103,Neurokinin 1 receptor,TACR1,inhibitor,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00193,Tramadol,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,agonist,N02AJ16;N02AJ13;N02AJ14;N02AX02
DB00194,Vidarabine,,P04293,DNA polymerase catalytic subunit,,inhibitor,J05AB03;S01AD06
DB00194,Vidarabine,,P09250,Thymidine kinase,TK,inducer,J05AB03;S01AD06
DB00194,Vidarabine,,Q9QNF7,Thymidine kinase,TK,inducer,J05AB03;S01AD06
DB00195,Betaxolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,S01ED02;C07AB05;S01ED52
DB00195,Betaxolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,S01ED02;C07AB05;S01ED52
DB00196,Fluconazole,,P10613,Cytochrome P450 51,ERG11,inhibitor,J01RA07;J02AC01;D01AC15
DB00197,Troglitazone,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,A10BG01
DB00197,Troglitazone,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,regulator,A10BG01
DB00197,Troglitazone,,P62508,Estrogen-related receptor gamma,ESRRG,inverse agonist,A10BG01
DB00197,Troglitazone,,P11474,Steroid hormone receptor ERR1,ESRRA,inverse agonist,A10BG01
DB00197,Troglitazone,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,A10BG01
DB00197,Troglitazone,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,A10BG01
DB00197,Troglitazone,,P09211,Glutathione S-transferase P,GSTP1,,A10BG01
DB00197,Troglitazone,,O60488,Long-chain-fatty-acid--CoA ligase 4,ACSL4,inhibitor,A10BG01
DB00197,Troglitazone,,P05121,Plasminogen activator inhibitor 1,SERPINE1,antagonist,A10BG01
DB00197,Troglitazone,,Q99808,Equilibrative nucleoside transporter 1,SLC29A1,inhibitor,A10BG01
DB00198,Oseltamivir,,P11485,Neuraminidase,,inhibitor,J05AH02
DB00198,Oseltamivir,,Q99519,Sialidase-1,NEU1,inhibitor,J05AH02
DB00198,Oseltamivir,,Q9Y3R4,Sialidase-2,NEU2,inhibitor,J05AH02
DB00199,Erythromycin,,,23S ribosomal RNA,,inhibitor,J01FA01;D10AF02;S01AA17;D10AF52
DB00199,Erythromycin,,O43193,Motilin receptor,MLNR,agonist,J01FA01;D10AF02;S01AA17;D10AF52
DB00199,Erythromycin,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,J01FA01;D10AF02;S01AA17;D10AF52
DB00200,Hydroxocobalamin,,Q99707,Methionine synthase,MTR,cofactor,B03BA53;V03AB33;B03BA03
DB00200,Hydroxocobalamin,,P22033,"Methylmalonyl-CoA mutase, mitochondrial",MUT,cofactor,B03BA53;V03AB33;B03BA03
DB00200,Hydroxocobalamin,,Q8IVH4,"Methylmalonic aciduria type A protein, mitochondrial",MMAA,other/unknown,B03BA53;V03AB33;B03BA03
DB00200,Hydroxocobalamin,,P20061,Transcobalamin-1,TCN1,other,B03BA53;V03AB33;B03BA03
DB00200,Hydroxocobalamin,,Q9BXJ7,Protein amnionless,AMN,other,B03BA53;V03AB33;B03BA03
DB00200,Hydroxocobalamin,,O60494,Cubilin,CUBN,other,B03BA53;V03AB33;B03BA03
DB00200,Hydroxocobalamin,,Q9Y4U1,Methylmalonic aciduria and homocystinuria type C protein,MMACHC,other/unknown,B03BA53;V03AB33;B03BA03
DB00201,Caffeine,,P30542,Adenosine receptor A1,ADORA1,antagonist,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,P29274,Adenosine receptor A2a,ADORA2A,antagonist,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,P29275,Adenosine receptor A2b,ADORA2B,antagonist,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,P0DMS8,Adenosine receptor A3,ADORA3,antagonist,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,Q01064,Phosphodiesterase enzymes,PDE1B,inhibitor,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,P21817,Ryanodine receptor 1,RYR1,,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,P54750,Cyclic nucleotide phosphodiesterase,PDE1A,inhibitor,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,P78527,DNA-dependent protein kinase catalytic subunit,PRKDC,inhibitor,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,inhibitor,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,inhibitor,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",PIK3CB,inhibitor,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,Q14643,"Inositol 1,4,5-trisphosphate receptor",ITPR1,inhibitor,D11AX26;R03DA20;V04CG30;N06BC01
DB00201,Caffeine,,Q13315,Serine-protein kinase ATM,ATM,inhibitor,D11AX26;R03DA20;V04CG30;N06BC01
DB00202,Succinylcholine,,Q9GZZ6,Neuronal Acetylcholine (nACh) Receptor Subunits,CHRNA10,agonist,M03AB01
DB00202,Succinylcholine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,agonist,M03AB01
DB00202,Succinylcholine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,agonist,M03AB01
DB00203,Sildenafil,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,inhibitor,G01AE10;G04BE03
DB00203,Sildenafil,,P18545,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,inhibitor,G01AE10;G04BE03
DB00203,Sildenafil,,Q13956,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6H,inhibitor,G01AE10;G04BE03
DB00203,Sildenafil,,P11926,Ornithine decarboxylase,ODC1,downregulator,G01AE10;G04BE03
DB00203,Sildenafil,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,downregulator,G01AE10;G04BE03
DB00204,Dofetilide,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C01BD04
DB00204,Dofetilide,,O95069,Potassium channel subfamily K member 2,KCNK2,inhibitor,C01BD04
DB00204,Dofetilide,,Q14500,ATP-sensitive inward rectifier potassium channel 12,KCNJ12,inhibitor,C01BD04
DB00205,Pyrimethamine,,P00374,Dihydrofolate reductase,DHFR,inhibitor,P01BF09;P01BD01;P01BD51;P01BF04
DB00205,Pyrimethamine,,P13922,Bifunctional dihydrofolate reductase-thymidylate synthase,,inhibitor,P01BF09;P01BD01;P01BD51;P01BF04
DB00205,Pyrimethamine,,P07686,Beta-hexosaminidase subunit beta,HEXB,,P01BF09;P01BD01;P01BD51;P01BF04
DB00206,Reserpine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,C02LA51;C02AA02;C02LA01;C02LA71;C02AA52
DB00206,Reserpine,,P54219,Chromaffin granule amine transporter,SLC18A1,inhibitor,C02LA51;C02AA02;C02LA01;C02LA71;C02AA52
DB00206,Reserpine,,O15392,Baculoviral IAP repeat-containing protein 5,BIRC5,,C02LA51;C02AA02;C02LA01;C02LA71;C02AA52
DB00207,Azithromycin,,,23S ribosomal RNA,,inhibitor,J01RA07;S01AA26;J01FA10;J01RA16
DB00207,Azithromycin,,Q9UM07,Protein-arginine deiminase type-4,PADI4,inhibitor,J01RA07;S01AA26;J01FA10;J01RA16
DB00208,Ticlopidine,,Q9H244,P2Y purinoceptor 12,P2RY12,antagonist,B01AC05
DB00209,Trospium,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,,A03DA06;G04BD09
DB00209,Trospium,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03DA06;G04BD09
DB00210,Adapalene,,P10826,Retinoic acid receptor beta,RARB,agonist,D10AD03;D10AD53
DB00210,Adapalene,,P13631,Retinoic acid receptor gamma,RARG,agonist,D10AD03;D10AD53
DB00210,Adapalene,,P28702,Retinoic acid receptor RXR-beta,RXRB,agonist,D10AD03;D10AD53
DB00210,Adapalene,,P48443,Retinoic acid receptor RXR-gamma,RXRG,agonist,D10AD03;D10AD53
DB00210,Adapalene,,P19793,Retinoic acid receptor RXR-alpha,RXRA,agonist,D10AD03;D10AD53
DB00210,Adapalene,,P05412,Transcription factor AP-1,JUN,antagonist,D10AD03;D10AD53
DB00210,Adapalene,,O60603,Toll-like receptor 2,TLR2,antagonist,D10AD03;D10AD53
DB00210,Adapalene,,P10276,Retinoic acid receptor alpha,RARA,,D10AD03;D10AD53
DB00210,Adapalene,,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,inhibitor,D10AD03;D10AD53
DB00211,Midodrine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,C01CA17
DB00211,Midodrine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,C01CA17
DB00211,Midodrine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,agonist,C01CA17
DB00212,Remikiren,,P00797,Renin,REN,inhibitor,C09XA01
DB00213,Pantoprazole,,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,inhibitor,A02BD04;A02BD11;A02BC02
DB00213,Pantoprazole,,O94760,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",DDAH1,inhibitor,A02BD04;A02BD11;A02BC02
DB00214,Torasemide,,P55011,Solute carrier family 12 member 2,SLC12A2,inhibitor,C03CA04;G01AE10
DB00214,Torasemide,,Q13621,Solute carrier family 12 member 1,SLC12A1,inhibitor,C03CA04;G01AE10
DB00215,Citalopram,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AB04
DB00215,Citalopram,,P35367,Histamine H1 receptor,HRH1,binder,N06AB04
DB00216,Eletriptan,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N02CC06
DB00216,Eletriptan,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N02CC06
DB00216,Eletriptan,,P30939,5-hydroxytryptamine receptor 1F,HTR1F,agonist,N02CC06
DB00216,Eletriptan,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N02CC06
DB00217,Bethanidine,,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,inhibitor,C02CC01
DB00217,Bethanidine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,agonist,C02CC01
DB00217,Bethanidine,,P08588,Beta adrenergic receptor,ADRB1,antagonist,C02CC01
DB00218,Moxifloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,S01AE07;J01MA14
DB00218,Moxifloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,S01AE07;J01MA14
DB00218,Moxifloxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,S01AE07;J01MA14
DB00218,Moxifloxacin,,P27169,Serum paraoxonase/arylesterase 1,PON1,inhibitor,S01AE07;J01MA14
DB00219,Oxyphenonium,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03AB53;A03AB03
DB00220,Nelfinavir,,O90777,HIV-1 protease,HIV-1 protease,inhibitor,J05AE04
DB00221,Isoetharine,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,R03CC06;R03AC07
DB00221,Isoetharine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03CC06;R03AC07
DB00222,Glimepiride,,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,inhibitor,A10BD04;A10BB12;A10BD06
DB00222,Glimepiride,,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,inhibitor,A10BD04;A10BB12;A10BD06
DB00222,Glimepiride,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,inducer,A10BD04;A10BB12;A10BD06
DB00223,Diflorasone,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AC10
DB00224,Indinavir,,Q72874,Human immunodeficiency virus type 1 protease,pol,inhibitor,J05AE02
DB00226,Guanadrel,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,partial agonist,
DB00227,Lovastatin,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,inhibitor,C10AA02;C10BA01
DB00227,Lovastatin,,P20701,Integrin alpha-L,ITGAL,inhibitor,C10AA02;C10BA01
DB00227,Lovastatin,,Q92769,Histone deacetylase 2,HDAC2,inhibitor,C10AA02;C10BA01
DB00228,Enflurane,,P14867,GABA(A) Receptor,GABRA1,potentiator,N01AB04
DB00228,Enflurane,,Q06432,Voltage-dependent calcium channel,CACNG1,inhibitor,N01AB04
DB00228,Enflurane,,Q06432,Voltage-dependent calcium channel,CACNG1,activator,N01AB04
DB00228,Enflurane,,P23415,Glycine receptor subunit alpha-1,GLRA1,potentiator,N01AB04
DB00228,Enflurane,,Q09470,Voltage-gated Potassium Channels,KCNA1,inhibitor,N01AB04
DB00228,Enflurane,,Q09470,Voltage-gated Potassium Channels,KCNA1,activator,N01AB04
DB00228,Enflurane,,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,inhibitor,N01AB04
DB00228,Enflurane,,Q05586,Glutamate (NMDA) receptor,GRIN1,antagonist,N01AB04
DB00228,Enflurane,,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,inhibitor,N01AB04
DB00228,Enflurane,,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,stimulator,N01AB04
DB00229,Cefotiam,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inducer,J01DC07
DB00230,Pregabalin,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,,N02BF02
DB00231,Temazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD07
DB00231,Temazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD07
DB00232,Methyclothiazide,,Q13621,Solute carrier family 12 member 1,SLC12A1,inhibitor,C03AA08;C03AB08
DB00232,Methyclothiazide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,C03AA08;C03AB08
DB00232,Methyclothiazide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,C03AA08;C03AB08
DB00232,Methyclothiazide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,C03AA08;C03AB08
DB00233,Aminosalicylic acid,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,J04AA02;J04AA03;J04AA01
DB00233,Aminosalicylic acid,,O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,inhibitor,J04AA02;J04AA03;J04AA01
DB00233,Aminosalicylic acid,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,J04AA02;J04AA03;J04AA01
DB00233,Aminosalicylic acid,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,unknown,J04AA02;J04AA03;J04AA01
DB00234,Reboxetine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AX18
DB00235,Milrinone,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,C01CE02
DB00236,Pipobroman,,,DNA,,cross-linking/alkylation,L01AX02
DB00237,Butabarbital,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CB01
DB00237,Butabarbital,,Q9GZZ6,Neuronal Acetylcholine (nACh) Receptor Subunits,CHRNA10,inhibitor,N05CB01
DB00237,Butabarbital,,P42261,Glutamate receptor 1,GRIA1,antagonist,N05CB01
DB00237,Butabarbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CB01
DB00237,Butabarbital,,P42263,Glutamate receptor 3,GRIA3,antagonist,N05CB01
DB00237,Butabarbital,,P48058,Glutamate receptor 4,GRIA4,antagonist,N05CB01
DB00237,Butabarbital,,P39086,"Glutamate receptor ionotropic, kainate 1",GRIK1,antagonist,N05CB01
DB00237,Butabarbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CB01
DB00237,Butabarbital,,Q13003,"Glutamate receptor ionotropic, kainate 3",GRIK3,antagonist,N05CB01
DB00237,Butabarbital,,Q16099,"Glutamate receptor ionotropic, kainate 4",GRIK4,antagonist,N05CB01
DB00237,Butabarbital,,Q16478,"Glutamate receptor ionotropic, kainate 5",GRIK5,antagonist,N05CB01
DB00238,Nevirapine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AG01;J05AR05;J05AR07
DB00239,Oxiconazole,,P10613,Cytochrome P450 51,ERG11,inhibitor,D01AC11;G01AF17;G01AF20
DB00239,Oxiconazole,,Q04782,Lanosterol synthase,ERG7,inhibitor,D01AC11;G01AF17;G01AF20
DB00239,Oxiconazole,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,partial agonist,D01AC11;G01AF17;G01AF20
DB00240,Alclometasone,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AB10;S01BA10
DB00241,Butalbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CB01
DB00241,Butalbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CB01
DB00241,Butalbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N05CB01
DB00241,Butalbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CB01
DB00241,Butalbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N05CB01
DB00241,Butalbital,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CB01
DB00241,Butalbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CB01
DB00241,Butalbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CB01
DB00241,Butalbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CB01
DB00241,Butalbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CB01
DB00241,Butalbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CB01
DB00242,Cladribine,,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,inhibitor,L04AA40;L01BB04
DB00242,Cladribine,,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,inhibitor,L04AA40;L01BB04
DB00242,Cladribine,,Q7LG56,Ribonucleoside-diphosphate reductase subunit M2 B,RRM2B,inhibitor,L04AA40;L01BB04
DB00242,Cladribine,,,DNA,,other/unknown,L04AA40;L01BB04
DB00242,Cladribine,,P09884,DNA polymerase alpha catalytic subunit,POLA1,inhibitor,L04AA40;L01BB04
DB00242,Cladribine,,Q07864,DNA polymerase epsilon catalytic subunit A,POLE,inhibitor,L04AA40;L01BB04
DB00242,Cladribine,,P56282,DNA polymerase epsilon subunit 2,POLE2,inhibitor,L04AA40;L01BB04
DB00242,Cladribine,,Q9NRF9,DNA polymerase epsilon subunit 3,POLE3,inhibitor,L04AA40;L01BB04
DB00242,Cladribine,,Q9NR33,DNA polymerase epsilon subunit 4,POLE4,inhibitor,L04AA40;L01BB04
DB00242,Cladribine,,P00491,Purine nucleoside phosphorylase,PNP,inducer,L04AA40;L01BB04
DB00243,Ranolazine,,P35498,Sodium channel protein,SCN1A,inhibitor,C01EB18
DB00243,Ranolazine,,Q14500,Inward rectifier potassium channel,KCNJ12,inhibitor,C01EB18
DB00243,Ranolazine,,Q13936,Voltage gated L-type calcium channel,CACNA1C,inhibitor,C01EB18
DB00243,Ranolazine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,C01EB18
DB00243,Ranolazine,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C01EB18
DB00243,Ranolazine,,,Fatty acid,,other/unknown,C01EB18
DB00244,Mesalazine,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,A07EC02
DB00244,Mesalazine,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,A07EC02
DB00244,Mesalazine,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,A07EC02
DB00244,Mesalazine,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,A07EC02
DB00244,Mesalazine,,O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,inhibitor,A07EC02
DB00244,Mesalazine,,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,inhibitor,A07EC02
DB00244,Mesalazine,,P35228,"Nitric oxide synthase, inducible",NOS2,inhibitor,A07EC02
DB00245,Benzatropine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N04AC01
DB00245,Benzatropine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N04AC01
DB00245,Benzatropine,,P35367,Histamine H1 receptor,HRH1,antagonist,N04AC01
DB00245,Benzatropine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N04AC01
DB00245,Benzatropine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N04AC01
DB00246,Ziprasidone,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AE04
DB00246,Ziprasidone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AE04
DB00246,Ziprasidone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N05AE04
DB00246,Ziprasidone,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,antagonist,N05AE04
DB00246,Ziprasidone,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AE04
DB00246,Ziprasidone,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AE04
DB00246,Ziprasidone,,P21918,Dopamine D5 receptor,DRD5,antagonist,N05AE04
DB00246,Ziprasidone,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AE04
DB00246,Ziprasidone,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AE04
DB00246,Ziprasidone,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,antagonist,N05AE04
DB00246,Ziprasidone,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,antagonist,N05AE04
DB00246,Ziprasidone,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N05AE04
DB00246,Ziprasidone,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N05AE04
DB00246,Ziprasidone,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AE04
DB00246,Ziprasidone,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AE04
DB00246,Ziprasidone,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AE04
DB00246,Ziprasidone,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N05AE04
DB00246,Ziprasidone,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N05AE04
DB00246,Ziprasidone,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N05AE04
DB00246,Ziprasidone,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05AE04
DB00246,Ziprasidone,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N05AE04
DB00246,Ziprasidone,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N05AE04
DB00246,Ziprasidone,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N05AE04
DB00246,Ziprasidone,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N05AE04
DB00246,Ziprasidone,,P46098,5-hydroxytryptamine 3 receptor,HTR3A,antagonist,N05AE04
DB00246,Ziprasidone,,P47898,5-hydroxytryptamine receptor 5A,HTR5A,antagonist,N05AE04
DB00247,Methysergide,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N02CA04
DB00247,Methysergide,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N02CA04
DB00247,Methysergide,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N02CA04
DB00247,Methysergide,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N02CA04
DB00247,Methysergide,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N02CA04
DB00247,Methysergide,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,binder,N02CA04
DB00247,Methysergide,,P30939,5-hydroxytryptamine receptor 1F,HTR1F,binder,N02CA04
DB00247,Methysergide,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,binder,N02CA04
DB00248,Cabergoline,,P14416,Dopamine D2 receptor,DRD2,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P35462,Dopamine D3 receptor,DRD3,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N04BC06;G02CB03
DB00248,Cabergoline,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P21917,Dopamine D4 receptor,DRD4,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N04BC06;G02CB03
DB00248,Cabergoline,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N04BC06;G02CB03
DB00248,Cabergoline,,P21918,Dopamine D5 receptor,DRD5,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P21728,Dopamine D1 receptor,DRD1,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,N04BC06;G02CB03
DB00248,Cabergoline,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N04BC06;G02CB03
DB00248,Cabergoline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,binder,N04BC06;G02CB03
DB00248,Cabergoline,,P35368,Alpha-1B adrenergic receptor,ADRA1B,binder,N04BC06;G02CB03
DB00248,Cabergoline,,P25100,Alpha-1D adrenergic receptor,ADRA1D,binder,N04BC06;G02CB03
DB00248,Cabergoline,,P08588,Beta-1 adrenergic receptor,ADRB1,binder,N04BC06;G02CB03
DB00248,Cabergoline,,P07550,Beta-2 adrenergic receptor,ADRB2,binder,N04BC06;G02CB03
DB00248,Cabergoline,,P21728,D(1) dopamine receptor,DRD1,agonist,N04BC06;G02CB03
DB00249,Idoxuridine,,,DNA,,other,D06BB01;J05AB02;S01AD01
DB00249,Idoxuridine,,Q9QNF7,Thymidine kinase,TK,unknown,D06BB01;J05AB02;S01AD01
DB00250,Dapsone,,P0C0X2,Inactive dihydropteroate synthase 2,folP2,inhibitor,J04BA50;J04BA51;D10AX05;J04BA02
DB00250,Dapsone,,P0C0X1,Dihydropteroate synthase 1,folP1,inhibitor,J04BA50;J04BA51;D10AX05;J04BA02
DB00251,Terconazole,,P10613,Cytochrome P450 51,ERG11,antagonist,G01AG02
DB00252,Phenytoin,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,N03AB02;N03AB52
DB00252,Phenytoin,,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,inhibitor,N03AB02;N03AB52
DB00252,Phenytoin,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,N03AB02;N03AB52
DB00252,Phenytoin,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,inhibitor,N03AB02;N03AB52
DB00252,Phenytoin,,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,inhibitor,N03AB02;N03AB52
DB00252,Phenytoin,,Q9UQD0,Sodium channel protein type 8 subunit alpha,SCN8A,inhibitor,N03AB02;N03AB52
DB00252,Phenytoin,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,N03AB02;N03AB52
DB00252,Phenytoin,,Q07699,Sodium channel subunit beta-1,SCN1B,,N03AB02;N03AB52
DB00252,Phenytoin,,Q9NY46,Sodium channel protein type 3 subunit alpha,SCN3A,,N03AB02;N03AB52
DB00252,Phenytoin,,P14867,GABA(A) Receptor,GABRA1,,N03AB02;N03AB52
DB00253,Medrysone,,P04150,Glucocorticoid receptor,NR3C1,agonist,S01BA08
DB00254,Doxycycline,,,30S ribosomal protein,,inhibitor,J01AA02;A01AB22;J01AA20
DB00255,Diethylstilbestrol,,Q92731,Estrogen receptor beta,ESR2,agonist,L02AA04;L02AA01;G03CC05;G03CB02
DB00255,Diethylstilbestrol,,P03372,Estrogen receptor alpha,ESR1,agonist,L02AA04;L02AA01;G03CC05;G03CB02
DB00255,Diethylstilbestrol,,P62508,Estrogen-related receptor gamma,ESRRG,agonist,L02AA04;L02AA01;G03CC05;G03CB02
DB00255,Diethylstilbestrol,,P11474,Steroid hormone receptor ERR1,ESRRA,,L02AA04;L02AA01;G03CC05;G03CB02
DB00255,Diethylstilbestrol,,O95718,Steroid hormone receptor ERR2,ESRRB,,L02AA04;L02AA01;G03CC05;G03CB02
DB00255,Diethylstilbestrol,,Q15596,Nuclear receptor coactivator 2,NCOA2,,L02AA04;L02AA01;G03CC05;G03CB02
DB00255,Diethylstilbestrol,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,L02AA04;L02AA01;G03CC05;G03CB02
DB00255,Diethylstilbestrol,,P10275,Androgen receptor,AR,antagonist,L02AA04;L02AA01;G03CC05;G03CB02
DB00255,Diethylstilbestrol,,P04278,Sex hormone-binding globulin,SHBG,,L02AA04;L02AA01;G03CC05;G03CB02
DB00256,Lymecycline,,P0A7V8,30S ribosomal protein S4,rpsD,inhibitor,J01AA04;J01AA20
DB00257,Clotrimazole,,P10613,Cytochrome P450 51,ERG11,antagonist,D01AC01;A01AB18;G01AF02;G01AF20
DB00257,Clotrimazole,,P10613,Cytochrome P450 51,ERG11,inhibitor,D01AC01;A01AB18;G01AF02;G01AF20
DB00257,Clotrimazole,,O15554,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,inhibitor,D01AC01;A01AB18;G01AF02;G01AF20
DB00257,Clotrimazole,,,Ergosterol,,inhibitor,D01AC01;A01AB18;G01AF02;G01AF20
DB00257,Clotrimazole,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,D01AC01;A01AB18;G01AF02;G01AF20
DB00257,Clotrimazole,,Q8TDS4,Hydroxycarboxylic acid receptor 2,HCAR2,partial agonist,D01AC01;A01AB18;G01AF02;G01AF20
DB00258,Calcium acetate,,,Phosphate,,binder,V03AE04;A11GB01;V03AE07
DB00259,Sulfanilamide,,P0AC13,Dihydropteroate synthase,folP,inhibitor,G01AE10;J01EB06;D06BA05
DB00260,Cycloserine,,P0A6J8,D-alanine--D-alanine ligase A,ddlA,inhibitor,J04AB01
DB00260,Cycloserine,,Q9L888,Alanine racemase,alr,inhibitor,J04AB01
DB00261,Anagrelide,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,L01XX35
DB00262,Carmustine,,,RNA,,other/unknown,L01AD01
DB00262,Carmustine,,P00390,"Glutathione reductase, mitochondrial",GSR,inhibitor,L01AD01
DB00262,Carmustine,,,DNA,,other/unknown,L01AD01
DB00263,Sulfisoxazole,,P0AC13,Dihydropteroate synthase,folP,inhibitor,J01EB05;G01AE10;S01AB02
DB00264,Metoprolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07FB02;C07FX05;C07FX03;C07FB13;C07AB02;C07BB52;C07CB02;C07BB02
DB00264,Metoprolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07FB02;C07FX05;C07FX03;C07FB13;C07AB02;C07BB52;C07CB02;C07BB02
DB00264,Metoprolol,,P08588,Beta adrenergic receptor,ADRB1,inhibitor,C07FB02;C07FX05;C07FX03;C07FB13;C07AB02;C07BB52;C07CB02;C07BB02
DB00266,Dicoumarol,,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,inhibitor,B01AA01
DB00266,Dicoumarol,,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,inhibitor,B01AA01
DB00266,Dicoumarol,,Q08257,Quinone oxidoreductase,CRYZ,inhibitor,B01AA01
DB00267,Cefmenoxime,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,S02AA18;J01DD05;S01AA31
DB00267,Cefmenoxime,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,S02AA18;J01DD05;S01AA31
DB00268,Ropinirole,,P35462,Dopamine D3 receptor,DRD3,agonist,N04BC04
DB00268,Ropinirole,,P14416,Dopamine D2 receptor,DRD2,agonist,N04BC04
DB00268,Ropinirole,,P21917,Dopamine D4 receptor,DRD4,agonist,N04BC04
DB00268,Ropinirole,,P35348,Alpha adrenergic receptor,ADRA1A,antagonist,N04BC04
DB00269,Chlorotrianisene,,P03372,Estrogen receptor alpha,ESR1,agonist,G03CA06
DB00270,Isradipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C08CA03
DB00270,Isradipine,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,inhibitor,C08CA03
DB00270,Isradipine,,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,inhibitor,C08CA03
DB00270,Isradipine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,C08CA03
DB00270,Isradipine,,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,inhibitor,C08CA03
DB00270,Isradipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,C08CA03
DB00270,Isradipine,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,C08CA03
DB00272,Betazole,,P25021,Histamine H2 receptor,HRH2,agonist,V04CG02
DB00273,Topiramate,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,A08AA51;N03AX11
DB00273,Topiramate,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,inhibitor,A08AA51;N03AX11
DB00273,Topiramate,,P39086,Kainate receptors,GRIK1,antagonist,A08AA51;N03AX11
DB00273,Topiramate,,P00918,Carbonic anhydrase 2,CA2,inhibitor,A08AA51;N03AX11
DB00273,Topiramate,,P22748,Carbonic anhydrase 4,CA4,inhibitor,A08AA51;N03AX11
DB00273,Topiramate,,Q13936,Voltage gated L-type calcium channel,CACNA1C,antagonist,A08AA51;N03AX11
DB00273,Topiramate,,P00915,Carbonic anhydrase 1,CA1,inhibitor,A08AA51;N03AX11
DB00273,Topiramate,,P07451,Carbonic anhydrase 3,CA3,inhibitor,A08AA51;N03AX11
DB00273,Topiramate,,Q15878,Voltage-dependent R-type calcium channel,CACNA1E,antagonist,A08AA51;N03AX11
DB00274,Cefmetazole,,C1KC03,Penicillin binding protein 2a,mecA,inhibitor,J01DC09
DB00274,Cefmetazole,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DC09
DB00274,Cefmetazole,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DC09
DB00274,Cefmetazole,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DC09
DB00274,Cefmetazole,,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,dacA,inhibitor,J01DC09
DB00274,Cefmetazole,,P08506,D-alanyl-D-alanine carboxypeptidase DacC,dacC,inhibitor,J01DC09
DB00275,Olmesartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,C09DA08;C09DX03;C09CA08;C09DB02
DB00276,Amsacrine,,,DNA,,intercalation,L01XX01
DB00276,Amsacrine,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,L01XX01
DB00276,Amsacrine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,L01XX01
DB00276,Amsacrine,,P02763,Alpha-1-acid glycoprotein 1,ORM1,,L01XX01
DB00276,Amsacrine,,P02768,Serum albumin,ALB,,L01XX01
DB00277,Theophylline,,P30542,Adenosine receptor A1,ADORA1,antagonist,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,P29274,Adenosine receptor A2a,ADORA2A,antagonist,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,P29275,Adenosine receptor A2b,ADORA2B,antagonist,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,inhibitor,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,inhibitor,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,Q92769,Histone deacetylase 2,HDAC2,activator,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,Q99829,Copine-1,CPNE1,,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,Q8TCT9,Minor histocompatibility antigen H13,HM13,,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,Q15155,Nodal modulator 1,NOMO1,,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,Q7Z5B4,Protein RIC-3,RIC3,,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00277,Theophylline,,Q9Y4R7,Tubulin monoglycylase TTLL3,TTLL3,,R03DA54;R03DA74;R03DA20;R03DA04;R03DB04
DB00278,Argatroban,,P00734,Prothrombin,F2,inhibitor,B01AE03
DB00279,Liothyronine,,P10827,Thyroid hormone receptor alpha,THRA,agonist,H03AA03;H03AA02
DB00279,Liothyronine,,P10828,Thyroid hormone receptor beta,THRB,agonist,H03AA03;H03AA02
DB00279,Liothyronine,,P12004,Proliferating cell nuclear antigen,PCNA,antagonist,H03AA03;H03AA02
DB00280,Disopyramide,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BA03
DB00280,Disopyramide,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,C01BA03
DB00280,Disopyramide,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,C01BA03
DB00280,Disopyramide,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,C01BA03
DB00280,Disopyramide,,Q9NZV8,Potassium voltage-gated channel subfamily D member 2,KCND2,inhibitor,C01BA03
DB00280,Disopyramide,,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,inhibitor,C01BA03
DB00280,Disopyramide,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C01BA03
DB00280,Disopyramide,,P19652,Alpha-1-acid glycoprotein 2,ORM2,,C01BA03
DB00281,Lidocaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,S01HA07;D04AB01;R02AD02;C01BB01;S02DA01;N01BB52;C05AD01;N01BB02
DB00281,Lidocaine,,Q15858,Sodium channel protein type 9 subunit alpha,SCN9A,inhibitor,S01HA07;D04AB01;R02AD02;C01BB01;S02DA01;N01BB52;C05AD01;N01BB02
DB00281,Lidocaine,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,S01HA07;D04AB01;R02AD02;C01BB01;S02DA01;N01BB52;C05AD01;N01BB02
DB00281,Lidocaine,,P00533,Epidermal growth factor receptor,EGFR,antagonist,S01HA07;D04AB01;R02AD02;C01BB01;S02DA01;N01BB52;C05AD01;N01BB02
DB00281,Lidocaine,,P35499,Sodium channel protein type 4 subunit alpha,SCN4A,,S01HA07;D04AB01;R02AD02;C01BB01;S02DA01;N01BB52;C05AD01;N01BB02
DB00281,Lidocaine,,P02763,Alpha-1-acid glycoprotein 1,ORM1,,S01HA07;D04AB01;R02AD02;C01BB01;S02DA01;N01BB52;C05AD01;N01BB02
DB00281,Lidocaine,,P19652,Alpha-1-acid glycoprotein 2,ORM2,,S01HA07;D04AB01;R02AD02;C01BB01;S02DA01;N01BB52;C05AD01;N01BB02
DB00282,Pamidronic acid,,P14324,Farnesyl pyrophosphate synthase,FDPS,inhibitor,M05BA03
DB00282,Pamidronic acid,,,Hydroxylapatite,,antagonist,M05BA03
DB00282,Pamidronic acid,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,inhibitor,M05BA03
DB00282,Pamidronic acid,,P42574,Caspase-3,CASP3,activator,M05BA03
DB00282,Pamidronic acid,,P55211,Caspase-9,CASP9,activator,M05BA03
DB00283,Clemastine,,P35367,Histamine H1 receptor,HRH1,antagonist,D04AA14;R06AA54;R06AA04
DB00284,Acarbose,,O43451,"Maltase-glucoamylase, intestinal",MGAM,inhibitor,A10BD17;A10BF01
DB00284,Acarbose,,P14410,"Sucrase-isomaltase, intestinal",SI,inhibitor,A10BD17;A10BF01
DB00284,Acarbose,,P04746,Pancreatic alpha-amylase,AMY2A,inhibitor,A10BD17;A10BF01
DB00284,Acarbose,,P10253,Lysosomal alpha-glucosidase,GAA,inhibitor,A10BD17;A10BF01
DB00285,Venlafaxine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX16
DB00285,Venlafaxine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AX16
DB00285,Venlafaxine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06AX16
DB00286,Conjugated estrogens,,Q92731,Estrogen receptor beta,ESR2,agonist,G03CA57;G03CC07
DB00286,Conjugated estrogens,,P03372,Estrogen receptor alpha,ESR1,agonist,G03CA57;G03CC07
DB00287,Travoprost,,P43088,Prostaglandin F2-alpha receptor,PTGFR,agonist,S01EE04
DB00288,Amcinonide,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AC11
DB00288,Amcinonide,,P04083,Annexin A1,ANXA1,agonist,D07AC11
DB00289,Atomoxetine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06BA09
DB00289,Atomoxetine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,binder,N06BA09
DB00289,Atomoxetine,,Q05586,NMDA receptor,GRIN1,blocker,N06BA09
DB00289,Atomoxetine,,P48549,G protein-activated inward rectifier potassium channel 1,KCNJ3,inhibitor,N06BA09
DB00289,Atomoxetine,,P41145,Kappa-type opioid receptor,OPRK1,partial agonist,N06BA09
DB00290,Bleomycin,,,DNA,,cleavage,L01DC01
DB00290,Bleomycin,,P18858,DNA ligase 1,LIG1,inhibitor,L01DC01
DB00290,Bleomycin,,P49916,DNA ligase 3,LIG3,inhibitor,L01DC01
DB00291,Chlorambucil,,,DNA,,cross-linking/alkylation,L01AA02
DB00292,Etomidate,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,N01AX07
DB00292,Etomidate,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,N01AX07
DB00292,Etomidate,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N01AX07
DB00293,Raltitrexed,,P04818,Thymidylate synthase,TYMS,inhibitor,L01BA03
DB00293,Raltitrexed,,Q05932,"Folylpolyglutamate synthase, mitochondrial",FPGS,antagonist,L01BA03
DB00294,Etonogestrel,,P06401,Progesterone receptor,PGR,agonist,G03AC08
DB00295,Morphine,,P35372,Mu-type opioid receptor,OPRM1,agonist,A07DA52;N02AA51;N02AA01;N02AG01
DB00295,Morphine,,P35372,Mu-type opioid receptor,OPRM1,regulator,A07DA52;N02AA51;N02AA01;N02AG01
DB00295,Morphine,,P41145,Kappa-type opioid receptor,OPRK1,agonist,A07DA52;N02AA51;N02AA01;N02AG01
DB00295,Morphine,,P41143,Delta-type opioid receptor,OPRD1,agonist,A07DA52;N02AA51;N02AA01;N02AG01
DB00295,Morphine,,Q9Y6Y9,Lymphocyte antigen 96,LY96,activator,A07DA52;N02AA51;N02AA01;N02AG01
DB00296,Ropivacaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,N01BB09
DB00297,Bupivacaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,N01BB01;N01BB59;N01BB51
DB00297,Bupivacaine,,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,other/unknown,N01BB01;N01BB59;N01BB51
DB00298,Dapiprazole,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,S01EX02
DB00298,Dapiprazole,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,S01EX02
DB00298,Dapiprazole,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,S01EX02
DB00299,Penciclovir,,P04293,DNA polymerase catalytic subunit,,inhibitor,D06BB06;J05AB13
DB00299,Penciclovir,,P06478,Thymidine kinase,TK,inducer,D06BB06;J05AB13
DB00300,Tenofovir disoproxil,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AR27;J05AF07;J05AR08;J05AR11;J05AR09;J05AR06;J05AR24;J05AR12;J05AR03
DB00300,Tenofovir disoproxil,,P24024,DNA polymerase/reverse transcriptase,P,inhibitor,J05AR27;J05AF07;J05AR08;J05AR11;J05AR09;J05AR06;J05AR24;J05AR12;J05AR03
DB00301,Flucloxacillin,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CF05
DB00302,Tranexamic acid,,P00747,Plasminogen,PLG,inhibitor,B02AA02
DB00303,Ertapenem,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DH03
DB00303,Ertapenem,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DH03
DB00303,Ertapenem,,P44469,Penicillin-binding protein 2,mrdA,inhibitor,J01DH03
DB00303,Ertapenem,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01DH03
DB00303,Ertapenem,,P45059,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DH03
DB00303,Ertapenem,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DH03
DB00303,Ertapenem,,P24228,D-alanyl-D-alanine carboxypeptidase DacB,dacB,inhibitor,J01DH03
DB00303,Ertapenem,,P08506,D-alanyl-D-alanine carboxypeptidase DacC,dacC,inhibitor,J01DH03
DB00304,Desogestrel,,P06401,Progesterone receptor,PGR,agonist,G03AC09;G03FB10;G03AB05;G03AA09
DB00304,Desogestrel,,P03372,Estrogen receptor alpha,ESR1,agonist,G03AC09;G03FB10;G03AB05;G03AA09
DB00305,Mitomycin,,,DNA,,cross-linking/alkylation,L01DC03
DB00306,Talbutal,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CA07
DB00306,Talbutal,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CA07
DB00306,Talbutal,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N05CA07
DB00306,Talbutal,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CA07
DB00306,Talbutal,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N05CA07
DB00306,Talbutal,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CA07
DB00306,Talbutal,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CA07
DB00306,Talbutal,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CA07
DB00306,Talbutal,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CA07
DB00306,Talbutal,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CA07
DB00306,Talbutal,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CA07
DB00307,Bexarotene,,P19793,Retinoic acid receptor RXR-alpha,RXRA,agonist,L01XF03
DB00307,Bexarotene,,P28702,Retinoic acid receptor RXR-beta,RXRB,agonist,L01XF03
DB00307,Bexarotene,,P48443,Retinoic acid receptor RXR-gamma,RXRG,agonist,L01XF03
DB00308,Ibutilide,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,activator,C01BD05
DB00308,Ibutilide,,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,activator,C01BD05
DB00308,Ibutilide,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C01BD05
DB00308,Ibutilide,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,activator,C01BD05
DB00308,Ibutilide,,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,activator,C01BD05
DB00308,Ibutilide,,O00180,Potassium channel subfamily K member 1,KCNK1,inhibitor,C01BD05
DB00308,Ibutilide,,Q9Y257,Potassium channel subfamily K member 6,KCNK6,inhibitor,C01BD05
DB00308,Ibutilide,,Q9H252,Potassium voltage-gated channel subfamily H member 6,KCNH6,inhibitor,C01BD05
DB00308,Ibutilide,,Q9NS40,Potassium voltage-gated channel subfamily H member 7,KCNH7,inhibitor,C01BD05
DB00308,Ibutilide,,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,inhibitor,C01BD05
DB00309,Vindesine,,Q9H4B7,Tubulin beta-1 chain,TUBB1,inhibitor,L01CA03
DB00310,Chlorthalidone,,P00915,Carbonic anhydrase 1,CA1,inhibitor,G01AE10;C03EA06;C03BB04;C03BA04
DB00310,Chlorthalidone,,Q13621,Solute carrier family 12 member 1,SLC12A1,inhibitor,G01AE10;C03EA06;C03BB04;C03BA04
DB00311,Ethoxzolamide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,
DB00311,Ethoxzolamide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,
DB00311,Ethoxzolamide,,P43166,Carbonic anhydrase 7,CA7,inhibitor,
DB00311,Ethoxzolamide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,
DB00311,Ethoxzolamide,,P07451,Carbonic anhydrase 3,CA3,inhibitor,
DB00312,Pentobarbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CB01;N05CA01
DB00312,Pentobarbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CB01;N05CA01
DB00312,Pentobarbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CB01;N05CA01
DB00312,Pentobarbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N05CB01;N05CA01
DB00312,Pentobarbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CB01;N05CA01
DB00312,Pentobarbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N05CB01;N05CA01
DB00312,Pentobarbital,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CB01;N05CA01
DB00312,Pentobarbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CB01;N05CA01
DB00312,Pentobarbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CB01;N05CA01
DB00312,Pentobarbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CB01;N05CA01
DB00312,Pentobarbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CB01;N05CA01
DB00312,Pentobarbital,,Q05586,NMDA receptor,GRIN1,antagonist,N05CB01;N05CA01
DB00312,Pentobarbital,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,N05CB01;N05CA01
DB00313,Valproic acid,,Q9UKV0,Histone deacetylase 9,HDAC9,inhibitor,N03AG01
DB00313,Valproic acid,,P45954,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",ACADSB,inhibitor,N03AG01
DB00313,Valproic acid,,Q02218,"2-oxoglutarate dehydrogenase, mitochondrial",OGDH,inhibitor,N03AG01
DB00313,Valproic acid,,P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,inhibitor,N03AG01
DB00313,Valproic acid,,P35498,Sodium channel protein,SCN1A,inhibitor,N03AG01
DB00313,Valproic acid,,Q92769,Histone deacetylase 2,HDAC2,inhibitor,N03AG01
DB00313,Valproic acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,N03AG01
DB00313,Valproic acid,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,N03AG01
DB00313,Valproic acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,N03AG01
DB00313,Valproic acid,,Q13547,Histone deacetylase,HDAC1,inhibitor,N03AG01
DB00313,Valproic acid,,P38936,Cyclin-dependent kinase inhibitor 1,CDKN1A,regulator,N03AG01
DB00313,Valproic acid,,P14210,Hepatocyte growth factor,HGF,inhibitor,N03AG01
DB00313,Valproic acid,,P11926,Ornithine decarboxylase,ODC1,downregulator,N03AG01
DB00313,Valproic acid,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,downregulator,N03AG01
DB00314,Capreomycin,,P9WJ63,16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA,tlyA,inhibitor,J04AB30
DB00315,Zolmitriptan,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N02CC03
DB00315,Zolmitriptan,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N02CC03
DB00315,Zolmitriptan,,P30939,5-hydroxytryptamine receptor 1F,HTR1F,agonist,N02CC03
DB00315,Zolmitriptan,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,agonist,N02CC03
DB00315,Zolmitriptan,,P34969,5-hydroxytryptamine receptor 7,HTR7,agonist,N02CC03
DB00315,Zolmitriptan,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N02CC03
DB00315,Zolmitriptan,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,N02CC03
DB00315,Zolmitriptan,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,agonist,N02CC03
DB00316,Acetaminophen,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,N02BE71;N02BE01;N02AJ13;N02AJ17;N02BE51;N02AJ06;N02AJ01
DB00316,Acetaminophen,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,N02BE71;N02BE01;N02AJ13;N02AJ17;N02BE51;N02AJ06;N02AJ01
DB00316,Acetaminophen,,Q15185,Prostaglandin E synthase 3,PTGES3,inhibitor,N02BE71;N02BE01;N02AJ13;N02AJ17;N02BE51;N02AJ06;N02AJ01
DB00316,Acetaminophen,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,activator,N02BE71;N02BE01;N02AJ13;N02AJ17;N02BE51;N02AJ06;N02AJ01
DB00317,Gefitinib,,P00533,Epidermal growth factor receptor,EGFR,antagonist,L01EB01
DB00318,Codeine,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AA79;R05DA04;N02AA59;N02AJ08;N02AJ06;N02AJ07
DB00318,Codeine,,P35372,Mu-type opioid receptor,OPRM1,regulator,N02AA79;R05DA04;N02AA59;N02AJ08;N02AJ06;N02AJ07
DB00318,Codeine,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N02AA79;R05DA04;N02AA59;N02AJ08;N02AJ06;N02AJ07
DB00318,Codeine,,P41143,Delta-type opioid receptor,OPRD1,agonist,N02AA79;R05DA04;N02AA59;N02AJ08;N02AJ06;N02AJ07
DB00319,Piperacillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CR50;J01CA12
DB00319,Piperacillin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01CR50;J01CA12
DB00319,Piperacillin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01CR50;J01CA12
DB00319,Piperacillin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01CR50;J01CA12
DB00320,Dihydroergotamine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P30939,5-hydroxytryptamine receptor 1F,HTR1F,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P14416,Dopamine D2 receptor,DRD2,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P35462,Dopamine D3 receptor,DRD3,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P21917,Dopamine D4 receptor,DRD4,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,Q13639,5-hydroxytryptamine receptor 4,HTR4,agonist,N02CA51;N02CA01
DB00320,Dihydroergotamine,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,N02CA51;N02CA01
DB00321,Amitriptyline,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA09;N06CA01
DB00321,Amitriptyline,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA09;N06CA01
DB00321,Amitriptyline,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,inhibitor,N06AA09;N06CA01
DB00321,Amitriptyline,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,inducer,N06AA09;N06CA01
DB00321,Amitriptyline,,P41143,Delta-type opioid receptor,OPRD1,agonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P04629,High affinity nerve growth factor receptor,NTRK1,agonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P04629,High affinity nerve growth factor receptor,NTRK1,activator,N06AA09;N06CA01
DB00321,Amitriptyline,,Q16620,BDNF/NT-3 growth factors receptor,NTRK2,agonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,inhibitor,N06AA09;N06CA01
DB00321,Amitriptyline,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AA09;N06CA01
DB00321,Amitriptyline,,O43526,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,inhibitor,N06AA09;N06CA01
DB00321,Amitriptyline,,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,inhibitor,N06AA09;N06CA01
DB00321,Amitriptyline,,P25021,Histamine H2 receptor,HRH2,blocker,N06AA09;N06CA01
DB00321,Amitriptyline,,Q9H3N8,Histamine H4 receptor,HRH4,binder,N06AA09;N06CA01
DB00321,Amitriptyline,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,agonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,binder,N06AA09;N06CA01
DB00321,Amitriptyline,,P35372,Mu-type opioid receptor,OPRM1,binder,N06AA09;N06CA01
DB00321,Amitriptyline,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,binder,N06AA09;N06CA01
DB00321,Amitriptyline,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N06AA09;N06CA01
DB00321,Amitriptyline,,O43525,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,inhibitor,N06AA09;N06CA01
DB00321,Amitriptyline,,P08909,5-hydroxytryptamine receptor 1C,Htr2c,antagonist,N06AA09;N06CA01
DB00321,Amitriptyline,,P11229,Muscarinic acetylcholine receptor,CHRM1,ligand,N06AA09;N06CA01
DB00321,Amitriptyline,,Q12809,HERG human cardiac K+ channel,KCNH2,blocker,N06AA09;N06CA01
DB00322,Floxuridine,,P04818,Thymidylate synthase,TYMS,,L01BC09
DB00323,Tolcapone,,P21964,Catechol O-methyltransferase,COMT,inhibitor,N04BX01
DB00324,Fluorometholone,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07XB04;D07AB06;S01BA07;S01BB03;C05AA06;D07CB03;S01CB05;S01CA07;D10AA01
DB00325,Nitroprusside,,P16066,Atrial natriuretic peptide receptor 1,NPR1,agonist,C02DD01
DB00327,Hydromorphone,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AA53;N02AA03;N02AG04
DB00327,Hydromorphone,,P41143,Delta-type opioid receptor,OPRD1,partial agonist,N02AA53;N02AA03;N02AG04
DB00327,Hydromorphone,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N02AA53;N02AA03;N02AG04
DB00328,Indomethacin,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00328,Indomethacin,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,inhibitor,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00328,Indomethacin,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00328,Indomethacin,,Q8N8N7,Prostaglandin reductase 2,PTGR2,inhibitor,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00328,Indomethacin,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,activator,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00328,Indomethacin,,Q04760,Lactoylglutathione lyase,GLO1,inhibitor,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00328,Indomethacin,,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,other/unknown,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00328,Indomethacin,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00328,Indomethacin,,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,inhibitor,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00328,Indomethacin,,P19525,"Interferon-induced, double-stranded RNA-activated protein kinase",EIF2AK2,inducer,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00328,Indomethacin,,P23219,Human Cyclooxygenases,PTGS1,inhibitor,S01CC02;M01AB51;S01BC01;M02AA23;M01AB01;C01EB03
DB00330,Ethambutol,,P9WNL5,Probable arabinosyltransferase C,embC,inhibitor,J04AK02;J04AM03;J04AM06;J04AM07
DB00330,Ethambutol,,P9WNL7,Probable arabinosyltransferase B,embB,inhibitor,J04AK02;J04AM03;J04AM06;J04AM07
DB00330,Ethambutol,,P9WNL9,Probable arabinosyltransferase A,embA,inhibitor,J04AK02;J04AM03;J04AM06;J04AM07
DB00331,Metformin,,Q16134,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial",ETFDH,inhibitor,A10BD23;A10BD02;A10BD18;A10BD11;A10BD25;A10BA02;A10BD22;A10BD14;A10BD16;A10BD17;A10BD05;A10BD15;A10BD07;A10BD10;A10BD13;A10BD26;A10BD20;A10BD08;A10BD27;A10BD03
DB00331,Metformin,,Q9Y478,5'-AMP-activated protein kinase subunit beta-1,PRKAB1,inducer,A10BD23;A10BD02;A10BD18;A10BD11;A10BD25;A10BA02;A10BD22;A10BD14;A10BD16;A10BD17;A10BD05;A10BD15;A10BD07;A10BD10;A10BD13;A10BD26;A10BD20;A10BD08;A10BD27;A10BD03
DB00331,Metformin,,Q9Y478,5'-AMP-activated protein kinase subunit beta-1,PRKAB1,activator,A10BD23;A10BD02;A10BD18;A10BD11;A10BD25;A10BA02;A10BD22;A10BD14;A10BD16;A10BD17;A10BD05;A10BD15;A10BD07;A10BD10;A10BD13;A10BD26;A10BD20;A10BD08;A10BD27;A10BD03
DB00331,Metformin,,P21695,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",GPD1,inhibitor,A10BD23;A10BD02;A10BD18;A10BD11;A10BD25;A10BA02;A10BD22;A10BD14;A10BD16;A10BD17;A10BD05;A10BD15;A10BD07;A10BD10;A10BD13;A10BD26;A10BD20;A10BD08;A10BD27;A10BD03
DB00332,Ipratropium,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,R03BB01;R01AX03;R03AL01;R03AL02
DB00332,Ipratropium,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,R03BB01;R01AX03;R03AL01;R03AL02
DB00332,Ipratropium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,R03BB01;R01AX03;R03AL01;R03AL02
DB00333,Methadone,,P35372,Mu-type opioid receptor,OPRM1,agonist,N07BC02;N02AC52
DB00333,Methadone,,Q05586,NMDA receptor,GRIN1,antagonist,N07BC02;N02AC52
DB00333,Methadone,,P41143,Delta-type opioid receptor,OPRD1,agonist,N07BC02;N02AC52
DB00333,Methadone,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,agonist,N07BC02;N02AC52
DB00333,Methadone,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,N07BC02;N02AC52
DB00333,Methadone,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,antagonist,N07BC02;N02AC52
DB00333,Methadone,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N07BC02;N02AC52
DB00333,Methadone,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,antagonist,N07BC02;N02AC52
DB00334,Olanzapine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P21918,Dopamine D5 receptor,DRD5,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P21728,D(1) dopamine receptor,DRD1,antagonist,N05AH53;N05AH03
DB00334,Olanzapine,,P08588,Beta adrenergic receptor,ADRB1,inhibitor,N05AH53;N05AH03
DB00334,Olanzapine,,P08908,5-hydroxytryptamine receptor 1,HTR1A,inhibitor,N05AH53;N05AH03
DB00334,Olanzapine,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,inhibitor,N05AH53;N05AH03
DB00335,Atenolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07CB53;C07AB03;C07FB03;C07DB01;C07BB03;C07CB03
DB00335,Atenolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07CB53;C07AB03;C07FB03;C07DB01;C07BB03;C07CB03
DB00336,Nitrofural,,P06715,Glutathione reductase,gor,inhibitor,B05CA03;S02AA02;D08AF01;D09AA03;S01AX04;P01CC02
DB00337,Pimecrolimus,,P42345,Serine/threonine-protein kinase mTOR,MTOR,potentiator,D11AH02
DB00337,Pimecrolimus,,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,potentiator,D11AH02
DB00338,Omeprazole,,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,inhibitor,A02BC01;A02BD05;A02BD16;A02BD01
DB00338,Omeprazole,,P35869,Aryl hydrocarbon receptor,AHR,agonist,A02BC01;A02BD05;A02BD16;A02BD01
DB00339,Pyrazinamide,,P95029,Fatty acid synthetase,fas,inhibitor,J04AK01;J04AM06;J04AM05
DB00340,Metixene,,P11229,Muscarinic acetylcholine receptor,CHRM1,antagonist,N04AA03
DB00341,Cetirizine,,P35367,Histamine H1 receptor,HRH1,antagonist,S01GX12;R06AE07
DB00342,Terfenadine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX12
DB00342,Terfenadine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,R06AX12
DB00342,Terfenadine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,binder,R06AX12
DB00342,Terfenadine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,binder,R06AX12
DB00342,Terfenadine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,binder,R06AX12
DB00342,Terfenadine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,binder,R06AX12
DB00342,Terfenadine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,R06AX12
DB00343,Diltiazem,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,blocker,C08DB01;C05AE03
DB00343,Diltiazem,,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,blocker,C08DB01;C05AE03
DB00344,Protriptyline,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA11
DB00344,Protriptyline,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA11
DB00346,Alfuzosin,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,G04CA01;G04CA51
DB00346,Alfuzosin,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,G04CA01;G04CA51
DB00346,Alfuzosin,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,G04CA01;G04CA51
DB00346,Alfuzosin,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,G04CA01;G04CA51
DB00347,Trimethadione,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,N03AC02
DB00348,Nitisinone,,P32754,4-hydroxyphenylpyruvate dioxygenase,HPD,inhibitor,A16AX04
DB00349,Clobazam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA09
DB00349,Clobazam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA09
DB00350,Minoxidil,,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,inducer,D11AX01;C02DC01
DB00350,Minoxidil,,P00797,Renin,REN,,D11AX01;C02DC01
DB00350,Minoxidil,,P23219,Prostaglandin G/H synthase 1,PTGS1,inducer,D11AX01;C02DC01
DB00351,Megestrol acetate,,P06401,Progesterone receptor,PGR,agonist,G03FB04;G03DB02;G03FA08;G03AC05;L02AB01;G03AA04;G03AB01
DB00351,Megestrol acetate,,P04150,Glucocorticoid receptor,NR3C1,agonist,G03FB04;G03DB02;G03FA08;G03AC05;L02AB01;G03AA04;G03AB01
DB00352,Tioguanine,,,DNA,,intercalation,L01BB03
DB00353,Methylergometrine,,P21728,Dopamine D1 receptor,DRD1,antagonist,G02AC01;G02AB01
DB00353,Methylergometrine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,,G02AC01;G02AB01
DB00354,Buclizine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AE51;R06AE01
DB00354,Buclizine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,R06AE51;R06AE01
DB00355,Aztreonam,,P42971,Penicillin-binding protein 3,pbpC,inhibitor,J01DF01
DB00355,Aztreonam,,P05193,Beta-lactamase,ampC,potentiator,J01DF01
DB00355,Aztreonam,,Q47066,Beta-lactamase Toho-1,bla,substrate,J01DF01
DB00356,Chlorzoxazone,,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,,M03BB03;M03BB53;M03BB73
DB00357,Aminoglutethimide,,P05108,"Cholesterol side-chain cleavage enzyme, mitochondrial",CYP11A1,inhibitor,L02BG01
DB00357,Aminoglutethimide,,P11511,Cytochrome P450 19A1,CYP19A1,inhibitor,L02BG01
DB00358,Mefloquine,,,Fe(II)-protoporphyrin IX,,binder,P01BF02;P01BC02
DB00358,Mefloquine,,,80S ribosomal subunit,,binder,P01BF02;P01BC02
DB00358,Mefloquine,,P29274,Adenosine receptor A2a,ADORA2A,antagonist,P01BF02;P01BC02
DB00359,Sulfadiazine,,Q27738,Dihydropteroate synthetase,,inhibitor,J01EE06;J01EC02;G01AE10;J01EE02
DB00360,Sapropterin,,P00439,Phenylalanine-4-hydroxylase,PAH,cofactor,A16AX07
DB00360,Sapropterin,,P29474,"Nitric oxide synthase, endothelial",NOS3,cofactor,A16AX07
DB00360,Sapropterin,,P07101,Tyrosine 3-monooxygenase,TH,cofactor,A16AX07
DB00360,Sapropterin,,P17752,Tryptophan 5-hydroxylase 1,TPH1,cofactor,A16AX07
DB00361,Vinorelbine,,P07437,Tubulin beta chain,TUBB,antagonist,L01CA04
DB00361,Vinorelbine,,P07437,Tubulin beta chain,TUBB,inhibitor,L01CA04
DB00362,Anidulafungin,,A2QLK4,"1,3-beta-glucan synthase component FKS1",fksA,inhibitor,J02AX06
DB00363,Clozapine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AH02
DB00363,Clozapine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AH02
DB00363,Clozapine,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AH02
DB00363,Clozapine,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AH02
DB00363,Clozapine,,P21918,Dopamine D5 receptor,DRD5,binder,N05AH02
DB00363,Clozapine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AH02
DB00363,Clozapine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,antagonist,N05AH02
DB00363,Clozapine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,antagonist,N05AH02
DB00363,Clozapine,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,antagonist,N05AH02
DB00363,Clozapine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AH02
DB00363,Clozapine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,N05AH02
DB00363,Clozapine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AH02
DB00363,Clozapine,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N05AH02
DB00363,Clozapine,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N05AH02
DB00363,Clozapine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N05AH02
DB00363,Clozapine,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AH02
DB00363,Clozapine,,Q9H3N8,Histamine H4 receptor,HRH4,antagonist,N05AH02
DB00363,Clozapine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AH02
DB00363,Clozapine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AH02
DB00363,Clozapine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N05AH02
DB00363,Clozapine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N05AH02
DB00363,Clozapine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,partial agonist,N05AH02
DB00363,Clozapine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,partial agonist,N05AH02
DB00363,Clozapine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N05AH02
DB00363,Clozapine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,partial agonist,N05AH02
DB00363,Clozapine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N05AH02
DB00363,Clozapine,,Q9NYX4,Neuron-specific vesicular protein calcyon,CALY,unknown,N05AH02
DB00363,Clozapine,,P09211,Glutathione S-transferase P,GSTP1,,N05AH02
DB00363,Clozapine,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,positive modulator,N05AH02
DB00363,Clozapine,,O75899,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,positive modulator,N05AH02
DB00363,Clozapine,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,antagonist,N05AH02
DB00363,Clozapine,,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,antagonist,N05AH02
DB00363,Clozapine,,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,antagonist,N05AH02
DB00364,Sucralfate,,P0DJD9,Pepsin A-5,PGA5,inhibitor,A02BX02
DB00364,Sucralfate,,P09038,Fibroblast growth factor 2,FGF2,agonist,A02BX02
DB00364,Sucralfate,,P09038,Fibroblast growth factor 2,FGF2,inducer,A02BX02
DB00364,Sucralfate,,P01133,Pro-epidermal growth factor,EGF,inducer,A02BX02
DB00364,Sucralfate,,P02671,Fibrinogen,FGA,binder,A02BX02
DB00365,Grepafloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MA11
DB00365,Grepafloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA11
DB00366,Doxylamine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AA09;R06AA59
DB00366,Doxylamine,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,,R06AA09;R06AA59
DB00366,Doxylamine,,P11229,Muscarinic acetylcholine receptor,CHRM1,antagonist,R06AA09;R06AA59
DB00367,Levonorgestrel,,P06401,Progesterone receptor,PGR,modulator,G03AB03;G03AD01;G03AC03;G03FB09;G03AA07;G03FA11
DB00367,Levonorgestrel,,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,inhibitor,G03AB03;G03AD01;G03AC03;G03FB09;G03AA07;G03FA11
DB00367,Levonorgestrel,,P03372,Estrogen receptor alpha,ESR1,other/unknown,G03AB03;G03AD01;G03AC03;G03FB09;G03AA07;G03FA11
DB00367,Levonorgestrel,,P10275,Androgen receptor,AR,binder,G03AB03;G03AD01;G03AC03;G03FB09;G03AA07;G03FA11
DB00367,Levonorgestrel,,P04278,Sex hormone-binding globulin,SHBG,inhibitor,G03AB03;G03AD01;G03AC03;G03FB09;G03AA07;G03FA11
DB00367,Levonorgestrel,,P04278,Sex hormone-binding globulin,SHBG,binder,G03AB03;G03AD01;G03AC03;G03FB09;G03AA07;G03FA11
DB00367,Levonorgestrel,,P04150,Glucocorticoid receptor,NR3C1,binder,G03AB03;G03AD01;G03AC03;G03FB09;G03AA07;G03FA11
DB00368,Norepinephrine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,C01CA03
DB00368,Norepinephrine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,C01CA03
DB00368,Norepinephrine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,agonist,C01CA03
DB00368,Norepinephrine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,C01CA03
DB00368,Norepinephrine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,C01CA03
DB00368,Norepinephrine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,C01CA03
DB00368,Norepinephrine,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,C01CA03
DB00368,Norepinephrine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,C01CA03
DB00368,Norepinephrine,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,C01CA03
DB00368,Norepinephrine,,P00439,Phenylalanine-4-hydroxylase,PAH,inhibitor,C01CA03
DB00368,Norepinephrine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,binder,C01CA03
DB00368,Norepinephrine,,P54219,Chromaffin granule amine transporter,SLC18A1,binder,C01CA03
DB00369,Cidofovir,,P08546,DNA polymerase catalytic subunit,UL54,inhibitor,J05AB12
DB00370,Mirtazapine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AX11
DB00370,Mirtazapine,,Q9UE69,5HT3 serotonin receptor,,antagonist,N06AX11
DB00370,Mirtazapine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N06AX11
DB00370,Mirtazapine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N06AX11
DB00370,Mirtazapine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AX11
DB00370,Mirtazapine,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N06AX11
DB00370,Mirtazapine,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AX11
DB00371,Meprobamate,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BC51;N05CX01;N05BC01
DB00371,Meprobamate,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,N05BC51;N05CX01;N05BC01
DB00371,Meprobamate,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,agonist,N05BC51;N05CX01;N05BC01
DB00371,Meprobamate,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,agonist,N05BC51;N05CX01;N05BC01
DB00371,Meprobamate,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,agonist,N05BC51;N05CX01;N05BC01
DB00371,Meprobamate,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,agonist,N05BC51;N05CX01;N05BC01
DB00371,Meprobamate,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,agonist,N05BC51;N05CX01;N05BC01
DB00372,Thiethylperazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,R06AD03
DB00373,Timolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07AA06;S01ED51;C07BA06;C07DA06;S01ED01
DB00373,Timolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07AA06;S01ED51;C07BA06;C07DA06;S01ED01
DB00373,Timolol,,P00720,Lysozyme,E,,C07AA06;S01ED51;C07BA06;C07DA06;S01ED01
DB00374,Treprostinil,,P43119,Prostacyclin receptor,PTGIR,agonist,B01AC21
DB00374,Treprostinil,,P43116,Prostaglandin E2 receptor EP2 subtype,PTGER2,agonist,B01AC21
DB00374,Treprostinil,,Q13258,Prostaglandin D2 receptor,PTGDR,agonist,B01AC21
DB00374,Treprostinil,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,agonist,B01AC21
DB00374,Treprostinil,,Q9H244,P2Y purinoceptor 12,P2RY12,agonist,B01AC21
DB00375,Colestipol,,,Bile acids,,binder,C10AC02
DB00376,Trihexyphenidyl,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N04AA01
DB00376,Trihexyphenidyl,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N04AA01
DB00376,Trihexyphenidyl,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N04AA01
DB00376,Trihexyphenidyl,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N04AA01
DB00376,Trihexyphenidyl,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N04AA01
DB00377,Palonosetron,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,A04AA55;A04AA05
DB00378,Dydrogesterone,,P06401,Progesterone receptor,PGR,agonist,G03FA14;G03DB01;G03FB08
DB00379,Mexiletine,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BB02
DB00379,Mexiletine,,P35869,Aryl hydrocarbon receptor,AHR,agonist,C01BB02
DB00380,Dexrazoxane,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,V03AF02
DB00380,Dexrazoxane,,Q02880,DNA topoisomerase 2-beta,TOP2B,,V03AF02
DB00381,Amlodipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C09BB13;C09BB04;C10BX18;C07FB12;C09DB05;C09XA53;C10BX03;C09BX04;C09DB07;C09DX06;C09BX01;C10BX11;C09DB02;C10BX09;C09DX01;C10BX19;C09DB01;C09XA54;C10BX07;C09BB03;C07FB07;C09DB06;C07FB13;C09DX08;C08CA01;C09BX03;C09DB04;C09DX03;C08GA02;C08CA51;C09DB09;C10BX14;C09BB07;C09DX07
DB00381,Amlodipine,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,inhibitor,C09BB13;C09BB04;C10BX18;C07FB12;C09DB05;C09XA53;C10BX03;C09BX04;C09DB07;C09DX06;C09BX01;C10BX11;C09DB02;C10BX09;C09DX01;C10BX19;C09DB01;C09XA54;C10BX07;C09BB03;C07FB07;C09DB06;C07FB13;C09DX08;C08CA01;C09BX03;C09DB04;C09DX03;C08GA02;C08CA51;C09DB09;C10BX14;C09BB07;C09DX07
DB00381,Amlodipine,,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,inhibitor,C09BB13;C09BB04;C10BX18;C07FB12;C09DB05;C09XA53;C10BX03;C09BX04;C09DB07;C09DX06;C09BX01;C10BX11;C09DB02;C10BX09;C09DX01;C10BX19;C09DB01;C09XA54;C10BX07;C09BB03;C07FB07;C09DB06;C07FB13;C09DX08;C08CA01;C09BX03;C09DB04;C09DX03;C08GA02;C08CA51;C09DB09;C10BX14;C09BB07;C09DX07
DB00381,Amlodipine,,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,inhibitor,C09BB13;C09BB04;C10BX18;C07FB12;C09DB05;C09XA53;C10BX03;C09BX04;C09DB07;C09DX06;C09BX01;C10BX11;C09DB02;C10BX09;C09DX01;C10BX19;C09DB01;C09XA54;C10BX07;C09BB03;C07FB07;C09DB06;C07FB13;C09DX08;C08CA01;C09BX03;C09DB04;C09DX03;C08GA02;C08CA51;C09DB09;C10BX14;C09BB07;C09DX07
DB00381,Amlodipine,,Q8IZS8,Voltage-dependent calcium channel subunit alpha-2/delta-3,CACNA2D3,inhibitor,C09BB13;C09BB04;C10BX18;C07FB12;C09DB05;C09XA53;C10BX03;C09BX04;C09DB07;C09DX06;C09BX01;C10BX11;C09DB02;C10BX09;C09DX01;C10BX19;C09DB01;C09XA54;C10BX07;C09BB03;C07FB07;C09DB06;C07FB13;C09DX08;C08CA01;C09BX03;C09DB04;C09DX03;C08GA02;C08CA51;C09DB09;C10BX14;C09BB07;C09DX07
DB00381,Amlodipine,,P00915,Carbonic anhydrase 1,CA1,inhibitor,C09BB13;C09BB04;C10BX18;C07FB12;C09DB05;C09XA53;C10BX03;C09BX04;C09DB07;C09DX06;C09BX01;C10BX11;C09DB02;C10BX09;C09DX01;C10BX19;C09DB01;C09XA54;C10BX07;C09BB03;C07FB07;C09DB06;C07FB13;C09DX08;C08CA01;C09BX03;C09DB04;C09DX03;C08GA02;C08CA51;C09DB09;C10BX14;C09BB07;C09DX07
DB00381,Amlodipine,,P17405,Sphingomyelin phosphodiesterase,SMPD1,inhibitor,C09BB13;C09BB04;C10BX18;C07FB12;C09DB05;C09XA53;C10BX03;C09BX04;C09DB07;C09DX06;C09BX01;C10BX11;C09DB02;C10BX09;C09DX01;C10BX19;C09DB01;C09XA54;C10BX07;C09BB03;C07FB07;C09DB06;C07FB13;C09DX08;C08CA01;C09BX03;C09DB04;C09DX03;C08GA02;C08CA51;C09DB09;C10BX14;C09BB07;C09DX07
DB00381,Amlodipine,,A0A024R8I1,Voltage-dependent N-type calcium channel,CACNA1B,inhibitor,C09BB13;C09BB04;C10BX18;C07FB12;C09DB05;C09XA53;C10BX03;C09BX04;C09DB07;C09DX06;C09BX01;C10BX11;C09DB02;C10BX09;C09DX01;C10BX19;C09DB01;C09XA54;C10BX07;C09BB03;C07FB07;C09DB06;C07FB13;C09DX08;C08CA01;C09BX03;C09DB04;C09DX03;C08GA02;C08CA51;C09DB09;C10BX14;C09BB07;C09DX07
DB00382,Tacrine,,P06276,Cholinesterase,BCHE,inhibitor,N06DA01
DB00382,Tacrine,,P22303,Acetylcholinesterase,ACHE,inhibitor,N06DA01
DB00382,Tacrine,,P23141,Liver carboxylesterase 1,CES1,,N06DA01
DB00383,Oxyphencyclimine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03AA01;A03CA03
DB00383,Oxyphencyclimine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03AA01;A03CA03
DB00383,Oxyphencyclimine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,A03AA01;A03CA03
DB00384,Triamterene,,P51170,Amiloride-sensitive sodium channel subunit gamma,SCNN1G,inhibitor,C03DB02
DB00384,Triamterene,,P37088,Amiloride-sensitive sodium channel subunit alpha,SCNN1A,inhibitor,C03DB02
DB00384,Triamterene,,P51168,Amiloride-sensitive sodium channel subunit beta,SCNN1B,inhibitor,C03DB02
DB00384,Triamterene,,P51172,Amiloride-sensitive sodium channel subunit delta,SCNN1D,inhibitor,C03DB02
DB00385,Valrubicin,,,DNA,,intercalation,L01DB09
DB00385,Valrubicin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,L01DB09
DB00387,Procyclidine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N04AA04
DB00387,Procyclidine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N04AA04
DB00387,Procyclidine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N04AA04
DB00387,Procyclidine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N04AA04
DB00388,Phenylephrine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,S01FB01;R01AB01;C01CA06;R01AA04;S01FB51;R01BA53;S01GA05;S01GA55;R01BA03
DB00388,Phenylephrine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,S01FB01;R01AB01;C01CA06;R01AA04;S01FB51;R01BA53;S01GA05;S01GA55;R01BA03
DB00388,Phenylephrine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,agonist,S01FB01;R01AB01;C01CA06;R01AA04;S01FB51;R01BA53;S01GA05;S01GA55;R01BA03
DB00389,Carbimazole,,P07202,Thyroid peroxidase,TPO,inhibitor,H03BB01
DB00390,Digoxin,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,inhibitor,C01AA05
DB00391,Sulpiride,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AL01
DB00391,Sulpiride,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AL01
DB00391,Sulpiride,,P00918,Carbonic anhydrase 2,CA2,inhibitor,N05AL01
DB00391,Sulpiride,,P07451,Carbonic anhydrase 3,CA3,inhibitor,N05AL01
DB00391,Sulpiride,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AL01
DB00392,Profenamine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N04AA05
DB00392,Profenamine,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,antagonist,N04AA05
DB00392,Profenamine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N04AA05
DB00393,Nimodipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C08CA06
DB00393,Nimodipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,C08CA06
DB00393,Nimodipine,,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,inhibitor,C08CA06
DB00393,Nimodipine,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,C08CA06
DB00393,Nimodipine,,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,inhibitor,C08CA06
DB00393,Nimodipine,,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,inhibitor,C08CA06
DB00393,Nimodipine,,P54284,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,inhibitor,C08CA06
DB00393,Nimodipine,,O00305,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,inhibitor,C08CA06
DB00393,Nimodipine,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,C08CA06
DB00393,Nimodipine,,P35869,Aryl hydrocarbon receptor,AHR,agonist,C08CA06
DB00394,Beclomethasone dipropionate,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07CC04;R03AL09;R03BA01;D07AC15;R03AK08;R03AK13;R01AD01;A07EA07
DB00395,Carisoprodol,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,activator,M03BA02;M03BA72;M03BA52
DB00395,Carisoprodol,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,modulator,M03BA02;M03BA72;M03BA52
DB00395,Carisoprodol,,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,modulator,M03BA02;M03BA72;M03BA52
DB00395,Carisoprodol,,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,,M03BA02;M03BA72;M03BA52
DB00395,Carisoprodol,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,modulator,M03BA02;M03BA72;M03BA52
DB00395,Carisoprodol,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,modulator,M03BA02;M03BA72;M03BA52
DB00396,Progesterone,,P06401,Progesterone receptor,PGR,agonist,G03FA04;G03DA04
DB00396,Progesterone,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,G03FA04;G03DA04
DB00396,Progesterone,,P08235,Mineralocorticoid receptor,NR3C2,agonist,G03FA04;G03DA04
DB00396,Progesterone,,P03372,Estrogen receptor alpha,ESR1,agonist,G03FA04;G03DA04
DB00396,Progesterone,,P03372,Estrogen receptor alpha,ESR1,inhibitor,G03FA04;G03DA04
DB00396,Progesterone,,P03372,Estrogen receptor alpha,ESR1,downregulator,G03FA04;G03DA04
DB00396,Progesterone,,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,substrate,G03FA04;G03DA04
DB00396,Progesterone,,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,inhibitor,G03FA04;G03DA04
DB00396,Progesterone,,P41145,Kappa-type opioid receptor,OPRK1,activator,G03FA04;G03DA04
DB00396,Progesterone,,P41145,Kappa-type opioid receptor,OPRK1,potentiator,G03FA04;G03DA04
DB00396,Progesterone,,P02763,Alpha-1-acid glycoprotein 1,ORM1,binder,G03FA04;G03DA04
DB00396,Progesterone,,P04150,Glucocorticoid receptor,NR3C1,partial agonist,G03FA04;G03DA04
DB00396,Progesterone,,P10275,Androgen receptor,AR,agonist,G03FA04;G03DA04
DB00396,Progesterone,,P10275,Androgen receptor,AR,potentiator,G03FA04;G03DA04
DB00396,Progesterone,,P04278,Sex hormone-binding globulin,SHBG,binder,G03FA04;G03DA04
DB00396,Progesterone,,P04278,Sex hormone-binding globulin,SHBG,potentiator,G03FA04;G03DA04
DB00396,Progesterone,,Q92731,Estrogen receptor beta,ESR2,agonist,G03FA04;G03DA04
DB00396,Progesterone,,Q92731,Estrogen receptor beta,ESR2,downregulator,G03FA04;G03DA04
DB00397,Phenylpropanolamine,,P21728,Dopamine D1 receptor,DRD1,partial agonist,R01BA51;R01BA01
DB00397,Phenylpropanolamine,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,R01BA51;R01BA01
DB00397,Phenylpropanolamine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R01BA51;R01BA01
DB00397,Phenylpropanolamine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,,R01BA51;R01BA01
DB00398,Sorafenib,,P15056,Serine/threonine-protein kinase B-raf,BRAF,inhibitor,L01EX02
DB00398,Sorafenib,,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,inhibitor,L01EX02
DB00398,Sorafenib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,inhibitor,L01EX02
DB00398,Sorafenib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EX02
DB00398,Sorafenib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,L01EX02
DB00398,Sorafenib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EX02
DB00398,Sorafenib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,L01EX02
DB00398,Sorafenib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,antagonist,L01EX02
DB00398,Sorafenib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EX02
DB00398,Sorafenib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,inhibitor,L01EX02
DB00399,Zoledronic acid,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,inhibitor,M05BB08;M05BA08
DB00399,Zoledronic acid,,,Hydroxylapatite,,antagonist,M05BB08;M05BA08
DB00399,Zoledronic acid,,,Hydroxylapatite,,binder,M05BB08;M05BA08
DB00399,Zoledronic acid,,P14324,Farnesyl pyrophosphate synthase,FDPS,inhibitor,M05BB08;M05BA08
DB00400,Griseofulvin,,Q5UBX3,Tubulin beta chain,,inhibitor,D01BA01;D01AA08
DB00400,Griseofulvin,,Q99456,"Keratin, type I cytoskeletal 12",KRT12,other/unknown,D01BA01;D01AA08
DB00401,Nisoldipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C08CA07
DB00401,Nisoldipine,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,inhibitor,C08CA07
DB00401,Nisoldipine,,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,inhibitor,C08CA07
DB00401,Nisoldipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,C08CA07
DB00401,Nisoldipine,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,C08CA07
DB00402,Eszopiclone,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CF04
DB00402,Eszopiclone,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CF04
DB00402,Eszopiclone,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,agonist,N05CF04
DB00402,Eszopiclone,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,agonist,N05CF04
DB00402,Eszopiclone,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,agonist,N05CF04
DB00403,Ceruletide,,P32238,Cholecystokinin receptor type A,CCKAR,inducer,V04CC04
DB00404,Alprazolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA12
DB00404,Alprazolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA12
DB00405,Dexbrompheniramine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AB06;R06AB56
DB00406,Gentian violet cation,,,DNA,,intercalation,G01AX09;D01AE02
DB00407,Ardeparin,,P01008,Antithrombin-III,SERPINC1,potentiator,
DB00407,Ardeparin,,P05546,Heparin cofactor 2,SERPIND1,agonist,
DB00408,Loxapine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AH01
DB00408,Loxapine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AH01
DB00408,Loxapine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AH01
DB00408,Loxapine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,binder,N05AH01
DB00408,Loxapine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,binder,N05AH01
DB00408,Loxapine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,binder,N05AH01
DB00408,Loxapine,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,binder,N05AH01
DB00408,Loxapine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,binder,N05AH01
DB00408,Loxapine,,P47898,5-hydroxytryptamine receptor 5A,HTR5A,binder,N05AH01
DB00408,Loxapine,,P50406,5-hydroxytryptamine receptor 6,HTR6,binder,N05AH01
DB00408,Loxapine,,P34969,5-hydroxytryptamine receptor 7,HTR7,binder,N05AH01
DB00408,Loxapine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,binder,N05AH01
DB00408,Loxapine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,binder,N05AH01
DB00408,Loxapine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,binder,N05AH01
DB00408,Loxapine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,binder,N05AH01
DB00408,Loxapine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,binder,N05AH01
DB00408,Loxapine,,P08588,Beta-1 adrenergic receptor,ADRB1,binder,N05AH01
DB00408,Loxapine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,binder,N05AH01
DB00408,Loxapine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,binder,N05AH01
DB00408,Loxapine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,binder,N05AH01
DB00408,Loxapine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,binder,N05AH01
DB00408,Loxapine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,binder,N05AH01
DB00408,Loxapine,,P21728,D(1) dopamine receptor,DRD1,binder,N05AH01
DB00408,Loxapine,,P35462,Dopamine D3 receptor,DRD3,binder,N05AH01
DB00408,Loxapine,,P21917,Dopamine D4 receptor,DRD4,binder,N05AH01
DB00408,Loxapine,,P21918,Dopamine D5 receptor,DRD5,binder,N05AH01
DB00408,Loxapine,,P35367,Histamine H1 receptor,HRH1,binder,N05AH01
DB00408,Loxapine,,P25021,Histamine H2 receptor,HRH2,binder,N05AH01
DB00408,Loxapine,,Q9H3N8,Histamine H4 receptor,HRH4,binder,N05AH01
DB00408,Loxapine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,binder,N05AH01
DB00408,Loxapine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,binder,N05AH01
DB00408,Loxapine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,binder,N05AH01
DB00408,Loxapine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AH01
DB00409,Remoxipride,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AL04
DB00409,Remoxipride,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AL04
DB00409,Remoxipride,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AL04
DB00409,Remoxipride,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,other/unknown,N05AL04
DB00409,Remoxipride,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,antagonist,N05AL04
DB00410,Mupirocin,,P41972,Isoleucine--tRNA ligase,ileS,inhibitor,R01AX06;D06AX09
DB00411,Carbamoylcholine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,agonist,N07AB01;S01EB02
DB00411,Carbamoylcholine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,agonist,N07AB01;S01EB02
DB00411,Carbamoylcholine,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,agonist,N07AB01;S01EB02
DB00411,Carbamoylcholine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,agonist,N07AB01;S01EB02
DB00411,Carbamoylcholine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,agonist,N07AB01;S01EB02
DB00412,Rosiglitazone,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,A10BD04;A10BG02;A10BD03
DB00412,Rosiglitazone,,O60488,Long-chain-fatty-acid--CoA ligase 4,ACSL4,inhibitor,A10BD04;A10BG02;A10BD03
DB00412,Rosiglitazone,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,A10BD04;A10BG02;A10BD03
DB00412,Rosiglitazone,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,A10BD04;A10BG02;A10BD03
DB00412,Rosiglitazone,,P19793,Retinoic acid receptor RXR-alpha,RXRA,,A10BD04;A10BG02;A10BD03
DB00412,Rosiglitazone,,P28702,Retinoic acid receptor RXR-beta,RXRB,,A10BD04;A10BG02;A10BD03
DB00412,Rosiglitazone,,P48443,Retinoic acid receptor RXR-gamma,RXRG,,A10BD04;A10BG02;A10BD03
DB00413,Pramipexole,,P35462,Dopamine D3 receptor,DRD3,agonist,N04BC05
DB00413,Pramipexole,,P14416,Dopamine D2 receptor,DRD2,agonist,N04BC05
DB00413,Pramipexole,,P21917,Dopamine D4 receptor,DRD4,agonist,N04BC05
DB00413,Pramipexole,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N04BC05
DB00413,Pramipexole,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,N04BC05
DB00414,Acetohexamide,,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,inhibitor,G01AE10;A10BB31
DB00415,Ampicillin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01CR50;J01CA51;J01CA01;S01AA19
DB00415,Ampicillin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01CR50;J01CA51;J01CA01;S01AA19
DB00415,Ampicillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CR50;J01CA51;J01CA01;S01AA19
DB00415,Ampicillin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CA51;J01CA01;S01AA19
DB00415,Ampicillin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01CR50;J01CA51;J01CA01;S01AA19
DB00415,Ampicillin,,P46059,Solute carrier family 15 member 1,SLC15A1,,J01CR50;J01CA51;J01CA01;S01AA19
DB00415,Ampicillin,,Q16348,Solute carrier family 15 member 2,SLC15A2,,J01CR50;J01CA51;J01CA01;S01AA19
DB00415,Ampicillin,,Q02763,Angiopoietin-1 receptor,TEK,,J01CR50;J01CA51;J01CA01;S01AA19
DB00416,Metocurine iodide,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,
DB00417,Phenoxymethylpenicillin,,Q53707,MecA PBP2' (penicillin binding protein 2'),mecA,inhibitor,J01CR50;J01CE10;J01CE02
DB00417,Phenoxymethylpenicillin,,Q8XJ01,Penicillin-binding protein 1A,pbpA,,J01CR50;J01CE10;J01CE02
DB00417,Phenoxymethylpenicillin,,P24228,D-alanyl-D-alanine carboxypeptidase DacB,dacB,,J01CR50;J01CE10;J01CE02
DB00417,Phenoxymethylpenicillin,,P12256,Penicillin acylase,,,J01CR50;J01CE10;J01CE02
DB00417,Phenoxymethylpenicillin,,P46059,Solute carrier family 15 member 1,SLC15A1,,J01CR50;J01CE10;J01CE02
DB00418,Secobarbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CB01;N05CA06
DB00418,Secobarbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CB01;N05CA06
DB00418,Secobarbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N05CB01;N05CA06
DB00418,Secobarbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CB01;N05CA06
DB00418,Secobarbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N05CB01;N05CA06
DB00418,Secobarbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CB01;N05CA06
DB00418,Secobarbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CB01;N05CA06
DB00418,Secobarbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CB01;N05CA06
DB00418,Secobarbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CB01;N05CA06
DB00418,Secobarbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CB01;N05CA06
DB00418,Secobarbital,,Q05586,NMDA receptor,GRIN1,antagonist,N05CB01;N05CA06
DB00419,Miglustat,,Q16739,Ceramide glucosyltransferase,UGCG,inhibitor,A16AX06
DB00420,Promazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AA03
DB00420,Promazine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AA03
DB00420,Promazine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AA03
DB00420,Promazine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AA03
DB00420,Promazine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05AA03
DB00420,Promazine,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AA03
DB00421,Spironolactone,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,C03DA01
DB00421,Spironolactone,,P04150,Glucocorticoid receptor,NR3C1,antagonist,C03DA01
DB00421,Spironolactone,,P10275,Androgen receptor,AR,antagonist,C03DA01
DB00421,Spironolactone,,P06401,Progesterone receptor,PGR,agonist,C03DA01
DB00421,Spironolactone,,P03372,Estrogen receptor,ESR1,agonist,C03DA01
DB00421,Spironolactone,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,agonist,C03DA01
DB00421,Spironolactone,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,inhibitor,C03DA01
DB00422,Methylphenidate,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06BA04
DB00422,Methylphenidate,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,N06BA04
DB00422,Methylphenidate,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06BA04
DB00423,Methocarbamol,,P00915,Carbonic anhydrase 1,CA1,inhibitor,M03BA73;M03BA03;M03BA53
DB00424,Hyoscyamine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03BA03;A03CB31
DB00424,Hyoscyamine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,A03BA03;A03CB31
DB00424,Hyoscyamine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03BA03;A03CB31
DB00424,Hyoscyamine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,A03BA03;A03CB31
DB00424,Hyoscyamine,,Q08828,Adenylate cyclase type 1,ADCY1,inhibitor,A03BA03;A03CB31
DB00425,Zolpidem,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,N05CF02
DB00425,Zolpidem,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,agonist,N05CF02
DB00425,Zolpidem,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,agonist,N05CF02
DB00425,Zolpidem,,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,agonist,N05CF02
DB00426,Famciclovir,,P04293,DNA polymerase catalytic subunit,,inhibitor,J05AB09;S01AD07
DB00427,Triprolidine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX07
DB00428,Streptozocin,,Q89ZI2,O-GlcNAcase BT_4395,,antagonist,L01AD04
DB00428,Streptozocin,,,DNA,,cross-linking/alkylation,L01AD04
DB00428,Streptozocin,,P11168,"Solute carrier family 2, facilitated glucose transporter member 2",SLC2A2,ligand,L01AD04
DB00428,Streptozocin,,O60502,Bifunctional protein NCOAT,MGEA5,,L01AD04
DB00429,Carboprost tromethamine,,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,agonist,G02AD04
DB00430,Cefpiramide,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DD11
DB00430,Cefpiramide,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DD11
DB00430,Cefpiramide,,Q07806,Penicillin-binding protein 1A,mrcA,inhibitor,J01DD11
DB00430,Cefpiramide,,Q9X6W0,Penicillin-binding protein 1B,ponB,inhibitor,J01DD11
DB00430,Cefpiramide,,P08506,D-alanyl-D-alanine carboxypeptidase DacC,dacC,inhibitor,J01DD11
DB00430,Cefpiramide,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DD11
DB00430,Cefpiramide,,C1KC03,Penicillin binding protein 2a,mecA,inhibitor,J01DD11
DB00431,Lindane,,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,antagonist,P03AB02
DB00431,Lindane,,P23415,Glycine receptor subunit alpha-1,GLRA1,antagonist,P03AB02
DB00431,Lindane,,P23416,Glycine receptor subunit alpha-2,GLRA2,antagonist,P03AB02
DB00431,Lindane,,O75311,Glycine receptor subunit alpha-3,GLRA3,antagonist,P03AB02
DB00431,Lindane,,P48167,Glycine receptor subunit beta,GLRB,antagonist,P03AB02
DB00431,Lindane,,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,,P03AB02
DB00431,Lindane,,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,,P03AB02
DB00431,Lindane,,P06401,Progesterone receptor,PGR,,P03AB02
DB00431,Lindane,,P03372,Estrogen receptor alpha,ESR1,,P03AB02
DB00431,Lindane,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,P03AB02
DB00432,Trifluridine,,,DNA,,other/unknown,L01BC59;S01AD02
DB00432,Trifluridine,,P04818,Thymidylate synthase,TYMS,inhibitor,L01BC59;S01AD02
DB00433,Prochlorperazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AB04
DB00433,Prochlorperazine,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AB04
DB00433,Prochlorperazine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N05AB04
DB00433,Prochlorperazine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,N05AB04
DB00434,Cyproheptadine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX02
DB00434,Cyproheptadine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,R06AX02
DB00434,Cyproheptadine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,R06AX02
DB00434,Cyproheptadine,,P25021,Histamine H2 receptor,HRH2,antagonist,R06AX02
DB00434,Cyproheptadine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,R06AX02
DB00434,Cyproheptadine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,R06AX02
DB00434,Cyproheptadine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,R06AX02
DB00434,Cyproheptadine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,R06AX02
DB00434,Cyproheptadine,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,R06AX02
DB00435,Nitric Oxide,,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,inducer,R07AX01
DB00435,Nitric Oxide,,P04731,Metallothionein-1A,MT1A,,R07AX01
DB00435,Nitric Oxide,,P14902,"Indoleamine 2,3-dioxygenase 1",IDO1,,R07AX01
DB00435,Nitric Oxide,,P29474,"Nitric oxide synthase, endothelial",NOS3,product of,R07AX01
DB00436,Bendroflumethiazide,,P55017,Solute carrier family 12 member 3,SLC12A3,inhibitor,C03AB01;C03EA13;G01AE10;C03AA01
DB00436,Bendroflumethiazide,,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,inducer,C03AB01;C03EA13;G01AE10;C03AA01
DB00436,Bendroflumethiazide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,C03AB01;C03EA13;G01AE10;C03AA01
DB00436,Bendroflumethiazide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,C03AB01;C03EA13;G01AE10;C03AA01
DB00436,Bendroflumethiazide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,C03AB01;C03EA13;G01AE10;C03AA01
DB00437,Allopurinol,,P47989,Xanthine dehydrogenase/oxidase,XDH,inhibitor,M04AA01;M04AA51
DB00438,Ceftazidime,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DD02
DB00438,Ceftazidime,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DD02
DB00438,Ceftazidime,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DD02
DB00438,Ceftazidime,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01DD02
DB00438,Ceftazidime,,Q47066,Beta-lactamase Toho-1,bla,substrate,J01DD02
DB00439,Cerivastatin,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,inhibitor,C10AA06
DB00440,Trimethoprim,,P0ABQ4,Dihydrofolate reductase,folA,inhibitor,J01EE03;J01EA01;J04AM08;J01EE01;J01EE04;J01EE02;J01EE05;J01EE07
DB00441,Gemcitabine,,,DNA,,cross-linking/alkylation,L01BC05
DB00441,Gemcitabine,,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,inhibitor,L01BC05
DB00441,Gemcitabine,,P04818,Thymidylate synthase,TYMS,inhibitor,L01BC05
DB00441,Gemcitabine,,P30085,UMP-CMP kinase,CMPK1,inhibitor,L01BC05
DB00442,Entecavir,,,DNA,,other,J05AF10
DB00443,Betamethasone,,P04150,Glucocorticoid receptor,NR3C1,agonist,R01AD06;D07BC01;S01BA06;S01BB04;S01CB04;H02AB01;C05AA05;S03CA06;D07XC01;D07AC01;A07EA04;S02BA07;R03BA04;S03BA03;S01CA05;D07CC01
DB00444,Teniposide,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,L01CB02
DB00445,Epirubicin,,,DNA,,intercalation,L01DB03
DB00445,Epirubicin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,L01DB03
DB00446,Chloramphenicol,,P0ADY7,50S ribosomal protein L16,rplP,inhibitor,D06AX02;S02AA01;D10AF03;S01AA01;G01AA05;J01BA01;S03AA08
DB00446,Chloramphenicol,,P24093,Dr hemagglutinin structural subunit,draA,antagonist,D06AX02;S02AA01;D10AF03;S01AA01;G01AA05;J01BA01;S03AA08
DB00446,Chloramphenicol,,P08174,Complement decay-accelerating factor,CD55,other,D06AX02;S02AA01;D10AF03;S01AA01;G01AA05;J01BA01;S03AA08
DB00447,Loracarbef,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01DC08
DB00447,Loracarbef,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01DC08
DB00448,Lansoprazole,,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,inhibitor,A02BC03;A02BD02;A02BD07;A02BD09;A02BD10;A02BD03;A02BC53
DB00448,Lansoprazole,,P10636,Microtubule-associated protein tau,MAPT,,A02BC03;A02BD02;A02BD07;A02BD09;A02BD10;A02BD03;A02BC53
DB00449,Dipivefrin,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,S01EA02
DB00449,Dipivefrin,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,S01EA02
DB00449,Dipivefrin,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,S01EA02
DB00449,Dipivefrin,,P06276,Cholinesterase,BCHE,substrate,S01EA02
DB00449,Dipivefrin,,P22303,Acetylcholinesterase,ACHE,inhibitor,S01EA02
DB00450,Droperidol,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AD08
DB00450,Droperidol,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AD08
DB00451,Levothyroxine,,P06756,Integrin alpha-V,ITGAV,,H03AA01;H03AA51
DB00451,Levothyroxine,,P05106,Integrin beta-3,ITGB3,,H03AA01;H03AA51
DB00451,Levothyroxine,,P10827,Thyroid hormone receptor alpha,THRA,agonist,H03AA01;H03AA51
DB00451,Levothyroxine,,P10828,Thyroid hormone receptor beta,THRB,agonist,H03AA01;H03AA51
DB00452,Framycetin,,,16S ribosomal RNA,,inhibitor,D09AA01;R01AX08;S01AA07
DB00452,Framycetin,,P0A7S3,30S ribosomal protein S12,rpsL,inhibitor,D09AA01;R01AX08;S01AA07
DB00452,Framycetin,,P61073,C-X-C chemokine receptor type 4,CXCR4,antagonist,D09AA01;R01AX08;S01AA07
DB00453,Clomocycline,,P0A7V8,30S ribosomal protein S4,rpsD,inhibitor,J01AA11
DB00453,Clomocycline,,P0A7X3,30S ribosomal protein S9,rpsI,inhibitor,J01AA11
DB00453,Clomocycline,,,16S ribosomal RNA,,inhibitor,J01AA11
DB00454,Meperidine,,P41145,Kappa-type opioid receptor,OPRK1,,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,antagonist,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,antagonist,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,antagonist,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,antagonist,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,antagonist,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,P11229,Muscarinic acetylcholine receptor,CHRM1,binder,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,binder,N02AB02;N02AB72;N02AB52;N02AG03
DB00454,Meperidine,,P23141,Liver carboxylesterase 1,CES1,,N02AB02;N02AB72;N02AB52;N02AG03
DB00455,Loratadine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX13
DB00455,Loratadine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,antagonist,R06AX13
DB00456,Cefalotin,,P15555,D-alanyl-D-alanine carboxypeptidase,,inhibitor,J01DB03
DB00456,Cefalotin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01DB03
DB00456,Cefalotin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01DB03
DB00456,Cefalotin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01DB03
DB00456,Cefalotin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01DB03
DB00456,Cefalotin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01DB03
DB00456,Cefalotin,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01DB03
DB00456,Cefalotin,,P00811,Beta-lactamase,ampC,potentiator,J01DB03
DB00457,Prazosin,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C02LE01;C02CA01
DB00457,Prazosin,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,C02LE01;C02CA01
DB00457,Prazosin,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,C02LE01;C02CA01
DB00457,Prazosin,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C02LE01;C02CA01
DB00457,Prazosin,,P08913,Alpha-2A adrenergic receptor,ADRA2A,binder,C02LE01;C02CA01
DB00457,Prazosin,,P18089,Alpha-2B adrenergic receptor,ADRA2B,binder,C02LE01;C02CA01
DB00457,Prazosin,,P35348,Alpha-1 adrenergic receptors,ADRA1A,,C02LE01;C02CA01
DB00458,Imipramine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA02
DB00458,Imipramine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA02
DB00458,Imipramine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AA02
DB00458,Imipramine,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AA02
DB00458,Imipramine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N06AA02
DB00458,Imipramine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,N06AA02
DB00458,Imipramine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N06AA02
DB00458,Imipramine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N06AA02
DB00458,Imipramine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N06AA02
DB00458,Imipramine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N06AA02
DB00458,Imipramine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N06AA02
DB00458,Imipramine,,Q9NZV8,Potassium voltage-gated channel subfamily D member 2,KCND2,inhibitor,N06AA02
DB00458,Imipramine,,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,inhibitor,N06AA02
DB00458,Imipramine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AA02
DB00458,Imipramine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,binder,N06AA02
DB00458,Imipramine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N06AA02
DB00458,Imipramine,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N06AA02
DB00458,Imipramine,,P21728,D(1) dopamine receptor,DRD1,binder,N06AA02
DB00458,Imipramine,,P14416,Dopamine D2 receptor,DRD2,binder,N06AA02
DB00458,Imipramine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,N06AA02
DB00458,Imipramine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06AA02
DB00458,Imipramine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,activator,N06AA02
DB00458,Imipramine,,P50406,5-hydroxytryptamine receptor 6,HTR6,binder,N06AA02
DB00458,Imipramine,,O95259,Potassium voltage-gated channel subfamily H member 1,KCNH1,,N06AA02
DB00458,Imipramine,,P19652,Alpha-1-acid glycoprotein 2,ORM2,,N06AA02
DB00459,Acitretin,,P19793,Retinoic acid receptor RXR-alpha,RXRA,agonist,D05BB02
DB00459,Acitretin,,P10276,Retinoic acid receptor alpha,RARA,agonist,D05BB02
DB00459,Acitretin,,P10826,Retinoic acid receptor beta,RARB,agonist,D05BB02
DB00459,Acitretin,,P13631,Retinoic acid receptor gamma,RARG,agonist,D05BB02
DB00459,Acitretin,,P28702,Retinoic acid receptor RXR-beta,RXRB,agonist,D05BB02
DB00459,Acitretin,,P48443,Retinoic acid receptor RXR-gamma,RXRG,agonist,D05BB02
DB00459,Acitretin,,P09455,Retinol-binding protein 1,RBP1,agonist,D05BB02
DB00459,Acitretin,,,Retinoic acid receptor RXR,,,D05BB02
DB00461,Nabumetone,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AX01
DB00461,Nabumetone,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AX01
DB00462,Methscopolamine bromide,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,
DB00462,Methscopolamine bromide,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,
DB00462,Methscopolamine bromide,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,
DB00463,Metharbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N03AA30
DB00463,Metharbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N03AA30
DB00463,Metharbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N03AA30
DB00463,Metharbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N03AA30
DB00463,Metharbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N03AA30
DB00463,Metharbital,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N03AA30
DB00463,Metharbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N03AA30
DB00463,Metharbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N03AA30
DB00463,Metharbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N03AA30
DB00463,Metharbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N03AA30
DB00463,Metharbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N03AA30
DB00464,Sodium tetradecyl sulfate,,P07225,Vitamin K-dependent protein S,PROS1,inhibitor,C05BB04
DB00464,Sodium tetradecyl sulfate,,P04070,Vitamin K-dependent protein C,PROC,inhibitor,C05BB04
DB00465,Ketorolac,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AB15;S01FB51;S01BC05
DB00465,Ketorolac,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AB15;S01FB51;S01BC05
DB00466,Picrotoxin,,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,antagonist,
DB00466,Picrotoxin,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,antagonist,
DB00466,Picrotoxin,,P23416,Glycine receptor subunit alpha-2,GLRA2,antagonist,
DB00466,Picrotoxin,,O75311,Glycine receptor subunit alpha-3,GLRA3,antagonist,
DB00466,Picrotoxin,,P23415,Glycine receptor subunit alpha-1,GLRA1,antagonist,
DB00467,Enoxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MA04
DB00467,Enoxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA04
DB00467,Enoxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,J01MA04
DB00468,Quinine,,,Fe(II)-protoporphyrin IX,,antagonist,M09AA72;P01BC01
DB00468,Quinine,,P14770,Platelet glycoprotein IX,GP9,other,M09AA72;P01BC01
DB00468,Quinine,,O15554,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,inhibitor,M09AA72;P01BC01
DB00469,Tenoxicam,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AC02
DB00469,Tenoxicam,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AC02
DB00470,Dronabinol,,P21554,Cannabinoid receptor 1,CNR1,agonist,A04AD10
DB00470,Dronabinol,,P34972,Cannabinoid receptor 2,CNR2,agonist,A04AD10
DB00471,Montelukast,,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,antagonist,R03DC03;R03DC53
DB00471,Montelukast,,P09917,Arachidonate 5-lipoxygenase,ALOX5,other/unknown,R03DC03;R03DC53
DB00472,Fluoxetine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06CA03;N06AB03
DB00472,Fluoxetine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06CA03;N06AB03
DB00472,Fluoxetine,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,N06CA03;N06AB03
DB00472,Fluoxetine,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,antagonist,N06CA03;N06AB03
DB00472,Fluoxetine,,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,antagonist,N06CA03;N06AB03
DB00472,Fluoxetine,,P61024,Cyclin-dependent kinases regulatory subunit 1,CKS1B,,N06CA03;N06AB03
DB00472,Fluoxetine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,N06CA03;N06AB03
DB00473,Hexylcaine,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,
DB00473,Hexylcaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,
DB00474,Methohexital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,antagonist,N05CB01;N01AF01;N05CA15
DB00475,Chlordiazepoxide,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA02
DB00475,Chlordiazepoxide,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA02
DB00476,Duloxetine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX21
DB00476,Duloxetine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AX21
DB00476,Duloxetine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06AX21
DB00477,Chlorpromazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AA01
DB00477,Chlorpromazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AA01
DB00477,Chlorpromazine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AA01
DB00477,Chlorpromazine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AA01
DB00477,Chlorpromazine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AA01
DB00477,Chlorpromazine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AA01
DB00477,Chlorpromazine,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AA01
DB00477,Chlorpromazine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,N05AA01
DB00477,Chlorpromazine,,P21728,D(1) dopamine receptor,DRD1,inhibitor,N05AA01
DB00477,Chlorpromazine,,P35462,Dopamine D3 receptor,DRD3,inhibitor,N05AA01
DB00477,Chlorpromazine,,P21917,Dopamine D4 receptor,DRD4,binder,N05AA01
DB00477,Chlorpromazine,,P21918,Dopamine D5 receptor,DRD5,inhibitor,N05AA01
DB00477,Chlorpromazine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,binder,N05AA01
DB00477,Chlorpromazine,,P28223,5-hydroxytryptamine 2 receptor,HTR2A,binder,N05AA01
DB00477,Chlorpromazine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,inhibitor,N05AA01
DB00477,Chlorpromazine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,inhibitor,N05AA01
DB00477,Chlorpromazine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05AA01
DB00477,Chlorpromazine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N05AA01
DB00477,Chlorpromazine,,P17405,Sphingomyelin phosphodiesterase,SMPD1,inhibitor,N05AA01
DB00477,Chlorpromazine,,P0DP23,Calmodulin,CALM1,inhibitor,N05AA01
DB00477,Chlorpromazine,,P02763,alpha1-acid glycoprotein,ORM1,binder,N05AA01
DB00477,Chlorpromazine,,P50406,5-hydroxytryptamine receptor 6,HTR6,binder,N05AA01
DB00477,Chlorpromazine,,P34969,5-hydroxytryptamine receptor 7,HTR7,binder,N05AA01
DB00477,Chlorpromazine,,Q9H3N8,Histamine H4 receptor,HRH4,binder,N05AA01
DB00478,Rimantadine,,P21430,Matrix protein 2,M,other/unknown,J05AC02
DB00479,Amikacin,,P0A7S3,30S ribosomal protein S12,rpsL,inhibitor,S01AA21;D06AX12;J01GB06;J01RA06
DB00480,Lenalidomide,,Q96SW2,Protein cereblon,CRBN,inhibitor,L04AX04
DB00480,Lenalidomide,,O14788,Tumor necrosis factor ligand superfamily member 11,TNFSF11,inhibitor,L04AX04
DB00480,Lenalidomide,,P33151,Cadherin-5,CDH5,antagonist,L04AX04
DB00480,Lenalidomide,,P35354,Prostaglandin G/H synthase 2,PTGS2,negative modulator,L04AX04
DB00481,Raloxifene,,P03372,Estrogen receptor alpha,ESR1,agonist,G03XC01
DB00481,Raloxifene,,Q92731,Estrogen receptor beta,ESR2,agonist,G03XC01
DB00481,Raloxifene,,P50453,Serpin B9,SERPINB9,,G03XC01
DB00481,Raloxifene,,P04155,Trefoil factor 1,TFF1,,G03XC01
DB00482,Celecoxib,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,N02AJ16;M01AH01;G01AE10;L01XX33;C08CA51
DB00482,Celecoxib,,P00918,Carbonic anhydrase 2,CA2,inhibitor,N02AJ16;M01AH01;G01AE10;L01XX33;C08CA51
DB00482,Celecoxib,,P07451,Carbonic anhydrase 3,CA3,inhibitor,N02AJ16;M01AH01;G01AE10;L01XX33;C08CA51
DB00482,Celecoxib,,P55287,Cadherin-11,CDH11,inhibitor,N02AJ16;M01AH01;G01AE10;L01XX33;C08CA51
DB00482,Celecoxib,,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,inhibitor,N02AJ16;M01AH01;G01AE10;L01XX33;C08CA51
DB00482,Celecoxib,,Q99519,Sialidase-1,NEU1,inhibitor,N02AJ16;M01AH01;G01AE10;L01XX33;C08CA51
DB00483,Gallamine triethiodide,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,
DB00483,Gallamine triethiodide,,P22303,Acetylcholinesterase,ACHE,inhibitor,
DB00483,Gallamine triethiodide,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,
DB00483,Gallamine triethiodide,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,,
DB00483,Gallamine triethiodide,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,,
DB00484,Brimonidine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,D11AX21;S01GA07;S01EA05
DB00484,Brimonidine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,D11AX21;S01GA07;S01EA05
DB00484,Brimonidine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,D11AX21;S01GA07;S01EA05
DB00485,Dicloxacillin,,A0A0E1R3H3,Penicillin-binding protein 3,pbpC,inhibitor,J01CR50;J01CF01
DB00485,Dicloxacillin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01CR50;J01CF01
DB00485,Dicloxacillin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01CR50;J01CF01
DB00485,Dicloxacillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CR50;J01CF01
DB00485,Dicloxacillin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CF01
DB00485,Dicloxacillin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01CR50;J01CF01
DB00486,Nabilone,,P34972,Cannabinoid receptor 2,CNR2,partial agonist,A04AD11
DB00486,Nabilone,,P21554,Cannabinoid receptor 1,CNR1,partial agonist,A04AD11
DB00487,Pefloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA03
DB00487,Pefloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MA03
DB00487,Pefloxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,J01MA03
DB00487,Pefloxacin,,Q06AK7,DNA topoisomerase 1,topA,inhibitor,J01MA03
DB00488,Altretamine,,,DNA,,other/unknown,L01XX03
DB00489,Sotalol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07AA07;C07BA07;C07FX02
DB00489,Sotalol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07AA07;C07BA07;C07FX02
DB00489,Sotalol,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C07AA07;C07BA07;C07FX02
DB00490,Buspirone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,N05BE01
DB00490,Buspirone,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05BE01
DB00490,Buspirone,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05BE01
DB00490,Buspirone,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05BE01
DB00490,Buspirone,,P35348,Alpha-1 adrenergic receptors,ADRA1A,partial agonist,N05BE01
DB00491,Miglitol,,P10253,Lysosomal alpha-glucosidase,GAA,antagonist,A10BF02
DB00491,Miglitol,,Q14697,Neutral alpha-glucosidase AB,GANAB,antagonist,A10BF02
DB00491,Miglitol,,Q8TET4,Neutral alpha-glucosidase C,GANC,antagonist,A10BF02
DB00491,Miglitol,,O43451,"Maltase-glucoamylase, intestinal",MGAM,antagonist,A10BF02
DB00491,Miglitol,,O43451,"Maltase-glucoamylase, intestinal",MGAM,inhibitor,A10BF02
DB00492,Fosinopril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09BA09;C09AA09
DB00493,Cefotaxime,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01DD01
DB00493,Cefotaxime,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01DD01
DB00493,Cefotaxime,,P42971,Penicillin-binding protein 3,pbpC,inhibitor,J01DD01
DB00493,Cefotaxime,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01DD01
DB00493,Cefotaxime,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01DD01
DB00493,Cefotaxime,,Q4U2R8,Solute carrier family 22 member 6,SLC22A6,,J01DD01
DB00493,Cefotaxime,,Q8TCC7,Solute carrier family 22 member 8,SLC22A8,,J01DD01
DB00493,Cefotaxime,,Q9NSA0,Solute carrier family 22 member 11,SLC22A11,,J01DD01
DB00493,Cefotaxime,,Q9Y694,Solute carrier family 22 member 7,SLC22A7,,J01DD01
DB00493,Cefotaxime,,P46059,Solute carrier family 15 member 1,SLC15A1,,J01DD01
DB00493,Cefotaxime,,P02768,Serum albumin,ALB,,J01DD01
DB00493,Cefotaxime,,B2ZTR6,Beta-lactamase,,,J01DD01
DB00493,Cefotaxime,,Q16348,Solute carrier family 15 member 2,SLC15A2,,J01DD01
DB00494,Entacapone,,P21964,Catechol O-methyltransferase,COMT,inhibitor,N04BX02
DB00495,Zidovudine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AR04;J05AF01;J05AR05;J05AR01
DB00495,Zidovudine,,O14746,Telomerase reverse transcriptase,TERT,inhibitor,J05AR04;J05AF01;J05AR05;J05AR01
DB00496,Darifenacin,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,G04BD10
DB00496,Darifenacin,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,G04BD10
DB00496,Darifenacin,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,G04BD10
DB00496,Darifenacin,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,G04BD10
DB00496,Darifenacin,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,G04BD10
DB00497,Oxycodone,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AA56;N02AA05;N02AA55;N02AJ18;N02AJ17;N02AJ19
DB00497,Oxycodone,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N02AA56;N02AA05;N02AA55;N02AJ18;N02AJ17;N02AJ19
DB00497,Oxycodone,,P41143,Delta-type opioid receptor,OPRD1,agonist,N02AA56;N02AA05;N02AA55;N02AJ18;N02AJ17;N02AJ19
DB00498,Phenindione,,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,inhibitor,B01AA02
DB00499,Flutamide,,P10275,Androgen receptor,AR,antagonist,L02BB01
DB00499,Flutamide,,P35869,Aryl hydrocarbon receptor,AHR,agonist,L02BB01
DB00499,Flutamide,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,L02BB01
DB00500,Tolmetin,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AB03;M02AA21
DB00500,Tolmetin,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AB03;M02AA21
DB00501,Cimetidine,,P25021,Histamine H2 receptor,HRH2,antagonist,A02BA51;A02BA01
DB00502,Haloperidol,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,,N05AD01
DB00502,Haloperidol,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AD01
DB00502,Haloperidol,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,other/unknown,N05AD01
DB00502,Haloperidol,,P35462,Dopamine D3 receptor,DRD3,inverse agonist,N05AD01
DB00502,Haloperidol,,Q99705,Melanin-concentrating hormone receptor 1,MCHR1,,N05AD01
DB00502,Haloperidol,,Q05940,Synaptic vesicular amine transporter,SLC18A2,,N05AD01
DB00502,Haloperidol,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,,N05AD01
DB00502,Haloperidol,,P35367,Histamine H1 receptor,HRH1,,N05AD01
DB00502,Haloperidol,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,,N05AD01
DB00502,Haloperidol,,P35348,Alpha-1A adrenergic receptor,ADRA1A,,N05AD01
DB00502,Haloperidol,,P08913,Alpha-2A adrenergic receptor,ADRA2A,,N05AD01
DB00502,Haloperidol,,P18089,Alpha-2B adrenergic receptor,ADRA2B,,N05AD01
DB00502,Haloperidol,,P18825,Alpha-2C adrenergic receptor,ADRA2C,,N05AD01
DB00502,Haloperidol,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,N05AD01
DB00502,Haloperidol,,P50406,5-hydroxytryptamine receptor 6,HTR6,,N05AD01
DB00502,Haloperidol,,P34969,5-hydroxytryptamine receptor 7,HTR7,,N05AD01
DB00502,Haloperidol,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,antagonist,N05AD01
DB00502,Haloperidol,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AD01
DB00503,Ritonavir,,Q72874,Human immunodeficiency virus type 1 protease,pol,inhibitor,J05AP53;J05AR10;J05AE30;J05AE03;J05AR23;J05AR26;J05AP52
DB00503,Ritonavir,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,J05AP53;J05AR10;J05AE30;J05AE03;J05AR23;J05AR26;J05AP52
DB00504,Levallorphan,,P35372,Mu-type opioid receptor,OPRM1,partial agonist,
DB00505,Tridihexethyl,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03AB08
DB00505,Tridihexethyl,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03AB08
DB00505,Tridihexethyl,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,A03AB08
DB00507,Nitazoxanide,,P94692,Pyruvate-flavodoxin oxidoreductase,por,antagonist,P01AX11
DB00507,Nitazoxanide,,P94692,Pyruvate-flavodoxin oxidoreductase,por,inhibitor,P01AX11
DB00508,Triflupromazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AA05
DB00508,Triflupromazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AA05
DB00508,Triflupromazine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N05AA05
DB00508,Triflupromazine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05AA05
DB00508,Triflupromazine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N05AA05
DB00509,Dextrothyroxine,,P10827,Thyroid hormone receptor alpha,THRA,agonist,C10AX01
DB00509,Dextrothyroxine,,P10828,Thyroid hormone receptor beta,THRB,agonist,C10AX01
DB00509,Dextrothyroxine,,P07202,Thyroid peroxidase,TPO,,C10AX01
DB00511,Acetyldigitoxin,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,inhibitor,C01AA01
DB00512,Vancomycin,,,D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan,,ligand,J01XA01;A07AA09;S01AA28
DB00513,Aminocaproic acid,,P00747,Plasminogen,PLG,inhibitor,B02AA01
DB00513,Aminocaproic acid,,P00750,Tissue-type plasminogen activator,PLAT,antagonist,B02AA01
DB00513,Aminocaproic acid,,P08519,Apolipoprotein(a),LPA,other,B02AA01
DB00514,Dextromethorphan,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,agonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,antagonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,R05DA09;N07XX59
DB00514,Dextromethorphan,,O00264,Membrane-associated progesterone receptor component 1,PGRMC1,binder,R05DA09;N07XX59
DB00514,Dextromethorphan,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,antagonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,antagonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,antagonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,P35372,Mu-type opioid receptor,OPRM1,agonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,P35372,Mu-type opioid receptor,OPRM1,regulator,R05DA09;N07XX59
DB00514,Dextromethorphan,,P41143,Delta-type opioid receptor,OPRD1,agonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,P41145,Kappa-type opioid receptor,OPRK1,agonist,R05DA09;N07XX59
DB00514,Dextromethorphan,,P04839,NADPH oxidase,CYBB,inhibitor,R05DA09;N07XX59
DB00514,Dextromethorphan,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,R05DA09;N07XX59
DB00515,Cisplatin,,,DNA,,cross-linking/alkylation,L01XA01
DB00515,Cisplatin,,P29372,DNA-3-methyladenine glycosylase,MPG,,L01XA01
DB00515,Cisplatin,,P01023,Alpha-2-macroglobulin,A2M,,L01XA01
DB00515,Cisplatin,,P02787,Serotransferrin,TF,,L01XA01
DB00515,Cisplatin,,O00244,Copper transport protein ATOX1,ATOX1,,L01XA01
DB00517,Anisotropine methylbromide,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,
DB00517,Anisotropine methylbromide,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,
DB00517,Anisotropine methylbromide,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,
DB00518,Albendazole,,F1L7U3,Tubulin beta-2 chain,,inhibitor,P02CA03
DB00518,Albendazole,,Q71U36,Tubulin alpha-1A chain,TUBA1A,inhibitor,P02CA03
DB00518,Albendazole,,P68371,Tubulin beta-4B chain,TUBB4B,inhibitor,P02CA03
DB00518,Albendazole,,P83223,Fumarate reductase flavoprotein subunit,,inhibitor,P02CA03
DB00519,Trandolapril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09AA10;C09BB10
DB00520,Caspofungin,,A2QLK4,"1,3-beta-glucan synthase component FKS1",fksA,inhibitor,J02AX04
DB00521,Carteolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,S01ED55;S01ED05;C07AA15
DB00521,Carteolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,S01ED55;S01ED05;C07AA15
DB00521,Carteolol,,P08588,Beta-1 adrenergic receptor,ADRB1,partial agonist,S01ED55;S01ED05;C07AA15
DB00522,Bentiromide,,P05981,Serine protease hepsin,HPN,ligand,V04CK03
DB00523,Alitretinoin,,P10276,Retinoic acid receptor alpha,RARA,agonist,L01XF02;D11AH04
DB00523,Alitretinoin,,P19793,Retinoic acid receptor RXR-alpha,RXRA,agonist,L01XF02;D11AH04
DB00523,Alitretinoin,,P10826,Retinoic acid receptor beta,RARB,agonist,L01XF02;D11AH04
DB00523,Alitretinoin,,P28702,Retinoic acid receptor RXR-beta,RXRB,agonist,L01XF02;D11AH04
DB00523,Alitretinoin,,P13631,Retinoic acid receptor gamma,RARG,agonist,L01XF02;D11AH04
DB00523,Alitretinoin,,P48443,Retinoic acid receptor RXR-gamma,RXRG,agonist,L01XF02;D11AH04
DB00523,Alitretinoin,,P17936,Insulin-like growth factor-binding protein 3,IGFBP3,,L01XF02;D11AH04
DB00523,Alitretinoin,,Q15238,Pregnancy-specific beta-1-glycoprotein 5,PSG5,,L01XF02;D11AH04
DB00523,Alitretinoin,,Q6V0L0,Cytochrome P450 26C1,CYP26C1,,L01XF02;D11AH04
DB00524,Metolazone,,P55017,Solute carrier family 12 member 3,SLC12A3,inhibitor,C03EA12;G01AE10;C03BA08
DB00525,Tolnaftate,,Q92206,Squalene monooxygenase,ERG1,inhibitor,D01AE18
DB00526,Oxaliplatin,,,DNA,,adduct,L01XA03
DB00526,Oxaliplatin,,,DNA,,cross-linking/alkylation,L01XA03
DB00527,Cinchocaine,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,D04AB02;S01HA06;S02DA04;N01BB06;C05AD04
DB00527,Cinchocaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,D04AB02;S01HA06;S02DA04;N01BB06;C05AD04
DB00527,Cinchocaine,,P0DP23,Calmodulin,CALM1,inhibitor,D04AB02;S01HA06;S02DA04;N01BB06;C05AD04
DB00528,Lercanidipine,,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,inhibitor,C09DB08;C09BB02;C08CA13
DB00529,Foscarnet,,P04293,DNA polymerase catalytic subunit,,inhibitor,J05AD01
DB00529,Foscarnet,,P08546,DNA polymerase catalytic subunit,UL54,inhibitor,J05AD01
DB00530,Erlotinib,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,agonist,L01EB02
DB00530,Erlotinib,,P00533,Epidermal growth factor receptor,EGFR,antagonist,L01EB02
DB00531,Cyclophosphamide,,,DNA,,cross-linking/alkylation,L01AA01
DB00531,Cyclophosphamide,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,L01AA01
DB00532,Mephenytoin,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,N03AB04;N03AB54
DB00532,Mephenytoin,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,N03AB04;N03AB54
DB00533,Rofecoxib,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AH02
DB00533,Rofecoxib,,P15502,Elastin,ELN,other/unknown,M01AH02
DB00534,Chlormerodrin,,Q13621,Solute carrier family 12 member 1,SLC12A1,inducer,
DB00534,Chlormerodrin,,P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,inhibitor,
DB00535,Cefdinir,,P08149,Penicillin-binding protein 2,penA,inhibitor,J01DD15
DB00535,Cefdinir,,Q60FT7,PBP3,pbp3,inhibitor,J01DD15
DB00535,Cefdinir,,P05164,Myeloperoxidase,MPO,inhibitor,J01DD15
DB00535,Cefdinir,,,Peptidoglycan transpeptidase,,inhibitor,J01DD15
DB00536,Guanidine,,P05091,"Aldehyde dehydrogenase, mitochondrial",ALDH2,inhibitor,
DB00536,Guanidine,,P07998,Ribonuclease pancreatic,RNASE1,,
DB00536,Guanidine,,,DNA,,,
DB00536,Guanidine,,P78352,Disks large homolog 4,DLG4,,
DB00536,Guanidine,,P00720,Lysozyme,E,,
DB00536,Guanidine,,Q14353,Guanidinoacetate N-methyltransferase,GAMT,,
DB00536,Guanidine,,P53608,Arginase,rocF,,
DB00537,Ciprofloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00537,Ciprofloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00537,Ciprofloxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00537,Ciprofloxacin,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00537,Ciprofloxacin,,P0AES4,DNA gyrase subunit A,gyrA,,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00537,Ciprofloxacin,,P0C1U9,DNA topoisomerase 4 subunit A,parC,,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00537,Ciprofloxacin,,Q59192,DNA topoisomerase 4 subunit B,parE,,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00537,Ciprofloxacin,,P05653,DNA gyrase subunit A,gyrA,,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00537,Ciprofloxacin,,C3T8E2,Multidrug resistance protein MdtK,mdtK,,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00537,Ciprofloxacin,,B4YQT9,Gyrase A,,,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00537,Ciprofloxacin,,P20831,DNA gyrase subunit A,gyrA,,J01RA11;S03AA07;J01MA02;S02AA15;J01RA10;J01RA12;S01AE03
DB00539,Toremifene,,P03372,Estrogen receptor alpha,ESR1,modulator,L02BA02
DB00539,Toremifene,,P04278,Sex hormone-binding globulin,SHBG,,L02BA02
DB00540,Nortriptyline,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA10
DB00540,Nortriptyline,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA10
DB00540,Nortriptyline,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AA10
DB00540,Nortriptyline,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N06AA10
DB00540,Nortriptyline,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AA10
DB00540,Nortriptyline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N06AA10
DB00540,Nortriptyline,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,N06AA10
DB00540,Nortriptyline,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AA10
DB00540,Nortriptyline,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,downregulator,N06AA10
DB00540,Nortriptyline,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N06AA10
DB00540,Nortriptyline,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,N06AA10
DB00540,Nortriptyline,,P08588,Beta adrenergic receptor,ADRB1,antagonist,N06AA10
DB00540,Nortriptyline,,P14416,Dopamine D2 receptor,DRD2,antagonist,N06AA10
DB00540,Nortriptyline,,O00264,Sigma receptor,PGRMC1,binder,N06AA10
DB00540,Nortriptyline,,P08909,5-hydroxytryptamine receptor 1C,Htr2c,antagonist,N06AA10
DB00540,Nortriptyline,,P11229,Muscarinic acetylcholine receptor,CHRM1,antagonist,N06AA10
DB00541,Vincristine,,P07437,Tubulin beta chain,TUBB,inhibitor,L01CA02
DB00541,Vincristine,,P68366,Tubulin alpha-4A chain,TUBA4A,inhibitor,L01CA02
DB00542,Benazepril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09BB13;C09BA07;C09AA07
DB00543,Amoxapine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA17
DB00543,Amoxapine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA17
DB00543,Amoxapine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N06AA17
DB00543,Amoxapine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N06AA17
DB00543,Amoxapine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N06AA17
DB00543,Amoxapine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N06AA17
DB00543,Amoxapine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N06AA17
DB00543,Amoxapine,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,antagonist,N06AA17
DB00543,Amoxapine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AA17
DB00543,Amoxapine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AA17
DB00543,Amoxapine,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N06AA17
DB00543,Amoxapine,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N06AA17
DB00543,Amoxapine,,P35462,Dopamine D3 receptor,DRD3,antagonist,N06AA17
DB00543,Amoxapine,,P21917,Dopamine D4 receptor,DRD4,antagonist,N06AA17
DB00543,Amoxapine,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AA17
DB00543,Amoxapine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N06AA17
DB00543,Amoxapine,,P11229,Muscarinic acetylcholine receptor,CHRM1,antagonist,N06AA17
DB00543,Amoxapine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N06AA17
DB00543,Amoxapine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,N06AA17
DB00543,Amoxapine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N06AA17
DB00543,Amoxapine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,antagonist,N06AA17
DB00543,Amoxapine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,N06AA17
DB00543,Amoxapine,,Q9H3N8,Histamine H4 receptor,HRH4,binder,N06AA17
DB00543,Amoxapine,,P14867,GABA(A) Receptor,GABRA1,binder,N06AA17
DB00543,Amoxapine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,binder,N06AA17
DB00544,Fluorouracil,,,DNA,,incorporation into and destabilization,L01BC52;L01BC02
DB00544,Fluorouracil,,,RNA,,incorporation into and destabilization,L01BC52;L01BC02
DB00544,Fluorouracil,,P04818,Thymidylate synthase,TYMS,other/unknown,L01BC52;L01BC02
DB00545,Pyridostigmine,,P06276,Cholinesterase,BCHE,inhibitor,N07AA02
DB00545,Pyridostigmine,,P22303,Acetylcholinesterase,ACHE,inhibitor,N07AA02
DB00546,Adinazolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA07
DB00546,Adinazolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA07
DB00547,Desoximetasone,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AC03;D07XC02
DB00548,Azelaic acid,,P66010,Thioredoxin reductase,trxB,inhibitor,D10AX03
DB00548,Azelaic acid,,P51857,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,inhibitor,D10AX03
DB00548,Azelaic acid,,P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,SRD5A2,inhibitor,D10AX03
DB00548,Azelaic acid,,P14679,Tyrosinase,TYR,inhibitor,D10AX03
DB00548,Azelaic acid,,P00582,DNA polymerase I,polA,inhibitor,D10AX03
DB00549,Zafirlukast,,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,antagonist,R03DC01
DB00550,Propylthiouracil,,P07202,Thyroid peroxidase,TPO,inhibitor,H03BA02
DB00551,Acetohydroxamic acid,,P18314,Urease subunit alpha,ureC,inhibitor,G04BX03
DB00551,Acetohydroxamic acid,,P39900,Macrophage metalloelastase,MMP12,inhibitor,G04BX03
DB00552,Pentostatin,,P00813,Adenosine deaminase,ADA,inhibitor,L01XX08
DB00553,Methoxsalen,,,DNA,,intercalation,D05BA02;D05AD02
DB00554,Piroxicam,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AC01;M02AA07;S01BC06
DB00554,Piroxicam,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AC01;M02AA07;S01BC06
DB00555,Lamotrigine,,Q15878,Voltage-dependent R-type calcium channel subunit alpha-1E (CACNA1E),CACNA1E,inhibitor,N03AX09
DB00555,Lamotrigine,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,inhibitor,N03AX09
DB00555,Lamotrigine,,P30542,Adenosine receptor A1,ADORA1,inhibitor,N03AX09
DB00555,Lamotrigine,,P29274,Adenosine receptor A2a,ADORA2A,inhibitor,N03AX09
DB00555,Lamotrigine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,inhibitor,N03AX09
DB00555,Lamotrigine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,inhibitor,N03AX09
DB00555,Lamotrigine,,P08588,Beta-1 adrenergic receptor,ADRB1,inhibitor,N03AX09
DB00555,Lamotrigine,,P21728,D(1) dopamine receptor,DRD1,inhibitor,N03AX09
DB00555,Lamotrigine,,P14416,Dopamine D2 receptor,DRD2,agonist,N03AX09
DB00555,Lamotrigine,,P14416,Dopamine D2 receptor,DRD2,inhibitor,N03AX09
DB00555,Lamotrigine,,P14867,GABA(A) Receptor,GABRA1,antagonist,N03AX09
DB00555,Lamotrigine,,P14867,GABA(A) Receptor,GABRA1,inducer,N03AX09
DB00555,Lamotrigine,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,inhibitor,N03AX09
DB00555,Lamotrigine,,P35367,Histamine H1 receptor,HRH1,antagonist,N03AX09
DB00555,Lamotrigine,,P41145,Kappa-type opioid receptor,OPRK1,inhibitor,N03AX09
DB00555,Lamotrigine,,P02708,Acetylcholine receptor subunit alpha,CHRNA1,inhibitor,N03AX09
DB00555,Lamotrigine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,inhibitor,N03AX09
DB00555,Lamotrigine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,inhibitor,N03AX09
DB00555,Lamotrigine,,P42261,Glutamate receptor 1,GRIA1,inhibitor,N03AX09
DB00557,Hydroxyzine,,P35367,Histamine H1 receptor,HRH1,inverse agonist,N05BB01;N05BB51
DB00557,Hydroxyzine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,N05BB01;N05BB51
DB00558,Zanamivir,,P06818,Neuraminidase,,inhibitor,J05AH01
DB00558,Zanamivir,,P27907,Neuraminidase,,inhibitor,J05AH01
DB00558,Zanamivir,,Q9Y3R4,Sialidase-2,NEU2,inhibitor,J05AH01
DB00559,Bosentan,,P24530,Endothelin B receptor,EDNRB,antagonist,G01AE10;C02KX01
DB00559,Bosentan,,P25101,Endothelin-1 receptor,EDNRA,antagonist,G01AE10;C02KX01
DB00560,Tigecycline,,,16S ribosomal RNA,,binder,J01AA20;J01AA12
DB00560,Tigecycline,,P0A7X3,30S ribosomal protein S9,rpsI,binder,J01AA20;J01AA12
DB00560,Tigecycline,,P0A7S3,30S ribosomal protein S12,rpsL,binder,J01AA20;J01AA12
DB00560,Tigecycline,,P0A7S9,30S ribosomal protein S13,rpsM,binder,J01AA20;J01AA12
DB00560,Tigecycline,,P0AG59,30S ribosomal protein S14,rpsN,binder,J01AA20;J01AA12
DB00560,Tigecycline,,P0A7U3,30S ribosomal protein S19,rpsS,binder,J01AA20;J01AA12
DB00561,Doxapram,,O14649,Potassium channel subfamily K member 3,KCNK3,inhibitor,R07AB01
DB00561,Doxapram,,Q9NPC2,Potassium channel subfamily K member 9,KCNK9,inhibitor,R07AB01
DB00562,Benzthiazide,,P55017,Solute carrier family 12 member 3,SLC12A3,inhibitor,G01AE10
DB00562,Benzthiazide,,P00915,Carbonic anhydrase,CA1,inhibitor,G01AE10
DB00562,Benzthiazide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,G01AE10
DB00562,Benzthiazide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,G01AE10
DB00562,Benzthiazide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,G01AE10
DB00562,Benzthiazide,,Q16790,Carbonic anhydrase 9,CA9,inhibitor,G01AE10
DB00562,Benzthiazide,,O43570,Carbonic anhydrase 12,CA12,inhibitor,G01AE10
DB00563,Methotrexate,,P04818,Thymidylate synthase,TYMS,inhibitor,L04AX03;L01BA01
DB00563,Methotrexate,,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,inhibitor,L04AX03;L01BA01
DB00563,Methotrexate,,P00374,Dihydrofolate reductase,DHFR,inhibitor,L04AX03;L01BA01
DB00564,Carbamazepine,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,inhibitor,N03AF01
DB00564,Carbamazepine,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,N03AF01
DB00564,Carbamazepine,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,N03AF01
DB00565,Cisatracurium,,Q9GZZ6,Neuronal Acetylcholine (nACh) Receptor Subunits,CHRNA10,antagonist,M03AC11
DB00565,Cisatracurium,,P02708,Acetylcholine receptor subunit alpha,CHRNA1,antagonist,M03AC11
DB00565,Cisatracurium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,M03AC11
DB00566,Succimer,,,Lead,,chelator,
DB00566,Succimer,,,Mercury,,chelator,
DB00566,Succimer,,,Cadmium,,chelator,
DB00566,Succimer,,,Arsenic,,chelator,
DB00567,Cephalexin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01DB01
DB00567,Cephalexin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01DB01
DB00567,Cephalexin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01DB01
DB00567,Cephalexin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01DB01
DB00567,Cephalexin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01DB01
DB00568,Cinnarizine,,P35367,Histamine H1 receptor,HRH1,antagonist,N07CA52;N07CA02
DB00568,Cinnarizine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,N07CA52;N07CA02
DB00568,Cinnarizine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,N07CA52;N07CA02
DB00568,Cinnarizine,,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,inhibitor,N07CA52;N07CA02
DB00568,Cinnarizine,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,N07CA52;N07CA02
DB00568,Cinnarizine,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,N07CA52;N07CA02
DB00568,Cinnarizine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,N07CA52;N07CA02
DB00568,Cinnarizine,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,inhibitor,N07CA52;N07CA02
DB00568,Cinnarizine,,P14416,Dopamine D2 receptor,DRD2,other/unknown,N07CA52;N07CA02
DB00568,Cinnarizine,,P21728,D(1) dopamine receptor,DRD1,binder,N07CA52;N07CA02
DB00568,Cinnarizine,,P11229,Muscarinic acetylcholine receptor,CHRM1,binder,N07CA52;N07CA02
DB00569,Fondaparinux,,P00742,Coagulation factor X,F10,inhibitor,B01AX05
DB00569,Fondaparinux,,P01008,Antithrombin-III,SERPINC1,potentiator,B01AX05
DB00570,Vinblastine,,Q71U36,Tubulin alpha-1A chain,TUBA1A,binder,L01CA01
DB00570,Vinblastine,,P07437,Tubulin beta chain,TUBB,binder,L01CA01
DB00570,Vinblastine,,Q9UJT1,Tubulin delta chain,TUBD1,binder,L01CA01
DB00570,Vinblastine,,P23258,Tubulin gamma-1 chain,TUBG1,binder,L01CA01
DB00570,Vinblastine,,Q9UJT0,Tubulin epsilon chain,TUBE1,binder,L01CA01
DB00570,Vinblastine,,P05412,Transcription factor AP-1,JUN,other/unknown,L01CA01
DB00571,Propranolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07FX01;C07AA05;C07BA05
DB00571,Propranolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07FX01;C07AA05;C07BA05
DB00571,Propranolol,,P13945,Beta-3 adrenergic receptor,ADRB3,antagonist,C07FX01;C07AA05;C07BA05
DB00571,Propranolol,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,other/unknown,C07FX01;C07AA05;C07BA05
DB00571,Propranolol,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,other/unknown,C07FX01;C07AA05;C07BA05
DB00572,Atropine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,S01FA01;A03CB03;A03BA01
DB00572,Atropine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,S01FA01;A03CB03;A03BA01
DB00572,Atropine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,S01FA01;A03CB03;A03BA01
DB00572,Atropine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,S01FA01;A03CB03;A03BA01
DB00572,Atropine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,S01FA01;A03CB03;A03BA01
DB00572,Atropine,,P23415,Glycine receptor subunit alpha-1,GLRA1,antagonist,S01FA01;A03CB03;A03BA01
DB00572,Atropine,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,S01FA01;A03CB03;A03BA01
DB00572,Atropine,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,,S01FA01;A03CB03;A03BA01
DB00573,Fenoprofen,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AE04
DB00573,Fenoprofen,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,activator,M01AE04
DB00573,Fenoprofen,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,M01AE04
DB00573,Fenoprofen,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AE04
DB00574,Fenfluramine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,substrate,A08AA02;N03AX26
DB00574,Fenfluramine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,A08AA02;N03AX26
DB00574,Fenfluramine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,A08AA02;N03AX26
DB00574,Fenfluramine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,A08AA02;N03AX26
DB00574,Fenfluramine,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,antagonist,A08AA02;N03AX26
DB00574,Fenfluramine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,A08AA02;N03AX26
DB00574,Fenfluramine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,agonist,A08AA02;N03AX26
DB00574,Fenfluramine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,A08AA02;N03AX26
DB00575,Clonidine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,S01EA04;C02LC01;C02AC01;N02CX02;C02LC51
DB00575,Clonidine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,S01EA04;C02LC01;C02AC01;N02CX02;C02LC51
DB00575,Clonidine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,S01EA04;C02LC01;C02AC01;N02CX02;C02LC51
DB00575,Clonidine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,S01EA04;C02LC01;C02AC01;N02CX02;C02LC51
DB00575,Clonidine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,S01EA04;C02LC01;C02AC01;N02CX02;C02LC51
DB00575,Clonidine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,agonist,S01EA04;C02LC01;C02AC01;N02CX02;C02LC51
DB00576,Sulfamethizole,,P0AC13,Dihydropteroate synthase,folP,inhibitor,J01EB02;B05CA04;G01AE10;S01AB01;D06BA04
DB00577,Valaciclovir,,Q9QNF7,Thymidine kinase,TK,substrate,J05AB11
DB00577,Valaciclovir,,P04293,DNA polymerase catalytic subunit,,inhibitor,J05AB11
DB00578,Carbenicillin,,P0AEB2,Penicillin-binding protein,dacA,inhibitor,J01CR50;J01CA03
DB00578,Carbenicillin,,Q47066,Beta-lactamase Toho-1,bla,substrate,J01CR50;J01CA03
DB00579,Mazindol,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,A08AA05
DB00579,Mazindol,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,A08AA05
DB00579,Mazindol,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,A08AA05
DB00579,Mazindol,,Q05940,Synaptic vesicular amine transporter,SLC18A2,,A08AA05
DB00580,Valdecoxib,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AH03;G01AE10
DB00580,Valdecoxib,,P00918,Carbonic anhydrase 2,CA2,inhibitor,M01AH03;G01AE10
DB00580,Valdecoxib,,P07451,Carbonic anhydrase 3,CA3,inhibitor,M01AH03;G01AE10
DB00581,Lactulose,,P06864,Evolved beta-galactosidase subunit alpha,ebgA,other,A06AD61;A06AD11
DB00582,Voriconazole,,P10613,Cytochrome P450 51,ERG11,antagonist,J02AC03
DB00582,Voriconazole,,P10613,Cytochrome P450 51,ERG11,inhibitor,J02AC03
DB00583,Levocarnitine,,P47989,Xanthine dehydrogenase/oxidase,XDH,,A16AA01
DB00583,Levocarnitine,,P23141,Liver carboxylesterase 1,CES1,,A16AA01
DB00583,Levocarnitine,,P05164,Myeloperoxidase,MPO,,A16AA01
DB00583,Levocarnitine,,P50416,"Carnitine O-palmitoyltransferase 1, liver isoform",CPT1A,activator,A16AA01
DB00583,Levocarnitine,,Q9H015,Solute carrier family 22 member 4,SLC22A4,,A16AA01
DB00583,Levocarnitine,,O76082,Solute carrier family 22 member 5,SLC22A5,,A16AA01
DB00583,Levocarnitine,,P43155,Carnitine O-acetyltransferase,CRAT,,A16AA01
DB00583,Levocarnitine,,Q8N8R3,Mitochondrial carnitine/acylcarnitine carrier protein CACL,SLC25A29,,A16AA01
DB00583,Levocarnitine,,O43772,Mitochondrial carnitine/acylcarnitine carrier protein,SLC25A20,,A16AA01
DB00583,Levocarnitine,,Q9UKG9,Peroxisomal carnitine O-octanoyltransferase,CROT,,A16AA01
DB00583,Levocarnitine,,P23786,"Carnitine O-palmitoyltransferase 2, mitochondrial",CPT2,,A16AA01
DB00584,Enalapril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09BA02;C09BB06;C09BB02;C09AA02
DB00585,Nizatidine,,P25021,Histamine H2 receptor,HRH2,antagonist,A02BA04
DB00586,Diclofenac,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,S01CC01;S01BC03;M01AB55;M02AA15;M01AB05;D11AX18
DB00586,Diclofenac,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,S01CC01;S01BC03;M01AB55;M02AA15;M01AB05;D11AX18
DB00587,Cinalukast,,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,antagonist,
DB00588,Fluticasone propionate,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB00588,Fluticasone propionate,,P06401,Progesterone receptor,PGR,agonist,
DB00588,Fluticasone propionate,,P47712,Cytosolic phospholipase A2,PLA2G4A,inhibitor,
DB00588,Fluticasone propionate,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,
DB00589,Lisuride,,P14416,Dopamine D2 receptor,DRD2,agonist,G02CB02;N02CA07
DB00589,Lisuride,,P35462,Dopamine D3 receptor,DRD3,agonist,G02CB02;N02CA07
DB00589,Lisuride,,P21917,Dopamine D4 receptor,DRD4,agonist,G02CB02;N02CA07
DB00589,Lisuride,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,G02CB02;N02CA07
DB00589,Lisuride,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,G02CB02;N02CA07
DB00589,Lisuride,,P21728,Dopamine D1 receptor,DRD1,antagonist,G02CB02;N02CA07
DB00589,Lisuride,,P21918,Dopamine D5 receptor,DRD5,antagonist,G02CB02;N02CA07
DB00589,Lisuride,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,G02CB02;N02CA07
DB00589,Lisuride,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,G02CB02;N02CA07
DB00589,Lisuride,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,G02CB02;N02CA07
DB00589,Lisuride,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,G02CB02;N02CA07
DB00589,Lisuride,,P08913,Alpha-2A adrenergic receptor,ADRA2A,other/unknown,G02CB02;N02CA07
DB00589,Lisuride,,P18089,Alpha-2B adrenergic receptor,ADRA2B,other/unknown,G02CB02;N02CA07
DB00589,Lisuride,,P18825,Alpha-2C adrenergic receptor,ADRA2C,other/unknown,G02CB02;N02CA07
DB00589,Lisuride,,P34969,5-hydroxytryptamine receptor 7,HTR7,,G02CB02;N02CA07
DB00590,Doxazosin,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C02CA04;G04CA55
DB00590,Doxazosin,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,C02CA04;G04CA55
DB00590,Doxazosin,,Q12809,HERG human cardiac K+ channel,KCNH2,inhibitor,C02CA04;G04CA55
DB00590,Doxazosin,,P35368,Alpha-1B adrenergic receptor,ADRA1B,,C02CA04;G04CA55
DB00591,Fluocinolone acetonide,,P04150,Glucocorticoid receptor,NR3C1,agonist,S01CA10;D07BC02;S02BA08;C05AA10;S01BA15;D07AC04;S02CA05;D07CC02
DB00591,Fluocinolone acetonide,,P04083,Annexin A1,ANXA1,inducer,S01CA10;D07BC02;S02BA08;C05AA10;S01BA15;D07AC04;S02CA05;D07CC02
DB00591,Fluocinolone acetonide,,P07355,Annexin A2,ANXA2,inducer,S01CA10;D07BC02;S02BA08;C05AA10;S01BA15;D07AC04;S02CA05;D07CC02
DB00591,Fluocinolone acetonide,,P12429,Annexin A3,ANXA3,inducer,S01CA10;D07BC02;S02BA08;C05AA10;S01BA15;D07AC04;S02CA05;D07CC02
DB00591,Fluocinolone acetonide,,P09525,Annexin A4,ANXA4,inducer,S01CA10;D07BC02;S02BA08;C05AA10;S01BA15;D07AC04;S02CA05;D07CC02
DB00591,Fluocinolone acetonide,,P08758,Annexin A5,ANXA5,inducer,S01CA10;D07BC02;S02BA08;C05AA10;S01BA15;D07AC04;S02CA05;D07CC02
DB00591,Fluocinolone acetonide,,P04054,Phospholipase A2,PLA2G1B,inhibitor,S01CA10;D07BC02;S02BA08;C05AA10;S01BA15;D07AC04;S02CA05;D07CC02
DB00592,Piperazine,,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,agonist,P02CB01
DB00593,Ethosuximide,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,N03AD01;N03AD51
DB00594,Amiloride,,P37088,Amiloride-sensitive sodium channel subunit alpha,SCNN1A,inhibitor,C03DB01
DB00594,Amiloride,,P51168,Amiloride-sensitive sodium channel subunit beta,SCNN1B,inhibitor,C03DB01
DB00594,Amiloride,,P51170,Amiloride-sensitive sodium channel subunit gamma,SCNN1G,inhibitor,C03DB01
DB00594,Amiloride,,P51172,Amiloride-sensitive sodium channel subunit delta,SCNN1D,inhibitor,C03DB01
DB00594,Amiloride,,P19801,Amiloride-sensitive amine oxidase [copper-containing],AOC1,inhibitor,C03DB01
DB00594,Amiloride,,Q16515,Acid-sensing ion channel 2,ASIC2,inhibitor,C03DB01
DB00594,Amiloride,,P78348,Acid-sensing ion channel 1,ASIC1,inhibitor,C03DB01
DB00594,Amiloride,,P19634,Sodium/hydrogen exchanger 1,SLC9A1,inhibitor,C03DB01
DB00594,Amiloride,,P00749,Urokinase-type plasminogen activator,PLAU,inhibitor,C03DB01
DB00595,Oxytetracycline,,P0A7X3,30S ribosomal protein S9,rpsI,inhibitor,J01AA06;G01AA07;S01AA04;A01AB25;J01AA56;D06AA03;J01AA20
DB00595,Oxytetracycline,,P0A7V8,30S ribosomal protein S4,rpsD,inhibitor,J01AA06;G01AA07;S01AA04;A01AB25;J01AA56;D06AA03;J01AA20
DB00595,Oxytetracycline,,,16S ribosomal RNA,,inhibitor,J01AA06;G01AA07;S01AA04;A01AB25;J01AA56;D06AA03;J01AA20
DB00596,Ulobetasol,,P04150,Glucocorticoid receptor,NR3C1,agonist,D05AX55;D07AC21
DB00598,Labetalol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07BG01;C07CG01;C07AG01
DB00598,Labetalol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07BG01;C07CG01;C07AG01
DB00598,Labetalol,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,C07BG01;C07CG01;C07AG01
DB00599,Thiopental,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,P42262,Glutamate receptor 2,GRIA2,antagonist,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,O00519,Fatty-acid amide hydrolase 1,FAAH,inhibitor,N01AF03;N05CB01;N05CA19
DB00599,Thiopental,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,,N01AF03;N05CB01;N05CA19
DB00600,Monobenzone,,P14679,Tyrosinase,TYR,inhibitor,D11AX13
DB00601,Linezolid,,,23S ribosomal RNA,,inhibitor,J01XX08
DB00603,Medroxyprogesterone acetate,,P06401,Progesterone receptor,PGR,agonist,G03AA08;G03DA02;G03FB06;G03FA12;L02AB02;G03AA17;G03AC06
DB00603,Medroxyprogesterone acetate,,P03372,Estrogen receptor alpha,ESR1,agonist,G03AA08;G03DA02;G03FB06;G03FA12;L02AB02;G03AA17;G03AC06
DB00603,Medroxyprogesterone acetate,,P08183,P-glycoprotein 1,ABCB1,inhibitor,G03AA08;G03DA02;G03FB06;G03FA12;L02AB02;G03AA17;G03AC06
DB00603,Medroxyprogesterone acetate,,P14867,GABA(A) Receptor,GABRA1,inhibitor,G03AA08;G03DA02;G03FB06;G03FA12;L02AB02;G03AA17;G03AC06
DB00604,Cisapride,,Q13639,5-hydroxytryptamine receptor 4,HTR4,agonist,A03FA02
DB00604,Cisapride,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,agonist,A03FA02
DB00604,Cisapride,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,A03FA02
DB00604,Cisapride,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,A03FA02
DB00605,Sulindac,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AB02
DB00605,Sulindac,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AB02
DB00605,Sulindac,,P15121,Aldose reductase,AKR1B1,inhibitor,M01AB02
DB00605,Sulindac,,P27361,Mitogen-activated protein kinase 3,MAPK3,inhibitor,M01AB02
DB00605,Sulindac,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,negative modulator,M01AB02
DB00605,Sulindac,,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,antagonist,M01AB02
DB00605,Sulindac,,O60218,Aldo-keto reductase family 1 member B10,AKR1B10,inhibitor,M01AB02
DB00606,Cyclothiazide,,P54710,Sodium/potassium-transporting ATPase subunit gamma,FXYD2,inhibitor,G01AE10;C03AB09;C03AA09
DB00606,Cyclothiazide,,P00915,Carbonic anhydrase,CA1,inhibitor,G01AE10;C03AB09;C03AA09
DB00606,Cyclothiazide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,G01AE10;C03AB09;C03AA09
DB00606,Cyclothiazide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,G01AE10;C03AB09;C03AA09
DB00606,Cyclothiazide,,Q6FHJ7,Secreted frizzled-related protein 4,SFRP4,inhibitor,G01AE10;C03AB09;C03AA09
DB00607,Nafcillin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01CR50;J01CF06
DB00607,Nafcillin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01CR50;J01CF06
DB00607,Nafcillin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01CR50;J01CF06
DB00607,Nafcillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CR50;J01CF06
DB00607,Nafcillin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CF06
DB00608,Chloroquine,,P09210,Glutathione S-transferase A2,GSTA2,inhibitor,P01BB52;P01BA01
DB00608,Chloroquine,,P01375,Tumor necrosis factor,TNF,inhibitor,P01BB52;P01BA01
DB00608,Chloroquine,,Q9NR96,Toll-like receptor 9,TLR9,inhibitor,P01BB52;P01BA01
DB00608,Chloroquine,,Q8ILQ7,Glutathione S-transferase,GST,inhibitor,P01BB52;P01BA01
DB00608,Chloroquine,,P09429,High mobility group protein B1,HMGB1,inhibitor,P01BB52;P01BA01
DB00608,Chloroquine,,P09488,Glutathione S-transferase Mu 1,GSTM1,inhibitor,P01BB52;P01BA01
DB00608,Chloroquine,,Q9BYF1,Angiotensin-converting enzyme 2,ACE2,modulator,P01BB52;P01BA01
DB00609,Ethionamide,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,inhibitor,J04AD03
DB00609,Ethionamide,,P9WIE5,Catalase-peroxidase,katG,other/unknown,J04AD03
DB00610,Metaraminol,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,C01CA09
DB00611,Butorphanol,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N02AF01
DB00611,Butorphanol,,P41143,Delta-type opioid receptor,OPRD1,agonist,N02AF01
DB00611,Butorphanol,,P35372,Mu-type opioid receptor,OPRM1,antagonist,N02AF01
DB00612,Bisoprolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07FX04;C07BB07;C07AB07;C09BX05;C09BX02;C09BX04;C07FB07
DB00612,Bisoprolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07FX04;C07BB07;C07AB07;C09BX05;C09BX02;C09BX04;C07FB07
DB00613,Amodiaquine,,,Fe(II)-protoporphyrin IX,,binder,P01BF03;P01BA06
DB00613,Amodiaquine,,P50135,Histamine N-methyltransferase,HNMT,inhibitor,P01BF03;P01BA06
DB00614,Furazolidone,,,DNA,,cross-linking/alkylation,G01AX06;P01AB51
DB00615,Rifabutin,,P0A7Z4,DNA-directed RNA polymerase subunit alpha,rpoA,inhibitor,J04AB04;A02BD16
DB00615,Rifabutin,,P0A8V2,DNA-directed RNA polymerase subunit beta,rpoB,inhibitor,J04AB04;A02BD16
DB00615,Rifabutin,,P0A8T7,DNA-directed RNA polymerase subunit beta',rpoC,inhibitor,J04AB04;A02BD16
DB00615,Rifabutin,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,other/unknown,J04AB04;A02BD16
DB00615,Rifabutin,,P14625,Endoplasmin,HSP90B1,other/unknown,J04AB04;A02BD16
DB00616,Candoxatril,,P08473,Neprilysin,MME,inhibitor,
DB00616,Candoxatril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,
DB00617,Paramethadione,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,inhibitor,N03AC01
DB00618,Demeclocycline,,,30S ribosomal protein,,inhibitor,J01AA01;D06AA01;J01AA20
DB00618,Demeclocycline,,P30518,Vasopressin V2 receptor,AVPR2,inhibitor,J01AA01;D06AA01;J01AA20
DB00619,Imatinib,,P11274,Breakpoint cluster region protein,BCR,inhibitor,L01EA01
DB00619,Imatinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,antagonist,L01EA01
DB00619,Imatinib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,inhibitor,L01EA01
DB00619,Imatinib,,P04629,High affinity nerve growth factor receptor,NTRK1,antagonist,L01EA01
DB00619,Imatinib,,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,antagonist,L01EA01
DB00619,Imatinib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,antagonist,L01EA01
DB00619,Imatinib,,Q08345,Epithelial discoidin domain-containing receptor 1,DDR1,antagonist,L01EA01
DB00619,Imatinib,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,L01EA01
DB00619,Imatinib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,antagonist,L01EA01
DB00619,Imatinib,,Q16832,Discoidin domain-containing receptor 2,DDR2,antagonist,L01EA01
DB00620,Triamcinolone,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AB09;R01AD11;R03BA06;D07BB03;A01AC01;H02AB08;D07CB01;S01BA05;D07XB02;S02CA04;C05AA12
DB00621,Oxandrolone,,P10275,Androgen receptor,AR,agonist,A14AA08
DB00622,Nicardipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C08CA04
DB00622,Nicardipine,,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,inhibitor,C08CA04
DB00622,Nicardipine,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,inhibitor,C08CA04
DB00622,Nicardipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,C08CA04
DB00622,Nicardipine,,P54750,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",PDE1A,inhibitor,C08CA04
DB00622,Nicardipine,,Q01064,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,inhibitor,C08CA04
DB00622,Nicardipine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C08CA04
DB00622,Nicardipine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,C08CA04
DB00622,Nicardipine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,C08CA04
DB00622,Nicardipine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,C08CA04
DB00622,Nicardipine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,C08CA04
DB00622,Nicardipine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,C08CA04
DB00622,Nicardipine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,C08CA04
DB00622,Nicardipine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,C08CA04
DB00622,Nicardipine,,P0DP23,Calmodulin,CALM1,other/unknown,C08CA04
DB00622,Nicardipine,,Q06432,Voltage-dependent calcium channel,CACNG1,inhibitor,C08CA04
DB00622,Nicardipine,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,C08CA04
DB00622,Nicardipine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,C08CA04
DB00622,Nicardipine,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,inhibitor,C08CA04
DB00623,Fluphenazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AB02
DB00623,Fluphenazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AB02
DB00623,Fluphenazine,,P0DP23,Calmodulin,CALM1,inhibitor,N05AB02
DB00623,Fluphenazine,,P10275,Androgen receptor,AR,,N05AB02
DB00623,Fluphenazine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,N05AB02
DB00623,Fluphenazine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,,N05AB02
DB00624,Testosterone,,P10275,Androgen receptor,AR,agonist,G03BA03;G03EA02
DB00624,Testosterone,,P03372,Estrogen receptor alpha,ESR1,inhibitor,G03BA03;G03EA02
DB00624,Testosterone,,P08235,Mineralocorticoid receptor,NR3C2,ligand,G03BA03;G03EA02
DB00625,Efavirenz,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AR06;J05AG03;J05AR11
DB00626,Bacitracin,,,C55-isoprenyl pyrophosphate,,antagonist,J01XX10;D06AX05;R02AB04
DB00626,Bacitracin,,P14735,Insulin-degrading enzyme,IDE,inhibitor,J01XX10;D06AX05;R02AB04
DB00626,Bacitracin,,P01023,Alpha-2-macroglobulin,A2M,inhibitor,J01XX10;D06AX05;R02AB04
DB00627,Niacin,,P49019,Hydroxycarboxylic acid receptor 3,HCAR3,agonist,C10AD02;C10AD52;C10BA01;C04AC01
DB00627,Niacin,,Q8TDS4,Hydroxycarboxylic acid receptor 2,HCAR2,agonist,C10AD02;C10AD52;C10BA01;C04AC01
DB00627,Niacin,,Q15274,Nicotinate-nucleotide pyrophosphorylase [carboxylating],QPRT,binder,C10AD02;C10AD52;C10BA01;C04AC01
DB00627,Niacin,,P40261,Nicotinamide N-methyltransferase,NNMT,binder,C10AD02;C10AD52;C10BA01;C04AC01
DB00628,Clorazepic acid,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA05
DB00628,Clorazepic acid,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA05
DB00629,Guanabenz,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,
DB00629,Guanabenz,,P18089,Alpha-2B adrenergic receptor,ADRA2B,binder,
DB00630,Alendronic acid,,P14324,Farnesyl pyrophosphate synthase,FDPS,inhibitor,M05BB03;M05BA04;M05BB06;M05BB05
DB00630,Alendronic acid,,,Hydroxylapatite,,antagonist,M05BB03;M05BA04;M05BB06;M05BB05
DB00630,Alendronic acid,,P29074,Tyrosine-protein phosphatase non-receptor type 4,PTPN4,inhibitor,M05BB03;M05BA04;M05BB06;M05BB05
DB00630,Alendronic acid,,Q13332,Receptor-type tyrosine-protein phosphatase S,PTPRS,inhibitor,M05BB03;M05BA04;M05BB06;M05BB05
DB00630,Alendronic acid,,P23469,Receptor-type tyrosine-protein phosphatase epsilon,PTPRE,inhibitor,M05BB03;M05BA04;M05BB06;M05BB05
DB00630,Alendronic acid,,P38606,V-type proton ATPase catalytic subunit A,ATP6V1A,inhibitor,M05BB03;M05BA04;M05BB06;M05BB05
DB00631,Clofarabine,,,DNA,,other/unknown,L01BB06
DB00631,Clofarabine,,P09884,DNA polymerase alpha catalytic subunit,POLA1,inhibitor,L01BB06
DB00631,Clofarabine,,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,inhibitor,L01BB06
DB00632,Docosanol,,P03200,Envelope glycoprotein GP350,,intercalation,D06BB11
DB00632,Docosanol,,P68344,Envelope glycoprotein GP340,,intercalation,D06BB11
DB00633,Dexmedetomidine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,N05CM18
DB00634,Sulfacetamide,,P0AC13,Dihydropteroate synthase,folP,inhibitor,D10AF06;S01AB04;G01AE10
DB00634,Sulfacetamide,,P0C002,Dihydropteroate synthase type-1,sulI,inhibitor,D10AF06;S01AB04;G01AE10
DB00634,Sulfacetamide,,P53848,Folic acid synthesis protein FOL1,FOL1,inhibitor,D10AF06;S01AB04;G01AE10
DB00635,Prednisone,,P04150,Glucocorticoid receptor,NR3C1,agonist,A07EA03;H02AB07
DB00636,Clofibrate,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,C10AB01
DB00637,Astemizole,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX11
DB00637,Astemizole,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,R06AX11
DB00637,Astemizole,,O95259,Potassium voltage-gated channel subfamily H member 1,KCNH1,,R06AX11
DB00637,Astemizole,,P10636,Microtubule-associated protein tau,MAPT,,R06AX11
DB00638,Inulin,,Q9F0I5,Cycloinulo-oligosaccharide fructanotransferase,cft,binder,V04CH01
DB00639,Butoconazole,,,Ergosterol,,other,G01AF20;G01AF15
DB00640,Adenosine,,P30542,Adenosine receptor A1,ADORA1,agonist,C01EB10
DB00640,Adenosine,,P29274,Adenosine receptor A2a,ADORA2A,agonist,C01EB10
DB00640,Adenosine,,P29275,Adenosine receptor A2b,ADORA2B,agonist,C01EB10
DB00640,Adenosine,,P0DMS8,Adenosine receptor A3,ADORA3,agonist,C01EB10
DB00641,Simvastatin,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,inhibitor,A10BH51;C10AA01;C10BX04;C10BA02;C10BX01;C10BA04
DB00641,Simvastatin,,P20701,Integrin alpha-L,ITGAL,inhibitory allosteric modulator,A10BH51;C10AA01;C10BX04;C10BA02;C10BX01;C10BA04
DB00641,Simvastatin,,Q92769,Histone deacetylase 2,HDAC2,inhibitor,A10BH51;C10AA01;C10BX04;C10BA02;C10BX01;C10BA04
DB00642,Pemetrexed,,P04818,Thymidylate synthase,TYMS,inhibitor,L01BA04
DB00642,Pemetrexed,,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,inhibitor,L01BA04
DB00642,Pemetrexed,,P00374,Dihydrofolate reductase,DHFR,inhibitor,L01BA04
DB00642,Pemetrexed,,P22102,Trifunctional purine biosynthetic protein adenosine-3,GART,inhibitor,L01BA04
DB00643,Mebendazole,,Q71U36,Tubulin alpha-1A chain,TUBA1A,inhibitor,P02CA51;P02CA01
DB00643,Mebendazole,,P68371,Tubulin beta-4B chain,TUBB4B,inhibitor,P02CA51;P02CA01
DB00644,Gonadorelin,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,agonist,V04CM01;H01CA01
DB00644,Gonadorelin,,Q96P88,Putative gonadotropin-releasing hormone II receptor,GNRHR2,agonist,V04CM01;H01CA01
DB00645,Dyclonine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,N01BX02;R02AD04
DB00646,Nystatin,,,Ergosterol,,binder,D01AA01;G01AA01;A07AA02;G01AA51
DB00647,Dextropropoxyphene,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AC04;N02AC54;N02AC74
DB00647,Dextropropoxyphene,,P41143,Delta-type opioid receptor,OPRD1,agonist,N02AC04;N02AC54;N02AC74
DB00647,Dextropropoxyphene,,P41145,Kappa-type opioid receptor,OPRK1,antagonist,N02AC04;N02AC54;N02AC74
DB00647,Dextropropoxyphene,,P23141,Liver carboxylesterase 1,CES1,,N02AC04;N02AC54;N02AC74
DB00647,Dextropropoxyphene,,Q05586,NMDA receptor,GRIN1,antagonist,N02AC04;N02AC54;N02AC74
DB00648,Mitotane,,P15538,"Cytochrome P450 11B1, mitochondrial",CYP11B1,inducer,L01XX23
DB00648,Mitotane,,P03372,Estrogen receptor alpha,ESR1,,L01XX23
DB00648,Mitotane,,P06401,Progesterone receptor,PGR,,L01XX23
DB00648,Mitotane,,P10275,Androgen receptor,AR,antagonist,L01XX23
DB00648,Mitotane,,P10109,"Adrenodoxin, mitochondrial",FDX1,unknown,L01XX23
DB00649,Stavudine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AF04;J05AR07
DB00651,Dyphylline,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,R03DA20;R03DB01;R03DA51;R03DA01
DB00651,Dyphylline,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,inhibitor,R03DA20;R03DB01;R03DA51;R03DA01
DB00651,Dyphylline,,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,inhibitor,R03DA20;R03DB01;R03DA51;R03DA01
DB00651,Dyphylline,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,inhibitor,R03DA20;R03DB01;R03DA51;R03DA01
DB00651,Dyphylline,,P30542,Adenosine receptor A1,ADORA1,antagonist,R03DA20;R03DB01;R03DA51;R03DA01
DB00651,Dyphylline,,P29274,Adenosine receptor A2a,ADORA2A,antagonist,R03DA20;R03DB01;R03DA51;R03DA01
DB00652,Pentazocine,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,agonist,N02AD01
DB00652,Pentazocine,,P35372,Mu-type opioid receptor,OPRM1,antagonist,N02AD01
DB00652,Pentazocine,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N02AD01
DB00653,Magnesium sulfate,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,inhibitor,A06AD04;V04CC02;D11AX05;B05XA05;A12CC02
DB00653,Magnesium sulfate,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,blocker,A06AD04;V04CC02;D11AX05;B05XA05;A12CC02
DB00654,Latanoprost,,P43088,Prostaglandin F2-alpha receptor,PTGFR,agonist,S01EE01;S01EE51
DB00655,Estrone,,P03372,Estrogen receptor alpha,ESR1,agonist,G03CC04;G03CA07
DB00655,Estrone,,Q92731,Estrogen receptor beta,ESR2,,G03CC04;G03CA07
DB00655,Estrone,,P10275,Androgen receptor,AR,,G03CC04;G03CA07
DB00655,Estrone,,P11511,Cytochrome P450 19A1,CYP19A1,,G03CC04;G03CA07
DB00655,Estrone,,P04278,Sex hormone-binding globulin,SHBG,,G03CC04;G03CA07
DB00656,Trazodone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AX05
DB00656,Trazodone,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,N06AX05
DB00656,Trazodone,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX05
DB00656,Trazodone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N06AX05
DB00656,Trazodone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,N06AX05
DB00656,Trazodone,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AX05
DB00656,Trazodone,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N06AX05
DB00656,Trazodone,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N06AX05
DB00656,Trazodone,,P08909,5-hydroxytryptamine receptor 1C,Htr2c,antagonist,N06AX05
DB00656,Trazodone,,P08909,5-hydroxytryptamine receptor 1C,Htr2c,partial agonist,N06AX05
DB00657,Mecamylamine,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,C02BB01
DB00657,Mecamylamine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,C02BB01
DB00657,Mecamylamine,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,C02BB01
DB00657,Mecamylamine,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,,C02BB01
DB00658,Sevelamer,,,Phosphate,,binder,V03AE02
DB00659,Acamprosate,,Q05586,Glutamate (NMDA) receptor,GRIN1,antagonist,N07BB03
DB00659,Acamprosate,,P41594,Metabotropic glutamate receptor 5,GRM5,antagonist,N07BB03
DB00659,Acamprosate,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,inhibitor,N07BB03
DB00661,Verapamil,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,inhibitor,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,inhibitor,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,inhibitor,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,P31645,Sodium-dependent serotonin transporter,SLC6A4,unknown,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,Q06432,Voltage-dependent calcium channel,CACNG1,inhibitor,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,P08183,P-glycoprotein 1,ABCB1,inhibitor,C09BB10;C08DA51;C08DA01
DB00661,Verapamil,,P08183,P-glycoprotein 1,ABCB1,blocker,C09BB10;C08DA51;C08DA01
DB00663,Flumethasone,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AB03;D07BB01;S02CA02;D07CB05;D07XB01
DB00664,Sulfametopyrazine,,Q27738,Dihydropteroate synthetase,,inhibitor,G01AE10;J01ED02;P01BF04
DB00665,Nilutamide,,P10275,Androgen receptor,AR,antagonist,L02BB02
DB00666,Nafarelin,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,agonist,H01CA02
DB00666,Nafarelin,,Q96P88,Putative gonadotropin-releasing hormone II receptor,GNRHR2,agonist,H01CA02
DB00668,Epinephrine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,A01AD01;R03AK01;B02BC09;C01CA24;S01EA01;R01AA14;R03AA01;S01EA51
DB00668,Epinephrine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,A01AD01;R03AK01;B02BC09;C01CA24;S01EA01;R01AA14;R03AA01;S01EA51
DB00668,Epinephrine,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,A01AD01;R03AK01;B02BC09;C01CA24;S01EA01;R01AA14;R03AA01;S01EA51
DB00668,Epinephrine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,A01AD01;R03AK01;B02BC09;C01CA24;S01EA01;R01AA14;R03AA01;S01EA51
DB00668,Epinephrine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,A01AD01;R03AK01;B02BC09;C01CA24;S01EA01;R01AA14;R03AA01;S01EA51
DB00668,Epinephrine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,A01AD01;R03AK01;B02BC09;C01CA24;S01EA01;R01AA14;R03AA01;S01EA51
DB00668,Epinephrine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,A01AD01;R03AK01;B02BC09;C01CA24;S01EA01;R01AA14;R03AA01;S01EA51
DB00668,Epinephrine,,P01375,Tumor necrosis factor,TNF,antagonist,A01AD01;R03AK01;B02BC09;C01CA24;S01EA01;R01AA14;R03AA01;S01EA51
DB00668,Epinephrine,,P01375,Tumor necrosis factor,TNF,agonist,A01AD01;R03AK01;B02BC09;C01CA24;S01EA01;R01AA14;R03AA01;S01EA51
DB00669,Sumatriptan,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N02CC01;G01AE10
DB00669,Sumatriptan,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N02CC01;G01AE10
DB00669,Sumatriptan,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N02CC01;G01AE10
DB00669,Sumatriptan,,P30939,5-hydroxytryptamine receptor 1F,HTR1F,agonist,N02CC01;G01AE10
DB00670,Pirenzepine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A02BX03
DB00671,Cefixime,,P44469,Penicillin-binding protein 2,mrdA,inhibitor,J01DD08;J01RA16;J01RA15
DB00671,Cefixime,,P0AEB2,Penicillin-binding protein,dacA,binder,J01DD08;J01RA16;J01RA15
DB00672,Chlorpropamide,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,inhibitor,G01AE10;A10BB02
DB00673,Aprepitant,,P25103,Neurokinin 1 receptor,TACR1,antagonist,A04AD12
DB00674,Galantamine,,P22303,Acetylcholinesterase,ACHE,inhibitor,N06DA04
DB00674,Galantamine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,allosteric modulator,N06DA04
DB00674,Galantamine,,A9X444,Muscle nicotinic acetylcholine receptor,,allosteric modulator,N06DA04
DB00674,Galantamine,,P06276,Cholinesterase,BCHE,inhibitor,N06DA04
DB00675,Tamoxifen,,P03372,Estrogen receptor alpha,ESR1,antagonist,L02BA01
DB00675,Tamoxifen,,P03372,Estrogen receptor alpha,ESR1,agonist,L02BA01
DB00675,Tamoxifen,,Q92731,Estrogen receptor beta,ESR2,antagonist,L02BA01
DB00675,Tamoxifen,,Q92731,Estrogen receptor beta,ESR2,agonist,L02BA01
DB00675,Tamoxifen,,P17252,Protein kinase C,PRKCA,inhibitor,L02BA01
DB00675,Tamoxifen,,P04278,Sex hormone-binding globulin,SHBG,inducer,L02BA01
DB00675,Tamoxifen,,Q15125,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",EBP,inhibitor,L02BA01
DB00675,Tamoxifen,,P10275,Androgen receptor,AR,,L02BA01
DB00675,Tamoxifen,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,L02BA01
DB00675,Tamoxifen,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,L02BA01
DB00675,Tamoxifen,,P62508,Estrogen-related receptor gamma,ESRRG,,L02BA01
DB00675,Tamoxifen,,P45983,Mitogen-activated protein kinase 8,MAPK8,modulator,L02BA01
DB00677,Isoflurophate,,P22303,Acetylcholinesterase,ACHE,inhibitor,
DB00677,Isoflurophate,,P06276,Cholinesterase,BCHE,inhibitor,
DB00677,Isoflurophate,,P02787,Serotransferrin,TF,,
DB00678,Losartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,C09CA01;C09DA01;C09DB06
DB00679,Thioridazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AC02
DB00679,Thioridazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AC02
DB00679,Thioridazine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AC02
DB00679,Thioridazine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AC02
DB00679,Thioridazine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AC02
DB00679,Thioridazine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,N05AC02
DB00680,Moricizine,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BG01
DB00681,Amphotericin B,,,Ergosterol,,binder,G01AA03;A07AA07;A01AB04;J02AA01
DB00682,Warfarin,,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,inhibitor,B01AA03
DB00682,Warfarin,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,B01AA03
DB00683,Midazolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD08
DB00683,Midazolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD08
DB00683,Midazolam,,P29274,Adenosine receptor A2a,ADORA2A,potentiator,N05CD08
DB00684,Tobramycin,,,16S ribosomal RNA,,inhibitor,S01AA12;J01GB01
DB00684,Tobramycin,,,23S ribosomal RNA,,inhibitor,S01AA12;J01GB01
DB00684,Tobramycin,,,Bacterial outer membrane,,incorporation into and destabilization,S01AA12;J01GB01
DB00684,Tobramycin,,,Cytoplasmic membrane,,incorporation into and destabilization,S01AA12;J01GB01
DB00685,Trovafloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MA13
DB00685,Trovafloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA13
DB00685,Trovafloxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,J01MA13
DB00686,Pentosan polysulfate,,P09038,Fibroblast growth factor 2,FGF2,antagonist,C05BA04;G04BX15
DB00686,Pentosan polysulfate,,P05230,Fibroblast growth factor 1,FGF1,antagonist,C05BA04;G04BX15
DB00686,Pentosan polysulfate,,P08620,Fibroblast growth factor 4,FGF4,inhibitor,C05BA04;G04BX15
DB00687,Fludrocortisone,,P08235,Mineralocorticoid receptor,NR3C2,agonist,S02CA07;S01CA06;H02AA02;S03CA05
DB00687,Fludrocortisone,,P04150,Glucocorticoid receptor,NR3C1,agonist,S02CA07;S01CA06;H02AA02;S03CA05
DB00688,Mycophenolate mofetil,,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,inhibitor,
DB00688,Mycophenolate mofetil,,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,inducer,
DB00688,Mycophenolate mofetil,,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,inhibitor,
DB00688,Mycophenolate mofetil,,Q03393,6-pyruvoyl tetrahydrobiopterin synthase,PTS,inhibitor,
DB00689,Cephaloglycin,,P02919,Penicillin-binding protein 1B,mrcB,antagonist,
DB00690,Flurazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD01
DB00690,Flurazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD01
DB00691,Moexipril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09AA13;C09BA13
DB00692,Phentolamine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,V03AB36;C04AB01
DB00692,Phentolamine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,V03AB36;C04AB01
DB00692,Phentolamine,,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,blocker,V03AB36;C04AB01
DB00693,Fluorescein,,P06310,Ig kappa chain V-II region RPMI 6410,,other,S01JA01;S01JA51
DB00693,Fluorescein,,,DNA,,other,S01JA01;S01JA51
DB00694,Daunorubicin,,,DNA,,intercalation,L01DB02;L01XY01
DB00694,Daunorubicin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,L01DB02;L01XY01
DB00694,Daunorubicin,,Q02880,DNA topoisomerase 2-beta,TOP2B,inhibitor,L01DB02;L01XY01
DB00695,Furosemide,,Q13621,Solute carrier family 12 member 1,SLC12A1,inhibitor,C03EB01;C03CA01;G01AE10;C03CB01
DB00695,Furosemide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,C03EB01;C03CA01;G01AE10;C03CB01
DB00695,Furosemide,,Q9HC97,G-protein coupled receptor 35,GPR35,agonist,C03EB01;C03CA01;G01AE10;C03CB01
DB00696,Ergotamine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,partial agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,partial agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,partial agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P14416,Dopamine D2 receptor,DRD2,agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,partial agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P21728,D(1) dopamine receptor,DRD1,agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P30939,5-hydroxytryptamine receptor 1F,HTR1F,agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,,N02CA02;N02CA52;N02CA72
DB00696,Ergotamine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,,N02CA02;N02CA52;N02CA72
DB00697,Tizanidine,,Q9Y2I1,Nischarin,NISCH,agonist,M03BX02
DB00697,Tizanidine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,agonist,M03BX02
DB00697,Tizanidine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,agonist,M03BX02
DB00698,Nitrofurantoin,,P52647,Probable pyruvate-flavodoxin oxidoreductase,ydbK,potentiator,J01XE01;J01XE51
DB00698,Nitrofurantoin,,P17117,Oxygen-insensitive NADPH nitroreductase,nfsA,potentiator,J01XE01;J01XE51
DB00698,Nitrofurantoin,,P0A7R5,30S ribosomal protein S10,rpsJ,inhibitor,J01XE01;J01XE51
DB00699,Nicergoline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C04AE02
DB00700,Eplerenone,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,C03DA04
DB00701,Amprenavir,,Q72874,Human immunodeficiency virus type 1 protease,pol,inhibitor,J05AE05
DB00703,Methazolamide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,G01AE10;S01EC05
DB00703,Methazolamide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,G01AE10;S01EC05
DB00703,Methazolamide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,G01AE10;S01EC05
DB00703,Methazolamide,,P43166,Carbonic anhydrase 7,CA7,inhibitor,G01AE10;S01EC05
DB00703,Methazolamide,,P07451,Carbonic anhydrase 3,CA3,inhibitor,G01AE10;S01EC05
DB00704,Naltrexone,,P35372,Mu-type opioid receptor,OPRM1,antagonist,N02AA56;N07BB04;A08AA62
DB00704,Naltrexone,,P41145,Kappa-type opioid receptor,OPRK1,antagonist,N02AA56;N07BB04;A08AA62
DB00704,Naltrexone,,P41143,Delta-type opioid receptor,OPRD1,antagonist,N02AA56;N07BB04;A08AA62
DB00704,Naltrexone,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,,N02AA56;N07BB04;A08AA62
DB00705,Delavirdine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AG02
DB00706,Tamsulosin,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,G04CA52;G04CA02;G01AE10;G04CA54;G04CA53
DB00706,Tamsulosin,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,G04CA52;G04CA02;G01AE10;G04CA54;G04CA53
DB00706,Tamsulosin,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,G04CA52;G04CA02;G01AE10;G04CA54;G04CA53
DB00707,Porfimer sodium,,P01130,Low-density lipoprotein receptor,LDLR,other/unknown,L01XD01
DB00707,Porfimer sodium,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,antagonist,L01XD01
DB00708,Sufentanil,,P35372,Mu-type opioid receptor,OPRM1,agonist,N01AH03
DB00708,Sufentanil,,P41143,Delta-type opioid receptor,OPRD1,agonist,N01AH03
DB00708,Sufentanil,,P41145,Kappa-type opioid receptor,OPRK1,,N01AH03
DB00709,Lamivudine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AR27;J05AR02;J05AR25;J05AR11;J05AR07;J05AR01;J05AR13;J05AR12;J05AR24;J05AR04;J05AR16;J05AR05;J05AF05
DB00709,Lamivudine,,,DNA,,binder,J05AR27;J05AR02;J05AR25;J05AR11;J05AR07;J05AR01;J05AR13;J05AR12;J05AR24;J05AR04;J05AR16;J05AR05;J05AF05
DB00709,Lamivudine,,Q05486,Protein P,P,inhibitor,J05AR27;J05AR02;J05AR25;J05AR11;J05AR07;J05AR01;J05AR13;J05AR12;J05AR24;J05AR04;J05AR16;J05AR05;J05AF05
DB00710,Ibandronate,,,Hydroxylapatite,,antagonist,M05BA06;M05BB09
DB00710,Ibandronate,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,inhibitor,M05BA06;M05BB09
DB00710,Ibandronate,,P14324,Farnesyl pyrophosphate synthase,FDPS,inhibitor,M05BA06;M05BB09
DB00711,Diethylcarbamazine,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,P02CB02
DB00711,Diethylcarbamazine,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,P02CB02
DB00712,Flurbiprofen,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M02AA19;M01AE09;R02AX01;S01BC04
DB00712,Flurbiprofen,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M02AA19;M01AE09;R02AX01;S01BC04
DB00713,Oxacillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CR50;J01CF04
DB00713,Oxacillin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01CR50;J01CF04
DB00713,Oxacillin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CF04
DB00713,Oxacillin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01CR50;J01CF04
DB00713,Oxacillin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01CR50;J01CF04
DB00713,Oxacillin,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CF04
DB00713,Oxacillin,,P46059,Solute carrier family 15 member 1,SLC15A1,,J01CR50;J01CF04
DB00713,Oxacillin,,D6R448,Penicillin-binding protein 2,mecA,,J01CR50;J01CF04
DB00713,Oxacillin,,Q16348,Solute carrier family 15 member 2,SLC15A2,,J01CR50;J01CF04
DB00713,Oxacillin,,Q47066,Beta-lactamase Toho-1,bla,substrate,J01CR50;J01CF04
DB00714,Apomorphine,,P21917,Dopamine D4 receptor,DRD4,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P14416,Dopamine D2 receptor,DRD2,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P35462,Dopamine D3 receptor,DRD3,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P21918,Dopamine D5 receptor,DRD5,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P21728,Dopamine D1 receptor,DRD1,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,G04BE07;N04BC07
DB00714,Apomorphine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,G04BE07;N04BC07
DB00715,Paroxetine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AB05
DB00715,Paroxetine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AB05
DB00715,Paroxetine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,N06AB05
DB00715,Paroxetine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,binder,N06AB05
DB00715,Paroxetine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,binder,N06AB05
DB00715,Paroxetine,,P08588,Beta adrenergic receptor,ADRB1,inhibitor,N06AB05
DB00715,Paroxetine,,P14416,Dopamine D2 receptor,DRD2,other/unknown,N06AB05
DB00715,Paroxetine,,P35367,Histamine H1 receptor,HRH1,inhibitor,N06AB05
DB00715,Paroxetine,,P08908,Serotonin Receptors,HTR1A,,N06AB05
DB00715,Paroxetine,,P11229,Muscarinic acetylcholine receptor,CHRM1,inhibitor,N06AB05
DB00715,Paroxetine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,agonist,N06AB05
DB00715,Paroxetine,,P21728,D(1) dopamine receptor,DRD1,other/unknown,N06AB05
DB00716,Nedocromil,,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,antagonist,R03BC03;R01AC07;S01GX04
DB00716,Nedocromil,,Q9NS75,Cysteinyl leukotriene receptor 2,CYSLTR2,antagonist,R03BC03;R01AC07;S01GX04
DB00716,Nedocromil,,P21462,fMet-Leu-Phe receptor,FPR1,antagonist,R03BC03;R01AC07;S01GX04
DB00716,Nedocromil,,Q13258,Prostaglandin D2 receptor,PTGDR,unknown,R03BC03;R01AC07;S01GX04
DB00716,Nedocromil,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,R03BC03;R01AC07;S01GX04
DB00717,Norethisterone,,P06401,Progesterone receptor,PGR,agonist,H01CC53;H01CC54;G03AA05;G03DC02;G03AB04;G03AC01;G03FA01;G03FB05
DB00717,Norethisterone,,P10275,Androgen receptor,AR,agonist,H01CC53;H01CC54;G03AA05;G03DC02;G03AB04;G03AC01;G03FA01;G03FB05
DB00717,Norethisterone,,P04150,Glucocorticoid receptor,NR3C1,agonist,H01CC53;H01CC54;G03AA05;G03DC02;G03AB04;G03AC01;G03FA01;G03FB05
DB00718,Adefovir dipivoxil,,P24024,DNA polymerase/reverse transcriptase,P,other,J05AF08
DB00719,Azatadine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX09
DB00720,Clodronic acid,,,Hydroxylapatite,,antagonist,M05BA02
DB00720,Clodronic acid,,P12235,ADP/ATP translocase 1,SLC25A4,inhibitor,M05BA02
DB00720,Clodronic acid,,P05141,ADP/ATP translocase 2,SLC25A5,inhibitor,M05BA02
DB00720,Clodronic acid,,P12236,ADP/ATP translocase 3,SLC25A6,inhibitor,M05BA02
DB00721,Procaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,N01BA52;C05AD05;S01HA05;N01BA02
DB00721,Procaine,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,antagonist,N01BA52;C05AD05;S01HA05;N01BA02
DB00721,Procaine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,N01BA52;C05AD05;S01HA05;N01BA02
DB00721,Procaine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N01BA52;C05AD05;S01HA05;N01BA02
DB00721,Procaine,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,N01BA52;C05AD05;S01HA05;N01BA02
DB00721,Procaine,,Q12791,Calcium-activated potassium channel,KCNMA1,blocker,N01BA52;C05AD05;S01HA05;N01BA02
DB00721,Procaine,,P47712,Cytosolic phospholipase A2,PLA2G4A,inhibitor,N01BA52;C05AD05;S01HA05;N01BA02
DB00721,Procaine,,Q86U10,60 kDa lysophospholipase,ASPG,inhibitor,N01BA52;C05AD05;S01HA05;N01BA02
DB00721,Procaine,,P21397,Monoamine oxidase,MAOA,inhibitor,N01BA52;C05AD05;S01HA05;N01BA02
DB00721,Procaine,,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,inhibitor,N01BA52;C05AD05;S01HA05;N01BA02
DB00721,Procaine,,Q9Y6K1,DNA (cytosine-5)-methyltransferase 3A,DNMT3A,inhibitor,N01BA52;C05AD05;S01HA05;N01BA02
DB00722,Lisinopril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09BA03;C10BX07;C09AA03;C09BB03
DB00722,Lisinopril,,P00797,Renin,REN,inhibitor,C09BA03;C10BX07;C09AA03;C09BB03
DB00723,Methoxamine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,C01CA10
DB00723,Methoxamine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,binder,C01CA10
DB00723,Methoxamine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,C01CA10
DB00724,Imiquimod,,Q9NYK1,Toll-like receptor 7,TLR7,agonist,D06BB10
DB00724,Imiquimod,,Q9NR97,Toll-like receptor 8,TLR8,agonist,D06BB10
DB00725,Homatropine methylbromide,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,A03CB04;A03BB06
DB00725,Homatropine methylbromide,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03CB04;A03BB06
DB00725,Homatropine methylbromide,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,A03CB04;A03BB06
DB00725,Homatropine methylbromide,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,A03CB04;A03BB06
DB00725,Homatropine methylbromide,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03CB04;A03BB06
DB00726,Trimipramine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA06
DB00726,Trimipramine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA06
DB00726,Trimipramine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06AA06
DB00726,Trimipramine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,N06AA06
DB00726,Trimipramine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N06AA06
DB00726,Trimipramine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N06AA06
DB00726,Trimipramine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N06AA06
DB00726,Trimipramine,,P14416,Dopamine D2 receptor,DRD2,other/unknown,N06AA06
DB00726,Trimipramine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,other/unknown,N06AA06
DB00726,Trimipramine,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AA06
DB00726,Trimipramine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AA06
DB00726,Trimipramine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,binder,N06AA06
DB00726,Trimipramine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,binder,N06AA06
DB00726,Trimipramine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N06AA06
DB00726,Trimipramine,,P21728,D(1) dopamine receptor,DRD1,binder,N06AA06
DB00726,Trimipramine,,P08588,Beta adrenergic receptor,ADRB1,binder,N06AA06
DB00726,Trimipramine,,P11229,Muscarinic acetylcholine receptor,CHRM1,binder,N06AA06
DB00726,Trimipramine,,P08909,5-hydroxytryptamine receptor 1C,Htr2c,binder,N06AA06
DB00727,Nitroglycerin,,P16066,Atrial natriuretic peptide receptor 1,NPR1,agonist,C01DA02;C01DA52;C05AE01
DB00728,Rocuronium,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,M03AC09
DB00728,Rocuronium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,M03AC09
DB00728,Rocuronium,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,M03AC09
DB00730,Thiabendazole,,P00363,Fumarate reductase flavoprotein subunit,frdA,inhibitor,D01AC06;P02CA02
DB00731,Nateglinide,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,inhibitor,A10BX03
DB00731,Nateglinide,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,A10BX03
DB00732,Atracurium besylate,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,
DB00733,Pralidoxime,,P22303,Acetylcholinesterase,ACHE,activator,V03AB04
DB00733,Pralidoxime,,P06276,Cholinesterase,BCHE,activator,V03AB04
DB00734,Risperidone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AX08
DB00734,Risperidone,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AX08
DB00734,Risperidone,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AX08
DB00734,Risperidone,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N05AX08
DB00734,Risperidone,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AX08
DB00734,Risperidone,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N05AX08
DB00734,Risperidone,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AX08
DB00734,Risperidone,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AX08
DB00734,Risperidone,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,antagonist,N05AX08
DB00734,Risperidone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AX08
DB00734,Risperidone,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N05AX08
DB00734,Risperidone,,,D(2L) dopamine receptor,,antagonist,N05AX08
DB00734,Risperidone,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AX08
DB00735,Naftifine,,Q14534,Squalene monooxygenase,SQLE,inhibitor,D01AE22
DB00736,Esomeprazole,,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,inhibitor,A02BD06;A02BC05;M01AE52
DB00736,Esomeprazole,,O94760,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",DDAH1,,A02BD06;A02BC05;M01AE52
DB00737,Meclizine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AE55;R06AE05
DB00737,Meclizine,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,inverse agonist,R06AE55;R06AE05
DB00738,Pentamidine,,O14717,tRNA (cytosine(38)-C(5))-methyltransferase,TRDMT1,other,P01CX01
DB00738,Pentamidine,,,DNA,,intercalation,P01CX01
DB00739,Hetacillin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01CA18;J01CR50
DB00739,Hetacillin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01CA18;J01CR50
DB00739,Hetacillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CA18;J01CR50
DB00739,Hetacillin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01CA18;J01CR50
DB00739,Hetacillin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01CA18;J01CR50
DB00740,Riluzole,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,N07XX02
DB00740,Riluzole,,Q9UPY5,Cystine/glutamate transporter,SLC7A11,inducer,N07XX02
DB00741,Hydrocortisone,,P04150,Glucocorticoid receptor,NR3C1,agonist,S01CB03;A01AC03;S01BA02;S01CA03;D07AA02;S01BB01;D07XA01;D07BA04;S02CA03;A07EA02;S02BA01;R01AD60;H02AB09;D07CA01;S03CA04;C05AA01
DB00741,Hydrocortisone,,P04083,Annexin A1,ANXA1,agonist,S01CB03;A01AC03;S01BA02;S01CA03;D07AA02;S01BB01;D07XA01;D07BA04;S02CA03;A07EA02;S02BA01;R01AD60;H02AB09;D07CA01;S03CA04;C05AA01
DB00744,Zileuton,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,
DB00745,Modafinil,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06BA07
DB00745,Modafinil,,P35368,Alpha-1B adrenergic receptor,ADRA1B,partial agonist,N06BA07
DB00746,Deferoxamine,,,Iron,,chelator,V03AC01
DB00746,Deferoxamine,,,Aluminum,,chelator,V03AC01
DB00746,Deferoxamine,,P05067,Amyloid beta A4 protein,APP,,V03AC01
DB00747,Scopolamine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05CM05;S01FA02;A04AD01;A04AD51
DB00747,Scopolamine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N05CM05;S01FA02;A04AD01;A04AD51
DB00747,Scopolamine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N05CM05;S01FA02;A04AD01;A04AD51
DB00747,Scopolamine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N05CM05;S01FA02;A04AD01;A04AD51
DB00747,Scopolamine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N05CM05;S01FA02;A04AD01;A04AD51
DB00747,Scopolamine,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,inhibitor,N05CM05;S01FA02;A04AD01;A04AD51
DB00747,Scopolamine,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,inducer,N05CM05;S01FA02;A04AD01;A04AD51
DB00747,Scopolamine,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,inhibitor,N05CM05;S01FA02;A04AD01;A04AD51
DB00747,Scopolamine,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,inducer,N05CM05;S01FA02;A04AD01;A04AD51
DB00747,Scopolamine,,P14410,"Sucrase-isomaltase, intestinal",SI,inhibitor,N05CM05;S01FA02;A04AD01;A04AD51
DB00748,Carbinoxamine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AA08
DB00749,Etodolac,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AB08
DB00749,Etodolac,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AB08
DB00749,Etodolac,,P19793,Retinoic acid receptor RXR-alpha,RXRA,other,M01AB08
DB00750,Prilocaine,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,N01BB54;N01BB04
DB00751,Epinastine,,P35367,Histamine H1 receptor,HRH1,antagonist,S01GX10;R06AX24
DB00751,Epinastine,,P25021,Histamine H2 receptor,HRH2,antagonist,S01GX10;R06AX24
DB00751,Epinastine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,unknown,S01GX10;R06AX24
DB00751,Epinastine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,unknown,S01GX10;R06AX24
DB00751,Epinastine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,S01GX10;R06AX24
DB00751,Epinastine,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,S01GX10;R06AX24
DB00752,Tranylcypromine,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,N06AF04
DB00752,Tranylcypromine,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,N06AF04
DB00753,Isoflurane,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,N01AB06
DB00753,Isoflurane,,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,inhibitor,N01AB06
DB00753,Isoflurane,,P23415,Glycine receptor subunit alpha-1,GLRA1,agonist,N01AB06
DB00753,Isoflurane,,P42261,Glutamate receptor 1,GRIA1,antagonist,N01AB06
DB00753,Isoflurane,,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,inducer,N01AB06
DB00753,Isoflurane,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N01AB06
DB00753,Isoflurane,,P30049,"ATP synthase subunit delta, mitochondrial",ATP5D,unknown,N01AB06
DB00753,Isoflurane,,P0DP23,Calmodulin,CALM1,other/unknown,N01AB06
DB00753,Isoflurane,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N01AB06
DB00753,Isoflurane,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,antagonist,N01AB06
DB00754,Ethotoin,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,N03AB01
DB00754,Ethotoin,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,N03AB01
DB00755,Tretinoin,,P10276,Retinoic acid receptor alpha,RARA,agonist,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,P10826,Retinoic acid receptor beta,RARB,agonist,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,P13631,Retinoic acid receptor gamma,RARG,agonist,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,P19793,Retinoic acid receptor RXR-alpha,RXRA,agonist,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,P28702,Retinoic acid receptor RXR-beta,RXRB,agonist,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,P48443,Retinoic acid receptor RXR-gamma,RXRG,agonist,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,P29762,Cellular retinoic acid-binding protein 1,CRABP1,binder,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,P49788,Retinoic acid receptor responder protein 1,RARRES1,agonist,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,P00352,Retinal dehydrogenase 1,ALDH1A1,substrate,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,O94788,Retinal dehydrogenase 2,ALDH1A2,substrate,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,Q8NFJ5,Retinoic acid-induced protein 3,GPRC5A,regulator,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,P31025,Lipocalin-1,LCN1,binder,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,Q9NY56,Odorant-binding protein 2a,OBP2A,binder,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,P02753,Retinol-binding protein 4,RBP4,binder,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,Q16654,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial",PDK4,upregulator,L01XF01;D10AD51;D10AD01
DB00755,Tretinoin,,Q14081,Carcinoembryonic antigen,,downregulator,L01XF01;D10AD51;D10AD01
DB00756,Hexachlorophene,,P06149,D-lactate dehydrogenase,dld,inhibitor,D08AE01
DB00756,Hexachlorophene,,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",SDHD,inhibitor,D08AE01
DB00756,Hexachlorophene,,P00367,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,inhibitor,D08AE01
DB00756,Hexachlorophene,,P03372,Estrogen receptor alpha,ESR1,,D08AE01
DB00757,Dolasetron,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,A04AA04
DB00758,Clopidogrel,,Q9H244,P2Y purinoceptor 12,P2RY12,antagonist,B01AC04
DB00759,Tetracycline,,P02359,30S ribosomal protein S7,rpsG,inhibitor,S02AA08;A02BD02;A01AB13;J01AA07;S01AA09;J01AA20;J01RA08;S03AA02;D06AA04;A02BD08
DB00759,Tetracycline,,P0AG59,30S ribosomal protein S14,rpsN,inhibitor,S02AA08;A02BD02;A01AB13;J01AA07;S01AA09;J01AA20;J01RA08;S03AA02;D06AA04;A02BD08
DB00759,Tetracycline,,P0A7V3,30S ribosomal protein S3,rpsC,inhibitor,S02AA08;A02BD02;A01AB13;J01AA07;S01AA09;J01AA20;J01RA08;S03AA02;D06AA04;A02BD08
DB00759,Tetracycline,,P0A7W7,30S ribosomal protein S8,rpsH,inhibitor,S02AA08;A02BD02;A01AB13;J01AA07;S01AA09;J01AA20;J01RA08;S03AA02;D06AA04;A02BD08
DB00759,Tetracycline,,P0A7U3,30S ribosomal protein S19,rpsS,inhibitor,S02AA08;A02BD02;A01AB13;J01AA07;S01AA09;J01AA20;J01RA08;S03AA02;D06AA04;A02BD08
DB00759,Tetracycline,,,16S ribosomal RNA,,inhibitor,S02AA08;A02BD02;A01AB13;J01AA07;S01AA09;J01AA20;J01RA08;S03AA02;D06AA04;A02BD08
DB00759,Tetracycline,,P04156,Major prion protein,PRNP,inhibitor,S02AA08;A02BD02;A01AB13;J01AA07;S01AA09;J01AA20;J01RA08;S03AA02;D06AA04;A02BD08
DB00759,Tetracycline,,C9EH48,Multidrug translocase MdfA,mdfA,,S02AA08;A02BD02;A01AB13;J01AA07;S01AA09;J01AA20;J01RA08;S03AA02;D06AA04;A02BD08
DB00759,Tetracycline,,Q9UM07,Protein-arginine deiminase type-4,PADI4,,S02AA08;A02BD02;A01AB13;J01AA07;S01AA09;J01AA20;J01RA08;S03AA02;D06AA04;A02BD08
DB00760,Meropenem,,P24228,D-alanyl-D-alanine carboxypeptidase DacB,dacB,inhibitor,J01DH02;J01DH52
DB00761,Potassium chloride,,P55011,Solute carrier family 12 member 2,SLC12A2,,A12BA51;B05XA01;A12BA01
DB00761,Potassium chloride,,Q13621,Solute carrier family 12 member 1,SLC12A1,binder,A12BA51;B05XA01;A12BA01
DB00761,Potassium chloride,,Q9H2X9,Solute carrier family 12 member 5,SLC12A5,,A12BA51;B05XA01;A12BA01
DB00761,Potassium chloride,,Q9UHW9,Solute carrier family 12 member 6,SLC12A6,,A12BA51;B05XA01;A12BA01
DB00761,Potassium chloride,,Q9Y666,Solute carrier family 12 member 7,SLC12A7,,A12BA51;B05XA01;A12BA01
DB00761,Potassium chloride,,Q9UP95,Solute carrier family 12 member 4,SLC12A4,,A12BA51;B05XA01;A12BA01
DB00762,Irinotecan,,Q969P6,"DNA topoisomerase I, mitochondrial",TOP1MT,inhibitor,L01CE02
DB00762,Irinotecan,,P11387,DNA topoisomerase 1,TOP1,inhibitor,L01CE02
DB00763,Methimazole,,P07202,Thyroid peroxidase,TPO,substrate,H03BB52;H03BB02
DB00763,Methimazole,,P07202,Thyroid peroxidase,TPO,inhibitor,H03BB52;H03BB02
DB00764,Mometasone,,P04150,Glucocorticoid receptor,NR3C1,agonist,R03AL12;R01AD59;R03AK14
DB00764,Mometasone,,P06401,Progesterone receptor,PGR,agonist,R03AL12;R01AD59;R03AK14
DB00765,Metyrosine,,P07101,Tyrosine 3-monooxygenase,TH,binder,C02KB01
DB00766,Clavulanic acid,,,Bacterial beta-lactamase enzymes,,inhibitor,
DB00767,Benzquinamide,,P35367,Histamine H1 receptor,HRH1,antagonist,
DB00767,Benzquinamide,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,
DB00767,Benzquinamide,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,
DB00767,Benzquinamide,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,
DB00767,Benzquinamide,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,
DB00767,Benzquinamide,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,
DB00768,Olopatadine,,P35367,Histamine H1 receptor,HRH1,antagonist,S01GX09;R01AC08
DB00768,Olopatadine,,P25021,Histamine H2 receptor,HRH2,antagonist,S01GX09;R01AC08
DB00768,Olopatadine,,Q9Y5N1,Histamine H3 receptor,HRH3,antagonist,S01GX09;R01AC08
DB00768,Olopatadine,,P23297,Protein S100-A1,S100A1,antagonist,S01GX09;R01AC08
DB00768,Olopatadine,,P80511,Protein S100-A12,S100A12,antagonist,S01GX09;R01AC08
DB00768,Olopatadine,,P04271,Protein S100-B,S100B,other/unknown,S01GX09;R01AC08
DB00768,Olopatadine,,Q99584,Protein S100-A13,S100A13,other/unknown,S01GX09;R01AC08
DB00768,Olopatadine,,P29034,Protein S100-A2,S100A2,antagonist,S01GX09;R01AC08
DB00769,Hydrocortamate,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB00770,Alprostadil,,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,agonist,C01EA01;G04BE01
DB00770,Alprostadil,,P43116,Prostaglandin E2 receptor EP2 subtype,PTGER2,agonist,C01EA01;G04BE01
DB00770,Alprostadil,,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,agonist,C01EA01;G04BE01
DB00770,Alprostadil,,P35408,Prostaglandin E2 receptor EP4 subtype,PTGER4,agonist,C01EA01;G04BE01
DB00770,Alprostadil,,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,agonist,C01EA01;G04BE01
DB00771,Clidinium,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03CA02
DB00772,Malathion,,P06276,Cholinesterase,BCHE,inhibitor,P03AX03
DB00773,Etoposide,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,L01CB01
DB00773,Etoposide,,Q02880,DNA topoisomerase 2-beta,TOP2B,inhibitor,L01CB01
DB00774,Hydroflumethiazide,,Q13621,Solute carrier family 12 member 1,SLC12A1,inhibitor,C03AA02;G01AE10;C03AH02;C03AB02
DB00774,Hydroflumethiazide,,P43166,Carbonic anhydrase 7,CA7,inhibitor,C03AA02;G01AE10;C03AH02;C03AB02
DB00774,Hydroflumethiazide,,Q16790,Carbonic anhydrase 9,CA9,inhibitor,C03AA02;G01AE10;C03AH02;C03AB02
DB00774,Hydroflumethiazide,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,inducer,C03AA02;G01AE10;C03AH02;C03AB02
DB00774,Hydroflumethiazide,,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,inducer,C03AA02;G01AE10;C03AH02;C03AB02
DB00774,Hydroflumethiazide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,C03AA02;G01AE10;C03AH02;C03AB02
DB00774,Hydroflumethiazide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,C03AA02;G01AE10;C03AH02;C03AB02
DB00774,Hydroflumethiazide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,C03AA02;G01AE10;C03AH02;C03AB02
DB00774,Hydroflumethiazide,,O43570,Carbonic anhydrase 12,CA12,inhibitor,C03AA02;G01AE10;C03AH02;C03AB02
DB00775,Tirofiban,,P08514,Integrin alpha-IIb,ITGA2B,antagonist,B01AC17
DB00775,Tirofiban,,P05106,Integrin beta-3,ITGB3,antagonist,B01AC17
DB00776,Oxcarbazepine,,P35498,Sodium channel protein,SCN1A,inhibitor,N03AF02
DB00777,Propiomazine,,P35367,Histamine H1 receptor,HRH1,antagonist,N05CM06
DB00777,Propiomazine,,P11229,Muscarinic acetylcholine receptor,CHRM1,antagonist,N05CM06
DB00777,Propiomazine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05CM06
DB00777,Propiomazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05CM06
DB00777,Propiomazine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05CM06
DB00777,Propiomazine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05CM06
DB00778,Roxithromycin,,P0A7J6,50S ribosomal protein L10,rplJ,inhibitor,J01FA06
DB00778,Roxithromycin,,P08183,P-glycoprotein 1,ABCB1,,J01FA06
DB00779,Nalidixic acid,,,DNA,,other,J01MB02
DB00780,Phenelzine,,P21397,Amine oxidase [flavin-containing] A,MAOA,antagonist,N06AF03
DB00780,Phenelzine,,P27338,Amine oxidase [flavin-containing] B,MAOB,antagonist,N06AF03
DB00780,Phenelzine,,Q16853,Membrane primary amine oxidase,AOC3,inhibitor,N06AF03
DB00780,Phenelzine,,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,inhibitor,N06AF03
DB00780,Phenelzine,,P24298,Alanine aminotransferase 1,GPT,inhibitor,N06AF03
DB00780,Phenelzine,,Q8TD30,Alanine aminotransferase 2,GPT2,inhibitor,N06AF03
DB00780,Phenelzine,,Q9UGI5,Glutamic acid decarboxylase,GAD65,inhibitor,N06AF03
DB00782,Propantheline,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03AB05;A03CA34
DB00783,Estradiol,,P03372,Estrogen receptor alpha,ESR1,agonist,G03FA16;G03FA06;G03FA09;G03FA14;G03CA53;G03FA12;G03FB12;G03FB03;G03FA15;G03FB02;G03FB10;G03FA10;G03EA01;G03FA04;G03FB11;G03FA01;G03FB09;G03FB08;G03EA03;G03AA14;G03AB08;G03FB01;G03FA03;H01CC54;G03FA08;G03FB06;G03EA02;G03AA17;G03FA11;G03FB07;G03FA17;G03FA07;G03FA02;G03HB01;H01CC53;G03FB04;G03FA13;G02BB01;G03CA03;G03FA05;G03FB05
DB00783,Estradiol,,Q92731,Estrogen receptor beta,ESR2,agonist,G03FA16;G03FA06;G03FA09;G03FA14;G03CA53;G03FA12;G03FB12;G03FB03;G03FA15;G03FB02;G03FB10;G03FA10;G03EA01;G03FA04;G03FB11;G03FA01;G03FB09;G03FB08;G03EA03;G03AA14;G03AB08;G03FB01;G03FA03;H01CC54;G03FA08;G03FB06;G03EA02;G03AA17;G03FA11;G03FB07;G03FA17;G03FA07;G03FA02;G03HB01;H01CC53;G03FB04;G03FA13;G02BB01;G03CA03;G03FA05;G03FB05
DB00783,Estradiol,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,binder,G03FA16;G03FA06;G03FA09;G03FA14;G03CA53;G03FA12;G03FB12;G03FB03;G03FA15;G03FB02;G03FB10;G03FA10;G03EA01;G03FA04;G03FB11;G03FA01;G03FB09;G03FB08;G03EA03;G03AA14;G03AB08;G03FB01;G03FA03;H01CC54;G03FA08;G03FB06;G03EA02;G03AA17;G03FA11;G03FB07;G03FA17;G03FA07;G03FA02;G03HB01;H01CC53;G03FB04;G03FA13;G02BB01;G03CA03;G03FA05;G03FB05
DB00783,Estradiol,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,binder,G03FA16;G03FA06;G03FA09;G03FA14;G03CA53;G03FA12;G03FB12;G03FB03;G03FA15;G03FB02;G03FB10;G03FA10;G03EA01;G03FA04;G03FB11;G03FA01;G03FB09;G03FB08;G03EA03;G03AA14;G03AB08;G03FB01;G03FA03;H01CC54;G03FA08;G03FB06;G03EA02;G03AA17;G03FA11;G03FB07;G03FA17;G03FA07;G03FA02;G03HB01;H01CC53;G03FB04;G03FA13;G02BB01;G03CA03;G03FA05;G03FB05
DB00783,Estradiol,,Q99527,G-protein coupled estrogen receptor 1,GPER1,binder,G03FA16;G03FA06;G03FA09;G03FA14;G03CA53;G03FA12;G03FB12;G03FB03;G03FA15;G03FB02;G03FB10;G03FA10;G03EA01;G03FA04;G03FB11;G03FA01;G03FB09;G03FB08;G03EA03;G03AA14;G03AB08;G03FB01;G03FA03;H01CC54;G03FA08;G03FB06;G03EA02;G03AA17;G03FA11;G03FB07;G03FA17;G03FA07;G03FA02;G03HB01;H01CC53;G03FB04;G03FA13;G02BB01;G03CA03;G03FA05;G03FB05
DB00783,Estradiol,,P00846,ATP synthase subunit a,MT-ATP6,inhibitor,G03FA16;G03FA06;G03FA09;G03FA14;G03CA53;G03FA12;G03FB12;G03FB03;G03FA15;G03FB02;G03FB10;G03FA10;G03EA01;G03FA04;G03FB11;G03FA01;G03FB09;G03FB08;G03EA03;G03AA14;G03AB08;G03FB01;G03FA03;H01CC54;G03FA08;G03FB06;G03EA02;G03AA17;G03FA11;G03FB07;G03FA17;G03FA07;G03FA02;G03HB01;H01CC53;G03FB04;G03FA13;G02BB01;G03CA03;G03FA05;G03FB05
DB00783,Estradiol,,Q14457,Beclin-1,BECN1,binder,G03FA16;G03FA06;G03FA09;G03FA14;G03CA53;G03FA12;G03FB12;G03FB03;G03FA15;G03FB02;G03FB10;G03FA10;G03EA01;G03FA04;G03FB11;G03FA01;G03FB09;G03FB08;G03EA03;G03AA14;G03AB08;G03FB01;G03FA03;H01CC54;G03FA08;G03FB06;G03EA02;G03AA17;G03FA11;G03FB07;G03FA17;G03FA07;G03FA02;G03HB01;H01CC53;G03FB04;G03FA13;G02BB01;G03CA03;G03FA05;G03FB05
DB00784,Mefenamic acid,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AG01
DB00784,Mefenamic acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AG01
DB00785,Cryptenamine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,
DB00785,Cryptenamine,,P08588,Beta adrenergic receptor,ADRB1,inhibitor,
DB00785,Cryptenamine,,P08588,Beta adrenergic receptor,ADRB1,potentiator,
DB00786,Marimastat,,P03956,Interstitial collagenase,MMP1,inhibitor,
DB00786,Marimastat,,P08253,72 kDa type IV collagenase,MMP2,inhibitor,
DB00786,Marimastat,,P08254,Stromelysin-1,MMP3,antagonist,
DB00786,Marimastat,,P09237,Matrilysin,MMP7,antagonist,
DB00786,Marimastat,,P22894,Neutrophil collagenase,MMP8,inhibitor,
DB00786,Marimastat,,P14780,Matrix metalloproteinase-9,MMP9,inhibitor,
DB00786,Marimastat,,P09238,Stromelysin-2,MMP10,antagonist,
DB00786,Marimastat,,P24347,Stromelysin-3,MMP11,antagonist,
DB00786,Marimastat,,P39900,Macrophage metalloelastase,MMP12,inhibitor,
DB00786,Marimastat,,P45452,Collagenase 3,MMP13,inhibitor,
DB00786,Marimastat,,P50281,Matrix metalloproteinase-14,MMP14,inhibitor,
DB00786,Marimastat,,P51511,Matrix metalloproteinase-15,MMP15,inhibitor,
DB00786,Marimastat,,P51512,Matrix metalloproteinase-16,MMP16,inhibitor,
DB00786,Marimastat,,Q9ULZ9,Matrix metalloproteinase-17,MMP17,inhibitor,
DB00786,Marimastat,,Q99542,Matrix metalloproteinase-19,MMP19,inhibitor,
DB00786,Marimastat,,O60882,Matrix metalloproteinase-20,MMP20,inhibitor,
DB00786,Marimastat,,Q8N119,Matrix metalloproteinase-21,MMP21,inhibitor,
DB00786,Marimastat,,O75900,Matrix metalloproteinase-23,MMP23A,inhibitor,
DB00786,Marimastat,,Q9Y5R2,Matrix metalloproteinase-24,MMP24,inhibitor,
DB00786,Marimastat,,Q9NPA2,Matrix metalloproteinase-25,MMP25,inhibitor,
DB00786,Marimastat,,Q9NRE1,Matrix metalloproteinase-26,MMP26,inhibitor,
DB00786,Marimastat,,Q9H306,Matrix metalloproteinase-27,MMP27,inhibitor,
DB00786,Marimastat,,Q9H239,Matrix metalloproteinase-28,MMP28,inhibitor,
DB00787,Acyclovir,,P04293,DNA polymerase catalytic subunit,,inhibitor,J05AB01;D06BB03;S01AD03;D06BB53
DB00787,Acyclovir,,P09252,DNA polymerase catalytic subunit,,inhibitor,J05AB01;D06BB03;S01AD03;D06BB53
DB00788,Naproxen,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,G02CC02;M02AA12;M01AE56;M01AE52;M01AE02
DB00788,Naproxen,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,G02CC02;M02AA12;M01AE56;M01AE52;M01AE02
DB00788,Naproxen,,Q51911,Peptostreptococcal albumin-binding protein,pab,,G02CC02;M02AA12;M01AE56;M01AE52;M01AE02
DB00789,Gadopentetic acid,,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,inhibitor,V08CA01
DB00790,Perindopril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09BX01;C09BA04;C10BX11;C10BX13;C09AA04;C09BX02;C10BX12;C09BB04;C10BX15;C10BX14;C09BX04
DB00790,Perindopril,,Q6FHJ7,Secreted frizzled-related protein 4,SFRP4,inhibitor,C09BX01;C09BA04;C10BX11;C10BX13;C09AA04;C09BX02;C10BX12;C09BB04;C10BX15;C10BX14;C09BX04
DB00791,Uracil mustard,,,DNA,,intercalation,L01AD08
DB00792,Tripelennamine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AC04;D04AA04
DB00794,Primidone,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CB01;N03AA03
DB00794,Primidone,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CB01;N03AA03
DB00794,Primidone,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N05CB01;N03AA03
DB00794,Primidone,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CB01;N03AA03
DB00794,Primidone,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N05CB01;N03AA03
DB00794,Primidone,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CB01;N03AA03
DB00794,Primidone,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CB01;N03AA03
DB00794,Primidone,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CB01;N03AA03
DB00794,Primidone,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CB01;N03AA03
DB00794,Primidone,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CB01;N03AA03
DB00794,Primidone,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CB01;N03AA03
DB00795,Sulfasalazine,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,G01AE10;A07EC01
DB00795,Sulfasalazine,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,G01AE10;A07EC01
DB00795,Sulfasalazine,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,G01AE10;A07EC01
DB00795,Sulfasalazine,,P24752,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,inhibitor,G01AE10;A07EC01
DB00795,Sulfasalazine,,P04054,Phospholipase A2,PLA2G1B,antagonist,G01AE10;A07EC01
DB00795,Sulfasalazine,,Q9UPY5,Cystine/glutamate transporter,SLC7A11,inhibitor,G01AE10;A07EC01
DB00795,Sulfasalazine,,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,inhibitor,G01AE10;A07EC01
DB00795,Sulfasalazine,,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,inhibitor,G01AE10;A07EC01
DB00795,Sulfasalazine,,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,inhibitor,G01AE10;A07EC01
DB00795,Sulfasalazine,,O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,,G01AE10;A07EC01
DB00795,Sulfasalazine,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,G01AE10;A07EC01
DB00796,Candesartan cilexetil,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,
DB00797,Tolazoline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,M02AX02;C04AB02
DB00797,Tolazoline,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,M02AX02;C04AB02
DB00797,Tolazoline,,P35367,Histamine H1 receptor,HRH1,agonist,M02AX02;C04AB02
DB00797,Tolazoline,,P25021,Histamine H2 receptor,HRH2,agonist,M02AX02;C04AB02
DB00797,Tolazoline,,P18825,Alpha-2C adrenergic receptor,ADRA2C,binder,M02AX02;C04AB02
DB00797,Tolazoline,,P18089,Alpha-2B adrenergic receptor,ADRA2B,binder,M02AX02;C04AB02
DB00798,Gentamicin,,P0A7S3,30S ribosomal protein S12,rpsL,binder,S01AA11;S02AA14;D06AX07;S03AA06;J01GB03
DB00798,Gentamicin,,,16S ribosomal RNA,,binder,S01AA11;S02AA14;D06AX07;S03AA06;J01GB03
DB00798,Gentamicin,,,23S ribosomal RNA,,inhibitor,S01AA11;S02AA14;D06AX07;S03AA06;J01GB03
DB00798,Gentamicin,,,Bacterial outer membrane,,incorporation into and destabilization,S01AA11;S02AA14;D06AX07;S03AA06;J01GB03
DB00798,Gentamicin,,,Cytoplasmic membrane,,incorporation into and destabilization,S01AA11;S02AA14;D06AX07;S03AA06;J01GB03
DB00798,Gentamicin,,P08164,NH(3)-dependent NAD(+) synthetase,nadE,inhibitor,S01AA11;S02AA14;D06AX07;S03AA06;J01GB03
DB00798,Gentamicin,,P00374,Dihydrofolate reductase,DHFR,,S01AA11;S02AA14;D06AX07;S03AA06;J01GB03
DB00799,Tazarotene,,P10276,Retinoic acid receptor alpha,RARA,agonist,D05AX55;D05AX05
DB00799,Tazarotene,,P28702,Retinoic acid receptor RXR-beta,RXRB,agonist,D05AX55;D05AX05
DB00799,Tazarotene,,P13631,Retinoic acid receptor gamma,RARG,agonist,D05AX55;D05AX05
DB00799,Tazarotene,,P10826,Retinoic acid receptor beta,RARB,agonist,D05AX55;D05AX05
DB00800,Fenoldopam,,P21918,Dopamine D5 receptor,DRD5,agonist,C01CA19
DB00800,Fenoldopam,,P21728,Dopamine D1 receptor,DRD1,agonist,C01CA19
DB00800,Fenoldopam,,P35368,Alpha-1B adrenergic receptor,ADRA1B,inhibitor,C01CA19
DB00800,Fenoldopam,,P25100,Alpha-1D adrenergic receptor,ADRA1D,inhibitor,C01CA19
DB00800,Fenoldopam,,P35348,Alpha-1A adrenergic receptor,ADRA1A,inhibitor,C01CA19
DB00800,Fenoldopam,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,C01CA19
DB00800,Fenoldopam,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,C01CA19
DB00800,Fenoldopam,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,C01CA19
DB00801,Halazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA13
DB00801,Halazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA13
DB00802,Alfentanil,,P35372,Mu-type opioid receptor,OPRM1,agonist,N01AH02
DB00803,Colistin,,,Bacterial outer membrane,,incorporation into and destabilization,J01XB01;A07AA10
DB00804,Dicyclomine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03AA07
DB00804,Dicyclomine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03AA07
DB00804,Dicyclomine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,A03AA07
DB00805,Minaprine,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,N06AX07
DB00805,Minaprine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N06AX07
DB00805,Minaprine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AX07
DB00805,Minaprine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AX07
DB00805,Minaprine,,P22303,Acetylcholinesterase,ACHE,inhibitor,N06AX07
DB00805,Minaprine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX07
DB00805,Minaprine,,P21728,Dopamine D1 receptor,DRD1,agonist,N06AX07
DB00805,Minaprine,,P14416,Dopamine D2 receptor,DRD2,agonist,N06AX07
DB00805,Minaprine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,agonist,N06AX07
DB00806,Pentoxifylline,,P29274,Adenosine receptor A2a,ADORA2A,agonist,C04AD03;R03DA20
DB00806,Pentoxifylline,,,Phosphodiesterase enzymes,,inhibitor,C04AD03;R03DA20
DB00806,Pentoxifylline,,P30542,Adenosine receptor A1,ADORA1,,C04AD03;R03DA20
DB00806,Pentoxifylline,,P21589,5'-nucleotidase,NT5E,inhibitor,C04AD03;R03DA20
DB00807,Proparacaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,S01HA04
DB00808,Indapamide,,P55017,Solute carrier family 12 member 3,SLC12A3,inhibitor,C03BA11;C09BX01;G01AE10;C10BX13
DB00809,Tropicamide,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,S01FA06;S01FA56
DB00809,Tropicamide,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,S01FA06;S01FA56
DB00809,Tropicamide,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,S01FA06;S01FA56
DB00809,Tropicamide,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,S01FA06;S01FA56
DB00810,Biperiden,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N04AA02
DB00811,Ribavirin,,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,inhibitor,J05AP01
DB00811,Ribavirin,,P26676,RNA-directed RNA polymerase L,L,antagonist,J05AP01
DB00811,Ribavirin,,P12823,Genome polyprotein,,inhibitor,J05AP01
DB00811,Ribavirin,,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,,J05AP01
DB00811,Ribavirin,,P16502,RNA-directed RNA polymerase catalytic subunit,PB1,inhibitor,J05AP01
DB00812,Phenylbutazone,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01BA01;M01AA01;M02AA01
DB00812,Phenylbutazone,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01BA01;M01AA01;M02AA01
DB00812,Phenylbutazone,,Q16647,Prostacyclin synthase,PTGIS,inhibitor,M01BA01;M01AA01;M02AA01
DB00813,Fentanyl,,P35372,Mu-type opioid receptor,OPRM1,agonist,N01AH01;N02AB03;N01AH51
DB00813,Fentanyl,,P41143,Delta-type opioid receptor,OPRD1,agonist,N01AH01;N02AB03;N01AH51
DB00813,Fentanyl,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N01AH01;N02AB03;N01AH51
DB00813,Fentanyl,,P08183,P-glycoprotein 1,ABCB1,,N01AH01;N02AB03;N01AH51
DB00814,Meloxicam,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,N01BB59;M01AC56;M01AC06
DB00814,Meloxicam,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,N01BB59;M01AC56;M01AC06
DB00816,Orciprenaline,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03AB03;R03CB03;R03CB53
DB00817,Rosoxacin,,P0AES6,DNA gyrase subunit B,gyrB,inhibitor,J01MB01
DB00817,Rosoxacin,,P0AFI2,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MB01
DB00818,Propofol,,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,potentiator,N01AX10
DB00818,Propofol,,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,potentiator,N01AX10
DB00818,Propofol,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N01AX10
DB00818,Propofol,,P35499,Sodium channel protein type 4 subunit alpha,SCN4A,inhibitor,N01AX10
DB00818,Propofol,,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,inhibitor,N01AX10
DB00819,Acetazolamide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,G01AE10;S01EC01
DB00819,Acetazolamide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,G01AE10;S01EC01
DB00819,Acetazolamide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,G01AE10;S01EC01
DB00819,Acetazolamide,,O43570,Carbonic anhydrase 12,CA12,inhibitor,G01AE10;S01EC01
DB00819,Acetazolamide,,Q9ULX7,Carbonic anhydrase 14,CA14,inhibitor,G01AE10;S01EC01
DB00819,Acetazolamide,,P07451,Carbonic anhydrase 3,CA3,inhibitor,G01AE10;S01EC01
DB00819,Acetazolamide,,P43166,Carbonic anhydrase 7,CA7,inhibitor,G01AE10;S01EC01
DB00819,Acetazolamide,,P29972,Aquaporin-1,AQP1,inhibitor,G01AE10;S01EC01
DB00820,Tadalafil,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,inhibitor,G04BE08;C02KX52;G04CB51;G04CA54;C02KX54
DB00820,Tadalafil,,Q9HCR9,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",PDE11A,inhibitor,G04BE08;C02KX52;G04CB51;G04CA54;C02KX54
DB00820,Tadalafil,,P18545,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,inhibitor,G04BE08;C02KX52;G04CB51;G04CA54;C02KX54
DB00821,Carprofen,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB00821,Carprofen,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB00822,Disulfiram,,P09172,Dopamine beta-hydroxylase,DBH,inhibitor,P03AA04;P03AA54;N07BB01
DB00822,Disulfiram,,P05091,"Aldehyde dehydrogenase, mitochondrial",ALDH2,inhibitor,P03AA04;P03AA54;N07BB01
DB00823,Ethynodiol diacetate,,P06401,Progesterone receptor,PGR,agonist,
DB00823,Ethynodiol diacetate,,P03372,Estrogen receptor alpha,ESR1,agonist,
DB00824,Enprofylline,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,
DB00824,Enprofylline,,P29275,Adenosine receptor A2b,ADORA2B,antagonist,
DB00824,Enprofylline,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,inhibitor,
DB00824,Enprofylline,,P30542,Adenosine receptor A1,ADORA1,inhibitor,
DB00824,Enprofylline,,P29274,Adenosine receptor A2a,ADORA2A,inhibitor,
DB00824,Enprofylline,,P0DMS8,Adenosine receptor A3,ADORA3,inhibitor,
DB00825,Levomenthol,,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,TRPM8,inducer,
DB00825,Levomenthol,,O75762,Transient receptor potential cation channel subfamily A member 1,TRPA1,inducer,
DB00825,Levomenthol,,Q8NET8,Transient receptor potential cation channel subfamily V member 3,TRPV3,inducer,
DB00825,Levomenthol,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,antagonist,
DB00825,Levomenthol,,P41145,Kappa-type opioid receptor,OPRK1,agonist,
DB00826,Natamycin,,,Ergosterol,,binder,G01AA02;D01AA02;A01AB10;S01AA10;A07AA03
DB00827,Cinoxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MB06
DB00827,Cinoxacin,,,DNA,,intercalation,J01MB06
DB00828,Fosfomycin,,P0A749,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,murA,inhibitor,S02AA17;J01XX01
DB00829,Diazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA01
DB00829,Diazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA01
DB00830,Phenmetrazine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,
DB00830,Phenmetrazine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,
DB00831,Trifluoperazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AB06
DB00831,Trifluoperazine,,Q9NYX4,Neuron-specific vesicular protein calcyon,CALY,antagonist,N05AB06
DB00831,Trifluoperazine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AB06
DB00831,Trifluoperazine,,P0DP23,Calmodulin,CALM1,inhibitor,N05AB06
DB00831,Trifluoperazine,,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,,N05AB06
DB00831,Trifluoperazine,,P26447,Protein S100-A4,S100A4,inhibitor,N05AB06
DB00833,Cefaclor,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01DC04
DB00833,Cefaclor,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01DC04
DB00834,Mifepristone,,P06401,Progesterone receptor,PGR,antagonist,G03XB01;G03XB51
DB00834,Mifepristone,,P04150,Glucocorticoid receptor,NR3C1,antagonist,G03XB01;G03XB51
DB00834,Mifepristone,,P07288,Prostate-specific antigen,KLK3,,G03XB01;G03XB51
DB00834,Mifepristone,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,G03XB01;G03XB51
DB00835,Brompheniramine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AB51;R06AB01
DB00835,Brompheniramine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,R06AB51;R06AB01
DB00835,Brompheniramine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,R06AB51;R06AB01
DB00835,Brompheniramine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,R06AB51;R06AB01
DB00835,Brompheniramine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,R06AB51;R06AB01
DB00835,Brompheniramine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,R06AB51;R06AB01
DB00836,Loperamide,,P35372,Mu-type opioid receptor,OPRM1,agonist,A07DA53;A07DA03
DB00836,Loperamide,,P41143,Delta-type opioid receptor,OPRD1,agonist,A07DA53;A07DA03
DB00836,Loperamide,,P41145,Kappa-type opioid receptor,OPRK1,agonist,A07DA53;A07DA03
DB00836,Loperamide,,P0DP23,Calmodulin,CALM1,inhibitor,A07DA53;A07DA03
DB00836,Loperamide,,P01189,Pro-opiomelanocortin,POMC,modulator,A07DA53;A07DA03
DB00836,Loperamide,,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,blocker,A07DA53;A07DA03
DB00836,Loperamide,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,blocker,A07DA53;A07DA03
DB00837,Progabide,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,N03AG05
DB00837,Progabide,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,agonist,N03AG05
DB00838,Clocortolone,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AB21
DB00839,Tolazamide,,Q09428,"Sulfonylurea receptor 1, Kir6.2",ABCC8,blocker,A10BB05;G01AE10
DB00841,Dobutamine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,agonist,C01CA07
DB00841,Dobutamine,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,C01CA07
DB00841,Dobutamine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,C01CA07
DB00841,Dobutamine,,P03372,Estrogen receptor alpha,ESR1,,C01CA07
DB00842,Oxazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA04
DB00842,Oxazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA04
DB00843,Donepezil,,P22303,Acetylcholinesterase,ACHE,inhibitor,N06DA52;N06DA53;N06DA02
DB00843,Donepezil,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,inducer,N06DA52;N06DA53;N06DA02
DB00843,Donepezil,,P06276,Cholinesterase,BCHE,inducer,N06DA52;N06DA53;N06DA02
DB00843,Donepezil,,P29475,"Nitric oxide synthase, brain",NOS1,inhibitor,N06DA52;N06DA53;N06DA02
DB00843,Donepezil,,P29475,"Nitric oxide synthase, brain",NOS1,inducer,N06DA52;N06DA53;N06DA02
DB00843,Donepezil,,P98066,Tumor necrosis factor-inducible gene 6 protein,TNFAIP6,inhibitor,N06DA52;N06DA53;N06DA02
DB00843,Donepezil,,P01584,Interleukin-1 beta,IL1B,inhibitor,N06DA52;N06DA53;N06DA02
DB00843,Donepezil,,P01584,Interleukin-1 beta,IL1B,inducer,N06DA52;N06DA53;N06DA02
DB00843,Donepezil,,Q00653,Nuclear factor NF-kappa-B,NFKB2,inhibitor,N06DA52;N06DA53;N06DA02
DB00843,Donepezil,,Q05586,NMDA receptor,GRIN1,downregulator,N06DA52;N06DA53;N06DA02
DB00844,Nalbuphine,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N02AF02
DB00844,Nalbuphine,,P35372,Mu-type opioid receptor,OPRM1,antagonist,N02AF02
DB00844,Nalbuphine,,P41143,Delta-type opioid receptor,OPRD1,antagonist,N02AF02
DB00845,Clofazimine,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,modulator,J04BA01;J04BA51
DB00845,Clofazimine,,P22001,Potassium voltage-gated channel subfamily A member 3,KCNA3,antagonist,J04BA01;J04BA51
DB00846,Flurandrenolide,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07CC03;D07AC07
DB00847,Cysteamine,,,Cystine,,cleavage,A16AA04;S01XA21
DB00847,Cysteamine,,P49146,Neuropeptide Y receptor type 2,NPY2R,other/unknown,A16AA04;S01XA21
DB00848,Levamisole,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,agonist,P02CE01
DB00848,Levamisole,,P10696,"Alkaline phosphatase, germ cell type",ALPPL2,inhibitor,P02CE01
DB00848,Levamisole,,Q23022,Acetylcholine receptor subunit alpha-type unc-38,unc-38,activator,P02CE01
DB00848,Levamisole,,Q9N587,Acetylcholine receptor subunit alpha-type unc-63,unc-63,activator,P02CE01
DB00848,Levamisole,,Q27218,Acetylcholine receptor subunit beta-type lev-1,lev-1,activator,P02CE01
DB00848,Levamisole,,P48181,Acetylcholine receptor subunit beta-type unc-29,unc-29,activator,P02CE01
DB00849,Methylphenobarbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N03AA01;N05CB01
DB00849,Methylphenobarbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N03AA01;N05CB01
DB00849,Methylphenobarbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N03AA01;N05CB01
DB00849,Methylphenobarbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N03AA01;N05CB01
DB00849,Methylphenobarbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N03AA01;N05CB01
DB00849,Methylphenobarbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N03AA01;N05CB01
DB00849,Methylphenobarbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N03AA01;N05CB01
DB00849,Methylphenobarbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N03AA01;N05CB01
DB00849,Methylphenobarbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N03AA01;N05CB01
DB00849,Methylphenobarbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N03AA01;N05CB01
DB00849,Methylphenobarbital,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,N03AA01;N05CB01
DB00850,Perphenazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AB03
DB00850,Perphenazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AB03
DB00850,Perphenazine,,P0DP23,Calmodulin,CALM1,inhibitor,N05AB03
DB00851,Dacarbazine,,,DNA,,cross-linking/alkylation,L01AX04
DB00851,Dacarbazine,,Q14181,DNA polymerase alpha subunit B,POLA2,other/unknown,L01AX04
DB00851,Dacarbazine,,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,inhibitor,L01AX04
DB00852,Pseudoephedrine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,R01BA52;R01BA02
DB00852,Pseudoephedrine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,R01BA52;R01BA02
DB00852,Pseudoephedrine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,R01BA52;R01BA02
DB00852,Pseudoephedrine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,R01BA52;R01BA02
DB00852,Pseudoephedrine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,R01BA52;R01BA02
DB00852,Pseudoephedrine,,P07550,Beta-2 adrenergic receptor,ADRB2,partial agonist,R01BA52;R01BA02
DB00852,Pseudoephedrine,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,R01BA52;R01BA02
DB00852,Pseudoephedrine,,P08588,Beta-1 adrenergic receptor,ADRB1,partial agonist,R01BA52;R01BA02
DB00852,Pseudoephedrine,,O95644,"Nuclear factor of activated T-cells, cytoplasmic 1",NFATC1,inhibitor,R01BA52;R01BA02
DB00852,Pseudoephedrine,,P01375,Tumor necrosis factor,TNF,inhibitor,R01BA52;R01BA02
DB00852,Pseudoephedrine,,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,inhibitor,R01BA52;R01BA02
DB00852,Pseudoephedrine,,P18846,activator protein 1,ATF1,inhibitor,R01BA52;R01BA02
DB00852,Pseudoephedrine,,P60568,Interleukin-2,IL2,inhibitor,R01BA52;R01BA02
DB00853,Temozolomide,,,DNA,,cross-linking/alkylation,L01AX03
DB00854,Levorphanol,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB00854,Levorphanol,,P41143,Delta-type opioid receptor,OPRD1,agonist,
DB00854,Levorphanol,,P41145,Kappa-type opioid receptor,OPRK1,agonist,
DB00855,Aminolevulinic acid,,P13716,Delta-aminolevulinic acid dehydratase,ALAD,inducer,L01XD04
DB00857,Terbinafine,,Q92206,Squalene monooxygenase,ERG1,inhibitor,D01AE15;D01BA02
DB00857,Terbinafine,,Q14534,Squalene monooxygenase,SQLE,inhibitor,D01AE15;D01BA02
DB00858,Drostanolone,,P10275,Androgen receptor,AR,agonist,
DB00859,Penicillamine,,,Copper,,chelator,M01CC01
DB00860,Prednisolone,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AA03;S01CA02;D07XA02;A01AC54;R01AD02;S01BB02;S01CB02;R01AD52;V03AB05;S03BA02;D07BA01;D07CA03;S01BA04;S02BA03;A01AC04;A07EA01;H02AB06;S02CA01;C05AA04;S03CA02
DB00861,Diflunisal,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,N02BA11
DB00861,Diflunisal,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,N02BA11
DB00862,Vardenafil,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,inhibitor,G04BE09
DB00862,Vardenafil,,P18545,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,inhibitor,G04BE09
DB00862,Vardenafil,,P18545,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,allosteric modulator,G04BE09
DB00862,Vardenafil,,Q13956,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6H,inhibitor,G04BE09
DB00862,Vardenafil,,Q13956,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6H,allosteric modulator,G04BE09
DB00863,Ranitidine,,P25021,Histamine H2 receptor,HRH2,antagonist,A02BA07;A02BA02
DB00863,Ranitidine,,P22303,Acetylcholinesterase,ACHE,inhibitor,A02BA07;A02BA02
DB00864,Tacrolimus,,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,inhibitor,D11AH01;L04AD02
DB00865,Benzphetamine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inducer,
DB00865,Benzphetamine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,
DB00865,Benzphetamine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,
DB00865,Benzphetamine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,
DB00866,Alprenolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07AA01
DB00866,Alprenolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07AA01
DB00866,Alprenolol,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,C07AA01
DB00866,Alprenolol,,P13945,Beta-3 adrenergic receptor,ADRB3,antagonist,C07AA01
DB00867,Ritodrine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,G02CA01
DB00867,Ritodrine,,P08588,Beta adrenergic receptor,ADRB1,agonist,G02CA01
DB00867,Ritodrine,,P08588,Beta adrenergic receptor,ADRB1,downregulator,G02CA01
DB00867,Ritodrine,,P48048,ATP-sensitive potassium channel,KCNJ1,activator,G02CA01
DB00867,Ritodrine,,P98194,Calcium transporting ATPases,ATP2C1,inhibitor,G02CA01
DB00867,Ritodrine,,Q12791,Calcium-activated potassium channel,KCNMA1,activator,G02CA01
DB00867,Ritodrine,,Q15746,"Myosin light chain kinase, smooth muscle",MYLK,inhibitor,G02CA01
DB00867,Ritodrine,,O75897,Sulfotransferase 1C4,SULT1C4,substrate,G02CA01
DB00868,Benzonatate,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,antagonist,R05DB01
DB00869,Dorzolamide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,G01AE10;S01EC03
DB00869,Dorzolamide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,G01AE10;S01EC03
DB00869,Dorzolamide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,G01AE10;S01EC03
DB00869,Dorzolamide,,P07451,Carbonic anhydrase 3,CA3,inhibitor,G01AE10;S01EC03
DB00870,Suprofen,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AE07
DB00870,Suprofen,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AE07
DB00871,Terbutaline,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03CC53;R03CC03;R03AC03
DB00871,Terbutaline,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,R03CC53;R03CC03;R03AC03
DB00871,Terbutaline,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,R03CC53;R03CC03;R03AC03
DB00872,Conivaptan,,P37288,Vasopressin V1a receptor,AVPR1A,antagonist,C03XA02
DB00872,Conivaptan,,P30518,Vasopressin V2 receptor,AVPR2,antagonist,C03XA02
DB14596,Loteprednol etabonate,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB00874,Guaifenesin,,Q05586,NMDA receptor,GRIN1,antagonist,R05CA03
DB00875,Flupentixol,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AF01
DB00875,Flupentixol,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AF01
DB00875,Flupentixol,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AF01
DB00875,Flupentixol,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AF01
DB00875,Flupentixol,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AF01
DB00875,Flupentixol,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AF01
DB00875,Flupentixol,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AF01
DB00875,Flupentixol,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05AF01
DB00876,Eprosartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,C09DA02;C09CA02
DB00877,Sirolimus,,P42345,Serine/threonine-protein kinase mTOR,MTOR,inhibitor,L01EG04;S01XA23;L04AA10
DB00878,Chlorhexidine,,,Bacterial outer membrane,,incorporation into and destabilization,R02AA05;S03AA04;D08AC52;D08AC02;S01AX09;D09AA12;B05CA02;A01AB03;S02AA09
DB00879,Emtricitabine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AR19;J05AR08;J05AR17;J05AF09;J05AR09;J05AR20;J05AR06;J05AR03;J05AR22;J05AR18
DB00880,Chlorothiazide,,P55017,Solute carrier family 12 member 3,SLC12A3,inhibitor,C03AB04;G01AE10;C03AA04;C03AH01
DB00880,Chlorothiazide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,C03AB04;G01AE10;C03AA04;C03AH01
DB00880,Chlorothiazide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,C03AB04;G01AE10;C03AA04;C03AH01
DB00881,Quinapril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09AA06;C09BA06
DB00882,Clomifene,,P03372,Estrogen receptor alpha,ESR1,antagonist,G03GB02
DB00882,Clomifene,,P03372,Estrogen receptor alpha,ESR1,agonist,G03GB02
DB00882,Clomifene,,P04278,Sex hormone-binding globulin,SHBG,,G03GB02
DB00883,Isosorbide dinitrate,,P16066,Atrial natriuretic peptide receptor 1,NPR1,agonist,C01DA08;C01DA58;C05AE02
DB00884,Risedronic acid,,,Hydroxylapatite,,antagonist,M05BB07;M05BB02;M05BB04;M05BA07
DB00884,Risedronic acid,,P14324,Farnesyl pyrophosphate synthase,FDPS,inhibitor,M05BB07;M05BB02;M05BB04;M05BA07
DB00886,Omapatrilat,,P08473,Neprilysin,MME,,
DB00886,Omapatrilat,,P12821,Angiotensin-converting enzyme,ACE,,
DB00887,Bumetanide,,Q13621,Solute carrier family 12 member 1,SLC12A1,inhibitor,G01AE10;C03CB02;C03EB02;C03CA02
DB00887,Bumetanide,,P55011,Solute carrier family 12 member 2,SLC12A2,inhibitor,G01AE10;C03CB02;C03EB02;C03CA02
DB00887,Bumetanide,,Q9UP95,Solute carrier family 12 member 4,SLC12A4,inhibitor,G01AE10;C03CB02;C03EB02;C03CA02
DB00887,Bumetanide,,Q9H2X9,Solute carrier family 12 member 5,SLC12A5,inhibitor,G01AE10;C03CB02;C03EB02;C03CA02
DB00887,Bumetanide,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,antagonist,G01AE10;C03CB02;C03EB02;C03CA02
DB00888,Mechlorethamine,,,DNA,,intercalation,L01AA05
DB00889,Granisetron,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,A04AA02
DB00890,Dienestrol,,P03372,Estrogen receptor alpha,ESR1,agonist,G03CB01;G03CC02
DB00890,Dienestrol,,P04278,Sex hormone-binding globulin,SHBG,,G03CB01;G03CC02
DB00891,Sulfapyridine,,Q49184,Dihydropteroate synthase type-1,sulI,inhibitor,G01AE10;J01EB04
DB00892,Oxybuprocaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,S01HA02;D04AB03
DB00893,Iron Dextran,,P68871,Hemoglobin subunit beta,HBB,activator,
DB00893,Iron Dextran,,P69905,Hemoglobin subunit alpha,HBA1,activator,
DB00893,Iron Dextran,,P02794,Ferritin heavy chain,FTH1,other,
DB00893,Iron Dextran,,P02792,Ferritin light chain,FTL,other,
DB00894,Testolactone,,P11511,Cytochrome P450 19A1,CYP19A1,inhibitor,
DB00895,Benzylpenicilloyl polylysine,,P30273,High affinity immunoglobulin epsilon receptor subunit gamma,FCER1G,agonist,J01CR50
DB00895,Benzylpenicilloyl polylysine,,P12319,High affinity immunoglobulin epsilon receptor subunit alpha,FCER1A,agonist,J01CR50
DB00896,Rimexolone,,P04150,Glucocorticoid receptor,NR3C1,agonist,H02AB12;S01BA13
DB00897,Triazolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD05
DB00897,Triazolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD05
DB00898,Ethanol,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,antagonist,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P23415,Glycine receptor subunit alpha-1,GLRA1,agonist,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P23416,Glycine receptor subunit alpha-2,GLRA2,agonist,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P42261,Glutamate receptor 1,GRIA1,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P42262,Glutamate receptor 2,GRIA2,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P48058,Glutamate receptor 4,GRIA4,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P42263,Glutamate receptor 3,GRIA3,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P48549,G protein-activated inward rectifier potassium channel 1,KCNJ3,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P48051,G protein-activated inward rectifier potassium channel 2,KCNJ6,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P19320,Vascular cell adhesion protein 1,VCAM1,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q99808,Equilibrative nucleoside transporter 1,SLC29A1,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P48544,G protein-activated inward rectifier potassium channel 4,KCNJ5,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P30532,Neuronal acetylcholine receptor subunit alpha-5,CHRNA5,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q15825,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q05901,Neuronal acetylcholine receptor subunit beta-3,CHRNB3,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q14542,Equilibrative nucleoside transporter 2,SLC29A2,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,A5X5Y0,5-hydroxytryptamine receptor 3E,HTR3E,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,O95264,5-hydroxytryptamine receptor 3B,HTR3B,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q70Z44,5-hydroxytryptamine receptor 3D,HTR3D,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q8WXA8,5-hydroxytryptamine receptor 3C,HTR3C,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q9Y698,Voltage-dependent calcium channel gamma-2 subunit,CACNG2,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,Q92806,G protein-activated inward rectifier potassium channel 3,KCNJ9,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P32004,Neural cell adhesion molecule L1,L1CAM,,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P22303,Acetylcholinesterase,ACHE,activator,V03AB16;V03AZ01;D08AX08
DB00898,Ethanol,,P40394,Alcohol dehydrogenase class 4 mu/sigma chain,ADH7,substrate,V03AB16;V03AZ01;D08AX08
DB00899,Remifentanil,,P35372,Mu-type opioid receptor,OPRM1,agonist,N01AH06
DB00899,Remifentanil,,P41143,Delta-type opioid receptor,OPRD1,agonist,N01AH06
DB00899,Remifentanil,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N01AH06
DB00900,Didanosine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AF02
DB00900,Didanosine,,P00491,Purine nucleoside phosphorylase,PNP,substrate,J05AF02
DB00901,Bitolterol,,P07550,Beta-2 adrenergic receptor,ADRB2,,R03AC17
DB00902,Methdilazine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AD04
DB00903,Etacrynic acid,,Q13621,Solute carrier family 12 member 1,SLC12A1,inhibitor,C03CC01
DB00903,Etacrynic acid,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,inhibitor,C03CC01
DB00903,Etacrynic acid,,Q9UJU2,Lymphoid enhancer-binding factor 1,LEF1,,C03CC01
DB00903,Etacrynic acid,,P09211,Glutathione S-transferase P,GSTP1,inhibitor,C03CC01
DB00904,Ondansetron,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,A04AA01
DB00904,Ondansetron,,Q13639,5-hydroxytryptamine receptor 4,HTR4,agonist,A04AA01
DB00904,Ondansetron,,P35372,Mu-type opioid receptor,OPRM1,other/unknown,A04AA01
DB00904,Ondansetron,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,other/unknown,A04AA01
DB00904,Ondansetron,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,other/unknown,A04AA01
DB00905,Bimatoprost,,P43088,Prostaglandin F2-alpha receptor,PTGFR,agonist,S01EE03
DB00905,Bimatoprost,,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,agonist,S01EE03
DB00905,Bimatoprost,,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,agonist,S01EE03
DB00906,Tiagabine,,P30531,Sodium- and chloride-dependent GABA transporter 1,SLC6A1,inhibitor,N03AG06
DB00907,Cocaine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,S01HA01;S02DA02;N01BC01;R02AD03
DB00907,Cocaine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,S01HA01;S02DA02;N01BC01;R02AD03
DB00907,Cocaine,,P35498,Sodium channel protein,SCN1A,inhibitor,S01HA01;S02DA02;N01BC01;R02AD03
DB00907,Cocaine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,S01HA01;S02DA02;N01BC01;R02AD03
DB00907,Cocaine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,S01HA01;S02DA02;N01BC01;R02AD03
DB00907,Cocaine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,S01HA01;S02DA02;N01BC01;R02AD03
DB00907,Cocaine,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,agonist,S01HA01;S02DA02;N01BC01;R02AD03
DB00907,Cocaine,,P23141,Liver carboxylesterase 1,CES1,binder,S01HA01;S02DA02;N01BC01;R02AD03
DB00908,Quinidine,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BA01;C01BA51;C01BA71
DB00908,Quinidine,,O00180,Potassium channel subfamily K member 1,KCNK1,inhibitor,C01BA01;C01BA51;C01BA71
DB00908,Quinidine,,Q9Y257,Potassium channel subfamily K member 6,KCNK6,inhibitor,C01BA01;C01BA51;C01BA71
DB00908,Quinidine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C01BA01;C01BA51;C01BA71
DB00908,Quinidine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C01BA01;C01BA51;C01BA71
DB00908,Quinidine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,C01BA01;C01BA51;C01BA71
DB00908,Quinidine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,C01BA01;C01BA51;C01BA71
DB00909,Zonisamide,,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q9NY46,Sodium channel protein type 3 subunit alpha,SCN3A,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P35499,Sodium channel protein type 4 subunit alpha,SCN4A,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q15858,Sodium channel protein type 9 subunit alpha,SCN9A,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q9UI33,Sodium channel protein type 11 subunit alpha,SCN11A,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q07699,Sodium channel subunit beta-1,SCN1B,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,O60939,Sodium channel subunit beta-2,SCN2B,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q9NY72,Sodium channel subunit beta-3,SCN3B,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q8IWT1,Sodium channel subunit beta-4,SCN4B,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P07451,Carbonic anhydrase 3,CA3,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P35218,"Carbonic anhydrase 5A, mitochondrial",CA5A,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",CA5B,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P23280,Carbonic anhydrase 6,CA6,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P43166,Carbonic anhydrase 7,CA7,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P35219,Carbonic anhydrase-related protein,CA8,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q16790,Carbonic anhydrase 9,CA9,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q9NS85,Carbonic anhydrase-related protein 10,CA10,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,O75493,Carbonic anhydrase-related protein 11,CA11,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,O43570,Carbonic anhydrase 12,CA12,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q8N1Q1,Carbonic anhydrase 13,CA13,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,Q9ULX7,Carbonic anhydrase 14,CA14,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,N03AX15;G01AE10
DB00909,Zonisamide,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,binder,N03AX15;G01AE10
DB00910,Paricalcitol,,P11473,Vitamin D3 receptor,VDR,agonist,H05BX02
DB00911,Tinidazole,,,DNA,,binder,J01RA11;J01RA13;A02BD09;J01XD02;G01AF20;G01AF21;P01AB02
DB00912,Repaglinide,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,inhibitor,A10BD14;A10BX02
DB00912,Repaglinide,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,A10BD14;A10BX02
DB00912,Repaglinide,,P35367,Histamine H1 receptor,HRH1,antagonist,A10BD14;A10BX02
DB00913,Anileridine,,P35372,Mu-type opioid receptor,OPRM1,agonist,N01AH05
DB00914,Phenformin,,Q13131,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,activator,A10BA01;A10BD01
DB00914,Phenformin,,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,inhibitor,A10BA01;A10BD01
DB00915,Amantadine,,P21430,Matrix protein 2,M,inhibitor,N04BB01
DB00915,Amantadine,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,antagonist,N04BB01
DB00915,Amantadine,,P14416,Dopamine D2 receptor,DRD2,agonist,N04BB01
DB00915,Amantadine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N04BB01
DB00915,Amantadine,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N04BB01
DB00915,Amantadine,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,antagonist,N04BB01
DB00916,Metronidazole,,O25608,Oxygen-insensitive NADPH nitroreductase,rdxA,potentiator,A02BD11;P01AB52;D06BX01;A02BD03;J01XD01;J01RA04;A02BD01;J01RA14;A02BD15;J01RA03;A01AB17;G01AF20;J01RA10;A02BD02;A02BD13;G01AF01;P01AB51;A02BD08;P01AB01
DB00916,Metronidazole,,,Anaerobic bacterial DNA,,inhibitor,A02BD11;P01AB52;D06BX01;A02BD03;J01XD01;J01RA04;A02BD01;J01RA14;A02BD15;J01RA03;A01AB17;G01AF20;J01RA10;A02BD02;A02BD13;G01AF01;P01AB51;A02BD08;P01AB01
DB00916,Metronidazole,,,Protozoal DNA,,inhibitor,A02BD11;P01AB52;D06BX01;A02BD03;J01XD01;J01RA04;A02BD01;J01RA14;A02BD15;J01RA03;A01AB17;G01AF20;J01RA10;A02BD02;A02BD13;G01AF01;P01AB51;A02BD08;P01AB01
DB00917,Dinoprostone,,P43116,Prostaglandin E2 receptor EP2 subtype,PTGER2,agonist,G02AD02
DB00917,Dinoprostone,,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,agonist,G02AD02
DB00917,Dinoprostone,,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,agonist,G02AD02
DB00917,Dinoprostone,,P35408,Prostaglandin E2 receptor EP4 subtype,PTGER4,agonist,G02AD02
DB00917,Dinoprostone,,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,agonist,G02AD02
DB00918,Almotriptan,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N02CC05
DB00918,Almotriptan,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N02CC05
DB00919,Spectinomycin,,P0A7S3,30S ribosomal protein S12,rpsL,inhibitor,J01XX04
DB00920,Ketotifen,,P35367,Histamine H1 receptor,HRH1,antagonist,S01GX08;R06AX17
DB00920,Ketotifen,,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,inhibitor,S01GX08;R06AX17
DB00921,Buprenorphine,,P41145,Kappa-type opioid receptor,OPRK1,antagonist,N07BC01;N07BC51;N02AE01
DB00921,Buprenorphine,,P35372,Mu-type opioid receptor,OPRM1,partial agonist,N07BC01;N07BC51;N02AE01
DB00921,Buprenorphine,,P41143,Delta-type opioid receptor,OPRD1,antagonist,N07BC01;N07BC51;N02AE01
DB00921,Buprenorphine,,P41146,Nociceptin receptor,OPRL1,,N07BC01;N07BC51;N02AE01
DB00922,Levosimendan,,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,potentiator,C01CX08
DB00922,Levosimendan,,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,inducer,C01CX08
DB00922,Levosimendan,,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,inducer,C01CX08
DB00922,Levosimendan,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,C01CX08
DB00923,Ceforanide,,Q70KI2,Penicillin-binding protein 2,pbpA,inhibitor,J01DC11
DB00924,Cyclobenzaprine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,M03BX08
DB00924,Cyclobenzaprine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,M03BX08
DB00924,Cyclobenzaprine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,M03BX08
DB00924,Cyclobenzaprine,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,M03BX08
DB00924,Cyclobenzaprine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,M03BX08
DB00924,Cyclobenzaprine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,M03BX08
DB00924,Cyclobenzaprine,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,M03BX08
DB00924,Cyclobenzaprine,,O00206,Toll-like receptor 4,TLR4,inhibitor,M03BX08
DB00924,Cyclobenzaprine,,Q06278,Aldehyde oxidase,AOX1,inhibitor,M03BX08
DB00925,Phenoxybenzamine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C04AX02
DB00925,Phenoxybenzamine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,C04AX02
DB00925,Phenoxybenzamine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,C04AX02
DB00925,Phenoxybenzamine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,C04AX02
DB00925,Phenoxybenzamine,,P0DP23,Calmodulin,CALM1,inhibitor,C04AX02
DB00925,Phenoxybenzamine,,P07550,Beta-2 adrenergic receptor,ADRB2,,C04AX02
DB00925,Phenoxybenzamine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,C04AX02
DB00925,Phenoxybenzamine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,C04AX02
DB00926,Etretinate,,P10276,Retinoic acid receptor alpha,RARA,agonist,D05BB01
DB00926,Etretinate,,P19793,Retinoic acid receptor RXR-alpha,RXRA,agonist,D05BB01
DB00926,Etretinate,,P10826,Retinoic acid receptor beta,RARB,agonist,D05BB01
DB00926,Etretinate,,P48443,Retinoic acid receptor RXR-gamma,RXRG,agonist,D05BB01
DB00926,Etretinate,,P28702,Retinoic acid receptor RXR-beta,RXRB,agonist,D05BB01
DB00926,Etretinate,,P13631,Retinoic acid receptor gamma,RARG,agonist,D05BB01
DB00927,Famotidine,,P25021,Histamine H2 receptor,HRH2,antagonist,A02BA03;A02BA53
DB00928,Azacitidine,,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,inhibitor,L01BC07
DB00928,Azacitidine,,,RNA,,other,L01BC07
DB00928,Azacitidine,,,DNA,,other,L01BC07
DB00929,Misoprostol,,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,agonist,G02AD06;A02BB01;M01AE56
DB00929,Misoprostol,,P43116,Prostaglandin E2 receptor EP2 subtype,PTGER2,agonist,G02AD06;A02BB01;M01AE56
DB00929,Misoprostol,,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,agonist,G02AD06;A02BB01;M01AE56
DB00929,Misoprostol,,P35408,Prostaglandin E2 receptor EP4 subtype,PTGER4,agonist,G02AD06;A02BB01;M01AE56
DB00930,Colesevelam,,,Bile acids,,binder,C10AC04
DB00931,Metacycline,,,16S ribosomal RNA,,inhibitor,J01AA05;J01AA20
DB00932,Tipranavir,,Q72874,Human immunodeficiency virus type 1 protease,pol,inhibitor,J05AE09
DB00933,Mesoridazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AC03
DB00933,Mesoridazine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AC03
DB00934,Maprotiline,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA21
DB00934,Maprotiline,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AA21
DB00934,Maprotiline,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N06AA21
DB00934,Maprotiline,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N06AA21
DB00934,Maprotiline,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N06AA21
DB00934,Maprotiline,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N06AA21
DB00934,Maprotiline,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N06AA21
DB00934,Maprotiline,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N06AA21
DB00934,Maprotiline,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,binder,N06AA21
DB00934,Maprotiline,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,binder,N06AA21
DB00934,Maprotiline,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N06AA21
DB00934,Maprotiline,,P14416,Dopamine D2 receptor,DRD2,binder,N06AA21
DB00934,Maprotiline,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,N06AA21
DB00935,Oxymetazoline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,partial agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00935,Oxymetazoline,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00935,Oxymetazoline,,P08913,Alpha-2A adrenergic receptor,ADRA2A,partial agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00935,Oxymetazoline,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00935,Oxymetazoline,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00935,Oxymetazoline,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00935,Oxymetazoline,,P25100,Alpha-1D adrenergic receptor,ADRA1D,agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00935,Oxymetazoline,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00935,Oxymetazoline,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00935,Oxymetazoline,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00935,Oxymetazoline,,P08909,5-hydroxytryptamine receptor 1C,Htr2c,partial agonist,S01GA04;D11AX27;R01AB07;R01AA05
DB00936,Salicylic acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,D01AE12;N02BA04;N02BA12;S01BC08
DB00936,Salicylic acid,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,D01AE12;N02BA04;N02BA12;S01BC08
DB00936,Salicylic acid,,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,inhibitor,D01AE12;N02BA04;N02BA12;S01BC08
DB00937,Diethylpropion,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,A08AA03
DB00937,Diethylpropion,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,A08AA03
DB00938,Salmeterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03AK06;R03AK12;R03AC12
DB00938,Salmeterol,,P08588,Beta-1 adrenergic receptor,ADRB1,inverse agonist,R03AK06;R03AK12;R03AC12
DB00938,Salmeterol,,P13945,Beta-3 adrenergic receptor,ADRB3,inverse agonist,R03AK06;R03AK12;R03AC12
DB00939,Meclofenamic acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AG04;M02AA18
DB00939,Meclofenamic acid,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AG04;M02AA18
DB00939,Meclofenamic acid,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,M01AG04;M02AA18
DB00939,Meclofenamic acid,,O43526,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,other,M01AG04;M02AA18
DB00939,Meclofenamic acid,,O43525,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,other,M01AG04;M02AA18
DB00940,Methantheline,,P25021,Histamine H2 receptor,HRH2,antagonist,A03AB07
DB00940,Methantheline,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,,A03AB07
DB00940,Methantheline,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,,A03AB07
DB00940,Methantheline,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,,A03AB07
DB00940,Methantheline,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,,A03AB07
DB00940,Methantheline,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03AB07
DB00941,Hexafluronium,,P06276,Cholinesterase,BCHE,inhibitor,M03AC05
DB00942,Cycrimine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,
DB00943,Zalcitabine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AF03
DB00944,Demecarium,,P22303,Acetylcholinesterase,ACHE,inhibitor,S01EB04
DB00944,Demecarium,,P06276,Cholinesterase,BCHE,inhibitor,S01EB04
DB00945,Acetylsalicylic acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,Q13131,5'-AMP-activated protein kinase,PRKAA1,activator,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P25101,Endothelin-1 receptor,EDNRA,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P04637,Cellular tumor antigen p53,TP53,inducer,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P11021,78 kDa glucose-regulated protein,HSPA5,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P11021,78 kDa glucose-regulated protein,HSPA5,binder,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P51812,Ribosomal protein S6 kinase alpha-3,RPS6KA3,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P25963,NF-kappa-B inhibitor alpha,NFKBIA,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P98066,Tumor necrosis factor-inducible gene 6 protein,TNFAIP6,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P98066,Tumor necrosis factor-inducible gene 6 protein,TNFAIP6,downregulator,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P29466,Caspase-1,CASP1,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P29466,Caspase-1,CASP1,downregulator,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P42574,Caspase-3,CASP3,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P42574,Caspase-3,CASP3,downregulator,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P28482,Extracellular signal-regulated kinase (ERK),MAPK1,,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P24385,G1/S-specific cyclin-D1,CCND1,downregulator,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P01106,Myc proto-oncogene protein,MYC,downregulator,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,P12004,Proliferating cell nuclear antigen,PCNA,downregulator,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,,Cyclin A,,downregulator,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00945,Acetylsalicylic acid,,Q99519,Sialidase-1,NEU1,inhibitor,B01AC06;C07FX04;C10BX04;M01BA03;N02BA71;C10BX02;B01AC56;N02AJ07;N02AJ02;N02BA01;C10BX05;N02BA51;A01AD05;C10BX01;C07FX03;N02AJ18;C10BX12;C10BX08;C10BX06;C07FX02
DB00946,Phenprocoumon,,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,inhibitor,B01AA04
DB00947,Fulvestrant,,P03372,Estrogen receptor alpha,ESR1,antagonist,L02BA03
DB00948,Mezlocillin,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CA10
DB00948,Mezlocillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CR50;J01CA10
DB00948,Mezlocillin,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01CR50;J01CA10
DB00949,Felbamate,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,antagonist,N03AX10
DB00949,Felbamate,,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,antagonist,N03AX10
DB00950,Fexofenadine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX26
DB00951,Isoniazid,,P9WIE5,Catalase-peroxidase,katG,other/unknown,J04AM04;J04AM01;J04AM03;J04AM02;J04AC01;J04AM06;J04AM05;J04AM07;J04AM08;J04AC51
DB00951,Isoniazid,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,adduct,J04AM04;J04AM01;J04AM03;J04AM02;J04AC01;J04AM06;J04AM05;J04AM07;J04AM08;J04AC51
DB00951,Isoniazid,,P10632,Cytochrome P450 2C8,CYP2C8,,J04AM04;J04AM01;J04AM03;J04AM02;J04AC01;J04AM06;J04AM05;J04AM07;J04AM08;J04AC51
DB00951,Isoniazid,,P05177,Cytochrome P450 1A2,CYP1A2,,J04AM04;J04AM01;J04AM03;J04AM02;J04AC01;J04AM06;J04AM05;J04AM07;J04AM08;J04AC51
DB00951,Isoniazid,,P08684,Cytochrome P450 3A4,CYP3A4,,J04AM04;J04AM01;J04AM03;J04AM02;J04AC01;J04AM06;J04AM05;J04AM07;J04AM08;J04AC51
DB00951,Isoniazid,,P33261,Cytochrome P450 2C19,CYP2C19,,J04AM04;J04AM01;J04AM03;J04AM02;J04AC01;J04AM06;J04AM05;J04AM07;J04AM08;J04AC51
DB00951,Isoniazid,,P9WNX1,Dihydrofolate reductase,folA,,J04AM04;J04AM01;J04AM03;J04AM02;J04AC01;J04AM06;J04AM05;J04AM07;J04AM08;J04AC51
DB00952,Naratriptan,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N02CC02
DB00952,Naratriptan,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N02CC02
DB00952,Naratriptan,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N02CC02
DB00952,Naratriptan,,P30939,5-hydroxytryptamine receptor 1F,HTR1F,agonist,N02CC02
DB00953,Rizatriptan,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N02CC04
DB00953,Rizatriptan,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N02CC04
DB00953,Rizatriptan,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N02CC04
DB00953,Rizatriptan,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,agonist,N02CC04
DB00953,Rizatriptan,,P30939,5-hydroxytryptamine receptor 1F,HTR1F,agonist,N02CC04
DB00953,Rizatriptan,,P34969,5-hydroxytryptamine receptor 7,HTR7,agonist,N02CC04
DB00954,Dirithromycin,,,23S ribosomal RNA,,inhibitor,J01FA13
DB00955,Netilmicin,,P0A7S3,30S ribosomal protein S12,rpsL,inhibitor,S01AA23;J01GB07
DB00955,Netilmicin,,,16S ribosomal RNA,,inhibitor,S01AA23;J01GB07
DB00956,Hydrocodone,,P35372,Mu-type opioid receptor,OPRM1,agonist,R05DA03
DB00956,Hydrocodone,,P41143,Delta-type opioid receptor,OPRD1,agonist,R05DA03
DB00956,Hydrocodone,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,ligand,R05DA03
DB00957,Norgestimate,,P06401,Progesterone receptor,PGR,agonist,G03AA11;G03FA13;G03AB09
DB00957,Norgestimate,,P03372,Estrogen receptor alpha,ESR1,agonist,G03AA11;G03FA13;G03AB09
DB00957,Norgestimate,,P10275,Androgen receptor,AR,partial agonist,G03AA11;G03FA13;G03AB09
DB00958,Carboplatin,,,DNA,,cross-linking/alkylation,L01XA02
DB00959,Methylprednisolone,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AA01;D10AA02;H02AB04;H02BX01;D07CA02;S03CA07;S01CA08
DB00959,Methylprednisolone,,P04083,Annexin A1,ANXA1,agonist,D07AA01;D10AA02;H02AB04;H02BX01;D07CA02;S03CA07;S01CA08
DB00960,Pindolol,,P08588,Beta-1 adrenergic receptor,ADRB1,partial agonist,C07CA03;C07AA03
DB00960,Pindolol,,P07550,Beta-2 adrenergic receptor,ADRB2,partial agonist,C07CA03;C07AA03
DB00960,Pindolol,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,C07CA03;C07AA03
DB00960,Pindolol,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,C07CA03;C07AA03
DB00960,Pindolol,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,inhibitor,C07CA03;C07AA03
DB00960,Pindolol,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,ligand,C07CA03;C07AA03
DB00960,Pindolol,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,other/unknown,C07CA03;C07AA03
DB00960,Pindolol,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,ligand,C07CA03;C07AA03
DB00961,Mepivacaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,N01BB53;N01BB03
DB00962,Zaleplon,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CF03
DB00963,Bromfenac,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,S01BC11
DB00963,Bromfenac,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,S01BC11
DB00964,Apraclonidine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,S01EA03
DB00964,Apraclonidine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,S01EA03
DB00964,Apraclonidine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,S01EA03
DB00966,Telmisartan,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,partial agonist,C09DB04;C09CA07;C09DX08;C09DA07
DB00966,Telmisartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,C09DB04;C09CA07;C09DX08;C09DA07
DB00967,Desloratadine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX27
DB00968,Methyldopa,,P20711,Aromatic-L-amino-acid decarboxylase,DDC,inhibitor,C02AB01
DB00968,Methyldopa,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,C02AB01
DB00969,Alosetron,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,A03AE01
DB00970,Dactinomycin,,,DNA,,adduct,L01DA01
DB00970,Dactinomycin,,P11388,DNA topoisomerase 2,TOP2A,inhibitor,L01DA01
DB00970,Dactinomycin,,P11387,DNA topoisomerase 1,TOP1,inhibitor,L01DA01
DB00972,Azelastine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX19;S01GX07;R01AC03
DB00972,Azelastine,,P25021,Histamine H2 receptor,HRH2,inhibitor,R06AX19;S01GX07;R01AC03
DB00972,Azelastine,,P04054,Phospholipase A2,PLA2G1B,inhibitor,R06AX19;S01GX07;R01AC03
DB00972,Azelastine,,Q16873,Leukotriene C4 synthase,LTC4S,inhibitor,R06AX19;S01GX07;R01AC03
DB00973,Ezetimibe,,Q9UHC9,Niemann-Pick C1-like protein 1,NPC1L1,inhibitor,C10BA02;C10BA11;C10BA10;C10BA05;C10BA12;C10AX09;C10BA06
DB00973,Ezetimibe,,P35610,Sterol O-acyltransferase 1,SOAT1,inhibitor,C10BA02;C10BA11;C10BA10;C10BA05;C10BA12;C10AX09;C10BA06
DB00973,Ezetimibe,,P15144,Aminopeptidase N,ANPEP,other,C10BA02;C10BA11;C10BA10;C10BA05;C10BA12;C10AX09;C10BA06
DB00974,Edetic acid,,,Lead,,chelator,
DB00974,Edetic acid,,,Iron,,chelator,
DB00974,Edetic acid,,,Manganese cation,,chelator,
DB00975,Dipyridamole,,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,inhibitor,B01AC07
DB00975,Dipyridamole,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,inhibitor,B01AC07
DB00975,Dipyridamole,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,inhibitor,B01AC07
DB00975,Dipyridamole,,P00813,Adenosine deaminase,ADA,inhibitor,B01AC07
DB00975,Dipyridamole,,P53805,Calcipressin-1,RCAN1,,B01AC07
DB00975,Dipyridamole,,P02763,Alpha-1-acid glycoprotein 1,ORM1,,B01AC07
DB00976,Telithromycin,,,23S ribosomal RNA,,inhibitor,J01FA15
DB00977,Ethinylestradiol,,P03372,Estrogen receptor alpha,ESR1,agonist,G03AA15;G03AA11;L02AA03;G03AA12;G03AA16;G03AB02;G03CA01;G03AA03;G03AA10;G03AB04;G03AB01;G03AB07;G03AA13;G03AA06;G03AA08;G03AA02;G03AA04;G03AA09;G03AB09;G03AA07;G03AB03;G03AA05;G03AB05;G03AB06;G03AA01
DB00977,Ethinylestradiol,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,agonist,G03AA15;G03AA11;L02AA03;G03AA12;G03AA16;G03AB02;G03CA01;G03AA03;G03AA10;G03AB04;G03AB01;G03AB07;G03AA13;G03AA06;G03AA08;G03AA02;G03AA04;G03AA09;G03AB09;G03AA07;G03AB03;G03AA05;G03AB05;G03AB06;G03AA01
DB00978,Lomefloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,S01AE04;J01MA07
DB00978,Lomefloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,S01AE04;J01MA07
DB00978,Lomefloxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,S01AE04;J01MA07
DB00979,Cyclopentolate,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,S01FA54;S01FA04
DB00980,Ramelteon,,P49286,Melatonin receptor type 1B,MTNR1B,multitarget,N05CH02
DB00980,Ramelteon,,P48039,Melatonin receptor type 1A,MTNR1A,multitarget,N05CH02
DB00981,Physostigmine,,P22303,Acetylcholinesterase,ACHE,inhibitor,S01EB05;V03AB19
DB00981,Physostigmine,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,S01EB05;V03AB19
DB00981,Physostigmine,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,,S01EB05;V03AB19
DB00982,Isotretinoin,,P13631,Retinoic acid receptor gamma,RARG,,D10AD04;D10AD54;D10BA01
DB00982,Isotretinoin,,P10276,Retinoic acid receptor alpha,RARA,other/unknown,D10AD04;D10AD54;D10BA01
DB00983,Formoterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03AL09;R03AL05;R03AK09;R03AL10;R03CC15;R03AL11;R03AL07;R03AK08;R03AC13;R03AK07;R03AK11
DB00983,Formoterol,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,R03AL09;R03AL05;R03AK09;R03AL10;R03CC15;R03AL11;R03AL07;R03AK08;R03AC13;R03AK07;R03AK11
DB00983,Formoterol,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,R03AL09;R03AL05;R03AK09;R03AL10;R03CC15;R03AL11;R03AL07;R03AK08;R03AC13;R03AK07;R03AK11
DB00984,Nandrolone phenpropionate,,P10275,Androgen receptor,AR,agonist,
DB00985,Dimenhydrinate,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AA11;R06AA61
DB00986,Glycopyrronium,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,R03AL09;R03AL04;R03BB06;D11AA01;A03AB02;R03AL11;R03AL07;A03CA05;R03AL12
DB00986,Glycopyrronium,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,R03AL09;R03AL04;R03BB06;D11AA01;A03AB02;R03AL11;R03AL07;A03CA05;R03AL12
DB00986,Glycopyrronium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,R03AL09;R03AL04;R03BB06;D11AA01;A03AB02;R03AL11;R03AL07;A03CA05;R03AL12
DB00986,Glycopyrronium,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,R03AL09;R03AL04;R03BB06;D11AA01;A03AB02;R03AL11;R03AL07;A03CA05;R03AL12
DB00986,Glycopyrronium,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,R03AL09;R03AL04;R03BB06;D11AA01;A03AB02;R03AL11;R03AL07;A03CA05;R03AL12
DB00987,Cytarabine,,P06746,DNA polymerase beta,POLB,inhibitor,L01BC01;L01XY01
DB00987,Cytarabine,,,DNA,,cross-linking/alkylation,L01BC01;L01XY01
DB00988,Dopamine,,P14416,Dopamine D2 receptor,DRD2,agonist,C01CA04
DB00988,Dopamine,,P21728,Dopamine D1 receptor,DRD1,agonist,C01CA04
DB00988,Dopamine,,P21918,Dopamine D5 receptor,DRD5,agonist,C01CA04
DB00988,Dopamine,,P35462,Dopamine D3 receptor,DRD3,agonist,C01CA04
DB00988,Dopamine,,P21917,Dopamine D4 receptor,DRD4,agonist,C01CA04
DB00988,Dopamine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inducer,C01CA04
DB00988,Dopamine,,P09172,Dopamine beta-hydroxylase,DBH,ligand,C01CA04
DB00988,Dopamine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,binder,C01CA04
DB00988,Dopamine,,P34969,5-hydroxytryptamine receptor 7,HTR7,binder,C01CA04
DB00988,Dopamine,,P21728,D(1) dopamine receptor,DRD1,agonist,C01CA04
DB00988,Dopamine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,C01CA04
DB00988,Dopamine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,C01CA04
DB00988,Dopamine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,,C01CA04
DB00988,Dopamine,,O95264,5-hydroxytryptamine receptor 3B,HTR3B,,C01CA04
DB00988,Dopamine,,P00441,Superoxide dismutase [Cu-Zn],SOD1,,C01CA04
DB00988,Dopamine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,,C01CA04
DB00989,Rivastigmine,,P22303,Acetylcholinesterase,ACHE,inhibitor,N06DA03
DB00989,Rivastigmine,,P06276,Cholinesterase,BCHE,inhibitor,N06DA03
DB00990,Exemestane,,P11511,Cytochrome P450 19A1,CYP19A1,inhibitor,L02BG06
DB00991,Oxaprozin,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AE12
DB00991,Oxaprozin,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AE12
DB00993,Azathioprine,,P63000,Ras-related C3 botulinum toxin substrate 1,RAC1,modulator,L04AX01
DB00994,Neomycin,,P0A7S3,30S ribosomal protein S12,rpsL,inhibitor,A07AA51;R02AB01;J01GB05;D06AX04;S03AA01;A01AB08;A07AA01;S02AA07;B05CA09;S01AA03
DB00994,Neomycin,,,16S ribosomal RNA,,inhibitor,A07AA51;R02AB01;J01GB05;D06AX04;S03AA01;A01AB08;A07AA01;S02AA07;B05CA09;S01AA03
DB00994,Neomycin,,P41180,Extracellular calcium-sensing receptor,CASR,,A07AA51;R02AB01;J01GB05;D06AX04;S03AA01;A01AB08;A07AA01;S02AA07;B05CA09;S01AA03
DB00995,Auranofin,,P30044,"Peroxiredoxin-5, mitochondrial",PRDX5,inhibitor,M01CB03
DB00995,Auranofin,,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,inhibitor,M01CB03
DB00996,Gabapentin,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,inhibitor,N02BF01
DB00996,Gabapentin,,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,inhibitor,N02BF01
DB00996,Gabapentin,,A0A024R8I1,Voltage-dependent N-type calcium channel,CACNA1B,inhibitor,N02BF01
DB00996,Gabapentin,,P30542,Adenosine receptor A1,ADORA1,agonist,N02BF01
DB00996,Gabapentin,,O43525,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,activator,N02BF01
DB00996,Gabapentin,,Q9NR82,Potassium voltage-gated channel subfamily KQT member 5,KCNQ5,activator,N02BF01
DB00997,Doxorubicin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,L01DB01
DB00997,Doxorubicin,,,DNA,,intercalation,L01DB01
DB00997,Doxorubicin,,Q14978,Nucleolar and coiled-body phosphoprotein 1,NOLC1,,L01DB01
DB00997,Doxorubicin,,P11387,DNA topoisomerase 1,TOP1,inhibitor,L01DB01
DB00997,Doxorubicin,,Q02880,DNA topoisomerase 2-beta,TOP2B,inhibitor,L01DB01
DB00998,Frovatriptan,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N02CC07
DB00998,Frovatriptan,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N02CC07
DB00999,Hydrochlorothiazide,,P55017,Solute carrier family 12 member 3,SLC12A3,inhibitor,C09BX03;C03AX01;C03AB03;C09DX03;C03EA01;C09DX06;C09XA52;G01AE10;C09DX01;C03AA03;C09XA54;C09DX08;C09DX07
DB00999,Hydrochlorothiazide,,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,inhibitor,C09BX03;C03AX01;C03AB03;C09DX03;C03EA01;C09DX06;C09XA52;G01AE10;C09DX01;C03AA03;C09XA54;C09DX08;C09DX07
DB01000,Cyclacillin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50
DB01000,Cyclacillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CR50
DB01000,Cyclacillin,,C1KC03,Penicillin binding protein 2a,mecA,inhibitor,J01CR50
DB01000,Cyclacillin,,P0AEB2,Penicillin-binding protein,dacA,inhibitor,J01CR50
DB01001,Salbutamol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03AK04;R03AC02;R03CC02;R03AK13;R03AL02
DB01001,Salbutamol,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,R03AK04;R03AC02;R03CC02;R03AK13;R03AL02
DB01001,Salbutamol,,P13945,Beta-3 adrenergic receptor,ADRB3,,R03AK04;R03AC02;R03CC02;R03AK13;R03AL02
DB01002,Levobupivacaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,N01BB10
DB01003,Cromoglicic acid,,P25815,Protein S100-P,S100P,antagonist,R03AK05;R03AK04;R03BC01;R01AC51;S01GX51;R01AC01;S01GX01;D11AH03;A07EB01
DB01004,Ganciclovir,,P04293,DNA polymerase catalytic subunit,,inhibitor,J05AB06;S01AD09
DB01004,Ganciclovir,,,DNA,,incorporation into and destabilization,J05AB06;S01AD09
DB01004,Ganciclovir,,Q9QNF7,Thymidine kinase,TK,substrate,J05AB06;S01AD09
DB01005,Hydroxyurea,,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,inhibitor,L01XX05
DB01006,Letrozole,,P11511,Cytochrome P450 19A1,CYP19A1,antagonist,L02BG04
DB01007,Tioconazole,,P10613,Cytochrome P450 51,ERG11,antagonist,G01AF20;D01AC07;G01AF08
DB01007,Tioconazole,,Q16850,Lanosterol 14-alpha demethylase,CYP51A1,inhibitor,G01AF20;D01AC07;G01AF08
DB01008,Busulfan,,,DNA,,cross-linking/alkylation,L01AB01
DB01009,Ketoprofen,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AE03;M02AA10;M01AE53
DB01009,Ketoprofen,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AE03;M02AA10;M01AE53
DB01009,Ketoprofen,,P25024,C-X-C chemokine receptor type 1,CXCR1,other,M01AE03;M02AA10;M01AE53
DB01010,Edrophonium,,P06276,Cholinesterase,BCHE,inhibitor,V04CX07
DB01010,Edrophonium,,P22303,Acetylcholinesterase,ACHE,inhibitor,V04CX07
DB01011,Metyrapone,,P15538,"Cytochrome P450 11B1, mitochondrial",CYP11B1,inhibitor,V04CD01
DB01011,Metyrapone,,P00183,Camphor 5-monooxygenase,camC,other/unknown,V04CD01
DB01012,Cinacalcet,,P41180,Extracellular calcium-sensing receptor,CASR,agonist,H05BX01
DB01013,Clobetasol propionate,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB01013,Clobetasol propionate,,P04083,Annexin A1,ANXA1,inducer,
DB01013,Clobetasol propionate,,P08235,Mineralocorticoid receptor,NR3C2,agonist,
DB01014,Balsalazide,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,A07EC04
DB01014,Balsalazide,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,A07EC04
DB01014,Balsalazide,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,A07EC04
DB01014,Balsalazide,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,A07EC04
DB01015,Sulfamethoxazole,,P0AC13,Dihydropteroate synthase,folP,antagonist,J04AM08;J01EE01;G01AE10;J01EC01
DB01016,Glyburide,,Q09428,"Sulfonylurea receptor 1, Kir6.2",ABCC8,blocker,A10BB01
DB01016,Glyburide,,O60706,ATP-binding cassette sub-family C member 9,ABCC9,modulator,A10BB01
DB01016,Glyburide,,O95342,Bile salt export pump,ABCB11,inhibitor,A10BB01
DB01016,Glyburide,,O95477,ATP-binding cassette sub-family A member 1,ABCA1,inhibitor,A10BB01
DB01016,Glyburide,,Q14654,Mitochondrial ATP-sensitive potassium channel,KCNJ11,inhibitor,A10BB01
DB01016,Glyburide,,P50416,"Carnitine O-palmitoyltransferase 1, liver isoform",CPT1A,inhibitor,A10BB01
DB01016,Glyburide,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,antagonist,A10BB01
DB01016,Glyburide,,Q8TD43,Transient receptor potential cation channel subfamily M member 4,TRPM4,inhibitor,A10BB01
DB01017,Minocycline,,P0A7X3,30S ribosomal protein S9,rpsI,inhibitor,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,P0A7V8,30S ribosomal protein S4,rpsD,inhibitor,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,,16S ribosomal RNA,,inhibitor,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,P01584,Interleukin-1 beta,IL1B,modulator,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,P14780,Matrix metalloproteinase-9,MMP9,inhibitor,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,P15692,Vascular endothelial growth factor A,VEGFA,inhibitor,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,P29466,Caspase-1,CASP1,negative modulator,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,P42574,Caspase-3,CASP3,negative modulator,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,P99999,Cytochrome c,CYCS,negative modulator,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,P28482,Mitogen-activated Protein Kinases,MAPK1,inhibitor,D10AF07;J01AA08;J01AA20;A01AB23
DB01017,Minocycline,,P35228,"Nitric oxide synthase, inducible",NOS2,inhibitor,D10AF07;J01AA08;J01AA20;A01AB23
DB01018,Guanfacine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,C02AC02
DB01018,Guanfacine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,binder,C02AC02
DB01019,Bethanechol,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,agonist,N07AB02
DB01019,Bethanechol,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,agonist,N07AB02
DB01019,Bethanechol,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,agonist,N07AB02
DB01019,Bethanechol,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,agonist,N07AB02
DB01019,Bethanechol,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,agonist,N07AB02
DB01020,Isosorbide mononitrate,,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,activator,C01DA14
DB01021,Trichlormethiazide,,P55017,Solute carrier family 12 member 3,SLC12A3,inhibitor,G01AE10;C03AA06;C03EA02;C03AB06
DB01021,Trichlormethiazide,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,inhibitor,G01AE10;C03AA06;C03EA02;C03AB06
DB01021,Trichlormethiazide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,G01AE10;C03AA06;C03EA02;C03AB06
DB01021,Trichlormethiazide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,G01AE10;C03AA06;C03EA02;C03AB06
DB01021,Trichlormethiazide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,G01AE10;C03AA06;C03EA02;C03AB06
DB01022,Phylloquinone,,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,substrate,B02BA01
DB01022,Phylloquinone,,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,inducer,B02BA01
DB01022,Phylloquinone,,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,cofactor,B02BA01
DB01022,Phylloquinone,,P02818,Osteocalcin,BGLAP,agonist,B02BA01
DB01023,Felodipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,inhibitor,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,inhibitor,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,inhibitor,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,P0DP23,Calmodulin,CALM1,other,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,Q01064,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,inhibitor,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,P54750,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",PDE1A,inhibitor,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,P02585,"Troponin C, skeletal muscle",TNNC2,other,C07FB02;C08CA02;C09BB05
DB01023,Felodipine,,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,other,C07FB02;C08CA02;C09BB05
DB01024,Mycophenolic acid,,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,inhibitor,L04AA06
DB01024,Mycophenolic acid,,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,inhibitor,L04AA06
DB01025,Amlexanox,,P80511,Protein S100-A12,S100A12,antagonist,A01AD07;R03DX01
DB01025,Amlexanox,,Q99584,Protein S100-A13,S100A13,antagonist,A01AD07;R03DX01
DB01025,Amlexanox,,P08700,Interleukin-3,IL3,antagonist,A01AD07;R03DX01
DB01025,Amlexanox,,P05230,Fibroblast growth factor 1,FGF1,inhibitor,A01AD07;R03DX01
DB01026,Ketoconazole,,P50859,Lanosterol 14-alpha demethylase,ERG11,inhibitor,G01AF11;G01AF20;J02AB02;H02CA03;D01AC08
DB01026,Ketoconazole,,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,inhibitor,G01AF11;G01AF20;J02AB02;H02CA03;D01AC08
DB01026,Ketoconazole,,P10275,Androgen receptor,AR,binder,G01AF11;G01AF20;J02AB02;H02CA03;D01AC08
DB01026,Ketoconazole,,P08686,Steroid 21-hydroxylase,CYP21A2,inhibitor,G01AF11;G01AF20;J02AB02;H02CA03;D01AC08
DB01026,Ketoconazole,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,G01AF11;G01AF20;J02AB02;H02CA03;D01AC08
DB01026,Ketoconazole,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,antagonist,G01AF11;G01AF20;J02AB02;H02CA03;D01AC08
DB01026,Ketoconazole,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,,G01AF11;G01AF20;J02AB02;H02CA03;D01AC08
DB01028,Methoxyflurane,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,N02BG09
DB01028,Methoxyflurane,,P42261,Glutamate receptor 1,GRIA1,antagonist,N02BG09
DB01028,Methoxyflurane,,P23415,Glycine receptor subunit alpha-1,GLRA1,agonist,N02BG09
DB01028,Methoxyflurane,,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,inducer,N02BG09
DB01028,Methoxyflurane,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N02BG09
DB01028,Methoxyflurane,,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,inhibitor,N02BG09
DB01028,Methoxyflurane,,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,unknown,N02BG09
DB01029,Irbesartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,C09CA04;C09DB05;C09DA04;C09DX07
DB01029,Irbesartan,,P05412,Transcription factor AP-1,JUN,other/unknown,C09CA04;C09DB05;C09DA04;C09DX07
DB01030,Topotecan,,P11387,DNA topoisomerase 1,TOP1,inhibitor,L01CE01
DB01030,Topotecan,,,DNA,,intercalation,L01CE01
DB01030,Topotecan,,Q969P6,"DNA topoisomerase I, mitochondrial",TOP1MT,inhibitor,L01CE01
DB01031,Ethinamate,,P00918,Carbonic anhydrase 2,CA2,inhibitor,
DB01031,Ethinamate,,P00915,Carbonic anhydrase 1,CA1,inhibitor,
DB01032,Probenecid,,Q4U2R8,Solute carrier family 22 member 6,SLC22A6,inhibitor,M04AB01;G01AE10
DB01032,Probenecid,,Q9NSA0,Solute carrier family 22 member 11,SLC22A11,inhibitor,M04AB01;G01AE10
DB01032,Probenecid,,Q8TCC7,Solute carrier family 22 member 8,SLC22A8,inhibitor,M04AB01;G01AE10
DB01032,Probenecid,,Q96RD7,Pannexin-1,PANX1,antagonist,M04AB01;G01AE10
DB01032,Probenecid,,Q9NYV7,Taste receptor type 2 member 16,TAS2R16,,M04AB01;G01AE10
DB01033,Mercaptopurine,,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,inhibitor,L01BB02;R03DA20
DB01033,Mercaptopurine,,Q06203,Amidophosphoribosyltransferase,PPAT,inhibitor,L01BB02;R03DA20
DB01033,Mercaptopurine,,P20839,Inosine-5'-monophosphate dehydrogenase,IMPDH1,inhibitor,L01BB02;R03DA20
DB01034,Cerulenin,,P0A953,3-oxoacyl-[acyl-carrier-protein] synthase 1,fabB,inhibitor,
DB01034,Cerulenin,,P0AAI5,3-oxoacyl-[acyl-carrier-protein] synthase 2,fabF,inhibitor,
DB01034,Cerulenin,,P0A6R0,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,inhibitor,
DB01034,Cerulenin,,P49327,Fatty acid synthase,FASN,inhibitor,
DB01035,Procainamide,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C01BA02
DB01035,Procainamide,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BA02
DB01035,Procainamide,,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,other,C01BA02
DB01036,Tolterodine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,G04BD07
DB01036,Tolterodine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,G04BD07
DB01036,Tolterodine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,G04BD07
DB01036,Tolterodine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,G04BD07
DB01036,Tolterodine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,G04BD07
DB01037,Selegiline,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,N04BD01
DB01037,Selegiline,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,N04BD01
DB01038,Carphenazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,
DB01038,Carphenazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,
DB01038,Carphenazine,,P21918,Dopamine D5 receptor,DRD5,antagonist,
DB01039,Fenofibrate,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,C10BA03;C10BA12;C10AB05;C10BA09;C10BA04
DB01039,Fenofibrate,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,partial agonist,C10BA03;C10BA12;C10AB05;C10BA09;C10BA04
DB01039,Fenofibrate,,Q9NPA2,Matrix metalloproteinase-25,MMP25,inhibitor,C10BA03;C10BA12;C10AB05;C10BA09;C10BA04
DB01041,Thalidomide,,Q96SW2,Protein cereblon,CRBN,inhibitor,L04AX02
DB01041,Thalidomide,,,DNA,,intercalation,L04AX02
DB01041,Thalidomide,,P02763,alpha1-acid glycoprotein,ORM1,binder,L04AX02
DB01042,Melphalan,,,DNA,,cross-linking/alkylation,L01AA03
DB01043,Memantine,,Q05586,Glutamate (NMDA) receptor,GRIN1,antagonist,N06DA52;N06DX01;N06DA53
DB01043,Memantine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,N06DA52;N06DX01;N06DA53
DB01043,Memantine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N06DA52;N06DX01;N06DA53
DB01043,Memantine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N06DA52;N06DX01;N06DA53
DB01043,Memantine,,P14416,Dopamine D2 receptor,DRD2,agonist,N06DA52;N06DX01;N06DA53
DB01043,Memantine,,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,binder,N06DA52;N06DX01;N06DA53
DB01043,Memantine,,P14867,GABA(A) Receptor,GABRA1,binder,N06DA52;N06DX01;N06DA53
DB01043,Memantine,,P23415,Glycine receptors,GLRA1,inhibitor,N06DA52;N06DX01;N06DA53
DB01044,Gatifloxacin,,P72524,DNA gyrase subunit A,gyrA,inhibitor,S01AE06;J01MA16
DB01044,Gatifloxacin,,P0A4L9,DNA gyrase subunit B,gyrB,inhibitor,S01AE06;J01MA16
DB01044,Gatifloxacin,,P72525,DNA topoisomerase 4 subunit A,parC,inhibitor,S01AE06;J01MA16
DB01044,Gatifloxacin,,Q59961,DNA topoisomerase 4 subunit B,parE,inhibitor,S01AE06;J01MA16
DB01045,Rifampicin,,P0A8V2,DNA-directed RNA polymerase subunit beta,rpoB,inhibitor,J04BA50;J04AM02;J04BA51;J04AB02;J04AM06;J04AM05;J04AM07
DB01045,Rifampicin,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,agonist,J04BA50;J04AM02;J04BA51;J04AB02;J04AM06;J04AM05;J04AM07
DB01046,Lubiprostone,,P51788,Chloride channel protein 2,CLCN2,inducer,A06AX03
DB01047,Fluocinonide,,P04150,Glucocorticoid receptor,NR3C1,agonist,C05AA11;D07AC08;D07CC05
DB01047,Fluocinonide,,Q99835,Smoothened homolog,SMO,agonist,C05AA11;D07AC08;D07CC05
DB01048,Abacavir,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AR13;J05AR02;J05AR04;J05AF06
DB01048,Abacavir,,P01889,"HLA class I histocompatibility antigen, B-57 alpha chain",HLA-B,,J05AR13;J05AR02;J05AR04;J05AF06
DB01049,Ergoloid mesylate,,P21728,Dopamine receptor,DRD1,antagonist,
DB01049,Ergoloid mesylate,,P21728,Dopamine receptor,DRD1,agonist,
DB01049,Ergoloid mesylate,,P35348,Alpha adrenergic receptor,ADRA1A,antagonist,
DB01049,Ergoloid mesylate,,P35348,Alpha adrenergic receptor,ADRA1A,agonist,
DB01049,Ergoloid mesylate,,P08588,Beta adrenergic receptor,ADRB1,antagonist,
DB01049,Ergoloid mesylate,,P08588,Beta adrenergic receptor,ADRB1,agonist,
DB01049,Ergoloid mesylate,,P08908,Serotonin Receptors,HTR1A,antagonist,
DB01049,Ergoloid mesylate,,P08908,Serotonin Receptors,HTR1A,agonist,
DB01050,Ibuprofen,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,G02CC01;C01EB16;M01AE01;M02AA13;R02AX02;N02AJ08;N02AJ19;M01AE51
DB01050,Ibuprofen,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,G02CC01;C01EB16;M01AE01;M02AA13;R02AX02;N02AJ08;N02AJ19;M01AE51
DB01050,Ibuprofen,,P10415,Apoptosis regulator Bcl-2,BCL2,modulator,G02CC01;C01EB16;M01AE01;M02AA13;R02AX02;N02AJ08;N02AJ19;M01AE51
DB01050,Ibuprofen,,P07204,Thrombomodulin,THBD,inducer,G02CC01;C01EB16;M01AE01;M02AA13;R02AX02;N02AJ08;N02AJ19;M01AE51
DB01050,Ibuprofen,,P12104,"Fatty acid-binding protein, intestinal",FABP2,binder,G02CC01;C01EB16;M01AE01;M02AA13;R02AX02;N02AJ08;N02AJ19;M01AE51
DB01050,Ibuprofen,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,activator,G02CC01;C01EB16;M01AE01;M02AA13;R02AX02;N02AJ08;N02AJ19;M01AE51
DB01050,Ibuprofen,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,inhibitor,G02CC01;C01EB16;M01AE01;M02AA13;R02AX02;N02AJ08;N02AJ19;M01AE51
DB01050,Ibuprofen,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,activator,G02CC01;C01EB16;M01AE01;M02AA13;R02AX02;N02AJ08;N02AJ19;M01AE51
DB01050,Ibuprofen,,P07359,Platelet glycoprotein Ib alpha chain,GP1BA,inducer,G02CC01;C01EB16;M01AE01;M02AA13;R02AX02;N02AJ08;N02AJ19;M01AE51
DB01050,Ibuprofen,,P31151,Protein S100-A7,S100A7,inducer,G02CC01;C01EB16;M01AE01;M02AA13;R02AX02;N02AJ08;N02AJ19;M01AE51
DB01051,Novobiocin,,P0A0K8,DNA gyrase subunit B,gyrB,inhibitor,
DB01051,Novobiocin,,Q06AK7,DNA topoisomerase 1,topA,inhibitor,
DB01053,Benzylpenicillin,,A0A0H2XJ39,Penicillin-binding protein 3,pbp3,inhibitor,J01CR50;J01CE01;S01AA14;J01CE08
DB01053,Benzylpenicillin,,Q8TCC7,Solute carrier family 22 member 8,SLC22A8,substrate,J01CR50;J01CE01;S01AA14;J01CE08
DB01053,Benzylpenicillin,,Q8TCC7,Solute carrier family 22 member 8,SLC22A8,inhibitor,J01CR50;J01CE01;S01AA14;J01CE08
DB01053,Benzylpenicillin,,P46059,Solute carrier family 15 member 1,SLC15A1,substrate,J01CR50;J01CE01;S01AA14;J01CE08
DB01053,Benzylpenicillin,,P46059,Solute carrier family 15 member 1,SLC15A1,inhibitor,J01CR50;J01CE01;S01AA14;J01CE08
DB01053,Benzylpenicillin,,Q16348,Solute carrier family 15 member 2,SLC15A2,inhibitor,J01CR50;J01CE01;S01AA14;J01CE08
DB01054,Nitrendipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C08CA08;C09BB06
DB01054,Nitrendipine,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,inhibitor,C08CA08;C09BB06
DB01054,Nitrendipine,,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,inhibitor,C08CA08;C09BB06
DB01054,Nitrendipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,C08CA08;C09BB06
DB01054,Nitrendipine,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,C08CA08;C09BB06
DB01054,Nitrendipine,,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,inhibitor,C08CA08;C09BB06
DB01054,Nitrendipine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,C08CA08;C09BB06
DB01054,Nitrendipine,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,inhibitor,C08CA08;C09BB06
DB01054,Nitrendipine,,Q12791,Calcium-activated potassium channel,KCNMA1,inhibitor,C08CA08;C09BB06
DB01055,Mimosine,,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,inhibitor,
DB01055,Mimosine,,P13500,C-C motif chemokine 2,CCL2,inhibitor,
DB01055,Mimosine,,P14679,Tyrosinase,TYR,inhibitor,
DB01056,Tocainide,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BB03
DB01057,Echothiophate,,P06276,Cholinesterase,BCHE,inhibitor,S01EB03
DB01058,Praziquantel,,,Schistosome calcium ion (Ca2+) channels,,other/unknown,P02BA01
DB01059,Norfloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01RA14;J01RA13;S01AE02;J01MA06
DB01059,Norfloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01RA14;J01RA13;S01AE02;J01MA06
DB01059,Norfloxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,J01RA14;J01RA13;S01AE02;J01MA06
DB01059,Norfloxacin,,P20831,DNA gyrase subunit A,gyrA,inhibitor,J01RA14;J01RA13;S01AE02;J01MA06
DB01059,Norfloxacin,,P11388,DNA topoisomerase 2,TOP2A,inhibitor,J01RA14;J01RA13;S01AE02;J01MA06
DB01059,Norfloxacin,,P0C1U9,DNA topoisomerase 4 subunit A,parC,inhibitor,J01RA14;J01RA13;S01AE02;J01MA06
DB01060,Amoxicillin,,Q8L103,Penicillin binding protein,PBP1,inhibitor,A02BD12;J01CR50;A02BD14;A02BD04;A02BD07;A02BD13;A02BD10;A02BD05;A02BD03;A02BD01;A02BD15;A02BD06;J01CA04;A02BD16;A02BD11
DB01061,Azlocillin,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CA09
DB01062,Oxybutynin,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,G04BD04
DB01062,Oxybutynin,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,G04BD04
DB01062,Oxybutynin,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,G04BD04
DB01063,Acetophenazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AB07
DB01063,Acetophenazine,,P10275,Androgen receptor,AR,,N05AB07
DB01064,Isoprenaline,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,C01CA02;R03AK02;R03AB02;R03CB01;R03CB51
DB01064,Isoprenaline,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,C01CA02;R03AK02;R03AB02;R03CB01;R03CB51
DB01064,Isoprenaline,,P07550,Beta-2 adrenergic receptor,ADRB2,binder,C01CA02;R03AK02;R03AB02;R03CB01;R03CB51
DB01064,Isoprenaline,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,C01CA02;R03AK02;R03AB02;R03CB01;R03CB51
DB01064,Isoprenaline,,P00441,Superoxide dismutase [Cu-Zn],SOD1,stabilization,C01CA02;R03AK02;R03AB02;R03CB01;R03CB51
DB01065,Melatonin,,P48039,Melatonin receptor type 1A,MTNR1A,agonist,N05CH01
DB01065,Melatonin,,P49286,Melatonin receptor type 1B,MTNR1B,agonist,N05CH01
DB01065,Melatonin,,P03372,Estrogen receptor alpha,ESR1,antagonist,N05CH01
DB01065,Melatonin,,Q92753,Nuclear receptor ROR-beta,RORB,agonist,N05CH01
DB01065,Melatonin,,P0DP23,Calmodulin,CALM1,,N05CH01
DB01065,Melatonin,,P05164,Myeloperoxidase,MPO,inhibitor,N05CH01
DB01065,Melatonin,,P11678,Eosinophil peroxidase,EPX,inhibitor,N05CH01
DB01065,Melatonin,,P27797,Calreticulin,CALR,,N05CH01
DB01065,Melatonin,,P46597,Acetylserotonin O-methyltransferase,ASMT,,N05CH01
DB01065,Melatonin,,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,N05CH01
DB01066,Cefditoren,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01DD16
DB01066,Cefditoren,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01DD16
DB01067,Glipizide,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,inhibitor,A10BB07
DB01067,Glipizide,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,A10BB07
DB01068,Clonazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N03AE01
DB01068,Clonazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N03AE01
DB01068,Clonazepam,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,partial agonist,N03AE01
DB01069,Promethazine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,P35348,Alpha adrenergic receptor,ADRA1A,antagonist,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,P0DP23,Calmodulin,CALM1,inhibitor,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,P25021,Histamine H2 receptor,HRH2,antagonist,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,Q99677,P2 Purinoceptors,LPAR4,inhibitor,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,inhibitor,R06AD52;D04AA10;V03AB05;R06AD02
DB01069,Promethazine,,Q09470,Voltage-gated Potassium Channels,KCNA1,inducer,R06AD52;D04AA10;V03AB05;R06AD02
DB01070,Dihydrotachysterol,,P11473,Vitamin D3 receptor,VDR,agonist,A11CC02
DB01071,Mequitazine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AD07
DB01072,Atazanavir,,Q72874,Human immunodeficiency virus type 1 protease,pol,inhibitor,J05AE08;J05AR15;J05AR23
DB01073,Fludarabine,,,DNA,,incorporation into and destabilization,L01BB05
DB01073,Fludarabine,,P27707,Deoxycytidine kinase,DCK,agonist,L01BB05
DB01073,Fludarabine,,P09884,DNA polymerase alpha catalytic subunit,POLA1,inhibitor,L01BB05
DB01073,Fludarabine,,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,inhibitor,L01BB05
DB01074,Perhexiline,,P50416,"Carnitine O-palmitoyltransferase 1, liver isoform",CPT1A,inhibitor,C08EX02
DB01074,Perhexiline,,P23786,"Carnitine O-palmitoyltransferase 2, mitochondrial",CPT2,inhibitor,C08EX02
DB01074,Perhexiline,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,,C08EX02
DB01075,Diphenhydramine,,P35367,Histamine H1 receptor,HRH1,antagonist,D04AA32;R06AA02;D04AA33;R06AA52
DB01075,Diphenhydramine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,D04AA32;R06AA02;D04AA33;R06AA52
DB01076,Atorvastatin,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,inhibitor,C10BA05;C10BX11;C10BX12;C10BX19;C10BX18;C10AA05;C10BX15;C10BX03;C10BX08;C10BX06
DB01076,Atorvastatin,,P27487,Dipeptidyl peptidase 4,DPP4,inhibitor,C10BA05;C10BX11;C10BX12;C10BX19;C10BX18;C10AA05;C10BX15;C10BX03;C10BX08;C10BX06
DB01076,Atorvastatin,,P35869,Aryl hydrocarbon receptor,AHR,agonist,C10BA05;C10BX11;C10BX12;C10BX19;C10BX18;C10AA05;C10BX15;C10BX03;C10BX08;C10BX06
DB01076,Atorvastatin,,Q92769,Histone deacetylase 2,HDAC2,inhibitor,C10BA05;C10BX11;C10BX12;C10BX19;C10BX18;C10AA05;C10BX15;C10BX03;C10BX08;C10BX06
DB01076,Atorvastatin,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,ligand,C10BA05;C10BX11;C10BX12;C10BX19;C10BX18;C10AA05;C10BX15;C10BX03;C10BX08;C10BX06
DB01077,Etidronic acid,,,Hydroxylapatite,,antagonist,M05BB01;M05BA01
DB01077,Etidronic acid,,Q13332,Receptor-type tyrosine-protein phosphatase S,PTPRS,inhibitor,M05BB01;M05BA01
DB01077,Etidronic acid,,P38606,V-type proton ATPase catalytic subunit A,ATP6V1A,inhibitor,M05BB01;M05BA01
DB01077,Etidronic acid,,P12235,ADP/ATP translocase 1,SLC25A4,inhibitor,M05BB01;M05BA01
DB01077,Etidronic acid,,P05141,ADP/ATP translocase 2,SLC25A5,inhibitor,M05BB01;M05BA01
DB01077,Etidronic acid,,P12236,ADP/ATP translocase 3,SLC25A6,inhibitor,M05BB01;M05BA01
DB01078,Deslanoside,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,inhibitor,C01AA07
DB01079,Tegaserod,,Q13639,5-hydroxytryptamine receptor 4,HTR4,antagonist,A06AX06
DB01079,Tegaserod,,Q13639,5-hydroxytryptamine receptor 4,HTR4,partial agonist,A06AX06
DB01079,Tegaserod,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,A06AX06
DB01079,Tegaserod,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,A06AX06
DB01079,Tegaserod,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,A06AX06
DB01080,Vigabatrin,,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,inhibitor,N03AG04
DB01081,Diphenoxylate,,P35372,Mu-type opioid receptor,OPRM1,agonist,A07DA01
DB01081,Diphenoxylate,,P41143,Delta-type opioid receptor,OPRD1,agonist,A07DA01
DB01082,Streptomycin,,,16S ribosomal RNA,,inhibitor,J04AM01;J01GA01;A07AA54;A07AA04
DB01082,Streptomycin,,,23S ribosomal RNA,,inhibitor,J04AM01;J01GA01;A07AA54;A07AA04
DB01082,Streptomycin,,P0A7S3,30S ribosomal protein S12,rpsL,inhibitor,J04AM01;J01GA01;A07AA54;A07AA04
DB01082,Streptomycin,,,Cytoplasmic membrane,,incorporation into and destabilization,J04AM01;J01GA01;A07AA54;A07AA04
DB01082,Streptomycin,,,Bacterial outer membrane,,incorporation into and destabilization,J04AM01;J01GA01;A07AA54;A07AA04
DB01082,Streptomycin,,Q9UM07,Protein-arginine deiminase type-4,PADI4,inhibitor,J04AM01;J01GA01;A07AA54;A07AA04
DB01083,Orlistat,,P16233,Pancreatic triacylglycerol lipase,PNLIP,inhibitor,A08AB01
DB01083,Orlistat,,P07098,Gastric triacylglycerol lipase,LIPF,inhibitor,A08AB01
DB01083,Orlistat,,P49327,Fatty acid synthase,FASN,inhibitor,A08AB01
DB01084,Emedastine,,P35367,Histamine H1 receptor,HRH1,antagonist,S01GX06
DB01085,Pilocarpine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,agonist,N07AX01;S01EB01;S01EB51
DB01085,Pilocarpine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,agonist,N07AX01;S01EB01;S01EB51
DB01085,Pilocarpine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,agonist,N07AX01;S01EB01;S01EB51
DB01085,Pilocarpine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,partial agonist,N07AX01;S01EB01;S01EB51
DB01085,Pilocarpine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,agonist,N07AX01;S01EB01;S01EB51
DB01086,Benzocaine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,C05AD03;R02AD01;D04AB04;N01BA05
DB01087,Primaquine,,,Fe(II)-protoporphyrin IX,,antagonist,P01BA03
DB01087,Primaquine,,P08729,"Keratin, type II cytoskeletal 7",KRT7,other/unknown,P01BA03
DB01087,Primaquine,,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,inhibitor,P01BA03
DB01088,Iloprost,,P43119,Prostacyclin receptor,PTGIR,agonist,B01AC11
DB01088,Iloprost,,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,agonist,B01AC11
DB01088,Iloprost,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,inducer,B01AC11
DB01088,Iloprost,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inducer,B01AC11
DB01088,Iloprost,,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,inducer,B01AC11
DB01088,Iloprost,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,inducer,B01AC11
DB01088,Iloprost,,P00750,Tissue-type plasminogen activator,PLAT,other/unknown,B01AC11
DB01088,Iloprost,,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,agonist,B01AC11
DB01089,Deserpidine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,C02LA03;C02AA05
DB01090,Pentolinium,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,antagonist,
DB01090,Pentolinium,,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,antagonist,
DB01090,Pentolinium,,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,antagonist,
DB01091,Butenafine,,Q14534,Squalene monooxygenase,SQLE,inhibitor,D01AE23
DB01092,Ouabain,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,inhibitor,C01AC01
DB01092,Ouabain,,P50993,Sodium/potassium-transporting ATPase subunit alpha-2,ATP1A2,inhibitor,C01AC01
DB01092,Ouabain,,P13637,Sodium/potassium-transporting ATPase subunit alpha-3,ATP1A3,inhibitor,C01AC01
DB01093,Dimethyl sulfoxide,,Q01344,Interleukin-5 receptor subunit alpha,IL5RA,downregulator,M02AX03;G04BX13
DB01093,Dimethyl sulfoxide,,Q8WXI7,Mucin-16,MUC16,downregulator,M02AX03;G04BX13
DB01093,Dimethyl sulfoxide,,P01106,Myc proto-oncogene protein,MYC,downregulator,M02AX03;G04BX13
DB01094,Hesperetin,,P55157,Microsomal triglyceride transfer protein large subunit,MTTP,antagonist,
DB01094,Hesperetin,,P35610,Sterol O-acyltransferase 1,SOAT1,inhibitor,
DB01094,Hesperetin,,P04278,Sex hormone-binding globulin,SHBG,,
DB01094,Hesperetin,,O75908,Sterol O-acyltransferase 2,SOAT2,inhibitor,
DB01095,Fluvastatin,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,inhibitor,C10AA04
DB01095,Fluvastatin,,Q92769,Histone deacetylase 2,HDAC2,inhibitor,C10AA04
DB01096,Oxamniquine,,,DNA,,other/unknown,P02BA02
DB01097,Leflunomide,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,inhibitor,L04AA13
DB01097,Leflunomide,,P35869,Aryl hydrocarbon receptor,AHR,agonist,L04AA13
DB01097,Leflunomide,,Q14289,Protein-tyrosine kinase 2-beta,PTK2B,antagonist,L04AA13
DB01098,Rosuvastatin,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,inhibitor,C10BX10;C10BX05;C10BX07;C10AA07;A10BH52;G01AE10;C10BX13;C10BX09;C10BA09;C10BX16;C10BX17;C10BX14;C10BA06
DB01098,Rosuvastatin,,P20701,Integrin alpha-L,ITGAL,inhibitory allosteric modulator,C10BX10;C10BX05;C10BX07;C10AA07;A10BH52;G01AE10;C10BX13;C10BX09;C10BA09;C10BX16;C10BX17;C10BX14;C10BA06
DB01099,Flucytosine,,,DNA,,cross-linking/alkylation,J02AX01;D01AE21
DB01099,Flucytosine,,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,other,J02AX01;D01AE21
DB01099,Flucytosine,,P12461,Thymidylate synthase,TMP1,inhibitor,J02AX01;D01AE21
DB01100,Pimozide,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AG02
DB01100,Pimozide,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AG02
DB01100,Pimozide,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,N05AG02
DB01100,Pimozide,,P0DP23,Calmodulin,CALM1,inhibitor,N05AG02
DB01101,Capecitabine,,,DNA,,incorporation into and destabilization,L01BC06
DB01101,Capecitabine,,,DNA,,inhibition of synthesis,L01BC06
DB01101,Capecitabine,,,RNA,,incorporation into and destabilization,L01BC06
DB01101,Capecitabine,,P04818,Thymidylate synthase,TYMS,inhibitor,L01BC06
DB01102,Arbutamine,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,C01CA22
DB01102,Arbutamine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,C01CA22
DB01102,Arbutamine,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,C01CA22
DB01103,Quinacrine,,,DNA,,intercalation,P01AX05
DB01103,Quinacrine,,O60733,85/88 kDa calcium-independent phospholipase A2,PLA2G6,inhibitor,P01AX05
DB01103,Quinacrine,,P47712,Cytosolic phospholipase A2,PLA2G4A,inhibitor,P01AX05
DB01103,Quinacrine,,Q15111,Inactive phospholipase C-like protein 1,PLCL1,inhibitor,P01AX05
DB01104,Sertraline,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AB06
DB01104,Sertraline,,P31645,Sodium-dependent serotonin transporter,SLC6A4,binder,N06AB06
DB01104,Sertraline,,P31645,Sodium-dependent serotonin transporter,SLC6A4,downregulator,N06AB06
DB01104,Sertraline,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06AB06
DB01104,Sertraline,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,binder,N06AB06
DB01104,Sertraline,,O00264,Sigma receptor,PGRMC1,inhibitor,N06AB06
DB01104,Sertraline,,O00264,Sigma receptor,PGRMC1,binder,N06AB06
DB01104,Sertraline,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AB06
DB01104,Sertraline,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,downregulator,N06AB06
DB01104,Sertraline,,Q7RTT9,Equilibrative nucleoside transporter 4,SLC29A4,,N06AB06
DB01105,Sibutramine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,A08AA10
DB01105,Sibutramine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,A08AA10
DB01105,Sibutramine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,A08AA10
DB01106,Levocabastine,,P35367,Histamine H1 receptor,HRH1,antagonist,R01AC02;S01GX02
DB01106,Levocabastine,,O95665,Neurotensin receptor type 2,NTSR2,partial antagonist,R01AC02;S01GX02
DB01107,Methyprylon,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CE02
DB01107,Methyprylon,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,N05CE02
DB01108,Trilostane,,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,inhibitor,H02CA01
DB01108,Trilostane,,P26439,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,HSD3B2,inhibitor,H02CA01
DB01108,Trilostane,,P03372,Estrogen receptor alpha,ESR1,allosteric modulator,H02CA01
DB01108,Trilostane,,Q92731,Estrogen receptor beta,ESR2,allosteric modulator,H02CA01
DB01109,Heparin,,P01008,Antithrombin-III,SERPINC1,potentiator,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,P00742,Coagulation factor X,F10,inhibitor,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,P16109,P-selectin,SELP,inhibitor,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,P22455,Fibroblast growth factor receptor 4,FGFR4,,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,P08620,Fibroblast growth factor 4,FGF4,,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,O95750,Fibroblast growth factor 19,FGF19,,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,P11362,Fibroblast growth factor receptor 1,FGFR1,,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,P05230,Fibroblast growth factor 1,FGF1,,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,P21802,Fibroblast growth factor receptor 2,FGFR2,,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,P09038,Fibroblast growth factor 2,FGF2,,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,P02776,Platelet factor 4,PF4,,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01109,Heparin,,P14210,Hepatocyte growth factor,HGF,,B01AB51;C05BA03;S01XA14;C05BA53;B01AB01
DB01110,Miconazole,,P10613,Cytochrome P450 51,ERG11,inhibitor,A07AC01;J02AB01;D01AC52;G01AF20;A01AB09;D01AC02;S02AA13;G01AF04
DB01110,Miconazole,,P29474,"Nitric oxide synthase, endothelial",NOS3,inhibitor,A07AC01;J02AB01;D01AC52;G01AF20;A01AB09;D01AC02;S02AA13;G01AF04
DB01110,Miconazole,,P35228,"Nitric oxide synthase, inducible",NOS2,inhibitor,A07AC01;J02AB01;D01AC52;G01AF20;A01AB09;D01AC02;S02AA13;G01AF04
DB01110,Miconazole,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,partial agonist,A07AC01;J02AB01;D01AC52;G01AF20;A01AB09;D01AC02;S02AA13;G01AF04
DB01110,Miconazole,,Q12791,Calcium-activated potassium channel,KCNMA1,inhibitor,A07AC01;J02AB01;D01AC52;G01AF20;A01AB09;D01AC02;S02AA13;G01AF04
DB01110,Miconazole,,Q09470,Voltage-gated Potassium Channels,KCNA1,inhibitor,A07AC01;J02AB01;D01AC52;G01AF20;A01AB09;D01AC02;S02AA13;G01AF04
DB01110,Miconazole,,Q14500,Inward rectifier potassium channel,KCNJ12,inhibitor,A07AC01;J02AB01;D01AC52;G01AF20;A01AB09;D01AC02;S02AA13;G01AF04
DB01110,Miconazole,,Q13936,Voltage gated L-type calcium channel,CACNA1C,inhibitor,A07AC01;J02AB01;D01AC52;G01AF20;A01AB09;D01AC02;S02AA13;G01AF04
DB01111,Colistimethate,,,Bacterial outer membrane,,incorporation into and destabilization,
DB01112,Cefuroxime,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,S01AA27;J01DC02;J01RA03
DB01113,Papaverine,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,G04BE02;A03AD01;G04BE52
DB01113,Papaverine,,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,inhibitor,G04BE02;A03AD01;G04BE52
DB01113,Papaverine,,Q01064,Phosphodiesterase enzymes,PDE1B,inhibitor,G04BE02;A03AD01;G04BE52
DB01114,Chlorpheniramine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AB54;R06AB04
DB01114,Chlorpheniramine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,R06AB54;R06AB04
DB01114,Chlorpheniramine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,R06AB54;R06AB04
DB01114,Chlorpheniramine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,R06AB54;R06AB04
DB01115,Nifedipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C08CA55;C08GA01;C08CA05;C07FB03
DB01115,Nifedipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,C08CA55;C08GA01;C08CA05;C07FB03
DB01115,Nifedipine,,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,inhibitor,C08CA55;C08GA01;C08CA05;C07FB03
DB01115,Nifedipine,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,agonist,C08CA55;C08GA01;C08CA05;C07FB03
DB01115,Nifedipine,,P0DP23,Calmodulin,CALM1,inhibitor,C08CA55;C08GA01;C08CA05;C07FB03
DB01115,Nifedipine,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,C08CA55;C08GA01;C08CA05;C07FB03
DB01115,Nifedipine,,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,inhibitor,C08CA55;C08GA01;C08CA05;C07FB03
DB01115,Nifedipine,,O43497,Voltage-dependent T-type calcium channel,CACNA1G,inhibitor,C08CA55;C08GA01;C08CA05;C07FB03
DB01116,Trimethaphan,,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,antagonist,C02BA01
DB01117,Atovaquone,,Q02768,Cytochrome b,MT-CYB,inhibitor,P01AX06;P01BB51
DB01117,Atovaquone,,Q08210,"Dihydroorotate dehydrogenase (quinone), mitochondrial",,inhibitor,P01AX06;P01BB51
DB01117,Atovaquone,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,inhibitor,P01AX06;P01BB51
DB01118,Amiodarone,,Q12809,HERG human cardiac K+ channel,KCNH2,inhibitor,C01BD01
DB01118,Amiodarone,,P08588,Beta adrenergic receptor,ADRB1,inhibitor,C01BD01
DB01118,Amiodarone,,P08588,Beta adrenergic receptor,ADRB1,downregulator,C01BD01
DB01118,Amiodarone,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,inhibitor,C01BD01
DB01118,Amiodarone,,Q13936,Voltage gated L-type calcium channel,CACNA1C,inhibitor,C01BD01
DB01118,Amiodarone,,P10827,Thyroid hormone receptor,THRA,antagonist,C01BD01
DB01118,Amiodarone,,P10827,Thyroid hormone receptor,THRA,binder,C01BD01
DB01118,Amiodarone,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,C01BD01
DB01118,Amiodarone,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,C01BD01
DB01118,Amiodarone,,Q86YN6,Peroxisome proliferator-activated receptor gamma coactivator 1-beta,PPARGC1B,agonist,C01BD01
DB01119,Diazoxide,,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,inducer,G01AE10;C02DA01;V03AH01
DB01119,Diazoxide,,P25705,Mitochondrial ATP synthase F1 domain,ATP5A1,inhibitor,G01AE10;C02DA01;V03AH01
DB01120,Gliclazide,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,binder,A10BB09;G01AE10
DB01120,Gliclazide,,P15692,Vascular endothelial growth factor A,VEGFA,other/unknown,A10BB09;G01AE10
DB01121,Phenacemide,,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,inhibitor,N03AX07
DB01122,Ambenonium,,P22303,Acetylcholinesterase,ACHE,inhibitor,N07AA30
DB01123,Proflavine,,,DNA,,intercalation,
DB01123,Proflavine,,P00734,Prothrombin,F2,other/unknown,
DB01123,Proflavine,,P0A0N4,HTH-type transcriptional regulator QacR,qacR,,
DB01123,Proflavine,,Q58L87,TetR family transcriptional repressor LfrR,lfrR,,
DB01124,Tolbutamide,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,inhibitor,V04CA01;A10BB03;G01AE10
DB01124,Tolbutamide,,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,inhibitor,V04CA01;A10BB03;G01AE10
DB01125,Anisindione,,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,inhibitor,
DB01126,Dutasteride,,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,inhibitor,G04CB02;G04CA52
DB01126,Dutasteride,,P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,SRD5A2,inhibitor,G04CB02;G04CA52
DB01127,Econazole,,P10613,Cytochrome P450 51,ERG11,antagonist,G01AF05;D01AC03;G01AF20;G01AF55
DB01127,Econazole,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,partial agonist,G01AF05;D01AC03;G01AF20;G01AF55
DB01128,Bicalutamide,,P10275,Androgen receptor,AR,antagonist,L02BB03;L02AE51
DB01129,Rabeprazole,,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,inhibitor,A02BD12;A02BD13;A02BC54;M01AA05;A02BC04;M02AA03
DB01130,Prednicarbate,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AC18
DB01131,Proguanil,,P00374,Dihydrofolate reductase,DHFR,inhibitor,P01BB01;P01BB51;P01BB52
DB01131,Proguanil,,P13922,Bifunctional dihydrofolate reductase-thymidylate synthase,,inhibitor,P01BB01;P01BB51;P01BB52
DB01132,Pioglitazone,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,A10BD09;A10BG03;A10BD05;A10BD06;A10BD12
DB01132,Pioglitazone,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,A10BD09;A10BG03;A10BD05;A10BD06;A10BD12
DB01133,Tiludronic acid,,,Hydroxylapatite,,antagonist,M05BA05
DB01133,Tiludronic acid,,,Hydroxylapatite,,binder,M05BA05
DB01133,Tiludronic acid,,,Adenosine triphosphate (ATP),,inhibitor,M05BA05
DB01133,Tiludronic acid,,Q05209,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,inhibitor,M05BA05
DB01133,Tiludronic acid,,P29350,Tyrosine-protein phosphatase non-receptor type 6,PTPN6,inhibitor,M05BA05
DB01133,Tiludronic acid,,P23469,Receptor-type tyrosine-protein phosphatase epsilon,PTPRE,inhibitor,M05BA05
DB01133,Tiludronic acid,,Q93050,V-ATPase Subunits,ATP6V0A1,inhibitor,M05BA05
DB01134,Desoxycorticosterone pivalate,,P08235,Mineralocorticoid receptor,NR3C2,agonist,
DB01135,Doxacurium,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,M03AC07
DB01135,Doxacurium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,M03AC07
DB01136,Carvedilol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07AG02;C07FX06
DB01136,Carvedilol,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C07AG02;C07FX06
DB01136,Carvedilol,,P35348,Alpha-1A adrenergic receptor,ADRA1A,potentiator,C07AG02;C07FX06
DB01136,Carvedilol,,P35348,Alpha-1 adrenergic receptors,ADRA1A,inhibitor,C07AG02;C07FX06
DB01136,Carvedilol,,O95298,NADH dehydrogenase [ubiquinone] 1 subunit C2,NDUFC2,inhibitor,C07AG02;C07FX06
DB01136,Carvedilol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07AG02;C07FX06
DB01136,Carvedilol,,P15692,Vascular endothelial growth factor A,VEGFA,other,C07AG02;C07FX06
DB01136,Carvedilol,,P16860,Natriuretic peptides B,NPPB,other,C07AG02;C07FX06
DB01136,Carvedilol,,P17302,Gap junction alpha-1 protein,GJA1,other,C07AG02;C07FX06
DB01136,Carvedilol,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C07AG02;C07FX06
DB01136,Carvedilol,,P19320,Vascular cell adhesion protein 1,VCAM1,inhibitor,C07AG02;C07FX06
DB01136,Carvedilol,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,C07AG02;C07FX06
DB01136,Carvedilol,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,C07AG02;C07FX06
DB01136,Carvedilol,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,C07AG02;C07FX06
DB01136,Carvedilol,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,C07AG02;C07FX06
DB01136,Carvedilol,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,C07AG02;C07FX06
DB01136,Carvedilol,,P16581,E-selectin,SELE,inhibitor,C07AG02;C07FX06
DB01136,Carvedilol,,Q16665,Hypoxia-inducible factor 1-alpha,HIF1A,modulator,C07AG02;C07FX06
DB01136,Carvedilol,,P48050,Inward rectifier potassium channel 4,KCNJ4,inhibitor,C07AG02;C07FX06
DB01136,Carvedilol,,P63252,Inward rectifier potassium channel 2,KCNJ2,inhibitor,C07AG02;C07FX06
DB01137,Levofloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MA12;A02BD10;J01RA05;S01AE05
DB01137,Levofloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA12;A02BD10;J01RA05;S01AE05
DB01138,Sulfinpyrazone,,Q96S37,Solute carrier family 22 member 12,SLC22A12,inhibitor,M04AB02
DB01138,Sulfinpyrazone,,P33527,Multidrug resistance-associated protein 1,ABCC1,inhibitor,M04AB02
DB01138,Sulfinpyrazone,,Q92887,Canalicular multispecific organic anion transporter 1,ABCC2,inhibitor,M04AB02
DB01138,Sulfinpyrazone,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,M04AB02
DB01139,Cefapirin,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01DB08
DB01140,Cefadroxil,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01DB05
DB01140,Cefadroxil,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01DB05
DB01140,Cefadroxil,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01DB05
DB01140,Cefadroxil,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01DB05
DB01141,Micafungin,,A2QLK4,"1,3-beta-glucan synthase component FKS1",fksA,inhibitor,J02AX05
DB01142,Doxepin,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P25021,Histamine H2 receptor,HRH2,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA12;D04AX01
DB01142,Doxepin,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA12;D04AX01
DB01142,Doxepin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N06AA12;D04AX01
DB01142,Doxepin,,P50406,5-hydroxytryptamine receptor 6,HTR6,binder,N06AA12;D04AX01
DB01142,Doxepin,,Q9H3N8,Histamine H4 receptor,HRH4,binder,N06AA12;D04AX01
DB01142,Doxepin,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,N06AA12;D04AX01
DB01143,Amifostine,,P10696,"Alkaline phosphatase, germ cell type",ALPPL2,inducer,V03AF05
DB01144,Diclofenamide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,G01AE10;S01EC02
DB01144,Diclofenamide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,G01AE10;S01EC02
DB01144,Diclofenamide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,G01AE10;S01EC02
DB01144,Diclofenamide,,P43166,Carbonic anhydrase 7,CA7,inhibitor,G01AE10;S01EC02
DB01144,Diclofenamide,,P07451,Carbonic anhydrase 3,CA3,inhibitor,G01AE10;S01EC02
DB01145,Sulfoxone,,Q27738,Dihydropteroate synthetase,,inhibitor,J04BA03
DB01146,Diphenylpyraline,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AA57;R06AA07
DB01146,Diphenylpyraline,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,R06AA57;R06AA07
DB01147,Cloxacillin,,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,dacA,inhibitor,J01CR50;J01CF02
DB01147,Cloxacillin,,P59676,Penicillin-binding protein 2X,pbpX,inhibitor,J01CR50;J01CF02
DB01147,Cloxacillin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CF02
DB01148,Flavoxate,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,G04BD02
DB01148,Flavoxate,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,G04BD02
DB01149,Nefazodone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AX06
DB01149,Nefazodone,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AX06
DB01149,Nefazodone,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX06
DB01149,Nefazodone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N06AX06
DB01149,Nefazodone,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AX06
DB01149,Nefazodone,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06AX06
DB01149,Nefazodone,,P35368,Alpha-1B adrenergic receptor,ADRA1B,other/unknown,N06AX06
DB01149,Nefazodone,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N06AX06
DB01149,Nefazodone,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N06AX06
DB01149,Nefazodone,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,antagonist,N06AX06
DB01150,Cefprozil,,Q04707,Penicillin-binding protein 1A,ponA,inhibitor,J01DC10
DB01150,Cefprozil,,P14677,Penicillin-binding protein 2x,pbpX,inhibitor,J01DC10
DB01150,Cefprozil,,P0A3M5,Penicillin-binding protein 2B,penA,inhibitor,J01DC10
DB01151,Desipramine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA01
DB01151,Desipramine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA01
DB01151,Desipramine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AA01
DB01151,Desipramine,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,N06AA01
DB01151,Desipramine,,P08588,Beta-1 adrenergic receptor,ADRB1,other,N06AA01
DB01151,Desipramine,,P17405,Sphingomyelin phosphodiesterase,SMPD1,inhibitor,N06AA01
DB01151,Desipramine,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AA01
DB01151,Desipramine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N06AA01
DB01151,Desipramine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N06AA01
DB01151,Desipramine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N06AA01
DB01151,Desipramine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N06AA01
DB01151,Desipramine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N06AA01
DB01151,Desipramine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N06AA01
DB01151,Desipramine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,binder,N06AA01
DB01151,Desipramine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,binder,N06AA01
DB01151,Desipramine,,P14416,Dopamine D2 receptor,DRD2,binder,N06AA01
DB01151,Desipramine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,binder,N06AA01
DB01152,Candicidin,,,Ergosterol,,antagonist,G01AA04
DB01153,Sertaconazole,,P10613,Cytochrome P450 51,ERG11,inhibitor,G01AF19;G01AF20;D01AC14
DB01154,Thiamylal,,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,inhibitor,N05CB01
DB01154,Thiamylal,,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,inhibitor,N05CB01
DB01154,Thiamylal,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,N05CB01
DB01155,Gemifloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MA15
DB01155,Gemifloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA15
DB01156,Bupropion,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,A08AA62;N06AX12
DB01156,Bupropion,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,A08AA62;N06AX12
DB01156,Bupropion,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,antagonist,A08AA62;N06AX12
DB01156,Bupropion,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,negative modulator,A08AA62;N06AX12
DB01157,Trimetrexate,,P00374,Dihydrofolate reductase,DHFR,inhibitor,P01AX07
DB01158,Bretylium,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,inhibitor,C01BD02
DB01159,Halothane,,O14649,Potassium channel subfamily K member 3,KCNK3,binder,N01AB01
DB01159,Halothane,,Q9NPC2,Potassium channel subfamily K member 9,KCNK9,binder,N01AB01
DB01159,Halothane,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N01AB01
DB01159,Halothane,,P20020,Plasma membrane calcium-transporting ATPase,ATP2B1,inhibitor,N01AB01
DB01159,Halothane,,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,inhibitor,N01AB01
DB01159,Halothane,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,antagonist,N01AB01
DB01159,Halothane,,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,antagonist,N01AB01
DB01159,Halothane,,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,antagonist,N01AB01
DB01159,Halothane,,P23415,Glycine receptor subunit alpha-1,GLRA1,allosteric modulator,N01AB01
DB01159,Halothane,,P08100,Rhodopsin,RHO,other,N01AB01
DB01159,Halothane,,P48051,G protein-activated inward rectifier potassium channel 2,KCNJ6,inhibitor,N01AB01
DB01159,Halothane,,P48549,G protein-activated inward rectifier potassium channel 1,KCNJ3,inhibitor,N01AB01
DB01159,Halothane,,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,inhibitor,N01AB01
DB01159,Halothane,,O15554,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,inhibitor,N01AB01
DB01159,Halothane,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,other/unknown,N01AB01
DB01159,Halothane,,P59768,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2,GNG2,other/unknown,N01AB01
DB01159,Halothane,,Q6W5P4,Neuropeptide S receptor,NPSR1,other/unknown,N01AB01
DB01160,Dinoprost tromethamine,,P43088,Prostaglandin F2-alpha receptor,PTGFR,agonist,
DB01160,Dinoprost tromethamine,,P43119,Prostacyclin receptor,PTGIR,antagonist,
DB01161,Chloroprocaine,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,inhibitor,N01BA04
DB01161,Chloroprocaine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N01BA04
DB01162,Terazosin,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,G04CA03
DB01162,Terazosin,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,G04CA03
DB01162,Terazosin,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,G04CA03
DB01162,Terazosin,,P01137,Transforming growth factor beta-1,TGFB1,inducer,G04CA03
DB01162,Terazosin,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,G04CA03
DB01162,Terazosin,,Q9H252,Potassium voltage-gated channel subfamily H member 6,KCNH6,inhibitor,G04CA03
DB01162,Terazosin,,Q9NS40,Potassium voltage-gated channel subfamily H member 7,KCNH7,inhibitor,G04CA03
DB01163,Amdinocillin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01CA11
DB01163,Amdinocillin,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01CA11
DB01163,Amdinocillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CA11
DB01163,Amdinocillin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01CA11
DB01163,Amdinocillin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01CA11
DB01163,Amdinocillin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01CA11
DB01164,Calcium chloride,,Q99584,Protein S100-A13,S100A13,,A12AA07;A11GB01;G04BA03;B05XA07
DB01165,Ofloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MA01;J01RA09;S01AE01;S02AA16
DB01165,Ofloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA01;J01RA09;S01AE01;S02AA16
DB01165,Ofloxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,J01MA01;J01RA09;S01AE01;S02AA16
DB01166,Cilostazol,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,B01AC23
DB01167,Itraconazole,,P14263,Lanosterol 14-alpha demethylase,ERG11,inhibitor,J02AC02
DB01168,Procarbazine,,P21397,Monoamine oxidase,MAOA,inhibitor,L01XB01
DB01168,Procarbazine,,,DNA,,cross-linking/alkylation,L01XB01
DB01169,Arsenic trioxide,,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,inducer,L01XX27
DB01169,Arsenic trioxide,,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,inhibitor,L01XX27
DB01169,Arsenic trioxide,,P05412,Transcription factor AP-1,JUN,inducer,L01XX27
DB01169,Arsenic trioxide,,P24385,G1/S-specific cyclin-D1,CCND1,antagonist,L01XX27
DB01169,Arsenic trioxide,,P27361,Mitogen-activated protein kinase 3,MAPK3,inducer,L01XX27
DB01169,Arsenic trioxide,,P28482,Mitogen-activated protein kinase 1,MAPK1,inducer,L01XX27
DB01169,Arsenic trioxide,,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,inducer,L01XX27
DB01169,Arsenic trioxide,,P38936,Cyclin-dependent kinase inhibitor 1,CDKN1A,,L01XX27
DB01169,Arsenic trioxide,,Q13547,Histone deacetylase 1,HDAC1,,L01XX27
DB01169,Arsenic trioxide,,P29590,Protein PML,PML,,L01XX27
DB01170,Guanethidine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inducer,S01EX01;C02CC02;C02LF01
DB01171,Moclobemide,,P21397,Amine oxidase [flavin-containing] A,MAOA,antagonist,N06AG02
DB01171,Moclobemide,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,N06AG02
DB01171,Moclobemide,,P21397,Monoamine oxidase,MAOA,antagonist,N06AG02
DB01171,Moclobemide,,P27338,Amine oxidase [flavin-containing] B,MAOB,antagonist,N06AG02
DB01172,Kanamycin,,P0A7S3,30S ribosomal protein S12,rpsL,inhibitor,S01AA24;J01GB04;A07AA08
DB01172,Kanamycin,,,16S ribosomal RNA,,inhibitor,S01AA24;J01GB04;A07AA08
DB01173,Orphenadrine,,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,antagonist,M03BC51;N04AB02;M03BC01
DB01173,Orphenadrine,,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,antagonist,M03BC51;N04AB02;M03BC01
DB01173,Orphenadrine,,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,antagonist,M03BC51;N04AB02;M03BC01
DB01173,Orphenadrine,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,antagonist,M03BC51;N04AB02;M03BC01
DB01173,Orphenadrine,,P35367,Histamine H1 receptor,HRH1,antagonist,M03BC51;N04AB02;M03BC01
DB01173,Orphenadrine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,M03BC51;N04AB02;M03BC01
DB01173,Orphenadrine,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,inhibitor,M03BC51;N04AB02;M03BC01
DB01174,Phenobarbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CB01;N03AA02
DB01174,Phenobarbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CB01;N03AA02
DB01174,Phenobarbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CB01;N03AA02
DB01174,Phenobarbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CB01;N03AA02
DB01174,Phenobarbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CB01;N03AA02
DB01174,Phenobarbital,,Q05586,NMDA receptor,GRIN1,antagonist,N05CB01;N03AA02
DB01174,Phenobarbital,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,N05CB01;N03AA02
DB01175,Escitalopram,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AB10
DB01175,Escitalopram,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,inhibitor,N06AB10
DB01175,Escitalopram,,P35367,Histamine H1 receptor,HRH1,inhibitor,N06AB10
DB01175,Escitalopram,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,inhibitor,N06AB10
DB01175,Escitalopram,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,inhibitor,N06AB10
DB01175,Escitalopram,,P35348,Alpha-1 adrenergic receptors,ADRA1A,inhibitor,N06AB10
DB01175,Escitalopram,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,inhibitor,N06AB10
DB01175,Escitalopram,,P08913,Alpha-2 adrenergic receptors,ADRA2A,inhibitor,N06AB10
DB01175,Escitalopram,,P14416,Dopamine D2 receptor,DRD2,inhibitor,N06AB10
DB01175,Escitalopram,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AB10
DB01175,Escitalopram,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06AB10
DB01176,Cyclizine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AE03;R06AE53
DB01176,Cyclizine,,P49888,Estrogen sulfotransferase,SULT1E1,inhibitor,R06AE03;R06AE53
DB01177,Idarubicin,,,DNA,,intercalation,L01DB06
DB01177,Idarubicin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,L01DB06
DB01178,Chlormezanone,,P30536,Translocator protein,TSPO,agonist,M03BB02;M03BB72;M03BB52
DB01179,Podofilox,,P68366,Tubulin alpha-4A chain,TUBA4A,inhibitor,D06BB04
DB01179,Podofilox,,P07437,Tubulin beta chain,TUBB,inhibitor,D06BB04
DB01179,Podofilox,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,D06BB04
DB01180,Rescinnamine,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C02LA52;C02LA02;C02AA01
DB01181,Ifosfamide,,,DNA,,other/unknown,L01AA06
DB01181,Ifosfamide,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,L01AA06
DB01182,Propafenone,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BC03
DB01182,Propafenone,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C01BC03
DB01182,Propafenone,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C01BC03
DB01182,Propafenone,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C01BC03
DB01183,Naloxone,,P35372,Mu-type opioid receptor,OPRM1,antagonist,A06AH04;N02AA53;V03AB15;N02AA55;N02AX51
DB01183,Naloxone,,P41143,Delta-type opioid receptor,OPRD1,antagonist,A06AH04;N02AA53;V03AB15;N02AA55;N02AX51
DB01183,Naloxone,,P41145,Kappa-type opioid receptor,OPRK1,antagonist,A06AH04;N02AA53;V03AB15;N02AA55;N02AX51
DB01183,Naloxone,,P16220,Cyclic AMP-responsive element-binding protein 1,CREB1,other/unknown,A06AH04;N02AA53;V03AB15;N02AA55;N02AX51
DB01183,Naloxone,,P03372,Estrogen receptor alpha,ESR1,antagonist,A06AH04;N02AA53;V03AB15;N02AA55;N02AX51
DB01183,Naloxone,,P03372,Estrogen receptor alpha,ESR1,other/unknown,A06AH04;N02AA53;V03AB15;N02AA55;N02AX51
DB01183,Naloxone,,O00206,Toll-like receptor 4,TLR4,inhibitor,A06AH04;N02AA53;V03AB15;N02AA55;N02AX51
DB01183,Naloxone,,P23141,Liver carboxylesterase 1,CES1,binder,A06AH04;N02AA53;V03AB15;N02AA55;N02AX51
DB01184,Domperidone,,P35462,Dopamine D3 receptor,DRD3,antagonist,A03FA03
DB01184,Domperidone,,P14416,Dopamine D2 receptor,DRD2,antagonist,A03FA03
DB01185,Fluoxymesterone,,P10275,Androgen receptor,AR,agonist,G03BA01
DB01185,Fluoxymesterone,,P03372,Estrogen receptor alpha,ESR1,antagonist,G03BA01
DB01185,Fluoxymesterone,,P04150,Glucocorticoid receptor,NR3C1,antagonist,G03BA01
DB01185,Fluoxymesterone,,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,inhibitor,G03BA01
DB01186,Pergolide,,P14416,Dopamine D2 receptor,DRD2,agonist,N04BC02
DB01186,Pergolide,,P35462,Dopamine D3 receptor,DRD3,agonist,N04BC02
DB01186,Pergolide,,P21917,Dopamine D4 receptor,DRD4,agonist,N04BC02
DB01186,Pergolide,,P21918,Dopamine D5 receptor,DRD5,agonist,N04BC02
DB01186,Pergolide,,P21728,Dopamine D1 receptor,DRD1,agonist,N04BC02
DB01186,Pergolide,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N04BC02
DB01186,Pergolide,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,agonist,N04BC02
DB01186,Pergolide,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,N04BC02
DB01186,Pergolide,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N04BC02
DB01186,Pergolide,,P08913,Alpha-2 adrenergic receptors,ADRA2A,agonist,N04BC02
DB01186,Pergolide,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N04BC02
DB01186,Pergolide,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,N04BC02
DB01186,Pergolide,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,N04BC02
DB01186,Pergolide,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,N04BC02
DB01186,Pergolide,,P25100,Alpha-1D adrenergic receptor,ADRA1D,agonist,N04BC02
DB01188,Ciclopirox,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,binder,D01AE14;G01AX12
DB01189,Desflurane,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N01AB07
DB01189,Desflurane,,P23415,Glycine receptor subunit alpha-1,GLRA1,agonist,N01AB07
DB01189,Desflurane,,P42261,Glutamate receptor 1,GRIA1,antagonist,N01AB07
DB01189,Desflurane,,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,inducer,N01AB07
DB01189,Desflurane,,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,inhibitor,N01AB07
DB01189,Desflurane,,P98194,Calcium transporting ATPases,ATP2C1,inhibitor,N01AB07
DB01189,Desflurane,,P30049,"ATP synthase subunit delta, mitochondrial",ATP5D,other/unknown,N01AB07
DB01190,Clindamycin,,Q2G0P0,50S ribosomal protein L1,rplA,inhibitor,D10AF01;J01FF01;D10AF51;G01AA10
DB01191,Dexfenfluramine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,A08AA04
DB01191,Dexfenfluramine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,A08AA04
DB01192,Oxymorphone,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AA11
DB01192,Oxymorphone,,P41143,Delta-type opioid receptor,OPRD1,antagonist,N02AA11
DB01193,Acebutolol,,P08588,Beta-1 adrenergic receptor,ADRB1,partial agonist,C07AB04;C07BB04
DB01193,Acebutolol,,P07550,Beta-2 adrenergic receptor,ADRB2,partial agonist,C07AB04;C07BB04
DB01194,Brinzolamide,,P00918,Carbonic anhydrase 2,CA2,inhibitor,S01EC54;S01EC04;G01AE10
DB01194,Brinzolamide,,P00915,Carbonic anhydrase 1,CA1,inhibitor,S01EC54;S01EC04;G01AE10
DB01194,Brinzolamide,,P22748,Carbonic anhydrase 4,CA4,inhibitor,S01EC54;S01EC04;G01AE10
DB01194,Brinzolamide,,P35218,"Carbonic anhydrase 5A, mitochondrial",CA5A,inhibitor,S01EC54;S01EC04;G01AE10
DB01194,Brinzolamide,,P07451,Carbonic anhydrase 3,CA3,inhibitor,S01EC54;S01EC04;G01AE10
DB01195,Flecainide,,P35499,Sodium channel protein type 4 subunit alpha,SCN4A,inhibitor,C01BC04
DB01195,Flecainide,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BC04
DB01195,Flecainide,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C01BC04
DB01195,Flecainide,,Q92736,Ryanodine receptor 2,RYR2,inhibitor,C01BC04
DB01196,Estramustine,,Q92731,Estrogen receptor beta,ESR2,other/unknown,L01XX11
DB01196,Estramustine,,P03372,Estrogen receptor alpha,ESR1,agonist,L01XX11
DB01196,Estramustine,,P11137,Microtubule-associated protein 2,MAP2,antagonist,L01XX11
DB01196,Estramustine,,P78559,Microtubule-associated protein 1A,MAP1A,antagonist,L01XX11
DB01197,Captopril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09AA01;C09BA01
DB01197,Captopril,,P08253,72 kDa type IV collagenase,MMP2,inhibitor,C09AA01;C09BA01
DB01197,Captopril,,P14780,Matrix metalloproteinase-9,MMP9,inhibitor,C09AA01;C09BA01
DB01197,Captopril,,P09960,Leukotriene A-4 hydrolase,LTA4H,inhibitor,C09AA01;C09BA01
DB01197,Captopril,,P46663,B1 bradykinin receptor,BDKRB1,,C09AA01;C09BA01
DB01198,Zopiclone,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CF01
DB01198,Zopiclone,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CF01
DB01198,Zopiclone,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CF01
DB01198,Zopiclone,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CF01
DB01198,Zopiclone,,P30536,Translocator protein,TSPO,agonist,N05CF01
DB01199,Tubocurarine,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,M03AA02
DB01199,Tubocurarine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,M03AA02
DB01199,Tubocurarine,,P22303,Acetylcholinesterase,ACHE,inhibitor,M03AA02
DB01199,Tubocurarine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,M03AA02
DB01200,Bromocriptine,,P14416,Dopamine D2 receptor,DRD2,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P35462,Dopamine D3 receptor,DRD3,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P21917,Dopamine D4 receptor,DRD4,antagonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P21918,Dopamine D5 receptor,DRD5,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P21728,Dopamine D1 receptor,DRD1,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,agonist,N04BC01;G02CB01
DB01200,Bromocriptine,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N04BC01;G02CB01
DB01201,Rifapentine,,P9WGY7,DNA-directed RNA polymerase subunit beta',rpoC,inhibitor,J04AB05
DB01202,Levetiracetam,,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,inhibitor,N03AX14
DB01202,Levetiracetam,,Q7L0J3,Synaptic vesicle glycoprotein 2A,SV2A,agonist,N03AX14
DB01203,Nadolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07BA12;C07AA12
DB01203,Nadolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07BA12;C07AA12
DB01204,Mitoxantrone,,,DNA,,intercalation,L01DB07
DB01204,Mitoxantrone,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,L01DB07
DB01205,Flumazenil,,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,antagonist,V03AB25
DB01205,Flumazenil,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,antagonist,V03AB25
DB01205,Flumazenil,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,V03AB25
DB01205,Flumazenil,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,antagonist,V03AB25
DB01206,Lomustine,,,DNA,,cross-linking/alkylation,L01AD02
DB01206,Lomustine,,Q9H169,Stathmin-4,STMN4,antagonist,L01AD02
DB01207,Ridogrel,,P24557,Thromboxane-A synthase,TBXAS1,inhibitor,
DB01207,Ridogrel,,P21731,Thromboxane A2 receptor,TBXA2R,antagonist,
DB01208,Sparfloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MA09
DB01208,Sparfloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA09
DB01208,Sparfloxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,J01MA09
DB01209,Dezocine,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AX03
DB01209,Dezocine,,P41145,Kappa-type opioid receptor,OPRK1,antagonist,N02AX03
DB01210,Levobunolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,S01ED03
DB01210,Levobunolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,S01ED03
DB01211,Clarithromycin,,P0A7J6,50S ribosomal protein L10,rplJ,inhibitor,A02BD12;A02BD14;A02BD07;A02BD04;A02BD09;A02BD05;J01FA09;A02BD06;A02BD11
DB01211,Clarithromycin,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,,A02BD12;A02BD14;A02BD07;A02BD04;A02BD09;A02BD05;J01FA09;A02BD06;A02BD11
DB01211,Clarithromycin,,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,SLCO1B1,,A02BD12;A02BD14;A02BD07;A02BD04;A02BD09;A02BD05;J01FA09;A02BD06;A02BD11
DB01211,Clarithromycin,,Q9NPD5,Solute carrier organic anion transporter family member 1B3,SLCO1B3,,A02BD12;A02BD14;A02BD07;A02BD04;A02BD09;A02BD05;J01FA09;A02BD06;A02BD11
DB01212,Ceftriaxone,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01DD04;J01DD54
DB01212,Ceftriaxone,,Q9NSA0,Solute carrier family 22 member 11,SLC22A11,,J01DD04;J01DD54
DB01212,Ceftriaxone,,Q4U2R8,Solute carrier family 22 member 6,SLC22A6,,J01DD04;J01DD54
DB01212,Ceftriaxone,,Q8TCC7,Solute carrier family 22 member 8,SLC22A8,,J01DD04;J01DD54
DB01212,Ceftriaxone,,P46059,Solute carrier family 15 member 1,SLC15A1,,J01DD04;J01DD54
DB01213,Fomepizole,,P07327,Alcohol dehydrogenase 1A,ADH1A,inhibitor,V03AB34
DB01213,Fomepizole,,P00325,Alcohol dehydrogenase 1B,ADH1B,inhibitor,V03AB34
DB01213,Fomepizole,,P00326,Alcohol dehydrogenase 1C,ADH1C,inhibitor,V03AB34
DB01213,Fomepizole,,P04040,Catalase,CAT,inhibitor,V03AB34
DB01214,Metipranolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,S01ED54;C07BA68;S01ED04
DB01214,Metipranolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,S01ED54;C07BA68;S01ED04
DB01215,Estazolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD04
DB01215,Estazolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD04
DB01216,Finasteride,,P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,SRD5A2,inhibitor,D11AX10;G04CA55;G04CA51;G04CB51;G04CB01
DB01216,Finasteride,,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,inhibitor,D11AX10;G04CA55;G04CA51;G04CB51;G04CB01
DB01216,Finasteride,,P51857,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,inhibitor,D11AX10;G04CA55;G04CA51;G04CB51;G04CB01
DB01217,Anastrozole,,P11511,Cytochrome P450 19A1,CYP19A1,inhibitor,L02BG03
DB01218,Halofantrine,,,Fe(II)-protoporphyrin IX,,antagonist,P01BX01
DB01218,Halofantrine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,P01BX01
DB01218,Halofantrine,,P46925,Plasmepsin-2,,inhibitor,P01BX01
DB01219,Dantrolene,,P21817,Ryanodine receptor 1,RYR1,antagonist,M03CA01
DB01220,Rifaximin,,P0A8V2,DNA-directed RNA polymerase subunit beta,rpoB,inhibitor,A07AA11;D06AX11
DB01220,Rifaximin,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,agonist,A07AA11;D06AX11
DB01221,Ketamine,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,antagonist,N01AX03
DB01221,Ketamine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,potentiator,N01AX03
DB01221,Ketamine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N01AX03
DB01221,Ketamine,,P06276,Cholinesterase,BCHE,inhibitor,N01AX03
DB01221,Ketamine,,P29475,"Nitric oxide synthase, brain",NOS1,inhibitor,N01AX03
DB01221,Ketamine,,P25103,Neurokinin 1 receptor,TACR1,antagonist,N01AX03
DB01221,Ketamine,,P14416,Dopamine D2 receptor,DRD2,agonist,N01AX03
DB01221,Ketamine,,P14416,Dopamine D2 receptor,DRD2,partial agonist,N01AX03
DB01221,Ketamine,,P41143,Delta-type opioid receptor,OPRD1,binder,N01AX03
DB01221,Ketamine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N01AX03
DB01221,Ketamine,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N01AX03
DB01221,Ketamine,,P35372,Mu-type opioid receptor,OPRM1,binder,N01AX03
DB01221,Ketamine,,P11229,Muscarinic acetylcholine receptor,CHRM1,binder,N01AX03
DB01221,Ketamine,,P28223,5-hydroxytryptamine receptor 2,HTR2A,antagonist,N01AX03
DB01221,Ketamine,,P08908,5-hydroxytryptamine receptor 1,HTR1A,antagonist,N01AX03
DB01222,Budesonide,,P04150,Glucocorticoid receptor,NR3C1,agonist,R03AL11;D07AC09;R01AD05;R03AK07;A07EA06;R03BA02;R03AK12
DB01222,Budesonide,,P04083,Annexin A1,ANXA1,substrate,R03AL11;D07AC09;R01AD05;R03AK07;A07EA06;R03BA02;R03AK12
DB01223,Aminophylline,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,R03DA55;R03DA05;R03DA20;R03DB05
DB01223,Aminophylline,,P30542,Adenosine receptor A1,ADORA1,antagonist,R03DA55;R03DA05;R03DA20;R03DB05
DB01223,Aminophylline,,P0DMS8,Adenosine receptor A3,ADORA3,antagonist,R03DA55;R03DA05;R03DA20;R03DB05
DB01223,Aminophylline,,Q92769,Histone deacetylase 2,HDAC2,activator,R03DA55;R03DA05;R03DA20;R03DB05
DB01224,Quetiapine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AH04
DB01224,Quetiapine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AH04
DB01224,Quetiapine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AH04
DB01224,Quetiapine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,N05AH04
DB01224,Quetiapine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,ligand,N05AH04
DB01224,Quetiapine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,ligand,N05AH04
DB01224,Quetiapine,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,ligand,N05AH04
DB01224,Quetiapine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,ligand,N05AH04
DB01224,Quetiapine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,ligand,N05AH04
DB01224,Quetiapine,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N05AH04
DB01224,Quetiapine,,P34969,5-hydroxytryptamine receptor 7,HTR7,ligand,N05AH04
DB01224,Quetiapine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AH04
DB01224,Quetiapine,,P21918,Dopamine D5 receptor,DRD5,ligand,N05AH04
DB01224,Quetiapine,,P35462,Dopamine D3 receptor,DRD3,ligand,N05AH04
DB01224,Quetiapine,,P21917,Dopamine D4 receptor,DRD4,ligand,N05AH04
DB01224,Quetiapine,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AH04
DB01224,Quetiapine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N05AH04
DB01224,Quetiapine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N05AH04
DB01224,Quetiapine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N05AH04
DB01224,Quetiapine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N05AH04
DB01224,Quetiapine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05AH04
DB01224,Quetiapine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,ligand,N05AH04
DB01224,Quetiapine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N05AH04
DB01224,Quetiapine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,ligand,N05AH04
DB01224,Quetiapine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,ligand,N05AH04
DB01225,Enoxaparin,,P01008,Antithrombin-III,SERPINC1,potentiator,B01AB05
DB01225,Enoxaparin,,P00742,Coagulation factor X,F10,inhibitor,B01AB05
DB01225,Enoxaparin,,P00734,Prothrombin,F2,inhibitor,B01AB05
DB01226,Mivacurium,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,M03AC10
DB01226,Mivacurium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,M03AC10
DB01226,Mivacurium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,partial agonist,M03AC10
DB01226,Mivacurium,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,M03AC10
DB01226,Mivacurium,,P06276,Cholinesterase,BCHE,,M03AC10
DB01227,Levacetylmethadol,,P35372,Mu-type opioid receptor,OPRM1,agonist,N07BC03
DB01227,Levacetylmethadol,,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,other/unknown,N07BC03
DB01227,Levacetylmethadol,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,antagonist,N07BC03
DB01228,Encainide,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BC08
DB01229,Paclitaxel,,Q9H4B7,Tubulin beta-1 chain,TUBB1,inhibitor,L01CD01;L01CD51
DB01229,Paclitaxel,,P10415,Apoptosis regulator Bcl-2,BCL2,inhibitor,L01CD01;L01CD51
DB01229,Paclitaxel,,P27816,Microtubule-associated protein 4,MAP4,,L01CD01;L01CD51
DB01229,Paclitaxel,,P11137,Microtubule-associated protein 2,MAP2,,L01CD01;L01CD51
DB01229,Paclitaxel,,P10636,Microtubule-associated protein tau,MAPT,,L01CD01;L01CD51
DB01229,Paclitaxel,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,inducer,L01CD01;L01CD51
DB01231,Diphenidol,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,
DB01231,Diphenidol,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,
DB01231,Diphenidol,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,
DB01232,Saquinavir,,Q72874,Human immunodeficiency virus type 1 protease,pol,inhibitor,J05AE01
DB01233,Metoclopramide,,Q13639,5-hydroxytryptamine receptor 4,HTR4,agonist,A03FA01
DB01233,Metoclopramide,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,A03FA01
DB01233,Metoclopramide,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,agonist,A03FA01
DB01233,Metoclopramide,,P14416,Dopamine D2 receptor,DRD2,antagonist,A03FA01
DB01234,Dexamethasone,,P04150,Glucocorticoid receptor,NR3C1,agonist,R01AD53;D07XB05;R01AD03;D10AA03;S01CB01;S02CA06;S03CA01;C05AA09;S01CA01;D07CB04;H02AB02;S01BA01;A01AC02;S03BA01;D07AB19;S02BA06
DB01234,Dexamethasone,,P51843,Nuclear receptor subfamily 0 group B member 1,NR0B1,stimulator,R01AD53;D07XB05;R01AD03;D10AA03;S01CB01;S02CA06;S03CA01;C05AA09;S01CA01;D07CB04;H02AB02;S01BA01;A01AC02;S03BA01;D07AB19;S02BA06
DB01234,Dexamethasone,,P04083,Annexin A1,ANXA1,agonist,R01AD53;D07XB05;R01AD03;D10AA03;S01CB01;S02CA06;S03CA01;C05AA09;S01CA01;D07CB04;H02AB02;S01BA01;A01AC02;S03BA01;D07AB19;S02BA06
DB01234,Dexamethasone,,P35228,"Nitric oxide synthase, inducible",NOS2,negative modulator,R01AD53;D07XB05;R01AD03;D10AA03;S01CB01;S02CA06;S03CA01;C05AA09;S01CA01;D07CB04;H02AB02;S01BA01;A01AC02;S03BA01;D07AB19;S02BA06
DB01234,Dexamethasone,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,agonist,R01AD53;D07XB05;R01AD03;D10AA03;S01CB01;S02CA06;S03CA01;C05AA09;S01CA01;D07CB04;H02AB02;S01BA01;A01AC02;S03BA01;D07AB19;S02BA06
DB01235,Levodopa,,P21728,Dopamine D1 receptor,DRD1,agonist,N04BA03;N04BA01;N04BA02
DB01235,Levodopa,,P21918,Dopamine D5 receptor,DRD5,agonist,N04BA03;N04BA01;N04BA02
DB01235,Levodopa,,P14416,Dopamine D2 receptor,DRD2,agonist,N04BA03;N04BA01;N04BA02
DB01235,Levodopa,,P35462,Dopamine D3 receptor,DRD3,agonist,N04BA03;N04BA01;N04BA02
DB01235,Levodopa,,P21917,Dopamine D4 receptor,DRD4,agonist,N04BA03;N04BA01;N04BA02
DB01236,Sevoflurane,,P14867,GABA(A) Receptor,GABRA1,agonist,N01AB08
DB01236,Sevoflurane,,P23415,Glycine receptor subunit alpha-1,GLRA1,agonist,N01AB08
DB01236,Sevoflurane,,P42261,Glutamate receptor 1,GRIA1,antagonist,N01AB08
DB01236,Sevoflurane,,P98194,Calcium transporting ATPases,ATP2C1,inhibitor,N01AB08
DB01236,Sevoflurane,,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,inhibitor,N01AB08
DB01236,Sevoflurane,,Q96ER9,Mitochondrial potassium channel,CCDC51,activator,N01AB08
DB01237,Bromodiphenhydramine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AA01
DB01238,Aripiprazole,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AX12
DB01238,Aripiprazole,,P14416,Dopamine D2 receptor,DRD2,partial agonist,N05AX12
DB01238,Aripiprazole,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AX12
DB01238,Aripiprazole,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,N05AX12
DB01238,Aripiprazole,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AX12
DB01238,Aripiprazole,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AX12
DB01238,Aripiprazole,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AX12
DB01238,Aripiprazole,,P35462,Dopamine D3 receptor,DRD3,partial agonist,N05AX12
DB01238,Aripiprazole,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,antagonist,N05AX12
DB01238,Aripiprazole,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,ligand,N05AX12
DB01238,Aripiprazole,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N05AX12
DB01238,Aripiprazole,,P34969,5-hydroxytryptamine receptor 7,HTR7,partial agonist,N05AX12
DB01238,Aripiprazole,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N05AX12
DB01238,Aripiprazole,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N05AX12
DB01238,Aripiprazole,,P18825,Alpha-2C adrenergic receptor,ADRA2C,other/unknown,N05AX12
DB01238,Aripiprazole,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AX12
DB01238,Aripiprazole,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,antagonist,N05AX12
DB01238,Aripiprazole,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,ligand,N05AX12
DB01238,Aripiprazole,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AX12
DB01238,Aripiprazole,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,partial agonist,N05AX12
DB01238,Aripiprazole,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,N05AX12
DB01238,Aripiprazole,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N05AX12
DB01238,Aripiprazole,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AX12
DB01238,Aripiprazole,,P21728,Dopamine D1 receptor,DRD1,partial agonist,N05AX12
DB01238,Aripiprazole,,P21728,Dopamine D1 receptor,DRD1,ligand,N05AX12
DB01238,Aripiprazole,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AX12
DB01238,Aripiprazole,,P21917,Dopamine D4 receptor,DRD4,partial agonist,N05AX12
DB01238,Aripiprazole,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N05AX12
DB01238,Aripiprazole,,P18089,Alpha-2B adrenergic receptor,ADRA2B,ligand,N05AX12
DB01238,Aripiprazole,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,antagonist,N05AX12
DB01238,Aripiprazole,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,ligand,N05AX12
DB01238,Aripiprazole,,P21918,Dopamine D5 receptor,DRD5,antagonist,N05AX12
DB01238,Aripiprazole,,P21918,Dopamine D5 receptor,DRD5,partial agonist,N05AX12
DB01238,Aripiprazole,,P21918,Dopamine D5 receptor,DRD5,ligand,N05AX12
DB01238,Aripiprazole,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,inverse agonist,N05AX12
DB01238,Aripiprazole,,P47898,5-hydroxytryptamine receptor 5A,HTR5A,ligand,N05AX12
DB01238,Aripiprazole,,P08588,Beta-1 adrenergic receptor,ADRB1,ligand,N05AX12
DB01238,Aripiprazole,,P07550,Beta-2 adrenergic receptor,ADRB2,ligand,N05AX12
DB01238,Aripiprazole,,P25021,Histamine H2 receptor,HRH2,ligand,N05AX12
DB01238,Aripiprazole,,Q9Y5N1,Histamine H3 receptor,HRH3,ligand,N05AX12
DB01238,Aripiprazole,,Q9H3N8,Histamine H4 receptor,HRH4,ligand,N05AX12
DB01238,Aripiprazole,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,ligand,N05AX12
DB01238,Aripiprazole,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,ligand,N05AX12
DB01238,Aripiprazole,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,ligand,N05AX12
DB01238,Aripiprazole,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,ligand,N05AX12
DB01238,Aripiprazole,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,ligand,N05AX12
DB01238,Aripiprazole,,P41145,Kappa-type opioid receptor,OPRK1,ligand,N05AX12
DB01238,Aripiprazole,,P35372,Mu-type opioid receptor,OPRM1,ligand,N05AX12
DB01238,Aripiprazole,,P41143,Delta-type opioid receptor,OPRD1,ligand,N05AX12
DB01238,Aripiprazole,,Q05586,Glutamate (NMDA) receptor,GRIN1,ligand,N05AX12
DB01238,Aripiprazole,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,modulator,N05AX12
DB01238,Aripiprazole,,P31645,Sodium-dependent serotonin transporter,SLC6A4,modulator,N05AX12
DB01239,Chlorprothixene,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AF03
DB01239,Chlorprothixene,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AF03
DB01239,Chlorprothixene,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AF03
DB01239,Chlorprothixene,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AF03
DB01239,Chlorprothixene,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AF03
DB01239,Chlorprothixene,,P08908,Serotonin Receptors,HTR1A,inhibitor,N05AF03
DB01239,Chlorprothixene,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05AF03
DB01239,Chlorprothixene,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N05AF03
DB01239,Chlorprothixene,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N05AF03
DB01239,Chlorprothixene,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N05AF03
DB01239,Chlorprothixene,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N05AF03
DB01240,Epoprostenol,,Q16647,Prostacyclin synthase,PTGIS,inducer,B01AC09
DB01240,Epoprostenol,,Q9H244,P2Y purinoceptor 12,P2RY12,agonist,B01AC09
DB01240,Epoprostenol,,P43119,Prostacyclin receptor,PTGIR,agonist,B01AC09
DB01241,Gemfibrozil,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,C10AB04
DB01241,Gemfibrozil,,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,SLCO1B1,inhibitor,C10AB04
DB01241,Gemfibrozil,,Q8TCC7,Solute carrier family 22 member 8,SLC22A8,inhibitor,C10AB04
DB01241,Gemfibrozil,,O94956,Solute carrier organic anion transporter family member 2B1,SLCO2B1,inhibitor,C10AB04
DB01241,Gemfibrozil,,Q9NPD5,Solute carrier organic anion transporter family member 1B3,SLCO1B3,inhibitor,C10AB04
DB01242,Clomipramine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA04
DB01242,Clomipramine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AA04
DB01242,Clomipramine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N06AA04
DB01242,Clomipramine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AA04
DB01242,Clomipramine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA04
DB01242,Clomipramine,,P09211,Glutathione S-transferase P,GSTP1,inhibitor,N06AA04
DB01244,Bepridil,,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,inhibitor,C08EA02
DB01244,Bepridil,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,C08EA02
DB01244,Bepridil,,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,inhibitor,C08EA02
DB01244,Bepridil,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,inhibitor,C08EA02
DB01244,Bepridil,,P51787,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,inhibitor,C08EA02
DB01244,Bepridil,,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,other,C08EA02
DB01244,Bepridil,,P0DP23,Calmodulin,CALM1,binder,C08EA02
DB01244,Bepridil,,Q01064,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,inhibitor,C08EA02
DB01244,Bepridil,,P54750,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",PDE1A,inhibitor,C08EA02
DB01244,Bepridil,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C08EA02
DB01245,Decamethonium,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,partial agonist,
DB01245,Decamethonium,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,
DB01245,Decamethonium,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,,
DB01245,Decamethonium,,P22303,Acetylcholinesterase,ACHE,inhibitor,
DB01246,Alimemazine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AD01
DB01247,Isocarboxazid,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,N06AF01
DB01247,Isocarboxazid,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,N06AF01
DB01248,Docetaxel,,Q9H4B7,Tubulin beta-1 chain,TUBB1,,L01CD02
DB01248,Docetaxel,,P11137,Microtubule-associated protein 2,MAP2,,L01CD02
DB01248,Docetaxel,,P27816,Microtubule-associated protein 4,MAP4,,L01CD02
DB01248,Docetaxel,,P10636,Microtubule-associated protein tau,MAPT,,L01CD02
DB01248,Docetaxel,,P10415,Apoptosis regulator Bcl-2,BCL2,,L01CD02
DB01248,Docetaxel,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,binder,L01CD02
DB01250,Olsalazine,,P23219,Human Cyclooxygenases,PTGS1,inhibitor,A07EC03
DB01250,Olsalazine,,P51580,Thiopurine S-methyltransferase,TPMT,inhibitor,A07EC03
DB01250,Olsalazine,,P01579,Interferon gamma,IFNG,,A07EC03
DB01250,Olsalazine,,P47989,Xanthine dehydrogenase/oxidase,XDH,inhibitor,A07EC03
DB01251,Gliquidone,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,inhibitor,A10BB08
DB01251,Gliquidone,,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,inhibitor,A10BB08
DB01252,Mitiglinide,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,inhibitor,A10BX08
DB01252,Mitiglinide,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,A10BX08
DB01253,Ergometrine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,G02AB03
DB01254,Dasatinib,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,L01EA02
DB01254,Dasatinib,,P00519,Tyrosine-protein kinase ABL1,ABL1,multitarget,L01EA02
DB01254,Dasatinib,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,inhibitor,L01EA02
DB01254,Dasatinib,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,multitarget,L01EA02
DB01254,Dasatinib,,P29317,Ephrin type-A receptor 2,EPHA2,antagonist,L01EA02
DB01254,Dasatinib,,P06239,Tyrosine-protein kinase Lck,LCK,inhibitor,L01EA02
DB01254,Dasatinib,,P06239,Tyrosine-protein kinase Lck,LCK,multitarget,L01EA02
DB01254,Dasatinib,,P07947,Tyrosine-protein kinase Yes,YES1,inhibitor,L01EA02
DB01254,Dasatinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,antagonist,L01EA02
DB01254,Dasatinib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,antagonist,L01EA02
DB01254,Dasatinib,,P51692,Signal transducer and activator of transcription 5B,STAT5B,inhibitor,L01EA02
DB01254,Dasatinib,,P42684,Tyrosine-protein kinase ABL2,ABL2,multitarget,L01EA02
DB01254,Dasatinib,,P06241,Tyrosine-protein kinase Fyn,FYN,inhibitor,L01EA02
DB01254,Dasatinib,,P06241,Tyrosine-protein kinase Fyn,FYN,multitarget,L01EA02
DB01254,Dasatinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,L01EA02
DB01254,Dasatinib,,Q92570,Nuclear receptor subfamily 4 group A member 3,NR4A3,inhibitor,L01EA02
DB01254,Dasatinib,,P11274,Breakpoint cluster region protein,BCR,inhibitor,L01EA02
DB01254,Dasatinib,,P41240,Tyrosine-protein kinase CSK,CSK,inhibitor,L01EA02
DB01254,Dasatinib,,P54756,Ephrin type-A receptor 5,EPHA5,inhibitor,L01EA02
DB01254,Dasatinib,,P54760,Ephrin type-B receptor 4,EPHB4,inhibitor,L01EA02
DB01254,Dasatinib,,P09769,Tyrosine-protein kinase Fgr,FGR,inhibitor,L01EA02
DB01254,Dasatinib,,P42685,Tyrosine-protein kinase FRK,FRK,binder,L01EA02
DB01254,Dasatinib,,P11142,Heat shock cognate 71 kDa protein,HSPA8,binder,L01EA02
DB01254,Dasatinib,,P07948,Tyrosine-protein kinase Lyn,LYN,inhibitor,L01EA02
DB01254,Dasatinib,,Q9NYL2,Mitogen-activated protein kinase kinase kinase MLT,ZAK,binder,L01EA02
DB01254,Dasatinib,,Q16539,Mitogen-activated protein kinase 14,MAPK14,binder,L01EA02
DB01254,Dasatinib,,Q06203,Amidophosphoribosyltransferase,PPAT,binder,L01EA02
DB01255,Lisdexamfetamine,,Q96RJ0,Trace amine-associated receptor 1,TAAR1,agonist,N06BA12
DB01256,Retapamulin,,Q9A1X4,50S ribosomal protein L3,rplC,inhibitor,D06AX13
DB01257,Eculizumab,,P01031,Complement C5,C5,antibody,L04AA25
DB01259,Lapatinib,,P00533,Epidermal growth factor receptor,EGFR,antagonist,L01EH01
DB01259,Lapatinib,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,antagonist,L01EH01
DB01260,Desonide,,P04150,Glucocorticoid receptor,NR3C1,agonist,S01BA11;D07BB02;D07AB08
DB01261,Sitagliptin,,P27487,Dipeptidyl peptidase 4,DPP4,inhibitor,A10BH51;A10BD24;A10BD07;A10BH01;A10BD12
DB01262,Decitabine,,,DNA,,other/unknown,L01BC08
DB01262,Decitabine,,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,inhibitor,L01BC08
DB01262,Decitabine,,Q9Y6K1,DNA (cytosine-5)-methyltransferase 3A,DNMT3A,inhibitor,L01BC08
DB01262,Decitabine,,Q9UBC3,DNA (cytosine-5)-methyltransferase 3B,DNMT3B,inhibitor,L01BC08
DB01262,Decitabine,,Q13547,Histone deacetylase,HDAC1,inhibitor,L01BC08
DB01263,Posaconazole,,P10613,Cytochrome P450 51,ERG11,antagonist,J02AC04
DB01264,Darunavir,,Q72874,Human immunodeficiency virus type 1 protease,pol,inhibitor,J05AR14;G01AE10;J05AR22;J05AR26;J05AE10
DB01265,Telbivudine,,,DNA,,,J05AF11
DB01265,Telbivudine,,Q05486,Protein P,P,,J05AF11
DB01267,Paliperidone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AX13
DB01267,Paliperidone,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AX13
DB01267,Paliperidone,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AX13
DB01267,Paliperidone,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AX13
DB01267,Paliperidone,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AX13
DB01267,Paliperidone,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AX13
DB01267,Paliperidone,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AX13
DB01267,Paliperidone,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AX13
DB01267,Paliperidone,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,antagonist,N05AX13
DB01267,Paliperidone,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N05AX13
DB01267,Paliperidone,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N05AX13
DB01267,Paliperidone,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,N05AX13
DB01267,Paliperidone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AX13
DB01267,Paliperidone,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AX13
DB01267,Paliperidone,,P34969,5-hydroxytryptamine receptor 7,HTR7,,N05AX13
DB01268,Sunitinib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,L01EX01
DB01268,Sunitinib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,L01EX01
DB01268,Sunitinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,L01EX01
DB01268,Sunitinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EX01
DB01268,Sunitinib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,inhibitor,L01EX01
DB01268,Sunitinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EX01
DB01268,Sunitinib,,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,inhibitor,L01EX01
DB01268,Sunitinib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,inhibitor,L01EX01
DB01268,Sunitinib,,P08581,Hepatocyte growth factor receptor,MET,inhibitor,L01EX01
DB01269,Panitumumab,,P00533,Epidermal growth factor receptor,EGFR,suppressor,L01FE02
DB01270,Ranibizumab,,P15692,Vascular endothelial growth factor A,VEGFA,antibody,S01LA04
DB01271,Idursulfase,,,Dermatan sulfate,,,A16AB09
DB01271,Idursulfase,,,Heparan sulfate,,,A16AB09
DB01271,Idursulfase,,O60664,Perilipin-3,PLIN3,,A16AB09
DB01272,Alglucosidase alfa,,P20645,Cation-dependent mannose-6-phosphate receptor,M6PR,binder,A16AB07
DB01272,Alglucosidase alfa,,,Glycogen,,cleavage,A16AB07
DB01273,Varenicline,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,partial agonist,S01XA28;N07BA03
DB01273,Varenicline,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,agonist,S01XA28;N07BA03
DB01273,Varenicline,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,partial agonist,S01XA28;N07BA03
DB01273,Varenicline,,Q15825,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,partial agonist,S01XA28;N07BA03
DB01273,Varenicline,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,partial agonist,S01XA28;N07BA03
DB01274,Arformoterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,
DB01275,Hydralazine,,Q16853,Membrane primary amine oxidase,AOC3,inhibitor,C02DB02;C02LG02
DB01275,Hydralazine,,Q16665,Hypoxia-inducible factor 1-alpha,HIF1A,inducer,C02DB02;C02LG02
DB01275,Hydralazine,,P13674,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,inhibitor,C02DB02;C02LG02
DB01276,Exenatide,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,A10BJ01
DB01277,Mecasermin,,P08069,Insulin-like growth factor 1 receptor,IGF1R,agonist,H01AC03
DB01277,Mecasermin,,P17936,Insulin-like growth factor-binding protein 3,IGFBP3,,H01AC03
DB01277,Mecasermin,,P06213,Insulin receptor,INSR,,H01AC03
DB01277,Mecasermin,,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,,H01AC03
DB01278,Pramlintide,,P30988,Calcitonin receptor,CALCR,agonist,A10BX05
DB01278,Pramlintide,,O60894,Receptor activity-modifying protein 1,RAMP1,agonist,A10BX05
DB01278,Pramlintide,,O60895,Receptor activity-modifying protein 2,RAMP2,agonist,A10BX05
DB01278,Pramlintide,,O60896,Receptor activity-modifying protein 3,RAMP3,agonist,A10BX05
DB01279,Galsulfase,,,Dermatan sulfate,,,A16AB08
DB01279,Galsulfase,,O60664,Perilipin-3,PLIN3,,A16AB08
DB01280,Nelarabine,,,DNA,,incorporation into and destabilization,L01BB07
DB01280,Nelarabine,,P09884,DNA polymerase alpha catalytic subunit,POLA1,inhibitor,L01BB07
DB01280,Nelarabine,,P18858,DNA ligase 1,LIG1,inhibitor,L01BB07
DB01280,Nelarabine,,P49642,DNA primase small subunit,PRIM1,inhibitor,L01BB07
DB01280,Nelarabine,,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,inhibitor,L01BB07
DB01281,Abatacept,,P33681,T-lymphocyte activation antigen CD80,CD80,antagonist,L04AA24
DB01281,Abatacept,,P42081,T-lymphocyte activation antigen CD86,CD86,antagonist,L04AA24
DB01281,Abatacept,,P16410,Cytotoxic T-lymphocyte protein 4,CTLA4,inhibitor,L04AA24
DB01282,Carbetocin,,P30559,Oxytocin receptor,OXTR,agonist,H01BB03
DB01283,Lumiracoxib,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AH06
DB01283,Lumiracoxib,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AH06
DB01284,Tetracosactide,,Q01718,Adrenocorticotropic hormone receptor,MC2R,agonist,H01AA02
DB01285,Corticotropin,,Q01718,Adrenocorticotropic hormone receptor,MC2R,agonist,H01AA01
DB01285,Corticotropin,,P06850,Corticoliberin,CRH,agonist,H01AA01
DB01288,Fenoterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03CC04;R03AL01;G02CA03;R03AC04
DB01288,Fenoterol,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,R03CC04;R03AL01;G02CA03;R03AC04
DB01288,Fenoterol,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,R03CC04;R03AL01;G02CA03;R03AC04
DB01289,Glisoxepide,,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,inhibitor,A10BB11
DB01289,Glisoxepide,,P01308,Insulin,INS,regulator,A10BB11
DB01291,Pirbuterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03CC07;R03AC08
DB01291,Pirbuterol,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,R03CC07;R03AC08
DB01295,Bevantolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07AB06;C07BB06
DB01295,Bevantolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07AB06;C07BB06
DB01295,Bevantolol,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C07AB06;C07BB06
DB01296,Glucosamine,,P01579,Interferon gamma,IFNG,inhibitor,M01AX05
DB01296,Glucosamine,,Q04206,Transcription factor p65,RELA,inhibitor,M01AX05
DB01297,Practolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07AB01
DB01298,Sulfacytine,,P0AC13,Dihydropteroate synthase,folP,inhibitor,G01AE10
DB01299,Sulfadoxine,,Q27738,Dihydropteroate synthetase,,,P01BF09;G01AE10
DB01299,Sulfadoxine,,P13922,Bifunctional dihydrofolate reductase-thymidylate synthase,,inhibitor,P01BF09;G01AE10
DB01301,Rolitetracycline,,P0A7X3,30S ribosomal protein S9,rpsI,inhibitor,J01AA20;J01AA09
DB01301,Rolitetracycline,,,16S ribosomal RNA,,inhibitor,J01AA20;J01AA09
DB01303,Oxtriphylline,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,R03DA20;R03DB02;R03DA02
DB01303,Oxtriphylline,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,inhibitor,R03DA20;R03DB02;R03DA02
DB01303,Oxtriphylline,,P29274,Adenosine receptor A2a,ADORA2A,antagonist,R03DA20;R03DB02;R03DA02
DB01303,Oxtriphylline,,P30542,Adenosine receptor A1,ADORA1,antagonist,R03DA20;R03DB02;R03DA02
DB01303,Oxtriphylline,,Q92769,Histone deacetylase 2,HDAC2,activator,R03DA20;R03DB02;R03DA02
DB01306,Insulin aspart,,P06213,Insulin receptor,INSR,agonist,A10AD06;A10AD05;A10AB05
DB01306,Insulin aspart,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,A10AD06;A10AD05;A10AB05
DB01307,Insulin detemir,,P06213,Insulin receptor,INSR,agonist,A10AE05
DB01307,Insulin detemir,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,A10AE05
DB01309,Insulin glulisine,,P06213,Insulin receptor,INSR,agonist,A10AB06
DB01309,Insulin glulisine,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,A10AB06
DB01319,Fosamprenavir,,Q72874,Human immunodeficiency virus type 1 protease,pol,inhibitor,J05AE07
DB01320,Fosphenytoin,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,N03AB05
DB01321,Josamycin,,P44345,50S ribosomal protein L4,rplD,inhibitor,J01FA07
DB01324,Polythiazide,,P55017,Solute carrier family 12 member 3,SLC12A3,inhibitor,C03AA05;G01AE10;C03AB05
DB01325,Quinethazone,,Q13621,Solute carrier family 12 member 1,SLC12A1,inhibitor,G01AE10;C03BA02;C03BB02
DB01325,Quinethazone,,P55011,Solute carrier family 12 member 2,SLC12A2,inhibitor,G01AE10;C03BA02;C03BB02
DB01325,Quinethazone,,P55017,Solute carrier family 12 member 3,SLC12A3,inhibitor,G01AE10;C03BA02;C03BB02
DB01325,Quinethazone,,P00915,Carbonic anhydrase 1,CA1,inhibitor,G01AE10;C03BA02;C03BB02
DB01325,Quinethazone,,P00918,Carbonic anhydrase 2,CA2,inhibitor,G01AE10;C03BA02;C03BB02
DB01326,Cefamandole,,Q70KI2,Penicillin-binding protein 2,pbpA,inhibitor,J01DC03
DB01327,Cefazolin,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DB04
DB01327,Cefazolin,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DB04
DB01327,Cefazolin,,P76577,Penicillin-binding protein 1C,pbpC,inhibitor,J01DB04
DB01327,Cefazolin,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01DB04
DB01327,Cefazolin,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DB04
DB01327,Cefazolin,,P27169,Serum paraoxonase/arylesterase 1,PON1,inhibitor,J01DB04
DB01327,Cefazolin,,P40933,Interleukin-15,IL15,inhibitor,J01DB04
DB01327,Cefazolin,,P60568,Interleukin-2,IL2,inhibitor,J01DB04
DB01328,Cefonicid,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DC06
DB01328,Cefonicid,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DC06
DB01328,Cefonicid,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DC06
DB01328,Cefonicid,,P24228,D-alanyl-D-alanine carboxypeptidase DacB,dacB,inhibitor,J01DC06
DB01328,Cefonicid,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01DC06
DB01329,Cefoperazone,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DD12
DB01329,Cefoperazone,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DD12
DB01329,Cefoperazone,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01DD12
DB01329,Cefoperazone,,Q07806,Penicillin-binding protein 1A,mrcA,inhibitor,J01DD12
DB01329,Cefoperazone,,Q9X6W0,Penicillin-binding protein 1B,ponB,inhibitor,J01DD12
DB01329,Cefoperazone,,P08506,D-alanyl-D-alanine carboxypeptidase DacC,dacC,inhibitor,J01DD12
DB01329,Cefoperazone,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DD12
DB01329,Cefoperazone,,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,dacA,inhibitor,J01DD12
DB01329,Cefoperazone,,P24228,D-alanyl-D-alanine carboxypeptidase DacB,dacB,inhibitor,J01DD12
DB01330,Cefotetan,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01DC05
DB01331,Cefoxitin,,P08506,D-alanyl-D-alanine carboxypeptidase DacC,dacC,inhibitor,J01DC01
DB01331,Cefoxitin,,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,dacA,inhibitor,J01DC01
DB01331,Cefoxitin,,P0AFI5,D-alanyl-D-alanine endopeptidase,pbpG,inhibitor,J01DC01
DB01331,Cefoxitin,,P24228,D-alanyl-D-alanine carboxypeptidase DacB,dacB,inhibitor,J01DC01
DB01331,Cefoxitin,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DC01
DB01331,Cefoxitin,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DC01
DB01331,Cefoxitin,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DC01
DB01331,Cefoxitin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01DC01
DB01331,Cefoxitin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01DC01
DB01331,Cefoxitin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01DC01
DB01331,Cefoxitin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01DC01
DB01331,Cefoxitin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01DC01
DB01332,Ceftizoxime,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DD07
DB01332,Ceftizoxime,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DD07
DB01332,Ceftizoxime,,,Peptidoglycan transpeptidase,,binder,J01DD07
DB01332,Ceftizoxime,,P08506,D-alanyl-D-alanine carboxypeptidase DacC,dacC,binder,J01DD07
DB01333,Cefradine,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DB09
DB01336,Metocurine,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,
DB01336,Metocurine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,
DB01337,Pancuronium,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,M03AC01
DB01337,Pancuronium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,M03AC01
DB01337,Pancuronium,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,M03AC01
DB01338,Pipecuronium,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,M03AC06
DB01338,Pipecuronium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,M03AC06
DB01338,Pipecuronium,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,M03AC06
DB01339,Vecuronium,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,M03AC03
DB01340,Cilazapril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09BA08;C09AA08
DB01341,Dihydroquinidine barbiturate,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,
DB01342,Forasartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,
DB01344,Tolevamer,,,Potassium,,binder,V03AE01
DB01345,Potassium cation,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,,
DB01346,Quinidine barbiturate,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,
DB01346,Quinidine barbiturate,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,
DB01346,Quinidine barbiturate,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,
DB01346,Quinidine barbiturate,,O00180,Potassium channel subfamily K member 1,KCNK1,inhibitor,
DB01346,Quinidine barbiturate,,P42262,Glutamate receptor 2,GRIA2,antagonist,
DB01347,Saprisartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,
DB01348,Spirapril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09AA11
DB01349,Tasosartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,C09CA05
DB01349,Tasosartan,,P50052,Type-2 angiotensin II receptor,AGTR2,antagonist,C09CA05
DB01351,Amobarbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CA02;N05CB01
DB01351,Amobarbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CA02;N05CB01
DB01351,Amobarbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CA02;N05CB01
DB01351,Amobarbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N05CA02;N05CB01
DB01351,Amobarbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CA02;N05CB01
DB01351,Amobarbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N05CA02;N05CB01
DB01351,Amobarbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CA02;N05CB01
DB01351,Amobarbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CA02;N05CB01
DB01351,Amobarbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CA02;N05CB01
DB01351,Amobarbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CA02;N05CB01
DB01352,Aprobarbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CA05
DB01352,Aprobarbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CA05
DB01352,Aprobarbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CA05
DB01352,Aprobarbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N05CA05
DB01352,Aprobarbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CA05
DB01352,Aprobarbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N05CA05
DB01352,Aprobarbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CA05
DB01352,Aprobarbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CA05
DB01352,Aprobarbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CA05
DB01352,Aprobarbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CA05
DB01353,Butobarbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CA03
DB01353,Butobarbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CA03
DB01353,Butobarbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N05CA03
DB01353,Butobarbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CA03
DB01353,Butobarbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N05CA03
DB01353,Butobarbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CA03
DB01353,Butobarbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CA03
DB01353,Butobarbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CA03
DB01353,Butobarbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CA03
DB01353,Butobarbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CA03
DB01354,Heptabarbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CA11
DB01354,Heptabarbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CA11
DB01354,Heptabarbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CA11
DB01354,Heptabarbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N05CA11
DB01354,Heptabarbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CA11
DB01354,Heptabarbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N05CA11
DB01354,Heptabarbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CA11
DB01354,Heptabarbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CA11
DB01354,Heptabarbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CA11
DB01354,Heptabarbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CA11
DB01355,Hexobarbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N01AF02;N05CA16
DB01355,Hexobarbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N01AF02;N05CA16
DB01355,Hexobarbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N01AF02;N05CA16
DB01355,Hexobarbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N01AF02;N05CA16
DB01355,Hexobarbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N01AF02;N05CA16
DB01355,Hexobarbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N01AF02;N05CA16
DB01355,Hexobarbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N01AF02;N05CA16
DB01355,Hexobarbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N01AF02;N05CA16
DB01355,Hexobarbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N01AF02;N05CA16
DB01355,Hexobarbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N01AF02;N05CA16
DB01356,Lithium cation,,P49841,Glycogen synthase kinase-3 beta,GSK3B,inhibitor,
DB01356,Lithium cation,,P29218,Inositol monophosphatase 1,IMPA1,inhibitor,
DB01356,Lithium cation,,O14732,Inositol monophosphatase 2,IMPA2,inhibitor,
DB01356,Lithium cation,,P42263,Glutamate receptor 3,GRIA3,potentiator,
DB01357,Mestranol,,P03372,Estrogen receptor alpha,ESR1,agonist,
DB01359,Penbutolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07CA23;C07AA23
DB01359,Penbutolol,,P08588,Beta-1 adrenergic receptor,ADRB1,partial agonist,C07CA23;C07AA23
DB01359,Penbutolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07CA23;C07AA23
DB01359,Penbutolol,,P07550,Beta-2 adrenergic receptor,ADRB2,partial agonist,C07CA23;C07AA23
DB01359,Penbutolol,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,C07CA23;C07AA23
DB01359,Penbutolol,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,antagonist,C07CA23;C07AA23
DB01363,Ephedra sinica root,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,negative modulator,
DB01363,Ephedra sinica root,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,negative modulator,
DB01363,Ephedra sinica root,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,
DB01363,Ephedra sinica root,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,
DB01363,Ephedra sinica root,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,
DB01363,Ephedra sinica root,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,
DB01363,Ephedra sinica root,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,
DB01363,Ephedra sinica root,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,
DB01363,Ephedra sinica root,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,
DB01363,Ephedra sinica root,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,
DB01363,Ephedra sinica root,,P31645,Sodium-dependent serotonin transporter,SLC6A4,negative modulator,
DB01363,Ephedra sinica root,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,
DB01363,Ephedra sinica root,,P54219,Chromaffin granule amine transporter,SLC18A1,inhibitor,
DB01364,Ephedrine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,S01FB02;R01AB05;C01CA26;R03CA02;A08AA56;R01AA03
DB01364,Ephedrine,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,S01FB02;R01AB05;C01CA26;R03CA02;A08AA56;R01AA03
DB01364,Ephedrine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,S01FB02;R01AB05;C01CA26;R03CA02;A08AA56;R01AA03
DB01364,Ephedrine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inverse agonist,S01FB02;R01AB05;C01CA26;R03CA02;A08AA56;R01AA03
DB01365,Mephentermine,,P35348,Alpha adrenergic receptor,ADRA1A,agonist,C01CA11
DB01365,Mephentermine,,P08588,Beta adrenergic receptor,ADRB1,agonist,C01CA11
DB01366,Procaterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03CC08;R03AC16
DB01367,Rasagiline,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,N04BD02
DB01367,Rasagiline,,P10415,Apoptosis regulator Bcl-2,BCL2,activator,N04BD02
DB01369,Quinupristin,,,23S ribosomal RNA,,inhibitor,
DB01369,Quinupristin,,P0A7J6,50S ribosomal protein L10,rplJ,inhibitor,
DB01369,Quinupristin,,P61177,50S ribosomal protein L22,rplV,inhibitor,
DB01370,Aluminium,,P06870,Kallikrein-1,KLK1,inhibitor,
DB01370,Aluminium,,P05067,Amyloid beta A4 protein,APP,,
DB01370,Aluminium,,P02787,Serotransferrin,TF,,
DB01370,Aluminium,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,binder,
DB01373,Calcium,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,ligand,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,agonist,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P02585,"Troponin C, skeletal muscle",TNNC2,agonist,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,agonist,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,agonist,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P04271,Protein S100-B,S100B,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P20810,Calpastatin,CAST,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P49747,Cartilage oligomeric matrix protein,COMP,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P0DP23,Calmodulin,CALM1,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P19801,Amiloride-sensitive amine oxidase [copper-containing],AOC1,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,Q99584,Protein S100-A13,S100A13,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P05187,"Alkaline phosphatase, placental type",ALPP,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P05109,Protein S100-A8,S100A8,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P06702,Protein S100-A9,S100A9,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P29034,Protein S100-A2,S100A2,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P00450,Ceruloplasmin,CP,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P12644,Bone morphogenetic protein 4,BMP4,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,P08493,Matrix Gla protein,MGP,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,Q8TAB3,Protocadherin-19,PCDH19,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01373,Calcium,,O75340,Programmed cell death protein 6,PDCD6,,M05BB01;A11AA02;M05BB08;A11GB01;M05BB02;M05BB04;M05BB05
DB01375,Aluminium monostearate,,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,stimulator,
DB01375,Aluminium monostearate,,P21796,Voltage-dependent anion-selective channel protein 1,VDAC1,inhibitor,
DB01375,Aluminium monostearate,,P45880,Voltage-dependent anion-selective channel protein 2,VDAC2,inhibitor,
DB01375,Aluminium monostearate,,Q9Y277,Voltage-dependent anion-selective channel protein 3,VDAC3,inhibitor,
DB01378,Magnesium cation,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,,
DB01380,Cortisone acetate,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB01380,Cortisone acetate,,P04083,Annexin A1,ANXA1,inducer,
DB01381,Ginkgo biloba,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06DX02;N06DA53
DB01381,Ginkgo biloba,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,inhibitor,N06DX02;N06DA53
DB01381,Ginkgo biloba,,P23415,Glycine receptor subunit alpha-1,GLRA1,antagonist,N06DX02;N06DA53
DB01381,Ginkgo biloba,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,negative modulator,N06DX02;N06DA53
DB01381,Ginkgo biloba,,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,negative modulator,N06DX02;N06DA53
DB01381,Ginkgo biloba,,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,negative modulator,N06DX02;N06DA53
DB01381,Ginkgo biloba,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,N06DX02;N06DA53
DB01381,Ginkgo biloba,,P35228,"Nitric oxide synthase, inducible",NOS2,inhibitor,N06DX02;N06DA53
DB01382,Glymidine,,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,other/unknown,A10BC01;G01AE10
DB01382,Glymidine,,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,inducer,A10BC01;G01AE10
DB01384,Paramethasone,,P04150,Glucocorticoid receptor,NR3C1,agonist,H02AB05
DB01388,Mibefradil,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,C08CX01
DB01388,Mibefradil,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,C08CX01
DB01388,Mibefradil,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C08CX01
DB01388,Mibefradil,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,C08CX01
DB01388,Mibefradil,,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,inhibitor,C08CX01
DB01388,Mibefradil,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,inhibitor,C08CX01
DB01388,Mibefradil,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,C08CX01
DB01388,Mibefradil,,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,inhibitor,C08CX01
DB01388,Mibefradil,,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,inhibitor,C08CX01
DB01388,Mibefradil,,P54284,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,inhibitor,C08CX01
DB01388,Mibefradil,,O00305,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,inhibitor,C08CX01
DB01390,Sodium bicarbonate,,,Hydrogen ions,,neutralizer,B05CB04;B05XA02
DB01392,Yohimbine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,G04BE04
DB01392,Yohimbine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,G04BE04
DB01392,Yohimbine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,G04BE04
DB01392,Yohimbine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,G04BE04
DB01392,Yohimbine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,partial agonist,G04BE04
DB01392,Yohimbine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,partial agonist,G04BE04
DB01392,Yohimbine,,P14416,Dopamine D2 receptor,DRD2,antagonist,G04BE04
DB01392,Yohimbine,,P35462,Dopamine D3 receptor,DRD3,antagonist,G04BE04
DB01392,Yohimbine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,G04BE04
DB01392,Yohimbine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,G04BE04
DB01392,Yohimbine,,P48048,ATP-sensitive potassium channel,KCNJ1,inhibitor,G04BE04
DB01392,Yohimbine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,G04BE04
DB01393,Bezafibrate,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,agonist,C10AB02
DB01393,Bezafibrate,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,C10AB02
DB01393,Bezafibrate,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,C10AB02
DB01393,Bezafibrate,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,partial agonist,C10AB02
DB01393,Bezafibrate,,P19793,Retinoic acid receptor RXR-alpha,RXRA,agonist,C10AB02
DB01393,Bezafibrate,,P28702,Retinoic acid receptor RXR-beta,RXRB,agonist,C10AB02
DB01393,Bezafibrate,,P48443,Retinoic acid receptor RXR-gamma,RXRG,agonist,C10AB02
DB01394,Colchicine,,P07437,Tubulin beta chain,TUBB,inhibitor,M04AC01
DB01394,Colchicine,,P07437,Tubulin beta chain,TUBB,binder,M04AC01
DB01395,Drospirenone,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,G03AA18;G03AC10;G03FA17;G03AA12
DB01395,Drospirenone,,P10275,Androgen receptor,AR,antagonist,G03AA18;G03AC10;G03FA17;G03AA12
DB01395,Drospirenone,,P06401,Progesterone receptor,PGR,agonist,G03AA18;G03AC10;G03FA17;G03AA12
DB01395,Drospirenone,,P04150,Glucocorticoid receptor,NR3C1,binder,G03AA18;G03AC10;G03FA17;G03AA12
DB01396,Digitoxin,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,inhibitor,C01AA04
DB01397,Magnesium salicylate,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB01397,Magnesium salicylate,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB01399,Salsalate,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,N02BA06
DB01399,Salsalate,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,N02BA06
DB01400,Neostigmine,,P22303,Acetylcholinesterase,ACHE,inhibitor,N07AA01;S01EB06;N07AA51
DB01401,Choline magnesium trisalicylate,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB01401,Choline magnesium trisalicylate,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB01403,Methotrimeprazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AA02
DB01403,Methotrimeprazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AA02
DB01403,Methotrimeprazine,,P21918,Dopamine D5 receptor,DRD5,antagonist,N05AA02
DB01403,Methotrimeprazine,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AA02
DB01403,Methotrimeprazine,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AA02
DB01403,Methotrimeprazine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AA02
DB01403,Methotrimeprazine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AA02
DB01403,Methotrimeprazine,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AA02
DB01403,Methotrimeprazine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05AA02
DB01403,Methotrimeprazine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N05AA02
DB01403,Methotrimeprazine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N05AA02
DB01403,Methotrimeprazine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N05AA02
DB01403,Methotrimeprazine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N05AA02
DB01403,Methotrimeprazine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AA02
DB01403,Methotrimeprazine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AA02
DB01403,Methotrimeprazine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,N05AA02
DB01403,Methotrimeprazine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N05AA02
DB01403,Methotrimeprazine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N05AA02
DB01403,Methotrimeprazine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N05AA02
DB01404,Ginseng,,P35869,Aryl hydrocarbon receptor,AHR,agonist,
DB01404,Ginseng,,P05231,Interleukin-6,IL6,antagonist,
DB01404,Ginseng,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB01405,Temafloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MA05
DB01405,Temafloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA05
DB01406,Danazol,,P03372,Estrogen receptor alpha,ESR1,agonist,G03XA01
DB01406,Danazol,,P10275,Androgen receptor,AR,agonist,G03XA01
DB01406,Danazol,,P06401,Progesterone receptor,PGR,agonist,G03XA01
DB01406,Danazol,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,negative modulator,G03XA01
DB01406,Danazol,,Q96P88,Putative gonadotropin-releasing hormone II receptor,GNRHR2,negative modulator,G03XA01
DB01406,Danazol,,P13500,C-C motif chemokine 2,CCL2,inhibitor,G03XA01
DB01407,Clenbuterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03CC13;R03AC14;R03CC63
DB01407,Clenbuterol,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,R03CC13;R03AC14;R03CC63
DB01407,Clenbuterol,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,R03CC13;R03AC14;R03CC63
DB01407,Clenbuterol,,P01138,Beta-nerve growth factor,NGF,stimulator,R03CC13;R03AC14;R03CC63
DB01407,Clenbuterol,,P01375,Tumor necrosis factor,TNF,other/unknown,R03CC13;R03AC14;R03CC63
DB01408,Bambuterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03CC12
DB01408,Bambuterol,,P06276,Cholinesterase,BCHE,inhibitor,R03CC12
DB01409,Tiotropium,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,R03AL06;R03BB04;R03BB54;R03AL10
DB01409,Tiotropium,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,R03AL06;R03BB04;R03BB54;R03AL10
DB01409,Tiotropium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,R03AL06;R03BB04;R03BB54;R03AL10
DB01409,Tiotropium,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,,R03AL06;R03BB04;R03BB54;R03AL10
DB01409,Tiotropium,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,,R03AL06;R03BB04;R03BB54;R03AL10
DB01410,Ciclesonide,,P04150,Glucocorticoid receptor,NR3C1,agonist,R03BA08;R01AD13
DB01411,Pranlukast,,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,antagonist,R03DC02
DB01411,Pranlukast,,P01375,Tumor necrosis factor,TNF,other/unknown,R03DC02
DB01411,Pranlukast,,P05113,Interleukin-5,IL5,antagonist,R03DC02
DB01411,Pranlukast,,P12724,Eosinophil cationic protein,RNASE3,other/unknown,R03DC02
DB01411,Pranlukast,,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,other/unknown,R03DC02
DB01411,Pranlukast,,Q02817,Mucin-2,MUC2,other/unknown,R03DC02
DB01411,Pranlukast,,Q00653,Nuclear factor NF-kappa-B,NFKB2,inhibitor,R03DC02
DB01412,Theobromine,,P30542,Adenosine receptor A1,ADORA1,antagonist,C03BD01;R03DA07;R03DA57
DB01412,Theobromine,,P29274,Adenosine receptor A2a,ADORA2A,antagonist,C03BD01;R03DA07;R03DA57
DB01412,Theobromine,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,C03BD01;R03DA07;R03DA57
DB01413,Cefepime,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DE01;J01RA06
DB01413,Cefepime,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DE01;J01RA06
DB01413,Cefepime,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01DE01;J01RA06
DB01413,Cefepime,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DE01;J01RA06
DB01413,Cefepime,,Q9X6W0,Penicillin-binding protein 1B,ponB,inhibitor,J01DE01;J01RA06
DB01413,Cefepime,,Q51504,Penicillin-binding protein 3,pbpB,inhibitor,J01DE01;J01RA06
DB01413,Cefepime,,Q9X6V3,Penicillin-binding protein 2,pbpA,inhibitor,J01DE01;J01RA06
DB01414,Cefacetrile,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DB10
DB01414,Cefacetrile,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DB10
DB01415,Ceftibuten,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DD14
DB01415,Ceftibuten,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DD14
DB01415,Ceftibuten,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DD14
DB01415,Ceftibuten,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01DD14
DB01416,Cefpodoxime,,P0AD68,Peptidoglycan synthase FtsI,ftsI,inhibitor,J01DD13
DB01418,Acenocoumarol,,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,inhibitor,B01AA07
DB01419,Antrafenine,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB01419,Antrafenine,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB01420,Testosterone propionate,,P10275,Androgen receptor,AR,agonist,
DB01421,Paromomycin,,Q5SHN7,30S ribosomal protein S10,rpsJ,inhibitor,A07AA06
DB01421,Paromomycin,,,16S ribosomal RNA,,inhibitor,A07AA06
DB01421,Paromomycin,,P08865,40S ribosomal protein SA,RPSA,inhibitor,A07AA06
DB01421,Paromomycin,,Q96L21,60S ribosomal protein L10-like,RPL10L,inhibitor,A07AA06
DB01422,Nitroxoline,,P50579,Methionine aminopeptidase 2,METAP2,inhibitor,J01XX07
DB01422,Nitroxoline,,,Magnesium cation,,chelator,J01XX07
DB01422,Nitroxoline,,,Manganese cation,,chelator,J01XX07
DB01425,Alizapride,,P14416,Dopamine D2 receptor,DRD2,antagonist,A03FA05
DB01426,Ajmaline,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BA05
DB01427,Amrinone,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)",PDE4A,inhibitor,C01CE01
DB01427,Amrinone,,,"cAMP-specific 3',5'-cyclic phosphodiesterase 3",,inhibitor,C01CE01
DB01427,Amrinone,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,C01CE01
DB01427,Amrinone,,Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,inhibitor,C01CE01
DB01427,Amrinone,,P01375,Tumor necrosis factor,TNF,inhibitor,C01CE01
DB01428,Oxybenzone,,P06401,Progesterone receptor,PGR,antagonist,
DB01428,Oxybenzone,,P10275,Androgen receptor,AR,antagonist,
DB01428,Oxybenzone,,P03372,Estrogen receptor alpha,ESR1,,
DB01428,Oxybenzone,,Q92731,Estrogen receptor beta,ESR2,,
DB01429,Aprindine,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BB04
DB01429,Aprindine,,P0DP23,Calmodulin,CALM1,inhibitor,C01BB04
DB01430,Almitrine,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,binder,R07AB07
DB01431,Allylestrenol,,P06401,Progesterone receptor,PGR,agonist,G03DC01
DB01431,Allylestrenol,,P03372,Estrogen receptor alpha,ESR1,agonist,G03DC01
DB01432,Cholestyramine,,,Bile acids,,binder,C10AC01
DB01433,Methadyl acetate,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB01435,Antipyrine,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,N02BB51;N02BB71;N02BB01;S02DA03
DB01435,Antipyrine,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,N02BB51;N02BB71;N02BB01;S02DA03
DB01436,Alfacalcidol,,P11473,Vitamin D3 receptor,VDR,agonist,A11CC03;M05BB06
DB01436,Alfacalcidol,,O15528,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",CYP27B1,,A11CC03;M05BB06
DB01436,Alfacalcidol,,P19793,Retinoic acid receptor RXR-alpha,RXRA,,A11CC03;M05BB06
DB01437,Glutethimide,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,agonist,N05CE01
DB01437,Glutethimide,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CE01
DB01438,Phenazopyridine,,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,inhibitor,G04BX06
DB01438,Phenazopyridine,,,Group A nerve fibers,,inhibitor,G04BX06
DB01439,3-Methylthiofentanyl,,P41145,Kappa-type opioid receptor,OPRK1,agonist,
DB01439,3-Methylthiofentanyl,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB01439,3-Methylthiofentanyl,,P41143,Delta-type opioid receptor,OPRD1,agonist,
DB01440,gamma-Hydroxybutyric acid,,Q9HAB3,Gamma-hydroxybutyrate (GHB) receptor,SLC52A2,agonist,
DB01440,gamma-Hydroxybutyric acid,,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,agonist,
DB01442,MMDA,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,
DB01442,MMDA,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,negative modulator,
DB01442,MMDA,,P31645,Sodium-dependent serotonin transporter,SLC6A4,negative modulator,
DB01442,MMDA,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,negative modulator,
DB01442,MMDA,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,
DB01442,MMDA,,P54219,Chromaffin granule amine transporter,SLC18A1,inhibitor,
DB01442,MMDA,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,
DB01442,MMDA,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,
DB01444,Dimethylthiambutene,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB01444,Dimethylthiambutene,,P41143,Delta-type opioid receptor,OPRD1,agonist,
DB01452,Diamorphine,,P35372,Mu-type opioid receptor,OPRM1,agonist,N07BC06
DB01452,Diamorphine,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N07BC06
DB01452,Diamorphine,,P41143,Delta-type opioid receptor,OPRD1,agonist,N07BC06
DB01452,Diamorphine,,P23141,Liver carboxylesterase 1,CES1,,N07BC06
DB01454,Midomafetamine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,
DB01454,Midomafetamine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,negative modulator,
DB01454,Midomafetamine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,negative modulator,
DB01454,Midomafetamine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,negative modulator,
DB01454,Midomafetamine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,
DB01454,Midomafetamine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,agonist,
DB01454,Midomafetamine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,
DB01463,Fencamfamin,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06BA06
DB01466,Ethylmorphine,,P35372,Mu-type opioid receptor,OPRM1,agonist,S01XA06;R05DA01
DB01472,4-Methoxyamphetamine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,
DB01472,4-Methoxyamphetamine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,
DB01472,4-Methoxyamphetamine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,
DB01472,4-Methoxyamphetamine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,
DB01472,4-Methoxyamphetamine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,
DB01472,4-Methoxyamphetamine,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,
DB01472,4-Methoxyamphetamine,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,
DB01481,1-Testosterone,,P10275,Androgen receptor,AR,agonist,
DB01483,Barbital,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05CA04
DB01483,Barbital,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05CA04
DB01483,Barbital,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05CA04
DB01483,Barbital,,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,N05CA04
DB01483,Barbital,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05CA04
DB01483,Barbital,,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,N05CA04
DB01483,Barbital,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,N05CA04
DB01483,Barbital,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,N05CA04
DB01483,Barbital,,P42262,Glutamate receptor 2,GRIA2,antagonist,N05CA04
DB01483,Barbital,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,N05CA04
DB01488,Dimethyltryptamine,,P50406,5-hydroxytryptamine receptor 6,HTR6,,
DB01488,Dimethyltryptamine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB01488,Dimethyltryptamine,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,,
DB01489,Camazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA15
DB01489,Camazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA15
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,potentiator,
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,potentiator,
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,antagonist,
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",,P42262,Glutamate receptor 2,GRIA2,antagonist,
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,antagonist,
DB01497,Etorphine,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB01497,Etorphine,,P41143,Delta-type opioid receptor,OPRD1,agonist,
DB01497,Etorphine,,P41145,Kappa-type opioid receptor,OPRK1,agonist,
DB01497,Etorphine,,P41146,Nociceptin receptor,OPRL1,agonist,
DB01497,Etorphine,,O60858,E3 ubiquitin-protein ligase TRIM13,TRIM13,agonist,
DB01497,Etorphine,,P01189,Pro-opiomelanocortin,POMC,,
DB01511,Delorazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,
DB01511,Delorazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,
DB01520,Tenocyclidine,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,antagonist,
DB01520,Tenocyclidine,,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,antagonist,
DB01520,Tenocyclidine,,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,antagonist,
DB01520,Tenocyclidine,,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,antagonist,
DB01520,Tenocyclidine,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,antagonist,
DB01520,Tenocyclidine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,antagonist,
DB01520,Tenocyclidine,,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,antagonist,
DB01535,Carfentanil,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB01535,Carfentanil,,P41143,Delta-type opioid receptor,OPRD1,agonist,
DB01535,Carfentanil,,P41145,Kappa-type opioid receptor,OPRK1,agonist,
DB01536,Androstenedione,,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,inducer,
DB01536,Androstenedione,,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,positive allosteric modulator,
DB01536,Androstenedione,,Q00441,6-deoxyerythronolide B hydroxylase,eryF,inducer,
DB01536,Androstenedione,,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,substrate,
DB01536,Androstenedione,,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,inducer,
DB01537,"4-Bromo-2,5-dimethoxyphenethylamine",,P28335,5-hydroxytryptamine receptor 2C,HTR2C,partial agonist,
DB01537,"4-Bromo-2,5-dimethoxyphenethylamine",,P28223,5-hydroxytryptamine receptor 2A,HTR2A,partial agonist,
DB01541,Boldenone,,P10275,Androgen receptor,AR,agonist,
DB01544,Flunitrazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD03
DB01544,Flunitrazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD03
DB01545,Ethyl loflazepate,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA18
DB01545,Ethyl loflazepate,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA18
DB01548,Diprenorphine,,P35372,Mu-type opioid receptor,OPRM1,antagonist,
DB01548,Diprenorphine,,P41143,Delta-type opioid receptor,OPRD1,antagonist,
DB01548,Diprenorphine,,P41145,Kappa-type opioid receptor,OPRK1,antagonist,
DB01548,Diprenorphine,,O60858,E3 ubiquitin-protein ligase TRIM13,TRIM13,,
DB01549,Rolicyclidine,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,,
DB01549,Rolicyclidine,,P14416,Dopamine D2 receptor,DRD2,,
DB01553,Cloxazolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA22
DB01553,Cloxazolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA22
DB01558,Bromazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA08
DB01558,Bromazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA08
DB01559,Clotiazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA21
DB01559,Clotiazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA21
DB01561,Androstanedione,,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,,
DB01561,Androstanedione,,P00947,Steroid Delta-isomerase,ksi,,
DB01564,Calusterone,,P10275,Androgen receptor,AR,,
DB01565,Dihydromorphine,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB01565,Dihydromorphine,,P41143,Delta-type opioid receptor,OPRD1,agonist,
DB01565,Dihydromorphine,,P41145,Kappa-type opioid receptor,OPRK1,agonist,
DB01565,Dihydromorphine,,O60858,E3 ubiquitin-protein ligase TRIM13,TRIM13,agonist,
DB01565,Dihydromorphine,,P01189,Pro-opiomelanocortin,POMC,agonist,
DB01567,Fludiazepam,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,potentiator,N05BA17
DB01567,Fludiazepam,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,potentiator,N05BA17
DB01567,Fludiazepam,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,potentiator,N05BA17
DB01567,Fludiazepam,,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,potentiator,N05BA17
DB01567,Fludiazepam,,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,potentiator,N05BA17
DB01567,Fludiazepam,,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,potentiator,N05BA17
DB01567,Fludiazepam,,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,potentiator,N05BA17
DB01567,Fludiazepam,,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,potentiator,N05BA17
DB01567,Fludiazepam,,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,potentiator,N05BA17
DB01567,Fludiazepam,,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,potentiator,N05BA17
DB01567,Fludiazepam,,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,potentiator,N05BA17
DB01567,Fludiazepam,,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,potentiator,N05BA17
DB01567,Fludiazepam,,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,potentiator,N05BA17
DB01567,Fludiazepam,,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,potentiator,N05BA17
DB01567,Fludiazepam,,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,potentiator,N05BA17
DB01567,Fludiazepam,,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,potentiator,N05BA17
DB01569,Formebolone,,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,inhibitor,
DB01571,3-Methylfentanyl,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB01571,3-Methylfentanyl,,P41143,Delta-type opioid receptor,OPRD1,agonist,
DB01571,3-Methylfentanyl,,P41145,Kappa-type opioid receptor,OPRK1,agonist,
DB01576,Dextroamphetamine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inducer,N06BA02
DB01576,Dextroamphetamine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,negative modulator,N06BA02
DB01576,Dextroamphetamine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,negative modulator,N06BA02
DB01576,Dextroamphetamine,,Q96RJ0,Trace amine-associated receptor 1,TAAR1,agonist,N06BA02
DB01576,Dextroamphetamine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N06BA02
DB01576,Dextroamphetamine,,P35348,Alpha adrenergic receptor,ADRA1A,inhibitor,N06BA02
DB01576,Dextroamphetamine,,P35348,Alpha adrenergic receptor,ADRA1A,inducer,N06BA02
DB01577,Metamfetamine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,negative modulator,N06BA03
DB01577,Metamfetamine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,negative modulator,N06BA03
DB01577,Metamfetamine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,negative modulator,N06BA03
DB01577,Metamfetamine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,N06BA03
DB01577,Metamfetamine,,P54219,Chromaffin granule amine transporter,SLC18A1,inhibitor,N06BA03
DB01577,Metamfetamine,,Q96RJ0,Trace amine-associated receptor 1,TAAR1,agonist,N06BA03
DB01577,Metamfetamine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,N06BA03
DB01577,Metamfetamine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,N06BA03
DB01577,Metamfetamine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,N06BA03
DB01577,Metamfetamine,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,N06BA03
DB01577,Metamfetamine,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,N06BA03
DB01579,Phendimetrazine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,
DB01579,Phendimetrazine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,negative modulator,
DB01579,Phendimetrazine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,
DB01580,Oxprenolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07BA02;C07AA02;C07CA02
DB01580,Oxprenolol,,P13945,Beta-3 adrenergic receptor,ADRB3,,C07BA02;C07AA02;C07CA02
DB01580,Oxprenolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07BA02;C07AA02;C07CA02
DB01581,Sulfamerazine,,P0AC13,Dihydropteroate synthase,folP,inhibitor,J01ED07;G01AE10;D06BA06;J01EE07
DB01582,Sulfamethazine,,P0AC13,Dihydropteroate synthase,folP,inhibitor,J01EB03;G01AE10;J01EE05
DB01583,Liotrix,,P10827,Thyroid hormone receptor alpha,THRA,agonist,
DB01583,Liotrix,,P10828,Thyroid hormone receptor beta,THRB,agonist,
DB01586,Ursodeoxycholic acid,,P52895,Aldo-keto reductase family 1 member C2,AKR1C2,inhibitor,A05AA02
DB01586,Ursodeoxycholic acid,,Q96RI1,Bile acid receptor,NR1H4,partial agonist,A05AA02
DB01587,Ketazolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA10
DB01587,Ketazolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA10
DB01588,Prazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA11
DB01588,Prazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA11
DB01589,Quazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD10
DB01589,Quazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD10
DB01590,Everolimus,,P42345,Serine/threonine-protein kinase mTOR,MTOR,inhibitor,L01EG02;L04AA18
DB01591,Solifenacin,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,G04BD08;G04CA53
DB01591,Solifenacin,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,G04BD08;G04CA53
DB01591,Solifenacin,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,G04BD08;G04CA53
DB01591,Solifenacin,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,G04BD08;G04CA53
DB01591,Solifenacin,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,G04BD08;G04CA53
DB01592,Iron,,P02786,Transferrin receptor protein 1,TFRC,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,Q9GZT9,Egl nine homolog 1,EGLN1,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,Q9BY41,Histone deacetylase 8,HDAC8,cofactor,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,Q9NZD4,Alpha-hemoglobin-stabilizing protein,AHSP,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,P69905,Hemoglobin subunit alpha,HBA1,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,Q16595,"Frataxin, mitochondrial",FXN,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,P02794,Ferritin heavy chain,FTH1,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,P39748,Flap endonuclease 1,FEN1,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,Q96FI4,Endonuclease 8-like 1,NEIL1,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,Q969S2,Endonuclease 8-like 2,NEIL2,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,P06746,DNA polymerase beta,POLB,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,P00450,Ceruloplasmin,CP,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01592,Iron,,P02787,Serotransferrin,TF,,B03AE02;A11AA01;B03AE01;B03AE04;B03AE03
DB01593,Zinc,,P46663,B1 bradykinin receptor,BDKRB1,,C05AX04
DB01593,Zinc,,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,,C05AX04
DB01593,Zinc,,P04075,Fructose-bisphosphate aldolase A,ALDOA,,C05AX04
DB01593,Zinc,,P68104,Elongation factor 1-alpha 1,EEF1A1,,C05AX04
DB01593,Zinc,,P06733,Alpha-enolase,ENO1,,C05AX04
DB01593,Zinc,,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,,C05AX04
DB01593,Zinc,,P15531,Nucleoside diphosphate kinase A,NME1,,C05AX04
DB01593,Zinc,,P07237,Protein disulfide-isomerase,P4HB,,C05AX04
DB01593,Zinc,,P30101,Protein disulfide-isomerase A3,PDIA3,,C05AX04
DB01593,Zinc,,Q06830,Peroxiredoxin-1,PRDX1,,C05AX04
DB01593,Zinc,,P78330,Phosphoserine phosphatase,PSPH,,C05AX04
DB01593,Zinc,,P60174,Triosephosphate isomerase,TPI1,,C05AX04
DB01593,Zinc,,P49411,"Elongation factor Tu, mitochondrial",TUFM,,C05AX04
DB01593,Zinc,,P03372,Estrogen receptor alpha,ESR1,cofactor,C05AX04
DB01593,Zinc,,P08700,Interleukin-3,IL3,,C05AX04
DB01593,Zinc,,P02795,Metallothionein-2,MT2A,,C05AX04
DB01593,Zinc,,O14618,Copper chaperone for superoxide dismutase,CCS,,C05AX04
DB01593,Zinc,,Q13547,Histone deacetylase 1,HDAC1,cofactor,C05AX04
DB01593,Zinc,,P56524,Histone deacetylase 4,HDAC4,cofactor,C05AX04
DB01593,Zinc,,P29372,DNA-3-methyladenine glycosylase,MPG,,C05AX04
DB01593,Zinc,,P04279,Semenogelin-1,SEMG1,,C05AX04
DB01593,Zinc,,P00441,Superoxide dismutase [Cu-Zn],SOD1,,C05AX04
DB01593,Zinc,,Q9BY41,Histone deacetylase 8,HDAC8,cofactor,C05AX04
DB01593,Zinc,,O15304,Apoptosis regulatory protein Siva,SIVA1,,C05AX04
DB01593,Zinc,,P23415,Glycine receptor subunit alpha-1,GLRA1,,C05AX04
DB01593,Zinc,,Q00987,E3 ubiquitin-protein ligase Mdm2,MDM2,,C05AX04
DB01593,Zinc,,P01308,Insulin,INS,,C05AX04
DB01593,Zinc,,P46939,Utrophin,UTRN,,C05AX04
DB01593,Zinc,,P45381,Aspartoacylase,ASPA,cofactor,C05AX04
DB01593,Zinc,,P05109,Protein S100-A8,S100A8,,C05AX04
DB01593,Zinc,,P06702,Protein S100-A9,S100A9,,C05AX04
DB01593,Zinc,,P14780,Matrix metalloproteinase-9,MMP9,,C05AX04
DB01593,Zinc,,O15350,Tumor protein p73,TP73,cofactor,C05AX04
DB01593,Zinc,,P29034,Protein S100-A2,S100A2,,C05AX04
DB01593,Zinc,,P04637,Cellular tumor antigen p53,TP53,,C05AX04
DB01593,Zinc,,P25713,Metallothionein-3,MT3,,C05AX04
DB01593,Zinc,,O75340,Programmed cell death protein 6,PDCD6,,C05AX04
DB01593,Zinc,,Q8N907,DAN domain family member 5,DAND5,cofactor,C05AX04
DB01593,Zinc,,P04731,Metallothionein-1A,MT1A,,C05AX04
DB01593,Zinc,,P04217,Alpha-1B-glycoprotein,A1BG,,C05AX04
DB01593,Zinc,,P01023,Alpha-2-macroglobulin,A2M,,C05AX04
DB01593,Zinc,,P01019,Angiotensinogen,AGT,,C05AX04
DB01593,Zinc,,P02765,Alpha-2-HS-glycoprotein,AHSG,,C05AX04
DB01593,Zinc,,P02743,Serum amyloid P-component,APCS,,C05AX04
DB01593,Zinc,,P02647,Apolipoprotein A-I,APOA1,,C05AX04
DB01593,Zinc,,P02652,Apolipoprotein A-II,APOA2,,C05AX04
DB01593,Zinc,,P06727,Apolipoprotein A-IV,APOA4,,C05AX04
DB01593,Zinc,,Q0VD83,Apolipoprotein B receptor,APOBR,,C05AX04
DB01593,Zinc,,P02649,Apolipoprotein E,APOE,,C05AX04
DB01593,Zinc,,O14791,Apolipoprotein L1,APOL1,,C05AX04
DB01593,Zinc,,P02746,Complement C1q subcomponent subunit B,C1QB,,C05AX04
DB01593,Zinc,,P02747,Complement C1q subcomponent subunit C,C1QC,,C05AX04
DB01593,Zinc,,P00736,Complement C1r subcomponent,C1R,,C05AX04
DB01593,Zinc,,P09871,Complement C1s subcomponent,C1S,,C05AX04
DB01593,Zinc,,P01024,Complement C3,C3,,C05AX04
DB01593,Zinc,,P0C0L5,Complement C4-B,C4B,,C05AX04
DB01593,Zinc,,P04003,C4b-binding protein alpha chain,C4BPA,,C05AX04
DB01593,Zinc,,P20851,C4b-binding protein beta chain,C4BPB,,C05AX04
DB01593,Zinc,,P01031,Complement C5,C5,,C05AX04
DB01593,Zinc,,P46736,Lys-63-specific deubiquitinase BRCC36,BRCC3,,C05AX04
DB01593,Zinc,,P07357,Complement component C8 alpha chain,C8A,,C05AX04
DB01593,Zinc,,P07358,Complement component C8 beta chain,C8B,,C05AX04
DB01593,Zinc,,P07360,Complement component C8 gamma chain,C8G,,C05AX04
DB01593,Zinc,,P00751,Complement factor B,CFB,,C05AX04
DB01593,Zinc,,P08603,Complement factor H,CFH,,C05AX04
DB01593,Zinc,,P05156,Complement factor I,CFI,,C05AX04
DB01593,Zinc,,P10909,Clusterin,CLU,,C05AX04
DB01593,Zinc,,P00450,Ceruloplasmin,CP,,C05AX04
DB01593,Zinc,,P15169,Carboxypeptidase N catalytic chain,CPN1,,C05AX04
DB01593,Zinc,,P22792,Carboxypeptidase N subunit 2,CPN2,,C05AX04
DB01593,Zinc,,P81605,Dermcidin,DCD,,C05AX04
DB01593,Zinc,,P15924,Desmoplakin,DSP,,C05AX04
DB01593,Zinc,,P00748,Coagulation factor XII,F12,,C05AX04
DB01593,Zinc,,P05160,Coagulation factor XIII B chain,F13B,,C05AX04
DB01593,Zinc,,P00734,Prothrombin,F2,,C05AX04
DB01593,Zinc,,O75636,Ficolin-3,FCN3,,C05AX04
DB01593,Zinc,,P02671,Fibrinogen alpha chain,FGA,,C05AX04
DB01593,Zinc,,P02751,Fibronectin,FN1,,C05AX04
DB01593,Zinc,,P06396,Gelsolin,GSN,,C05AX04
DB01593,Zinc,,P69905,Hemoglobin subunit alpha,HBA1,,C05AX04
DB01593,Zinc,,P68871,Hemoglobin subunit beta,HBB,,C05AX04
DB01593,Zinc,,P00739,Haptoglobin-related protein,HPR,,C05AX04
DB01593,Zinc,,Q86YZ3,Hornerin,HRNR,,C05AX04
DB01593,Zinc,,P35858,Insulin-like growth factor-binding protein complex acid labile subunit,IGFALS,,C05AX04
DB01593,Zinc,,P01876,Ig alpha-1 chain C region,IGHA1,,C05AX04
DB01593,Zinc,,P01871,Ig mu chain C region,IGHM,,C05AX04
DB01593,Zinc,,P01599,Immunoglobulin kappa variable 1-17,IGKV1-17,,C05AX04
DB01593,Zinc,,P01619,Ig kappa chain V-III region GOL,,,C05AX04
DB01593,Zinc,,P80748,Immunoglobulin lambda variable 3-21,IGLV3-21,,C05AX04
DB01593,Zinc,,P19827,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,,C05AX04
DB01593,Zinc,,P19823,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,,C05AX04
DB01593,Zinc,,Q06033,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,,C05AX04
DB01593,Zinc,,Q14624,Inter-alpha-trypsin inhibitor heavy chain H4,ITIH4,,C05AX04
DB01593,Zinc,,P01591,Immunoglobulin J chain,JCHAIN,,C05AX04
DB01593,Zinc,,P14923,Junction plakoglobin,JUP,,C05AX04
DB01593,Zinc,,P03952,Plasma kallikrein,KLKB1,,C05AX04
DB01593,Zinc,,P01042,Kininogen-1,KNG1,,C05AX04
DB01593,Zinc,,P04264,"Keratin, type II cytoskeletal 1",KRT1,,C05AX04
DB01593,Zinc,,P13645,"Keratin, type I cytoskeletal 10",KRT10,,C05AX04
DB01593,Zinc,,P02533,"Keratin, type I cytoskeletal 14",KRT14,,C05AX04
DB01593,Zinc,,P08779,"Keratin, type I cytoskeletal 16",KRT16,,C05AX04
DB01593,Zinc,,P35908,"Keratin, type II cytoskeletal 2 epidermal",KRT2,,C05AX04
DB01593,Zinc,,P13647,"Keratin, type II cytoskeletal 5",KRT5,,C05AX04
DB01593,Zinc,,P02538,"Keratin, type II cytoskeletal 6A",KRT6A,,C05AX04
DB01593,Zinc,,P35527,"Keratin, type I cytoskeletal 9",KRT9,,C05AX04
DB01593,Zinc,,P19652,Alpha-1-acid glycoprotein 2,ORM2,,C05AX04
DB01593,Zinc,,Q96PD5,N-acetylmuramoyl-L-alanine amidase,PGLYRP2,,C05AX04
DB01593,Zinc,,P27169,Serum paraoxonase/arylesterase 1,PON1,,C05AX04
DB01593,Zinc,,P20742,Pregnancy zone protein,PZP,,C05AX04
DB01593,Zinc,,P31151,Protein S100-A7,S100A7,,C05AX04
DB01593,Zinc,,P49908,Selenoprotein P,SEPP1,,C05AX04
DB01593,Zinc,,P01009,Alpha-1-antitrypsin,SERPINA1,,C05AX04
DB01593,Zinc,,P01011,Alpha-1-antichymotrypsin,SERPINA3,,C05AX04
DB01593,Zinc,,P29622,Kallistatin,SERPINA4,,C05AX04
DB01593,Zinc,,P08185,Corticosteroid-binding globulin,SERPINA6,,C05AX04
DB01593,Zinc,,P05546,Heparin cofactor 2,SERPIND1,,C05AX04
DB01593,Zinc,,P04278,Sex hormone-binding globulin,SHBG,,C05AX04
DB01593,Zinc,,P02787,Serotransferrin,TF,,C05AX04
DB01593,Zinc,,P02766,Transthyretin,TTR,,C05AX04
DB01593,Zinc,,P04004,Vitronectin,VTN,,C05AX04
DB01593,Zinc,,P51693,Amyloid-like protein 1,APLP1,cofactor,C05AX04
DB01593,Zinc,,Q06481,Amyloid-like protein 2,APLP2,cofactor,C05AX04
DB01593,Zinc,,P05067,Amyloid beta A4 protein,APP,cofactor,C05AX04
DB01593,Zinc,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,C05AX04
DB01594,Cinolazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD13
DB01594,Cinolazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD13
DB01595,Nitrazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD02
DB01595,Nitrazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD02
DB01595,Nitrazepam,,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,other/unknown,N05CD02
DB01597,Cilastatin,,P16444,Dipeptidase 1,DPEP1,inhibitor,J01DH51;J01DH56
DB01598,Imipenem,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01DH51;J01DH56
DB01598,Imipenem,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DH51;J01DH56
DB01598,Imipenem,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DH51;J01DH56
DB01598,Imipenem,,P42971,Penicillin-binding protein 3,pbpC,inhibitor,J01DH51;J01DH56
DB01598,Imipenem,,P72355,Penicillin-binding protein 4,pbp4,,J01DH51;J01DH56
DB01598,Imipenem,,P52664,Beta-lactamase,blaB,activator,J01DH51;J01DH56
DB01599,Probucol,,O95477,ATP-binding cassette sub-family A member 1,ABCA1,inhibitor,C10AX02
DB01599,Probucol,,P23141,Liver carboxylesterase 1,CES1,,C10AX02
DB01600,Tiaprofenic acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AE11
DB01600,Tiaprofenic acid,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AE11
DB01601,Lopinavir,,Q72874,Human immunodeficiency virus type 1 protease,pol,inhibitor,J05AR10
DB01602,Bacampicillin,,P0AEB2,Penicillin-binding protein,dacA,inhibitor,J01CR50;J01CA06
DB01603,Meticillin,,Q53707,MecA PBP2' (penicillin binding protein 2'),mecA,inhibitor,J01CR50;J01CF03
DB01603,Meticillin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01CR50;J01CF03
DB01603,Meticillin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01CR50;J01CF03
DB01603,Meticillin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01CR50;J01CF03
DB01603,Meticillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CR50;J01CF03
DB01603,Meticillin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CF03
DB01604,Pivampicillin,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CA02
DB01605,Pivmecillinam,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,J01CR50;J01CA08
DB01606,Tazobactam,,P62594,Beta-lactamase TEM,bla,inhibitor,J01CG02
DB01606,Tazobactam,,P18251,Beta-lactamase Ohio-1,,inhibitor,J01CG02
DB01606,Tazobactam,,P0AD63,Beta-lactamase SHV-1,bla,inhibitor,J01CG02
DB01607,Ticarcillin,,C1KC03,Penicillin binding protein 2a,mecA,inhibitor,J01CR50;J01CA13
DB01608,Periciazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AC01
DB01608,Periciazine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N05AC01
DB01608,Periciazine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AC01
DB01608,Periciazine,,P10275,Androgen receptor,AR,,N05AC01
DB01609,Deferasirox,,,Iron,,chelator,V03AC03
DB01610,Valganciclovir,,,DNA,,adduct,J05AB14
DB01611,Hydroxychloroquine,,Q9NYK1,Toll-like receptor 7,TLR7,antagonist,P01BA02
DB01611,Hydroxychloroquine,,Q9NR96,Toll-like receptor 9,TLR9,antagonist,P01BA02
DB01611,Hydroxychloroquine,,,DNA,,cross-linking/alkylation,P01BA02
DB01611,Hydroxychloroquine,,Q9BYF1,Angiotensin-converting enzyme 2,ACE2,modulator,P01BA02
DB01612,Amyl Nitrite,,P16066,Atrial natriuretic peptide receptor 1,NPR1,agonist,V03AB22
DB01613,Erythrityl tetranitrate,,P16066,Atrial natriuretic peptide receptor 1,NPR1,agonist,C01DA63;C01DA13
DB01613,Erythrityl tetranitrate,,P20594,Atrial natriuretic peptide receptor 2,NPR2,agonist,C01DA63;C01DA13
DB01614,Acepromazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AA04
DB01614,Acepromazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AA04
DB01614,Acepromazine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AA04
DB01614,Acepromazine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AA04
DB01614,Acepromazine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AA04
DB01614,Acepromazine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AA04
DB01615,Aceprometazine,,P35367,Histamine H1 receptor,HRH1,antagonist,
DB01616,Alverine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,A03AX08;A03AX58
DB01618,Molindone,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AE02
DB01618,Molindone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AE02
DB01618,Molindone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AE02
DB01618,Molindone,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,other/unknown,N05AE02
DB01619,Phenindamine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX04
DB01620,Pheniramine,,Q9H3N8,Histamine H4 receptor,HRH4,inverse agonist,R06AB05;D04AA16
DB01620,Pheniramine,,P35367,Histamine H1 receptor,HRH1,inverse agonist,R06AB05;D04AA16
DB01620,Pheniramine,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,,R06AB05;D04AA16
DB01621,Pipotiazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AC04
DB01621,Pipotiazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AC04
DB01621,Pipotiazine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AC04
DB01621,Pipotiazine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AC04
DB01622,Thioproperazine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AB08
DB01622,Thioproperazine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AB08
DB01622,Thioproperazine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AB08
DB01622,Thioproperazine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AB08
DB01623,Thiothixene,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AF04
DB01623,Thiothixene,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AF04
DB01623,Thiothixene,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AF04
DB01624,Zuclopenthixol,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AF05
DB01624,Zuclopenthixol,,P21918,Dopamine D5 receptor,DRD5,antagonist,N05AF05
DB01624,Zuclopenthixol,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AF05
DB01624,Zuclopenthixol,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AF05
DB01624,Zuclopenthixol,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N05AF05
DB01624,Zuclopenthixol,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AF05
DB01624,Zuclopenthixol,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AF05
DB01625,Isopropamide,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03CA01;A03AB09
DB01625,Isopropamide,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,A03CA01;A03AB09
DB01626,Pargyline,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,C02LL01;C02KC01
DB01626,Pargyline,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,C02LL01;C02KC01
DB01627,Lincomycin,,,23S ribosomal RNA,,binder,J01FF02
DB01628,Etoricoxib,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AH05
DB01629,5-fluorouridine,,P00441,Superoxide dismutase [Cu-Zn],SOD1,,
DB01629,5-fluorouridine,,P12758,Uridine phosphorylase,udp,,
DB01630,SC-74020,,P08253,72 kDa type IV collagenase,MMP2,,
DB01631,Methyl nonanoate,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB01631,Methyl nonanoate,,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,,
DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,,
DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,,P08870,Orotate phosphoribosyltransferase,pyrE,substrate,
DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,,Q9NWZ5,Uridine-cytidine kinase-like 1,UCKL1,,
DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,,Q27796,Hypoxanthine-guanine phosphoribosyltransferase,HGPRTase,,
DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,,P07741,Adenine phosphoribosyltransferase,APRT,,
DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,,Q8VP84,Anthranilate phosphoribosyltransferase,trpD,,
DB01633,Deoxy-2-fluoro-beta-D-cellotrioside,,O85465,Endoglucanase 5A,cel5A,,
DB01634,2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,,P46883,Primary amine oxidase,tynA,,
DB01639,N-Methyl-Pyridoxal-5'-Phosphate,,P00509,Aspartate aminotransferase,aspC,,
DB01640,"6-(4-{[2-(3-iodobenzyl)-3-oxocyclohex-1-en-1-yl]amino}phenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one",,Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,,
DB01642,methyl beta-D-glucopyranoside,,O85465,Endoglucanase 5A,cel5A,,
DB01642,methyl beta-D-glucopyranoside,,P37698,Endoglucanase F,celCCF,,
DB01642,methyl beta-D-glucopyranoside,,Q79G13,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",celA1,,
DB01643,Thymidine monophosphate,,P9WKE1,Thymidylate kinase,tmk,product of,
DB01643,Thymidine monophosphate,,P23919,Thymidylate kinase,DTYMK,product of,
DB01643,Thymidine monophosphate,,P04818,Thymidylate synthase,TYMS,product of,
DB01643,Thymidine monophosphate,,P06612,DNA topoisomerase 1,topA,,
DB01643,Thymidine monophosphate,,P00469,Thymidylate synthase,thyA,product of,
DB01643,Thymidine monophosphate,,O52806,PCZA361.16,,,
DB01643,Thymidine monophosphate,,P03007,DNA polymerase III subunit epsilon,dnaQ,,
DB01643,Thymidine monophosphate,,Q9HU22,Glucose-1-phosphate thymidylyltransferase,rmlA,,
DB01644,"3,6-dihydroxy-xanthene-9-propionic acid",,P00390,"Glutathione reductase, mitochondrial",GSR,,
DB01645,Genistein,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB01645,Genistein,,P03372,Estrogen receptor alpha,ESR1,,
DB01645,Genistein,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB01645,Genistein,,O95718,Steroid hormone receptor ERR2,ESRRB,agonist,
DB01645,Genistein,,P11474,Steroid hormone receptor ERR1,ESRRA,agonist,
DB01645,Genistein,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB01645,Genistein,,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,,
DB01645,Genistein,,Q99527,G-protein coupled estrogen receptor 1,GPER1,,
DB01645,Genistein,,Q16678,Cytochrome P450 1B1,CYP1B1,,
DB01645,Genistein,,P04278,Sex hormone-binding globulin,SHBG,,
DB01645,Genistein,,Q92731,Estrogen receptor beta,ESR2,,
DB01645,Genistein,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB01645,Genistein,,Q14289,Protein-tyrosine kinase 2-beta,PTK2B,,
DB01645,Genistein,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,activator,
DB01646,N-Acetylmethionine,,P08100,Rhodopsin,RHO,,
DB01646,N-Acetylmethionine,,Q44244,N-acylamino acid racemase,Aaar,,
DB01647,Daxalipram,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,,
DB01649,7-methyl-GpppA,,Q96C86,m7GpppX diphosphatase,DCPS,,
DB01649,7-methyl-GpppA,,P06730,Eukaryotic translation initiation factor 4E,EIF4E,,
DB01650,trans-2-hydroxycinnamic acid,,P46072,Major NAD(P)H-flavin oxidoreductase,,,
DB01651,"Methyl 4,6-O-[(1R)-1-carboxyethylidene]-beta-D-galactopyranoside",,P02743,Serum amyloid P-component,APCS,,
DB01652,4-hydroxybenzoyl-CoA,,O68600,4-chlorobenzoyl CoA dehalogenase,fcbB,,
DB01652,4-hydroxybenzoyl-CoA,,P56653,4-hydroxybenzoyl-CoA thioesterase,,,
DB01655,L-gulonic acid 6-phosphate,,P39304,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,ulaD,,
DB01656,Roflumilast,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)",PDE4A,inhibitor,R03DX07
DB01657,"2-amino-3-[4-hydroxy-6-oxo-3-(2-phenyl-cyclopropylimino)-cyclohexa-1,4-dienyl]-propionic acid",,P46883,Primary amine oxidase,tynA,,
DB01661,1-(5-phospho-D-ribosyl)-ATP,,P60757,ATP phosphoribosyltransferase,hisG,,
DB01662,Trans-O-Hydroxy-Alpha-Methyl Cinnamate,,P17538,Chymotrypsinogen B,CTRB1,,
DB01663,"lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)",,P00183,Camphor 5-monooxygenase,camC,,
DB01664,(S)-DES-ME-AMPA,,P42262,Glutamate receptor 2,GRIA2,,
DB01665,2H-Benzimidazol-2-amine,,P07477,Trypsin-1,PRSS1,,
DB01666,D-Myo-Inositol-Hexasulphate,,Q7WUJ1,Myo-inositol hexaphosphate phosphohydrolase,phyA,,
DB01666,D-Myo-Inositol-Hexasulphate,,P19883,Follistatin,FST,,
DB01667,8-azaguanine,,P00491,Purine nucleoside phosphorylase,PNP,,
DB01668,Nanaomycin D,,Q53908,ActVA 6 protein,actVA 6,,
DB01669,Virginiamycin M1,,P50870,Streptogramin A acetyltransferase,vatD,,
DB01670,Propyl acetate,,Q06174,Carboxylesterase,est,,
DB01671,p-Hydroxymercuribenzoic acid,,P00918,Carbonic anhydrase 2,CA2,,
DB01672,"2,3-Dihydroxy-Benzoic Acid",,P40871,"2,3-dihydroxybenzoate-AMP ligase",dhbE,,
DB01672,"2,3-Dihydroxy-Benzoic Acid",,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,,
DB01673,Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine,,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,murD,,
DB01673,Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine,,P45066,UDP-N-acetylmuramate--L-alanine ligase,murC,,
DB01675,Methacrylyl-Coenzyme A,,Q9UKU7,"Isobutyryl-CoA dehydrogenase, mitochondrial",ACAD8,,
DB01676,Trinitrotoluene,,P71278,Pentaerythritol tetranitrate reductase,onr,,
DB01677,Fumaric acid,,P80040,Malate dehydrogenase,mdh,,D05AX01
DB01677,Fumaric acid,,P83223,Fumarate reductase flavoprotein subunit,,,D05AX01
DB01677,Fumaric acid,,P23368,"NAD-dependent malic enzyme, mitochondrial",ME2,,D05AX01
DB01677,Fumaric acid,,P16930,Fumarylacetoacetase,FAH,,D05AX01
DB01677,Fumaric acid,,P0C278,Fumarate reductase flavoprotein subunit,fccA,,D05AX01
DB01678,RU84687,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB01681,Benzene Hexacarboxylic Acid,,P15259,Phosphoglycerate mutase 2,PGAM2,,
DB01683,Chymostatin,,Q8RJN5,Peptide amidase,pam,,
DB01684,1-Hydroxy-1-Thio-Glycerol,,P48147,Prolyl endopeptidase,PREP,,
DB01685,Topiroxostat,,P47989,Xanthine dehydrogenase/oxidase,XDH,,
DB01686,"N,N-dimethylarginine",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB01686,"N,N-dimethylarginine",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB01688,P-Cresol,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB01689,Inhibitor Idd 384,,P15121,Aldose reductase,AKR1B1,,
DB01690,Bis(Adenosine)-5'-Triphosphate,,P0A6I9,Dephospho-CoA kinase,coaE,,
DB01691,Indole Naphthyridinone,,P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,
DB01692,Dithioerythritol,,P22262,Listeriolysin regulatory protein,prfA,,
DB01692,Dithioerythritol,,P9WHE9,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB01692,Dithioerythritol,,P04183,"Thymidine kinase, cytosolic",TK1,,
DB01694,D-tartaric acid,,P37672,"2,3-diketo-L-gulonate reductase",dlgD,,
DB01694,D-tartaric acid,,Q9P2W7,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1,B3GAT1,,
DB01694,D-tartaric acid,,Q9NP99,Triggering receptor expressed on myeloid cells 1,TREM1,,
DB01694,D-tartaric acid,,P26196,Probable ATP-dependent RNA helicase DDX6,DDX6,,
DB01694,D-tartaric acid,,Q746J6,Cytochrome P450,,,
DB01694,D-tartaric acid,,Q9NWT6,Hypoxia-inducible factor 1-alpha inhibitor,HIF1AN,,
DB01694,D-tartaric acid,,P9WNX3,D-3-phosphoglycerate dehydrogenase,serA,,
DB01694,D-tartaric acid,,O25927,Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase,lpxA,,
DB01694,D-tartaric acid,,P21283,V-type proton ATPase subunit C 1,ATP6V1C1,,
DB01694,D-tartaric acid,,Q9HU21,"dTDP-4-dehydrorhamnose 3,5-epimerase",rmlC,,
DB01694,D-tartaric acid,,Q9KVB4,Putative uncharacterized protein,,,
DB01694,D-tartaric acid,,Q51782,Phosphonoacetate hydrolase,phnA,,
DB01694,D-tartaric acid,,A0A0H2URW2,Putative uncharacterized protein,,,
DB01695,N-Hydroxy-4-phosphonobutanamide,,P60174,Triosephosphate isomerase,TPI1,,
DB01698,Rutin,,P16152,Carbonyl reductase [NADPH] 1,CBR1,,C05CA51;C05CA01
DB01698,Rutin,,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,,C05CA51;C05CA01
DB01699,(4e)-4-Aminohex-4-Enoic Acid,,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,,
DB01700,AICA ribonucleotide,,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,,
DB01701,"1,2-Dichloro-Propane",,P51698,Haloalkane dehalogenase,linB,,
DB01702,"2-(3,4-Dihydroxyphenyl)Acetic Acid",,P06875,Penicillin G acylase,pac,,
DB01702,"2-(3,4-Dihydroxyphenyl)Acetic Acid",,P00436,"Protocatechuate 3,4-dioxygenase alpha chain",pcaG,,
DB01702,"2-(3,4-Dihydroxyphenyl)Acetic Acid",,P00437,"Protocatechuate 3,4-dioxygenase beta chain",pcaH,,
DB01702,"2-(3,4-Dihydroxyphenyl)Acetic Acid",,,DNA,,,
DB01702,"2-(3,4-Dihydroxyphenyl)Acetic Acid",,Q44048,"3,4-dihydroxyphenylacetate 2,3-dioxygenase",mndD,,
DB01702,"2-(3,4-Dihydroxyphenyl)Acetic Acid",,Q45135,"Homoprotocatechuate 2,3-dioxygenase",,,
DB01703,N-(2-ferrocenylethyl)maleimide,,P00183,Camphor 5-monooxygenase,camC,,
DB01704,"2,4-Dihydroxy-Trans Cinnamic Acid",,P17538,Chymotrypsinogen B,CTRB1,,
DB01705,Bis(5-Amidino-Benzimidazolyl)Methane,,P07477,Trypsin-1,PRSS1,,
DB01705,Bis(5-Amidino-Benzimidazolyl)Methane,,P10844,Botulinum neurotoxin type B,botB,,
DB01708,Prasterone,,P03372,Estrogen receptor alpha,ESR1,binder,G03EA03;G03XX01;A14AA07
DB01708,Prasterone,,Q92731,Estrogen receptor beta,ESR2,activator,G03EA03;G03XX01;A14AA07
DB01708,Prasterone,,P14867,GABA(A) Receptor,GABRA1,antagonist,G03EA03;G03XX01;A14AA07
DB01708,Prasterone,,Q05586,NMDA receptor,GRIN1,agonist,G03EA03;G03XX01;A14AA07
DB01708,Prasterone,,P10275,Androgen receptor,AR,agonist,G03EA03;G03XX01;A14AA07
DB01708,Prasterone,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,activator,G03EA03;G03XX01;A14AA07
DB01708,Prasterone,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,agonist,G03EA03;G03XX01;A14AA07
DB01708,Prasterone,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,G03EA03;G03XX01;A14AA07
DB01708,Prasterone,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,activator,G03EA03;G03XX01;A14AA07
DB01709,2-phospho-D-glyceric acid,,O66496,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB01709,2-phospho-D-glyceric acid,,Q9X519,"2,3-bisphosphoglycerate-independent phosphoglycerate mutase",gpmI,,
DB01709,2-phospho-D-glyceric acid,,Q07412,Triosephosphate isomerase,TPI,,
DB01709,2-phospho-D-glyceric acid,,P13929,Beta-enolase,ENO3,,
DB01710,Porphyrin Fe(III),,P02144,Myoglobin,MB,,
DB01711,"2,3,4,5,6-Pentafluorobenzyl Alcohol",,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB01712,"(3R)-4-(p-toluenesulfonyl)-1,4-thiazane-3-carboxylicacid-L-phenylalanine ethyl ester",,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB01713,UDP-alpha-D-xylose,,P0C0F4,UDP-glucose 6-dehydrogenase,hasB,,
DB01715,"7,8-Diamino-Nonanoic Acid",,P13000,ATP-dependent dethiobiotin synthetase BioD 1,bioD1,,
DB01717,Bis(Adenosine)-5'-Pentaphosphate,,P16304,Adenylate kinase,adk,,
DB01717,Bis(Adenosine)-5'-Pentaphosphate,,P27142,Adenylate kinase,adk,,
DB01717,Bis(Adenosine)-5'-Pentaphosphate,,P84139,Adenylate kinase,adk,,
DB01717,Bis(Adenosine)-5'-Pentaphosphate,,P54819,"Adenylate kinase 2, mitochondrial",AK2,,
DB01717,Bis(Adenosine)-5'-Pentaphosphate,,Q96MA6,Adenylate kinase 8,AK8,,
DB01717,Bis(Adenosine)-5'-Pentaphosphate,,P69441,Adenylate kinase,adk,,
DB01717,Bis(Adenosine)-5'-Pentaphosphate,,P00568,Adenylate kinase isoenzyme 1,AK1,,
DB01718,Cetrimonium,,P9WPB7,Cyclopropane mycolic acid synthase 1,cmaA1,,D08AJ04;D11AC01;R02AA17;D08AJ02
DB01718,Cetrimonium,,Q79FX6,Cyclopropane mycolic acid synthase MmaA2,mmaA2,,D08AJ04;D11AC01;R02AA17;D08AJ02
DB01719,Thio-Maltopentaose,,P30920,Cyclomaltodextrin glucanotransferase,,,
DB01720,(2Z)-2-(Benzoylamino)-3-[4-(2-bromophenoxy)phenyl]acrylic acid,,P26662,Genome polyprotein,,,
DB01721,"N-[2-hydroxy-1-indanyl]-5-[(2-tertiarybutylaminocarbonyl)-4(benzo[1,3]dioxol-5-ylmethyl)-piperazino]-4-hydroxy-2-(1-phenylethyl)-pentanamide",,P35963,Gag-Pol polyprotein,gag-pol,,
DB01723,"{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid",,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB01725,"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",,P00734,Prothrombin,F2,,
DB01725,"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB01725,"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",,P07477,Trypsin-1,PRSS1,,
DB01726,2-Aminophenol,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB01727,Isocitric Acid,,P08200,Isocitrate dehydrogenase [NADP],icd,,
DB01727,Isocitric Acid,,P16100,Isocitrate dehydrogenase [NADP],icd,,
DB01727,Isocitric Acid,,Q99798,"Aconitate hydratase, mitochondrial",ACO2,,
DB01727,Isocitric Acid,,P48735,"Isocitrate dehydrogenase [NADP], mitochondrial",IDH2,,
DB01727,Isocitric Acid,,O75874,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,,
DB01727,Isocitric Acid,,P77541,Methylisocitrate lyase,prpB,,
DB01728,"1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine",,P08100,Rhodopsin,RHO,,
DB01731,(S)-wiskostatin,,P42768,Wiskott-Aldrich syndrome protein,WAS,,
DB01732,"(4R,5S,6S,7R)-1,3-dibenzyl-4,7-bis(phenoxymethyl)-5,6-dihydroxy-1,3 diazepan-2-one",,P03366,Gag-Pol polyprotein,gag-pol,,
DB01733,L-Phospholactate,,P14618,Pyruvate kinase PKM,PKM,,
DB01734,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB01735,3-Chloroalaninate,,Q00740,1-aminocyclopropane-1-carboxylate deaminase,acdS,,
DB01736,[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium,,P12235,ADP/ATP translocase 1,SLC25A4,,
DB01737,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",,P07477,Trypsin-1,PRSS1,,
DB01738,Phosphorylcolamine,,P05771,Protein kinase C beta type,PRKCB,,
DB01741,CRA_17693,,P07477,Trypsin-1,PRSS1,,
DB01742,(3r)-1-Acetyl-3-Methylpiperidine,,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,,
DB01744,Camphor,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,agonist,C01EB02
DB01744,Camphor,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,activator,C01EB02
DB01744,Camphor,,Q8NET8,Transient receptor potential cation channel subfamily V member 3,TRPV3,agonist,C01EB02
DB01744,Camphor,,Q8NET8,Transient receptor potential cation channel subfamily V member 3,TRPV3,activator,C01EB02
DB01744,Camphor,,O75762,Transient receptor potential cation channel subfamily A member 1,TRPA1,inhibitor,C01EB02
DB01744,Camphor,,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,TRPM8,activator,C01EB02
DB01744,Camphor,,P00183,Camphor 5-monooxygenase,camC,substrate,C01EB02
DB01745,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,,P07477,Trypsin-1,PRSS1,,
DB01747,Coprogen,,P07822,Iron(3+)-hydroxamate-binding protein FhuD,fhuD,,
DB01748,N-Benzyl-4-Sulfamoyl-Benzamide,,P00918,Carbonic anhydrase 2,CA2,,
DB01750,1-naphthaleneacetic acid,,P63208,S-phase kinase-associated protein 1,SKP1,,
DB01752,S-adenosyl-L-homocysteine,,P07617,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,PAPS,,
DB01752,S-adenosyl-L-homocysteine,,O87696,Cobalt-precorrin-4 C(11)-methyltransferase,cbiF,,
DB01752,S-adenosyl-L-homocysteine,,P22061,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,PCMT1,,
DB01752,S-adenosyl-L-homocysteine,,P12823,Genome polyprotein,,,
DB01752,S-adenosyl-L-homocysteine,,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB01752,S-adenosyl-L-homocysteine,,P9WPB5,Cyclopropane mycolic acid synthase 2,cmaA2,,
DB01752,S-adenosyl-L-homocysteine,,P14751,Modification methylase RsrI,rsrIM,,
DB01752,S-adenosyl-L-homocysteine,,Q86VU5,Catechol O-methyltransferase domain-containing protein 1,COMTD1,,
DB01752,S-adenosyl-L-homocysteine,,Q06528,Carminomycin 4-O-methyltransferase,dnrK,,
DB01752,S-adenosyl-L-homocysteine,,Q14353,Guanidinoacetate N-methyltransferase,GAMT,,
DB01752,S-adenosyl-L-homocysteine,,P0ACC1,Release factor glutamine methyltransferase,prmC,,
DB01752,S-adenosyl-L-homocysteine,,Q9WYV8,Release factor glutamine methyltransferase,prmC,,
DB01752,S-adenosyl-L-homocysteine,,O60678,Protein arginine N-methyltransferase 3,PRMT3,,
DB01752,S-adenosyl-L-homocysteine,,P50135,Histamine N-methyltransferase,HNMT,,
DB01752,S-adenosyl-L-homocysteine,,Q9WZX6,Ribosomal RNA small subunit methyltransferase H,rsmH,,
DB01752,S-adenosyl-L-homocysteine,,P13956,rRNA adenine N-6-methyltransferase,ermC',,
DB01752,S-adenosyl-L-homocysteine,,O14717,tRNA (cytosine(38)-C(5))-methyltransferase,TRDMT1,,
DB01752,S-adenosyl-L-homocysteine,,Q14749,Glycine N-methyltransferase,GNMT,,
DB01752,S-adenosyl-L-homocysteine,,P44868,tRNA (cytidine(34)-2'-O)-methyltransferase,trmL,,
DB01752,S-adenosyl-L-homocysteine,,P11409,Modification methylase PvuII,pvuIIM,,
DB01752,S-adenosyl-L-homocysteine,,P04392,DNA adenine methylase,DAM,,
DB01752,S-adenosyl-L-homocysteine,,P9WPB3,Cyclopropane mycolic acid synthase 3,pcaA,,
DB01752,S-adenosyl-L-homocysteine,,Q99873,Protein arginine N-methyltransferase 1,PRMT1,,
DB01752,S-adenosyl-L-homocysteine,,P25924,Siroheme synthase,cysG,,
DB01752,S-adenosyl-L-homocysteine,,P05102,Modification methylase HhaI,hhaIM,,
DB01752,S-adenosyl-L-homocysteine,,Q8WTS6,Histone-lysine N-methyltransferase SETD7,SETD7,,
DB01752,S-adenosyl-L-homocysteine,,P43912,tRNA (guanine-N(1)-)-methyltransferase,trmD,,
DB01752,S-adenosyl-L-homocysteine,,Q79FX6,Cyclopropane mycolic acid synthase MmaA2,mmaA2,,
DB01752,S-adenosyl-L-homocysteine,,Q9H2P9,Diphthine synthase,DPH5,,
DB01752,S-adenosyl-L-homocysteine,,Q54527,RdmB,rdmB,,
DB01752,S-adenosyl-L-homocysteine,,P0A876,tRNA (guanine-N(1)-)-methyltransferase,trmD,,
DB01752,S-adenosyl-L-homocysteine,,P21631,Uroporphyrinogen-III C-methyltransferase,cobA,,
DB01752,S-adenosyl-L-homocysteine,,Q5SKH6,Uncharacterized protein,,,
DB01752,S-adenosyl-L-homocysteine,,P07801,Chemotaxis protein methyltransferase,cheR,,
DB01752,S-adenosyl-L-homocysteine,,P14385,Modification methylase TaqI,taqIM,,
DB01752,S-adenosyl-L-homocysteine,,Q56308,Protein-L-isoaspartate O-methyltransferase,pcm,,
DB01753,4-oxo-nicotinamide-adenine dinucleotide phosphate,,P9WIQ3,NADPH-ferredoxin reductase FprA,fprA,,
DB01754,"3,4-Dihydroxy-1-Methylquinolin-2(1h)-One",,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB01755,N-[Isoleucinyl]-N'-[adenosyl]-diaminosufone,,P56690,Isoleucine--tRNA ligase,ileS,,
DB01756,4-phospho-L-threonic acid,,P49247,Ribose-5-phosphate isomerase,RPIA,,
DB01758,3-Iodo-Tyrosine,,P0AGJ9,Tyrosine--tRNA ligase,tyrS,,
DB01760,2-Methoxy-3-Isopropylpyrazine,,Q8WX39,Epididymal-specific lipocalin-9,LCN9,,
DB01761,4-[5-[2-(1-phenyl-ethylamino)-pyrimidin-4-yl]-1-methyl-4-(3-trifluoromethylphenyl)-1H-imidazol-2-yl]-piperidine,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB01762,Acetoacetic acid,,P16930,Fumarylacetoacetase,FAH,,
DB01763,7-thionicotinamide-adenine-dinucleotide phosphate,,Q13423,"NAD(P) transhydrogenase, mitochondrial",NNT,,
DB01764,Dalfopristin,,P50870,Streptogramin A acetyltransferase,vatD,inhibitor,
DB01765,"(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB01766,Beta-(2-Naphthyl)-Alanine,,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,,
DB01766,Beta-(2-Naphthyl)-Alanine,,Q13526,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,PIN1,,
DB01766,Beta-(2-Naphthyl)-Alanine,,P00734,Prothrombin,F2,,
DB01767,Hemi-Babim,,P07477,Trypsin-1,PRSS1,,
DB01767,Hemi-Babim,,P00734,Prothrombin,F2,,
DB01768,Methylumbelliferyl sialic acid,,Q26966,Trans-sialidase,,,
DB01771,CRA_10991,,P07477,Trypsin-1,PRSS1,,
DB01772,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB01773,4-[3-carboxymethyl-3-(4-phosphonooxy-benzyl)-ureido]-4-[(3-cyclohexyl-propyl)-methyl-carbamoyl]butyric acid,,P63185,Tyrosine-protein kinase transforming protein Src,V-SRC,,
DB01774,Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,,P67910,ADP-L-glycero-D-manno-heptose-6-epimerase,hldD,,
DB01775,Dihydroxyacetone,,P45510,Dihydroxyacetone kinase,dhaK,,
DB01776,M-Cresol,,P01308,Insulin,INS,,
DB01777,CoA-S-trimethylene-acetyl-tryptamine,,Q16613,Serotonin N-acetyltransferase,AANAT,,
DB01778,8-Aminotheophylline,,P56740,Dihydroneopterin aldolase,folB,,
DB01779,Glycerol 2-phosphate,,Q07412,Triosephosphate isomerase,TPI,,
DB01780,Fusicoccin,,P62258,14-3-3 protein epsilon,YWHAE,,
DB01782,Pyrazolanthrone,,Q9UQF2,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,,
DB01782,Pyrazolanthrone,,P45983,Mitogen-activated protein kinase 8,MAPK8,,
DB01782,Pyrazolanthrone,,P33981,Dual specificity protein kinase TTK,TTK,,
DB01782,Pyrazolanthrone,,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB01783,Pantothenic acid,,P0A6I3,Pantothenate kinase,coaA,,D03AX04;A11HA31
DB01784,4-Flourobenzenesulfonamide,,P00918,Carbonic anhydrase 2,CA2,,
DB01785,Dimethylallyl Diphosphate,,P14324,Farnesyl pyrophosphate synthase,FDPS,,
DB01785,Dimethylallyl Diphosphate,,Q13907,Isopentenyl-diphosphate Delta-isomerase 1,IDI1,,
DB01785,Dimethylallyl Diphosphate,,P62623,4-hydroxy-3-methylbut-2-enyl diphosphate reductase,ispH,,
DB01786,D-Alanine,,P43133,Thermolysin,nprS,,
DB01786,D-Alanine,,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB01788,2-methyl-5-methylidenepyrimidin-4-imine,,P39594,Thiamine-phosphate synthase,thiE,,
DB01789,"1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene",,P30920,Cyclomaltodextrin glucanotransferase,,,
DB01790,(Rp)-cAMPS,,P10644,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,,
DB01791,Piclamilast,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,,
DB01791,Piclamilast,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,,
DB01791,Piclamilast,,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,,
DB01791,Piclamilast,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB01792,Adenylyl-(3'-5')-uridine 3'-monophosphate,,P00587,Diphtheria toxin,,,
DB01793,SB-409513,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB01795,Phenylboronic acid,,Q9L9D7,Cocaine esterase,cocE,,
DB01796,Quinolinic Acid,,P30012,Nicotinate-nucleotide pyrophosphorylase [carboxylating],nadC,,
DB01796,Quinolinic Acid,,P9WJJ7,Nicotinate-nucleotide pyrophosphorylase [carboxylating],nadC,,
DB01799,4-Hydroxy-3-Methyl Butyl Diphosphate,,Q46822,Isopentenyl-diphosphate Delta-isomerase,idi,,
DB01800,4-Nitrocatechol sulfate,,P15289,Arylsulfatase A,ARSA,,
DB01800,4-Nitrocatechol sulfate,,P15273,Tyrosine-protein phosphatase YopH,yopH,,
DB01803,2-(Trimethylammonium)Ethyl Thiol,,A0A0H3JWX6,NPQTN specific sortase B,srtB,,
DB01804,"2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate",,Q00740,1-aminocyclopropane-1-carboxylate deaminase,acdS,,
DB01805,Monoisopropylphosphorylserine,,P07478,Trypsin-2,PRSS2,,
DB01805,Monoisopropylphosphorylserine,,P00782,Subtilisin BPN',apr,,
DB01805,Monoisopropylphosphorylserine,,P07477,Trypsin-1,PRSS1,,
DB01805,Monoisopropylphosphorylserine,,P22303,Acetylcholinesterase,ACHE,,
DB01806,10-decarboxymethylaclacinomycin A,,Q54528,RdmC,rdmC,,
DB01807,"N-[(3Z)-5-Tert-butyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-ylidene]-N'-(4-chlorophenyl)urea",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB01808,Thiarsahydroxy-Cysteine,,P08692,Arsenate reductase,arsC,,
DB01809,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,,
DB01809,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",,P08631,Tyrosine-protein kinase HCK,HCK,,
DB01810,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",,Q9UBX1,Cathepsin F,CTSF,,
DB01810,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",,P25779,Cruzipain,,,
DB01811,"3h-Indole-5,6-Diol",,P02788,Lactotransferrin,LTF,,
DB01812,"Adenosine 3',5'-diphosphate",,O14792,Heparan sulfate glucosamine 3-O-sulfotransferase 1,HS3ST1,,
DB01812,"Adenosine 3',5'-diphosphate",,O00204,Sulfotransferase family cytosolic 2B member 1,SULT2B1,,
DB01812,"Adenosine 3',5'-diphosphate",,P10153,Non-secretory ribonuclease,RNASE2,,
DB01812,"Adenosine 3',5'-diphosphate",,P50225,Sulfotransferase 1A1,SULT1A1,,
DB01812,"Adenosine 3',5'-diphosphate",,Q9Y663,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,,
DB01812,"Adenosine 3',5'-diphosphate",,P07998,Ribonuclease pancreatic,RNASE1,,
DB01812,"Adenosine 3',5'-diphosphate",,Q06520,Bile salt sulfotransferase,SULT2A1,,
DB01812,"Adenosine 3',5'-diphosphate",,P49888,Estrogen sulfotransferase,SULT1E1,,
DB01812,"Adenosine 3',5'-diphosphate",,P06612,DNA topoisomerase 1,topA,,
DB01812,"Adenosine 3',5'-diphosphate",,P52848,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,NDST1,,
DB01812,"Adenosine 3',5'-diphosphate",,P0A2W7,Holo-[acyl-carrier-protein] synthase,acpS,,
DB01812,"Adenosine 3',5'-diphosphate",,O43704,Sulfotransferase family cytosolic 1B member 1,SULT1B1,,
DB01813,Pyridoxyl-Glutamic Acid-5'-Monophosphate,,P06986,Histidinol-phosphate aminotransferase,hisC,,
DB01813,Pyridoxyl-Glutamic Acid-5'-Monophosphate,,P0AB80,Branched-chain-amino-acid aminotransferase,ilvE,,
DB01814,2-Tridecanoyloxy-Pentadecanoic Acid,,P06971,Ferrichrome-iron receptor,fhuA,,
DB01815,Nz-(Dicarboxymethyl)Lysine,,P0A872,Transaldolase B,talB,,
DB01816,Castanospermine,,P29717,"Glucan 1,3-beta-glucosidase",XOG1,,
DB01817,Threonine-Aspartic Ester,,P00805,L-asparaginase 2,ansB,,
DB01818,O3-Sulfonylgalactose,,P11226,Mannose-binding protein C,MBL2,,
DB01819,Phosphoenolpyruvate,,P0A716,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB01819,Phosphoenolpyruvate,,P13929,Beta-enolase,ENO3,,
DB01819,Phosphoenolpyruvate,,P35558,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,,
DB01819,Phosphoenolpyruvate,,O66496,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB01819,Phosphoenolpyruvate,,Q9WYH8,Phospho-2-dehydro-3-deoxyheptonate aldolase,aroF,,
DB01819,Phosphoenolpyruvate,,P0AB91,"Phospho-2-dehydro-3-deoxyheptonate aldolase, Phe-sensitive",aroG,,
DB01819,Phosphoenolpyruvate,,Q57265,Capsule biosynthesis protein,synC,,
DB01820,2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB01821,"L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB01821,"L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide",,P29475,"Nitric oxide synthase, brain",NOS1,,
DB01822,"(4R,5R)-1,2-dithiane-4,5-diol",,P12256,Penicillin acylase,,,
DB01823,Beta-D-Glucopyranose Spirohydantoin,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB01824,"(3S)-Tetrahydro-3-furanyl {(2S,3S)-4-[(2S,4R)-4-{(1S,2R)-2-[(S)-amino(hydroxy)methoxy]-2,3-dihydro-1H-inden-1-yl}-2-benzyl-3-oxo-2-pyrrolidinyl]-3-hydroxy-1-phenyl-2-butanyl}carbamate",,P03366,Gag-Pol polyprotein,gag-pol,,
DB01825,2-amino-8-methyl-4(1H)-quinazolinone,,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB01826,N-Butyl Isocyanide,,P00183,Camphor 5-monooxygenase,camC,,
DB01826,N-Butyl Isocyanide,,P02144,Myoglobin,MB,,
DB01826,N-Butyl Isocyanide,,P00147,Cytochrome c',,,
DB01826,N-Butyl Isocyanide,,P9WN25,Group 1 truncated hemoglobin GlbN,glbN,,
DB01827,"2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide",,P17931,Galectin-3,LGALS3,,
DB01828,Methylamine,,P69681,Ammonia channel,amtB,,
DB01829,Desulfo-coenzyme A,,P26841,Chloramphenicol acetyltransferase,cat,,
DB01830,AP-22408,,P06239,Tyrosine-protein kinase Lck,LCK,,
DB01831,Tryptophanyl-5'amp,,P23381,"Tryptophan--tRNA ligase, cytoplasmic",WARS,,
DB01831,Tryptophanyl-5'amp,,P00953,Tryptophan--tRNA ligase,trpS,,
DB01832,4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid,,P16930,Fumarylacetoacetase,FAH,,
DB01833,Canavanine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB01834,"(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",,P09211,Glutathione S-transferase P,GSTP1,,
DB01834,"(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",,P09488,Glutathione S-transferase Mu 1,GSTM1,,
DB01835,4R-Fluoro-N6-ethanimidoyl-L-lysine,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB01836,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",,P07477,Trypsin-1,PRSS1,,
DB01837,O-acetyl-L-serine,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB01839,Propylene glycol,,Q8GEZ8,B12-independent glycerol dehydratase,dhaB1,,
DB01840,2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate,,Q9NPH2,Inositol-3-phosphate synthase 1,ISYNA1,,
DB01841,"4,6-Dideoxyglucose",,Q60053,Neopullulanase 1,tvaI,,
DB01841,"4,6-Dideoxyglucose",,P05618,Cyclomaltodextrin glucanotransferase,cgt,,
DB01841,"4,6-Dideoxyglucose",,P19571,"Glucan 1,4-alpha-maltohexaosidase",,,
DB01841,"4,6-Dideoxyglucose",,P00691,Alpha-amylase,amyE,,
DB01841,"4,6-Dideoxyglucose",,P30920,Cyclomaltodextrin glucanotransferase,,,
DB01842,3'-Phosphate-Adenosine-5'-Diphosphate,,P07998,Ribonuclease pancreatic,RNASE1,,
DB01842,3'-Phosphate-Adenosine-5'-Diphosphate,,P9WQG9,Aminoglycoside 2'-N-acetyltransferase,aac,,
DB01843,"(5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB01844,"N,N-dimethylformamide",,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB01844,"N,N-dimethylformamide",,P00797,Renin,REN,,
DB01846,Oxidized coenzyme A,,O06644,Formyl-coenzyme A transferase,frc,,
DB01846,Oxidized coenzyme A,,P10802,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex,,,
DB01847,N-Carbamyl-D-Valine,,P60327,N-carbamoyl-D-amino acid hydrolase,,,
DB01851,Tetrabutylammonium Ion,,P01834,Ig kappa chain C region,IGKC,,
DB01851,Tetrabutylammonium Ion,,P0A334,pH-gated potassium channel KcsA,kcsA,,
DB01852,Kaempherol,,Q6NUS8,UDP-glucuronosyltransferase 3A1,UGT3A1,,
DB01853,Bacteriochlorophyll A,,P11741,Bacteriochlorophyll a protein,,,
DB01853,Bacteriochlorophyll A,,Q46393,Bacteriochlorophyll a protein,fmoA,,
DB01854,5-Bromonicotinamide,,P52961,GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1,ART1,,
DB01856,Pimelic Acid,,P56220,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",dapD,,
DB01857,Phosphoaspartate,,P71447,Beta-phosphoglucomutase,pgmB,,
DB01857,Phosphoaspartate,,P41789,Nitrogen regulation protein NR(I),glnG,,
DB01858,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,,P43235,Cathepsin K,CTSK,,
DB01859,4-CDP-2-C-methyl-D-erythritol 2-phosphate,,P62619,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB01860,Cordycepin Triphosphate,,P51003,Poly(A) polymerase alpha,PAPOLA,,
DB01861,Uridine diphosphate glucose,,P09148,Galactose-1-phosphate uridylyltransferase,galT,,
DB01861,Uridine diphosphate glucose,,Q14376,UDP-glucose 4-epimerase,GALE,,
DB01861,Uridine diphosphate glucose,,P31677,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",otsA,,
DB01861,Uridine diphosphate glucose,,P26393,Glucose-1-phosphate thymidylyltransferase,rmlA,,
DB01861,Uridine diphosphate glucose,,P09147,UDP-glucose 4-epimerase,galE,,
DB01861,Uridine diphosphate glucose,,P04547,DNA beta-glucosyltransferase,bgt,,
DB01861,Uridine diphosphate glucose,,Q7Z4J2,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,,
DB01861,Uridine diphosphate glucose,,Q8KN66,WbpP,,,
DB01861,Uridine diphosphate glucose,,P46976,Glycogenin-1,GYG1,,
DB01861,Uridine diphosphate glucose,,Q13304,Uracil nucleotide/cysteinyl leukotriene receptor,GPR17,regulator,
DB01862,Isopropyl beta-D-thiogalactopyranoside,,P00722,Beta-galactosidase,lacZ,,
DB01862,Isopropyl beta-D-thiogalactopyranoside,,P07464,Galactoside O-acetyltransferase,lacA,,
DB01862,Isopropyl beta-D-thiogalactopyranoside,,P03023,Lactose operon repressor,lacI,,
DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",,P23677,Inositol-trisphosphate 3-kinase A,ITPKA,,
DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",,Q99418,Cytohesin-2,CYTH2,,
DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",,O43739,Cytohesin-3,CYTH3,,
DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,,
DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",,Q9H4M7,Pleckstrin homology domain-containing family A member 4,PLEKHA4,,
DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",,Q9UN19,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,DAPP1,,
DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,,P62330,ADP-ribosylation factor 6,ARF6,,
DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,,Q08188,Protein-glutamine gamma-glutamyltransferase E,TGM3,,
DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,,P9WN95,Cell division protein FtsZ,ftsZ,,
DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,,P62491,Ras-related protein Rab-11A,RAB11A,,
DB01865,3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,,P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,
DB01866,RU79256,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB01868,Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate,,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB01870,"1,4-dithio-alpha-D-glucopyranose",,P19961,Alpha-amylase 2B,AMY2B,,
DB01871,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,,Q9UBX1,Cathepsin F,CTSF,,
DB01871,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,,P25779,Cruzipain,,,
DB01872,2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,,Q46079,Chondroitinase-B,cslB,,
DB01872,2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,,Q54873,Hyaluronate lyase,,,
DB01872,2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,,Q59288,Chondroitinase-AC,cslA,,
DB01872,2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,,P84141,Chondroitinase (Chondroitin lyase),,,
DB01873,Epothilone D,,Q13748,Tubulin alpha 3C/D chain,TUBA3C,,
DB01873,Epothilone D,,P07437,Tubulin beta chain,TUBB,,
DB01873,Epothilone D,,Q9H4B7,Tubulin beta-1 chain,TUBB1,,
DB01873,Epothilone D,,P68371,Tubulin beta-4B chain,TUBB4B,,
DB01873,Epothilone D,,P04350,Tubulin beta-4A chain,TUBB4A,,
DB01873,Epothilone D,,P68366,Tubulin alpha-4A chain,TUBA4A,,
DB01873,Epothilone D,,Q13509,Tubulin beta-3 chain,TUBB3,,
DB01873,Epothilone D,,Q9BQE3,Tubulin alpha-1C chain,TUBA1C,,
DB01873,Epothilone D,,Q9NY65,Tubulin alpha-8 chain,TUBA8,,
DB01873,Epothilone D,,P68363,Tubulin alpha-1B chain,TUBA1B,,
DB01873,Epothilone D,,Q71U36,Tubulin alpha-1A chain,TUBA1A,,
DB01875,8-azaxanthine,,Q45697,Uric acid degradation bifunctional protein,uao,,
DB01876,Bis(5-Amidino-2-Benzimidazolyl)Methanone,,P07477,Trypsin-1,PRSS1,,
DB01877,"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",,P08254,Stromelysin-1,MMP3,,
DB01878,Benzophenone,,P03372,Estrogen receptor alpha,ESR1,,
DB01878,Benzophenone,,Q92731,Estrogen receptor beta,ESR2,,
DB01879,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,,P33038,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,murA,,
DB01880,"3,4-Dihydroxycinnamic Acid",,Q3IWB0,Histidine ammonia-lyase,hutH,,
DB01880,"3,4-Dihydroxycinnamic Acid",,P14174,Macrophage migration inhibitory factor,MIF,,
DB01880,"3,4-Dihydroxycinnamic Acid",,P16113,Photoactive yellow protein,pyp,,
DB01881,"2-Methylpentane-1,2,4-Triol",,P24300,Xylose isomerase,xylA,,
DB01882,"(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol",,P0A078,Methionine aminopeptidase,map,,
DB01882,"(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol",,P0A079,Methionine aminopeptidase,map,,
DB01883,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,,P15917,Lethal factor,lef,,
DB01884,2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB01885,D-Galctopyranosyl-1-On,,P00722,Beta-galactosidase,lacZ,,
DB01887,"N,N-[2,5-O-Dibenzyl-glucaryl]-DI-[1-amino-indan-2-OL]",,P12499,Gag-Pol polyprotein,gag-pol,,
DB01887,"N,N-[2,5-O-Dibenzyl-glucaryl]-DI-[1-amino-indan-2-OL]",,P03366,Gag-Pol polyprotein,gag-pol,,
DB01888,"4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB01889,"16,17-Androstene-3-Ol",,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,,
DB01890,"N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide",,P05019,Insulin-like growth factor I,IGF1,,
DB01890,"N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide",,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB01891,Tl-3-093,,P16088,Pol polyprotein,pol,,
DB01891,Tl-3-093,,P03366,Gag-Pol polyprotein,gag-pol,,
DB01892,Hyperforin,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB01892,Hyperforin,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB01892,Hyperforin,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,
DB01893,N6-Benzyl Adenosine-5'-Diphosphate,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB01895,Aspartyl-Adenosine-5'-Monophosphate,,P36419,Aspartate--tRNA ligase,aspS,,
DB01896,M-Aminophenylboronic Acid,,P00811,Beta-lactamase,ampC,,
DB01897,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,,O60760,Hematopoietic prostaglandin D synthase,HPGDS,,
DB01899,Nd1-Phosphonohistidine,,P08877,Phosphocarrier protein HPr,ptsH,,
DB01901,Sucrosofate,,P21802,Fibroblast growth factor receptor 2,FGFR2,ligand,
DB01901,Sucrosofate,,P05230,Fibroblast growth factor 1,FGF1,,
DB01902,"1-Ethyl-Pyrrolidine-2,5-Dione",,P46459,Vesicle-fusing ATPase,NSF,,
DB01902,"1-Ethyl-Pyrrolidine-2,5-Dione",,Q86YB8,ERO1-like protein beta,ERO1B,,
DB01903,5-Bromo-2'-deoxyuridine 5'-(dihydrogen phosphate),,Q9WYT0,Thymidylate synthase ThyX,thyX,,
DB01905,2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,,P07477,Trypsin-1,PRSS1,,
DB01905,2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB01906,"3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid",,P56740,Dihydroneopterin aldolase,folB,,
DB01908,RU85493,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB01909,Alpha-Cyclodextrin (Cyclohexa-Amylose),,P30920,Cyclomaltodextrin glucanotransferase,,,
DB01910,Sinefungin,,P14751,Modification methylase RsrI,rsrIM,,
DB01910,Sinefungin,,Q54527,RdmB,rdmB,,
DB01910,Sinefungin,,P13956,rRNA adenine N-6-methyltransferase,ermC',,
DB01910,Sinefungin,,P14385,Modification methylase TaqI,taqIM,,
DB01911,N-Methylmesoporphyrin,,P32396,Ferrochelatase,hemH,,
DB01912,"2,2':6',2''-Terpyridine Platinum(Ii)",,P06653,Autolysin,lytA,,
DB01912,"2,2':6',2''-Terpyridine Platinum(Ii)",,Q46730,Truncated transposase,tnp,,
DB01915,S-Hydroxycysteine,,P01024,Complement C3,C3,,
DB01915,S-Hydroxycysteine,,P00282,Azurin,azu,,
DB01915,S-Hydroxycysteine,,P09211,Glutathione S-transferase P,GSTP1,,
DB01915,S-Hydroxycysteine,,Q9BWD1,"Acetyl-CoA acetyltransferase, cytosolic",ACAT2,,
DB01915,S-Hydroxycysteine,,P08263,Glutathione S-transferase A1,GSTA1,,
DB01915,S-Hydroxycysteine,,P02689,Myelin P2 protein,PMP2,,
DB01915,S-Hydroxycysteine,,P07097,Acetyl-CoA acetyltransferase,phbA,,
DB01915,S-Hydroxycysteine,,P00782,Subtilisin BPN',apr,,
DB01917,Putrescine,,P08588,Beta-1 adrenergic receptor,ADRB1,,
DB01917,Putrescine,,P07550,Beta-2 adrenergic receptor,ADRB2,,
DB01917,Putrescine,,P11926,Ornithine decarboxylase,ODC1,,
DB01917,Putrescine,,P17707,S-adenosylmethionine decarboxylase proenzyme,AMD1,,
DB01917,Putrescine,,P31133,Putrescine-binding periplasmic protein,potF,,
DB01918,[Methyltelluro]Acetate,,P40859,Monomeric sarcosine oxidase,soxA,,
DB01919,Pentanal,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB01920,1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose,,P00722,Beta-galactosidase,lacZ,,
DB01921,Xylose-derived lactam oxime,,P07986,Exoglucanase/xylanase,cex,,
DB01922,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",,P04746,Pancreatic alpha-amylase,AMY2A,,
DB01923,L-Xylulose 5-Phosphate,,P39304,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,ulaD,,
DB01925,"2'-Chloro-Biphenyl-2,3-Diol",,P47228,"Biphenyl-2,3-diol 1,2-dioxygenase",bphC,,
DB01926,Carboxymycobactin S,,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,,
DB01927,Duroquinone,,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,,
DB01929,"5-Chloryl-2,4,6-quinazolinetriamine",,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFRL1,,
DB01929,"5-Chloryl-2,4,6-quinazolinetriamine",,P22906,Dihydrofolate reductase,DFR1,,
DB01930,"2,4-Dihydroxy-3,3-Dimethyl-Butyrate",,P9WIL5,Pantothenate synthetase,panC,,
DB01931,"5,7-Dichlorokynurenic acid",,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,,
DB01932,5-Methylpyrrole,,P00720,Lysozyme,E,,
DB01933,7-Hydroxystaurosporine,,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB01934,Arylomycin A2,,P00803,Signal peptidase I,lepB,,
DB01935,3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid,,P00800,Thermolysin,npr,,
DB01935,3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid,,P43133,Thermolysin,nprS,,
DB01936,alpha-D-arabinofuranose,,P0A9J6,Ribokinase,rbsK,,
DB01937,Guanosine-2'-monophosphate,,P05798,Guanyl-specific ribonuclease Sa,rnaSA,,
DB01938,L-Histidine Beta Naphthylamide,,P10943,Hut operon positive regulatory protein,hutP,,
DB01939,5-Amidino-Benzimidazole,,P07477,Trypsin-1,PRSS1,,
DB01940,Balanol Analog 2,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB01941,LG-100268,,P28702,Retinoic acid receptor RXR-beta,RXRB,,
DB01942,Formic acid,,Q46891,Putative hydroxypyruvate isomerase YgbM,ygbM,,
DB01942,Formic acid,,Q59643,Delta-aminolevulinic acid dehydratase,hemB,,
DB01942,Formic acid,,P09601,Heme oxygenase 1,HMOX1,,
DB01942,Formic acid,,P07998,Ribonuclease pancreatic,RNASE1,,
DB01942,Formic acid,,P0A6D3,3-phosphoshikimate 1-carboxyvinyltransferase,aroA,,
DB01942,Formic acid,,P00780,Subtilisin Carlsberg,apr,,
DB01942,Formic acid,,P05230,Fibroblast growth factor 1,FGF1,,
DB01942,Formic acid,,P0A6K3,Peptide deformylase,def,,
DB01942,Formic acid,,P05041,Para-aminobenzoate synthase component 1,pabB,,
DB01942,Formic acid,,P00918,Carbonic anhydrase 2,CA2,,
DB01942,Formic acid,,P0A7E1,Dihydroorotate dehydrogenase (quinone),pyrD,,
DB01942,Formic acid,,Q60099,(S)-2-haloacid dehalogenase,dhlB,,
DB01942,Formic acid,,P0A1V8,Beta-lactamase OXA-2,bla,,
DB01942,Formic acid,,P42321,Catalase,katA,,
DB01942,Formic acid,,O07347,Signal recognition particle protein,ffh,,
DB01942,Formic acid,,P22629,Streptavidin,,,
DB01942,Formic acid,,P0A733,Methylglyoxal synthase,mgsA,,
DB01942,Formic acid,,Q13363,C-terminal-binding protein 1,CTBP1,,
DB01942,Formic acid,,Q9X0N8,6-phosphogluconolactonase,pgl,,
DB01942,Formic acid,,P9WPE1,Citrate lyase subunit beta-like protein,citE,,
DB01942,Formic acid,,O14936,Peripheral plasma membrane protein CASK,CASK,,
DB01942,Formic acid,,P9WKE9,Guanylate kinase,gmk,,
DB01942,Formic acid,,Q9X278,Probable butyrate kinase 2,buk2,,
DB01942,Formic acid,,Q9BVM4,Gamma-glutamylaminecyclotransferase,GGACT,,
DB01942,Formic acid,,P20472,Parvalbumin alpha,PVALB,,
DB01942,Formic acid,,P14621,Acylphosphatase-2,ACYP2,,
DB01942,Formic acid,,Q81C15,Uncharacterized protein,,,
DB01942,Formic acid,,P80357,Arginine N-succinyltransferase subunit alpha,astA,,
DB01942,Formic acid,,P39841,Putative mannose-6-phosphate isomerase YvyI,yvyI,,
DB01942,Formic acid,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB01942,Formic acid,,Q9X0V0,"ABC-type transporter, periplasmic subunit",,,
DB01942,Formic acid,,P75914,Probable phosphatase YcdX,ycdX,,
DB01942,Formic acid,,Q7DC80,Phenazine biosynthesis protein PhzD,phzD1,,
DB01942,Formic acid,,O34714,Oxalate decarboxylase OxdC,oxdC,,
DB01942,Formic acid,,P16544,Putative ketoacyl reductase,actIII,,
DB01942,Formic acid,,Q9NQX3,Gephyrin,GPHN,,
DB01942,Formic acid,,Q81F54,Glyoxalase family protein,,,
DB01942,Formic acid,,Q99418,Cytohesin-2,CYTH2,,
DB01942,Formic acid,,Q06700,Glutaconyl-CoA decarboxylase subunit alpha,gcdA,,
DB01942,Formic acid,,Q9WXS0,"Transcriptional regulator, IclR family",,,
DB01942,Formic acid,,P77872,Catalase,katA,,
DB01942,Formic acid,,Q9X0F9,Putative L-rhamnose mutarotase,,,
DB01942,Formic acid,,Q8ILQ7,Glutathione S-transferase,GST,,
DB01942,Formic acid,,Q27796,Hypoxanthine-guanine phosphoribosyltransferase,HGPRTase,,
DB01942,Formic acid,,O31465,Glutaminase 1,glsA1,,
DB01942,Formic acid,,P77454,Glutaminase 1,glsA1,,
DB01942,Formic acid,,P30749,Molybdopterin synthase catalytic subunit,moaE,,
DB01942,Formic acid,,Q9X0L5,"Aminotransferase, putative",,,
DB01942,Formic acid,,Q9Z4N6,Iron binding protein FbpA,fbpA,,
DB01942,Formic acid,,Q5SHZ4,DNA gyrase subunit B,gyrB,,
DB01944,(S)-blebbistatin,,Q7Z406,Myosin-14,MYH14,,
DB01946,Bisindolylmaleimide VIII,,Q09013,Myotonin-protein kinase,DMPK,,
DB01946,Bisindolylmaleimide VIII,,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB01947,RU78262,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB01948,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB01949,"2-Amino-N,3,3-Trimethylbutanamide",,P14780,Matrix metalloproteinase-9,MMP9,,
DB01950,AR-AO-14418,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB01951,Gpi-1046,,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB01952,"1,N6-Ethenoadenine",,O25323,Endonuclease III,,,
DB01953,Inhibitor of P38 Kinase,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB01954,Rolipram,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB01954,Rolipram,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,,
DB01954,Rolipram,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)",PDE4A,inhibitor,
DB01955,"1,4-Butanediol",,Q9UKM7,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,,
DB01955,"1,4-Butanediol",,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB01955,"1,4-Butanediol",,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB01955,"1,4-Butanediol",,P45124,Ribosomal small subunit pseudouridine synthase A,rsuA,,
DB01955,"1,4-Butanediol",,P0C0T5,Penicillin-insensitive murein endopeptidase,mepA,,
DB01956,Taurine,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,inhibitor,
DB01956,Taurine,,P23416,Glycine receptor subunit alpha-2,GLRA2,agonist,
DB01956,Taurine,,O75311,Glycine receptor subunit alpha-3,GLRA3,agonist,
DB01956,Taurine,,P14867,GABA(A) Receptor,GABRA1,agonist,
DB01956,Taurine,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,agonist,
DB01956,Taurine,,P23415,Glycine receptor subunit alpha-1,GLRA1,agonist,
DB01956,Taurine,,P37610,Alpha-ketoglutarate-dependent taurine dioxygenase,tauD,,
DB01956,Taurine,,P54965,Choloylglycine hydrolase,cbh,,
DB01957,3-Chlorophenol,,P00720,Lysozyme,E,,
DB01958,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFRL1,,
DB01958,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",,P22906,Dihydrofolate reductase,DFR1,,
DB01959,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB01959,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,,
DB01960,"7-methyl-7,8-dihydroguanosine-5'-diphosphate",,Q96C86,m7GpppX diphosphatase,DCPS,,
DB01960,"7-methyl-7,8-dihydroguanosine-5'-diphosphate",,P07617,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,PAPS,,
DB01960,"7-methyl-7,8-dihydroguanosine-5'-diphosphate",,P06730,Eukaryotic translation initiation factor 4E,EIF4E,,
DB01961,Cytidine 3'-monophosphate,,P07998,Ribonuclease pancreatic,RNASE1,,
DB01962,Phosphonotyrosine,,P08631,Tyrosine-protein kinase HCK,HCK,,
DB01962,Phosphonotyrosine,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB01962,Phosphonotyrosine,,P10721,Mast/stem cell growth factor receptor Kit,KIT,,
DB01963,Phenylethane Boronic Acid,,P17538,Chymotrypsinogen B,CTRB1,,
DB01964,AL5424,,P00918,Carbonic anhydrase 2,CA2,,
DB01965,"2'-Deoxyuridine 5'-alpha,beta-imido-triphosphate",,P9WNS5,Deoxyuridine 5'-triphosphate nucleotidohydrolase,dut,,
DB01965,"2'-Deoxyuridine 5'-alpha,beta-imido-triphosphate",,P06968,Deoxyuridine 5'-triphosphate nucleotidohydrolase,dut,,
DB01966,Di-Stearoyl-3-Sn-Phosphatidylethanolamine,,P07602,Proactivator polypeptide,PSAP,,
DB01967,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",,P77173,Cell division protein ZipA,zipA,,
DB01967,"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",,Q83QN9,Cell division protein ZipA homolog,zipA,,
DB01968,2-Thioethenamine,,P43683,Lantibiotic mersacidin,mrsA,,
DB01969,Trifluoroacetonyl coenzyme A,,O75390,"Citrate synthase, mitochondrial",CS,,
DB01970,"Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide",,Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,,
DB01971,trans-urocanic acid,,Q88CZ6,Urocanate hydratase,hutU,,
DB01972,Guanosine-5'-Monophosphate,,Q16774,Guanylate kinase,GUK1,,
DB01972,Guanosine-5'-Monophosphate,,Q9A5I5,Response regulator PleD,pleD,,
DB01972,Guanosine-5'-Monophosphate,,Q38087,DNA polymerase,43,,
DB01972,Guanosine-5'-Monophosphate,,P78352,Disks large homolog 4,DLG4,,
DB01972,Guanosine-5'-Monophosphate,,P36959,GMP reductase 1,GMPR,,
DB01972,Guanosine-5'-Monophosphate,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,,
DB01972,Guanosine-5'-Monophosphate,,P49773,Histidine triad nucleotide-binding protein 1,HINT1,,
DB01972,Guanosine-5'-Monophosphate,,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,,
DB01972,Guanosine-5'-Monophosphate,,P00497,Amidophosphoribosyltransferase,purF,,
DB01972,Guanosine-5'-Monophosphate,,Q08188,Protein-glutamine gamma-glutamyltransferase E,TGM3,,
DB01972,Guanosine-5'-Monophosphate,,P41007,Bifunctional protein PyrR,pyrR,,
DB01972,Guanosine-5'-Monophosphate,,P0A9M5,Xanthine phosphoribosyltransferase,gpt,,
DB01972,Guanosine-5'-Monophosphate,,P0AG16,Amidophosphoribosyltransferase,purF,,
DB01972,Guanosine-5'-Monophosphate,,Q05599,Bifunctional adenosylcobalamin biosynthesis protein CobU,cobU,,
DB01973,O-Benzylsulfonyl-Serine,,P29600,Subtilisin Savinase,,,
DB01973,O-Benzylsulfonyl-Serine,,P07478,Trypsin-2,PRSS2,,
DB01973,O-Benzylsulfonyl-Serine,,P0A115,Carboxymethylenebutenolidase,clcD,,
DB01973,O-Benzylsulfonyl-Serine,,P16753,Capsid scaffolding protein,UL80,,
DB01973,O-Benzylsulfonyl-Serine,,P27693,Alkaline protease,,,
DB01975,AMPCPR,,P83844,ADP-ribose pyrophosphatase,nudF,,
DB01975,AMPCPR,,O33199,MutT/nudix family protein,,,
DB01977,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB01978,"7,9-Dimethylguanine",,P07617,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,PAPS,,
DB01979,Methyl alpha-D-mannoside,,P11226,Mannose-binding protein C,MBL2,,
DB01980,Para-Iodo-D-Phenylalanine Hydroxamic Acid,,Q01693,Bacterial leucyl aminopeptidase,,,
DB01981,"3,6-Anhydro-2-(hydrogen sulfate)-alpha-D-galactopyranose",,Q9F5I8,Iota-carrageenase,cgiA,,
DB01982,D-Mannuronic Acid,,Q9KWT6,AlgQ1,algQ1,,
DB01982,D-Mannuronic Acid,,Q9KWT5,AlgQ2,algQ2,,
DB01983,2(S)-Amino-6-Boronohexanoic Acid,,P05089,Arginase-1,ARG1,,
DB01985,N-acetyl-L-arginine,,Q05581,Clavaminate synthase 1,cs1,,
DB01986,3-Fluoro-2-Methyl-Aniline,,P00720,Lysozyme,E,,
DB01987,Cocarboxylase,,,RNA,,binder,
DB01987,Cocarboxylase,,P27696,"Acetolactate synthase, catabolic",budB,cofactor,
DB01987,Cocarboxylase,,P27696,"Acetolactate synthase, catabolic",budB,product of,
DB01987,Cocarboxylase,,P0AFG8,Pyruvate dehydrogenase E1 component,aceE,,
DB01987,Cocarboxylase,,P94692,Pyruvate-flavodoxin oxidoreductase,por,,
DB01987,Cocarboxylase,,P23234,Indole-3-pyruvate decarboxylase,ipdC,,
DB01987,Cocarboxylase,,Q9LCV9,Carboxyethylarginine synthase,ceaS,,
DB01987,Cocarboxylase,,P27302,Transketolase 1,tktA,,
DB01988,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB01989,Methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate,,Q9Y6L7,Tolloid-like protein 2,TLL2,,
DB01990,Cholesterol sulfate,,P35398,Nuclear receptor ROR-alpha,RORA,,
DB01991,TU-514,,O67648,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,lpxC,,
DB01992,Coenzyme A,,P07464,Galactoside O-acetyltransferase,lacA,,
DB01992,Coenzyme A,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,,
DB01992,Coenzyme A,,P0A8V9,Fatty acid metabolism regulator protein,fadR,,
DB01992,Coenzyme A,,Q92993,Histone acetyltransferase KAT5,KAT5,,
DB01992,Coenzyme A,,P56220,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",dapD,,
DB01992,Coenzyme A,,Q9BWD1,"Acetyl-CoA acetyltransferase, cytosolic",ACAT2,,
DB01992,Coenzyme A,,P07097,Acetyl-CoA acetyltransferase,phbA,,
DB01992,Coenzyme A,,P50870,Streptogramin A acetyltransferase,vatD,,
DB01992,Coenzyme A,,O75390,"Citrate synthase, mitochondrial",CS,,
DB01992,Coenzyme A,,P0A6R0,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB01992,Coenzyme A,,O06644,Formyl-coenzyme A transferase,frc,,
DB01992,Coenzyme A,,P10802,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex,,,
DB01992,Coenzyme A,,P0A6I3,Pantothenate kinase,coaA,,
DB01992,Coenzyme A,,Q8ZKF6,Acetyl-coenzyme A synthetase,acs,,
DB01992,Coenzyme A,,P07108,Acyl-CoA-binding protein,DBI,,
DB01992,Coenzyme A,,P69903,Formyl-coenzyme A transferase,frc,,
DB01992,Coenzyme A,,P43155,Carnitine O-acetyltransferase,CRAT,,
DB01992,Coenzyme A,,P31572,Crotonobetainyl-CoA:carnitine CoA-transferase,caiB,,
DB01992,Coenzyme A,,P09373,Formate acetyltransferase 1,pflB,,
DB01992,Coenzyme A,,P9WK17,Malate synthase G,glcB,,
DB01992,Coenzyme A,,P13702,3-hydroxy-3-methylglutaryl-coenzyme A reductase,mvaA,,
DB01992,Coenzyme A,,P0A6I8,Phosphopantetheine adenylyltransferase,coaD,,
DB01992,Coenzyme A,,P96618,Holo-[acyl-carrier-protein] synthase,acpS,,
DB01992,Coenzyme A,,P21340,Protease synthase and sporulation negative regulatory protein PAI 1,paiA,,
DB01992,Coenzyme A,,P23181,Gentamicin 3'-acetyltransferase,aacC1,,
DB01992,Coenzyme A,,P0ACC7,Bifunctional protein GlmU,glmU,,
DB01992,Coenzyme A,,Q8ZPC0,Acetyl transferase,rimL,,
DB01992,Coenzyme A,,O32248,Uncharacterized N-acetyltransferase YvbK,yvbK,,
DB01992,Coenzyme A,,Q9R381,Aminoglycoside N(6')-acetyltransferase type 1,,,
DB01992,Coenzyme A,,Q81EE4,Acyl-CoA hydrolase,,,
DB01992,Coenzyme A,,P44886,Uncharacterized acyl-CoA thioester hydrolase HI_0827,,,
DB01992,Coenzyme A,,Q9F6D4,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB01992,Coenzyme A,,P9WJM7,Mycothiol acetyltransferase,mshD,,
DB01992,Coenzyme A,,Q92830,Histone acetyltransferase KAT2A,KAT2A,,
DB01992,Coenzyme A,,Q9KEQ1,Acyl-CoA hydrolase,,,
DB01992,Coenzyme A,,Q92831,Histone acetyltransferase KAT2B,KAT2B,,
DB01992,Coenzyme A,,P9WNP5,"1,4-Dihydroxy-2-naphthoyl-CoA synthase",menB,,
DB01992,Coenzyme A,,Q9LCX9,Citrate synthase,cit,,
DB01992,Coenzyme A,,P9WQG9,Aminoglycoside 2'-N-acetyltransferase,aac,,
DB01992,Coenzyme A,,Q47764,Aac(6')-Ii protein,aac(6')-Ii,,
DB01992,Coenzyme A,,P39135,4'-phosphopantetheinyl transferase sfp,sfp,,
DB01992,Coenzyme A,,Q9HYX1,Uncharacterized protein,,,
DB01992,Coenzyme A,,P43886,Serine acetyltransferase,cysE,,
DB01992,Coenzyme A,,O34002,Citrate synthase,gltA,,
DB01992,Coenzyme A,,Q04416,4-hydroxybenzoyl-CoA thioesterase,fcbC,,
DB01993,N-(5'-Phosphopyridoxyl)-D-Alanine,,P10724,Alanine racemase,alr,,
DB01996,3-Methylpyridine,,P45452,Collagenase 3,MMP13,,
DB01996,3-Methylpyridine,,P08254,Stromelysin-1,MMP3,,
DB01997,3-Bromo-7-Nitroindazole,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB01997,3-Bromo-7-Nitroindazole,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB01997,3-Bromo-7-Nitroindazole,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB01998,"2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol",,P01009,Alpha-1-antitrypsin,SERPINA1,,
DB02001,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFRL1,,
DB02001,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",,P22906,Dihydrofolate reductase,DFR1,,
DB02004,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB02005,2-Oxo-3-Pentenoic Acid,,Q01468,2-hydroxymuconate tautomerase,xylH,,
DB02007,alpha-D-glucose 6-phosphate,,P19367,Hexokinase-1,HK1,,
DB02007,alpha-D-glucose 6-phosphate,,P26276,Phosphomannomutase/phosphoglucomutase,algC,,
DB02007,alpha-D-glucose 6-phosphate,,P54716,Maltose-6'-phosphate glucosidase,glvA,,
DB02007,alpha-D-glucose 6-phosphate,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02007,alpha-D-glucose 6-phosphate,,P31677,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",otsA,,
DB02007,alpha-D-glucose 6-phosphate,,P17169,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],glmS,,
DB02007,alpha-D-glucose 6-phosphate,,Q9X108,6-phospho-beta-glucosidase BglT,bglT,,
DB02007,alpha-D-glucose 6-phosphate,,P06744,Glucose-6-phosphate isomerase,GPI,,
DB02007,alpha-D-glucose 6-phosphate,,P15121,Aldose reductase,AKR1B1,,
DB02008,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,,P35558,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,,
DB02009,L-756423,,P03366,Gag-Pol polyprotein,gag-pol,,
DB02010,Staurosporine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,,
DB02010,Staurosporine,,P06239,Tyrosine-protein kinase Lck,LCK,,
DB02010,Staurosporine,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB02010,Staurosporine,,Q08881,Tyrosine-protein kinase ITK/TSK,ITK,,
DB02010,Staurosporine,,P43405,Tyrosine-protein kinase SYK,SYK,,
DB02010,Staurosporine,,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,,
DB02010,Staurosporine,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB02010,Staurosporine,,P41240,Tyrosine-protein kinase CSK,CSK,,
DB02010,Staurosporine,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02010,Staurosporine,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB02010,Staurosporine,,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB02010,Staurosporine,,Q04759,Protein kinase C theta type,PRKCQ,,
DB02010,Staurosporine,,P43403,Tyrosine-protein kinase ZAP-70,ZAP70,,
DB02010,Staurosporine,,P17252,Protein kinase C,PRKCA,inhibitor,
DB02011,N-(Phosphonoacetyl)-L-Ornithine,,P00480,"Ornithine carbamoyltransferase, mitochondrial",OTC,,
DB02014,"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02015,Dihydrofolic Acid,,P0ABQ4,Dihydrofolate reductase,folA,,
DB02015,Dihydrofolic Acid,,Q8I814,Putative pteridine reductase 2,ptr2,,
DB02016,R048-8071,,P48449,Lanosterol synthase,LSS,,
DB02017,Imidazole-Derived Cellobiose,,O85465,Endoglucanase 5A,cel5A,,
DB02018,Amido Phenyl Pyruvic Acid,,P20231,Tryptase beta-2,TPSB2,,
DB02019,Acetyl Dithranol,,Q53908,ActVA 6 protein,actVA 6,,
DB02020,Alrestatin,,P15121,Aldose reductase,AKR1B1,,
DB02021,Fidarestat,,O60218,Aldo-keto reductase family 1 member B10,AKR1B10,inhibitor,
DB02021,Fidarestat,,P15121,Aldose reductase,AKR1B1,inhibitor,
DB02022,4-Amino-5-Hydroxymethyl-2-Methylpyrimidine,,P25052,Thiaminase-2,tenA,,
DB02022,4-Amino-5-Hydroxymethyl-2-Methylpyrimidine,,P55882,Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase,thiD,,
DB02023,8-oxo-dGMP,,P08337,8-oxo-dGTP diphosphatase,mutT,,
DB02024,3-phenylpropionic acid,,P00509,Aspartate aminotransferase,aspC,,
DB02024,3-phenylpropionic acid,,P95468,Aromatic-amino-acid aminotransferase,tyrB,,
DB02024,3-phenylpropionic acid,,Q75WK2,Aminotransferase,,,
DB02026,"Furo[2,3d]Pyrimidine Antifolate",,P16184,Dihydrofolate reductase,,,
DB02027,N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02027,N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB02028,"(1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)]",,P50607,Tubby protein homolog,TUB,,
DB02029,N-Cyclohexyl-N'-(4-Iodophenyl)Urea,,P34913,Bifunctional epoxide hydrolase 2,EPHX2,,
DB02030,Alpha-Ribazole-5'-Phosphate,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB02031,"(6S)-5,6,7,8-tetrahydrofolic acid",,O34453,Nitric oxide synthase oxygenase,nos,,
DB02031,"(6S)-5,6,7,8-tetrahydrofolic acid",,P0A884,Thymidylate synthase,thyA,,
DB02032,Epicaptopril,,P52700,Metallo-beta-lactamase L1,,,
DB02032,Epicaptopril,,P26918,Beta-lactamase,cphA,,
DB02032,Epicaptopril,,Q9KKU4,"Organic hydroperoxide resistance protein, putative",,,
DB02032,Epicaptopril,,P12821,Angiotensin-converting enzyme,ACE,,
DB02032,Epicaptopril,,Q9K578,FEZ-1 protein,blaFEZ-1,,
DB02032,Epicaptopril,,O08498,Carbapenem-hydrolyzing beta-lactamase BlaB-1,blaB1,,
DB02033,"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",,P03366,Gag-Pol polyprotein,gag-pol,,
DB02034,Tridolgosir,,Q16706,Alpha-mannosidase 2,MAN2A1,,
DB02035,Hexadecanesulfonyl fluoride,,P50897,Palmitoyl-protein thioesterase 1,PPT1,,
DB02036,"2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide",,Q9I7A8,Peptide deformylase,def,,
DB02038,"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",,P16932,"2,2-dialkylglycine decarboxylase",dgdA,,
DB02038,"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",,P10724,Alanine racemase,alr,,
DB02038,"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",,Q8ZNF3,UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase,arnB,,
DB02038,"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",,P28305,Aminodeoxychorismate lyase,pabC,,
DB02039,S-Acetyl-Cysteine,,Q92993,Histone acetyltransferase KAT5,KAT5,,
DB02039,S-Acetyl-Cysteine,,P07097,Acetyl-CoA acetyltransferase,phbA,,
DB02039,S-Acetyl-Cysteine,,P0A6R0,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB02039,S-Acetyl-Cysteine,,A0A0H3K1U2,3-hydroxy-3-methylglutaryl CoA synthase,mvaS,,
DB02041,Isoluminol,,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB02042,2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol,,Q53908,ActVA 6 protein,actVA 6,,
DB02042,2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol,,P96622,mRNA interferase EndoA,ndoA,,
DB02043,"1,2-Dipalmitoyl-Phosphatidyl-Glycerole",,P43457,V-type sodium ATPase subunit K,ntpK,,
DB02044,N-[3-(aminomethyl)benzyl]acetamidine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02044,N-[3-(aminomethyl)benzyl]acetamidine,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB02044,N-[3-(aminomethyl)benzyl]acetamidine,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB02045,Amylamine,,P07477,Trypsin-1,PRSS1,,
DB02046,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,,
DB02047,(+)-2-(4-biphenyl)propionic acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB02048,"1,2,4-Triazole-Carboxamidine",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02049,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,,P45452,Collagenase 3,MMP13,,
DB02051,4-Nitrophenyl (3S)-3-({N-[(benzyloxy)carbonyl]-L-phenylalanyl}amino)-5-phenyl-1-pentanesulfonate,,P25779,Cruzipain,,,
DB02052,Indirubin-3'-monoxime,,Q15078,Cyclin-dependent kinase 5 activator 1,CDK5R1,,
DB02052,Indirubin-3'-monoxime,,P24941,Cyclin-dependent kinase 2,CDK2,inhibitor,
DB02052,Indirubin-3'-monoxime,,P35869,Aryl hydrocarbon receptor,AHR,agonist,
DB02052,Indirubin-3'-monoxime,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB02052,Indirubin-3'-monoxime,,Q00535,Cyclin-dependent kinase 5,CDK5,inhibitor,
DB02052,Indirubin-3'-monoxime,,P06493,Cyclin-dependent kinase 1,CDK1,binder,
DB02053,Ribose-5-phosphate,,Q5SIR5,Ribose-5-phosphate isomerase A,rpiA,,
DB02053,Ribose-5-phosphate,,O66496,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB02053,Ribose-5-phosphate,,Q84CU3,ADP-ribose pyrophosphatase,ndx4,,
DB02054,Gabaculine,,P04181,"Ornithine aminotransferase, mitochondrial",OAT,,
DB02054,Gabaculine,,P24630,"Glutamate-1-semialdehyde 2,1-aminomutase",hemL,,
DB02056,Prostaglandin D2,,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,,
DB02056,Prostaglandin D2,,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,,
DB02057,(S)-AMPA,,P42262,Glutamate receptor 2,GRIA2,,
DB02058,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone,,P11362,Fibroblast growth factor receptor 1,FGFR1,,
DB02058,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone,,P21802,Fibroblast growth factor receptor 2,FGFR2,,
DB02059,Adenosine-5-Diphosphoribose,,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,,
DB02059,Adenosine-5-Diphosphoribose,,P00438,p-hydroxybenzoate hydroxylase,pobA,,
DB02059,Adenosine-5-Diphosphoribose,,P83844,ADP-ribose pyrophosphatase,nudF,,
DB02059,Adenosine-5-Diphosphoribose,,P26397,"CDP-glucose 4,6-dehydratase",rfbG,,
DB02059,Adenosine-5-Diphosphoribose,,P13639,Elongation factor 2,EEF2,,
DB02059,Adenosine-5-Diphosphoribose,,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,,
DB02059,Adenosine-5-Diphosphoribose,,P0A9S1,Lactaldehyde reductase,fucO,,
DB02059,Adenosine-5-Diphosphoribose,,O33199,MutT/nudix family protein,,,
DB02059,Adenosine-5-Diphosphoribose,,P45799,ADP compounds hydrolase NudE,nudE,,
DB02059,Adenosine-5-Diphosphoribose,,Q84CU3,ADP-ribose pyrophosphatase,ndx4,,
DB02059,Adenosine-5-Diphosphoribose,,Q9NTG7,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",SIRT3,,
DB02060,Cyclohexanone,,P71278,Pentaerythritol tetranitrate reductase,onr,,
DB02061,Cellobiose,,P37700,Endoglucanase G,celCCG,,
DB02061,Cellobiose,,O85465,Endoglucanase 5A,cel5A,,
DB02061,Cellobiose,,P19424,Endoglucanase,,,
DB02062,"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB02062,"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",,P08473,Neprilysin,MME,,
DB02063,CRA_16847,,P07477,Trypsin-1,PRSS1,,
DB02065,4-Deoxylactose,,P96945,Glycosyl transferase,lgtC,,
DB02066,N7-Methyl-Formycin A,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB02067,Triglu-5-formyl-tetrahydrofolate,,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,,
DB02068,Delta-Amino Valeric Acid,,P50440,"Glycine amidinotransferase, mitochondrial",GATM,,
DB02068,Delta-Amino Valeric Acid,,P13716,Delta-aminolevulinic acid dehydratase,ALAD,,
DB02069,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,,P00918,Carbonic anhydrase 2,CA2,,
DB02071,WAY-151693,,P45452,Collagenase 3,MMP13,,
DB02072,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02073,Biliverdine IX Alpha,,P09601,Heme oxygenase 1,HMOX1,,
DB02073,Biliverdine IX Alpha,,P02144,Myoglobin,MB,,
DB02073,Biliverdine IX Alpha,,P30043,Flavin reductase (NADPH),BLVRB,,
DB02075,"[(2R,3R,4S,5S)-3,4-Dihydroxy-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-2-pyrrolidinyl]methyl dihydrogen phosphate",,P20035,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,LACZ,,
DB02076,6-phospho-D-gluconic acid,,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,,
DB02076,6-phospho-D-gluconic acid,,P06744,Glucose-6-phosphate isomerase,GPI,,
DB02076,6-phospho-D-gluconic acid,,P46859,Thermoresistant gluconokinase,gntK,,
DB02077,L-N(omega)-nitroarginine-(4R)-amino-L-proline amide,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02077,L-N(omega)-nitroarginine-(4R)-amino-L-proline amide,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB02078,Triglyme,,P35080,Profilin-2,PFN2,,
DB02078,Triglyme,,P61320,Outer-membrane lipoprotein LolB,lolB,,
DB02078,Triglyme,,A9CJ63,Uncharacterized protein,,,
DB02078,Triglyme,,A0A2U2H3H7,Serine acetyltransferase,cysE,,
DB02078,Triglyme,,P06241,Tyrosine-protein kinase Fyn,FYN,,
DB02078,Triglyme,,P30405,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,,
DB02078,Triglyme,,Q734I1,"Transcriptional regulator, GntR family",,,
DB02078,Triglyme,,Q5LRQ9,"ABC transporter, periplasmic substrate-binding protein",,,
DB02078,Triglyme,,A0A6L7H165,Transketolase,tkt2,,
DB02078,Triglyme,,P61322,Outer-membrane lipoprotein LolB,lolB,,
DB02079,Aminooxyacetic acid,,P21549,Serine--pyruvate aminotransferase,AGXT,,
DB02080,"1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene",,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB02080,"1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene",,P00803,Signal peptidase I,lepB,,
DB02081,Bis-Benzamidine,,P07477,Trypsin-1,PRSS1,,
DB02082,Phosphoaminophosphonic acid guanylate ester,,Q92930,Ras-related protein Rab-8B,RAB8B,,
DB02083,"N,N-dimethylglycine",,P40859,Monomeric sarcosine oxidase,soxA,,
DB02084,CRA_17312,,P07477,Trypsin-1,PRSS1,,
DB02085,1-Aminocyclopropanecarboxylic Acid,,Q00740,1-aminocyclopropane-1-carboxylate deaminase,acdS,,
DB02086,"(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium",,P12497,Gag-Pol polyprotein,gag-pol,,
DB02087,"3,5-Difluorobenzenesulfonamide",,P00918,Carbonic anhydrase 2,CA2,,
DB02088,Norleucine Phosphonate,,P0AE18,Methionine aminopeptidase,map,,
DB02089,CP-526423,,,"Glycogen phosphorylase, liver form",,,
DB02090,A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,,P08254,Stromelysin-1,MMP3,,
DB02091,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",,P20248,Cyclin-A2,CCNA2,,
DB02091,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02092,Cholesteryl Linoleate,,P32947,Lipase 3,LIP3,,
DB02093,5-phospho-D-arabinohydroxamic acid,,P06744,Glucose-6-phosphate isomerase,GPI,,
DB02094,N-2-Thiophen-2-Yl-Acetamide Boronic Acid,,P00811,Beta-lactamase,ampC,,
DB02095,Isatin,,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB02096,FR221647,,P00813,Adenosine deaminase,ADA,,
DB02097,Cytidine,,Q9BZX2,Uridine-cytidine kinase 2,UCK2,,
DB02098,Adenosine-2'-5'-Diphosphate,,P12724,Eosinophil cationic protein,RNASE3,,
DB02098,Adenosine-2'-5'-Diphosphate,,P07998,Ribonuclease pancreatic,RNASE1,,
DB02098,Adenosine-2'-5'-Diphosphate,,P10153,Non-secretory ribonuclease,RNASE2,,
DB02101,"(S,R)-fidarestat",,P15121,Aldose reductase,AKR1B1,,
DB02102,Mozenavir,,P04585,Gag-Pol polyprotein,gag-pol,,
DB02103,2-Chlorodideoxyadenosine,,P14625,Endoplasmin,HSP90B1,,
DB02104,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",,P00374,Dihydrofolate reductase,DHFR,,
DB02105,"3,5-Dinitrocatechol",,P21964,Catechol O-methyltransferase,COMT,,
DB02106,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",,P10828,Thyroid hormone receptor beta,THRB,,
DB02107,Leucine - Reduced Carbonyl,,Q6UWN8,Serine protease inhibitor Kazal-type 6,SPINK6,,
DB02108,2-Aminoethanimidic Acid,,P07858,Cathepsin B,CTSB,,
DB02109,Hadacidin,,P0A7D4,Adenylosuccinate synthetase,purA,,
DB02109,Hadacidin,,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,,
DB02109,Hadacidin,,Q9U8D3,Adenylosuccinate synthetase,Adss,inhibitor,
DB02110,Protoporphyrin Ix Containing Co,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB02110,Protoporphyrin Ix Containing Co,,P99999,Cytochrome c,CYCS,,
DB02111,3-hydroxyisoxazole-4-carboxylic acid,,Q27743,L-lactate dehydrogenase,,,
DB02112,Zk-806450,,P07477,Trypsin-1,PRSS1,,
DB02113,6-Methylpurine,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB02114,Cumidine,,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB02115,Daidzin,,P05091,"Aldehyde dehydrogenase, mitochondrial",ALDH2,,
DB02116,Olomoucine,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB02116,Olomoucine,,P24941,Cyclin-dependent kinase 2,CDK2,inhibitor,
DB02116,Olomoucine,,Q00535,Cyclin-dependent kinase 5,CDK5,inhibitor,
DB02116,Olomoucine,,P06493,Cyclin-dependent kinase 1,CDK1,binder,
DB02118,CP-271485,,P39900,Macrophage metalloelastase,MMP12,,
DB02119,"6-Hydroxymethyl-7,8-Dihydropterin",,P26281,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,folK,,
DB02119,"6-Hydroxymethyl-7,8-Dihydropterin",,P56740,Dihydroneopterin aldolase,folB,,
DB02120,"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",,P05618,Cyclomaltodextrin glucanotransferase,cgt,,
DB02120,"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",,P30920,Cyclomaltodextrin glucanotransferase,,,
DB02120,"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",,P19571,"Glucan 1,4-alpha-maltohexaosidase",,,
DB02120,"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",,P00691,Alpha-amylase,amyE,,
DB02120,"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",,Q60053,Neopullulanase 1,tvaI,,
DB02121,Butyramide,,P27017,Aliphatic amidase expression-regulating protein,amiC,,
DB02122,4-iodo-acetamido phenylboronic acid,,P05364,Beta-lactamase,ampC,,
DB02122,4-iodo-acetamido phenylboronic acid,,P14489,Beta-lactamase OXA-10,bla,,
DB02123,Glycochenodeoxycholic Acid,,P0AET8,7-alpha-hydroxysteroid dehydrogenase,hdhA,,
DB02124,"(2s,3s)-Trans-2,3-Dihydro-3-Hydroxyanthranilic Acid",,Q51792,"Trans-2,3-dihydro-3-hydroxyanthranilate isomerase",phzF,,
DB02125,Adamantanone,,P00183,Camphor 5-monooxygenase,camC,,
DB02126,4-Carboxycinnamic Acid,,P69905,Hemoglobin subunit alpha,HBA1,,
DB02126,4-Carboxycinnamic Acid,,P68871,Hemoglobin subunit beta,HBB,,
DB02127,Diisopropyl methylphosphonate,,P0A434,Parathion hydrolase,opd,,
DB02127,Diisopropyl methylphosphonate,,P0A433,Parathion hydrolase,opd,,
DB02128,[1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester,,P25779,Cruzipain,,,
DB02129,Dihydroorotic Acid,,P05020,Dihydroorotase,pyrC,,
DB02130,Vanillic acid,,P26602,Chorismate--pyruvate lyase,ubiC,,
DB02131,N-1-methylheptylformamide,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB02132,Zenarestat,,P15121,Aldose reductase,AKR1B1,,
DB02133,Chlorophyll A,,P04190,Beta-lactamase 2,blm,,
DB02134,Xanthine,,P45563,Purine nucleoside phosphorylase 2,xapA,,
DB02134,Xanthine,,P0A9M5,Xanthine phosphoribosyltransferase,gpt,,
DB02135,"1-deoxy-1-{2,6,8-trioxo-7-[4-(phosphonooxy)butyl]-1,2,3,6,7,8-hexahydro-9H-purin-9-yl}-D-arabinitol",,P9WHE9,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB02136,Cephalosporin analog,,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB02137,Molybdenum cofactor,,Q46509,Aldehyde oxidoreductase,mop,,
DB02138,Diethyl 4-Methylbenzylphosphonate,,P0A434,Parathion hydrolase,opd,,
DB02138,Diethyl 4-Methylbenzylphosphonate,,P0A433,Parathion hydrolase,opd,,
DB02139,(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine,,P33247,Squalene--hopene cyclase,shc,,
DB02140,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,,P09668,Pro-cathepsin H,CTSH,,
DB02141,"S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02142,Pyridoxamine-5'-Phosphate,,P10724,Alanine racemase,alr,,
DB02142,Pyridoxamine-5'-Phosphate,,P24630,"Glutamate-1-semialdehyde 2,1-aminomutase",hemL,,
DB02142,Pyridoxamine-5'-Phosphate,,Q9X0D0,Histidinol-phosphate aminotransferase,hisC,,
DB02142,Pyridoxamine-5'-Phosphate,,P19938,D-alanine aminotransferase,dat,,
DB02142,Pyridoxamine-5'-Phosphate,,Q56232,Aspartate aminotransferase,aspC,,
DB02142,Pyridoxamine-5'-Phosphate,,P22256,4-aminobutyrate aminotransferase GabT,gabT,,
DB02142,Pyridoxamine-5'-Phosphate,,Q16773,Kynurenine--oxoglutarate transaminase 1,CCBL1,,
DB02142,Pyridoxamine-5'-Phosphate,,P06986,Histidinol-phosphate aminotransferase,hisC,,
DB02142,Pyridoxamine-5'-Phosphate,,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,,
DB02142,Pyridoxamine-5'-Phosphate,,Q8ZNF3,UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase,arnB,,
DB02143,1-hydroxy-2-isopropylguanidine,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB02144,"1,2-diacyl-sn-glycero-3-phosphoinositol",,Q00169,Phosphatidylinositol transfer protein alpha isoform,PITPNA,,
DB02145,Butyl alcohol,,P51698,Haloalkane dehalogenase,linB,,
DB02147,Cyclo-Tetrametavanadate,,P15879,Mono-ADP-ribosyltransferase C3,C3,,
DB02148,3-Amino-4-Oxybenzyl-2-Butanone,,P07858,Cathepsin B,CTSB,,
DB02151,Methionine Phosphonate,,P00959,Methionine--tRNA ligase,metG,,
DB02151,Methionine Phosphonate,,P0AE18,Methionine aminopeptidase,map,,
DB02152,K-252a,,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,,
DB02152,K-252a,,P08581,Hepatocyte growth factor receptor,MET,,
DB02153,3-sulfino-L-alanine,,P77150,Pyridoxamine kinase,pdxY,,
DB02153,3-sulfino-L-alanine,,P04190,Beta-lactamase 2,blm,,
DB02153,3-sulfino-L-alanine,,P51003,Poly(A) polymerase alpha,PAPOLA,,
DB02153,3-sulfino-L-alanine,,P19080,Chorismate mutase AroH,aroH,,
DB02153,3-sulfino-L-alanine,,P00390,"Glutathione reductase, mitochondrial",GSR,,
DB02153,3-sulfino-L-alanine,,Q9RRU8,S-ribosylhomocysteine lyase,luxS,,
DB02153,3-sulfino-L-alanine,,P0A115,Carboxymethylenebutenolidase,clcD,,
DB02153,3-sulfino-L-alanine,,Q57366,Dimethyl sulfoxide/trimethylamine N-oxide reductase,dmsA,,
DB02153,3-sulfino-L-alanine,,P32119,Peroxiredoxin-2,PRDX2,,
DB02153,3-sulfino-L-alanine,,Q8NX78,Peptide deformylase,def,,
DB02153,3-sulfino-L-alanine,,Q9ZIV5,Malonamidase E2,,,
DB02153,3-sulfino-L-alanine,,Q9FD87,HMG-CoA synthase,mvaS,,
DB02153,3-sulfino-L-alanine,,P84124,Osmotically inducible protein C,tthHB8IM,,
DB02154,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",,Q79MP6,Beta-lactamase,blaIMP-1,,
DB02154,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",,P52699,Beta-lactamase IMP-1,,,
DB02155,3-[(3-sec-butyl-4-hydroxybenzoyl)amino]azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB02158,"(2S,3S,4R,5S)-2-(4-Amino-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-[(methylsulfanyl)methyl]-3,4-pyrrolidinediol",,Q13126,S-methyl-5'-thioadenosine phosphorylase,MTAP,,
DB02158,"(2S,3S,4R,5S)-2-(4-Amino-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-[(methylsulfanyl)methyl]-3,4-pyrrolidinediol",,P0AF12,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,mtnN,,
DB02159,(R)-Propylene glycol,,P39126,Isocitrate dehydrogenase [NADP],icd,,
DB02159,(R)-Propylene glycol,,P61626,Lysozyme C,LYZ,,
DB02160,S-Butyryl-Cystein,,P07097,Acetyl-CoA acetyltransferase,phbA,,
DB02161,Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester,,P23141,Liver carboxylesterase 1,CES1,,
DB02162,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,,P49773,Histidine triad nucleotide-binding protein 1,HINT1,,
DB02163,"2,5-Xylidine",,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB02164,N-sulfo-flavin mononucleotide,,Q9UJM8,Hydroxyacid oxidase 1,HAO1,,
DB02165,Zinc trihydroxide,,P09488,Glutathione S-transferase Mu 1,GSTM1,,
DB02166,Propidium,,P22303,Acetylcholinesterase,ACHE,,
DB02168,6-bromopurine,,Q8RLY5,Nucleoside deoxyribosyltransferase-I,ptd,,
DB02169,"9,10-Deepithio-9,10-Didehydroacanthifolicin",,P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,PPP1CC,,
DB02170,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB02172,"2,5-Dideoxy-2,5-Imino-D-Glucitol",,P12070,Xylose isomerase,xylA,,
DB02174,D-Glutamine,,P56868,Glutamate racemase,murI,,
DB02175,Malonic acid,,P0A793,Aspartate 1-decarboxylase,panD,,
DB02175,Malonic acid,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB02175,Malonic acid,,O07015,Sigma factor SigB regulation protein RsbQ,rsbQ,,
DB02175,Malonic acid,,Q9FCA6,Putative cytochrome P450,cyp158a2,,
DB02175,Malonic acid,,P09012,U1 small nuclear ribonucleoprotein A,SNRPA,,
DB02175,Malonic acid,,Q9ZIV5,Malonamidase E2,,,
DB02175,Malonic acid,,Q8ZPC0,Acetyl transferase,rimL,,
DB02177,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,,P20701,Integrin alpha-L,ITGAL,,
DB02178,Phenylacetaldehyde,,P46883,Primary amine oxidase,tynA,,
DB02180,Myristoyl-Coa,,P30418,Glycylpeptide N-tetradecanoyltransferase,NMT1,,
DB02180,Myristoyl-Coa,,O60551,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,,
DB02181,2'-Deoxyguanosine-5'-Triphosphate,,P15531,Nucleoside diphosphate kinase A,NME1,,
DB02181,2'-Deoxyguanosine-5'-Triphosphate,,P07071,Anaerobic ribonucleoside-triphosphate reductase,NRDD,,
DB02182,Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe),,P0ABE7,Soluble cytochrome b562,cybC,,
DB02183,Adenosine-5'-ditungstate,,P49773,Histidine triad nucleotide-binding protein 1,HINT1,,
DB02184,"D-1,4-dithiothreitol",,P9WHE9,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB02185,"2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One",,Q6UWM7,Lactase-like protein,LCTL,,
DB02186,N-acetyl-beta-D-galactosamine 6-sulfate,,Q59288,Chondroitinase-AC,cslA,,
DB02186,N-acetyl-beta-D-galactosamine 6-sulfate,,Q54873,Hyaluronate lyase,,,
DB02187,Equilin,,P03372,Estrogen receptor alpha,ESR1,,
DB02187,Equilin,,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,,
DB02188,N-Methylmesoporphyrin containing copper,,P32396,Ferrochelatase,hemH,,
DB02189,"2',3'-Dideoxyadenosine triphosphate",,P04053,DNA nucleotidylexotransferase,DNTT,,
DB02190,(S)-oxalosuccinic acid,,P08200,Isocitrate dehydrogenase [NADP],icd,,
DB02191,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",,P77173,Cell division protein ZipA,zipA,,
DB02191,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",,Q83QN9,Cell division protein ZipA homolog,zipA,,
DB02192,Phenylethyl alcohol,,P0A433,Parathion hydrolase,opd,,
DB02195,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,,Q16222,UDP-N-acetylhexosamine pyrophosphorylase,UAP1,,
DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,,Q14376,UDP-glucose 4-epimerase,GALE,,
DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,,P27828,UDP-N-acetylglucosamine 2-epimerase,wecB,,
DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,,P16442,Histo-blood group ABO system transferase,ABO,,
DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,,P17443,UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase,murG,,
DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,,Q9UBQ6,Exostosin-like 2,EXTL2,,
DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,,Q8KN66,WbpP,,,
DB02197,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02198,2-Bromoacetyl Group,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB02200,3-[N-[benzyloxycarbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonylmethylbenzene,,P25779,Cruzipain,,,
DB02201,Malonate Ion,,Q84FH6,Chorismate mutase AroH,aroH,,
DB02201,Malonate Ion,,Q99470,Stromal cell-derived factor 2,SDF2,,
DB02205,(+)-Rutamarin alcohol,,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,,
DB02205,(+)-Rutamarin alcohol,,P22513,"Glyceraldehyde-3-phosphate dehydrogenase, glycosomal",,,
DB02207,7-Nitroindazole,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02207,7-Nitroindazole,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB02207,7-Nitroindazole,,P29475,"Nitric oxide synthase, brain",NOS1,inhibitor,
DB02209,Pyridoxine phosphate,,P0A794,Pyridoxine 5'-phosphate synthase,pdxJ,,
DB02209,Pyridoxine phosphate,,P11926,Ornithine decarboxylase,ODC1,,
DB02210,"Hexane-1,6-Diol",,P01112,GTPase HRas,HRAS,,
DB02210,"Hexane-1,6-Diol",,P04150,Glucocorticoid receptor,NR3C1,,
DB02210,"Hexane-1,6-Diol",,P00720,Lysozyme,E,,
DB02210,"Hexane-1,6-Diol",,Q56313,Holliday junction ATP-dependent DNA helicase RuvB,ruvB,,
DB02210,"Hexane-1,6-Diol",,P04054,Phospholipase A2,PLA2G1B,,
DB02210,"Hexane-1,6-Diol",,Q820S6,"Chain A, Red Copper Protein Nitrosocyanin",,,
DB02211,(R)-N-methyl-N-2-propynyl-1-indanamine,,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB02213,Metanitrophenyl-Alpha-D-Galactoside,,P32890,Heat-labile enterotoxin B chain,eltB,,
DB02213,Metanitrophenyl-Alpha-D-Galactoside,,P01556,Cholera enterotoxin subunit B,ctxB,,
DB02214,"6,7-dioxo-5H-8-ribitylaminolumazine",,O66529,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB02215,Furoyl-Leucine,,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,,
DB02216,S-Methylcysteine,,P07339,Cathepsin D,CTSD,,
DB02216,S-Methylcysteine,,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,,
DB02217,Dpb-T,,Q9NPB1,"5'(3')-deoxyribonucleotidase, mitochondrial",NT5M,,
DB02218,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",,P19961,Alpha-amylase 2B,AMY2B,,
DB02218,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",,P04746,Pancreatic alpha-amylase,AMY2A,,
DB02218,"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",,O82839,Amylase,,,
DB02220,AL7089A,,P00918,Carbonic anhydrase 2,CA2,,
DB02221,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",,P00918,Carbonic anhydrase 2,CA2,,
DB02222,"2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine",,P00491,Purine nucleoside phosphorylase,PNP,,
DB02223,LY231514 tetra glu,,P0A884,Thymidylate synthase,thyA,,
DB02225,"1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine",,P09598,Phospholipase C,plc,,
DB02226,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",,P22303,Acetylcholinesterase,ACHE,,
DB02227,"4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid",,P84141,Chondroitinase (Chondroitin lyase),,,
DB02228,2-deoxy-2-fluoro-β-D-galactose,,P00722,Beta-galactosidase,lacZ,,
DB02229,5'-O-[(L-methionyl)-sulphamoyl]adenosine,,P00959,Methionine--tRNA ligase,metG,,
DB02230,Immucillin-G,,P00491,Purine nucleoside phosphorylase,PNP,,
DB02232,"1,2-Dihydroxybenzene",,P07773,"Catechol 1,2-dioxygenase",catA,,
DB02232,"1,2-Dihydroxybenzene",,P47228,"Biphenyl-2,3-diol 1,2-dioxygenase",bphC,,
DB02233,6-hydroxy-D-norleucine,,P06608,L-asparaginase,ansB,,
DB02234,S-Ethylisothiourea,,P0A094,Nitric oxide synthase oxygenase,nos,,
DB02234,S-Ethylisothiourea,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB02234,S-Ethylisothiourea,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02235,L-methionine (R)-S-oxide,,P29422,Catalase,katA,,
DB02235,L-methionine (R)-S-oxide,,Q93UV9,Protease,PROF,,
DB02235,L-methionine (R)-S-oxide,,P05067,Amyloid beta A4 protein,APP,,
DB02236,Glycinamide Ribonucleotide,,P33221,Phosphoribosylglycinamide formyltransferase 2,purT,,
DB02236,Glycinamide Ribonucleotide,,P08179,Phosphoribosylglycinamide formyltransferase,purN,,
DB02236,Glycinamide Ribonucleotide,,P22102,Trifunctional purine biosynthetic protein adenosine-3,GART,,
DB02237,Maltotetraose,,P13507,"Glucan 1,4-alpha-maltotetraohydrolase",amyP,,
DB02237,Maltotetraose,,Q08751,Neopullulanase 2,tvaII,,
DB02238,4-methylthio-2-oxobutanoic acid,,Q75WK2,Aminotransferase,,,
DB02239,Laevulinic Acid,,P13716,Delta-aminolevulinic acid dehydratase,ALAD,,
DB02240,Quinacrine mustard,,P28593,Trypanothione reductase,TPR,inhibitor,
DB02242,Cyclohexanepropanoic acid,,P95468,Aromatic-amino-acid aminotransferase,tyrB,,
DB02243,4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide,,Q9UBX1,Cathepsin F,CTSF,,
DB02247,Hydrolyzed Cephalothin,,P00811,Beta-lactamase,ampC,,
DB02249,2-Ethoxyethanol,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB02251,O-Succinylbenzoate,,Q47Q21,O-succinylbenzoate-CoA synthase,menC,,
DB02251,O-Succinylbenzoate,,Q44244,N-acylamino acid racemase,Aaar,,
DB02251,O-Succinylbenzoate,,P29208,o-succinylbenzoate synthase,menC,,
DB02252,Iodobenzene,,P37698,Endoglucanase F,celCCF,,
DB02253,"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",,P74334,"Apocarotenoid-15,15'-oxygenase",,,
DB02254,Trifluoro-thiamin phosphate,,P39594,Thiamine-phosphate synthase,thiE,,
DB02255,Ilomastat,,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,,
DB02255,Ilomastat,,P16112,Aggrecan core protein,ACAN,,
DB02255,Ilomastat,,P15917,Lethal factor,lef,,
DB02256,2'-Deoxyuridine,,P12758,Uridine phosphorylase,udp,,
DB02256,2'-Deoxyuridine,,P0A884,Thymidylate synthase,thyA,,
DB02257,N-Bromoacetyl-Aminoethyl Phosphate,,P13376,Glucose-6-phosphate isomerase B,pgiB,,
DB02258,SR11254,,P13631,Retinoic acid receptor gamma,RARG,,
DB02259,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02260,4-Oxosebacic Acid,,P13716,Delta-aminolevulinic acid dehydratase,ALAD,,
DB02260,4-Oxosebacic Acid,,P0ACB2,Delta-aminolevulinic acid dehydratase,hemB,,
DB02261,Platelet Activating Factor,,P25105,Platelet-activating factor receptor,PTAFR,,
DB02261,Platelet Activating Factor,,P17900,Ganglioside GM2 activator,GM2A,,
DB02262,Orotic acid,,P08870,Orotate phosphoribosyltransferase,pyrE,,
DB02262,Orotic acid,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB02262,Orotic acid,,P0A7E1,Dihydroorotate dehydrogenase (quinone),pyrD,,
DB02262,Orotic acid,,P05020,Dihydroorotase,pyrC,inhibitor,
DB02262,Orotic acid,,Q53ZE5,Dihydroorotate dehydrogenase A (fumarate),pyrDA,,
DB02263,D-glyceraldehyde 3-phosphate,,P0A9B2,Glyceraldehyde-3-phosphate dehydrogenase A,gapA,,
DB02263,D-glyceraldehyde 3-phosphate,,P00362,Glyceraldehyde-3-phosphate dehydrogenase,gap,,
DB02263,D-glyceraldehyde 3-phosphate,,Q59931,NADP-dependent glyceraldehyde-3-phosphate dehydrogenase,gapN,,
DB02264,O2-Sulfo-Glucuronic Acid,,P05230,Fibroblast growth factor 1,FGF1,,
DB02264,O2-Sulfo-Glucuronic Acid,,P14210,Hepatocyte growth factor,HGF,,
DB02264,O2-Sulfo-Glucuronic Acid,,Q9Y663,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,,
DB02264,O2-Sulfo-Glucuronic Acid,,P68638,Complement control protein C3,,,
DB02265,Ethyl-Trimethyl-Silane,,P04958,Tetanus toxin,tetX,,
DB02266,Flufenamic acid,,P35354,Prostaglandin G/H synthase 2,PTGS2,,M01AG03
DB02266,Flufenamic acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,,M01AG03
DB02266,Flufenamic acid,,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,,M01AG03
DB02266,Flufenamic acid,,P10275,Androgen receptor,AR,,M01AG03
DB02266,Flufenamic acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,activator,M01AG03
DB02266,Flufenamic acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,M01AG03
DB02267,Argininosuccinate,,P04424,Argininosuccinate lyase,ASL,,
DB02267,Argininosuccinate,,P59846,Argininosuccinate synthase,argG,,
DB02268,4-(Acetylamino)-3-Amino Benzoic Acid,,P06820,Neuraminidase,,,
DB02269,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,,P07477,Trypsin-1,PRSS1,,
DB02270,Dimethylallyl S-Thiolodiphosphate,,P58758,Adenylate dimethylallyltransferase,tzs,,
DB02270,Dimethylallyl S-Thiolodiphosphate,,P16384,tRNA dimethylallyltransferase,miaA,,
DB02270,Dimethylallyl S-Thiolodiphosphate,,P22939,Farnesyl diphosphate synthase,ispA,,
DB02271,S-(2-oxo)pentadecylcoa,,O60551,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,,
DB02272,Porphobilinogen,,P13716,Delta-aminolevulinic acid dehydratase,ALAD,,
DB02274,7-Keto-8-Aminopelargonic Acid,,P12995,Adenosylmethionine-8-amino-7-oxononanoate aminotransferase,bioA,,
DB02276,(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,,P0A6K3,Peptide deformylase,def,,
DB02277,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB02278,"7,8-dihydro-7,7-dimethyl-6-hydroxypterin",,P43777,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,folK,,
DB02279,Benzoylformic Acid,,Q9UJM8,Hydroxyacid oxidase 1,HAO1,,
DB02280,(R)-Mandelic acid,,P20906,Benzoylformate decarboxylase,mdlC,,
DB02280,(R)-Mandelic acid,,P11444,Mandelate racemase,mdlA,,
DB02281,Formycin,,Q13126,S-methyl-5'-thioadenosine phosphorylase,MTAP,,
DB02281,Formycin,,P0AF12,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,mtnN,,
DB02282,5'-S-methyl-5'-thioadenosine,,P14751,Modification methylase RsrI,rsrIM,,
DB02282,5'-S-methyl-5'-thioadenosine,,Q13126,S-methyl-5'-thioadenosine phosphorylase,MTAP,,
DB02283,2-Phenylamino-Ethanesulfonic Acid,,P46828,Catabolite control protein A,ccpA,,
DB02285,Protoporphyrin,,P02792,Ferritin light chain,FTL,,
DB02287,2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine,,P00734,Prothrombin,F2,,
DB02287,2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine,,P07477,Trypsin-1,PRSS1,,
DB02287,2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB02288,CRA-9334,,P07477,Trypsin-1,PRSS1,,
DB02289,2-Aminopropanedioic Acid,,P51691,Arylsulfatase,atsA,,
DB02290,"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",,P9WHE9,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB02292,Irosustat,,P08842,Steryl-sulfatase,STS,inhibitor,
DB02292,Irosustat,,P00918,Carbonic anhydrase 2,CA2,,
DB02294,"(5R,6S,7S,8S)-5-hydroxymethyl-6,7,8-trihydroxy-tetrazolo[1,5-A]piperidine",,P00722,Beta-galactosidase,lacZ,,
DB02296,Isoamyl alcohol,,P00797,Renin,REN,,
DB02297,2-Amino-6-Chloropyrazine,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02299,Arginineamide,,P22459,Potassium voltage-gated channel subfamily A member 4,KCNA4,,
DB02300,Calcipotriol,,P11473,Vitamin D3 receptor,VDR,antagonist,D05AX52;D05AX02
DB02301,"5,10-Methylene-6-Hydrofolic Acid",,P0A884,Thymidylate synthase,thyA,,
DB02301,"5,10-Methylene-6-Hydrofolic Acid",,P15925,Folylpolyglutamate synthase,fgs,,
DB02301,"5,10-Methylene-6-Hydrofolic Acid",,P00469,Thymidylate synthase,thyA,,
DB02302,Symmetric dimethylarginine,,P51698,Haloalkane dehalogenase,linB,,
DB02303,"(5S)-5-Iododihydro-2,4(1H,3H)-pyrimidinedione",,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,,
DB02305,"4,5-Dehydro-D-Glucuronic Acid",,Q59288,Chondroitinase-AC,cslA,,
DB02306,Palmitoyl-Linoleoyl Phosphatidylcholine,,Q9UKL6,Phosphatidylcholine transfer protein,PCTP,,
DB02307,N-(1-carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagine,,P14756,Pseudolysin,lasB,,
DB02308,"4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium",,P35030,Trypsin-3,PRSS3,,
DB02309,5-monophosphate-9-beta-D-ribofuranosyl xanthine,,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,,
DB02309,5-monophosphate-9-beta-D-ribofuranosyl xanthine,,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,,
DB02310,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",,P50579,Methionine aminopeptidase 2,METAP2,,
DB02311,Methyl Methylsulfinylmethyl Sulfide,,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB02312,beta-D-galactose 6-phosphate,,P11546,6-phospho-beta-galactosidase,lacG,,
DB02313,"Ethyl (4R)-4-{[(2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-{[(5-methyl-1,2-oxazol-3-yl)carbonyl]amino}-4-oxoheptanoyl]amino}-5-[(3S)-2-oxo-3-pyrrolidinyl]pentanoate",,P04936,Genome polyprotein,,,
DB02314,Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate,,P22188,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",murE,,
DB02314,Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate,,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,murD,,
DB02315,Cyclic GMP,,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,,
DB02315,Cyclic GMP,,Q9UL51,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,HCN2,,
DB02315,Cyclic GMP,,P10644,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,,
DB02316,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",,P0A6R0,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB02317,Alpha-D-Galactose-1-Phosphate,,P71447,Beta-phosphoglucomutase,pgmB,,
DB02318,2-deoxy-2-fluoro-alpha-D-mannosyl fluoride,,Q16706,Alpha-mannosidase 2,MAN2A1,,
DB02319,"5,6-dihydroxy-NADP",,Q46856,Alcohol dehydrogenase YqhD,yqhD,,
DB02320,N-beta-D-glucopyranosylacetamide,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02320,N-beta-D-glucopyranosylacetamide,,,"Glycogen phosphorylase, liver form",,,
DB02321,"5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol",,O34667,S-ribosylhomocysteine lyase,luxS,,
DB02322,Heparin Disaccharide I-S,,P13501,C-C motif chemokine 5,CCL5,,
DB02323,EM-1745,,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,,
DB02324,5-Iodo-2'-Deoxyuridine-5'-Monophosphate,,Q9QNF7,Thymidine kinase,TK,substrate,
DB02326,1-Hydroxyamine-2-Isobutylmalonic Acid,,P22894,Neutrophil collagenase,MMP8,,
DB02327,Triethylene glycol,,P27696,"Acetolactate synthase, catabolic",budB,,
DB02327,Triethylene glycol,,Q65CX5,"Arabinogalactan endo-1,4-beta-galactosidase",ganB,,
DB02327,Triethylene glycol,,Q9RME2,Phosphoserine aminotransferase,serC,,
DB02328,2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid,,P32929,Cystathionine gamma-lyase,CTH,,
DB02329,Carbenoxolone,,P19992,3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase,,,A02BX01;A02BX71;A02BX51
DB02329,Carbenoxolone,,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,inhibitor,A02BX01;A02BX71;A02BX51
DB02331,"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",,P26663,Genome polyprotein,,,
DB02332,Flavin-N7 protonated-adenine dinucleotide,,P12676,Cholesterol oxidase,choA,,
DB02333,Deoxyuridine-5'-Triphosphate,,Q02169,Septum formation protein Maf,maf,,
DB02333,Deoxyuridine-5'-Triphosphate,,P16088,Pol polyprotein,pol,,
DB02333,Deoxyuridine-5'-Triphosphate,,P28248,Deoxycytidine triphosphate deaminase,dcd,,
DB02333,Deoxyuridine-5'-Triphosphate,,P9WNS5,Deoxyuridine 5'-triphosphate nucleotidohydrolase,dut,,
DB02333,Deoxyuridine-5'-Triphosphate,,P06968,Deoxyuridine 5'-triphosphate nucleotidohydrolase,dut,,
DB02334,(R)-2-Hydroxy-3-Sulfopropanoic Acid,,Q97E82,Probable 2-phosphosulfolactate phosphatase,comB,,
DB02335,2-Aminothiazoline,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02336,RU83876,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB02337,S-(D-Carboxybutyl)-L-Homocysteine,,Q93088,Betaine--homocysteine S-methyltransferase 1,BHMT,,
DB02338,NADPH,,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,,
DB02338,NADPH,,P11411,Glucose-6-phosphate 1-dehydrogenase,zwf,,
DB02338,NADPH,,Q01782,Pteridine reductase 1,PTR1,,
DB02338,NADPH,,Q07982,Glucose--fructose oxidoreductase,gfo,,
DB02338,NADPH,,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,,
DB02338,NADPH,,Q9UDR5,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,,
DB02339,Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin,,P33247,Squalene--hopene cyclase,shc,,
DB02340,N-Acetyl-Serine,,P00488,Coagulation factor XIII A chain,F13A1,,
DB02341,"Mdl 101,146",,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB02341,"Mdl 101,146",,P08246,Neutrophil elastase,ELANE,,
DB02342,2-Methoxyestradiol,,P21964,Catechol O-methyltransferase,COMT,,
DB02342,2-Methoxyestradiol,,P04798,Cytochrome P450 1A1,CYP1A1,,
DB02342,2-Methoxyestradiol,,Q16678,Cytochrome P450 1B1,CYP1B1,,
DB02342,2-Methoxyestradiol,,P11511,Cytochrome P450 19A1,CYP19A1,,
DB02342,2-Methoxyestradiol,,Q16665,Hypoxia-inducible factor 1-alpha,HIF1A,,
DB02343,"3,6,9,12,15-Pentaoxaheptadecane",,Q8Y7N7,Glutamate racemase,murI,,
DB02343,"3,6,9,12,15-Pentaoxaheptadecane",,P22303,Acetylcholinesterase,ACHE,,
DB02343,"3,6,9,12,15-Pentaoxaheptadecane",,P83788,Kynureninase,kynU,,
DB02345,Selenocysteine,,P49913,Cathelicidin antimicrobial peptide,CAMP,,
DB02345,Selenocysteine,,P15531,Nucleoside diphosphate kinase A,NME1,,
DB02345,Selenocysteine,,P07658,Formate dehydrogenase H,fdhF,,
DB02345,Selenocysteine,,P77444,Cysteine desulfurase,sufS,,
DB02346,3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside,,Q55793,Probable cysteine desulfurase,csd,,
DB02347,2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid,,P42262,Glutamate receptor 2,GRIA2,,
DB02348,Monofluorophosphate ion,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02350,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",,P08254,Stromelysin-1,MMP3,,
DB02352,3-(Benzyloxy)Pyridin-2-Amine,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB02352,3-(Benzyloxy)Pyridin-2-Amine,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB02353,Heparin Disaccharide Iii-S,,P13501,C-C motif chemokine 5,CCL5,,
DB02354,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,,P07477,Trypsin-1,PRSS1,,
DB02355,Adenosine-5'-Rp-Alpha-Thio-Triphosphate,,O32393,Adenylate cyclase,cyaC,,
DB02358,LY374571,,P11586,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,,
DB02359,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB02360,Bis-Napthyl Beta-Ketophosphonic Acid,,P08311,Cathepsin G,CTSG,,
DB02361,S-Methyl Thiocysteine Group,,P37700,Endoglucanase G,celCCG,,
DB02362,Aminobenzoic acid,,P00438,p-hydroxybenzoate hydroxylase,pobA,substrate,D02BA01;D11AX23
DB02363,2'-Monophosphoadenosine-5'-Diphosphate,,P43876,Shikimate dehydrogenase,aroE,,
DB02363,2'-Monophosphoadenosine-5'-Diphosphate,,P07998,Ribonuclease pancreatic,RNASE1,,
DB02363,2'-Monophosphoadenosine-5'-Diphosphate,,P0ABQ4,Dihydrofolate reductase,folA,,
DB02364,2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid,,P0ADA1,Acyl-CoA thioesterase I,tesA,,
DB02365,"1,10-Phenanthroline",,P52700,Metallo-beta-lactamase L1,,,
DB02365,"1,10-Phenanthroline",,P02941,Methyl-accepting chemotaxis protein II,tar,,
DB02366,CRA_10762,,P07477,Trypsin-1,PRSS1,,
DB02367,(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,,P08254,Stromelysin-1,MMP3,,
DB02368,N-Acetyl-L-Citrulline,,Q8P8J2,N-acetylornithine carbamoyltransferase,argF',,
DB02370,Nz-(1-Carboxyethyl)-Lysine,,Q9X1K9,4-hydroxy-tetrahydrodipicolinate synthase,dapA,,
DB02371,"2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid",,P09871,Complement C1s subcomponent,C1S,,
DB02373,Adenosine monotungstate,,P49789,Bis(5'-adenosyl)-triphosphatase,FHIT,,
DB02374,Xylose-Derived Imidazole,,P07986,Exoglucanase/xylanase,cex,,
DB02375,Myricetin,,P23458,Tyrosine-protein kinase JAK1,JAK1,,
DB02375,Myricetin,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB02376,"D-gluconhydroximo-1,5-lactam",,P09848,Lactase-phlorizin hydrolase,LCT,,
DB02377,Guanine,,P00491,Purine nucleoside phosphorylase,PNP,,
DB02377,Guanine,,P45563,Purine nucleoside phosphorylase 2,xapA,,
DB02377,Guanine,,P0A9M5,Xanthine phosphoribosyltransferase,gpt,,
DB02377,Guanine,,P30793,GTP cyclohydrolase 1,GCH1,inhibitor,
DB02377,Guanine,,Q9X1T2,Purine nucleoside phosphorylase,,,
DB02378,MMI-175,,P56817,Beta-secretase 1,BACE1,,
DB02379,Beta-D-Glucose,,,DNA,,,
DB02379,Beta-D-Glucose,,Q46079,Chondroitinase-B,cslB,,
DB02379,Beta-D-Glucose,,O85465,Endoglucanase 5A,cel5A,,
DB02379,Beta-D-Glucose,,Q6UWM7,Lactase-like protein,LCTL,,
DB02379,Beta-D-Glucose,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02379,Beta-D-Glucose,,P15587,Xylose isomerase,xylA,,
DB02379,Beta-D-Glucose,,P35557,Glucokinase,GCK,,
DB02379,Beta-D-Glucose,,P06971,Ferrichrome-iron receptor,fhuA,,
DB02379,Beta-D-Glucose,,Q60053,Neopullulanase 1,tvaI,,
DB02379,Beta-D-Glucose,,P30920,Cyclomaltodextrin glucanotransferase,,,
DB02379,Beta-D-Glucose,,P02144,Myoglobin,MB,,
DB02379,Beta-D-Glucose,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB02379,Beta-D-Glucose,,P19367,Hexokinase-1,HK1,,
DB02379,Beta-D-Glucose,,P00691,Alpha-amylase,amyE,,
DB02379,Beta-D-Glucose,,P07986,Exoglucanase/xylanase,cex,,
DB02379,Beta-D-Glucose,,P05618,Cyclomaltodextrin glucanotransferase,cgt,,
DB02379,Beta-D-Glucose,,P37700,Endoglucanase G,celCCG,,
DB02379,Beta-D-Glucose,,P47929,Galectin-7,LGALS7,,
DB02379,Beta-D-Glucose,,P01556,Cholera enterotoxin subunit B,ctxB,,
DB02379,Beta-D-Glucose,,Q57366,Dimethyl sulfoxide/trimethylamine N-oxide reductase,dmsA,,
DB02379,Beta-D-Glucose,,P19961,Alpha-amylase 2B,AMY2B,,
DB02379,Beta-D-Glucose,,Q08751,Neopullulanase 2,tvaII,,
DB02379,Beta-D-Glucose,,P10844,Botulinum neurotoxin type B,botB,,
DB02379,Beta-D-Glucose,,P04958,Tetanus toxin,tetX,,
DB02379,Beta-D-Glucose,,P24300,Xylose isomerase,xylA,,
DB02379,Beta-D-Glucose,,P19571,"Glucan 1,4-alpha-maltohexaosidase",,,
DB02379,Beta-D-Glucose,,P13507,"Glucan 1,4-alpha-maltotetraohydrolase",amyP,,
DB02379,Beta-D-Glucose,,P37698,Endoglucanase F,celCCF,,
DB02379,Beta-D-Glucose,,Q07982,Glucose--fructose oxidoreductase,gfo,,
DB02379,Beta-D-Glucose,,P12528,Bifunctional tail protein,9,,
DB02379,Beta-D-Glucose,,,"Glycogen phosphorylase, liver form",,,
DB02379,Beta-D-Glucose,,P35247,Pulmonary surfactant-associated protein D,SFTPD,,
DB02379,Beta-D-Glucose,,P01574,Interferon beta,IFNB1,,
DB02379,Beta-D-Glucose,,P29957,Alpha-amylase,amy,,
DB02379,Beta-D-Glucose,,Q7Z4J2,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,,
DB02379,Beta-D-Glucose,,P46926,Glucosamine-6-phosphate isomerase 1,GNPDA1,,
DB02379,Beta-D-Glucose,,P36924,Beta-amylase,spoII,,
DB02379,Beta-D-Glucose,,Q9BW91,"ADP-ribose pyrophosphatase, mitochondrial",NUDT9,,
DB02379,Beta-D-Glucose,,O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,SMARCA5,,
DB02379,Beta-D-Glucose,,P26827,Cyclomaltodextrin glucanotransferase,amyA,,
DB02379,Beta-D-Glucose,,P01552,Enterotoxin type B,entB,,
DB02379,Beta-D-Glucose,,P04745,Alpha-amylase 1,AMY1A,,
DB02379,Beta-D-Glucose,,P00490,Maltodextrin phosphorylase,malP,,
DB02379,Beta-D-Glucose,,P69178,Shiga-like toxin 1 subunit B,stxB,,
DB02379,Beta-D-Glucose,,O14594,Neurocan core protein,NCAN,,
DB02379,Beta-D-Glucose,,P23904,Beta-glucanase,,,
DB02379,Beta-D-Glucose,,P13650,Quinoprotein glucose dehydrogenase B,gdhB,,
DB02379,Beta-D-Glucose,,P00692,Alpha-amylase,,,
DB02379,Beta-D-Glucose,,P0AEX9,Maltose-binding periplasmic protein,malE,,
DB02379,Beta-D-Glucose,,P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,
DB02379,Beta-D-Glucose,,P0C2S2,Endoglucanase A,celA,,
DB02379,Beta-D-Glucose,,P0C2S5,"Cellulose 1,4-beta-cellobiosidase (reducing end) CelS",celS,,
DB02379,Beta-D-Glucose,,P0AEE5,D-galactose-binding periplasmic protein,mglB,,
DB02379,Beta-D-Glucose,,Q54331,Cellulase B,celB,,
DB02379,Beta-D-Glucose,,P0AC38,Aspartate ammonia-lyase,aspA,,
DB02379,Beta-D-Glucose,,Q79G13,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",celA1,,
DB02379,Beta-D-Glucose,,P0A6V8,Glucokinase,glk,,
DB02379,Beta-D-Glucose,,O82839,Amylase,,,
DB02379,Beta-D-Glucose,,Q9HYN5,Fucose-binding lectin PA-IIL,lecB,,
DB02379,Beta-D-Glucose,,Q9KG76,BH0236 protein,,,
DB02379,Beta-D-Glucose,,Q9WXN1,Laminarinase,,,
DB02379,Beta-D-Glucose,,Q8GJ44,"Endo-1,4-beta-xylanase A",xynA,,
DB02379,Beta-D-Glucose,,O07653,Cellulase B,celB,,
DB02379,Beta-D-Glucose,,P14090,Endoglucanase C,cenC,,
DB02379,Beta-D-Glucose,,Q9ZB17,Aldose 1-epimerase,galM,,
DB02379,Beta-D-Glucose,,Q9ZEU2,Amylosucrase,ams,,
DB02379,Beta-D-Glucose,,P04746,Pancreatic alpha-amylase,AMY2A,,
DB02379,Beta-D-Glucose,,O34974,Putative monooxygenase MoxC,moxC,,
DB02379,Beta-D-Glucose,,P54583,Endoglucanase E1,,,
DB02379,Beta-D-Glucose,,P23905,D-galactose-binding periplasmic protein,mglB,,
DB02379,Beta-D-Glucose,,P23827,Ecotin,eco,,
DB02379,Beta-D-Glucose,,P17802,A/G-specific adenine glycosylase,mutY,,
DB02379,Beta-D-Glucose,,Q701N4,Keratin-associated protein 5-2,KRTAP5-2,,
DB02379,Beta-D-Glucose,,Q9BZZ2,Sialoadhesin,SIGLEC1,,
DB02379,Beta-D-Glucose,,P38940,Neopullulanase,nplT,,
DB02379,Beta-D-Glucose,,Q60037,"Endo-1,4-beta-xylanase A",xynA,,
DB02379,Beta-D-Glucose,,P26466,Maltoporin,lamB,,
DB02379,Beta-D-Glucose,,Q26609,Hexokinase,,,
DB02379,Beta-D-Glucose,,P40943,"Endo-1,4-beta-xylanase",,,
DB02379,Beta-D-Glucose,,P02943,Maltoporin,lamB,,
DB02379,Beta-D-Glucose,,P05162,Galectin-2,LGALS2,,
DB02379,Beta-D-Glucose,,Q9RX51,Malto-oligosyltrehalose trehalohydrolase,treZ,,
DB02379,Beta-D-Glucose,,Q7WT42,Inorganic polyphosphate/ATP-glucomannokinase,ppgmk,,
DB02379,Beta-D-Glucose,,Q48436,Diacetyl reductase [(S)-acetoin forming],budC,,
DB02379,Beta-D-Glucose,,P49302,Capsid protein VP1,,,
DB02379,Beta-D-Glucose,,Q7SI98,Hydrolase,,,
DB02379,Beta-D-Glucose,,Q6L8H2,Keratin-associated protein 5-3,KRTAP5-3,,
DB02379,Beta-D-Glucose,,P23340,Endoglucanase C307,celC307,,
DB02379,Beta-D-Glucose,,P94622,"Endo-1,4-beta glucanase EngF",engF,,
DB02379,Beta-D-Glucose,,P26221,Endoglucanase E-4,celD,,
DB02379,Beta-D-Glucose,,Q47644,Orf protein,stx2eB,,
DB02381,nor-NOHA,,P05089,Arginase-1,ARG1,,
DB02382,Namn,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB02382,Namn,,P9WJJ7,Nicotinate-nucleotide pyrophosphorylase [carboxylating],nadC,,
DB02383,Tolrestat,,P14550,Alcohol dehydrogenase [NADP(+)],AKR1A1,,A10XA01
DB02383,Tolrestat,,O60218,Aldo-keto reductase family 1 member B10,AKR1B10,,A10XA01
DB02383,Tolrestat,,P15121,Aldose reductase,AKR1B1,inhibitor,A10XA01
DB02384,(E)-2-Fluoro-P-Hydroxycinnamate,,P31992,Tautomerase PptA,pptA,,
DB02386,Leucine Phosphonic Acid,,Q01693,Bacterial leucyl aminopeptidase,,,
DB02386,Leucine Phosphonic Acid,,P28838,Cytosol aminopeptidase,LAP3,,
DB02388,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB02391,"2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One",,P00491,Purine nucleoside phosphorylase,PNP,,
DB02393,"D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate",,P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,,
DB02394,Oxiranpseudoglucose,,P30920,Cyclomaltodextrin glucanotransferase,,,
DB02395,"3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol",,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,,
DB02396,Methylethylamine,,P02144,Myoglobin,MB,,
DB02398,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB02399,L-Rhamnitol,,P32170,L-rhamnose isomerase,rhaA,,
DB02400,ES-936,,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,,
DB02401,"4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid",,Q27743,L-lactate dehydrogenase,,,
DB02401,"4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid",,P07195,L-lactate dehydrogenase B chain,LDHB,,
DB02402,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFRL1,,
DB02402,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",,P22906,Dihydrofolate reductase,DFR1,,
DB02403,2-Fluoroaniline,,P00720,Lysozyme,E,,
DB02404,1-Deoxy-1-Thio-Heptaethylene Glycol,,P22303,Acetylcholinesterase,ACHE,,
DB02405,12-Bromododecanoic Acid,,P09466,Glycodelin,PAEP,,
DB02406,N-Valeric Acid,,P96965,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",cumD,,
DB02407,6-O-Cyclohexylmethyl Guanine,,P20248,Cyclin-A2,CCNA2,,
DB02407,6-O-Cyclohexylmethyl Guanine,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02408,"(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol",,P0A078,Methionine aminopeptidase,map,,
DB02408,"(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol",,P0A079,Methionine aminopeptidase,map,,
DB02410,"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",,P94692,Pyruvate-flavodoxin oxidoreductase,por,,
DB02411,"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",,P03369,Gag-Pol polyprotein,gag-pol,,
DB02413,Hydroxyethylcysteine,,Q04095,Gag-Pro-Pol polyprotein,gag-pro-pol,,
DB02414,Cyclo(his-pro),,P11797,Chitinase B,chiB,,
DB02415,N-Octyl-2-Hydroxyethyl Sulfoxide,,P17315,Colicin I receptor,cirA,,
DB02415,N-Octyl-2-Hydroxyethyl Sulfoxide,,Q9K597,Outer membrane porin C,ompC,,
DB02415,N-Octyl-2-Hydroxyethyl Sulfoxide,,P06971,Ferrichrome-iron receptor,fhuA,,
DB02418,"(R,R)-2,3-Butanediol",,P62837,Ubiquitin-conjugating enzyme E2 D2,UBE2D2,,
DB02419,Ethyl Oxo(Piperidin-1-Yl)Acetate,,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,,
DB02420,"[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02421,Uridine-5'-diphosphate-mannose,,P09147,UDP-glucose 4-epimerase,galE,,
DB02422,Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside,,Q9UKM7,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,,
DB02424,Geldanamycin,,P14625,Endoplasmin,HSP90B1,inhibitor,
DB02424,Geldanamycin,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB02424,Geldanamycin,,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB02425,Hexadecyl Octanoate,,P9WMC1,HTH-type transcriptional regulator EthR,ethR,,
DB02426,Carboxyatractyloside,,P12235,ADP/ATP translocase 1,SLC25A4,,
DB02427,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",,P00374,Dihydrofolate reductase,DHFR,,
DB02427,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",,P16184,Dihydrofolate reductase,,,
DB02428,Quinaldic Acid,,P04584,Gag-Pol polyprotein,gag-pol,,
DB02429,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,,P00918,Carbonic anhydrase 2,CA2,,
DB02430,Trehalose-6-Phosphate,,P36673,HTH-type transcriptional regulator TreR,treR,,
DB02431,Cytidine-5'-Triphosphate,,P42216,3-deoxy-manno-octulosonate cytidylyltransferase,kpsU,,
DB02431,Cytidine-5'-Triphosphate,,Q9BZX2,Uridine-cytidine kinase 2,UCK2,,
DB02431,Cytidine-5'-Triphosphate,,Q9X1B3,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,ispD,,
DB02431,Cytidine-5'-Triphosphate,,P27623,Glycerol-3-phosphate cytidylyltransferase,tagD,,
DB02431,Cytidine-5'-Triphosphate,,Q46893,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,ispD,,
DB02431,Cytidine-5'-Triphosphate,,P0ABQ0,Coenzyme A biosynthesis bifunctional protein CoaBC,coaBC,,
DB02431,Cytidine-5'-Triphosphate,,Q7SIB1,CCA-adding enzyme,cca,,
DB02431,Cytidine-5'-Triphosphate,,P26396,Glucose-1-phosphate cytidylyltransferase,rfbF,,
DB02432,RU90395,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB02433,"{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid",,P0A716,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB02433,"{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid",,O66496,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB02434,4-(2-Thienyl)Butyric Acid,,P95468,Aromatic-amino-acid aminotransferase,tyrB,,
DB02435,Aminomethylcyclohexane,,P33038,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,murA,,
DB02435,Aminomethylcyclohexane,,P07477,Trypsin-1,PRSS1,,
DB02436,{4-[(2S)-2-({[(1S)-1-Carboxy-2-phenylethyl]carbamoyl}amino)-3-oxo-3-(pentylamino)propyl]phenoxy}malonic acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02437,(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,,P0A433,Parathion hydrolase,opd,,
DB02437,(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,,P08192,Bifunctional protein FolC,folC,,
DB02437,(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,,P39377,Isoaspartyl dipeptidase,iadA,,
DB02438,3-O-Methylfructose in Linear Form,,P15587,Xylose isomerase,xylA,,
DB02441,"2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB02442,Dioxyselenocysteine,,P00782,Subtilisin BPN',apr,,
DB02443,Methicillin Acyl-Serine,,P07944,Beta-lactam-inducible penicillin-binding protein,pbp,,
DB02445,2-Deoxy-2-Amino Glucitol-6-Phosphate,,P17169,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],glmS,,
DB02445,2-Deoxy-2-Amino Glucitol-6-Phosphate,,P46926,Glucosamine-6-phosphate isomerase 1,GNPDA1,,
DB02445,2-Deoxy-2-Amino Glucitol-6-Phosphate,,P0A759,Glucosamine-6-phosphate deaminase,nagB,,
DB02446,Glutamine hydroxamate,,P17169,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],glmS,,
DB02447,"3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02448,N-Tridecanoic Acid,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB02448,N-Tridecanoic Acid,,P04054,Phospholipase A2,PLA2G1B,,
DB02448,N-Tridecanoic Acid,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB02449,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,,P08254,Stromelysin-1,MMP3,,
DB02450,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",,Q79MP6,Beta-lactamase,blaIMP-1,,
DB02450,"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",,P52699,Beta-lactamase IMP-1,,,
DB02451,B-nonylglucoside,,Q5SJ79,Cytochrome c oxidase subunit 1,cbaA,,
DB02451,B-nonylglucoside,,Q5SJ80,Cytochrome c oxidase subunit 2,cbaB,,
DB02451,B-nonylglucoside,,P82543,Cytochrome c oxidase polypeptide 2A,cbaD,,
DB02451,B-nonylglucoside,,P08100,Rhodopsin,RHO,,
DB02451,B-nonylglucoside,,P29972,Aquaporin-1,AQP1,,
DB02451,B-nonylglucoside,,P04118,Colipase,CLPS,,
DB02451,B-nonylglucoside,,P16233,Pancreatic triacylglycerol lipase,PNLIP,,
DB02451,B-nonylglucoside,,Q56408,Cytochrome c oxidase subunit 1,cbaA,,
DB02451,B-nonylglucoside,,P98052,Cytochrome c oxidase subunit 2,cbaB,,
DB02451,B-nonylglucoside,,P30301,Lens fiber major intrinsic protein,MIP,,
DB02451,B-nonylglucoside,,P09391,Rhomboid protease GlpG,glpG,,
DB02451,B-nonylglucoside,,P48549,G protein-activated inward rectifier potassium channel 1,KCNJ3,,
DB02451,B-nonylglucoside,,Q146M9,Putative inward rectifier potassium channel,,,
DB02451,B-nonylglucoside,,P60063,Arginine/agmatine antiporter,adiC,,
DB02452,Thymidine 5'-triphosphate,,P04183,"Thymidine kinase, cytosolic",TK1,,
DB02452,Thymidine 5'-triphosphate,,P07071,Anaerobic ribonucleoside-triphosphate reductase,NRDD,,
DB02452,Thymidine 5'-triphosphate,,P9WKE1,Thymidylate kinase,tmk,,
DB02452,Thymidine 5'-triphosphate,,P61888,Glucose-1-phosphate thymidylyltransferase 2,rffH,,
DB02452,Thymidine 5'-triphosphate,,P03692,DNA primase/helicase,,,
DB02452,Thymidine 5'-triphosphate,,P26393,Glucose-1-phosphate thymidylyltransferase,rmlA,,
DB02452,Thymidine 5'-triphosphate,,O00142,"Thymidine kinase 2, mitochondrial",TK2,,
DB02452,Thymidine 5'-triphosphate,,Q9PPP5,Thymidine kinase,tdk,,
DB02452,Thymidine 5'-triphosphate,,Q08698,Ribonucleoside-diphosphate reductase 2 subunit alpha,nrdE,,
DB02452,Thymidine 5'-triphosphate,,Q9HU22,Glucose-1-phosphate thymidylyltransferase,rmlA,,
DB02453,Antimonous acid,,P08690,Arsenical pump-driving ATPase,arsA,,
DB02456,Aracytidine 5'-monophosphate,,P0A6I0,Cytidylate kinase,cmk,,
DB02457,Undecyl-Phosphinic Acid Butyl Ester,,P07098,Gastric triacylglycerol lipase,LIPF,,
DB02458,"S-(2,4-dinitrophenyl)glutathione",,P09488,Glutathione S-transferase Mu 1,GSTM1,,
DB02458,"S-(2,4-dinitrophenyl)glutathione",,P28161,Glutathione S-transferase Mu 2,GSTM2,,
DB02459,4-guanidinobenzoic acid,,P00751,Complement factor B,CFB,,
DB02460,Hydrogenobyrinic acid,,P21638,Precorrin-8X methylmutase,cobH,,
DB02461,S-Methyl Phosphocysteine,,P0AE67,Chemotaxis protein CheY,cheY,,
DB02462,Thiocoumarin,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB02463,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,,P07477,Trypsin-1,PRSS1,,
DB02464,Benzylamine,,P07477,Trypsin-1,PRSS1,,
DB02464,Benzylamine,,P07478,Trypsin-2,PRSS2,,
DB02465,Methoxy arachidonyl fluorophosphonate,,O00519,Fatty-acid amide hydrolase 1,FAAH,,
DB02466,BMS-181156,,P13631,Retinoic acid receptor gamma,RARG,,
DB02467,L-methionine (S)-S-oxide,,P0A884,Thymidylate synthase,thyA,,
DB02467,L-methionine (S)-S-oxide,,Q79G13,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",celA1,,
DB02467,L-methionine (S)-S-oxide,,P20339,Ras-related protein Rab-5A,RAB5A,,
DB02467,L-methionine (S)-S-oxide,,Q54331,Cellulase B,celB,,
DB02467,L-methionine (S)-S-oxide,,P22364,Amicyanin,mauC,,
DB02467,L-methionine (S)-S-oxide,,P80561,Aminopeptidase S,,,
DB02468,12-Phenylheme,,P09601,Heme oxygenase 1,HMOX1,,
DB02469,"4,6-dideoxy-4-amino-beta-D-glucopyranoside",,P30920,Cyclomaltodextrin glucanotransferase,,,
DB02470,D-Glycero-D-Mannopyranose-7-Phosphate,,Q9HVZ0,Phosphoheptose isomerase,gmhA,,
DB02471,Nojirimycine Tetrazole,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02471,Nojirimycine Tetrazole,,Q6UWM7,Lactase-like protein,LCTL,,
DB02471,Nojirimycine Tetrazole,,P09848,Lactase-phlorizin hydrolase,LCT,,
DB02472,"7,8-dihydroinosine",,P00813,Adenosine deaminase,ADA,,
DB02473,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB02474,BMSC-0013,,P01556,Cholera enterotoxin subunit B,ctxB,,
DB02475,Deoxyamidinoproclavaminic acid,,Q05581,Clavaminate synthase 1,cs1,,
DB02477,N-({4-[4-(2-Methyl-1H-imidazol-1-yl)butyl]phenyl}acetyl)-L-seryl-N-(2-cyclohexylethyl)-L-lysinamide,,P30418,Glycylpeptide N-tetradecanoyltransferase,NMT1,,
DB02479,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,,P00918,Carbonic anhydrase 2,CA2,,
DB02480,(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate,,Q46822,Isopentenyl-diphosphate Delta-isomerase,idi,,
DB02481,N-Benzylformamide,,P00325,Alcohol dehydrogenase 1B,ADH1B,,
DB02482,Phosphonothreonine,,Q04759,Protein kinase C theta type,PRKCQ,,
DB02482,Phosphonothreonine,,O14965,Aurora kinase A,AURKA,,
DB02482,Phosphonothreonine,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB02482,Phosphonothreonine,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB02482,Phosphonothreonine,,P22694,cAMP-dependent protein kinase catalytic subunit beta,PRKACB,,
DB02482,Phosphonothreonine,,P50613,Cyclin-dependent kinase 7,CDK7,,
DB02482,Phosphonothreonine,,P97084,Threonine-phosphate decarboxylase,cobD,,
DB02482,Phosphonothreonine,,P08100,Rhodopsin,RHO,,
DB02482,Phosphonothreonine,,P31949,Protein S100-A11,S100A11,,
DB02482,Phosphonothreonine,,P53778,Mitogen-activated protein kinase 12,MAPK12,,
DB02483,Etheno-NAD,,Q10588,ADP-ribosyl cyclase 2,BST1,,
DB02483,Etheno-NAD,,P00338,L-lactate dehydrogenase A chain,LDHA,,
DB02484,Cytidine 5'-diphosphoglycerol,,P27623,Glycerol-3-phosphate cytidylyltransferase,tagD,,
DB02485,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,,Q8NFW8,N-acylneuraminate cytidylyltransferase,CMAS,,
DB02486,2-Hydroxyethyl Disulfide,,P00720,Lysozyme,E,,
DB02486,2-Hydroxyethyl Disulfide,,P08263,Glutathione S-transferase A1,GSTA1,,
DB02489,9-Methylguanine,,P56740,Dihydroneopterin aldolase,folB,,
DB02490,(Diaminomethyl-Methyl-Amino)-Acetic Acid,,P06732,Creatine kinase M-type,CKM,,
DB02491,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,,P21802,Fibroblast growth factor receptor 2,FGFR2,,
DB02492,Ghavamiol,,Q16706,Alpha-mannosidase 2,MAN2A1,,
DB02493,Hydantocidin-5'-phosphate,,P0A7D4,Adenylosuccinate synthetase,purA,,
DB02494,(S)-3-phenyllactic acid,,Q59771,L-phenylalanine dehydrogenase,pdh,,
DB02494,(S)-3-phenyllactic acid,,Q96L21,60S ribosomal protein L10-like,RPL10L,,
DB02494,(S)-3-phenyllactic acid,,P40429,60S ribosomal protein L13a,RPL13A,,
DB02494,(S)-3-phenyllactic acid,,P62829,60S ribosomal protein L23,RPL23,,
DB02494,(S)-3-phenyllactic acid,,P61313,60S ribosomal protein L15,RPL15,,
DB02494,(S)-3-phenyllactic acid,,P84098,60S ribosomal protein L19,RPL19,,
DB02494,(S)-3-phenyllactic acid,,P62750,60S ribosomal protein L23a,RPL23A,,
DB02494,(S)-3-phenyllactic acid,,Q9UHA3,Probable ribosome biogenesis protein RLP24,RSL24D1,,
DB02494,(S)-3-phenyllactic acid,,Q9UNX3,60S ribosomal protein L26-like 1,RPL26L1,,
DB02494,(S)-3-phenyllactic acid,,P62917,60S ribosomal protein L8,RPL8,,
DB02494,(S)-3-phenyllactic acid,,P61927,60S ribosomal protein L37,RPL37,,
DB02494,(S)-3-phenyllactic acid,,P39023,60S ribosomal protein L3,RPL3,,
DB02494,(S)-3-phenyllactic acid,,P62913,60S ribosomal protein L11,RPL11,,
DB02494,(S)-3-phenyllactic acid,,P55769,NHP2-like protein 1,SNU13,,
DB02494,(S)-3-phenyllactic acid,,P15085,Carboxypeptidase A1,CPA1,,
DB02495,9-(4-hydroxybutyl)-N2-phenylguanine,,Q9QNF7,Thymidine kinase,TK,inhibitor,
DB02496,1-Deoxy-D-xylulose 5-phosphate,,P0A794,Pyridoxine 5'-phosphate synthase,pdxJ,,
DB02496,1-Deoxy-D-xylulose 5-phosphate,,P45568,1-deoxy-D-xylulose 5-phosphate reductoisomerase,dxr,,
DB02497,L-Alpha-Glycerophosphorylserine,,P08758,Annexin A5,ANXA5,,
DB02498,Carba-nicotinamide-adenine-dinucleotide,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB02499,Dinor-N(Omega)-Hydroxy-L-Arginine,,P05089,Arginase-1,ARG1,,
DB02500,6-(Dihydroxy-Isobutyl)-Thymine,,Q9QNF7,Thymidine kinase,TK,substrate,
DB02501,N(2)-succinyl-L-arginine,,P76216,N-succinylarginine dihydrolase,astB,,
DB02503,4-(Carboxyvin-2-Yl)Phenylboronic Acid,,P00811,Beta-lactamase,ampC,,
DB02504,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB02505,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),,P46925,Plasmepsin-2,,,
DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",,P62136,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit,PPP1CA,,
DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",,P30153,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,PPP2R1A,,
DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",,P67775,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,PPP2CA,,
DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",,Q13362,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PPP2R5C,,
DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",,P63151,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform,PPP2R2A,,
DB02508,Isopentyl Pyrophosphate,,P14324,Farnesyl pyrophosphate synthase,FDPS,,
DB02508,Isopentyl Pyrophosphate,,P71278,Pentaerythritol tetranitrate reductase,onr,,
DB02508,Isopentyl Pyrophosphate,,A0A0H2UXE9,Geranyltranstransferase (Farnesyldiphosphate synthase),ispA,,
DB02508,Isopentyl Pyrophosphate,,P22939,Farnesyl diphosphate synthase,ispA,,
DB02509,Farnesol,,Q96RI1,Bile acid receptor,NR1H4,agonist,
DB02509,Farnesol,,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB02510,5'-O-(L-Prolylsulfamoyl)adenosine,,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,,
DB02511,2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,,P46881,Phenylethylamine oxidase,,,
DB02512,"1,6-Fructose Diphosphate (Linear Form)",,P05062,Fructose-bisphosphate aldolase B,ALDOB,,
DB02512,"1,6-Fructose Diphosphate (Linear Form)",,P04075,Fructose-bisphosphate aldolase A,ALDOA,,
DB02514,(2Z)-3-{[Oxido(oxo)phosphoranyl]oxy}-2-phenylacrylate,,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB02515,sn-glycerol 3-phosphate,,P05062,Fructose-bisphosphate aldolase B,ALDOB,,
DB02515,sn-glycerol 3-phosphate,,P0A794,Pyridoxine 5'-phosphate synthase,pdxJ,,
DB02515,sn-glycerol 3-phosphate,,Q07412,Triosephosphate isomerase,TPI,,
DB02515,sn-glycerol 3-phosphate,,P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,,
DB02516,(R)-carnitinyl-CoA betaine,,P31572,Crotonobetainyl-CoA:carnitine CoA-transferase,caiB,,
DB02517,D-Glutamic Acid,,P43133,Thermolysin,nprS,,
DB02518,N-Acetylalanine,,P15121,Aldose reductase,AKR1B1,,
DB02519,Indirubin-5-sulphonate,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02519,Indirubin-5-sulphonate,,Q07785,Cell division control protein 2 homolog,CRK2,,
DB02521,Flaviolin,,Q4R2T2,Prenyltransferase,,,
DB02521,Flaviolin,,Q9FCA6,Putative cytochrome P450,cyp158a2,,
DB02522,Phosphonopyruvate,,P22983,"Pyruvate, phosphate dikinase",ppdK,,
DB02524,"2',3'-O-{4-[Hydroxy(oxido)-λ5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",,Q56310,Chemotaxis protein CheA,cheA,,
DB02526,CRA_10655,,P07477,Trypsin-1,PRSS1,,
DB02526,CRA_10655,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB02527,Cyclic adenosine monophosphate,,Q9UL51,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,HCN2,,
DB02527,Cyclic adenosine monophosphate,,P10644,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,,
DB02527,Cyclic adenosine monophosphate,,P31323,cAMP-dependent protein kinase type II-beta regulatory subunit,PRKAR2B,,
DB02527,Cyclic adenosine monophosphate,,P0ACJ8,cAMP-activated global transcriptional regulator CRP,crp,,
DB02527,Cyclic adenosine monophosphate,,P94182,Adenylate cyclase,cyaB2,,
DB02527,Cyclic adenosine monophosphate,,Q98GN8,Cyclic nucleotide-gated potassium channel mll3241,,,
DB02528,Tetrazolyl Histidine,,P02144,Myoglobin,MB,,
DB02529,"(2R,4S,5R,6R)-5-Acetamido-4-amino-6-(diethylcarbamoyl)oxane-2-carboxylic acid",,P03472,Neuraminidase,,,
DB02530,gamma-Aminobutyric acid,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,,
DB02530,gamma-Aminobutyric acid,,O75899,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,,
DB02530,gamma-Aminobutyric acid,,P50440,"Glycine amidinotransferase, mitochondrial",GATM,,
DB02531,Isobutyric acid,,P96965,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",cumD,,
DB02532,"2,4,6-Triaminoquinazoline",,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 2,DHRS4L1,,
DB02532,"2,4,6-Triaminoquinazoline",,Q01782,Pteridine reductase 1,PTR1,,
DB02534,2-Allylphenol,,P00720,Lysozyme,E,,
DB02535,Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide,,P00918,Carbonic anhydrase 2,CA2,,
DB02537,2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine,,P46881,Phenylethylamine oxidase,,,
DB02538,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02540,"10-formyl-5,8,10-trideazafolic acid",,P08179,Phosphoribosylglycinamide formyltransferase,purN,,
DB02541,4-Hydroxybutan-1-Aminium,,P35030,Trypsin-3,PRSS3,,
DB02542,(4s)-5-Fluoro-L-Leucine,,P0CG47,Polyubiquitin-B,UBB,,
DB02543,Pyrrole-2-Carboxylate,,P40859,Monomeric sarcosine oxidase,soxA,,
DB02544,"N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine",,P33247,Squalene--hopene cyclase,shc,,
DB02545,Fexaramine,,Q96RI1,Bile acid receptor,NR1H4,,
DB02546,Vorinostat,,Q13547,Histone deacetylase 1,HDAC1,inhibitor,L01XH01
DB02546,Vorinostat,,Q92769,Histone deacetylase 2,HDAC2,inhibitor,L01XH01
DB02546,Vorinostat,,O15379,Histone deacetylase 3,HDAC3,inhibitor,L01XH01
DB02546,Vorinostat,,Q9UBN7,Histone deacetylase 6,HDAC6,inhibitor,L01XH01
DB02546,Vorinostat,,Q9BY41,Histone deacetylase 8,HDAC8,,L01XH01
DB02546,Vorinostat,,O67135,Acetoin utilization protein,acuC1,,L01XH01
DB02546,Vorinostat,,Q13547,Histone deacetylase,HDAC1,inhibitor,L01XH01
DB02547,Guanosine-5'-Diphosphate-Rhamnose,,O60547,"GDP-mannose 4,6 dehydratase",GMDS,,
DB02548,D-glucitol 6-phosphate,,P06744,Glucose-6-phosphate isomerase,GPI,,
DB02549,3'-O-Acetylthymidine-5'-diphosphate,,P26394,"dTDP-4-dehydrorhamnose 3,5-epimerase",rfbC,,
DB02550,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB02551,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB02552,Geranyl Diphosphate,,P62617,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB02552,Geranyl Diphosphate,,P14324,Farnesyl pyrophosphate synthase,FDPS,,
DB02552,Geranyl Diphosphate,,Q4R2T2,Prenyltransferase,,,
DB02552,Geranyl Diphosphate,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB02552,Geranyl Diphosphate,,P9WFF5,"(2Z,6E)-farnesyl diphosphate synthase",,,
DB02552,Geranyl Diphosphate,,P9WFF7,Decaprenyl diphosphate synthase,uppS,,
DB02552,Geranyl Diphosphate,,P62619,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB02552,Geranyl Diphosphate,,Q9PM68,Bifunctional enzyme IspD/IspF,ispDF,,
DB02553,Glutathionylspermidine disulfide,,P00390,"Glutathione reductase, mitochondrial",GSR,,
DB02555,SP4160,,P60568,Interleukin-2,IL2,,
DB02556,D-Phenylalanine,,Q16773,Kynurenine--oxoglutarate transaminase 1,CCBL1,,
DB02556,D-Phenylalanine,,P06850,Corticoliberin,CRH,,
DB02557,Phosphoramidon,,P23276,Kell blood group glycoprotein,KEL,,
DB02557,Phosphoramidon,,P08473,Neprilysin,MME,inhibitor,
DB02558,N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine,,P08473,Neprilysin,MME,,
DB02559,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",,P00374,Dihydrofolate reductase,DHFR,,
DB02559,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",,P16184,Dihydrofolate reductase,,,
DB02560,[(1S)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron,,P00780,Subtilisin Carlsberg,apr,,
DB02561,Beta-D-Fructopyranose,,Q9HYN5,Fucose-binding lectin PA-IIL,lecB,,
DB02562,"Quinonoid 7,8-Tetrahydrobiopterin",,P00439,Phenylalanine-4-hydroxylase,PAH,,
DB02563,Hexanoyl-CoA,,P30084,"Enoyl-CoA hydratase, mitochondrial",ECHS1,,
DB02565,4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide,,Q9BY41,Histone deacetylase 8,HDAC8,,
DB02566,8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,,P0C8P8,Thiostrepton,tpdA,,
DB02566,8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,,P29395,50S ribosomal protein L11,rplK,,
DB02567,PD173955,,P00521,Tyrosine-protein kinase transforming protein Abl,ABL,,
DB02568,Peldesine,,P00491,Purine nucleoside phosphorylase,PNP,,
DB02569,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",,P15531,Nucleoside diphosphate kinase A,NME1,,
DB02570,PD150606,,P04632,Calpain small subunit 1,CAPNS1,,
DB02571,Allysine,,Q88K39,Glutaminase-asparaginase,ansB,,
DB02572,"1,3-bis-([3-[3-[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)-benzoylamino]-propyl}-piperazin-1-yl)-propylamino-3,4-dioxo-cyclobutenyl]-amino-propoxy-ethoxy-ethoxy]-propyl-]amino-carbonyloxy)-2-amino-propane",,P01556,Cholera enterotoxin subunit B,ctxB,,
DB02573,"2'-deoxycytidine-2'-deoxyadenosine-3',5'-monophosphate",,P07998,Ribonuclease pancreatic,RNASE1,,
DB02574,BV2,,P01556,Cholera enterotoxin subunit B,ctxB,,
DB02576,F-Loop of Vitamin B12,,Q05488,Methylaspartate mutase S chain,glmS,,
DB02578,N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine,,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB02579,Acrylic Acid,,P0AD63,Beta-lactamase SHV-1,bla,,
DB02580,Pentaglyme,,P35080,Profilin-2,PFN2,,
DB02580,Pentaglyme,,A3FMN7,Restriction endonuclease R.BpuJI,bpuJIR,,
DB02580,Pentaglyme,,L0DSL2,Eight-heme nitrite reductase,nir,,
DB02580,Pentaglyme,,Q82EE4,Uncharacterized protein,,,
DB02580,Pentaglyme,,Q74EF5,"Sensor cyclic diguanylate phosphodiesterase, GAF and GAF domain-containing",,,
DB02580,Pentaglyme,,B7JA91,Putative uncharacterized protein,,,
DB02580,Pentaglyme,,Q3JWH7,"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase",gpmA,,
DB02580,Pentaglyme,,Q8ZIV7,Adenylosuccinate synthetase,purA,,
DB02580,Pentaglyme,,Q2LU76,Hypothetical cytosolic protein,,,
DB02580,Pentaglyme,,A7B6P0,"EDD domain protein, DegV family",,,
DB02580,Pentaglyme,,Q87MW5,Uncharacterized protein,,,
DB02581,"N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide",,P60568,Interleukin-2,IL2,,
DB02583,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",,P00374,Dihydrofolate reductase,DHFR,,
DB02585,4-(Hydroxymethyl)Benzamidine,,P35030,Trypsin-3,PRSS3,,
DB02586,"4,7-Dimethyl-[1,10]Phenanthroline",,P00282,Azurin,azu,,
DB02587,Colforsin,,Q08462,Adenylate cyclase type 2,ADCY2,,
DB02587,Colforsin,,P63092,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,GNAS,,
DB02587,Colforsin,,O95622,Adenylate cyclase type 5,ADCY5,,
DB02587,Colforsin,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,inhibitor,
DB02587,Colforsin,,Q08828,Adenylate cyclase,ADCY1,activator,
DB02587,Colforsin,,Q12791,Calcium-activated potassium channel,KCNMA1,activator,
DB02587,Colforsin,,Q92793,CREB-binding protein,CREBBP,activator,
DB02587,Colforsin,,P28482,Extracellular signal-regulated kinase (ERK),MAPK1,activator,
DB02587,Colforsin,,Q02817,Mucin-2,MUC2,activator,
DB02587,Colforsin,,P05121,Plasminogen activator inhibitor 1,SERPINE1,inhibitor,
DB02588,"(2R)-2-[(1R)-1-{[(2S)-2-Carboxy-2-(4-hydroxyphenyl)acetyl]amino}-1-methoxy-2-oxoethyl]-5-methylene-5,6-dihydro-2H-1,3-oxazine-4-carboxylic acid",,P00811,Beta-lactamase,ampC,,
DB02589,Se-Ethyl-Isoselenourea,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02590,Abequose,,P12528,Bifunctional tail protein,9,,
DB02591,"5,6-Dimethylbenzimidazole",,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB02592,Carbaphosphonate,,Q6GGU4,3-dehydroquinate synthase,aroB,,
DB02593,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",,P25910,Beta-lactamase type II,ccrA,,
DB02594,2'-Deoxycytidine,,O00142,"Thymidine kinase 2, mitochondrial",TK2,,
DB02594,2'-Deoxycytidine,,P0AE22,Class B acid phosphatase,aphA,,
DB02594,2'-Deoxycytidine,,P27707,Deoxycytidine kinase,DCK,,
DB02595,"(2R,3S,5S)-2-(Hydroxymethyl)-5-[(2-sulfoethyl)carbamoyl]-3-pyrrolidiniumyl 2-acetamido-2-deoxy-4-O-sulfo-beta-D-glucopyranoside",,P41052,Membrane-bound lytic murein transglycosylase B,mltB,,
DB02595,"(2R,3S,5S)-2-(Hydroxymethyl)-5-[(2-sulfoethyl)carbamoyl]-3-pyrrolidiniumyl 2-acetamido-2-deoxy-4-O-sulfo-beta-D-glucopyranoside",,P0AGC3,Soluble lytic murein transglycosylase,slt,,
DB02596,"alpha,beta-Methyleneadenosine 5'-triphosphate",,P26281,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,folK,,
DB02596,"alpha,beta-Methyleneadenosine 5'-triphosphate",,P9WIL5,Pantothenate synthetase,panC,,
DB02596,"alpha,beta-Methyleneadenosine 5'-triphosphate",,P08164,NH(3)-dependent NAD(+) synthetase,nadE,,
DB02596,"alpha,beta-Methyleneadenosine 5'-triphosphate",,Q96T66,Nicotinamide mononucleotide adenylyltransferase 3,NMNAT3,,
DB02596,"alpha,beta-Methyleneadenosine 5'-triphosphate",,O32393,Adenylate cyclase,cyaC,,
DB02596,"alpha,beta-Methyleneadenosine 5'-triphosphate",,Q94M05,NTPase P4,4,,
DB02596,"alpha,beta-Methyleneadenosine 5'-triphosphate",,O07732,Probable lignin peroxidase LipJ,lipJ,,
DB02596,"alpha,beta-Methyleneadenosine 5'-triphosphate",,Q9XB61,Carbapenam-3-carboxylate synthase,carA,,
DB02597,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",,P00800,Thermolysin,npr,,
DB02597,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",,P43133,Thermolysin,nprS,,
DB02597,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",,P08473,Neprilysin,MME,,
DB02598,"N-Alpha-Acetyl-3,5-Diiodotyrosylglycine",,P19021,Peptidyl-glycine alpha-amidating monooxygenase,PAM,,
DB02599,"2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB02600,Oseltamivir acid,,P03472,Neuraminidase,,,
DB02602,AL7182,,P00918,Carbonic anhydrase 2,CA2,,
DB02603,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02604,2-Deoxy-Glucose-6-Phosphate,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02606,2-Butanol,,P14941,NADP-dependent isopropanol dehydrogenase,adh,,
DB02607,Adenosine Phosphonoacetic Acid,,P15531,Nucleoside diphosphate kinase A,NME1,,
DB02608,"N-[(1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)-2-propanyl]acetamide",,Q56148,Chloramphenicol 3-O phosphotransferase,,,
DB02609,4-Hydroxy-L-Threonine-5-Monophosphate,,P19624,4-hydroxythreonine-4-phosphate dehydrogenase,pdxA,,
DB02610,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",,P00918,Carbonic anhydrase 2,CA2,,
DB02611,Balanol Analog 1,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB02613,Capric dimethyl amine oxide,,P54317,Pancreatic lipase-related protein 2,PNLIPRP2,,
DB02613,Capric dimethyl amine oxide,,P06971,Ferrichrome-iron receptor,fhuA,,
DB02613,Capric dimethyl amine oxide,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB02613,Capric dimethyl amine oxide,,P06653,Autolysin,lytA,,
DB02614,1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid,,P62593,Beta-lactamase TEM,bla,,
DB02614,1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid,,P62594,Beta-lactamase TEM,bla,,
DB02615,Compound 19,,P03372,Estrogen receptor alpha,ESR1,,
DB02615,Compound 19,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02616,FR117016,,P00813,Adenosine deaminase,ADA,,
DB02617,"1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane",,P00183,Camphor 5-monooxygenase,camC,,
DB02620,3-(4-{2-[2-(2-bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02621,Latrunculin A,,P68133,"Actin, alpha skeletal muscle",ACTA1,inhibitor,
DB02621,Latrunculin A,,P06396,Gelsolin,GSN,,
DB02621,Latrunculin A,,Q46220,Iota toxin component Ia,,,
DB02622,2-(Oxalyl-Amino)-Benzoic Acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02623,Aminophosphonic acid-guanylate ester,,P60953,Cell division control protein 42 homolog,CDC42,,
DB02624,Homoserine Lactone,,P19634,Sodium/hydrogen exchanger 1,SLC9A1,,
DB02625,(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid,,Q8I372,"Formylmethionine deformylase, putative",,,
DB02626,Phenylferricrocin-iron,,P06971,Ferrichrome-iron receptor,fhuA,,
DB02627,"4,4'-Biphenyldiboronic Acid",,P00811,Beta-lactamase,ampC,,
DB02628,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",,P98170,E3 ubiquitin-protein ligase XIAP,XIAP,,
DB02629,"N,N-[2,5-O-di-2-fluoro-benzyl-glucaryl]-di-[1-amino-indan-2-ol]",,P03366,Gag-Pol polyprotein,gag-pol,,
DB02630,L-xylitol 5-phosphate,,P39304,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,ulaD,,
DB02632,4-nitrophenyl-beta-D-galactoside,,P07464,Galactoside O-acetyltransferase,lacA,,
DB02632,4-nitrophenyl-beta-D-galactoside,,P00722,Beta-galactosidase,lacZ,,
DB02633,Cibacron Blue,,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,,
DB02633,Cibacron Blue,,P09211,Glutathione S-transferase P,GSTP1,,
DB02635,N-[O-Phosphono-Pyridoxyl]-Isoleucine,,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,,
DB02636,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB02637,Oxaloacetate Ion,,O75390,"Citrate synthase, mitochondrial",CS,,
DB02637,Oxaloacetate Ion,,Q9ZF99,Malate dehydrogenase,mdh,,
DB02637,Oxaloacetate Ion,,P35270,Sepiapterin reductase,SPR,,
DB02637,Oxaloacetate Ion,,Q70AC7,Methylmalonyl-CoA carboxyltransferase 5S subunit,,,
DB02637,Oxaloacetate Ion,,Q9RUZ0,Citrate lyase subunit beta-like protein,,,
DB02638,Terlipressin,,P37288,Vasopressin V1a receptor,AVPR1A,agonist,H01BA04
DB02638,Terlipressin,,P47901,Vasopressin V1b receptor,AVPR1B,agonist,H01BA04
DB02638,Terlipressin,,P30518,Vasopressin V2 receptor,AVPR2,agonist,H01BA04
DB02640,Fumagillin,,P50579,Methionine aminopeptidase 2,METAP2,ligand,P01AX10
DB02641,Heptanamide,,Q9ZAG3,"Limonene-1,2-epoxide hydrolase",limA,,
DB02642,[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,,P62593,Beta-lactamase TEM,bla,,
DB02642,[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,,P00807,Beta-lactamase,blaZ,,
DB02642,[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,,P62594,Beta-lactamase TEM,bla,,
DB02643,"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",,P05019,Insulin-like growth factor I,IGF1,,
DB02643,"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB02643,"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",,P03276,Penton protein,,,
DB02644,N-omega-propyl-L-arginine,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB02644,N-omega-propyl-L-arginine,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB02645,"3,4-Epoxybutyl-Alpha-D-Glucopyranoside",,P36924,Beta-amylase,spoII,,
DB02646,Nitrosoethane,,P02144,Myoglobin,MB,,
DB02647,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02648,(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,,P43155,Carnitine O-acetyltransferase,CRAT,,
DB02648,(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,,Q9UKG9,Peroxisomal carnitine O-octanoyltransferase,CROT,,
DB02649,3-Amino-3-Oxopropanoic Acid,,Q9ZIV5,Malonamidase E2,,,
DB02651,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02652,L-[(N-Hydroxyamino)Carbonyl]Phenylalanine,,P15085,Carboxypeptidase A1,CPA1,,
DB02655,D-Aspartic Acid,,P43133,Thermolysin,nprS,,
DB02655,D-Aspartic Acid,,P06608,L-asparaginase,ansB,,
DB02656,LY-294002,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB02656,LY-294002,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB02657,Glucosamine 6-Phosphate,,P17169,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],glmS,,
DB02657,Glucosamine 6-Phosphate,,O34450,N-acetylglucosamine-6-phosphate deacetylase,nagA,,
DB02658,"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",,P22073,Beta-glucosidase A,bglA,,
DB02659,Cholic Acid,,P00326,Alcohol dehydrogenase 1C,ADH1C,,A05AA03
DB02659,Cholic Acid,,P62508,Estrogen-related receptor gamma,ESRRG,,A05AA03
DB02659,Cholic Acid,,P51161,Gastrotropin,FABP6,,A05AA03
DB02659,Cholic Acid,,P13073,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",COX4I1,,A05AA03
DB02659,Cholic Acid,,P00395,Cytochrome c oxidase subunit 1,MT-CO1,,A05AA03
DB02659,Cholic Acid,,P00403,Cytochrome c oxidase subunit 2,MT-CO2,,A05AA03
DB02659,Cholic Acid,,P00414,Cytochrome c oxidase subunit 3,MT-CO3,,A05AA03
DB02659,Cholic Acid,,P20674,"Cytochrome c oxidase subunit 5A, mitochondrial",COX5A,,A05AA03
DB02659,Cholic Acid,,P10606,"Cytochrome c oxidase subunit 5B, mitochondrial",COX5B,,A05AA03
DB02659,Cholic Acid,,P09669,Cytochrome c oxidase subunit 6C,COX6C,,A05AA03
DB02659,Cholic Acid,,P24311,"Cytochrome c oxidase subunit 7B, mitochondrial",COX7B,,A05AA03
DB02659,Cholic Acid,,P15954,"Cytochrome c oxidase subunit 7C, mitochondrial",COX7C,,A05AA03
DB02659,Cholic Acid,,P10176,"Cytochrome c oxidase subunit 8A, mitochondrial",COX8A,,A05AA03
DB02659,Cholic Acid,,Q02221,"Cytochrome c oxidase subunit 6A2, mitochondrial",COX6A2,,A05AA03
DB02659,Cholic Acid,,P14854,Cytochrome c oxidase subunit 6B1,COX6B1,,A05AA03
DB02659,Cholic Acid,,P24310,"Cytochrome c oxidase subunit 7A1, mitochondrial",COX7A1,,A05AA03
DB02659,Cholic Acid,,P04054,Phospholipase A2,PLA2G1B,,A05AA03
DB02659,Cholic Acid,,P23141,Liver carboxylesterase 1,CES1,,A05AA03
DB02659,Cholic Acid,,P54965,Choloylglycine hydrolase,cbh,,A05AA03
DB02659,Cholic Acid,,Q96RI1,Bile acid receptor,NR1H4,,A05AA03
DB02659,Cholic Acid,,Q8TDU6,G-protein coupled bile acid receptor 1,GPBAR1,,A05AA03
DB02659,Cholic Acid,,P22830,"Ferrochelatase, mitochondrial",FECH,,A05AA03
DB02660,Filaminast,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,
DB02661,"Adenosine-5'-diphosphate-2',3'-vanadate",,O43252,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,PAPSS1,,
DB02662,Novo Nordisk a/S Compound,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02663,2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid,,P0A1P6,Glutamine synthetase,glnA,,
DB02664,1-Butane Boronic Acid,,Q01693,Bacterial leucyl aminopeptidase,,,
DB02665,"(1R,2S)-2-Phenylcyclopropanaminium",,P07477,Trypsin-1,PRSS1,,
DB02666,(C8-R)-hydantocidin 5'-phosphate,,P0A7D4,Adenylosuccinate synthetase,purA,,
DB02667,Vitamin B 12 factor IIIm,,Q2RJ67,5-methyltetrahydrofolate--homocysteine S-methyltransferase,,,
DB02668,JE-2147,,P03369,Gag-Pol polyprotein,gag-pol,,
DB02669,RB106,,P00800,Thermolysin,npr,,
DB02669,RB106,,P43133,Thermolysin,nprS,,
DB02670,4-Deoxy-Alpha-D-Glucose,,P30920,Cyclomaltodextrin glucanotransferase,,,
DB02670,4-Deoxy-Alpha-D-Glucose,,O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,SMARCA5,,
DB02671,1-Methylimidazole,,P02144,Myoglobin,MB,,
DB02671,1-Methylimidazole,,P23222,Sensor protein FixL,fixL,,
DB02673,"(4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium",,P22303,Acetylcholinesterase,ACHE,,
DB02674,"4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid",,P22629,Streptavidin,,,
DB02676,"2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol",,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB02677,D-naphthyl-1-acetamido boronic acid alanine,,P00780,Subtilisin Carlsberg,apr,,
DB02678,beta-D-Galactosamine,,P47929,Galectin-7,LGALS7,,
DB02679,Cyanamide,,P43235,Cathepsin K,CTSK,,
DB02679,Cyanamide,,P00918,Carbonic anhydrase 2,CA2,,
DB02680,"1,3-Dinitrobenzene",,P49424,"Mannan endo-1,4-beta-mannosidase",manA,,
DB02681,"2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium",,P12758,Uridine phosphorylase,udp,,
DB02681,"2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium",,P61024,Cyclin-dependent kinases regulatory subunit 1,CKS1B,,
DB02683,Inhibitor Bea428,,P03366,Gag-Pol polyprotein,gag-pol,,
DB02684,5'-O-(L-Cysteinylsulfamoyl)adenosine,,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,,
DB02685,3-Methylphenylalanine,,P07858,Cathepsin B,CTSB,,
DB02686,Undecyl-Beta-D-Maltopyranoside,,P43457,V-type sodium ATPase subunit K,ntpK,,
DB02688,"2,3-Didehydroalanine",,P43683,Lantibiotic mersacidin,mrsA,,
DB02689,S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine,,P05089,Arginase-1,ARG1,,
DB02690,NU1025,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB02691,Glycocholic acid,,P51161,Gastrotropin,FABP6,,
DB02693,"(4S,5S)-1,2-dithiane-4,5-diol",,P9WHE9,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB02694,Pantoyl Adenylate,,P9WIL5,Pantothenate synthetase,panC,,
DB02695,O1-Pentyl-Mannose,,P81180,Cyanovirin-N,,,
DB02696,"6-Aminohexyl-uridine-C1,5'-diphosphate",,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,,
DB02697,Hydroxyaminovaline,,P45452,Collagenase 3,MMP13,,
DB02697,Hydroxyaminovaline,,P08254,Stromelysin-1,MMP3,,
DB02700,3-Deoxy-D-Glucosamine,,P06971,Ferrichrome-iron receptor,fhuA,,
DB02701,Nicotinamide,,Q10588,ADP-ribosyl cyclase 2,BST1,product of,A11HA01
DB02701,Nicotinamide,,P11439,Exotoxin A,eta,product of,A11HA01
DB02701,Nicotinamide,,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,,A11HA01
DB02701,Nicotinamide,,P00338,L-lactate dehydrogenase A chain,LDHA,,A11HA01
DB02701,Nicotinamide,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,binder,A11HA01
DB02702,XV638,,P04585,Gag-Pol polyprotein,gag-pol,,
DB02703,Fusidic acid,,P13551,Elongation factor G,fusA,inhibitor,S01AA13;D09AA02;J01XC01;D06AX01
DB02703,Fusidic acid,,P62580,Chloramphenicol acetyltransferase,cat,inhibitor,S01AA13;D09AA02;J01XC01;D06AX01
DB02703,Fusidic acid,,P00484,Chloramphenicol acetyltransferase 3,cat3,inhibitor,S01AA13;D09AA02;J01XC01;D06AX01
DB02704,"(2R,3R,4R,5R)-3,4-Dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide",,P03366,Gag-Pol polyprotein,gag-pol,,
DB02705,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB02706,Mercaptocarboxylate Inhibitor,,P52699,Beta-lactamase IMP-1,,,
DB02709,Resveratrol,,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,
DB02709,Resveratrol,,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB02709,Resveratrol,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB02709,Resveratrol,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB02709,Resveratrol,,P16050,Arachidonate 15-lipoxygenase,ALOX15,,
DB02709,Resveratrol,,P09917,Arachidonate 5-lipoxygenase,ALOX5,,
DB02709,Resveratrol,,P35869,Aryl hydrocarbon receptor,AHR,,
DB02709,Resveratrol,,Q8TCG2,Phosphatidylinositol 4-kinase type 2-beta,PI4K2B,,
DB02709,Resveratrol,,P08648,Integrin alpha-5,ITGA5,,
DB02709,Resveratrol,,P05106,Integrin beta-3,ITGB3,,
DB02709,Resveratrol,,P05067,Amyloid beta A4 protein,APP,,
DB02709,Resveratrol,,P37840,Alpha-synuclein,SNCA,,
DB02709,Resveratrol,,Q96EB6,NAD-dependent protein deacetylase sirtuin-1,SIRT1,,
DB02709,Resveratrol,,P03372,Estrogen receptor alpha,ESR1,,
DB02709,Resveratrol,,P48039,Melatonin receptor type 1A,MTNR1A,,
DB02709,Resveratrol,,P49286,Melatonin receptor type 1B,MTNR1B,,
DB02709,Resveratrol,,Q86T13,C-type lectin domain family 14 member A,CLEC14A,,
DB02709,Resveratrol,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB02709,Resveratrol,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,,
DB02709,Resveratrol,,P11166,"Solute carrier family 2, facilitated glucose transporter member 1",SLC2A1,,
DB02709,Resveratrol,,P16152,Carbonyl reductase [NADPH] 1,CBR1,inhibitor,
DB02709,Resveratrol,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB02709,Resveratrol,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB02709,Resveratrol,,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,inhibitor,
DB02709,Resveratrol,,Q92945,Far upstream element-binding protein 2,KHSRP,,
DB02709,Resveratrol,,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,inhibitor,
DB02710,"2,3,-Dihydroxybenzoylserine",,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,,
DB02711,"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",,P9WHE9,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB02712,Sorbinil,,P15121,Aldose reductase,AKR1B1,inhibitor,
DB02713,Acetylamino-Acetic Acid,,O31616,Glycine oxidase,thiO,,
DB02714,3'-Uridinemonophosphate,,P07998,Ribonuclease pancreatic,RNASE1,,
DB02715,Compound 18,,P03372,Estrogen receptor alpha,ESR1,,
DB02716,7-methyl-guanosine-5'-triphosphate,,P06730,Eukaryotic translation initiation factor 4E,EIF4E,,
DB02717,Cellotetraose,,Q59325,"Cellulose 1,4-beta-cellobiosidase",cbhA,,
DB02719,C-(1-hydrogyl-beta-D-glucopyranosyl) formamide,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02720,alpha-D-glucopyranosyl-2-carboxylic acid amide,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02721,4-Iodopyrazole,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB02721,4-Iodopyrazole,,P00325,Alcohol dehydrogenase 1B,ADH1B,,
DB02721,4-Iodopyrazole,,P07327,Alcohol dehydrogenase 1A,ADH1A,,
DB02721,4-Iodopyrazole,,P9WPP7,Mycocyclosin synthase,cyp121,,
DB02722,4-O-methyl-beta-D-glucuronic acid,,Q8VVD2,Alpha-glucuronidase,aguA,,
DB02723,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",,P00734,Prothrombin,F2,,
DB02724,Delta-2-Albomycin A1,,P07822,Iron(3+)-hydroxamate-binding protein FhuD,fhuD,,
DB02724,Delta-2-Albomycin A1,,P06971,Ferrichrome-iron receptor,fhuA,,
DB02725,"2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid",,P12995,Adenosylmethionine-8-amino-7-oxononanoate aminotransferase,bioA,,
DB02726,2-Phosphoglycolic Acid,,Q7ADF8,2-deoxyglucose-6-phosphate phosphatase,yniC,,
DB02726,2-Phosphoglycolic Acid,,P13929,Beta-enolase,ENO3,,
DB02726,2-Phosphoglycolic Acid,,P30613,Pyruvate kinase PKLR,PKLR,,
DB02726,2-Phosphoglycolic Acid,,Q07412,Triosephosphate isomerase,TPI,,
DB02726,2-Phosphoglycolic Acid,,O35000,Glucosamine-6-phosphate deaminase 1,nagB,,
DB02726,2-Phosphoglycolic Acid,,P00512,6-phosphofructokinase,pfkA,,
DB02726,2-Phosphoglycolic Acid,,P60174,Triosephosphate isomerase,TPI1,,
DB02726,2-Phosphoglycolic Acid,,P14618,Pyruvate kinase PKM,PKM,,
DB02726,2-Phosphoglycolic Acid,,P00943,Triosephosphate isomerase,tpiA,,
DB02726,2-Phosphoglycolic Acid,,P0A733,Methylglyoxal synthase,mgsA,,
DB02726,2-Phosphoglycolic Acid,,P09104,Gamma-enolase,ENO2,,
DB02726,2-Phosphoglycolic Acid,,P50921,Triosephosphate isomerase,tpiA,,
DB02726,2-Phosphoglycolic Acid,,P0AB91,"Phospho-2-dehydro-3-deoxyheptonate aldolase, Phe-sensitive",aroG,,
DB02727,2-butyl-1-hydroxyguanidine,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB02728,7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester,,P14174,Macrophage migration inhibitory factor,MIF,,
DB02729,SD146,,P04585,Gag-Pol polyprotein,gag-pol,,
DB02730,4-Methylthio-Alpha-D-Mannose,,P19961,Alpha-amylase 2B,AMY2B,,
DB02731,Ethylmercurithiosalicylic acid,,P55809,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",OXCT1,,
DB02731,Ethylmercurithiosalicylic acid,,Q9X180,Multi-sensor signal transduction histidine kinase,,,
DB02733,Purvalanol,,P78362,SRSF protein kinase 2,SRPK2,,
DB02733,Purvalanol,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02733,Purvalanol,,Q07785,Cell division control protein 2 homolog,CRK2,,
DB02733,Purvalanol,,P11802,Cyclin-dependent kinase 4,CDK4,,
DB02733,Purvalanol,,P28482,Mitogen-activated protein kinase 1,MAPK1,inhibitor,
DB02733,Purvalanol,,P27361,Mitogen-activated protein kinase 3,MAPK3,inhibitor,
DB02734,4-Deoxy-D-Mannuronic Acid,,Q9KWT6,AlgQ1,algQ1,,
DB02734,4-Deoxy-D-Mannuronic Acid,,Q9KWT5,AlgQ2,algQ2,,
DB02735,2-Amino-3-Oxo-4-Sulfo-Butyric Acid,,P08842,Steryl-sulfatase,STS,,
DB02736,Acetamide,,P27017,Aliphatic amidase expression-regulating protein,amiC,,
DB02738,Adenosine-5'-Pentaphosphate,,Q75UV1,Diadenosine hexaphosphate hydrolase,ndx1,,
DB02740,3-Indolebutyric Acid,,P61769,Beta-2-microglobulin,B2M,,
DB02740,3-Indolebutyric Acid,,P01848,T-cell receptor alpha chain C region,TRAC,,
DB02740,3-Indolebutyric Acid,,P01850,T-cell receptor beta-1 chain C region,TRBC1,,
DB02740,3-Indolebutyric Acid,,P04439,"HLA class I histocompatibility antigen, A-2 alpha chain",HLA-A,,
DB02740,3-Indolebutyric Acid,,P95468,Aromatic-amino-acid aminotransferase,tyrB,,
DB02741,CD564,,P13631,Retinoic acid receptor gamma,RARG,,
DB02742,Kifunensine,,Q16706,Alpha-mannosidase 2,MAN2A1,,
DB02742,Kifunensine,,Q9UKM7,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,,
DB02742,Kifunensine,,P31723,"Mannosyl-oligosaccharide alpha-1,2-mannosidase",MSDC,,
DB02743,beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose,,Q65CX5,"Arabinogalactan endo-1,4-beta-galactosidase",ganB,,
DB02744,RPR131247,,P07477,Trypsin-1,PRSS1,,
DB02745,Uridine,,P62312,U6 snRNA-associated Sm-like protein LSm6,LSM6,,
DB02745,Uridine,,P0A927,Nucleoside-specific channel-forming protein tsx,tsx,,
DB02746,Phthalic Acid,,P03372,Estrogen receptor alpha,ESR1,,
DB02746,Phthalic Acid,,P06401,Progesterone receptor,PGR,,
DB02746,Phthalic Acid,,Q92731,Estrogen receptor beta,ESR2,,
DB02746,Phthalic Acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB02746,Phthalic Acid,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB02746,Phthalic Acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB02746,Phthalic Acid,,P19793,Retinoic acid receptor RXR-alpha,RXRA,,
DB02746,Phthalic Acid,,P28702,Retinoic acid receptor RXR-beta,RXRB,,
DB02746,Phthalic Acid,,P48443,Retinoic acid receptor RXR-gamma,RXRG,,
DB02746,Phthalic Acid,,P9WJJ7,Nicotinate-nucleotide pyrophosphorylase [carboxylating],nadC,,
DB02749,Pyromellitic Acid,,P05042,Fumarate hydratase class II,fumC,,
DB02750,S-(Methylmercury)-L-Cysteine,,Q7Z2Z2,Elongation factor Tu GTP-binding domain-containing protein 1,EFTUD1,,
DB02751,Glycocyamine,,Q14353,Guanidinoacetate N-methyltransferase,GAMT,,
DB02752,Tosyl-D-Proline,,P0A884,Thymidylate synthase,thyA,,
DB02753,Selenoinosine,,Q8RLY5,Nucleoside deoxyribosyltransferase-I,ptd,,
DB02754,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB02754,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB02755,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,,P20645,Cation-dependent mannose-6-phosphate receptor,M6PR,,
DB02757,Pyrazole,,P03372,Estrogen receptor alpha,ESR1,,
DB02757,Pyrazole,,Q92731,Estrogen receptor beta,ESR2,,
DB02757,Pyrazole,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB02758,Indolepropionic acid,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB02758,Indolepropionic acid,,P00509,Aspartate aminotransferase,aspC,,
DB02758,Indolepropionic acid,,P95468,Aromatic-amino-acid aminotransferase,tyrB,,
DB02759,4-methyl-umbelliferyl-N-acetyl-chitobiose,,P61626,Lysozyme C,LYZ,,
DB02761,S-Mercaptocysteine,,P77444,Cysteine desulfurase,sufS,,
DB02761,S-Mercaptocysteine,,P0A6V7,Thiosulfate sulfurtransferase GlpE,glpE,,
DB02761,S-Mercaptocysteine,,Q01770,Hydroxylamine reductase,hcp,,
DB02761,S-Mercaptocysteine,,Q7K9G0,3-mercaptopyruvate sulfurtransferase,MST,,
DB02761,S-Mercaptocysteine,,Q9ZHG9,L-cysteine/cystine lyase C-DES,c-des,,
DB02761,S-Mercaptocysteine,,P31142,3-mercaptopyruvate sulfurtransferase,sseA,,
DB02761,S-Mercaptocysteine,,P31101,Hydroxylamine reductase,hcp,,
DB02761,S-Mercaptocysteine,,Q16762,Thiosulfate sulfurtransferase,TST,,
DB02761,S-Mercaptocysteine,,Q5SJI0,Sulfurtransferase,,,
DB02762,RU79072,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB02763,5-Mercapto-2-Nitro-Benzoic Acid,,P29460,Interleukin-12 subunit beta,IL12B,,
DB02763,5-Mercapto-2-Nitro-Benzoic Acid,,P0A006,Protein ArsC,arsC,,
DB02765,R-9-(2-hydroxypropyl)adenine,,Q9QNF7,Thymidine kinase,TK,ligand,
DB02765,R-9-(2-hydroxypropyl)adenine,,P09250,Thymidine kinase,TK,ligand,
DB02766,(3R)-3-{[(Benzyloxy)carbonyl]amino}-2-oxo-4-phenylbutane-1-diazonium,,P0C0J0,Streptopain,speB,,
DB02767,(R)-3-hydroxytetradecanoic acid,,P02929,Protein TonB,tonB,,
DB02767,(R)-3-hydroxytetradecanoic acid,,Q9Y6Y9,Lymphocyte antigen 96,LY96,,
DB02767,(R)-3-hydroxytetradecanoic acid,,O00206,Toll-like receptor 4,TLR4,,
DB02767,(R)-3-hydroxytetradecanoic acid,,P06971,Ferrichrome-iron receptor,fhuA,,
DB02768,Tert-Butyloxycarbonyl Group,,P03366,Gag-Pol polyprotein,gag-pol,,
DB02770,7-alpha-D-Ribofuranosyl-2-aminopurine-5'-phosphate,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB02772,Sucrose,,Q8TE23,Taste receptor type 1 member 2,TAS1R2,,
DB02772,Sucrose,,P00811,Beta-lactamase,ampC,,
DB02772,Sucrose,,P61626,Lysozyme C,LYZ,,
DB02772,Sucrose,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB02772,Sucrose,,Q59976,Beta-glucosidase,bgl3,,
DB02772,Sucrose,,Q9ZEU2,Amylosucrase,ams,,
DB02772,Sucrose,,Q9L5C8,Beta-lactamase,blaCTX-M-9a,,
DB02772,Sucrose,,Q939N4,Beta-lactamase CTX-M,,,
DB02772,Sucrose,,P71119,Heme oxygenase,hmuO,,
DB02772,Sucrose,,O00244,Copper transport protein ATOX1,ATOX1,,
DB02772,Sucrose,,Q9Y3I0,tRNA-splicing ligase RtcB homolog,RTCB,,
DB02772,Sucrose,,P83689,Orange carotenoid-binding protein,,,
DB02772,Sucrose,,P22340,Sucrose porin,scrY,,
DB02772,Sucrose,,P05655,Levansucrase,sacB,,
DB02773,(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB02774,"1,3-Propanediol",,P51698,Haloalkane dehalogenase,linB,,
DB02774,"1,3-Propanediol",,P84077,ADP-ribosylation factor 1,ARF1,,
DB02776,1-Hexadecanosulfonic Acid,,P20261,Lipase 1,LIP1,,
DB02776,1-Hexadecanosulfonic Acid,,Q7SIG1,Hydrolase,,,
DB02778,"2,5-Anhydroglucitol-1,6-Biphosphate",,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,,
DB02779,Dodecyltrimethylammonium,,Q06124,Tyrosine-protein phosphatase non-receptor type 11,PTPN11,,
DB02780,Beta-3-Cysteine,,P12488,Envelope glycoprotein gp160,env,,
DB02783,4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,,P22256,4-aminobutyrate aminotransferase GabT,gabT,,
DB02783,4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,,P00505,"Aspartate aminotransferase, mitochondrial",GOT2,,
DB02784,N-(Bromoacetyl)-beta-alanyl-N-(2-{4-[(carboxycarbonyl)amino]phenyl}ethyl)-L-serinamide,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02785,"(2S)-1-[(2S,4R)-4-Benzyl-2-hydroxy-5-{[(1S,2R,5S)-2-hydroxy-5-methylcyclopentyl]amino}-5-oxopentyl]-4-{[6-chloro-5-(4-methyl-1-piperazinyl)-2-pyrazinyl]carbonyl}-N-(2-methyl-2-propanyl)-2-piperazineca rboxamide",,P03366,Gag-Pol polyprotein,gag-pol,,
DB02786,2-Anhydro-3-Fluoro-Quinic Acid,,P15474,3-dehydroquinate dehydratase,aroQ,,
DB02787,N-Acetylmannosaminitol,,Q57265,Capsule biosynthesis protein,synC,,
DB02789,Pregnenolone,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB02789,Pregnenolone,,O00204,Sulfotransferase family cytosolic 2B member 1,SULT2B1,,
DB02790,Phenyl-uridine-5'-diphosphate,,P09147,UDP-glucose 4-epimerase,galE,,
DB02793,Isochorismic Acid,,Q7DC80,Phenazine biosynthesis protein PhzD,phzD1,,
DB02794,"(2S)-2-({4-[(2S)-1-(2-Amino-4-oxo-1,4-dihydro-6-quinazolinyl)-3-{[2-({(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydro-2-furanyl}amino)-2-oxoethyl]amino}-2-hydroxy-2-propanyl]benzoyl}ami no)pentanedioic acid",,P08179,Phosphoribosylglycinamide formyltransferase,purN,,
DB02795,P-Anisic Acid,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB02795,P-Anisic Acid,,P04054,Phospholipase A2,PLA2G1B,,
DB02796,9-deazainosine,,P00491,Purine nucleoside phosphorylase,PNP,,
DB02797,3-Nitrophenylboronic Acid,,P00811,Beta-lactamase,ampC,,
DB02798,Alpha-Methylene Adenosine Monophosphate,,P14193,Ribose-phosphate pyrophosphokinase,prs,,
DB02799,N-[2-(1-maleimidyl)ethyl]-7-diethylaminocoumarin-3-carboxamide,,P0AG82,Phosphate-binding protein PstS,pstS,,
DB02800,"5-hydroxymethyl-5,6-dihydrofolic acid",,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,,
DB02800,"5-hydroxymethyl-5,6-dihydrofolic acid",,P75430,Probable 5-formyltetrahydrofolate cyclo-ligase,,,
DB02801,"2,3-Anhydro-quinic acid",,P15474,3-dehydroquinate dehydratase,aroQ,,
DB02801,"2,3-Anhydro-quinic acid",,P9WPX7,3-dehydroquinate dehydratase,aroQ,,
DB02802,3-(alpha-D-Galactopyranosyloxy)-5-nitrobenzamide,,P01556,Cholera enterotoxin subunit B,ctxB,,
DB02803,"3-Phenyl-1,2-Propandiol",,P00797,Renin,REN,,
DB02804,A-98881,,P12499,Gag-Pol polyprotein,gag-pol,,
DB02805,Arabinouridine 3'-phosphate,,P07998,Ribonuclease pancreatic,RNASE1,,
DB02809,"Brodimoprim-4,6-Dicarboxylate",,P00381,Dihydrofolate reductase,folA,,
DB02810,N-(2-Acetamido)Iminodiacetic Acid,,Q9I7A8,Peptide deformylase,def,,
DB02811,Diethyl phosphonate,,P9WQN9,Diacylglycerol acyltransferase/mycolyltransferase Ag85C,fbpC,,
DB02811,Diethyl phosphonate,,P06276,Cholinesterase,BCHE,,
DB02812,RWJ-56423,,P07477,Trypsin-1,PRSS1,inhibitor,
DB02813,"2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone",,P07686,Beta-hexosaminidase subunit beta,HEXB,,
DB02813,"2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone",,P11797,Chitinase B,chiB,,
DB02816,"7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem",,P05364,Beta-lactamase,ampC,,
DB02817,5-Exo-Hydroxycamphor,,P00183,Camphor 5-monooxygenase,camC,,
DB02818,Iodo-Willardiine,,P42262,Glutamate receptor 2,GRIA2,,
DB02819,"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB02820,"1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct",,Q99714,3-hydroxyacyl-CoA dehydrogenase type-2,HSD17B10,,
DB02821,Canaline,,P04181,"Ornithine aminotransferase, mitochondrial",OAT,inhibitor,
DB02822,Para-Bromobenzyl Alcohol,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB02823,Phosphonoacetic Acid,,P00634,Alkaline phosphatase,phoA,,
DB02824,N-Pyridoxyl-Glycine-5-Monophosphate,,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,,
DB02824,N-Pyridoxyl-Glycine-5-Monophosphate,,P11926,Ornithine decarboxylase,ODC1,,
DB02824,N-Pyridoxyl-Glycine-5-Monophosphate,,P0A827,Serine hydroxymethyltransferase,glyA,,
DB02824,N-Pyridoxyl-Glycine-5-Monophosphate,,Q9X266,L-allo-threonine aldolase,,,
DB02825,Methylphosphinate,,P22303,Acetylcholinesterase,ACHE,,
DB02827,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02828,5-Fluorolevulinic Acid,,Q59643,Delta-aminolevulinic acid dehydratase,hemB,,
DB02829,4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid,,P06820,Neuraminidase,,,
DB02830,FR236913,,P00813,Adenosine deaminase,ADA,,
DB02831,Dihydrogenphosphate,,Q7Z4W1,L-xylulose reductase,DCXR,,
DB02831,Dihydrogenphosphate,,P0AG82,Phosphate-binding protein PstS,pstS,,
DB02832,Siroheme,,P17846,Sulfite reductase [NADPH] hemoprotein beta-component,cysI,,
DB02833,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,,P20248,Cyclin-A2,CCNA2,,
DB02833,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02834,IDD552,,P15121,Aldose reductase,AKR1B1,,
DB02835,"Alpha-D-Glucose 1,6-Bisphosphate",,P71447,Beta-phosphoglucomutase,pgmB,,
DB02835,"Alpha-D-Glucose 1,6-Bisphosphate",,P36871,Phosphoglucomutase-1,PGM1,,
DB02836,Guanosine 5'-diphosphate 2':3'-cyclic monophosphate,,P0A7D4,Adenylosuccinate synthetase,purA,,
DB02836,Guanosine 5'-diphosphate 2':3'-cyclic monophosphate,,Q54089,Bifunctional (p)ppGpp synthase/hydrolase RelA,relA,,
DB02837,4-(Hydrogen sulfate)-beta-D-galactopyranose,,P11226,Mannose-binding protein C,MBL2,,
DB02838,"3,4-Dihydro-2h-Pyrrolium-5-Carboxylate",,P14920,D-amino-acid oxidase,DAO,,
DB02839,"2,4-Dihydroxybenzoic Acid",,P20586,p-hydroxybenzoate hydroxylase,pobA,,
DB02839,"2,4-Dihydroxybenzoic Acid",,P00438,p-hydroxybenzoate hydroxylase,pobA,,
DB02840,"4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB02841,[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,,P62593,Beta-lactamase TEM,bla,,
DB02841,[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,,P62594,Beta-lactamase TEM,bla,,
DB02841,[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,,Q9L5C8,Beta-lactamase,blaCTX-M-9a,,
DB02842,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,,,DNA,,intercalation,
DB02843,alpha-D-glucose-1-phosphate,,P26276,Phosphomannomutase/phosphoglucomutase,algC,,
DB02843,alpha-D-glucose-1-phosphate,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02843,alpha-D-glucose-1-phosphate,,P00490,Maltodextrin phosphorylase,malP,,
DB02843,alpha-D-glucose-1-phosphate,,P19926,Glucose-1-phosphatase,agp,,
DB02843,alpha-D-glucose-1-phosphate,,Q9HU22,Glucose-1-phosphate thymidylyltransferase,rmlA,,
DB02844,"S-Adenosyl-1,8-Diamino-3-Thiooctane",,Q9WZC2,Spermidine synthase,speE,,
DB02845,Methylphosphinic Acid,,P06276,Cholinesterase,BCHE,,
DB02845,Methylphosphinic Acid,,P22303,Acetylcholinesterase,ACHE,,
DB02845,Methylphosphinic Acid,,P22266,Esterase,estA,,
DB02846,L-thioproline,,P08758,Annexin A5,ANXA5,,
DB02848,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,,
DB02849,N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate,,P16932,"2,2-dialkylglycine decarboxylase",dgdA,,
DB02850,DAS869,,P32754,4-hydroxyphenylpyruvate dioxygenase,HPD,,
DB02851,Thiocamphor,,P00183,Camphor 5-monooxygenase,camC,,
DB02852,Domoic Acid,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,,
DB02854,Aetiocholanolone,,P01859,Ig gamma-2 chain C region,IGHG2,,
DB02854,Aetiocholanolone,,Q06520,Bile salt sulfotransferase,SULT2A1,,
DB02854,Aetiocholanolone,,P9WGT1,3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase,fabG3,,
DB02854,Aetiocholanolone,,Q8NBQ5,Estradiol 17-beta-dehydrogenase 11,HSD17B11,,
DB02855,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,,P07858,Cathepsin B,CTSB,,
DB02856,Ethyl N-methylcarbamate,,P69178,Shiga-like toxin 1 subunit B,stxB,,
DB02857,Guanosine,,Q38087,DNA polymerase,43,,
DB02857,Guanosine,,P00491,Purine nucleoside phosphorylase,PNP,,
DB02857,Guanosine,,Q5SID9,Purine nucleoside phosphorylase,,,
DB02858,3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid,,P00811,Beta-lactamase,ampC,,
DB02859,Soraphen A,,O00763,Acetyl-CoA carboxylase 2,ACACB,,
DB02860,Calyculin A,,P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,PPP1CC,,
DB02861,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",,P00918,Carbonic anhydrase 2,CA2,,
DB02865,Glucosamine 4-Phosphate,,P06971,Ferrichrome-iron receptor,fhuA,,
DB02866,Dansylamide,,P00918,Carbonic anhydrase 2,CA2,,
DB02867,D-Mannose 1-phosphate,,P26276,Phosphomannomutase/phosphoglucomutase,algC,,
DB02868,Deacetoxyvinzolidine,,P0DP23,Calmodulin,CALM1,,
DB02869,3-amino-5-phenylpentane,,P43235,Cathepsin K,CTSK,,
DB02869,3-amino-5-phenylpentane,,O60911,Cathepsin L2,CTSV,,
DB02870,N-Allylaniline,,P00720,Lysozyme,E,,
DB02871,3-Butylthiolane 1-Oxide,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB02872,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",,Q00987,E3 ubiquitin-protein ligase Mdm2,MDM2,,
DB02873,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB02875,CRA_1802,,P07477,Trypsin-1,PRSS1,,
DB02876,"3-(4-carbamoyl-1-carboxy-2-methylsulfonyl-buta-1,3-dienylamino)-indolizine-2-carboxylic acid",,P05364,Beta-lactamase,ampC,,
DB02877,Arotinoid acid,,P10826,Retinoic acid receptor beta,RARB,,
DB02878,3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid,,P13716,Delta-aminolevulinic acid dehydratase,ALAD,,
DB02879,"2,3-Di-O-Sulfo-Alpha-D-Glucopyranose",,P29723,47 kDa membrane antigen,,,
DB02883,"2',3'-Dideoxycytidine-5'-Monophosphate",,P0A6I0,Cytidylate kinase,cmk,,
DB02884,3-Cyclohexyl-L-alanine,,P08048,Zinc finger Y-chromosomal protein,ZFY,,
DB02885,4-Imino-5-methidyl-2-trifluoromethylpyrimidine,,P39594,Thiamine-phosphate synthase,thiE,,
DB02887,Stavudine triphosphate,,P15531,Nucleoside diphosphate kinase A,NME1,,
DB02888,FKB-001,,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB02889,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",,P04746,Pancreatic alpha-amylase,AMY2A,,
DB02890,6-hydroxyuridine-5'-phosphate,,P11172,Uridine 5'-monophosphate synthase,UMPS,,
DB02890,6-hydroxyuridine-5'-phosphate,,P08244,Orotidine 5'-phosphate decarboxylase,pyrF,,
DB02892,L-2-Amino-6-Methylene-Pimelic Acid,,P04964,Meso-diaminopimelate D-dehydrogenase,ddh,,
DB02893,D-Methionine,,P50579,Methionine aminopeptidase 2,METAP2,,
DB02893,D-Methionine,,Q9KQN0,"Transcriptional regulator, HTH_3 family",,,
DB02894,"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",,P00918,Carbonic anhydrase 2,CA2,,
DB02895,3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol,,P00390,"Glutathione reductase, mitochondrial",GSR,,
DB02896,Methylthioinosine,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB02897,Acetylphosphate,,P32055,GDP-L-fucose synthase,fcl,,
DB02897,Acetylphosphate,,P39646,Phosphate acetyltransferase,pta,,
DB02898,(5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02899,N-Carboxymethionine,,P41020,Urease subunit alpha,ureC,,
DB02899,N-Carboxymethionine,,P41021,Urease subunit beta,ureB,,
DB02899,N-Carboxymethionine,,P41022,Urease subunit gamma,ureA,,
DB02899,N-Carboxymethionine,,P26789,Light-harvesting protein B-800/850 alpha chain,,,
DB02899,N-Carboxymethionine,,P26790,Light-harvesting protein B-800/850 beta chain,,,
DB02899,N-Carboxymethionine,,Q5SII2,Probable rRNA methylase,rsmF,,
DB02899,N-Carboxymethionine,,P0A884,Thymidylate synthase,thyA,,
DB02900,alpha-D-mannose 6-phosphate,,P26276,Phosphomannomutase/phosphoglucomutase,algC,,
DB02900,alpha-D-mannose 6-phosphate,,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,,
DB02900,alpha-D-mannose 6-phosphate,,P20645,Cation-dependent mannose-6-phosphate receptor,M6PR,,
DB02901,Stanolone,,P03372,Estrogen receptor alpha,ESR1,,A14AA01;G03BB02
DB02901,Stanolone,,P08235,Mineralocorticoid receptor,NR3C2,,A14AA01;G03BB02
DB02901,Stanolone,,P10275,Androgen receptor,AR,,A14AA01;G03BB02
DB02901,Stanolone,,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,,A14AA01;G03BB02
DB02902,3'-phospho-5'-adenylyl sulfate,,P49888,Estrogen sulfotransferase,SULT1E1,,
DB02903,"1,3-bis-([[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)-benzoylamino]-propyl}-piperazin-1-yl)-propylamino-3,4-dioxo-cyclobutenyl]-amino-ethyl]-amino-carbonyloxy)-2-amino-propane",,P01556,Cholera enterotoxin subunit B,ctxB,,
DB02904,Beta-3-Serine,,P12488,Envelope glycoprotein gp160,env,,
DB02905,N7-(5'-Phospho-alpha-ribosyl)-2-hydroxypurine,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB02906,"(2s,4s)-Alpha-Campholinic Acid",,Q93TU6,6-oxocamphor hydrolase,camK,,
DB02907,2-Amino-Vinyl-Phosphate,,P06971,Ferrichrome-iron receptor,fhuA,,
DB02908,RU78783,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB02909,5-(2-Chlorophenyl)Furan-2-Carboxylic Acid,,P9WK19,Methionine aminopeptidase 2,map,,
DB02909,5-(2-Chlorophenyl)Furan-2-Carboxylic Acid,,P0AE18,Methionine aminopeptidase,map,,
DB02910,Octanoyl-Coenzyme A,,P30084,"Enoyl-CoA hydratase, mitochondrial",ECHS1,,
DB02910,Octanoyl-Coenzyme A,,P42126,"Enoyl-CoA delta isomerase 1, mitochondrial",ECI1,,
DB02910,Octanoyl-Coenzyme A,,P11310,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADM,,
DB02911,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02912,Propanoyl-CoA,,Q9X4K7,Propionyl-CoA carboxylase complex B subunit,pccB,,
DB02915,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",,P20248,Cyclin-A2,CCNA2,,
DB02915,"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02917,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,,Q9BY41,Histone deacetylase 8,HDAC8,,
DB02918,Zardaverine,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB02919,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",,P00374,Dihydrofolate reductase,DHFR,,
DB02921,(South)-Methanocarba-Thymidine,,Q9QNF7,Thymidine kinase,TK,inhibitor,
DB02923,"Biphenyl-2,3-Diol",,P0A108,"1,2-dihydroxynaphthalene dioxygenase",doxG,,
DB02923,"Biphenyl-2,3-Diol",,P47228,"Biphenyl-2,3-diol 1,2-dioxygenase",bphC,,
DB02923,"Biphenyl-2,3-Diol",,P17297,"Biphenyl-2,3-diol 1,2-dioxygenase",bphC,,
DB02924,"(4R)-limonene 1α,2α-epoxide",,Q8WX39,Epididymal-specific lipocalin-9,LCN9,,
DB02925,Piretanide,,Q13621,Solute carrier family 12 member 1,SLC12A1,inhibitor,C03CA03;G01AE10
DB02927,"Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid",,P13000,ATP-dependent dethiobiotin synthetase BioD 1,bioD1,,
DB02928,3-Amino-6-Hydroxy-Tyrosine,,P46883,Primary amine oxidase,tynA,,
DB02929,K201 free base,,P08758,Annexin A5,ANXA5,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,Q10588,ADP-ribosyl cyclase 2,BST1,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,P17600,Synapsin-1,SYN1,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,O14874,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",BCKDK,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,P54278,Mismatch repair endonuclease PMS2,PMS2,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,P62219,Protein RecA,recA,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,P42443,Protein RecA,recA,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,Q59560,Protein RecA,recA,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,Q56148,Chloramphenicol 3-O phosphotransferase,,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,P33221,Phosphoribosylglycinamide formyltransferase 2,purT,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,P15043,ATP-dependent DNA helicase RecQ,recQ,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,P06710,DNA polymerase III subunit tau,dnaX,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,P9WI81,Serine/threonine-protein kinase PknB,pknB,,
DB02930,Adenosine 5'-[gamma-thio]triphosphate,,Q7BK04,Cag alpha,cag-alfa,,
DB02931,CoA-s-acetyl tryptamine,,Q16613,Serotonin N-acetyltransferase,AANAT,,
DB02932,(R)-Bicalutamide,,P10275,Androgen receptor,AR,,
DB02933,5'-Deoxy-5'-(Methylthio)-Tubercidin,,Q13126,S-methyl-5'-thioadenosine phosphorylase,MTAP,,
DB02933,5'-Deoxy-5'-(Methylthio)-Tubercidin,,P0AF12,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,mtnN,,
DB02934,9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB02935,Diglyme,,P14625,Endoplasmin,HSP90B1,,
DB02936,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB02937,"Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate",,P18843,NH(3)-dependent NAD(+) synthetase,nadE,,
DB02937,"Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate",,P0A6F3,Glycerol kinase,glpK,,
DB02938,Heptanoic acid,,P04054,Phospholipase A2,PLA2G1B,,
DB02940,"(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid",,P0C8P8,Thiostrepton,tpdA,,
DB02940,"(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid",,P29395,50S ribosomal protein L11,rplK,,
DB02941,3-(1-Aminoethyl)Nonanedioic Acid,,P13000,ATP-dependent dethiobiotin synthetase BioD 1,bioD1,,
DB02942,"Inositol 1,3-Bisphosphate",,Q15075,Early endosome antigen 1,EEA1,,
DB02943,N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine,,P08263,Glutathione S-transferase A1,GSTA1,,
DB02945,alpha-L-iduronic acid,,Q59288,Chondroitinase-AC,cslA,,
DB02947,2-Fluoro-2'-Deoxyadenosine,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB02948,Fosmidomycin,,P45568,1-deoxy-D-xylulose 5-phosphate reductoisomerase,dxr,,
DB02949,2-Acetyl-Protoporphyrin Ix,,P04164,Cytochrome c-552,cycA,,
DB02950,Hymenialdisine,,P24941,Cyclin-dependent kinase 2,CDK2,inhibitor,
DB02950,Hymenialdisine,,Q00535,Cyclin-dependent kinase 5,CDK5,inhibitor,
DB02950,Hymenialdisine,,P06493,Cyclin-dependent kinase 1,CDK1,,
DB02951,3-Hydroxypyruvic Acid,,Q07412,Triosephosphate isomerase,TPI,,
DB02951,3-Hydroxypyruvic Acid,,P0A6L6,N-acetylneuraminate lyase,nanA,,
DB02952,2-aminoisobutyric acid,,P06850,Corticoliberin,CRH,,
DB02952,2-aminoisobutyric acid,,P01303,Pro-neuropeptide Y,NPY,,
DB02953,2-Thiomethyl-3-Phenylpropanoic Acid,,P22894,Neutrophil collagenase,MMP8,,
DB02954,(Carboxyhydroxyamino)Ethanoic Acid,,P0A7D4,Adenylosuccinate synthetase,purA,,
DB02954,(Carboxyhydroxyamino)Ethanoic Acid,,Q83P33,Adenylosuccinate synthetase,purA,,
DB02955,Ricinoleic acid,,P21554,Cannabinoid receptor 1,CNR1,,
DB02955,Ricinoleic acid,,P34972,Cannabinoid receptor 2,CNR2,,
DB02955,Ricinoleic acid,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,,
DB02956,Pentasulfide-Sulfur,,Q56748,Sulfide dehydrogenase,sud,,
DB02959,Oxitriptan,,Q9RVD6,Tryptophan--tRNA ligase 2,trpS2,,N06AX01
DB02961,Rhamnose,,P32170,L-rhamnose isomerase,rhaA,,
DB02962,Benzimidazole,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB02963,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02964,"8,9,10-Trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-one",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB02965,Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine,,P04391,Ornithine carbamoyltransferase chain I,argI,,
DB02966,Fluoro-Willardiine,,P42262,Glutamate receptor 2,GRIA2,,
DB02967,N-Ethylmaleimide,,Q05315,Galectin-10,CLC,,
DB02968,Penicillin G Acyl-Serine,,P18357,Regulatory protein BlaR1,blaR1,,
DB02968,Penicillin G Acyl-Serine,,P07944,Beta-lactam-inducible penicillin-binding protein,pbp,,
DB02969,5-(2-hydroxyethyl)-4-methylthiazole,,P39593,Hydroxyethylthiazole kinase,thiM,,
DB02970,2-Propyl-Aniline,,P00720,Lysozyme,E,,
DB02972,1-Benzyl-(R)-Propylamine,,P03366,Gag-Pol polyprotein,gag-pol,,
DB02973,4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB02974,4-(4-Chlorophenyl)Imidazole,,P20813,Cytochrome P450 2B6,CYP2B6,,
DB02975,GE-2270A,,Q83JC4,Elongation factor Tu,tufA,,
DB02976,Uridine-5'-diphosphate-2-deoxy-2-fluorogalactose,,P96945,Glycosyl transferase,lgtC,,
DB02976,Uridine-5'-diphosphate-2-deoxy-2-fluorogalactose,,Q93EK7,LgtC,lgtC,,
DB02977,PNU177836,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB02979,"N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02980,Thymidine-5'-(dithio)phosphate,,P24289,Nuclease P1,,,
DB02981,Vitamin B6 Complexed with 2-Amino-Hexanoic Acid,,P00509,Aspartate aminotransferase,aspC,,
DB02983,Para-Mercury-Benzenesulfonic Acid,,Q05315,Galectin-10,CLC,,
DB02983,Para-Mercury-Benzenesulfonic Acid,,Q92731,Estrogen receptor beta,ESR2,,
DB02984,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB02985,8-iodo-guanine,,P81989,Purine nucleoside phosphorylase,punA,,
DB02986,"N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide",,P00918,Carbonic anhydrase 2,CA2,,
DB02987,Cysteine-S-acetamide,,P07998,Ribonuclease pancreatic,RNASE1,,
DB02987,Cysteine-S-acetamide,,P00973,2'-5'-oligoadenylate synthase 1,OAS1,,
DB02988,Imino-Tryptophan,,P14920,D-amino-acid oxidase,DAO,,
DB02989,CRA_10972,,P07477,Trypsin-1,PRSS1,,
DB02990,S-(2-Acetamidoethyl) hexadecanethioate,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,
DB02991,S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB02992,1-Deoxy-6-O-Phosphono-1-[(Phosphonomethyl)Amino]-L-Threo-Hexitol,,O66496,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB02994,Cacodylic acid,,P12497,Gag-Pol polyprotein,gag-pol,,
DB02994,Cacodylic acid,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB02994,Cacodylic acid,,P15121,Aldose reductase,AKR1B1,,
DB02994,Cacodylic acid,,P11488,Guanine nucleotide-binding protein G(t) subunit alpha-1,GNAT1,,
DB02995,Cyclohexylammonium Ion,,P33038,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,murA,,
DB02996,2-(Thiomethylene)-4-Methylpentanoic Acid,,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,,
DB02998,Metribolone,,P10275,Androgen receptor,AR,activator,
DB02998,Metribolone,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB02998,Metribolone,,P08235,Mineralocorticoid receptor,NR3C2,,
DB02998,Metribolone,,P06401,Progesterone receptor,PGR,,
DB02998,Metribolone,,P07288,Prostate-specific antigen,KLK3,activator,
DB02999,Quisqualic acid,,P42262,Glutamate receptor 2,GRIA2,,
DB02999,Quisqualic acid,,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,,
DB03000,S-9-(2-hydroxypropyl)adenine,,P17402,Thymidine kinase,TK,inducer,
DB03000,S-9-(2-hydroxypropyl)adenine,,P00813,Adenosine deaminase,ADA,inhibitor,
DB03003,Glutathione sulfonic acid,,Q03013,Glutathione S-transferase Mu 4,GSTM4,,
DB03003,Glutathione sulfonic acid,,P08263,Glutathione S-transferase A1,GSTA1,,
DB03003,Glutathione sulfonic acid,,P09211,Glutathione S-transferase P,GSTP1,,
DB03003,Glutathione sulfonic acid,,P0A9D2,Glutathione S-transferase GstA,gstA,,
DB03005,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",,P22303,Acetylcholinesterase,ACHE,,
DB03006,Arsanilic acid,,P61626,Lysozyme C,LYZ,,
DB03008,5-fluoro-beta-L-gulosyl fluoride,,Q16706,Alpha-mannosidase 2,MAN2A1,,
DB03010,Patupilone,,Q13748,Tubulin alpha 3C/D chain,TUBA3C,,
DB03010,Patupilone,,P07437,Tubulin beta chain,TUBB,,
DB03010,Patupilone,,Q9H4B7,Tubulin beta-1 chain,TUBB1,,
DB03010,Patupilone,,P68371,Tubulin beta-4B chain,TUBB4B,,
DB03010,Patupilone,,P04350,Tubulin beta-4A chain,TUBB4A,,
DB03010,Patupilone,,P68366,Tubulin alpha-4A chain,TUBA4A,,
DB03010,Patupilone,,Q13509,Tubulin beta-3 chain,TUBB3,,
DB03010,Patupilone,,Q9BQE3,Tubulin alpha-1C chain,TUBA1C,,
DB03010,Patupilone,,Q9NY65,Tubulin alpha-8 chain,TUBA8,,
DB03010,Patupilone,,P68363,Tubulin alpha-1B chain,TUBA1B,,
DB03010,Patupilone,,Q71U36,Tubulin alpha-1A chain,TUBA1A,,
DB03011,Adenosine-5'-(Dithio)Phosphate,,P24289,Nuclease P1,,,
DB03012,Phenylalanine-N-Sulfonamide,,P15085,Carboxypeptidase A1,CPA1,,
DB03013,N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine,,Q54468,Chitobiase,chb,,
DB03013,N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine,,P61626,Lysozyme C,LYZ,,
DB03013,N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine,,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,,
DB03015,"6-hydroxy-1,6-dihydro purine nucleoside",,P00813,Adenosine deaminase,ADA,,
DB03016,CRA_1801,,P07477,Trypsin-1,PRSS1,,
DB03017,Lauric acid,,Q82122,Genome polyprotein,,,
DB03017,Lauric acid,,P23008,Genome polyprotein,,,
DB03017,Lauric acid,,P04936,Genome polyprotein,,,
DB03017,Lauric acid,,P41235,Hepatocyte nuclear factor 4-alpha,HNF4A,,
DB03017,Lauric acid,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB03017,Lauric acid,,P98155,Very low-density lipoprotein receptor,VLDLR,,
DB03017,Lauric acid,,Q9NZD2,Glycolipid transfer protein,GLTP,,
DB03017,Lauric acid,,P0AAI5,3-oxoacyl-[acyl-carrier-protein] synthase 2,fabF,,
DB03017,Lauric acid,,P02788,Lactotransferrin,LTF,,
DB03017,Lauric acid,,P02929,Protein TonB,tonB,,
DB03017,Lauric acid,,P07360,Complement component C8 gamma chain,C8G,,
DB03017,Lauric acid,,Q9UNK4,Group IID secretory phospholipase A2,PLA2G2D,,
DB03017,Lauric acid,,Q9I194,Acyl-homoserine lactone acylase PvdQ,pvdQ,,
DB03017,Lauric acid,,Q9Y6Y9,Lymphocyte antigen 96,LY96,,
DB03017,Lauric acid,,O00206,Toll-like receptor 4,TLR4,,
DB03017,Lauric acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB03017,Lauric acid,,P06971,Ferrichrome-iron receptor,fhuA,,
DB03017,Lauric acid,,P17900,Ganglioside GM2 activator,GM2A,,
DB03017,Lauric acid,,P11766,Alcohol dehydrogenase class-3,ADH5,,
DB03017,Lauric acid,,P9WNG3,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB03017,Lauric acid,,P0A953,3-oxoacyl-[acyl-carrier-protein] synthase 1,fabB,,
DB03018,"3,4-dimethylaniline",,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB03019,"4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB03020,5-beta-D-ribofuranosylnicotinamide adenine dinucleotide,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB03021,Ulapualide A,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB03022,"3-[2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate",,P9WHE9,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB03023,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",,P07948,Tyrosine-protein kinase Lyn,LYN,,
DB03023,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03023,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",,P06239,Tyrosine-protein kinase Lck,LCK,,
DB03024,2-Methyl-3-(2-Aminothiazolo)Propanal,,P00797,Renin,REN,,
DB03026,Phosphoglycolohydroxamic Acid,,P0AB74,"D-tagatose-1,6-bisphosphate aldolase subunit KbaY",kbaY,,
DB03026,Phosphoglycolohydroxamic Acid,,P0AB71,Fructose-bisphosphate aldolase class 2,fbaA,,
DB03026,Phosphoglycolohydroxamic Acid,,P60174,Triosephosphate isomerase,TPI1,,
DB03026,Phosphoglycolohydroxamic Acid,,P0A733,Methylglyoxal synthase,mgsA,,
DB03026,Phosphoglycolohydroxamic Acid,,P32169,Rhamnulose-1-phosphate aldolase,rhaD,,
DB03026,Phosphoglycolohydroxamic Acid,,P0AB87,L-fuculose phosphate aldolase,fucA,,
DB03028,1h-Benoximidazole-2-Carboxylic Acid,,P07339,Cathepsin D,CTSD,,
DB03030,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,,P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,
DB03031,Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide,,P00183,Camphor 5-monooxygenase,camC,,
DB03032,S-octylglutathione,,Q03013,Glutathione S-transferase Mu 4,GSTM4,,
DB03033,4-methoxybenzenesulfinate,,P45452,Collagenase 3,MMP13,,
DB03033,4-methoxybenzenesulfinate,,P08254,Stromelysin-1,MMP3,,
DB03034,D-Levofloxacin,,P06653,Autolysin,lytA,,
DB03035,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB03037,Oxidized Acetyl Dithranol,,Q53908,ActVA 6 protein,actVA 6,,
DB03038,LY341770,,P0A884,Thymidylate synthase,thyA,,
DB03039,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",,P00918,Carbonic anhydrase 2,CA2,,
DB03040,Nitrilotriacetic acid,,P02788,Lactotransferrin,LTF,,
DB03041,UDP-alpha-D-glucuronic acid,,Q14376,UDP-glucose 4-epimerase,GALE,substrate,
DB03041,UDP-alpha-D-glucuronic acid,,O94766,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,B3GAT3,,
DB03041,UDP-alpha-D-glucuronic acid,,P0C0F4,UDP-glucose 6-dehydrogenase,hasB,,
DB03042,5-Phosphoarabinonic Acid,,P13376,Glucose-6-phosphate isomerase B,pgiB,,
DB03042,5-Phosphoarabinonic Acid,,P06744,Glucose-6-phosphate isomerase,GPI,,
DB03044,Doramapimod,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB03045,Pantothenyl-Aminoethanol-Acetate Pivalic Acid,,P07097,Acetyl-CoA acetyltransferase,phbA,,
DB03046,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB03048,6-Carboxymethyluracil,,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,,
DB03049,S-Selanyl Cysteine,,P77444,Cysteine desulfurase,sufS,,
DB03051,(S)-2-Tetrahydrofuroic acid,,Q46444,Quinohemoprotein ethanol dehydrogenase type-1,qheDH,,
DB03051,(S)-2-Tetrahydrofuroic acid,,P09546,Bifunctional protein PutA,putA,,
DB03052,Dazoxiben,,P24557,Thromboxane-A synthase,TBXAS1,inhibitor,
DB03053,1-Aminocyclopropylphosphonate,,Q00740,1-aminocyclopropane-1-carboxylate deaminase,acdS,,
DB03056,4-Piperidino-Piperidine,,P23141,Liver carboxylesterase 1,CES1,,
DB03057,Malonaldehyde,,P0AD63,Beta-lactamase SHV-1,bla,,
DB03058,2-Aminobenzyl alcohol,,P00746,Complement factor D,CFD,,
DB03059,Acetoacetyl-CoA,,Q16836,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,,
DB03059,Acetoacetyl-CoA,,P07097,Acetyl-CoA acetyltransferase,phbA,,
DB03059,Acetoacetyl-CoA,,P16219,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADS,,
DB03059,Acetoacetyl-CoA,,P30084,"Enoyl-CoA hydratase, mitochondrial",ECHS1,,
DB03059,Acetoacetyl-CoA,,P9WNP5,"1,4-Dihydroxy-2-naphthoyl-CoA synthase",menB,,
DB03059,Acetoacetyl-CoA,,Q06319,"Acyl-CoA dehydrogenase, short-chain specific",,,
DB03059,Acetoacetyl-CoA,,Q9FD87,HMG-CoA synthase,mvaS,,
DB03059,Acetoacetyl-CoA,,A0A0H3K1U2,3-hydroxy-3-methylglutaryl CoA synthase,mvaS,,
DB03060,Sri-9662,,P00374,Dihydrofolate reductase,DHFR,,
DB03061,(R)-N-(1-Methyl-Hexyl)-Formamide,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB03062,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,,P30419,Glycylpeptide N-tetradecanoyltransferase 1,NMT1,,
DB03062,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,,P30418,Glycylpeptide N-tetradecanoyltransferase,NMT1,,
DB03063,"N-[(2S,3S)-4-[2-[(5S)-3a,4,5,6,7,7a-Hexahydro-1,3-benzodioxol-5-yl]ethyl-[3-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3,5-dimethoxy-4-phenylmethoxybenzamide",,P46925,Plasmepsin-2,,,
DB03064,"3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline",,Q9UJM8,Hydroxyacid oxidase 1,HAO1,,
DB03065,7-Nitroindazole-2-Carboxamidine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB03066,D-Lactic acid,,Q53464,(S)-2-haloacid dehalogenase,,,
DB03067,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03068,Zebularine,,P0ABF6,Cytidine deaminase,cdd,,
DB03069,Cytidine-5'-diphospho-beta-D-xylose,,P26397,"CDP-glucose 4,6-dehydratase",rfbG,,
DB03070,Selenazole-4-carboxyamide-adenine dinucleotide,,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,,
DB03072,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB03073,3-Methoxybenzamide,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB03074,7-cyano-7-deazaguanine,,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB03075,(Diphosphono)Aminophosphonic Acid,,P0A820,S-adenosylmethionine synthase,metK,,
DB03076,"3-[[(3R,4S,5S,6R)-7-Benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide",,P03366,Gag-Pol polyprotein,gag-pol,,
DB03077,"3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione",,Q57193,Cholera enterotoxin B subunit,ctxB,,
DB03077,"3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione",,P01556,Cholera enterotoxin subunit B,ctxB,,
DB03078,PASBN,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03079,Alpha-Ribazole-5'-Phosphate Derivative,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB03081,"[N-[N-(4-Methoxy-2,3,6-trimethylphenylsulfonyl)-L-aspartyl]-D-(4-amidino-phenylalanyl)]-piperidine",,P07477,Trypsin-1,PRSS1,,
DB03082,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB03083,IC261,,P78368,Casein kinase I isoform gamma-2,CSNK1G2,,
DB03084,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB03085,Glycolic acid,,P11413,Glucose-6-phosphate 1-dehydrogenase,G6PD,inhibitor,
DB03086,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",,P50579,Methionine aminopeptidase 2,METAP2,,
DB03087,2-(Sec-Butyl)Thiazole,,Q8WX39,Epididymal-specific lipocalin-9,LCN9,,
DB03088,Pidolic acid,,P19961,Alpha-amylase 2B,AMY2B,,A12CC08
DB03088,Pidolic acid,,P15692,Vascular endothelial growth factor A,VEGFA,,A12CC08
DB03088,Pidolic acid,,P04746,Pancreatic alpha-amylase,AMY2A,,A12CC08
DB03088,Pidolic acid,,P0CG04,Ig lambda-1 chain C regions,IGLC1,,A12CC08
DB03088,Pidolic acid,,P01709,Ig lambda chain V-II region MGC,,,A12CC08
DB03088,Pidolic acid,,Q03403,Trefoil factor 2,TFF2,,A12CC08
DB03088,Pidolic acid,,P00091,Cytochrome c2,cycA,,A12CC08
DB03088,Pidolic acid,,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,,A12CC08
DB03088,Pidolic acid,,Q7SIE2,"Endo-1,4-beta-xylanase",,,A12CC08
DB03088,Pidolic acid,,O68601,Dissimilatory copper-containing nitrite reductase,nir,,A12CC08
DB03088,Pidolic acid,,Q701N4,Keratin-associated protein 5-2,KRTAP5-2,,A12CC08
DB03088,Pidolic acid,,O43612,Orexin,HCRT,,A12CC08
DB03088,Pidolic acid,,P80075,C-C motif chemokine 8,CCL8,,A12CC08
DB03088,Pidolic acid,,P00138,Cytochrome c',,,A12CC08
DB03090,Ethylaminobenzylmethylcarbonyl Group,,P0DJ06,Candidapepsin-2,SAP2,,
DB03091,Isoglutamine,,P0ABA0,ATP synthase subunit b,atpF,,
DB03092,5-Hydroxymethyl-Chonduritol,,P19961,Alpha-amylase 2B,AMY2B,,
DB03092,5-Hydroxymethyl-Chonduritol,,P04745,Alpha-amylase 1,AMY1A,,
DB03092,5-Hydroxymethyl-Chonduritol,,P04746,Pancreatic alpha-amylase,AMY2A,,
DB03093,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB03095,Tetramethylammonium,,Q14376,UDP-glucose 4-epimerase,GALE,,
DB03096,2-Morpholinoethylamine,,P07339,Cathepsin D,CTSD,,
DB03097,"PMP-hydroxyisoxazole, pyridoxamine-5-phosphate-hydroxyisoxazole",,P10724,Alanine racemase,alr,,
DB03098,[Methylseleno]Acetate,,P40859,Monomeric sarcosine oxidase,soxA,,
DB03100,6-Nitroindazole,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB03100,6-Nitroindazole,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB03101,Ribose-1-Phosphate,,P12758,Uridine phosphorylase,udp,,
DB03101,Ribose-1-Phosphate,,P00491,Purine nucleoside phosphorylase,PNP,,
DB03102,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB03103,Thymidine-5'- Diphosphate,,P15531,Nucleoside diphosphate kinase A,NME1,,
DB03104,2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03106,scyllo-inositol,,P04062,Glucosylceramidase,GBA,,
DB03106,scyllo-inositol,,P14262,1-phosphatidylinositol phosphodiesterase,,,
DB03106,scyllo-inositol,,O14735,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,CDIPT,inhibitor,
DB03106,scyllo-inositol,,P34024,1-phosphatidylinositol phosphodiesterase,plcA,,
DB03107,beta-Alanine,,P9WIL5,Pantothenate synthetase,panC,,
DB03108,4-phospho-D-erythronic acid,,P9WKD7,Ribose-5-phosphate isomerase B,rpiB,,
DB03109,2-acetylamino-2-deoxy-b-D-allopyranose,,Q13231,Chitotriosidase-1,CHIT1,,
DB03109,2-acetylamino-2-deoxy-b-D-allopyranose,,P11797,Chitinase B,chiB,,
DB03109,2-acetylamino-2-deoxy-b-D-allopyranose,,P07254,Chitinase A,chiA,,
DB03110,2-Chlorophenol,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB03111,Glucosamine 1-Phosphate,,P06971,Ferrichrome-iron receptor,fhuA,,
DB03112,"6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid",,P22629,Streptavidin,,,
DB03113,3-Fluoro-2-(Phosphonooxy)Propanoic Acid,,P0A716,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB03114,PAS219,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03115,"5-Bromo-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide",,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,,
DB03116,5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate,,P0A6D3,3-phosphoshikimate 1-carboxyvinyltransferase,aroA,,
DB03117,2-carboxypropyl-coenzyme A,,P52045,Methylmalonyl-CoA decarboxylase,scpB,,
DB03118,(2Z)-1-(5-Chloro-1H-indol-3-yl)-3-hydroxy-3-(1H-tetrazol-5-yl)-2-propen-1-one,,P12497,Gag-Pol polyprotein,gag-pol,,
DB03120,p-Toluenesulfonic acid,,P61626,Lysozyme C,LYZ,,
DB03120,p-Toluenesulfonic acid,,P09668,Pro-cathepsin H,CTSH,,
DB03121,(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB03124,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,,P42574,Caspase-3,CASP3,,
DB03125,"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",,P00374,Dihydrofolate reductase,DHFR,,
DB03125,"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",,P00381,Dihydrofolate reductase,folA,,
DB03126,Mant-Adp,,Q7Z406,Myosin-14,MYH14,,
DB03127,Benzamidine,,P06870,Kallikrein-1,KLK1,,
DB03127,Benzamidine,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB03127,Benzamidine,,P07477,Trypsin-1,PRSS1,,
DB03127,Benzamidine,,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB03127,Benzamidine,,Q92876,Kallikrein-6,KLK6,,
DB03127,Benzamidine,,P07478,Trypsin-2,PRSS2,,
DB03127,Benzamidine,,P35030,Trypsin-3,PRSS3,,
DB03127,Benzamidine,,O00244,Copper transport protein ATOX1,ATOX1,,
DB03127,Benzamidine,,P42126,"Enoyl-CoA delta isomerase 1, mitochondrial",ECI1,,
DB03127,Benzamidine,,P00775,Trypsin,sprT,,
DB03127,Benzamidine,,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,ST14,,
DB03128,Acetylcholine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,,S01EB09
DB03128,Acetylcholine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,,S01EB09
DB03128,Acetylcholine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,,S01EB09
DB03128,Acetylcholine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,,S01EB09
DB03128,Acetylcholine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,S01EB09
DB03129,"Diamino-N-[3-(1,3,2-dioxaborolan-2-yloxy)propyl]methaniminium",,P35030,Trypsin-3,PRSS3,,
DB03130,S-P-Nitrobenzyloxycarbonylglutathione,,Q04760,Lactoylglutathione lyase,GLO1,,
DB03132,3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid,,P60174,Triosephosphate isomerase,TPI1,,
DB03132,3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid,,P52270,"Triosephosphate isomerase, glycosomal",,,
DB03133,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03134,L-2-aminopimelic acid,,P56220,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",dapD,,
DB03135,[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid,,P60174,Triosephosphate isomerase,TPI1,,
DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,,P00734,Prothrombin,F2,,
DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,,P07477,Trypsin-1,PRSS1,,
DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB03137,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB03138,Perchlorate,,P0A006,Protein ArsC,arsC,,
DB03139,"6-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid",,P22629,Streptavidin,,,
DB03140,4-Carboxyphenylboronic Acid,,P00811,Beta-lactamase,ampC,,
DB03141,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",,P03366,Gag-Pol polyprotein,gag-pol,,
DB03141,"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",,Q9Q2G8,V-1 protease,ORF,,
DB03142,Alpha-L-Arabinose,,P02924,L-arabinose-binding periplasmic protein,araF,,
DB03142,Alpha-L-Arabinose,,P0A9E0,Arabinose operon regulatory protein,araC,,
DB03142,Alpha-L-Arabinose,,Q9ZB17,Aldose 1-epimerase,galM,,
DB03143,Nonan-1-Ol,,P21905,"ATP synthase subunit c, sodium ion specific",atpE,,
DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,,O34453,Nitric oxide synthase oxygenase,nos,,
DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,,P05089,Arginase-1,ARG1,,
DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB03145,4-Methyl-5-Hydroxyethylthiazole Phosphate,,P39594,Thiamine-phosphate synthase,thiE,,
DB03146,2-deazo-6-thiophosphate guanosine-5'-monophosphate,,P0A7D4,Adenylosuccinate synthetase,purA,,
DB03147,Flavin adenine dinucleotide,,Q16795,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial",NDUFA9,cofactor,
DB03147,Flavin adenine dinucleotide,,P20586,p-hydroxybenzoate hydroxylase,pobA,,
DB03147,Flavin adenine dinucleotide,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB03147,Flavin adenine dinucleotide,,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,,
DB03147,Flavin adenine dinucleotide,,P00438,p-hydroxybenzoate hydroxylase,pobA,,
DB03147,Flavin adenine dinucleotide,,P83223,Fumarate reductase flavoprotein subunit,,,
DB03147,Flavin adenine dinucleotide,,Q86YB8,ERO1-like protein beta,ERO1B,,
DB03147,Flavin adenine dinucleotide,,P00390,"Glutathione reductase, mitochondrial",GSR,,
DB03147,Flavin adenine dinucleotide,,P9WIQ3,NADPH-ferredoxin reductase FprA,fprA,,
DB03147,Flavin adenine dinucleotide,,P00387,NADH-cytochrome b5 reductase 3,CYB5R3,,
DB03147,Flavin adenine dinucleotide,,P12676,Cholesterol oxidase,choA,,
DB03147,Flavin adenine dinucleotide,,Q9WYT0,Thymidylate synthase ThyX,thyX,,
DB03147,Flavin adenine dinucleotide,,P37063,Pyruvate oxidase,pox5,,
DB03147,Flavin adenine dinucleotide,,P06715,Glutathione reductase,gor,,
DB03147,Flavin adenine dinucleotide,,P40859,Monomeric sarcosine oxidase,soxA,,
DB03147,Flavin adenine dinucleotide,,P28593,Trypanothione reductase,TPR,,
DB03147,Flavin adenine dinucleotide,,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,
DB03147,Flavin adenine dinucleotide,,P26440,"Isovaleryl-CoA dehydrogenase, mitochondrial",IVD,,
DB03147,Flavin adenine dinucleotide,,P47989,Xanthine dehydrogenase/oxidase,XDH,,
DB03147,Flavin adenine dinucleotide,,P22637,Cholesterol oxidase,choB,,
DB03147,Flavin adenine dinucleotide,,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,,
DB03147,Flavin adenine dinucleotide,,P06149,D-lactate dehydrogenase,dld,,
DB03147,Flavin adenine dinucleotide,,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,,
DB03147,Flavin adenine dinucleotide,,Q9UKU7,"Isobutyryl-CoA dehydrogenase, mitochondrial",ACAD8,,
DB03147,Flavin adenine dinucleotide,,O95831,"Apoptosis-inducing factor 1, mitochondrial",AIFM1,,
DB03147,Flavin adenine dinucleotide,,P37747,UDP-galactopyranose mutase,glf,,
DB03147,Flavin adenine dinucleotide,,P39662,Flavohemoprotein,hmp,,
DB03147,Flavin adenine dinucleotide,,O31616,Glycine oxidase,thiO,,
DB03147,Flavin adenine dinucleotide,,P16435,NADPH--cytochrome P450 reductase,POR,,
DB03147,Flavin adenine dinucleotide,,Q92947,"Glutaryl-CoA dehydrogenase, mitochondrial",GCDH,,
DB03147,Flavin adenine dinucleotide,,P11310,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADM,,
DB03147,Flavin adenine dinucleotide,,P14920,D-amino-acid oxidase,DAO,,
DB03147,Flavin adenine dinucleotide,,P09546,Bifunctional protein PutA,putA,,
DB03147,Flavin adenine dinucleotide,,P61497,Deoxyribodipyrimidine photo-lyase,phr,,
DB03147,Flavin adenine dinucleotide,,P21397,Amine oxidase [flavin-containing] A,MAOA,,
DB03147,Flavin adenine dinucleotide,,P16219,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADS,,
DB03147,Flavin adenine dinucleotide,,Q96RQ9,L-amino-acid oxidase,IL4I1,,
DB03147,Flavin adenine dinucleotide,,P42593,"2,4-dienoyl-CoA reductase [NADPH]",fadH,,
DB03147,Flavin adenine dinucleotide,,Q56839,"2-oxopropyl-CoM reductase, carboxylating",xecC,,
DB03147,Flavin adenine dinucleotide,,P0C278,Fumarate reductase flavoprotein subunit,fccA,,
DB03147,Flavin adenine dinucleotide,,P0A9P4,Thioredoxin reductase,trxB,,
DB03147,Flavin adenine dinucleotide,,P0AEZ1,"5,10-methylenetetrahydrofolate reductase",metF,,
DB03147,Flavin adenine dinucleotide,,Q9AGP8,"N,N-dimethylglycine oxidase",dmg,,
DB03147,Flavin adenine dinucleotide,,P37062,NADH peroxidase,npr,,
DB03147,Flavin adenine dinucleotide,,P21890,Ferredoxin--NADP reductase,petH,,
DB03147,Flavin adenine dinucleotide,,P38038,Sulfite reductase [NADPH] flavoprotein alpha-component,cysJ,,
DB03147,Flavin adenine dinucleotide,,Q44532,Ferredoxin--NADP reductase,fpr,,
DB03147,Flavin adenine dinucleotide,,Q06319,"Acyl-CoA dehydrogenase, short-chain specific",,,
DB03147,Flavin adenine dinucleotide,,Q52437,Ferredoxin reductase,bphA4,,
DB03147,Flavin adenine dinucleotide,,P18925,Dihydrolipoyl dehydrogenase,,,
DB03147,Flavin adenine dinucleotide,,Q888A4,"Amine oxidase, flavin-containing protein",,,
DB03147,Flavin adenine dinucleotide,,P00914,Deoxyribodipyrimidine photo-lyase,phrB,,
DB03147,Flavin adenine dinucleotide,,P05327,Deoxyribodipyrimidine photo-lyase,phr,,
DB03147,Flavin adenine dinucleotide,,P10902,L-aspartate oxidase,nadB,,
DB03147,Flavin adenine dinucleotide,,P77967,Cryptochrome DASH,cry,,
DB03147,Flavin adenine dinucleotide,,P09622,"Dihydrolipoyl dehydrogenase, mitochondrial",DLD,,
DB03147,Flavin adenine dinucleotide,,Q9Z4P0,Fumarate reductase flavoprotein subunit,ifcA,,
DB03147,Flavin adenine dinucleotide,,Q9UHQ9,NADH-cytochrome b5 reductase 1,CYB5R1,,
DB03147,Flavin adenine dinucleotide,,Q7SID9,Oxidoreductase,,,
DB03147,Flavin adenine dinucleotide,,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB03147,Flavin adenine dinucleotide,,P22570,"NADPH:adrenodoxin oxidoreductase, mitochondrial",FDXR,,
DB03147,Flavin adenine dinucleotide,,Q15067,Peroxisomal acyl-coenzyme A oxidase 1,ACOX1,,
DB03147,Flavin adenine dinucleotide,,P08373,UDP-N-acetylenolpyruvoylglucosamine reductase,murB,,
DB03147,Flavin adenine dinucleotide,,P55789,FAD-linked sulfhydryl oxidase ALR,GFER,,
DB03147,Flavin adenine dinucleotide,,P61432,UDP-N-acetylenolpyruvoylglucosamine reductase,murB,,
DB03147,Flavin adenine dinucleotide,,P24232,Flavohemoprotein,hmp,,
DB03147,Flavin adenine dinucleotide,,Q9LAG2,Phenol 2-hydroxylase component B,pheA2,,
DB03147,Flavin adenine dinucleotide,,Q9RA47,Methylenetetrahydrofolate reductase,metF,,
DB03147,Flavin adenine dinucleotide,,P16640,Putidaredoxin reductase,camA,,
DB03147,Flavin adenine dinucleotide,,P9WHH7,NAD(P)H dehydrogenase (quinone),lpdA,,
DB03147,Flavin adenine dinucleotide,,P9WIQ1,UDP-galactopyranose mutase,glf,,
DB03147,Flavin adenine dinucleotide,,P55792,4-hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA-Delta-isomerase,abfD,,
DB03147,Flavin adenine dinucleotide,,P09788,4-cresol dehydrogenase [hydroxylating] flavoprotein subunit,pchF,,
DB03147,Flavin adenine dinucleotide,,P19480,Alkyl hydroperoxide reductase subunit F,ahpF,,
DB03147,Flavin adenine dinucleotide,,Q51225,Outer membrane protein p64k or PM-6,m-6,,
DB03147,Flavin adenine dinucleotide,,Q94655,Glutathione reductase,GR2,,
DB03147,Flavin adenine dinucleotide,,Q47PU3,Phenylacetone monooxygenase,pamO,,
DB03147,Flavin adenine dinucleotide,,P07771,"Benzoate 1,2-dioxygenase electron transfer component",benC,,
DB03147,Flavin adenine dinucleotide,,Q72JJ3,Putative acyl-CoA dehydrogenase,,,
DB03147,Flavin adenine dinucleotide,,Q9KIE5,FkbI,fkbI,,
DB03147,Flavin adenine dinucleotide,,P09063,Dihydrolipoyl dehydrogenase,lpdV,,
DB03147,Flavin adenine dinucleotide,,P14218,Dihydrolipoyl dehydrogenase,lpd,,
DB03147,Flavin adenine dinucleotide,,P35340,Alkyl hydroperoxide reductase subunit F,ahpF,,
DB03147,Flavin adenine dinucleotide,,P58558,Ferredoxin--NADP reductase,petH,,
DB03147,Flavin adenine dinucleotide,,P28861,Ferredoxin--NADP reductase,fpr,,
DB03147,Flavin adenine dinucleotide,,Q9RC23,Mersacidin decarboxylase,mrsD,,
DB03148,Adenosine 5'-methylenediphosphate,,,DNA,,,
DB03148,Adenosine 5'-methylenediphosphate,,P14193,Ribose-phosphate pyrophosphokinase,prs,,
DB03148,Adenosine 5'-methylenediphosphate,,O33199,MutT/nudix family protein,,,
DB03148,Adenosine 5'-methylenediphosphate,,P07024,Protein UshA,ushA,,
DB03150,"2',3'-Dideoxythymidine-5'-Monophosphate",,P23919,Thymidylate kinase,DTYMK,,
DB03151,mu4-sulfido-quadro-tetracopper,,Q7SIA3,Oxidoreductase,,,
DB03151,mu4-sulfido-quadro-tetracopper,,Q51705,Nitrous-oxide reductase,nosZ,,
DB03152,B-2-Octylglucoside,,Q93RD8,H subunit of photosynthetic reaction center complex,puhA,,
DB03152,B-2-Octylglucoside,,P60844,Aquaporin Z,aqpZ,,
DB03152,B-2-Octylglucoside,,Q02761,Cytochrome b,petB,,
DB03152,B-2-Octylglucoside,,Q02762,Ubiquinol-cytochrome c reductase iron-sulfur subunit,petA,,
DB03152,B-2-Octylglucoside,,Q02760,Cytochrome c1,petC,,
DB03152,B-2-Octylglucoside,,P08100,Rhodopsin,RHO,,
DB03152,B-2-Octylglucoside,,Q08188,Protein-glutamine gamma-glutamyltransferase E,TGM3,,
DB03152,B-2-Octylglucoside,,P19821,"DNA polymerase I, thermostable",polA,,
DB03152,B-2-Octylglucoside,,O68874,Aquaporin Z,aqpZ,,
DB03153,"3H-pyrazolo[4,3-d]pyrimidin-7-ol",,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,,
DB03154,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB03155,2'-fluoro-2'-deoxyuridine 3'-monophosphate,,P07998,Ribonuclease pancreatic,RNASE1,,
DB03156,beta-D-glucuronic acid,,Q54873,Hyaluronate lyase,,,
DB03156,beta-D-glucuronic acid,,Q59288,Chondroitinase-AC,cslA,,
DB03156,beta-D-glucuronic acid,,Q8VVD2,Alpha-glucuronidase,aguA,,
DB03157,"N,O-didansyl-L-tyrosine",,P0A884,Thymidylate synthase,thyA,,
DB03158,"D-Myo-Inositol-1,4-Bisphosphate",,P32019,"Type II inositol 1,4,5-trisphosphate 5-phosphatase",INPP5B,,
DB03159,CRA_8696,,P00734,Prothrombin,F2,,
DB03159,CRA_8696,,P07477,Trypsin-1,PRSS1,,
DB03159,CRA_8696,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB03160,N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate,,P12998,8-amino-7-oxononanoate synthase,bioF,,
DB03161,Thymidine-5'-diphospho-beta-D-xylose,,P95780,"dTDP-glucose 4,6-dehydratase",rmlB,,
DB03161,Thymidine-5'-diphospho-beta-D-xylose,,Q8GIQ0,"DTDP-4-dehydrorhamnose 3,5-epimerase",rmlC,,
DB03162,"4-oxo-4,5-dihydro-1,2,5-thiadiazole-3-carboxylic acid",,Q27743,L-lactate dehydrogenase,,,
DB03163,2-oxopropyl-CoM,,Q56839,"2-oxopropyl-CoM reductase, carboxylating",xecC,,
DB03164,6-amino-1-methyl-7H-purin-1-ium,,P07617,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,PAPS,,
DB03165,2-Dimethylamino-Ethyl-Diphosphate,,Q46822,Isopentenyl-diphosphate Delta-isomerase,idi,,
DB03169,(S)-Hmg-Coa,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,,
DB03169,(S)-Hmg-Coa,,P13702,3-hydroxy-3-methylglutaryl-coenzyme A reductase,mvaA,,
DB03169,(S)-Hmg-Coa,,A0A0H3K1U2,3-hydroxy-3-methylglutaryl CoA synthase,mvaS,,
DB03170,Dephospho Coenzyme A,,P0A6I8,Phosphopantetheine adenylyltransferase,coaD,,
DB03171,Indole-3-Propanol Phosphate,,P00929,Tryptophan synthase alpha chain,trpA,,
DB03171,Indole-3-Propanol Phosphate,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB03171,Indole-3-Propanol Phosphate,,P16608,Tryptophan synthase alpha chain,trpA,,
DB03172,Tubercidin,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB03173,CRA_10433,,P07477,Trypsin-1,PRSS1,,
DB03174,Phosphonoacetaldehyde,,O31156,Phosphonoacetaldehyde hydrolase,phnX,,
DB03175,Propyl alcohol,,P61626,Lysozyme C,LYZ,,D08AX03;D08AX53
DB03176,KB-141,,P10827,Thyroid hormone receptor alpha,THRA,,
DB03176,KB-141,,P10828,Thyroid hormone receptor beta,THRB,,
DB03177,5-methylbenzimidazole,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB03178,"Guanosine-2',3'-cyclophosphorothioate",,P05798,Guanyl-specific ribonuclease Sa,rnaSA,,
DB03179,Sinapoyl coenzyme A,,Q86VU5,Catechol O-methyltransferase domain-containing protein 1,COMTD1,,
DB03180,"4,5-Dimethyl-1,2-phenylenediamine",,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB03181,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",,P10828,Thyroid hormone receptor beta,THRB,,
DB03182,alpha-Fluoro-carboxymethyldethia coenzyme A complex,,O75390,"Citrate synthase, mitochondrial",CS,,
DB03183,"1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB03185,"1-Beta-Ribofuranosyl-1,3-Diazepinone",,P32320,Cytidine deaminase,CDA,,
DB03186,Adenylate-3'-phosphate-[[2'-deoxy-uridine-5'-phosphate]-3'-phosphate],,P07998,Ribonuclease pancreatic,RNASE1,,
DB03187,6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid,,P23434,"Glycine cleavage system H protein, mitochondrial",GCSH,,
DB03189,Cu-Cyclam,,P61626,Lysozyme C,LYZ,,
DB03190,6-o-Capryloylsucrose,,P59676,Penicillin-binding protein 2X,pbpX,,
DB03191,3-Oxiran-2ylalanine,,Q00266,S-adenosylmethionine synthase isoform type-1,MAT1A,,
DB03192,(R)-3-hydroxydecanoyl-CoA,,P51659,Peroxisomal multifunctional enzyme type 2,HSD17B4,,
DB03193,Stearic acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB03193,Stearic acid,,Q9UNK4,Group IID secretory phospholipase A2,PLA2G2D,,
DB03194,Methyl beta-L-fucopyranoside,,P11226,Mannose-binding protein C,MBL2,,
DB03195,3'-Fluoro-3'-deoxythymidine 5'-monophosphate,,P23919,Thymidylate kinase,DTYMK,,
DB03196,4-Nitrophenyl-Ara,,Q9XBQ3,Intracellular exo-alpha-(1->5)-L-arabinofuranosidase,abfA,,
DB03197,6-Hydroxymethylpterin,,P26281,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,folK,,
DB03198,Thio-Maltohexaose,,P30920,Cyclomaltodextrin glucanotransferase,,,
DB03199,4-Methoxy-E-Rhodomycin T,,Q06528,Carminomycin 4-O-methyltransferase,dnrK,,
DB03200,7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB03201,D-Cysteine,,P15085,Carboxypeptidase A1,CPA1,,
DB03202,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB03203,Sphingosine,,P03300,Genome polyprotein,,,
DB03203,Sphingosine,,P03303,Genome polyprotein,,,
DB03203,Sphingosine,,P13900,Genome polyprotein,,,
DB03203,Sphingosine,,P03302,Genome polyprotein,,,
DB03203,Sphingosine,,P15151,Poliovirus receptor,PVR,,
DB03203,Sphingosine,,Q9NZD2,Glycolipid transfer protein,GLTP,,
DB03205,Pyrroloquinoline Quinone,,Q46444,Quinohemoprotein ethanol dehydrogenase type-1,qheDH,,
DB03205,Pyrroloquinoline Quinone,,P13650,Quinoprotein glucose dehydrogenase B,gdhB,,
DB03205,Pyrroloquinoline Quinone,,P27505,Pyrroloquinoline-quinone synthase,pqqC,,
DB03205,Pyrroloquinoline Quinone,,Q9Z4J7,Quinoprotein ethanol dehydrogenase,exaA,,
DB03205,Pyrroloquinoline Quinone,,Q8GR64,Quinohemoprotein alcohol dehydrogenase ADH IIB,qbdA,,
DB03206,Duvoglustat,,P05618,Cyclomaltodextrin glucanotransferase,cgt,,
DB03206,Duvoglustat,,Q08638,Beta-glucosidase A,bglA,,
DB03206,Duvoglustat,,Q9UKM7,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,,
DB03206,Duvoglustat,,P31723,"Mannosyl-oligosaccharide alpha-1,2-mannosidase",MSDC,,
DB03206,Duvoglustat,,P12070,Xylose isomerase,xylA,,
DB03207,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",,P22894,Neutrophil collagenase,MMP8,,
DB03210,4-Aminohydrocinnamic Acid,,P95468,Aromatic-amino-acid aminotransferase,tyrB,,
DB03211,(3-Formyl-but-3-Enyl)-Phosphonic Acid,,P22513,"Glyceraldehyde-3-phosphate dehydrogenase, glycosomal",,,
DB03212,4-Deoxyglucarate,,P0AES2,Glucarate dehydratase,gudD,,
DB03213,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,,P07477,Trypsin-1,PRSS1,,
DB03214,Vinylglycine,,Q96RQ9,L-amino-acid oxidase,IL4I1,,
DB03214,Vinylglycine,,Q96QU6,1-aminocyclopropane-1-carboxylate synthase-like protein 1,ACCS,,
DB03215,"(2s,5s)-5-Carboxymethylproline",,Q9XB61,Carbapenam-3-carboxylate synthase,carA,,
DB03216,"(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",,P23526,Adenosylhomocysteinase,AHCY,,
DB03217,DPI59,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03218,N-acetyl-N'-beta-D-glucopyranosyl urea,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03219,11-Deoxy-Beta-Rhodomycin,,Q54527,RdmB,rdmB,,
DB03220,FR-234938,,P00813,Adenosine deaminase,ADA,,
DB03221,AL7099A,,P00918,Carbonic anhydrase 2,CA2,,
DB03222,dATP,,P07071,Anaerobic ribonucleoside-triphosphate reductase,NRDD,,
DB03222,dATP,,Q59560,Protein RecA,recA,,
DB03222,dATP,,P62219,Protein RecA,recA,,
DB03222,dATP,,P03692,DNA primase/helicase,,,
DB03222,dATP,,P06746,DNA polymerase beta,POLB,,
DB03222,dATP,,Q08698,Ribonucleoside-diphosphate reductase 2 subunit alpha,nrdE,,
DB03223,Diphthamide,,P13639,Elongation factor 2,EEF2,,
DB03224,2-Formyl-Protoporphryn Ix,,P04164,Cytochrome c-552,cycA,,
DB03225,D-Tryptophan,,P14920,D-amino-acid oxidase,DAO,,
DB03226,Trifluoroethanol,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB03226,Trifluoroethanol,,P01112,GTPase HRas,HRAS,,
DB03226,Trifluoroethanol,,P42328,Alcohol dehydrogenase,,,
DB03227,Nicotinamide Mononucleotide,,Q10588,ADP-ribosyl cyclase 2,BST1,,
DB03227,Nicotinamide Mononucleotide,,Q9HAN9,Nicotinamide mononucleotide adenylyltransferase 1,NMNAT1,,
DB03227,Nicotinamide Mononucleotide,,Q96T66,Nicotinamide mononucleotide adenylyltransferase 3,NMNAT3,,
DB03227,Nicotinamide Mononucleotide,,Q837V6,DNA ligase,ligA,,
DB03228,"5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide",,P38489,Oxygen-insensitive NAD(P)H nitroreductase,nfsB,,
DB03229,alpha-Ketoisocaproic acid,,P18548,Deacetoxycephalosporin C synthase,cefE,,
DB03229,alpha-Ketoisocaproic acid,,P17584,D-2-hydroxyisocaproate dehydrogenase,,,
DB03230,Adenosine-5'-Propylphosphate,,Q8ZKF6,Acetyl-coenzyme A synthetase,acs,,
DB03231,"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",,P56740,Dihydroneopterin aldolase,folB,,
DB03232,"2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol",,P0A8X2,Protein YceI,yceI,,
DB03233,3'-deoxy-3'-aminothymidine monophosphate,,P23919,Thymidylate kinase,DTYMK,,
DB03234,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",,P33247,Squalene--hopene cyclase,shc,,
DB03235,N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,,P01556,Cholera enterotoxin subunit B,ctxB,,
DB03237,"2,3-Dihydroxy-5-Oxo-Hexanedioate",,P0AES2,Glucarate dehydratase,gudD,,
DB03238,"3,5-Difluoroaniline",,P00720,Lysozyme,E,,
DB03240,"(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid",,P42262,Glutamate receptor 2,GRIA2,,
DB03241,1-Amino-1-Carbonyl Pentane,,P0DJ06,Candidapepsin-2,SAP2,,
DB03242,P-Aminophenyl-Alpha-D-Galactopyranoside,,P32890,Heat-labile enterotoxin B chain,eltB,,
DB03243,4-Fluorobenzylamine,,P07477,Trypsin-1,PRSS1,,
DB03245,S-4-Nitrobutyryl-CoA,,Q92947,"Glutaryl-CoA dehydrogenase, mitochondrial",GCDH,,
DB03246,Beta-L-Arabinose,,P02924,L-arabinose-binding periplasmic protein,araF,,
DB03247,Flavin mononucleotide,,P30043,Flavin reductase (NADPH),BLVRB,,
DB03247,Flavin mononucleotide,,Q9UJM8,Hydroxyacid oxidase 1,HAO1,,
DB03247,Flavin mononucleotide,,Q9NVS9,Pyridoxine-5'-phosphate oxidase,PNPO,,
DB03247,Flavin mononucleotide,,P46072,Major NAD(P)H-flavin oxidoreductase,,,
DB03247,Flavin mononucleotide,,Q969G6,Riboflavin kinase,RFK,,
DB03247,Flavin mononucleotide,,P17117,Oxygen-insensitive NADPH nitroreductase,nfsA,,
DB03247,Flavin mononucleotide,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB03247,Flavin mononucleotide,,P0A7E1,Dihydroorotate dehydrogenase (quinone),pyrD,,
DB03247,Flavin mononucleotide,,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,,
DB03247,Flavin mononucleotide,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB03247,Flavin mononucleotide,,P00322,Flavodoxin,,,
DB03247,Flavin mononucleotide,,P38489,Oxygen-insensitive NAD(P)H nitroreductase,nfsB,,
DB03247,Flavin mononucleotide,,P0A2Y7,Chorismate synthase,aroC,,
DB03247,Flavin mononucleotide,,P42593,"2,4-dienoyl-CoA reductase [NADPH]",fadH,,
DB03247,Flavin mononucleotide,,Q53ZE5,Dihydroorotate dehydrogenase A (fumarate),pyrDA,,
DB03247,Flavin mononucleotide,,P0AFI7,Pyridoxine/pyridoxamine 5'-phosphate oxidase,pdxH,,
DB03247,Flavin mononucleotide,,P71278,Pentaerythritol tetranitrate reductase,onr,,
DB03247,Flavin mononucleotide,,P63462,FMN-dependent NADH-azoreductase,azoR,,
DB03247,Flavin mononucleotide,,P30197,Epidermin decarboxylase,epiD,,
DB03247,Flavin mononucleotide,,P41407,FMN-dependent NADH-azoreductase,azoR,,
DB03247,Flavin mononucleotide,,P56122,Chorismate synthase,aroC,,
DB03247,Flavin mononucleotide,,P0A3D9,Flavodoxin,isiB,,
DB03247,Flavin mononucleotide,,P00323,Flavodoxin,,,
DB03247,Flavin mononucleotide,,P10340,Flavodoxin,isiB,,
DB03247,Flavin mononucleotide,,Q8DW21,Putative uncharacterized protein,,,
DB03247,Flavin mononucleotide,,O34974,Putative monooxygenase MoxC,moxC,,
DB03247,Flavin mononucleotide,,Q9WXV1,tRNA-dihydrouridine synthase,,,
DB03247,Flavin mononucleotide,,P50618,Protein NrdI,nrdI,,
DB03247,Flavin mononucleotide,,P69772,Probable aromatic acid decarboxylase,ecdB,,
DB03247,Flavin mononucleotide,,P20932,(S)-mandelate dehydrogenase,mdlB,,
DB03247,Flavin mononucleotide,,O07529,FMN-dependent NADPH-azoreductase,azr,,
DB03247,Flavin mononucleotide,,Q9ZK53,Flavodoxin,fldA,,
DB03247,Flavin mononucleotide,,O00141,Serine/threonine-protein kinase Sgk1,SGK1,,
DB03247,Flavin mononucleotide,,Q01234,Oxygen-insensitive NAD(P)H nitroreductase,nfsB,,
DB03247,Flavin mononucleotide,,Q9FDN7,Nitric oxide reductase,fprA,,
DB03247,Flavin mononucleotide,,Q746I8,Isopentenyl-diphosphate delta-isomerase,fni,,
DB03247,Flavin mononucleotide,,P16099,Trimethylamine dehydrogenase,tmd,,
DB03247,Flavin mononucleotide,,Q9F0J6,Rubredoxin-oxygen oxidoreductase,roo,,
DB03247,Flavin mononucleotide,,Q9WZW1,Riboflavin biosynthesis protein RibF,,,
DB03247,Flavin mononucleotide,,Q51990,Morphinone reductase,morB,,
DB03247,Flavin mononucleotide,,Q56691,NADPH-flavin oxidoreductase,frp,,
DB03247,Flavin mononucleotide,,O75676,Ribosomal protein S6 kinase alpha-4,RPS6KA4,,
DB03247,Flavin mononucleotide,,Q51793,Phenazine biosynthesis protein PhzG,phzG,,
DB03247,Flavin mononucleotide,,Q9NYQ3,Hydroxyacid oxidase 2,HAO2,,
DB03247,Flavin mononucleotide,,Q9RYU4,NAD(P)H dehydrogenase (quinone),,,
DB03247,Flavin mononucleotide,,P61949,Flavodoxin-1,fldA,,
DB03247,Flavin mononucleotide,,P50740,Isopentenyl-diphosphate delta-isomerase,fni,,
DB03247,Flavin mononucleotide,,Q60049,NADH dehydrogenase,nox,,
DB03247,Flavin mononucleotide,,Q46604,FMN-binding protein,,,
DB03247,Flavin mononucleotide,,Q81EW9,Nitroreductase family protein,,,
DB03247,Flavin mononucleotide,,P16435,NADPH--cytochrome P450 reductase,POR,,
DB03247,Flavin mononucleotide,,Q96CD2,Phosphopantothenoylcysteine decarboxylase,PPCDC,,
DB03247,Flavin mononucleotide,,O69755,PhzG,phzG,,
DB03247,Flavin mononucleotide,,P55038,Ferredoxin-dependent glutamate synthase 2,gltS,,
DB03248,2-(Phosphonooxy)Butanoic Acid,,O66496,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB03250,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03251,RWJ-51084,,P07477,Trypsin-1,PRSS1,,
DB03252,D-Lysine,,Q9HTQ2,"Alanine racemase, catabolic",dadX,,
DB03252,D-Lysine,,P00861,Diaminopimelate decarboxylase,lysA,,
DB03253,(2s)-Pyrrolidin-2-Ylmethylamine,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB03254,4-Phenyl-1h-Imidazole,,Q9FCA6,Putative cytochrome P450,cyp158a2,,
DB03255,Phenol,,P02768,Serum albumin,ALB,,C05BB05;R02AA19;N01BX03;D08AE03
DB03255,Phenol,,P00800,Thermolysin,npr,,C05BB05;R02AA19;N01BX03;D08AE03
DB03256,(6R)-Folinic acid,,Q5KUI2,Serine hydroxymethyltransferase,glyA,,
DB03256,(6R)-Folinic acid,,Q9WY54,Aminomethyltransferase,gcvT,,
DB03256,(6R)-Folinic acid,,P77398,Bifunctional polymyxin resistance protein ArnA,arnA,,
DB03256,(6R)-Folinic acid,,O95954,Formimidoyltransferase-cyclodeaminase,FTCD,,
DB03256,(6R)-Folinic acid,,Q9AGP8,"N,N-dimethylglycine oxidase",dmg,,
DB03257,"5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid",,P03472,Neuraminidase,,,
DB03258,2'-Deoxycytidine 5'-triphosphate,,P07071,Anaerobic ribonucleoside-triphosphate reductase,NRDD,,
DB03258,2'-Deoxycytidine 5'-triphosphate,,P28248,Deoxycytidine triphosphate deaminase,dcd,,
DB03258,2'-Deoxycytidine 5'-triphosphate,,P19821,"DNA polymerase I, thermostable",polA,,
DB03258,2'-Deoxycytidine 5'-triphosphate,,Q08698,Ribonucleoside-diphosphate reductase 2 subunit alpha,nrdE,,
DB03259,"2',6'-Dichloro-Biphenyl-2,6-Diol",,P47228,"Biphenyl-2,3-diol 1,2-dioxygenase",bphC,,
DB03260,Hexamethylene diamine,,Q9RZ04,"Agmatinase, putative",,,
DB03262,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",,P00918,Carbonic anhydrase 2,CA2,,
DB03264,Dodecyl-Coa,,P9WNG3,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB03264,Dodecyl-Coa,,P94548,Fatty acid metabolism regulator protein,fadR,,
DB03267,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,,P35558,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,,
DB03268,RU82197,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03270,"2,6-Difluorobenzenesulfonamide",,P00918,Carbonic anhydrase 2,CA2,,
DB03273,3'-Oxo-Adenosine,,P23526,Adenosylhomocysteinase,AHCY,,
DB03274,"2',5'-Dideoxyuridine",,P0A884,Thymidylate synthase,thyA,,
DB03276,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",,P62993,Growth factor receptor-bound protein 2,GRB2,,
DB03277,alpha-maltotriose,,P19961,Alpha-amylase 2B,AMY2B,,
DB03277,alpha-maltotriose,,Q9RHZ6,Maltose binding protein,malE,,
DB03278,D-Treitol,,P09373,Formate acetyltransferase 1,pflB,,
DB03279,Dodecyl-Alpha-D-Maltoside,,P13631,Retinoic acid receptor gamma,RARG,,
DB03280,p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate,,P9WKE1,Thymidylate kinase,tmk,ligand,
DB03280,p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate,,P23919,Thymidylate kinase,DTYMK,ligand,
DB03280,p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate,,P0A721,Thymidylate kinase,tmk,ligand,
DB03280,p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate,,P24425,Thymidine kinase,TK,ligand,
DB03280,p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate,,P23331,Thymidine kinase,tdk,ligand,
DB03283,beta-L-fucose,,P22303,Acetylcholinesterase,ACHE,,
DB03283,beta-L-fucose,,Q9WYE2,"Alpha-L-fucosidase, putative",,,
DB03284,"2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid",,P84141,Chondroitinase (Chondroitin lyase),,,
DB03286,C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03288,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,,,"Glycogen phosphorylase, liver form",,,
DB03289,Thiarsa Dihydroxy Cysteine,,P08692,Arsenate reductase,arsC,,
DB03290,L-naphthyl-1-acetamido boronic acid alanine,,P00780,Subtilisin Carlsberg,apr,,
DB03292,3-Phosphono-D-alanine,,P78330,Phosphoserine phosphatase,PSPH,,
DB03294,"1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide",,P00918,Carbonic anhydrase 2,CA2,,
DB03296,3'-beta-Sialyl-beta-lactose,,Q26966,Trans-sialidase,,,
DB03297,Benzylsulfonic acid,,P23946,Chymase,CMA1,,
DB03297,Benzylsulfonic acid,,P00782,Subtilisin BPN',apr,,
DB03297,Benzylsulfonic acid,,O07015,Sigma factor SigB regulation protein RsbQ,rsbQ,,
DB03297,Benzylsulfonic acid,,P04179,"Superoxide dismutase [Mn], mitochondrial",SOD2,,
DB03297,Benzylsulfonic acid,,P05981,Serine protease hepsin,HPN,,
DB03297,Benzylsulfonic acid,,Q8GB52,Extracellular subtilisin-like serine proteinase,,,
DB03297,Benzylsulfonic acid,,Q53547,Carboxylesterase 2,estB,,
DB03298,Phenylphosphate,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03299,N-Succinyl Phenylglycine,,Q44244,N-acylamino acid racemase,Aaar,,
DB03300,Pterin Cytosine Dinucleotide,,Q9REC4,Aldehyde oxidoreductase,MOD,,
DB03301,2-Allyl-6-Methyl-Phenol,,P00720,Lysozyme,E,,
DB03304,7-Deaza-7-Aminomethyl-Guanine,,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB03305,N(G)-Iminoethylornithine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB03306,RU78300,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03307,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB03308,L-Leucyl-Hydroxylamine,,P43133,Thermolysin,nprS,,
DB03309,N-cyclohexyltaurine,,O00204,Sulfotransferase family cytosolic 2B member 1,SULT2B1,,
DB03309,N-cyclohexyltaurine,,P72181,Nitrite reductase,nirS,,
DB03309,N-cyclohexyltaurine,,P19622,Homeobox protein engrailed-2,EN2,,
DB03309,N-cyclohexyltaurine,,P50597,Ribonuclease PH,rph,,
DB03309,N-cyclohexyltaurine,,P81180,Cyanovirin-N,,,
DB03309,N-cyclohexyltaurine,,P03422,Phosphoprotein,P/V,,
DB03310,Glutathione disulfide,,O75715,Glutathione peroxidase,GPX5,,
DB03310,Glutathione disulfide,,P10620,Microsomal glutathione S-transferase 1,MGST1,activator,
DB03310,Glutathione disulfide,,P08263,Glutathione S-transferases (Cytosolic),GSTA1,activator,
DB03310,Glutathione disulfide,,P28161,Glutathione S-transferase Mu 2,GSTM2,activator,
DB03310,Glutathione disulfide,,P00390,"Glutathione reductase, mitochondrial",GSR,substrate,
DB03311,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB03312,Brivudine,,O00142,"Thymidine kinase 2, mitochondrial",TK2,substrate,J05AB15
DB03312,Brivudine,,Q91CQ6,DNA polymerase,DNApol,inhibitor,J05AB15
DB03312,Brivudine,,P13159,Thymidine kinase,TK,substrate,J05AB15
DB03313,Cephalosporin C,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,
DB03313,Cephalosporin C,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,
DB03313,Cephalosporin C,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,
DB03313,Cephalosporin C,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,
DB03313,Cephalosporin C,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,
DB03313,Cephalosporin C,,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB03314,5-fluorotryptophan,,P60174,Triosephosphate isomerase,TPI1,,
DB03314,5-fluorotryptophan,,P09488,Glutathione S-transferase Mu 1,GSTM1,,
DB03315,Guanosine 3'-monophosphate,,P48068,Ribonuclease,,,
DB03315,Guanosine 3'-monophosphate,,P41007,Bifunctional protein PyrR,pyrR,,
DB03316,"1,4-Dioxane",,P00780,Subtilisin Carlsberg,apr,,
DB03316,"1,4-Dioxane",,Q9Y275,Tumor necrosis factor ligand superfamily member 13B,TNFSF13B,,
DB03316,"1,4-Dioxane",,Q9Y6I3,Epsin-1,EPN1,,
DB03316,"1,4-Dioxane",,P03316,Structural polyprotein,,,
DB03316,"1,4-Dioxane",,P10600,Transforming growth factor beta-3,TGFB3,,
DB03317,Ferroheme C,,P24474,Nitrite reductase,nirS,,
DB03317,Ferroheme C,,P24092,High-molecular-weight cytochrome c,hmcA,,
DB03317,Ferroheme C,,Q9RQB9,Cytochrome c'',cycA,,
DB03317,Ferroheme C,,Q46444,Quinohemoprotein ethanol dehydrogenase type-1,qheDH,,
DB03317,Ferroheme C,,P72181,Nitrite reductase,nirS,,
DB03317,Ferroheme C,,Q52369,Cytochrome c4,cc4,,
DB03317,Ferroheme C,,P99999,Cytochrome c,CYCS,,
DB03317,Ferroheme C,,P0ABK9,Cytochrome c-552,nrfA,,
DB03317,Ferroheme C,,P00091,Cytochrome c2,cycA,,
DB03317,Ferroheme C,,Q55013,Cytochrome c-550,psbV,,
DB03317,Ferroheme C,,P54820,Cytochrome c-552,cycM,,
DB03317,Ferroheme C,,P00101,Cytochrome c-551,nirM,,
DB03317,Ferroheme C,,P00137,Cytochrome c3,cyd,,
DB03317,Ferroheme C,,P81040,Split-Soret cytochrome c,,,
DB03317,Ferroheme C,,P9WN25,Group 1 truncated hemoglobin GlbN,glbN,,
DB03317,Ferroheme C,,P82599,Cytochrome c-553,,,
DB03317,Ferroheme C,,P11712,Cytochrome P450 2C9,CYP2C9,,
DB03317,Ferroheme C,,Q9RN68,Nine-heme cytochrome c,,,
DB03317,Ferroheme C,,P00136,"Cytochrome c3, 13 kDa",,,
DB03317,Ferroheme C,,P14532,Cytochrome c551 peroxidase,ccpA,,
DB03317,Ferroheme C,,P00132,Cytochrome c3,,,
DB03317,Ferroheme C,,P00148,Cytochrome c',cycP,,
DB03317,Ferroheme C,,Q9L915,Cytochrome c3,cytc3,,
DB03319,"(2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate",,P42262,Glutamate receptor 2,GRIA2,,
DB03320,3-Amino-Alanine,,P12488,Envelope glycoprotein gp160,env,,
DB03321,Des(carbamimidoyl) zanamivir,,P03472,Neuraminidase,,,
DB03323,Maltose,,P30920,Cyclomaltodextrin glucanotransferase,,,
DB03323,Maltose,,P19961,Alpha-amylase 2B,AMY2B,,
DB03323,Maltose,,P36924,Beta-amylase,spoII,,
DB03323,Maltose,,P19531,Maltogenic alpha-amylase,amyM,,
DB03323,Maltose,,P00490,Maltodextrin phosphorylase,malP,,
DB03323,Maltose,,P0AEX9,Maltose-binding periplasmic protein,malE,,
DB03323,Maltose,,O33830,Alpha-glucosidase,aglA,,
DB03323,Maltose,,Q9RHZ6,Maltose binding protein,malE,,
DB03323,Maltose,,Q9RX51,Malto-oligosyltrehalose trehalohydrolase,treZ,,
DB03325,Tyrosyladenylate,,P0AGJ9,Tyrosine--tRNA ligase,tyrS,,
DB03326,"Deoxycytidylyl-3',5'-guanosine",,P07998,Ribonuclease pancreatic,RNASE1,,
DB03327,{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid,,P10724,Alanine racemase,alr,,
DB03328,Dioxo(sulfanyl)molybdenum,,P47989,Xanthine dehydrogenase/oxidase,XDH,,
DB03329,2-Pyridinethiol,,P07858,Cathepsin B,CTSB,,
DB03330,S-(N-hydroxy-N-iodophenylcarbamoyl)glutathione,,Q04760,Lactoylglutathione lyase,GLO1,,
DB03331,"N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine",,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,,
DB03332,"5,6-Cyclic-Tetrahydropteridine",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB03333,(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester,,P00918,Carbonic anhydrase 2,CA2,,
DB03335,(+)-1-bromo-2-propanol,,P51698,Haloalkane dehalogenase,linB,,
DB03336,BIA,,P21964,Catechol O-methyltransferase,COMT,,
DB03337,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,,P07477,Trypsin-1,PRSS1,,
DB03338,Heptyl glucoside,,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB03338,Heptyl glucoside,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB03340,3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid,,P45494,Beta-Ala-Xaa dipeptidase,pepV,,
DB03341,CoA-S-acetyl 5-bromotryptamine,,Q16613,Serotonin N-acetyltransferase,AANAT,,
DB03342,4-(Acetylamino)-3-Guanidinobenzoic Acid,,P03474,Neuraminidase,,,
DB03343,Malate Like Intermediate,,P0C278,Fumarate reductase flavoprotein subunit,fccA,,
DB03344,"Inositol-(1,3,4,5,6)-Pentakisphosphate",,O43739,Cytohesin-3,CYTH3,,
DB03345,Mercaptoethanol,,P00720,Lysozyme,E,,
DB03345,Mercaptoethanol,,Q04760,Lactoylglutathione lyase,GLO1,,
DB03345,Mercaptoethanol,,Q9NVS9,Pyridoxine-5'-phosphate oxidase,PNPO,,
DB03345,Mercaptoethanol,,Q07982,Glucose--fructose oxidoreductase,gfo,,
DB03345,Mercaptoethanol,,P01009,Alpha-1-antitrypsin,SERPINA1,,
DB03345,Mercaptoethanol,,P0AFI7,Pyridoxine/pyridoxamine 5'-phosphate oxidase,pdxH,,
DB03345,Mercaptoethanol,,P09382,Galectin-1,LGALS1,,
DB03345,Mercaptoethanol,,P03765,Protein ninB,ninB,,
DB03345,Mercaptoethanol,,Q96GD3,Polycomb protein SCMH1,SCMH1,,
DB03345,Mercaptoethanol,,O25323,Endonuclease III,,,
DB03346,"3,3',5,5'-tetrachlorobiphenyl-4,4'-diol",,P49888,Estrogen sulfotransferase,SULT1E1,,
DB03347,Triethyl phosphate,,P0A434,Parathion hydrolase,opd,,
DB03347,Triethyl phosphate,,P04637,Cellular tumor antigen p53,TP53,,
DB03347,Triethyl phosphate,,P0A433,Parathion hydrolase,opd,,
DB03348,Huperzine B,,P22303,Acetylcholinesterase,ACHE,,
DB03349,8-Bromo-Adenosine-5'-Monophosphate,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,,
DB03349,8-Bromo-Adenosine-5'-Monophosphate,,P49773,Histidine triad nucleotide-binding protein 1,HINT1,,
DB03350,Cobalt hexammine ion,,P02930,Outer membrane protein TolC,tolC,,
DB03350,Cobalt hexammine ion,,P0A2Y7,Chorismate synthase,aroC,,
DB03351,Sri-9439,,P00374,Dihydrofolate reductase,DHFR,,
DB03352,S-Arsonocysteine,,P08692,Arsenate reductase,arsC,,
DB03352,S-Arsonocysteine,,P0A006,Protein ArsC,arsC,,
DB03352,S-Arsonocysteine,,Q7K9G0,3-mercaptopyruvate sulfurtransferase,MST,,
DB03353,2-Iminobiotin,,P22629,Streptavidin,,,
DB03354,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03355,5'-O-(L-Threonylsulfamoyl)adenosine,,P0A8M5,Threonine--tRNA ligase,thrS,,
DB03355,5'-O-(L-Threonylsulfamoyl)adenosine,,Q8NW68,Threonine--tRNA ligase,thrS,,
DB03357,(S)-Mandelic acid,,P11444,Mandelate racemase,mdlA,,
DB03358,"7-Methyl-7,8-dihydroguanosine 5'-(tetrahydrogen triphosphate)",,P07617,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,PAPS,,
DB03359,"M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene",,P22303,Acetylcholinesterase,ACHE,,
DB03360,N-Acetylproline,,Q9XB59,(5R)-carbapenem-3-carboxylate synthase,carC,,
DB03361,"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",,P27696,"Acetolactate synthase, catabolic",budB,,
DB03363,3-Acetylpyridine Adenine Dinucleotide,,P04036,4-hydroxy-tetrahydrodipicolinate reductase,dapB,,
DB03364,N-Carbamyl-D-Methionine,,P60327,N-carbamoyl-D-amino acid hydrolase,,,
DB03365,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB03366,Imidazole,,P40859,Monomeric sarcosine oxidase,soxA,,
DB03366,Imidazole,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB03366,Imidazole,,P02144,Myoglobin,MB,,
DB03366,Imidazole,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB03366,Imidazole,,P54819,"Adenylate kinase 2, mitochondrial",AK2,,
DB03366,Imidazole,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB03366,Imidazole,,Q46822,Isopentenyl-diphosphate Delta-isomerase,idi,,
DB03366,Imidazole,,P31677,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",otsA,,
DB03366,Imidazole,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB03366,Imidazole,,Q9NQX3,Gephyrin,GPHN,,
DB03366,Imidazole,,P0A6B1,Acyl carrier protein,acpP,,
DB03366,Imidazole,,P23222,Sensor protein FixL,fixL,,
DB03366,Imidazole,,P99999,Cytochrome c,CYCS,,
DB03366,Imidazole,,P74645,Circadian clock protein KaiB,kaiB,,
DB03366,Imidazole,,P06988,Histidinol dehydrogenase,hisD,,
DB03366,Imidazole,,P0ADA1,Acyl-CoA thioesterase I,tesA,,
DB03366,Imidazole,,P17802,A/G-specific adenine glycosylase,mutY,,
DB03366,Imidazole,,P31491,YopE regulator,yerA,,
DB03366,Imidazole,,Q12965,Unconventional myosin-Ie,MYO1E,,
DB03366,Imidazole,,Q14565,Meiotic recombination protein DMC1/LIM15 homolog,DMC1,,
DB03366,Imidazole,,O34598,Guanine deaminase,guaD,,
DB03366,Imidazole,,P26514,"Endo-1,4-beta-xylanase A",xlnA,,
DB03366,Imidazole,,P04252,Bacterial hemoglobin,vhb,,
DB03366,Imidazole,,Q816R0,Molybdenum cofactor biosynthesis protein B,moaB,,
DB03366,Imidazole,,P14739,Uracil-DNA glycosylase inhibitor,UGI,,
DB03366,Imidazole,,Q9ZNA2,Recombination protein RecR,recR,,
DB03367,PF-00356231,,P39900,Macrophage metalloelastase,MMP12,,
DB03368,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",,P08254,Stromelysin-1,MMP3,,
DB03369,9-Aminophenanthrene,,Q00441,6-deoxyerythronolide B hydroxylase,eryF,,
DB03370,FR239087,,P00813,Adenosine deaminase,ADA,,
DB03371,Modified Ribosylated Glutamyl Ester,,Q8RLY5,Nucleoside deoxyribosyltransferase-I,ptd,,
DB03372,"3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One",,P60568,Interleukin-2,IL2,,
DB03373,ZK-806711,,P07477,Trypsin-1,PRSS1,,
DB03374,"3,5-Diiodotyrosine",,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB03374,"3,5-Diiodotyrosine",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB03374,"3,5-Diiodotyrosine",,Q9KFR4,Alpha-amylase G-6,,,
DB03374,"3,5-Diiodotyrosine",,P07477,Trypsin-1,PRSS1,,
DB03374,"3,5-Diiodotyrosine",,P33590,Nickel-binding periplasmic protein,nikA,,
DB03374,"3,5-Diiodotyrosine",,Q6PHW0,Iodotyrosine dehalogenase 1,IYD,,
DB03376,5'-O-(N-(Alanyl)sulfamoyl)adenosine,,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,,
DB03379,2-Carboxyethylphosphonic Acid,,P60174,Triosephosphate isomerase,TPI1,,
DB03380,L-tyrosinamide,,P01303,Pro-neuropeptide Y,NPY,,
DB03380,L-tyrosinamide,,Q86WA6,Valacyclovir hydrolase,BPHL,,
DB03381,Hexadecanal,,P08100,Rhodopsin,RHO,,
DB03381,Hexadecanal,,P07108,Acyl-CoA-binding protein,DBI,,
DB03382,S-oxy-L-cysteine,,P0A793,Aspartate 1-decarboxylase,panD,,
DB03382,S-oxy-L-cysteine,,P48147,Prolyl endopeptidase,PREP,,
DB03382,S-oxy-L-cysteine,,O67040,Exopolyphosphatase,ppx,,
DB03382,S-oxy-L-cysteine,,O53240,Conserved protein,,,
DB03382,S-oxy-L-cysteine,,P9WG35,Probable thiol peroxidase,tpx,,
DB03382,S-oxy-L-cysteine,,P00441,Superoxide dismutase [Cu-Zn],SOD1,,
DB03382,S-oxy-L-cysteine,,P37062,NADH peroxidase,npr,,
DB03383,CP-320626,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03384,Fica,,P55210,Caspase-7,CASP7,,
DB03385,4-Methylimidazole,,P00918,Carbonic anhydrase 2,CA2,,
DB03385,4-Methylimidazole,,P02144,Myoglobin,MB,,
DB03385,4-Methylimidazole,,P35218,"Carbonic anhydrase 5A, mitochondrial",CA5A,,
DB03388,"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",,P26660,Genome polyprotein,,,
DB03389,alpha-D-Xylopyranose,,Q46079,Chondroitinase-B,cslB,,
DB03389,alpha-D-Xylopyranose,,Q59288,Chondroitinase-AC,cslA,,
DB03389,alpha-D-Xylopyranose,,P07986,Exoglucanase/xylanase,cex,,
DB03389,alpha-D-Xylopyranose,,P36924,Beta-amylase,spoII,,
DB03389,alpha-D-Xylopyranose,,Q9ZB17,Aldose 1-epimerase,galM,,
DB03389,alpha-D-Xylopyranose,,Q59675,"Endo-beta-1,4-xylanase",xyn10C,,
DB03389,alpha-D-Xylopyranose,,Q9KB30,Reducing end xylose-releasing exo-oligoxylanase,,,
DB03389,alpha-D-Xylopyranose,,P40943,"Endo-1,4-beta-xylanase",,,
DB03389,alpha-D-Xylopyranose,,Q7SIE2,"Endo-1,4-beta-xylanase",,,
DB03389,alpha-D-Xylopyranose,,Q8GJ44,"Endo-1,4-beta-xylanase A",xynA,,
DB03389,alpha-D-Xylopyranose,,P26514,"Endo-1,4-beta-xylanase A",xlnA,,
DB03389,alpha-D-Xylopyranose,,P09850,"Endo-1,4-beta-xylanase",xlnA,,
DB03389,alpha-D-Xylopyranose,,Q7SI98,Hydrolase,,,
DB03389,alpha-D-Xylopyranose,,Q8RJN8,"Endo-1,4-beta-xylanase",xyl,,
DB03389,alpha-D-Xylopyranose,,P09848,Lactase-phlorizin hydrolase,LCT,,
DB03389,alpha-D-Xylopyranose,,O68541,Endoxylanase,xynC,,
DB03390,"(2R,3R)-2,3-Dihydroxy-4-oxo-4-(propylamino)butanoic acid",,P15309,Prostatic acid phosphatase,ACPP,,
DB03392,"(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03393,Sanglifehrin A,,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,,
DB03394,Heptaethylene glycol,,P16152,Carbonyl reductase [NADPH] 1,CBR1,,
DB03395,Enalkiren,,P00797,Renin,REN,inhibitor,
DB03396,"(2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide",,P50579,Methionine aminopeptidase 2,METAP2,,
DB03397,Uridine-Diphosphate-N-Acetylglucosamine,,Q16222,UDP-N-acetylhexosamine pyrophosphorylase,UAP1,,
DB03397,Uridine-Diphosphate-N-Acetylglucosamine,,P0A751,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,murA,,
DB03397,Uridine-Diphosphate-N-Acetylglucosamine,,Q14376,UDP-glucose 4-epimerase,GALE,,
DB03397,Uridine-Diphosphate-N-Acetylglucosamine,,P09147,UDP-glucose 4-epimerase,galE,,
DB03397,Uridine-Diphosphate-N-Acetylglucosamine,,Q9UBQ6,Exostosin-like 2,EXTL2,,
DB03397,Uridine-Diphosphate-N-Acetylglucosamine,,P26572,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",MGAT1,,
DB03397,Uridine-Diphosphate-N-Acetylglucosamine,,P0ACC7,Bifunctional protein GlmU,glmU,,
DB03397,Uridine-Diphosphate-N-Acetylglucosamine,,Q97R46,Bifunctional protein GlmU,glmU,,
DB03399,Ethyl Isocyanide,,P02144,Myoglobin,MB,,
DB03400,3-(P-Tolyl)Propionic Acid,,P95468,Aromatic-amino-acid aminotransferase,tyrB,,
DB03401,"1D-myo-inositol 1,4,5-trisphosphate",,Q99418,Cytohesin-2,CYTH2,,
DB03401,"1D-myo-inositol 1,4,5-trisphosphate",,Q9Y6I3,Epsin-1,EPN1,,
DB03401,"1D-myo-inositol 1,4,5-trisphosphate",,P51178,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",PLCD1,,
DB03401,"1D-myo-inositol 1,4,5-trisphosphate",,P35241,Radixin,RDX,,
DB03401,"1D-myo-inositol 1,4,5-trisphosphate",,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,,
DB03401,"1D-myo-inositol 1,4,5-trisphosphate",,Q14643,"Inositol 1,4,5-trisphosphate receptor type 1",ITPR1,,
DB03401,"1D-myo-inositol 1,4,5-trisphosphate",,P23677,Inositol-trisphosphate 3-kinase A,ITPKA,,
DB03403,Cytidine-5'-Monophosphate,,Q9BZX2,Uridine-cytidine kinase 2,UCK2,,
DB03403,Cytidine-5'-Monophosphate,,P42216,3-deoxy-manno-octulosonate cytidylyltransferase,kpsU,,
DB03403,Cytidine-5'-Monophosphate,,P62619,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB03403,Cytidine-5'-Monophosphate,,Q9PM68,Bifunctional enzyme IspD/IspF,ispDF,,
DB03403,Cytidine-5'-Monophosphate,,P30085,UMP-CMP kinase,CMPK1,,
DB03403,Cytidine-5'-Monophosphate,,Q8RQP5,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB03403,Cytidine-5'-Monophosphate,,P0A6I0,Cytidylate kinase,cmk,,
DB03403,Cytidine-5'-Monophosphate,,P0ABQ0,Coenzyme A biosynthesis bifunctional protein CoaBC,coaBC,,
DB03403,Cytidine-5'-Monophosphate,,Q9LAK3,"Alpha-2,3-/2,8-sialyltransferase",cst-II,,
DB03405,N2-[(Benzyloxy)carbonyl]-N-[(3R)-1-{N-[(benzyloxy)carbonyl]-L-leucyl}-4-oxo-3-pyrrolidinyl]-L-leucinamide,,P43235,Cathepsin K,CTSK,,
DB03408,gamma-Glutamylcysteine,,P48637,Glutathione synthetase,GSS,,
DB03410,4-hydroxycoumarin,,P46072,Major NAD(P)H-flavin oxidoreductase,,,
DB03411,"2-Hydroxymethyl-Pyrrolidine-3,4-Diol",,P9WP01,Purine nucleoside phosphorylase,punA,,
DB03412,6-hydroxynorleucine,,P06608,L-asparaginase,ansB,,
DB03413,Deoxyuridine-5'-Diphosphate,,P33316,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",DUT,,
DB03413,Deoxyuridine-5'-Diphosphate,,P06968,Deoxyuridine 5'-triphosphate nucleotidohydrolase,dut,,
DB03413,Deoxyuridine-5'-Diphosphate,,P9WNS5,Deoxyuridine 5'-triphosphate nucleotidohydrolase,dut,,
DB03413,Deoxyuridine-5'-Diphosphate,,O15923,Deoxyuridine triphosphatase,Tcdut,,
DB03413,Deoxyuridine-5'-Diphosphate,,P03371,Pol polyprotein,pol,,
DB03414,5-Thio-a/B-D-Mannopyranosylamine,,Q16706,Alpha-mannosidase 2,MAN2A1,,
DB03415,3-thiaoctanoyl-CoA,,P11310,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADM,,
DB03416,Thiamine(1+) monophosphate,,P39594,Thiamine-phosphate synthase,thiE,,
DB03417,"(2S,3R)-2-[[4-(Tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid",,P07477,Trypsin-1,PRSS1,,
DB03419,Uracil,,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,,
DB03419,Uracil,,Q9NWZ5,Uridine-cytidine kinase-like 1,UCKL1,,
DB03419,Uracil,,P10186,Uracil-DNA glycosylase,,,
DB03419,Uracil,,Q8X444,Uracil-DNA glycosylase,ung,,
DB03419,Uracil,,P0AA43,Ribosomal small subunit pseudouridine synthase A,rsuA,,
DB03419,Uracil,,Q5SKC5,Uracil-DNA glycosylase,udg,,
DB03419,Uracil,,P77836,Pyrimidine-nucleoside phosphorylase,pdp,,
DB03420,"2,4-deoxy-4-guanidino-5-N-acetyl-neuraminic acid",,P03472,Neuraminidase,,,
DB03421,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",,P32890,Heat-labile enterotoxin B chain,eltB,,
DB03423,S-Adenosyl-L-Homoselenocysteine,,P43985,tRNA (cmo5U34)-methyltransferase,cmoA,,
DB03424,Ubenimex,,Q01693,Bacterial leucyl aminopeptidase,,,
DB03424,Ubenimex,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB03425,"2s,4r-4-Methylglutamate",,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,,
DB03428,SU9516,,P24941,Cyclin-dependent kinase 2,CDK2,inhibitor,
DB03428,SU9516,,Q00535,Cyclin-dependent kinase 5,CDK5,inhibitor,
DB03428,SU9516,,P06493,Cyclin-dependent kinase 1,CDK1,binder,
DB03429,Tetrastearoyl cardiolipin,,P12235,ADP/ATP translocase 1,SLC25A4,,
DB03430,(S)-4-hydroxymandelonitrile,,Q6UWM7,Lactase-like protein,LCTL,,
DB03433,{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid,,P97084,Threonine-phosphate decarboxylase,cobD,,
DB03434,3-(N-morpholino)propanesulfonic acid,,P33221,Phosphoribosylglycinamide formyltransferase 2,purT,,
DB03434,3-(N-morpholino)propanesulfonic acid,,P31434,Alpha-xylosidase,yicI,,
DB03434,3-(N-morpholino)propanesulfonic acid,,P22749,Granulysin,GNLY,,
DB03435,Uridine-5'-Diphosphate,,P27828,UDP-N-acetylglucosamine 2-epimerase,wecB,,
DB03435,Uridine-5'-Diphosphate,,P16442,Histo-blood group ABO system transferase,ABO,,
DB03435,Uridine-5'-Diphosphate,,P09148,Galactose-1-phosphate uridylyltransferase,galT,,
DB03435,Uridine-5'-Diphosphate,,P16088,Pol polyprotein,pol,,
DB03435,Uridine-5'-Diphosphate,,Q9P2W7,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1,B3GAT1,,
DB03435,Uridine-5'-Diphosphate,,P31677,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",otsA,,
DB03435,Uridine-5'-Diphosphate,,Q9UBQ6,Exostosin-like 2,EXTL2,,
DB03435,Uridine-5'-Diphosphate,,Q7Z4J2,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,,
DB03435,Uridine-5'-Diphosphate,,P39621,Spore coat polysaccharide biosynthesis protein SpsA,spsA,,
DB03435,Uridine-5'-Diphosphate,,P30085,UMP-CMP kinase,CMPK1,,
DB03435,Uridine-5'-Diphosphate,,P04547,DNA beta-glucosyltransferase,bgt,,
DB03435,Uridine-5'-Diphosphate,,P09147,UDP-glucose 4-epimerase,galE,,
DB03435,Uridine-5'-Diphosphate,,O94766,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,B3GAT3,,
DB03435,Uridine-5'-Diphosphate,,Q8T8E9,UDP-galactose 4-epimerase,galE,,
DB03435,Uridine-5'-Diphosphate,,P46976,Glycogenin-1,GYG1,,
DB03435,Uridine-5'-Diphosphate,,Q13304,Uracil nucleotide/cysteinyl leukotriene receptor,GPR17,regulator,
DB03436,Gallichrome,,P07822,Iron(3+)-hydroxamate-binding protein FhuD,fhuD,antagonist,
DB03437,"(2R,4S)-2-[(1R)-1-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid",,P00811,Beta-lactamase,ampC,,
DB03439,"4,6-dideoxy-4-amino-alpha-D-glucose",,P04745,Alpha-amylase 1,AMY1A,,
DB03439,"4,6-dideoxy-4-amino-alpha-D-glucose",,P04746,Pancreatic alpha-amylase,AMY2A,,
DB03440,N-hexadecanoylglycine,,P14779,Bifunctional P-450/NADPH-P450 reductase,cyp102A1,,
DB03441,2-Benzyl-3-Iodopropanoic Acid,,P15085,Carboxypeptidase A1,CPA1,,
DB03442,Acid yellow 54 free acid,,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,,
DB03443,bis(5-amidino-benzimidazolyl)methanone zinc,,P07477,Trypsin-1,PRSS1,,
DB03444,6-bromoindirubin-3'-oxime,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB03445,Tazobactam trans-enamine intermediate,,P0AD63,Beta-lactamase SHV-1,bla,,
DB03446,N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,,P32890,Heat-labile enterotoxin B chain,eltB,,
DB03447,Uridylyl-2'-5'-phospho-adenosine,,P07998,Ribonuclease pancreatic,RNASE1,,
DB03448,2'-Deoxyuridine 3'-Monophosphate,,P07998,Ribonuclease pancreatic,RNASE1,,
DB03448,2'-Deoxyuridine 3'-Monophosphate,,P34096,Ribonuclease 4,RNASE4,,
DB03449,N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB03449,N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB03450,Cephalothin Group,,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB03450,Cephalothin Group,,Q47066,Beta-lactamase Toho-1,bla,,
DB03451,Lexacalcitol,,P11473,Vitamin D3 receptor,VDR,,
DB03452,3-Trimethylsilylsuccinic Acid,,P05042,Fumarate hydratase class II,fumC,,
DB03453,Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate,,P60568,Interleukin-2,IL2,,
DB03454,"3-methyl-benzene-1,2-diol",,P47228,"Biphenyl-2,3-diol 1,2-dioxygenase",bphC,,
DB03455,(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid,,P60568,Interleukin-2,IL2,,
DB03456,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,,P43235,Cathepsin K,CTSK,,
DB03459,Sparfosic acid,,P0A789,Aspartate carbamoyltransferase catalytic chain,pyrB,,
DB03459,Sparfosic acid,,P27708,CAD protein,CAD,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P08200,Isocitrate dehydrogenase [NADP],icd,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P15121,Aldose reductase,AKR1B1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P11411,Glucose-6-phosphate 1-dehydrogenase,zwf,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P52895,Aldo-keto reductase family 1 member C2,AKR1C2,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q13423,"NAD(P) transhydrogenase, mitochondrial",NNT,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P35270,Sepiapterin reductase,SPR,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q01782,Pteridine reductase 1,PTR1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q7Z4W1,L-xylulose reductase,DCXR,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,O75874,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P11413,Glucose-6-phosphate 1-dehydrogenase,G6PD,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P00374,Dihydrofolate reductase,DHFR,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P67910,ADP-L-glycero-D-manno-heptose-6-epimerase,hldD,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P11586,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P30043,Flavin reductase (NADPH),BLVRB,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P16100,Isocitrate dehydrogenase [NADP],icd,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P16184,Dihydrofolate reductase,,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q08257,Quinone oxidoreductase,CRYZ,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P00325,Alcohol dehydrogenase 1B,ADH1B,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P16435,NADPH--cytochrome P450 reductase,POR,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P15770,Shikimate dehydrogenase,aroE,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P14941,NADP-dependent isopropanol dehydrogenase,adh,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P32055,GDP-L-fucose synthase,fcl,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P44801,Aspartate-semialdehyde dehydrogenase,asd,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P42593,"2,4-dienoyl-CoA reductase [NADPH]",fadH,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P48163,NADP-dependent malic enzyme,ME1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P0ABQ4,Dihydrofolate reductase,folA,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P0C188,NAD(P) transhydrogenase subunit beta,pntB,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P0AEK2,3-oxoacyl-[acyl-carrier-protein] reductase FabG,fabG,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q6UWP2,Dehydrogenase/reductase SDR family member 11,DHRS11,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P40925,"Malate dehydrogenase, cytoplasmic",MDH1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P76187,Oxidoreductase YdhF,ydhF,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q8I814,Putative pteridine reductase 2,ptr2,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q92506,Estradiol 17-beta-dehydrogenase 8,HSD17B8,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P14550,Alcohol dehydrogenase [NADP(+)],AKR1A1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P16544,Putative ketoacyl reductase,actIII,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q16698,"2,4-dienoyl-CoA reductase, mitochondrial",DECR1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q9WYS2,"Oxidoreductase, short chain dehydrogenase/reductase family",,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q9GV41,Prostaglandin F synthase,,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P80874,General stress protein 69,yhdN,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P21890,Ferredoxin--NADP reductase,petH,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P55818,Bifunctional protein MdtA,mtdA,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q9X022,Alcohol dehydrogenase,,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P22570,"NADPH:adrenodoxin oxidoreductase, mitochondrial",FDXR,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P58558,Ferredoxin--NADP reductase,petH,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P06632,"2,5-diketo-D-gluconic acid reductase A",dkgA,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P46336,Protein IolS,iolS,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q59931,NADP-dependent glyceraldehyde-3-phosphate dehydrogenase,gapN,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q14914,Prostaglandin reductase 1,PTGR1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P38038,Sulfite reductase [NADPH] flavoprotein alpha-component,cysJ,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,O60218,Aldo-keto reductase family 1 member B10,AKR1B10,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q9WZS7,Alcohol dehydrogenase (NADP(+)),,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q56694,NADP-dependent fatty aldehyde dehydrogenase,aldH,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 2,DHRS4L1,,
DB03461,Nicotinamide adenine dinucleotide phosphate,,Q9X0A2,Aldehyde reductase,,,
DB03462,Thymine,,P61497,Deoxyribodipyrimidine photo-lyase,phr,,
DB03462,Thymine,,P07650,Thymidine phosphorylase,deoA,,
DB03464,Formycin-5'-Monophosphate,,P0AE12,AMP nucleosidase,amn,,
DB03466,BMS184394,,P13631,Retinoic acid receptor gamma,RARG,,
DB03467,Naringenin,,Q9AIU0,HTH-type transcriptional regulator TtgR,ttgR,,
DB03467,Naringenin,,P03372,Estrogen receptor alpha,ESR1,,
DB03467,Naringenin,,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,antagonist,
DB03467,Naringenin,,Q16678,Cytochrome P450 1B1,CYP1B1,,
DB03467,Naringenin,,Q9P2N6,KAT8 regulatory NSL complex subunit 3,KANSL3,,
DB03467,Naringenin,,P04278,Sex hormone-binding globulin,SHBG,,
DB03467,Naringenin,,P11511,Cytochrome P450 19A1,CYP19A1,inhibitor,
DB03467,Naringenin,,Q92731,Estrogen receptor beta,ESR2,partial agonist,
DB03468,"1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB03469,Heme D,,P24474,Nitrite reductase,nirS,,
DB03469,Heme D,,P72181,Nitrite reductase,nirS,,
DB03470,Trypanothione,,P28593,Trypanothione reductase,TPR,,
DB03471,6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB03472,Cyclohexyl-Hexyl-Beta-D-Maltoside,,P0AD63,Beta-lactamase SHV-1,bla,,
DB03472,Cyclohexyl-Hexyl-Beta-D-Maltoside,,P0A9Z7,Beta-lactamase SHV-2,bla,,
DB03473,N5-Methylglutamine,,Q9WYV8,Release factor glutamine methyltransferase,prmC,,
DB03475,"1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One",,P03474,Neuraminidase,,,
DB03476,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB03477,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,,P35354,Prostaglandin G/H synthase 2,PTGS2,,
DB03478,2'-O-Acetyl Adenosine-5-Diphosphoribose,,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,,
DB03479,"8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03480,Brequinar Analog,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB03481,"5,10-Dimethylene Tetrahydromethanopterin",,Q9FA38,Formaldehyde-activating enzyme,fae,,
DB03482,8-demethyl-8-dimethylamino-flavin-adenine-dinucleotide,,P20586,p-hydroxybenzoate hydroxylase,pobA,,
DB03483,(4S)-5-[[(2S)-1-[[(2S)-1-Amino-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-4-benzamido-5-oxopentanoic acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB03484,sn-glycero-3-phosphoethanolamine,,P08758,Annexin A5,ANXA5,,
DB03485,alpha-D-Fucopyranose,,P02788,Lactotransferrin,LTF,,
DB03485,alpha-D-Fucopyranose,,P02924,L-arabinose-binding periplasmic protein,araF,,
DB03486,Phosphomethylphosphonic acid guanosyl ester,,Q8WVQ1,Soluble calcium-activated nucleotidase 1,CANT1,,
DB03487,(S)-Aspartimide,,P61626,Lysozyme C,LYZ,,
DB03487,(S)-Aspartimide,,P0AE67,Chemotaxis protein CheY,cheY,,
DB03488,Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,,P31677,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",otsA,,
DB03489,2-Keto-3-Deoxygluconate,,Q746L7,2-keto-3-deoxy-gluconate kinase,,,
DB03490,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB03491,2'-Deoxyguanosine-5'-Diphosphate,,P15531,Nucleoside diphosphate kinase A,NME1,,
DB03492,"lambda-bis(2,2'-bipyridine)imidazole osmium (II)",,P00282,Azurin,azu,,
DB03493,7-Methylguanosine,,P07617,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,PAPS,,
DB03495,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",,P04746,Pancreatic alpha-amylase,AMY2A,,
DB03496,Alvocidib,,P11216,"Glycogen phosphorylase, brain form",PYGB,,
DB03496,Alvocidib,,,"Glycogen phosphorylase, liver form",,,
DB03496,Alvocidib,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03496,Alvocidib,,P50613,Cyclin-dependent kinase 7,CDK7,,
DB03496,Alvocidib,,Q00535,Cyclin-dependent kinase 5,CDK5,,
DB03496,Alvocidib,,P50750,Cyclin-dependent kinase 9,CDK9,,
DB03496,Alvocidib,,P06493,Cyclin-dependent kinase 1,CDK1,,
DB03496,Alvocidib,,Q00534,Cyclin-dependent kinase 6,CDK6,,
DB03496,Alvocidib,,P00533,Epidermal growth factor receptor,EGFR,,
DB03496,Alvocidib,,P11802,Cyclin-dependent kinase 4,CDK4,,
DB03496,Alvocidib,,P49336,Cyclin-dependent kinase 8,CDK8,,
DB03496,Alvocidib,,P24941,Cyclin-dependent kinase 2,CDK2,inhibitor,
DB03498,Mercaptomethyl Phosphonate,,P00634,Alkaline phosphatase,phoA,,
DB03499,D-Malic acid,,P23368,"NAD-dependent malic enzyme, mitochondrial",ME2,,
DB03499,D-Malic acid,,O75390,"Citrate synthase, mitochondrial",CS,,
DB03499,D-Malic acid,,P74645,Circadian clock protein KaiB,kaiB,,
DB03499,D-Malic acid,,P05042,Fumarate hydratase class II,fumC,,
DB03499,D-Malic acid,,P9WK17,Malate synthase G,glcB,,
DB03499,D-Malic acid,,Q57265,Capsule biosynthesis protein,synC,,
DB03500,Tricosanoic acid,,P32947,Lipase 3,LIP3,,
DB03501,Galactose-uridine-5'-diphosphate,,P16442,Histo-blood group ABO system transferase,ABO,,
DB03501,Galactose-uridine-5'-diphosphate,,Q14376,UDP-glucose 4-epimerase,GALE,,
DB03501,Galactose-uridine-5'-diphosphate,,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,,
DB03501,Galactose-uridine-5'-diphosphate,,Q13304,Uracil nucleotide/cysteinyl leukotriene receptor,GPR17,regulator,
DB03502,(4s)-4-{[(2s)-2-Amino-3-Oxopropyl]Sulfanyl}-L-Homoserinate,,P44801,Aspartate-semialdehyde dehydrogenase,asd,,
DB03503,"4-Acetyl-4-guanidino-6-methyl(propyl)carboxamide-4,5-dihydro-2H-pyran-2-carboxylic acid",,P03472,Neuraminidase,,,
DB03504,"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB03505,"2,6-diaminoquinazolin-4-ol",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB03506,"5H-pyrrolo[3,2-d]pyrimidin-4-amine",,P07741,Adenine phosphoribosyltransferase,APRT,,
DB03507,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",,P19438,Tumor necrosis factor receptor superfamily member 1A,TNFRSF1A,,
DB03509,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB03510,6-O-Phosphoryl Inosine Monophosphate,,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,,
DB03510,6-O-Phosphoryl Inosine Monophosphate,,Q9U8D3,Adenylosuccinate synthetase,Adss,,
DB03512,"Uridine-2',3'-vanadate",,P07998,Ribonuclease pancreatic,RNASE1,,
DB03515,Equilenin,,P07445,Steroid Delta-isomerase,ksi,,
DB03515,Equilenin,,P00947,Steroid Delta-isomerase,ksi,,
DB03516,Eniluracil,,Q06278,Aldehyde oxidase,AOX1,,
DB03516,Eniluracil,,P47989,Xanthine dehydrogenase/oxidase,XDH,inhibitor,
DB03516,Eniluracil,,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,,
DB03517,[Methylthio]Acetate,,P40859,Monomeric sarcosine oxidase,soxA,,
DB03518,Mevalonic acid,,P13702,3-hydroxy-3-methylglutaryl-coenzyme A reductase,mvaA,,
DB03522,Aspartic Acid-4-Carboxymethyl Ester,,Q60099,(S)-2-haloacid dehalogenase,dhlB,,
DB03523,Brequinar,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB03524,"N-[3-[4-(3-aminopropyl)piperazin-1-yl]propyl]-3-[(2-thiophen-2-ylacetyl)amino]-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzamide",,P01556,Cholera enterotoxin subunit B,ctxB,,
DB03525,RU79073,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03526,AL5927,,P00918,Carbonic anhydrase 2,CA2,,
DB03528,9-Beta-D-Xylofuranosyl-Adenine,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB03530,Acylated ceftazidime,,P00811,Beta-lactamase,ampC,,
DB03530,Acylated ceftazidime,,P18357,Regulatory protein BlaR1,blaR1,,
DB03531,Flavin-adenine dinucleotide-N5-isobutyl ketone,,P14920,D-amino-acid oxidase,DAO,,
DB03532,Phosphomethylphosphonic acid guanylate ester,,O08398,Cell division protein FtsZ,ftsZ,,
DB03533,Acetyleneurea,,P22629,Streptavidin,,,
DB03534,3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,,P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,
DB03535,Z-Pro-Prolinal,,P48147,Prolyl endopeptidase,PREP,,
DB03535,Z-Pro-Prolinal,,Q9X6R4,Prolyl endopeptidase,,,
DB03536,Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate,,Q9UBX1,Cathepsin F,CTSF,,
DB03536,Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate,,P25779,Cruzipain,,,
DB03539,2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose,,Q13231,Chitotriosidase-1,CHIT1,,
DB03540,Norcamphor,,P00183,Camphor 5-monooxygenase,camC,,
DB03541,"10-Propargyl-5,8-Dideazafolic Acid",,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,
DB03541,"10-Propargyl-5,8-Dideazafolic Acid",,P04818,Thymidylate synthase,TYMS,,
DB03541,"10-Propargyl-5,8-Dideazafolic Acid",,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 2,DHRS4L1,,
DB03541,"10-Propargyl-5,8-Dideazafolic Acid",,P00469,Thymidylate synthase,thyA,,
DB03541,"10-Propargyl-5,8-Dideazafolic Acid",,P0A884,Thymidylate synthase,thyA,,
DB03541,"10-Propargyl-5,8-Dideazafolic Acid",,P13100,Thymidylate synthase,THYA,,
DB03542,L-Myo-Inositol-1-Phosphate,,P29218,Inositol monophosphatase 1,IMPA1,,
DB03543,1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate,,Q56320,N-(5'-phosphoribosyl)anthranilate isomerase,trpF,,
DB03543,1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate,,P00909,Tryptophan biosynthesis protein TrpCF,trpC,,
DB03544,S-Phosphocysteine,,P69795,"N,N'-diacetylchitobiose-specific phosphotransferase enzyme IIB component",chbB,,
DB03544,S-Phosphocysteine,,P0AF93,Enamine/imine deaminase,ridA,,
DB03546,"N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid",,P22102,Trifunctional purine biosynthetic protein adenosine-3,GART,,
DB03548,3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid,,P06971,Ferrichrome-iron receptor,fhuA,,
DB03549,Biotinyl P-Nitroaniline,,P22629,Streptavidin,,,
DB03551,"(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium",,P00491,Purine nucleoside phosphorylase,PNP,,
DB03551,"(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium",,P9WP01,Purine nucleoside phosphorylase,punA,,
DB03552,3-Tyrosine,,P07101,Tyrosine 3-monooxygenase,TH,,
DB03553,Glutaric Acid,,P00509,Aspartate aminotransferase,aspC,,
DB03553,Glutaric Acid,,P0AB80,Branched-chain-amino-acid aminotransferase,ilvE,,
DB03553,Glutaric Acid,,P69908,Glutamate decarboxylase alpha,gadA,,
DB03554,5-Iodouracil,,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,,
DB03555,CRA_11092,,P07477,Trypsin-1,PRSS1,,
DB03556,"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",,P16152,Carbonyl reductase [NADPH] 1,CBR1,,
DB03556,"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",,Q9KL51,DevB protein,,,
DB03557,4-[[(2S)-1-[[6-[(1-Amino-1-oxo-3-sulfanylpropan-2-yl)amino]-6-oxohexyl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[[2-[4-[difluoro(phosphono)methyl]phenyl]acetyl]amino]-4-oxobutanoic acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB03558,SP-876,,P0A884,Thymidylate synthase,thyA,,
DB03559,Cyclohexylformamide,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB03559,Cyclohexylformamide,,P08319,Alcohol dehydrogenase 4,ADH4,,
DB03562,Tetrahydrodeoxyuridine,,P19079,Cytidine deaminase,cdd,,
DB03564,"(4r)-2-Methylpentane-2,4-Diol",,P24300,Xylose isomerase,xylA,,
DB03564,"(4r)-2-Methylpentane-2,4-Diol",,P83849,1-pyrroline-5-carboxylate dehydrogenase,,,
DB03565,1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine,,P04054,Phospholipase A2,PLA2G1B,,
DB03566,Spermidine,,P08588,Beta-1 adrenergic receptor,ADRB1,,
DB03566,Spermidine,,P07550,Beta-2 adrenergic receptor,ADRB2,,
DB03566,Spermidine,,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,,
DB03566,Spermidine,,P23181,Gentamicin 3'-acetyltransferase,aacC1,,
DB03566,Spermidine,,P0AFK9,Spermidine/putrescine-binding periplasmic protein,potD,,
DB03568,Butyric Acid,,Q53464,(S)-2-haloacid dehalogenase,,,
DB03568,Butyric Acid,,P06276,Cholinesterase,BCHE,,
DB03568,Butyric Acid,,P96965,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",cumD,,
DB03569,"4,5-Dehydro-L-Iduronic Acid",,Q59288,Chondroitinase-AC,cslA,,
DB03570,Tris-Hydroxymethyl-Methyl-Ammonium,,P00282,Azurin,azu,,
DB03570,Tris-Hydroxymethyl-Methyl-Ammonium,,P25053,Regulatory protein TenI,tenI,,
DB03570,Tris-Hydroxymethyl-Methyl-Ammonium,,Q5SHF5,Pantothenate synthetase,panC,,
DB03571,"3-(5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(3,5-dichlorobenzyl)-benzamide",,P56740,Dihydroneopterin aldolase,folB,,
DB03572,FR230513,,P00813,Adenosine deaminase,ADA,,
DB03573,WRR-99,,Q9UBX1,Cathepsin F,CTSF,,
DB03573,WRR-99,,P25779,Cruzipain,,,
DB03574,Ferricrocin-iron,,P06971,Ferrichrome-iron receptor,fhuA,,
DB03575,Phencyclidine,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,antagonist,
DB03575,Phencyclidine,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,,
DB03576,N-Pyridoxyl-Threonine-5-Monophosphate,,Q9X266,L-allo-threonine aldolase,,,
DB03577,Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,,P15309,Prostatic acid phosphatase,ACPP,,
DB03581,Glucose-6-Phosphate,,P17169,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],glmS,,
DB03581,Glucose-6-Phosphate,,P06744,Glucose-6-phosphate isomerase,GPI,,
DB03582,N~2~-Succinylornithine,,P76216,N-succinylarginine dihydrolase,astB,,
DB03583,"(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB03584,4-Thio-beta-D-glucopyranose,,P37700,Endoglucanase G,celCCG,,
DB03584,4-Thio-beta-D-glucopyranose,,O85465,Endoglucanase 5A,cel5A,,
DB03584,4-Thio-beta-D-glucopyranose,,P37698,Endoglucanase F,celCCF,,
DB03584,4-Thio-beta-D-glucopyranose,,Q79G13,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",celA1,,
DB03585,Oxyphenbutazone,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,M01AA03;M02AA04;S01BC02
DB03586,"(3R,4R,5S,6R)-6-Fluoro-3,4,5-trihydroxytetrahydro-2H-pyran-2-olate",,P31434,Alpha-xylosidase,yicI,,
DB03587,Pyruvaldehyde,,P04054,Phospholipase A2,PLA2G1B,,
DB03588,Diphenylacetic acid,,P07858,Cathepsin B,CTSB,,
DB03589,Mesoxalic acid,,P23368,"NAD-dependent malic enzyme, mitochondrial",ME2,,
DB03590,"2,6-Diaminopimelic Acid",,P22188,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",murE,,
DB03590,"2,6-Diaminopimelic Acid",,P04964,Meso-diaminopimelate D-dehydrogenase,ddh,,
DB03591,RU82209,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03592,Pterin-6-Yl-Methyl-Monophosphate,,P9WND1,Dihydropteroate synthase 1,folP1,,
DB03592,Pterin-6-Yl-Methyl-Monophosphate,,Q81VW8,Dihydropteroate synthase,folP,,
DB03593,7-methyl-5'-guanylic acid,,Q96C86,m7GpppX diphosphatase,DCPS,,
DB03594,"1,2,4-Triazole",,P00918,Carbonic anhydrase 2,CA2,,
DB03595,CRA_9785,,P07477,Trypsin-1,PRSS1,,
DB03596,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,,P00918,Carbonic anhydrase 2,CA2,,
DB03597,gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,,
DB03597,gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine,,Q03013,Glutathione S-transferase Mu 4,GSTM4,,
DB03597,gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine,,O76083,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",PDE9A,,
DB03598,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",,P00918,Carbonic anhydrase 2,CA2,,
DB03600,Capric acid,,P09958,Furin,FURIN,,
DB03600,Capric acid,,Q51911,Peptostreptococcal albumin-binding protein,pab,,
DB03600,Capric acid,,Q9NZD2,Glycolipid transfer protein,GLTP,,
DB03600,Capric acid,,P9WK83,Octanoyltransferase,lipB,,
DB03600,Capric acid,,Q6ZZJ1,Putative uncharacterized protein tcp14,tcp14,,
DB03600,Capric acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,ligand,
DB03600,Capric acid,,P0A953,3-oxoacyl-[acyl-carrier-protein] synthase 1,fabB,,
DB03602,S-benzylglutathione,,Q04760,Lactoylglutathione lyase,GLO1,,
DB03602,S-benzylglutathione,,P08263,Glutathione S-transferase A1,GSTA1,,
DB03603,Glucaric acid,,P0AES2,Glucarate dehydratase,gudD,,
DB03604,Tiratricol,,P10828,Thyroid hormone receptor beta,THRB,,H03AA04;D11AX08
DB03605,"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",,P26663,Genome polyprotein,,,
DB03606,(S)-Rolipram,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,
DB03606,(S)-Rolipram,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB03607,[(1R)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron,,P00780,Subtilisin Carlsberg,apr,,
DB03608,Diminazene,,P0A0N4,HTH-type transcriptional regulator QacR,qacR,,
DB03608,Diminazene,,P07477,Trypsin-1,PRSS1,,
DB03608,Diminazene,,P19801,Amiloride-sensitive amine oxidase [copper-containing],AOC1,,
DB03608,Diminazene,,P30044,"Peroxiredoxin-5, mitochondrial",PRDX5,,
DB03609,3'-deoxyguanosine,,P00491,Purine nucleoside phosphorylase,PNP,,
DB03611,L-2-amino-4-methoxy-cis-but-3-enoic acid,,Q00266,S-adenosylmethionine synthase isoform type-1,MAT1A,,
DB03612,3-Hydroxybutyryl-Coenzyme A,,Q16836,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,,
DB03613,4-hydroxyphenacyl coenzyme A,,Q04416,4-hydroxybenzoyl-CoA thioesterase,fcbC,,
DB03613,4-hydroxyphenacyl coenzyme A,,P56653,4-hydroxybenzoyl-CoA thioesterase,,,
DB03614,Mecobalamin,,Q99707,Methionine synthase,MTR,cofactor,B03BA05
DB03615,Ribostamycin,,P07237,Protein disulfide-isomerase,P4HB,,J01GB10
DB03615,Ribostamycin,,P0A7S3,30S ribosomal protein S12,rpsL,,J01GB10
DB03615,Ribostamycin,,Q9R381,Aminoglycoside N(6')-acetyltransferase type 1,,,J01GB10
DB03615,Ribostamycin,,P9WQG9,Aminoglycoside 2'-N-acetyltransferase,aac,,J01GB10
DB03616,Kabiramide C,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB03619,Deoxycholic acid,,P07445,Steroid Delta-isomerase,ksi,,D11AX24
DB03619,Deoxycholic acid,,Q8GGK7,PpcA,ppcA,,D11AX24
DB03619,Deoxycholic acid,,Q7Z2Z2,Elongation factor Tu GTP-binding domain-containing protein 1,EFTUD1,,D11AX24
DB03619,Deoxycholic acid,,P54965,Choloylglycine hydrolase,cbh,,D11AX24
DB03619,Deoxycholic acid,,P25553,Lactaldehyde dehydrogenase,aldA,,D11AX24
DB03619,Deoxycholic acid,,P31224,Acriflavine resistance protein B,acrB,,D11AX24
DB03619,Deoxycholic acid,,P33517,Cytochrome c oxidase subunit 1,ctaD,,D11AX24
DB03619,Deoxycholic acid,,Q03736,Cytochrome c oxidase subunit 2,ctaC,,D11AX24
DB03619,Deoxycholic acid,,Q96RI1,Bile acid receptor,NR1H4,,D11AX24
DB03619,Deoxycholic acid,,P09211,Glutathione S-transferase P,GSTP1,,D11AX24
DB03619,Deoxycholic acid,,Q8TDU6,G-protein coupled bile acid receptor 1,GPBAR1,,D11AX24
DB03619,Deoxycholic acid,,P08263,Glutathione S-transferases (Cytosolic),GSTA1,inhibitor,D11AX24
DB03621,"L-709,587",,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB03622,"5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione",,P22894,Neutrophil collagenase,MMP8,,
DB03623,"9-(4-Hydroxyphenyl)-2,7-Phenanthroline",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB03624,7-(Carboxyamino)-8-Amino-Nonanoic Acid,,P13000,ATP-dependent dethiobiotin synthetase BioD 1,bioD1,,
DB03626,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,,
DB03627,Adamantane,,P00183,Camphor 5-monooxygenase,camC,,
DB03628,ISO24,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03629,Pyridoxal-5'-Phosphate-N-Oxide,,P00509,Aspartate aminotransferase,aspC,,
DB03631,"3-(4-hydroxy-3-imino-6-oxo-cyclohexa-1,4-dienyl)-alanine",,P46883,Primary amine oxidase,tynA,,
DB03632,Argifin,,Q13231,Chitotriosidase-1,CHIT1,,
DB03632,Argifin,,Q873X9,Chitinase,chiB1,,
DB03633,Lpc-Ether,,P17900,Ganglioside GM2 activator,GM2A,,
DB03633,Lpc-Ether,,P04054,Phospholipase A2,PLA2G1B,,
DB03635,Ethanesulfonic acid,,P02775,Platelet basic protein,PPBP,,
DB03635,Ethanesulfonic acid,,O31156,Phosphonoacetaldehyde hydrolase,phnX,,
DB03636,Glycinamide,,P22894,Neutrophil collagenase,MMP8,,
DB03637,Guanidine-3-propanol,,P35030,Trypsin-3,PRSS3,,
DB03639,1-Guanidinium-7-Aminoheptane,,P49366,Deoxyhypusine synthase,DHPS,inhibitor,
DB03640,Beta-Hydroxyaspartic Acid,,P62594,Beta-lactamase TEM,bla,,
DB03641,"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",,Q0P8G4,DUTPase,dut,,
DB03642,N-[(2S)-4-Methyl-1-oxo-1-{[(4S)-3-oxo-1-(2-pyridinylsulfonyl)-4-azepanyl]amino}-2-pentanyl]-1-benzofuran-2-carboxamide,,P43235,Cathepsin K,CTSK,,
DB03643,CRA_1144,,P07477,Trypsin-1,PRSS1,,
DB03643,CRA_1144,,P05981,Serine protease hepsin,HPN,,
DB03644,3-hydroxyanthranilic acid,,Q51792,"Trans-2,3-dihydro-3-hydroxyanthranilate isomerase",phzF,,
DB03645,Phosphonoacetohydroxamic Acid,,P13929,Beta-enolase,ENO3,,
DB03647,3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,,P26660,Genome polyprotein,,,
DB03648,"(2S,2'S)-2,2'-(1,2-Hydrazinediylbis{methylene[(2S)-1-oxo-2,1-hexanediyl]imino})bis(6-amino-N-phenylhexanamide)",,Q8I372,"Formylmethionine deformylase, putative",,,
DB03649,"[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate",,P45568,1-deoxy-D-xylulose 5-phosphate reductoisomerase,dxr,,
DB03650,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB03651,Picric acid,,P71278,Pentaerythritol tetranitrate reductase,onr,,
DB03652,beta-D-Galactopyranuronic acid,,Q9KWT6,AlgQ1,algQ1,,
DB03652,beta-D-Galactopyranuronic acid,,Q9KWT5,AlgQ2,algQ2,,
DB03654,"S,S-Propylthiocysteine",,P00644,Thermonuclease,nuc,,
DB03654,"S,S-Propylthiocysteine",,P22262,Listeriolysin regulatory protein,prfA,,
DB03657,1-deoxy-1-methoxycarbamido-beta-D-glucopyranose,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03658,"(2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid",,P00811,Beta-lactamase,ampC,,
DB03659,Butylamine,,P0DJ06,Candidapepsin-2,SAP2,,
DB03660,4-Iodo-L-phenylalanine,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB03660,4-Iodo-L-phenylalanine,,P80561,Aminopeptidase S,,,
DB03660,4-Iodo-L-phenylalanine,,P00720,Lysozyme,E,,
DB03660,4-Iodo-L-phenylalanine,,P42790,Pseudomonalisin,pcp,,
DB03661,L-cysteic acid,,P0A6R0,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB03661,L-cysteic acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB03661,L-cysteic acid,,P12256,Penicillin acylase,,,
DB03661,L-cysteic acid,,O34667,S-ribosylhomocysteine lyase,luxS,,
DB03661,L-cysteic acid,,P04531,Deoxynucleotide monophosphate kinase,1,,
DB03661,L-cysteic acid,,P30305,M-phase inducer phosphatase 2,CDC25B,,
DB03661,L-cysteic acid,,Q9K2N0,Beta-lactamase class B VIM-2,blaVIM-2,,
DB03661,L-cysteic acid,,Q9X0G9,Ribose 5-phosphate isomerase B,,,
DB03661,L-cysteic acid,,P07711,Cathepsin L1,CTSL,,
DB03661,L-cysteic acid,,Q05514,Methylaspartate ammonia-lyase,,,
DB03661,L-cysteic acid,,Q5MYR6,1-cys peroxiredoxin,prx,,
DB03661,L-cysteic acid,,P43522,Peptide deformylase,def,,
DB03661,L-cysteic acid,,Q9H4G4,Golgi-associated plant pathogenesis-related protein 1,GLIPR2,,
DB03661,L-cysteic acid,,Q9X0P2,Glutamine amidotransferase class-I,,,
DB03661,L-cysteic acid,,P96113,Peptide deformylase,def,,
DB03662,Vitamin B6 Complexed with 2-Amino-Pentanoic Acid,,P00509,Aspartate aminotransferase,aspC,,
DB03663,"1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB03664,P1-(adenosine-5'-P5-(uridine-5')pentaphosphate,,P30085,UMP-CMP kinase,CMPK1,,
DB03666,Zidovudine monophosphate,,P23919,Thymidylate kinase,DTYMK,,
DB03666,Zidovudine monophosphate,,P9WKE1,Thymidylate kinase,tmk,,
DB03667,Acetic Acid Salicyloyl-Amino-Ester,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB03668,6-oxouridine 5'-phosphate,,P08244,Orotidine 5'-phosphate decarboxylase,pyrF,,
DB03669,4-Fluorophenethyl Alcohol,,P00720,Lysozyme,E,,
DB03670,"2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB03672,9-N-Phenylmethylamino-Tacrine,,P06276,Cholinesterase,BCHE,,
DB03673,beta-2-Thienyl-L-alanine,,P00439,Phenylalanine-4-hydroxylase,PAH,,
DB03676,Cystein-S-Yl Cacodylate,,P12497,Gag-Pol polyprotein,gag-pol,,
DB03676,Cystein-S-Yl Cacodylate,,Q47NK3,"Proteinase inhibitor I4, serpin",,,
DB03677,N-Cyclohexyl-N'-Decylurea,,P34913,Bifunctional epoxide hydrolase 2,EPHX2,,
DB03679,2-Hydroxy-Tryptophan,,Q46444,Quinohemoprotein ethanol dehydrogenase type-1,qheDH,,
DB03680,Tartronate,,P23368,"NAD-dependent malic enzyme, mitochondrial",ME2,,
DB03680,Tartronate,,Q16798,"NADP-dependent malic enzyme, mitochondrial",ME3,,
DB03683,2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid,,P14780,Matrix metalloproteinase-9,MMP9,,
DB03685,Uridine monophosphate,,Q9NWZ5,Uridine-cytidine kinase-like 1,UCKL1,,
DB03685,Uridine monophosphate,,P09148,Galactose-1-phosphate uridylyltransferase,galT,,
DB03685,Uridine monophosphate,,P00469,Thymidylate synthase,thyA,,
DB03685,Uridine monophosphate,,Q7Z4J2,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,,
DB03685,Uridine monophosphate,,P62312,U6 snRNA-associated Sm-like protein LSm6,LSM6,,
DB03685,Uridine monophosphate,,Q9WZI0,Uracil phosphoribosyltransferase,upp,,
DB03685,Uridine monophosphate,,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,,
DB03685,Uridine monophosphate,,Q96AZ6,Interferon-stimulated gene 20 kDa protein,ISG20,,
DB03685,Uridine monophosphate,,P25971,Orotidine 5'-phosphate decarboxylase,pyrF,,
DB03685,Uridine monophosphate,,P41007,Bifunctional protein PyrR,pyrR,,
DB03685,Uridine monophosphate,,Q5KUI3,Uracil phosphoribosyltransferase,upp,,
DB03685,Uridine monophosphate,,P77398,Bifunctional polymyxin resistance protein ArnA,arnA,,
DB03685,Uridine monophosphate,,P0AA43,Ribosomal small subunit pseudouridine synthase A,rsuA,,
DB03686,S-(4-nitrobenzyl)glutathione,,P09211,Glutathione S-transferase P,GSTP1,,
DB03687,4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol,,P62619,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB03687,4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol,,Q83LD8,4-diphosphocytidyl-2-C-methyl-D-erythritol kinase,ispE,,
DB03687,4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol,,Q46893,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,ispD,,
DB03688,Hydracrylic acid,,P13001,Pimelyl-[acyl-carrier protein] methyl ester esterase,bioH,,
DB03690,"(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide",,Q00169,Phosphatidylinositol transfer protein alpha isoform,PITPNA,,
DB03691,WRR-112,,Q9UBX1,Cathepsin F,CTSF,,
DB03691,WRR-112,,P25779,Cruzipain,,,
DB03692,1-Hexadecanosulfonyl-O-L-Serine,,P0A921,Phospholipase A1,pldA,,
DB03693,N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide,,P78368,Casein kinase I isoform gamma-2,CSNK1G2,,
DB03695,Piritrexim,,P00374,Dihydrofolate reductase,DHFR,,
DB03696,Lanosterol,,P48449,Lanosterol synthase,LSS,,
DB03697,4-Sulfonamide-[1-(4-Aminobutane)]Benzamide,,P00918,Carbonic anhydrase 2,CA2,,
DB03698,5-Mercaptoethanol-2-decenoyl-coenzyme A,,P42593,"2,4-dienoyl-CoA reductase [NADPH]",fadH,,
DB03699,Succinyl-Coenzyme A,,P56220,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",dapD,,
DB03700,D-Threonine,,P43133,Thermolysin,nprS,,
DB03701,Vanoxerine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,antagonist,
DB03701,Vanoxerine,,Q12809,HERG human cardiac K+ channel,KCNH2,blocker,
DB03702,"N-{4-[(Carboxymethyl)carbamoyl]benzoyl}-L-valyl-N-[(3S)-1,1,1-trifluoro-4-methyl-2-oxo-3-pentanyl]-L-prolinamide",,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB03703,Cyclohexanol,,P00325,Alcohol dehydrogenase 1B,ADH1B,,
DB03704,12-Hydroxydodecanoic Acid,,P11766,Alcohol dehydrogenase class-3,ADH5,,
DB03705,6-Methylamino-5-Nitroisocytosine,,Q81VW8,Dihydropteroate synthase,folP,,
DB03706,1-Hydroxy-2-S-glutathionyl-3-para-nitrophenoxy-propane,,Q03013,Glutathione S-transferase Mu 4,GSTM4,,
DB03707,S-Ethyl-N-Phenyl-Isothiourea,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB03707,S-Ethyl-N-Phenyl-Isothiourea,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB03708,Adenosine 5'-phosphosulfate,,O43252,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,PAPSS1,,
DB03708,Adenosine 5'-phosphosulfate,,Q5SKH7,ATP sulfurylase (Sulfate adenylyltransferase),,,
DB03709,Bicine,,P00747,Plasminogen,PLG,,
DB03709,Bicine,,P41052,Membrane-bound lytic murein transglycosylase B,mltB,,
DB03709,Bicine,,P9WIQ1,UDP-galactopyranose mutase,glf,,
DB03710,[(1S)-4-(1-Aminobutylideneamino)-1-carboxybutyl]azanium,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB03711,6-Hydroxy-6-Methyl-Heptan-3-One,,Q8WX39,Epididymal-specific lipocalin-9,LCN9,,
DB03712,RU85053,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03714,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB03716,5'-Fluoro-5'-Deoxyadenosine,,Q70GK9,5'-fluoro-5'-deoxy-adenosine synthase,flA,,
DB03717,"3-Hydroxy-4-(3,4,5-trihydroxy-tetrahydro-pyran-2-yloxy)-piperidin-2-one",,P07986,Exoglucanase/xylanase,cex,,
DB03719,N-Ethyl-5'-Carboxamido Adenosine,,P14625,Endoplasmin,HSP90B1,,
DB03721,N-acetyl-alpha-neuraminic acid,,P42216,3-deoxy-manno-octulosonate cytidylyltransferase,kpsU,,
DB03721,N-acetyl-alpha-neuraminic acid,,P04958,Tetanus toxin,tetX,,
DB03721,N-acetyl-alpha-neuraminic acid,,P01556,Cholera enterotoxin subunit B,ctxB,,
DB03721,N-acetyl-alpha-neuraminic acid,,P10844,Botulinum neurotoxin type B,botB,,
DB03721,N-acetyl-alpha-neuraminic acid,,P16109,P-selectin,SELP,,
DB03721,N-acetyl-alpha-neuraminic acid,,P11226,Mannose-binding protein C,MBL2,,
DB03721,N-acetyl-alpha-neuraminic acid,,P16581,E-selectin,SELE,,
DB03721,N-acetyl-alpha-neuraminic acid,,P05451,Lithostathine-1-alpha,REG1A,,
DB03721,N-acetyl-alpha-neuraminic acid,,Q04830,Endo-N-acetylneuraminidase,,,
DB03721,N-acetyl-alpha-neuraminic acid,,P01552,Enterotoxin type B,entB,,
DB03721,N-acetyl-alpha-neuraminic acid,,P03472,Neuraminidase,,,
DB03721,N-acetyl-alpha-neuraminic acid,,P32884,Hemagglutinin-neuraminidase,HN,,
DB03721,N-acetyl-alpha-neuraminic acid,,Q64822,Fiber,L5,,
DB03721,N-acetyl-alpha-neuraminic acid,,Q9BZZ2,Sialoadhesin,SIGLEC1,,
DB03721,N-acetyl-alpha-neuraminic acid,,P25311,Zinc-alpha-2-glycoprotein,AZGP1,,
DB03721,N-acetyl-alpha-neuraminic acid,,P49302,Capsid protein VP1,,,
DB03721,N-acetyl-alpha-neuraminic acid,,Q64823,Fiber,L5,,
DB03721,N-acetyl-alpha-neuraminic acid,,P23141,Liver carboxylesterase 1,CES1,,
DB03722,"3,4-Dihydro-5-Methyl-Isoquinolinone",,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB03723,2'-Deoxy-thymidine-beta-L-rhamnose,,P26392,dTDP-4-dehydrorhamnose reductase,rfbD,,
DB03723,2'-Deoxy-thymidine-beta-L-rhamnose,,Q9HU22,Glucose-1-phosphate thymidylyltransferase,rmlA,,
DB03725,5'-Guanylylmethylenebisphosphonate,,P35558,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,,
DB03726,Purine Riboside-5'-Monophosphate,,P07998,Ribonuclease pancreatic,RNASE1,,
DB03727,Coproporphyrin I,,P06132,Uroporphyrinogen decarboxylase,UROD,,
DB03728,p-Chlorobenzoic acid,,Q8GN86,4-chlorobenzoyl CoA ligase,,,
DB03729,2-Amino-1H-benzimidazol-5-ol,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB03730,"3,9-Dimethyladenine",,O25323,Endonuclease III,,,
DB03731,S-2-(Boronoethyl)-L-Cysteine,,P05089,Arginase-1,ARG1,,
DB03731,S-2-(Boronoethyl)-L-Cysteine,,P78540,"Arginase-2, mitochondrial",ARG2,,
DB03732,Etheno-Nadp,,Q10588,ADP-ribosyl cyclase 2,BST1,,
DB03733,Ethylene Dichloride,,P51698,Haloalkane dehalogenase,linB,,
DB03734,Xylarohydroxamate,,P0AES2,Glucarate dehydratase,gudD,,
DB03735,9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB03736,2-Cyclopropylmethylenepropanal,,P00797,Renin,REN,,
DB03737,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB03738,Pantothenoylaminoethenethiol,,Q96CD2,Phosphopantothenoylcysteine decarboxylase,PPCDC,,
DB03739,3-Hydroxyimino Quinic Acid,,P9WPX7,3-dehydroquinate dehydratase,aroQ,,
DB03740,N-acetyl-alpha-D-glucosamine,,P12821,Angiotensin-converting enzyme,ACE,,
DB03740,N-acetyl-alpha-D-glucosamine,,P22303,Acetylcholinesterase,ACHE,,
DB03740,N-acetyl-alpha-D-glucosamine,,P04062,Glucosylceramidase,GBA,,
DB03740,N-acetyl-alpha-D-glucosamine,,O34928,Probable polysaccharide deacetylase PdaA,pdaA,,
DB03740,N-acetyl-alpha-D-glucosamine,,Q9Y286,Sialic acid-binding Ig-like lectin 7,SIGLEC7,,
DB03740,N-acetyl-alpha-D-glucosamine,,P32884,Hemagglutinin-neuraminidase,HN,,
DB03740,N-acetyl-alpha-D-glucosamine,,Q9HYN5,Fucose-binding lectin PA-IIL,lecB,,
DB03740,N-acetyl-alpha-D-glucosamine,,P05884,Envelope glycoprotein gp160,env,,
DB03740,N-acetyl-alpha-D-glucosamine,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB03741,2-Methylbutanoic Acid,,P96965,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",cumD,,
DB03742,Compound 4-D,,P03372,Estrogen receptor alpha,ESR1,,
DB03744,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",,,"Glycogen phosphorylase, liver form",,,
DB03745,Arabinose-5-phosphate,,O66496,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB03745,Arabinose-5-phosphate,,Q5SIR5,Ribose-5-phosphate isomerase A,rpiA,,
DB03746,"3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate",,P24670,3-dehydroquinate dehydratase,aroD,,
DB03747,N-Acetyl-glucosamine thiazoline,,P07686,Beta-hexosaminidase subunit beta,HEXB,,
DB03747,N-Acetyl-glucosamine thiazoline,,O85361,B-N-acetylhexosaminidase,hex,,
DB03748,Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester,,P33247,Squalene--hopene cyclase,shc,,
DB03749,"4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB03750,Isovaleric Acid,,P00509,Aspartate aminotransferase,aspC,,
DB03750,Isovaleric Acid,,P42790,Pseudomonalisin,pcp,,
DB03750,Isovaleric Acid,,P96965,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",cumD,,
DB03751,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,,P26391,"dTDP-glucose 4,6-dehydratase",rfbB,,
DB03751,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,,Q8GIQ0,"DTDP-4-dehydrorhamnose 3,5-epimerase",rmlC,,
DB03751,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,,P95780,"dTDP-glucose 4,6-dehydratase",rmlB,,
DB03751,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,,Q9HU22,Glucose-1-phosphate thymidylyltransferase,rmlA,,
DB03751,2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,,Q9ZGH3,"dTDP-glucose 4,6-dehydratase",desIV,,
DB03752,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB03753,Flurbiprofen Methyl Ester,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB03754,Tromethamine,,P05067,Amyloid beta A4 protein,APP,inhibitor,B05XX02;B05BB03
DB03755,"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",,P15925,Folylpolyglutamate synthase,fgs,,
DB03756,Doconexent,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,activator,
DB03756,Doconexent,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,activator,
DB03756,Doconexent,,P19793,Retinoic acid receptor RXR-alpha,RXRA,activator,
DB03756,Doconexent,,P28702,Retinoic acid receptor RXR-beta,RXRB,activator,
DB03756,Doconexent,,P48443,Retinoic acid receptor RXR-gamma,RXRG,activator,
DB03756,Doconexent,,P36956,Sterol regulatory element-binding protein 1,SREBF1,inhibitor,
DB03756,Doconexent,,P01106,Myc proto-oncogene protein,MYC,inhibitor,
DB03757,N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-L-alanyl-L-alaninamide,,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB03758,Radicicol,,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB03758,Radicicol,,P14625,Endoplasmin,HSP90B1,,
DB03758,Radicicol,,P10515,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",DLAT,,
DB03758,Radicicol,,Q15120,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial",PDK3,,
DB03758,Radicicol,,P0DM80,Virulence sensor histidine kinase PhoQ,phoQ,,
DB03759,FG-9041,,P42262,Glutamate receptor 2,GRIA2,,
DB03760,Dihydrolipoic Acid,,P23434,"Glycine cleavage system H protein, mitochondrial",GCSH,,
DB03760,Dihydrolipoic Acid,,P10515,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",DLAT,,
DB03760,Dihydrolipoic Acid,,Q15120,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial",PDK3,,
DB03760,Dihydrolipoic Acid,,Q9WY54,Aminomethyltransferase,gcvT,,
DB03761,5-fluoro-2'-deoxyuridine-5'-monophosphate,,P0A884,Thymidylate synthase,thyA,,
DB03761,5-fluoro-2'-deoxyuridine-5'-monophosphate,,P00469,Thymidylate synthase,thyA,,
DB03761,5-fluoro-2'-deoxyuridine-5'-monophosphate,,Q9WYT0,Thymidylate synthase ThyX,thyX,,
DB03761,5-fluoro-2'-deoxyuridine-5'-monophosphate,,P0CI79,Thymidylate synthase 1,thyA1,,
DB03763,5-methyl-2'-deoxypseudouridine,,Q9R5V5,Nucleoside deoxyribosyltransferase,ntd,,
DB03765,2'-cytidylic acid,,P07998,Ribonuclease pancreatic,RNASE1,,
DB03766,Propanoic acid,,P10724,Alanine racemase,alr,,S01AX10
DB03766,Propanoic acid,,Q9NQX3,Gephyrin,GPHN,,S01AX10
DB03766,Propanoic acid,,P96965,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",cumD,,S01AX10
DB03767,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,,P25774,Cathepsin S,CTSS,,
DB03768,"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",,P03369,Gag-Pol polyprotein,gag-pol,,
DB03769,D-Eritadenine,,P23526,Adenosylhomocysteinase,AHCY,,
DB03771,Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,,P33247,Squalene--hopene cyclase,shc,,
DB03772,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol",,P16442,Histo-blood group ABO system transferase,ABO,,
DB03773,alpha-D-quinovopyranose,,P04746,Pancreatic alpha-amylase,AMY2A,,
DB03773,alpha-D-quinovopyranose,,P30920,Cyclomaltodextrin glucanotransferase,,,
DB03773,alpha-D-quinovopyranose,,P00692,Alpha-amylase,,,
DB03773,alpha-D-quinovopyranose,,Q9ZB17,Aldose 1-epimerase,galM,,
DB03773,alpha-D-quinovopyranose,,P26827,Cyclomaltodextrin glucanotransferase,amyA,,
DB03775,Dethiobiotin,,P9WPQ5,ATP-dependent dethiobiotin synthetase BioD,bioD,,
DB03775,Dethiobiotin,,P13000,ATP-dependent dethiobiotin synthetase BioD 1,bioD1,,
DB03775,Dethiobiotin,,P12996,Biotin synthase,bioB,,
DB03777,Bisindolylmaleimide I,,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB03777,Bisindolylmaleimide I,,P41743,Protein kinase C iota type,PRKCI,,
DB03777,Bisindolylmaleimide I,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB03779,Glucosaminyl-(Alpha-6)-D-Myo-Inositol,,P14262,1-phosphatidylinositol phosphodiesterase,,,
DB03780,2-Aminoquinazolin-4(3h)-One,,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB03781,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",,O00763,Acetyl-CoA carboxylase 2,ACACB,,
DB03782,N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB03783,Phenacetin,,P23219,Prostaglandin G/H synthase 1,PTGS1,,N02BE73;N02BE03;N02BE53
DB03784,Elaidamide,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB03785,Mevinolinic acid,,P13702,3-hydroxy-3-methylglutaryl-coenzyme A reductase,mvaA,,
DB03787,"(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate",,P16932,"2,2-dialkylglycine decarboxylase",dgdA,,
DB03788,GC-24,,P10828,Thyroid hormone receptor beta,THRB,,
DB03790,L-methionine sulfone,,P42321,Catalase,katA,,
DB03791,GW-3965,,P55055,Oxysterols receptor LXR-beta,NR1H2,,
DB03792,5-Aminouracil,,P07998,Ribonuclease pancreatic,RNASE1,,
DB03793,Benzoic acid,,P46059,Solute carrier family 15 member 1,SLC15A1,,A16AX30;A16AX11;V04CG30
DB03793,Benzoic acid,,Q9L9D7,Cocaine esterase,cocE,product of,A16AX30;A16AX11;V04CG30
DB03793,Benzoic acid,,P14920,D-amino-acid oxidase,DAO,,A16AX30;A16AX11;V04CG30
DB03793,Benzoic acid,,O67987,"Chlorocatechol 1,2-dioxygenase",clcA,substrate,A16AX30;A16AX11;V04CG30
DB03793,Benzoic acid,,P96965,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",cumD,,A16AX30;A16AX11;V04CG30
DB03793,Benzoic acid,,O31168,Non-heme chloroperoxidase,cpo,,A16AX30;A16AX11;V04CG30
DB03793,Benzoic acid,,Q01234,Oxygen-insensitive NAD(P)H nitroreductase,nfsB,,A16AX30;A16AX11;V04CG30
DB03793,Benzoic acid,,Q5PXQ6,"Hydroxyquinol 1,2-dioxygenase",chqB,,A16AX30;A16AX11;V04CG30
DB03793,Benzoic acid,,Q52546,Replication protein,repA,,A16AX30;A16AX11;V04CG30
DB03795,2-Dehydropantoate,,P31057,3-methyl-2-oxobutanoate hydroxymethyltransferase,panB,,
DB03796,Palmitic Acid,,P00709,Alpha-lactalbumin,LALBA,,
DB03796,Palmitic Acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB03796,Palmitic Acid,,P08100,Rhodopsin,RHO,,
DB03796,Palmitic Acid,,P50897,Palmitoyl-protein thioesterase 1,PPT1,,
DB03796,Palmitic Acid,,P02689,Myelin P2 protein,PMP2,,
DB03796,Palmitic Acid,,P09466,Glycodelin,PAEP,,
DB03796,Palmitic Acid,,Q14541,Hepatocyte nuclear factor 4-gamma,HNF4G,,
DB03796,Palmitic Acid,,P83812,Lipid binding protein,,,
DB03796,Palmitic Acid,,P10632,Cytochrome P450 2C8,CYP2C8,,
DB03796,Palmitic Acid,,O43617,Trafficking protein particle complex subunit 3,TRAPPC3,,
DB03796,Palmitic Acid,,Q9X1H9,Fatty acid-binding protein TM_1468,,,
DB03798,2'-Deoxycytidine-5'-Monophosphate,,P00469,Thymidylate synthase,thyA,,
DB03798,2'-Deoxycytidine-5'-Monophosphate,,P08773,Deoxycytidylate 5-hydroxymethyltransferase,42,,
DB03799,Trifluoromethionine,,P00959,Methionine--tRNA ligase,metG,,
DB03799,Trifluoromethionine,,P0AE18,Methionine aminopeptidase,map,,
DB03800,Deoxyuridine monophosphate,,P06968,Deoxyuridine 5'-triphosphate nucleotidohydrolase,dut,,
DB03800,Deoxyuridine monophosphate,,P00469,Thymidylate synthase,thyA,,
DB03800,Deoxyuridine monophosphate,,P0A884,Thymidylate synthase,thyA,,
DB03800,Deoxyuridine monophosphate,,P04818,Thymidylate synthase,TYMS,,
DB03800,Deoxyuridine monophosphate,,Q9WYT0,Thymidylate synthase ThyX,thyX,,
DB03800,Deoxyuridine monophosphate,,P16088,Pol polyprotein,pol,,
DB03800,Deoxyuridine monophosphate,,P9WNS5,Deoxyuridine 5'-triphosphate nucleotidohydrolase,dut,,
DB03800,Deoxyuridine monophosphate,,P13100,Thymidylate synthase,THYA,,
DB03801,Lysine Nz-Carboxylic Acid,,P14489,Beta-lactamase OXA-10,bla,,
DB03801,Lysine Nz-Carboxylic Acid,,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,murD,,
DB03801,Lysine Nz-Carboxylic Acid,,P10724,Alanine racemase,alr,,
DB03801,Lysine Nz-Carboxylic Acid,,P22188,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",murE,,
DB03801,Lysine Nz-Carboxylic Acid,,P0A433,Parathion hydrolase,opd,,
DB03801,Lysine Nz-Carboxylic Acid,,P15925,Folylpolyglutamate synthase,fgs,,
DB03801,Lysine Nz-Carboxylic Acid,,P05020,Dihydroorotase,pyrC,,
DB03801,Lysine Nz-Carboxylic Acid,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB03801,Lysine Nz-Carboxylic Acid,,Q8VTT5,D-hydantoinase,hyuA,,
DB03801,Lysine Nz-Carboxylic Acid,,P13661,Beta-lactamase OXA-1,bla,,
DB03801,Lysine Nz-Carboxylic Acid,,P81006,L-hydantoinase,lhyD,,
DB03801,Lysine Nz-Carboxylic Acid,,Q45515,D-hydantoinase,,,
DB03801,Lysine Nz-Carboxylic Acid,,Q70AC7,Methylmalonyl-CoA carboxyltransferase 5S subunit,,,
DB03801,Lysine Nz-Carboxylic Acid,,P39377,Isoaspartyl dipeptidase,iadA,,
DB03801,Lysine Nz-Carboxylic Acid,,P0A1V8,Beta-lactamase OXA-2,bla,,
DB03801,Lysine Nz-Carboxylic Acid,,Q9HTQ2,"Alanine racemase, catabolic",dadX,,
DB03801,Lysine Nz-Carboxylic Acid,,O25323,Endonuclease III,,,
DB03801,Lysine Nz-Carboxylic Acid,,Q7SIE9,Hydrolase,,,
DB03801,Lysine Nz-Carboxylic Acid,,Q9WYE2,"Alpha-L-fucosidase, putative",,,
DB03802,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",,P03372,Estrogen receptor alpha,ESR1,,
DB03803,"N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine]",,P03366,Gag-Pol polyprotein,gag-pol,,
DB03804,5-Bromothienyldeoxyuridine,,Q9QNF7,Thymidine kinase,TK,ligand,
DB03807,"1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,,
DB03808,Hexamidine,,P0A0N4,HTH-type transcriptional regulator QacR,qacR,,S03AA05;D08AC04;R02AA18;R01AX07;S01AX08
DB03808,Hexamidine,,P0A0N5,HTH-type transcriptional regulator QacR,qacR,,S03AA05;D08AC04;R02AA18;R01AX07;S01AX08
DB03809,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB03811,Histidinol,,P06988,Histidinol dehydrogenase,hisD,,
DB03811,Histidinol,,P60906,Histidine--tRNA ligase,hisS,,
DB03812,"3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate",,P9WHE9,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB03813,2-Decenoyl N-acetyl cysteamine,,P0A6Q3,3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase,fabA,,
DB03813,2-Decenoyl N-acetyl cysteamine,,P0A6Q5,3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase,fabA,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P22303,Acetylcholinesterase,ACHE,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P17169,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],glmS,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P22906,Dihydrofolate reductase,DFR1,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P25006,Copper-containing nitrite reductase,nirK,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P23946,Chymase,CMA1,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P09211,Glutathione S-transferase P,GSTP1,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,Q01770,Hydroxylamine reductase,hcp,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P00861,Diaminopimelate decarboxylase,lysA,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P31434,Alpha-xylosidase,yicI,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,Q9ZAG3,"Limonene-1,2-epoxide hydrolase",limA,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P49424,"Mannan endo-1,4-beta-mannosidase",manA,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P00521,Tyrosine-protein kinase transforming protein Abl,ABL,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P0ACC7,Bifunctional protein GlmU,glmU,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P0AEG6,Thiol:disulfide interchange protein DsbC,dsbC,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P0A9B2,Glyceraldehyde-3-phosphate dehydrogenase A,gapA,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P20932,(S)-mandelate dehydrogenase,mdlB,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,O68601,Dissimilatory copper-containing nitrite reductase,nir,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P0A6Y5,33 kDa chaperonin,hslO,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P76270,Free methionine-R-sulfoxide reductase,msrC,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,Q88H32,Ornithine cyclodeaminase,,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P09417,Dihydropteridine reductase,QDPR,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P04424,Argininosuccinate lyase,ASL,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P0A8D6,O-acetyl-ADP-ribose deacetylase,ymdB,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P36405,ADP-ribosylation factor-like protein 3,ARL3,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P52664,Beta-lactamase,blaB,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P45314,3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC,,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,Q9Y468,Lethal(3)malignant brain tumor-like protein 1,L3MBTL1,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P06276,Cholinesterase,BCHE,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P54548,Ribonuclease Z,rnz,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P30041,Peroxiredoxin-6,PRDX6,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,Q9X9L0,Hypothetical gliding protein,mglB,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,Q9X5N2,Prolyl endopeptidase Pep,pep,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,Q8IWL2,Pulmonary surfactant-associated protein A1,SFTPA1,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,P60355,Manganese catalase,,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,Q84FH6,Chorismate mutase AroH,aroH,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,Q9FCA6,Putative cytochrome P450,cyp158a2,,
DB03814,2-(N-morpholino)ethanesulfonic acid,,Q6NXR0,Interferon-inducible GTPase 5,IRGC,,
DB03815,Fucitol,,P69923,L-fucose isomerase,fucI,,
DB03816,Difluoromethionine,,P00959,Methionine--tRNA ligase,metG,,
DB03817,"L-2,4-diaminobutyric acid",,P12488,Envelope glycoprotein gp160,env,,
DB03818,N-[Tosyl-D-Prolinyl]Amino-Ethanethiol,,P0A884,Thymidylate synthase,thyA,,
DB03820,"(2S,5R,6R)-6-({(6S)-6-[(Ammonioacetyl)amino]-6-carboxylatohexanoyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB03821,2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid,,P15289,Arylsulfatase A,ARSA,,
DB03822,Ethyl dihydrogen phosphate,,P0A433,Parathion hydrolase,opd,,
DB03822,Ethyl dihydrogen phosphate,,P06276,Cholinesterase,BCHE,,
DB03824,"7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB03825,Rhodamine 6G,,P0A0N5,HTH-type transcriptional regulator QacR,qacR,,
DB03825,Rhodamine 6G,,P31224,Acriflavine resistance protein B,acrB,,
DB03827,"(3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine",,P09598,Phospholipase C,plc,,
DB03828,RU78299,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03830,Phosphorylated Dihydropteroate,,P08192,Bifunctional protein FolC,folC,,
DB03832,"3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium",,Q9UKG9,Peroxisomal carnitine O-octanoyltransferase,CROT,,
DB03833,"2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole",,O32449,Proline iminopeptidase,pip,,
DB03834,"(3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine",,P0AD63,Beta-lactamase SHV-1,bla,,
DB03835,"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB03836,"1,3,5-trichlorobenzene",,P00183,Camphor 5-monooxygenase,camC,,
DB03837,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,,P25774,Cathepsin S,CTSS,,
DB03840,Tetra(Imidazole)Diaquacopper (Ii),,P00282,Azurin,azu,,
DB03841,Niraxostat,,P47989,Xanthine dehydrogenase/oxidase,XDH,,
DB03842,2-Chloro-6-Methyl-Aniline,,P00720,Lysozyme,E,,
DB03843,Formaldehyde,,,Hematopoietic stem cells,,,
DB03843,Formaldehyde,,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB03844,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",,P00918,Carbonic anhydrase 2,CA2,,
DB03845,P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate,,P23919,Thymidylate kinase,DTYMK,,
DB03846,2'-deoxy-5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate),,P9WKE1,Thymidylate kinase,tmk,,
DB03847,gamma-carboxy-L-glutamic acid,,P00734,Prothrombin,F2,,
DB03847,gamma-carboxy-L-glutamic acid,,P02818,Osteocalcin,BGLAP,,
DB03847,gamma-carboxy-L-glutamic acid,,P00742,Coagulation factor X,F10,,
DB03848,Benzenesulfinic acid,,P55055,Oxysterols receptor LXR-beta,NR1H2,,
DB03849,Cilomilast,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,inhibitor,
DB03849,Cilomilast,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,
DB03850,Jaspisamide A,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB03854,Cadaverine,,Q46893,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,ispD,,
DB03855,L-Threonohydroxamate 4-Phosphate,,P39304,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,ulaD,,
DB03856,L-Eflornithine,,P11926,Ornithine decarboxylase,ODC1,,
DB03857,"1,4-dithio-beta-D-glucopyranose",,P37698,Endoglucanase F,celCCF,,
DB03859,1-thio-beta-D-glucopyranose,,P37700,Endoglucanase G,celCCG,,
DB03860,ICI-164384,,Q92731,Estrogen receptor beta,ESR2,,
DB03861,"(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine",,P07686,Beta-hexosaminidase subunit beta,HEXB,,
DB03861,"(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine",,Q9Y691,Calcium-activated potassium channel subunit beta-2,KCNMB2,,
DB03862,Tetrahydrooxazine,,O85465,Endoglucanase 5A,cel5A,,
DB03862,Tetrahydrooxazine,,Q08638,Beta-glucosidase A,bglA,,
DB03863,2-O-Methyl-beta-L-fucopyranose,,Q59288,Chondroitinase-AC,cslA,,
DB03863,2-O-Methyl-beta-L-fucopyranose,,Q46079,Chondroitinase-B,cslB,,
DB03864,Monothioglycerol,,P48147,Prolyl endopeptidase,PREP,,
DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,,P00734,Prothrombin,F2,,
DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,,P07477,Trypsin-1,PRSS1,,
DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,,P05981,Serine protease hepsin,HPN,,
DB03866,Prostaglandin G2,,P35354,Prostaglandin G/H synthase 2,PTGS2,,
DB03867,3-nitro-L-tyrosine,,P00390,"Glutathione reductase, mitochondrial",GSR,,
DB03868,3-Dehydroquinic Acid,,Q48255,3-dehydroquinate dehydratase,aroQ,,
DB03869,5'-O-(L-Serylsulfamoyl)adenosine,,P0A8M5,Threonine--tRNA ligase,thrS,,
DB03870,"Ara-Alpha(1,3)-Xyl",,Q9XBQ3,Intracellular exo-alpha-(1->5)-L-arabinofuranosidase,abfA,,
DB03871,"lambda-bis(2,2'-bipyridine)imidazole ruthenium (II)",,P00282,Azurin,azu,,
DB03874,"(4e,8e,12z,16z)-N,N,4,8,13,17,21-Heptamethyldocosa-4,8,12,16,20-Pentaen-1-Amine",,P33247,Squalene--hopene cyclase,shc,,
DB03876,"Thieno[2,3-B]Pyridine-2-Carboxamidine",,P07477,Trypsin-1,PRSS1,,
DB03876,"Thieno[2,3-B]Pyridine-2-Carboxamidine",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB03877,AL-4623,,P00918,Carbonic anhydrase 2,CA2,,
DB03878,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,,P00519,Tyrosine-protein kinase ABL1,ABL1,,
DB03878,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,,P00521,Tyrosine-protein kinase transforming protein Abl,ABL,,
DB03879,alpha-L-methyl-fucose,,P11226,Mannose-binding protein C,MBL2,,
DB03879,alpha-L-methyl-fucose,,Q59288,Chondroitinase-AC,cslA,,
DB03880,Batimastat,,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,,
DB03880,Batimastat,,Q9UNA0,A disintegrin and metalloproteinase with thrombospondin motifs 5,ADAMTS5,,
DB03880,Batimastat,,P22894,Neutrophil collagenase,MMP8,,
DB03880,Batimastat,,P39900,Macrophage metalloelastase,MMP12,,
DB03880,Batimastat,,P51512,Matrix metalloproteinase-16,MMP16,,
DB03881,"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium",,Q8I3X4,"Purine nucleotide phosphorylase, putative",,,
DB03881,"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium",,P00491,Purine nucleoside phosphorylase,PNP,,
DB03882,"5-Alpha-Androstane-3-Beta,17beta-Diol",,Q92731,Estrogen receptor beta,ESR2,agonist,
DB03884,Phenylpyruvic acid,,Q59771,L-phenylalanine dehydrogenase,pdh,,
DB03884,Phenylpyruvic acid,,Q9UJM8,Hydroxyacid oxidase 1,HAO1,,
DB03884,Phenylpyruvic acid,,P51852,Indole-3-pyruvate decarboxylase,ipdC,,
DB03884,Phenylpyruvic acid,,Q7NSZ5,Putative uncharacterized protein,,,
DB03884,Phenylpyruvic acid,,P39639,Bacilysin biosynthesis protein BacB,bacB,,
DB03884,Phenylpyruvic acid,,A1A2B5,Probable chorismate mutase,pheA,,
DB03886,Biopterin,,P35270,Sepiapterin reductase,SPR,,
DB03886,Biopterin,,Q03393,6-pyruvoyl tetrahydrobiopterin synthase,PTS,,
DB03886,Biopterin,,P00374,Dihydrofolate reductase,DHFR,,
DB03887,Alpha-Adenosine Monophosphate,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB03888,N-Allyl-6-{[3-(4-bromophenyl)-1-methyl-1H-indazol-6-yl]oxy}-N-methyl-1-hexanamine,,P33247,Squalene--hopene cyclase,shc,,
DB03889,S-(N-hydroxy-N-bromophenylcarbamoyl)glutathione,,Q16775,"Hydroxyacylglutathione hydrolase, mitochondrial",HAGH,,
DB03890,N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB03891,"Dibenzyl (carbonylbis{2,1-hydrazinediyl[(2S)-4-methyl-1-oxo-1,2-pentanediyl]})biscarbamate",,P43235,Cathepsin K,CTSK,,
DB03892,5-N-Allyl-arginine,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB03893,Thionicotinamide-Adenine-Dinucleotide,,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,,
DB03894,N-Propargyl-1(S)-Aminoindan,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,
DB03895,Malachite Green,,P0A0N5,HTH-type transcriptional regulator QacR,qacR,,
DB03896,Triphosphoric acid,,P51003,Poly(A) polymerase alpha,PAPOLA,,
DB03897,Phloretic acid,,P31013,Tyrosine phenol-lyase,tpl,,
DB03897,Phloretic acid,,O67636,Prephenate dehydrogenase,tyrA,,
DB03897,Phloretic acid,,P31012,Tyrosine phenol-lyase,tpl,,
DB03899,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB03900,tert-butanol,,P07998,Ribonuclease pancreatic,RNASE1,,
DB03900,tert-butanol,,P60174,Triosephosphate isomerase,TPI1,,
DB03900,tert-butanol,,P50579,Methionine aminopeptidase 2,METAP2,,
DB03900,tert-butanol,,P47228,"Biphenyl-2,3-diol 1,2-dioxygenase",bphC,,
DB03900,tert-butanol,,P0DP23,Calmodulin,CALM1,,
DB03901,5-Oxoprolinal,,P94690,Acidic cytochrome c3,,,
DB03902,Oxalic Acid,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB03903,Tmr,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB03904,Urea,,P00378,Dihydrofolate reductase,DHFR,activator,D02AE01;B05BC02;D02AE51
DB03904,Urea,,P05089,Arginase-1,ARG1,,D02AE01;B05BC02;D02AE51
DB03904,Urea,,P00918,Carbonic anhydrase 2,CA2,,D02AE01;B05BC02;D02AE51
DB03904,Urea,,P35222,Catenin beta-1,CTNNB1,,D02AE01;B05BC02;D02AE51
DB03904,Urea,,Q8XB74,Sulfoxide reductase catalytic subunit YedY,yedY,,D02AE01;B05BC02;D02AE51
DB03905,Succinamide-CoA,,P56220,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",dapD,,
DB03906,2-Phenylheme,,P09601,Heme oxygenase 1,HMOX1,,
DB03907,"N-[(E)-3-[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitrobenzamide",,P21964,Catechol O-methyltransferase,COMT,,
DB03908,"N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane]",,P03366,Gag-Pol polyprotein,gag-pol,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,P15925,Folylpolyglutamate synthase,fgs,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,Q56310,Chemotaxis protein CheA,cheA,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,P45066,UDP-N-acetylmuramate--L-alanine ligase,murC,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,P46859,Thermoresistant gluconokinase,gntK,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,P33221,Phosphoribosylglycinamide formyltransferase 2,purT,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,P06213,Insulin receptor,INSR,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,O00764,Pyridoxal kinase,PDXK,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,P00558,Phosphoglycerate kinase 1,PGK1,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,P9WI81,Serine/threonine-protein kinase PknB,pknB,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,P0A9J6,Ribokinase,rbsK,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,Q8ZKR2,Putative sugar kinase,,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,Q9X278,Probable butyrate kinase 2,buk2,,
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,Q12756,Kinesin-like protein KIF1A,KIF1A,,
DB03910,"S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB03911,L-Xylopyranose,,P24300,Xylose isomerase,xylA,,
DB03912,D-pantetheine 4'-phosphate,,Q72K87,Phosphopantetheine adenylyltransferase,coaD,,
DB03912,D-pantetheine 4'-phosphate,,P0A6I8,Phosphopantetheine adenylyltransferase,coaD,,
DB03912,D-pantetheine 4'-phosphate,,Q9WZK0,Phosphopantetheine adenylyltransferase,coaD,,
DB03915,2-Amino-3-Ketobutyric Acid,,P0AB77,2-amino-3-ketobutyrate coenzyme A ligase,kbl,,
DB03916,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,,P77173,Cell division protein ZipA,zipA,,
DB03916,4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,,Q83QN9,Cell division protein ZipA homolog,zipA,,
DB03918,"6S-5,6,7,8-Tetrahydrobiopterin",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB03919,Ethyl-Carbamic Acid Methyl Ester,,P69178,Shiga-like toxin 1 subunit B,stxB,,
DB03921,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,,P36897,TGF-beta receptor type-1,TGFBR1,,
DB03923,Feruloyl Coenzyme A,,Q86VU5,Catechol O-methyltransferase domain-containing protein 1,COMTD1,,
DB03924,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB03925,Freselestat,,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB03925,Freselestat,,P08246,Neutrophil elastase,ELANE,inhibitor,
DB03927,Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine,,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB03928,"Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol",,P32929,Cystathionine gamma-lyase,CTH,,
DB03929,D-Serine,,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,,
DB03929,D-Serine,,P23415,Glycine receptor subunit alpha-1,GLRA1,,
DB03929,D-Serine,,P29508,Serpin B3,SERPINB3,,
DB03929,D-Serine,,P36275,Head decoration protein,shp,,
DB03931,Diguanosine-5'-Triphosphate,,Q84424,mRNA-capping enzyme,,,
DB03932,LFA703,,P20701,Integrin alpha-L,ITGAL,,
DB03933,C-1027 Aromatized chromophore,,Q06110,Antitumor antibiotic C-1027 apoprotein,cagA,,
DB03934,Zinc protoporphyrin,,P99999,Cytochrome c,CYCS,,
DB03935,"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",,P09038,Fibroblast growth factor 2,FGF2,,
DB03935,"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",,P08758,Annexin A5,ANXA5,,
DB03936,1-Deoxy-Ribofuranose-5'-Phosphate,,P0A716,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB03937,D-erythrose 4-phosphate,,O66496,2-dehydro-3-deoxyphosphooctonate aldolase,kdsA,,
DB03937,D-erythrose 4-phosphate,,P06744,Glucose-6-phosphate isomerase,GPI,,
DB03937,D-erythrose 4-phosphate,,Q9WYH8,Phospho-2-dehydro-3-deoxyheptonate aldolase,aroF,,
DB03938,Deacetoxycephalosporin C,,P18548,Deacetoxycephalosporin C synthase,cefE,,
DB03939,"(4S)-4-hydroxy-3,4-dihydro-2(1H)-pyrimidinone",,P25524,Cytosine deaminase,codA,,
DB03940,Oxamic Acid,,Q27743,L-lactate dehydrogenase,,,
DB03940,Oxamic Acid,,P16115,L-lactate dehydrogenase,ldh,,
DB03940,Oxamic Acid,,P00338,L-lactate dehydrogenase A chain,LDHA,,
DB03940,Oxamic Acid,,P07195,L-lactate dehydrogenase B chain,LDHB,,
DB03940,Oxamic Acid,,P09373,Formate acetyltransferase 1,pflB,,
DB03940,Oxamic Acid,,P30901,D-lactate dehydrogenase,,,
DB03942,Carboxylic PRPP,,P37551,Pur operon repressor,purR,,
DB03942,Carboxylic PRPP,,P0A9M5,Xanthine phosphoribosyltransferase,gpt,,
DB03942,Carboxylic PRPP,,P0AG16,Amidophosphoribosyltransferase,purF,,
DB03944,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,,
DB03945,"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",,P02741,C-reactive protein,CRP,,
DB03945,"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",,Q96BH3,Epididymal sperm-binding protein 1,ELSPBP1,,
DB03945,"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",,P0A076,Gamma-hemolysin component B,hlgB,,
DB03947,D-Xylulose,,P24300,Xylose isomerase,xylA,,
DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,,
DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,,
DB03949,N-[(2S)-3-Phenyl-2-sulfanylpropanoyl]-L-phenylalanyl-L-tyrosine,,P43133,Thermolysin,nprS,,
DB03950,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,,P00918,Carbonic anhydrase 2,CA2,,
DB03951,N-acetyl-D-glucosamine-6-phosphate,,P46926,Glucosamine-6-phosphate isomerase 1,GNPDA1,,
DB03951,N-acetyl-D-glucosamine-6-phosphate,,P0A759,Glucosamine-6-phosphate deaminase,nagB,,
DB03952,9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB03953,Thiocitrulline,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB03955,1-deoxymannojirimycin,,Q16706,Alpha-mannosidase 2,MAN2A1,,
DB03956,"Inositol 2,4,5-trisphosphate",,P51178,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",PLCD1,,
DB03957,SP2456,,P60568,Interleukin-2,IL2,,
DB03958,7-methyl-guanosine-5'-triphosphate-5'-guanosine,,Q96C86,m7GpppX diphosphatase,DCPS,,
DB03958,7-methyl-guanosine-5'-triphosphate-5'-guanosine,,P0CK31,RNA-directed RNA polymerase lambda-3,L1,,
DB03959,"N,O6-Disulfo-Glucosamine",,P09038,Fibroblast growth factor 2,FGF2,,
DB03959,"N,O6-Disulfo-Glucosamine",,P05230,Fibroblast growth factor 1,FGF1,,
DB03959,"N,O6-Disulfo-Glucosamine",,Q9Y663,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,,
DB03959,"N,O6-Disulfo-Glucosamine",,P14210,Hepatocyte growth factor,HGF,,
DB03959,"N,O6-Disulfo-Glucosamine",,P68638,Complement control protein C3,,,
DB03959,"N,O6-Disulfo-Glucosamine",,P08758,Annexin A5,ANXA5,,
DB03961,"2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate",,P62619,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB03962,Nicotinamide 8-bromo-adenine dinucleotide phosphate,,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,,
DB03963,S-(Dimethylarsenic)Cysteine,,O60603,Toll-like receptor 2,TLR2,,
DB03963,S-(Dimethylarsenic)Cysteine,,P16753,Capsid scaffolding protein,UL80,,
DB03963,S-(Dimethylarsenic)Cysteine,,P12497,Gag-Pol polyprotein,gag-pol,,
DB03963,S-(Dimethylarsenic)Cysteine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB03963,S-(Dimethylarsenic)Cysteine,,Q9Y678,Coatomer subunit gamma-1,COPG1,,
DB03963,S-(Dimethylarsenic)Cysteine,,P03300,Genome polyprotein,,,
DB03963,S-(Dimethylarsenic)Cysteine,,Q13426,DNA repair protein XRCC4,XRCC4,,
DB03963,S-(Dimethylarsenic)Cysteine,,P0A745,Peptide methionine sulfoxide reductase MsrA,msrA,,
DB03964,4-Hydroxy-Aconitate Ion,,Q99798,"Aconitate hydratase, mitochondrial",ACO2,,
DB03966,Clorobiocin,,P0AES6,DNA gyrase subunit B,gyrB,,
DB03967,Dodecyl sulfate,,P61626,Lysozyme C,LYZ,,
DB03967,Dodecyl sulfate,,P37001,Lipid A palmitoyltransferase PagP,pagP,,
DB03968,"1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine",,P00797,Renin,REN,,
DB03970,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",,P0AD64,Beta-lactamase SHV-1,bla,,
DB03970,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",,P05364,Beta-lactamase,ampC,,
DB03970,"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",,P0AD63,Beta-lactamase SHV-1,bla,,
DB03971,Acarbose Derived Hexasaccharide,,P19531,Maltogenic alpha-amylase,amyM,,
DB03971,Acarbose Derived Hexasaccharide,,P04746,Pancreatic alpha-amylase,AMY2A,ligand,
DB03973,"3-[2,6,8-Trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate",,P9WHE9,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB03974,L-homoarginine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB03975,Mercuribenzoic Acid,,P00918,Carbonic anhydrase 2,CA2,,
DB03975,Mercuribenzoic Acid,,P69488,Divalent-cation tolerance protein CutA,cutA,,
DB03976,Phosphorylisopropane,,P07478,Trypsin-2,PRSS2,,
DB03976,Phosphorylisopropane,,P17538,Chymotrypsinogen B,CTRB1,,
DB03976,Phosphorylisopropane,,P07477,Trypsin-1,PRSS1,,
DB03976,Phosphorylisopropane,,P03234,Capsid scaffolding protein,,,
DB03977,Trimethyllysine,,P99999,Cytochrome c,CYCS,,
DB03977,Trimethyllysine,,P0DP23,Calmodulin,CALM1,,
DB03978,Tyrosinal,,Q5UPJ7,Tyrosine--tRNA ligase,YARS,,
DB03978,Tyrosinal,,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,,
DB03978,Tyrosinal,,P83453,Tyrosine--tRNA ligase,tyrS,,
DB03978,Tyrosinal,,P42790,Pseudomonalisin,pcp,,
DB03979,1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol,,P39662,Flavohemoprotein,hmp,,
DB03980,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB03981,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",,P09038,Fibroblast growth factor 2,FGF2,,
DB03981,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",,Q9Y663,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,,
DB03981,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",,P08758,Annexin A5,ANXA5,,
DB03982,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB03983,"{[2-Amino-4-oxo-6,7-di(sulfanyl-κS)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum",,P51687,"Sulfite oxidase, mitochondrial",SUOX,,
DB03984,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,,P25774,Cathepsin S,CTSS,,
DB03986,6-methyl-formycin A,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB03987,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",,P00374,Dihydrofolate reductase,DHFR,,
DB03987,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",,P16184,Dihydrofolate reductase,,,
DB03988,"2,6-Diamino-Hexanoic Acid Amide",,P18509,Pituitary adenylate cyclase-activating polypeptide,ADCYAP1,,
DB03989,D-Allopyranose,,P39265,D-allose-binding periplasmic protein,alsB,,
DB03991,"2-deoxy-2,3-dehydro-N-acetylneuraminic acid",,P12564,Hemagglutinin-neuraminidase,HN,,
DB03991,"2-deoxy-2,3-dehydro-N-acetylneuraminic acid",,Q02834,Sialidase,nedA,,
DB03991,"2-deoxy-2,3-dehydro-N-acetylneuraminic acid",,P03472,Neuraminidase,,,
DB03991,"2-deoxy-2,3-dehydro-N-acetylneuraminic acid",,P32884,Hemagglutinin-neuraminidase,HN,,
DB03991,"2-deoxy-2,3-dehydro-N-acetylneuraminic acid",,Q9Y3R4,Sialidase-2,NEU2,,
DB03993,Isocaproic acid,,P0AB80,Branched-chain-amino-acid aminotransferase,ilvE,,
DB03994,Ethanolamine,,Q9RP17,Surface protein A,nspA,,
DB03994,Ethanolamine,,P12429,Annexin A3,ANXA3,,
DB03995,Betadex,,Q08751,Neopullulanase 2,tvaII,,
DB03995,Betadex,,P0AEX9,Maltose-binding periplasmic protein,malE,,
DB03995,Betadex,,O69007,Maltogenic amylase,,,
DB03996,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",,P52732,Kinesin-like protein KIF11,KIF11,,
DB03997,L-histidinol phosphate,,P06986,Histidinol-phosphate aminotransferase,hisC,,
DB03997,L-histidinol phosphate,,Q9X0D0,Histidinol-phosphate aminotransferase,hisC,,
DB03999,Butylphosphonate,,P25275,Lipase,lip,,
DB04000,Bromo-Willardiine,,P42262,Glutamate receptor 2,GRIA2,,
DB04001,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB04002,4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide,,P00918,Carbonic anhydrase 2,CA2,,
DB04003,{4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid,,P06239,Tyrosine-protein kinase Lck,LCK,,
DB04004,"2,6-Diamino-8-(2-Dimethylaminoethylsulfanylmethyl)-3h-Quinazolin-4-One",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB04005,Uridine 5'-triphosphate,,Q9BZX2,Uridine-cytidine kinase 2,UCK2,,
DB04005,Uridine 5'-triphosphate,,P26662,Genome polyprotein,,,
DB04005,Uridine 5'-triphosphate,,P26663,Genome polyprotein,,,
DB04006,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB04007,Bromo-WR99210,,P9WNX1,Dihydrofolate reductase,folA,,
DB04008,Zinc;[amino-[2-[[5-[amino(azaniumylidene)methyl]benzimidazol-1-id-2-yl]methyl]benzimidazol-1-id-5-yl]methylidene]azanium,,P07477,Trypsin-1,PRSS1,,
DB04009,Dimethyl Propionate Ester Heme,,P00167,Cytochrome b5,CYB5A,,
DB04010,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB04012,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine",,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB04013,1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04014,Alsterpaullone,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB04014,Alsterpaullone,,Q00535,Cyclin-dependent kinase 5,CDK5,,
DB04014,Alsterpaullone,,P06493,Cyclin-dependent kinase 1,CDK1,inhibitor,
DB04015,Methionine Phosphinate,,P00959,Methionine--tRNA ligase,metG,,
DB04015,Methionine Phosphinate,,P0AE18,Methionine aminopeptidase,map,,
DB04016,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,,P08311,Cathepsin G,CTSG,,
DB04016,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,,P23946,Chymase,CMA1,,
DB04017,Clorgiline,,P21397,Amine oxidase [flavin-containing] A,MAOA,,
DB04018,S-Isopropyl-Isothiourea,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB04020,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",,Q92731,Estrogen receptor beta,ESR2,,
DB04021,MF268,,P22303,Acetylcholinesterase,ACHE,,
DB04022,Guanosine tetraphosphate,,P42085,Xanthine phosphoribosyltransferase,xpt,,
DB04022,Guanosine tetraphosphate,,P20964,GTPase ObgE,obg,,
DB04023,GDP-alpha-D-mannuronic acid,,P11759,GDP-mannose 6-dehydrogenase,algD,,
DB04024,Serine-3'-aminoadenosine,,P0A8M5,Threonine--tRNA ligase,thrS,,
DB04027,D-arginine,,P06732,Creatine kinase M-type,CKM,,
DB04028,Tyvelose,,P12528,Bifunctional tail protein,9,,
DB04029,Phenylalanylamide,,P08617,Genome polyprotein,,,
DB04029,Phenylalanylamide,,P13901,Genome polyprotein,,,
DB04029,Phenylalanylamide,,Q9LCC8,D-Amino acid amidase,daaA,,
DB04030,"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",,P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,
DB04031,Serine vanadate,,P00634,Alkaline phosphatase,phoA,,
DB04032,Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide,,P00183,Camphor 5-monooxygenase,camC,,
DB04033,Z-Ala Prolinal,,Q9X5N2,Prolyl endopeptidase Pep,pep,,
DB04034,Ribulose-5-Phosphate,,P39304,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,ulaD,,
DB04035,Ceftazidime BATSI,,P00811,Beta-lactamase,ampC,,
DB04035,Ceftazidime BATSI,,P62593,Beta-lactamase TEM,bla,,
DB04035,Ceftazidime BATSI,,Q939N4,Beta-lactamase CTX-M,,,
DB04036,Coenzyme A persulfide,,P26440,"Isovaleryl-CoA dehydrogenase, mitochondrial",IVD,,
DB04037,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",,P62593,Beta-lactamase TEM,bla,,
DB04037,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",,P62594,Beta-lactamase TEM,bla,,
DB04039,3-Oxo-Pentadecanoic Acid,,P06129,Vitamin B12 transporter BtuB,btuB,,
DB04039,3-Oxo-Pentadecanoic Acid,,P00646,Colicin-E3,ceaC,,
DB04039,3-Oxo-Pentadecanoic Acid,,P06971,Ferrichrome-iron receptor,fhuA,,
DB04040,"N-[1,3-Di(4-morpholinyl)-2-propanyl]-3-(α-D-galactopyranosyloxy)-5-nitrobenzamide",,P32890,Heat-labile enterotoxin B chain,eltB,,
DB04041,Nitrocefin Acyl-Serine,,P07944,Beta-lactam-inducible penicillin-binding protein,pbp,,
DB04042,"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",,P03366,Gag-Pol polyprotein,gag-pol,,
DB04043,Carboxymycobactin T,,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,,
DB04044,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04045,(R)-methylmalonyl-CoA,,Q8GBW6,Methylmalonyl-CoA carboxyltransferase 12S subunit,,,
DB04047,6-hydroxymethylpterin diphosphate,,P26281,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,folK,,
DB04047,6-hydroxymethylpterin diphosphate,,Q81VW8,Dihydropteroate synthase,folP,,
DB04048,N-Carbamoyl-Alanine,,P32119,Peroxiredoxin-2,PRDX2,,
DB04050,N-Propyl Isocyanide,,P02144,Myoglobin,MB,,
DB04051,5-phenylpentanoic acid,,P95468,Aromatic-amino-acid aminotransferase,tyrB,,
DB04052,"3,4-Xylenol",,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB04053,Hypophosphite,,P52197,Thiosulfate sulfurtransferase,rhdA,,
DB04054,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB04055,"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04057,"N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid",,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,,
DB04058,N-Carbamoylphenylalanine,,P15085,Carboxypeptidase A1,CPA1,,
DB04058,N-Carbamoylphenylalanine,,P60327,N-carbamoyl-D-amino acid hydrolase,,,
DB04059,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB04062,beta-D-fucose,,P02924,L-arabinose-binding periplasmic protein,araF,,
DB04062,beta-D-fucose,,P0A9E0,Arabinose operon regulatory protein,araC,,
DB04063,alpha-Methylleucine,,P0AB80,Branched-chain-amino-acid aminotransferase,ilvE,,
DB04064,Nogalaviketone,,Q9RN59,Nogalonic acid methyl ester cyclase,snoaL,,
DB04065,N-Cyclopentyl-N-Cyclobutylformamide,,P07327,Alcohol dehydrogenase 1A,ADH1A,,
DB04066,p-Coumaric acid,,Q14914,Prostaglandin reductase 1,PTGR1,,
DB04066,p-Coumaric acid,,Q3IWB0,Histidine ammonia-lyase,hutH,,
DB04066,p-Coumaric acid,,P16113,Photoactive yellow protein,pyp,,
DB04066,p-Coumaric acid,,Q9X2W8,PPH,pph,,
DB04067,4-hydroxybenzyl coenzyme A,,Q04416,4-hydroxybenzoyl-CoA thioesterase,fcbC,,
DB04067,4-hydroxybenzyl coenzyme A,,P56653,4-hydroxybenzoyl-CoA thioesterase,,,
DB04068,"2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate",,P15531,Nucleoside diphosphate kinase A,NME1,,
DB04069,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",,P53355,Death-associated protein kinase 1,DAPK1,,
DB04070,6-Deoxyerythronolide B,,Q00441,6-deoxyerythronolide B hydroxylase,eryF,,
DB04071,Cpad,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB04072,Alpha-Methylisocitric Acid,,Q99798,"Aconitate hydratase, mitochondrial",ACO2,,
DB04073,N-{3-[4-(3-amino-propyl)-piperazin-1-yl]-propyl}-3-nitro-5-(galactopyranosyl)-beta-benzamide,,P01556,Cholera enterotoxin subunit B,ctxB,,
DB04074,alpha-Ketoisovalerate,,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,,
DB04074,alpha-Ketoisovalerate,,Q9JZW6,3-methyl-2-oxobutanoate hydroxymethyltransferase,panB,,
DB04074,alpha-Ketoisovalerate,,P18548,Deacetoxycephalosporin C synthase,cefE,,
DB04074,alpha-Ketoisovalerate,,P9WQB3,2-isopropylmalate synthase,leuA,,
DB04075,N-Acetyl-L-Glutamate,,P0A6C8,Acetylglutamate kinase,argB,,
DB04075,N-Acetyl-L-Glutamate,,Q9HTN2,Acetylglutamate kinase,argB,,
DB04076,Hypoxanthine,,P00491,Purine nucleoside phosphorylase,PNP,,
DB04079,"Heptane-1,2,3-Triol",,P08100,Rhodopsin,RHO,,
DB04079,"Heptane-1,2,3-Triol",,P02974,Fimbrial protein,pilE1,,
DB04079,"Heptane-1,2,3-Triol",,P13036,Fe(3+) dicitrate transport protein FecA,fecA,,
DB04080,RU78191,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB04081,"(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide",,P00918,Carbonic anhydrase 2,CA2,,
DB04082,Decyloxy-Methanol,,P0A805,Ribosome-recycling factor,frr,,
DB04082,Decyloxy-Methanol,,P0A808,Ribosome-recycling factor,frr,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,Q16773,Kynurenine--oxoglutarate transaminase 1,CCBL1,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,P11926,Ornithine decarboxylase,ODC1,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,P12995,Adenosylmethionine-8-amino-7-oxononanoate aminotransferase,bioA,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,P21549,Serine--pyruvate aminotransferase,AGXT,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,P00509,Aspartate aminotransferase,aspC,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,P83786,Aspartate aminotransferase,,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,Q9X266,L-allo-threonine aldolase,,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,P13254,Methionine gamma-lyase,mdeA,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,P00935,Cystathionine gamma-synthase,metB,,
DB04083,N(6)-(pyridoxal phosphate)-L-lysine,,P33447,Tyrosine aminotransferase,,,
DB04084,2-deoxy-2-fluoro-α-D-mannose,,P49424,"Mannan endo-1,4-beta-mannosidase",manA,,
DB04085,Bis(N-maleimidomethyl)ether,,P00282,Azurin,azu,,
DB04086,"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",,O85465,Endoglucanase 5A,cel5A,,
DB04087,Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate,,P0A6L0,Deoxyribose-phosphate aldolase,deoC,,
DB04087,Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate,,Q5SJ28,Deoxyribose-phosphate aldolase,deoC,,
DB04088,2-[{4-[(2S)-2-{[(Allyloxy)carbonyl]amino}-3-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}amino)-3-oxopropyl]phenyl}(carboxycarbonyl)amino]benzoic acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB04089,AL5300,,P00918,Carbonic anhydrase 2,CA2,,
DB04090,RH-1,,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,,
DB04092,Apstatin,,P15034,Xaa-Pro aminopeptidase,pepP,,
DB04094,4-hydroxybutan-2-one,,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB04095,9-Deazahypoxanthine,,P9WP01,Purine nucleoside phosphorylase,punA,,
DB04097,Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose,,P09147,UDP-glucose 4-epimerase,galE,,
DB04098,Balanol,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB04099,Deamido-Nad+,,P18843,NH(3)-dependent NAD(+) synthetase,nadE,,
DB04099,Deamido-Nad+,,P08164,NH(3)-dependent NAD(+) synthetase,nadE,,
DB04099,Deamido-Nad+,,Q9HAN9,Nicotinamide mononucleotide adenylyltransferase 1,NMNAT1,,
DB04099,Deamido-Nad+,,P54455,Nicotinate-nucleotide adenylyltransferase,nadD,,
DB04099,Deamido-Nad+,,Q96T66,Nicotinamide mononucleotide adenylyltransferase 3,NMNAT3,,
DB04099,Deamido-Nad+,,O25096,NH(3)-dependent NAD(+) synthetase,nadE,,
DB04100,"Tricarbonyl(1,10-phenanthroline)rhenium(1+)",,P00282,Azurin,azu,,
DB04101,"N'-[4-(2,4-Dimethyl-1,3-thiazol-5-yl)-2-pyrimidinyl]-N-hydroxyimidoformamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB04103,3-Methylcytosine,,P07617,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,PAPS,,
DB04104,3-Methyladenine,,P05100,DNA-3-methyladenine glycosylase 1,tag,,
DB04105,N-Heptylformamide,,P00325,Alcohol dehydrogenase 1B,ADH1B,,
DB04106,Fotemustine,,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,,L01AD05
DB04107,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,,P07477,Trypsin-1,PRSS1,,
DB04108,"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",,P50579,Methionine aminopeptidase 2,METAP2,,
DB04109,"[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine",,P35030,Trypsin-3,PRSS3,,
DB04112,(2R)-2-Acetamido-3-(octadecyloxy)propyl 2-(methylsulfanyl)ethyl hydrogen phosphate,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB04113,N-Formylpiperidine,,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB04114,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",,P22303,Acetylcholinesterase,ACHE,,
DB04115,Berberine,,O15392,Baculoviral IAP repeat-containing protein 5,BIRC5,,
DB04115,Berberine,,P0A0N5,HTH-type transcriptional regulator QacR,qacR,,
DB04116,Allolactose,,P00722,Beta-galactosidase,lacZ,,
DB04117,"4-(N,N-Dimethylamino)cinnamoyl-CoA",,P30084,"Enoyl-CoA hydratase, mitochondrial",ECHS1,,
DB04119,Hexatantalum Dodecabromide,,Q9UQM7,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,,
DB04119,Hexatantalum Dodecabromide,,P22314,Ubiquitin-like modifier-activating enzyme 1,UBA1,,
DB04120,"4-Methyl-1,2-Benzenediol",,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB04120,"4-Methyl-1,2-Benzenediol",,P07773,"Catechol 1,2-dioxygenase",catA,,
DB04121,Guanosine-3'-monophosphate-5'-diphosphate,,P84077,ADP-ribosylation factor 1,ARF1,,
DB04122,beta-D-glucose 6-phosphate,,P11411,Glucose-6-phosphate 1-dehydrogenase,zwf,,
DB04123,(P-Iodophenylacetylamino)Methylphosphinic Acid,,P05364,Beta-lactamase,ampC,,
DB04124,Aurodox,,P60339,Elongation factor Tu-B,tufB,,
DB04125,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,,P07477,Trypsin-1,PRSS1,,
DB04126,N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,,P07858,Cathepsin B,CTSB,,
DB04126,N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,,P09668,Pro-cathepsin H,CTSH,,
DB04127,beta-D-arabinofuranose 5-phosphate,,P0A7Z3,Ribose-5-phosphate isomerase A,rpiA,,
DB04128,"5-Nitroso-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione",,O66529,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB04129,Willardiine,,P42262,Glutamate receptor 2,GRIA2,,
DB04130,5-Methoxybenzimidazole,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB04131,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",,Q54528,RdmC,rdmC,,
DB04132,S-Hexylglutathione,,Q04760,Lactoylglutathione lyase,GLO1,,
DB04132,S-Hexylglutathione,,Q03013,Glutathione S-transferase Mu 4,GSTM4,,
DB04132,S-Hexylglutathione,,P09211,Glutathione S-transferase P,GSTP1,,
DB04132,S-Hexylglutathione,,Q8ILQ7,Glutathione S-transferase,GST,,
DB04132,S-Hexylglutathione,,P08263,Glutathione S-transferase A1,GSTA1,ligand,
DB04132,S-Hexylglutathione,,P0CG29,Glutathione S-transferase theta-2,GSTT2,,
DB04133,Degraded Cephaloridine,,Q8XJ01,Penicillin-binding protein 1A,pbpA,inhibitor,
DB04133,Degraded Cephaloridine,,P00807,Beta-lactamase,blaZ,,
DB04135,"(4S)-5-Fluoro-4-hydroxy-3,4-dihydro-2(1H)-pyrimidinone",,P25524,Cytosine deaminase,codA,,
DB04136,Lysophosphotidylserine,,P00734,Prothrombin,F2,,
DB04137,Guanosine-5'-Triphosphate,,P11124,RNA-directed RNA polymerase,P2,,
DB04137,Guanosine-5'-Triphosphate,,Q9NWZ5,Uridine-cytidine kinase-like 1,UCKL1,,
DB04137,Guanosine-5'-Triphosphate,,P01112,GTPase HRas,HRAS,,
DB04137,Guanosine-5'-Triphosphate,,P26663,Genome polyprotein,,,
DB04137,Guanosine-5'-Triphosphate,,P61587,Rho-related GTP-binding protein RhoE,RND3,,
DB04137,Guanosine-5'-Triphosphate,,P19711,Genome polyprotein,,,
DB04137,Guanosine-5'-Triphosphate,,Q15382,GTP-binding protein Rheb,RHEB,,
DB04137,Guanosine-5'-Triphosphate,,P0A6T8,GTP cyclohydrolase 1,folE,,
DB04137,Guanosine-5'-Triphosphate,,P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,,
DB04137,Guanosine-5'-Triphosphate,,P20339,Ras-related protein Rab-5A,RAB5A,,
DB04137,Guanosine-5'-Triphosphate,,P38424,Probable GTP-binding protein EngB,engB,,
DB04137,Guanosine-5'-Triphosphate,,Q84424,mRNA-capping enzyme,,,
DB04137,Guanosine-5'-Triphosphate,,P03300,Genome polyprotein,,,
DB04137,Guanosine-5'-Triphosphate,,P84077,ADP-ribosylation factor 1,ARF1,,
DB04137,Guanosine-5'-Triphosphate,,P32173,Molybdenum cofactor guanylyltransferase,mobA,,
DB04137,Guanosine-5'-Triphosphate,,P43099,"Ornithine decarboxylase, inducible",odcI,,
DB04137,Guanosine-5'-Triphosphate,,P00367,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,,
DB04137,Guanosine-5'-Triphosphate,,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,,
DB04137,Guanosine-5'-Triphosphate,,P10114,Ras-related protein Rap-2a,RAP2A,,
DB04138,"5-[Bis(2-bromoethyl)amino]-N-(2,3-dioxopropyl)-2,4-dinitrobenzamide",,P38489,Oxygen-insensitive NAD(P)H nitroreductase,nfsB,,
DB04139,6-Hydroxypropylthymine,,Q9QNF7,Thymidine kinase,TK,ligand,
DB04140,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,,P08254,Stromelysin-1,MMP3,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,P00156,Cytochrome b,MT-CYB,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,P21912,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",SDHB,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",SDHD,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,Q16134,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial",ETFDH,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",SDHC,,
DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,P16442,Histo-blood group ABO system transferase,ABO,,
DB04142,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB04143,Indole-3-Glycerol Phosphate,,P00929,Tryptophan synthase alpha chain,trpA,,
DB04143,Indole-3-Glycerol Phosphate,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB04144,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",,Q00987,E3 ubiquitin-protein ligase Mdm2,MDM2,,
DB04147,Dodecyldimethylamine N-oxide,,P0C0Y8,Reaction center protein L chain,pufL,,
DB04147,Dodecyldimethylamine N-oxide,,P0C0Y9,Reaction center protein M chain,pufM,,
DB04147,Dodecyldimethylamine N-oxide,,P0C0Y7,Reaction center protein H chain,puhA,,
DB04147,Dodecyldimethylamine N-oxide,,P98002,Cytochrome c oxidase subunit 1-beta,ctaDII,,
DB04147,Dodecyldimethylamine N-oxide,,P08306,Cytochrome c oxidase subunit 2,ctaC,,
DB04147,Dodecyldimethylamine N-oxide,,P01593,Ig kappa chain V-I region Bi,,,
DB04147,Dodecyldimethylamine N-oxide,,P01764,Ig heavy chain V-III region VH26,IGHV3-23,,
DB04147,Dodecyldimethylamine N-oxide,,P07173,Photosynthetic reaction center cytochrome c subunit,pufC,,
DB04147,Dodecyldimethylamine N-oxide,,P06008,Reaction center protein H chain,puhA,,
DB04147,Dodecyldimethylamine N-oxide,,P06009,Reaction center protein L chain,pufL,,
DB04147,Dodecyldimethylamine N-oxide,,P06010,Reaction center protein M chain,pufM,,
DB04147,Dodecyldimethylamine N-oxide,,Q93RD8,H subunit of photosynthetic reaction center complex,puhA,,
DB04147,Dodecyldimethylamine N-oxide,,P60981,Destrin,DSTN,,
DB04147,Dodecyldimethylamine N-oxide,,P08100,Rhodopsin,RHO,,
DB04147,Dodecyldimethylamine N-oxide,,P0C0X8,Cytochrome c2,cycA,,
DB04147,Dodecyldimethylamine N-oxide,,Q14494,Nuclear factor erythroid 2-related factor 1,NFE2L1,,
DB04147,Dodecyldimethylamine N-oxide,,P33247,Squalene--hopene cyclase,shc,,
DB04147,Dodecyldimethylamine N-oxide,,P06129,Vitamin B12 transporter BtuB,btuB,,
DB04147,Dodecyldimethylamine N-oxide,,P00646,Colicin-E3,ceaC,,
DB04147,Dodecyldimethylamine N-oxide,,P42512,Fe(3+)-pyochelin receptor,fptA,,
DB04147,Dodecyldimethylamine N-oxide,,P02689,Myelin P2 protein,PMP2,,
DB04147,Dodecyldimethylamine N-oxide,,P0A915,Outer membrane protein W,ompW,,
DB04147,Dodecyldimethylamine N-oxide,,P26789,Light-harvesting protein B-800/850 alpha chain,,,
DB04147,Dodecyldimethylamine N-oxide,,P26790,Light-harvesting protein B-800/850 beta chain,,,
DB04147,Dodecyldimethylamine N-oxide,,P02929,Protein TonB,tonB,,
DB04147,Dodecyldimethylamine N-oxide,,P17315,Colicin I receptor,cirA,,
DB04147,Dodecyldimethylamine N-oxide,,P06716,Colicin-Ia,cia,,
DB04147,Dodecyldimethylamine N-oxide,,P23528,Cofilin-1,CFL1,,
DB04147,Dodecyldimethylamine N-oxide,,P09391,Rhomboid protease GlpG,glpG,,
DB04147,Dodecyldimethylamine N-oxide,,P76045,Outer membrane protein G,ompG,,
DB04147,Dodecyldimethylamine N-oxide,,P07110,Outer membrane usher protein PapC,papC,,
DB04147,Dodecyldimethylamine N-oxide,,P69856,Probable N-acetylneuraminic acid outer membrane channel protein NanC,nanC,,
DB04147,Dodecyldimethylamine N-oxide,,Q3J170,Reaction center protein H chain,puhA,,
DB04147,Dodecyldimethylamine N-oxide,,Q3J1A5,Reaction center protein L chain,pufL,,
DB04147,Dodecyldimethylamine N-oxide,,Q3J1A6,Reaction center protein M chain,pufM,,
DB04147,Dodecyldimethylamine N-oxide,,Q5RT80,Outer membrane protein II,porB,,
DB04147,Dodecyldimethylamine N-oxide,,Q98GN8,Cyclic nucleotide-gated potassium channel mll3241,,,
DB04147,Dodecyldimethylamine N-oxide,,P69681,Ammonia channel,amtB,,
DB04147,Dodecyldimethylamine N-oxide,,A0A0H2WWQ9,Penicillin-binding protein 2,pbp2,,
DB04147,Dodecyldimethylamine N-oxide,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB04147,Dodecyldimethylamine N-oxide,,Q46704,TraO protein,traO,,
DB04147,Dodecyldimethylamine N-oxide,,Q46705,TraF protein,traF,,
DB04147,Dodecyldimethylamine N-oxide,,Q46702,TraN protein,traN,,
DB04147,Dodecyldimethylamine N-oxide,,Q4KH25,"Outer membrane porin, OprD family",,,
DB04147,Dodecyldimethylamine N-oxide,,P13036,Fe(3+) dicitrate transport protein FecA,fecA,,
DB04147,Dodecyldimethylamine N-oxide,,P10384,Long-chain fatty acid transport protein,fadL,,
DB04147,Dodecyldimethylamine N-oxide,,P37001,Lipid A palmitoyltransferase PagP,pagP,,
DB04147,Dodecyldimethylamine N-oxide,,P0AGG2,Acyl-CoA thioesterase 2,tesB,,
DB04147,Dodecyldimethylamine N-oxide,,P27338,Amine oxidase [flavin-containing] B,MAOB,ligand,
DB04149,(R)-Rolipram,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,
DB04149,(R)-Rolipram,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB04150,"N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine",,P19021,Peptidyl-glycine alpha-amidating monooxygenase,PAM,,
DB04151,1-Methylhistidine,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB04152,"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",,P42262,Glutamate receptor 2,GRIA2,,
DB04153,S-Hydroxymethyl Glutathione,,P11766,Alcohol dehydrogenase class-3,ADH5,,
DB04154,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",,P77173,Cell division protein ZipA,zipA,,
DB04154,"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",,Q83QN9,Cell division protein ZipA homolog,zipA,,
DB04155,2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose,,P00722,Beta-galactosidase,lacZ,,
DB04156,Aspartate beryllium trifluoride,,Q9GZU7,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,CTDSP1,,
DB04156,Aspartate beryllium trifluoride,,P75792,Sugar phosphatase YbiV,ybiV,,
DB04156,Aspartate beryllium trifluoride,,P0AE67,Chemotaxis protein CheY,cheY,,
DB04157,N-[(Aminooxy)Carbonyl]Aniline,,P11797,Chitinase B,chiB,,
DB04158,"6-(adenosine tetraphosphate-methyl)-7,8-dihydropterin",,P26281,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,folK,,
DB04160,Pyrophosphoric acid,,P22939,Farnesyl diphosphate synthase,ispA,modulator,
DB04162,"5-Nitro-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione",,P61713,"6,7-dimethyl-8-ribityllumazine synthase 2",ribH2,,
DB04162,"5-Nitro-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione",,P11998,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB04163,"5-Phenylsulfanyl-2,4-Quinazolinediamine",,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFRL1,,
DB04163,"5-Phenylsulfanyl-2,4-Quinazolinediamine",,P22906,Dihydrofolate reductase,DFR1,,
DB04164,"4,6-Dideoxy-4-{[(1S,5R,6S)-3-formyl-5,6-dihydroxy-4-oxo-2-cyclohexen-1-yl]amino}-α-D-xylo-hex-5-enopyranose",,P29957,Alpha-amylase,amy,,
DB04165,Valpromide,,Q9ZAG3,"Limonene-1,2-epoxide hydrolase",limA,,N03AG02
DB04166,Anthranilic acid,,Q96RQ9,L-amino-acid oxidase,IL4I1,,
DB04166,Anthranilic acid,,P14920,D-amino-acid oxidase,DAO,,
DB04167,Aceglutamide,,Q9RYA6,N-acylamino acid racemase,menC,,
DB04168,Bropirimine,,P56740,Dihydroneopterin aldolase,folB,,
DB04169,"3,5-Diaminophthalhydrazide",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB04170,4-bromo-3-hydroxy-3-methyl butyl diphosphate,,Q46822,Isopentenyl-diphosphate Delta-isomerase,idi,,
DB04172,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB04173,Fructose,,P02943,Maltoporin,lamB,,V06DC02
DB04174,3'-1-carboxy-1-phosphonooxy-ethoxy-uridine-diphosphate-N-acetylglucosamine,,P33038,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,murA,,
DB04175,Mdl-29951,,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,,
DB04176,"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB04178,Di-Stearoyl-3-Sn-Phosphatidylcholine,,P17213,Bactericidal permeability-increasing protein,BPI,,
DB04178,Di-Stearoyl-3-Sn-Phosphatidylcholine,,P12235,ADP/ATP translocase 1,SLC25A4,,
DB04179,Benzofuran,,P00720,Lysozyme,E,,
DB04180,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",,P00918,Carbonic anhydrase 2,CA2,,
DB04182,"(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid",,O34667,S-ribosylhomocysteine lyase,luxS,,
DB04183,Methylmalonic Acid,,Q8GBW6,Methylmalonyl-CoA carboxyltransferase 12S subunit,,,
DB04185,Norvaline,,P50440,"Glycine amidinotransferase, mitochondrial",GATM,,
DB04185,Norvaline,,P00480,"Ornithine carbamoyltransferase, mitochondrial",OTC,,
DB04186,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB04187,"(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",,P09488,Glutathione S-transferase Mu 1,GSTM1,,
DB04188,MDL72527,,Q9NWM0,Spermine oxidase,SMOX,inhibitor,
DB04190,"2,5-dibenzyloxy-3-hydroxy-hexanedioic acid bis-[(2-hydroxy-indan-1-yl)-amide]",,P03366,Gag-Pol polyprotein,gag-pol,,
DB04191,Skf 107457,,P05896,Gag-Pol polyprotein,gag-pol,,
DB04194,Triacetylchitotriose,,P61626,Lysozyme C,LYZ,,
DB04195,Heptulose-2-Phosphate,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04196,Pteroic acid,,Q81VW8,Dihydropteroate synthase,folP,,
DB04197,Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine,,P05089,Arginase-1,ARG1,,
DB04198,Formycin B,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB04198,Formycin B,,Q27796,Hypoxanthine-guanine phosphoribosyltransferase,HGPRTase,,
DB04199,1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,,P0A1X2,Lipoprotein MxiM,mxiM,,
DB04199,1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,,Q7DB61,GrlR,,,
DB04199,1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,,P0A1X3,Lipoprotein MxiM,mxiM,,
DB04200,Matairesinol,,Q6PKH6,Dehydrogenase/reductase SDR family member 4-like 2,DHRS4L2,,
DB04201,Histidyl-Adenosine Monophosphate,,P60906,Histidine--tRNA ligase,hisS,,
DB04201,Histidyl-Adenosine Monophosphate,,P56194,Histidine--tRNA ligase,hisS,,
DB04203,3-Mercuri-4-Aminobenzenesulfonamide,,P00918,Carbonic anhydrase 2,CA2,,
DB04204,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB04205,"Thymidine-3',5'-Diphosphate",,P06612,DNA topoisomerase 1,topA,,
DB04205,"Thymidine-3',5'-Diphosphate",,P00644,Thermonuclease,nuc,,
DB04206,7-Aza-L-tryptophan,,P03706,Lysozyme,R,,
DB04207,L-Saccharopine,,Q9UDR5,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,,
DB04208,"3-(3,4-dimethoxyphenyl)propanoic acid",,P95468,Aromatic-amino-acid aminotransferase,tyrB,,
DB04209,Dequalinium,,P98170,E3 ubiquitin-protein ligase XIAP,XIAP,antagonist,D08AH01;R02AA02;G01AC05
DB04209,Dequalinium,,P98170,E3 ubiquitin-protein ligase XIAP,XIAP,inhibitor,D08AH01;R02AA02;G01AC05
DB04209,Dequalinium,,P29973,cGMP-gated cation channel alpha-1,CNGA1,blocker,D08AH01;R02AA02;G01AC05
DB04209,Dequalinium,,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,inhibitor,D08AH01;R02AA02;G01AC05
DB04209,Dequalinium,,P0A0N4,HTH-type transcriptional regulator QacR,qacR,regulator,D08AH01;R02AA02;G01AC05
DB04209,Dequalinium,,Q7AKE4,Response regulator RamR,ramR,regulator,D08AH01;R02AA02;G01AC05
DB04209,Dequalinium,,P0DP23,Calmodulin,CALM1,antagonist,D08AH01;R02AA02;G01AC05
DB04209,Dequalinium,,Q9UGI6,Small conductance calcium-activated potassium channel protein 3,KCNN3,blocker,D08AH01;R02AA02;G01AC05
DB04209,Dequalinium,,P17252,Protein kinase C,PRKCA,inhibitor,D08AH01;R02AA02;G01AC05
DB04209,Dequalinium,,P37840,Alpha-synuclein,SNCA,modulator,D08AH01;R02AA02;G01AC05
DB04209,Dequalinium,,A5U4F6,L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase,mshC,inhibitor,D08AH01;R02AA02;G01AC05
DB04210,"3-(alpha-D-galactopyranosyloxy)-N-(3-{4-[3-({2-[(3-{4-[3-({[3-(hexopyranosyloxy)-5-nitrophenyl]carbonyl}amino)propyl]piperazin-1-yl}propyl)amino]-3,4-dioxocyclobut-1-en-1-yl}amino)propyl]piperazin-1-yl}propyl)-5-nitrobenzamide",,P01556,Cholera enterotoxin subunit B,ctxB,,
DB04212,2-Iminiopropanoate,,Q00740,1-aminocyclopropane-1-carboxylate deaminase,acdS,,
DB04213,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,,P34913,Bifunctional epoxide hydrolase 2,EPHX2,,
DB04214,4-Nitrophenyl Phosphate,,P24666,Low molecular weight phosphotyrosine protein phosphatase,ACP1,,
DB04214,4-Nitrophenyl Phosphate,,Q9BVJ7,Dual specificity protein phosphatase 23,DUSP23,,
DB04215,CRA_9076,,P07477,Trypsin-1,PRSS1,,
DB04216,Quercetin,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB04216,Quercetin,,Q6NUS8,UDP-glucuronosyltransferase 3A1,UGT3A1,,
DB04216,Quercetin,,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,,
DB04216,Quercetin,,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,,
DB04216,Quercetin,,P36542,"ATP synthase subunit gamma, mitochondrial",ATP5C1,,
DB04216,Quercetin,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB04216,Quercetin,,Q9AIU0,HTH-type transcriptional regulator TtgR,ttgR,,
DB04216,Quercetin,,Q6NVY1,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial",HIBCH,,
DB04216,Quercetin,,Q5G940,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB04216,Quercetin,,O94768,Serine/threonine-protein kinase 17B,STK17B,,
DB04216,Quercetin,,P03372,Estrogen receptor alpha,ESR1,,
DB04216,Quercetin,,Q92731,Estrogen receptor beta,ESR2,,
DB04216,Quercetin,,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,inhibitor,
DB04216,Quercetin,,P35869,Aryl hydrocarbon receptor,AHR,,
DB04216,Quercetin,,Q16678,Cytochrome P450 1B1,CYP1B1,,
DB04216,Quercetin,,P60709,"Actin, cytoplasmic 1",ACTB,,
DB04216,Quercetin,,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB04216,Quercetin,,P67870,Casein kinase II subunit beta,CSNK2B,,
DB04216,Quercetin,,O00303,Eukaryotic translation initiation factor 3 subunit F,EIF3F,,
DB04216,Quercetin,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB04216,Quercetin,,P54652,Heat shock-related 70 kDa protein 2,HSPA2,,
DB04216,Quercetin,,Q9Y230,RuvB-like 2,RUVBL2,,
DB04216,Quercetin,,Q15393,Splicing factor 3B subunit 3,SF3B3,,
DB04216,Quercetin,,P22314,Ubiquitin-like modifier-activating enzyme 1,UBA1,,
DB04216,Quercetin,,P04278,Sex hormone-binding globulin,SHBG,,
DB04216,Quercetin,,P16152,Carbonyl reductase [NADPH] 1,CBR1,,
DB04216,Quercetin,,P17676,CCAAT/enhancer-binding protein beta,CEBPB,inhibitor,
DB04216,Quercetin,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,
DB04216,Quercetin,,P08631,Tyrosine-protein kinase HCK,HCK,,
DB04217,L-2-amino-3-butynoic acid,,P77444,Cysteine desulfurase,sufS,,
DB04217,L-2-amino-3-butynoic acid,,P32929,Cystathionine gamma-lyase,CTH,,
DB04218,1-Deaza-Adenosine,,P00813,Adenosine deaminase,ADA,,
DB04220,CGP 4832,,P06971,Ferrichrome-iron receptor,fhuA,,
DB04221,Didecyldimethylammonium,,,Phospholipid membrane,,,D08AJ06
DB04221,Didecyldimethylammonium,,P9WPB5,Cyclopropane mycolic acid synthase 2,cmaA2,,D08AJ06
DB04223,Nitroarginine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB04223,Nitroarginine,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB04224,Oleic Acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB04224,Oleic Acid,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB04224,Oleic Acid,,P19793,Retinoic acid receptor RXR-alpha,RXRA,,
DB04224,Oleic Acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,ligand,
DB04224,Oleic Acid,,P02689,Myelin P2 protein,PMP2,,
DB04227,"9-Amino-2-deoxy-2,3-dehydro-n-acetyl-neuraminic acid",,P03472,Neuraminidase,,,
DB04229,"7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane",,P04377,Pseudoazurin,,,
DB04230,Nitromethyldethia coenzyme A,,O75390,"Citrate synthase, mitochondrial",CS,,
DB04231,Tetra(imidazole)diaquacopper (I),,P00282,Azurin,azu,,
DB04232,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,,P08254,Stromelysin-1,MMP3,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P04118,Colipase,CLPS,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P16233,Pancreatic triacylglycerol lipase,PNLIP,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P08100,Rhodopsin,RHO,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P74334,"Apocarotenoid-15,15'-oxygenase",,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P76045,Outer membrane protein G,ompG,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P0A915,Outer membrane protein W,ompW,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,Q48152,Adhesin,hia,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P05695,Porin P,oprP,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P32722,Porin D,oprD,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P31243,Porin,,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,Q9HUR5,Vanillate porin OpdK,opdK,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P07110,Outer membrane usher protein PapC,papC,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,Q9K597,Outer membrane porin C,ompC,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,Q9RBW8,TbuX,tbuX,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,A5W4F4,Membrane protein involved in aromatic hydrocarbon degradation,,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,Q9HVJ6,Probable outer membrane protein,,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,Q72JD8,Hypothetical conserved protein,,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,O33407,Esterase EstA,estA,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P33247,Squalene--hopene cyclase,shc,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P06129,Vitamin B12 transporter BtuB,btuB,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P39767,Porin,opmA,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P02931,Outer membrane protein F,ompF,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P10384,Long-chain fatty acid transport protein,fadL,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P0A917,Outer membrane protein X,ompX,,
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,P0A910,Outer membrane protein A,ompA,,
DB04234,N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide,,P43235,Cathepsin K,CTSK,,
DB04235,4-Amino Hexanoic Acid,,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,,
DB04237,Tris(Hydroxyethyl)Aminomethane,,P04745,Alpha-amylase 1,AMY1A,,
DB04237,Tris(Hydroxyethyl)Aminomethane,,O67987,"Chlorocatechol 1,2-dioxygenase",clcA,,
DB04237,Tris(Hydroxyethyl)Aminomethane,,P00778,Alpha-lytic protease,alpha-LP,,
DB04238,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,,P07477,Trypsin-1,PRSS1,,
DB04239,2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB04241,N-Pyridoxyl-2-Methylalanine-5-Phosphate,,P16932,"2,2-dialkylglycine decarboxylase",dgdA,,
DB04242,4-hydroxybenzoic acid,,P20586,p-hydroxybenzoate hydroxylase,pobA,,
DB04242,4-hydroxybenzoic acid,,P26602,Chorismate--pyruvate lyase,ubiC,,
DB04242,4-hydroxybenzoic acid,,P00438,p-hydroxybenzoate hydroxylase,pobA,,
DB04242,4-hydroxybenzoic acid,,Q04416,4-hydroxybenzoyl-CoA thioesterase,fcbC,,
DB04243,TMP,,P0AGE0,Single-stranded DNA-binding protein,ssb,,
DB04244,(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,,P43235,Cathepsin K,CTSK,,
DB04246,CRA_23653,,P07477,Trypsin-1,PRSS1,,
DB04248,beta-(1->4)-galactotriose,,Q65CX5,"Arabinogalactan endo-1,4-beta-galactosidase",ganB,,
DB04249,Zinc Substituted Heme C,,P99999,Cytochrome c,CYCS,,
DB04250,Butyrylthiocholine,,P06276,Cholinesterase,BCHE,substrate,
DB04252,N-Carbamoylaspartic acid,,P05020,Dihydroorotase,pyrC,,
DB04253,Tretazicar,,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,
DB04253,Tretazicar,,P38489,Oxygen-insensitive NAD(P)H nitroreductase,nfsB,,
DB04254,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB04255,Inhibitor BEA388,,P03366,Gag-Pol polyprotein,gag-pol,,
DB04256,(S)-alpha-methyl-4-carboxyphenylglycine,,Q13255,Metabotropic glutamate receptor 1,GRM1,,
DB04257,Palmitoleic Acid,,O67648,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,lpxC,,
DB04257,Palmitoleic Acid,,O31440,Fatty-acid peroxygenase,cypC,,
DB04257,Palmitoleic Acid,,P14779,Bifunctional P-450/NADPH-P450 reductase,cyp102A1,,
DB04258,Seocalcitol,,P11473,Vitamin D3 receptor,VDR,,
DB04260,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",,P00491,Purine nucleoside phosphorylase,PNP,,
DB04261,Carbamic Acid,,P00808,Beta-lactamase,penP,,
DB04262,3-(7-hydroxy-8-ribityllumazine-6-yl) propionic acid,,O66529,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB04263,Geneticin,,P11926,Ornithine decarboxylase,ODC1,,
DB04264,"(10R)-10-formyl-5,8,10-trideazafolic acid",,P08179,Phosphoribosylglycinamide formyltransferase,purN,,
DB04265,N-acetyl-beta-neuraminic acid,,P04958,Tetanus toxin,tetX,,
DB04265,N-acetyl-beta-neuraminic acid,,Q02834,Sialidase,nedA,,
DB04265,N-acetyl-beta-neuraminic acid,,Q04830,Endo-N-acetylneuraminidase,,,
DB04265,N-acetyl-beta-neuraminic acid,,P12564,Hemagglutinin-neuraminidase,HN,,
DB04267,Dipicolinic acid,,P04036,4-hydroxy-tetrahydrodipicolinate reductase,dapB,,
DB04267,Dipicolinic acid,,P9WP23,4-hydroxy-tetrahydrodipicolinate reductase,dapB,,
DB04268,Methylumbelliferyl chitotriose,,P61626,Lysozyme C,LYZ,,
DB04269,Cyclotheonamide A,,P07477,Trypsin-1,PRSS1,,
DB04270,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB04271,"3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB04272,Citric acid,,C7C422,Metallo-beta-lactamase type 2,blaNDM-1,inhibitor,A09AB04
DB04272,Citric acid,,P15121,Aldose reductase,AKR1B1,inhibitor,A09AB04
DB04272,Citric acid,,P39126,Isocitrate dehydrogenase [NADP],icd,substrate,A09AB04
DB04272,Citric acid,,P39126,Isocitrate dehydrogenase [NADP],icd,inhibitor,A09AB04
DB04272,Citric acid,,P00808,Beta-lactamase,penP,weak inhibitor,A09AB04
DB04272,Citric acid,,P04190,Beta-lactamase 2,blm,,A09AB04
DB04272,Citric acid,,O75390,"Citrate synthase, mitochondrial",CS,,A09AB04
DB04272,Citric acid,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,A09AB04
DB04272,Citric acid,,P07998,Ribonuclease pancreatic,RNASE1,,A09AB04
DB04272,Citric acid,,P12724,Eosinophil cationic protein,RNASE3,,A09AB04
DB04272,Citric acid,,P05042,Fumarate hydratase class II,fumC,inhibitor,A09AB04
DB04272,Citric acid,,Q9X0N8,6-phosphogluconolactonase,pgl,,A09AB04
DB04272,Citric acid,,Q96RQ9,L-amino-acid oxidase,IL4I1,,A09AB04
DB04272,Citric acid,,Q9GZU7,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,CTDSP1,,A09AB04
DB04272,Citric acid,,P83787,Cytochrome c peroxidase,,,A09AB04
DB04272,Citric acid,,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,,A09AB04
DB04272,Citric acid,,P11922,Invasin,,,A09AB04
DB04272,Citric acid,,P13299,Intron-associated endonuclease 1,ITEVIR,,A09AB04
DB04272,Citric acid,,P10930,Short tail fiber protein,12,,A09AB04
DB04272,Citric acid,,P40926,"Malate dehydrogenase, mitochondrial",MDH2,,A09AB04
DB04272,Citric acid,,Q2QJL3,N5-carboxyaminoimidazole ribonucleotide mutase,purE,,A09AB04
DB04272,Citric acid,,P38516,50S ribosomal protein L4,rplD,,A09AB04
DB04272,Citric acid,,P15086,Carboxypeptidase B,CPB1,,A09AB04
DB04272,Citric acid,,P03277,Hexon protein,,,A09AB04
DB04272,Citric acid,,Q9WZW1,Riboflavin biosynthesis protein RibF,,,A09AB04
DB04272,Citric acid,,O33833,Beta-fructosidase,bfrA,,A09AB04
DB04272,Citric acid,,A0A5P8YJZ1,Putative stringent starvation protein A,sspA,,A09AB04
DB04272,Citric acid,,Q9LCX9,Citrate synthase,cit,,A09AB04
DB04272,Citric acid,,P46849,RNA 3'-terminal phosphate cyclase,rtcA,,A09AB04
DB04272,Citric acid,,P62312,U6 snRNA-associated Sm-like protein LSm6,LSM6,,A09AB04
DB04272,Citric acid,,Q9HB21,Pleckstrin homology domain-containing family A member 1,PLEKHA1,,A09AB04
DB04272,Citric acid,,P21408,Fe(3+)-binding periplasmic protein,fbpA,,A09AB04
DB04272,Citric acid,,Q9WZ40,Signal recognition particle receptor FtsY,ftsY,,A09AB04
DB04272,Citric acid,,P0A753,Nicotinate-nucleotide adenylyltransferase,nadD,,A09AB04
DB04272,Citric acid,,Q9X286,N utilization substance protein B homolog,nusB,,A09AB04
DB04272,Citric acid,,P07360,Complement component C8 gamma chain,C8G,,A09AB04
DB04272,Citric acid,,Q9CBQ2,Ribonucleoside-diphosphate reductase subunit beta,nrdF,,A09AB04
DB04272,Citric acid,,P9WN39,Glutamine synthetase 1,glnA1,,A09AB04
DB04272,Citric acid,,O34002,Citrate synthase,gltA,,A09AB04
DB04272,Citric acid,,Q9GV41,Prostaglandin F synthase,,,A09AB04
DB04272,Citric acid,,P07741,Adenine phosphoribosyltransferase,APRT,,A09AB04
DB04272,Citric acid,,Q9HU22,Glucose-1-phosphate thymidylyltransferase,rmlA,,A09AB04
DB04272,Citric acid,,Q81F54,Glyoxalase family protein,,,A09AB04
DB04272,Citric acid,,P33644,Laccase domain protein YfiH,yfiH,,A09AB04
DB04272,Citric acid,,P44725,Ribose-5-phosphate isomerase A,rpiA,,A09AB04
DB04272,Citric acid,,P04079,GMP synthase [glutamine-hydrolyzing],guaA,,A09AB04
DB04272,Citric acid,,Q9BY32,Inosine triphosphate pyrophosphatase,ITPA,,A09AB04
DB04272,Citric acid,,Q37875,Lysozyme,17,,A09AB04
DB04272,Citric acid,,Q9X1F0,Glycerol uptake operon antiterminator regulatory protein,,,A09AB04
DB04272,Citric acid,,P32427,"3-carboxy-cis,cis-muconate cycloisomerase",pcaB,,A09AB04
DB04272,Citric acid,,P06672,Pyruvate decarboxylase,pdc,,A09AB04
DB04273,"8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB04275,N-acetylserotonin,,P35270,Sepiapterin reductase,SPR,,
DB04276,4-[[(2S)-2-[[(2S)-3-Carboxy-2-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butyl-(diaminomethylidene)azanium,,A0A0H3JWX6,NPQTN specific sortase B,srtB,,
DB04276,4-[[(2S)-2-[[(2S)-3-Carboxy-2-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butyl-(diaminomethylidene)azanium,,P07384,Calpain-1 catalytic subunit,CAPN1,,
DB04277,Fructose -6-Phosphate,,O35000,Glucosamine-6-phosphate deaminase 1,nagB,,
DB04278,2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide,,P60568,Interleukin-2,IL2,,
DB04279,3-Isopropylmalic Acid,,P08200,Isocitrate dehydrogenase [NADP],icd,,
DB04279,3-Isopropylmalic Acid,,Q56268,3-isopropylmalate dehydrogenase,leuB,,
DB04280,"3,4-Dihydro-2'-deoxyuridine-5'-monophosphate",,P16006,Deoxycytidylate deaminase,CD,,
DB04281,"2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone",,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB04282,2-deoxy-2-fluoro-α-D-glucose,,P07986,Exoglucanase/xylanase,cex,,
DB04282,2-deoxy-2-fluoro-α-D-glucose,,P22073,Beta-glucosidase A,bglA,,
DB04282,2-deoxy-2-fluoro-α-D-glucose,,Q54331,Cellulase B,celB,,
DB04282,2-deoxy-2-fluoro-α-D-glucose,,P09848,Lactase-phlorizin hydrolase,LCT,,
DB04284,L-proline betaine,,P0AFM2,Glycine betaine-binding periplasmic protein,proX,,
DB04285,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB04286,beta-D-Ribopyranose,,P02925,D-ribose-binding periplasmic protein,rbsB,,
DB04286,beta-D-Ribopyranose,,P36946,D-ribose pyranase,rbsD,,
DB04287,KH064,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB04288,2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB04289,Genz-10850,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,
DB04293,7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,,P00811,Beta-lactamase,ampC,,
DB04294,5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate,,P9WJJ7,Nicotinate-nucleotide pyrophosphorylase [carboxylating],nadC,,
DB04295,N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04296,5-Oxo-L-Norleucine,,P0AG16,Amidophosphoribosyltransferase,purF,,
DB04297,Trichostatin A,,Q8WUI4,Histone deacetylase 7,HDAC7,,
DB04297,Trichostatin A,,Q9BY41,Histone deacetylase 8,HDAC8,,
DB04297,Trichostatin A,,O67135,Acetoin utilization protein,acuC1,,
DB04297,Trichostatin A,,Q14790,Caspase-8,CASP8,activator,
DB04297,Trichostatin A,,P34995,Prostaglandin E2 Receptors,PTGER1,regulator,
DB04297,Trichostatin A,,P01375,Tumor necrosis factor,TNF,downregulator,
DB04298,"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",,P26663,Genome polyprotein,,,
DB04299,Maleic acid,,P00509,Aspartate aminotransferase,aspC,,
DB04299,Maleic acid,,P28593,Trypanothione reductase,TPR,,
DB04299,Maleic acid,,Q56232,Aspartate aminotransferase,aspC,,
DB04299,Maleic acid,,P95468,Aromatic-amino-acid aminotransferase,tyrB,,
DB04299,Maleic acid,,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,,
DB04301,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,,P07477,Trypsin-1,PRSS1,,
DB04302,"4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One",,P9WQD9,3-oxoacyl-[acyl-carrier-protein] synthase 1,kasA,,
DB04302,"4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One",,P0A953,3-oxoacyl-[acyl-carrier-protein] synthase 1,fabB,,
DB04303,4-O-methyl-alpha-D-glucuronic acid,,O68541,Endoxylanase,xynC,,
DB04303,4-O-methyl-alpha-D-glucuronic acid,,Q8VVD2,Alpha-glucuronidase,aguA,,
DB04304,L-Gluconic Acid,,P22073,Beta-glucosidase A,bglA,,
DB04306,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFRL1,,
DB04306,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",,P22906,Dihydrofolate reductase,DFR1,,
DB04307,5-Hydroxy-N-Propargyl-1(R)-Aminoindan,,P27338,Amine oxidase [flavin-containing] B,MAOB,ligand,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,P68826,Peptide deformylase,def,,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,Q93LE9,Peptide deformylase,def,,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,Q819U0,Peptide deformylase 1,def1,,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,Q819K2,Peptide deformylase 2,def2,,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,Q82ZJ0,Peptide deformylase,def,,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,P68771,Peptide deformylase,def,,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,Q9HBH1,"Peptide deformylase, mitochondrial",PDF,,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,Q9I7A8,Peptide deformylase,def,,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,P0A6K3,Peptide deformylase,def,,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,O31410,Peptide deformylase 2,,,
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,Q8NX78,Peptide deformylase,def,,
DB04311,4-Phenylbutylamine,,P07477,Trypsin-1,PRSS1,,
DB04312,"2,3-Difluorobenzyl Alcohol",,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB04314,1-Methylcytosine,,P07617,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,PAPS,,
DB04315,Guanosine-5'-Diphosphate,,P01112,GTPase HRas,HRAS,,
DB04315,Guanosine-5'-Diphosphate,,P61586,Transforming protein RhoA,RHOA,,
DB04315,Guanosine-5'-Diphosphate,,P21980,Protein-glutamine gamma-glutamyltransferase 2,TGM2,,
DB04315,Guanosine-5'-Diphosphate,,P62491,Ras-related protein Rab-11A,RAB11A,,
DB04315,Guanosine-5'-Diphosphate,,P0A7D4,Adenylosuccinate synthetase,purA,,
DB04315,Guanosine-5'-Diphosphate,,P9WN95,Cell division protein FtsZ,ftsZ,,
DB04315,Guanosine-5'-Diphosphate,,Q08188,Protein-glutamine gamma-glutamyltransferase E,TGM3,,
DB04315,Guanosine-5'-Diphosphate,,Q92930,Ras-related protein Rab-8B,RAB8B,,
DB04315,Guanosine-5'-Diphosphate,,P62330,ADP-ribosylation factor 6,ARF6,,
DB04315,Guanosine-5'-Diphosphate,,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,,
DB04315,Guanosine-5'-Diphosphate,,P13551,Elongation factor G,fusA,,
DB04315,Guanosine-5'-Diphosphate,,P49411,"Elongation factor Tu, mitochondrial",TUFM,,
DB04315,Guanosine-5'-Diphosphate,,Q9X1F8,GTPase Der,der,,
DB04315,Guanosine-5'-Diphosphate,,P32056,GDP-mannose mannosyl hydrolase,gmm,,
DB04315,Guanosine-5'-Diphosphate,,P38424,Probable GTP-binding protein EngB,engB,,
DB04315,Guanosine-5'-Diphosphate,,P41091,Eukaryotic translation initiation factor 2 subunit 3,EIF2S3,,
DB04315,Guanosine-5'-Diphosphate,,P63096,Guanine nucleotide-binding protein G(i) subunit alpha-1,GNAI1,,
DB04315,Guanosine-5'-Diphosphate,,O07347,Signal recognition particle protein,ffh,,
DB04315,Guanosine-5'-Diphosphate,,P11488,Guanine nucleotide-binding protein G(t) subunit alpha-1,GNAT1,,
DB04315,Guanosine-5'-Diphosphate,,P60339,Elongation factor Tu-B,tufB,,
DB04315,Guanosine-5'-Diphosphate,,P51151,Ras-related protein Rab-9A,RAB9A,,
DB04315,Guanosine-5'-Diphosphate,,P15531,Nucleoside diphosphate kinase A,NME1,,
DB04315,Guanosine-5'-Diphosphate,,Q15382,GTP-binding protein Rheb,RHEB,,
DB04315,Guanosine-5'-Diphosphate,,P60953,Cell division control protein 42 homolog,CDC42,,
DB04315,Guanosine-5'-Diphosphate,,Q83JC4,Elongation factor Tu,tufA,,
DB04315,Guanosine-5'-Diphosphate,,P84077,ADP-ribosylation factor 1,ARF1,,
DB04315,Guanosine-5'-Diphosphate,,P13639,Elongation factor 2,EEF2,,
DB04315,Guanosine-5'-Diphosphate,,Q54089,Bifunctional (p)ppGpp synthase/hydrolase RelA,relA,,
DB04315,Guanosine-5'-Diphosphate,,P10114,Ras-related protein Rap-2a,RAP2A,,
DB04315,Guanosine-5'-Diphosphate,,Q7Z2Z2,Elongation factor Tu GTP-binding domain-containing protein 1,EFTUD1,,
DB04315,Guanosine-5'-Diphosphate,,P40616,ADP-ribosylation factor-like protein 1,ARL1,,
DB04315,Guanosine-5'-Diphosphate,,P62826,GTP-binding nuclear protein Ran,RAN,,
DB04315,Guanosine-5'-Diphosphate,,P51149,Ras-related protein Rab-7a,RAB7A,,
DB04315,Guanosine-5'-Diphosphate,,Q6NXR0,Interferon-inducible GTPase 5,IRGC,,
DB04315,Guanosine-5'-Diphosphate,,P15170,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,GSPT1,,
DB04315,Guanosine-5'-Diphosphate,,P20339,Ras-related protein Rab-5A,RAB5A,,
DB04315,Guanosine-5'-Diphosphate,,P68104,Elongation factor 1-alpha 1,EEF1A1,,
DB04315,Guanosine-5'-Diphosphate,,P18085,ADP-ribosylation factor 4,ARF4,,
DB04315,Guanosine-5'-Diphosphate,,O60547,"GDP-mannose 4,6 dehydratase",GMDS,,
DB04315,Guanosine-5'-Diphosphate,,P11233,Ras-related protein Ral-A,RALA,,
DB04315,Guanosine-5'-Diphosphate,,Q01698,Elongation factor Tu,tuf,,
DB04315,Guanosine-5'-Diphosphate,,Q96KC2,ADP-ribosylation factor-like protein 5B,ARL5B,,
DB04315,Guanosine-5'-Diphosphate,,Q26000,GTPase (Rab6),rab6,,
DB04315,Guanosine-5'-Diphosphate,,P36405,ADP-ribosylation factor-like protein 3,ARL3,,
DB04315,Guanosine-5'-Diphosphate,,P22392,Nucleoside diphosphate kinase B,NME2,,
DB04315,Guanosine-5'-Diphosphate,,Q51366,"GDP-mannose 4,6-dehydratase",gmd,,
DB04315,Guanosine-5'-Diphosphate,,P63000,Ras-related C3 botulinum toxin substrate 1,RAC1,,
DB04315,Guanosine-5'-Diphosphate,,Q9X242,Putative ribosome biogenesis GTPase RsgA,rsgA,,
DB04315,Guanosine-5'-Diphosphate,,Q9Y6B6,GTP-binding protein SAR1b,SAR1B,,
DB04315,Guanosine-5'-Diphosphate,,Q9U8D3,Adenylosuccinate synthetase,Adss,,
DB04315,Guanosine-5'-Diphosphate,,Q9Y689,ADP-ribosylation factor-like protein 5A,ARL5A,,
DB04316,D-[(N-Hydroxyamino)Carbonyl]Phenylalanine,,P15085,Carboxypeptidase A1,CPA1,,
DB04317,"3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid",,P00864,Phosphoenolpyruvate carboxylase,ppc,,
DB04318,Nα-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide,,P24347,Stromelysin-3,MMP11,,
DB04320,2-Bromo-2-Propene-1-Ol,,P51698,Haloalkane dehalogenase,linB,,
DB04322,LY249543,,P11586,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,,
DB04324,Ovalicin,,P53582,Methionine aminopeptidase 1,METAP1,,
DB04324,Ovalicin,,P50579,Methionine aminopeptidase 2,METAP2,,
DB04325,Phenethylamine,,P46883,Primary amine oxidase,tynA,,
DB04325,Phenethylamine,,P07477,Trypsin-1,PRSS1,,
DB04325,Phenethylamine,,P07478,Trypsin-2,PRSS2,,
DB04326,Dihydroxyacetone phosphate,,P04075,Fructose-bisphosphate aldolase A,ALDOA,,
DB04326,Dihydroxyacetone phosphate,,P60174,Triosephosphate isomerase,TPI1,,
DB04326,Dihydroxyacetone phosphate,,P05062,Fructose-bisphosphate aldolase B,ALDOB,,
DB04326,Dihydroxyacetone phosphate,,P0AB87,L-fuculose phosphate aldolase,fucA,,
DB04327,Phosphatidylethanolamine,,P60484,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",PTEN,substrate,
DB04327,Phosphatidylethanolamine,,Q9UNN8,Endothelial protein C receptor,PROCR,,
DB04327,Phosphatidylethanolamine,,Q8YSC4,Bacteriorhodopsin,,,
DB04328,Shikimate-3-Phosphate,,P0A6D3,3-phosphoshikimate 1-carboxyvinyltransferase,aroA,,
DB04328,Shikimate-3-Phosphate,,Q9S400,3-phosphoshikimate 1-carboxyvinyltransferase,aroA,,
DB04330,Bilh 434,,P04015,Regulatory protein E2,E2,,
DB04331,Monastrol,,P52732,Kinesin-like protein KIF11,KIF11,,
DB04334,6-hydroxydopa quinone,,Q16853,Membrane primary amine oxidase,AOC3,,
DB04334,6-hydroxydopa quinone,,P46883,Primary amine oxidase,tynA,,
DB04334,6-hydroxydopa quinone,,P46881,Phenylethylamine oxidase,,,
DB04335,Inosine,,P00491,Purine nucleoside phosphorylase,PNP,,G01AX02;S01XA10;D06BB05
DB04335,Inosine,,Q9GPQ4,IAG-nucleoside hydrolase,,,G01AX02;S01XA10;D06BB05
DB04335,Inosine,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,G01AX02;S01XA10;D06BB05
DB04336,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,,P07477,Trypsin-1,PRSS1,,
DB04337,Isocyanomethane,,P02144,Myoglobin,MB,,
DB04338,SB220025,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB04338,SB220025,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB04339,Carbocisteine,,Q63HM9,PI-PLC X domain-containing protein 3,PLCXD3,inhibitor,R05CB03
DB04339,Carbocisteine,,Q9UNP4,"Lactosylceramide alpha-2,3-sialyltransferase",ST3GAL5,inducer,R05CB03
DB04340,2-[(Dioxidophosphoranyl)oxy]benzoate,,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB04342,7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,,P14489,Beta-lactamase OXA-10,bla,,
DB04343,Glyoxylic acid,,P37330,Malate synthase G,glcB,,
DB04343,Glyoxylic acid,,P9WKK7,Isocitrate lyase,icl,,
DB04343,Glyoxylic acid,,P9WK17,Malate synthase G,glcB,,
DB04343,Glyoxylic acid,,P9WGY3,Putative regulator of ribonuclease activity,rraA,,
DB04345,Lumichrome,,P30043,Flavin reductase (NADPH),BLVRB,,
DB04345,Lumichrome,,Q9WZW1,Riboflavin biosynthesis protein RibF,,,
DB04346,"(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran",,Q8Z2X8,Autoinducer 2-binding protein LsrB,lsrB,,
DB04347,3-Dehydroshikimate,,Q6GII7,3-dehydroquinate dehydratase,aroD,,
DB04347,3-Dehydroshikimate,,P15474,3-dehydroquinate dehydratase,aroQ,,
DB04348,Taurocholic acid,,P19835,Bile salt-activated lipase,CEL,,
DB04348,Taurocholic acid,,Q96RI1,Bile acid receptor,NR1H4,,
DB04348,Taurocholic acid,,P51161,Gastrotropin,FABP6,ligand,
DB04349,"(S)-propane-1,2-diol",,P39126,Isocitrate dehydrogenase [NADP],icd,,
DB04349,"(S)-propane-1,2-diol",,O07015,Sigma factor SigB regulation protein RsbQ,rsbQ,,
DB04350,Argadin,,Q13231,Chitotriosidase-1,CHIT1,,
DB04350,Argadin,,Q873X9,Chitinase,chiB1,,
DB04351,Aconitate Ion,,Q99798,"Aconitate hydratase, mitochondrial",ACO2,,
DB04351,Aconitate Ion,,P36683,Aconitate hydratase 2,acnB,,
DB04352,beta-D-Ribose-5-phosphate,,P36946,D-ribose pyranase,rbsD,,
DB04352,beta-D-Ribose-5-phosphate,,Q9BW91,"ADP-ribose pyrophosphatase, mitochondrial",NUDT9,,
DB04353,"Tert-butyl N-[(2S,5R)-6-[[(2S)-5-amino-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-benzyl-3,6-dioxo-1-phenylhexan-2-yl]carbamate",,P12499,Gag-Pol polyprotein,gag-pol,,
DB04356,9-Deazaguanine,,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,,
DB04359,Vinylsulfonic acid,,O31156,Phosphonoacetaldehyde hydrolase,phnX,,
DB04360,Benzo[B]Thiophene-2-Boronic Acid,,P00811,Beta-lactamase,ampC,,
DB04361,Methyldiazene,,P13650,Quinoprotein glucose dehydrogenase B,gdhB,,
DB04363,Mesobiliverdin IV alpha,,P30043,Flavin reductase (NADPH),BLVRB,,
DB04365,Arecoline,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,,
DB04365,Arecoline,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,,
DB04366,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,,P15531,Nucleoside diphosphate kinase A,NME1,,
DB04367,Debromohymenialdisine,,Q07912,Activated CDC42 kinase 1,TNK2,,
DB04367,Debromohymenialdisine,,P49759,Dual specificity protein kinase CLK1,CLK1,,
DB04368,Bb-3497,,P0A6K3,Peptide deformylase,def,,
DB04368,Bb-3497,,Q9HBH1,"Peptide deformylase, mitochondrial",PDF,inhibitor,
DB04369,"1,3,2-Dioxaborolan-2-Ol",,P35030,Trypsin-3,PRSS3,,
DB04371,AL6528,,P00918,Carbonic anhydrase 2,CA2,,
DB04372,L-Dilinoleoyllecithin,,Q9UKL6,Phosphatidylcholine transfer protein,PCTP,,
DB04373,"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",,P46925,Plasmepsin-2,,,
DB04374,"4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole",,Q9UJM8,Hydroxyacid oxidase 1,HAO1,,
DB04376,13-Acetylphorbol,,Q05655,Protein kinase C delta type,PRKCD,,
DB04377,Meglutol,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,,C10AX05
DB04378,"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",,P46925,Plasmepsin-2,,,
DB04379,N-Methyl-N-(Methylbenzyl)Formamide,,P00797,Renin,REN,,
DB04380,Allantoate,,P77425,Allantoate amidohydrolase,allC,,
DB04381,Crotonaldehyde,,P05091,"Aldehyde dehydrogenase, mitochondrial",ALDH2,,
DB04382,2-Deoxy-alpha-D-galactopyranose,,P00722,Beta-galactosidase,lacZ,,
DB04385,3-Deazacytidine,,P0ABF6,Cytidine deaminase,cdd,,
DB04386,"4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose",,Q9AQS0,Xanthan lyase,xly,,
DB04387,1-Hydroxy-2-Amino-3-Cyclohexylpropane,,P00797,Renin,REN,,
DB04387,1-Hydroxy-2-Amino-3-Cyclohexylpropane,,P0DJ06,Candidapepsin-2,SAP2,,
DB04388,4-Carboxy-4-Aminobutanal,,Q88K39,Glutaminase-asparaginase,ansB,,
DB04389,Ado-P-Ch2-P-Ps-Ado,,P49789,Bis(5'-adenosyl)-triphosphatase,FHIT,,
DB04391,Aeruginosin 98-B,,P07477,Trypsin-1,PRSS1,,
DB04392,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,,
DB04392,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",,P41407,FMN-dependent NADH-azoreductase,azoR,,
DB04392,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",,P38489,Oxygen-insensitive NAD(P)H nitroreductase,nfsB,,
DB04393,Soneclosan,,O24990,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,
DB04394,3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide,,P00918,Carbonic anhydrase 2,CA2,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P23919,Thymidylate kinase,DTYMK,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q56310,Chemotaxis protein CheA,cheA,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P08069,Insulin-like growth factor 1 receptor,IGF1R,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P45510,Dihydroxyacetone kinase,dhaK,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P0A6I3,Pantothenate kinase,coaA,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P19367,Hexokinase-1,HK1,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P33221,Phosphoribosylglycinamide formyltransferase 2,purT,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P06239,Tyrosine-protein kinase Lck,LCK,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P29317,Ephrin type-A receptor 2,EPHA2,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P59846,Argininosuccinate synthase,argG,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P0A820,S-adenosylmethionine synthase,metK,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P45066,UDP-N-acetylmuramate--L-alanine ligase,murC,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P23367,DNA mismatch repair protein MutL,mutL,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q99661,Kinesin-like protein KIF2C,KIF2C,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P23677,Inositol-trisphosphate 3-kinase A,ITPKA,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q02880,DNA topoisomerase 2-beta,TOP2B,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P48637,Glutathione synthetase,GSS,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q83LD8,4-diphosphocytidyl-2-C-methyl-D-erythritol kinase,ispE,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q16877,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",PFKFB4,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P0A3Y5,Aminoglycoside 3'-phosphotransferase,aphA,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P53355,Death-associated protein kinase 1,DAPK1,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P08690,Arsenical pump-driving ATPase,arsA,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P0A6C8,Acetylglutamate kinase,argB,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P0AES6,DNA gyrase subunit B,gyrB,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P0AEJ4,Osmolarity sensor protein EnvZ,envZ,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P0A6H7,ATP-dependent protease ATPase subunit HslU,hslU,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P29323,Ephrin type-B receptor 2,EPHB2,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q04230,TrwB,trwB,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P55072,Transitional endoplasmic reticulum ATPase,VCP,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q96QT4,Transient receptor potential cation channel subfamily M member 7,TRPM7,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q12756,Kinesin-like protein KIF1A,KIF1A,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P49368,T-complex protein 1 subunit gamma,CCT3,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q9WZ57,Rod shape-determining protein MreB,,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P78362,SRSF protein kinase 2,SRPK2,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P53778,Mitogen-activated protein kinase 12,MAPK12,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q9RA63,Chaperone protein ClpB,clpB,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P37093,Type II secretion system protein E,epsE,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P23837,Sensor protein PhoQ,phoQ,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P20083,DNA topoisomerase 4 subunit B,parE,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P51570,Galactokinase,GALK1,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P0A7G9,Protein RecA,recA,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,Q06609,DNA repair protein RAD51 homolog 1,RAD51,,
DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,,P03960,Potassium-transporting ATPase B chain,kdpB,,
DB04396,Thiodigalactoside,,P32890,Heat-labile enterotoxin B chain,eltB,,
DB04396,Thiodigalactoside,,P02920,Lactose permease,lacY,,
DB04396,Thiodigalactoside,,O14594,Neurocan core protein,NCAN,,
DB04396,Thiodigalactoside,,P09382,Galectin-1,LGALS1,,
DB04397,Alpha-D-Glucose-1-Phosphate-6-Vanadate,,P36871,Phosphoglucomutase-1,PGM1,,
DB04398,Lactic acid,,P09546,Bifunctional protein PutA,putA,,G01AD01
DB04398,Lactic acid,,Q9RW27,NimA-related protein,,,G01AD01
DB04400,"L-erythro-7,8-dihydrobiopterin",,P00439,Phenylalanine-4-hydroxylase,PAH,,
DB04400,"L-erythro-7,8-dihydrobiopterin",,Q01782,Pteridine reductase 1,PTR1,,
DB04400,"L-erythro-7,8-dihydrobiopterin",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB04400,"L-erythro-7,8-dihydrobiopterin",,P07101,Tyrosine 3-monooxygenase,TH,,
DB04400,"L-erythro-7,8-dihydrobiopterin",,P61457,Pterin-4-alpha-carbinolamine dehydratase,PCBD1,,
DB04400,"L-erythro-7,8-dihydrobiopterin",,P56740,Dihydroneopterin aldolase,folB,,
DB04401,Betaine aldehyde,,P77674,Gamma-aminobutyraldehyde dehydrogenase,prr,,
DB04404,Allosamizoline,,Q13231,Chitotriosidase-1,CHIT1,,
DB04404,Allosamizoline,,P11797,Chitinase B,chiB,,
DB04404,Allosamizoline,,P07254,Chitinase A,chiA,,
DB04405,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",,P39900,Macrophage metalloelastase,MMP12,,
DB04407,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB04408,Ncs-Chromophore,,P0A3S0,Neocarzinostatin,ncsA,,
DB04409,Naphthalene Trisulfonate,,P05230,Fibroblast growth factor 1,FGF1,,
DB04410,3-Phenylpropylamine,,P07477,Trypsin-1,PRSS1,,
DB04410,3-Phenylpropylamine,,P07478,Trypsin-2,PRSS2,,
DB04411,Alpha-N-Dichloroacetyl-P-Aminophenylserinol,,Q56148,Chloramphenicol 3-O phosphotransferase,,,
DB04414,Heptamolybdate,,P52687,Sensor histidine kinase CitA,citA,,
DB04416,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",,P08254,Stromelysin-1,MMP3,,
DB04417,P-Nitrophenol,,P50225,Sulfotransferase 1A1,SULT1A1,,
DB04417,P-Nitrophenol,,P19961,Alpha-amylase 2B,AMY2B,,
DB04418,Adenylosuccinic acid,,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,,
DB04419,D-norleucine,,P00439,Phenylalanine-4-hydroxylase,PAH,,
DB04419,D-norleucine,,P01270,Parathyroid hormone,PTH,,
DB04419,D-norleucine,,P20823,Hepatocyte nuclear factor 1-alpha,HNF1A,,
DB04422,Homocysteine,,O34667,S-ribosylhomocysteine lyase,luxS,,
DB04422,Homocysteine,,Q9X112,5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase,metE,,
DB04422,Homocysteine,,Q9WYA5,5-methyltetrahydrofolate S-homocysteine methyltransferase,,,
DB04424,RPR128515,,P07477,Trypsin-1,PRSS1,,
DB04425,"7,8-Dihydroneopterin",,P56740,Dihydroneopterin aldolase,folB,,
DB04426,Alpha-Methyl-N-Acetyl-D-Glucosamine,,P11226,Mannose-binding protein C,MBL2,,
DB04427,N-{(3S)-1-[(Benzyloxy)sulfamoyl]-5-phenyl-3-pentanyl}-Nα-[(4-methyl-1-piperazinyl)carbonyl]-L-phenylalaninamide,,P25779,Cruzipain,,,
DB04429,4'-Hydroxyflavanone,,P04278,Sex hormone-binding globulin,SHBG,,
DB04430,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,,P62593,Beta-lactamase TEM,bla,,
DB04430,3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,,P62594,Beta-lactamase TEM,bla,,
DB04432,ZK-805623,,P07477,Trypsin-1,PRSS1,,
DB04433,Verpacamide A,,P11797,Chitinase B,chiB,,
DB04434,Naphthyridine Inhibitor,,P36897,TGF-beta receptor type-1,TGFBR1,,
DB04436,3-Fluoro-L-tyrosine,,P04179,"Superoxide dismutase [Mn], mitochondrial",SOD2,,
DB04438,Brivudine monophosphate,,P0C0E6,Thymidine kinase,,,
DB04439,Modified Acarbose Pentasaccharide,,P80099,4-alpha-glucanotransferase,mgtA,,
DB04440,Nebularine,,P00813,Adenosine deaminase,ADA,,
DB04441,2-Fluoroadenosine,,P0ABP8,Purine nucleoside phosphorylase DeoD-type,deoD,,
DB04442,"Imino[2-(2-oxo-1,2-dihydro-3-pyridinyl)-1H-benzimidazol-5-yl]methanaminium",,P07477,Trypsin-1,PRSS1,,
DB04444,Tetrafluoroaluminate Ion,,Q7Z406,Myosin-14,MYH14,,
DB04444,Tetrafluoroaluminate Ion,,P62219,Protein RecA,recA,,
DB04444,Tetrafluoroaluminate Ion,,P0A6C8,Acetylglutamate kinase,argB,,
DB04444,Tetrafluoroaluminate Ion,,P63096,Guanine nucleotide-binding protein G(i) subunit alpha-1,GNAI1,,
DB04444,Tetrafluoroaluminate Ion,,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,,
DB04444,Tetrafluoroaluminate Ion,,P11488,Guanine nucleotide-binding protein G(t) subunit alpha-1,GNAT1,,
DB04444,Tetrafluoroaluminate Ion,,P30085,UMP-CMP kinase,CMPK1,,
DB04444,Tetrafluoroaluminate Ion,,P35749,Myosin-11,MYH11,,
DB04444,Tetrafluoroaluminate Ion,,P0A9J6,Ribokinase,rbsK,,
DB04445,Mercuric iodide,,Q06520,Bile salt sulfotransferase,SULT2A1,,D08AK30
DB04446,Benzo[B]Thiophene-2-Carboxamidine,,P07477,Trypsin-1,PRSS1,,
DB04447,"1,4-Dithiothreitol",,P0A884,Thymidylate synthase,thyA,,
DB04447,"1,4-Dithiothreitol",,P60174,Triosephosphate isomerase,TPI1,,
DB04447,"1,4-Dithiothreitol",,O43708,Maleylacetoacetate isomerase,GSTZ1,,
DB04447,"1,4-Dithiothreitol",,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,,
DB04447,"1,4-Dithiothreitol",,P22262,Listeriolysin regulatory protein,prfA,,
DB04447,"1,4-Dithiothreitol",,P21340,Protease synthase and sporulation negative regulatory protein PAI 1,paiA,,
DB04447,"1,4-Dithiothreitol",,P96618,Holo-[acyl-carrier-protein] synthase,acpS,,
DB04447,"1,4-Dithiothreitol",,P06988,Histidinol dehydrogenase,hisD,,
DB04447,"1,4-Dithiothreitol",,P15770,Shikimate dehydrogenase,aroE,,
DB04447,"1,4-Dithiothreitol",,P09382,Galectin-1,LGALS1,,
DB04447,"1,4-Dithiothreitol",,Q9UQM7,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,,
DB04447,"1,4-Dithiothreitol",,P60493,50S ribosomal protein L27,rpmA,,
DB04447,"1,4-Dithiothreitol",,P00352,Retinal dehydrogenase 1,ALDH1A1,,
DB04447,"1,4-Dithiothreitol",,Q9HZZ3,Organic hydroperoxide resistance protein,ohr,,
DB04447,"1,4-Dithiothreitol",,P32427,"3-carboxy-cis,cis-muconate cycloisomerase",pcaB,,
DB04447,"1,4-Dithiothreitol",,Q96QT4,Transient receptor potential cation channel subfamily M member 7,TRPM7,,
DB04447,"1,4-Dithiothreitol",,Q9RC92,Unsaturated glucuronyl hydrolase,ugl,,
DB04447,"1,4-Dithiothreitol",,P65389,Cyclic pyranopterin monophosphate synthase,moaA,,
DB04447,"1,4-Dithiothreitol",,Q02192,C protein alpha-antigen,bca,,
DB04447,"1,4-Dithiothreitol",,Q9UJ68,Mitochondrial peptide methionine sulfoxide reductase,MSRA,,
DB04447,"1,4-Dithiothreitol",,O87949,Chaperone protein TorD,torD,,
DB04447,"1,4-Dithiothreitol",,O15169,Axin-1,AXIN1,,
DB04447,"1,4-Dithiothreitol",,P23284,Peptidyl-prolyl cis-trans isomerase B,PPIB,,
DB04447,"1,4-Dithiothreitol",,Q9ZEU2,Amylosucrase,ams,,
DB04448,"2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene",,P00326,Alcohol dehydrogenase 1C,ADH1C,,
DB04450,Heptyl 1-Thiohexopyranoside,,P08100,Rhodopsin,RHO,,
DB04450,Heptyl 1-Thiohexopyranoside,,Q9L6V3,NADPH:ferredoxin reductase,fpr,,
DB04450,Heptyl 1-Thiohexopyranoside,,P0A6A8,Acyl carrier protein,acpP,,
DB04450,Heptyl 1-Thiohexopyranoside,,P53554,Biotin biosynthesis cytochrome P450,bioI,,
DB04451,4-Methylpiperazin-1-Yl Carbonyl Group,,P0DJ06,Candidapepsin-2,SAP2,,
DB04451,4-Methylpiperazin-1-Yl Carbonyl Group,,O60911,Cathepsin L2,CTSV,,
DB04452,Aminoquinuride,,P15917,Lethal factor,lef,,
DB04453,"4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose",,P04746,Pancreatic alpha-amylase,AMY2A,ligand,
DB04454,Alpha-Aminobutyric Acid,,P50440,"Glycine amidinotransferase, mitochondrial",GATM,,
DB04454,Alpha-Aminobutyric Acid,,P03369,Gag-Pol polyprotein,gag-pol,,
DB04454,Alpha-Aminobutyric Acid,,P01133,Pro-epidermal growth factor,EGF,,
DB04454,Alpha-Aminobutyric Acid,,P43683,Lantibiotic mersacidin,mrsA,,
DB04455,"N,N,N-trimethylglycinium",,P74645,Circadian clock protein KaiB,kaiB,,
DB04455,"N,N,N-trimethylglycinium",,P0AFM2,Glycine betaine-binding periplasmic protein,proX,,
DB04456,Arsenous acid,,P08692,Arsenate reductase,arsC,,
DB04456,Arsenous acid,,P08690,Arsenical pump-driving ATPase,arsA,,
DB04457,2'-Deoxyguanosine-5'-Monophosphate,,P0A884,Thymidylate synthase,thyA,,
DB04457,2'-Deoxyguanosine-5'-Monophosphate,,P04531,Deoxynucleotide monophosphate kinase,1,,
DB04459,"3,4-Dichloroisocoumarin",,P00746,Complement factor D,CFD,,
DB04460,(C8-S)-Hydantocidin 5'-phosphate,,P0A7D4,Adenylosuccinate synthetase,purA,,
DB04461,Coproporphyrinogen III,,P06132,Uroporphyrinogen decarboxylase,UROD,,
DB04462,Tetrabromo-2-Benzotriazole,,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB04463,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",,P16152,Carbonyl reductase [NADPH] 1,CBR1,ligand,
DB04464,N-Formylmethionine,,Q92696,Geranylgeranyl transferase type-2 subunit alpha,RABGGTA,,
DB04464,N-Formylmethionine,,P53611,Geranylgeranyl transferase type-2 subunit beta,RABGGTB,,
DB04464,N-Formylmethionine,,P07173,Photosynthetic reaction center cytochrome c subunit,pufC,,
DB04464,N-Formylmethionine,,P06008,Reaction center protein H chain,puhA,,
DB04464,N-Formylmethionine,,P06009,Reaction center protein L chain,pufL,,
DB04464,N-Formylmethionine,,P06010,Reaction center protein M chain,pufM,,
DB04464,N-Formylmethionine,,P35089,Light-harvesting protein B-800/820 alpha chain,,,
DB04464,N-Formylmethionine,,P35094,Light-harvesting protein B-800/820 beta chain,,,
DB04464,N-Formylmethionine,,P26789,Light-harvesting protein B-800/850 alpha chain,,,
DB04464,N-Formylmethionine,,P26790,Light-harvesting protein B-800/850 beta chain,,,
DB04464,N-Formylmethionine,,P01008,Antithrombin-III,SERPINC1,,
DB04464,N-Formylmethionine,,P61769,Beta-2-microglobulin,B2M,,
DB04464,N-Formylmethionine,,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,,
DB04464,N-Formylmethionine,,P01889,"HLA class I histocompatibility antigen, B-27 alpha chain",HLA-B,,
DB04464,N-Formylmethionine,,P09152,Respiratory nitrate reductase 1 alpha chain,narG,,
DB04464,N-Formylmethionine,,P11349,Respiratory nitrate reductase 1 beta chain,narH,,
DB04464,N-Formylmethionine,,P11350,Respiratory nitrate reductase 1 gamma chain,narI,,
DB04464,N-Formylmethionine,,P29377,Protein S100-G,S100G,,
DB04464,N-Formylmethionine,,P00269,Rubredoxin,rub,,
DB04464,N-Formylmethionine,,P13073,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",COX4I1,,
DB04464,N-Formylmethionine,,P00395,Cytochrome c oxidase subunit 1,MT-CO1,,
DB04464,N-Formylmethionine,,P00403,Cytochrome c oxidase subunit 2,MT-CO2,,
DB04464,N-Formylmethionine,,P00414,Cytochrome c oxidase subunit 3,MT-CO3,,
DB04464,N-Formylmethionine,,P20674,"Cytochrome c oxidase subunit 5A, mitochondrial",COX5A,,
DB04464,N-Formylmethionine,,P10606,"Cytochrome c oxidase subunit 5B, mitochondrial",COX5B,,
DB04464,N-Formylmethionine,,P09669,Cytochrome c oxidase subunit 6C,COX6C,,
DB04464,N-Formylmethionine,,P24311,"Cytochrome c oxidase subunit 7B, mitochondrial",COX7B,,
DB04464,N-Formylmethionine,,P15954,"Cytochrome c oxidase subunit 7C, mitochondrial",COX7C,,
DB04464,N-Formylmethionine,,P10176,"Cytochrome c oxidase subunit 8A, mitochondrial",COX8A,,
DB04464,N-Formylmethionine,,Q02221,"Cytochrome c oxidase subunit 6A2, mitochondrial",COX6A2,,
DB04464,N-Formylmethionine,,P14854,Cytochrome c oxidase subunit 6B1,COX6B1,,
DB04464,N-Formylmethionine,,P24310,"Cytochrome c oxidase subunit 7A1, mitochondrial",COX7A1,,
DB04464,N-Formylmethionine,,P23882,Methionyl-tRNA formyltransferase,fmt,,
DB04464,N-Formylmethionine,,P22629,Streptavidin,,,
DB04464,N-Formylmethionine,,P04271,Protein S100-B,S100B,,
DB04464,N-Formylmethionine,,P0C1V1,Delta-hemolysin,hld,,
DB04464,N-Formylmethionine,,P0CG48,Polyubiquitin-C,UBC,,
DB04464,N-Formylmethionine,,A5HEI4,AtpH,atpH,,
DB04464,N-Formylmethionine,,P39300,Probable L-ascorbate-6-phosphate lactonase UlaG,ulaG,,
DB04464,N-Formylmethionine,,P19909,Immunoglobulin G-binding protein G,spg,,
DB04464,N-Formylmethionine,,P0A6W9,Glutamate--cysteine ligase,gshA,,
DB04464,N-Formylmethionine,,P07998,Ribonuclease pancreatic,RNASE1,,
DB04464,N-Formylmethionine,,Q16740,"Putative ATP-dependent Clp protease proteolytic subunit, mitochondrial",CLPP,,
DB04465,Lactose,,P17931,Galectin-3,LGALS3,,
DB04465,Lactose,,Q02834,Sialidase,nedA,,
DB04465,Lactose,,P16278,Beta-galactosidase,GLB1,,
DB04465,Lactose,,P00722,Beta-galactosidase,lacZ,,
DB04465,Lactose,,Q7Z4J2,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,,
DB04465,Lactose,,Q9NZD2,Glycolipid transfer protein,GLTP,,
DB04465,Lactose,,Q7SI98,Hydrolase,,,
DB04465,Lactose,,P26514,"Endo-1,4-beta-xylanase A",xlnA,,
DB04466,SR12813,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB04467,N-(5'-phosphopyridoxyl)-L-alanine,,P00509,Aspartate aminotransferase,aspC,,
DB04467,N-(5'-phosphopyridoxyl)-L-alanine,,P10724,Alanine racemase,alr,,
DB04467,N-(5'-phosphopyridoxyl)-L-alanine,,Q9ZHG9,L-cysteine/cystine lyase C-DES,c-des,,
DB04468,Afimoxifene,,P04155,Trefoil factor 1,TFF1,,
DB04468,Afimoxifene,,P11474,Steroid hormone receptor ERR1,ESRRA,inhibitor,
DB04468,Afimoxifene,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB04468,Afimoxifene,,P04278,Sex hormone-binding globulin,SHBG,,
DB04468,Afimoxifene,,P03372,Estrogen receptor alpha,ESR1,,
DB04468,Afimoxifene,,Q92731,Estrogen receptor beta,ESR2,,
DB04468,Afimoxifene,,P62508,Estrogen-related receptor gamma,ESRRG,,
DB04469,"1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB04470,CRA_10656,,P07477,Trypsin-1,PRSS1,,
DB04471,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",,P03372,Estrogen receptor alpha,ESR1,,
DB04472,(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol,,O00182,Galectin-9,LGALS9,,
DB04472,(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol,,Q93D82,Halohydrin dehalogenase,hheC,,
DB04473,alpha-L-fucose,,P27914,Genome polyprotein,,,
DB04473,alpha-L-fucose,,P05884,Envelope glycoprotein gp160,env,,
DB04473,alpha-L-fucose,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB04473,alpha-L-fucose,,P27915,Genome polyprotein,,,
DB04474,8-anilinonaphthalene-1-sulfonic acid,,P31151,Protein S100-A7,S100A7,,
DB04474,8-anilinonaphthalene-1-sulfonic acid,,P33038,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,murA,,
DB04476,"Trencam-3,2-Hopo",,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,,
DB04477,"2'-Deoxy-2'-[(3,5-dimethoxybenzoyl)amino]-N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]adenosine",,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,,
DB04478,"Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine",,Q00796,Sorbitol dehydrogenase,SORD,,
DB04480,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",,P36897,TGF-beta receptor type-1,TGFBR1,,
DB04481,Erythritol,,Q9X112,5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase,metE,,
DB04482,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,,P42216,3-deoxy-manno-octulosonate cytidylyltransferase,kpsU,,
DB04482,Cmp-2-Keto-3-Deoxy-Octulosonic Acid,,P44490,3-deoxy-manno-octulosonate cytidylyltransferase,kdsB,,
DB04483,2-deoxy-2-fluoro-β-D-mannose,,P49424,"Mannan endo-1,4-beta-mannosidase",manA,,
DB04485,Thymidine,,P9WKE1,Thymidylate kinase,tmk,substrate,
DB04485,Thymidine,,P12758,Uridine phosphorylase,udp,,
DB04485,Thymidine,,P24425,Thymidine kinase,TK,substrate,
DB04485,Thymidine,,O00142,"Thymidine kinase 2, mitochondrial",TK2,substrate,
DB04485,Thymidine,,P0A927,Nucleoside-specific channel-forming protein tsx,tsx,,
DB04485,Thymidine,,Q9HU22,Glucose-1-phosphate thymidylyltransferase,rmlA,,
DB04485,Thymidine,,P04183,"Thymidine kinase, cytosolic",TK1,substrate,
DB04487,N-Methylleucine,,P02778,C-X-C motif chemokine 10,CXCL10,,
DB04488,"(6S)-N-[(2S,3R,6R,7R)-3-(Acetyloxymethyl)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]octan-7-yl]-6-[(2-aminoacetyl)amino]-7-hydroxy-7-oxoheptanimidate",,P15555,D-alanyl-D-alanine carboxypeptidase,,,
DB04489,Guanidinoethylmercaptosuccinic acid,,O75976,Carboxypeptidase D,CPD,,
DB04490,3-(Mercaptomethylene)Pyridine,,P04584,Gag-Pol polyprotein,gag-pol,,
DB04491,Diisopropylphosphono Group,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB04491,Diisopropylphosphono Group,,P00782,Subtilisin BPN',apr,,
DB04491,Diisopropylphosphono Group,,P00751,Complement factor B,CFB,,
DB04491,Diisopropylphosphono Group,,Q9KX40,Esterase EstB,estB,,
DB04492,2-(acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose,,Q46079,Chondroitinase-B,cslB,,
DB04493,Fructose-6-phosphate,,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,,
DB04493,Fructose-6-phosphate,,P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,,
DB04493,Fructose-6-phosphate,,P00512,6-phosphofructokinase,pfkA,,
DB04493,Fructose-6-phosphate,,Q16877,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",PFKFB4,,
DB04493,Fructose-6-phosphate,,P06744,Glucose-6-phosphate isomerase,GPI,,
DB04494,Dihydroxy(oxo)molybdenum(6+),,P52687,Sensor histidine kinase CitA,citA,,
DB04495,Paratoulene phosphate,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB04496,4-Phospho-D-erythronohydroxamic acid,,P9WKD7,Ribose-5-phosphate isomerase B,rpiB,,
DB04498,Aspartate Semialdehyde,,P44801,Aspartate-semialdehyde dehydrogenase,asd,,
DB04499,(R)-styrene oxide,,Q93D82,Halohydrin dehalogenase,hheC,,
DB04501,Camphane,,P00183,Camphor 5-monooxygenase,camC,,
DB04502,WRR-204,,P25779,Cruzipain,,,
DB04503,Sp-722,,P0A884,Thymidylate synthase,thyA,,
DB04505,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB04508,"Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside",,P32884,Hemagglutinin-neuraminidase,HN,,
DB04510,3-phospho-D-glyceric acid,,Q07412,Triosephosphate isomerase,TPI,,
DB04510,3-phospho-D-glyceric acid,,Q9X519,"2,3-bisphosphoglycerate-independent phosphoglycerate mutase",gpmI,,
DB04510,3-phospho-D-glyceric acid,,P15259,Phosphoglycerate mutase 2,PGAM2,,
DB04510,3-phospho-D-glyceric acid,,P60174,Triosephosphate isomerase,TPI1,,
DB04510,3-phospho-D-glyceric acid,,P00558,Phosphoglycerate kinase 1,PGK1,,
DB04510,3-phospho-D-glyceric acid,,P36204,Bifunctional PGK/TIM,pgk/tpi,,
DB04511,N-Succinyl Methionine,,Q44244,N-acylamino acid racemase,Aaar,,
DB04512,2-Isobutyl-3-methoxypyrazine,,Q8WX39,Epididymal-specific lipocalin-9,LCN9,,
DB04513,N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,,P0DP23,Calmodulin,CALM1,,
DB04513,N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,,
DB04513,N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,,P19429,"Troponin I, cardiac muscle",TNNI3,,
DB04514,Uridylyl-2'-5'-phospho-guanosine,,P07998,Ribonuclease pancreatic,RNASE1,,
DB04515,2-O-methyl-alpha-L-fucopyranose,,Q46079,Chondroitinase-B,cslB,,
DB04516,2-Deoxy-Glucitol-6-Phosphate,,Q9NPH2,Inositol-3-phosphate synthase 1,ISYNA1,,
DB04517,Dipyrromethane Cofactor,,P06983,Porphobilinogen deaminase,hemC,,
DB04518,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB04519,Caprylic acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB04519,Caprylic acid,,P0A953,3-oxoacyl-[acyl-carrier-protein] synthase 1,fabB,,
DB04519,Caprylic acid,,P0ADA1,Acyl-CoA thioesterase I,tesA,,
DB04520,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",,Q54276,Chitinase,chiB,,
DB04520,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",,P11797,Chitinase B,chiB,,
DB04521,4-S-Glutathionyl-5-pentyl-tetrahydro-furan-2-ol,,Q16772,Glutathione S-transferase A3,GSTA3,,
DB04522,Dexfosfoserine,,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB04522,Dexfosfoserine,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB04522,Dexfosfoserine,,Q04759,Protein kinase C theta type,PRKCQ,,
DB04522,Dexfosfoserine,,,"Glycogen phosphorylase, liver form",,,
DB04522,Dexfosfoserine,,P26276,Phosphomannomutase/phosphoglucomutase,algC,,
DB04522,Dexfosfoserine,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04522,Dexfosfoserine,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB04522,Dexfosfoserine,,O32723,Anti-sigma F factor antagonist,spoIIAA,,
DB04522,Dexfosfoserine,,P02974,Fimbrial protein,pilE1,,
DB04522,Dexfosfoserine,,P00634,Alkaline phosphatase,phoA,,
DB04522,Dexfosfoserine,,P08100,Rhodopsin,RHO,,
DB04522,Dexfosfoserine,,P29508,Serpin B3,SERPINB3,,
DB04522,Dexfosfoserine,,P51584,"Endo-1,4-beta-xylanase Y",xynY,,
DB04522,Dexfosfoserine,,Q9UL54,Serine/threonine-protein kinase TAO2,TAOK2,,
DB04522,Dexfosfoserine,,Q03721,Potassium voltage-gated channel subfamily C member 4,KCNC4,,
DB04522,Dexfosfoserine,,P05451,Lithostathine-1-alpha,REG1A,,
DB04522,Dexfosfoserine,,Q15796,Mothers against decapentaplegic homolog 2,SMAD2,,
DB04522,Dexfosfoserine,,O31465,Glutaminase 1,glsA1,,
DB04522,Dexfosfoserine,,P25924,Siroheme synthase,cysG,,
DB04522,Dexfosfoserine,,P07515,Phosphocarrier protein HPr,ptsH,,
DB04522,Dexfosfoserine,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,,
DB04523,Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate,,P43235,Cathepsin K,CTSK,,
DB04524,Malonyl-CoA,,P0A6R0,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB04525,N-(3-Carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB04526,L-Glycero-D-Manno-Heptopyranose,,P06971,Ferrichrome-iron receptor,fhuA,,
DB04527,beta-Hydroxyasparagine,,O00187,Mannan-binding lectin serine protease 2,MASP2,,
DB04528,"2,4-Dinitrophenol",,P71278,Pentaerythritol tetranitrate reductase,onr,,
DB04529,Desvancosaminyl vancomycin,,Q9AFC7,Glycosyltransferase GtfD,gtfD,,
DB04529,Desvancosaminyl vancomycin,,P96558,Glycosyltransferase GtfA,gtfA,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P0A884,Thymidylate synthase,thyA,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P04818,Thymidylate synthase,TYMS,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P05089,Arginase-1,ARG1,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P00722,Beta-galactosidase,lacZ,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P39126,Isocitrate dehydrogenase [NADP],icd,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P36952,Serpin B5,SERPINB5,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P0AEX9,Maltose-binding periplasmic protein,malE,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P0ACB2,Delta-aminolevulinic acid dehydratase,hemB,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P9WH11,"dTDP-4-dehydrorhamnose 3,5-epimerase",rmlC,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,Q01064,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,O60493,Sorting nexin-3,SNX3,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,P39805,Transcription antiterminator LicT,licT,,
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",,Q99418,Cytohesin-2,CYTH2,,
DB04531,S-Benzylcysteine,,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,,
DB04532,Indole,,P00720,Lysozyme,E,,
DB04532,Indole,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB04533,2-Amino-4-methylphenol,,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,cobT,,
DB04534,5-Nitroindazole,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB04534,5-Nitroindazole,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB04537,Tryptophanamide,,P23381,"Tryptophan--tRNA ligase, cytoplasmic",WARS,,
DB04537,Tryptophanamide,,P00953,Tryptophan--tRNA ligase,trpS,,
DB04538,threo-3-methyl-L-aspartic acid,,O66145,3-methylaspartate ammonia-lyase,,,
DB04539,Glyphosate,,P11511,Cytochrome P450 19A1,CYP19A1,,
DB04539,Glyphosate,,P0A6D3,3-phosphoshikimate 1-carboxyvinyltransferase,aroA,,
DB04539,Glyphosate,,Q9S400,3-phosphoshikimate 1-carboxyvinyltransferase,aroA,inhibitor,
DB04540,Cholesterol,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,,
DB04540,Cholesterol,,P11473,Vitamin D3 receptor,VDR,,
DB04540,Cholesterol,,Q9ULY5,C-type lectin domain family 4 member E,CLEC4E,ligand,
DB04540,Cholesterol,,P35398,Nuclear receptor ROR-alpha,RORA,,
DB04541,Cyclo(prolylglycyl),,P11797,Chitinase B,chiB,,
DB04542,Zidovudine diphosphate,,P15531,Nucleoside diphosphate kinase A,NME1,,
DB04543,"2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB04544,1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04545,Afegostat,,O85465,Endoglucanase 5A,cel5A,,
DB04545,Afegostat,,Q08638,Beta-glucosidase A,bglA,,
DB04545,Afegostat,,Q79G13,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",celA1,,
DB04546,3-Deazaadenosine,,Q9GPQ4,IAG-nucleoside hydrolase,,,
DB04547,Inhibitor BEA409,,P03366,Gag-Pol polyprotein,gag-pol,,
DB04548,4-Deoxy-D-Glucuronic Acid,,Q54873,Hyaluronate lyase,,,
DB04548,4-Deoxy-D-Glucuronic Acid,,Q46079,Chondroitinase-B,cslB,,
DB04548,4-Deoxy-D-Glucuronic Acid,,Q53591,Hyaluronate lyase,hylB,,
DB04548,4-Deoxy-D-Glucuronic Acid,,Q9KWU1,Alginate lyase,aly,,
DB04549,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",,P00918,Carbonic anhydrase 2,CA2,,
DB04551,"beta-D-fructofuranose 1,6-bisphosphate",,P30613,Pyruvate kinase PKLR,PKLR,,
DB04551,"beta-D-fructofuranose 1,6-bisphosphate",,P0A6F3,Glycerol kinase,glpK,,
DB04552,Niflumic acid,,P04054,Phospholipase A2,PLA2G1B,inhibitor,M02AA17;M01AX02
DB04552,Niflumic acid,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M02AA17;M01AX02
DB04552,Niflumic acid,,P51800,Chloride channel protein ClC-Ka,CLCNKA,inducer,M02AA17;M01AX02
DB04552,Niflumic acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,,M02AA17;M01AX02
DB04552,Niflumic acid,,P47712,Cytosolic phospholipase A2,PLA2G4A,,M02AA17;M01AX02
DB04552,Niflumic acid,,O60656,UDP-glucuronosyltransferase 1-9,UGT1A9,,M02AA17;M01AX02
DB04553,2-Oxobutanoic Acid,,Q00740,1-aminocyclopropane-1-carboxylate deaminase,acdS,,
DB04553,2-Oxobutanoic Acid,,Q70AC7,Methylmalonyl-CoA carboxyltransferase 5S subunit,,,
DB04554,8-Bromoadenosine-5'-Diphosphate,,P0A820,S-adenosylmethionine synthase,metK,,
DB04555,Cytidine-5'-Diphosphate,,P62619,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB04555,Cytidine-5'-Diphosphate,,P42216,3-deoxy-manno-octulosonate cytidylyltransferase,kpsU,,
DB04555,Cytidine-5'-Diphosphate,,Q8RQP5,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB04555,Cytidine-5'-Diphosphate,,P0A0Z8,N-acylneuraminate cytidylyltransferase,neuA,,
DB04555,Cytidine-5'-Diphosphate,,P0A6I0,Cytidylate kinase,cmk,,
DB04555,Cytidine-5'-Diphosphate,,P14169,CDP-paratose 2-epimerase,rfbE,,
DB04556,NAP-226-90,,P22303,Acetylcholinesterase,ACHE,,
DB04557,Arachidonic Acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB04557,Arachidonic Acid,,Q96RI1,Bile acid receptor,NR1H4,ligand,
DB04557,Arachidonic Acid,,P19793,Retinoic acid receptor RXR-alpha,RXRA,,
DB04557,Arachidonic Acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB04557,Arachidonic Acid,,P29498,14 kDa fatty acid-binding protein,,,
DB04559,N-(Chlorophenyl)-N'-hydroxyguanidine,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB04560,"4,7-Dioxosebacic Acid",,P13716,Delta-aminolevulinic acid dehydratase,ALAD,,
DB04560,"4,7-Dioxosebacic Acid",,Q59334,Delta-aminolevulinic acid dehydratase,hemB,,
DB04560,"4,7-Dioxosebacic Acid",,P0ACB2,Delta-aminolevulinic acid dehydratase,hemB,,
DB04561,"4-acetamido-2,4-didexoy-D-glycero-beta-D-galacto-octopyranosylphosphonic acid",,P29768,Sialidase,nanH,,
DB04562,Tricarballylic acid,,Q99798,"Aconitate hydratase, mitochondrial",ACO2,,
DB04563,CRA_9678,,P07477,Trypsin-1,PRSS1,,
DB04564,Gluconolactone,,P09848,Lactase-phlorizin hydrolase,LCT,,
DB04565,4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid,,P06820,Neuraminidase,,,
DB04566,Inosinic Acid,,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04566,Inosinic Acid,,P0A7D4,Adenylosuccinate synthetase,purA,,
DB04566,Inosinic Acid,,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,,
DB04566,Inosinic Acid,,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,,
DB04566,Inosinic Acid,,Q83P33,Adenylosuccinate synthetase,purA,,
DB04566,Inosinic Acid,,P0C0H6,Inosine-5'-monophosphate dehydrogenase,guaB,,
DB04566,Inosinic Acid,,P0A9M2,Hypoxanthine phosphoribosyltransferase,hpt,,
DB04566,Inosinic Acid,,Q27796,Hypoxanthine-guanine phosphoribosyltransferase,HGPRTase,,
DB04568,5-Aminoimidazole Ribonucleoside,,Q8ZKR2,Putative sugar kinase,,,
DB04569,Benzyl formate,,P43133,Thermolysin,nprS,,
DB04570,Latamoxef,,P42971,Penicillin-binding protein 3,pbpC,inhibitor,J01DD06
DB04570,Latamoxef,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DD06
DB04570,Latamoxef,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DD06
DB04570,Latamoxef,,P24228,D-alanyl-D-alanine carboxypeptidase DacB,dacB,inhibitor,J01DD06
DB04571,Trioxsalen,,,DNA,,cross-linking/alkylation,D05BA01;D05AD01
DB04572,Thiotepa,,,DNA,,cross-linking/alkylation,L01AC01
DB04573,Estriol,,P03372,Estrogen receptor alpha,ESR1,agonist,G03CC06;G03CA04
DB04573,Estriol,,Q92731,Estrogen receptor beta,ESR2,agonist,G03CC06;G03CA04
DB04573,Estriol,,P04278,Sex hormone-binding globulin,SHBG,,G03CC06;G03CA04
DB04574,Estrone sulfate,,P03372,Estrogen receptor alpha,ESR1,agonist,
DB04574,Estrone sulfate,,Q92731,Estrogen receptor beta,ESR2,agonist,
DB04575,Quinestrol,,P03372,Estrogen receptor alpha,ESR1,agonist,
DB04575,Quinestrol,,P03372,Estrogen receptor alpha,ESR1,modulator,
DB04576,Fleroxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,J01MA08
DB04576,Fleroxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA08
DB04576,Fleroxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,J01MA08
DB04577,1-(1-phenylcyclopentyl)methylamine,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB04578,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB04579,"N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine",,P07858,Cathepsin B,CTSB,,
DB04580,1-Methyl-2-quinolone,,Q57VC7,Putative uncharacterized protein,,,
DB04581,1-benzylimidazole,,Q16769,Glutaminyl-peptide cyclotransferase,QPCT,,
DB04583,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB04585,DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID,,P05089,Arginase-1,ARG1,,
DB04586,o-Bromophenol,,P0A884,Thymidylate synthase,thyA,,
DB04588,"N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB04590,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,,P08709,Coagulation factor VII,F7,,
DB04591,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",,P00734,Prothrombin,F2,,
DB04592,3-Bromo-3-buten-1-ol,,P22869,Methane monooxygenase component A alpha chain,mmoX,,
DB04593,3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID,,P08709,Coagulation factor VII,F7,,
DB04594,3-hydroxyglutaric acid,,P35914,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",HMGCL,,
DB04596,"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",,Q9AQS0,Xanthan lyase,xly,,
DB04597,"[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]",,Q9AQS0,Xanthan lyase,xly,,
DB04598,2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID,,Q1LCS4,"3-hydroxyanthranilate 3,4-dioxygenase",nbaC,,
DB04599,Aniracetam,,P42262,Glutamate receptor 2,GRIA2,,N06BX11
DB04599,Aniracetam,,P42263,Glutamate receptor 3,GRIA3,,N06BX11
DB04599,Aniracetam,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,N06BX11
DB04599,Aniracetam,,P14416,Dopamine D2 receptor,DRD2,,N06BX11
DB04600,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",,P00918,Carbonic anhydrase 2,CA2,,
DB04601,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",,P00918,Carbonic anhydrase 2,CA2,,
DB04602,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,,P61927,60S ribosomal protein L37,RPL37,,
DB04604,5-iodotubercidin,,Q8TF76,Serine/threonine-protein kinase haspin,GSG2,,
DB04604,5-iodotubercidin,,P27361,Mitogen-activated protein kinase 3,MAPK3,,
DB04604,5-iodotubercidin,,P78368,Casein kinase I isoform gamma-2,CSNK1G2,,
DB04605,5-Aminoisoquinoline,,Q57VC7,Putative uncharacterized protein,,,
DB04606,2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE),,P08709,Coagulation factor VII,F7,,
DB04607,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB04608,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",,P30291,Wee1-like protein kinase,WEE1,,
DB04609,INHIBITOR Q8467 OF DUPONT MERCK,,P04585,Gag-Pol polyprotein,gag-pol,,
DB04610,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",,P26281,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,folK,,
DB04612,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",,P98170,E3 ubiquitin-protein ligase XIAP,XIAP,,
DB04614,(R)-tacrine(10)-hupyridone,,P22303,Acetylcholinesterase,ACHE,,
DB04615,(S)-tacrine(10)-hupyridone,,P22303,Acetylcholinesterase,ACHE,,
DB04616,TACRINE(8)-4-AMINOQUINOLINE,,P22303,Acetylcholinesterase,ACHE,,
DB04617,"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",,P22303,Acetylcholinesterase,ACHE,,
DB04618,"4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE",,P04746,Pancreatic alpha-amylase,AMY2A,,
DB04619,Acetophenone,,Q84EX5,R-specific alcohol dehydrogenase,radh,,
DB04620,Cycloleucine,,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,,
DB04622,N-acetylhistamine,,Q16769,Glutaminyl-peptide cyclotransferase,QPCT,,
DB04623,"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",,Q8Q3H0,Pol protein,pol,,
DB04624,DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),,O52646,Aklanonic acid methyl ester cyclase,acma,,
DB04626,Apramycin,,,16S ribosomal RNA,,,
DB04627,Cyclouridine,,P0A1F6,Uridine phosphorylase,udp,,
DB04628,Allosamidin,,P11797,Chitinase B,chiB,,
DB04628,Allosamidin,,P07254,Chitinase A,chiA,,
DB04629,Aplyronine A,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB04630,Aldosterone,,P04150,Glucocorticoid receptor,NR3C1,,H02AA01
DB04630,Aldosterone,,P08235,Mineralocorticoid receptor,NR3C2,agonist,H02AA01
DB04631,Atpenin A5,,P07014,Succinate dehydrogenase iron-sulfur subunit,sdhB,,
DB04631,Atpenin A5,,P69054,Succinate dehydrogenase cytochrome b556 subunit,sdhC,,
DB04631,Atpenin A5,,P0AC44,Succinate dehydrogenase hydrophobic membrane anchor subunit,sdhD,,
DB04631,Atpenin A5,,P0AC41,Succinate dehydrogenase flavoprotein subunit,sdhA,,
DB04632,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB04633,"N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine",,P21673,Diamine acetyltransferase 1,SAT1,,
DB04634,N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE,,P08617,Genome polyprotein,,,
DB04634,N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE,,P06441,Genome polyprotein,,,
DB04634,N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE,,P13901,Genome polyprotein,,,
DB04636,Glutamine t-butyl ester,,Q16769,Glutaminyl-peptide cyclotransferase,QPCT,,
DB04637,6-Bromo-1-hexanol,,P22869,Methane monooxygenase component A alpha chain,mmoX,,
DB04638,"2,5-di-tert-butylhydroquinone",,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,,
DB04639,Biphenylalanine,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB04639,Biphenylalanine,,P35961,Envelope glycoprotein gp160,env,,
DB04640,"Naphthalene-2,6-disulfonic acid",,Q8P9V9,Bacterioferritin comigratory protein,,,
DB04640,"Naphthalene-2,6-disulfonic acid",,Q27743,L-lactate dehydrogenase,,,
DB04641,"3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID",,Q27743,L-lactate dehydrogenase,,,
DB04642,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04643,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04644,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04645,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB04646,Dibromothymoquinone,,P83793,Apocytochrome f,petA,,
DB04646,Dibromothymoquinone,,P83797,Cytochrome b6-f complex subunit 5,petG,,
DB04646,Dibromothymoquinone,,P83795,Cytochrome b6-f complex subunit 6,petL,,
DB04646,Dibromothymoquinone,,P83796,Cytochrome b6-f complex subunit 7,petM,,
DB04646,Dibromothymoquinone,,P83798,Cytochrome b6-f complex subunit 8,petN,,
DB04646,Dibromothymoquinone,,P83791,Cytochrome b6,petB,,
DB04646,Dibromothymoquinone,,P83794,Cytochrome b6-f complex iron-sulfur subunit,petC,,
DB04646,Dibromothymoquinone,,P83792,Cytochrome b6-f complex subunit 4,petD,,
DB04647,BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA,,P0AEB3,D-alanyl-D-alanine carboxypeptidase DacA,dacA,,
DB04647,BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA,,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,dacA,,
DB04648,S-propylamine-L-cysteine,,P05089,Arginase-1,ARG1,,
DB04649,TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,,P0C2P0,Blasticidin-S deaminase,bsd,,
DB04650,"5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID",,P22629,Streptavidin,,,
DB04651,BIOTINOL-5-AMP,,P06709,Bifunctional protein BirA,birA,,
DB04652,Corticosterone,,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,substrate,
DB04652,Corticosterone,,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,product of,
DB04652,Corticosterone,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB04652,Corticosterone,,P08235,Mineralocorticoid receptor,NR3C2,,
DB04653,N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1S)-3-fluoro-1-(4-hydroxybenzyl)-2-oxopropyl]-L-leucinamide,,P07384,Calpain-1 catalytic subunit,CAPN1,,
DB04654,4-PIPERIDIN-4-YLBUTANAL,,P07477,Trypsin-1,PRSS1,,
DB04654,4-PIPERIDIN-4-YLBUTANAL,,P20231,Tryptase beta-2,TPSB2,,
DB04655,Metoprine,,P50135,Histamine N-methyltransferase,HNMT,,
DB04656,"1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID",,P15474,3-dehydroquinate dehydratase,aroQ,,
DB04657,Carboxin,,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,,
DB04658,Calystegine B2,,Q08638,Beta-glucosidase A,bglA,,
DB04659,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",,P09848,Lactase-phlorizin hydrolase,LCT,,
DB04660,Choline alfoscerate,,P17900,Ganglioside GM2 activator,GM2A,,N07AX02
DB04661,cis-tetracosenoyl sulfatide,,P15813,Antigen-presenting glycoprotein CD1d,CD1D,,
DB04662,OLOMOUCINE II,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB04664,Cyclohexyl-pentyl-maltoside,,P20813,Cytochrome P450 2B6,CYP2B6,,
DB04665,Coumarin,,P11509,Cytochrome P450 2A6,CYP2A6,,
DB04669,TRIAZOLOPYRIMIDINE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB04671,[(1S)-4-[[Amino-[(2R)-2-amino-2-carboxyethyl]sulfanylmethylidene]amino]-1-carboxybutyl]azanium,,P13981,Arginine deiminase,arcA,,
DB04672,"Cyclic 3',5'-thymidine monophosphate",,Q9NPB1,"5'(3')-deoxyribonucleotidase, mitochondrial",NT5M,,
DB04673,4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE,,P00742,Coagulation factor X,F10,,
DB04674,"2-HYDROXY-3,5-DIIODOBENZOIC ACID",,P25101,Endothelin-1 receptor,EDNRA,,
DB04674,"2-HYDROXY-3,5-DIIODOBENZOIC ACID",,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,,
DB04676,Dansyllysine,,P01877,Ig alpha-2 chain C region,IGHA2,,
DB04677,N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE,,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB04678,H TYPE II TRISACCHARIDE,,P16442,Histo-blood group ABO system transferase,ABO,,
DB04679,Human blood group H type 1 trisaccharide,,P16442,Histo-blood group ABO system transferase,ABO,,
DB04680,GALACTOSE GREASE,,P16442,Histo-blood group ABO system transferase,ABO,,
DB04681,BETA-METHYLLACTOSIDE,,P16442,Histo-blood group ABO system transferase,ABO,,
DB04682,Octylphenoxy polyethoxyethanol,,P02585,"Troponin C, skeletal muscle",TNNC2,,
DB04683,"(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE",,Q13285,Steroidogenic factor 1,NR5A1,,
DB04685,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",,P33316,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",DUT,,
DB04685,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",,Q8II92,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, putative",,,
DB04687,DIMETHYL THIOPHOSPHATE,,Q93LD7,Phosphotriesterase,opdA,,
DB04688,Methylecgonine,,P01859,Ig gamma-2 chain C region,IGHG2,,
DB04688,Methylecgonine,,P01834,Ig kappa chain C region,IGKC,,
DB04689,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB04690,Camptothecin,,P11387,DNA topoisomerase 1,TOP1,inhibitor,
DB04693,"Estrane-3,17-dione",,P00947,Steroid Delta-isomerase,ksi,,
DB04695,Farnesyl thiopyrophosphate,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB04695,Farnesyl thiopyrophosphate,,Q03426,Mevalonate kinase,MVK,,
DB04695,Farnesyl thiopyrophosphate,,A9JQL9,Dehydrosqualene synthase,crtM,,
DB04695,Farnesyl thiopyrophosphate,,P60472,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",ispU,,
DB04696,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",,P0A884,Thymidylate synthase,thyA,,
DB04697,TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE,,P00734,Prothrombin,F2,,
DB04698,"N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide",,Q48255,3-dehydroquinate dehydratase,aroQ,,
DB04699,gamma-Butyrolactone,,Q8XL08,O-GlcNAcase NagJ,nagJ,,
DB04700,GLUTATHIONE SULFINATE,,Q9Y2Q3,Glutathione S-transferase kappa 1,GSTK1,,
DB04701,S-Methyl glutathione,,P28161,Glutathione S-transferase Mu 2,GSTM2,,
DB04702,"S-[(2E)-3,7-DIMETHYLOCTA-2,6-DIENYL] TRIHYDROGENTHIODIPHOSPHATE",,Q4R2T2,Prenyltransferase,,,
DB04703,Hesperidin,,Q96GD4,Aurora kinase B,AURKB,regulator,
DB04707,Hydroxyfasudil,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB04707,Hydroxyfasudil,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB04707,Hydroxyfasudil,,Q13464,Rho-associated protein kinase 1,ROCK1,inhibitor,
DB04709,"(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE",,P10275,Androgen receptor,AR,,
DB04713,4-Iodo-D-phenylalanine,,P80561,Aminopeptidase S,,,
DB04714,ISOPENTENYL PYROPHOSPHATE,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB04714,ISOPENTENYL PYROPHOSPHATE,,A0R559,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB04714,ISOPENTENYL PYROPHOSPHATE,,P9WFF7,Decaprenyl diphosphate synthase,uppS,,
DB04714,ISOPENTENYL PYROPHOSPHATE,,P62623,4-hydroxy-3-methylbut-2-enyl diphosphate reductase,ispH,,
DB04714,ISOPENTENYL PYROPHOSPHATE,,P60472,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",ispU,,
DB04714,ISOPENTENYL PYROPHOSPHATE,,P14324,Farnesyl pyrophosphate synthase,FDPS,,
DB04715,IMIDAZOPYRIDAZIN 1,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",,O43293,Death-associated protein kinase 3,DAPK3,,
DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",,P23458,Tyrosine-protein kinase JAK1,JAK1,,
DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",,P52333,Tyrosine-protein kinase JAK3,JAK3,,
DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",,P29597,Non-receptor tyrosine-protein kinase TYK2,TYK2,,
DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",,O60674,Tyrosine-protein kinase JAK2,JAK2,,
DB04719,"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB04720,"S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB04721,"N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB04722,"2-[3-chloro-6-[2,2-difluoro-2-(1-oxidopyridin-1-ium-2-yl)ethyl]imino-1-hydroxypyridin-2-yl]-N-[(1R)-1-(3-chlorophenyl)ethyl]acetamide",,P00734,Prothrombin,F2,,
DB04723,2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID,,P15086,Carboxypeptidase B,CPB1,,
DB04724,"(S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide",,P20701,Integrin alpha-L,ITGAL,,
DB04725,Licofelone,,P09917,Arachidonate 5-lipoxygenase,ALOX5,,
DB04725,Licofelone,,P35354,Prostaglandin G/H synthase 2,PTGS2,,
DB04725,Licofelone,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB04727,"1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea",,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB04729,Gentamicin C1a,,P0A7S3,30S ribosomal protein S12,rpsL,adduct,
DB04729,Gentamicin C1a,,,16S ribosomal RNA,,adduct,
DB04731,1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE,,P29827,Lantibiotic cinnamycin,cinA,,
DB04732,N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID,,P9WHT9,Proteasome subunit beta,prcB,,
DB04732,N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID,,P9WHU1,Proteasome subunit alpha,prcA,,
DB04733,"1,6-DI-O-PHOSPHONO-D-MANNITOL",,P04075,Fructose-bisphosphate aldolase A,ALDOA,,
DB04734,Citraconic acid,,P0C278,Fumarate reductase flavoprotein subunit,fccA,,
DB04735,MONOGALACTOSYL-DIACYLGLYCEROL,,P0A444,Photosystem Q(B) protein 1,psbA1,,
DB04736,"2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE",,Q96LB9,Peptidoglycan recognition protein 3,PGLYRP3,,
DB04738,Motuporin,,P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,PPP1CC,,
DB04739,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB04740,Moxalactam (hydrolyzed),,P52700,Metallo-beta-lactamase L1,,,
DB04741,Myxothiazol,,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,,
DB04742,"(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid",,P39045,D-alanyl-D-alanine carboxypeptidase,dac,,
DB04743,Nimesulide,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AX17;M02AA26
DB04743,Nimesulide,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,M01AX17;M02AA26
DB04743,Nimesulide,,P02788,Lactotransferrin,LTF,,M01AX17;M02AA26
DB04745,2-Hydroxyquinoline,,O05935,"2-oxo-1,2-dihydroquinoline 8-monooxygenase, oxygenase component",oxoO,,
DB04746,"(10E,12Z)-octadecadienoic acid",,Q6A8X5,Putative aminooxidase,,,
DB04747,11-TRANS-13-TRANS-15-CIS-OCTADECATRIENOIC ACID,,Q6A8X5,Putative aminooxidase,,,
DB04749,2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE,,P52699,Beta-lactamase IMP-1,,,
DB04751,Purvalanol A,,Q9Y6M4,Casein kinase I isoform gamma-3,CSNK1G3,,
DB04751,Purvalanol A,,Q15418,Ribosomal protein S6 kinase alpha-1,RPS6KA1,,
DB04751,Purvalanol A,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB04752,Phosphatidyl ethanol,,Q13285,Steroidogenic factor 1,NR5A1,,
DB04753,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",,P00491,Purine nucleoside phosphorylase,PNP,,
DB04754,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",,P00491,Purine nucleoside phosphorylase,PNP,,
DB04757,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",,P00491,Purine nucleoside phosphorylase,PNP,,
DB04758,2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE),,P08709,Coagulation factor VII,F7,,
DB04759,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",,P45452,Collagenase 3,MMP13,,
DB04760,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",,P45452,Collagenase 3,MMP13,,
DB04761,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",,P45452,Collagenase 3,MMP13,,
DB04762,N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE,,P00509,Aspartate aminotransferase,aspC,,
DB04763,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",,P00918,Carbonic anhydrase 2,CA2,,
DB04764,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,,P20231,Tryptase beta-2,TPSB2,,
DB04765,N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE,,P00509,Aspartate aminotransferase,aspC,,
DB04767,N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID,,P08709,Coagulation factor VII,F7,,
DB04768,Pyrithiamine Pyrophosphate,,Q9H3S4,Thiamin pyrophosphokinase 1,TPK1,,
DB04769,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB04770,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",,O00764,Pyridoxal kinase,PDXK,,
DB04771,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,,P00734,Prothrombin,F2,,
DB04772,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,,P00734,Prothrombin,F2,,
DB04773,METHYL (3R)-3-{[(3R)-3-{[(3R)-3-HYDROXYBUTANOYL]OXY}BUTANOYL]OXY}BUTANOATE,,Q4W9V8,"Polyhydroxybutyrate depolymerase, putative",,,
DB04774,Reidispongiolide A,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB04775,Reidispongiolide C,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB04776,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,,O00764,Pyridoxal kinase,PDXK,,
DB04777,(R)-4-Nitrostyrene oxide,,Q93D82,Halohydrin dehalogenase,hheC,,
DB04779,ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE,,P09848,Lactase-phlorizin hydrolase,LCT,,
DB04781,5-hydroxyvaleric acid,,P13716,Delta-aminolevulinic acid dehydratase,ALAD,,
DB04782,(S)-4-Nitrostyrene oxide,,Q7AUG5,"2,3-dichloro-1-propanol dehalogenase",dehB,,
DB04783,Sphinxolide B,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB04784,(R)-1-phenylethanol,,Q84EX5,R-specific alcohol dehydrogenase,radh,,
DB04786,Suramin,,P41231,P2Y purinoceptor 2,P2RY2,antagonist,P01CX02
DB04786,Suramin,,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,inhibitor,P01CX02
DB04786,Suramin,,P23945,Follicle-stimulating hormone receptor,FSHR,antagonist,P01CX02
DB04786,Suramin,,P21817,Ryanodine receptor 1,RYR1,agonist,P01CX02
DB04786,Suramin,,P00734,Prothrombin,F2,inhibitor,P01CX02
DB04786,Suramin,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,inhibitor,P01CX02
DB04786,Suramin,,P68638,Complement control protein C3,,,P01CX02
DB04787,Tanaproget,,P06401,Progesterone receptor,PGR,agonist,
DB04788,Tagetitoxin,,Q8RQE9,DNA-directed RNA polymerase subunit beta,rpoB,,
DB04788,Tagetitoxin,,Q8RQE8,DNA-directed RNA polymerase subunit beta',rpoC,,
DB04789,5-methyltetrahydrofolic acid,,P48728,"Aminomethyltransferase, mitochondrial",AMT,,
DB04790,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",,P07477,Trypsin-1,PRSS1,,
DB04791,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",,P07477,Trypsin-1,PRSS1,,
DB04792,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",,P07477,Trypsin-1,PRSS1,,
DB04793,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",,P07477,Trypsin-1,PRSS1,,
DB04794,Bifonazole,,P10613,Cytochrome P450 51,ERG11,inhibitor,D01AC10;D01AC60
DB04794,Bifonazole,,P20813,Cytochrome P450 2B6,CYP2B6,,D01AC10;D01AC60
DB04795,Thenoyltrifluoroacetone,,P23141,Liver carboxylesterase 1,CES1,,
DB04795,Thenoyltrifluoroacetone,,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,,
DB04796,Inecalcitol,,P11473,Vitamin D3 receptor,VDR,,
DB04797,Triazolopyridine,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB04798,THIO-ATPA,,P42262,Glutamate receptor 2,GRIA2,,
DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,,
DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",,P00156,Cytochrome b,MT-CYB,,
DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,,
DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,,
DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,,
DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,,
DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,,
DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,,
DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,,
DB04799,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,,
DB04800,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB04801,cis-Vaccenic acid,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB04803,Verdoheme,,P09601,Heme oxygenase 1,HMOX1,,
DB04805,Virginiamycin S1,,P61927,60S ribosomal protein L37,RPL37,,
DB04807,4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,,P31434,Alpha-xylosidase,yicI,,
DB04809,SALOPHEN-10-PROPIONATE IRON CHELATE,,Q54AI1,Heme oxygenase,hmuO,,
DB04810,Salophen-10-carboxylate iron chelate,,Q54AI1,Heme oxygenase,hmuO,,
DB04811,Salophen iron chelate,,Q54AI1,Heme oxygenase,hmuO,,
DB04817,Metamizole,,P23219,Prostaglandin G/H synthase 1,PTGS1,,N02BB72;N02BB02;N02BB52
DB04820,Nialamide,,P27338,Amine oxidase [flavin-containing] B,MAOB,,N06AF02
DB04820,Nialamide,,P21397,Amine oxidase [flavin-containing] A,MAOA,,N06AF02
DB04820,Nialamide,,P21964,Catechol O-methyltransferase,COMT,,N06AF02
DB04821,Nomifensine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,N06AX04
DB04821,Nomifensine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,,N06AX04
DB04821,Nomifensine,,P27338,Amine oxidase [flavin-containing] B,MAOB,,N06AX04
DB04821,Nomifensine,,P21397,Amine oxidase [flavin-containing] A,MAOA,,N06AX04
DB04821,Nomifensine,,P05164,Myeloperoxidase,MPO,,N06AX04
DB04821,Nomifensine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,N06AX04
DB04821,Nomifensine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,,N06AX04
DB04824,Phenolphthalein,,O60656,UDP-glucuronosyltransferase 1-9,UGT1A9,,A06AB04
DB04824,Phenolphthalein,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,A06AB04
DB04824,Phenolphthalein,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,,A06AB04
DB04824,Phenolphthalein,,P03372,Estrogen receptor alpha,ESR1,agonist,A06AB04
DB04824,Phenolphthalein,,P04278,Sex hormone-binding globulin,SHBG,,A06AB04
DB04825,Prenylamine,,P0DP23,Calmodulin,CALM1,,C01DX52;C01DX02
DB04825,Prenylamine,,Q9H1R3,"Myosin light chain kinase 2, skeletal/cardiac muscle",MYLK2,inhibitor,C01DX52;C01DX02
DB04828,Zomepirac,,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,,M01AB04
DB04829,Lysergic acid diethylamide,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB04829,Lysergic acid diethylamide,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,agonist,
DB04829,Lysergic acid diethylamide,,P50406,5-hydroxytryptamine receptor 6,HTR6,,
DB04832,Zimelidine,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,N06AB02
DB04832,Zimelidine,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,N06AB02
DB04832,Zimelidine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,N06AB02
DB04834,Rapacuronium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,
DB04835,Maraviroc,,P51681,C-C chemokine receptor type 5,CCR5,antagonist,J05AX09
DB04835,Maraviroc,,P51681,C-C chemokine receptor type 5,CCR5,inhibitor,J05AX09
DB04836,Amineptine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,N06AA19
DB04836,Amineptine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,N06AA19
DB04837,Clofedanol,,P35367,Histamine H1 receptor,HRH1,antagonist,R05DB10
DB04838,Cyclandelate,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,inhibitor,C04AX01
DB04838,Cyclandelate,,P23141,Liver carboxylesterase 1,CES1,,C04AX01
DB04839,Cyproterone acetate,,P10275,Androgen receptor,AR,antagonist,G03HB01;G03HA01
DB04839,Cyproterone acetate,,P07288,Prostate-specific antigen,KLK3,,G03HB01;G03HA01
DB04840,Debrisoquine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inducer,C02CC04
DB04841,Flunarizine,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,N07CA03
DB04841,Flunarizine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,N07CA03
DB04841,Flunarizine,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,inhibitor,N07CA03
DB04841,Flunarizine,,P0DP23,Calmodulin,CALM1,antagonist,N07CA03
DB04841,Flunarizine,,P35367,Histamine H1 receptor,HRH1,antagonist,N07CA03
DB04842,Fluspirilene,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AG01
DB04842,Fluspirilene,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AG01
DB04842,Fluspirilene,,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,inhibitor,N05AG01
DB04843,Mepenzolate,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03AB12
DB04843,Mepenzolate,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03AB12
DB04844,Tetrabenazine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,N07XX06
DB04844,Tetrabenazine,,P14416,Dopamine D2 receptor,DRD2,inhibitor,N07XX06
DB04845,Ixabepilone,,Q13509,Tubulin beta-3 chain,TUBB3,inhibitor,L01DC04
DB04846,Celiprolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07AB08
DB04846,Celiprolol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,C07AB08
DB04846,Celiprolol,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,C07AB08
DB04846,Celiprolol,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,C07AB08
DB04846,Celiprolol,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,C07AB08
DB04846,Celiprolol,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,C07AB08
DB04847,Roxadustat,,Q9GZT9,Egl nine homolog 1,EGLN1,inhibitor,B03XA05
DB04847,Roxadustat,,Q96KS0,Egl nine homolog 2,EGLN2,inhibitor,B03XA05
DB04847,Roxadustat,,Q9H6Z9,Egl nine homolog 3,EGLN3,inhibitor,B03XA05
DB04849,Cediranib,,P35968,Vascular endothelial growth factor receptor 2,KDR,,L01EK02
DB04850,Posizolid,,,23S ribosomal RNA,,antagonist,
DB04850,Posizolid,,,23S ribosomal RNA,,blocker,
DB04850,Posizolid,,P21397,Amine oxidase [flavin-containing] A,MAOA,,
DB04851,Biricodar,,Q2M3G0,ATP-binding cassette sub-family B member 5,ABCB5,,
DB04851,Biricodar,,P33527,Multidrug resistance-associated protein 1,ABCC1,,
DB04851,Biricodar,,Q9UNQ0,ATP-binding cassette sub-family G member 2,ABCG2,,
DB04852,Implitapide,,P55157,Microsomal triglyceride transfer protein large subunit,MTTP,,
DB04853,Binodenoson,,P29274,Adenosine receptor A2a,ADORA2A,,
DB04854,Febuxostat,,P47989,Xanthine dehydrogenase/oxidase,XDH,inhibitor,M04AA03
DB04855,Dronedarone,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C01BD07
DB04855,Dronedarone,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,C01BD07
DB04855,Dronedarone,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,C01BD07
DB04855,Dronedarone,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,C01BD07
DB04855,Dronedarone,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,C01BD07
DB04855,Dronedarone,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,C01BD07
DB04855,Dronedarone,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,C01BD07
DB04855,Dronedarone,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C01BD07
DB04855,Dronedarone,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,C01BD07
DB04855,Dronedarone,,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,inhibitor,C01BD07
DB04855,Dronedarone,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,C01BD07
DB04855,Dronedarone,,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,inhibitor,C01BD07
DB04855,Dronedarone,,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,inhibitor,C01BD07
DB04855,Dronedarone,,P54284,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,inhibitor,C01BD07
DB04855,Dronedarone,,O00305,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,inhibitor,C01BD07
DB04855,Dronedarone,,O95069,Potassium channel subfamily K member 2,KCNK2,inhibitor,C01BD07
DB04855,Dronedarone,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,C01BD07
DB04855,Dronedarone,,P48549,G protein-activated inward rectifier potassium channel 1,KCNJ3,inhibitor,C01BD07
DB04855,Dronedarone,,P51787,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,inhibitor,C01BD07
DB04855,Dronedarone,,Q14500,Inward rectifier potassium channel,KCNJ12,inhibitor,C01BD07
DB04855,Dronedarone,,P32418,Sodium/calcium exchanger 1,SLC8A1,inhibitor,C01BD07
DB04855,Dronedarone,,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,inhibitor,C01BD07
DB04855,Dronedarone,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C01BD07
DB04855,Dronedarone,,P10827,Thyroid hormone receptor alpha,THRA,inhibitor,C01BD07
DB04856,Dexloxiglumide,,P32238,Cholecystokinin receptor type A,CCKAR,,
DB04857,Brasofensine,,P14416,Dopamine D2 receptor,DRD2,,
DB04858,Tirapazamine,,,DNA,,,
DB04859,Zanapezil,,P22303,Acetylcholinesterase,ACHE,,
DB04860,Isatoribine,,Q9NYK1,Toll-like receptor 7,TLR7,,
DB04861,Nebivolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07FB12;C09DX05;C07BB12;C07AB12
DB04861,Nebivolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07FB12;C09DX05;C07BB12;C07AB12
DB04861,Nebivolol,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,C07FB12;C09DX05;C07BB12;C07AB12
DB04862,Merimepodib,,P0C0H6,Inosine-5'-monophosphate dehydrogenase,guaB,,
DB04863,Lefradafiban,,P08514,Integrin alpha-IIb,ITGA2B,,
DB04863,Lefradafiban,,P05106,Integrin beta-3,ITGB3,,
DB04864,Huperzine A,,P22303,Acetylcholinesterase,ACHE,inhibitor,
DB04865,Omacetaxine mepesuccinate,,P20276,50S ribosomal protein L2,rpl2,antagonist,L01XX40
DB04865,Omacetaxine mepesuccinate,,P39023,60S ribosomal protein L3,RPL3,antagonist,L01XX40
DB04866,Halofuginone,,P02452,Collagen alpha-1(I) chain,COL1A1,,
DB04866,Halofuginone,,P08253,72 kDa type IV collagenase,MMP2,,
DB04867,Lintitript,,P32238,Cholecystokinin receptor type A,CCKAR,,
DB04868,Nilotinib,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,L01EA03
DB04868,Nilotinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,antagonist,L01EA03
DB04869,Olcegepant,,Q16602,Calcitonin gene-related peptide type 1 receptor,CALCRL,antagonist,
DB04869,Olcegepant,,P06881,Calcitonin gene-related peptide 1,CALCA,,
DB04871,Lorcaserin,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,,A08AA11
DB04872,Osanetant,,P29371,Neuromedin-K receptor,TACR3,,
DB04873,Piboserod,,Q13639,5-hydroxytryptamine receptor 4,HTR4,,
DB04874,Picoplatin,,,DNA,,,
DB04875,Pralnacasan,,P29466,Caspase-1,CASP1,,
DB04876,Vildagliptin,,P27487,Dipeptidyl peptidase 4,DPP4,inhibitor,A10BH02;A10BD08
DB04877,Voacamine,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB04878,Voglibose,,O43451,"Maltase-glucoamylase, intestinal",MGAM,inhibitor,A10BF03
DB04879,Vatalanib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,,
DB04879,Vatalanib,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB04879,Vatalanib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,,
DB04880,Enoximone,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,C01CE03
DB04881,Elacridar,,P08183,P-glycoprotein 1,ABCB1,,
DB04882,Edotecarin,,P11387,DNA topoisomerase 1,TOP1,,
DB04883,Darusentan,,P25101,Endothelin-1 receptor,EDNRA,,
DB04884,Dapoxetine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,G04BX14
DB04884,Dapoxetine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,,G04BX14
DB04884,Dapoxetine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,,G04BX14
DB04885,Cilansetron,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,,A03AE03
DB04886,Calanolide A,,P03369,Gag-Pol polyprotein,gag-pol,,
DB04887,Brecanavir,,Q72874,Human immunodeficiency virus type 1 protease,pol,,
DB04888,Bifeprunox,,P14416,Dopamine D2 receptor,DRD2,,
DB04888,Bifeprunox,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB04889,Bicifadine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,
DB04889,Bicifadine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,
DB04889,Bicifadine,,P14416,Dopamine D2 receptor,DRD2,,
DB04890,Bepotastine,,P35367,Histamine H1 receptor,HRH1,antagonist,
DB04891,Becocalcidiol,,Q15648,Mediator of RNA polymerase II transcription subunit 1,MED1,,
DB04891,Becocalcidiol,,P11473,Vitamin D3 receptor,VDR,,
DB04892,Phenserine,,P06276,Cholinesterase,BCHE,inhibitor,
DB04892,Phenserine,,P05067,Amyloid beta A4 protein,APP,,
DB04892,Phenserine,,P22303,Acetylcholinesterase,ACHE,,
DB04893,AZD3409,,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB04893,AZD3409,,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB04894,Vapreotide,,P30874,Somatostatin receptor type 2,SSTR2,inducer,H01CB04
DB04894,Vapreotide,,P35346,Somatostatin receptor type 5,SSTR5,agonist,H01CB04
DB04894,Vapreotide,,P25103,Neurokinin 1 receptor,TACR1,antagonist,H01CB04
DB04895,Pegaptanib,,P15692,Vascular endothelial growth factor A,VEGFA,antagonist,S01LA03
DB04896,Milnacipran,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX17
DB04896,Milnacipran,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AX17
DB04896,Milnacipran,,Q05586,NMDA receptor,GRIN1,inhibitor,N06AX17
DB04898,Ximelagatran,,P00734,Prothrombin,F2,inhibitor,B01AE05
DB04899,Nesiritide,,P16066,Atrial natriuretic peptide receptor 1,NPR1,binder,C01DX19
DB04899,Nesiritide,,P20594,Atrial natriuretic peptide receptor 2,NPR2,,C01DX19
DB04899,Nesiritide,,P17342,Atrial natriuretic peptide receptor 3,NPR3,,C01DX19
DB04901,Galiximab,,P33681,T-lymphocyte activation antigen CD80,CD80,antibody,
DB04903,Pagoclone,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,,
DB04903,Pagoclone,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,,
DB04905,Tesmilifene,,P08183,P-glycoprotein 1,ABCB1,inducer,
DB04905,Tesmilifene,,P35367,Histamine H1 receptor,HRH1,antagonist,
DB04908,Flibanserin,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,G02CX02
DB04908,Flibanserin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,G02CX02
DB04908,Flibanserin,,P21917,Dopamine D4 receptor,DRD4,antagonist,G02CX02
DB04908,Flibanserin,,P21917,Dopamine D4 receptor,DRD4,agonist,G02CX02
DB04910,Oxibendazole,,P68371,Tubulin beta-4B chain,TUBB4B,,
DB04911,Oritavancin,,,Peptidoglycan precursors,,binder,J01XA05
DB04911,Oritavancin,,,Bacterial cell wall peptide bridging segments,,inhibitor,J01XA05
DB04911,Oritavancin,,,Pentaglycyl bridging segment,,disruptor,J01XA05
DB04912,Stannsoporfin,,P09601,Heme oxygenase 1,HMOX1,,
DB04912,Stannsoporfin,,P30519,Heme oxygenase 2,HMOX2,,
DB04915,Idronoxil,,Q16206,Ecto-NOX disulfide-thiol exchanger 2,ENOX2,,
DB04917,Renzapride,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,,
DB04917,Renzapride,,Q13639,5-hydroxytryptamine receptor 4,HTR4,,
DB04918,Ceftobiprole,,Q7DHH4,MecA,mecA,,
DB04918,Ceftobiprole,,P14677,Penicillin-binding protein 2x,pbpX,,
DB04918,Ceftobiprole,,P0AD68,Peptidoglycan synthase FtsI,ftsI,,
DB04919,Alfimeprase,,P02671,Fibrinogen alpha chain,FGA,,
DB04919,Alfimeprase,,P02675,Fibrinogen beta chain,FGB,,
DB04920,Clevidipine,,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,,C08CA16
DB04920,Clevidipine,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,,C08CA16
DB04920,Clevidipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,,C08CA16
DB04920,Clevidipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,,C08CA16
DB04924,Itopride,,P14416,Dopamine D2 receptor,DRD2,,A03FA07
DB04924,Itopride,,P22303,Acetylcholinesterase,ACHE,inhibitor,A03FA07
DB04925,Desmoteplase,,P00747,Plasminogen,PLG,,
DB04926,Neramexane,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,,
DB04929,DG031,,P20292,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,,
DB04930,Permethrin,,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,inhibitor,P03AC54;P03AC04
DB04930,Permethrin,,P03372,Estrogen receptor alpha,ESR1,,P03AC54;P03AC04
DB04930,Permethrin,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,P03AC54;P03AC04
DB04931,Afamelanotide,,Q01726,Melanocyte-stimulating hormone receptor,MC1R,agonist,D02BB02
DB04932,Defibrotide,,P30542,Adenosine receptor A1,ADORA1,,B01AX01
DB04932,Defibrotide,,P29274,Adenosine receptor A2a,ADORA2A,,B01AX01
DB04932,Defibrotide,,P29275,Adenosine receptor A2b,ADORA2B,,B01AX01
DB04933,Eritoran,,O00206,Toll-like receptor 4,TLR4,,
DB04934,Rifalazil,,P0A8V2,DNA-directed RNA polymerase subunit beta,rpoB,,
DB04938,Ospemifene,,P03372,Estrogen receptor alpha,ESR1,antagonist,G03XC05
DB04938,Ospemifene,,P03372,Estrogen receptor alpha,ESR1,agonist,G03XC05
DB04941,Crofelemer,,Q5XXA6,Anoctamin-1,ANO1,antagonist,A07XA06
DB04941,Crofelemer,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,antagonist,A07XA06
DB04942,Tamibarotene,,P10276,Retinoic acid receptor alpha,RARA,agonist,
DB04942,Tamibarotene,,P10826,Retinoic acid receptor beta,RARB,agonist,
DB04946,Iloperidone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AX14
DB04946,Iloperidone,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AX14
DB04946,Iloperidone,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AX14
DB04946,Iloperidone,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AX14
DB04946,Iloperidone,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AX14
DB04946,Iloperidone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AX14
DB04946,Iloperidone,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N05AX14
DB04946,Iloperidone,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N05AX14
DB04946,Iloperidone,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AX14
DB04946,Iloperidone,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AX14
DB04946,Iloperidone,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N05AX14
DB04947,Altropane,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,,
DB04948,Lofexidine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,N07BC04
DB04948,Lofexidine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,N07BC04
DB04948,Lofexidine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N07BC04
DB04948,Lofexidine,,P34969,5-hydroxytryptamine receptor 7,HTR7,agonist,N07BC04
DB04948,Lofexidine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,N07BC04
DB04948,Lofexidine,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,agonist,N07BC04
DB04950,Ranpirnase,,,DNA,,,
DB04953,Ezogabine,,O43526,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,,N03AX21
DB04953,Ezogabine,,O43525,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,,N03AX21
DB04953,Ezogabine,,P56696,Potassium voltage-gated channel subfamily KQT member 4,KCNQ4,,N03AX21
DB04953,Ezogabine,,Q9NR82,Potassium voltage-gated channel subfamily KQT member 5,KCNQ5,,N03AX21
DB04954,Tecadenoson,,P30542,Adenosine receptor A1,ADORA1,,
DB04956,Afelimomab,,P01375,Tumor necrosis factor,TNF,,L04AB03
DB04957,Azimilide,,P15382,Potassium voltage-gated channel subfamily E member 1,KCNE1,,
DB04957,Azimilide,,P51787,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,,
DB04957,Azimilide,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,,
DB04958,Epratuzumab,,P20273,B-cell receptor CD22,CD22,antibody,
DB04958,Epratuzumab,,P20273,B-cell receptor CD22,CD22,regulator,
DB04959,Verpasep caltespen,,P08729,"Keratin, type II cytoskeletal 7",KRT7,,
DB04959,Verpasep caltespen,,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,,
DB04960,Tipifarnib,,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB04961,Troxacitabine,,,DNA,,,
DB04964,Oregovomab,,Q8WXI7,Mucin-16,MUC16,,
DB04967,Lucanthone,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,
DB04967,Lucanthone,,P27695,DNA-(apurinic or apyrimidinic site) lyase,APEX1,inhibitor,
DB04967,Lucanthone,,,DNA,,intercalation,
DB04967,Lucanthone,,P11387,DNA topoisomerase 1,TOP1,inhibitor,
DB04970,Lesopitron,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB04971,Reglitazar,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB04971,Reglitazar,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB04972,Canfosfamide,,P09211,Glutathione S-transferase P,GSTP1,,
DB04973,LErafAON,,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,,
DB04974,Rimiducid,,P42345,Serine/threonine-protein kinase mTOR,MTOR,ligand,
DB04975,Banoxantrone,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB04977,Plitidepsin,,Q05639,Elongation factor 1-alpha 2,EEF1A2,,L01XX57
DB04978,SP1049C,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB04982,Talampanel,,P42261,Glutamate receptor 1,GRIA1,,
DB04982,Talampanel,,P42262,Glutamate receptor 2,GRIA2,,
DB04982,Talampanel,,P42263,Glutamate receptor 3,GRIA3,,
DB04982,Talampanel,,P48058,Glutamate receptor 4,GRIA4,,
DB04983,Denufosol,,P41231,P2Y purinoceptor 2,P2RY2,,
DB04985,Tigapotide,,P08865,40S ribosomal protein SA,RPSA,,
DB04988,IGN311,,P00533,Epidermal growth factor receptor,EGFR,,
DB04988,IGN311,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,,
DB04991,XL784,,O14672,Disintegrin and metalloproteinase domain-containing protein 10,ADAM10,,
DB04992,AP5346,,,DNA,,,
DB04996,Satraplatin,,,DNA,,,L01XA04
DB04997,ATL1102,,P13612,Integrin alpha-4,ITGA4,,
DB04998,AGRO100,,Q9Y6K9,NF-kappa-B essential modulator,IKBKG,,
DB05001,PSN9301,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB05003,Imexon,,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,,
DB05003,Imexon,,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,,
DB05004,Peptide YY (3-36),,P49146,Neuropeptide Y receptor type 2,NPY2R,,
DB05004,Peptide YY (3-36),,P25929,Neuropeptide Y receptor type 1,NPY1R,,
DB05004,Peptide YY (3-36),,Q15761,Neuropeptide Y receptor type 5,NPY5R,,
DB05004,Peptide YY (3-36),,P50391,Neuropeptide Y receptor type 4,NPY4R,,
DB05009,Apadenoson,,P29274,Adenosine receptor A2a,ADORA2A,,
DB05010,SGS-742,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,,
DB05010,SGS-742,,O75899,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,,
DB05012,XEN-2174,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,
DB05013,Ingenol mebutate,,Q05655,Protein kinase C delta type,PRKCD,ligand,D06BX02
DB05013,Ingenol mebutate,,P17252,Protein kinase C alpha type,PRKCA,ligand,D06BX02
DB05014,XL999,,P22607,Fibroblast growth factor receptor 3,FGFR3,,
DB05014,XL999,,P11362,Fibroblast growth factor receptor 1,FGFR1,,
DB05014,XL999,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB05014,XL999,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,,
DB05014,XL999,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,,
DB05014,XL999,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,,
DB05015,Belinostat,,Q13547,Histone deacetylase,HDAC1,inhibitor,L01XH04
DB05017,YSIL6,,P01375,Tumor necrosis factor,TNF,,
DB05017,YSIL6,,P05231,Interleukin-6,IL6,,
DB05018,Migalastat,,P06280,Alpha-galactosidase A,GLA,stabilization,A16AX14
DB05020,Besifovir dipivoxil,,O11885,DNA polymerase,,,
DB05022,Amonafide,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB05022,Amonafide,,Q02880,DNA topoisomerase 2-beta,TOP2B,,
DB05023,ATL1101,,P08069,Insulin-like growth factor 1 receptor,IGF1R,,
DB05024,CTA018,,Q07973,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",CYP24A1,,
DB05024,CTA018,,P11473,Vitamin D3 receptor,VDR,,
DB05025,Arimoclomol,,P00441,Superoxide dismutase [Cu-Zn],SOD1,,N07XX17
DB05032,REV131,,Q9H3N8,Histamine H4 receptor,HRH4,,
DB05033,INCB7839,,Q13443,Disintegrin and metalloproteinase domain-containing protein 9,ADAM9,,
DB05034,Ularitide,,P16066,Atrial natriuretic peptide receptor 1,NPR1,,
DB05035,Eprotirome,,P10827,Thyroid hormone receptor alpha,THRA,,
DB05035,Eprotirome,,P10828,Thyroid hormone receptor beta,THRB,,
DB05036,Grn163l,,Q86US8,Telomerase-binding protein EST1A,SMG6,,
DB05036,Grn163l,,Q96KG9,N-terminal kinase-like protein,SCYL1,,
DB05036,Grn163l,,Q15185,Prostaglandin E synthase 3,PTGES3,,
DB05036,Grn163l,,O14746,Telomerase reverse transcriptase,TERT,,
DB05038,Anatibant,,P30411,B2 bradykinin receptor,BDKRB2,antagonist,
DB05039,Indacaterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03AC18;R03AL04;R03AL12;R03AK14
DB05042,SGS518,,P50406,5-hydroxytryptamine receptor 6,HTR6,,
DB05044,PSN357,,,"Glycogen phosphorylase, liver form",,,
DB05045,Obinepitide,,P50391,Neuropeptide Y receptor type 4,NPY4R,,
DB05045,Obinepitide,,P49146,Neuropeptide Y receptor type 2,NPY2R,,
DB05046,V1003,,P41145,Kappa-type opioid receptor,OPRK1,,
DB05046,V1003,,P35372,Mu-type opioid receptor,OPRM1,,
DB05047,CX-717,,P23560,Brain-derived neurotrophic factor,BDNF,,
DB05047,CX-717,,P42261,Glutamate receptor 1,GRIA1,,
DB05047,CX-717,,P42262,Glutamate receptor 2,GRIA2,,
DB05047,CX-717,,P42263,Glutamate receptor 3,GRIA3,,
DB05047,CX-717,,P48058,Glutamate receptor 4,GRIA4,,
DB05049,DDP733,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,,
DB05050,ADL5859,,P41143,Delta-type opioid receptor,OPRD1,,
DB05052,MF101,,Q92731,Estrogen receptor beta,ESR2,,
DB05053,MB-07803,,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,,
DB05060,R1626,,O39930,RNA-dependent RNA-polymerase,NS5b,,
DB05064,INCB13739,,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB05069,ATG003,,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,,
DB05069,ATG003,,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,,
DB05070,ADX10059,,P41594,Metabotropic glutamate receptor 5,GRM5,,
DB05072,AV608,,P25103,Neurokinin 1 receptor,TACR1,,
DB05075,TG-100801,,P17948,Vascular endothelial growth factor receptor 1,FLT1,,
DB05075,TG-100801,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB05075,TG-100801,,P35916,Vascular endothelial growth factor receptor 3,FLT4,,
DB05075,TG-100801,,P41240,Tyrosine-protein kinase CSK,CSK,,
DB05077,SLV319,,P21554,Cannabinoid receptor 1,CNR1,,
DB05078,AER001,,P24394,Interleukin-4 receptor subunit alpha,IL4R,,
DB05078,AER001,,Q14627,Interleukin-13 receptor subunit alpha-2,IL13RA2,,
DB05079,HY10275,,P35367,Histamine H1 receptor,HRH1,,
DB05079,HY10275,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB05080,OBE101,,P35367,Histamine H1 receptor,HRH1,,
DB05080,OBE101,,Q9Y5N1,Histamine H3 receptor,HRH3,,
DB05084,Abaloparatide,,Q03431,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,agonist,H05AA04
DB05085,TM30339,,P50391,Neuropeptide Y receptor type 4,NPY4R,,
DB05087,Ganaxolone,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N03AX27
DB05088,Tetrathiomolybdate,,P05067,Amyloid beta A4 protein,APP,,
DB05091,M0002,,P30518,Vasopressin V2 receptor,AVPR2,,
DB05092,CDP323,,P13612,Integrin alpha-4,ITGA4,,
DB05095,Cimicoxib,,P35354,Prostaglandin G/H synthase 2,PTGS2,,
DB05096,LY2140023,,Q14416,Metabotropic glutamate receptor 2,GRM2,,
DB05096,LY2140023,,Q14832,Metabotropic glutamate receptor 3,GRM3,,
DB05097,Labetuzumab,,P06731,Carcinoembryonic antigen-related cell adhesion molecule 5,CEACAM5,inhibitor,
DB05098,Leptin,,P48357,Leptin receptor,LEPR,,
DB05099,Ancrod,,P02671,Fibrinogen alpha chain,FGA,,B01AD09
DB05101,Matuzumab,,P00533,Epidermal growth factor receptor,EGFR,,
DB05102,Rupintrivir,,P03303,Genome polyprotein,,,
DB05103,AN-9,,P10415,Apoptosis regulator Bcl-2,BCL2,downregulator,
DB05103,AN-9,,Q14790,Caspase-8,CASP8,regulator,
DB05104,Asimadoline,,P41145,Kappa-type opioid receptor,OPRK1,,
DB05105,Pleconaril,,Q8V397,Polyprotein,,,J05AX06
DB05107,16-Bromoepiandrosterone,,P11413,Glucose-6-phosphate 1-dehydrogenase,G6PD,,
DB05109,Trabectedin,,,DNA,,binder,L01CX01
DB05110,VIR201,,P01579,Interferon gamma,IFNG,,
DB05111,Fontolizumab,,P01579,Interferon gamma,IFNG,,
DB05115,NN344,,P06213,Insulin receptor,INSR,,
DB05116,Thymectacin,,P04818,Thymidylate synthase,TYMS,,
DB05119,Rilapladib,,Q13093,Platelet-activating factor acetylhydrolase,PLA2G7,,
DB05120,AT1391,,P06213,Insulin receptor,INSR,,
DB05121,1D09C3,,P01903,HLA-DR,HLA-DRA,,
DB05122,R1295,,P13612,Integrin alpha-4,ITGA4,,
DB05122,R1295,,P16144,Integrin beta-4,ITGB4,,
DB05122,R1295,,P26010,Integrin beta-7,ITGB7,,
DB05125,SC12267,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB05127,ANA971,,Q9NYK1,Toll-like receptor 7,TLR7,,
DB05129,Elsamitrucin,,,DNA,,,
DB05129,Elsamitrucin,,P11387,DNA topoisomerase 1,TOP1,,
DB05129,Elsamitrucin,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB05130,INCB3284,,P41597,C-C chemokine receptor type 2,CCR2,,
DB05131,TTP889,,P00740,Coagulation factor IX,F9,,
DB05133,VP025,,P01584,Interleukin-1 beta,IL1B,,
DB05134,Tanespimycin,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB05134,Tanespimycin,,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB05137,Lobeline,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,
DB05137,Lobeline,,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,,
DB05137,Lobeline,,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,,
DB05139,CR002,,Q9GZP0,Platelet-derived growth factor D,PDGFD,,
DB05141,LY2181308,,O15392,Baculoviral IAP repeat-containing protein 5,BIRC5,,
DB05142,ND7001,,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,,
DB05146,XL820,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB05146,XL820,,P10721,Mast/stem cell growth factor receptor Kit,KIT,,
DB05146,XL820,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,,
DB05146,XL820,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,,
DB05147,CYT997,,Q71U36,Tubulin alpha-1A chain,TUBA1A,,
DB05147,CYT997,,P68363,Tubulin alpha-1B chain,TUBA1B,,
DB05147,CYT997,,Q9BQE3,Tubulin alpha-1C chain,TUBA1C,,
DB05147,CYT997,,P68366,Tubulin alpha-4A chain,TUBA4A,,
DB05147,CYT997,,Q13748,Tubulin alpha 3C/D chain,TUBA3C,,
DB05147,CYT997,,Q6PEY2,Tubulin alpha-3E chain,TUBA3E,,
DB05147,CYT997,,Q9H853,Putative tubulin-like protein alpha-4B,TUBA4B,,
DB05147,CYT997,,Q9H4B7,Tubulin beta-1 chain,TUBB1,,
DB05147,CYT997,,Q13885,Tubulin beta-2A chain,TUBB2A,,
DB05147,CYT997,,Q9BVA1,Tubulin beta-2B chain,TUBB2B,,
DB05147,CYT997,,P68371,Tubulin beta-4B chain,TUBB4B,,
DB05147,CYT997,,Q13509,Tubulin beta-3 chain,TUBB3,,
DB05147,CYT997,,P04350,Tubulin beta-4A chain,TUBB4A,,
DB05147,CYT997,,P07437,Tubulin beta chain,TUBB,,
DB05147,CYT997,,Q9BUF5,Tubulin beta-6 chain,TUBB6,,
DB05149,XL844,,O96017,Serine/threonine-protein kinase Chk2,CHEK2,,
DB05149,XL844,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB05150,CAD106,,P05067,Amyloid beta A4 protein,APP,,
DB05152,NGX267,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,,
DB05154,Pretomanid,,P95029,Fatty acid synthetase,fas,other/unknown,J04AK08
DB05154,Pretomanid,,P9WJY5,Uncharacterized MFS-type transporter EfpA,efpA,other/unknown,J04AK08
DB05154,Pretomanid,,P9WIP7,Nucleoid-associated protein Lsr2,lsr2,other/unknown,J04AK08
DB05154,Pretomanid,,A0A0T9AZ62,"Cyd operon, Mycobacterium tuberculosis",cydC,other/unknown,J04AK08
DB05154,Pretomanid,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,other/unknown,J04AK08
DB05155,CR665,,P41145,Kappa-type opioid receptor,OPRK1,,
DB05157,KC706,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB05157,KC706,,Q15759,Mitogen-activated protein kinase 11,MAPK11,,
DB05157,KC706,,P53778,Mitogen-activated protein kinase 12,MAPK12,,
DB05157,KC706,,O15264,Mitogen-activated protein kinase 13,MAPK13,,
DB05159,CCX915,,P41597,C-C chemokine receptor type 2,CCR2,,
DB05161,Elafin,,P08246,Neutrophil elastase,ELANE,,
DB05161,Elafin,,P24158,Myeloblastin,PRTN3,,
DB05164,CMLVAX100,,A1Z199,BCR/ABL p210 fusion protein,BCR/ABL fusion,,
DB05165,LY2275796,,P06730,Eukaryotic translation initiation factor 4E,EIF4E,,
DB05166,APD668,,Q8TDV5,Glucose-dependent insulinotropic receptor,GPR119,,
DB05168,Vintafolide,,P14207,Folate receptor beta,FOLR2,,L01CA06
DB05168,Vintafolide,,P41439,Folate receptor gamma,FOLR3,,L01CA06
DB05168,Vintafolide,,P15328,Folate receptor alpha,FOLR1,,L01CA06
DB05169,AT9283,,O14965,Aurora kinase A,AURKA,,
DB05169,AT9283,,Q96GD4,Aurora kinase B,AURKB,,
DB05171,E-2012,,Q96BI3,Gamma-secretase subunit APH-1A,APH1A,,
DB05171,E-2012,,Q9NZ42,Gamma-secretase subunit PEN-2,PSENEN,,
DB05177,DG051,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB05183,MLN0415,,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,,
DB05184,XL228,,P08069,Insulin-like growth factor 1 receptor,IGF1R,,
DB05184,XL228,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB05184,XL228,,P00519,Tyrosine-protein kinase ABL1,ABL1,,
DB05184,XL228,,P42684,Tyrosine-protein kinase ABL2,ABL2,,
DB05187,Elafibranor,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB05187,Elafibranor,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB05187,Elafibranor,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB05188,KD3010,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB05190,XL281,,P15056,Serine/threonine-protein kinase B-raf,BRAF,,
DB05190,XL281,,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,,
DB05191,Atl146e,,P29274,Adenosine receptor A2a,ADORA2A,,
DB05192,MB07811,,P10828,Thyroid hormone receptor beta,THRB,,
DB05194,KB002,,P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,,
DB05194,KB002,,P04141,Granulocyte-macrophage colony-stimulating factor,CSF2,,
DB05194,KB002,,Q16498,GM-CSF receptor alpha subunit,CSF2RA,,
DB05198,CYC116,,O14965,Aurora kinase A,AURKA,,
DB05198,CYC116,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB05199,LX1031,,P17752,Tryptophan 5-hydroxylase 1,TPH1,,
DB05200,AT2220,,P10253,Lysosomal alpha-glucosidase,GAA,,
DB05201,V24343,,P21554,Cannabinoid receptor 1,CNR1,,
DB05202,Egaptivon pegol,,P04275,von Willebrand factor,VWF,,
DB05202,Egaptivon pegol,,P07359,Platelet glycoprotein Ib alpha chain,GP1BA,,
DB05203,SPP1148,,P00797,Renin,REN,,
DB05203,SPP1148,,Q9BYF1,Angiotensin-converting enzyme 2,ACE2,,
DB05204,XL418,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB05205,CX157,,P21397,Amine oxidase [flavin-containing] A,MAOA,,
DB05207,SD118,,P01375,Tumor necrosis factor,TNF,,
DB05207,SD118,,P14778,Interleukin-1 receptor type 1,IL1R1,,
DB05209,Rozrolimupab,,A6PZ59,Rhesus blood group D antigen,RHD,,
DB05210,SF1126,,P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,,
DB05210,SF1126,,O00459,Phosphatidylinositol 3-kinase regulatory subunit beta,PIK3R2,,
DB05210,SF1126,,Q92569,Phosphatidylinositol 3-kinase regulatory subunit gamma,PIK3R3,,
DB05210,SF1126,,P78527,DNA-dependent protein kinase catalytic subunit,PRKDC,,
DB05210,SF1126,,P42345,Serine/threonine-protein kinase mTOR,MTOR,,
DB05212,HE3286,,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,,
DB05212,HE3286,,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,,
DB05214,KD7040,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB05217,GMX1777,,P43490,Nicotinamide phosphoribosyltransferase,NAMPT,inhibitor,
DB05218,PN0621,,P01375,Tumor necrosis factor,TNF,,
DB05219,Crisaborole,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,inhibitor,D11AH06
DB05219,Crisaborole,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,D11AH06
DB05219,Crisaborole,,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,inhibitor,D11AH06
DB05219,Crisaborole,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,inhibitor,D11AH06
DB05220,Alisertib,,O14965,Aurora kinase A,AURKA,inhibitor,
DB05220,Alisertib,,O14965,Aurora kinase A,AURKA,regulator,
DB05222,KB001,,O30527,PcrV,pcrV,,
DB05223,Pracinostat,,Q13547,Histone deacetylase 1,HDAC1,,
DB05223,Pracinostat,,Q92769,Histone deacetylase 2,HDAC2,,
DB05223,Pracinostat,,O15379,Histone deacetylase 3,HDAC3,,
DB05223,Pracinostat,,Q9UBN7,Histone deacetylase 6,HDAC6,,
DB05224,REP8839,,Q6GJI1,Methionine--tRNA ligase,metG,,
DB05225,AM103,,P20292,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,inhibitor,
DB05226,BTA9881,,P13843,Fusion glycoprotein F0,F,,
DB05227,APD791,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB05228,RDEA806,,P03369,Gag-Pol polyprotein,gag-pol,,
DB05229,Beraprost,,P43119,Prostacyclin receptor,PTGIR,,B01AC19
DB05232,Tetrodotoxin,,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,,
DB05232,Tetrodotoxin,,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,,
DB05232,Tetrodotoxin,,Q9NY46,Sodium channel protein type 3 subunit alpha,SCN3A,,
DB05232,Tetrodotoxin,,Q9UQD0,Sodium channel protein type 8 subunit alpha,SCN8A,,
DB05233,AP1081,,P03372,Estrogen receptor alpha,ESR1,,
DB05234,LGD2941,,P10275,Androgen receptor,AR,,
DB05235,NRP409,,Q14894,Ketimine reductase mu-crystallin,CRYM,,
DB05235,NRP409,,P10827,Thyroid hormone receptor alpha,THRA,,
DB05239,Cobimetinib,,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,inhibitor,L01EE02
DB05241,XL765,,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,,
DB05241,XL765,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB05241,XL765,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,,
DB05241,XL765,,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",PIK3CB,,
DB05241,XL765,,P42345,Serine/threonine-protein kinase mTOR,MTOR,,
DB05243,XL019,,O60674,Tyrosine-protein kinase JAK2,JAK2,,
DB05245,Silver sulfadiazine,,,DNA,,binder,D06BA01;G01AE10;D06BA51
DB05246,Methsuximide,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,N03AD03
DB05249,FavId,,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,,
DB05252,Fenoxaprop-ethyl,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB05253,Telapristone acetate,,P06401,Progesterone receptor,PGR,,
DB05254,Fibrinolysin,,P05121,Plasminogen activator inhibitor 1,SERPINE1,,B01AD05;B06AA02
DB05254,Fibrinolysin,,P00749,Urokinase-type plasminogen activator,PLAU,,B01AD05;B06AA02
DB05255,Ronacaleret,,P41180,Extracellular calcium-sensing receptor,CASR,antagonist,
DB05258,Interferon alfa,,P17181,Interferon alpha/beta receptor 1,IFNAR1,,
DB05259,Glatiramer,,P01911,"HLA class II histocompatibility antigen, DRB1-1 beta chain",HLA-DRB1,binder,L03AX13
DB05259,Glatiramer,,P01911,"HLA class II histocompatibility antigen, DRB1-15 beta chain",HLA-DRB1,binder,L03AX13
DB05259,Glatiramer,,P01911,"HLA class II histocompatibility antigen, DRB1-4 beta chain",HLA-DRB1,binder,L03AX13
DB05260,Gallium nitrate,,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,inhibitor,
DB05260,Gallium nitrate,,P21281,"V-type proton ATPase subunit B, brain isoform",ATP6V1B2,inhibitor,
DB05262,Oxypurinol,,P47989,Xanthine dehydrogenase/oxidase,XDH,,
DB05264,NPI 32101,,P32927,Cytokine receptor common subunit beta,CSF2RB,,
DB05265,Ecabet,,P18314,Urease subunit alpha,ureC,inhibitor,
DB05265,Ecabet,,Q8NFA2,NADPH oxidase organizer 1,NOXO1,antagonist,
DB05266,Ibudilast,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,inhibitor,R03DC04
DB05266,Ibudilast,,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,inhibitor,R03DC04
DB05266,Ibudilast,,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,inhibitor,R03DC04
DB05266,Ibudilast,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,inhibitor,R03DC04
DB05266,Ibudilast,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,R03DC04
DB05268,iCo-007,,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,,
DB05271,Rotigotine,,P35462,Dopamine D3 receptor,DRD3,agonist,N04BC09
DB05271,Rotigotine,,P21917,Dopamine D4 receptor,DRD4,agonist,N04BC09
DB05271,Rotigotine,,P14416,Dopamine D2 receptor,DRD2,agonist,N04BC09
DB05271,Rotigotine,,P21918,Dopamine D5 receptor,DRD5,agonist,N04BC09
DB05271,Rotigotine,,P21728,Dopamine D1 receptor,DRD1,agonist,N04BC09
DB05271,Rotigotine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N04BC09
DB05271,Rotigotine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N04BC09
DB05276,Hepatitis B immune globulin,,Q69600,HBsAg,S gene,,J06BB04
DB05282,MCC,,O95831,"Apoptosis-inducing factor 1, mitochondrial",AIFM1,,
DB05284,CA4P,,P07437,Tubulin beta chain,TUBB,,
DB05289,Tarenflurbil,,Q9Y6K9,NF-kappa-B essential modulator,IKBKG,,
DB05290,SPP 301,,P25101,Endothelin-1 receptor,EDNRA,,
DB05294,Vandetanib,,P15692,Vascular endothelial growth factor A,VEGFA,inhibitor,L01EX04
DB05294,Vandetanib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,L01EX04
DB05294,Vandetanib,,Q13882,Protein-tyrosine kinase 6,PTK6,inhibitor,L01EX04
DB05294,Vandetanib,,Q02763,Angiopoietin-1 receptor,TEK,inhibitor,L01EX04
DB05294,Vandetanib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,,L01EX04
DB05295,Eldecalcitol,,P11473,Vitamin D3 receptor,VDR,,
DB05297,Paclitaxel docosahexaenoic acid,,P10415,Apoptosis regulator Bcl-2,BCL2,,
DB05298,Tetomilast,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB05299,Keyhole limpet hemocyanin,,P60568,Interleukin-2,IL2,,
DB05301,LAX-101,,Q13393,Phospholipase D1,PLD1,,
DB05301,LAX-101,,P29466,Caspase-1,CASP1,,
DB05303,OMS-103HP,,P01375,Tumor necrosis factor,TNF,,
DB05303,OMS-103HP,,P14778,Interleukin-1 receptor type 1,IL1R1,,
DB05304,Girentuximab,,Q16790,Carbonic anhydrase 9,CA9,,
DB05304,Girentuximab,,P60568,Interleukin-2,IL2,,
DB05305,Cintredekin besudotox,,P35225,Interleukin-13,IL13,,
DB05308,ANX-510,,P04818,Thymidylate synthase,TYMS,,
DB05309,TP-508,,P08620,Fibroblast growth factor 4,FGF4,,
DB05311,Ecallantide,,P03952,Plasma kallikrein,KLKB1,inhibitor,B06AC03
DB05316,Pimavanserin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,inverse agonist,N05AX17
DB05316,Pimavanserin,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,inverse agonist,N05AX17
DB05316,Pimavanserin,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,binder,N05AX17
DB05317,TAK-475,,P37268,Squalene synthase,FDFT1,,
DB05317,TAK-475,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,,
DB05319,Oportuzumab monatox,,P16422,Epithelial cell adhesion molecule,EPCAM,,L01FX16
DB05321,PEG-uricase,,Q45697,Uric acid degradation bifunctional protein,uao,,
DB05327,Ranirestat,,P15121,Aldose reductase,AKR1B1,,
DB05328,VGV-1,,P04585,Gag-Pol polyprotein,gag-pol,,
DB05332,Romiplostim,,P40238,Thrombopoietin receptor,MPL,agonist,B02BX04
DB05337,SOT-107,,P48060,Glioma pathogenesis-related protein 1,GLIPR1,,
DB05339,MN-305,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB05343,Arundic acid,,P04271,Protein S100-B,S100B,,
DB05345,SO-101,,P35367,Histamine H1 receptor,HRH1,,
DB05351,Dexlansoprazole,,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,inhibitor,A02BC06
DB05351,Dexlansoprazole,,P51164,Potassium-transporting ATPase subunit beta,ATP4B,inhibitor,A02BC06
DB05351,Dexlansoprazole,,O94760,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",DDAH1,,A02BC06
DB05361,SR-123781A,,P01008,Antithrombin-III,SERPINC1,,
DB05361,SR-123781A,,P25116,Proteinase-activated receptor 1,F2R,,
DB05362,SSR-126517E,,P00742,Coagulation factor X,F10,,
DB05364,ROX-888,,P10147,C-C motif chemokine 3,CCL3,,
DB05367,Actelion-1,,P25101,Endothelin-1 receptor,EDNRA,,
DB05369,HZT-501,,P25021,Histamine H2 receptor,HRH2,,
DB05374,Rindopepimut,,P00533,Epidermal growth factor receptor,EGFR,,
DB05381,Histamine,,P35367,Histamine H1 receptor,HRH1,agonist,L03AX14;V04CG03
DB05381,Histamine,,P25021,Histamine H2 receptor,HRH2,agonist,L03AX14;V04CG03
DB05381,Histamine,,Q9Y5N1,Histamine H3 receptor,HRH3,agonist,L03AX14;V04CG03
DB05381,Histamine,,Q9H3N8,Histamine H4 receptor,HRH4,agonist,L03AX14;V04CG03
DB05381,Histamine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,,L03AX14;V04CG03
DB05382,Iodine,,Q92911,Sodium/iodide cotransporter,SLC5A5,substrate,D08AG03
DB05382,Iodine,,,Microbial proteins,,unknown,D08AG03
DB05383,Pimagedine,,P35228,"Nitric oxide synthase, inducible",NOS2,inhibitor,
DB05383,Pimagedine,,P35228,"Nitric oxide synthase, inducible",NOS2,downregulator,
DB05383,Pimagedine,,P15121,Aldose reductase,AKR1B1,,
DB05383,Pimagedine,,P35625,Metalloproteinase inhibitor 3,TIMP3,,
DB05383,Pimagedine,,P19801,Amiloride-sensitive amine oxidase [copper-containing],AOC1,inhibitor,
DB05386,Regramostim,,P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,,
DB05386,Regramostim,,Q16498,GM-CSF receptor alpha subunit,CSF2RA,,
DB05387,Neovastat,,P08253,72 kDa type IV collagenase,MMP2,,
DB05387,Neovastat,,P14780,Matrix metalloproteinase-9,MMP9,,
DB05387,Neovastat,,P39900,Macrophage metalloelastase,MMP12,,
DB05389,Tetrachlorodecaoxide,,Q7L5Y9,Macrophage erythroblast attacher,MAEA,,
DB05389,Tetrachlorodecaoxide,,Q86VB7,Scavenger receptor cysteine-rich type 1 protein M130,CD163,,
DB05390,INS 316,,P41231,P2Y purinoceptor 2,P2RY2,,
DB05391,Liposomal prostaglandin E1,,P07359,Platelet glycoprotein Ib alpha chain,GP1BA,,
DB05395,Amibegron,,P13945,Beta-3 adrenergic receptor,ADRB3,,
DB05398,C31G,,P03366,Gag-Pol polyprotein,gag-pol,,
DB05398,C31G,,P21926,CD9 antigen,CD9,,
DB05399,Succinobucol,,P19320,Vascular cell adhesion protein 1,VCAM1,,
DB05403,CEP-1347,,P53778,Mitogen-activated protein kinase 12,MAPK12,,
DB05404,AZD 3355,,P04637,Cellular tumor antigen p53,TP53,,
DB05407,TBC-3711,,P05305,Endothelin-1,EDN1,,
DB05408,Emricasan,,P29466,Caspase-1,CASP1,,
DB05408,Emricasan,,P42574,Caspase-3,CASP3,,
DB05408,Emricasan,,P55210,Caspase-7,CASP7,,
DB05412,Talmapimod,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB05412,Talmapimod,,P01375,Tumor necrosis factor,TNF,,
DB05412,Talmapimod,,P01584,Interleukin-1 beta,IL1B,,
DB05412,Talmapimod,,P00403,Cytochrome c oxidase subunit 2,MT-CO2,,
DB05413,Tifuvirtide,,P05154,Plasma serine protease inhibitor,SERPINA5,,
DB05414,Pipendoxifene,,Q81ZL8,"Integrase, catalytic core",,,
DB05415,OSI-461,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,,
DB05416,Cardarine,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,agonist,
DB05416,Cardarine,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,
DB05417,GW 468816,,P23415,Glycine receptor subunit alpha-1,GLRA1,,
DB05418,GW 597599,,P25103,Neurokinin 1 receptor,TACR1,,
DB05419,ADX-10061,,Q9NYX4,Neuron-specific vesicular protein calcyon,CALY,,
DB05420,Gallium maltolate,,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,,
DB05421,CP-122721,,P25103,Neurokinin 1 receptor,TACR1,,
DB05422,OPC-14523,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,
DB05423,ORG-34517,,P04150,Glucocorticoid receptor,NR3C1,,
DB05424,Canertinib,,P00533,Epidermal growth factor receptor,EGFR,,
DB05428,Motexafin gadolinium,,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,,
DB05428,Motexafin gadolinium,,Q9NNW7,"Thioredoxin reductase 2, mitochondrial",TXNRD2,,
DB05428,Motexafin gadolinium,,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,,
DB05429,Bertilimumab,,P51671,Eotaxin,CCL11,,
DB05431,MLN-977,,P09917,Arachidonate 5-lipoxygenase,ALOX5,,
DB05432,DAS-431 IV,,Q9NYX4,Neuron-specific vesicular protein calcyon,CALY,,
DB05434,ABT-510,,P09038,Fibroblast growth factor 2,FGF2,,
DB05434,ABT-510,,P14210,Hepatocyte growth factor,HGF,,
DB05434,ABT-510,,P15692,Vascular endothelial growth factor A,VEGFA,,
DB05434,ABT-510,,P10145,Interleukin-8,CXCL8,,
DB05442,Etiprednol dicloacetate,,P01584,Interleukin-1 beta,IL1B,,
DB05443,ADL 10-0101,,P41145,Kappa-type opioid receptor,OPRK1,,
DB05446,LJP 1082,,P02749,Beta-2-glycoprotein 1,APOH,,
DB05447,AVI-4557,,P41235,Hepatocyte nuclear factor 4-alpha,HNF4A,,
DB05448,PX-12,,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,,
DB05449,FM-VP4,,P08183,P-glycoprotein 1,ABCB1,,
DB05451,P54,,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,,
DB05451,P54,,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,,
DB05452,PH-284,,P37288,Vasopressin V1a receptor,AVPR1A,,
DB05452,PH-284,,P47901,Vasopressin V1b receptor,AVPR1B,,
DB05455,SR 121463,,P47901,Vasopressin V1b receptor,AVPR1B,,
DB05457,OSI-7904L,,P04818,Thymidylate synthase,TYMS,,
DB05458,Pozanicline,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,
DB05458,Pozanicline,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,,
DB05459,Briakinumab,,P29460,Interleukin-12 subunit beta,IL12B,,L04AC09
DB05459,Briakinumab,,Q9NPF7,Interleukin-23 subunit alpha,IL23A,,L04AC09
DB05460,Ezatiostat,,P09211,Glutathione S-transferase P,GSTP1,,
DB05461,OPC-28326,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,,
DB05461,OPC-28326,,P18825,Alpha-2C adrenergic receptor,ADRA2C,,
DB05461,OPC-28326,,P18089,Alpha-2B adrenergic receptor,ADRA2B,,
DB05463,ISS-1018,,Q9NR96,Toll-like receptor 9,TLR9,,
DB05464,NOX-700,,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,,
DB05464,NOX-700,,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,,
DB05465,Tandutinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,,
DB05465,Tandutinib,,Q9GZP0,Platelet-derived growth factor D,PDGFD,,
DB05466,R673,,P25103,Neurokinin 1 receptor,TACR1,,
DB05467,Palovarotene,,P13631,Retinoic acid receptor gamma,RARG,agonist,M09AX11
DB05468,R411,,P13612,Integrin alpha-4,ITGA4,,
DB05469,R450,,P35348,Alpha-1A adrenergic receptor,ADRA1A,,
DB05469,R450,,P35368,Alpha-1B adrenergic receptor,ADRA1B,,
DB05469,R450,,P25100,Alpha-1D adrenergic receptor,ADRA1D,,
DB05470,VX-702,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB05470,VX-702,,P01375,Tumor necrosis factor,TNF,,
DB05470,VX-702,,P01584,Interleukin-1 beta,IL1B,,
DB05470,VX-702,,P05231,Interleukin-6,IL6,,
DB05471,SGN-30,,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,,
DB05471,SGN-30,,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,,
DB05472,Human interferon omega-1,,P17181,Interferon alpha/beta receptor 1,IFNAR1,,
DB05472,Human interferon omega-1,,P48551,Interferon alpha/beta receptor 2,IFNAR2,,
DB05475,Golotimod,,O60603,Toll-like receptor 2,TLR2,,
DB05475,Golotimod,,O00206,Toll-like receptor 4,TLR4,,
DB05475,Golotimod,,Q9NYK1,Toll-like receptor 7,TLR7,,
DB05475,Golotimod,,Q9NR96,Toll-like receptor 9,TLR9,,
DB05476,WX-UK1,,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,,
DB05478,Pradefovir mesylate,,P08684,Cytochrome P450 3A4,CYP3A4,,
DB05479,CZEN 002,,Q01726,Melanocyte-stimulating hormone receptor,MC1R,,
DB05481,Recombinant alpha 1-antitrypsin,,P01009,Alpha-1-antitrypsin,SERPINA1,,
DB05482,SN-38,,P11387,DNA topoisomerase 1,TOP1,,
DB05483,Picolinic acid,,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,,
DB05483,Picolinic acid,,P08048,Zinc finger Y-chromosomal protein,ZFY,,
DB05484,MDX-018,,P10145,Interleukin-8,CXCL8,,
DB05487,Custirsen,,P03372,Estrogen receptor alpha,ESR1,,
DB05487,Custirsen,,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,,
DB05487,Custirsen,,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,,
DB05488,Technetium Tc-99m ciprofloxacin,,P0AES6,DNA gyrase subunit B,gyrB,,
DB05488,Technetium Tc-99m ciprofloxacin,,Q02880,DNA topoisomerase 2-beta,TOP2B,,
DB05489,ACA 125,,P00521,Tyrosine-protein kinase transforming protein Abl,ABL,,
DB05490,AMG-131,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,partial agonist,
DB05492,Epicept NP-1,,P35372,Mu-type opioid receptor,OPRM1,,
DB05492,Epicept NP-1,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB05492,Epicept NP-1,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,,
DB05492,Epicept NP-1,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,,
DB05492,Epicept NP-1,,P35348,Alpha-1A adrenergic receptor,ADRA1A,,
DB05492,Epicept NP-1,,P35368,Alpha-1B adrenergic receptor,ADRA1B,,
DB05492,Epicept NP-1,,P25100,Alpha-1D adrenergic receptor,ADRA1D,,
DB05492,Epicept NP-1,,P08913,Alpha-2A adrenergic receptor,ADRA2A,,
DB05492,Epicept NP-1,,P18089,Alpha-2B adrenergic receptor,ADRA2B,,
DB05492,Epicept NP-1,,P18825,Alpha-2C adrenergic receptor,ADRA2C,,
DB05492,Epicept NP-1,,P35367,Histamine H1 receptor,HRH1,,
DB05492,Epicept NP-1,,P41146,Nociceptin receptor,OPRL1,,
DB05494,Elacytarabine,,P27707,Deoxycytidine kinase,DCK,,
DB05495,PG-530742,,P14780,Matrix metalloproteinase-9,MMP9,,
DB05501,Mavorixafor,,P61073,C-X-C chemokine receptor type 4,CXCR4,antagonist,
DB05501,Mavorixafor,,P61073,C-X-C chemokine receptor type 4,CXCR4,inhibitor,
DB05501,Mavorixafor,,P51681,C-C chemokine receptor type 5,CCR5,,
DB05505,NM-702,,P24557,Thromboxane-A synthase,TBXAS1,,
DB05506,ISIS 113715,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB05507,VX-765,,P29466,Caspase-1,CASP1,,
DB05507,VX-765,,P01584,Interleukin-1 beta,IL1B,,
DB05509,LI-301,,P35372,Mu-type opioid receptor,OPRM1,,
DB05509,LI-301,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB05511,Piclidenoson,,P0DMS8,Adenosine receptor A3,ADORA3,,
DB05513,Atiprimod,,P05231,Interleukin-6,IL6,,
DB05513,Atiprimod,,P01375,Tumor necrosis factor,TNF,,
DB05514,Cobiprostone,,P51788,Chloride channel protein 2,CLCN2,,
DB05518,Managlinat dialanetil,,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,,
DB05521,Telaprevir,,B0B3C9,NS3/4A protein,NS3/4A,inhibitor,J05AP02
DB05521,Telaprevir,,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,SLCO1B1,inhibitor,J05AP02
DB05521,Telaprevir,,O94956,Solute carrier organic anion transporter family member 2B1,SLCO2B1,inhibitor,J05AP02
DB05524,Pelitinib,,P00533,Epidermal growth factor receptor,EGFR,,
DB05528,Mipomersen,,,mRNA of ApoB-100,,binder,C10AX11
DB05530,CPG 10101,,Q9NR96,Toll-like receptor 9,TLR9,,
DB05532,BMS-488043,,Q5NUL3,Free fatty acid receptor 4,FFAR4,,
DB05533,QR-333,,P15121,Aldose reductase,AKR1B1,,
DB05540,Alanosine,,P0A786,Aspartate carbamoyltransferase catalytic chain,pyrB,,
DB05540,Alanosine,,P30520,Adenylosuccinate synthetase isozyme 2,ADSS,,
DB05540,Alanosine,,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,,
DB05541,Brivaracetam,,Q7L0J3,Synaptic vesicle glycoprotein 2A,SV2A,unknown,N03AX23
DB05541,Brivaracetam,,P35498,Sodium channel protein,SCN1A,inhibitor,N03AX23
DB05542,Naronapride,,Q13639,5-hydroxytryptamine receptor 4,HTR4,agonist,
DB05550,Iratumumab,,P28908,Tumor necrosis factor receptor superfamily member 8,TNFRSF8,antibody,
DB05550,Iratumumab,,P28908,Tumor necrosis factor receptor superfamily member 8,TNFRSF8,regulator,
DB05552,TG100-115,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,inhibitor,
DB05552,TG100-115,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,inhibitor,
DB05553,Regrelor,,Q9H244,P2Y purinoceptor 12,P2RY12,antagonist,
DB05559,NF-kappaB Decoy,,Q00653,Nuclear factor NF-kappa-B,NFKB2,inhibitor,
DB05562,Naluzotan,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,
DB05578,Ramucirumab,,P35968,Vascular endothelial growth factor receptor 2,KDR,antagonist,L01FG02
DB05590,Bedoradrine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,
DB05595,Farletuzumab,,P15328,Folate receptor alpha,FOLR1,antibody,
DB05607,PRX-08066,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,
DB05624,Teverelix,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,antagonist,
DB05630,Sodium stibogluconate,,P11387,DNA topoisomerase 1,TOP1,inhibitor,P01CB02
DB05642,DDP-225,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,,
DB05642,DDP-225,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,
DB05644,KP-1461,,P03369,Gag-Pol polyprotein,gag-pol,,
DB05659,Faropenem medoxomil,,Q04707,Penicillin-binding protein 1A,ponA,,
DB05659,Faropenem medoxomil,,P0A3M5,Penicillin-binding protein 2B,penA,,
DB05659,Faropenem medoxomil,,P0AD69,Peptidoglycan synthase FtsI,ftsI,,
DB05662,NP-50301,,P03372,Estrogen receptor alpha,ESR1,,
DB05667,Levoketoconazole,,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,inhibitor,H02CA04
DB05667,Levoketoconazole,,P15538,"Cytochrome P450 11B1, mitochondrial",CYP11B1,inhibitor,H02CA04
DB05667,Levoketoconazole,,P19099,"Cytochrome P450 11B2, mitochondrial",CYP11B2,inhibitor,H02CA04
DB05667,Levoketoconazole,,P05108,"Cholesterol side-chain cleavage enzyme, mitochondrial",CYP11A1,inhibitor,H02CA04
DB05667,Levoketoconazole,,Q16850,Lanosterol 14-alpha demethylase,CYP51A1,inhibitor,H02CA04
DB05668,Palifosfamide,,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,,
DB05675,EP-2104R,,P02671,Fibrinogen alpha chain,FGA,,
DB05676,Apremilast,,Q86V67,Phosphodiesterase isozyme 4,PDE4,antagonist,L04AA32
DB05678,SLx-4090,,P55157,Microsomal triglyceride transfer protein large subunit,MTTP,inhibitor,
DB05679,Ustekinumab,,P29460,Interleukin-23,IL12B,inhibitor,L04AC05
DB05679,Ustekinumab,,P29460,Interleukin-12 subunit beta,IL12B,inhibitor,L04AC05
DB05685,FX06,,P33151,Cadherin-5,CDH5,,
DB05687,BL-1020,,P14416,Dopamine D2 receptor,DRD2,,
DB05687,BL-1020,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB05688,CRx-119,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,
DB05688,CRx-119,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,
DB05695,NPS-2143,,P41180,Extracellular calcium-sensing receptor,CASR,,
DB05697,Trabedersen,,P61812,Transforming growth factor beta-2,TGFB2,,
DB05706,13-deoxydoxorubicin,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB05706,13-deoxydoxorubicin,,,DNA,,,
DB05708,GTS-21,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,
DB05710,Gantacurium,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,antagonist,
DB05712,AZD-9684,,Q96IY4,Carboxypeptidase B2,CPB2,,
DB05713,LY-517717,,P00742,Coagulation factor X,F10,,
DB05714,Flovagatran,,P00734,Prothrombin,F2,,
DB05736,MIV-701,,P43235,Cathepsin K,CTSK,,
DB05737,Varespladib methyl,,P14555,"Phospholipase A2, membrane associated",PLA2G2A,,
DB05737,Varespladib methyl,,O15496,Group 10 secretory phospholipase A2,PLA2G10,,
DB05739,CYT006-AngQb,,P30556,Type-1 angiotensin II receptor,AGTR1,,
DB05739,CYT006-AngQb,,P50052,Type-2 angiotensin II receptor,AGTR2,,
DB05740,RPI-78M,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,,
DB05740,RPI-78M,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,,
DB05740,RPI-78M,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,
DB05740,RPI-78M,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,
DB05740,RPI-78M,,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,,
DB05740,RPI-78M,,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,,
DB05744,CRx-139,,P01375,Tumor necrosis factor,TNF,,
DB05744,CRx-139,,P05231,Interleukin-6,IL6,,
DB05744,CRx-139,,P02741,C-reactive protein,CRP,,
DB05744,CRx-139,,P22301,Interleukin-10,IL10,,
DB05749,MPI-674,,P11511,Cytochrome P450 19A1,CYP19A1,,
DB05750,AVE-1625,,P21554,Cannabinoid receptor 1,CNR1,,
DB05752,ALKS 27,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,,
DB05752,ALKS 27,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,,
DB05752,ALKS 27,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,,
DB05752,ALKS 27,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,,
DB05752,ALKS 27,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,,
DB05758,CYT007-TNFQb,,P01375,Tumor necrosis factor,TNF,,
DB05766,Norclozapine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,,
DB05766,Norclozapine,,P14416,Dopamine D2 receptor,DRD2,,
DB05766,Norclozapine,,P35462,Dopamine D3 receptor,DRD3,,
DB05767,Andrographolide,,P01375,Tumor necrosis factor,TNF,,
DB05767,Andrographolide,,P01584,Interleukin-1 beta,IL1B,,
DB05767,Andrographolide,,P05231,Interleukin-6,IL6,,
DB05767,Andrographolide,,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,,
DB05767,Andrographolide,,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,,
DB05771,LLL-3348,,P22301,Interleukin-10,IL10,,
DB05773,Trastuzumab emtansine,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,antibody,L01FD03
DB05777,Thrombomodulin Alfa,,P00734,Prothrombin,F2,inhibitor,
DB05777,Thrombomodulin Alfa,,P12259,Coagulation factor V,F5,,
DB05785,LGD-1550,,P10276,Retinoic acid receptor alpha,RARA,,
DB05785,LGD-1550,,P10826,Retinoic acid receptor beta,RARB,,
DB05785,LGD-1550,,P13631,Retinoic acid receptor gamma,RARG,,
DB05785,LGD-1550,,P05412,Transcription factor AP-1,JUN,,
DB05786,Irofulven,,Q96AE4,Far upstream element-binding protein 1,FUBP1,,
DB05787,LM-609,,P05106,Integrin beta-3,ITGB3,,
DB05790,SR 140333,,P25103,Neurokinin 1 receptor,TACR1,,
DB05792,Arylacenamide,,Q5T1J1,"HCG20471, isoform CRA_c",SIGMAR1,,
DB05793,PRO-542,,Q5NUL3,Free fatty acid receptor 4,FFAR4,,
DB05796,Daglutril,,P08473,Neprilysin,MME,,
DB05797,TNX-901,,P12319,High affinity immunoglobulin epsilon receptor subunit alpha,FCER1A,,
DB05798,GEM-231,,P13861,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,,
DB05798,GEM-231,,P10644,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,,
DB05801,GTI 2040,,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,,
DB05806,Cositecan,,P11387,DNA topoisomerase 1,TOP1,,
DB05812,Abiraterone,,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,inhibitor,L02BX03
DB05814,GPI-1485,,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB05824,CNS-5161,,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,,
DB05829,Parathyroid hormone,,P49190,Parathyroid hormone 2 receptor,PTH2R,activator,H05AA03
DB05829,Parathyroid hormone,,Q03431,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,activator,H05AA03
DB05831,ING-1,,P16422,Epithelial cell adhesion molecule,EPCAM,,
DB05838,OPC-51803,,P30518,Vasopressin V2 receptor,AVPR2,,
DB05846,Mito-4509,,P05067,Amyloid beta A4 protein,APP,,
DB05848,humanized SMART Anti-IL-12 Antibody,,P29460,Interleukin-12 subunit beta,IL12B,,
DB05849,NCX 950,,P07550,Beta-2 adrenergic receptor,ADRB2,,
DB05854,CLX-0921,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB05855,Rivanicline,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,,
DB05855,Rivanicline,,P10145,Interleukin-8,CXCL8,antagonist,
DB05864,PPI-2458,,P50579,Methionine aminopeptidase 2,METAP2,,
DB05867,99mTc-14 F7 Mab,,Q9UNP4,"Lactosylceramide alpha-2,3-sialyltransferase",ST3GAL5,,
DB05868,Ciluprevir,,P26664,Genome polyprotein,,,
DB05869,Ethyl pyruvate,,P01375,Tumor necrosis factor,TNF,,
DB05869,Ethyl pyruvate,,P09429,High mobility group protein B1,HMGB1,,
DB05871,UC-781,,P03366,Gag-Pol polyprotein,gag-pol,,
DB05879,AME-527,,P01375,Tumor necrosis factor,TNF,,
DB05882,CHF 4227,,P03372,Estrogen receptor alpha,ESR1,,
DB05882,CHF 4227,,Q92731,Estrogen receptor beta,ESR2,,
DB05883,ABX-PTH,,P01270,Parathyroid hormone,PTH,,
DB05885,Seletracetam,,Q7L0J3,Synaptic vesicle glycoprotein 2A,SV2A,modulator,
DB05885,Seletracetam,,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,blocker,
DB05885,Seletracetam,,P23415,Glycine receptor (alpha-1/beta),GLRA1,binding,
DB05888,MEM 1414,,Q4ZHU6,CAMP phosphodiesterase,PDE4,,
DB05889,Inotuzumab ozogamicin,,P20273,B-cell receptor CD22,CD22,antibody,L01FB01
DB05889,Inotuzumab ozogamicin,,P20273,B-cell receptor CD22,CD22,regulator,L01FB01
DB05890,Veglin,,P15692,Vascular endothelial growth factor A,VEGFA,,
DB05892,RI 624,,P01138,Beta-nerve growth factor,NGF,,
DB05895,HGS-TR2J,,O14763,Tumor necrosis factor receptor superfamily member 10B,TNFRSF10B,,
DB05897,rhIGFBP-3,,P08069,Insulin-like growth factor 1 receptor,IGF1R,,
DB05905,TD-2749,,Q13639,5-hydroxytryptamine receptor 4,HTR4,,
DB05906,CCR5 mAb,,P51681,C-C chemokine receptor type 5,CCR5,,
DB05913,OSI-930,,P10721,Mast/stem cell growth factor receptor Kit,KIT,,
DB05913,OSI-930,,P17948,Vascular endothelial growth factor receptor 1,FLT1,,
DB05915,Stamulumab,,O14793,Growth/differentiation factor 8,MSTN,,
DB05916,CT-011,,Q15116,Programmed cell death protein 1,PDCD1,,
DB05920,RTA 744,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB05928,Dovitinib,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,suppressor,
DB05930,SB-559448,,P40238,Thrombopoietin receptor,MPL,,
DB05931,Pegdinetanib,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB05932,Denibulin,,P15692,Vascular endothelial growth factor A,VEGFA,,
DB05932,Denibulin,,P17948,Vascular endothelial growth factor receptor 1,FLT1,,
DB05932,Denibulin,,P35916,Vascular endothelial growth factor receptor 3,FLT4,,
DB05933,MK-4721,,O43653,Prostate stem cell antigen,PSCA,,
DB05934,CTCE-0214,,P48061,Stromal cell-derived factor 1,CXCL12,,
DB05936,CVT-6883,,P29275,Adenosine receptor A2b,ADORA2B,,
DB05938,Edonerpic,,P05067,Amyloid beta A4 protein,APP,,
DB05939,MK-0354,,Q99527,G-protein coupled estrogen receptor 1,GPER1,,
DB05941,Leronlimab,,P51681,C-C chemokine receptor type 5,CCR5,antagonist,
DB05943,Resatorvid,,P32927,Cytokine receptor common subunit beta,CSF2RB,,
DB05943,Resatorvid,,P31785,Cytokine receptor common subunit gamma,IL2RG,,
DB05944,Varlitinib,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,,
DB05944,Varlitinib,,P00533,Epidermal growth factor receptor,EGFR,,
DB05945,MDX-1303,,P58335,Anthrax toxin receptor 2,ANTXR2,,
DB05945,MDX-1303,,Q9H6X2,Anthrax toxin receptor 1,ANTXR1,,
DB05950,Contulakin-G,,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,,
DB05956,EVT-101,,P19793,Retinoic acid receptor RXR-alpha,RXRA,,
DB05956,EVT-101,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,,
DB05959,ENMD-1198,,Q9Y6Q6,Tumor necrosis factor receptor superfamily member 11A,TNFRSF11A,,
DB05959,ENMD-1198,,Q16665,Hypoxia-inducible factor 1-alpha,HIF1A,,
DB05959,ENMD-1198,,P40763,Signal transducer and activator of transcription 3,STAT3,,
DB05961,PPL-100,,P05155,Plasma protease C1 inhibitor,SERPING1,,
DB05961,PPL-100,,P05154,Plasma serine protease inhibitor,SERPINA5,,
DB05961,PPL-100,,P01009,Alpha-1-antitrypsin,SERPINA1,,
DB05964,Amitifadine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,
DB05964,Amitifadine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,
DB05964,Amitifadine,,P14416,Dopamine D2 receptor,DRD2,,
DB05966,TAS-108,,P03372,Estrogen receptor alpha,ESR1,,
DB05966,TAS-108,,Q92731,Estrogen receptor beta,ESR2,,
DB05967,ANZ-100,,Q969F8,KiSS-1 receptor,KISS1R,,
DB05968,PR-104,,P01375,Tumor necrosis factor,TNF,,
DB05969,SNS-032,,P50613,Cyclin-dependent kinase 7,CDK7,,
DB05969,SNS-032,,P15692,Vascular endothelial growth factor A,VEGFA,,
DB05971,Archexin,,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,,
DB05983,Bardoxolone methyl,,P25963,NF-kappa-B inhibitor alpha,NFKBIA,,
DB05984,RAF-265,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB05984,RAF-265,,P15056,Serine/threonine-protein kinase B-raf,BRAF,,
DB05990,Obeticholic acid,,Q96RI1,Bile acid receptor,NR1H4,agonist,A05AA04
DB05992,Plinabulin,,P01375,Tumor necrosis factor,TNF,,
DB05993,PRX-07034,,P50406,5-hydroxytryptamine receptor 6,HTR6,,
DB05996,Glembatumumab vedotin,,Q14956,Transmembrane glycoprotein NMB,GPNMB,binder,
DB06011,AMG-222,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB06013,Aldoxorubicin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,
DB06014,Eteplirsen,,,DMD-001 gene (exon 51 target site),,binding,M09AX06
DB06016,Cariprazine,,P35462,Dopamine D3 receptor,DRD3,partial agonist,N05AX15
DB06016,Cariprazine,,P14416,Dopamine D2 receptor,DRD2,partial agonist,N05AX15
DB06016,Cariprazine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,N05AX15
DB06016,Cariprazine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N05AX15
DB06016,Cariprazine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AX15
DB06016,Cariprazine,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AX15
DB06016,Cariprazine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AX15
DB06016,Cariprazine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AX15
DB06021,AV-412,,P00533,Epidermal growth factor receptor,EGFR,,
DB06021,AV-412,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,,
DB06039,PA-1050040,,O93182,Gag polyprotein,gag,,
DB06040,Filanesib,,P52732,Kinesin-like protein KIF11,KIF11,,
DB06042,ZEN-012,,P07437,Tubulin beta chain,TUBB,,
DB06042,ZEN-012,,Q9H4B7,Tubulin beta-1 chain,TUBB1,,
DB06042,ZEN-012,,Q13509,Tubulin beta-3 chain,TUBB3,,
DB06042,ZEN-012,,P04350,Tubulin beta-4A chain,TUBB4A,,
DB06042,ZEN-012,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB06042,ZEN-012,,Q02880,DNA topoisomerase 2-beta,TOP2B,,
DB06043,Olaratumab,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,antagonist,L01FX10
DB06050,TB-402,,P00451,Coagulation factor VIII,F8,,
DB06058,XTL-6865,,P26664,Genome polyprotein,,,
DB06061,AZD-8330,,Q13233,Mitogen-activated protein kinase kinase kinase 1,MAP3K1,,
DB06064,KAI-1455,,Q02156,Protein kinase C epsilon type,PRKCE,,
DB06069,XMT-1001,,P11387,DNA topoisomerase 1,TOP1,,
DB06070,SNX-5422,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB06070,SNX-5422,,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB06073,CTS-21166,,P56817,Beta-secretase 1,BACE1,inhibitor,
DB06075,Linsitinib,,P06213,Insulin receptor,INSR,inhibitor,
DB06075,Linsitinib,,P08069,Insulin-like growth factor 1 receptor,IGF1R,inhibitor,
DB06077,Lumateperone,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N05AD10
DB06077,Lumateperone,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,,N05AD10
DB06077,Lumateperone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AD10
DB06077,Lumateperone,,P14416,Dopamine D2 receptor,DRD2,partial agonist,N05AD10
DB06077,Lumateperone,,P21728,Dopamine D1 receptor,DRD1,,N05AD10
DB06080,Linifanib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,,
DB06080,Linifanib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,,
DB06080,Linifanib,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB06080,Linifanib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,,
DB06080,Linifanib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,,
DB06080,Linifanib,,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,,
DB06081,Caplacizumab,,P04275,von Willebrand factor,VWF,,B01AX07
DB06082,PX-478,,Q16665,Hypoxia-inducible factor 1-alpha,HIF1A,inhibitor,
DB06083,Tapinarof,,P35869,Aryl hydrocarbon receptor,AHR,agonist,
DB06089,ICA-105665,,P51787,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,,
DB06089,ICA-105665,,O43525,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,,
DB06089,ICA-105665,,P56696,Potassium voltage-gated channel subfamily KQT member 4,KCNQ4,,
DB06089,ICA-105665,,Q9NR82,Potassium voltage-gated channel subfamily KQT member 5,KCNQ5,,
DB06089,ICA-105665,,O43526,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,,
DB06090,Bradanicline,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,
DB06094,Apatorsen,,P04792,Heat shock protein beta-1,HSPB1,,
DB06096,NXN-188,,P29475,"Nitric oxide synthase, brain",NOS1,,
DB06096,NXN-188,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,,
DB06096,NXN-188,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,,
DB06097,GSK-923295,,Q02224,Centromere-associated protein E,CENPE,,
DB06098,PRLX 93936,,P45880,Voltage-dependent anion-selective channel protein 2,VDAC2,,
DB06098,PRLX 93936,,Q9Y277,Voltage-dependent anion-selective channel protein 3,VDAC3,,
DB06101,IMC-1C11,,P17948,Vascular endothelial growth factor receptor 1,FLT1,,
DB06101,IMC-1C11,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB06101,IMC-1C11,,P35916,Vascular endothelial growth factor receptor 3,FLT4,,
DB06103,VX-148,,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,,
DB06103,VX-148,,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,,
DB06109,YKP-1358,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB06109,YKP-1358,,P14416,Dopamine D2 receptor,DRD2,antagonist,
DB06116,Eldelumab,,P02778,C-X-C motif chemokine 10,CXCL10,,
DB06124,L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal,,P20807,Calpain-3,CAPN3,,
DB06127,Bisegliptin,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB06133,Dimethylcurcumin,,P10275,Androgen receptor,AR,inhibitor,
DB06134,SNS-314,,O14965,Aurora kinase A,AURKA,,
DB06134,SNS-314,,Q9UQB9,Aurora kinase C,AURKC,,
DB06137,Tirbanibulin,,P07437,Tubulin beta chain,TUBB,inhibitor,D06BX03
DB06137,Tirbanibulin,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,inhibitor,D06BX03
DB06138,IRL-1620,,P24530,Endothelin B receptor,EDNRB,,
DB06140,SUVN-502,,P50406,5-hydroxytryptamine receptor 6,HTR6,,
DB06144,Sertindole,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AE03
DB06144,Sertindole,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AE03
DB06144,Sertindole,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AE03
DB06144,Sertindole,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N05AE03
DB06144,Sertindole,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,N05AE03
DB06144,Sertindole,,P35348,Alpha-1A adrenergic receptor,ADRA1A,,N05AE03
DB06144,Sertindole,,P35368,Alpha-1B adrenergic receptor,ADRA1B,,N05AE03
DB06144,Sertindole,,P25100,Alpha-1D adrenergic receptor,ADRA1D,,N05AE03
DB06145,Spiramycin,,Q9A1X4,50S ribosomal protein L3,rplC,antagonist,J01RA04;J01FA02
DB06145,Spiramycin,,Q9A1X4,50S ribosomal protein L3,rplC,inhibitor,J01RA04;J01FA02
DB06147,Sulfathiazole,,Q27738,Dihydropteroate synthetase,,inhibitor,G01AE10;J01EB07;D06BA02
DB06148,Mianserin,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N06AX03
DB06148,Mianserin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AX03
DB06148,Mianserin,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AX03
DB06148,Mianserin,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AX03
DB06148,Mianserin,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AX03
DB06148,Mianserin,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX03
DB06148,Mianserin,,Q9H3N8,Histamine H4 receptor,HRH4,binder,N06AX03
DB06148,Mianserin,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,blocker,N06AX03
DB06148,Mianserin,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N06AX03
DB06148,Mianserin,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,binder,N06AX03
DB06148,Mianserin,,P30939,5-hydroxytryptamine receptor 1F,HTR1F,binder,N06AX03
DB06148,Mianserin,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N06AX03
DB06148,Mianserin,,P35462,Dopamine D3 receptor,DRD3,binder,N06AX03
DB06148,Mianserin,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N06AX03
DB06148,Mianserin,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,binder,N06AX03
DB06148,Mianserin,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N06AX03
DB06148,Mianserin,,P14416,Dopamine D2 receptor,DRD2,antagonist,N06AX03
DB06148,Mianserin,,P50406,5-hydroxytryptamine receptor 6,HTR6,binder,N06AX03
DB06148,Mianserin,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N06AX03
DB06148,Mianserin,,P21728,D(1) dopamine receptor,DRD1,binder,N06AX03
DB06149,Teicoplanin,,,D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan,,inhibitor,J01XA02
DB06151,Acetylcysteine,,P48637,Glutathione synthetase,GSS,stimulator,R05CB01;S01XA08;V03AB23
DB06151,Acetylcysteine,,Q9UPY5,Cystine/glutamate transporter,SLC7A11,activator,R05CB01;S01XA08;V03AB23
DB06151,Acetylcysteine,,,NAPQI (N-acetyl-p-benzoquinone imine),,reducer,R05CB01;S01XA08;V03AB23
DB06151,Acetylcysteine,,Q03154,Aminoacylase-1,ACY1,substrate,R05CB01;S01XA08;V03AB23
DB06151,Acetylcysteine,,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,inhibitor,R05CB01;S01XA08;V03AB23
DB06151,Acetylcysteine,,O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,inhibitor,R05CB01;S01XA08;V03AB23
DB06151,Acetylcysteine,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,activator,R05CB01;S01XA08;V03AB23
DB06151,Acetylcysteine,,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,activator,R05CB01;S01XA08;V03AB23
DB06151,Acetylcysteine,,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,activator,R05CB01;S01XA08;V03AB23
DB06151,Acetylcysteine,,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,activator,R05CB01;S01XA08;V03AB23
DB06151,Acetylcysteine,,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,activator,R05CB01;S01XA08;V03AB23
DB06152,Nylidrin,,P48551,Interferon alpha/beta receptor 2,IFNAR2,agonist,C04AA02;G02CA02
DB06152,Nylidrin,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,antagonist,C04AA02;G02CA02
DB06152,Nylidrin,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,agonist,C04AA02;G02CA02
DB06153,Pizotifen,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N02CX01
DB06153,Pizotifen,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N02CX01
DB06153,Pizotifen,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N02CX01
DB06153,Pizotifen,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N02CX01
DB06153,Pizotifen,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N02CX01
DB06153,Pizotifen,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N02CX01
DB06153,Pizotifen,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,N02CX01
DB06153,Pizotifen,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,antagonist,N02CX01
DB06153,Pizotifen,,P35367,Histamine H1 receptor,HRH1,antagonist,N02CX01
DB06153,Pizotifen,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N02CX01
DB06153,Pizotifen,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N02CX01
DB06153,Pizotifen,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,N02CX01
DB06153,Pizotifen,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N02CX01
DB06153,Pizotifen,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N02CX01
DB06153,Pizotifen,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N02CX01
DB06154,Pentaerythritol tetranitrate,,P69905,Hemoglobin subunit alpha,HBA1,agonist,C01DA55;C01DA05
DB06154,Pentaerythritol tetranitrate,,P68871,Hemoglobin subunit beta,HBB,agonist,C01DA55;C01DA05
DB06154,Pentaerythritol tetranitrate,,,Free radicals,,antagonist,C01DA55;C01DA05
DB06155,Rimonabant,,P21554,Cannabinoid receptor 1,CNR1,antagonist,A08AX01
DB06155,Rimonabant,,Q9Y2T6,G-protein coupled receptor 55,GPR55,,A08AX01
DB06156,Tesofensine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,
DB06156,Tesofensine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,
DB06156,Tesofensine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,,
DB06157,Istaroxime,,P16615,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,ATP2A2,,
DB06157,Istaroxime,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,,
DB06159,Rubitecan,,P11387,DNA topoisomerase 1,TOP1,,
DB06162,Lumiliximab,,P06734,Low affinity immunoglobulin epsilon Fc receptor,FCER2,antibody,
DB06162,Lumiliximab,,P06734,Low affinity immunoglobulin epsilon Fc receptor,FCER2,regulator,
DB06168,Canakinumab,,P01584,Interleukin-1 beta,IL1B,binder,L04AC08
DB06168,Canakinumab,,P01584,Interleukin-1 beta,IL1B,antibody,L04AC08
DB06174,Noscapine,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,,R05DA07
DB06176,Romidepsin,,Q13547,Histone deacetylase 1,HDAC1,antagonist,L01XH02
DB06176,Romidepsin,,Q13547,Histone deacetylase 1,HDAC1,inhibitor,L01XH02
DB06176,Romidepsin,,Q92769,Histone deacetylase 2,HDAC2,antagonist,L01XH02
DB06176,Romidepsin,,Q92769,Histone deacetylase 2,HDAC2,inhibitor,L01XH02
DB06176,Romidepsin,,P56524,Histone deacetylase 4,HDAC4,inhibitor,L01XH02
DB06176,Romidepsin,,Q9UBN7,Histone deacetylase 6,HDAC6,inhibitor,L01XH02
DB06176,Romidepsin,,P33527,Multidrug resistance-associated protein 1,ABCC1,,L01XH02
DB06176,Romidepsin,,Q13547,Histone deacetylase,HDAC1,inhibitor,L01XH02
DB06184,AEG35156,,P98170,E3 ubiquitin-protein ligase XIAP,XIAP,,
DB06185,Forodesine,,P00491,Purine nucleoside phosphorylase,PNP,,
DB06186,Ipilimumab,,P16410,Cytotoxic T-lymphocyte protein 4,CTLA4,inhibitor,L01FX04
DB06186,Ipilimumab,,P16410,Cytotoxic T-lymphocyte protein 4,CTLA4,antibody,L01FX04
DB06190,Solabegron,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,
DB06191,Zosuquidar,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB06194,Elocalcitol,,P11473,Vitamin D3 receptor,VDR,,
DB06195,Seliciclib,,P06493,Cyclin-dependent kinase 1,CDK1,,
DB06195,Seliciclib,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB06195,Seliciclib,,P27361,Mitogen-activated protein kinase 3,MAPK3,,
DB06195,Seliciclib,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB06195,Seliciclib,,P50613,Cyclin-dependent kinase 7,CDK7,,
DB06195,Seliciclib,,P50750,Cyclin-dependent kinase 9,CDK9,,
DB06195,Seliciclib,,P49674,Casein kinase I isoform epsilon,CSNK1E,,
DB06196,Icatibant,,P30411,B2 bradykinin receptor,BDKRB2,antagonist,B06AC02
DB06196,Icatibant,,P15144,Aminopeptidase N,ANPEP,inhibitor,B06AC02
DB06198,Alovudine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,
DB06199,Atrasentan,,P25101,Endothelin-1 receptor,EDNRA,,
DB06201,Rufinamide,,Q15858,Sodium channel protein type 9 subunit alpha,SCN9A,modulator,N03AF03
DB06201,Rufinamide,,P41594,Metabotropic glutamate receptor 5,GRM5,inhibitor,N03AF03
DB06202,Lasofoxifene,,P03372,Estrogen receptor alpha,ESR1,antagonist,G03XC03
DB06202,Lasofoxifene,,P03372,Estrogen receptor alpha,ESR1,agonist,G03XC03
DB06202,Lasofoxifene,,P03372,Estrogen receptor alpha,ESR1,negative modulator,G03XC03
DB06202,Lasofoxifene,,Q92731,Estrogen receptor beta,ESR2,agonist,G03XC03
DB06202,Lasofoxifene,,P34972,Cannabinoid receptor 2,CNR2,inverse agonist,G03XC03
DB06203,Alogliptin,,P27487,Dipeptidyl peptidase 4,DPP4,inhibitor,A10BD13;A10BD09;A10BH04
DB06204,Tapentadol,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AX06
DB06204,Tapentadol,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N02AX06
DB06204,Tapentadol,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N02AX06
DB06204,Tapentadol,,P41143,Delta-type opioid receptor,OPRD1,agonist,N02AX06
DB06204,Tapentadol,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N02AX06
DB06205,Hyaluronidase (human recombinant),,,Hyaluronic acid,,modulator,
DB06205,Hyaluronidase (human recombinant),,,Hyaluronic acid,,metabolizer,
DB06205,Hyaluronidase (human recombinant),,P01137,Transforming growth factor beta-1,TGFB1,inhibitor,
DB06207,Silodosin,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,G04CA04
DB06207,Silodosin,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,G04CA04
DB06207,Silodosin,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,G04CA04
DB06207,Silodosin,,Q12809,HERG human cardiac K+ channel,KCNH2,blocker,G04CA04
DB06209,Prasugrel,,Q9H244,P2Y purinoceptor 12,P2RY12,antagonist,B01AC22
DB06210,Eltrombopag,,P40238,Thrombopoietin receptor,MPL,agonist,B02BX05
DB06211,Doripenem,,P02918,Penicillin-binding protein 1A,mrcA,antagonist,J01DH04
DB06211,Doripenem,,P02918,Penicillin-binding protein 1A,mrcA,inhibitor,J01DH04
DB06211,Doripenem,,P02919,Penicillin-binding protein 1B,mrcB,antagonist,J01DH04
DB06211,Doripenem,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DH04
DB06211,Doripenem,,P0AD65,Penicillin-binding protein 2,mrdA,antagonist,J01DH04
DB06211,Doripenem,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,J01DH04
DB06211,Doripenem,,Q51504,Penicillin-binding protein 3,pbpB,antagonist,J01DH04
DB06211,Doripenem,,Q51504,Penicillin-binding protein 3,pbpB,inhibitor,J01DH04
DB06211,Doripenem,,P72355,Penicillin-binding protein 4,pbp4,antagonist,J01DH04
DB06211,Doripenem,,P72355,Penicillin-binding protein 4,pbp4,inhibitor,J01DH04
DB06212,Tolvaptan,,P30518,Vasopressin V2 receptor,AVPR2,antagonist,C03XA01
DB06212,Tolvaptan,,P37288,Vasopressin V1a receptor,AVPR1A,antagonist,C03XA01
DB06213,Regadenoson,,P29274,Adenosine receptor A2a,ADORA2A,agonist,C01EB21
DB06216,Asenapine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AH05
DB06216,Asenapine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AH05
DB06216,Asenapine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AH05
DB06216,Asenapine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,antagonist,N05AH05
DB06216,Asenapine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N05AH05
DB06216,Asenapine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05AH05
DB06216,Asenapine,,P47898,5-hydroxytryptamine receptor 5A,HTR5A,antagonist,N05AH05
DB06216,Asenapine,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N05AH05
DB06216,Asenapine,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N05AH05
DB06216,Asenapine,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AH05
DB06216,Asenapine,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AH05
DB06216,Asenapine,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AH05
DB06216,Asenapine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AH05
DB06216,Asenapine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N05AH05
DB06216,Asenapine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,antagonist,N05AH05
DB06216,Asenapine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N05AH05
DB06216,Asenapine,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AH05
DB06216,Asenapine,,P25021,Histamine H2 receptor,HRH2,antagonist,N05AH05
DB06216,Asenapine,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,N05AH05
DB06216,Asenapine,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,N05AH05
DB06217,Vernakalant,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,blocker,C01BG11
DB06217,Vernakalant,,P22460,Potassium voltage-gated channel subfamily A member 5,KCNA5,blocker,C01BG11
DB06217,Vernakalant,,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,blocker,C01BG11
DB06217,Vernakalant,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,blocker,C01BG11
DB06218,Lacosamide,,Q15858,Sodium channel protein type 9 subunit alpha,SCN9A,blocker,N03AX18
DB06218,Lacosamide,,Q9NY46,Sodium channel protein type 3 subunit alpha,SCN3A,blocker,N03AX18
DB06218,Lacosamide,,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,blocker,N03AX18
DB06219,Dalbavancin,,,D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan,,binder,J01XA04
DB06226,Nelipepimut-S,,P04439,"HLA class I histocompatibility antigen, A-2 alpha chain",HLA-A,,
DB06226,Nelipepimut-S,,P04439,"HLA class I histocompatibility antigen, A-3 alpha chain",HLA-A,,
DB06228,Rivaroxaban,,P00742,Coagulation factor X,F10,antagonist,B01AF01
DB06229,Ocaperidone,,P14416,Dopamine D2 receptor,DRD2,,
DB06229,Ocaperidone,,P35367,Histamine H1 receptor,HRH1,,
DB06229,Ocaperidone,,P35348,Alpha-1A adrenergic receptor,ADRA1A,,
DB06229,Ocaperidone,,P35368,Alpha-1B adrenergic receptor,ADRA1B,,
DB06229,Ocaperidone,,P08913,Alpha-2A adrenergic receptor,ADRA2A,,
DB06229,Ocaperidone,,P25100,Alpha-1D adrenergic receptor,ADRA1D,,
DB06229,Ocaperidone,,P18089,Alpha-2B adrenergic receptor,ADRA2B,,
DB06229,Ocaperidone,,P18825,Alpha-2C adrenergic receptor,ADRA2C,,
DB06229,Ocaperidone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB06229,Ocaperidone,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,,
DB06229,Ocaperidone,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,,
DB06230,Nalmefene,,P41145,Kappa-type opioid receptor,OPRK1,partial agonist,N07BB05
DB06230,Nalmefene,,P41143,Delta-type opioid receptor,OPRD1,antagonist,N07BB05
DB06230,Nalmefene,,P35372,Mu-type opioid receptor,OPRM1,antagonist,N07BB05
DB06231,Caldaret,,P32418,Sodium/calcium exchanger 1,SLC8A1,,
DB06233,Ridaforolimus,,P42345,Serine/threonine-protein kinase mTOR,MTOR,inhibitor,L01EG03
DB06234,Maribavir,,P16788,Serine/threonine protein kinase UL97,UL97,inhibitor,J05AX10
DB06236,Elvucitabine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,
DB06237,Avanafil,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,inhibitor,G04BE10
DB06240,Tariquidar,,P08183,P-glycoprotein 1,ABCB1,,
DB06241,Clenoliximab,,P01730,T-cell surface glycoprotein CD4,CD4,,
DB06243,Eflornithine,,P11926,Ornithine decarboxylase,ODC1,inhibitor,P01CX03;D11AX16
DB06245,Lanoteplase,,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,,
DB06245,Lanoteplase,,P02671,Fibrinogen alpha chain,FGA,,
DB06245,Lanoteplase,,P06870,Kallikrein-1,KLK1,,
DB06245,Lanoteplase,,O15230,Laminin subunit alpha-5,LAMA5,,
DB06245,Lanoteplase,,P00742,Coagulation factor X,F10,,
DB06245,Lanoteplase,,P02751,Fibronectin,FN1,,
DB06245,Lanoteplase,,P05120,Plasminogen activator inhibitor 2,SERPINB2,,
DB06245,Lanoteplase,,P05452,Tetranectin,CLEC3B,,
DB06245,Lanoteplase,,P05787,"Keratin, type II cytoskeletal 8",KRT8,,
DB06245,Lanoteplase,,P07355,Annexin A2,ANXA2,,
DB06245,Lanoteplase,,P07942,Laminin subunit beta-1,LAMB1,,
DB06245,Lanoteplase,,P11047,Laminin subunit gamma-1,LAMC1,,
DB06245,Lanoteplase,,P25391,Laminin subunit alpha-1,LAMA1,,
DB06245,Lanoteplase,,P27797,Calreticulin,CALR,,
DB06245,Lanoteplase,,P27824,Calnexin,CANX,,
DB06245,Lanoteplase,,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,,
DB06245,Lanoteplase,,Q16787,Laminin subunit alpha-3,LAMA3,,
DB06246,Exisulind,,P09211,Glutathione S-transferase P,GSTP1,inhibitor,
DB06246,Exisulind,,P15121,Aldose reductase,AKR1B1,inhibitor,
DB06246,Exisulind,,O60218,Aldo-keto reductase family 1 member B10,AKR1B10,inhibitor,
DB06246,Exisulind,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB06246,Exisulind,,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,,
DB06246,Exisulind,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,,
DB06246,Exisulind,,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,,
DB06247,CX516,,P42261,Glutamate receptor 1,GRIA1,,
DB06248,Amelubant,,Q9NPC1,Leukotriene B4 receptor 2,LTB4R2,,
DB06248,Amelubant,,Q15722,Leukotriene B4 receptor 1,LTB4R,,
DB06249,Arzoxifene,,P03372,Estrogen receptor alpha,ESR1,,
DB06249,Arzoxifene,,Q92731,Estrogen receptor beta,ESR2,,
DB06255,Incadronic acid,,P14324,Farnesyl pyrophosphate synthase,FDPS,inhibitor,
DB06255,Incadronic acid,,P42574,Caspase-3,CASP3,activator,
DB06255,Incadronic acid,,P49662,Caspase-4,CASP4,activator,
DB06255,Incadronic acid,,P55210,Caspase-7,CASP7,activator,
DB06258,Bimoclomol,,Q00613,Heat shock factor protein 1,HSF1,,
DB06262,Droxidopa,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,C01CA27
DB06262,Droxidopa,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,C01CA27
DB06262,Droxidopa,,P25100,Alpha-1D adrenergic receptor,ADRA1D,agonist,C01CA27
DB06262,Droxidopa,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,C01CA27
DB06262,Droxidopa,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,C01CA27
DB06262,Droxidopa,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,C01CA27
DB06262,Droxidopa,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,C01CA27
DB06262,Droxidopa,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,C01CA27
DB06262,Droxidopa,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,C01CA27
DB06262,Droxidopa,,P00439,Phenylalanine-4-hydroxylase,PAH,inhibitor,C01CA27
DB06263,Amrubicin,,P11388,DNA topoisomerase 2-alpha,TOP2A,,L01DB10
DB06263,Amrubicin,,,DNA,,,L01DB10
DB06266,Lonidamine,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,,L01XX07
DB06266,Lonidamine,,P19367,Hexokinase-1,HK1,,L01XX07
DB06267,Udenafil,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,inhibitor,G04BE11;G01AE10
DB06268,Sitaxentan,,P25101,Endothelin-1 receptor,EDNRA,antagonist,C02KX03
DB06268,Sitaxentan,,P24530,Endothelin B receptor,EDNRB,antagonist,C02KX03
DB06271,Sulodexide,,P05546,Heparin cofactor 2,SERPIND1,agonist,B01AB11
DB06271,Sulodexide,,P01008,Antithrombin-III,SERPINC1,potentiator,B01AB11
DB06273,Tocilizumab,,P08887,Interleukin-6 receptor subunit alpha,IL6R,inhibitor,L04AC07
DB06273,Tocilizumab,,P08887,Interleukin-6 receptor subunit alpha,IL6R,antibody,L04AC07
DB06274,Alvimopan,,P35372,Mu-type opioid receptor,OPRM1,antagonist,A06AH02
DB06274,Alvimopan,,P41145,Kappa-type opioid receptor,OPRK1,antagonist,A06AH02
DB06274,Alvimopan,,P41143,Delta-type opioid receptor,OPRD1,antagonist,A06AH02
DB06281,Torcetrapib,,P11597,Cholesteryl ester transfer protein,CETP,antagonist,
DB06282,Levocetirizine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AE09
DB06282,Levocetirizine,,P35367,Histamine H1 receptor,HRH1,inhibitor,R06AE09
DB06283,Ziconotide,,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,inhibitor,N02BG08
DB06283,Ziconotide,,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,inhibitor,N02BG08
DB06285,Teriparatide,,Q03431,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,ligand,H05AA02
DB06287,Temsirolimus,,P42345,Serine/threonine-protein kinase mTOR,MTOR,inhibitor,L01EG01
DB06288,Amisulpride,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N05AL05
DB06288,Amisulpride,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AL05
DB06288,Amisulpride,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AL05
DB06288,Amisulpride,,P35462,Dopamine D3 receptor,DRD3,antagonist,N05AL05
DB06288,Amisulpride,,P35372,Mu-type opioid receptor,OPRM1,agonist,N05AL05
DB06288,Amisulpride,,P41143,Delta-type opioid receptor,OPRD1,agonist,N05AL05
DB06288,Amisulpride,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N05AL05
DB06290,Simeprevir,,Q91RS4,NS3 protease,,inhibitor,G01AE10;J05AP05
DB06290,Simeprevir,,B0B3C9,NS3/4A protein,NS3/4A,inhibitor,G01AE10;J05AP05
DB06292,Dapagliflozin,,P31639,Sodium/glucose cotransporter 2,SLC5A2,antagonist,A10BK01;A10BD15;A10BD21;A10BD25
DB06292,Dapagliflozin,,P31639,Sodium/glucose cotransporter 2,SLC5A2,inhibitor,A10BK01;A10BD15;A10BD21;A10BD25
DB06307,Apoptone,,P10415,Apoptosis regulator Bcl-2,BCL2,,
DB06311,Darapladib,,P47712,Cytosolic phospholipase A2,PLA2G4A,,
DB06314,SGX-523,,P08581,Hepatocyte growth factor receptor,MET,,
DB06317,Elotuzumab,,Q9NQ25,SLAM family member 7,SLAMF7,modulator,L01FX08
DB06318,AVE9633,,P20138,Myeloid cell surface antigen CD33,CD33,,
DB06321,R-348,,P52333,Tyrosine-protein kinase JAK3,JAK3,,
DB06322,Carotuximab,,P17813,Endoglin,ENG,,
DB06324,XmAb 2513,,P28908,Tumor necrosis factor receptor superfamily member 8,TNFRSF8,,
DB06325,Pegpleranib,,P01127,Platelet-derived growth factor subunit B,PDGFB,,
DB06328,Methoxyamine,,,DNA,,,
DB06329,RG-7795,,Q9NYK1,Toll-like receptor 7,TLR7,,
DB06331,4-O-Demethylpenclomedine,,,DNA,,,
DB06333,Trodusquemine,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB06333,Trodusquemine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,,
DB06333,Trodusquemine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,
DB06335,Saxagliptin,,P27487,Dipeptidyl peptidase 4,DPP4,inhibitor,A10BD21;A10BD25;A10BH03;A10BD10
DB06342,Coltuximab ravtansine,,P15391,B-lymphocyte antigen CD19,CD19,,
DB06343,Teprotumumab,,P08069,Insulin-like growth factor 1 receptor,IGF1R,binder,L04AA53
DB06343,Teprotumumab,,P08069,Insulin-like growth factor 1 receptor,IGF1R,antibody,L04AA53
DB06345,AR-9281,,P34913,Bifunctional epoxide hydrolase 2,EPHX2,,
DB06346,Fiboflapon,,P20292,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,,
DB06347,Cenisertib,,O14965,Aurora kinase A,AURKA,,
DB06350,Elinogrel,,Q9H244,P2Y purinoceptor 12,P2RY12,,
DB06354,Tezampanel,,P39086,"Glutamate receptor ionotropic, kainate 1",GRIK1,,
DB06354,Tezampanel,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,,
DB06356,TRC093,,P53420,Collagen alpha-4(IV) chain,COL4A4,,
DB06358,Iclaprim,,P00374,Dihydrofolate reductase,DHFR,,J01EA03
DB06359,G4460,,P10242,Transcriptional activator Myb,MYB,,
DB06360,Lucatumumab,,P25942,Tumor necrosis factor receptor superfamily member 5,CD40,,
DB06362,Becatecarin,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB06362,Becatecarin,,Q02880,DNA topoisomerase 2-beta,TOP2B,,
DB06366,Pertuzumab,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,binder,L01FD02;L01XY02
DB06366,Pertuzumab,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,antibody,L01FD02;L01XY02
DB06367,Relacatib,,P43235,Cathepsin K,CTSK,inhibitor,
DB06371,Siplizumab,,P06729,T-cell surface antigen CD2,CD2,,
DB06372,Rilonacept,,P01584,Interleukin-1 beta,IL1B,binder,L04AC04
DB06372,Rilonacept,,P01583,Interleukin-1 alpha,IL1A,binder,L04AC04
DB06372,Rilonacept,,P18510,Interleukin-1 receptor antagonist protein,IL1RN,binder,L04AC04
DB06374,Elacestrant,,P03372,Estrogen receptor alpha,ESR1,antagonist,
DB06376,CHGN111,,P49759,Dual specificity protein kinase CLK1,CLK1,,
DB06393,Xaliproden,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,N07XX03
DB06401,Bazedoxifene,,P03372,Estrogen receptor alpha,ESR1,antagonist,G03XC02;G03CC07
DB06401,Bazedoxifene,,P03372,Estrogen receptor alpha,ESR1,agonist,G03XC02;G03CC07
DB06401,Bazedoxifene,,Q92731,Estrogen receptor beta,ESR2,,G03XC02;G03CC07
DB06403,Ambrisentan,,P25101,Endothelin-1 receptor,EDNRA,antagonist,C02KX02;C02KX52
DB06403,Ambrisentan,,P24530,Endothelin B receptor,EDNRB,antagonist,C02KX02;C02KX52
DB06404,Human C1-esterase inhibitor,,P00736,Complement C1r subcomponent,C1R,inhibitor,B06AC01
DB06404,Human C1-esterase inhibitor,,P09871,Complement C1s subcomponent,C1S,inhibitor,B06AC01
DB06404,Human C1-esterase inhibitor,,P03952,Plasma kallikrein,KLKB1,inhibitor,B06AC01
DB06404,Human C1-esterase inhibitor,,P00748,Coagulation factor XII,F12,inhibitor,B06AC01
DB06404,Human C1-esterase inhibitor,,P03951,Coagulation factor XI,F11,inhibitor,B06AC01
DB06404,Human C1-esterase inhibitor,,P00750,Tissue-type plasminogen activator,PLAT,inhibitor,B06AC01
DB06404,Human C1-esterase inhibitor,,P00734,Prothrombin,F2,inhibitor,B06AC01
DB06406,Idraparinux,,P00742,Coagulation factor X,F10,,
DB06408,Taribavirin,,,DNA,,,
DB06408,Taribavirin,,P26676,RNA-directed RNA polymerase L,L,,
DB06408,Taribavirin,,P22413,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,ENPP1,,
DB06408,Taribavirin,,P16502,RNA-directed RNA polymerase catalytic subunit,PB1,,
DB06408,Taribavirin,,P49902,Cytosolic purine 5'-nucleotidase,NT5C2,,
DB06408,Taribavirin,,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,,
DB06409,Morphine glucuronide,,P35372,Mu-type opioid receptor,OPRM1,,
DB06409,Morphine glucuronide,,P41143,Delta-type opioid receptor,OPRD1,,
DB06409,Morphine glucuronide,,P41145,Kappa-type opioid receptor,OPRK1,,
DB06410,Doxercalciferol,,P11473,Vitamin D3 receptor,VDR,suppressor,H05BX03
DB06412,Oxymetholone,,P10275,Androgen receptor,AR,agonist,A14AA05
DB06412,Oxymetholone,,P10275,Androgen receptor,AR,activator,A14AA05
DB06412,Oxymetholone,,P16860,Natriuretic peptides B,NPPB,,A14AA05
DB06413,Armodafinil,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,antagonist,N06BA13
DB06413,Armodafinil,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06BA13
DB06414,Etravirine,,P03366,Gag-Pol polyprotein,gag-pol,,J05AG04
DB06414,Etravirine,,P04585,Gag-Pol polyprotein,gag-pol,,J05AG04
DB06414,Etravirine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AG04
DB06419,Cethromycin,,,23S ribosomal RNA,,antagonist,
DB06420,Annamycin,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB06420,Annamycin,,,DNA,,,
DB06421,Declopramide,,,DNA,,,
DB06421,Declopramide,,P11388,DNA topoisomerase 2-alpha,TOP2A,,
DB06421,Declopramide,,Q02880,DNA topoisomerase 2-beta,TOP2B,,
DB06422,Ticalopride,,Q13639,5-hydroxytryptamine receptor 4,HTR4,,
DB06422,Ticalopride,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,,
DB06423,Endostatin,,P08253,72 kDa type IV collagenase,MMP2,,
DB06423,Endostatin,,P14780,Matrix metalloproteinase-9,MMP9,,
DB06423,Endostatin,,P45452,Collagenase 3,MMP13,,
DB06423,Endostatin,,Q05397,Focal adhesion kinase 1,PTK2,,
DB06423,Endostatin,,P16581,E-selectin,SELE,,
DB06429,Talnetant,,P29371,Neuromedin-K receptor,TACR3,antagonist,
DB06433,Tezacitabine,,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,,
DB06436,Semaxanib,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB06439,Tyloxapol,,P06858,Lipoprotein lipase,LPL,inhibitor,R05CA01
DB06441,Cangrelor,,Q9H244,P2Y purinoceptor 12,P2RY12,inhibitor,B01AC25
DB06442,Avasimibe,,P23141,Liver carboxylesterase 1,CES1,,
DB06444,Dexanabinol,,P01375,Tumor necrosis factor,TNF,,
DB06446,Dotarizine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB06446,Dotarizine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB06446,Dotarizine,,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,,
DB06446,Dotarizine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,,
DB06447,E5531,,O00206,Toll-like receptor 4,TLR4,,
DB06448,Lonafarnib,,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,inhibitor,A16AX20
DB06448,Lonafarnib,,P49356,Protein farnesyltransferase subunit beta,FNTB,inhibitor,A16AX20
DB06451,Aprinocarsen,,P17252,Protein kinase C alpha type,PRKCA,,
DB06454,Sarizotan,,P14416,Dopamine D2 receptor,DRD2,partial agonist,
DB06454,Sarizotan,,P35462,Dopamine D3 receptor,DRD3,ligand,
DB06454,Sarizotan,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB06457,Tecastemizole,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,,
DB06460,Enrasentan,,P25101,Endothelin-1 receptor,EDNRA,,
DB06460,Enrasentan,,P24530,Endothelin B receptor,EDNRB,,
DB06468,Cariporide,,P19634,Sodium/hydrogen exchanger 1,SLC9A1,,
DB06469,Lestaurtinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,,
DB06470,Clomethiazole,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,,N05CX04;N05CM02
DB06471,Naxifylline,,P30542,Adenosine receptor A1,ADORA1,antagonist,
DB06472,Fradafiban,,P08514,Integrin alpha-IIb,ITGA2B,,
DB06472,Fradafiban,,P05106,Integrin beta-3,ITGB3,,
DB06474,Sibrotuzumab,,Q12884,Seprase,FAP,,
DB06475,Ruplizumab,,P29965,CD40 ligand,CD40LG,,
DB06477,Sumanirole,,P14416,Dopamine D2 receptor,DRD2,,
DB06477,Sumanirole,,P35462,Dopamine D3 receptor,DRD3,,
DB06477,Sumanirole,,P21917,Dopamine D4 receptor,DRD4,,
DB06479,Propentofylline,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,,N06BC02
DB06480,Prucalopride,,Q13639,5-hydroxytryptamine receptor 4,HTR4,agonist,A06AX05
DB06481,Manitimus,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB06486,Enzastaurin,,P05771,Protein kinase C beta type,PRKCB,,
DB06486,Enzastaurin,,Q96GD4,Aurora kinase B,AURKB,,
DB06486,Enzastaurin,,O14965,Aurora kinase A,AURKA,,
DB06486,Enzastaurin,,Q96Q40,Cyclin-dependent kinase 15,CDK15,,
DB06486,Enzastaurin,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB06486,Enzastaurin,,O96017,Serine/threonine-protein kinase Chk2,CHEK2,,
DB06486,Enzastaurin,,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,,
DB06486,Enzastaurin,,P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,,
DB06492,Mirococept,,P01024,Complement C3,C3,,
DB06494,Sufugolix,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,,
DB06495,Onercept,,P01375,Tumor necrosis factor,TNF,,
DB06497,Aplaviroc,,P51681,C-C chemokine receptor type 5,CCR5,antagonist,
DB06503,MLN2222,,P00751,Complement factor B,CFB,,
DB06506,Repinotan,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB06510,Muraglitazar,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB06510,Muraglitazar,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB06511,AMGN-0007,,O14788,Tumor necrosis factor ligand superfamily member 11,TNFSF11,,
DB06512,Deramciclane,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,
DB06512,Deramciclane,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,inverse agonist,
DB06515,Resiniferatoxin,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,,
DB06518,R-1487,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB06521,Ertiprotafib,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB06521,Ertiprotafib,,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,,
DB06521,Ertiprotafib,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB06521,Ertiprotafib,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB06525,Ganstigmine,,P22303,Acetylcholinesterase,ACHE,,
DB06530,Resiquimod,,Q9NYK1,Toll-like receptor 7,TLR7,,
DB06530,Resiquimod,,Q9NR97,Toll-like receptor 8,TLR8,,
DB06533,Ragaglitazar,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB06533,Ragaglitazar,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB06534,Thrombopoietin,,P40238,Thrombopoietin receptor,MPL,,
DB06536,Tesaglitazar,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB06536,Tesaglitazar,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB06538,Robalzotan,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB06543,Astaxanthin,,P25963,NF-kappa-B inhibitor alpha,NFKBIA,,
DB06546,Atibuclimab,,P08571,Monocyte differentiation antigen CD14,CD14,,
DB06548,Minodronic acid,,P14324,Farnesyl pyrophosphate synthase,FDPS,inhibitor,
DB06548,Minodronic acid,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,inhibitor,
DB06549,Labradimil,,P30411,B2 bradykinin receptor,BDKRB2,agonist,
DB06550,Bivatuzumab,,P16070,CD44 antigen,CD44,,
DB06552,Anpocogin,,P08709,Coagulation factor VII,F7,,
DB06552,Anpocogin,,P13726,Tissue factor,F3,,
DB06552,Anpocogin,,P00742,Coagulation factor X,F10,,
DB06558,Tezosentan,,P25101,Endothelin-1 receptor,EDNRA,,
DB06558,Tezosentan,,P24530,Endothelin B receptor,EDNRB,,
DB06560,Pascolizumab,,P05112,Interleukin-4,IL4,,
DB06579,Adipiplon,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,partial agonist,
DB06581,Bevirimat,,P04585,Gag-Pol polyprotein,gag-pol,,
DB06584,TG4010,,P15941,Mucin-1,MUC1,,
DB06584,TG4010,,P60568,Interleukin-2,IL2,,
DB06586,Cetilistat,,P16233,Pancreatic triacylglycerol lipase,PNLIP,,
DB06587,Mitemcinal,,O43193,Motilin receptor,MLNR,,
DB06589,Pazopanib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,L01EX03
DB06589,Pazopanib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EX03
DB06589,Pazopanib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,,L01EX03
DB06589,Pazopanib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,inhibitor,L01EX03
DB06589,Pazopanib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,L01EX03
DB06589,Pazopanib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,L01EX03
DB06589,Pazopanib,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,L01EX03
DB06589,Pazopanib,,Q08881,Tyrosine-protein kinase ITK/TSK,ITK,inhibitor,L01EX03
DB06589,Pazopanib,,P05230,Fibroblast growth factor 1,FGF1,inhibitor,L01EX03
DB06589,Pazopanib,,Q9UQQ2,SH2B adapter protein 3,SH2B3,inhibitor,L01EX03
DB06594,Agomelatine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N06AX22
DB06594,Agomelatine,,P48039,Melatonin receptor type 1A,MTNR1A,agonist,N06AX22
DB06594,Agomelatine,,P49286,Melatonin receptor type 1B,MTNR1B,agonist,N06AX22
DB06595,Midostaurin,,P17252,Protein kinase C alpha type,PRKCA,antagonist,L01EX10
DB06595,Midostaurin,,P17252,Protein kinase C alpha type,PRKCA,inhibitor,L01EX10
DB06595,Midostaurin,,P35968,Vascular endothelial growth factor receptor 2,KDR,antagonist,L01EX10
DB06595,Midostaurin,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EX10
DB06595,Midostaurin,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,antagonist,L01EX10
DB06595,Midostaurin,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,inhibitor,L01EX10
DB06595,Midostaurin,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,antagonist,L01EX10
DB06595,Midostaurin,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,L01EX10
DB06595,Midostaurin,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,antagonist,L01EX10
DB06595,Midostaurin,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EX10
DB06595,Midostaurin,,P10721,Mast/stem cell growth factor receptor Kit,KIT,antagonist,L01EX10
DB06595,Midostaurin,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,L01EX10
DB06599,Lexatumumab,,O14763,Tumor necrosis factor receptor superfamily member 10B,TNFRSF10B,,
DB06602,Reslizumab,,P05113,Interleukin-5,IL5,antagonist,R03DX08
DB06602,Reslizumab,,P05113,Interleukin-5,IL5,regulator,R03DX08
DB06603,Panobinostat,,Q13547,Histone deacetylase,HDAC1,inhibitor,L01XH03
DB06605,Apixaban,,P00742,Coagulation factor X,F10,inhibitor,B01AF02
DB06606,Teplizumab,,P07766,T-cell surface glycoprotein CD3 epsilon chain,CD3E,antibody,
DB06607,Catumaxomab,,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,agonist,L01FX03
DB06607,Catumaxomab,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,agonist,L01FX03
DB06607,Catumaxomab,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,agonist,L01FX03
DB06607,Catumaxomab,,P07766,T-cell surface glycoprotein CD3 epsilon chain,CD3E,agonist,L01FX03
DB06607,Catumaxomab,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,agonist,L01FX03
DB06607,Catumaxomab,,P16422,Epithelial cell adhesion molecule,EPCAM,ligand,L01FX03
DB06612,Mepolizumab,,P05113,Interleukin-5,IL5,antagonist,R03DX09
DB06612,Mepolizumab,,P05113,Interleukin-5,IL5,regulator,R03DX09
DB06614,Peramivir,,P03472,Neuraminidase,,,J05AH03
DB06614,Peramivir,,P06818,Neuraminidase,,,J05AH03
DB06614,Peramivir,,P27907,Neuraminidase,,,J05AH03
DB06616,Bosutinib,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,L01EA04
DB06616,Bosutinib,,P07948,Tyrosine-protein kinase Lyn,LYN,inhibitor,L01EA04
DB06616,Bosutinib,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,inhibitor,L01EA04
DB06616,Bosutinib,,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,inhibitor,L01EA04
DB06616,Bosutinib,,P36507,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,inhibitor,L01EA04
DB06616,Bosutinib,,Q9Y2U5,Mitogen-activated protein kinase kinase kinase 2,MAP3K2,inhibitor,L01EA04
DB06616,Bosutinib,,Q13555,Calcium/calmodulin-dependent protein kinase type II subunit gamma,CAMK2G,inhibitor,L01EA04
DB06616,Bosutinib,,P09769,Tyrosine-protein kinase Fgr,FGR,inhibitor,L01EA04
DB06616,Bosutinib,,P08631,Tyrosine-protein kinase HCK,HCK,inhibitor,L01EA04
DB06616,Bosutinib,,P42680,Tyrosine-protein kinase Tec,TEC,inhibitor,L01EA04
DB06616,Bosutinib,,Q9H2G2,STE20-like serine/threonine-protein kinase,SLK,inhibitor,L01EA04
DB06619,Amdoxovir,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,
DB06623,Flupirtine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,,N02BG07
DB06626,Axitinib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,L01EK01
DB06626,Axitinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EK01
DB06626,Axitinib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,inhibitor,L01EK01
DB06634,Casopitant,,P08684,Cytochrome P450 3A4,CYP3A4,,A04AD13
DB06634,Casopitant,,P25103,Neurokinin 1 receptor,TACR1,,A04AD13
DB06635,Otamixaban,,P00742,Coagulation factor X,F10,,
DB06636,Isavuconazonium,,P50859,Lanosterol 14-alpha demethylase,ERG11,,
DB06637,Dalfampridine,,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,antagonist,N07XX07
DB06637,Dalfampridine,,P16389,Potassium voltage-gated channel subfamily A member 2,KCNA2,antagonist,N07XX07
DB06637,Dalfampridine,,P22001,Potassium voltage-gated channel subfamily A member 3,KCNA3,antagonist,N07XX07
DB06637,Dalfampridine,,P22459,Potassium voltage-gated channel subfamily A member 4,KCNA4,antagonist,N07XX07
DB06637,Dalfampridine,,P22460,Potassium voltage-gated channel subfamily A member 5,KCNA5,antagonist,N07XX07
DB06637,Dalfampridine,,P17658,Potassium voltage-gated channel subfamily A member 6,KCNA6,antagonist,N07XX07
DB06637,Dalfampridine,,Q96RP8,Potassium voltage-gated channel subfamily A member 7,KCNA7,antagonist,N07XX07
DB06637,Dalfampridine,,Q16322,Potassium voltage-gated channel subfamily A member 10,KCNA10,antagonist,N07XX07
DB06637,Dalfampridine,,Q14721,Potassium voltage-gated channel subfamily B member 1,KCNB1,antagonist,N07XX07
DB06637,Dalfampridine,,Q92953,Potassium voltage-gated channel subfamily B member 2,KCNB2,antagonist,N07XX07
DB06637,Dalfampridine,,P48547,Potassium voltage-gated channel subfamily C member 1,KCNC1,antagonist,N07XX07
DB06637,Dalfampridine,,Q96PR1,Potassium voltage-gated channel subfamily C member 2,KCNC2,antagonist,N07XX07
DB06637,Dalfampridine,,Q14003,Potassium voltage-gated channel subfamily C member 3,KCNC3,antagonist,N07XX07
DB06637,Dalfampridine,,Q9NSA2,Potassium voltage-gated channel subfamily D member 1,KCND1,antagonist,N07XX07
DB06637,Dalfampridine,,Q9NZV8,Potassium voltage-gated channel subfamily D member 2,KCND2,antagonist,N07XX07
DB06637,Dalfampridine,,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,antagonist,N07XX07
DB06641,Perifosine,,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,,
DB06641,Perifosine,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB06641,Perifosine,,P17252,Protein kinase C alpha type,PRKCA,,
DB06642,Bevasiranib,,P15692,Vascular endothelial growth factor A,VEGFA,,
DB06643,Denosumab,,O14788,Tumor necrosis factor ligand superfamily member 11,TNFSF11,antibody,M05BX04
DB06650,Ofatumumab,,P11836,B-lymphocyte antigen CD20,MS4A1,antibody,L01FA02;L04AA52
DB06650,Ofatumumab,,P11836,B-lymphocyte antigen CD20,MS4A1,regulator,L01FA02;L04AA52
DB06652,Vicriviroc,,P51681,C-C chemokine receptor type 5,CCR5,antagonist,
DB06654,Safinamide,,P27338,Amine oxidase [flavin-containing] B,MAOB,antagonist,N04BD03
DB06655,Liraglutide,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,A10AE56;A10BJ02
DB06660,Saredutant,,P21452,Substance-K receptor,TACR2,,
DB06663,Pasireotide,,P30872,Somatostatin receptor type 1,SSTR1,,H01CB05
DB06663,Pasireotide,,P30874,Somatostatin receptor type 2,SSTR2,,H01CB05
DB06663,Pasireotide,,P32745,Somatostatin receptor type 3,SSTR3,,H01CB05
DB06663,Pasireotide,,P35346,Somatostatin receptor type 5,SSTR5,,H01CB05
DB06670,Odanacatib,,P43235,Cathepsin K,CTSK,inhibitor,
DB06674,Golimumab,,P01375,Tumor necrosis factor,TNF,antibody,L04AB06
DB06677,Clazosentan,,P25101,Endothelin-1 receptor,EDNRA,,
DB06678,Esmirtazapine,,P35367,Histamine H1 receptor,HRH1,inverse agonist,
DB06678,Esmirtazapine,,P28223,5-hydroxytryptamine receptor 2,HTR2A,inverse agonist,
DB06678,Esmirtazapine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,
DB06680,Asoprisnil,,P06401,Progesterone receptor,PGR,,
DB06681,Belatacept,,P42081,T-lymphocyte activation antigen CD86,CD86,antagonist,L04AA28
DB06681,Belatacept,,P33681,T-lymphocyte activation antigen CD80,CD80,antagonist,L04AA28
DB06684,Vilazodone,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX24
DB06684,Vilazodone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N06AX24
DB06688,Sipuleucel-T,,P15309,Prostatic acid phosphatase,ACPP,other,L03AX17
DB06689,Ethanolamine oleate,,,Calcium ions,,chelator,C05BB01
DB06689,Ethanolamine oleate,,P00748,Coagulation factor XII,F12,activator,C05BB01
DB06691,Mepyramine,,P35367,Histamine H1 receptor,HRH1,antagonist,D04AA02;R06AC01
DB06692,Aprotinin,,P07477,Trypsin-1,PRSS1,,B02AB01
DB06692,Aprotinin,,P17538,Chymotrypsinogen B,CTRB1,,B02AB01
DB06692,Aprotinin,,P00747,Plasminogen,PLG,,B02AB01
DB06692,Aprotinin,,P06870,Kallikrein-1,KLK1,,B02AB01
DB06693,Mevastatin,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,inhibitor,
DB06694,Xylometazoline,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,R01AB06;R01AA07;S01GA53;S01GA03
DB06694,Xylometazoline,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,R01AB06;R01AA07;S01GA53;S01GA03
DB06694,Xylometazoline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,R01AB06;R01AA07;S01GA53;S01GA03
DB06694,Xylometazoline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,partial agonist,R01AB06;R01AA07;S01GA53;S01GA03
DB06694,Xylometazoline,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,R01AB06;R01AA07;S01GA53;S01GA03
DB06694,Xylometazoline,,P25100,Alpha-1D adrenergic receptor,ADRA1D,agonist,R01AB06;R01AA07;S01GA53;S01GA03
DB06694,Xylometazoline,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,R01AB06;R01AA07;S01GA53;S01GA03
DB06695,Dabigatran etexilate,,P00734,Prothrombin,F2,inhibitor,B01AE07
DB06696,Arbekacin,,P0A7S3,30S ribosomal protein S12,rpsL,inhibitor,J01GB12
DB06698,Betahistine,,P35367,Histamine H1 receptor,HRH1,agonist,N07CA01
DB06698,Betahistine,,Q9Y5N1,Histamine H3 receptor,HRH3,antagonist,N07CA01
DB06699,Degarelix,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,antagonist,L02BX02
DB06700,Desvenlafaxine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AX23
DB06700,Desvenlafaxine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX23
DB06700,Desvenlafaxine,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06AX23
DB06701,Dexmethylphenidate,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06BA11;N06BA15
DB06701,Dexmethylphenidate,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06BA11;N06BA15
DB06701,Dexmethylphenidate,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06BA11;N06BA15
DB06702,Fesoterodine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,G04BD11
DB06702,Fesoterodine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,G04BD11
DB06702,Fesoterodine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,G04BD11
DB06702,Fesoterodine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,G04BD11
DB06702,Fesoterodine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,G04BD11
DB06706,Isometheptene,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,A03AX10
DB06706,Isometheptene,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,A03AX10
DB06707,Levonordefrin,,P08913,Alpha-2 adrenergic receptors,ADRA2A,agonist,
DB06709,Methacholine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,agonist,V04CX03
DB06709,Methacholine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,agonist,V04CX03
DB06709,Methacholine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,agonist,V04CX03
DB06709,Methacholine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,agonist,V04CX03
DB06709,Methacholine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,agonist,V04CX03
DB06710,Methyltestosterone,,P10275,Androgen receptor,AR,agonist,G03BA02;G03EA01;G03EK01
DB06710,Methyltestosterone,,P03372,Estrogen receptor alpha,ESR1,,G03BA02;G03EA01;G03EK01
DB06711,Naphazoline,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,R01AB02;S01GA01;S01GA51;R01AA08
DB06711,Naphazoline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,R01AB02;S01GA01;S01GA51;R01AA08
DB06712,Nilvadipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,C08CA10
DB06712,Nilvadipine,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,inhibitor,C08CA10
DB06712,Nilvadipine,,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,inhibitor,C08CA10
DB06712,Nilvadipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,inhibitor,C08CA10
DB06712,Nilvadipine,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,C08CA10
DB06712,Nilvadipine,,Q8IZS8,Voltage-dependent calcium channel subunit alpha-2/delta-3,CACNA2D3,inhibitor,C08CA10
DB06712,Nilvadipine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,C08CA10
DB06712,Nilvadipine,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,inhibitor,C08CA10
DB06712,Nilvadipine,,Q13936,Voltage gated L-type calcium channel,CACNA1C,blocker,C08CA10
DB06712,Nilvadipine,,O43497,Voltage-dependent T-type calcium channel,CACNA1G,inhibitor,C08CA10
DB06713,Norelgestromin,,P06401,Progesterone receptor,PGR,agonist,G03AA13
DB06713,Norelgestromin,,P02768,Serum albumin,ALB,,G03AA13
DB06713,Norelgestromin,,P10275,Androgen receptor,AR,partial agonist,G03AA13
DB06714,Propylhexedrine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,,
DB06714,Propylhexedrine,,Q96RJ0,Trace amine-associated receptor 1,TAAR1,agonist,
DB06715,Potassium Iodide,,,Tyrosine,,binder,S01XA04;V03AB21;R05CA02
DB06716,Fospropofol,,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,potentiator,
DB06716,Fospropofol,,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,potentiator,
DB06718,Stanozolol,,P10275,Androgen receptor,AR,agonist,A14AA02
DB06718,Stanozolol,,,Glucocorticoid binding proteins,,binder,A14AA02
DB06719,Buserelin,,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,,L02AE01
DB06719,Buserelin,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,,L02AE01
DB06720,Velaglucerase alfa,,P04062,Glucosylceramidase,GBA,,A16AB10
DB06725,Lornoxicam,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AC05
DB06725,Lornoxicam,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AC05
DB06726,Bufuralol,,P08588,Beta adrenergic receptor,ADRB1,antagonist,
DB06728,Aniline,,P06870,Kallikrein-1,KLK1,,
DB06728,Aniline,,P02768,Serum albumin,ALB,,
DB06729,Sulfaphenazole,,P0AC13,Dihydropteroate synthase,folP,inhibitor,S01AB05;J01ED08;G01AE10
DB06730,Gestodene,,P06401,Progesterone receptor,PGR,binder,G03AA10;G03AB06
DB06730,Gestodene,,P06401,Progesterone receptor,PGR,activator,G03AA10;G03AB06
DB06732,beta-Naphthoflavone,,P03372,Estrogen receptor alpha,ESR1,,
DB06732,beta-Naphthoflavone,,P11474,Steroid hormone receptor ERR1,ESRRA,,
DB06732,beta-Naphthoflavone,,P10589,COUP transcription factor 1,NR2F1,,
DB06732,beta-Naphthoflavone,,P35869,Aryl hydrocarbon receptor,AHR,agonist,
DB06732,beta-Naphthoflavone,,Q16678,Cytochrome P450 1B1,CYP1B1,,
DB06733,Bafilomycin A1,,P38606,V-type proton ATPase catalytic subunit A,ATP6V1A,inhibitor,
DB06734,Bafilomycin B1,,P38606,V-type proton ATPase catalytic subunit A,ATP6V1A,inhibitor,
DB06736,Aceclofenac,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AB16;M02AA25
DB06736,Aceclofenac,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AB16;M02AA25
DB06738,Ketobemidone,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AB01;N02AG02
DB06738,Ketobemidone,,P41145,Kappa-type opioid receptor,OPRK1,agonist,N02AB01;N02AG02
DB06738,Ketobemidone,,P41143,Delta-type opioid receptor,OPRD1,agonist,N02AB01;N02AG02
DB06738,Ketobemidone,,Q05586,NMDA receptor,GRIN1,antagonist,N02AB01;N02AG02
DB06739,Seratrodast,,P21731,Thromboxane A2 receptor,TBXA2R,antagonist,R03DX06
DB06741,Gavestinel,,Q05586,Glutamate (NMDA) receptor,GRIN1,antagonist,
DB06749,Ginsenoside Rb1,,Q9NPD5,Solute carrier organic anion transporter family member 1B3,SLCO1B3,inhibitor,
DB06750,Ginsenoside Rg1,,Q9NPD5,Solute carrier organic anion transporter family member 1B3,SLCO1B3,,
DB06751,Drotaverine,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,inhibitor,A03AD02
DB06751,Drotaverine,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,inhibitor,A03AD02
DB06752,Chymopapain,,P13727,Bone marrow proteoglycan,PRG2,degradation,M09AB01
DB06754,Danaparoid,,P01008,Antithrombin-III,SERPINC1,positive allosteric modulator,B01AB09
DB06755,Beta carotene,,,Free radicals,,binder,A11CA02;D02BB01
DB06756,Betaine,,Q93088,Betaine--homocysteine S-methyltransferase 1,BHMT,substrate,A16AA06;A09AB02
DB06757,Manganese,,P50213,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",IDH3A,,
DB06757,Manganese,,P51553,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",IDH3G,,
DB06757,Manganese,,Q15750,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1,TAB1,,
DB06757,Manganese,,P05089,Arginase-1,ARG1,,
DB06757,Manganese,,P02787,Serotransferrin,TF,,
DB06759,Fomivirsen,,P06434,30 kDa immediate-early protein 2,UL122,antisense oligonucleotide,S01AD08
DB06759,Fomivirsen,,P06435,45 kDa immediate-early protein 2,UL122,antisense oligonucleotide,S01AD08
DB06764,Tetryzoline,,P35348,Alpha-1 adrenergic receptors,ADRA1A,agonist,S01GA02;S01GA52;R01AB03;R01AA06
DB06764,Tetryzoline,,P08913,Alpha-2 adrenergic receptors,ADRA2A,agonist,S01GA02;S01GA52;R01AB03;R01AA06
DB06766,Alcaftadine,,P35367,Histamine H1 receptor,HRH1,antagonist,S01GX11
DB06771,Besifloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,antagonist,S01AE08
DB06771,Besifloxacin,,P72525,DNA topoisomerase 4 subunit A,parC,antagonist,S01AE08
DB06771,Besifloxacin,,P43700,DNA gyrase subunit A,gyrA,antagonist,S01AE08
DB06771,Besifloxacin,,P72524,DNA gyrase subunit A,gyrA,antagonist,S01AE08
DB06772,Cabazitaxel,,Q9H4B7,Tubulin beta-1 chain,TUBB1,inhibitor,L01CD04
DB06773,Human calcitonin,,P12814,Alpha-actinin-1,ACTN1,incorporation into and destabilization,H05BA03
DB06774,Capsaicin,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,agonist,M02AB01;N01BX04
DB06774,Capsaicin,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,regulator,M02AB01;N01BX04
DB06774,Capsaicin,,Q99623,Prohibitin-2,PHB2,,M02AB01;N01BX04
DB06775,Carglumic acid,,P31327,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",CPS1,allosteric modulator,A16AA05
DB06776,Sodium cellulose phosphate,,,Calcium ions,,binder,V03AG01
DB06777,Chenodeoxycholic acid,,Q96RI1,Bile acid receptor,NR1H4,other,A05AA01
DB06777,Chenodeoxycholic acid,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,A05AA01
DB06777,Chenodeoxycholic acid,,Q8TDU6,G-protein coupled bile acid receptor 1,GPBAR1,,A05AA01
DB06777,Chenodeoxycholic acid,,P52895,Aldo-keto reductase family 1 member C2,AKR1C2,substrate,A05AA01
DB06779,Dalteparin,,P01008,Antithrombin-III,SERPINC1,potentiator,B01AB04
DB06779,Dalteparin,,P15692,Vascular endothelial growth factor A,VEGFA,inhibitor,B01AB04
DB06779,Dalteparin,,P16109,P-selectin,SELP,inhibitor,B01AB04
DB06780,Desoxycorticosterone acetate,,P08235,Mineralocorticoid receptor,NR3C2,agonist,
DB06781,Difluprednate,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AC19
DB06782,Dimercaprol,,,Arsenic,,chelator,V03AB09
DB06782,Dimercaprol,,,Cadmium,,chelator,V03AB09
DB06782,Dimercaprol,,,Mercury,,chelator,V03AB09
DB06782,Dimercaprol,,P05067,Amyloid beta A4 protein,APP,,V03AB09
DB06785,Ganirelix,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,antagonist,H01CC01
DB06786,Halcinonide,,Q99835,Smoothened homolog,SMO,agonist,D07AD02
DB06786,Halcinonide,,Q99835,Smoothened homolog,SMO,activator,D07AD02
DB06787,Hexocyclium,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03AB10
DB06787,Hexocyclium,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03AB10
DB06787,Hexocyclium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,A03AB10
DB06787,Hexocyclium,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,A03AB10
DB06788,Histrelin,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,agonist,L02AE05
DB06789,Hydroxyprogesterone caproate,,P06401,Progesterone receptor,PGR,agonist,
DB06791,Lanreotide,,P30874,Somatostatin receptor type 2,SSTR2,agonist,H01CB03
DB06791,Lanreotide,,P35346,Somatostatin receptor type 5,SSTR5,agonist,H01CB03
DB06792,Lanthanum carbonate,,,Phosphate,,binder,V03AE03
DB06795,Mafenide,,P23280,Carbonic anhydrase 6,CA6,antagonist,G01AE10;D06BA03
DB06800,Methylnaltrexone,,P35372,Mu-type opioid receptor,OPRM1,antagonist,A06AH01
DB06800,Methylnaltrexone,,P41145,Kappa-type opioid receptor,OPRK1,antagonist,A06AH01
DB06802,Nepafenac,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,S01BC10
DB06802,Nepafenac,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,S01BC10
DB06803,Niclosamide,,,DNA,,antagonist,P02DA01
DB06809,Plerixafor,,P61073,C-X-C chemokine receptor type 4,CXCR4,antagonist,L03AX16
DB06809,Plerixafor,,P61073,C-X-C chemokine receptor type 4,CXCR4,inhibitor,L03AX16
DB06810,Plicamycin,,,DNA,,antagonist,L01DC02
DB06813,Pralatrexate,,P00374,Dihydrofolate reductase,DHFR,substrate,L01BA05
DB06813,Pralatrexate,,P00374,Dihydrofolate reductase,DHFR,inhibitor,L01BA05
DB06813,Pralatrexate,,P04818,Thymidylate synthase,TYMS,substrate,L01BA05
DB06813,Pralatrexate,,P04818,Thymidylate synthase,TYMS,inhibitor,L01BA05
DB06813,Pralatrexate,,Q05932,"Folylpolyglutamate synthase, mitochondrial",FPGS,substrate,L01BA05
DB06814,Protokylol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,
DB06817,Raltegravir,,Q7ZJM1,Integrase,pol,inhibitor,J05AR16;J05AJ01
DB06819,Phenylbutyric acid,,P95468,Aromatic-amino-acid aminotransferase,tyrB,,A16AX03
DB06819,Phenylbutyric acid,,Q13547,Histone deacetylase,HDAC1,inhibitor,A16AX03
DB06820,Sulconazole,,P50859,Lanosterol 14-alpha demethylase,ERG11,inhibitor,D01AC09
DB06821,Sulfameter,,P0AC13,Dihydropteroate synthase,folP,inhibitor,J01ED04;G01AE10
DB06822,Tinzaparin,,P01008,Antithrombin-III,SERPINC1,potentiator,B01AB10
DB06822,Tinzaparin,,P13612,Integrin alpha-4,ITGA4,inhibitor,B01AB10
DB06822,Tinzaparin,,P48061,Stromal cell-derived factor 1,CXCL12,binder,B01AB10
DB06825,Triptorelin,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,agonist,L02AE04
DB06827,Viomycin,,P9WJ63,16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA,tlyA,inhibitor,
DB06828,5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB06829,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB06830,"(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB06831,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB06831,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,,
DB06832,Prinaberel,,Q92731,Estrogen receptor beta,ESR2,,
DB06832,Prinaberel,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB06833,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,,P11474,Steroid hormone receptor ERR1,ESRRA,,
DB06834,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",,P43405,Tyrosine-protein kinase SYK,SYK,,
DB06835,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,,P15086,Carboxypeptidase B,CPB1,,
DB06836,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB06836,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",,Q8NEB9,Phosphatidylinositol 3-kinase catalytic subunit type 3,PIK3C3,,
DB06837,"(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",,Q9UNA0,A disintegrin and metalloproteinase with thrombospondin motifs 5,ADAMTS5,,
DB06838,methyl L-phenylalaninate,,P02974,Fimbrial protein,pilE1,,
DB06838,methyl L-phenylalaninate,,P00734,Prothrombin,F2,,
DB06840,"diethyl [(1R)-1,5-diaminopentyl]boronate",,P07477,Trypsin-1,PRSS1,,
DB06841,"[(2R)-1-[(2S)-2-[[(2S,3S)-1-Chloro-6-(diaminomethylideneamino)-2-hydroxyhexan-3-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium",,P00734,Prothrombin,F2,,
DB06842,(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,,
DB06842,(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB06843,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",,P63092,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,GNAS,,
DB06843,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",,Q08462,Adenylate cyclase type 2,ADCY2,,
DB06843,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",,O95622,Adenylate cyclase type 5,ADCY5,,
DB06844,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",,P20248,Cyclin-A2,CCNA2,,
DB06844,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB06845,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,,P07477,Trypsin-1,PRSS1,,
DB06845,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,,P00734,Prothrombin,F2,,
DB06847,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,A0A0M3KKX1,Dihydrofolate reductase (dfrB),dfrB,,
DB06848,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",,Q15661,Tryptase alpha/beta-1,TPSAB1,,
DB06849,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",,Q15661,Tryptase alpha/beta-1,TPSAB1,,
DB06850,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,,P07477,Trypsin-1,PRSS1,,
DB06850,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,,P00734,Prothrombin,F2,,
DB06851,N-(pyridin-3-ylmethyl)aniline,,Q3JUV5,Inorganic pyrophosphatase,ppa,,
DB06851,N-(pyridin-3-ylmethyl)aniline,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB06852,CHIR-124,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB06853,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,P07477,Trypsin-1,PRSS1,,
DB06853,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06855,6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB06855,6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine,,P07477,Trypsin-1,PRSS1,,
DB06856,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB06857,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB06858,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06858,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,P07477,Trypsin-1,PRSS1,,
DB06859,N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE,,P00734,Prothrombin,F2,,
DB06860,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",,P00469,Thymidylate synthase,thyA,,
DB06861,6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE,,P00734,Prothrombin,F2,,
DB06862,2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID,,P42574,Caspase-3,CASP3,,
DB06864,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",,P29208,o-succinylbenzoate synthase,menC,,
DB06865,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,,P00734,Prothrombin,F2,,
DB06866,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,,P00734,Prothrombin,F2,,
DB06867,"3,6,9,12,15,18-HEXAOXAICOSANE",,Q13526,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,PIN1,,
DB06868,N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06869,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,,P00734,Prothrombin,F2,,
DB06870,Tetrahydrogestrinone,,P10275,Androgen receptor,AR,,
DB06871,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,,P03372,Estrogen receptor alpha,ESR1,,
DB06871,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB06872,"1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE",,P12758,Uridine phosphorylase,udp,,
DB06873,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",,P12758,Uridine phosphorylase,udp,,
DB06874,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",,P03366,Gag-Pol polyprotein,gag-pol,,
DB06875,ERB-196,,Q92731,Estrogen receptor beta,ESR2,,
DB06875,ERB-196,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB06876,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB06877,"N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE",,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB06878,1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06879,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB06880,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB06881,(1Z)-2-HYDROXY-3-OXOHEX-1-EN-1-YL DIHYDROGEN PHOSPHATE,,Q5L1E2,"2,3-diketo-5-methylthiopentyl-1-phosphate enolase",mtnW,,
DB06882,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB06882,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB06883,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB06884,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,,P62508,Estrogen-related receptor gamma,ESRRG,,
DB06884,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,,P48552,Nuclear receptor-interacting protein 1,NRIP1,,
DB06886,N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,,P00781,Subtilisin DY,apr,,
DB06887,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB06888,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB06889,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",,Q9L5C8,Beta-lactamase,blaCTX-M-9a,,
DB06890,(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE,,P10614,Lanosterol 14-alpha demethylase,ERG11,,
DB06891,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",,P00918,Carbonic anhydrase 2,CA2,,
DB06892,"(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide",,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,,
DB06893,Decylsulfonic acid,,Q9I5I9,SDS hydrolase SdsA1,sdsA1,,
DB06894,1-Dodecanol,,Q9I5I9,SDS hydrolase SdsA1,sdsA1,,
DB06894,1-Dodecanol,,O00519,Fatty-acid amide hydrolase 1,FAAH,,
DB06896,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",,P08581,Hepatocyte growth factor receptor,MET,,
DB06897,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",,P53350,Serine/threonine-protein kinase PLK1,PLK1,,
DB06898,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",,P03372,Estrogen receptor alpha,ESR1,,
DB06898,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB06899,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",,P00797,Renin,REN,,
DB06900,1-[4-(hydroxymethyl)phenyl]guanidine,,Q16651,Prostasin,PRSS8,,
DB06901,2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL,,P08217,Chymotrypsin-like elastase family member 2A,CELA2A,,
DB06902,p-Cumylphenol,,P62508,Estrogen-related receptor gamma,ESRRG,,
DB06903,"(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid",,Q82IZ1,1-deoxypentalenic acid 11-beta-hydroxylase,ptlH,,
DB06904,"(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE",,P00803,Signal peptidase I,lepB,,
DB06905,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",,Q13362,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PPP2R5C,,
DB06905,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",,P67775,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,PPP2CA,,
DB06905,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",,P30153,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,PPP2R1A,,
DB06906,ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate,,P56740,Dihydroneopterin aldolase,folB,,
DB06908,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB06908,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB06909,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,,
DB06910,"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",,P04585,Gag-Pol polyprotein,gag-pol,,
DB06911,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06912,"UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE",,P61626,Lysozyme C,LYZ,,
DB06913,"(3R)-3-[3,5-Bis(trifluoromethyl)anilino]-2-cyano-3-sulfanylpropanamide",,Q99AU2,Genome polyprotein,,,
DB06914,"1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE",,P09601,Heme oxygenase 1,HMOX1,,
DB06916,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB06917,(4-fluorophenyl)(pyridin-4-yl)methanone,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB06918,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,,P07477,Trypsin-1,PRSS1,,
DB06919,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06920,Eribaxaban,,P00742,Coagulation factor X,F10,,
DB06921,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,,P15086,Carboxypeptidase B,CPB1,,
DB06922,"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",,P00811,Beta-lactamase,ampC,,
DB06923,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,,P07477,Trypsin-1,PRSS1,,
DB06924,(2R)-2-benzyl-3-nitropropanoic acid,,P15085,Carboxypeptidase A1,CPA1,,
DB06925,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,,P06239,Tyrosine-protein kinase Lck,LCK,,
DB06926,"(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid",,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB06927,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,,Q92731,Estrogen receptor beta,ESR2,,
DB06927,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB06927,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,,P03372,Estrogen receptor alpha,ESR1,,
DB06928,(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID,,Q04609,Glutamate carboxypeptidase 2,FOLH1,,
DB06929,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06930,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",,P56817,Beta-secretase 1,BACE1,,
DB06931,"(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB06932,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB06933,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB06934,(1R)-3-chloro-1-phenylpropan-1-ol,,P00720,Lysozyme,E,,
DB06936,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06937,"4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL",,Q92731,Estrogen receptor beta,ESR2,,
DB06938,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB06939,"N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB06940,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB06941,(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide,,P04271,Protein S100-B,S100B,,
DB06942,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06943,(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol,,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,,
DB06944,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,,P20248,Cyclin-A2,CCNA2,,
DB06944,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB06945,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,,Q9UNA0,A disintegrin and metalloproteinase with thrombospondin motifs 5,ADAMTS5,,
DB06946,"(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid",,Q8GMG0,"MIO-dependent tyrosine 2,3-aminomutase",,,
DB06947,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06948,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,,P20248,Cyclin-A2,CCNA2,,
DB06948,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB06949,"N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide",,Q5G940,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB06950,"4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",,Q5G940,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB06951,(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB06952,(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID,,Q51948,2-hydroxychromene-2-carboxylate isomerase,nahD,,
DB06953,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB06953,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB06954,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",,P00918,Carbonic anhydrase 2,CA2,,
DB06955,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",,Q83WG3,Cytochrome P450,staP,,
DB06956,"N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB06957,"4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB06958,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB06959,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB06959,(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB06960,"N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide",,Q9I596,Neutral ceramidase,,,
DB06961,"5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB06962,JNJ-27390467,,P20231,Tryptase beta-2,TPSB2,,
DB06963,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",,P53350,Serine/threonine-protein kinase PLK1,PLK1,,
DB06964,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB06965,Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester,,P22088,Lipase,lipA,,
DB06966,Hexylphosphonic acid (S)-2-methyl-3-phenylpropyl ester,,P22088,Lipase,lipA,,
DB06967,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",,P00797,Renin,REN,,
DB06968,"1,1'-HEXANE-1,6-DIYLBIS(1H-IMIDAZOLE)",,P00282,Azurin,azu,,
DB06969,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB06970,"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",,Q8DNV6,UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase,murF,,
DB06971,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",,P22894,Neutrophil collagenase,MMP8,,
DB06972,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",,P20701,Integrin alpha-L,ITGAL,,
DB06973,Bisphenol A,,P62508,Estrogen-related receptor gamma,ESRRG,,
DB06974,"5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one",,P26663,Genome polyprotein,,,
DB06976,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB06977,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB06978,"N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide",,Q5G940,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB06979,"5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid",,Q9UJM8,Hydroxyacid oxidase 1,HAO1,,
DB06980,(2S)-2-(1H-indol-3-yl)hexanoic acid,,P63208,S-phase kinase-associated protein 1,SKP1,,
DB06981,(2S)-2-(1H-indol-3-yl)pentanoic acid,,P63208,S-phase kinase-associated protein 1,SKP1,,
DB06982,(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid,,P63208,S-phase kinase-associated protein 1,SKP1,,
DB06983,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB06984,"(1R,2R,3R,4S,5R)-4-(Benzylamino)-5-(methylthio)cyclopentane-1,2,3-triol",,Q16706,Alpha-mannosidase 2,MAN2A1,,
DB06986,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB06987,(R)-Atenolol,,P02788,Lactotransferrin,LTF,,
DB06987,(R)-Atenolol,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB06988,2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE,,P46881,Phenylethylamine oxidase,,,
DB06989,{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID,,P23467,Receptor-type tyrosine-protein phosphatase beta,PTPRB,,
DB06990,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",,P13051,Uracil-DNA glycosylase,UNG,,
DB06991,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB06992,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB06993,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB06994,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB06995,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,,P08581,Hepatocyte growth factor receptor,MET,,
DB06996,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB06997,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",,P08581,Hepatocyte growth factor receptor,MET,,
DB06998,"[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid",,P0A988,DNA polymerase III subunit beta,dnaN,,
DB06999,PLX-4720,,P15056,Serine/threonine-protein kinase B-raf,BRAF,,
DB07000,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",,P15056,Serine/threonine-protein kinase B-raf,BRAF,,
DB07001,"(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB07002,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07003,"(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07004,2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide,,P04271,Protein S100-B,S100B,,
DB07005,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,,P00734,Prothrombin,F2,,
DB07006,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",,P30291,Wee1-like protein kinase,WEE1,,
DB07007,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07008,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07009,"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07009,"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",,Q92731,Estrogen receptor beta,ESR2,,
DB07010,N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB07010,N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB07011,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07012,"6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB07013,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,,P45452,Collagenase 3,MMP13,,
DB07014,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB07015,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07016,"(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline",,P00734,Prothrombin,F2,,
DB07017,"(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB07018,5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE,,P03366,Gag-Pol polyprotein,gag-pol,,
DB07019,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",,P56817,Beta-secretase 1,BACE1,,
DB07020,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",,P45984,Mitogen-activated protein kinase 9,MAPK9,,
DB07021,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07022,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,,P03951,Coagulation factor XI,F11,,
DB07023,"(1R)-2-[(Diaminomethylene)amino]-1-{4-[(4R)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]phenyl}ethyl nicotinate",,P03951,Coagulation factor XI,F11,,
DB07024,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07025,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07026,"(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",,P39900,Macrophage metalloelastase,MMP12,,
DB07027,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB07028,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,,P15121,Aldose reductase,AKR1B1,,
DB07029,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07030,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,,P15121,Aldose reductase,AKR1B1,,
DB07031,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",,P13631,Retinoic acid receptor gamma,RARG,,
DB07032,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,,Q92731,Estrogen receptor beta,ESR2,,
DB07033,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB07034,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07035,"(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE",,P03366,Gag-Pol polyprotein,gag-pol,,
DB07036,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",,Q92731,Estrogen receptor beta,ESR2,,
DB07037,(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07038,2-(cyclohexylamino)benzoic acid,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07039,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,,P10275,Androgen receptor,AR,,
DB07040,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",,Q837V6,DNA ligase,ligA,,
DB07041,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",,Q837V6,DNA ligase,ligA,,
DB07041,"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",,P43813,DNA ligase,ligA,,
DB07042,"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",,Q837V6,DNA ligase,ligA,,
DB07043,"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",,Q837V6,DNA ligase,ligA,,
DB07044,"3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",,Q5G940,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB07045,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",,Q99933,BAG family molecular chaperone regulator 1,BAG1,,
DB07045,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",,P11142,Heat shock cognate 71 kDa protein,HSPA8,,
DB07046,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,,
DB07048,"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",,P00918,Carbonic anhydrase 2,CA2,,
DB07049,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",,P00918,Carbonic anhydrase 2,CA2,,
DB07051,"3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER",,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB07052,5'-S-ethyl-5'-thioadenosine,,P9WGV3,Adenosylhomocysteinase,ahcY,,
DB07053,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07054,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07055,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",,Q9L5C8,Beta-lactamase,blaCTX-M-9a,,
DB07056,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB07057,(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid,,P00811,Beta-lactamase,ampC,,
DB07058,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB07059,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",,P00797,Renin,REN,,
DB07060,3-(INDOL-3-YL) LACTATE,,Q9UJM8,Hydroxyacid oxidase 1,HAO1,,
DB07060,3-(INDOL-3-YL) LACTATE,,P20932,(S)-mandelate dehydrogenase,mdlB,,
DB07061,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",,O60551,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,,
DB07062,"N-{3-[4-Hydroxy-1-(3-methylbutyl)-2-oxo-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide",,P26663,Genome polyprotein,,,
DB07063,Lidorestat,,P15121,Aldose reductase,AKR1B1,,
DB07064,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",,P52732,Kinesin-like protein KIF11,KIF11,,
DB07065,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07066,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB07067,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07068,"(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID",,P23467,Receptor-type tyrosine-protein phosphatase beta,PTPRB,,
DB07069,m-Hydroxyhippuric acid,,Q16719,Kynureninase,KYNU,,
DB07070,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB07071,"(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenethyl)guanidine",,P03951,Coagulation factor XI,F11,,
DB07072,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07073,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB07074,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,,P03951,Coagulation factor XI,F11,,
DB07075,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07076,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB07077,"(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenyl)guanidine",,P03951,Coagulation factor XI,F11,,
DB07078,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07079,3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol,,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,,
DB07080,TO-901317,,P55055,Oxysterols receptor LXR-beta,NR1H2,,
DB07080,TO-901317,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB07080,TO-901317,,P28702,Retinoic acid receptor RXR-beta,RXRB,,
DB07080,TO-901317,,Q13133,Oxysterols receptor LXR-alpha,NR1H3,,
DB07080,TO-901317,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07080,TO-901317,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB07081,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07082,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",,P55055,Oxysterols receptor LXR-beta,NR1H2,,
DB07083,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,,P00734,Prothrombin,F2,,
DB07084,"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",,P02931,Outer membrane protein F,ompF,,
DB07085,2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,,Q99AU2,Genome polyprotein,,,
DB07086,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB07086,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,P03372,Estrogen receptor alpha,ESR1,,
DB07087,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,P03372,Estrogen receptor alpha,ESR1,,
DB07087,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB07088,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,,P07477,Trypsin-1,PRSS1,,
DB07088,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,,P00734,Prothrombin,F2,,
DB07089,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,,P56817,Beta-secretase 1,BACE1,,
DB07090,(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,
DB07091,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,,P07477,Trypsin-1,PRSS1,,
DB07091,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,,P00734,Prothrombin,F2,,
DB07092,"(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07093,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",,P15121,Aldose reductase,AKR1B1,,
DB07094,"1-(2,2'-bithiophen-5-yl)methanamine",,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB07095,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,,P07477,Trypsin-1,PRSS1,,
DB07095,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,,P00734,Prothrombin,F2,,
DB07096,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB07097,"4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",,Q5G940,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB07098,"4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",,Q5G940,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB07099,N-[4-(benzyloxy)phenyl]glycinamide,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB07100,"4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB07101,Mirdametinib,,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,,
DB07102,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB07103,2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE,,P00800,Thermolysin,npr,,
DB07104,4-amino-N-[4-(benzyloxy)phenyl]butanamide,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB07105,2-[2-(4-Chloro-Phenylsulfanyl)-Acetylamino]-3-(4-Guanidino-Phenyl)-Propionamide,,P00734,Prothrombin,F2,,
DB07106,SKF-91488,,P50135,Histamine N-methyltransferase,HNMT,inhibitor,
DB07107,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07107,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07108,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",,Q07817,Bcl-2-like protein 1,BCL2L1,,
DB07109,Isoferulic acid,,Q55813,O-methyltransferase,,,
DB07110,4-(4-FLUOROBENZYL)PIPERIDINE,,P56817,Beta-secretase 1,BACE1,,
DB07111,"(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid",,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07112,N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE,,Q9GZT9,Egl nine homolog 1,EGLN1,,
DB07113,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",,P00797,Renin,REN,,
DB07114,4-[(METHYLSULFONYL)AMINO]BENZOIC ACID,,P00811,Beta-lactamase,ampC,,
DB07115,"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",,Q8N1Q1,Carbonic anhydrase 13,CA13,,
DB07116,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,,P13051,Uracil-DNA glycosylase,UNG,,
DB07117,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",,P14780,Matrix metalloproteinase-9,MMP9,,
DB07118,Hymecromone,,A0A0H2Z368,Arylsulfate sulfotransferase,assT,,A05AX02
DB07119,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07119,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,,Q92731,Estrogen receptor beta,ESR2,,
DB07120,"3-Carbamimidamido-1,1-diphenylurea",,P00734,Prothrombin,F2,,
DB07121,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,,
DB07122,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,,P00749,Urokinase-type plasminogen activator,PLAU,,
DB07123,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,
DB07124,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07125,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",,O43293,Death-associated protein kinase 3,DAPK3,,
DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,,P20248,Cyclin-A2,CCNA2,,
DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07127,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",,P23467,Receptor-type tyrosine-protein phosphatase beta,PTPRB,,
DB07128,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",,P00734,Prothrombin,F2,,
DB07129,"(2R)-1-(2,6-dimethylphenoxy)propan-2-amine",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB07130,4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07131,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,,P07477,Trypsin-1,PRSS1,,
DB07131,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,,P00734,Prothrombin,F2,,
DB07132,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB07133,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB07134,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07135,"(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07136,BX-528,,P15086,Carboxypeptidase B,CPB1,,
DB07137,(2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide,,P20248,Cyclin-A2,CCNA2,,
DB07137,(2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07138,Neflamapimod,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07139,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,,P15121,Aldose reductase,AKR1B1,,
DB07140,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,P00374,Dihydrofolate reductase,DHFR,,
DB07140,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,A0A0M3KKX1,Dihydrofolate reductase (dfrB),dfrB,,
DB07141,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,P00374,Dihydrofolate reductase,DHFR,,
DB07142,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,P00374,Dihydrofolate reductase,DHFR,,
DB07142,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,A0A0M3KKX1,Dihydrofolate reductase (dfrB),dfrB,,
DB07143,D-phenylalanyl-N-benzyl-L-prolinamide,,P00734,Prothrombin,F2,,
DB07144,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,P00374,Dihydrofolate reductase,DHFR,,
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,,
DB07146,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",,P06239,Tyrosine-protein kinase Lck,LCK,,
DB07147,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,,
DB07148,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",,P48147,Prolyl endopeptidase,PREP,,
DB07149,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB07150,4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07150,4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,,Q92731,Estrogen receptor beta,ESR2,,
DB07151,4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB07152,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,,P36897,TGF-beta receptor type-1,TGFBR1,,
DB07153,"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",,A0A0M3KKX1,Dihydrofolate reductase (dfrB),dfrB,,
DB07154,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07155,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,
DB07156,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",,P08069,Insulin-like growth factor 1 receptor,IGF1R,,
DB07157,"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",,P15086,Carboxypeptidase B,CPB1,,
DB07158,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07159,Tamatinib,,P43405,Tyrosine-protein kinase SYK,SYK,inhibitor,
DB07160,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE",,P07858,Cathepsin B,CTSB,,
DB07161,5-phenyl-1H-indazol-3-amine,,O60674,Tyrosine-protein kinase JAK2,JAK2,,
DB07162,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,,O60674,Tyrosine-protein kinase JAK2,JAK2,,
DB07163,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07164,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",,P20248,Cyclin-A2,CCNA2,,
DB07164,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07165,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,,P00734,Prothrombin,F2,,
DB07167,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,,
DB07168,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,,Q13554,Calcium/calmodulin-dependent protein kinase type II subunit beta,CAMK2B,,
DB07169,"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",,P26663,Genome polyprotein,,,
DB07170,"5'-FLUORO-2',5'-DIDEOXYADENOSINE",,Q70GK9,5'-fluoro-5'-deoxy-adenosine synthase,flA,,
DB07171,"5-(2-hydroxyethyl)nonane-1,9-diol",,P42892,Endothelin-converting enzyme 1,ECE1,,
DB07172,"(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid",,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07173,"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE",,P55263,Adenosine kinase,ADK,,
DB07174,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",,P00797,Renin,REN,,
DB07175,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,,P56817,Beta-secretase 1,BACE1,,
DB07177,"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",,Q14914,Prostaglandin reductase 1,PTGR1,,
DB07177,"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",,Q8N8N7,Prostaglandin reductase 2,PTGR2,,
DB07178,5-PENTYL-2-PHENOXYPHENOL,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,
DB07179,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07180,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",,P51955,Serine/threonine-protein kinase Nek2,NEK2,,
DB07181,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07182,(2S)-2-(3-Carbamimidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid,,P15086,Carboxypeptidase B,CPB1,,
DB07183,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB07184,"6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione",,P04585,Gag-Pol polyprotein,gag-pol,,
DB07185,2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,,Q99AU2,Genome polyprotein,,,
DB07186,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",,O14965,Aurora kinase A,AURKA,,
DB07186,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",,P53350,Serine/threonine-protein kinase PLK1,PLK1,,
DB07187,CP-744809,,P15121,Aldose reductase,AKR1B1,,
DB07188,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,
DB07189,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,,
DB07190,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,,P00734,Prothrombin,F2,,
DB07192,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,
DB07193,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07194,"2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide",,P43405,Tyrosine-protein kinase SYK,SYK,,
DB07195,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,P03372,Estrogen receptor alpha,ESR1,,
DB07195,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB07196,N-methyl-1-(2-thiophen-2-ylphenyl)methanamine,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB07197,4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07198,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,,Q92731,Estrogen receptor beta,ESR2,,
DB07198,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07199,"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",,P26663,Genome polyprotein,,,
DB07199,"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",,O39930,RNA-dependent RNA-polymerase,NS5b,,
DB07200,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",,P26663,Genome polyprotein,,,
DB07200,"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",,O39930,RNA-dependent RNA-polymerase,NS5b,,
DB07202,6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE,,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,,
DB07203,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,,P20248,Cyclin-A2,CCNA2,,
DB07203,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07204,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07204,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07205,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,,
DB07206,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,,P56817,Beta-secretase 1,BACE1,,
DB07207,2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,,P08709,Coagulation factor VII,F7,,
DB07207,2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,,P13726,Tissue factor,F3,,
DB07208,"(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid",,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07209,"(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid",,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07210,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07211,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,,P00734,Prothrombin,F2,,
DB07211,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,,P00742,Coagulation factor X,F10,,
DB07212,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,,P03951,Coagulation factor XI,F11,,
DB07213,"(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07215,GW-590735,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07215,GW-590735,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB07216,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB07216,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB07217,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB07218,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",,Q9UQF2,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,,
DB07218,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",,P45983,Mitogen-activated protein kinase 8,MAPK8,,
DB07219,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",,P07858,Cathepsin B,CTSB,,
DB07220,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07221,"(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM",,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB07222,(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,
DB07223,CA-074 methyl ester,,P07858,Cathepsin B,CTSB,,
DB07224,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE",,P07858,Cathepsin B,CTSB,,
DB07225,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE",,P07858,Cathepsin B,CTSB,,
DB07226,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",,P30291,Wee1-like protein kinase,WEE1,,
DB07227,L-778123,,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB07227,L-778123,,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB07227,L-778123,,P53609,Geranylgeranyl transferase type-1 subunit beta,PGGT1B,,
DB07228,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07229,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",,P07477,Trypsin-1,PRSS1,,
DB07230,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,,Q92731,Estrogen receptor beta,ESR2,,
DB07230,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07231,"N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE",,P07858,Cathepsin B,CTSB,,
DB07232,Veliparib,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,L01XK05
DB07232,Veliparib,,Q9UGN5,Poly [ADP-ribose] polymerase 2,PARP2,,L01XK05
DB07233,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,,
DB07234,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,,
DB07235,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07236,3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,,Q92731,Estrogen receptor beta,ESR2,,
DB07236,3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07237,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB07238,Nesbuvir,,P26663,Genome polyprotein,,,
DB07238,Nesbuvir,,Q9WMX2,Genome polyprotein,,,
DB07239,7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07241,"7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole",,Q8KI25,Putative FAD-monooxygenase,rbmD,,
DB07242,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",,O43293,Death-associated protein kinase 3,DAPK3,,
DB07242,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB07243,"(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07244,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB07244,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",,P00797,Renin,REN,,
DB07245,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,,P56817,Beta-secretase 1,BACE1,,
DB07246,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",,P14780,Matrix metalloproteinase-9,MMP9,,
DB07247,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",,P08709,Coagulation factor VII,F7,,
DB07247,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",,P13726,Tissue factor,F3,,
DB07248,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",,Q05397,Focal adhesion kinase 1,PTK2,,
DB07249,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",,P54760,Ephrin type-B receptor 4,EPHB4,,
DB07250,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",,P54760,Ephrin type-B receptor 4,EPHB4,,
DB07251,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",,P54760,Ephrin type-B receptor 4,EPHB4,,
DB07252,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",,P54760,Ephrin type-B receptor 4,EPHB4,,
DB07253,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",,P54760,Ephrin type-B receptor 4,EPHB4,,
DB07254,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",,P54760,Ephrin type-B receptor 4,EPHB4,,
DB07255,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",,P54760,Ephrin type-B receptor 4,EPHB4,,
DB07256,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",,P54760,Ephrin type-B receptor 4,EPHB4,,
DB07257,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",,P30291,Wee1-like protein kinase,WEE1,,
DB07258,(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB07259,1-(4-thiophen-2-ylphenyl)methanamine,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB07260,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB07261,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",,P00742,Coagulation factor X,F10,,
DB07262,1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene,,P0ABQ4,Dihydrofolate reductase,folA,,
DB07263,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07264,(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB07265,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",,P30291,Wee1-like protein kinase,WEE1,,
DB07266,AKI-001,,O14965,Aurora kinase A,AURKA,,
DB07267,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,,P36897,TGF-beta receptor type-1,TGFBR1,,
DB07268,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,,P45983,Mitogen-activated protein kinase 8,MAPK8,,
DB07269,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,,P15086,Carboxypeptidase B,CPB1,,
DB07270,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,,
DB07271,"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07272,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",,Q9UQF2,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,,
DB07272,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",,P45983,Mitogen-activated protein kinase 8,MAPK8,,
DB07273,1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE,,Q99AU2,Genome polyprotein,,,
DB07274,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB07275,"3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one",,Q99AU2,Genome polyprotein,,,
DB07276,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",,Q9UQF2,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,,
DB07276,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",,P45983,Mitogen-activated protein kinase 8,MAPK8,,
DB07277,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,,P00734,Prothrombin,F2,,
DB07277,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,,P00742,Coagulation factor X,F10,,
DB07278,GW-813893,,P00734,Prothrombin,F2,,
DB07278,GW-813893,,P00742,Coagulation factor X,F10,,
DB07279,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,,P00734,Prothrombin,F2,,
DB07280,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,,P55263,Adenosine kinase,ADK,,
DB07281,"N~3~-BENZYLPYRIDINE-2,3-DIAMINE",,P56817,Beta-secretase 1,BACE1,,
DB07284,"N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",,P56817,Beta-secretase 1,BACE1,,
DB07285,"(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID",,P14780,Matrix metalloproteinase-9,MMP9,,
DB07286,BMS-564929,,P10275,Androgen receptor,AR,,
DB07287,"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,
DB07288,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,,P17948,Vascular endothelial growth factor receptor 1,FLT1,,
DB07289,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07290,(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,,P15917,Lethal factor,lef,,
DB07291,5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile,,Q3JUV5,Inorganic pyrophosphatase,ppa,,
DB07292,"4-(2-amino-1,3-thiazol-4-yl)phenol",,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB07293,benzyl (2-oxopropyl)carbamate,,P0C6X7,Replicase polyprotein 1ab,rep,,
DB07294,"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",,P13631,Retinoic acid receptor gamma,RARG,,
DB07295,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07296,(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,,P08373,UDP-N-acetylenolpyruvoylglucosamine reductase,murB,,
DB07297,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",,P06239,Tyrosine-protein kinase Lck,LCK,,
DB07298,"3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07299,4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE,,P03951,Coagulation factor XI,F11,,
DB07300,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB07301,Carbazole,,Q8GI16,Ferredoxin CarAc,carAc,,
DB07301,Carbazole,,Q84II6,Terminal oxygenase component of carbazole,carAa,,
DB07302,9(S)-HODE,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07303,"N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",,P56817,Beta-secretase 1,BACE1,,
DB07304,5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,,P0AE18,Methionine aminopeptidase,map,,
DB07305,5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,,P0AE18,Methionine aminopeptidase,map,,
DB07306,ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07307,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07308,5-(2-CHLOROBENZYL)-2-FUROIC ACID,,P0AE18,Methionine aminopeptidase,map,,
DB07309,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,,P50579,Methionine aminopeptidase 2,METAP2,,
DB07310,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB07311,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07312,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,,
DB07313,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,,P50579,Methionine aminopeptidase 2,METAP2,,
DB07314,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07315,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",,,"Glycogen phosphorylase, liver form",,,
DB07316,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB07317,(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB07318,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07319,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB07320,"4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07321,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,,
DB07322,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",,P50579,Methionine aminopeptidase 2,METAP2,,
DB07323,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",,P50579,Methionine aminopeptidase 2,METAP2,,
DB07324,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB07325,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB07326,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB07327,R-95845,,P03366,Gag-Pol polyprotein,gag-pol,,
DB07327,R-95845,,P03367,Gag-Pol polyprotein,gag-pol,,
DB07328,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07329,1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID,,P01859,Ig gamma-2 chain C region,IGHG2,,
DB07330,A-620223,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB07331,p-Nitrophenylacetic acid,,P06875,Penicillin G acylase,pac,,
DB07332,"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",,P03366,Gag-Pol polyprotein,gag-pol,,
DB07332,"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",,P04585,Gag-Pol polyprotein,gag-pol,,
DB07333,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB07334,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB07335,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB07335,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB07336,4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07337,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",,P03366,Gag-Pol polyprotein,gag-pol,,
DB07338,Acifluorfen,,P56601,Protoporphyrinogen oxidase,hemY,,
DB07338,Acifluorfen,,P32397,Protoporphyrinogen oxidase,hemY,,
DB07339,"(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione",,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,
DB07340,Reversine,,Q96GD4,Aurora kinase B,AURKB,,
DB07340,Reversine,,Q9NQS7,Inner centromere protein,INCENP,,
DB07341,"octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside",,P16442,Histo-blood group ABO system transferase,ABO,,
DB07342,1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone,,P09601,Heme oxygenase 1,HMOX1,,
DB07343,"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",,P03366,Gag-Pol polyprotein,gag-pol,,
DB07344,"3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL",,Q8IVS2,"Malonyl-CoA-acyl carrier protein transacylase, mitochondrial",MCAT,,
DB07345,4-(2-aminoethyl)-2-cyclohexylphenol,,P56817,Beta-secretase 1,BACE1,,
DB07346,4-(2-aminoethyl)-2-ethylphenol,,P56817,Beta-secretase 1,BACE1,,
DB07347,4-(2-Aminoethyl)Benzenesulfonyl Fluoride,,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,,
DB07347,4-(2-Aminoethyl)Benzenesulfonyl Fluoride,,P21281,"V-type proton ATPase subunit B, brain isoform",ATP6V1B2,,
DB07348,Brefeldin A,,Q99418,Cytohesin-2,CYTH2,,
DB07348,Brefeldin A,,P84077,ADP-ribosylation factor 1,ARF1,,
DB07349,"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",,P09152,Respiratory nitrate reductase 1 alpha chain,narG,,
DB07349,"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",,P11349,Respiratory nitrate reductase 1 beta chain,narH,,
DB07349,"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",,P11350,Respiratory nitrate reductase 1 gamma chain,narI,,
DB07349,"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",,P60844,Aquaporin Z,aqpZ,,
DB07350,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,,Q9BY41,Histone deacetylase 8,HDAC8,,
DB07351,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,,P15085,Carboxypeptidase A1,CPA1,,
DB07352,Apigenin,,Q5G940,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB07353,"4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL",,P00734,Prothrombin,F2,,
DB07354,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",,P11387,DNA topoisomerase 1,TOP1,,
DB07355,3-(heptyloxy)benzoic acid,,O67648,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,lpxC,,
DB07356,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07357,"4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",,P16442,Histo-blood group ABO system transferase,ABO,,
DB07358,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",,P35557,Glucokinase,GCK,,
DB07359,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",,P35557,Glucokinase,GCK,,
DB07360,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",,O14965,Aurora kinase A,AURKA,,
DB07362,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",,O14965,Aurora kinase A,AURKA,,
DB07363,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",,P00918,Carbonic anhydrase 2,CA2,,
DB07364,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",,Q00535,Cyclin-dependent kinase 5,CDK5,,
DB07364,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",,Q15078,Cyclin-dependent kinase 5 activator 1,CDK5R1,,
DB07365,1-Naphthyl-L-alanine,,P06202,Periplasmic oligopeptide-binding protein,oppA,,
DB07365,1-Naphthyl-L-alanine,,P16088,Pol polyprotein,pol,,
DB07366,2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER,,P00734,Prothrombin,F2,,
DB07367,"(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol",,Q08638,Beta-glucosidase A,bglA,,
DB07368,4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE,,P07477,Trypsin-1,PRSS1,,
DB07369,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",,P08581,Hepatocyte growth factor receptor,MET,,
DB07370,"(3Z,5S,6R,7S,8R,8aS)-3-(octylimino)hexahydro[1,3]thiazolo[3,4-a]pyridine-5,6,7,8-tetrol",,Q08638,Beta-glucosidase A,bglA,,
DB07371,3-(10-methyl-9-anthryl)propanoic acid,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB07373,Boldione,,P71278,Pentaerythritol tetranitrate reductase,onr,,
DB07374,Anisomycin,,Q96L21,60S ribosomal protein L10-like,RPL10L,,
DB07374,Anisomycin,,P40429,60S ribosomal protein L13a,RPL13A,,
DB07374,Anisomycin,,P62829,60S ribosomal protein L23,RPL23,,
DB07374,Anisomycin,,P61313,60S ribosomal protein L15,RPL15,,
DB07374,Anisomycin,,P84098,60S ribosomal protein L19,RPL19,,
DB07374,Anisomycin,,P62750,60S ribosomal protein L23a,RPL23A,,
DB07374,Anisomycin,,Q9UHA3,Probable ribosome biogenesis protein RLP24,RSL24D1,,
DB07374,Anisomycin,,Q9UNX3,60S ribosomal protein L26-like 1,RPL26L1,,
DB07374,Anisomycin,,P62917,60S ribosomal protein L8,RPL8,,
DB07374,Anisomycin,,P61927,60S ribosomal protein L37,RPL37,,
DB07374,Anisomycin,,P39023,60S ribosomal protein L3,RPL3,,
DB07374,Anisomycin,,P62913,60S ribosomal protein L11,RPL11,,
DB07374,Anisomycin,,P55769,NHP2-like protein 1,SNU13,,
DB07375,Etiocholanedione,,P01859,Ig gamma-2 chain C region,IGHG2,,
DB07375,Etiocholanedione,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB07375,Etiocholanedione,,P01834,Ig kappa chain C region,IGKC,,
DB07375,Etiocholanedione,,P06310,Ig kappa chain V-II region RPMI 6410,,,
DB07376,5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),,P00734,Prothrombin,F2,,
DB07376,5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),,P08709,Coagulation factor VII,F7,,
DB07377,"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",,P50579,Methionine aminopeptidase 2,METAP2,,
DB07378,"4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",,P16442,Histo-blood group ABO system transferase,ABO,,
DB07379,(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol,,Q00534,Cyclin-dependent kinase 6,CDK6,,
DB07379,(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol,,Q01043,Cyclin homolog,72,,
DB07380,"1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",,P17538,Chymotrypsinogen B,CTRB1,,
DB07381,(S)-atrolactic acid,,P11444,Mandelate racemase,mdlA,,
DB07382,"N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",,O75460,Serine/threonine-protein kinase/endoribonuclease IRE1,ERN1,,
DB07383,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",,P17538,Chymotrypsinogen B,CTRB1,,
DB07384,1-ACETYL-2-CARBOXYPIPERIDINE,,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,,
DB07384,1-ACETYL-2-CARBOXYPIPERIDINE,,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,,
DB07384,1-ACETYL-2-CARBOXYPIPERIDINE,,P36542,"ATP synthase subunit gamma, mitochondrial",ATP5C1,,
DB07385,"3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE",,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,,
DB07387,3-(BUTYLSULPHONYL)-PROPANOIC ACID,,P60174,Triosephosphate isomerase,TPI1,,
DB07388,ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07388,ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB07389,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07390,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide",,P08254,Stromelysin-1,MMP3,,
DB07391,"(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE",,O32449,Proline iminopeptidase,pip,,
DB07392,Atrazine,,P07173,Photosynthetic reaction center cytochrome c subunit,pufC,,
DB07392,Atrazine,,P06008,Reaction center protein H chain,puhA,,
DB07392,Atrazine,,P06009,Reaction center protein L chain,pufL,,
DB07392,Atrazine,,P06010,Reaction center protein M chain,pufM,,
DB07393,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",,P00390,"Glutathione reductase, mitochondrial",GSR,,
DB07394,AUROVERTIN B,,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,,
DB07394,AUROVERTIN B,,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,,
DB07394,AUROVERTIN B,,P36542,"ATP synthase subunit gamma, mitochondrial",ATP5C1,,
DB07395,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",,,"Glycogen phosphorylase, liver form",,,
DB07396,AVE-2865,,,"Glycogen phosphorylase, liver form",,,
DB07397,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",,P22894,Neutrophil collagenase,MMP8,,
DB07398,"2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",,P9WI73,Serine/threonine-protein kinase PknG,pknG,,
DB07400,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,,P00734,Prothrombin,F2,,
DB07401,Azoxystrobin,,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,,
DB07401,Azoxystrobin,,P00156,Cytochrome b,MT-CYB,,
DB07401,Azoxystrobin,,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,,
DB07401,Azoxystrobin,,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,,
DB07401,Azoxystrobin,,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,,
DB07401,Azoxystrobin,,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,,
DB07401,Azoxystrobin,,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,,
DB07401,Azoxystrobin,,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,,
DB07401,Azoxystrobin,,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,,
DB07401,Azoxystrobin,,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,,
DB07403,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",,Q15118,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial",PDK1,,
DB07404,BPH-608,,P60472,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",ispU,,
DB07405,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB07406,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,,
DB07407,5-(2-METHOXYPHENYL)-2-FUROIC ACID,,P0AE18,Methionine aminopeptidase,map,,
DB07408,5-(2-NITROPHENYL)-2-FUROIC ACID,,P0AE18,Methionine aminopeptidase,map,,
DB07409,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",,P60472,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",ispU,,
DB07410,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB07410,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,,P60472,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",ispU,,
DB07411,PHENYLALANINE BORONIC ACID,,P00778,Alpha-lytic protease,alpha-LP,,
DB07412,1-biphenyl-2-ylmethanamine,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07413,5'-S-[2-(decylamino)ethyl]-5'-thioadenosine,,Q79FX8,Hydroxymycolate synthase MmaA4,mmaA4,,
DB07414,"(5S)-1-benzyl-3-(1,1-dioxido-1,2-benzisothiazol-3-yl)-4-hydroxy-5-(1-methylethyl)-1,5-dihydro-2H-pyrrol-2-one",,P26663,Genome polyprotein,,,
DB07415,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,,P56817,Beta-secretase 1,BACE1,,
DB07416,(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,,P0A334,pH-gated potassium channel KcsA,kcsA,,
DB07416,(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,,P01834,Ig kappa chain C region,IGKC,,
DB07416,(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,,P0A333,pH-gated potassium channel KcsA,kcsA,,
DB07418,bis(4-nitrophenyl) hydrogen phosphate,,P20581,Uncharacterized protein PA1000,,,
DB07419,S-23,,P10275,Androgen receptor,AR,,
DB07420,(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,,A9JQL9,Dehydrosqualene synthase,crtM,,
DB07421,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",,P10275,Androgen receptor,AR,,
DB07422,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,,P10275,Androgen receptor,AR,,
DB07423,Andarine,,P10275,Androgen receptor,AR,,
DB07424,Tripotassium (1R)-4-biphenyl-4-yl-1-phosphonatobutane-1-sulfonate,,A9JQL9,Dehydrosqualene synthase,crtM,,
DB07425,Sobetirome,,Q59FW3,"Thyroid hormone receptor, alpha isoform 1 variant",,,
DB07425,Sobetirome,,P10828,Thyroid hormone receptor beta,THRB,,
DB07426,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",,P60472,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",ispU,,
DB07427,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,,P69905,Hemoglobin subunit alpha,HBA1,,
DB07427,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,,P68871,Hemoglobin subunit beta,HBB,,
DB07428,4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,,P69905,Hemoglobin subunit alpha,HBA1,,
DB07428,4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,,P68871,Hemoglobin subunit beta,HBB,,
DB07429,2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,,Q820T1,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB07430,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,,
DB07431,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,,
DB07431,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07432,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",,Q9KU37,Beta-hexosaminidase,nagZ,,
DB07432,"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",,Q89ZI2,O-GlcNAcase BT_4395,,,
DB07433,(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE,,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB07434,HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,,P00800,Thermolysin,npr,,
DB07435,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",,Q9UBT6,DNA polymerase kappa,POLK,,
DB07435,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",,P52026,DNA polymerase I,polA,,
DB07436,N-(1-PHENYL-PROPYL)-FORMAMIDE,,P16753,Capsid scaffolding protein,UL80,,
DB07437,5-Benzylacyclouridine,,P12758,Uridine phosphorylase,udp,,
DB07437,5-Benzylacyclouridine,,Q16831,Uridine phosphorylase 1,UPP1,,
DB07439,"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",,P12758,Uridine phosphorylase,udp,,
DB07440,4-TERT-BUTYLBENZENESULFONIC ACID,,P00734,Prothrombin,F2,,
DB07441,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",,P01857,Ig gamma-1 chain C region,IGHG1,,
DB07441,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",,P01834,Ig kappa chain C region,IGKC,,
DB07443,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB07444,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",,P53355,Death-associated protein kinase 1,DAPK1,,
DB07445,"N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE",,O25928,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB07446,N-(biphenyl-4-ylsulfonyl)-D-leucine,,P39900,Macrophage metalloelastase,MMP12,,
DB07447,5beta-dihydrotestosterone,,P51857,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,,
DB07448,(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid,,P28838,Cytosol aminopeptidase,LAP3,,
DB07449,N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamide,,Q9UM07,Protein-arginine deiminase type-4,PADI4,,
DB07450,(R)-minalrestat,,P15121,Aldose reductase,AKR1B1,,
DB07451,1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,,P03366,Gag-Pol polyprotein,gag-pol,,
DB07452,"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB07453,alpha-Naphthoflavone,,P05177,Cytochrome P450 1A2,CYP1A2,,
DB07454,(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,,P10275,Androgen receptor,AR,,
DB07455,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",,P42262,Glutamate receptor 2,GRIA2,,
DB07456,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB07457,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,,
DB07458,"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07459,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07460,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,,Q05397,Focal adhesion kinase 1,PTK2,,
DB07461,"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",,P00734,Prothrombin,F2,,
DB07462,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",,P21964,Catechol O-methyltransferase,COMT,,
DB07463,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol",,Q9KPI8,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,mtnN,,
DB07464,1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID,,P62593,Beta-lactamase TEM,bla,,
DB07465,"(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07466,(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID,,P62593,Beta-lactamase TEM,bla,,
DB07467,(S)-Indapamide,,P00918,Carbonic anhydrase 2,CA2,,
DB07468,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",,Q7Z406,Myosin-14,MYH14,,
DB07469,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",,Q7Z406,Myosin-14,MYH14,,
DB07470,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",,Q7Z406,Myosin-14,MYH14,,
DB07471,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",,P20248,Cyclin-A2,CCNA2,,
DB07471,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07472,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",,P04585,Gag-Pol polyprotein,gag-pol,,
DB07473,"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER",,P04585,Gag-Pol polyprotein,gag-pol,,
DB07474,3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE,,P08069,Insulin-like growth factor 1 receptor,IGF1R,,
DB07476,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,,P00918,Carbonic anhydrase 2,CA2,,
DB07477,Felbinac,,P07711,Cathepsin L1,CTSL,,M02AA08
DB07478,"3,4-Biphenyldiol",,P0A108,"1,2-dihydroxynaphthalene dioxygenase",doxG,,
DB07479,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",,P06746,DNA polymerase beta,POLB,,
DB07480,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07481,"tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB07482,(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07483,"1,1'-BIPHENYL-2-SULFINIC ACID",,P54997,2'-hydroxybiphenyl-2-sulfinate desulfinase,soxB,,
DB07484,"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",,P15085,Carboxypeptidase A1,CPA1,,
DB07485,Bisphenol Z,,P62508,Estrogen-related receptor gamma,ESRRG,,
DB07486,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",,P20701,Integrin alpha-L,ITGAL,,
DB07487,"(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE",,P00800,Thermolysin,npr,,
DB07488,"{4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone",,Q9Y6M4,Casein kinase I isoform gamma-3,CSNK1G3,,
DB07489,"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",,Q9Y6M4,Casein kinase I isoform gamma-3,CSNK1G3,,
DB07490,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",,P00363,Fumarate reductase flavoprotein subunit,frdA,,
DB07490,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",,P0AC47,Fumarate reductase iron-sulfur subunit,frdB,,
DB07490,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",,P0A8Q0,Fumarate reductase subunit C,frdC,,
DB07490,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",,P0A8Q3,Fumarate reductase subunit D,frdD,,
DB07491,"5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid",,P07477,Trypsin-1,PRSS1,,
DB07492,Bromamphenicol,,P24093,Dr hemagglutinin structural subunit,draA,,
DB07493,5-Bromoindirubin,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07494,"(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE",,Q494W8,CHRNA7-FAM7A fusion protein,CHRFAM7A,,
DB07495,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB07496,"1,3-diphenylurea",,P95276,Epoxide hydrolase,,,
DB07497,"5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal",,C0H419,Biotin/lipoyl attachment protein,yngHB,,
DB07497,"5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal",,P11498,"Pyruvate carboxylase, mitochondrial",PC,,
DB07497,"5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal",,A0A0H3JRU9,Pyruvate carboxylase,pycA,,
DB07498,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",,P15121,Aldose reductase,AKR1B1,,
DB07499,"N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide",,P03355,Gag-Pol polyprotein,gag-pol,,
DB07500,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB07501,(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07502,"4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB07503,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB07504,(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07505,"N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide",,P03367,Gag-Pol polyprotein,gag-pol,,
DB07506,L-BENZYLSUCCINIC ACID,,P15085,Carboxypeptidase A1,CPA1,,
DB07506,L-BENZYLSUCCINIC ACID,,P00800,Thermolysin,npr,,
DB07506,L-BENZYLSUCCINIC ACID,,Q9HB40,Retinoid-inducible serine carboxypeptidase,SCPEP1,,
DB07507,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",,P00469,Thymidylate synthase,thyA,,
DB07508,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,,P00734,Prothrombin,F2,,
DB07509,difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07510,"3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid",,P47229,"2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",bphD,,
DB07511,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",,P00469,Thymidylate synthase,thyA,,
DB07512,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB07513,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB07514,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB07515,"1-(2-{[(6-amino-2-methylpyridin-3-yl)methyl]amino}ethyl)-6-chloro-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-1,4-dihydropyrazin-2-ol",,P00734,Prothrombin,F2,,
DB07516,"(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid",,P47229,"2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",bphD,,
DB07518,(2R)-2-ETHYL-1-HEXANESULFONIC ACID,,Q9WWU5,Putative alkylsulfatase,atsK,,
DB07519,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",,P56817,Beta-secretase 1,BACE1,,
DB07520,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",,P25774,Cathepsin S,CTSS,,
DB07521,"(3Z,6S)-6-Chloro-1-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]amino}ethyl)-3-({2-[(2R)-2-piperidinyl]ethyl}imino)-2-piperazinol",,P00734,Prothrombin,F2,,
DB07522,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",,P00734,Prothrombin,F2,,
DB07524,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB07525,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",,P11362,Fibroblast growth factor receptor 1,FGFR1,,
DB07526,N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE,,P52699,Beta-lactamase IMP-1,,,
DB07527,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",,P00734,Prothrombin,F2,,
DB07528,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB07529,"(5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07530,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07530,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",,P11473,Vitamin D3 receptor,VDR,,
DB07531,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07533,"4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]-2-Furyl}-N-Methylbenzenesulfonamide",,P20248,Cyclin-A2,CCNA2,,
DB07533,"4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]-2-Furyl}-N-Methylbenzenesulfonamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07534,"4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]furan-2-Yl}benzenesulfonamide",,P20248,Cyclin-A2,CCNA2,,
DB07534,"4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]furan-2-Yl}benzenesulfonamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07535,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,,P56817,Beta-secretase 1,BACE1,,
DB07536,"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",,O67648,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,lpxC,,
DB07537,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB07538,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",,P20248,Cyclin-A2,CCNA2,,
DB07538,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07539,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",,P20248,Cyclin-A2,CCNA2,,
DB07539,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07540,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07541,4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid,,P00811,Beta-lactamase,ampC,,
DB07542,5-Amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid,,P07339,Cathepsin D,CTSD,,
DB07543,(S)-carazolol,,P00720,Lysozyme,E,,
DB07543,(S)-carazolol,,P07550,Beta-2 adrenergic receptor,ADRB2,,
DB07544,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,,
DB07545,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,,O14965,Aurora kinase A,AURKA,,
DB07546,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,,P19784,Casein kinase II subunit alpha',CSNK2A2,,
DB07547,5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,,Q99AU2,Genome polyprotein,,,
DB07548,"2-(6-Chloro-3-{[2,2-difluoro-2-(2-pyridinyl)ethyl]amino}-2-oxo-1(2H)-pyrazinyl)-N-[(2-fluoro-6-pyridinyl)methyl]acetamide",,P00734,Prothrombin,F2,,
DB07549,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",,P00734,Prothrombin,F2,,
DB07550,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",,P00734,Prothrombin,F2,,
DB07551,"(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",,P07173,Photosynthetic reaction center cytochrome c subunit,pufC,,
DB07551,"(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",,P06008,Reaction center protein H chain,puhA,,
DB07551,"(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",,P06009,Reaction center protein L chain,pufL,,
DB07551,"(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",,P06010,Reaction center protein M chain,pufM,,
DB07552,"(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",,P07173,Photosynthetic reaction center cytochrome c subunit,pufC,,
DB07552,"(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",,P06008,Reaction center protein H chain,puhA,,
DB07552,"(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",,P06009,Reaction center protein L chain,pufL,,
DB07552,"(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",,P06010,Reaction center protein M chain,pufM,,
DB07553,"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",,Q70I53,Histone deacetylase-like amidohydrolase,hdaH,,
DB07555,"Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium",,P22303,Acetylcholinesterase,ACHE,,
DB07556,CGS-27023,,P39900,Macrophage metalloelastase,MMP12,,
DB07556,CGS-27023,,P03956,Interstitial collagenase,MMP1,,
DB07557,"3,20-Pregnanedione",,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07557,"3,20-Pregnanedione",,P19793,Retinoic acid receptor RXR-alpha,RXRA,,
DB07557,"3,20-Pregnanedione",,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,,
DB07557,"3,20-Pregnanedione",,P51857,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,,
DB07558,acetylleucyl-leucyl-norleucinal,,O14818,Proteasome subunit alpha type-7,PSMA7,,
DB07559,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB07560,N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,,P10614,Lanosterol 14-alpha demethylase,ERG11,,
DB07561,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB07562,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07562,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",,P20248,Cyclin-A2,CCNA2,,
DB07563,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",,P43235,Cathepsin K,CTSK,,
DB07564,"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB07565,Chloramphenicol succinate,,P24093,Dr hemagglutinin structural subunit,draA,inhibitor,
DB07567,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",,P03372,Estrogen receptor alpha,ESR1,,
DB07568,"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",,P10614,Lanosterol 14-alpha demethylase,ERG11,,
DB07569,CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE,,P10614,Lanosterol 14-alpha demethylase,ERG11,,
DB07570,3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,,P26663,Genome polyprotein,,,
DB07571,"N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",,P0A6G7,ATP-dependent Clp protease proteolytic subunit,clpP,,
DB07572,3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate,,P10614,Lanosterol 14-alpha demethylase,ERG11,,
DB07573,"(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol",,P56817,Beta-secretase 1,BACE1,,
DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",,Q9H169,Stathmin-4,STMN4,,
DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",,Q9BVA1,Tubulin beta-2B chain,TUBB2B,,
DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",,Q71U36,Tubulin alpha-1A chain,TUBA1A,,
DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",,Q9BQE3,Tubulin alpha-1C chain,TUBA1C,,
DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",,P68363,Tubulin alpha-1B chain,TUBA1B,,
DB07575,"2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE",,P12497,Gag-Pol polyprotein,gag-pol,,
DB07577,"2,4-Diamino-5-phenyl-6-ethylpyrimidine",,P04818,Thymidylate synthase,TYMS,,
DB07578,CP-94707,,P03366,Gag-Pol polyprotein,gag-pol,,
DB07579,"Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane",,P02743,Serum amyloid P-component,APCS,,
DB07580,"BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE",,P02743,Serum amyloid P-component,APCS,,
DB07581,5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID,,P04584,Gag-Pol polyprotein,gag-pol,,
DB07582,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",,P26664,Genome polyprotein,,,
DB07582,"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",,Q91RS4,NS3 protease,,,
DB07583,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07583,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07584,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,,
DB07584,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB07585,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,,
DB07585,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB07586,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",,Q9BY41,Histone deacetylase 8,HDAC8,,
DB07587,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",,P25774,Cathepsin S,CTSS,,
DB07588,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",,Q83WG3,Cytochrome P450,staP,,
DB07589,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",,P25774,Cathepsin S,CTSS,,
DB07590,"S-[3-(3,4-DICHLOROPHENYL)-3-OXOPROPYL]-L-CYSTEINE",,A0A6L8PZR0,Sortase B,srtB,,
DB07591,N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE,,P0AE18,Methionine aminopeptidase,map,,
DB07592,(2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate,,P43235,Cathepsin K,CTSK,,
DB07593,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,,P43235,Cathepsin K,CTSK,,
DB07594,CCT-018159,,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB07594,CCT-018159,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB07595,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07596,"(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate",,P00918,Carbonic anhydrase 2,CA2,,
DB07597,"CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB07598,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",,P42262,Glutamate receptor 2,GRIA2,,
DB07599,[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID,,P62593,Beta-lactamase TEM,bla,,
DB07601,"4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB07602,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,,P00533,Epidermal growth factor receptor,EGFR,,
DB07604,"(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE",,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,,
DB07605,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",,P00742,Coagulation factor X,F10,,
DB07606,"6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07607,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07608,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,,Q13627,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,DYRK1A,,
DB07609,"N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE",,P11509,Cytochrome P450 2A6,CYP2A6,,
DB07610,"1,2-Dihydroxynaphthalene",,P0A108,"1,2-dihydroxynaphthalene dioxygenase",doxG,,
DB07611,DECANE-1-THIOL,,P9WNG3,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB07612,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07613,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,,O60760,Hematopoietic prostaglandin D synthase,HPGDS,,
DB07614,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",,O60760,Hematopoietic prostaglandin D synthase,HPGDS,,
DB07615,Tranilast,,O60760,Hematopoietic prostaglandin D synthase,HPGDS,inhibitor,
DB07616,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",,O60760,Hematopoietic prostaglandin D synthase,HPGDS,,
DB07617,N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,,P11509,Cytochrome P450 2A6,CYP2A6,,
DB07618,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07619,"N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB07620,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",,P0C6X7,Replicase polyprotein 1ab,rep,,
DB07620,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",,P0C6U8,Replicase polyprotein 1a,,,
DB07621,(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,,P11509,Cytochrome P450 2A6,CYP2A6,,
DB07622,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07623,"4,4'-DIPYRIDYL DISULFIDE",,P11509,Cytochrome P450 2A6,CYP2A6,,
DB07624,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB07625,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB07626,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB07627,(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE,,P07384,Calpain-1 catalytic subunit,CAPN1,,
DB07628,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",,P14618,Pyruvate kinase PKM,PKM,,
DB07629,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",,P00742,Coagulation factor X,F10,,
DB07630,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",,P00742,Coagulation factor X,F10,,
DB07631,Lauryldimethylbetaine,,Q53119,AppA protein,appA,,
DB07632,"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",,P00918,Carbonic anhydrase 2,CA2,,
DB07633,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,,P16442,Histo-blood group ABO system transferase,ABO,,
DB07634,"(2,6-Dimethylphenoxy)acetic acid",,P04584,Gag-Pol polyprotein,gag-pol,,
DB07635,"4,4'-Dihydroxybenzophenone",,P10614,Lanosterol 14-alpha demethylase,ERG11,,
DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",,P00156,Cytochrome b,MT-CYB,,
DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,,
DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,,
DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,,
DB07636,"5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione",,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,,
DB07637,Dibromotyrosine,,P19235,Erythropoietin receptor,EPOR,,H03BX02
DB07638,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",,P03372,Estrogen receptor alpha,ESR1,,
DB07638,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",,Q92731,Estrogen receptor beta,ESR2,,
DB07639,3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER,,P00734,Prothrombin,F2,,
DB07640,"2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione",,O67931,Sulfide-quinone reductase,sqr,,
DB07640,"2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione",,B7JBP8,"Sulfide-quinone reductase, putative",,,
DB07641,Decyl(dimethyl)phosphine oxide,,P21397,Amine oxidase [flavin-containing] A,MAOA,,
DB07642,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",,Q96C86,m7GpppX diphosphatase,DCPS,,
DB07643,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",,Q96C86,m7GpppX diphosphatase,DCPS,,
DB07644,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",,Q96C86,m7GpppX diphosphatase,DCPS,,
DB07645,Sebacic acid,,P69905,Hemoglobin subunit alpha,HBA1,,
DB07645,Sebacic acid,,P68871,Hemoglobin subunit beta,HBB,,
DB07646,"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",,P95673,Light-harvesting protein B-800/850 beta 1 chain,B1,,
DB07646,"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",,P97253,Light-harvesting protein B-800/850 alpha chain,A1,,
DB07646,"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB07647,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07648,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07649,"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",,P0AF14,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,mtnN,,
DB07650,Decyl formate,,P9WNG3,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB07651,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07652,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",,Q9UBT6,DNA polymerase kappa,POLK,,
DB07652,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",,Q9KEI9,Ribonuclease H,rnhA,,
DB07653,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07654,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07655,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07657,PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER,,P04054,Phospholipase A2,PLA2G1B,,
DB07658,AC-(D)Phe-pro-borolys-OH,,P00734,Prothrombin,F2,,
DB07659,AC-(D)PHE-PRO-BOROHOMOLYS-OH,,P00734,Prothrombin,F2,,
DB07660,AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH,,P00734,Prothrombin,F2,,
DB07661,"1,6-Naphthalenediol",,Q4R2T2,Prenyltransferase,,,
DB07662,PD-168393,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB07662,PD-168393,,P00533,Epidermal growth factor receptor,EGFR,,
DB07663,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",,P00811,Beta-lactamase,ampC,,
DB07664,K-00546,,Q9Y6M4,Casein kinase I isoform gamma-3,CSNK1G3,,
DB07664,K-00546,,Q9H2G2,STE20-like serine/threonine-protein kinase,SLK,,
DB07664,K-00546,,Q16566,Calcium/calmodulin-dependent protein kinase type IV,CAMK4,,
DB07664,K-00546,,P49761,Dual specificity protein kinase CLK3,CLK3,,
DB07664,K-00546,,P42684,Tyrosine-protein kinase ABL2,ABL2,,
DB07665,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",,P00734,Prothrombin,F2,,
DB07666,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07667,"2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",,P22629,Streptavidin,,,
DB07668,alpha-Methyl-2-hydroxy-4-diethylaminocinnamic acid,,P17538,Chymotrypsinogen B,CTRB1,,
DB07669,"2,3-Dimethyl-1,4-naphthoquinone",,P17412,Fumarate reductase flavoprotein subunit,frdA,,
DB07669,"2,3-Dimethyl-1,4-naphthoquinone",,P17596,Fumarate reductase iron-sulfur subunit,frdB,,
DB07669,"2,3-Dimethyl-1,4-naphthoquinone",,P17413,Fumarate reductase cytochrome b subunit,frdC,,
DB07670,"N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide",,P33260,Cytochrome P450 2C18,CYP2C18,,
DB07671,"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",,P0AC41,Succinate dehydrogenase flavoprotein subunit,sdhA,,
DB07671,"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",,P07014,Succinate dehydrogenase iron-sulfur subunit,sdhB,,
DB07671,"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",,P69054,Succinate dehydrogenase cytochrome b556 subunit,sdhC,,
DB07671,"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",,P0AC44,Succinate dehydrogenase hydrophobic membrane anchor subunit,sdhD,,
DB07672,TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB07673,(2S)-2-Methyl-3-phenylpropanoic acid,,P00800,Thermolysin,npr,,
DB07674,"O,O-DIETHYL HYDROGEN THIOPHOSPHATE",,Q93LD7,Phosphotriesterase,opdA,,
DB07675,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07676,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB07676,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",,Q16566,Calcium/calmodulin-dependent protein kinase type IV,CAMK4,,
DB07677,"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one",,Q9Y6F1,Poly [ADP-ribose] polymerase 3,PARP3,,
DB07678,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",,P03372,Estrogen receptor alpha,ESR1,,
DB07678,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB07679,"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",,P03369,Gag-Pol polyprotein,gag-pol,,
DB07680,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,,P23946,Chymase,CMA1,,
DB07681,DODECANESULFONATE ION,,P06276,Cholinesterase,BCHE,,
DB07683,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",,P39900,Macrophage metalloelastase,MMP12,,
DB07684,5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,,P00750,Tissue-type plasminogen activator,PLAT,,
DB07685,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07686,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07687,"4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07688,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07688,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",,P20248,Cyclin-A2,CCNA2,,
DB07689,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 2,DHRS4L1,,
DB07691,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB07692,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",,P14618,Pyruvate kinase PKM,PKM,,
DB07696,methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate,,P42574,Caspase-3,CASP3,,
DB07697,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",,P14618,Pyruvate kinase PKM,PKM,,
DB07698,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",,Q8TF76,Serine/threonine-protein kinase haspin,GSG2,,
DB07700,"3-carboxamido-1,3,5(10)-estratrien-17(R)-spiro-2'(5',5'-dimethyl-6'oxo)tetrahydropyran",,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,,
DB07701,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",,P22303,Acetylcholinesterase,ACHE,,
DB07702,17alpha-Estriol,,Q9HCD5,Nuclear receptor coactivator 5,NCOA5,,
DB07702,17alpha-Estriol,,Q92731,Estrogen receptor beta,ESR2,,
DB07703,"(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE",,Q9ZGI2,Type I polyketide synthase PikAIV,pikAIV,,
DB07704,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB07705,(S)-econazole,,P9WPN5,Cytochrome P450 130,cyp130,,
DB07705,(S)-econazole,,Q16850,Lanosterol 14-alpha demethylase,CYP51A1,,
DB07706,2-Hydroxyestradiol,,O32393,Adenylate cyclase,cyaC,,
DB07707,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",,P03372,Estrogen receptor alpha,ESR1,,
DB07707,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB07708,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,,P03372,Estrogen receptor alpha,ESR1,,
DB07708,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB07710,PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE,,P00918,Carbonic anhydrase 2,CA2,,
DB07711,"(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol",,P00813,Adenosine deaminase,ADA,,
DB07712,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,,P03372,Estrogen receptor alpha,ESR1,,
DB07712,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB07713,"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",,P22894,Neutrophil collagenase,MMP8,,
DB07714,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",,P00390,"Glutathione reductase, mitochondrial",GSR,,
DB07715,Emodin,,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB07715,Emodin,,P16544,Putative ketoacyl reductase,actIII,,
DB07715,Emodin,,Q5G940,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB07715,Emodin,,P35869,Aryl hydrocarbon receptor,AHR,agonist,
DB07716,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",,P01834,Ig kappa chain C region,IGKC,,
DB07717,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",,P10275,Androgen receptor,AR,,
DB07718,4-Hydroxyphenylpyruvic acid,,P00734,Prothrombin,F2,,
DB07718,4-Hydroxyphenylpyruvic acid,,P14174,Macrophage migration inhibitory factor,MIF,,
DB07718,4-Hydroxyphenylpyruvic acid,,O67636,Prephenate dehydrogenase,tyrA,,
DB07719,"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07720,Epibatidine,,Q494W8,CHRNA7-FAM7A fusion protein,CHRFAM7A,,
DB07720,Epibatidine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,
DB07720,Epibatidine,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,,
DB07720,Epibatidine,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,agonist,
DB07720,Epibatidine,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,agonist,
DB07720,Epibatidine,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,agonist,
DB07720,Epibatidine,,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,agonist,
DB07721,DIETHYL 4-METHOXYPHENYL PHOSPHATE,,Q93LD7,Phosphotriesterase,opdA,,
DB07722,3-(4-NITRO-PHENOXY)-PROPAN-1-OL,,Q88016,Pol polyprotein,pol,,
DB07723,3-(5-methoxy-1H-indol-3-yl)propanoic acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07724,Indeglitazar,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB07724,Indeglitazar,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB07724,Indeglitazar,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB07724,Indeglitazar,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07726,t-Butylhydroquinone,,P26137,Hemagglutinin,HA,,
DB07726,t-Butylhydroquinone,,P03437,Hemagglutinin,HA,,
DB07728,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,,
DB07728,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",,Q16644,MAP kinase-activated protein kinase 3,MAPKAPK3,,
DB07729,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,,Q9L5C8,Beta-lactamase,blaCTX-M-9a,,
DB07730,"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB07731,CAN-508,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07732,2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,,P00929,Tryptophan synthase alpha chain,trpA,,
DB07732,2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB07733,"1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE",,P29466,Caspase-1,CASP1,,
DB07734,N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide,,P56817,Beta-secretase 1,BACE1,,
DB07735,"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",,P56817,Beta-secretase 1,BACE1,,
DB07736,(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide,,P56817,Beta-secretase 1,BACE1,,
DB07737,(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,,P56817,Beta-secretase 1,BACE1,,
DB07738,"N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",,P56817,Beta-secretase 1,BACE1,,
DB07739,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB07740,"(7R,12R,13R)-13-formyl-12,14-dihydroxy-3,5,7-trimethyltetradeca-2,4-dienoic acid",,Q01581,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",HMGCS1,,
DB07741,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",,P00734,Prothrombin,F2,,
DB07742,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",,P00918,Carbonic anhydrase 2,CA2,,
DB07743,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",,P0C6X7,Replicase polyprotein 1ab,rep,,
DB07743,"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",,P0C6U8,Replicase polyprotein 1a,,,
DB07744,Z-Val-Ala-Asp fluoromethyl ketone,,P29466,Caspase-1,CASP1,,
DB07745,2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,,P00929,Tryptophan synthase alpha chain,trpA,,
DB07745,2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB07746,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,,P50579,Methionine aminopeptidase 2,METAP2,,
DB07747,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB07748,2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,,P00929,Tryptophan synthase alpha chain,trpA,,
DB07748,2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB07749,2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE,,P17538,Chymotrypsinogen B,CTRB1,,
DB07750,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07751,"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07754,DCFBC,,Q04609,Glutamate carboxypeptidase 2,FOLH1,,
DB07755,"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07756,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",,P22303,Acetylcholinesterase,ACHE,,
DB07757,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",,Q92731,Estrogen receptor beta,ESR2,,
DB07758,"5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID",,P0AE18,Methionine aminopeptidase,map,,
DB07759,5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID,,P0AE18,Methionine aminopeptidase,map,,
DB07760,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",,P13051,Uracil-DNA glycosylase,UNG,,
DB07761,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07762,4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,,P03474,Neuraminidase,,,
DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,,
DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,P00156,Cytochrome b,MT-CYB,,
DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,,
DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,,
DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,,
DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,,
DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,,
DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,,
DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,,
DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,,
DB07764,Fluorescin,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB07765,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 2,DHRS4L1,,
DB07766,"(2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}",,Q9UQM7,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,,
DB07766,"(2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}",,Q00536,Cyclin-dependent kinase 16,CDK16,,
DB07767,Ferulic acid,,P51584,"Endo-1,4-beta-xylanase Y",xynY,,
DB07767,Ferulic acid,,P10478,"Endo-1,4-beta-xylanase Z",xynZ,,
DB07767,Ferulic acid,,D2YW37,Est1e,,,
DB07767,Ferulic acid,,Q55813,O-methyltransferase,,,
DB07768,Epitestosterone,,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,,
DB07768,Epitestosterone,,P52895,Aldo-keto reductase family 1 member C2,AKR1C2,,
DB07769,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,,P10275,Androgen receptor,AR,,
DB07770,5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,,Q99AU2,Genome polyprotein,,,
DB07771,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",,P01116,GTPase KRas,KRAS,,
DB07771,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB07771,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB07772,"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",,P22894,Neutrophil collagenase,MMP8,,
DB07773,5-FLUOROINDOLE PROPANOL PHOSPHATE,,P00929,Tryptophan synthase alpha chain,trpA,,
DB07773,5-FLUOROINDOLE PROPANOL PHOSPHATE,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB07776,Flavone,,P0A3R9,Neocarzinostatin,ncsA,,
DB07776,Flavone,,P11474,Steroid hormone receptor ERR1,ESRRA,agonist,
DB07776,Flavone,,O95718,Steroid hormone receptor ERR2,ESRRB,agonist,
DB07776,Flavone,,Q16678,Cytochrome P450 1B1,CYP1B1,,
DB07778,(S)-famoxadone,,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,,
DB07778,(S)-famoxadone,,P00156,Cytochrome b,MT-CYB,,
DB07778,(S)-famoxadone,,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,,
DB07778,(S)-famoxadone,,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,,
DB07778,(S)-famoxadone,,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,,
DB07778,(S)-famoxadone,,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,,
DB07778,(S)-famoxadone,,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,,
DB07778,(S)-famoxadone,,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,,
DB07778,(S)-famoxadone,,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,,
DB07778,(S)-famoxadone,,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,,
DB07779,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07780,Farnesyl diphosphate,,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB07780,Farnesyl diphosphate,,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB07780,Farnesyl diphosphate,,P01116,GTPase KRas,KRAS,,
DB07780,Farnesyl diphosphate,,Q8EBR3,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",ispF,,
DB07780,Farnesyl diphosphate,,P14324,Farnesyl pyrophosphate synthase,FDPS,,
DB07780,Farnesyl diphosphate,,P60472,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",ispU,,
DB07780,Farnesyl diphosphate,,P29559,Lantibiotic nisin-Z,nisZ,,
DB07780,Farnesyl diphosphate,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB07780,Farnesyl diphosphate,,P9WFF5,"(2Z,6E)-farnesyl diphosphate synthase",,,
DB07780,Farnesyl diphosphate,,Q92696,Geranylgeranyl transferase type-2 subunit alpha,RABGGTA,,
DB07780,Farnesyl diphosphate,,P53611,Geranylgeranyl transferase type-2 subunit beta,RABGGTB,,
DB07781,N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA,,P04585,Gag-Pol polyprotein,gag-pol,,
DB07782,4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,,P39594,Thiamine-phosphate synthase,thiE,,
DB07783,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,,P00813,Adenosine deaminase,ADA,,
DB07784,"[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID",,P01834,Ig kappa chain C region,IGKC,,
DB07785,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",,P00813,Adenosine deaminase,ADA,,
DB07786,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",,P00813,Adenosine deaminase,ADA,,
DB07787,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB07788,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB07789,"1-[5-Methyl-2-(trifluoromethyl)furan-3-yl]-3-[5-[2-[[6-(1H-1,2,4-triazol-5-ylamino)pyrimidin-4-yl]amino]ethyl]-1,3-thiazol-2-yl]urea",,P53350,Serine/threonine-protein kinase PLK1,PLK1,,
DB07790,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07791,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07792,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB07793,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB07794,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB07795,Fisetin,,Q01043,Cyclin homolog,72,,
DB07795,Fisetin,,Q00534,Cyclin-dependent kinase 6,CDK6,,
DB07796,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",,P00734,Prothrombin,F2,,
DB07797,N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA,,P04585,Gag-Pol polyprotein,gag-pol,,
DB07798,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB07800,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,,P00742,Coagulation factor X,F10,,
DB07801,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,,O14965,Aurora kinase A,AURKA,,
DB07802,"3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB07803,2-phenyl-1H-imidazole-4-carboxylic acid,,P00811,Beta-lactamase,ampC,,
DB07804,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",,P00742,Coagulation factor X,F10,,
DB07805,"3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE",,Q5HEB7,D-alanine--D-alanine ligase,ddl,,
DB07806,"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",,P03366,Gag-Pol polyprotein,gag-pol,,
DB07807,"(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB07808,"(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid",,Q9L5C8,Beta-lactamase,blaCTX-M-9a,,
DB07809,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,,P00734,Prothrombin,F2,,
DB07810,Phloretin,,Q9AIU0,HTH-type transcriptional regulator TtgR,ttgR,,
DB07811,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07812,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",,P31751,RAC-beta serine/threonine-protein kinase,AKT2,,
DB07812,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB07813,GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,,Q7MUW6,Prolyl tripeptidyl peptidase,ptpA,,
DB07814,Gibberellic acid,,Q6P093,Arylacetamide deacetylase-like 2,AADACL2,,
DB07815,Gibberellin A4,,Q6P093,Arylacetamide deacetylase-like 2,AADACL2,,
DB07816,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB07817,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",,Q4L5E3,Phenylalanine--tRNA ligase alpha subunit,pheS,,
DB07817,"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",,Q4L5E4,Phenylalanine--tRNA ligase beta subunit,pheT,,
DB07818,"(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE",,P10845,Botulinum neurotoxin type A,botA,,
DB07818,"(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE",,Q7B8V4,BoNT/A,bont/a,,
DB07819,(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,,P10845,Botulinum neurotoxin type A,botA,,
DB07819,(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,,Q7B8V4,BoNT/A,bont/a,,
DB07820,"6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL",,P04585,Gag-Pol polyprotein,gag-pol,,
DB07821,"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",,P23141,Liver carboxylesterase 1,CES1,,
DB07821,"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",,Q15102,Platelet-activating factor acetylhydrolase IB subunit gamma,PAFAH1B3,,
DB07821,"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",,Q13093,Platelet-activating factor acetylhydrolase,PLA2G7,,
DB07823,"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",,Q9L5C8,Beta-lactamase,blaCTX-M-9a,,
DB07823,"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",,P00811,Beta-lactamase,ampC,,
DB07824,"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",,Q9L5C8,Beta-lactamase,blaCTX-M-9a,,
DB07824,"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",,P00811,Beta-lactamase,ampC,,
DB07825,(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid,,P00811,Beta-lactamase,ampC,,
DB07826,2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,,P04585,Gag-Pol polyprotein,gag-pol,,
DB07827,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",,P45452,Collagenase 3,MMP13,,
DB07829,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07830,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07831,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",,P00519,Tyrosine-protein kinase ABL1,ABL1,,
DB07832,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07833,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07834,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07835,"N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07836,1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL,,P04054,Phospholipase A2,PLA2G1B,,
DB07837,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",,O00141,Serine/threonine-protein kinase Sgk1,SGK1,,
DB07838,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,,O60551,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,,
DB07839,"N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",,P25774,Cathepsin S,CTSS,,
DB07840,"(E)-[4-(3,5-Difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol",,P11362,Fibroblast growth factor receptor 1,FGFR1,,
DB07841,Geranylgeranyl diphosphate,,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB07841,Geranylgeranyl diphosphate,,P53609,Geranylgeranyl transferase type-1 subunit beta,PGGT1B,,
DB07841,Geranylgeranyl diphosphate,,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB07841,Geranylgeranyl diphosphate,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB07841,Geranylgeranyl diphosphate,,P14324,Farnesyl pyrophosphate synthase,FDPS,,
DB07841,Geranylgeranyl diphosphate,,Q92696,Geranylgeranyl transferase type-2 subunit alpha,RABGGTA,,
DB07841,Geranylgeranyl diphosphate,,P53611,Geranylgeranyl transferase type-2 subunit beta,RABGGTB,,
DB07842,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07843,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,,P00742,Coagulation factor X,F10,,
DB07844,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,,P00742,Coagulation factor X,F10,,
DB07845,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",,P45983,Mitogen-activated protein kinase 8,MAPK8,,
DB07846,"(3,4,8b-Trimethyl-3-oxido-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-3-ium-7-yl) N-(2-ethylphenyl)carbamate",,P22303,Acetylcholinesterase,ACHE,,
DB07847,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,,P00742,Coagulation factor X,F10,,
DB07848,5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,,P00742,Coagulation factor X,F10,,
DB07849,S-NONYL-CYSTEINE,,P09211,Glutathione S-transferase P,GSTP1,,
DB07850,"(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid",,P00811,Beta-lactamase,ampC,,
DB07851,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB07852,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",,P20248,Cyclin-A2,CCNA2,,
DB07852,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07853,"2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile",,Q9H2G2,STE20-like serine/threonine-protein kinase,SLK,,
DB07853,"2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile",,Q13557,Calcium/calmodulin-dependent protein kinase type II subunit delta,CAMK2D,,
DB07853,"2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile",,Q9P289,Serine/threonine-protein kinase MST4,STK26,,
DB07854,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07854,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07855,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07855,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07856,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07856,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07857,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07857,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07858,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07858,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,,P31751,RAC-beta serine/threonine-protein kinase,AKT2,,
DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB07860,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07860,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07861,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,,P47205,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,lpxC,,
DB07862,"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFRL1,,
DB07863,2-chloro-5-nitro-N-phenylbenzamide,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB07863,2-chloro-5-nitro-N-phenylbenzamide,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB07863,2-chloro-5-nitro-N-phenylbenzamide,,P19793,Retinoic acid receptor RXR-alpha,RXRA,,
DB07864,4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE,,P04585,Gag-Pol polyprotein,gag-pol,,
DB07865,3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one,,Q9L5C8,Beta-lactamase,blaCTX-M-9a,,
DB07866,"(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB07867,6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE,,P04585,Gag-Pol polyprotein,gag-pol,,
DB07868,6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE,,P04585,Gag-Pol polyprotein,gag-pol,,
DB07869,6-Chloro-4-[(R)-cyclohexylsulfinyl]-3-propyl-2(1H)-quinolinone,,P04585,Gag-Pol polyprotein,gag-pol,,
DB07870,Haloxyfop-P,,O00763,Acetyl-CoA carboxylase 2,ACACB,,
DB07871,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,,P04585,Gag-Pol polyprotein,gag-pol,,
DB07872,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,,P00742,Coagulation factor X,F10,,
DB07873,Lauryl alcohol diphosphonic acid,,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB07874,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",,P56817,Beta-secretase 1,BACE1,,
DB07875,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",,P00742,Coagulation factor X,F10,,
DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,,Q13464,Rho-associated protein kinase 1,ROCK1,,
DB07877,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB07877,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB07878,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",,P25774,Cathepsin S,CTSS,,
DB07879,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",,P56524,Histone deacetylase 4,HDAC4,,
DB07880,2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID,,P22629,Streptavidin,,,
DB07881,N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB07882,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",,P01834,Ig kappa chain C region,IGKC,,
DB07883,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB07884,Opaviraline,,P04585,Gag-Pol polyprotein,gag-pol,,
DB07885,Talviraline,,P03366,Gag-Pol polyprotein,gag-pol,,
DB07887,"(R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)benzyl)guanidine",,P03951,Coagulation factor XI,F11,,
DB07888,"3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER",,P14174,Macrophage migration inhibitory factor,MIF,,
DB07889,"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07890,4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID,,P00929,Tryptophan synthase alpha chain,trpA,,
DB07890,4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB07892,1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE,,P04585,Gag-Pol polyprotein,gag-pol,,
DB07893,PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE,,P01834,Ig kappa chain C region,IGKC,,
DB07894,4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID,,P00929,Tryptophan synthase alpha chain,trpA,,
DB07894,4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB07895,ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB07895,ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB07896,(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid,,O52791,4-hydroxymandelate synthase,,,
DB07897,1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE,,P00734,Prothrombin,F2,,
DB07898,"(2R)-3-[(tetrahydroxyphosphoranyl)oxy]-1,2-propanediyl dibutanoate",,P84147,Phospholipase D,,,
DB07899,(2S) N-acetyl-L-alanyl-αL-phenylalanyl-chloroethylketone,,P17538,Chymotrypsinogen B,CTRB1,,
DB07900,3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE,,P22894,Neutrophil collagenase,MMP8,,
DB07901,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,,P53582,Methionine aminopeptidase 1,METAP1,,
DB07902,"TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE",,P53582,Methionine aminopeptidase 1,METAP1,,
DB07903,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",,P53582,Methionine aminopeptidase 1,METAP1,,
DB07905,Hypothemycin,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB07906,"[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB07907,(2S)-2-HYDROXYOCTANOIC ACID,,Q9UJM8,Hydroxyacid oxidase 1,HAO1,,
DB07907,(2S)-2-HYDROXYOCTANOIC ACID,,P20932,(S)-mandelate dehydrogenase,mdlB,,
DB07908,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,,P07737,Profilin-1,PFN1,,
DB07909,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",,Q7Z3Y4,Uncharacterized protein,,,
DB07909,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",,P01857,Ig gamma-1 chain C region,IGHG1,,
DB07909,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",,P01834,Ig kappa chain C region,IGKC,,
DB07910,"(2S)-2-amino-3-phenylpropane-1,1-diol",,P04585,Gag-Pol polyprotein,gag-pol,,
DB07910,"(2S)-2-amino-3-phenylpropane-1,1-diol",,P03369,Gag-Pol polyprotein,gag-pol,,
DB07910,"(2S)-2-amino-3-phenylpropane-1,1-diol",,P04587,Gag-Pol polyprotein,gag-pol,,
DB07911,"(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE",,P47229,"2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",bphD,,
DB07911,"(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE",,P9WNH5,"4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase",hsaD,,
DB07912,2-OXOHEPTYLPHOSPHONIC ACID,,Q9UHY7,Enolase-phosphatase E1,ENOPH1,,
DB07913,HOMOPHENYLALANINYLMETHANE,,Q9UBX1,Cathepsin F,CTSF,,
DB07914,"2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid",,Q59721,Glutathione S-transferase,bphK,,
DB07914,"2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid",,Q0S9X1,"Catechol 2,3-dioxygenase",,,
DB07915,"(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid",,P47229,"2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",bphD,,
DB07916,3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID,,P29466,Caspase-1,CASP1,,
DB07917,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,,O60760,Hematopoietic prostaglandin D synthase,HPGDS,,
DB07918,2-heptyl-4-hydroxyquinoline N-oxide,,P00363,Fumarate reductase flavoprotein subunit,frdA,,
DB07918,2-heptyl-4-hydroxyquinoline N-oxide,,P0AC47,Fumarate reductase iron-sulfur subunit,frdB,,
DB07918,2-heptyl-4-hydroxyquinoline N-oxide,,P0A8Q0,Fumarate reductase subunit C,frdC,,
DB07918,2-heptyl-4-hydroxyquinoline N-oxide,,P0A8Q3,Fumarate reductase subunit D,frdD,,
DB07918,2-heptyl-4-hydroxyquinoline N-oxide,,P24183,"Formate dehydrogenase, nitrate-inducible, major subunit",fdnG,,
DB07918,2-heptyl-4-hydroxyquinoline N-oxide,,P0AAJ3,"Formate dehydrogenase, nitrate-inducible, iron-sulfur subunit",fdnH,,
DB07918,2-heptyl-4-hydroxyquinoline N-oxide,,P0AEK7,"Formate dehydrogenase, nitrate-inducible, cytochrome b556(fdn) subunit",fdnI,,
DB07918,2-heptyl-4-hydroxyquinoline N-oxide,,Q72EF4,NapC/NirT cytochrome c family protein,,,
DB07918,2-heptyl-4-hydroxyquinoline N-oxide,,Q72EF3,"Cytochrome c nitrite reductase, catalytic subunit NfrA, putative",,,
DB07919,Harmine,,P21397,Amine oxidase [flavin-containing] A,MAOA,,
DB07920,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,,P39900,Macrophage metalloelastase,MMP12,,
DB07921,2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide,,P39900,Macrophage metalloelastase,MMP12,,
DB07922,N-oxo-2-(phenylsulfonylamino)ethanamide,,P39900,Macrophage metalloelastase,MMP12,,
DB07923,octyl alpha-L-altropyranoside,,P60844,Aquaporin Z,aqpZ,,
DB07924,octyl beta-D-galactopyranoside,,P60844,Aquaporin Z,aqpZ,,
DB07925,4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID,,P00929,Tryptophan synthase alpha chain,trpA,,
DB07925,4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,,P03956,Interstitial collagenase,MMP1,,
DB07927,3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,,P00811,Beta-lactamase,ampC,,
DB07928,N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE,,P07026,Regulatory protein SdiA,sdiA,,
DB07929,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",,Q13133,Oxysterols receptor LXR-alpha,NR1H3,,
DB07929,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",,P28702,Retinoic acid receptor RXR-beta,RXRB,,
DB07930,(3R)-3-HYDROXYDODECANOIC ACID,,Q15067,Peroxisomal acyl-coenzyme A oxidase 1,ACOX1,,
DB07931,Hexestrol,,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,,
DB07931,Hexestrol,,P03372,Estrogen receptor alpha,ESR1,,
DB07931,Hexestrol,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB07931,Hexestrol,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,,
DB07932,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",,P03372,Estrogen receptor alpha,ESR1,,
DB07932,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB07933,Erteberel,,Q92731,Estrogen receptor beta,ESR2,,
DB07933,Erteberel,,P03372,Estrogen receptor alpha,ESR1,,
DB07934,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,,P00734,Prothrombin,F2,,
DB07935,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",,Q72547,Reverse transcriptase/RNaseH,pol,,
DB07936,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07937,"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",,Q836J0,Glutamate racemase,murI,,
DB07938,(S)-iclaprim,,P0A017,Dihydrofolate reductase,folA,,
DB07939,N-(3-MERCAPTOPROPANOYL)-D-ALANINE,,P52700,Metallo-beta-lactamase L1,,,
DB07940,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",,P06276,Cholinesterase,BCHE,,
DB07941,PH-797804,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07942,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07943,SD-0006,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB07944,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,,P00734,Prothrombin,F2,,
DB07946,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",,P00734,Prothrombin,F2,,
DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,,P31751,RAC-beta serine/threonine-protein kinase,AKT2,,
DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB07949,"({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB07950,Indoleacetic acid,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB07950,Indoleacetic acid,,P63208,S-phase kinase-associated protein 1,SKP1,,
DB07950,Indoleacetic acid,,Q16773,Kynurenine--oxoglutarate transaminase 1,CCBL1,,
DB07951,N-(indole-3-acetyl)-L-aspartic acid,,P00929,Tryptophan synthase alpha chain,trpA,,
DB07951,N-(indole-3-acetyl)-L-aspartic acid,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB07952,N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,,P00929,Tryptophan synthase alpha chain,trpA,,
DB07952,N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB07953,N-[1H-INDOL-3-YL-ACETYL]VALINE ACID,,P00929,Tryptophan synthase alpha chain,trpA,,
DB07953,N-[1H-INDOL-3-YL-ACETYL]VALINE ACID,,P0A2K1,Tryptophan synthase beta chain,trpB,,
DB07954,3-isobutyl-1-methyl-7H-xanthine,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,,
DB07954,3-isobutyl-1-methyl-7H-xanthine,,Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,,
DB07954,3-isobutyl-1-methyl-7H-xanthine,,Q13946,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",PDE7A,,
DB07954,3-isobutyl-1-methyl-7H-xanthine,,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB07954,3-isobutyl-1-methyl-7H-xanthine,,O76083,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",PDE9A,,
DB07954,3-isobutyl-1-methyl-7H-xanthine,,O60658,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",PDE8A,,
DB07954,3-isobutyl-1-methyl-7H-xanthine,,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,,
DB07954,3-isobutyl-1-methyl-7H-xanthine,,P18545,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,,
DB07955,(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE,,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB07956,[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB07957,METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE,,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB07958,(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB07959,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB07960,"5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID",,Q9Y3R4,Sialidase-2,NEU2,,
DB07961,"1-(4-Cyano-phenyl)-3-[2-(2,6-dichloro-phenyl)-1-imino-ethyl]-thiourea",,P03366,Gag-Pol polyprotein,gag-pol,,
DB07964,"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,,
DB07965,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,,P43235,Cathepsin K,CTSK,,
DB07966,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB07967,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,,P43235,Cathepsin K,CTSK,,
DB07968,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,,,"Glycogen phosphorylase, liver form",,,
DB07969,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,,P08581,Hepatocyte growth factor receptor,MET,,
DB07970,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,,Q15375,Ephrin type-A receptor 7,EPHA7,,
DB07971,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",,P9WPN5,Cytochrome P450 130,cyp130,,
DB07972,1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,,P9WPN5,Cytochrome P450 130,cyp130,,
DB07973,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,,P00742,Coagulation factor X,F10,,
DB07974,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,,P00742,Coagulation factor X,F10,,
DB07975,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB07976,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB07977,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB07978,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB07979,"(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID",,P14920,D-amino-acid oxidase,DAO,,
DB07981,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB07982,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB07983,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB07984,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,,P23219,Prostaglandin G/H synthase 1,PTGS1,,
DB07985,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,,P07477,Trypsin-1,PRSS1,,
DB07986,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,,P08254,Stromelysin-1,MMP3,,
DB07987,"[2-(5-Mercapto-[1,3,4]thiadiazol-2-ylcarbamoyl)-1-phenyl-ethyl]-carbamic acid benzyl ester",,P08254,Stromelysin-1,MMP3,,
DB07988,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2yl)-ureido]-N-methyl-3-pentafluorophenyl-propionamide",,P08254,Stromelysin-1,MMP3,,
DB07989,2-(ACETYL-HYDROXY-AMINO)-4-METHYL-PENTANOIC ACID METHYL ESTER,,P00800,Thermolysin,npr,,
DB07990,"(RP,SP)-O-(2R)-(1-PHENOXYBUT-2-YL)-METHYLPHOSPHONIC ACID CHLORIDE",,P22088,Lipase,lipA,,
DB07991,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,,P03372,Estrogen receptor alpha,ESR1,,
DB07993,"N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",,P56817,Beta-secretase 1,BACE1,,
DB07994,"N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",,P56817,Beta-secretase 1,BACE1,,
DB07995,H-89,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07995,H-89,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07995,H-89,,Q8TF76,Serine/threonine-protein kinase haspin,GSG2,,
DB07995,H-89,,P19525,"Interferon-induced, double-stranded RNA-activated protein kinase",EIF2AK2,inhibitor,
DB07996,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07996,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07997,N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB07997,N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB07999,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",,P15121,Aldose reductase,AKR1B1,,
DB08000,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",,P15121,Aldose reductase,AKR1B1,,
DB08001,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB08003,ISOTHIAZOLIDINONE ANALOG,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB08004,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",,Q8TF76,Serine/threonine-protein kinase haspin,GSG2,,
DB08005,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB08006,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB08007,(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID,,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB08008,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB08009,SU-11652,,Q96NX5,Calcium/calmodulin-dependent protein kinase type 1G,CAMK1G,,
DB08010,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB08011,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB08012,Pirodavir,,P03300,Genome polyprotein,,,
DB08012,Pirodavir,,P03302,Genome polyprotein,,,
DB08013,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,,P03302,Genome polyprotein,,,
DB08013,(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,,P03300,Genome polyprotein,,,
DB08014,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,,P03300,Genome polyprotein,,,
DB08014,(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,,P03302,Genome polyprotein,,,
DB08015,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB08016,"4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE",,P9WHE9,"6,7-dimethyl-8-ribityllumazine synthase",ribH,,
DB08017,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,,P03303,Genome polyprotein,,,
DB08017,3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,,P23008,Genome polyprotein,,,
DB08018,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",,P29475,"Nitric oxide synthase, brain",NOS1,,
DB08018,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB08019,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",,P29475,"Nitric oxide synthase, brain",NOS1,,
DB08019,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",,P29474,"Nitric oxide synthase, endothelial",NOS3,,
DB08020,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",,Q92731,Estrogen receptor beta,ESR2,,
DB08020,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",,P03372,Estrogen receptor alpha,ESR1,,
DB08021,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB08022,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB08023,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB08024,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08025,"N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB08026,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB08027,CAP-1,,P12497,Gag-Pol polyprotein,gag-pol,,
DB08028,"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",,P22894,Neutrophil collagenase,MMP8,,
DB08029,N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide,,P08254,Stromelysin-1,MMP3,,
DB08030,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,,P08254,Stromelysin-1,MMP3,,
DB08031,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",,P26663,Genome polyprotein,,,
DB08032,"N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",,P52732,Kinesin-like protein KIF11,KIF11,,
DB08033,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",,P52732,Kinesin-like protein KIF11,KIF11,,
DB08034,"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",,P03366,Gag-Pol polyprotein,gag-pol,,
DB08035,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",,P10275,Androgen receptor,AR,,
DB08036,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",,Q8KI25,Putative FAD-monooxygenase,rbmD,,
DB08037,MK-0731,,P52732,Kinesin-like protein KIF11,KIF11,,
DB08038,"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",,P49862,Kallikrein-7,KLK7,,
DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",,P0DP23,Calmodulin,CALM1,,
DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",,Q13557,Calcium/calmodulin-dependent protein kinase type II subunit delta,CAMK2D,,
DB08040,Kelatorphan,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB08041,3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,,P03367,Gag-Pol polyprotein,gag-pol,,
DB08042,"N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB08043,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,,P00519,Tyrosine-protein kinase ABL1,ABL1,,
DB08044,ABT-341,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08045,"4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL",,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB08046,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,,P00918,Carbonic anhydrase 2,CA2,,
DB08047,"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",,P03372,Estrogen receptor alpha,ESR1,,
DB08047,"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB08048,"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",,P03372,Estrogen receptor alpha,ESR1,,
DB08048,"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB08049,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",,P21964,Catechol O-methyltransferase,COMT,,
DB08050,5-phenyl-2-keto-valeric acid,,P51852,Indole-3-pyruvate decarboxylase,ipdC,,
DB08051,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08052,PP-121,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB08053,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB08054,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB08055,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",,P06239,Tyrosine-protein kinase Lck,LCK,,
DB08056,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",,P06239,Tyrosine-protein kinase Lck,LCK,,
DB08057,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",,P06239,Tyrosine-protein kinase Lck,LCK,,
DB08058,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",,Q9Y6F1,Poly [ADP-ribose] polymerase 3,PARP3,,
DB08059,Wortmannin,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB08059,Wortmannin,,P53350,Serine/threonine-protein kinase PLK1,PLK1,,
DB08059,Wortmannin,,P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,,
DB08059,Wortmannin,,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,,
DB08060,4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID,,P21549,Serine--pyruvate aminotransferase,AGXT,,
DB08061,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,,P00734,Prothrombin,F2,,
DB08062,"3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE",,P00734,Prothrombin,F2,,
DB08063,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",,P19793,Retinoic acid receptor RXR-alpha,RXRA,,
DB08063,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",,Q13133,Oxysterols receptor LXR-alpha,NR1H3,,
DB08064,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08065,2-(1H-pyrazol-3-yl)-1H-benzimidazole,,O14965,Aurora kinase A,AURKA,,
DB08066,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,,O14965,Aurora kinase A,AURKA,,
DB08066,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08067,4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM,,O60674,Tyrosine-protein kinase JAK2,JAK2,,
DB08068,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08069,"4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE",,P52700,Metallo-beta-lactamase L1,,,
DB08070,2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08070,2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08071,"(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine",,P9WQ77,Probable L-lysine-epsilon aminotransferase,lat,,
DB08072,"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,,P31751,RAC-beta serine/threonine-protein kinase,AKT2,,
DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08074,3-(3-Methyl-2-buten-1-yl)-3H-purin-6-amine,,P24182,Biotin carboxylase,accC,,
DB08075,"4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine",,P24182,Biotin carboxylase,accC,,
DB08076,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",,P24182,Biotin carboxylase,accC,,
DB08077,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",,P69905,Hemoglobin subunit alpha,HBA1,,
DB08077,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",,P68871,Hemoglobin subunit beta,HBB,,
DB08078,{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB08079,AMG-208,,P08581,Hepatocyte growth factor receptor,MET,inhibitor,
DB08080,Latrunculin B,,P68133,"Actin, alpha skeletal muscle",ACTA1,,
DB08080,Latrunculin B,,Q969V6,MKL/myocardin-like protein 1,MKL1,,
DB08080,Latrunculin B,,Q8WWL2,Protein spire homolog 2,SPIRE2,,
DB08081,3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,,P33905,Transcriptional activator protein TraR,traR,,
DB08081,3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,,P55407,Probable transcriptional activator protein TraR,traR,,
DB08081,3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,,P55408,Probable transcriptional repressor TraM,traM,,
DB08082,N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE,,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB08083,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",,P00918,Carbonic anhydrase 2,CA2,,
DB08084,IDD594,,P15121,Aldose reductase,AKR1B1,,
DB08085,1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE,,P10828,Thyroid hormone receptor beta,THRB,,
DB08086,N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine,,P14779,Bifunctional P-450/NADPH-P450 reductase,cyp102A1,,
DB08087,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",,P10275,Androgen receptor,AR,,
DB08088,"2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile",,P10275,Androgen receptor,AR,,
DB08089,LGD-2226,,P10275,Androgen receptor,AR,,
DB08090,"(3Z,5S,6R,7S,8R,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol",,Q08638,Beta-glucosidase A,bglA,,
DB08091,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08092,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08093,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08094,RO-4584820,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08095,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08096,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08097,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08098,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",,P15121,Aldose reductase,AKR1B1,,
DB08099,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",,P00797,Renin,REN,,
DB08105,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,murD,,
DB08106,N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,murD,,
DB08107,N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,murD,,
DB08108,N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,murD,,
DB08109,"(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",,P05364,Beta-lactamase,ampC,,
DB08110,"(1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",,P05364,Beta-lactamase,ampC,,
DB08111,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",,Q59EB3,Met proto-oncogene variant,,,
DB08112,N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,,P14900,UDP-N-acetylmuramoylalanine--D-glutamate ligase,murD,,
DB08113,3-pyridin-4-yl-1H-indazole,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08113,3-pyridin-4-yl-1H-indazole,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08114,"5-benzyl-1,3-thiazol-2-amine",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08114,"5-benzyl-1,3-thiazol-2-amine",,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08115,2-aminoethyl naphthalen-1-ylacetate,,P04587,Gag-Pol polyprotein,gag-pol,,
DB08116,"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",,P0AD64,Beta-lactamase SHV-1,bla,,
DB08118,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",,P35557,Glucokinase,GCK,,
DB08119,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",,P17538,Chymotrypsinogen B,CTRB1,,
DB08120,"6,8-DIMERCAPTO-OCTANOIC ACID AMIDE",,P10802,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex,,,
DB08121,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB08122,"N-Methyl-4-{[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}benzenesulfonamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08123,"N-methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08124,"3-{[(2,2-dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5-(1,3-oxazol-5-yl)-1,3-dihydro-2H-indol-2-one",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08125,"4-{[(2-Oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}-N-(1,3-thiazol-2-yl)benzenesulfonamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08126,"3-{[4-([amino(imino)methyl]aminosulfonyl)anilino]methylene}-2-oxo-2,3-dihydro-1H-indole",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08128,"(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB08129,(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol,,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB08130,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,,
DB08131,"2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID",,P0A884,Thymidylate synthase,thyA,,
DB08132,5-hydroxynaphthalene-1-sulfonamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08133,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08134,4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08135,N-phenyl-1H-pyrazole-3-carboxamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08136,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08137,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08138,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08139,"5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08140,"5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08141,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08142,AT-7519,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08142,AT-7519,,P06493,Cyclin-dependent kinase 1,CDK1,,
DB08143,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",,P00742,Coagulation factor X,F10,,
DB08144,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",,P24182,Biotin carboxylase,accC,,
DB08145,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",,P24182,Biotin carboxylase,accC,,
DB08146,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",,P24182,Biotin carboxylase,accC,,
DB08147,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB08148,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08148,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08149,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08149,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08150,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08150,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08151,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB08152,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,,P00734,Prothrombin,F2,,
DB08153,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB08154,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08155,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,,P00915,Carbonic anhydrase 1,CA1,,
DB08155,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,,P00918,Carbonic anhydrase 2,CA2,,
DB08156,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,,P00915,Carbonic anhydrase 1,CA1,,
DB08156,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,,P00918,Carbonic anhydrase 2,CA2,,
DB08157,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,,P00915,Carbonic anhydrase 1,CA1,,
DB08157,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,,P00918,Carbonic anhydrase 2,CA2,,
DB08158,"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",,Q8AAK6,Beta-mannosidase,,,
DB08159,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",,P11387,DNA topoisomerase 1,TOP1,,
DB08160,"(2S)-2-AMINO-4-(METHYLSULFANYL)-1-(1,3-THIAZOL-2-YL)BUTANE-1,1-DIOL",,P0A078,Methionine aminopeptidase,map,,
DB08161,(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID,,Q7BJM5,Class B carbapenemase VIM-2,VIM-2,,
DB08162,Fasudil,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,C04AX32
DB08162,Fasudil,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,C04AX32
DB08162,Fasudil,,Q13464,Rho-associated protein kinase 1,ROCK1,,C04AX32
DB08162,Fasudil,,O75116,Rho-associated protein kinase 2,ROCK2,,C04AX32
DB08163,5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,,P17707,S-adenosylmethionine decarboxylase proenzyme,AMD1,,
DB08164,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08165,indane-5-sulfonamide,,P00918,Carbonic anhydrase 2,CA2,,
DB08166,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB08167,Methylthioninium,,P22303,Acetylcholinesterase,ACHE,,
DB08167,Methylthioninium,,Q8NMG3,"Bacterial regulatory protein, TetR family",,,
DB08168,Coumarin 120,,P0AFL3,Peptidyl-prolyl cis-trans isomerase A,ppiA,,
DB08168,Coumarin 120,,P30405,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,,
DB08168,Coumarin 120,,Q9BY41,Histone deacetylase 8,HDAC8,,
DB08169,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB08170,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",,P09237,Matrilysin,MMP7,,
DB08171,11-MERCAPTOUNDECANOIC ACID,,P9WNG3,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB08172,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB08173,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,,P00742,Coagulation factor X,F10,,
DB08174,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",,P00742,Coagulation factor X,F10,,
DB08175,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB08175,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",,P28702,Retinoic acid receptor RXR-beta,RXRB,,
DB08175,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",,Q13133,Oxysterols receptor LXR-alpha,NR1H3,,
DB08176,(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE,,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB08177,(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,,P15917,Lethal factor,lef,,
DB08178,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08178,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",,P20248,Cyclin-A2,CCNA2,,
DB08179,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",,Q04760,Lactoylglutathione lyase,GLO1,,
DB08180,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB08180,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,,P53609,Geranylgeranyl transferase type-1 subunit beta,PGGT1B,,
DB08181,2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID,,P22629,Streptavidin,,,
DB08182,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08182,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",,P20248,Cyclin-A2,CCNA2,,
DB08184,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,,P07477,Trypsin-1,PRSS1,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,Q01698,Elongation factor Tu,tuf,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,Q5SHN3,30S ribosomal protein S12,rpsL,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,Q5SHN7,30S ribosomal protein S10,rpsJ,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P80376,30S ribosomal protein S11,rpsK,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P80377,30S ribosomal protein S13,rpsM,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P0DOY6,30S ribosomal protein S14 type Z,rpsZ,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,Q5SJ76,30S ribosomal protein S15,rpsO,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,Q5SJH3,30S ribosomal protein S16,rpsP,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P0DOY7,30S ribosomal protein S17,rpsQ,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,Q5SLQ0,30S ribosomal protein S18,rpsR,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,Q5SHP2,30S ribosomal protein S19,rpsS,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P80380,30S ribosomal protein S20,rpsT,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P80373,30S ribosomal protein S4,rpsD,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,Q5SHQ5,30S ribosomal protein S5,rpsE,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,Q5SLP8,30S ribosomal protein S6,rpsF,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P17291,30S ribosomal protein S7,rpsG,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P0DOY9,30S ribosomal protein S8,rpsH,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P80374,30S ribosomal protein S9,rpsI,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,Q5SIH3,30S ribosomal protein Thx,rpsU,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P62658,30S ribosomal protein S17,rpsQ,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P62661,30S ribosomal protein S20,rpsT,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P62662,30S ribosomal protein S2,rpsB,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P62663,30S ribosomal protein S3,rpsC,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P62669,30S ribosomal protein S9,rpsI,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P62660,30S ribosomal protein S19,rpsS,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P80371,30S ribosomal protein S2,rpsB,,
DB08185,2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,P80372,30S ribosomal protein S3,rpsC,,
DB08186,(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE,,Q92831,Histone acetyltransferase KAT2B,KAT2B,,
DB08187,N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide,,P00734,Prothrombin,F2,,
DB08188,Emivirine,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08190,N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,
DB08191,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",,O00141,Serine/threonine-protein kinase Sgk1,SGK1,,
DB08192,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB08193,2-(3-NITROPHENYL)ACETIC ACID,,P06875,Penicillin G acylase,pac,,
DB08194,"4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB08195,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,,P25774,Cathepsin S,CTSS,,
DB08196,"2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",,P22629,Streptavidin,,,
DB08197,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB08198,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",,P52732,Kinesin-like protein KIF11,KIF11,,
DB08199,N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE,,P52700,Metallo-beta-lactamase L1,,,
DB08200,(1R)-menthyl hexyl phosphonate group,,P06276,Cholinesterase,BCHE,,
DB08201,(1S)-menthyl hexyl phosphonate group,,P06276,Cholinesterase,BCHE,,
DB08202,4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE,,P00918,Carbonic anhydrase 2,CA2,,
DB08203,"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE",,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFRL1,,
DB08204,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,,P00469,Thymidylate synthase,thyA,,
DB08208,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,,
DB08209,Methyl red,,Q9I5F3,FMN-dependent NADH-azoreductase 1,azoR1,,
DB08210,"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE",,P35557,Glucokinase,GCK,,
DB08211,5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08212,1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,,P03366,Gag-Pol polyprotein,gag-pol,,
DB08213,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",,P42574,Caspase-3,CASP3,,
DB08214,4-(1H-IMIDAZOL-1-YL)PHENOL,,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB08215,Terbutryn,,P07173,Photosynthetic reaction center cytochrome c subunit,pufC,,
DB08215,Terbutryn,,P06008,Reaction center protein H chain,puhA,,
DB08215,Terbutryn,,P06009,Reaction center protein L chain,pufL,,
DB08215,Terbutryn,,P06010,Reaction center protein M chain,pufM,,
DB08215,Terbutryn,,P0C0Y8,Reaction center protein L chain,pufL,,
DB08215,Terbutryn,,P0C0Y9,Reaction center protein M chain,pufM,,
DB08215,Terbutryn,,P0C0Y7,Reaction center protein H chain,puhA,,
DB08216,2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID,,P22629,Streptavidin,,,
DB08217,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",,P06730,Eukaryotic translation initiation factor 4E,EIF4E,,
DB08217,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",,O06796,Uncharacterized protein,,,
DB08217,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",,P06731,Carcinoembryonic antigen-related cell adhesion molecule 5,CEACAM5,,
DB08217,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",,Q57254,Afimbrial adhesin AFA-III,afaE3,,
DB08218,"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",,P20248,Cyclin-A2,CCNA2,,
DB08218,"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08219,"4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine",,P20248,Cyclin-A2,CCNA2,,
DB08219,"4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08220,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB08220,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",,Q96RI1,Bile acid receptor,NR1H4,,
DB08221,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,,Q02763,Angiopoietin-1 receptor,TEK,,
DB08222,METHOXYUNDECYLPHOSPHINIC ACID,,P04118,Colipase,CLPS,,
DB08222,METHOXYUNDECYLPHOSPHINIC ACID,,P16233,Pancreatic triacylglycerol lipase,PNLIP,,
DB08224,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",,P23141,Liver carboxylesterase 1,CES1,,
DB08226,Myxopyronin B,,Q9Z9H6,DNA-directed RNA polymerase subunit alpha,rpoA,,
DB08226,Myxopyronin B,,Q8RQE9,DNA-directed RNA polymerase subunit beta,rpoB,,
DB08226,Myxopyronin B,,Q8RQE8,DNA-directed RNA polymerase subunit beta',rpoC,,
DB08226,Myxopyronin B,,Q8RQE7,DNA-directed RNA polymerase subunit omega,rpoZ,,
DB08226,Myxopyronin B,,Q5SKW1,RNA polymerase sigma factor,sigA,,
DB08227,"1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE",,P0AEX9,Maltose-binding periplasmic protein,malE,,
DB08228,"5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one",,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,
DB08229,[N-(3-dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid,,P42574,Caspase-3,CASP3,,
DB08230,Tricetin,,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB08231,Myristic acid,,P03300,Genome polyprotein,,,
DB08231,Myristic acid,,Q82122,Genome polyprotein,,,
DB08231,Myristic acid,,P23008,Genome polyprotein,,,
DB08231,Myristic acid,,P12915,Genome polyprotein,,,
DB08231,Myristic acid,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08231,Myristic acid,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08231,Myristic acid,,Q66282,Genome polyprotein,,,
DB08231,Myristic acid,,P21404,Genome polyprotein,,,
DB08231,Myristic acid,,P06210,Genome polyprotein,,,
DB08231,Myristic acid,,O91734,Genome polyprotein,,,
DB08231,Myristic acid,,P29813,Genome polyprotein,,,
DB08231,Myristic acid,,P0A8V6,Fatty acid metabolism regulator protein,fadR,,
DB08231,Myristic acid,,O75521,"Enoyl-CoA delta isomerase 2, mitochondrial",ECI2,,
DB08231,Myristic acid,,P35243,Recoverin,RCVRN,,
DB08231,Myristic acid,,P0DP23,Calmodulin,CALM1,,
DB08231,Myristic acid,,P09142,Non-fluorescent flavoprotein,luxF,,
DB08231,Myristic acid,,P13900,Genome polyprotein,,,
DB08231,Myristic acid,,P00519,Tyrosine-protein kinase ABL1,ABL1,,
DB08231,Myristic acid,,O67648,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,lpxC,,
DB08231,Myristic acid,,P03302,Genome polyprotein,,,
DB08231,Myristic acid,,P41235,Hepatocyte nuclear factor 4-alpha,HNF4A,,
DB08231,Myristic acid,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB08231,Myristic acid,,P04324,Protein Nef,nef,,
DB08231,Myristic acid,,P06971,Ferrichrome-iron receptor,fhuA,,
DB08231,Myristic acid,,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB08231,Myristic acid,,P63098,Calcineurin subunit B type 1,PPP3R1,,
DB08231,Myristic acid,,Q08209,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,PPP3CA,,
DB08231,Myristic acid,,P9WPF1,Alpha-pyrone synthesis polyketide synthase-like Pks18,pks18,,
DB08231,Myristic acid,,P12497,Gag-Pol polyprotein,gag-pol,,
DB08231,Myristic acid,,O43617,Trafficking protein particle complex subunit 3,TRAPPC3,,
DB08231,Myristic acid,,P01308,Insulin,INS,,
DB08231,Myristic acid,,P22055,Genome polyprotein,,,
DB08231,Myristic acid,,Q71LY2,Polyprotein,,,
DB08231,Myristic acid,,P17900,Ganglioside GM2 activator,GM2A,,
DB08231,Myristic acid,,P62330,ADP-ribosylation factor 6,ARF6,,
DB08231,Myristic acid,,Q9Y6Y9,Lymphocyte antigen 96,LY96,,
DB08231,Myristic acid,,P02929,Protein TonB,tonB,,
DB08231,Myristic acid,,Q72497,Gag polyprotein,gag,,
DB08231,Myristic acid,,P04584,Gag-Pol polyprotein,gag-pol,,
DB08231,Myristic acid,,P84077,ADP-ribosylation factor 1,ARF1,,
DB08231,Myristic acid,,P43080,Guanylyl cyclase-activating protein 1,GUCA1A,,
DB08231,Myristic acid,,P9WH69,R2-like ligand binding oxidase,nrdB,,
DB08231,Myristic acid,,P15151,Poliovirus receptor,PVR,,
DB08231,Myristic acid,,O00206,Toll-like receptor 4,TLR4,,
DB08231,Myristic acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB08232,"[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid",,P08709,Coagulation factor VII,F7,,
DB08232,"[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid",,P13726,Tissue factor,F3,,
DB08233,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,,P20248,Cyclin-A2,CCNA2,,
DB08233,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08234,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",,Q81R22,Dihydrofolate reductase,dfrA,,
DB08234,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",,P00374,Dihydrofolate reductase,DHFR,,
DB08234,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",,A0A0M3KKX1,Dihydrofolate reductase (dfrB),dfrB,,
DB08234,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",,P0A017,Dihydrofolate reductase,folA,,
DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,O15143,Actin-related protein 2/3 complex subunit 1B,ARPC1B,,
DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,P61160,Actin-related protein 2,ACTR2,,
DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,P61158,Actin-related protein 3,ACTR3,,
DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,O15144,Actin-related protein 2/3 complex subunit 2,ARPC2,,
DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,O15145,Actin-related protein 2/3 complex subunit 3,ARPC3,,
DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,P59998,Actin-related protein 2/3 complex subunit 4,ARPC4,,
DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,O15511,Actin-related protein 2/3 complex subunit 5,ARPC5,,
DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,O15143,Actin-related protein 2/3 complex subunit 1B,ARPC1B,,
DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,P61160,Actin-related protein 2,ACTR2,,
DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,P61158,Actin-related protein 3,ACTR3,,
DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,O15144,Actin-related protein 2/3 complex subunit 2,ARPC2,,
DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,O15145,Actin-related protein 2/3 complex subunit 3,ARPC3,,
DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,P59998,Actin-related protein 2/3 complex subunit 4,ARPC4,,
DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,O15511,Actin-related protein 2/3 complex subunit 5,ARPC5,,
DB08237,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),,Q9UBT6,DNA polymerase kappa,POLK,,
DB08238,5-aminonaphthalene-2-sulfonic acid,,P05230,Fibroblast growth factor 1,FGF1,,
DB08239,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",,P52732,Kinesin-like protein KIF11,KIF11,,
DB08240,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,,P04075,Fructose-bisphosphate aldolase A,ALDOA,,
DB08241,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,,P20248,Cyclin-A2,CCNA2,,
DB08241,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08242,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08244,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",,P52732,Kinesin-like protein KIF11,KIF11,,
DB08245,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,,Q38087,DNA polymerase,43,,
DB08246,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",,P52732,Kinesin-like protein KIF11,KIF11,,
DB08247,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08248,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,,P20248,Cyclin-A2,CCNA2,,
DB08248,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08249,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,,
DB08249,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",,P28793,Fatty acid oxidation complex subunit alpha,fadB,,
DB08249,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",,P28790,3-ketoacyl-CoA thiolase,fadA,,
DB08249,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",,P48632,Ferripyoverdine receptor,fpvA,,
DB08250,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",,P52732,Kinesin-like protein KIF11,KIF11,,
DB08251,4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID,,P42574,Caspase-3,CASP3,,
DB08252,2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID,,P22629,Streptavidin,,,
DB08253,NAM NAPTHYLAMINOALANINE,,P16088,Pol polyprotein,pol,,
DB08254,2-Naphthalenesulfonic acid,,P00734,Prothrombin,F2,,
DB08254,2-Naphthalenesulfonic acid,,P07477,Trypsin-1,PRSS1,,
DB08255,"(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL",,Q89ZI2,O-GlcNAcase BT_4395,,,
DB08256,N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE,,P34913,Bifunctional epoxide hydrolase 2,EPHX2,,
DB08257,4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID,,P34913,Bifunctional epoxide hydrolase 2,EPHX2,,
DB08258,6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID,,P34913,Bifunctional epoxide hydrolase 2,EPHX2,,
DB08259,7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID,,P34913,Bifunctional epoxide hydrolase 2,EPHX2,,
DB08260,"(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide",,Q08638,Beta-glucosidase A,bglA,,
DB08261,"2-hydroxy-7-methoxy-5-methyl-naphthalene-1-carboxylic acid meso-2,5-dihydroxy-cyclopent-3-enyl ester",,P0A3R9,Neocarzinostatin,ncsA,,
DB08262,"2,6-dicarboxynaphthalene",,P69905,Hemoglobin subunit alpha,HBA1,,
DB08262,"2,6-dicarboxynaphthalene",,P68871,Hemoglobin subunit beta,HBB,,
DB08263,N-(carboxycarbonyl)-D-phenylalanine,,Q9NWT6,Hypoxia-inducible factor 1-alpha inhibitor,HIF1AN,,
DB08264,"(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene",,P0A110,"Naphthalene 1,2-dioxygenase subunit alpha",ndoB,,
DB08264,"(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene",,P0A112,"Naphthalene 1,2-dioxygenase subunit beta",ndoC,,
DB08265,"2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL",,P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,
DB08266,"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",,Q5SHR6,DNA-directed RNA polymerase subunit alpha,rpoA,,
DB08266,"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",,Q8RQE9,DNA-directed RNA polymerase subunit beta,rpoB,,
DB08266,"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",,Q8RQE8,DNA-directed RNA polymerase subunit beta',rpoC,,
DB08266,"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",,Q8RQE7,DNA-directed RNA polymerase subunit omega,rpoZ,,
DB08266,"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",,Q5SKW1,RNA polymerase sigma factor,sigA,,
DB08267,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB08268,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB08270,"N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",,P43235,Cathepsin K,CTSK,,
DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,,P09238,Stromelysin-2,MMP10,,
DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,,P39900,Macrophage metalloelastase,MMP12,,
DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,,P08254,Stromelysin-1,MMP3,,
DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,,O60882,Matrix metalloproteinase-20,MMP20,,
DB08272,(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,,Q9A1B7,Glutamate racemase,murI,,
DB08273,4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,,P23083,Ig heavy chain V-I region ND,IGHV1-2,,
DB08273,4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,,P04211,Ig lambda chain V region 4A,,,
DB08274,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",,P04584,Gag-Pol polyprotein,gag-pol,,
DB08275,N-DODECANOYL-L-TYROSINE,,Q8KNZ7,Long-chain N-acyl amino acid synthase,,,
DB08276,trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-),,Q7Z406,Myosin-14,MYH14,,
DB08277,"2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB08278,"1-(2-cyclopropylethyl)-3-(1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl)-6-fluoro-4-hydroxy-2(1H)-quinolinone",,P26663,Genome polyprotein,,,
DB08279,3-{ISOPROPYL[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]AMINO}-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,,P26663,Genome polyprotein,,,
DB08280,"(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB08281,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",,P03366,Gag-Pol polyprotein,gag-pol,,
DB08282,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",,P03366,Gag-Pol polyprotein,gag-pol,,
DB08283,"(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL",,P04062,Glucosylceramidase,GBA,,
DB08284,"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate",,P03366,Gag-Pol polyprotein,gag-pol,,
DB08285,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08285,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",,P20248,Cyclin-A2,CCNA2,,
DB08286,1-Naphthoxyacetic acid,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08286,1-Naphthoxyacetic acid,,P04584,Gag-Pol polyprotein,gag-pol,,
DB08287,"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide",,P43235,Cathepsin K,CTSK,,
DB08289,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,,P01834,Ig kappa chain C region,IGKC,,
DB08291,N-(3-AMINOPROPYL)-2-NITROBENZENAMINE,,Q92831,Histone acetyltransferase KAT2B,KAT2B,,
DB08292,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB08293,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB08294,2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,,P23083,Ig heavy chain V-I region ND,IGHV1-2,,
DB08294,2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB08295,4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,,P23083,Ig heavy chain V-I region ND,IGHV1-2,,
DB08295,4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,,P04211,Ig lambda chain V region 4A,,,
DB08296,5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB08297,ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,,P03023,Lactose operon repressor,lacI,,
DB08299,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,,
DB08299,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,,
DB08299,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,,
DB08300,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,,
DB08301,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,,P00918,Carbonic anhydrase 2,CA2,,
DB08302,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB08303,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",,P42262,Glutamate receptor 2,GRIA2,,
DB08304,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",,P42262,Glutamate receptor 2,GRIA2,,
DB08305,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",,P42262,Glutamate receptor 2,GRIA2,,
DB08306,3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid,,P00811,Beta-lactamase,ampC,,
DB08307,"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",,Q53586,4-hydroxyphenylpyruvate dioxygenase,hpd,,
DB08308,"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",,P00947,Steroid Delta-isomerase,ksi,,
DB08309,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08309,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,,P20248,Cyclin-A2,CCNA2,,
DB08310,"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",,P9WIJ3,Peptide deformylase,def,,
DB08312,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08313,Nocodazole,,O60760,Hematopoietic prostaglandin D synthase,HPGDS,,
DB08314,"(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE",,P24182,Biotin carboxylase,accC,,
DB08315,"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",,P24182,Biotin carboxylase,accC,,
DB08316,"4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one",,P24182,Biotin carboxylase,accC,,
DB08317,"5-methyl-6-phenylquinazoline-2,4-diamine",,P24182,Biotin carboxylase,accC,,
DB08318,"6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine",,P24182,Biotin carboxylase,accC,,
DB08319,"2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID",,P54997,2'-hydroxybiphenyl-2-sulfinate desulfinase,soxB,,
DB08320,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",,P03372,Estrogen receptor alpha,ESR1,,
DB08320,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB08321,"(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol",,Q16706,Alpha-mannosidase 2,MAN2A1,,
DB08322,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB08323,3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE,,P01859,Ig gamma-2 chain C region,IGHG2,,
DB08324,N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE,,P25084,Transcriptional activator protein LasR,lasR,,
DB08325,2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol,,Q9HCP0,Casein kinase I isoform gamma-1,CSNK1G1,,
DB08325,2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol,,Q12866,Tyrosine-protein kinase Mer,MERTK,,
DB08326,"2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE",,Q96GR2,Long-chain-fatty-acid--CoA ligase ACSBG1,ACSBG1,,
DB08327,Homogentisic acid,,P06875,Penicillin G acylase,pac,,
DB08328,PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID,,P07097,Acetyl-CoA acetyltransferase,phbA,,
DB08329,Sulthiame,,P00918,Carbonic anhydrase 2,CA2,,N03AX03;G01AE10
DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,,
DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,P00156,Cytochrome b,MT-CYB,,
DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,,
DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,,
DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,,
DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,,
DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,,
DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,,
DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,,
DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,,
DB08331,"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",,P03355,Gag-Pol polyprotein,gag-pol,,
DB08332,9-(2-carboxyethyl)-10-methylanthracene endoperoxide,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB08333,4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,,P14174,Macrophage migration inhibitory factor,MIF,,
DB08334,3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,,P14174,Macrophage migration inhibitory factor,MIF,,
DB08335,"4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME",,P14174,Macrophage migration inhibitory factor,MIF,,
DB08336,"2-Methyl-2-propanyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate",,P00811,Beta-lactamase,ampC,,
DB08337,"2-Methyl-2-propanyl [(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate",,P00811,Beta-lactamase,ampC,,
DB08338,"19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB08339,PD-166326,,P00519,Tyrosine-protein kinase ABL1,ABL1,,
DB08340,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB08341,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",,Q14289,Protein-tyrosine kinase 2-beta,PTK2B,,
DB08342,S-palmitoyl-L-cysteine,,O75865,Trafficking protein particle complex subunit 6A,TRAPPC6A,,
DB08342,S-palmitoyl-L-cysteine,,O43617,Trafficking protein particle complex subunit 3,TRAPPC3,,
DB08342,S-palmitoyl-L-cysteine,,Q86SZ2,Trafficking protein particle complex subunit 6B,TRAPPC6B,,
DB08342,S-palmitoyl-L-cysteine,,Q8IUR0,Trafficking protein particle complex subunit 5,TRAPPC5,,
DB08342,S-palmitoyl-L-cysteine,,Q9Y296,Trafficking protein particle complex subunit 4,TRAPPC4,,
DB08342,S-palmitoyl-L-cysteine,,Q9Y5R8,Trafficking protein particle complex subunit 1,TRAPPC1,,
DB08344,4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,,P43889,Bifunctional protein GlmU,glmU,,
DB08345,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB08346,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB08347,4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,,P08588,Beta-1 adrenergic receptor,ADRB1,,
DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,P11439,Exotoxin A,eta,,
DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,P13639,Elongation factor 2,EEF2,,
DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,Q5EK40,Cholix toxin,chxA,,
DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,Q9Y6F1,Poly [ADP-ribose] polymerase 3,PARP3,,
DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,Q460N3,Poly [ADP-ribose] polymerase 15,PARP15,,
DB08349,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08350,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",,P00519,Tyrosine-protein kinase ABL1,ABL1,,
DB08351,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08352,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08353,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB08354,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB08355,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",,P20248,Cyclin-A2,CCNA2,,
DB08355,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08356,"4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol",,Q16654,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial",PDK4,,
DB08357,Diethylene glycol diethyl ether,,P22303,Acetylcholinesterase,ACHE,,
DB08357,Diethylene glycol diethyl ether,,P40406,Uncharacterized lipoprotein YbbD,nagZ,,
DB08357,Diethylene glycol diethyl ether,,Q6FEW8,Phosphoenolpyruvate-protein phosphotransferase,ptsP,,
DB08358,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,,
DB08358,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",,Q16644,MAP kinase-activated protein kinase 3,MAPKAPK3,,
DB08359,2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE,,P0A953,3-oxoacyl-[acyl-carrier-protein] synthase 1,fabB,,
DB08360,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB08361,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",,P43405,Tyrosine-protein kinase SYK,SYK,,
DB08362,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB08363,1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,,P04637,Cellular tumor antigen p53,TP53,,
DB08364,1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE,,Q9KM65,CAI-1 autoinducer synthase,cqsA,,
DB08365,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",,P30291,Wee1-like protein kinase,WEE1,,
DB08366,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",,P0AAI5,3-oxoacyl-[acyl-carrier-protein] synthase 2,fabF,,
DB08367,(R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE,,P44783,Rhomboid protease GlpG,glpG,,
DB08368,"OCTANE-1,3,5,7-TETRACARBOXYLIC ACID",,P15085,Carboxypeptidase A1,CPA1,,
DB08369,1-(biphenyl-4-ylmethyl)-1H-imidazole,,P20813,Cytochrome P450 2B6,CYP2B6,,
DB08370,S-(4-BROMOBENZYL)CYSTEINE,,P09211,Glutathione S-transferase P,GSTP1,,
DB08371,p-Benzoyl-L-phenylalanine,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB08371,p-Benzoyl-L-phenylalanine,,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,,
DB08372,1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,,P03366,Gag-Pol polyprotein,gag-pol,,
DB08372,1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08373,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",,P11684,Uteroglobin,SCGB1A1,,
DB08374,Phenylalanylmethylchloride,,P17538,Chymotrypsinogen B,CTRB1,,
DB08375,"(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid",,Q8DR59,Penicillin-binding protein 1A,pbpA,,
DB08375,"(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid",,Q47066,Beta-lactamase Toho-1,bla,,
DB08375,"(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid",,P00811,Beta-lactamase,ampC,,
DB08376,"(2R)-3-(phosphonooxy)propane-1,2-diyl diheptanoate",,Q53728,Phospholipase D,,,
DB08377,N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB08378,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",,P14649,Myosin light chain 6B,MYL6B,,
DB08378,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",,P19105,Myosin regulatory light chain 12A,MYL12A,,
DB08378,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",,P12883,Myosin-7,MYH7,,
DB08379,6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08382,Gosogliptin,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08383,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,,
DB08384,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,,
DB08385,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,,O00519,Fatty-acid amide hydrolase 1,FAAH,,
DB08386,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,,
DB08387,Mardepodect,,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,,
DB08388,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",,P45452,Collagenase 3,MMP13,,
DB08389,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,,
DB08390,"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",,P26663,Genome polyprotein,,,
DB08391,PQ-10,,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,,
DB08392,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB08393,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB08394,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB08395,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08396,"4-{[(Z)-(5-oxo-2-phenyl-1,3-oxazol-4(5H)-ylidene)methyl]amino}butanoic acid",,P01768,Ig heavy chain V-III region CAM,IGHV3-30,,
DB08397,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB08398,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,P03372,Estrogen receptor alpha,ESR1,,
DB08398,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB08399,Piceatannol,,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,,
DB08399,Piceatannol,,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,,
DB08399,Piceatannol,,P36542,"ATP synthase subunit gamma, mitochondrial",ATP5C1,,
DB08400,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,,O00519,Fatty-acid amide hydrolase 1,FAAH,,
DB08401,(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID,,O70038,Penicillin-binding protein 1B,pbp1b,,
DB08402,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB08402,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB08402,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",,P19793,Retinoic acid receptor RXR-alpha,RXRA,,
DB08403,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,,P03956,Interstitial collagenase,MMP1,,
DB08403,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,,P22894,Neutrophil collagenase,MMP8,,
DB08404,"S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE",,P0A6A8,Acyl carrier protein,acpP,,
DB08405,"S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE",,P0A6A8,Acyl carrier protein,acpP,,
DB08406,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",,P00374,Dihydrofolate reductase,DHFR,,
DB08407,Platensimycin,,P0AAI5,3-oxoacyl-[acyl-carrier-protein] synthase 2,fabF,,
DB08408,"(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate",,P07097,Acetyl-CoA acetyltransferase,phbA,,
DB08409,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB08409,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,,P01859,Ig gamma-2 chain C region,IGHG2,,
DB08410,PARA-NITROBENZYL GLUTARYL GLYCINIC ACID,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB08411,N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB08412,6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB08413,METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,,P01834,Ig kappa chain C region,IGKC,,
DB08413,METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,,P05187,"Alkaline phosphatase, placental type",ALPP,,
DB08414,PNU-142721,,P03366,Gag-Pol polyprotein,gag-pol,,
DB08416,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",,P00918,Carbonic anhydrase 2,CA2,,
DB08418,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",,P00918,Carbonic anhydrase 2,CA2,,
DB08419,(1S)-1-(PHENOXYMETHYL)PROPYL METHYLPHOSPHONOCHLORIDOATE,,P22088,Lipase,lipA,,
DB08420,1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID,,P07477,Trypsin-1,PRSS1,,
DB08421,PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE,,P04584,Gag-Pol polyprotein,gag-pol,,
DB08422,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,,P00734,Prothrombin,F2,,
DB08423,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08424,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08426,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",,P00742,Coagulation factor X,F10,,
DB08427,Prephenic acid,,P19080,Chorismate mutase AroH,aroH,,
DB08428,3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL,,P03367,Gag-Pol polyprotein,gag-pol,,
DB08428,3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL,,P03366,Gag-Pol polyprotein,gag-pol,,
DB08429,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08430,PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,,Q6UWM7,Lactase-like protein,LCTL,,
DB08431,"[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID",,Q9ZGI2,Type I polyketide synthase PikAIV,pikAIV,,
DB08432,THYMIDINE-5'-THIOPHOSPHATE,,P00582,DNA polymerase I,polA,,
DB08433,phenyl ethenesulfonate,,P15273,Tyrosine-protein phosphatase YopH,yopH,,
DB08434,2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,,P00524,Tyrosine-protein kinase transforming protein Src,V-SRC,,
DB08435,"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid",,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB08436,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB08437,Puromycin,,Q96L21,60S ribosomal protein L10-like,RPL10L,,
DB08437,Puromycin,,P40429,60S ribosomal protein L13a,RPL13A,,
DB08437,Puromycin,,P62829,60S ribosomal protein L23,RPL23,,
DB08437,Puromycin,,P61313,60S ribosomal protein L15,RPL15,,
DB08437,Puromycin,,P84098,60S ribosomal protein L19,RPL19,,
DB08437,Puromycin,,P62750,60S ribosomal protein L23a,RPL23A,,
DB08437,Puromycin,,Q9UHA3,Probable ribosome biogenesis protein RLP24,RSL24D1,,
DB08437,Puromycin,,Q9UNX3,60S ribosomal protein L26-like 1,RPL26L1,,
DB08437,Puromycin,,P62917,60S ribosomal protein L8,RPL8,,
DB08437,Puromycin,,P61927,60S ribosomal protein L37,RPL37,,
DB08437,Puromycin,,P39023,60S ribosomal protein L3,RPL3,,
DB08437,Puromycin,,P62913,60S ribosomal protein L11,RPL11,,
DB08437,Puromycin,,P0A8P1,Leucyl/phenylalanyl-tRNA--protein transferase,aat,,
DB08438,"(2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID",,Q54873,Hyaluronate lyase,,,
DB08439,Parecoxib,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AH04
DB08439,Parecoxib,,P02788,Lactotransferrin,LTF,,M01AH04
DB08440,"N-1,10-phenanthrolin-5-ylacetamide",,P0ABE7,Soluble cytochrome b562,cybC,,
DB08441,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08442,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB08443,"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB08444,"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",,P04585,Gag-Pol polyprotein,gag-pol,,
DB08445,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08446,"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",,P04585,Gag-Pol polyprotein,gag-pol,,
DB08447,3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,
DB08448,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",,P00374,Dihydrofolate reductase,DHFR,,
DB08449,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",,P15121,Aldose reductase,AKR1B1,,
DB08450,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,,P36897,TGF-beta receptor type-1,TGFBR1,,
DB08451,N-(QUINOLIN-8-YL)METHANESULFONAMIDE,,P0AE18,Methionine aminopeptidase,map,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P00156,Cytochrome b,MT-CYB,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P83791,Cytochrome b6,petB,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P83793,Apocytochrome f,petA,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P83794,Cytochrome b6-f complex iron-sulfur subunit,petC,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P83792,Cytochrome b6-f complex subunit 4,petD,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P83797,Cytochrome b6-f complex subunit 5,petG,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P83795,Cytochrome b6-f complex subunit 6,petL,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P83796,Cytochrome b6-f complex subunit 7,petM,,
DB08453,2-Nonyl-4-quinolinol 1-oxide,,P83798,Cytochrome b6-f complex subunit 8,petN,,
DB08454,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,,Q8IU85,Calcium/calmodulin-dependent protein kinase type 1D,CAMK1D,,
DB08456,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-4-phenyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",,P00720,Lysozyme,E,,
DB08457,"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",,P03366,Gag-Pol polyprotein,gag-pol,,
DB08458,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,,P33247,Squalene--hopene cyclase,shc,,
DB08459,"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",,P04585,Gag-Pol polyprotein,gag-pol,,
DB08460,MK-4965,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08461,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",,P10275,Androgen receptor,AR,,
DB08462,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB08463,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08463,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,,P20248,Cyclin-A2,CCNA2,,
DB08464,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB08464,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",,P14625,Endoplasmin,HSP90B1,,
DB08465,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",,P08238,Heat shock protein HSP 90-beta,HSP90AB1,,
DB08465,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",,P14625,Endoplasmin,HSP90B1,,
DB08466,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB08469,"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",,P9WMC1,HTH-type transcriptional regulator EthR,ethR,,
DB08470,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",,P9WMC1,HTH-type transcriptional regulator EthR,ethR,,
DB08471,"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",,P9WMC1,HTH-type transcriptional regulator EthR,ethR,,
DB08472,(R)-Fluoxetine,,O67854,Transporter,snf,,
DB08473,Dichlororibofuranosylbenzimidazole,,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB08474,3-(CARBOXYAMIDE(2-CARBOXYAMIDE-2-TERTBUTYLETHYL))PENTAN,,P04584,Gag-Pol polyprotein,gag-pol,,
DB08475,"[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate",,P37957,Lipase EstA,estA,,
DB08476,3-AMINO-AZACYCLOTRIDECAN-2-ONE,,P22894,Neutrophil collagenase,MMP8,,
DB08478,N-[2-Chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,,P04818,Thymidylate synthase,TYMS,,
DB08479,"N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide",,P04818,Thymidylate synthase,TYMS,,
DB08480,4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN,,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB08481,4-Methyl-N-[5-(5-methyl-furan-2-ylmethylene)-4-oxo-thiazolidin-2-ylidene]-benzenesulfonamide,,P26663,Genome polyprotein,,,
DB08482,[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER,,P03956,Interstitial collagenase,MMP1,,
DB08484,4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE,,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,,
DB08485,"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",,P15474,3-dehydroquinate dehydratase,aroQ,,
DB08486,Efaproxiral,,P69905,Hemoglobin subunit alpha,HBA1,,L01XD06
DB08486,Efaproxiral,,P68871,Hemoglobin subunit beta,HBB,,L01XD06
DB08487,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,,P00742,Coagulation factor X,F10,,
DB08488,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",,P00742,Coagulation factor X,F10,,
DB08489,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",,P09237,Matrilysin,MMP7,,
DB08490,CTS-1027,,P45452,Collagenase 3,MMP13,,
DB08491,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,,P03956,Interstitial collagenase,MMP1,,
DB08492,(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID,,P16050,Arachidonate 15-lipoxygenase,ALOX15,,
DB08493,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",,P09237,Matrilysin,MMP7,,
DB08494,"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",,P04585,Gag-Pol polyprotein,gag-pol,,
DB08495,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,,P00742,Coagulation factor X,F10,,
DB08497,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",,P42574,Caspase-3,CASP3,,
DB08498,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",,P42574,Caspase-3,CASP3,,
DB08499,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",,P42574,Caspase-3,CASP3,,
DB08500,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB08501,"DIETHYL PROPANE-1,3-DIYLBISCARBAMATE",,P69178,Shiga-like toxin 1 subunit B,stxB,,
DB08502,Capravirine,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08502,Capravirine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,
DB08503,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",,P11217,"Glycogen phosphorylase, muscle form",PYGM,,
DB08504,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08505,methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate,,Q70I53,Histone deacetylase-like amidohydrolase,hdaH,,
DB08506,N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine,,P04825,Aminopeptidase N,pepN,,
DB08507,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,,P08254,Stromelysin-1,MMP3,,
DB08508,N-BENZOYL-D-ALANINE,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,,
DB08509,1-[6-(2-CHLORO-4-METHYXYPHENOXY)-HEXYL]-IMIDAZOLE,,P03303,Genome polyprotein,,,
DB08510,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,,P01859,Ig gamma-2 chain C region,IGHG2,,
DB08511,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB08512,"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB08513,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB08513,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,,P06213,Insulin receptor,INSR,,
DB08513,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,,P35568,Insulin receptor substrate 1,IRS1,,
DB08514,"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,P28720,Queuine tRNA-ribosyltransferase,tgt,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P25786,Proteasome subunit alpha type-1,PSMA1,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P25787,Proteasome subunit alpha type-2,PSMA2,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P25788,Proteasome subunit alpha type-3,PSMA3,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P25789,Proteasome subunit alpha type-4,PSMA4,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P28066,Proteasome subunit alpha type-5,PSMA5,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P60900,Proteasome subunit alpha type-6,PSMA6,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,O14818,Proteasome subunit alpha type-7,PSMA7,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P20618,Proteasome subunit beta type-1,PSMB1,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P49721,Proteasome subunit beta type-2,PSMB2,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P49720,Proteasome subunit beta type-3,PSMB3,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P28070,Proteasome subunit beta type-4,PSMB4,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P28074,Proteasome subunit beta type-5,PSMB5,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,P28072,Proteasome subunit beta type-6,PSMB6,,
DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,Q99436,Proteasome subunit beta type-7,PSMB7,,
DB08516,(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE],,P27338,Amine oxidase [flavin-containing] B,MAOB,,
DB08517,Sakuranetin,,Q5G940,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,fabZ,,
DB08519,"N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB08520,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB08521,4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08521,4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB08522,4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08523,[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL,,Q8DP79,Peptide deformylase,def,,
DB08523,[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL,,P0A6K3,Peptide deformylase,def,,
DB08524,2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,,Q8DP79,Peptide deformylase,def,,
DB08525,HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE,,Q8DP79,Peptide deformylase,def,,
DB08526,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,,P09668,Pro-cathepsin H,CTSH,,
DB08527,"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",,P20248,Cyclin-A2,CCNA2,,
DB08527,"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08528,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",,P04585,Gag-Pol polyprotein,gag-pol,,
DB08529,"(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)",,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,,
DB08530,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08531,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08532,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08533,"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08534,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08535,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08536,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08537,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08538,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08539,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08540,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",,P03303,Genome polyprotein,,,
DB08541,"[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzo[g]isochromen-3-yl]acetic acid",,Q53901,ActII protein,actII,,
DB08542,"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",,P9WNW7,Iron-dependent extradiol dioxygenase,hsaC,,
DB08543,1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,,P03303,Genome polyprotein,,,
DB08544,(S)-Fluoxetine,,O67854,Transporter,snf,,
DB08545,(1S)-1-Phenylethyl (4-acetamidobenzyl)phosphonate,,Q6PYX1,Hepatitis B virus receptor binding protein,,,
DB08546,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",,P00734,Prothrombin,F2,,
DB08547,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,,P01859,Ig gamma-2 chain C region,IGHG2,,
DB08548,"[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate",,P37957,Lipase EstA,estA,,
DB08549,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB08551,3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid,,P00811,Beta-lactamase,ampC,,
DB08551,3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid,,P62593,Beta-lactamase TEM,bla,,
DB08551,3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid,,Q9L5C8,Beta-lactamase,blaCTX-M-9a,,
DB08552,(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid,,P00811,Beta-lactamase,ampC,,
DB08553,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",,P15056,Serine/threonine-protein kinase B-raf,BRAF,,
DB08554,N-(3-carboxypropanoyl)-L-norvaline,,Q5LI27,Putative ornithine carbamoyltransferase,,,
DB08554,N-(3-carboxypropanoyl)-L-norvaline,,Q8P8J2,N-acetylornithine carbamoyltransferase,argF',,
DB08555,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",,P53779,Mitogen-activated protein kinase 10,MAPK10,,
DB08556,"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",,Q99AU2,Genome polyprotein,,,
DB08557,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB08558,"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",,O25927,Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase,lpxA,,
DB08558,"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",,P9WQN9,Diacylglycerol acyltransferase/mycolyltransferase Ag85C,fbpC,,
DB08558,"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",,P08588,Beta-1 adrenergic receptor,ADRB1,,
DB08558,"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",,P09848,Lactase-phlorizin hydrolase,LCT,,
DB08559,"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda~4~-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",,P06875,Penicillin G acylase,pac,,
DB08560,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB08561,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",,P45452,Collagenase 3,MMP13,,
DB08562,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,,P01834,Ig kappa chain C region,IGKC,,
DB08562,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB08562,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,,P01615,Ig kappa chain V-II region TEW,IGKV2D-28,,
DB08564,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,,
DB08565,L-1-naphthyl-2-acetamido-ethane boronic acid,,P17538,Chymotrypsinogen B,CTRB1,,
DB08566,D-1-naphthyl-2-acetamido-ethane boronic acid,,P17538,Chymotrypsinogen B,CTRB1,,
DB08568,A-674563,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08568,A-674563,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08569,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08569,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08570,4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID,,P03474,Neuraminidase,,,
DB08570,4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID,,P06820,Neuraminidase,,,
DB08571,4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID,,P06820,Neuraminidase,,,
DB08572,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,,P20248,Cyclin-A2,CCNA2,,
DB08572,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08573,3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID,,P00811,Beta-lactamase,ampC,,
DB08574,"(5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one",,P55196,Afadin,MLLT4,,
DB08575,"2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM",,P08473,Neprilysin,MME,,
DB08576,"1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE",,O32449,Proline iminopeptidase,pip,,
DB08577,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,,P11362,Fibroblast growth factor receptor 1,FGFR1,,
DB08578,4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid,,P26663,Genome polyprotein,,,
DB08579,"4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline",,P26663,Genome polyprotein,,,
DB08580,4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,,P26663,Genome polyprotein,,,
DB08581,"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",,P26663,Genome polyprotein,,,
DB08582,"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",,P26663,Genome polyprotein,,,
DB08583,"2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide",,P00519,Tyrosine-protein kinase ABL1,ABL1,,
DB08585,"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate",,Q02054,Actinorhodin polyketide synthase acyl carrier protein,,,
DB08586,"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate",,Q02054,Actinorhodin polyketide synthase acyl carrier protein,,,
DB08587,Sinapic acid,,P51584,"Endo-1,4-beta-xylanase Y",xynY,,
DB08588,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08589,SYRINGATE,,P51584,"Endo-1,4-beta-xylanase Y",xynY,,
DB08590,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,,Q9NWZ3,Interleukin-1 receptor-associated kinase 4,IRAK4,,
DB08591,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB08593,"1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE",,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB08594,TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE,,P43235,Cathepsin K,CTSK,,
DB08595,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,P03372,Estrogen receptor alpha,ESR1,,
DB08595,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB08596,5'-deoxy-5'-piperidin-1-ylthymidine,,P07998,Ribonuclease pancreatic,RNASE1,,
DB08597,Dorsomorphin,,Q04771,Activin receptor type-1,ACVR1,,
DB08597,Dorsomorphin,,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,,
DB08598,R-82913,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08598,R-82913,,P03366,Gag-Pol polyprotein,gag-pol,,
DB08599,N-[(4-methoxyphenyl)sulfonyl]-D-alanine,,P39900,Macrophage metalloelastase,MMP12,,
DB08600,Tivirapine,,P03366,Gag-Pol polyprotein,gag-pol,,
DB08601,Tributyltin,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB08601,Tributyltin,,P19793,Retinoic acid receptor RXR-alpha,RXRA,,
DB08602,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",,Q13946,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",PDE7A,,
DB08603,N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide,,P15636,Protease 1,,,
DB08604,Triclosan,,P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,D08AE04;D09AA06
DB08604,Triclosan,,P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],inhA,,D08AE04;D09AA06
DB08604,Triclosan,,O24990,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,D08AE04;D09AA06
DB08604,Triclosan,,A0A6L8PBX8,Enoyl-[acyl-carrier-protein] reductase [NADH],fabI,,D08AE04;D09AA06
DB08604,Triclosan,,Q6GI75,Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI,fabI,,D08AE04;D09AA06
DB08604,Triclosan,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,D08AE04;D09AA06
DB08604,Triclosan,,P10275,Androgen receptor,AR,,D08AE04;D09AA06
DB08604,Triclosan,,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,inverse agonist,D08AE04;D09AA06
DB08604,Triclosan,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,D08AE04;D09AA06
DB08604,Triclosan,,P07202,Thyroid peroxidase,TPO,weak inhibitor,D08AE04;D09AA06
DB08605,"6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL",,Q16698,"2,4-dienoyl-CoA reductase, mitochondrial",DECR1,,
DB08605,"6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL",,P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,fabI,,
DB08606,"(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL",,P0AF12,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,mtnN,,
DB08607,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",,P10632,Cytochrome P450 2C8,CYP2C8,,
DB08608,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",,Q15119,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",PDK2,,
DB08609,"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide",,Q15119,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",PDK2,,
DB08610,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,,Q15119,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",PDK2,,
DB08611,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",,P25774,Cathepsin S,CTSS,,
DB08612,"1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE",,Q9UKY3,Putative inactive carboxylesterase 4,CES1P1,,
DB08613,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",,P56524,Histone deacetylase 4,HDAC4,,
DB08614,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB08615,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",,P22303,Acetylcholinesterase,ACHE,,
DB08617,"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE",,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,,
DB08618,3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,,P01859,Ig gamma-2 chain C region,IGHG2,,
DB08619,Testosterone succinate,,P0A3R9,Neocarzinostatin,ncsA,,
DB08620,Thiacloprid,,Q494W8,CHRNA7-FAM7A fusion protein,CHRFAM7A,,
DB08621,Thiamphenicol,,P24093,Dr hemagglutinin structural subunit,draA,,J01BA02;J01BA52
DB08622,"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",,P03369,Gag-Pol polyprotein,gag-pol,,
DB08623,"2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID",,P00811,Beta-lactamase,ampC,,
DB08624,"1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine",,P00734,Prothrombin,F2,,
DB08624,"1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine",,P35869,Aryl hydrocarbon receptor,AHR,,
DB08626,Thiorphan,,P08473,Neprilysin,MME,inhibitor,
DB08627,"(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE",,P0A953,3-oxoacyl-[acyl-carrier-protein] synthase 1,fabB,,
DB08628,"(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE",,P0A953,3-oxoacyl-[acyl-carrier-protein] synthase 1,fabB,,
DB08629,"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,,
DB08629,"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,,
DB08629,"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",,P36542,"ATP synthase subunit gamma, mitochondrial",ATP5C1,,
DB08631,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB08632,Trimesic acid,,P69905,Hemoglobin subunit alpha,HBA1,,
DB08632,Trimesic acid,,P68871,Hemoglobin subunit beta,HBB,,
DB08633,TNP-470,,P50579,Methionine aminopeptidase 2,METAP2,,
DB08634,6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08635,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,,P01768,Ig heavy chain V-III region CAM,IGHV3-30,,
DB08636,2-Hydroxybenzalpyruvate,,Q51948,2-hydroxychromene-2-carboxylate isomerase,nahD,,
DB08637,4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID,,Q51948,2-hydroxychromene-2-carboxylate isomerase,nahD,,
DB08638,1-hydroperoxy-L-tryptophan,,Q939D2,Catalase-peroxidase,katG,,
DB08639,Dapivirine,,P03366,Gag-Pol polyprotein,gag-pol,,G01AX17
DB08640,"(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB08641,"(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,,
DB08642,"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",,P00374,Dihydrofolate reductase,DHFR,,
DB08643,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,,P08254,Stromelysin-1,MMP3,,
DB08644,{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER,,P27958,Genome polyprotein,,,
DB08645,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",,P00918,Carbonic anhydrase 2,CA2,,
DB08646,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,P22364,Amicyanin,mauC,,
DB08646,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,P29894,Methylamine dehydrogenase heavy chain,mauB,,
DB08646,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,P22619,Methylamine dehydrogenase light chain,mauA,,
DB08646,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,P29899,Cytochrome c-L,moxG,,
DB08646,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,Q8VUS8,Quinohemoprotein amine dehydrogenase subunit gamma,qhnDH,,
DB08646,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,Q8VUT0,Quinohemoprotein amine dehydrogenase 60 kDa subunit,,,
DB08646,TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,Q8VUS7,Quinohemoprotein amine dehydrogenase 40 kDa subunit,,,
DB08647,Trazeolide,,P01834,Ig kappa chain C region,IGKC,,
DB08648,"8-Hydroxy-2-oxa-bicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",,P0A9J8,P-protein,pheA,,
DB08648,"8-Hydroxy-2-oxa-bicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",,P19080,Chorismate mutase AroH,aroH,,
DB08648,"8-Hydroxy-2-oxa-bicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",,P9WIB9,Secreted chorismate mutase,,,
DB08649,(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL,,P84887,Aralkylamine dehydrogenase light chain,aauA,,
DB08649,(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL,,P84888,Aralkylamine dehydrogenase heavy chain,aauB,,
DB08651,3'-THIO-THYMIDINE-5'-PHOSPHATE,,P04390,Type-2 restriction enzyme EcoRV,ecoRVR,,
DB08651,3'-THIO-THYMIDINE-5'-PHOSPHATE,,Q02880,DNA topoisomerase 2-beta,TOP2B,,
DB08652,Indoleacetamide,,P84887,Aralkylamine dehydrogenase light chain,aauA,,
DB08652,Indoleacetamide,,P84888,Aralkylamine dehydrogenase heavy chain,aauB,,
DB08653,Tryptamine,,P84887,Aralkylamine dehydrogenase light chain,aauA,,
DB08653,Tryptamine,,P84888,Aralkylamine dehydrogenase heavy chain,aauB,,
DB08654,"TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",,P11086,Phenylethanolamine N-methyltransferase,PNMT,,
DB08655,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",,Q92793,CREB-binding protein,CREBBP,,
DB08656,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,,P0C6X7,Replicase polyprotein 1ab,rep,,
DB08657,2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,,Q9FBC5,Trans-2-enoyl-ACP reductase II,fabK,,
DB08658,Ethyl hydrogen diethylamidophosphate,,P06276,Cholinesterase,BCHE,,
DB08659,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,,P00918,Carbonic anhydrase 2,CA2,,
DB08660,Quinalizarin,,P68400,Casein kinase II subunit alpha,CSNK2A1,,
DB08661,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",,P07998,Ribonuclease pancreatic,RNASE1,,
DB08662,3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,,P03367,Gag-Pol polyprotein,gag-pol,,
DB08663,4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,,P04584,Gag-Pol polyprotein,gag-pol,,
DB08664,({3-[1-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-propyl]-phenylcarbamoyl}-methyl)-carbamic acid tert-butyl ester,,P04584,Gag-Pol polyprotein,gag-pol,,
DB08665,"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",,P04585,Gag-Pol polyprotein,gag-pol,,
DB08666,5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine,,P0AE18,Methionine aminopeptidase,map,,
DB08667,4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine,,P0AE18,Methionine aminopeptidase,map,,
DB08668,3-(5-Amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid,,P0AE18,Methionine aminopeptidase,map,,
DB08669,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",,P0AE18,Methionine aminopeptidase,map,,
DB08670,"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",,P0AE18,Methionine aminopeptidase,map,,
DB08671,5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine,,P0AE18,Methionine aminopeptidase,map,,
DB08672,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08673,"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08674,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB08674,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB08675,"(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid",,Q16647,Prostacyclin synthase,PTGIS,,
DB08676,"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,,
DB08676,"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",,P49356,Protein farnesyltransferase subunit beta,FNTB,,
DB08677,N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08678,(4-ETHYLPHENYL)SULFAMIC ACID,,P23467,Receptor-type tyrosine-protein phosphatase beta,PTPRB,,
DB08680,N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08681,1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE,,P04585,Gag-Pol polyprotein,gag-pol,,
DB08682,"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE",,P04585,Gag-Pol polyprotein,gag-pol,,
DB08683,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB08684,O-Decyl Hydrogen Thiocarbonate,,P9WNG3,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB08685,"1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine",,Q3JP94,Glutaryl-CoA dehydrogenase,,,
DB08686,"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",,P04584,Gag-Pol polyprotein,gag-pol,,
DB08687,FG-2216,,Q9GZT9,Egl nine homolog 1,EGLN1,,
DB08687,FG-2216,,Q16665,Hypoxia-inducible factor 1-alpha,HIF1A,,
DB08688,2-Undecanone,,Q9NPJ3,Acyl-coenzyme A thioesterase 13,ACOT13,,
DB08689,Ubiquinone Q1,,P07173,Photosynthetic reaction center cytochrome c subunit,pufC,,
DB08689,Ubiquinone Q1,,P06008,Reaction center protein H chain,puhA,,
DB08689,Ubiquinone Q1,,P06009,Reaction center protein L chain,pufL,,
DB08689,Ubiquinone Q1,,P06010,Reaction center protein M chain,pufM,,
DB08689,Ubiquinone Q1,,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,,
DB08689,Ubiquinone Q1,,P21912,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",SDHB,,
DB08689,Ubiquinone Q1,,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",SDHD,,
DB08689,Ubiquinone Q1,,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",SDHC,,
DB08689,Ubiquinone Q1,,P0AEG4,Thiol:disulfide interchange protein DsbA,dsbA,,
DB08689,Ubiquinone Q1,,P0A6M2,Disulfide bond formation protein B,dsbB,,
DB08689,Ubiquinone Q1,,Q72LA5,NrfC protein,nrfC,,
DB08689,Ubiquinone Q1,,Q72LA4,Thiosulfate reductase,,,
DB08689,Ubiquinone Q1,,Q72LA6,Hypothetical membrane spanning protein,,,
DB08690,Ubiquinone Q2,,P0AC41,Succinate dehydrogenase flavoprotein subunit,sdhA,,
DB08690,Ubiquinone Q2,,P07014,Succinate dehydrogenase iron-sulfur subunit,sdhB,,
DB08690,Ubiquinone Q2,,P69054,Succinate dehydrogenase cytochrome b556 subunit,sdhC,,
DB08690,Ubiquinone Q2,,P0AC44,Succinate dehydrogenase hydrophobic membrane anchor subunit,sdhD,,
DB08690,Ubiquinone Q2,,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,,
DB08690,Ubiquinone Q2,,P00156,Cytochrome b,MT-CYB,,
DB08690,Ubiquinone Q2,,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,,
DB08690,Ubiquinone Q2,,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,,
DB08690,Ubiquinone Q2,,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,,
DB08690,Ubiquinone Q2,,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,,
DB08690,Ubiquinone Q2,,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,,
DB08690,Ubiquinone Q2,,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,,
DB08690,Ubiquinone Q2,,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,,
DB08690,Ubiquinone Q2,,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,,
DB08690,Ubiquinone Q2,,P07173,Photosynthetic reaction center cytochrome c subunit,pufC,,
DB08690,Ubiquinone Q2,,P06008,Reaction center protein H chain,puhA,,
DB08690,Ubiquinone Q2,,P06009,Reaction center protein L chain,pufL,,
DB08690,Ubiquinone Q2,,P06010,Reaction center protein M chain,pufM,,
DB08690,Ubiquinone Q2,,P0A6M2,Disulfide bond formation protein B,dsbB,,
DB08690,Ubiquinone Q2,,Q02761,Cytochrome b,petB,,
DB08690,Ubiquinone Q2,,Q02762,Ubiquinol-cytochrome c reductase iron-sulfur subunit,petA,,
DB08690,Ubiquinone Q2,,Q02760,Cytochrome c1,petC,,
DB08690,Ubiquinone Q2,,P0C0Y8,Reaction center protein L chain,pufL,,
DB08690,Ubiquinone Q2,,P0C0Y9,Reaction center protein M chain,pufM,,
DB08690,Ubiquinone Q2,,P0C0Y7,Reaction center protein H chain,puhA,,
DB08691,"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",,P49759,Dual specificity protein kinase CLK1,CLK1,,
DB08691,"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",,P49761,Dual specificity protein kinase CLK3,CLK3,,
DB08692,D-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid,,P17538,Chymotrypsinogen B,CTRB1,,
DB08693,L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid,,P17538,Chymotrypsinogen B,CTRB1,,
DB08694,Variolin B,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08694,Variolin B,,P20248,Cyclin-A2,CCNA2,,
DB08695,3-(4-nitrophenyl)-1H-pyrazole,,O60760,Hematopoietic prostaglandin D synthase,HPGDS,,
DB08697,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",,P00749,Urokinase-type plasminogen activator,PLAU,,
DB08698,"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",,Q9ZLT0,Glutamate racemase,murI,,
DB08699,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",,Q13555,Calcium/calmodulin-dependent protein kinase type II subunit gamma,CAMK2G,,
DB08701,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",,P26663,Genome polyprotein,,,
DB08701,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",,P26661,Genome polyprotein,,,
DB08702,"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",,P52700,Metallo-beta-lactamase L1,,,
DB08703,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",,P80192,Mitogen-activated protein kinase kinase kinase 9,MAP3K9,,
DB08704,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",,Q9KU37,Beta-hexosaminidase,nagZ,,
DB08705,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB08706,"(2S)-({(5Z)-5-[(5-Ethyl-2-furyl)methylene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl}amino)(4-fluorophenyl)acetic acid",,P26663,Genome polyprotein,,,
DB08707,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB08708,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB08709,"2,3-diphenyl-1H-indole-7-carboxylic acid",,P11309,Serine/threonine-protein kinase pim-1,PIM1,,
DB08710,"(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-[[(S)-(4-fluorophenyl)-(2H-tetrazol-5-yl)methyl]amino]-1,3-thiazol-4-one",,P26663,Genome polyprotein,,,
DB08711,Methyl vanillate,,P51584,"Endo-1,4-beta-xylanase Y",xynY,,
DB08712,11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID,,P9WNG3,3-oxoacyl-[acyl-carrier-protein] synthase 3,fabH,,
DB08713,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",,Q82122,Genome polyprotein,,,
DB08714,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",,Q82122,Genome polyprotein,,,
DB08715,"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",,Q82122,Genome polyprotein,,,
DB08717,"[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid",,Q7SIA5,Carboxylesterase,,,
DB08718,"4-(3-ethylthiophen-2-yl)benzene-1,2-diol",,P0AE18,Methionine aminopeptidase,map,,
DB08719,"5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",,P03303,Genome polyprotein,,,
DB08720,"5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole",,P03303,Genome polyprotein,,,
DB08721,"5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole",,P03303,Genome polyprotein,,,
DB08722,5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole,,P03303,Genome polyprotein,,,
DB08723,WIN-54954,,P03303,Genome polyprotein,,,
DB08723,WIN-54954,,P23008,Genome polyprotein,,,
DB08724,5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,,P03303,Genome polyprotein,,,
DB08725,"(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole",,P03303,Genome polyprotein,,,
DB08726,"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",,P21404,Genome polyprotein,,,
DB08726,"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",,P03302,Genome polyprotein,,,
DB08726,"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",,P03303,Genome polyprotein,,,
DB08727,"3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole",,P03303,Genome polyprotein,,,
DB08728,"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",,P03303,Genome polyprotein,,,
DB08728,"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",,P23008,Genome polyprotein,,,
DB08729,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,,
DB08730,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,,Q16539,Mitogen-activated protein kinase 14,MAPK14,,
DB08731,"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",,P00811,Beta-lactamase,ampC,,
DB08732,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,,P0C6X7,Replicase polyprotein 1ab,rep,,
DB08732,NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,,P0C6U8,Replicase polyprotein 1a,,,
DB08733,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,,
DB08734,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",,P04818,Thymidylate synthase,TYMS,,
DB08737,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",,P03372,Estrogen receptor alpha,ESR1,,
DB08738,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,,P48147,Prolyl endopeptidase,PREP,,
DB08739,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",,P48147,Prolyl endopeptidase,PREP,,
DB08740,"CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE",,P07339,Cathepsin D,CTSD,,
DB08741,"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",,P0A017,Dihydrofolate reductase,folA,,
DB08742,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB08742,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",,P11473,Vitamin D3 receptor,VDR,,
DB08743,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",,P27487,Dipeptidyl peptidase 4,DPP4,,
DB08744,Casimiroin,,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,,
DB08745,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,,P00742,Coagulation factor X,F10,,
DB08746,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,,P00742,Coagulation factor X,F10,,
DB08747,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",,O92972,Genome polyprotein,,,
DB08748,4-(Dimethylamino)benzoic acid,,P0C6X7,Replicase polyprotein 1ab,rep,,
DB08748,4-(Dimethylamino)benzoic acid,,A7J8L3,Orf1a polyprotein,orf1ab,,
DB08749,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,,P56817,Beta-secretase 1,BACE1,,
DB08750,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",,P35228,"Nitric oxide synthase, inducible",NOS2,,
DB08751,"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE",,P01112,GTPase HRas,HRAS,,
DB08752,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,,P25774,Cathepsin S,CTSS,,
DB08753,"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",,Q672W7,Peptide deformylase,def,,
DB08754,N-Caffeoyltyramine,,Q672W7,Peptide deformylase,def,,
DB08755,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,,P25774,Cathepsin S,CTSS,,
DB08756,Y-27632,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,,
DB08756,Y-27632,,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,,
DB08756,Y-27632,,Q13464,Rho-associated protein kinase 1,ROCK1,,
DB08756,Y-27632,,O75116,Rho-associated protein kinase 2,ROCK2,,
DB08757,5-(2-chlorophenyl)furan-2-carbohydrazide,,P0AE18,Methionine aminopeptidase,map,,
DB08758,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",,P0AE18,Methionine aminopeptidase,map,,
DB08759,"[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID",,Q9ZGI2,Type I polyketide synthase PikAIV,pikAIV,,
DB08760,(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB08761,"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",,P9WPP7,Mycocyclosin synthase,cyp121,,
DB08762,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,,P15085,Carboxypeptidase A1,CPA1,,
DB08763,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,,P07477,Trypsin-1,PRSS1,,
DB08765,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",,P00918,Carbonic anhydrase 2,CA2,,
DB08765,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",,P14174,Macrophage migration inhibitory factor,MIF,,
DB08766,Zofenoprilat,,P28838,Cytosol aminopeptidase,LAP3,,
DB08767,2-(4-METHOXYPHENYL)ACETAMIDE,,P84887,Aralkylamine dehydrogenase light chain,aauA,,
DB08767,2-(4-METHOXYPHENYL)ACETAMIDE,,P84888,Aralkylamine dehydrogenase heavy chain,aauB,,
DB08768,N(6)-dimethylallyladenine,,P24941,Cyclin-dependent kinase 2,CDK2,,
DB08770,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",,P29274,Adenosine receptor A2a,ADORA2A,,
DB08771,"(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one",,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,,
DB08772,Zopolrestat,,O60218,Aldo-keto reductase family 1 member B10,AKR1B10,,
DB08772,Zopolrestat,,P15121,Aldose reductase,AKR1B1,,
DB08773,2-(4-hydroxyphenyl)benzo[b]thiophen-6-ol,,P03372,Estrogen receptor alpha,ESR1,,
DB08773,2-(4-hydroxyphenyl)benzo[b]thiophen-6-ol,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB08774,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB08775,Benzoyl-tyrosine-alanine-fluoro-methyl ketone,,Q9UBX1,Cathepsin F,CTSF,,
DB08776,"N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB08777,"5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB08778,"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB08779,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB08780,6-MORPHOLIN-4-YL-9H-PURINE,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB08781,"1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE",,O14757,Serine/threonine-protein kinase Chk1,CHEK1,,
DB08782,4-(2-AMINOETHYL)BENZENESULFONAMIDE,,P00918,Carbonic anhydrase 2,CA2,,
DB08783,(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid,,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,,
DB08784,2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID,,Q9HBL8,NmrA-like family domain-containing protein 1,NMRAL1,,
DB08785,4-Methylcoumarin,,P16218,Endoglucanase H,celH,,
DB08786,4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB08787,"4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB08788,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB08789,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB08790,1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID,,O60760,Hematopoietic prostaglandin D synthase,HPGDS,,
DB08791,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",,P08581,Hepatocyte growth factor receptor,MET,,
DB08795,Azidocillin,,Q8DNB6,Penicillin-binding protein 2a,pbp2a,inhibitor,J01CE04
DB08795,Azidocillin,,Q7CRA4,Penicillin-binding protein 1b,pbp1b,inhibitor,J01CE04
DB08795,Azidocillin,,Q75Y35,Penicillin-binding protein 3,pbp3,inhibitor,J01CE04
DB08795,Azidocillin,,Q8DR59,Penicillin-binding protein 1A,pbpA,inhibitor,J01CE04
DB08795,Azidocillin,,P0A3M6,Penicillin-binding protein 2B,penA,inhibitor,J01CE04
DB08798,Sulfamoxole,,Q27738,Dihydropteroate synthetase,,inhibitor,J01EE04;J01EC03
DB08799,Antazoline,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX05;R01AC04
DB08800,Chloropyramine,,P35367,Histamine H1 receptor,HRH1,antagonist,D04AA09;R06AC53;R06AC03
DB08801,Dimetindene,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AB03;D04AA13
DB08801,Dimetindene,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,R06AB03;D04AA13
DB08802,Isothipendyl,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AD09;D04AA22
DB08804,Nandrolone decanoate,,P10275,Androgen receptor,AR,agonist,
DB08804,Nandrolone decanoate,,P01100,Proto-oncogene c-Fos,FOS,inducer,
DB08804,Nandrolone decanoate,,P28223,5-hydroxytryptamine 2 receptor,HTR2A,modulator,
DB08804,Nandrolone decanoate,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,modulator,
DB08804,Nandrolone decanoate,,P08069,Insulin-like growth factor 1 receptor,IGF1R,inducer,
DB08804,Nandrolone decanoate,,P21728,Dopamine receptor,DRD1,modulator,
DB08805,Metiamide,,P25021,Histamine H2 receptor,HRH2,antagonist,
DB08806,Roxatidine acetate,,P25021,Histamine H2 receptor,HRH2,antagonist,A02BA06
DB08807,Bopindolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07AA17;C07CA17
DB08807,Bopindolol,,P08588,Beta-1 adrenergic receptor,ADRB1,partial agonist,C07AA17;C07CA17
DB08807,Bopindolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07AA17;C07CA17
DB08807,Bopindolol,,P07550,Beta-2 adrenergic receptor,ADRB2,partial agonist,C07AA17;C07CA17
DB08807,Bopindolol,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,C07AA17;C07CA17
DB08807,Bopindolol,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,,C07AA17;C07CA17
DB08807,Bopindolol,,P13945,Beta-3 adrenergic receptor,ADRB3,,C07AA17;C07CA17
DB08808,Bupranolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,C07AA19
DB08808,Bupranolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,C07AA19
DB08808,Bupranolol,,P13945,Beta-3 adrenergic receptor,ADRB3,antagonist,C07AA19
DB08809,Dichloroacetic acid,,Q15118,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial",PDK1,inhibitor,
DB08809,Dichloroacetic acid,,O43708,Maleylacetoacetate isomerase,GSTZ1,,
DB08810,Cinitapride,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,A03FA08
DB08810,Cinitapride,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,A03FA08
DB08810,Cinitapride,,Q13639,5-hydroxytryptamine receptor 4,HTR4,agonist,A03FA08
DB08811,Tofisopam,,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,inhibitor,N05BA23
DB08811,Tofisopam,,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,inhibitor,N05BA23
DB08811,Tofisopam,,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,inhibitor,N05BA23
DB08811,Tofisopam,,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,inhibitor,N05BA23
DB08813,Nadroparin,,P01008,Antithrombin-III,SERPINC1,potentiator,B01AB06
DB08813,Nadroparin,,P16109,P-selectin,SELP,inhibitor,B01AB06
DB08813,Nadroparin,,P01100,Proto-oncogene c-Fos,FOS,inhibitor,B01AB06
DB08813,Nadroparin,,P01106,Myc proto-oncogene protein,MYC,inhibitor,B01AB06
DB08814,Triflusal,,P23219,Prostaglandin G/H synthase 1,PTGS1,antagonist,B01AC18
DB08814,Triflusal,,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,antagonist,B01AC18
DB08814,Triflusal,,P35228,"Nitric oxide synthase, inducible",NOS2,agonist,B01AC18
DB08814,Triflusal,,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,antagonist,B01AC18
DB08815,Lurasidone,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AE05
DB08815,Lurasidone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AE05
DB08815,Lurasidone,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N05AE05
DB08815,Lurasidone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N05AE05
DB08815,Lurasidone,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N05AE05
DB08815,Lurasidone,,P08913,Alpha-2A adrenergic receptor,ADRA2A,,N05AE05
DB08816,Ticagrelor,,Q9H244,P2Y purinoceptor 12,P2RY12,inhibitor,B01AC24
DB08818,Hyaluronic acid,,P16070,CD44 antigen,CD44,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,P05362,Intercellular adhesion molecule 1,ICAM1,inhibitor,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,P05362,Intercellular adhesion molecule 1,ICAM1,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,O75330,Hyaluronan mediated motility receptor,HMMR,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,O14594,Neurocan core protein,NCAN,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,P13611,Versican core protein,VCAN,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,Q07021,"Complement component 1 Q subcomponent-binding protein, mitochondrial",C1QBP,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,P10915,Hyaluronan and proteoglycan link protein 1,HAPLN1,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,Q96S86,Hyaluronan and proteoglycan link protein 3,HAPLN3,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,Q14520,Hyaluronan-binding protein 2,HABP2,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,Q6UX15,Layilin,LAYN,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,Q8WWQ8,Stabilin-2,STAB2,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,P98066,Tumor necrosis factor-inducible gene 6 protein,TNFAIP6,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,Q9BZV3,Interphotoreceptor matrix proteoglycan 2,IMPG2,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,Q5JVS0,Intracellular hyaluronan-binding protein 4,HABP4,binder,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08818,Hyaluronic acid,,Q9Y5Y7,Lymphatic vessel endothelial hyaluronic acid receptor 1,LYVE1,,S01KA51;S01KA01;D03AX05;M09AX01;R01AX09
DB08819,Tafluprost,,P43088,Prostaglandin F2-alpha receptor,PTGFR,agonist,S01EE05
DB08820,Ivacaftor,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,potentiator,R07AX32;R07AX31;R07AX02;R07AX30
DB08822,Azilsartan medoxomil,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,C09CA09;C09DA09
DB08826,Deferiprone,,,Iron,,chelator,V03AC02
DB08827,Lomitapide,,P55157,Microsomal triglyceride transfer protein large subunit,MTTP,antagonist,C10AX12
DB08828,Vismodegib,,Q99835,Smoothened homolog,SMO,antagonist,L01XJ01
DB08828,Vismodegib,,Q99835,Smoothened homolog,SMO,inhibitor,L01XJ01
DB08834,Tauroursodeoxycholic acid,,P08648,Integrin alpha-5,ITGA5,activator,
DB08835,Spaglumic acid,,Q04609,Glutamate carboxypeptidase 2,FOLH1,ligand,R01AC05;S01GX03
DB08836,Temocapril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09AA14
DB08837,Tetraethylammonium,,P0A334,pH-gated potassium channel KcsA,kcsA,inhibitor,
DB08837,Tetraethylammonium,,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,agonist,
DB08837,Tetraethylammonium,,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,inhibitor,
DB08837,Tetraethylammonium,,Q08460,Calcium-activated potassium channel subunit alpha-1,Kcnma1,inhibitor,
DB08837,Tetraethylammonium,,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,blocker,
DB08838,Agmatine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,
DB08838,Agmatine,,Q9Y2I1,Nischarin,NISCH,agonist,
DB08838,Agmatine,,P02708,Acetylcholine receptor subunit alpha,CHRNA1,antagonist,
DB08838,Agmatine,,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,antagonist,
DB08838,Agmatine,,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,antagonist,
DB08838,Agmatine,,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,antagonist,
DB08838,Agmatine,,Q9UHC3,Acid-sensing ion channel 3,ASIC3,agonist,
DB08839,Serotonin,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,
DB08839,Serotonin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB08839,Serotonin,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,,
DB08839,Serotonin,,O95264,5-hydroxytryptamine receptor 3B,HTR3B,,
DB08839,Serotonin,,Q05940,Synaptic vesicular amine transporter,SLC18A2,,
DB08844,Uric acid,,,"Glycogen phosphorylase, liver form",,,
DB08845,Oxogluric acid,,P00509,Aspartate aminotransferase,aspC,,
DB08846,Ellagic acid,,P00915,Carbonic anhydrase 1,CA1,inhibitor,
DB08846,Ellagic acid,,P00918,Carbonic anhydrase 2,CA2,inhibitor,
DB08846,Ellagic acid,,P07451,Carbonic anhydrase 3,CA3,inhibitor,
DB08846,Ellagic acid,,P22748,Carbonic anhydrase 4,CA4,inhibitor,
DB08846,Ellagic acid,,P35218,"Carbonic anhydrase 5A, mitochondrial",CA5A,inhibitor,
DB08846,Ellagic acid,,Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",CA5B,inhibitor,
DB08846,Ellagic acid,,P23280,Carbonic anhydrase 6,CA6,inhibitor,
DB08846,Ellagic acid,,P43166,Carbonic anhydrase 7,CA7,inhibitor,
DB08846,Ellagic acid,,Q16790,Carbonic anhydrase 9,CA9,inhibitor,
DB08846,Ellagic acid,,O43570,Carbonic anhydrase 12,CA12,inhibitor,
DB08846,Ellagic acid,,Q9ULX7,Carbonic anhydrase 14,CA14,inhibitor,
DB08846,Ellagic acid,,P68400,Casein kinase II subunit alpha,CSNK2A1,inhibitor,
DB08846,Ellagic acid,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,inhibitor,
DB08846,Ellagic acid,,P17252,Protein kinase C alpha type,PRKCA,inhibitor,
DB08846,Ellagic acid,,P05771,Protein kinase C beta type,PRKCB,inhibitor,
DB08846,Ellagic acid,,P43405,Tyrosine-protein kinase SYK,SYK,inhibitor,
DB08846,Ellagic acid,,Q14534,Squalene monooxygenase,SQLE,inhibitor,
DB08848,Guvacine,,Q9NSD5,Sodium- and chloride-dependent GABA transporter 2,SLC6A13,inhibitor,
DB08848,Guvacine,,P30531,Sodium- and chloride-dependent GABA transporter 1,SLC6A1,inhibitor,
DB08848,Guvacine,,P48066,Sodium- and chloride-dependent GABA transporter 3,SLC6A11,inhibitor,
DB08848,Guvacine,,P48065,Sodium- and chloride-dependent betaine transporter,SLC6A12,inhibitor,
DB08855,Leukotriene C4,,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,,
DB08855,Leukotriene C4,,Q9NS75,Cysteinyl leukotriene receptor 2,CYSLTR2,,
DB08855,Leukotriene C4,,P33527,Multidrug resistance-associated protein 1,ABCC1,,
DB08860,Pitavastatin,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,inhibitor,C10AA08
DB08860,Pitavastatin,,P20701,Integrin alpha-L,ITGAL,,C10AA08
DB08862,Cholecystokinin,,P32238,Cholecystokinin receptor type A,CCKAR,agonist,V04CK02
DB08862,Cholecystokinin,,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,agonist,V04CK02
DB08862,Cholecystokinin,,P27361,Mitogen-activated protein kinase 3,MAPK3,,V04CK02
DB08862,Cholecystokinin,,P01133,Pro-epidermal growth factor,EGF,,V04CK02
DB08862,Cholecystokinin,,P05771,Protein kinase C beta type,PRKCB,agonist,V04CK02
DB08862,Cholecystokinin,,P32239,Gastrin/cholecystokinin type B receptor,CCKBR,agonist,V04CK02
DB08864,Rilpivirine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AR19;J05AR21;J05AR08;J05AG05
DB08864,Rilpivirine,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,agonist,J05AR19;J05AR21;J05AR08;J05AG05
DB08865,Crizotinib,,Q9UM73,ALK tyrosine kinase receptor,ALK,inhibitor,L01ED01
DB08865,Crizotinib,,P08581,Hepatocyte growth factor receptor,MET,inhibitor,L01ED01
DB08865,Crizotinib,,P08922,Proto-oncogene tyrosine-protein kinase ROS,ROS1,inhibitor,L01ED01
DB08865,Crizotinib,,Q04912,Macrophage-stimulating protein receptor,MST1R,inhibitor,L01ED01
DB08867,Ulipristal,,P06401,Progesterone receptor,PGR,modulator,G03AD02;G03XB02
DB08867,Ulipristal,,P04150,Glucocorticoid receptor,NR3C1,antagonist,G03AD02;G03XB02
DB08867,Ulipristal,,P10275,Androgen receptor,AR,,G03AD02;G03XB02
DB08868,Fingolimod,,Q9H228,Sphingosine 1-phosphate receptor 5,S1PR5,modulator,L04AA27
DB08868,Fingolimod,,P21453,Sphingosine 1-phosphate receptor 1,S1PR1,modulator,L04AA27
DB08868,Fingolimod,,Q99500,Sphingosine 1-phosphate receptor 3,S1PR3,modulator,L04AA27
DB08868,Fingolimod,,Q13547,Histone deacetylase 1,HDAC1,inhibitor,L04AA27
DB08868,Fingolimod,,O95977,Sphingosine 1-phosphate receptor 4,S1PR4,modulator,L04AA27
DB08869,Tesamorelin,,Q02643,Growth hormone-releasing hormone receptor,GHRHR,binder,H01AC06
DB08870,Brentuximab vedotin,,P28908,Tumor necrosis factor receptor superfamily member 8,TNFRSF8,binder,L01FX05
DB08870,Brentuximab vedotin,,P28908,Tumor necrosis factor receptor superfamily member 8,TNFRSF8,antibody,L01FX05
DB08870,Brentuximab vedotin,,P28908,Tumor necrosis factor receptor superfamily member 8,TNFRSF8,regulator,L01FX05
DB08871,Eribulin,,P10415,Apoptosis regulator Bcl-2,BCL2,,L01XX41
DB08871,Eribulin,,Q9H4B7,Tubulin beta-1 chain,TUBB1,,L01XX41
DB08872,Gabapentin enacarbil,,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,,
DB08872,Gabapentin enacarbil,,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,,
DB08873,Boceprevir,,B0B3C9,NS3/4A protein,NS3/4A,inhibitor,J05AP03
DB08874,Fidaxomicin,,Q18BX5,RNA polymerase sigma factor,sigA1,inhibitor,A07AA12
DB08875,Cabozantinib,,P08581,Hepatocyte growth factor receptor,MET,antagonist,L01EX07
DB08875,Cabozantinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,antagonist,L01EX07
DB08875,Cabozantinib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,antagonist,L01EX07
DB08876,Taliglucerase alfa,,,Glucocerebroside,,,A16AB11
DB08877,Ruxolitinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,D11AH09;L01EJ01
DB08877,Ruxolitinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,D11AH09;L01EJ01
DB08877,Ruxolitinib,,P52333,Tyrosine-protein kinase JAK3,JAK3,inhibitor,D11AH09;L01EJ01
DB08877,Ruxolitinib,,P29597,Non-receptor tyrosine-protein kinase TYK2,TYK2,inhibitor,D11AH09;L01EJ01
DB08879,Belimumab,,Q9Y275,Tumor necrosis factor ligand superfamily member 13B,TNFSF13B,antibody,L04AA26
DB08880,Teriflunomide,,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,inhibitor,L04AA31
DB08881,Vemurafenib,,P15056,Serine/threonine-protein kinase B-raf,BRAF,inhibitor,G01AE10;L01EC01
DB08882,Linagliptin,,P27487,Dipeptidyl peptidase 4,DPP4,inhibitor,A10BH05;A10BD19;A10BD11;A10BD27
DB08883,Perampanel,,P42261,Glutamate receptor 1,GRIA1,antagonist,N03AX22
DB08885,Aflibercept,,P15692,Vascular endothelial growth factor A,VEGFA,inhibitor,S01LA05;L01XX44
DB08885,Aflibercept,,P15692,Vascular endothelial growth factor A,VEGFA,binder,S01LA05;L01XX44
DB08885,Aflibercept,,P49763,Placenta growth factor,PGF,inhibitor,S01LA05;L01XX44
DB08885,Aflibercept,,P49763,Placenta growth factor,PGF,binder,S01LA05;L01XX44
DB08885,Aflibercept,,P49765,Vascular endothelial growth factor B,VEGFB,inhibitor,S01LA05;L01XX44
DB08885,Aflibercept,,P49765,Vascular endothelial growth factor B,VEGFB,binder,S01LA05;L01XX44
DB08888,Ocriplasmin,,P02751,Fibronectin,FN1,cleavage,S01XA22
DB08888,Ocriplasmin,,P01023,Alpha-2-macroglobulin,A2M,ligand,S01XA22
DB08888,Ocriplasmin,,P08697,Alpha-2-antiplasmin,SERPINF2,ligand,S01XA22
DB08889,Carfilzomib,,P28074,Proteasome subunit beta type-5,PSMB5,inhibitor,L01XG02
DB08889,Carfilzomib,,P28062,Proteasome subunit beta type-8,PSMB8,inhibitor,L01XG02
DB08889,Carfilzomib,,P20618,Proteasome subunit beta type-1,PSMB1,inhibitor,L01XG02
DB08889,Carfilzomib,,P28065,Proteasome subunit beta type-9,PSMB9,inhibitor,L01XG02
DB08889,Carfilzomib,,P49721,Proteasome subunit beta type-2,PSMB2,inhibitor,L01XG02
DB08889,Carfilzomib,,P40306,Proteasome subunit beta type-10,PSMB10,inhibitor,L01XG02
DB08890,Linaclotide,,P25092,Heat-stable enterotoxin receptor,GUCY2C,agonist,A06AX04
DB08891,Arbaclofen,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,agonist,
DB08891,Arbaclofen,,O75899,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,agonist,
DB08892,Arbaclofen Placarbil,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,agonist,
DB08892,Arbaclofen Placarbil,,O75899,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,agonist,
DB08893,Mirabegron,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,G04BD12
DB08893,Mirabegron,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,G04BD12
DB08894,Peginesatide,,P19235,Erythropoietin receptor,EPOR,stimulator,B03XA04
DB08895,Tofacitinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,L04AA29
DB08895,Tofacitinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,antagonist,L04AA29
DB08895,Tofacitinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,L04AA29
DB08895,Tofacitinib,,P52333,Tyrosine-protein kinase JAK3,JAK3,inhibitor,L04AA29
DB08895,Tofacitinib,,P29597,Non-receptor tyrosine-protein kinase TYK2,TYK2,,L04AA29
DB08896,Regorafenib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,L01EX05
DB08896,Regorafenib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EX05
DB08896,Regorafenib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,inhibitor,L01EX05
DB08896,Regorafenib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,L01EX05
DB08896,Regorafenib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,inhibitor,L01EX05
DB08896,Regorafenib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,L01EX05
DB08896,Regorafenib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EX05
DB08896,Regorafenib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,L01EX05
DB08896,Regorafenib,,Q02763,Angiopoietin-1 receptor,TEK,inhibitor,L01EX05
DB08896,Regorafenib,,Q16832,Discoidin domain-containing receptor 2,DDR2,inhibitor,L01EX05
DB08896,Regorafenib,,P04629,High affinity nerve growth factor receptor,NTRK1,inhibitor,L01EX05
DB08896,Regorafenib,,P29317,Ephrin type-A receptor 2,EPHA2,inhibitor,L01EX05
DB08896,Regorafenib,,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,inhibitor,L01EX05
DB08896,Regorafenib,,P15056,Serine/threonine-protein kinase B-raf,BRAF,inhibitor,L01EX05
DB08896,Regorafenib,,Q15759,Mitogen-activated protein kinase 11,MAPK11,inhibitor,L01EX05
DB08896,Regorafenib,,P42685,Tyrosine-protein kinase FRK,FRK,inhibitor,L01EX05
DB08896,Regorafenib,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,L01EX05
DB08896,Regorafenib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,inhibitor,L01EX05
DB08897,Aclidinium,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,R03BB05;R03AL05
DB08897,Aclidinium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,R03BB05;R03AL05
DB08897,Aclidinium,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,R03BB05;R03AL05
DB08897,Aclidinium,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,R03BB05;R03AL05
DB08897,Aclidinium,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,R03BB05;R03AL05
DB08899,Enzalutamide,,P10275,Androgen receptor,AR,inhibitor,L02BB04
DB08900,Teduglutide,,O95838,Glucagon-like peptide 2 receptor,GLP2R,agonist,A16AX08
DB08901,Ponatinib,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,L01EA05
DB08901,Ponatinib,,P11274,Breakpoint cluster region protein,BCR,inhibitor,L01EA05
DB08901,Ponatinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,L01EA05
DB08901,Ponatinib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,inhibitor,L01EA05
DB08901,Ponatinib,,Q02763,Angiopoietin-1 receptor,TEK,inhibitor,L01EA05
DB08901,Ponatinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EA05
DB08901,Ponatinib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EA05
DB08901,Ponatinib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,L01EA05
DB08901,Ponatinib,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,L01EA05
DB08901,Ponatinib,,P22455,Fibroblast growth factor receptor 4,FGFR4,inhibitor,L01EA05
DB08901,Ponatinib,,P06239,Tyrosine-protein kinase Lck,LCK,inhibitor,L01EA05
DB08901,Ponatinib,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,inhibitor,L01EA05
DB08901,Ponatinib,,P07948,Tyrosine-protein kinase Lyn,LYN,inhibitor,L01EA05
DB08901,Ponatinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EA05
DB08901,Ponatinib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,inhibitor,L01EA05
DB08902,Raxibacumab,,P13423,Protective antigen,pagA,antibody,J06BC02
DB08903,Bedaquiline,,P9WPS1,ATP synthase subunit c,atpE,inhibitor,J04AK05
DB08904,Certolizumab pegol,,P01375,Tumor necrosis factor,TNF,neutralizer,L04AB05
DB08906,Fluticasone furoate,,P04150,Glucocorticoid receptor,NR3C1,agonist,R03AL08;R01AD12;R03AK10;R03BA09
DB08906,Fluticasone furoate,,P06401,Progesterone receptor,PGR,agonist,R03AL08;R01AD12;R03AK10;R03BA09
DB08906,Fluticasone furoate,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,R03AL08;R01AD12;R03AK10;R03BA09
DB08907,Canagliflozin,,P31639,Sodium/glucose cotransporter 2,SLC5A2,inhibitor,A10BD16;A10BK02
DB08908,Dimethyl fumarate,,Q14145,Kelch-like ECH-associated protein 1,KEAP1,binder,L04AX07
DB08908,Dimethyl fumarate,,Q04206,Transcription factor p65,RELA,inhibitor,L04AX07
DB08908,Dimethyl fumarate,,Q04206,Transcription factor p65,RELA,binder,L04AX07
DB08910,Pomalidomide,,Q96SW2,Protein cereblon,CRBN,inhibitor,L04AX06
DB08910,Pomalidomide,,P01375,Tumor necrosis factor,TNF,inhibitor,L04AX06
DB08910,Pomalidomide,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,L04AX06
DB08911,Trametinib,,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,inhibitor,L01EE01
DB08911,Trametinib,,P36507,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,inhibitor,L01EE01
DB08912,Dabrafenib,,P15056,Serine/threonine-protein kinase B-raf,BRAF,inhibitor,L01EC02
DB08912,Dabrafenib,,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,inhibitor,L01EC02
DB08912,Dabrafenib,,P57059,Serine/threonine-protein kinase SIK1,SIK1,inhibitor,L01EC02
DB08912,Dabrafenib,,Q8NG66,Serine/threonine-protein kinase Nek11,NEK11,inhibitor,L01EC02
DB08912,Dabrafenib,,P53667,LIM domain kinase 1,LIMK1,inhibitor,L01EC02
DB08915,Aleglitazar,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,
DB08915,Aleglitazar,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,
DB08915,Aleglitazar,,Q15788,Nuclear receptor coactivator 1,NCOA1,,
DB08916,Afatinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,L01EB03
DB08916,Afatinib,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,inhibitor,L01EB03
DB08916,Afatinib,,Q15303,Receptor tyrosine-protein kinase erbB-4,ERBB4,inhibitor,L01EB03
DB08918,Levomilnacipran,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX28
DB08918,Levomilnacipran,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AX28
DB08922,Perospirone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,inverse agonist,
DB08922,Perospirone,,P14416,Dopamine D2 receptor,DRD2,antagonist,
DB08922,Perospirone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,
DB08922,Perospirone,,P35367,Histamine H1 receptor,HRH1,inverse agonist,
DB08922,Perospirone,,P21917,Dopamine D4 receptor,DRD4,antagonist,
DB08922,Perospirone,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,
DB08927,Amperozide,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,
DB08930,Dolutegravir,,Q7ZJM1,Integrase,pol,inhibitor,J05AR27;J05AJ03;J05AR13;J05AR25;J05AR21
DB08931,Riociguat,,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,agonist,C02KX05
DB08931,Riociguat,,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,stimulator,C02KX05
DB08932,Macitentan,,P25101,Endothelin-1 receptor,EDNRA,antagonist,C02KX04;C02KX54
DB08932,Macitentan,,P24530,Endothelin B receptor,EDNRB,antagonist,C02KX04;C02KX54
DB08933,Luliconazole,,P10613,Cytochrome P450 51,ERG11,inhibitor,D01AC18
DB08934,Sofosbuvir,,O39930,RNA-dependent RNA-polymerase,NS5b,inhibitor,J05AP08;J05AP51;J05AP55;J05AP56
DB08935,Obinutuzumab,,P11836,B-lymphocyte antigen CD20,MS4A1,antibody,L01FA03
DB08935,Obinutuzumab,,P11836,B-lymphocyte antigen CD20,MS4A1,regulator,L01FA03
DB08936,Chlorcyclizine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AE04
DB08949,Inositol nicotinate,,P49019,Hydroxycarboxylic acid receptor 3,HCAR3,agonist,C04AC03
DB08949,Inositol nicotinate,,Q8TDS4,Hydroxycarboxylic acid receptor 2,HCAR2,agonist,C04AC03
DB08950,Indoramin,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,C02CA02
DB08951,Indoprofen,,P14618,Pyruvate kinase PKM,PKM,inhibitor,M01AE10
DB08954,Ifenprodil,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,antagonist,C04AX28
DB08954,Ifenprodil,,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,antagonist,C04AX28
DB08954,Ifenprodil,,P48549,G protein-activated inward rectifier potassium channel 1,KCNJ3,antagonist,C04AX28
DB08954,Ifenprodil,,P48051,G protein-activated inward rectifier potassium channel 2,KCNJ6,antagonist,C04AX28
DB08954,Ifenprodil,,P48544,G protein-activated inward rectifier potassium channel 4,KCNJ5,antagonist,C04AX28
DB08960,Hexamethonium,,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,antagonist,
DB08964,Gemeprost,,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,agonist,G02AD03
DB08964,Gemeprost,,P43116,Prostaglandin E2 receptor EP2 subtype,PTGER2,agonist,G02AD03
DB08995,Diosmin,,P35869,Aryl hydrocarbon receptor,AHR,agonist,C05CA03;C05CA53
DB08996,Dimetacrine,,P22303,Acetylcholinesterase,ACHE,antagonist,N06AA18
DB09006,Clinofibrate,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,
DB09006,Clinofibrate,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB09006,Clinofibrate,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,,
DB09013,Befunolol,,P08588,Beta-1 adrenergic receptor,ADRB1,,S01ED06
DB09013,Befunolol,,P07550,Beta-2 adrenergic receptor,ADRB2,,S01ED06
DB09014,Captodiame,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,N05BB02
DB09014,Captodiame,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,agonist,N05BB02
DB09014,Captodiame,,P35462,Dopamine D3 receptor,DRD3,agonist,N05BB02
DB09016,Butriptyline,,P31645,Sodium-dependent serotonin transporter,SLC6A4,antagonist,N06AA15
DB09016,Butriptyline,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA15
DB09016,Butriptyline,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AA15
DB09016,Butriptyline,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AA15
DB09017,Brotizolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD09
DB09017,Brotizolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD09
DB09018,Bromopride,,P14416,Dopamine D2 receptor,DRD2,antagonist,A03FA04
DB09019,Bromhexine,,O15393,Transmembrane protease serine 2,TMPRSS2,,R05CB02
DB09019,Bromhexine,,Q9BYF1,Angiotensin-converting enzyme 2,ACE2,binder,R05CB02
DB09020,Bisacodyl,,Q92482,Aquaporin-3,AQP3,negative modulator,A06AB52;A06AB02;A06AG02
DB09020,Bisacodyl,,P05023,Sodium/Potassium Transporting ATPase,ATP1A1,inhibitor,A06AB52;A06AB02;A06AG02
DB09026,Aliskiren,,P00797,Renin,REN,inhibitor,C09XA54;C09XA53;C09DX02;C09XA02;C09XA52
DB09027,Ledipasvir,,Q5L478,Nonstructural protein 5A,NS5A,inhibitor,J05AP51
DB09028,Cytisine,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,agonist,
DB09028,Cytisine,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,agonist,
DB09028,Cytisine,,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,agonist,
DB09028,Cytisine,,Q15825,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,agonist,
DB09028,Cytisine,,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,partial agonist,
DB09029,Secukinumab,,Q16552,Interleukin-17A,IL17A,inhibitor,L04AC10
DB09030,Vorapaxar,,P25116,Proteinase-activated receptor 1,F2R,antagonist,B01AC26
DB09031,Miltefosine,,P08183,P-glycoprotein 1,ABCB1,,P01CX04
DB09033,Vedolizumab,,P13612,Integrin alpha-4,ITGA4,antibody,L04AA33
DB09033,Vedolizumab,,P26010,Integrin beta-7,ITGB7,antibody,L04AA33
DB09034,Suvorexant,,O43613,Orexin receptor type 1,HCRTR1,antagonist,N05CM19
DB09034,Suvorexant,,O43614,Orexin receptor type 2,HCRTR2,antagonist,N05CM19
DB09035,Nivolumab,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,L01FF01;L01XY03
DB09035,Nivolumab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,L01FF01;L01XY03
DB09035,Nivolumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,L01FF01;L01XY03
DB09035,Nivolumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,antibody,L01FF01;L01XY03
DB09036,Siltuximab,,P05231,Interleukin-6,IL6,antagonist,L04AC11
DB09036,Siltuximab,,P05231,Interleukin-6,IL6,antibody,L04AC11
DB09037,Pembrolizumab,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,L01FF02
DB09037,Pembrolizumab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,L01FF02
DB09037,Pembrolizumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,L01FF02
DB09037,Pembrolizumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,antibody,L01FF02
DB09038,Empagliflozin,,P31639,Sodium/glucose cotransporter 2,SLC5A2,inhibitor,A10BD19;A10BD20;A10BK03;A10BD27
DB09039,Eliglustat,,Q16739,Ceramide glucosyltransferase,UGCG,inhibitor,A16AX10
DB09040,Efinaconazole,,P50859,Lanosterol 14-alpha demethylase,ERG11,inhibitor,D01AC19
DB09041,Tavaborole,,A0A178ESV1,leucine--tRNA ligase,,inhibitor,D01AE24
DB09042,Tedizolid phosphate,,,23S ribosomal RNA,,inhibitor,
DB09043,Albiglutide,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,A10BJ04
DB09045,Dulaglutide,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,A10BJ05
DB09046,Metreleptin,,P48357,Leptin receptor,LEPR,agonist,A16AA07
DB09047,Finafloxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,
DB09047,Finafloxacin,,P43702,DNA topoisomerase 4 subunit A,parC,inhibitor,
DB09047,Finafloxacin,,P11388,DNA topoisomerase 2-alpha,TOP2A,inhibitor,
DB09048,Netupitant,,P25103,Neurokinin 1 receptor,TACR1,antagonist,
DB09049,Naloxegol,,P35372,Mu-type opioid receptor,OPRM1,antagonist,A06AH03
DB09050,Ceftolozane,,Q9X6W0,Penicillin-binding protein 1B,ponB,inhibitor,
DB09050,Ceftolozane,,Q51504,Penicillin-binding protein 3,pbpB,inhibitor,
DB09050,Ceftolozane,,P76577,Penicillin-binding protein 1C,pbpC,inhibitor,
DB09050,Ceftolozane,,P0AD65,Penicillin-binding protein 2,mrdA,inhibitor,
DB09050,Ceftolozane,,P0AEB2,Penicillin-binding protein,dacA,,
DB09052,Blinatumomab,,P15391,B-lymphocyte antigen CD19,CD19,antibody,L01FX07
DB09052,Blinatumomab,,P15391,B-lymphocyte antigen CD19,CD19,activator,L01FX07
DB09052,Blinatumomab,,P15391,B-lymphocyte antigen CD19,CD19,regulator,L01FX07
DB09052,Blinatumomab,,P04234,T-cell surface glycoprotein CD3 delta chain,CD3D,antibody,L01FX07
DB09052,Blinatumomab,,P04234,T-cell surface glycoprotein CD3 delta chain,CD3D,activator,L01FX07
DB09053,Ibrutinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,L01EL01
DB09054,Idelalisib,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,inhibitor,L01EM01
DB09057,Anthrax immune globulin human,,P13423,Protective antigen,pagA,antibody,
DB09059,Atosiban,,P30559,Oxytocin receptor,OXTR,antagonist,G02CX01
DB09059,Atosiban,,P37288,Vasopressin V1a receptor,AVPR1A,antagonist,G02CX01
DB09059,Atosiban,,P47901,Vasopressin V1b receptor,AVPR1B,antagonist,G02CX01
DB09059,Atosiban,,P30518,Vasopressin V2 receptor,AVPR2,antagonist,G02CX01
DB09060,Avibactam,,P62593,Beta-lactamase TEM,bla,inhibitor,
DB09060,Avibactam,,Q939N4,Beta-lactamase CTX-M,,inhibitor,
DB09060,Avibactam,,P05364,Beta-lactamase,ampC,inhibitor,
DB09060,Avibactam,,P0AD63,Beta-lactamase SHV-1,bla,inhibitor,
DB09060,Avibactam,,P0A9Z7,Beta-lactamase SHV-2,bla,inhibitor,
DB09060,Avibactam,,P0AD64,Beta-lactamase SHV-1,bla,inhibitor,
DB09060,Avibactam,,A0A023W3H0,Class D OXA-48 carbapenemase,OXA-48,inhibitor,
DB09060,Avibactam,,Q9F663,Carbapenem-hydrolyzing beta-lactamase KPC,bla,inhibitor,
DB09060,Avibactam,,Q9EXV5,Beta-lactamase CTX-M-15,blaUOE-1,inhibitor,
DB09060,Avibactam,,P37321,Extended-spectrum beta-lactamase PER-1,per1,inhibitor,
DB09061,Cannabidiol,,P21554,Cannabinoid receptor 1,CNR1,antagonist,N03AX24
DB09061,Cannabidiol,,P21554,Cannabinoid receptor 1,CNR1,modulator,N03AX24
DB09061,Cannabidiol,,P34972,Cannabinoid receptor 2,CNR2,antagonist,N03AX24
DB09061,Cannabidiol,,P47775,G-protein coupled receptor 12,GPR12,inverse agonist,N03AX24
DB09061,Cannabidiol,,P23415,Glycine receptor subunit alpha-1,GLRA1,,N03AX24
DB09061,Cannabidiol,,P23415,Glycine receptor (alpha-1/beta),GLRA1,allosteric modulator,N03AX24
DB09061,Cannabidiol,,O75311,Glycine receptor subunit alpha-3,GLRA3,potentiator,N03AX24
DB09061,Cannabidiol,,Q14330,N-arachidonyl glycine receptor,GPR18,,N03AX24
DB09061,Cannabidiol,,Q9Y2T6,G-protein coupled receptor 55,GPR55,antagonist,N03AX24
DB09061,Cannabidiol,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N03AX24
DB09061,Cannabidiol,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,N03AX24
DB09061,Cannabidiol,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,N03AX24
DB09061,Cannabidiol,,P41143,Delta-type opioid receptor,OPRD1,,N03AX24
DB09061,Cannabidiol,,P35372,Mu-type opioid receptor,OPRM1,,N03AX24
DB09061,Cannabidiol,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,activator,N03AX24
DB09061,Cannabidiol,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,activator,N03AX24
DB09061,Cannabidiol,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,,N03AX24
DB09061,Cannabidiol,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,,N03AX24
DB09061,Cannabidiol,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,,N03AX24
DB09061,Cannabidiol,,O75762,Transient receptor potential cation channel subfamily A member 1,TRPA1,agonist,N03AX24
DB09061,Cannabidiol,,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,TRPM8,,N03AX24
DB09061,Cannabidiol,,Q9Y5S1,Transient receptor potential cation channel subfamily V member 2,TRPV2,activator,N03AX24
DB09061,Cannabidiol,,Q8NET8,Transient receptor potential cation channel subfamily V member 3,TRPV3,activator,N03AX24
DB09061,Cannabidiol,,Q9HBA0,Transient receptor potential cation channel subfamily V member 4,TRPV4,activator,N03AX24
DB09061,Cannabidiol,,P21796,Voltage-dependent anion-selective channel protein 1,VDAC1,,N03AX24
DB09061,Cannabidiol,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,N03AX24
DB09061,Cannabidiol,,P30542,Adenosine receptor A1,ADORA1,activator,N03AX24
DB09061,Cannabidiol,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,N03AX24
DB09061,Cannabidiol,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,N03AX24
DB09061,Cannabidiol,,P24752,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,inhibitor,N03AX24
DB09061,Cannabidiol,,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,inhibitor,N03AX24
DB09061,Cannabidiol,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,stimulator,N03AX24
DB09061,Cannabidiol,,P00390,"Glutathione reductase, mitochondrial",GSR,stimulator,N03AX24
DB09061,Cannabidiol,,P07203,Glutathione peroxidase 1,GPX1,stimulator,N03AX24
DB09061,Cannabidiol,,P14902,"Indoleamine 2,3-dioxygenase 1",IDO1,inhibitor,N03AX24
DB09061,Cannabidiol,,Q16678,Cytochrome P450 1B1,CYP1B1,inhibitor,N03AX24
DB09061,Cannabidiol,,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,inhibitor,N03AX24
DB09061,Cannabidiol,,P04040,Catalase,CAT,inhibitor,N03AX24
DB09061,Cannabidiol,,P20815,Cytochrome P450 3A5,CYP3A5,inhibitor,N03AX24
DB09061,Cannabidiol,,P10635,Cytochrome P450 2D6,CYP2D6,inhibitor,N03AX24
DB09061,Cannabidiol,,P00441,Superoxide dismutase [Cu-Zn],SOD1,inhibitor,N03AX24
DB09061,Cannabidiol,,P05177,Cytochrome P450 1A2,CYP1A2,inhibitor,N03AX24
DB09061,Cannabidiol,,P24462,Cytochrome P450 3A7,CYP3A7,inhibitor,N03AX24
DB09061,Cannabidiol,,Q16613,Serotonin N-acetyltransferase,AANAT,inhibitor,N03AX24
DB09061,Cannabidiol,,Q02083,N-acylethanolamine-hydrolyzing acid amidase,NAAA,inhibitor,N03AX24
DB09063,Ceritinib,,Q9UM73,ALK tyrosine kinase receptor,ALK,antagonist,L01ED02
DB09064,Ciprofibrate,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,C10AB08
DB09065,Cobicistat,,P08684,Cytochrome P450 3A4,CYP3A4,inhibitor,J05AR09;J05AR15;J05AR14;J05AR22;J05AR18;V03AX03
DB09065,Cobicistat,,P20815,Cytochrome P450 3A5,CYP3A5,inhibitor,J05AR09;J05AR15;J05AR14;J05AR22;J05AR18;V03AX03
DB09065,Cobicistat,,P24462,Cytochrome P450 3A7,CYP3A7,inhibitor,J05AR09;J05AR15;J05AR14;J05AR22;J05AR18;V03AX03
DB09066,Corifollitropin alfa,,P23945,Follicle-stimulating hormone receptor,FSHR,agonist,G03GA09
DB09067,Corticorelin ovine triflutate,,P34998,Corticotropin-releasing factor receptor 1,CRHR1,ligand,
DB09068,Vortioxetine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AX26
DB09068,Vortioxetine,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,N06AX26
DB09068,Vortioxetine,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N06AX26
DB09068,Vortioxetine,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,partial agonist,N06AX26
DB09068,Vortioxetine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N06AX26
DB09068,Vortioxetine,,P08588,Beta-1 adrenergic receptor,ADRB1,ligand,N06AX26
DB09068,Vortioxetine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,blocker,N06AX26
DB09069,Trimetazidine,,P42765,"3-ketoacyl-CoA thiolase, mitochondrial",ACAA2,inhibitor,C01EB15
DB09070,Tibolone,,P03372,Estrogen receptor alpha,ESR1,antagonist,G03CX01
DB09070,Tibolone,,P03372,Estrogen receptor alpha,ESR1,agonist,G03CX01
DB09071,Tasimelteon,,P48039,Melatonin receptor type 1A,MTNR1A,agonist,N05CH03
DB09071,Tasimelteon,,P49286,Melatonin receptor type 1B,MTNR1B,agonist,N05CH03
DB09072,Sodium oxybate,,Q9UBS5,GABA(B) Receptor,GABBR1,agonist,N01AX11;N07XX04
DB09072,Sodium oxybate,,Q9HAB3,Gamma-hydroxybutyrate (GHB) receptor,SLC52A2,agonist,N01AX11;N07XX04
DB09073,Palbociclib,,P11802,Cyclin-dependent kinase 4,CDK4,inhibitor,L01EF01
DB09073,Palbociclib,,Q00534,Cyclin-dependent kinase 6,CDK6,inhibitor,L01EF01
DB09074,Olaparib,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,inhibitor,L01XK01
DB09074,Olaparib,,Q9UGN5,Poly [ADP-ribose] polymerase 2,PARP2,inhibitor,L01XK01
DB09074,Olaparib,,Q9Y6F1,Poly [ADP-ribose] polymerase 3,PARP3,inhibitor,L01XK01
DB09074,Olaparib,,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,inhibitor,L01XK01
DB09075,Edoxaban,,P00742,Coagulation factor X,F10,inhibitor,B01AF03
DB09076,Umeclidinium,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,R03AL08;R03AL03;R03BB07
DB09076,Umeclidinium,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,R03AL08;R03AL03;R03BB07
DB09076,Umeclidinium,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,R03AL08;R03AL03;R03BB07
DB09076,Umeclidinium,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,R03AL08;R03AL03;R03BB07
DB09076,Umeclidinium,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,R03AL08;R03AL03;R03BB07
DB09077,Dinutuximab,,,GD2 disialoganglioside,,inhibitor,L01FX06
DB09078,Lenvatinib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,L01EX08
DB09078,Lenvatinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EX08
DB09078,Lenvatinib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,inhibitor,L01EX08
DB09078,Lenvatinib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EX08
DB09078,Lenvatinib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,L01EX08
DB09078,Lenvatinib,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,L01EX08
DB09078,Lenvatinib,,P22455,Fibroblast growth factor receptor 4,FGFR4,inhibitor,L01EX08
DB09078,Lenvatinib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,inhibitor,L01EX08
DB09078,Lenvatinib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,inhibitor,L01EX08
DB09078,Lenvatinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,L01EX08
DB09079,Nintedanib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,L01EX09
DB09079,Nintedanib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EX09
DB09079,Nintedanib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,inhibitor,L01EX09
DB09079,Nintedanib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,inhibitor,L01EX09
DB09079,Nintedanib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,L01EX09
DB09079,Nintedanib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EX09
DB09079,Nintedanib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,L01EX09
DB09079,Nintedanib,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,L01EX09
DB09079,Nintedanib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EX09
DB09079,Nintedanib,,P06239,Tyrosine-protein kinase Lck,LCK,inhibitor,L01EX09
DB09079,Nintedanib,,P07948,Tyrosine-protein kinase Lyn,LYN,inhibitor,L01EX09
DB09079,Nintedanib,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,inhibitor,L01EX09
DB09080,Olodaterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03AL06;R03AC19
DB09082,Vilanterol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03AL08;R03AK10;R03AL03
DB09083,Ivabradine,,Q9UL51,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,HCN2,inhibitor,C01EB17;C07FX05;C07FX06
DB09085,Tetracaine,,P21817,Ryanodine receptor 1,RYR1,modulator,C05AD02;N01BA03;D04AB06;N01BA53;S01HA03
DB09085,Tetracaine,,Q92736,Ryanodine receptor 2,RYR2,modulator,C05AD02;N01BA03;D04AB06;N01BA53;S01HA03
DB09085,Tetracaine,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,blocker,C05AD02;N01BA03;D04AB06;N01BA53;S01HA03
DB09086,Eugenol,,P03372,Estrogen receptor alpha,ESR1,,
DB09086,Eugenol,,Q92731,Estrogen receptor beta,ESR2,,
DB09086,Eugenol,,P10275,Androgen receptor,AR,antagonist,
DB09086,Eugenol,,Q8NET8,Transient receptor potential cation channel subfamily V member 3,TRPV3,,
DB09088,Amylocaine,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,blocker,
DB09089,Trimebutine,,P35372,Mu-type opioid receptor,OPRM1,agonist,A03AA05
DB09089,Trimebutine,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,inhibitor,A03AA05
DB09089,Trimebutine,,Q12791,Calcium-activated potassium channel,KCNMA1,inhibitor,A03AA05
DB09089,Trimebutine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03AA05
DB09089,Trimebutine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,A03AA05
DB09089,Trimebutine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03AA05
DB09089,Trimebutine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,A03AA05
DB09089,Trimebutine,,O43497,Voltage-dependent T-type calcium channel,CACNA1G,activator,A03AA05
DB09090,Pinaverium,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,antagonist,A03AX04
DB09090,Pinaverium,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,inhibitor,A03AX04
DB09091,Tixocortol,,P04150,Glucocorticoid receptor,NR3C1,binder,R01AD57;R01AD07;A07EA05
DB09091,Tixocortol,,Q92769,Histone deacetylase 2,HDAC2,stimulator,R01AD57;R01AD07;A07EA05
DB09092,Xanthinol,,Q13423,"NAD(P) transhydrogenase, mitochondrial",NNT,cofactor,C04AD02
DB09092,Xanthinol,,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,cofactor,C04AD02
DB09092,Xanthinol,,P50213,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",IDH3A,cofactor,C04AD02
DB09092,Xanthinol,,Q02218,"2-oxoglutarate dehydrogenase, mitochondrial",OGDH,cofactor,C04AD02
DB09092,Xanthinol,,P40926,"Malate dehydrogenase, mitochondrial",MDH2,cofactor,C04AD02
DB09092,Xanthinol,,P39023,60S ribosomal protein L3,RPL3,binder,C04AD02
DB09093,Chlortetracycline,,,16S ribosomal RNA,,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09093,Chlortetracycline,,P0A7V3,30S ribosomal protein S3,rpsC,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09093,Chlortetracycline,,P0A7W7,30S ribosomal protein S8,rpsH,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09093,Chlortetracycline,,P0A7U3,30S ribosomal protein S19,rpsS,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09093,Chlortetracycline,,P0AG59,30S ribosomal protein S14,rpsN,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09093,Chlortetracycline,,P02359,30S ribosomal protein S7,rpsG,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09093,Chlortetracycline,,P84077,ADP-ribosylation factor 1,ARF1,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09093,Chlortetracycline,,P29422,Catalase,katA,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09093,Chlortetracycline,,P54762,Ephrin type-B receptor 1,EPHB1,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09093,Chlortetracycline,,P16233,Pancreatic triacylglycerol lipase,PNLIP,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09093,Chlortetracycline,,Q9UM07,Protein-arginine deiminase type-4,PADI4,inhibitor,D06AA02;S01AA02;J01AA03;J01AA20;A01AB21
DB09095,Difluocortolone,,P12429,Annexin A3,ANXA3,inducer,D07AC06;D07XC04;D07BC04
DB09095,Difluocortolone,,P04150,Glucocorticoid receptor,NR3C1,binder,D07AC06;D07XC04;D07BC04
DB09096,Benzoyl peroxide,,P04040,Catalase,CAT,inhibitor,D10AE01;D10AE51
DB09096,Benzoyl peroxide,,O75715,Glutathione peroxidase,GPX5,inhibitor,D10AE01;D10AE51
DB09096,Benzoyl peroxide,,Q96A70,Arginine decarboxylase,AZIN2,activator,D10AE01;D10AE51
DB09096,Benzoyl peroxide,,P17252,Protein kinase C,PRKCA,inhibitor,D10AE01;D10AE51
DB09096,Benzoyl peroxide,,P08294,Superoxide Dismutases,SOD3,inhibitor,D10AE01;D10AE51
DB09097,Quinagolide,,P14416,Dopamine D2 receptor,DRD2,agonist,G02CB04
DB09097,Quinagolide,,P21728,D(1) dopamine receptor,DRD1,agonist,G02CB04
DB09098,Somatrem,,P10912,Growth hormone receptor,GHR,agonist,H01AC02
DB09098,Somatrem,,P08069,Insulin-like growth factor 1 receptor,IGF1R,,H01AC02
DB09099,Somatostatin,,P30872,Somatostatin receptor type 1,SSTR1,agonist,H01CB01
DB09099,Somatostatin,,P30874,Somatostatin receptor type 2,SSTR2,agonist,H01CB01
DB09099,Somatostatin,,P32745,Somatostatin receptor type 3,SSTR3,agonist,H01CB01
DB09099,Somatostatin,,P31391,Somatostatin receptor type 4,SSTR4,agonist,H01CB01
DB09099,Somatostatin,,P35346,Somatostatin receptor type 5,SSTR5,agonist,H01CB01
DB09100,"Thyroid, porcine",,P10827,Thyroid hormone receptor alpha,THRA,substrate,
DB09100,"Thyroid, porcine",,P10828,Thyroid hormone receptor beta,THRB,substrate,
DB09101,Elvitegravir,,Q7ZJM1,Integrase,pol,inhibitor,J05AJ02;J05AR09;J05AR18
DB09102,Daclatasvir,,Q5L478,Nonstructural protein 5A,NS5A,inhibitor,J05AP58;J05AP07
DB09103,Ancestim,,P10721,Mast/stem cell growth factor receptor Kit,KIT,agonist,L03AA12
DB09105,Asfotase alfa,,,Pyrophosphate,,ligand,A16AB13
DB09107,Methoxy polyethylene glycol-epoetin beta,,P19235,Erythropoietin receptor,EPOR,stimulator,B03XA03
DB09108,Simoctocog alfa,,P04275,von Willebrand factor,VWF,binding,
DB09109,Turoctocog alfa,,P00740,Coagulation factor IX,F9,activator,
DB09109,Turoctocog alfa,,P00742,Coagulation factor X,F10,activator,
DB09109,Turoctocog alfa,,P00734,Prothrombin,F2,binder,
DB09112,Nitrous acid,,P69905,Hemoglobin subunit alpha,HBA1,oxidizer,V03AB08
DB09112,Nitrous acid,,P68871,Hemoglobin subunit beta,HBB,oxidizer,V03AB08
DB09112,Nitrous acid,,P02144,Myoglobin,MB,oxidizer,V03AB08
DB09116,Calcium carbimide,,P48448,Aldehyde dehydrogenase family 3 member B2,ALDH3B2,antagonist,N07BB02
DB09116,Calcium carbimide,,P48448,Aldehyde dehydrogenase family 3 member B2,ALDH3B2,inhibitor,N07BB02
DB09118,Stiripentol,,P14867,GABA(A) Receptor,GABRA1,agonist,N03AX17
DB09118,Stiripentol,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N03AX17
DB09118,Stiripentol,,P00338,L-lactate dehydrogenase A chain,LDHA,inhibitor,N03AX17
DB09118,Stiripentol,,P07195,L-lactate dehydrogenase B chain,LDHB,inhibitor,N03AX17
DB09119,Eslicarbazepine acetate,,Q99571,P2X purinoceptor 4,P2RX4,antagonist,
DB09120,Zucapsaicin,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,agonist,M02AB02
DB09120,Zucapsaicin,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,activator,M02AB02
DB09121,Aurothioglucose,,Q08828,Adenylate cyclase type 1,ADCY1,,M01CB04
DB09121,Aurothioglucose,,Q08462,Adenylate cyclase type 2,ADCY2,,M01CB04
DB09121,Aurothioglucose,,O95622,Adenylate cyclase type 5,ADCY5,,M01CB04
DB09122,Peginterferon beta-1a,,P17181,Interferon alpha/beta receptor 1,IFNAR1,activator,L03AB13
DB09122,Peginterferon beta-1a,,P17181,Interferon alpha/beta receptor 1,IFNAR1,downregulator,L03AB13
DB09123,Dienogest,,P06401,Progesterone receptor,PGR,agonist,G03AB08;G03DB08;G03FA15;G03AA16
DB09123,Dienogest,,P10275,Androgen receptor,AR,antagonist,G03AB08;G03DB08;G03FA15;G03AA16
DB09124,Medrogestone,,P06401,Progesterone receptor,PGR,ligand,G03DB03;G03FB07
DB09126,Chorionic Gonadotropin (Human),,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,ligand,G03GA01
DB09128,Brexpiprazole,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,N05AX16
DB09128,Brexpiprazole,,P14416,Dopamine D2 receptor,DRD2,partial agonist,N05AX16
DB09128,Brexpiprazole,,P35462,Dopamine D3 receptor,DRD3,partial agonist,N05AX16
DB09128,Brexpiprazole,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AX16
DB09128,Brexpiprazole,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N05AX16
DB09128,Brexpiprazole,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N05AX16
DB09128,Brexpiprazole,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,N05AX16
DB09128,Brexpiprazole,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N05AX16
DB09128,Brexpiprazole,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,N05AX16
DB09128,Brexpiprazole,,P18825,Alpha-2C adrenergic receptor,ADRA2C,antagonist,N05AX16
DB09128,Brexpiprazole,,P35367,Histamine H1 receptor,HRH1,antagonist,N05AX16
DB09128,Brexpiprazole,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N05AX16
DB09129,Chromic chloride,,P06213,Insulin receptor,INSR,activator,
DB09130,Copper,,P05067,Amyloid beta A4 protein,APP,binder,
DB09130,Copper,,P23526,Adenosylhomocysteinase,AHCY,allosteric modulator,
DB09130,Copper,,P62807,Histone H2B type 1-C/E/F/G/I,HIST1H2BC,,
DB09130,Copper,,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,,
DB09130,Copper,,P15531,Nucleoside diphosphate kinase A,NME1,,
DB09130,Copper,,P10412,Histone H1.4,HIST1H1E,,
DB09130,Copper,,Q06830,Peroxiredoxin-1,PRDX1,,
DB09130,Copper,,P05109,Protein S100-A8,S100A8,,
DB09130,Copper,,P08865,40S ribosomal protein SA,RPSA,,
DB09130,Copper,,P63261,"Actin, cytoplasmic 2",ACTG1,,
DB09130,Copper,,P06733,Alpha-enolase,ENO1,,
DB09130,Copper,,P68104,Elongation factor 1-alpha 1,EEF1A1,,
DB09130,Copper,,P05787,"Keratin, type II cytoskeletal 8",KRT8,,
DB09130,Copper,,P07237,Protein disulfide-isomerase,P4HB,,
DB09130,Copper,,P30101,Protein disulfide-isomerase A3,PDIA3,,
DB09130,Copper,,P10809,"60 kDa heat shock protein, mitochondrial",HSPD1,,
DB09130,Copper,,P48723,Heat shock 70 kDa protein 13,HSPA13,,
DB09130,Copper,,P11021,78 kDa glucose-regulated protein,HSPA5,,
DB09130,Copper,,P14625,Endoplasmin,HSP90B1,,
DB09130,Copper,,P02787,Serotransferrin,TF,,
DB09130,Copper,,Q08288,Cell growth-regulating nucleolar protein,Lyar,,
DB09130,Copper,,P15880,40S ribosomal protein S2,RPS2,,
DB09130,Copper,,Q07955,Serine/arginine-rich splicing factor 1,SRSF1,,
DB09130,Copper,,P22626,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,,
DB09130,Copper,,P31943,Heterogeneous nuclear ribonucleoprotein H,HNRNPH1,,
DB09130,Copper,,P31942,Heterogeneous nuclear ribonucleoprotein H3,HNRNPH3,,
DB09130,Copper,,P61987,Cobalt-precorrin-5B C(1)-methyltransferase,cbiD,,
DB09130,Copper,,P14866,Heterogeneous nuclear ribonucleoprotein L,HNRNPL,,
DB09130,Copper,,P23246,"Splicing factor, proline- and glutamine-rich",SFPQ,,
DB09130,Copper,,Q15428,Splicing factor 3A subunit 2,SF3A2,,
DB09130,Copper,,P63244,Receptor of activated protein C kinase 1,RACK1,,
DB09130,Copper,,P12814,Alpha-actinin-1,ACTN1,,
DB09130,Copper,,Q03154,Aminoacylase-1,ACY1,,
DB09130,Copper,,P09525,Annexin A4,ANXA4,,
DB09130,Copper,,P08758,Annexin A5,ANXA5,,
DB09130,Copper,,P27797,Calreticulin,CALR,,
DB09130,Copper,,P14618,Pyruvate kinase PKM,PKM,,
DB09130,Copper,,P14550,Alcohol dehydrogenase [NADP(+)],AKR1A1,,
DB09130,Copper,,P00387,NADH-cytochrome b5 reductase 3,CYB5R3,,
DB09130,Copper,,P00390,"Glutathione reductase, mitochondrial",GSR,,
DB09130,Copper,,P29401,Transketolase,TKT,,
DB09130,Copper,,P32119,Peroxiredoxin-2,PRDX2,,
DB09130,Copper,,P30041,Peroxiredoxin-6,PRDX6,,
DB09130,Copper,,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,,
DB09130,Copper,,P11142,Heat shock cognate 71 kDa protein,HSPA8,,
DB09130,Copper,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,,
DB09130,Copper,,Q15185,Prostaglandin E synthase 3,PTGES3,,
DB09130,Copper,,P31948,Stress-induced-phosphoprotein 1,STIP1,,
DB09130,Copper,,P56537,Eukaryotic translation initiation factor 6,EIF6,,
DB09130,Copper,,P60842,Eukaryotic initiation factor 4A-I,EIF4A1,,
DB09130,Copper,,P06744,Glucose-6-phosphate isomerase,GPI,,
DB09130,Copper,,P00338,L-lactate dehydrogenase A chain,LDHA,,
DB09130,Copper,,P00558,Phosphoglycerate kinase 1,PGK1,,
DB09130,Copper,,Q13748,Tubulin alpha 3C/D chain,TUBA3C,,
DB09130,Copper,,P07437,Tubulin beta chain,TUBB,,
DB09130,Copper,,P23528,Cofilin-1,CFL1,,
DB09130,Copper,,P31946,14-3-3 protein beta/alpha,YWHAB,,
DB09130,Copper,,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,,
DB09130,Copper,,P48637,Glutathione synthetase,GSS,,
DB09130,Copper,,P51858,Hepatoma-derived growth factor,HDGF,,
DB09130,Copper,,P50213,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",IDH3A,,
DB09130,Copper,,O00299,Chloride intracellular channel protein 1,CLIC1,,
DB09130,Copper,,Q06323,Proteasome activator complex subunit 1,PSME1,,
DB09130,Copper,,P30086,Phosphatidylethanolamine-binding protein 1,PEBP1,,
DB09130,Copper,,P18669,Phosphoglycerate mutase 1,PGAM1,,
DB09130,Copper,,P43487,Ran-specific GTPase-activating protein,RANBP1,,
DB09130,Copper,,O60701,UDP-glucose 6-dehydrogenase,UGDH,,
DB09130,Copper,,P61769,Beta-2-microglobulin,B2M,,
DB09130,Copper,,O75880,"Protein SCO1 homolog, mitochondrial",SCO1,,
DB09130,Copper,,F7VJQ1,Alternative prion protein,PRNP,,
DB09130,Copper,,P23415,Glycine receptor subunit alpha-1,GLRA1,,
DB09130,Copper,,P42858,Huntingtin,HTT,,
DB09130,Copper,,Q96FI4,Endonuclease 8-like 1,NEIL1,,
DB09130,Copper,,Q969S2,Endonuclease 8-like 2,NEIL2,,
DB09130,Copper,,Q6MZM0,Hephaestin-like protein 1,HEPHL1,cofactor,
DB09130,Copper,,P05121,Plasminogen activator inhibitor 1,SERPINE1,,
DB09130,Copper,,P29034,Protein S100-A2,S100A2,,
DB09130,Copper,,P26447,Protein S100-A4,S100A4,,
DB09130,Copper,,P37840,Alpha-synuclein,SNCA,,
DB09130,Copper,,P23560,Brain-derived neurotrophic factor,BDNF,cofactor,
DB09130,Copper,,Q99497,Protein DJ-1,PARK7,,
DB09130,Copper,,P10997,Islet amyloid polypeptide,IAPP,,
DB09130,Copper,,Q9UHF0,Tachykinin-3,TAC3,,
DB09130,Copper,,P04217,Alpha-1B-glycoprotein,A1BG,,
DB09130,Copper,,P43652,Afamin,AFM,,
DB09130,Copper,,P01019,Angiotensinogen,AGT,,
DB09130,Copper,,P02765,Alpha-2-HS-glycoprotein,AHSG,,
DB09130,Copper,,P02743,Serum amyloid P-component,APCS,,
DB09130,Copper,,P02647,Apolipoprotein A-I,APOA1,,
DB09130,Copper,,P02652,Apolipoprotein A-II,APOA2,,
DB09130,Copper,,P06727,Apolipoprotein A-IV,APOA4,,
DB09130,Copper,,Q0VD83,Apolipoprotein B receptor,APOBR,,
DB09130,Copper,,P02655,Apolipoprotein C-II,APOC2,,
DB09130,Copper,,P02656,Apolipoprotein C-III,APOC3,,
DB09130,Copper,,P05090,Apolipoprotein D,APOD,,
DB09130,Copper,,P02649,Apolipoprotein E,APOE,,
DB09130,Copper,,P02749,Beta-2-glycoprotein 1,APOH,,
DB09130,Copper,,P25311,Zinc-alpha-2-glycoprotein,AZGP1,,
DB09130,Copper,,P02747,Complement C1q subcomponent subunit C,C1QC,,
DB09130,Copper,,P09871,Complement C1s subcomponent,C1S,,
DB09130,Copper,,P01024,Complement C3,C3,,
DB09130,Copper,,P0C0L5,Complement C4-B,C4B,,
DB09130,Copper,,P04003,C4b-binding protein alpha chain,C4BPA,,
DB09130,Copper,,P01031,Complement C5,C5,,
DB09130,Copper,,P07358,Complement component C8 beta chain,C8B,,
DB09130,Copper,,P02748,Complement component C9,C9,,
DB09130,Copper,,P08603,Complement factor H,CFH,,
DB09130,Copper,,P05156,Complement factor I,CFI,,
DB09130,Copper,,P05452,Tetranectin,CLEC3B,,
DB09130,Copper,,P10909,Clusterin,CLU,,
DB09130,Copper,,P00734,Prothrombin,F2,,
DB09130,Copper,,Q07021,"Complement component 1 Q subcomponent-binding protein, mitochondrial",C1QBP,,
DB09130,Copper,,P06396,Gelsolin,GSN,,
DB09130,Copper,,P69905,Hemoglobin subunit alpha,HBA1,,
DB09130,Copper,,P68871,Hemoglobin subunit beta,HBB,,
DB09130,Copper,,P45973,Chromobox protein homolog 5,CBX5,,
DB09130,Copper,,P00739,Haptoglobin-related protein,HPR,,
DB09130,Copper,,P35858,Insulin-like growth factor-binding protein complex acid labile subunit,IGFALS,,
DB09130,Copper,,P01857,Ig gamma-1 chain C region,IGHG1,,
DB09130,Copper,,P01861,Ig gamma-4 chain C region,IGHG4,,
DB09130,Copper,,P01619,Ig kappa chain V-III region GOL,,,
DB09130,Copper,,P15814,Immunoglobulin lambda-like polypeptide 1,IGLL1,,
DB09130,Copper,,P19823,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,,
DB09130,Copper,,P01042,Kininogen-1,KNG1,,
DB09130,Copper,,P04264,"Keratin, type II cytoskeletal 1",KRT1,,
DB09130,Copper,,P13645,"Keratin, type I cytoskeletal 10",KRT10,,
DB09130,Copper,,P35908,"Keratin, type II cytoskeletal 2 epidermal",KRT2,,
DB09130,Copper,,P35527,"Keratin, type I cytoskeletal 9",KRT9,,
DB09130,Copper,,P02750,Leucine-rich alpha-2-glycoprotein,LRG1,,
DB09130,Copper,,P51884,Lumican,LUM,,
DB09130,Copper,,Q96PD5,N-acetylmuramoyl-L-alanine amidase,PGLYRP2,,
DB09130,Copper,,P00747,Plasminogen,PLG,,
DB09130,Copper,,P27169,Serum paraoxonase/arylesterase 1,PON1,,
DB09130,Copper,,P02775,Platelet basic protein,PPBP,,
DB09130,Copper,,P01009,Alpha-1-antitrypsin,SERPINA1,,
DB09130,Copper,,P29622,Kallistatin,SERPINA4,,
DB09130,Copper,,P08185,Corticosteroid-binding globulin,SERPINA6,,
DB09130,Copper,,P05543,Thyroxine-binding globulin,SERPINA7,,
DB09130,Copper,,P01008,Antithrombin-III,SERPINC1,,
DB09130,Copper,,P05546,Heparin cofactor 2,SERPIND1,,
DB09130,Copper,,P36955,Pigment epithelium-derived factor,SERPINF1,,
DB09130,Copper,,P08697,Alpha-2-antiplasmin,SERPINF2,,
DB09130,Copper,,P05155,Plasma protease C1 inhibitor,SERPING1,,
DB09130,Copper,,P02766,Transthyretin,TTR,,
DB09130,Copper,,P04004,Vitronectin,VTN,,
DB09130,Copper,,P51693,Amyloid-like protein 1,APLP1,cofactor,
DB09131,Cupric Chloride,,P04070,Vitamin K-dependent protein C,PROC,,
DB09131,Cupric Chloride,,P04080,Cystatin-B,CSTB,,
DB09140,Oxygen,,P00395,Cytochrome c oxidase subunit 1,MT-CO1,agonist,V03AN01
DB09140,Oxygen,,P00395,Cytochrome c oxidase subunit 1,MT-CO1,activator,V03AN01
DB09140,Oxygen,,Q9Y5S8,NADPH oxidase 1,NOX1,agonist,V03AN01
DB09140,Oxygen,,Q9Y5S8,NADPH oxidase 1,NOX1,activator,V03AN01
DB09141,Protamine sulfate,,P00742,Coagulation factor X,F10,,
DB09141,Protamine sulfate,,P01008,Antithrombin-III,SERPINC1,,
DB09142,Sincalide,,P32238,Cholecystokinin receptor type A,CCKAR,agonist,V04CC03
DB09142,Sincalide,,P32239,Gastrin/cholecystokinin type B receptor,CCKBR,agonist,V04CC03
DB09143,Sonidegib,,Q99835,Smoothened homolog,SMO,antagonist,L01XJ02
DB09147,Ferric pyrophosphate,,P02792,Ferritin light chain,FTL,binder,
DB09147,Ferric pyrophosphate,,P69905,Hemoglobin subunit alpha,HBA1,binder,
DB09147,Ferric pyrophosphate,,P68871,Hemoglobin subunit beta,HBB,binder,
DB09148,Florbetaben F-18,,P05067,Amyloid beta A4 protein,APP,binder,V09AX06
DB09149,Florbetapir (18F),,P05067,Amyloid beta A4 protein,APP,binder,V09AX05
DB09151,Flutemetamol (18F),,P05067,Amyloid beta A4 protein,APP,binder,V09AX04
DB09165,Technetium Tc-99m pyrophosphate,,,Hydroxyapatite,,ligand,V09BA03
DB09165,Technetium Tc-99m pyrophosphate,,,Amorphous calcium phosphate,,ligand,V09BA03
DB09166,Etizolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA19
DB09166,Etizolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA19
DB09166,Etizolam,,P25105,Platelet-activating factor receptor,PTAFR,antagonist,N05BA19
DB09167,Dosulepin,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,N06AA16
DB09167,Dosulepin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AA16
DB09167,Dosulepin,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AA16
DB09167,Dosulepin,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N06AA16
DB09167,Dosulepin,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N06AA16
DB09167,Dosulepin,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N06AA16
DB09167,Dosulepin,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N06AA16
DB09167,Dosulepin,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,N06AA16
DB09167,Dosulepin,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,N06AA16
DB09167,Dosulepin,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N06AA16
DB09167,Dosulepin,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AA16
DB09167,Dosulepin,,P31645,Sodium-dependent serotonin transporter,SLC6A4,inhibitor,N06AA16
DB09173,Butyrfentanyl,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB09173,Butyrfentanyl,,P41145,Kappa-type opioid receptor,OPRK1,agonist,
DB09173,Butyrfentanyl,,P41143,Delta-type opioid receptor,OPRD1,agonist,
DB09183,Dasabuvir,,P87764,Nonstructural protein 5B (NS5B),NS5b,inhibitor,J05AP09;J05AP52
DB09185,Viloxazine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06AX09
DB09185,Viloxazine,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,antagonist,N06AX09
DB09185,Viloxazine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,N06AX09
DB09185,Viloxazine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,N06AX09
DB09185,Viloxazine,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,N06AX09
DB09185,Viloxazine,,P35367,Histamine H1 receptor,HRH1,antagonist,N06AX09
DB09185,Viloxazine,,P25021,Histamine H2 receptor,HRH2,antagonist,N06AX09
DB09185,Viloxazine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,N06AX09
DB09185,Viloxazine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,N06AX09
DB09185,Viloxazine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,N06AX09
DB09185,Viloxazine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,N06AX09
DB09185,Viloxazine,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,N06AX09
DB09185,Viloxazine,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,N06AX09
DB09186,Nisoxetine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,
DB09194,Etoperidone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N06AB09
DB09194,Etoperidone,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,N06AB09
DB09194,Etoperidone,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N06AB09
DB09194,Etoperidone,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,N06AB09
DB09194,Etoperidone,,P14416,Dopamine D2 receptor,DRD2,antagonist,N06AB09
DB09194,Etoperidone,,P11229,Muscarinic acetylcholine receptor,CHRM1,antagonist,N06AB09
DB09195,Lorpiprazole,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,
DB09195,Lorpiprazole,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,antagonist,
DB09195,Lorpiprazole,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,
DB09195,Lorpiprazole,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,
DB09195,Lorpiprazole,,P35367,Histamine H1 receptor,HRH1,antagonist,
DB09195,Lorpiprazole,,P31645,Sodium-dependent serotonin transporter,SLC6A4,antagonist,
DB09198,Lobeglitazone,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,activator,A10BG04;A10BD26
DB09201,Ciglitazone,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,
DB09202,Cirazoline,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,
DB09202,Cirazoline,,P35368,Alpha-1B adrenergic receptor,ADRA1B,partial agonist,
DB09202,Cirazoline,,P25100,Alpha-1D adrenergic receptor,ADRA1D,partial agonist,
DB09202,Cirazoline,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,
DB09203,Synephrine,,P35348,Alpha-1 adrenergic receptors,ADRA1A,,S01GA06;S01GA56;C01CA08
DB09204,Arotinolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,
DB09204,Arotinolol,,P07550,Beta-2 adrenergic receptor,ADRB2,antagonist,
DB09204,Arotinolol,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,
DB09205,Moxisylyte,,P35348,Alpha adrenergic receptor,ADRA1A,antagonist,C04AX10;G04BE06
DB09207,AS-8112,,P14416,Dopamine D2 receptor,DRD2,antagonist,
DB09207,AS-8112,,P35462,Dopamine D3 receptor,DRD3,antagonist,
DB09207,AS-8112,,Q9UE69,5HT3 serotonin receptor,,antagonist,
DB09208,Pegloticase,,,Uric acid,,substrate,M04AX02
DB09208,Pegloticase,,,Uric acid,,metabolizer,M04AX02
DB09209,Pholcodine,,P35372,Mu-type opioid receptor,OPRM1,antagonist,R05DA08
DB09209,Pholcodine,,P41145,Kappa-type opioid receptor,OPRK1,antagonist,R05DA08
DB09209,Pholcodine,,P41143,Delta-type opioid receptor,OPRD1,antagonist,R05DA08
DB09211,Limaprost,,P43116,Prostaglandin E2 receptor EP2 subtype,PTGER2,agonist,
DB09211,Limaprost,,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,agonist,
DB09211,Limaprost,,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,agonist,
DB09211,Limaprost,,P35408,Prostaglandin E2 receptor EP4 subtype,PTGER4,,
DB09212,Loxoprofen,,P35354,Prostaglandin G/H synthase 2,PTGS2,antagonist,M02AA31
DB09212,Loxoprofen,,P23219,Prostaglandin G/H synthase 1,PTGS1,antagonist,M02AA31
DB09213,Dexibuprofen,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AE14
DB09213,Dexibuprofen,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AE14
DB09213,Dexibuprofen,,P10415,Apoptosis regulator Bcl-2,BCL2,negative modulator,M01AE14
DB09213,Dexibuprofen,,P07204,Thrombomodulin,THBD,modulator,M01AE14
DB09213,Dexibuprofen,,P00750,Tissue-type plasminogen activator,PLAT,modulator,M01AE14
DB09213,Dexibuprofen,,P12104,"Fatty acid-binding protein, intestinal",FABP2,binder,M01AE14
DB09213,Dexibuprofen,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,activator,M01AE14
DB09213,Dexibuprofen,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,inhibitor,M01AE14
DB09213,Dexibuprofen,,P46059,Solute carrier family 15 member 1,SLC15A1,,M01AE14
DB09213,Dexibuprofen,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,,M01AE14
DB09213,Dexibuprofen,,P07359,Platelet glycoprotein Ib alpha chain,GP1BA,,M01AE14
DB09213,Dexibuprofen,,P31151,Protein S100-A7,S100A7,,M01AE14
DB09214,Dexketoprofen,,P23219,Prostaglandin G/H synthase 1,PTGS1,antagonist,M02AA27;N02AJ14;M01AE17
DB09214,Dexketoprofen,,P35354,Prostaglandin G/H synthase 2,PTGS2,antagonist,M02AA27;N02AJ14;M01AE17
DB09215,Droxicam,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AC04
DB09215,Droxicam,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AC04
DB09216,Tolfenamic acid,,P23219,Prostaglandin G/H synthase 1,PTGS1,antagonist,M01AG02
DB09216,Tolfenamic acid,,P35354,Prostaglandin G/H synthase 2,PTGS2,antagonist,M01AG02
DB09217,Firocoxib,,P35354,Prostaglandin G/H synthase 2,PTGS2,,
DB09220,Nicorandil,,O60706,ATP-binding cassette sub-family C member 9,ABCC9,activator,C01DX16
DB09221,Polaprezinc,,P01375,Tumor necrosis factor,TNF,inhibitor,
DB09221,Polaprezinc,,P05231,Interleukin-6,IL6,inhibitor,
DB09221,Polaprezinc,,P08700,Interleukin-3,IL3,inhibitor,
DB09221,Polaprezinc,,P17948,Vascular endothelial growth factor receptor 1,FLT1,agonist,
DB09221,Polaprezinc,,P01138,Beta-nerve growth factor,NGF,agonist,
DB09221,Polaprezinc,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,agonist,
DB09221,Polaprezinc,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,agonist,
DB09221,Polaprezinc,,P08238,Heat shock protein HSP 90-beta,HSP90AB1,agonist,
DB09223,Blonanserin,,P14416,Dopamine D2 receptor,DRD2,antagonist,
DB09223,Blonanserin,,P35462,Dopamine D3 receptor,DRD3,antagonist,
DB09223,Blonanserin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,
DB09224,Melperone,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AD03
DB09225,Zotepine,,P21728,D(1) dopamine receptor,DRD1,antagonist,N05AX11
DB09225,Zotepine,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AX11
DB09225,Zotepine,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,N05AX11
DB09225,Zotepine,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,N05AX11
DB09225,Zotepine,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,antagonist,N05AX11
DB09225,Zotepine,,P31645,Sodium-dependent serotonin transporter,SLC6A4,antagonist,N05AX11
DB09225,Zotepine,,P50406,5-hydroxytryptamine receptor 6,HTR6,antagonist,N05AX11
DB09227,Barnidipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,antagonist,C08CA12
DB09227,Barnidipine,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,antagonist,C08CA12
DB09227,Barnidipine,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,C08CA12
DB09227,Barnidipine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,antagonist,C08CA12
DB09227,Barnidipine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,C08CA12
DB09228,Conestat alfa,,P00736,Complement C1r subcomponent,C1R,inhibitor,B06AC04
DB09228,Conestat alfa,,P09871,Complement C1s subcomponent,C1S,inhibitor,B06AC04
DB09228,Conestat alfa,,P03952,Plasma kallikrein,KLKB1,inhibitor,B06AC04
DB09228,Conestat alfa,,P00748,Coagulation factor XII,F12,inhibitor,B06AC04
DB09228,Conestat alfa,,P00734,Prothrombin,F2,inhibitor,B06AC04
DB09228,Conestat alfa,,P03951,Coagulation factor XI,F11,inhibitor,B06AC04
DB09228,Conestat alfa,,P00750,Tissue-type plasminogen activator,PLAT,inhibitor,B06AC04
DB09229,Aranidipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,antagonist,
DB09229,Aranidipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,antagonist,
DB09229,Aranidipine,,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,antagonist,
DB09229,Aranidipine,,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,antagonist,
DB09229,Aranidipine,,P35348,Alpha adrenergic receptor,ADRA1A,agonist,
DB09229,Aranidipine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,
DB09230,Azelnidipine,,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,agonist,
DB09231,Benidipine,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,antagonist,C08CA15
DB09231,Benidipine,,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,antagonist,C08CA15
DB09231,Benidipine,,O43497,Voltage-dependent T-type calcium channel,CACNA1G,antagonist,C08CA15
DB09232,Cilnidipine,,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,antagonist,C08CA14
DB09232,Cilnidipine,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,antagonist,C08CA14
DB09235,Efonidipine,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,antagonist,
DB09235,Efonidipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,,
DB09235,Efonidipine,,Q13936,Voltage gated L-type calcium channel,CACNA1C,blocker,
DB09235,Efonidipine,,Q06432,Voltage-dependent calcium channel,CACNG1,inhibitor,
DB09235,Efonidipine,,O43497,Voltage-dependent T-type calcium channel,CACNA1G,inhibitor,
DB09235,Efonidipine,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,
DB09235,Efonidipine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,
DB09236,Lacidipine,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,antagonist,C08CA09
DB09237,Levamlodipine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,antagonist,C08CA17
DB09237,Levamlodipine,,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,antagonist,C08CA17
DB09237,Levamlodipine,,P29474,"Nitric oxide synthase, endothelial",NOS3,agonist,C08CA17
DB09237,Levamlodipine,,P35228,"Nitric oxide synthase, inducible",NOS2,agonist,C08CA17
DB09238,Manidipine,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,blocker,C08CA11;C09BB12
DB09238,Manidipine,,O43497,Voltage-dependent T-type calcium channel,CACNA1G,inhibitor,C08CA11;C09BB12
DB09238,Manidipine,,O43497,Voltage-dependent T-type calcium channel,CACNA1G,blocker,C08CA11;C09BB12
DB09238,Manidipine,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,inhibitor,C08CA11;C09BB12
DB09238,Manidipine,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,inhibitor,C08CA11;C09BB12
DB09238,Manidipine,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,inhibitor,C08CA11;C09BB12
DB09239,Niguldipine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,
DB09241,Methylene blue,,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,inhibitor,V03AB17;V04CG05
DB09241,Methylene blue,,P29475,"Nitric oxide synthase, brain",NOS1,inhibitor,V03AB17;V04CG05
DB09242,Moxonidine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,C02AC05;C02LC05
DB09242,Moxonidine,,Q9Y2I1,Nischarin,NISCH,agonist,C02AC05;C02LC05
DB09244,Pirlindole,,P21397,Amine oxidase [flavin-containing] A,MAOA,antagonist,
DB09244,Pirlindole,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,
DB09244,Pirlindole,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,
DB09245,Toloxatone,,P21397,Amine oxidase [flavin-containing] A,MAOA,antagonist,N06AG03
DB09256,Tegafur,,P04818,Thymidylate synthase,TYMS,inhibitor,L01BC03;L01BC53
DB09257,Gimeracil,,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,inhibitor,
DB09258,Bemiparin,,P00742,Coagulation factor X,F10,antagonist,B01AB12
DB09258,Bemiparin,,P01008,Antithrombin-III,SERPINC1,antagonist,B01AB12
DB09258,Bemiparin,,P05546,Heparin cofactor 2,SERPIND1,antagonist,B01AB12
DB09262,Imidafenacin,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,G04BD14
DB09262,Imidafenacin,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,G04BD14
DB09262,Imidafenacin,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,G04BD14
DB09263,Patiromer,,,Potassium,,binder,
DB09265,Lixisenatide,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,A10AE54;A10BJ03
DB09266,Technetium Tc-99m tilmanocept,,P22897,Macrophage mannose receptor 1,MRC1,ligand,V09IA09
DB09270,Ubidecarenone,,P56181,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",NDUFV3,cofactor,C01EB09
DB09270,Ubidecarenone,,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,cofactor,C01EB09
DB09272,Eluxadoline,,P35372,Mu-type opioid receptor,OPRM1,agonist,A07DA06
DB09272,Eluxadoline,,P41143,Delta-type opioid receptor,OPRD1,antagonist,A07DA06
DB09272,Eluxadoline,,P41145,Kappa-type opioid receptor,OPRK1,agonist,A07DA06
DB09273,Doxofylline,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,R03DA11
DB09273,Doxofylline,,P29274,Adenosine receptor A2a,ADORA2A,antagonist,R03DA11
DB09273,Doxofylline,,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,inhibitor,R03DA11
DB09274,Artesunate,,P04926,Malaria protein EXP-1,EXP-1,inhibitor,P01BE03;P01BF09;P01BF02;P01BF03;P01BF06;P01BF04
DB09275,Bismuth subcitrate potassium,,O25926,ATP-dependent Clp protease ATP-binding subunit ClpX,clpX,antagonist,A02BD08;A02BX05
DB09279,Fimasartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,C09DA10;C09CA10;C09DB09;C10BX16
DB09280,Lumacaftor,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,modulator,R07AX30
DB09282,Molsidomine,,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,agonist,C01DX12
DB09283,Trapidil,,P54750,Cyclic nucleotide phosphodiesterase,PDE1A,inhibitor,C01DX11
DB09283,Trapidil,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,antagonist,C01DX11
DB09285,Morniflumate,,P09917,Arachidonate 5-lipoxygenase,ALOX5,antagonist,M01AX22
DB09285,Morniflumate,,P35354,Prostaglandin G/H synthase 2,PTGS2,,M01AX22
DB09285,Morniflumate,,Q15722,Leukotriene B4 receptor 1,LTB4R,antagonist,M01AX22
DB09285,Morniflumate,,P21731,Thromboxane A2 receptor,TBXA2R,,M01AX22
DB09286,Pipamperone,,P14416,Dopamine D2 receptor,DRD2,antagonist,N05AD05
DB09286,Pipamperone,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,N05AD05
DB09286,Pipamperone,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N05AD05
DB09286,Pipamperone,,P21917,Dopamine D4 receptor,DRD4,antagonist,N05AD05
DB09286,Pipamperone,,P21728,Dopamine D1 receptor,DRD1,antagonist,N05AD05
DB09286,Pipamperone,,P35462,Dopamine D3 receptor,DRD3,,N05AD05
DB09286,Pipamperone,,P41595,5-hydroxytryptamine receptor 2B,HTR2B,,N05AD05
DB09286,Pipamperone,,P08913,Alpha-2A adrenergic receptor,ADRA2A,antagonist,N05AD05
DB09288,Propacetamol,,P23219,Prostaglandin G/H synthase 1,PTGS1,antagonist,N02BE05
DB09288,Propacetamol,,P35354,Prostaglandin G/H synthase 2,PTGS2,antagonist,N02BE05
DB09288,Propacetamol,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,antagonist,N02BE05
DB09288,Propacetamol,,P21554,Cannabinoid receptor 1,CNR1,antagonist,N02BE05
DB09289,Tianeptine,,P35372,Mu-type opioid receptor,OPRM1,agonist,N06AX14
DB09289,Tianeptine,,P42261,Glutamate receptor 1,GRIA1,modulator,N06AX14
DB09289,Tianeptine,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,inhibitor,N06AX14
DB09289,Tianeptine,,P35462,Dopamine D3 receptor,DRD3,agonist,N06AX14
DB09290,Ramosetron,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,
DB09291,Rolapitant,,P25103,Neurokinin 1 receptor,TACR1,antagonist,A04AD14
DB09292,Sacubitril,,P08473,Neprilysin,MME,antagonist,C09DX04
DB09292,Sacubitril,,P08473,Neprilysin,MME,inhibitor,C09DX04
DB09295,Talniflumate,,P23219,Prostaglandin G/H synthase 1,PTGS1,antagonist,
DB09295,Talniflumate,,P35354,Prostaglandin G/H synthase 2,PTGS2,antagonist,
DB09295,Talniflumate,,P51800,Chloride channel protein ClC-Ka,CLCNKA,antagonist,
DB09296,Ombitasvir,,Q5L478,Nonstructural protein 5A,NS5A,inhibitor,J05AP53;J05AP52
DB09297,Paritaprevir,,B0B3C9,NS3/4A protein,NS3/4A,inhibitor,J05AP53;J05AP52
DB09299,Tenofovir alafenamide,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AR19;J05AR20;J05AR17;J05AF13;J05AR22;J05AR18
DB09299,Tenofovir alafenamide,,Q3MS49,Reverse transcriptase,rt,inhibitor,J05AR19;J05AR20;J05AR17;J05AF13;J05AR22;J05AR18
DB09299,Tenofovir alafenamide,,I6TLU5,DNA polymerase,,inhibitor,J05AR19;J05AR20;J05AR17;J05AF13;J05AR22;J05AR18
DB09300,Butylscopolamine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03DB04;A03BB01
DB09300,Butylscopolamine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,A03DB04;A03BB01
DB09301,Chondroitin sulfate,,P23560,Brain-derived neurotrophic factor,BDNF,,M01AX25
DB09301,Chondroitin sulfate,,P39905,Glial cell line-derived neurotrophic factor,GDNF,,M01AX25
DB09301,Chondroitin sulfate,,P15692,Vascular endothelial growth factor A,VEGFA,,M01AX25
DB09301,Chondroitin sulfate,,P13500,C-C motif chemokine 2,CCL2,,M01AX25
DB09302,Alirocumab,,Q8NBP7,Proprotein convertase subtilisin/kexin type 9,PCSK9,inhibitor,C10AX14
DB09303,Evolocumab,,Q8NBP7,Proprotein convertase subtilisin/kexin type 9,PCSK9,inhibitor,C10AX13
DB09304,Setiptiline,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,
DB09304,Setiptiline,,P08908,Serotonin Receptors,HTR1A,antagonist,
DB09310,Catridecacog,,P05160,Coagulation factor XIII B chain,F13B,,B02BD11
DB09317,"Synthetic Conjugated Estrogens, A",,P03372,Estrogen receptor alpha,ESR1,ligand,
DB09318,"Synthetic Conjugated Estrogens, B",,P03372,Estrogen receptor alpha,ESR1,ligand,
DB09319,Carindacillin,,P0AEB2,Penicillin-binding protein,dacA,inhibitor,J01CR50;J01CA05
DB09324,Sulbactam,,P00807,Beta-lactamase,blaZ,inhibitor,J01CG01
DB09325,Sodium fluoride,,,Hydroxyapatite,,,A01AA51;A01AA01;A12CD01
DB09327,Tegafur-uracil,,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,antagonist,
DB09327,Tegafur-uracil,,P04818,Thymidylate synthase,TYMS,antagonist,
DB09327,Tegafur-uracil,,,RNA,,,
DB09327,Tegafur-uracil,,,DNA,,,
DB09329,"Antihemophilic factor (recombinant), PEGylated",,P04275,von Willebrand factor,VWF,binder,
DB09330,Osimertinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,L01EB04
DB09330,Osimertinib,,P00533,Epidermal growth factor receptor,EGFR,regulator,L01EB04
DB09331,Daratumumab,,P28907,ADP-ribosyl cyclase 1,CD38,antibody,L01FC01
DB09332,Kappadione,,P00734,Prothrombin,F2,agonist,
DB09332,Kappadione,,P08709,Coagulation factor VII,F7,agonist,
DB09332,Kappadione,,P00740,Coagulation factor IX,F9,agonist,
DB09332,Kappadione,,P00742,Coagulation factor X,F10,agonist,
DB09332,Kappadione,,P04070,Vitamin K-dependent protein C,PROC,agonist,
DB09332,Kappadione,,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,agonist,
DB09332,Kappadione,,P07225,Vitamin K-dependent protein S,PROS1,agonist,
DB09333,Iopodic acid,,P55073,Thyroxine 5-deiodinase,DIO3,antagonist,V08AC08;V08AC10
DB09334,Seractide acetate,,Q01718,Adrenocorticotropic hormone receptor,MC2R,agonist,
DB09336,Technetium Tc-99m nofetumomab merpentan,,P16422,Epithelial cell adhesion molecule,EPCAM,binder,
DB09336,Technetium Tc-99m nofetumomab merpentan,,P11836,B-lymphocyte antigen CD20,MS4A1,binder,
DB09338,Mersalyl,,P05186,"Alkaline phosphatase, tissue-nonspecific isozyme",ALPL,antagonist,C03BC01
DB09338,Mersalyl,,P29972,Aquaporin-1,AQP1,,C03BC01
DB09338,Mersalyl,,P53985,Monocarboxylate transporter 1,SLC16A1,antagonist,C03BC01
DB09342,Propoxycaine,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,blocker,
DB09343,Tipiracil,,P19971,Thymidine phosphorylase,TYMP,inhibitor,
DB09345,Pramocaine,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,blocker,D04AB07;C05AD07
DB09348,Propiolactone,,,DNA,,adduct,
DB09351,Levobetaxolol,,P08588,Beta-1 adrenergic receptor,ADRB1,antagonist,
DB09363,Rauwolfia serpentina root,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,C02AA03;C02LA08
DB09369,Polyestradiol phosphate,,P03372,Estrogen receptor alpha,ESR1,agonist,L02AA02
DB09371,Norethynodrel,,P03372,Estrogen receptor alpha,ESR1,,G03FA09
DB09371,Norethynodrel,,P10275,Androgen receptor,AR,,G03FA09
DB09371,Norethynodrel,,P04278,Sex hormone-binding globulin,SHBG,,G03FA09
DB09389,Norgestrel,,P06401,Progesterone receptor,PGR,binder,G03FA10;G03FB01;G03AA06
DB09389,Norgestrel,,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,inhibitor,G03FA10;G03FB01;G03AA06
DB09389,Norgestrel,,P10275,Androgen receptor,AR,agonist,G03FA10;G03FB01;G03AA06
DB09401,Isosorbide,,Q02108,Guanylate cyclase,GUCY1A1,activator,
DB09409,Magnesium acetate tetrahydrate,,Q05586,Glutamate (NMDA) receptor,GRIN1,ligand,
DB09418,Potassium perchlorate,,Q92911,Sodium/iodide cotransporter,SLC5A5,inhibitor,H03BC01
DB09421,Protirelin,,P34981,Thyrotropin Releasing Hormone Receptor,TRHR,ligand,V04CJ02
DB09422,Soybean oil,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,activator,
DB09456,Insulin beef,,P06213,Insulin receptor,INSR,agonist,A10AD02;A10AC02;A10AE02;A10AB02
DB09456,Insulin beef,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,A10AD02;A10AC02;A10AE02;A10AB02
DB09460,Sodium carbonate,,P00915,Carbonic anhydrase 1,CA1,inhibitor,
DB09460,Sodium carbonate,,P00918,Carbonic anhydrase 2,CA2,inhibitor,
DB09460,Sodium carbonate,,P22748,Carbonic anhydrase 4,CA4,inhibitor,
DB09460,Sodium carbonate,,Q16790,Carbonic anhydrase 9,CA9,inhibitor,
DB09462,Glycerin,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,agonist,A06AX01;A06AG04
DB09462,Glycerin,,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,,A06AX01;A06AG04
DB09462,Glycerin,,Q9NPH2,Inositol-3-phosphate synthase 1,ISYNA1,,A06AX01;A06AG04
DB09462,Glycerin,,P00325,Alcohol dehydrogenase 1B,ADH1B,,A06AX01;A06AG04
DB09462,Glycerin,,Q14643,"Inositol 1,4,5-trisphosphate receptor type 1",ITPR1,,A06AX01;A06AG04
DB09462,Glycerin,,P09466,Glycodelin,PAEP,,A06AX01;A06AG04
DB09462,Glycerin,,P17050,Alpha-N-acetylgalactosaminidase,NAGA,,A06AX01;A06AG04
DB09462,Glycerin,,P84077,ADP-ribosylation factor 1,ARF1,,A06AX01;A06AG04
DB09462,Glycerin,,O43252,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,PAPSS1,,A06AX01;A06AG04
DB09462,Glycerin,,P23367,DNA mismatch repair protein MutL,mutL,,A06AX01;A06AG04
DB09462,Glycerin,,P69924,Ribonucleoside-diphosphate reductase 1 subunit beta,nrdB,,A06AX01;A06AG04
DB09462,Glycerin,,P17802,A/G-specific adenine glycosylase,mutY,,A06AX01;A06AG04
DB09462,Glycerin,,O14717,tRNA (cytosine(38)-C(5))-methyltransferase,TRDMT1,,A06AX01;A06AG04
DB09462,Glycerin,,O43708,Maleylacetoacetate isomerase,GSTZ1,,A06AX01;A06AG04
DB09472,Sodium sulfate,,P00918,Carbonic anhydrase 2,CA2,inhibitor,A06AD13;A12CA02
DB09472,Sodium sulfate,,P00915,Carbonic anhydrase 1,CA1,inhibitor,A06AD13;A12CA02
DB09477,Enalaprilat,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,
DB09477,Enalaprilat,,P46663,B1 bradykinin receptor,BDKRB1,,
DB09481,Magnesium carbonate,,Q05586,Glutamate (NMDA) receptor,GRIN1,blocker,A02AA01;V03AE04;A06AD01
DB09488,Acrivastine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX18
DB09510,Urea C-13,,Q8KT33,Urease,ureB,substrate,V04CX05
DB09513,Urea C-14,,Q8KT33,Urease,ureB,substrate,
DB09517,Sodium ferric gluconate complex,,P02792,Ferritin light chain,FTL,binding,
DB09517,Sodium ferric gluconate complex,,P68871,Hemoglobin subunit beta,HBB,binding,
DB09517,Sodium ferric gluconate complex,,P69905,Hemoglobin subunit alpha,HBA1,binding,
DB09526,Hydroquinone,,P14679,Tyrosinase,TYR,inhibitor,D11AX11
DB09526,Hydroquinone,,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,activator,D11AX11
DB09532,Secretin human,,P47872,Secretin receptor,SCTR,ligand,V04CK01
DB09535,Octocrylene,,P03372,Estrogen receptor alpha,ESR1,,
DB09535,Octocrylene,,Q92731,Estrogen receptor beta,ESR2,,
DB09536,Titanium dioxide,,Q9UEW3,Macrophage receptor MARCO,MARCO,,
DB09539,Omega-3-acid ethyl esters,,P36956,Sterol regulatory element-binding protein 1,SREBF1,inhibitor,
DB09552,Thonzonium,,P21283,V-type proton ATPase subunit C 1,ATP6V1C1,inhibitor,
DB09555,Dexchlorpheniramine maleate,,P35367,Histamine H1 receptor,HRH1,antagonist,
DB09559,Necitumumab,,P00533,Epidermal growth factor receptor,EGFR,antagonist,L01FE03
DB09564,Insulin degludec,,P06213,Insulin receptor,INSR,agonist,A10AD06;A10AE56;A10AE06
DB09564,Insulin degludec,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,A10AD06;A10AE56;A10AE06
DB09568,Omega-3-carboxylic acids,,Q96PD7,Diacylglycerol O-acyltransferase 2,DGAT2,antagonist,
DB09568,Omega-3-carboxylic acids,,Q99714,3-hydroxyacyl-CoA dehydrogenase type-2,HSD17B10,potentiator,
DB09568,Omega-3-carboxylic acids,,P30084,"Enoyl-CoA hydratase, mitochondrial",ECHS1,potentiator,
DB09568,Omega-3-carboxylic acids,,Q16836,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,potentiator,
DB09568,Omega-3-carboxylic acids,,Q9GZR5,Elongation of very long chain fatty acids protein 4,ELOVL4,potentiator,
DB09568,Omega-3-carboxylic acids,,P06858,Lipoprotein lipase,LPL,stimulator,
DB10770,Foreskin fibroblast (neonatal),,P17948,Vascular endothelial growth factor receptor 1,FLT1,agonist,
DB10770,Foreskin fibroblast (neonatal),,P05231,Interleukin-6,IL6,agonist,
DB10770,Foreskin fibroblast (neonatal),,P14778,Interleukin-1 receptor type 1,IL1R1,agonist,
DB10770,Foreskin fibroblast (neonatal),,P37173,TGF-beta receptor type-2,TGFBR2,agonist,
DB10770,Foreskin fibroblast (neonatal),,P05230,Fibroblast growth factor 1,FGF1,agonist,
DB10770,Foreskin fibroblast (neonatal),,P01579,Interferon gamma,IFNG,agonist,
DB10770,Foreskin fibroblast (neonatal),,P21802,Fibroblast growth factor receptor 2,FGFR2,agonist,
DB10770,Foreskin fibroblast (neonatal),,P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,agonist,
DB10770,Foreskin fibroblast (neonatal),,P09619,Platelet-derived growth factor receptor beta,PDGFRB,agonist,
DB10770,Foreskin fibroblast (neonatal),,P01137,Transforming growth factor beta-1,TGFB1,agonist,
DB10770,Foreskin fibroblast (neonatal),,P01375,Tumor necrosis factor,TNF,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P05230,Fibroblast growth factor 1,FGF1,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P00533,Epidermal growth factor receptor,EGFR,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P01584,Interleukin-1 beta,IL1B,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P05231,Interleukin-6,IL6,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P01579,Interferon gamma,IFNG,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P37173,TGF-beta receptor type-2,TGFBR2,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P01137,Transforming growth factor beta-1,TGFB1,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P01375,Tumor necrosis factor,TNF,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P15692,Vascular endothelial growth factor A,VEGFA,agonist,
DB10772,Foreskin keratinocyte (neonatal),,P21802,Fibroblast growth factor receptor 2,FGFR2,agonist,
DB10989,Hepatitis A Vaccine,,,B-lymphocytes,,inducer,
DB11059,Carboxymethylcellulose,,P11166,"Solute carrier family 2, facilitated glucose transporter member 1",SLC2A1,binder,
DB11064,Homosalate,,P06401,Progesterone receptor,PGR,antagonist,
DB11064,Homosalate,,P10275,Androgen receptor,AR,antagonist,
DB11064,Homosalate,,P03372,Estrogen receptor alpha,ESR1,,
DB11065,Pancrelipase amylase,,,Dietary starch,,cleavage,
DB11066,Pancrelipase protease,,,Dietary protein,,cleavage,
DB11071,Phenyl salicylate,,P23219,Prostaglandin G/H synthase 1,PTGS1,antagonist,G04BX12
DB11071,Phenyl salicylate,,P35354,Prostaglandin G/H synthase 2,PTGS2,antagonist,G04BX12
DB11075,Hypromellose,,P16422,Epithelial cell adhesion molecule,EPCAM,,S01KA02
DB11077,Polyethylene glycol 400,,P22413,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,ENPP1,other,
DB11077,Polyethylene glycol 400,,Q9BUP3,Oxidoreductase HTATIP2,HTATIP2,,
DB11079,Trolamine salicylate,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB11079,Trolamine salicylate,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB11081,Aluminum chloride,,P00367,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,inactivator,D10AX01
DB11085,Resorcinol,,P07202,Thyroid peroxidase,TPO,,D10AX02;S01AX06
DB11087,Pyrethrum extract,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB11090,Potassium nitrate,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,agonist,
DB11093,Calcium citrate,,P41180,Extracellular calcium-sensing receptor,CASR,agonist,A12AA13;A11GB01
DB11093,Calcium citrate,,P27797,Calreticulin,CALR,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,Q99828,Calcium and integrin-binding protein 1,CIB1,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,O75340,Programmed cell death protein 6,PDCD6,agonist,A12AA13;A11GB01
DB11093,Calcium citrate,,P30626,Sorcin,SRI,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,Q99653,Calcineurin B homologous protein 1,CHP1,agonist,A12AA13;A11GB01
DB11093,Calcium citrate,,P09486,SPARC,SPARC,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,P27824,Calnexin,CANX,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,P35556,Fibrillin-2,FBN2,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,P04271,Protein S100-B,S100B,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,O14958,Calsequestrin-2,CASQ2,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,Q15493,Regucalcin,RGN,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,Q9UBV8,Peflin,PEF1,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,P06703,Protein S100-A6,S100A6,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,P13693,Translationally-controlled tumor protein,TPT1,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,O75838,Calcium and integrin-binding family member 2,CIB2,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,Q99584,Protein S100-A13,S100A13,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,P31415,Calsequestrin-1,CASQ1,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,Q02818,Nucleobindin-1,NUCB1,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,P80303,Nucleobindin-2,NUCB2,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,P0DP23,Calmodulin,CALM1,agonist,A12AA13;A11GB01
DB11093,Calcium citrate,,Q75N90,Fibrillin-3,FBN3,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,P28676,Grancalcin,GCA,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,Q9ULU8,Calcium-dependent secretion activator 1,CADPS,agonist,A12AA13;A11GB01
DB11093,Calcium citrate,,P0DP24,Calmodulin-2,CALM2,agonist,A12AA13;A11GB01
DB11093,Calcium citrate,,P0DP25,Calmodulin-3,CALM3,agonist,A12AA13;A11GB01
DB11093,Calcium citrate,,Q96FQ6,Protein S100-A16,S100A16,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,P22676,Calretinin,CALB2,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,Q13938,Calcyphosin,CAPS,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,Q86UW7,Calcium-dependent secretion activator 2,CADPS2,agonist,A12AA13;A11GB01
DB11093,Calcium citrate,,Q96L12,Calreticulin-3,CALR3,ligand,A12AA13;A11GB01
DB11093,Calcium citrate,,Q9ULB1,Neurexin-1,NRXN1,agonist,A12AA13;A11GB01
DB11093,Calcium citrate,,P62166,Neuronal calcium sensor 1,NCS1,ligand,A12AA13;A11GB01
DB11094,Vitamin D,,P11473,Vitamin D3 receptor,VDR,,
DB11094,Vitamin D,,P02774,Vitamin D-binding protein,GC,,
DB11098,Potassium bicarbonate,,,Hydrogen ions,,neutralizer,A12BA04
DB11113,Castor oil,,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,agonist,A06AB05
DB11113,Castor oil,,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,activator,A06AB05
DB11113,Castor oil,,P35408,Prostaglandin E2 receptor EP4 subtype,PTGER4,agonist,A06AB05
DB11120,Turpentine,,P28482,Mitogen-activated protein kinase 1,MAPK1,,
DB11124,Racepinephrine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,agonist,
DB11124,Racepinephrine,,P35368,Alpha-1B adrenergic receptor,ADRA1B,agonist,
DB11124,Racepinephrine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,
DB11124,Racepinephrine,,P18089,Alpha-2B adrenergic receptor,ADRA2B,agonist,
DB11124,Racepinephrine,,P18825,Alpha-2C adrenergic receptor,ADRA2C,agonist,
DB11124,Racepinephrine,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,
DB11124,Racepinephrine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,
DB11124,Racepinephrine,,P25100,Alpha-1D adrenergic receptor,ADRA1D,antagonist,
DB11124,Racepinephrine,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,
DB11130,Opium,,P41143,Delta-type opioid receptor,OPRD1,agonist,A07DA02;N02AA02
DB11130,Opium,,P41145,Kappa-type opioid receptor,OPRK1,agonist,A07DA02;N02AA02
DB11130,Opium,,P35372,Mu-type opioid receptor,OPRM1,agonist,A07DA02;N02AA02
DB11131,Capsicum oleoresin,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,agonist,
DB11131,Capsicum oleoresin,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,activator,
DB11132,Silicon dioxide,,Q9UEW3,Macrophage receptor MARCO,MARCO,,
DB11133,Omega-3 fatty acids,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,ligand,A05BA10
DB11133,Omega-3 fatty acids,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,activator,A05BA10
DB11133,Omega-3 fatty acids,,P36956,Sterol regulatory element-binding protein 1,SREBF1,inhibitor,A05BA10
DB11136,Chromium,,P00167,Cytochrome b5,CYB5A,substrate,
DB11148,Butamben,,Q06432,Voltage-dependent calcium channel,CACNG1,inhibitor,
DB11148,Butamben,,P48048,ATP-sensitive potassium channel,KCNJ1,antagonist,
DB11148,Butamben,,O75762,Transient receptor potential cation channel subfamily A member 1,TRPA1,inhibitor,
DB11148,Butamben,,Q9HBA0,Transient receptor potential cation channel subfamily V member 4,TRPV4,inhibitor,
DB11155,Triclocarban,,Q6GI75,Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI,fabI,antagonist,
DB11156,Pyrantel,,Q9HC97,G-protein coupled receptor 35,GPR35,,P02CC01
DB11156,Pyrantel,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,P02CC01
DB11156,Pyrantel,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,agonist,P02CC01
DB11157,Anthralin,,P35908,"Keratin, type II cytoskeletal 2 epidermal",KRT2,antagonist,D05AC01;D05AC51
DB11157,Anthralin,,Q99456,"Keratin, type I cytoskeletal 12",KRT12,antagonist,D05AC01;D05AC51
DB11157,Anthralin,,Q9UQF2,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,agonist,D05AC01;D05AC51
DB11160,Phenyltoloxamine,,P70174,Histamine H1 receptor,Hrh1,inverse agonist,
DB11166,Antithrombin Alfa,,P00734,Prothrombin,F2,inhibitor,
DB11166,Antithrombin Alfa,,P00742,Coagulation factor X,F10,inhibitor,
DB11181,Homatropine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,S01FA05
DB11181,Homatropine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,S01FA05
DB11181,Homatropine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,S01FA05
DB11181,Homatropine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,S01FA05
DB11181,Homatropine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,S01FA05
DB11185,Sulisobenzone,,,Skin epithelial cells,,protector,
DB11186,Pentoxyverine,,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,agonist,R05DB05
DB11186,Pentoxyverine,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,R05DB05
DB11186,Pentoxyverine,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,inhibitor,R05DB05
DB11186,Pentoxyverine,,P41145,Kappa-type opioid receptor,OPRK1,agonist,R05DB05
DB11186,Pentoxyverine,,P35372,Mu-type opioid receptor,OPRM1,antagonist,R05DB05
DB11193,Papain,,O00206,Toll-like receptor 4,TLR4,activator,
DB11195,Xylitol,,P12070,Xylose isomerase,xylA,,
DB11195,Xylitol,,P24300,Xylose isomerase,xylA,,
DB11195,Xylitol,,P15587,Xylose isomerase,xylA,,
DB11195,Xylitol,,P12851,Xylose isomerase,xylA,,
DB11195,Xylitol,,Q54873,Hyaluronate lyase,,,
DB11200,Aluminum zirconium octachlorohydrex gly,,,Sweat ducts,,antagonist,
DB11201,Menthyl salicylate,,P23219,Prostaglandin G/H synthase 1,PTGS1,antagonist,
DB11201,Menthyl salicylate,,P35354,Prostaglandin G/H synthase 2,PTGS2,antagonist,
DB11217,Arbutin,,P14679,Tyrosinase,TYR,inhibitor,
DB11219,Enzacamene,,P06401,Progesterone receptor,PGR,antagonist,
DB11219,Enzacamene,,P10275,Androgen receptor,AR,antagonist,
DB11219,Enzacamene,,Q92731,Estrogen receptor beta,ESR2,,
DB11219,Enzacamene,,P03372,Estrogen receptor alpha,ESR1,,
DB11221,Dioxybenzone,,P04278,Sex hormone-binding globulin,SHBG,binder,
DB11235,Thonzylamine,,P35367,Histamine H1 receptor,HRH1,antagonist,D04AA01;R06AC06;R01AC06
DB11235,Thonzylamine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,D04AA01;R06AC06;R01AC06
DB11235,Thonzylamine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,D04AA01;R06AC06;R01AC06
DB11235,Thonzylamine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,D04AA01;R06AC06;R01AC06
DB11235,Thonzylamine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,D04AA01;R06AC06;R01AC06
DB11235,Thonzylamine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,D04AA01;R06AC06;R01AC06
DB11251,Tocopherol,,,Free radicals,,binder,A11HA03
DB11254,Hexylresorcinol,,P11387,DNA topoisomerase 1,TOP1,inhibitor,R02AA12
DB11254,Hexylresorcinol,,P21980,Protein-glutamine gamma-glutamyltransferase 2,TGM2,inhibitor,R02AA12
DB11254,Hexylresorcinol,,P14679,Tyrosinase,TYR,inhibitor,R02AA12
DB11263,Polydatin,,P14618,Pyruvate kinase PKM,PKM,inhibitor,
DB11273,Dihydroergocornine,,P08908,Serotonin Receptors,HTR1A,antagonist,
DB11273,Dihydroergocornine,,P08908,Serotonin Receptors,HTR1A,agonist,
DB11273,Dihydroergocornine,,P08588,Beta adrenergic receptor,ADRB1,antagonist,
DB11273,Dihydroergocornine,,P08588,Beta adrenergic receptor,ADRB1,agonist,
DB11273,Dihydroergocornine,,P35348,Alpha adrenergic receptor,ADRA1A,antagonist,
DB11273,Dihydroergocornine,,P35348,Alpha adrenergic receptor,ADRA1A,agonist,
DB11274,Dihydro-alpha-ergocryptine,,P14416,Dopamine D2 receptor,DRD2,agonist,
DB11274,Dihydro-alpha-ergocryptine,,P21728,D(1) dopamine receptor,DRD1,partial agonist,
DB11274,Dihydro-alpha-ergocryptine,,P35462,Dopamine D3 receptor,DRD3,partial agonist,
DB11275,Epicriptine,,P21728,Dopamine receptor,DRD1,agonist,
DB11278,DL-Methylephedrine,,P08588,Beta-1 adrenergic receptor,ADRB1,agonist,
DB11278,DL-Methylephedrine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,agonist,
DB11278,DL-Methylephedrine,,P35348,Alpha adrenergic receptor,ADRA1A,agonist,
DB11278,DL-Methylephedrine,,P08588,Beta adrenergic receptor,ADRB1,agonist,
DB11294,Coccidioides immitis spherule,,P04439,"HLA class I histocompatibility antigen, A-2 alpha chain",HLA-A,binder,
DB11294,Coccidioides immitis spherule,,P01903,HLA-DR,HLA-DRA,binder,
DB11294,Coccidioides immitis spherule,,P04439,"HLA class I histocompatibility antigen, A-3 alpha chain",HLA-A,,
DB11294,Coccidioides immitis spherule,,P01889,"HLA class I histocompatibility antigen, B-27 alpha chain",HLA-B,,
DB11300,Thrombin,,P03951,Coagulation factor XI,F11,activator,B02BC06;B02BD30
DB11300,Thrombin,,P00488,Coagulation factor XIII A chain,F13A1,activator,B02BC06;B02BD30
DB11300,Thrombin,,P05160,Coagulation factor XIII B chain,F13B,activator,B02BC06;B02BD30
DB11300,Thrombin,,P02671,Fibrinogen alpha chain,FGA,activator,B02BC06;B02BD30
DB11300,Thrombin,,P02675,Fibrinogen beta chain,FGB,activator,B02BC06;B02BD30
DB11300,Thrombin,,P02679,Fibrinogen gamma chain,FGG,activator,B02BC06;B02BD30
DB11300,Thrombin,,P12259,Coagulation factor V,F5,activator,B02BC06;B02BD30
DB11300,Thrombin,,P00451,Coagulation factor VIII,F8,activator,B02BC06;B02BD30
DB11300,Thrombin,,P25116,Proteinase-activated receptor 1,F2R,,B02BC06;B02BD30
DB11300,Thrombin,,Q96RI0,Proteinase-activated receptor 4,F2RL3,,B02BC06;B02BD30
DB11311,Prothrombin,,P02671,Fibrinogen alpha chain,FGA,cleavage,
DB11311,Prothrombin,,P02675,Fibrinogen beta chain,FGB,cleavage,
DB11311,Prothrombin,,P00488,Coagulation factor XIII A chain,F13A1,agonist,
DB11311,Prothrombin,,Q96IY4,Carboxypeptidase B2,CPB2,agonist,
DB11312,Protein C,,P12259,Coagulation factor V,F5,inactivator,B01AD12
DB11312,Protein C,,P00451,Coagulation factor VIII,F8,inactivator,B01AD12
DB11323,Glycol salicylate,,P23219,Prostaglandin G/H synthase 1,PTGS1,antagonist,
DB11323,Glycol salicylate,,P35354,Prostaglandin G/H synthase 2,PTGS2,antagonist,
DB11324,Nonivamide,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,agonist,
DB11327,Dipyrithione,,P35228,"Nitric oxide synthase, inducible",NOS2,antagonist,
DB11327,Dipyrithione,,P35354,Prostaglandin G/H synthase 2,PTGS2,,
DB11328,Tetradecyl hydrogen sulfate (ester),,Q9UNN8,Endothelial protein C receptor,PROCR,antagonist,
DB11332,Sinapultide,,,Lung epithelial cells,,agonist,
DB11338,Clove oil,,P19320,Vascular cell adhesion protein 1,VCAM1,antagonist,
DB11338,Clove oil,,P02778,C-X-C motif chemokine 10,CXCL10,,
DB11338,Clove oil,,P02452,Collagen alpha-1(I) chain,COL1A1,,
DB11338,Clove oil,,P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,,
DB11345,(S)-camphor,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,agonist,
DB11345,(S)-camphor,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,activator,
DB11345,(S)-camphor,,Q8NET8,Transient receptor potential cation channel subfamily V member 3,TRPV3,agonist,
DB11345,(S)-camphor,,Q8NET8,Transient receptor potential cation channel subfamily V member 3,TRPV3,activator,
DB11345,(S)-camphor,,O75762,Transient receptor potential cation channel subfamily A member 1,TRPA1,inhibitor,
DB11345,(S)-camphor,,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,TRPM8,activator,
DB11348,Calcium Phosphate,,P41180,Extracellular calcium-sensing receptor,CASR,agonist,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P27797,Calreticulin,CALR,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q99828,Calcium and integrin-binding protein 1,CIB1,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,O75340,Programmed cell death protein 6,PDCD6,agonist,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P30626,Sorcin,SRI,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q99653,Calcineurin B homologous protein 1,CHP1,agonist,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P09486,SPARC,SPARC,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P27824,Calnexin,CANX,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P35556,Fibrillin-2,FBN2,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P04271,Protein S100-B,S100B,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,O14958,Calsequestrin-2,CASQ2,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q15493,Regucalcin,RGN,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q9UBV8,Peflin,PEF1,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P06703,Protein S100-A6,S100A6,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P13693,Translationally-controlled tumor protein,TPT1,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,O75838,Calcium and integrin-binding family member 2,CIB2,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q99584,Protein S100-A13,S100A13,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P31415,Calsequestrin-1,CASQ1,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q02818,Nucleobindin-1,NUCB1,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P80303,Nucleobindin-2,NUCB2,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P0DP23,Calmodulin,CALM1,agonist,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q75N90,Fibrillin-3,FBN3,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P28676,Grancalcin,GCA,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q9ULU8,Calcium-dependent secretion activator 1,CADPS,agonist,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P0DP24,Calmodulin-2,CALM2,agonist,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P0DP25,Calmodulin-3,CALM3,agonist,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q96FQ6,Protein S100-A16,S100A16,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P22676,Calretinin,CALB2,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q13938,Calcyphosin,CAPS,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q86UW7,Calcium-dependent secretion activator 2,CADPS2,agonist,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q96L12,Calreticulin-3,CALR3,ligand,A12AA01;A11GB01
DB11348,Calcium Phosphate,,Q9ULB1,Neurexin-1,NRXN1,agonist,A12AA01;A11GB01
DB11348,Calcium Phosphate,,P62166,Neuronal calcium sensor 1,NCS1,ligand,A12AA01;A11GB01
DB11359,Guaiacol,,P02768,Serum albumin,ALB,,
DB11362,Selexipag,,P43119,Prostacyclin receptor,PTGIR,agonist,B01AC27
DB11363,Alectinib,,Q9UM73,ALK tyrosine kinase receptor,ALK,inhibitor,L01ED03
DB11365,Sennosides,,Q92482,Aquaporin-3,AQP3,inhibitor,A06AB56;A06AB06
DB11365,Sennosides,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,A06AB56;A06AB06
DB11367,Cefroxadine,,P02919,Penicillin-binding protein 1B,mrcB,inhibitor,J01DB11
DB11386,Chlorobutanol,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,,A04AD54;A04AD04
DB11397,Dichlorvos,,P02787,Serotransferrin,TF,,
DB11397,Dichlorvos,,P06276,Cholinesterase,BCHE,,
DB11421,Imidacloprid,,Q494W8,CHRNA7-FAM7A fusion protein,CHRFAM7A,,
DB11425,Luprostiol,,P10275,Androgen receptor,AR,inhibitor,
DB11429,Mibolerone,,P10275,Androgen receptor,AR,,
DB11431,Moxidectin,,Q25634,Glutamate-gated chloride channel,GluClX,binder,P02CX03
DB11431,Moxidectin,,,GABA-A gated chloride channel,,binder,P02CX03
DB11431,Moxidectin,,,ABC transporters,,binder,P02CX03
DB11447,Phenothiazine,,P10275,Androgen receptor,AR,,
DB11455,Robenacoxib,,Q8SPQ9,Cyclooxygenase 2,PTGS2,inhibitor,
DB11477,Xylazine,,P08913,Alpha-2 adrenergic receptors,ADRA2A,agonist,
DB11478,Zeranol,,P03372,Estrogen receptor alpha,ESR1,,
DB11478,Zeranol,,P04278,Sex hormone-binding globulin,SHBG,,
DB11496,2-mercaptobenzothiazole,,P07202,Thyroid peroxidase,TPO,inhibitor,
DB11541,Ractopamine,,P03372,Estrogen receptor alpha,ESR1,,
DB11560,Lesinurad,,Q96S37,Solute carrier family 22 member 12,SLC22A12,inhibitor,M04AB05
DB11560,Lesinurad,,Q9NSA0,Solute carrier family 22 member 11,SLC22A11,inhibitor,M04AB05
DB11564,Insulin argine,,P06213,Insulin receptor,INSR,agonist,
DB11564,Insulin argine,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,
DB11567,Insulin peglispro,,P06213,Insulin receptor,INSR,,
DB11567,Insulin peglispro,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,
DB11568,Insulin tregopil,,P06213,Insulin receptor,INSR,agonist,
DB11568,Insulin tregopil,,P08069,Insulin-like growth factor 1 receptor,IGF1R,activator,
DB11569,Ixekizumab,,Q16552,Interleukin-17A,IL17A,antibody,L04AC13
DB11571,Human thrombin,,P12259,Coagulation factor V,F5,activator,
DB11571,Human thrombin,,P00451,Coagulation factor VIII,F8,activator,
DB11571,Human thrombin,,P03951,Coagulation factor XI,F11,activator,
DB11571,Human thrombin,,P00488,Coagulation factor XIII A chain,F13A1,activator,
DB11571,Human thrombin,,P05160,Coagulation factor XIII B chain,F13B,activator,
DB11571,Human thrombin,,P02671,Fibrinogen alpha chain,FGA,activator,
DB11571,Human thrombin,,P02675,Fibrinogen beta chain,FGB,activator,
DB11571,Human thrombin,,P02679,Fibrinogen gamma chain,FGG,activator,
DB11572,Thrombin alfa,,P12259,Coagulation factor V,F5,activator,
DB11572,Thrombin alfa,,P00451,Coagulation factor VIII,F8,activator,
DB11572,Thrombin alfa,,P02671,Fibrinogen alpha chain,FGA,activator,
DB11572,Thrombin alfa,,P02675,Fibrinogen beta chain,FGB,activator,
DB11572,Thrombin alfa,,P02679,Fibrinogen gamma chain,FGG,activator,
DB11574,Elbasvir,,Q5L478,Nonstructural protein 5A,NS5A,inhibitor,J05AP54;J05AP10
DB11575,Grazoprevir,,B0B3C9,NS3/4A protein,NS3/4A,antagonist,J05AP11;J05AP54
DB11577,Indigotindisulfonic acid,,P35348,Alpha adrenergic receptor,ADRA1A,agonist,V04CH02
DB11580,Ravulizumab,,P01031,Complement C5,C5,inhibitor,L04AA43
DB11581,Venetoclax,,P10415,Apoptosis regulator Bcl-2,BCL2,antagonist,L01XX52
DB11581,Venetoclax,,P10415,Apoptosis regulator Bcl-2,BCL2,inhibitor,L01XX52
DB11582,Thiocolchicoside,,P14867,GABA(A) Receptor,GABRA1,antagonist,M03BX05;M03BX55
DB11582,Thiocolchicoside,,P23415,Glycine receptor subunit alpha-1,GLRA1,antagonist,M03BX05;M03BX55
DB11582,Thiocolchicoside,,O14788,Tumor necrosis factor ligand superfamily member 11,TNFSF11,antagonist,M03BX05;M03BX55
DB11584,Pipradrol,,P21728,D(1) dopamine receptor,DRD1,agonist,N06BX15
DB11586,Asunaprevir,,P26663,Genome polyprotein,,inhibitor,J05AP06;J05AP58
DB11587,Etafedrine,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,
DB11588,Carbon monoxide,,P02144,Myoglobin,MB,inhibitor,V04CX08
DB11590,Thimerosal,,Q99707,Methionine synthase,MTR,antagonist,D08AK06
DB11590,Thimerosal,,Q9UPY5,Cystine/glutamate transporter,SLC7A11,antagonist,D08AK06
DB11590,Thimerosal,,P54710,Sodium/potassium-transporting ATPase subunit gamma,FXYD2,antagonist,D08AK06
DB11591,Bilastine,,P35367,Histamine H1 receptor,HRH1,antagonist,S01GX13;R06AX29
DB11595,Atezolizumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,L01FF05
DB11595,Atezolizumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,antibody,L01FF05
DB11595,Atezolizumab,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,L01FF05
DB11596,Levoleucovorin,,P0A827,Serine hydroxymethyltransferase,glyA,,V03AF10;V03AF04
DB11597,Human Rho(D) immune globulin,,A6PZ59,Rhesus blood group D antigen,RHD,antibody,J06BB01
DB11598,Antithrombin III human,,P01008,Antithrombin-III,SERPINC1,agonist,B01AB02
DB11601,Tuberculin purified protein derivative,,O60603,Toll-like receptor 2,TLR2,ligand,
DB11603,"Rabies immune globulin, human",,P08667,Rabies Virus Proteins,G,antibody,
DB11604,"Tetanus immune globulin, human",,P04958,Tetanus toxin,tetX,antibody,J06BB02
DB11605,Myrrh,,Q96RI1,Bile acid receptor,NR1H4,antagonist,
DB11605,Myrrh,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,partial agonist,
DB11605,Myrrh,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,
DB11606,Susoctocog alfa,,P04275,von Willebrand factor,VWF,binding,B02BD14
DB11607,Efmoroctocog alfa,,P04275,von Willebrand factor,VWF,binding,
DB11611,Lifitegrast,,P20701,Integrin alpha-L,ITGAL,antagonist,S01XA25
DB11613,Velpatasvir,,Q5L478,Nonstructural protein 5A,NS5A,inhibitor,J05AP55;J05AP56
DB11614,Rupatadine,,P25105,Platelet-activating factor receptor,PTAFR,antagonist,R06AX28
DB11614,Rupatadine,,P35367,Histamine H1 receptor,HRH1,antagonist,R06AX28
DB11619,Gestrinone,,P04278,Sex hormone-binding globulin,SHBG,antagonist,G03XA02
DB11619,Gestrinone,,P06401,Progesterone receptor,PGR,antagonist,G03XA02
DB11619,Gestrinone,,P06401,Progesterone receptor,PGR,agonist,G03XA02
DB11619,Gestrinone,,P04150,Glucocorticoid receptor,NR3C1,antagonist,G03XA02
DB11619,Gestrinone,,P10275,Androgen receptor,AR,antagonist,G03XA02
DB11619,Gestrinone,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,antagonist,G03XA02
DB11619,Gestrinone,,P03372,Estrogen receptor alpha,ESR1,antagonist,G03XA02
DB11619,Gestrinone,,P03372,Estrogen receptor alpha,ESR1,agonist,G03XA02
DB11623,Candoxatrilat,,P08473,Neprilysin,MME,inhibitor,
DB11626,Tasonermin,,P19438,Tumor necrosis factor receptor superfamily member 1A,TNFRSF1A,agonist,L03AX11
DB11626,Tasonermin,,P20333,Tumor necrosis factor receptor superfamily member 1B,TNFRSF1B,agonist,L03AX11
DB11632,Opicapone,,P21964,Catechol O-methyltransferase,COMT,inhibitor,N04BX04
DB11633,Isavuconazole,,P50859,Lanosterol 14-alpha demethylase,ERG11,inhibitor,J02AC05
DB11633,Isavuconazole,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,inhibitor,J02AC05
DB11633,Isavuconazole,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,inhibitor,J02AC05
DB11633,Isavuconazole,,P48051,G protein-activated inward rectifier potassium channel 2,KCNJ6,inhibitor,J02AC05
DB11633,Isavuconazole,,Q92806,G protein-activated inward rectifier potassium channel 3,KCNJ9,inhibitor,J02AC05
DB11633,Isavuconazole,,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,inhibitor,J02AC05
DB11633,Isavuconazole,,P22460,Potassium voltage-gated channel subfamily A member 5,KCNA5,inhibitor,J02AC05
DB11633,Isavuconazole,,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,inhibitor,J02AC05
DB11633,Isavuconazole,,P51787,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,inhibitor,J02AC05
DB11633,Isavuconazole,,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,inhibitor,J02AC05
DB11635,Tocofersolan,,P08183,P-glycoprotein 1,ABCB1,antagonist,A11HA08
DB11638,Artenimol,,P63261,"Actin, cytoplasmic 2",ACTG1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P49419,Alpha-aminoadipic semialdehyde dehydrogenase,ALDH7A1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P07355,Annexin A2,ANXA2,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,O75964,"ATP synthase subunit g, mitochondrial",ATP5L,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P48047,"ATP synthase subunit O, mitochondrial",ATP5O,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P20810,Calpastatin,CAST,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P49368,T-complex protein 1 subunit gamma,CCT3,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P23528,Cofilin-1,CFL1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,O00299,Chloride intracellular channel protein 1,CLIC1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P21291,Cysteine and glycine-rich protein 1,CSRP1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q16555,Dihydropyrimidinase-related protein 2,DPYSL2,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P15924,Desmoplakin,DSP,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P68104,Elongation factor 1-alpha 1,EEF1A1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P06733,Alpha-enolase,ENO1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P21333,Filamin-A,FLNA,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q9C0B1,Alpha-ketoglutarate-dependent dioxygenase FTO,FTO,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P11413,Glucose-6-phosphate 1-dehydrogenase,G6PD,ligand,P01BF05;P01BE05
DB11638,Artenimol,,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P06744,Glucose-6-phosphate isomerase,GPI,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P22626,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q14103,Heterogeneous nuclear ribonucleoprotein D0,HNRNPD,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P61978,Heterogeneous nuclear ribonucleoprotein K,HNRNPK,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q5SSJ5,Heterochromatin protein 1-binding protein 3,HP1BP3,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P04792,Heat shock protein beta-1,HSPB1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P46940,Ras GTPase-activating-like protein IQGAP1,IQGAP1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q92945,Far upstream element-binding protein 2,KHSRP,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P00338,L-lactate dehydrogenase A chain,LDHA,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P07195,L-lactate dehydrogenase B chain,LDHB,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P09382,Galectin-1,LGALS1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P27816,Microtubule-associated protein 4,MAP4,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P40925,"Malate dehydrogenase, cytoplasmic",MDH1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P55786,Puromycin-sensitive aminopeptidase,NPEPPS,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P07737,Profilin-1,PFN1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P00558,Phosphoglycerate kinase 1,PGK1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P14618,Pyruvate kinase PKM,PKM,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q06830,Peroxiredoxin-1,PRDX1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P27635,60S ribosomal protein L10,RPL10,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P50914,60S ribosomal protein L14,RPL14,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q07020,60S ribosomal protein L18,RPL18,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P62750,60S ribosomal protein L23a,RPL23A,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P42766,60S ribosomal protein L35,RPL35,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P36578,60S ribosomal protein L4,RPL4,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P62277,40S ribosomal protein S13,RPS13,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P08708,40S ribosomal protein S17,RPS17,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P62269,40S ribosomal protein S18,RPS18,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P39019,40S ribosomal protein S19,RPS19,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P62857,40S ribosomal protein S28,RPS28,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P46782,40S ribosomal protein S5,RPS5,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P62753,40S ribosomal protein S6,RPS6,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P62241,40S ribosomal protein S8,RPS8,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P46781,40S ribosomal protein S9,RPS9,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q15637,Splicing factor 1,SF1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P23246,"Splicing factor, proline- and glutamine-rich",SFPQ,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P62316,Small nuclear ribonucleoprotein Sm D2,SNRPD2,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P37108,Signal recognition particle 14 kDa protein,SRP14,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q08170,Serine/arginine-rich splicing factor 4,SRSF4,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q01995,Transgelin,TAGLN,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P37802,Transgelin-2,TAGLN2,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P60174,Triosephosphate isomerase,TPI1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P09493,Tropomyosin alpha-1 chain,TPM1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q71U36,Tubulin alpha-1A chain,TUBA1A,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P08670,Vimentin,VIM,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q15942,Zyxin,ZYX,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P11142,Heat shock cognate 71 kDa protein,HSPA8,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q9BUF5,Tubulin beta-6 chain,TUBB6,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P04350,Tubulin beta-4A chain,TUBB4A,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P07437,Tubulin beta chain,TUBB,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P04075,Fructose-bisphosphate aldolase A,ALDOA,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P99999,Cytochrome c,CYCS,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P18669,Phosphoglycerate mutase 1,PGAM1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P35579,Myosin-9,MYH9,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P07237,Protein disulfide-isomerase,P4HB,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P17844,Probable ATP-dependent RNA helicase DDX5,DDX5,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P34897,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q13838,Spliceosome RNA helicase DDX39B,DDX39B,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P06748,Nucleophosmin,NPM1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I3Z5,Translationally-controlled tumor protein homolog,TCTP,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q5R2K6,P-type Ca2+-transporting ATPase,serca,antagonist,P01BF05;P01BE05
DB11638,Artenimol,,Q6LFH8,Ornithine aminotransferase,OAT,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q00080,Elongation factor 1-alpha,MEF-1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P13568,Multidrug resistance protein,MDR1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IKW5,Elongation factor 2,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P86287,Actin-1,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IKK7,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P14223,Fructose-bisphosphate aldolase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C6KT34,"Cell division cycle protein 48 homologue,putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IC05,Heat shock protein 90,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IKF0,Eukaryotic initiation factor 4A,H45,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C6KTA4,Pyruvate kinase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q27743,L-lactate dehydrogenase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C0H4Y6,Protein disulfide-isomerase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IDH5,"Thioredoxin-related protein, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8II73,Spermidine synthase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I2Z8,Probable ATP-dependent 6-phosphofructokinase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8ILF7,Glutamate dehydrogenase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I0V4,"Endoplasmin homolog, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P20035,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,LACZ,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IJN7,Enolase,ENO,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IKH8,40S ribosomal protein S3,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,A0A143ZZK9,Non-SERCA-type Ca2+-transporting P-ATPase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P14642,Tubulin alpha chain,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P13817,Knob-associated histidine-rich protein,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q7K6A4,S-adenosylmethionine synthase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IKR1,"V-type H(+)-translocating pyrophosphatase, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I431,60S ribosomal protein L4,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IDQ9,Phosphoethanolamine N-methyltransferase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,O97313,40S ribosomal protein S3a,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IJT2,Conserved Plasmodium membrane protein,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IJC6,60S ribosomal protein L3,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C0H571,High molecular weight rhoptry protein 2,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,T1RTG8,Serine repeat antigen 5,SERA5,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C0H5C2,40S ribosomal protein S19,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I6U8,Glycophorin-binding protein,GBP,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q08853,Calcium-transporting ATPase,ATP6,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q76NM6,V-type proton ATPase catalytic subunit A,vapA,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I3T9,60S ribosomal protein L2,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I0X2,Acyl-CoA synthetase,ACS3,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IM16,Plasmepsin IV,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q7KQM4,Plasmepsin-1,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q9N623,Chloroquine resistance transporter,CRT,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C0H4V6,14-3-3 protein,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I5G6,"Isoleucine--tRNA ligase, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C6S3C7,Plasmodium exported protein,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q7KQL5,Tubulin beta chain,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IKM5,60S ribosomal protein L27,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IL86,"Sec62, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IJR6,"Autophagy-related protein 18, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I492,Mature parasite-infected erythrocyte surface antigen,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C0H4L1,"Importin-7, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IAW0,Importin subunit alpha,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q76NN7,Peptidyl-prolyl cis-trans isomerase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IB72,"DnaJ protein, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P13827,Merozoite surface protein 1,MSP-1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IDD3,Glutamate--tRNA ligase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,O77323,T-complex protein 1 subunit eta,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P46925,Plasmepsin-2,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C0H546,"Chaperone, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I4R5,Rhoptry neck protein 3,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IBN5,"40S ribosomal protein S5, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I487,Skeleton-binding protein 1,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I3X4,"Purine nucleotide phosphorylase, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P50250,Adenosylhomocysteinase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IJA9,Adenosine deaminase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IJ60,Methionine--tRNA ligase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IEN3,Carbamoyl phosphate synthetase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IDP8,Aspartate carbamoyltransferase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I4W4,"Signal recognition particle receptor, beta subunit",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,O77361,Parasite-infected erythrocyte surface protein,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C6KSR5,"Coatomer alpha subunit, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q02155,Hexokinase,HK,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IBI3,Proteasome subunit alpha type,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IJ74,Haloacid dehalogenase-like hydrolase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8III5,"Insulinase, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IHS5,40S ribosomal protein S21,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IDP1,Ubiquitin-conjugating enzyme E2,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I5Y3,Eukaryotic translation initiation factor 3 subunit C,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IEM3,"60S ribosomal protein L24, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IE82,60S ribosomal protein L23,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IDI5,"60S ribosomal protein L17, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IM15,HAP protein,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C0H5H0,"Heat shock protein 110, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8ILV2,"60S ribosomal protein L10, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IM74,"Lysophospholipase, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8I5H4,Polyadenylate-binding protein,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8ID50,Ubiquitin-60S ribosomal protein L40,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IE67,Phosphoribosylpyrophosphate synthetase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IL80,Thioredoxin peroxidase 1,TPx1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,O96221,Protein transport protein SEC31,Sec31p,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IIJ9,Dipeptidyl aminopeptidase 1,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P13830,Ring-infected erythrocyte surface antigen,RESA,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q9TY94,ATP-dependent RNA helicase UAP56,UAP56,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IBS5,Calcium-dependent protein kinase 4,CPK4,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P38545,GTP-binding nuclear protein Ran,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IB78,Nucleoside transporter 2,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C0H4X5,Anamorsin homolog,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C0H551,"Glutamine synthetase, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IJK8,"60S ribosomal protein L30e, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IIR9,"Casein kinase 2, alpha subunit",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IIA4,Threonine--tRNA ligase,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q7KQK0,cAMP-dependent protein kinase regulatory subunit,PKAr,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IDV0,"Elongation factor 1-gamma, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IKL4,Thioredoxin-like protein,tlp1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8ILK3,60S ribosomal protein L21,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8ILE8,"60S ribosomal protein L14, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IKM6,Inner membrane complex sub-compartment protein 3,,ligand,P01BF05;P01BE05
DB11638,Artenimol,,Q8IL88,"HSP40, subfamily A, putative",,ligand,P01BF05;P01BE05
DB11638,Artenimol,,C6KT50,Pyridoxal 5'-phosphate synthase subunit Pdx1,pdx1,ligand,P01BF05;P01BE05
DB11638,Artenimol,,P02768,Serum albumin,ALB,ligand,P01BF05;P01BE05
DB11639,Dibotermin alfa,,Q13873,Bone morphogenetic protein receptor type-2,BMPR2,ligand,M05BC01
DB11639,Dibotermin alfa,,P36894,Bone morphogenetic protein receptor type-1A,BMPR1A,ligand,M05BC01
DB11640,Amifampridine,,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,blocker,N07XX05
DB11641,Vinflunine,,P07437,Tubulin beta chain,TUBB,inhibitor,L01CA05
DB11642,Pitolisant,,Q9Y5N1,Histamine H3 receptor,HRH3,antagonist,N07XX11
DB11642,Pitolisant,,Q9Y5N1,Histamine H3 receptor,HRH3,inverse agonist,N07XX11
DB11642,Pitolisant,,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,blocker,N07XX11
DB11644,Tafamidis,,P02766,Transthyretin,TTR,chaperone,N07XX08
DB11652,Tucatinib,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,inhibitor,L01EH03
DB11652,Tucatinib,,P21860,Receptor tyrosine-protein kinase erbB-3,ERBB3,inhibitor,L01EH03
DB11653,Bremelanotide,,Q01726,Melanocyte-stimulating hormone receptor,MC1R,agonist,G02CX05
DB11653,Bremelanotide,,P32245,Melanocortin receptor 4,MC4R,agonist,G02CX05
DB11653,Bremelanotide,,P41968,Melanocortin receptor 3,MC3R,agonist,G02CX05
DB11653,Bremelanotide,,P33032,Melanocortin receptor 5,MC5R,agonist,G02CX05
DB11653,Bremelanotide,,Q01718,Adrenocorticotropic hormone receptor,MC2R,agonist,G02CX05
DB11660,Latanoprostene bunod,,P43088,Prostaglandin F2-alpha receptor,PTGFR,agonist,S01EE06
DB11672,Curcumin,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB11672,Curcumin,,P11473,Vitamin D3 receptor,VDR,,
DB11672,Curcumin,,O15440,Multidrug resistance-associated protein 5,ABCC5,inhibitor,
DB11672,Curcumin,,P16152,Carbonyl reductase [NADPH] 1,CBR1,,
DB11672,Curcumin,,P09211,Glutathione S-transferase P,GSTP1,,
DB11674,Equol,,Q92731,Estrogen receptor beta,ESR2,agonist,
DB11674,Equol,,P04278,Sex hormone-binding globulin,SHBG,,
DB11676,Galidesivir,,Q05318,RNA-directed RNA polymerase L,L,inhibitor,
DB11679,Fruquintinib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,
DB11679,Fruquintinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,
DB11679,Fruquintinib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,inhibitor,
DB11682,Daprodustat,,Q9GZT9,Egl nine homolog 1,EGLN1,inhibitor,B03XA07
DB11682,Daprodustat,,Q96KS0,Egl nine homolog 2,EGLN2,inhibitor,B03XA07
DB11682,Daprodustat,,Q9H6Z9,Egl nine homolog 3,EGLN3,inhibitor,B03XA07
DB11689,Selumetinib,,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,inhibitor,L01EE04
DB11689,Selumetinib,,P36507,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,inhibitor,L01EE04
DB11691,Naldemedine,,P35372,Mu-type opioid receptor,OPRM1,antagonist,A06AH05
DB11691,Naldemedine,,P41143,Delta-type opioid receptor,OPRD1,antagonist,A06AH05
DB11691,Naldemedine,,P41145,Kappa-type opioid receptor,OPRK1,antagonist,A06AH05
DB11692,Pavinetant,,P29371,Neuromedin-K receptor,TACR3,antagonist,
DB11693,Voclosporin,,P49069,Calcium signal-modulating cyclophilin ligand,CAMLG,binder,L04AD03
DB11693,Voclosporin,,P63098,Calcineurin subunit B type 1,PPP3R1,inhibitor,L04AD03
DB11693,Voclosporin,,Q96LZ3,Calcineurin subunit B type 2,PPP3R2,inhibitor,L04AD03
DB11697,Pacritinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,L01EJ03
DB11697,Pacritinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EJ03
DB11699,Tropisetron,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,antagonist,A04AA03
DB11700,Setmelanotide,,P32245,Melanocortin receptor 4,MC4R,agonist,A08AA12
DB11703,Acalabrutinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,L01EL02
DB11712,Tezacaftor,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,positive allosteric modulator,R07AX32;R07AX31
DB11714,Durvalumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,L01FF03
DB11714,Durvalumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,antibody,L01FF03
DB11714,Durvalumab,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,L01FF03
DB11714,Durvalumab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,L01FF03
DB11718,Encorafenib,,P15056,Serine/threonine-protein kinase B-raf,BRAF,inhibitor,L01EC03
DB11718,Encorafenib,,P24385,G1/S-specific cyclin-D1,CCND1,inhibitor,L01EC03
DB11718,Encorafenib,,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,inhibitor,L01EC03
DB11718,Encorafenib,,P45983,Mitogen-activated protein kinase 8,MAPK8,inhibitor,L01EC03
DB11718,Encorafenib,,P45984,Mitogen-activated protein kinase 9,MAPK9,inhibitor,L01EC03
DB11718,Encorafenib,,P53779,Mitogen-activated protein kinase 10,MAPK10,inhibitor,L01EC03
DB11718,Encorafenib,,P53667,LIM domain kinase 1,LIMK1,inhibitor,L01EC03
DB11718,Encorafenib,,P53671,LIM domain kinase 2,LIMK2,inhibitor,L01EC03
DB11718,Encorafenib,,P45985,Dual specificity mitogen-activated protein kinase kinase 4,MAP2K4,inhibitor,L01EC03
DB11718,Encorafenib,,Q9NRP7,Serine/threonine-protein kinase 36,STK36,inhibitor,L01EC03
DB11723,Dutogliptin,,P27487,Dipeptidyl peptidase 4,DPP4,,
DB11726,Encenicline,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,partial agonist,
DB11730,Ribociclib,,P11802,Cyclin-dependent kinase 4,CDK4,antagonist,L01EF02
DB11730,Ribociclib,,P11802,Cyclin-dependent kinase 4,CDK4,inhibitor,L01EF02
DB11730,Ribociclib,,Q00534,Cyclin-dependent kinase 6,CDK6,antagonist,L01EF02
DB11730,Ribociclib,,Q00534,Cyclin-dependent kinase 6,CDK6,inhibitor,L01EF02
DB11731,Depatuxizumab mafodotin,,P07437,Tubulin beta chain,TUBB,nucleotide exchange blocker,
DB11731,Depatuxizumab mafodotin,,P00533,Epidermal growth factor receptor,EGFR,antibody,
DB11731,Depatuxizumab mafodotin,,P15391,B-lymphocyte antigen CD19,CD19,regulator,
DB11732,Lasmiditan,,P30939,5-hydroxytryptamine receptor 1F,HTR1F,agonist,N02CC08
DB11737,Icotinib,,P00533,Epidermal growth factor receptor,EGFR,antagonist,L01EB08
DB11738,Rilmenidine,,P08913,Alpha-2A adrenergic receptor,ADRA2A,,C02AC06
DB11739,Vonoprazan,,P20648,Hydrogen potassium ATPase,ATP4A,inhibitor,A02BD14;A02BD15;A02BC08
DB11740,Adavosertib,,P30291,Wee1-like protein kinase,WEE1,inhibitor,
DB11745,Otenabant,,P21554,Cannabinoid receptor 1,CNR1,,
DB11751,Cabotegravir,,Q7ZJM1,Integrase,pol,inhibitor,J05AJ04
DB11752,Bryostatin 1,,P17252,Protein kinase C alpha type,PRKCA,activator,
DB11752,Bryostatin 1,,Q02156,Protein kinase C epsilon type,PRKCE,activator,
DB11752,Bryostatin 1,,Q14790,Caspase-8,CASP8,inhibitor,
DB11752,Bryostatin 1,,Q15139,Serine/threonine-protein kinase D1,PRKD1,activator,
DB11752,Bryostatin 1,,P42081,T-lymphocyte activation antigen CD86,CD86,inducer,
DB11752,Bryostatin 1,,P35354,Prostaglandin G/H synthase 2,PTGS2,inducer,
DB11752,Bryostatin 1,,P24385,G1/S-specific cyclin-D1,CCND1,inhibitor,
DB11752,Bryostatin 1,,P01375,Tumor necrosis factor,TNF,inducer,
DB11752,Bryostatin 1,,Q9Z1N9,Protein unc-13 homolog B,Unc13b,ligand,
DB11753,Rifamycin,,P0A8V2,DNA-directed RNA polymerase subunit beta,rpoB,binder,S01AA16;S02AA12;D06AX15;A07AA13;J04AB03
DB11753,Rifamycin,,P0A7Z4,DNA-directed RNA polymerase subunit alpha,rpoA,binder,S01AA16;S02AA12;D06AX15;A07AA13;J04AB03
DB11753,Rifamycin,,P0A8T7,DNA-directed RNA polymerase subunit beta',rpoC,binder,S01AA16;S02AA12;D06AX15;A07AA13;J04AB03
DB11755,Tetrahydrocannabivarin,,P21554,Cannabinoid receptor 1,CNR1,antagonist,
DB11755,Tetrahydrocannabivarin,,Q9Y2T6,G-protein coupled receptor 55,GPR55,partial agonist,
DB11755,Tetrahydrocannabivarin,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,
DB11755,Tetrahydrocannabivarin,,Q9Y5S1,Transient receptor potential cation channel subfamily V member 2,TRPV2,agonist,
DB11755,Tetrahydrocannabivarin,,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,TRPM8,antagonist,
DB11755,Tetrahydrocannabivarin,,O75762,Transient receptor potential cation channel subfamily A member 1,TRPA1,agonist,
DB11755,Tetrahydrocannabivarin,,P34972,Cannabinoid receptor 2,CNR2,partial agonist,
DB11757,Istradefylline,,P29274,Adenosine receptor A2a,ADORA2A,antagonist,N04CX01
DB11757,Istradefylline,,P30542,Adenosine receptor A1,ADORA1,antagonist,N04CX01
DB11758,Cenicriviroc,,P41597,C-C chemokine receptor type 2,CCR2,inhibitor,
DB11760,Talazoparib,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,inhibitor,L01XK04
DB11760,Talazoparib,,Q9UGN5,Poly [ADP-ribose] polymerase 2,PARP2,inhibitor,L01XK04
DB11761,Tenapanor,,P48764,Sodium/hydrogen exchanger 3,SLC9A3,inhibitor,A06AX08
DB11763,Momelotinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,
DB11763,Momelotinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,
DB11763,Momelotinib,,P52333,Tyrosine-protein kinase JAK3,JAK3,inhibitor,
DB11763,Momelotinib,,P29597,Non-receptor tyrosine-protein kinase TYK2,TYK2,inhibitor,
DB11763,Momelotinib,,Q04771,Activin receptor type-1,ACVR1,inhibitor,
DB11763,Momelotinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,
DB11764,Spebrutinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB11767,Sarilumab,,P08887,Interleukin-6 receptor subunit alpha,IL6R,antagonist,L04AC14
DB11767,Sarilumab,,P08887,Interleukin-6 receptor subunit alpha,IL6R,antibody,L04AC14
DB11767,Sarilumab,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,unknown,L04AC14
DB11767,Sarilumab,,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,unknown,L04AC14
DB11767,Sarilumab,,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,unknown,L04AC14
DB11767,Sarilumab,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,unknown,L04AC14
DB11767,Sarilumab,,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,unknown,L04AC14
DB11771,Tremelimumab,,P16410,Cytotoxic T-lymphocyte protein 4,CTLA4,inhibitor,L01FX20
DB11771,Tremelimumab,,P16410,Cytotoxic T-lymphocyte protein 4,CTLA4,antibody,L01FX20
DB11772,Pilaralisib,,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,,
DB11779,Danoprevir,,P26664,Genome polyprotein,,,
DB11781,Tosedostat,,P55786,Puromycin-sensitive aminopeptidase,NPEPPS,,
DB11781,Tosedostat,,P09960,Leukotriene A-4 hydrolase,LTA4H,,
DB11791,Capmatinib,,P08581,Hepatocyte growth factor receptor,MET,inhibitor,L01EX17
DB11793,Niraparib,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,inhibitor,L01XK02
DB11793,Niraparib,,Q9UGN5,Poly [ADP-ribose] polymerase 2,PARP2,inhibitor,L01XK02
DB11796,Fostemsavir,,P12488,Envelope glycoprotein gp160,env,inhibitor,J05AX29
DB11799,Bictegravir,,Q72547,Reverse transcriptase/RNaseH,pol,antagonist,J05AR20
DB11799,Bictegravir,,Q7ZJM1,Integrase,pol,antagonist,J05AR20
DB11800,Tivozanib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,L01EK03
DB11800,Tivozanib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EK03
DB11800,Tivozanib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,inhibitor,L01EK03
DB11800,Tivozanib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,L01EK03
DB11800,Tivozanib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,L01EK03
DB11800,Tivozanib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EK03
DB11800,Tivozanib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,inhibitor,L01EK03
DB11800,Tivozanib,,Q13882,Protein-tyrosine kinase 6,PTK6,,L01EK03
DB11800,Tivozanib,,Q02763,Angiopoietin-1 receptor,TEK,,L01EK03
DB11800,Tivozanib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EK03
DB11800,Tivozanib,,P08581,Hepatocyte growth factor receptor,MET,inhibitor,L01EK03
DB11811,Arhalofenate,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB11817,Baricitinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,L04AA37
DB11817,Baricitinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,L04AA37
DB11817,Baricitinib,,P52333,Tyrosine-protein kinase JAK3,JAK3,inhibitor,L04AA37
DB11817,Baricitinib,,P29597,Non-receptor tyrosine-protein kinase TYK2,TYK2,inhibitor,L04AA37
DB11820,Nifurtimox,,,Nitroreductases,,activator,P01CC01
DB11820,Nifurtimox,,P22513,"Glyceraldehyde-3-phosphate dehydrogenase, glycosomal",,inhibitor,P01CC01
DB11823,Esketamine,,Q05586,NMDA receptor,GRIN1,antagonist,N06AX27;N01AX14
DB11823,Esketamine,,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,antagonist,N06AX27;N01AX14
DB11823,Esketamine,,P13639,Elongation factor 2,EEF2,inhibitor,N06AX27;N01AX14
DB11823,Esketamine,,P23560,Brain-derived neurotrophic factor,BDNF,agonist,N06AX27;N01AX14
DB11823,Esketamine,,Q16620,BDNF/NT-3 growth factors receptor,NTRK2,,N06AX27;N01AX14
DB11827,Ertugliflozin,,P31639,Sodium/glucose cotransporter 2,SLC5A2,inhibitor,A10BD23;A10BK04;A10BD24
DB11828,Neratinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,L01EH02
DB11830,Mocetinostat,,Q13547,Histone deacetylase 1,HDAC1,,
DB11830,Mocetinostat,,O15379,Histone deacetylase 3,HDAC3,,
DB11830,Mocetinostat,,Q92769,Histone deacetylase 2,HDAC2,,
DB11831,Dinitrochlorobenzene,,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,,
DB11831,Dinitrochlorobenzene,,P09211,Glutathione S-transferase P,GSTP1,,
DB11834,Guselkumab,,Q9NPF7,Interleukin-23 subunit alpha,IL23A,blocker,L04AC16
DB11837,Osilodrostat,,P15538,"Cytochrome P450 11B1, mitochondrial",CYP11B1,inhibitor,H02CA02
DB11837,Osilodrostat,,P19099,"Cytochrome P450 11B2, mitochondrial",CYP11B2,inhibitor,H02CA02
DB11840,Dalotuzumab,,P08069,Insulin-like growth factor 1 receptor,IGF1R,antibody,
DB11840,Dalotuzumab,,P08069,Insulin-like growth factor 1 receptor,IGF1R,regulator,
DB11841,Entinostat,,Q13547,Histone deacetylase,HDAC1,inhibitor,L01XH05
DB11842,Angiotensin II,,P30556,Type-1 angiotensin II receptor,AGTR1,agonist,C01CX09
DB11850,Ublituximab,,P11836,B-lymphocyte antigen CD20,MS4A1,binder,L04AA57
DB11850,Ublituximab,,P11836,B-lymphocyte antigen CD20,MS4A1,antibody,L04AA57
DB11853,Relugolix,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,antagonist,H01CC54;L02BX04
DB11854,Astodrimer,,P35961,Envelope glycoprotein gp160,env,,
DB11855,Revefenacin,,P11229,Muscarinic acetylcholine receptor,CHRM1,antagonist,R03BB08
DB11856,Ligelizumab,,P01854,Immunoglobulin heavy constant epsilon,IGHE,antibody,
DB11858,Leukotriene D4,,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,,
DB11858,Leukotriene D4,,Q9NS75,Cysteinyl leukotriene receptor 2,CYSLTR2,,
DB11859,Brexanolone,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N06AX29
DB11866,Romosozumab,,Q9BQB4,Sclerostin,SOST,inhibitor,M05BX06
DB11886,Infigratinib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EN03
DB11886,Infigratinib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,L01EN03
DB11886,Infigratinib,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,L01EN03
DB11886,Infigratinib,,P22455,Fibroblast growth factor receptor 4,FGFR4,inhibitor,L01EN03
DB11901,Apalutamide,,P10275,Androgen receptor,AR,antagonist,L02BB05
DB11901,Apalutamide,,P14867,GABA(A) Receptor,GABRA1,antagonist,L02BB05
DB11914,Lebrikizumab,,P35225,Interleukin-13,IL13,antibody,
DB11915,Valbenazine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,N07XX13
DB11921,Deflazacort,,P04150,Glucocorticoid receptor,NR3C1,agonist,H02AB13
DB11928,Vosoritide,,P20594,Atrial natriuretic peptide receptor 2,NPR2,agonist,M05BX07
DB11936,Bempedoic acid,,P53396,ATP-citrate synthase,ACLY,inhibitor,C10AX15;C10BA10
DB11937,Kynurenic Acid,,P35869,Aryl hydrocarbon receptor,AHR,,
DB11937,Kynurenic Acid,,Q9HC97,G-protein coupled receptor 35,GPR35,,
DB11938,Difelikefalin,,P41145,Kappa-type opioid receptor,OPRK1,agonist,V03AX04
DB11942,Selinexor,,O14980,Exportin-1,XPO1,inhibitor,L01XX66
DB11943,Delafloxacin,,P0AFI2,DNA topoisomerase 4 subunit A,parC,inhibitor,J01MA23
DB11943,Delafloxacin,,P0AES4,DNA gyrase subunit A,gyrA,inhibitor,J01MA23
DB11945,Avelumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,L01FF04
DB11945,Avelumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,antibody,L01FF04
DB11948,Lapachone,,P10745,Retinol-binding protein 3,RBP3,,
DB11949,Vestipitant,,P25103,Neurokinin 1 receptor,TACR1,,
DB11951,Lemborexant,,O43613,Orexin receptor type 1,HCRTR1,antagonist,N05CM21
DB11951,Lemborexant,,O43614,Orexin receptor type 2,HCRTR2,antagonist,N05CM21
DB11952,Duvelisib,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,inhibitor,L01EM04
DB11952,Duvelisib,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,inhibitor,L01EM04
DB11962,GSK-1059615,,P42345,Serine/threonine-protein kinase mTOR,MTOR,inhibitor,
DB11962,GSK-1059615,,Q8NEB9,Phosphatidylinositol 3-kinase catalytic subunit type 3,PIK3C3,inhibitor,
DB11963,Dacomitinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,L01EB07
DB11967,Binimetinib,,P36507,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,inhibitor,L01EE03
DB11967,Binimetinib,,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,inhibitor,L01EE03
DB11973,Tesevatinib,,P01133,Pro-epidermal growth factor,EGF,,
DB11973,Tesevatinib,,P54760,Ephrin type-B receptor 4,EPHB4,,
DB11973,Tesevatinib,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,,
DB11976,Anifrolumab,,P17181,Interferon alpha/beta receptor 1,IFNAR1,inhibitor,L04AA51
DB11978,Glasdegib,,Q99835,Smoothened homolog,SMO,inhibitor,L01XJ03
DB11979,Elagolix,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,antagonist,H01CC53;H01CC03
DB11986,Entrectinib,,P04629,High affinity nerve growth factor receptor,NTRK1,inhibitor,L01EX14
DB11986,Entrectinib,,Q16288,NT-3 growth factor receptor,NTRK3,inhibitor,L01EX14
DB11986,Entrectinib,,P08922,Proto-oncogene tyrosine-protein kinase ROS,ROS1,inhibitor,L01EX14
DB11986,Entrectinib,,Q16620,BDNF/NT-3 growth factors receptor,NTRK2,inhibitor,L01EX14
DB11986,Entrectinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,L01EX14
DB11986,Entrectinib,,Q07912,Activated CDC42 kinase 1,TNK2,,L01EX14
DB11988,Ocrelizumab,,P11836,B-lymphocyte antigen CD20,MS4A1,antagonist,L04AA36
DB11988,Ocrelizumab,,P11836,B-lymphocyte antigen CD20,MS4A1,antibody,L04AA36
DB11994,Diacerein,,Q13133,Oxysterols receptor LXR-alpha,NR1H3,inhibitor,M01AX21
DB11994,Diacerein,,P55055,Oxysterols receptor LXR-beta,NR1H2,inhibitor,M01AX21
DB11994,Diacerein,,,Arylamine N-acetyltransferase,,inhibitor,M01AX21
DB11994,Diacerein,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,M01AX21
DB11994,Diacerein,,P05177,Cytochrome P450 1A2,CYP1A2,inhibitor,M01AX21
DB11994,Diacerein,,P08684,Cytochrome P450 3A Subfamily,CYP3A4,inhibitor,M01AX21
DB11994,Diacerein,,P05181,Cytochrome P450 2E1,CYP2E1,inhibitor,M01AX21
DB11994,Diacerein,,P11712,Cytochrome P450 2C9,CYP2C9,inhibitor,M01AX21
DB11994,Diacerein,,P10635,Cytochrome P450 2D6,CYP2D6,inhibitor,M01AX21
DB11995,Avatrombopag,,P40238,Thrombopoietin receptor,MPL,agonist,B02BX08
DB12001,Abemaciclib,,P11802,Cyclin-dependent kinase 4,CDK4,inhibitor,L01EF03
DB12001,Abemaciclib,,Q00534,Cyclin-dependent kinase 6,CDK6,inhibitor,L01EF03
DB12005,Nirogacestat,,P49768,Presenilin-1,PSEN1,inhibitor,
DB12007,Isoflavone,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,
DB12007,Isoflavone,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,
DB12008,Prexasertib,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,inhibitor,
DB12010,Fostamatinib,,P43405,Tyrosine-protein kinase SYK,SYK,inhibitor,B02BX09
DB12010,Fostamatinib,,P0DMS8,Adenosine receptor A3,ADORA3,antagonist,B02BX09
DB12010,Fostamatinib,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,B02BX09
DB12010,Fostamatinib,,O00519,Fatty-acid amide hydrolase 1,FAAH,inhibitor,B02BX09
DB12010,Fostamatinib,,Q99808,Equilibrative nucleoside transporter 1,SLC29A1,inhibitor,B02BX09
DB12010,Fostamatinib,,P22309,UDP-glucuronosyltransferase 1-1,UGT1A1,inhibitor,B02BX09
DB12010,Fostamatinib,,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,inhibitor,B02BX09
DB12010,Fostamatinib,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,B02BX09
DB12010,Fostamatinib,,P25774,Cathepsin S,CTSS,inhibitor,B02BX09
DB12010,Fostamatinib,,P07711,Cathepsin L1,CTSL,inhibitor,B02BX09
DB12010,Fostamatinib,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,B02BX09
DB12010,Fostamatinib,,P62344,Calcium-dependent protein kinase 1,CPK1,inhibitor,B02BX09
DB12010,Fostamatinib,,P9WI81,Serine/threonine-protein kinase PknB,pknB,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UK32,Ribosomal protein S6 kinase alpha-6,RPS6KA6,inhibitor,B02BX09
DB12010,Fostamatinib,,P29597,Non-receptor tyrosine-protein kinase TYK2,TYK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8NI60,"Atypical kinase COQ8A, mitochondrial",COQ8A,inhibitor,B02BX09
DB12010,Fostamatinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,B02BX09
DB12010,Fostamatinib,,P08581,Hepatocyte growth factor receptor,MET,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8IY84,Serine/threonine-protein kinase NIM1,NIM1K,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9P289,Serine/threonine-protein kinase MST4,STK26,inhibitor,B02BX09
DB12010,Fostamatinib,,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9Y6E0,Serine/threonine-protein kinase 24,STK24,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13188,Serine/threonine-protein kinase 3,STK3,inhibitor,B02BX09
DB12010,Fostamatinib,,P42680,Tyrosine-protein kinase Tec,TEC,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9BYT3,Serine/threonine-protein kinase 33,STK33,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8TDR2,Serine/threonine-protein kinase 35,STK35,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9NRP7,Serine/threonine-protein kinase 36,STK36,inhibitor,B02BX09
DB12010,Fostamatinib,,Q15208,Serine/threonine-protein kinase 38,STK38,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9Y2H1,Serine/threonine-protein kinase 38-like,STK38L,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UEW8,STE20/SPS1-related proline-alanine-rich protein kinase,STK39,inhibitor,B02BX09
DB12010,Fostamatinib,,Q7L7X3,Serine/threonine-protein kinase TAO1,TAOK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UL54,Serine/threonine-protein kinase TAO2,TAOK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9H2K8,Serine/threonine-protein kinase TAO3,TAOK3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UHD2,Serine/threonine-protein kinase TBK1,TBK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q02763,Angiopoietin-1 receptor,TEK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q15569,Dual specificity testis-specific protein kinase 1,TESK1,inhibitor,B02BX09
DB12010,Fostamatinib,,P36897,TGF-beta receptor type-1,TGFBR1,inhibitor,B02BX09
DB12010,Fostamatinib,,P37173,TGF-beta receptor type-2,TGFBR2,inhibitor,B02BX09
DB12010,Fostamatinib,,P35590,Tyrosine-protein kinase receptor Tie-1,TIE1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UKI8,Serine/threonine-protein kinase tousled-like 1,TLK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q86UE8,Serine/threonine-protein kinase tousled-like 2,TLK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UKE5,TRAF2 and NCK-interacting protein kinase,TNIK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13470,Non-receptor tyrosine-protein kinase TNK1,TNK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q07912,Activated CDC42 kinase 1,TNK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q59H18,Serine/threonine-protein kinase TNNI3K,TNNI3K,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9BXA7,Testis-specific serine/threonine-protein kinase 1,TSSK1B,inhibitor,B02BX09
DB12010,Fostamatinib,,P33981,Dual specificity protein kinase TTK,TTK,inhibitor,B02BX09
DB12010,Fostamatinib,,P42681,Tyrosine-protein kinase TXK,TXK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q06418,Tyrosine-protein kinase receptor TYRO3,TYRO3,inhibitor,B02BX09
DB12010,Fostamatinib,,O75385,Serine/threonine-protein kinase ULK1,ULK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8IYT8,Serine/threonine-protein kinase ULK2,ULK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q6PHR2,Serine/threonine-protein kinase ULK3,ULK3,inhibitor,B02BX09
DB12010,Fostamatinib,,P30291,Wee1-like protein kinase,WEE1,inhibitor,B02BX09
DB12010,Fostamatinib,,P07947,Tyrosine-protein kinase Yes,YES1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q56UN5,Mitogen-activated protein kinase kinase kinase 19,MAP3K19,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9NYL2,Mitogen-activated protein kinase kinase kinase MLT,ZAK,inhibitor,B02BX09
DB12010,Fostamatinib,,P43403,Tyrosine-protein kinase ZAP-70,ZAP70,inhibitor,B02BX09
DB12010,Fostamatinib,,Q2M2I8,AP2-associated protein kinase 1,AAK1,inhibitor,B02BX09
DB12010,Fostamatinib,,P42684,Tyrosine-protein kinase ABL2,ABL2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q04771,Activin receptor type-1,ACVR1,inhibitor,B02BX09
DB12010,Fostamatinib,,P36896,Activin receptor type-1B,ACVR1B,inhibitor,B02BX09
DB12010,Fostamatinib,,Q96D53,"Atypical kinase COQ8B, mitochondrial",COQ8B,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UM73,ALK tyrosine kinase receptor,ALK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8NFD2,Ankyrin repeat and protein kinase domain-containing protein 1,ANKK1,inhibitor,B02BX09
DB12010,Fostamatinib,,O14965,Aurora kinase A,AURKA,inhibitor,B02BX09
DB12010,Fostamatinib,,Q96GD4,Aurora kinase B,AURKB,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UQB9,Aurora kinase C,AURKC,inhibitor,B02BX09
DB12010,Fostamatinib,,P30530,Tyrosine-protein kinase receptor UFO,AXL,inhibitor,B02BX09
DB12010,Fostamatinib,,P51451,Tyrosine-protein kinase Blk,BLK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9NSY1,BMP-2-inducible protein kinase,BMP2K,inhibitor,B02BX09
DB12010,Fostamatinib,,O00238,Bone morphogenetic protein receptor type-1B,BMPR1B,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13873,Bone morphogenetic protein receptor type-2,BMPR2,inhibitor,B02BX09
DB12010,Fostamatinib,,P51813,Cytoplasmic tyrosine-protein kinase BMX,BMX,inhibitor,B02BX09
DB12010,Fostamatinib,,P15056,Serine/threonine-protein kinase B-raf,BRAF,inhibitor,B02BX09
DB12010,Fostamatinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q14012,Calcium/calmodulin-dependent protein kinase type 1,CAMK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8IU85,Calcium/calmodulin-dependent protein kinase type 1D,CAMK1D,inhibitor,B02BX09
DB12010,Fostamatinib,,Q96NX5,Calcium/calmodulin-dependent protein kinase type 1G,CAMK1G,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UQM7,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13554,Calcium/calmodulin-dependent protein kinase type II subunit beta,CAMK2B,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13557,Calcium/calmodulin-dependent protein kinase type II subunit delta,CAMK2D,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13555,Calcium/calmodulin-dependent protein kinase type II subunit gamma,CAMK2G,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8N5S9,Calcium/calmodulin-dependent protein kinase kinase 1,CAMKK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q96RR4,Calcium/calmodulin-dependent protein kinase kinase 2,CAMKK2,inhibitor,B02BX09
DB12010,Fostamatinib,,O14936,Peripheral plasma membrane protein CASK,CASK,inhibitor,B02BX09
DB12010,Fostamatinib,,P07498,Kappa-casein,CSN3,inhibitor,B02BX09
DB12010,Fostamatinib,,P06493,Cyclin-dependent kinase 1,CDK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q6DT37,Serine/threonine-protein kinase MRCK gamma,CDC42BPG,inhibitor,B02BX09
DB12010,Fostamatinib,,P11802,Cyclin-dependent kinase 4,CDK4,inhibitor,B02BX09
DB12010,Fostamatinib,,Q00532,Cyclin-dependent kinase-like 1,CDKL1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q92772,Cyclin-dependent kinase-like 2,CDKL2,inhibitor,B02BX09
DB12010,Fostamatinib,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,inhibitor,B02BX09
DB12010,Fostamatinib,,O96017,Serine/threonine-protein kinase Chk2,CHEK2,inhibitor,B02BX09
DB12010,Fostamatinib,,O14578,Citron Rho-interacting kinase,CIT,inhibitor,B02BX09
DB12010,Fostamatinib,,P49759,Dual specificity protein kinase CLK1,CLK1,inhibitor,B02BX09
DB12010,Fostamatinib,,P49760,Dual specificity protein kinase CLK2,CLK2,inhibitor,B02BX09
DB12010,Fostamatinib,,P49761,Dual specificity protein kinase CLK3,CLK3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9HAZ1,Dual specificity protein kinase CLK4,CLK4,inhibitor,B02BX09
DB12010,Fostamatinib,,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,inhibitor,B02BX09
DB12010,Fostamatinib,,P41240,Tyrosine-protein kinase CSK,CSK,inhibitor,B02BX09
DB12010,Fostamatinib,,P48729,Casein kinase I isoform alpha,CSNK1A1,inhibitor,B02BX09
DB12010,Fostamatinib,,P68400,Casein kinase II subunit alpha,CSNK2A1,inhibitor,B02BX09
DB12010,Fostamatinib,,P19784,Casein kinase II subunit alpha',CSNK2A2,inhibitor,B02BX09
DB12010,Fostamatinib,,P53355,Death-associated protein kinase 1,DAPK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UIK4,Death-associated protein kinase 2,DAPK2,inhibitor,B02BX09
DB12010,Fostamatinib,,O43293,Death-associated protein kinase 3,DAPK3,inhibitor,B02BX09
DB12010,Fostamatinib,,O15075,Serine/threonine-protein kinase DCLK1,DCLK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8N568,Serine/threonine-protein kinase DCLK2,DCLK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9C098,Serine/threonine-protein kinase DCLK3,DCLK3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q08345,Epithelial discoidin domain-containing receptor 1,DDR1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q16832,Discoidin domain-containing receptor 2,DDR2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13627,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,DYRK1A,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9Y463,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,DYRK1B,inhibitor,B02BX09
DB12010,Fostamatinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9BQI3,Eukaryotic translation initiation factor 2-alpha kinase 1,EIF2AK1,inhibitor,B02BX09
DB12010,Fostamatinib,,P19525,"Interferon-induced, double-stranded RNA-activated protein kinase",EIF2AK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9P2K8,eIF-2-alpha kinase GCN2,EIF2AK4,inhibitor,B02BX09
DB12010,Fostamatinib,,P21709,Ephrin type-A receptor 1,EPHA1,inhibitor,B02BX09
DB12010,Fostamatinib,,P29317,Ephrin type-A receptor 2,EPHA2,inhibitor,B02BX09
DB12010,Fostamatinib,,P29320,Ephrin type-A receptor 3,EPHA3,inhibitor,B02BX09
DB12010,Fostamatinib,,P54764,Ephrin type-A receptor 4,EPHA4,inhibitor,B02BX09
DB12010,Fostamatinib,,P54756,Ephrin type-A receptor 5,EPHA5,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UF33,Ephrin type-A receptor 6,EPHA6,inhibitor,B02BX09
DB12010,Fostamatinib,,Q15375,Ephrin type-A receptor 7,EPHA7,inhibitor,B02BX09
DB12010,Fostamatinib,,P29322,Ephrin type-A receptor 8,EPHA8,inhibitor,B02BX09
DB12010,Fostamatinib,,P54762,Ephrin type-B receptor 1,EPHB1,inhibitor,B02BX09
DB12010,Fostamatinib,,P29323,Ephrin type-B receptor 2,EPHB2,inhibitor,B02BX09
DB12010,Fostamatinib,,P54760,Ephrin type-B receptor 4,EPHB4,inhibitor,B02BX09
DB12010,Fostamatinib,,O15197,Ephrin type-B receptor 6,EPHB6,inhibitor,B02BX09
DB12010,Fostamatinib,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q15303,Receptor tyrosine-protein kinase erbB-4,ERBB4,inhibitor,B02BX09
DB12010,Fostamatinib,,O75460,Serine/threonine-protein kinase/endoribonuclease IRE1,ERN1,inhibitor,B02BX09
DB12010,Fostamatinib,,P16591,Tyrosine-protein kinase Fer,FER,inhibitor,B02BX09
DB12010,Fostamatinib,,P07332,Tyrosine-protein kinase Fes/Fps,FES,inhibitor,B02BX09
DB12010,Fostamatinib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,B02BX09
DB12010,Fostamatinib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,B02BX09
DB12010,Fostamatinib,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,B02BX09
DB12010,Fostamatinib,,P09769,Tyrosine-protein kinase Fgr,FGR,inhibitor,B02BX09
DB12010,Fostamatinib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,B02BX09
DB12010,Fostamatinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,B02BX09
DB12010,Fostamatinib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,inhibitor,B02BX09
DB12010,Fostamatinib,,P42345,Serine/threonine-protein kinase mTOR,MTOR,inhibitor,B02BX09
DB12010,Fostamatinib,,P42685,Tyrosine-protein kinase FRK,FRK,inhibitor,B02BX09
DB12010,Fostamatinib,,P06241,Tyrosine-protein kinase Fyn,FYN,inhibitor,B02BX09
DB12010,Fostamatinib,,O14976,Cyclin-G-associated kinase,GAK,inhibitor,B02BX09
DB12010,Fostamatinib,,P49840,Glycogen synthase kinase-3 alpha,GSK3A,inhibitor,B02BX09
DB12010,Fostamatinib,,P49841,Glycogen synthase kinase-3 beta,GSK3B,inhibitor,B02BX09
DB12010,Fostamatinib,,P08631,Tyrosine-protein kinase HCK,HCK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9H2X6,Homeodomain-interacting protein kinase 2,HIPK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9H422,Homeodomain-interacting protein kinase 3,HIPK3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UPZ9,Serine/threonine-protein kinase ICK,ICK,inhibitor,B02BX09
DB12010,Fostamatinib,,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,inhibitor,B02BX09
DB12010,Fostamatinib,,Q14164,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,IKBKE,inhibitor,B02BX09
DB12010,Fostamatinib,,P06213,Insulin receptor,INSR,inhibitor,B02BX09
DB12010,Fostamatinib,,P14616,Insulin receptor-related protein,INSRR,inhibitor,B02BX09
DB12010,Fostamatinib,,P51617,Interleukin-1 receptor-associated kinase 1,IRAK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9Y616,Interleukin-1 receptor-associated kinase 3,IRAK3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9NWZ3,Interleukin-1 receptor-associated kinase 4,IRAK4,inhibitor,B02BX09
DB12010,Fostamatinib,,Q08881,Tyrosine-protein kinase ITK/TSK,ITK,inhibitor,B02BX09
DB12010,Fostamatinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,B02BX09
DB12010,Fostamatinib,,P52333,Tyrosine-protein kinase JAK3,JAK3,inhibitor,B02BX09
DB12010,Fostamatinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9Y2K2,Serine/threonine-protein kinase SIK3,SIK3,inhibitor,B02BX09
DB12010,Fostamatinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,B02BX09
DB12010,Fostamatinib,,O95835,Serine/threonine-protein kinase LATS1,LATS1,inhibitor,B02BX09
DB12010,Fostamatinib,,P06239,Tyrosine-protein kinase Lck,LCK,inhibitor,B02BX09
DB12010,Fostamatinib,,P53667,LIM domain kinase 1,LIMK1,inhibitor,B02BX09
DB12010,Fostamatinib,,P53671,LIM domain kinase 2,LIMK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q5S007,Leucine-rich repeat serine/threonine-protein kinase 2,LRRK2,inhibitor,B02BX09
DB12010,Fostamatinib,,P29376,Leukocyte tyrosine kinase receptor,LTK,inhibitor,B02BX09
DB12010,Fostamatinib,,P07948,Tyrosine-protein kinase Lyn,LYN,inhibitor,B02BX09
DB12010,Fostamatinib,,P36507,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,inhibitor,B02BX09
DB12010,Fostamatinib,,P46734,Dual specificity mitogen-activated protein kinase kinase 3,MAP2K3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13163,Dual specificity mitogen-activated protein kinase kinase 5,MAP2K5,inhibitor,B02BX09
DB12010,Fostamatinib,,P52564,Dual specificity mitogen-activated protein kinase kinase 6,MAP2K6,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13233,Mitogen-activated protein kinase kinase kinase 1,MAP3K1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q02779,Mitogen-activated protein kinase kinase kinase 10,MAP3K10,inhibitor,B02BX09
DB12010,Fostamatinib,,Q16584,Mitogen-activated protein kinase kinase kinase 11,MAP3K11,inhibitor,B02BX09
DB12010,Fostamatinib,,Q12852,Mitogen-activated protein kinase kinase kinase 12,MAP3K12,inhibitor,B02BX09
DB12010,Fostamatinib,,O43283,Mitogen-activated protein kinase kinase kinase 13,MAP3K13,inhibitor,B02BX09
DB12010,Fostamatinib,,Q6ZN16,Mitogen-activated protein kinase kinase kinase 15,MAP3K15,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9Y2U5,Mitogen-activated protein kinase kinase kinase 2,MAP3K2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q99759,Mitogen-activated protein kinase kinase kinase 3,MAP3K3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9Y6R4,Mitogen-activated protein kinase kinase kinase 4,MAP3K4,inhibitor,B02BX09
DB12010,Fostamatinib,,O95382,Mitogen-activated protein kinase kinase kinase 6,MAP3K6,inhibitor,B02BX09
DB12010,Fostamatinib,,P80192,Mitogen-activated protein kinase kinase kinase 9,MAP3K9,inhibitor,B02BX09
DB12010,Fostamatinib,,Q92918,Mitogen-activated protein kinase kinase kinase kinase 1,MAP4K1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q12851,Mitogen-activated protein kinase kinase kinase kinase 2,MAP4K2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8IVH8,Mitogen-activated protein kinase kinase kinase kinase 3,MAP4K3,inhibitor,B02BX09
DB12010,Fostamatinib,,O95819,Mitogen-activated protein kinase kinase kinase kinase 4,MAP4K4,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9Y4K4,Mitogen-activated protein kinase kinase kinase kinase 5,MAP4K5,inhibitor,B02BX09
DB12010,Fostamatinib,,P53779,Mitogen-activated protein kinase 10,MAPK10,inhibitor,B02BX09
DB12010,Fostamatinib,,O15264,Mitogen-activated protein kinase 13,MAPK13,inhibitor,B02BX09
DB12010,Fostamatinib,,Q16539,Mitogen-activated protein kinase 14,MAPK14,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8TD08,Mitogen-activated protein kinase 15,MAPK15,inhibitor,B02BX09
DB12010,Fostamatinib,,P31152,Mitogen-activated protein kinase 4,MAPK4,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13164,Mitogen-activated protein kinase 7,MAPK7,inhibitor,B02BX09
DB12010,Fostamatinib,,P45984,Mitogen-activated protein kinase 9,MAPK9,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8IW41,MAP kinase-activated protein kinase 5,MAPKAPK5,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9P0L2,Serine/threonine-protein kinase MARK1,MARK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q7KZI7,Serine/threonine-protein kinase MARK2,MARK2,inhibitor,B02BX09
DB12010,Fostamatinib,,P27448,MAP/microtubule affinity-regulating kinase 3,MARK3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q96L34,MAP/microtubule affinity-regulating kinase 4,MARK4,inhibitor,B02BX09
DB12010,Fostamatinib,,Q7Z460,CLIP-associating protein 1,CLASP1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9Y2H9,Microtubule-associated serine/threonine-protein kinase 1,MAST1,inhibitor,B02BX09
DB12010,Fostamatinib,,P42679,Megakaryocyte-associated tyrosine-protein kinase,MATK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q14680,Maternal embryonic leucine zipper kinase,MELK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q12866,Tyrosine-protein kinase Mer,MERTK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8N4C8,Misshapen-like kinase 1,MINK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9BUB5,MAP kinase-interacting serine/threonine-protein kinase 1,MKNK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9HBH9,MAP kinase-interacting serine/threonine-protein kinase 2,MKNK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q04912,Macrophage-stimulating protein receptor,MST1R,inhibitor,B02BX09
DB12010,Fostamatinib,,O15146,"Muscle, skeletal receptor tyrosine-protein kinase",MUSK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q15746,"Myosin light chain kinase, smooth muscle",MYLK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9H1R3,"Myosin light chain kinase 2, skeletal/cardiac muscle",MYLK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q32MK0,Myosin light chain kinase 3,MYLK3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q86YV6,Myosin light chain kinase family member 4,MYLK4,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8NEV4,Myosin-IIIa,MYO3A,inhibitor,B02BX09
DB12010,Fostamatinib,,Q96PY6,Serine/threonine-protein kinase Nek1,NEK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8NG66,Serine/threonine-protein kinase Nek11,NEK11,inhibitor,B02BX09
DB12010,Fostamatinib,,P51955,Serine/threonine-protein kinase Nek2,NEK2,inhibitor,B02BX09
DB12010,Fostamatinib,,P51956,Serine/threonine-protein kinase Nek3,NEK3,inhibitor,B02BX09
DB12010,Fostamatinib,,P51957,Serine/threonine-protein kinase Nek4,NEK4,inhibitor,B02BX09
DB12010,Fostamatinib,,Q6P3R8,Serine/threonine-protein kinase Nek5,NEK5,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8TD19,Serine/threonine-protein kinase Nek9,NEK9,inhibitor,B02BX09
DB12010,Fostamatinib,,P04629,High affinity nerve growth factor receptor,NTRK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q16620,BDNF/NT-3 growth factors receptor,NTRK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q16288,NT-3 growth factor receptor,NTRK3,inhibitor,B02BX09
DB12010,Fostamatinib,,O60285,NUAK family SNF1-like kinase 1,NUAK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9H093,NUAK family SNF1-like kinase 2,NUAK2,inhibitor,B02BX09
DB12010,Fostamatinib,,O95747,Serine/threonine-protein kinase OSR1,OXSR1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13153,Serine/threonine-protein kinase PAK 1,PAK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13177,Serine/threonine-protein kinase PAK 2,PAK2,inhibitor,B02BX09
DB12010,Fostamatinib,,O75914,Serine/threonine-protein kinase PAK 3,PAK3,inhibitor,B02BX09
DB12010,Fostamatinib,,O96013,Serine/threonine-protein kinase PAK 4,PAK4,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9NQU5,Serine/threonine-protein kinase PAK 6,PAK6,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9P286,Serine/threonine-protein kinase PAK 5,PAK5,inhibitor,B02BX09
DB12010,Fostamatinib,,Q00536,Cyclin-dependent kinase 16,CDK16,inhibitor,B02BX09
DB12010,Fostamatinib,,Q00537,Cyclin-dependent kinase 17,CDK17,inhibitor,B02BX09
DB12010,Fostamatinib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,inhibitor,B02BX09
DB12010,Fostamatinib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,B02BX09
DB12010,Fostamatinib,,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q96Q40,Cyclin-dependent kinase 15,CDK15,inhibitor,B02BX09
DB12010,Fostamatinib,,Q16816,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",PHKG1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UBF8,Phosphatidylinositol 4-kinase beta,PI4KB,inhibitor,B02BX09
DB12010,Fostamatinib,,O00750,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,PIK3C2B,inhibitor,B02BX09
DB12010,Fostamatinib,,O75747,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma,PIK3C2G,inhibitor,B02BX09
DB12010,Fostamatinib,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,inhibitor,B02BX09
DB12010,Fostamatinib,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,inhibitor,B02BX09
DB12010,Fostamatinib,,P11309,Serine/threonine-protein kinase pim-1,PIM1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q86V86,Serine/threonine-protein kinase pim-3,PIM3,inhibitor,B02BX09
DB12010,Fostamatinib,,P78356,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,PIP4K2B,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8TBX8,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,PIP4K2C,inhibitor,B02BX09
DB12010,Fostamatinib,,Q99640,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,PKMYT1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q16512,Serine/threonine-protein kinase N1,PKN1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q16513,Serine/threonine-protein kinase N2,PKN2,inhibitor,B02BX09
DB12010,Fostamatinib,,P53350,Serine/threonine-protein kinase PLK1,PLK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9NYY3,Serine/threonine-protein kinase PLK2,PLK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9H4B4,Serine/threonine-protein kinase PLK3,PLK3,inhibitor,B02BX09
DB12010,Fostamatinib,,O00444,Serine/threonine-protein kinase PLK4,PLK4,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13131,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13131,5'-AMP-activated protein kinase,PRKAA1,inhibitor,B02BX09
DB12010,Fostamatinib,,P22694,cAMP-dependent protein kinase catalytic subunit beta,PRKACB,inhibitor,B02BX09
DB12010,Fostamatinib,,Q05655,Protein kinase C delta type,PRKCD,inhibitor,B02BX09
DB12010,Fostamatinib,,Q02156,Protein kinase C epsilon type,PRKCE,inhibitor,B02BX09
DB12010,Fostamatinib,,P05129,Protein kinase C gamma type (PRKCG),PRKCG,inhibitor,B02BX09
DB12010,Fostamatinib,,P41743,Protein kinase C iota type,PRKCI,inhibitor,B02BX09
DB12010,Fostamatinib,,Q04759,Protein kinase C theta type,PRKCQ,inhibitor,B02BX09
DB12010,Fostamatinib,,Q15139,Serine/threonine-protein kinase D1,PRKD1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13237,cGMP-dependent protein kinase 2,PRKG2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,inhibitor,B02BX09
DB12010,Fostamatinib,,Q05397,Focal adhesion kinase 1,PTK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q14289,Protein-tyrosine kinase 2-beta,PTK2B,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13882,Protein-tyrosine kinase 6,PTK6,inhibitor,B02BX09
DB12010,Fostamatinib,,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,inhibitor,B02BX09
DB12010,Fostamatinib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9BRS2,Serine/threonine-protein kinase RIO1,RIOK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9BVS4,Serine/threonine-protein kinase RIO2,RIOK2,inhibitor,B02BX09
DB12010,Fostamatinib,,O14730,Serine/threonine-protein kinase RIO3,RIOK3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q13546,Receptor-interacting serine/threonine-protein kinase 1,RIPK1,inhibitor,B02BX09
DB12010,Fostamatinib,,O43353,Receptor-interacting serine/threonine-protein kinase 2,RIPK2,inhibitor,B02BX09
DB12010,Fostamatinib,,P57078,Receptor-interacting serine/threonine-protein kinase 4,RIPK4,inhibitor,B02BX09
DB12010,Fostamatinib,,O75116,Rho-associated protein kinase 2,ROCK2,inhibitor,B02BX09
DB12010,Fostamatinib,,P08922,Proto-oncogene tyrosine-protein kinase ROS,ROS1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q15418,Ribosomal protein S6 kinase alpha-1,RPS6KA1,inhibitor,B02BX09
DB12010,Fostamatinib,,P51812,Ribosomal protein S6 kinase alpha-3,RPS6KA3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q52WX2,Serine/threonine-protein kinase SBK1,SBK1,inhibitor,B02BX09
DB12010,Fostamatinib,,P0C264,Uncharacterized serine/threonine-protein kinase SBK3,SBK3,inhibitor,B02BX09
DB12010,Fostamatinib,,Q96BR1,Serine/threonine-protein kinase Sgk3,SGK3,inhibitor,B02BX09
DB12010,Fostamatinib,,P57059,Serine/threonine-protein kinase SIK1,SIK1,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9H0K1,Serine/threonine-protein kinase SIK2,SIK2,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9H2G2,STE20-like serine/threonine-protein kinase,SLK,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9NRH2,SNF-related serine/threonine-protein kinase,SNRK,inhibitor,B02BX09
DB12010,Fostamatinib,,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9H3Y6,Tyrosine-protein kinase Srms,SRMS,inhibitor,B02BX09
DB12010,Fostamatinib,,O94804,Serine/threonine-protein kinase 10,STK10,inhibitor,B02BX09
DB12010,Fostamatinib,,O75716,Serine/threonine-protein kinase 16,STK16,inhibitor,B02BX09
DB12010,Fostamatinib,,Q9UEE5,Serine/threonine-protein kinase 17A,STK17A,inhibitor,B02BX09
DB12010,Fostamatinib,,O94768,Serine/threonine-protein kinase 17B,STK17B,inhibitor,B02BX09
DB12010,Fostamatinib,,Q8WU08,Serine/threonine-protein kinase 32A,STK32A,inhibitor,B02BX09
DB12015,Alpelisib,,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,inhibitor,L01EM03
DB12016,Ponesimod,,P21453,Sphingosine 1-phosphate receptor 1,S1PR1,agonist,L04AA50
DB12016,Ponesimod,,P21453,Sphingosine 1-phosphate receptor 1,S1PR1,modulator,L04AA50
DB12016,Ponesimod,,P21453,Sphingosine 1-phosphate receptor 1,S1PR1,regulator,L04AA50
DB12018,Ulocuplumab,,P61073,C-X-C chemokine receptor type 4,CXCR4,inhibitor,
DB12020,Tecovirimat,,P33815,Envelope protein F13,,inhibitor,J05AX24
DB12023,Benralizumab,,Q01344,Interleukin-5 receptor subunit alpha,IL5RA,antibody,R03DX10
DB12023,Benralizumab,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,binding,R03DX10
DB12026,Voxilaprevir,,B0B3C9,NS3/4A protein,NS3/4A,inhibitor,J05AP56
DB12034,Gantenerumab,,P05067,Amyloid beta A4 protein,APP,antagonist,
DB12034,Gantenerumab,,P05067,Amyloid beta A4 protein,APP,binder,
DB12034,Gantenerumab,,P05067,Amyloid beta A4 protein,APP,antibody,
DB12061,Pardoprunox,,P14416,Dopamine D2 receptor,DRD2,,
DB12061,Pardoprunox,,P35462,Dopamine D3 receptor,DRD3,,
DB12061,Pardoprunox,,P21917,Dopamine D4 receptor,DRD4,,
DB12061,Pardoprunox,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB12062,Volasertib,,P53350,Serine/threonine-protein kinase PLK1,PLK1,inhibitor,
DB12070,Letermovir,,F5HC79,CMV DNA Terminase Complex,TRM1,inhibitor,J05AX18
DB12077,Urelumab,,Q07011,Tumor necrosis factor receptor superfamily member 9,TNFRSF9,,
DB12093,Tetrahydropalmatine,,P21728,Dopamine D1 receptor,DRD1,antagonist,
DB12093,Tetrahydropalmatine,,P14416,Dopamine D2 receptor,DRD2,antagonist,
DB12095,Telotristat ethyl,,Q8IWU9,Tryptophan 5-hydroxylase 2,TPH2,antagonist,
DB12095,Telotristat ethyl,,P17752,Tryptophan 5-hydroxylase 1,TPH1,antagonist,
DB12098,L-Baclofen,,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,agonist,
DB12107,Vaborbactam,,P05364,Beta-lactamase,ampC,inhibitor,J01DH52
DB12107,Vaborbactam,,Q9F663,Carbapenem-hydrolyzing beta-lactamase KPC,bla,inhibitor,J01DH52
DB12107,Vaborbactam,,Q93LQ9,Beta-lactamase (KPC-2),KPC-2,inhibitor,J01DH52
DB12107,Vaborbactam,,Q939N4,Beta-lactamase CTX-M,,inhibitor,J01DH52
DB12107,Vaborbactam,,A0A068JFB7,Beta-lactamase (blaSHV),blaSHV,inhibitor,J01DH52
DB12107,Vaborbactam,,P0AD64,Beta-lactamase SHV-1,bla,inhibitor,J01DH52
DB12107,Vaborbactam,,P62593,Beta-lactamase TEM,bla,inhibitor,J01DH52
DB12107,Vaborbactam,,Q9X757,Beta-lactamase (MIR-1),MIR-1,inhibitor,J01DH52
DB12107,Vaborbactam,,Q53IN1,Beta-lactamase,fox-7,inhibitor,J01DH52
DB12110,m-Chlorophenylpiperazine,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,
DB12114,Poziotinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,
DB12114,Poziotinib,,P00533,Epidermal growth factor receptor,EGFR,binder,
DB12116,Epigallocatechin gallate,,P35869,Aryl hydrocarbon receptor,AHR,,
DB12116,Epigallocatechin gallate,,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,inhibitor,
DB12116,Epigallocatechin gallate,,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFRL1,,
DB12118,Sotatercept,,P27037,Activin receptor type-2A,ACVR2A,,
DB12119,Gevokizumab,,P01584,Interleukin-1 beta,IL1B,,
DB12121,Entospletinib,,P43405,Tyrosine-protein kinase SYK,SYK,inhibitor,
DB12128,Ulimorelin,,Q92847,Growth hormone secretagogue receptor type 1,GHSR,,
DB12129,Tideglusib,,P49841,Glycogen synthase kinase-3 beta,GSK3B,antagonist,
DB12130,Lorlatinib,,Q9UM73,ALK tyrosine kinase receptor,ALK,inhibitor,L01ED05
DB12140,Dilmapimod,,P01375,Tumor necrosis factor,TNF,,
DB12140,Dilmapimod,,P01584,Interleukin-1 beta,IL1B,,
DB12140,Dilmapimod,,P05231,Interleukin-6,IL6,,
DB12141,Gilteritinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EX13
DB12141,Gilteritinib,,P30530,Tyrosine-protein kinase receptor UFO,AXL,inhibitor,L01EX13
DB12141,Gilteritinib,,Q9UM73,ALK tyrosine kinase receptor,ALK,inhibitor,L01EX13
DB12141,Gilteritinib,,P08908,Serotonin Receptors,HTR1A,inhibitor,L01EX13
DB12147,Erdafitinib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EN01
DB12147,Erdafitinib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,L01EN01
DB12147,Erdafitinib,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,L01EN01
DB12147,Erdafitinib,,P22455,Fibroblast growth factor receptor 4,FGFR4,inhibitor,L01EN01
DB12147,Erdafitinib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,substrate,L01EN01
DB12147,Erdafitinib,,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,substrate,L01EN01
DB12147,Erdafitinib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,substrate,L01EN01
DB12147,Erdafitinib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,substrate,L01EN01
DB12147,Erdafitinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,substrate,L01EN01
DB12147,Erdafitinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,substrate,L01EN01
DB12151,Brincidofovir,,P0DOO6,DNA polymerase,POL,inhibitor,J05AB17
DB12151,Brincidofovir,,,Variola virus DNA,,incorporation into and destabilization,J05AB17
DB12153,Citicoline,,A0A0H2UQB5,LicC protein,licC,,N06BX06
DB12157,Fasinumab,,P01138,Beta-nerve growth factor,NGF,inhibitor,
DB12159,Dupilumab,,P24394,Interleukin-4 receptor subunit alpha,IL4R,inhibitor,D11AH05
DB12159,Dupilumab,,P24394,Interleukin-4 receptor subunit alpha,IL4R,antibody,D11AH05
DB12159,Dupilumab,,P35225,Interleukin-13,IL13,inhibitor,D11AH05
DB12159,Dupilumab,,P35225,Interleukin-13,IL13,antibody,D11AH05
DB12159,Dupilumab,,P05112,Interleukin-4,IL4,inhibitor,D11AH05
DB12159,Dupilumab,,P05112,Interleukin-4,IL4,antibody,D11AH05
DB12161,Deutetrabenazine,,Q05940,Synaptic vesicular amine transporter,SLC18A2,inhibitor,N07XX16
DB12163,Sarpogrelate,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,,
DB12163,Sarpogrelate,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,inverse agonist,
DB12169,Tralokinumab,,P35225,Interleukin-13,IL13,antibody,D11AH07
DB12177,Eplivanserin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB12177,Eplivanserin,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,,
DB12184,Gepirone,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,N06AX19
DB12189,Etrolizumab,,P26010,Integrin beta-7,ITGB7,binder,
DB12189,Etrolizumab,,P26010,Integrin beta-7,ITGB7,antibody,
DB12191,Obatoclax,,P10415,Apoptosis regulator Bcl-2,BCL2,,
DB12200,Tivantinib,,P08581,Hepatocyte growth factor receptor,MET,,
DB12202,Zalutumumab,,P00533,Epidermal growth factor receptor,EGFR,antagonist,
DB12218,Capivasertib,,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,inhibitor,
DB12218,Capivasertib,,P31751,RAC-beta serine/threonine-protein kinase,AKT2,inhibitor,
DB12218,Capivasertib,,Q9Y243,RAC-gamma serine/threonine-protein kinase,AKT3,inhibitor,
DB12228,Telcagepant,,Q16602,Calcitonin gene-related peptide type 1 receptor,CALCRL,,
DB12228,Telcagepant,,P06881,Calcitonin gene-related peptide 1,CALCA,,
DB12228,Telcagepant,,P10092,Calcitonin gene-related peptide 2,CALCB,,
DB12235,Estetrol,,P03372,Estrogen receptor alpha,ESR1,agonist,G03AA18
DB12235,Estetrol,,P03372,Estrogen receptor alpha,ESR1,modulator,G03AA18
DB12235,Estetrol,,P03372,Estrogen receptor alpha,ESR1,regulator,G03AA18
DB12235,Estetrol,,Q92731,Estrogen receptor beta,ESR2,agonist,G03AA18
DB12236,Bexagliflozin,,P31639,Sodium/glucose cotransporter 2,SLC5A2,inhibitor,
DB12239,Balicatib,,P43235,Cathepsin K,CTSK,inhibitor,
DB12240,Polatuzumab vedotin,,P40259,B-cell antigen receptor complex-associated protein beta chain,CD79B,antibody,L01FX14
DB12245,Triclabendazole,,Q6IX08,Excretory Secretory (ES) proteins,,inhibitor,P02BX04
DB12248,Tulobuterol,,P07550,Beta-2 adrenergic receptor,ADRB2,regulator,R03CC11;R03AC11
DB12250,Cixutumumab,,P08069,Insulin-like growth factor 1 receptor,IGF1R,,
DB12255,Vadadustat,,Q9GZT9,Egl nine homolog 1,EGLN1,inhibitor,B03XA08
DB12255,Vadadustat,,Q96KS0,Egl nine homolog 2,EGLN2,inhibitor,B03XA08
DB12255,Vadadustat,,Q9H6Z9,Egl nine homolog 3,EGLN3,inhibitor,B03XA08
DB12255,Vadadustat,,Q16665,Hypoxia-inducible factor 1-alpha,HIF1A,stabilization,B03XA08
DB12255,Vadadustat,,Q99814,Endothelial PAS domain-containing protein 1,EPAS1,stabilization,B03XA08
DB12267,Brigatinib,,Q9UM73,ALK tyrosine kinase receptor,ALK,inhibitor,L01ED04
DB12267,Brigatinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,L01ED04
DB12267,Brigatinib,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,L01ED04
DB12267,Brigatinib,,P08069,Insulin-like growth factor 1 receptor,IGF1R,inhibitor,L01ED04
DB12267,Brigatinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01ED04
DB12267,Brigatinib,,P06213,Insulin receptor,INSR,binding,L01ED04
DB12267,Brigatinib,,P08581,Hepatocyte growth factor receptor,MET,inhibitor,L01ED04
DB12267,Brigatinib,,Q15303,Receptor tyrosine-protein kinase erbB-4,ERBB4,inhibitor,L01ED04
DB12267,Brigatinib,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,inhibitor,L01ED04
DB12271,ORE-1001,,P15169,Carboxypeptidase N catalytic chain,CPN1,,
DB12271,ORE-1001,,P22792,Carboxypeptidase N subunit 2,CPN2,,
DB12274,Aducanumab,,P05067,Amyloid beta A4 protein,APP,antagonist,N06DX03
DB12274,Aducanumab,,P05067,Amyloid beta A4 protein,APP,binder,N06DX03
DB12274,Aducanumab,,P05067,Amyloid beta A4 protein,APP,antibody,N06DX03
DB12278,Propiverine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,G04BD06
DB12278,Propiverine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,G04BD06
DB12278,Propiverine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,G04BD06
DB12278,Propiverine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,,G04BD06
DB12278,Propiverine,,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,antagonist,G04BD06
DB12278,Propiverine,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,G04BD06
DB12278,Propiverine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,G04BD06
DB12284,LY-2608204,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,inhibitor,
DB12285,Verubecestat,,P56817,Beta-secretase 1,BACE1,inhibitor,
DB12301,Doravirine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,J05AR24;J05AG06
DB12305,Dasotraline,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,,
DB12305,Dasotraline,,P31645,Sodium-dependent serotonin transporter,SLC6A4,,
DB12305,Dasotraline,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,
DB12307,Foretinib,,P14210,Hepatocyte growth factor,HGF,,
DB12307,Foretinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,,
DB12317,Vanucizumab,,O15123,Angiopoietin-2,ANGPT2,regulator,
DB12317,Vanucizumab,,P15692,Vascular endothelial growth factor A,VEGFA,regulator,
DB12319,Benzbromarone,,P11712,Cytochrome P450 2C9,CYP2C9,inhibitor,M04AB03
DB12319,Benzbromarone,,P33261,Cytochrome P450 2C19,CYP2C19,inhibitor,M04AB03
DB12323,Radotinib,,P00519,Tyrosine-protein kinase ABL1,ABL1,antagonist,
DB12328,Cantharidin,,P35869,Aryl hydrocarbon receptor,AHR,agonist,
DB12329,Eravacycline,,P0A7V8,30S ribosomal protein S4,rpsD,inhibitor,J01AA13;J01AA20
DB12332,Rucaparib,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,inhibitor,L01XK03
DB12332,Rucaparib,,Q9UGN5,Poly [ADP-ribose] polymerase 2,PARP2,inhibitor,L01XK03
DB12332,Rucaparib,,Q9Y6F1,Poly [ADP-ribose] polymerase 3,PARP3,inhibitor,L01XK03
DB12334,Milataxel,,Q9H4B7,Tubulin beta-1 chain,TUBB1,,
DB12334,Milataxel,,P07437,Tubulin beta chain,TUBB,,
DB12339,Radezolid,,Q9P2E9,Ribosome-binding protein 1,RRBP1,inhibitor,
DB12339,Radezolid,,Q2G0P0,50S ribosomal protein L1,rplA,binder,
DB12340,Navitoclax,,P10415,Apoptosis regulator Bcl-2,BCL2,inhibitor,
DB12340,Navitoclax,,Q92843,Bcl-2-like protein 2,BCL2L2,,
DB12340,Navitoclax,,Q92934,Bcl2 antagonist of cell death,BAD,,
DB12364,Betrixaban,,P00742,Coagulation factor X,F10,inhibitor,B01AF04
DB12371,Siponimod,,Q9H228,Sphingosine 1-phosphate receptor 5,S1PR5,modulator,L04AA42
DB12371,Siponimod,,P21453,Sphingosine 1-phosphate receptor 1,S1PR1,,L04AA42
DB12377,Relebactam,,P62593,Beta-lactamase TEM,bla,inhibitor,J01DH56
DB12377,Relebactam,,P0AD63,Beta-lactamase SHV-1,bla,inhibitor,J01DH56
DB12377,Relebactam,,Q939N4,Beta-lactamase CTX-M,,inhibitor,J01DH56
DB12377,Relebactam,,Q93LQ9,Beta-lactamase (KPC-2),KPC-2,inhibitor,J01DH56
DB12377,Relebactam,,P05364,Beta-lactamase,ampC,inhibitor,J01DH56
DB12379,Indirubin,,P04798,Cytochrome P450 1A1,CYP1A1,substrate,
DB12379,Indirubin,,P35869,Aryl hydrocarbon receptor,AHR,agonist,
DB12404,Remimazolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD14
DB12404,Remimazolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD14
DB12411,Bemcentinib,,P0DTC2,Spike glycoprotein,S,inhibitor,
DB12418,Saccharin,,P07451,Carbonic anhydrase 3,CA3,inhibitor,
DB12436,Vofopitant,,P25103,Neurokinin 1 receptor,TACR1,,
DB12442,Alvespimycin,,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,inhibitor,
DB12445,Nitroaspirin,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB12450,Propyl Gallate,,P03372,Estrogen receptor alpha,ESR1,,
DB12455,Omadacycline,,P0A7V3,30S ribosomal protein S3,rpsC,inhibitor,J01AA15;J01AA20
DB12455,Omadacycline,,P02359,30S ribosomal protein S7,rpsG,inhibitor,J01AA15;J01AA20
DB12455,Omadacycline,,P0A7W7,30S ribosomal protein S8,rpsH,inhibitor,J01AA15;J01AA20
DB12455,Omadacycline,,P0A7U3,30S ribosomal protein S19,rpsS,inhibitor,J01AA15;J01AA20
DB12455,Omadacycline,,P0AG59,30S ribosomal protein S14,rpsN,inhibitor,J01AA15;J01AA20
DB12455,Omadacycline,,,16S ribosomal RNA,,inhibitor,J01AA15;J01AA20
DB12457,Rimegepant,,Q16602,Calcitonin gene-related peptide type 1 receptor,CALCRL,antagonist,N02CD06
DB12458,Muscimol,,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,,
DB12458,Muscimol,,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,,
DB12458,Muscimol,,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,,
DB12465,Ketanserin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,inverse agonist,C02KD01
DB12466,Favipiravir,,Q809M3,RNA-directed RNA polymerase catalytic subunit,PB1,,J05AX27
DB12470,Dexelvucitabine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,
DB12471,Ibrexafungerp,,P40989,"1,3-beta-glucan synthase component GSC2",GSC2,inhibitor,J02AX07
DB12471,Ibrexafungerp,,P06780,GTP-binding protein RHO1,RHO1,inhibitor,J02AX07
DB12478,Piribedil,,P14416,Dopamine D2 receptor,DRD2,,N04BC08
DB12478,Piribedil,,P35462,Dopamine D3 receptor,DRD3,,N04BC08
DB12483,Copanlisib,,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,inhibitor,L01EM02
DB12483,Copanlisib,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,inhibitor,L01EM02
DB12483,Copanlisib,,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",PIK3CB,inhibitor,L01EM02
DB12483,Copanlisib,,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,inhibitor,L01EM02
DB12489,Mirvetuximab soravtansine,,P15328,Folate receptor alpha,FOLR1,binder,
DB12498,Mogamulizumab,,P51679,C-C chemokine receptor type 4,CCR4,antagonist,L01FX09
DB12499,Clascoterone,,P10275,Androgen receptor,AR,antagonist,D10AX06
DB12500,Fedratinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,G01AE10;L01EJ02
DB12500,Fedratinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,G01AE10;L01EJ02
DB12500,Fedratinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,G01AE10;L01EJ02
DB12513,Omaveloxolone,,Q14145,Kelch-like ECH-associated protein 1,KEAP1,inhibitor,
DB12518,Raclopride,,P14416,Dopamine D2 receptor,DRD2,antagonist,
DB12520,Plozalizumab,,P41597,C-C chemokine receptor type 2,CCR2,,
DB12530,Inebilizumab,,P15391,B-lymphocyte antigen CD19,CD19,binder,L04AA47
DB12532,Oxetacaine,,P01350,Gastrin,GAST,inhibition of synthesis,C05AD06
DB12537,"1,2-Benzodiazepine",,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,
DB12537,"1,2-Benzodiazepine",,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,
DB12540,Lecozotan,,P08908,5-hydroxytryptamine receptor 1,HTR1A,regulator,
DB12540,Lecozotan,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,antagonist,
DB12543,Samidorphan,,P35372,Mu-type opioid receptor,OPRM1,antagonist,N05AH53
DB12543,Samidorphan,,P41145,Kappa-type opioid receptor,OPRK1,partial agonist,N05AH53
DB12543,Samidorphan,,P41143,Delta-type opioid receptor,OPRD1,partial agonist,N05AH53
DB12548,Sparsentan,,P25101,Endothelin-1 receptor,EDNRA,antagonist,
DB12548,Sparsentan,,P50052,Type-2 angiotensin II receptor,AGTR2,antagonist,
DB12555,Nelotanserin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB12556,MK-5108,,O14965,Aurora kinase A,AURKA,regulator,
DB12565,Abexinostat,,Q13547,Histone deacetylase 1,HDAC1,,
DB12565,Abexinostat,,Q13547,Histone deacetylase,HDAC1,inhibitor,
DB12569,Tonapofylline,,P30542,Adenosine receptor A1,ADORA1,,
DB12579,JNJ-37822681,,P14416,Dopamine D2 receptor,DRD2,antagonist,
DB12582,Piperine,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB12589,Dacetuzumab,,P25942,Tumor necrosis factor receptor superfamily member 5,CD40,,
DB12597,Asciminib,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,L01EA06
DB12597,Asciminib,,P00519,Tyrosine-protein kinase ABL1,ABL1,allosteric modulator,L01EA06
DB12598,Nafamostat,,P00734,Prothrombin,F2,inhibitor,
DB12598,Nafamostat,,P00742,Coagulation factor X,F10,inhibitor,
DB12598,Nafamostat,,P00748,Coagulation factor XII,F12,inhibitor,
DB12598,Nafamostat,,P07477,Trypsin-1,PRSS1,inhibitor,
DB12598,Nafamostat,,P06870,Kallikrein-1,KLK1,inhibitor,
DB12598,Nafamostat,,P05362,Intercellular adhesion molecule 1,ICAM1,inhibitor,
DB12610,Ebselen,,P34913,Bifunctional epoxide hydrolase 2,EPHX2,inhibitor,
DB12611,PF-477736,,O14757,Serine/threonine-protein kinase Chk1,CHEK1,inhibitor,
DB12612,Ozanimod,,P21453,Sphingosine 1-phosphate receptor 1,S1PR1,agonist,L04AA38
DB12612,Ozanimod,,Q9H228,Sphingosine 1-phosphate receptor 5,S1PR5,agonist,L04AA38
DB12615,Plazomicin,,L0LZJ6,30S ribosomal protein S11,rpsK,inhibitor,J01GB14
DB12615,Plazomicin,,P0AG59,30S ribosomal protein S14,rpsN,inhibitor,J01GB14
DB12622,Lupeol,,P08246,Neutrophil elastase,ELANE,inhibitor,
DB12637,Onapristone,,P04150,Glucocorticoid receptor,NR3C1,,
DB12637,Onapristone,,Q6QNK2,Probable G-protein coupled receptor 133,ADGRD1,,
DB12645,Givinostat,,Q13547,Histone deacetylase,HDAC1,inhibitor,
DB12651,Bardoxolone,,Q14790,Caspase-8,CASP8,,
DB12662,Naveglitazar,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB12668,Metenkefalin,,P41143,Delta-type opioid receptor,OPRD1,agonist,
DB12668,Metenkefalin,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB12670,Rolofylline,,P30542,Adenosine receptor A1,ADORA1,,
DB12674,Lurbinectedin,,,DNA,,adduct,L01XX69
DB12688,Moxetumomab pasudotox,,P20273,B-cell receptor CD22,CD22,binder,L01FB02
DB12688,Moxetumomab pasudotox,,P20273,B-cell receptor CD22,CD22,antibody,L01FB02
DB12688,Moxetumomab pasudotox,,P20273,B-cell receptor CD22,CD22,regulator,L01FB02
DB12688,Moxetumomab pasudotox,,P13639,Elongation factor 2,EEF2,inactivator,L01FB02
DB12693,Ritanserin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,inverse agonist,
DB12695,Phenethyl Isothiocyanate,,P62736,"Actin, aortic smooth muscle",ACTA2,,
DB12695,Phenethyl Isothiocyanate,,P60709,"Actin, cytoplasmic 1",ACTB,,
DB12695,Phenethyl Isothiocyanate,,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,,
DB12695,Phenethyl Isothiocyanate,,P56385,"ATP synthase subunit e, mitochondrial",ATP5I,,
DB12695,Phenethyl Isothiocyanate,,O75964,"ATP synthase subunit g, mitochondrial",ATP5L,,
DB12695,Phenethyl Isothiocyanate,,O43169,Cytochrome b5 type B,CYB5B,,
DB12695,Phenethyl Isothiocyanate,,Q9NR28,"Diablo homolog, mitochondrial",DIABLO,,
DB12695,Phenethyl Isothiocyanate,,Q8TF61,F-box only protein 41,FBXO41,,
DB12695,Phenethyl Isothiocyanate,,P52597,Heterogeneous nuclear ribonucleoprotein F,HNRNPF,,
DB12695,Phenethyl Isothiocyanate,,P61978,Heterogeneous nuclear ribonucleoprotein K,HNRNPK,,
DB12695,Phenethyl Isothiocyanate,,P34932,Heat shock 70 kDa protein 4,HSPA4,,
DB12695,Phenethyl Isothiocyanate,,P04792,Heat shock protein beta-1,HSPB1,,
DB12695,Phenethyl Isothiocyanate,,P61604,"10 kDa heat shock protein, mitochondrial",HSPE1,,
DB12695,Phenethyl Isothiocyanate,,Q92598,Heat shock protein 105 kDa,HSPH1,,
DB12695,Phenethyl Isothiocyanate,,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,,
DB12695,Phenethyl Isothiocyanate,,Q9Y266,Nuclear migration protein nudC,NUDC,,
DB12695,Phenethyl Isothiocyanate,,Q13219,Pappalysin-1,PAPPA,,
DB12695,Phenethyl Isothiocyanate,,P25788,Proteasome subunit alpha type-3,PSMA3,,
DB12695,Phenethyl Isothiocyanate,,P17980,26S protease regulatory subunit 6A,PSMC3,,
DB12695,Phenethyl Isothiocyanate,,P43487,Ran-specific GTPase-activating protein,RANBP1,,
DB12695,Phenethyl Isothiocyanate,,P60903,Protein S100-A10,S100A10,,
DB12695,Phenethyl Isothiocyanate,,Q12874,Splicing factor 3A subunit 3,SF3A3,,
DB12695,Phenethyl Isothiocyanate,,Q969G3,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,SMARCE1,,
DB12695,Phenethyl Isothiocyanate,,Q96I99,"Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial",SUCLG2,,
DB12695,Phenethyl Isothiocyanate,,O43399,Tumor protein D54,TPD52L2,,
DB12695,Phenethyl Isothiocyanate,,P09493,Tropomyosin alpha-1 chain,TPM1,,
DB12695,Phenethyl Isothiocyanate,,P06753,Tropomyosin alpha-3 chain,TPM3,,
DB12695,Phenethyl Isothiocyanate,,P67936,Tropomyosin alpha-4 chain,TPM4,,
DB12695,Phenethyl Isothiocyanate,,Q71U36,Tubulin alpha-1A chain,TUBA1A,,
DB12695,Phenethyl Isothiocyanate,,Q13748,Tubulin alpha 3C/D chain,TUBA3C,,
DB12695,Phenethyl Isothiocyanate,,P68366,Tubulin alpha-4A chain,TUBA4A,,
DB12695,Phenethyl Isothiocyanate,,Q9H4B7,Tubulin beta-1 chain,TUBB1,,
DB12695,Phenethyl Isothiocyanate,,Q13885,Tubulin beta-2A chain,TUBB2A,,
DB12695,Phenethyl Isothiocyanate,,Q13509,Tubulin beta-3 chain,TUBB3,,
DB12695,Phenethyl Isothiocyanate,,P68371,Tubulin beta-4B chain,TUBB4B,,
DB12695,Phenethyl Isothiocyanate,,P10599,Thioredoxin,TXN,,
DB12695,Phenethyl Isothiocyanate,,P09936,Ubiquitin carboxyl-terminal hydrolase isozyme L1,UCHL1,,
DB12695,Phenethyl Isothiocyanate,,P54578,Ubiquitin carboxyl-terminal hydrolase 14,USP14,,
DB12695,Phenethyl Isothiocyanate,,P55072,Transitional endoplasmic reticulum ATPase,VCP,,
DB12695,Phenethyl Isothiocyanate,,P08670,Vimentin,VIM,,
DB12695,Phenethyl Isothiocyanate,,P31946,14-3-3 protein beta/alpha,YWHAB,,
DB12695,Phenethyl Isothiocyanate,,P62258,14-3-3 protein epsilon,YWHAE,,
DB12695,Phenethyl Isothiocyanate,,Q04917,14-3-3 protein eta,YWHAH,,
DB12695,Phenethyl Isothiocyanate,,P27348,14-3-3 protein theta,YWHAQ,,
DB12695,Phenethyl Isothiocyanate,,P63104,14-3-3 protein zeta/delta,YWHAZ,,
DB12698,Ibalizumab,,P51681,C-C chemokine receptor type 5,CCR5,antagonist,J05AX23
DB12698,Ibalizumab,,P61073,C-X-C chemokine receptor type 4,CXCR4,antagonist,J05AX23
DB12698,Ibalizumab,,P01730,T-cell surface glycoprotein CD4,CD4,antagonist,J05AX23
DB12702,Velusetrag,,Q13639,5-hydroxytryptamine receptor 4,HTR4,,
DB12709,Tributyrin,,P42574,Caspase-3,CASP3,activator,
DB12713,Sotagliflozin,,P31639,Sodium/glucose cotransporter 2,SLC5A2,inhibitor,A10BK06
DB12713,Sotagliflozin,,P13866,Sodium/glucose cotransporter 1,SLC5A1,inhibitor,A10BK06
DB12715,MSX-122,,P61073,C-X-C chemokine receptor type 4,CXCR4,antagonist,
DB12715,MSX-122,,P61073,C-X-C chemokine receptor type 4,CXCR4,partial antagonist,
DB12731,Daporinad,,P43490,Nicotinamide phosphoribosyltransferase,NAMPT,inhibitor,
DB12733,Dipraglurant,,P41594,Metabotropic glutamate receptor 5,GRM5,,
DB12741,DTP-348,,Q16790,Carbonic anhydrase 9,CA9,inhibitor,
DB12742,Amuvatinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,,
DB12742,Amuvatinib,,P08581,Hepatocyte growth factor receptor,MET,,
DB12742,Amuvatinib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,,
DB12742,Amuvatinib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,,
DB12742,Amuvatinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,,
DB12742,Amuvatinib,,Q06609,DNA repair protein RAD51 homolog 1,RAD51,,
DB12747,Tertomotide,,O14746,Telomerase reverse transcriptase,TERT,,
DB12753,Racivir,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,
DB12756,TAK-901,,Q96GD4,Aurora kinase B,AURKB,inhibitor,
DB12756,TAK-901,,Q07812,Apoptosis regulator BAX,BAX,activator,
DB12764,Opaganib,,Q9NRA0,Sphingosine kinase 2,SPHK2,inhibitor,
DB12769,Lometrexol,,P0ABQ4,Dihydrofolate reductase,folA,,
DB12773,Sifalimumab,,P01563,Interferon alpha-2,IFNA2,,
DB12783,Benserazide,,P20711,Aromatic-L-amino-acid decarboxylase,DDC,inhibitor,
DB12789,Dinoprost,,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,agonist,G02AD01
DB12808,Trifarotene,,P13631,Retinoic acid receptor gamma,RARG,agonist,D10AD06
DB12808,Trifarotene,,P10826,Retinoic acid receptor beta,RARB,agonist,D10AD06
DB12808,Trifarotene,,P10276,Retinoic acid receptor alpha,RARA,agonist,D10AD06
DB12816,Terpinen-4-ol,,P22303,Acetylcholinesterase,ACHE,inhibitor,
DB12816,Terpinen-4-ol,,P10415,Apoptosis regulator Bcl-2,BCL2,regulator,
DB12816,Terpinen-4-ol,,P98170,E3 ubiquitin-protein ligase XIAP,XIAP,downregulator,
DB12816,Terpinen-4-ol,,P09923,Intestinal-type alkaline phosphatase,ALPI,downregulator,
DB12816,Terpinen-4-ol,,Q00653,Nuclear factor NF-kappa-B,NFKB2,downregulator,
DB12825,Lefamulin,,P61182,50S ribosomal protein L22,rplV,binder,J01XX12
DB12831,Gabexate,,P03952,Plasma kallikrein,KLKB1,inhibitor,
DB12831,Gabexate,,P00734,Prothrombin,F2,inhibitor,
DB12831,Gabexate,,P00747,Plasminogen,PLG,inhibitor,
DB12836,Grapiprant,,P35408,Prostaglandin E2 receptor EP4 subtype,PTGER4,antagonist,
DB12843,Oleandrin,,P14780,Matrix metalloproteinase-9,MMP9,inhibitor,
DB12843,Oleandrin,,P14780,Matrix metalloproteinase-9,MMP9,downregulator,
DB12843,Oleandrin,,P08253,72 kDa type IV collagenase,MMP2,inhibitor,
DB12843,Oleandrin,,P08253,72 kDa type IV collagenase,MMP2,downregulator,
DB12843,Oleandrin,,P10415,Apoptosis regulator Bcl-2,BCL2,downregulator,
DB12843,Oleandrin,,P01138,Beta-nerve growth factor,NGF,inhibitor,
DB12843,Oleandrin,,P42574,Caspase-3,CASP3,regulator,
DB12843,Oleandrin,,Q14790,Caspase-8,CASP8,regulator,
DB12843,Oleandrin,,P29323,Ephrin type-B receptor 2,EPHB2,activator,
DB12843,Oleandrin,,P10145,Interleukin-8,CXCL8,inhibitor,
DB12843,Oleandrin,,,Nuclear factor kappa-light-chain-enhancer of activated B cells,,inhibitor,
DB12843,Oleandrin,,P01133,Pro-epidermal growth factor,EGF,inhibitor,
DB12843,Oleandrin,,P42345,Serine/threonine-protein kinase mTOR,MTOR,downregulator,
DB12845,Amatuximab,,Q13421,Mesothelin,MSLN,,
DB12847,Pyroxamide,,Q13547,Histone deacetylase,HDAC1,inhibitor,
DB12852,MK-0752,,Q96BI3,Gamma-secretase subunit APH-1A,APH1A,inhibitor,
DB12855,Apricitabine,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,
DB12865,Etelcalcetide,,P41180,Extracellular calcium-sensing receptor,CASR,agonist,H05BX04
DB12872,Vonicog alfa,,P00451,Coagulation factor VIII,F8,stabilization,
DB12872,Vonicog alfa,,P02452,Collagen alpha-1(I) chain,COL1A1,binder,
DB12874,Quizartinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EX11
DB12887,Tazemetostat,,Q15910,Histone-lysine N-methyltransferase EZH2,EZH2,inhibitor,L01XX72
DB12887,Tazemetostat,,Q92800,Histone-lysine N-methyltransferase EZH1,EZH1,inhibitor,L01XX72
DB12890,Dihydrexidine,,P21728,Dopamine D1 receptor,DRD1,,
DB12893,Sacituzumab govitecan,,P09758,Tumor-associated calcium signal transducer 2,TACSTD2,antibody,L01FX17
DB12893,Sacituzumab govitecan,,P11387,DNA topoisomerase 1,TOP1,inhibitor,L01FX17
DB12893,Sacituzumab govitecan,,Q96AE4,Far upstream element-binding protein 1,FUBP1,inhibitor,L01FX17
DB12917,Bimekizumab,,Q16552,Interleukin-17A,IL17A,antibody,L04AC21
DB12917,Bimekizumab,,Q96PD4,Interleukin-17F,IL17F,antibody,L04AC21
DB12924,Ozenoxacin,,P43700,DNA gyrase subunit A,gyrA,inhibitor,D06AX14
DB12924,Ozenoxacin,,P0AFI2,DNA topoisomerase 4 subunit A,parC,inhibitor,D06AX14
DB12941,Darolutamide,,P10275,Androgen receptor,AR,antagonist,L02BB06
DB12941,Darolutamide,,P06401,Progesterone receptor,PGR,antagonist,L02BB06
DB12960,INCB-9471,,P51681,C-C chemokine receptor type 5,CCR5,,
DB12961,Leukotriene B4,,Q15722,Leukotriene B4 receptor 1,LTB4R,,
DB12961,Leukotriene B4,,Q9NPC1,Leukotriene B4 receptor 2,LTB4R2,,
DB12961,Leukotriene B4,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,activator,
DB12965,Silver,,Q14872,Metallothionein,MTF1,binder,D08AL30
DB12965,Silver,,P00450,Ceruloplasmin,CP,binder,D08AL30
DB12965,Silver,,P02768,Serum albumin,ALB,binder,D08AL30
DB12965,Silver,,P01023,Alpha-2-macroglobulin,A2M,binder,D08AL30
DB12978,Pexidartinib,,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,inhibitor,L01EX15
DB12978,Pexidartinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,L01EX15
DB12978,Pexidartinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EX15
DB12978,Pexidartinib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,L01EX15
DB12980,CHS-828,,P43490,Nicotinamide phosphoribosyltransferase,NAMPT,inhibitor,
DB13003,Cortivazol,,P04150,Glucocorticoid receptor,NR3C1,,H02AB17
DB13007,Enfortumab vedotin,,Q96NY8,Nectin-4,NECTIN4,binder,L01FX13
DB13007,Enfortumab vedotin,,Q96NY8,Nectin-4,NECTIN4,antibody,L01FX13
DB13009,Carbendazim,,P35869,Aryl hydrocarbon receptor,AHR,agonist,
DB13014,Hypericin,,P08263,Glutathione S-transferase A1,GSTA1,,
DB13014,Hypericin,,P09211,Glutathione S-transferase P,GSTP1,inhibitor,
DB13025,Tiapride,,P14416,Dopamine D2 receptor,DRD2,blocker,N05AL03
DB13025,Tiapride,,P35462,Dopamine D3 receptor,DRD3,blocker,N05AL03
DB13025,Tiapride,,P08908,Serotonin Receptors,HTR1A,antagonist,N05AL03
DB13025,Tiapride,,P35348,Alpha-1 adrenergic receptors,ADRA1A,antagonist,N05AL03
DB13025,Tiapride,,P08913,Alpha-2 adrenergic receptors,ADRA2A,antagonist,N05AL03
DB13036,Ramatroban,,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,,
DB13044,Gossypol,,Q07817,Bcl-2-like protein 1,BCL2L1,,
DB13048,PAC-1,,P42574,Caspase-3,CASP3,activator,
DB13055,Oteseconazole,,P10613,Cytochrome P450 51,ERG11,inhibitor,J02AC06
DB13061,MLN8054,,O14965,Aurora kinase A,AURKA,,
DB13074,Macimorelin,,Q92847,Growth hormone secretagogue receptor type 1,GHSR,agonist,V04CD06
DB13083,Talarozole,,O43174,Cytochrome P450 26A1,CYP26A1,,
DB13092,Meclocycline,,P02359,30S ribosomal protein S7,rpsG,antagonist,D10AF04
DB13119,GSK-364735,,P04585,Gag-Pol polyprotein,gag-pol,,
DB13123,OTX-008,,P09382,Galectin-1,LGALS1,inhibitor,
DB13125,Lusutrombopag,,P40238,Thrombopoietin receptor,MPL,agonist,B02BX07
DB13127,Olokizumab,,P05231,Interleukin-6,IL6,antagonist,L04AC23
DB13133,Von Willebrand factor human,,P00451,Coagulation factor VIII,F8,carrier,B02BD06;B02BD10
DB13133,Von Willebrand factor human,,P00451,Coagulation factor VIII,F8,stabilization,B02BD06;B02BD10
DB13133,Von Willebrand factor human,,P02452,Collagen alpha-1(I) chain,COL1A1,binder,B02BD06;B02BD10
DB13133,Von Willebrand factor human,,P07306,Asialoglycoprotein receptor 1,ASGR1,ligand,B02BD06;B02BD10
DB13133,Von Willebrand factor human,,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,,B02BD06;B02BD10
DB13139,Levosalbutamol,,P07550,Beta-2 adrenergic receptor,ADRB2,agonist,
DB13140,Bezlotoxumab,,P18177,Clostridium difficile Toxin B,toxB,antibody,J06BC03
DB13140,Bezlotoxumab,,P18177,Clostridium difficile Toxin B,toxB,neutralizer,J06BC03
DB13144,Lenograstim,,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,agonist,L03AA10
DB13145,Nedaplatin,,,DNA,,ligand,
DB13145,Nedaplatin,,,Glutathione,,ligand,
DB13146,Fluciclovine (18F),,Q15758,Neutral amino acid transporter B(0),SLC1A5,binder,V09IX12
DB13146,Fluciclovine (18F),,Q9UM01,Y+L amino acid transporter 1,SLC7A7,binder,V09IX12
DB13146,Fluciclovine (18F),,Q8WY07,Cationic amino acid transporter 3,SLC7A3,binder,V09IX12
DB13146,Fluciclovine (18F),,Q05586,Glutamate (NMDA) receptor,GRIN1,inhibitor,V09IX12
DB13146,Fluciclovine (18F),,P42261,Glutamate receptor 1,GRIA1,inhibitor,V09IX12
DB13146,Fluciclovine (18F),,P42262,Glutamate receptor 2,GRIA2,inhibitor,V09IX12
DB13146,Fluciclovine (18F),,P42263,Glutamate receptor 3,GRIA3,inhibitor,V09IX12
DB13146,Fluciclovine (18F),,P48058,Glutamate receptor 4,GRIA4,inhibitor,V09IX12
DB13147,Pancrelipase lipase,,,Dietary fat,,cleavage,
DB13149,Protein S human,,P12259,Coagulation factor V,F5,antagonist,
DB13149,Protein S human,,P00742,Coagulation factor X,F10,antagonist,
DB13149,Protein S human,,P04070,Vitamin K-dependent protein C,PROC,cofactor,
DB13150,Coagulation factor VII human,,P13726,Tissue factor,F3,activator,B02BD01;B02BD05
DB13150,Coagulation factor VII human,,P00742,Coagulation factor X,F10,activator,B02BD01;B02BD05
DB13150,Coagulation factor VII human,,P00740,Coagulation factor IX,F9,activator,B02BD01;B02BD05
DB13151,Anti-inhibitor coagulant complex,,P00742,Coagulation factor X,F10,agonist,B02BD03
DB13151,Anti-inhibitor coagulant complex,,P00734,Prothrombin,F2,agonist,B02BD03
DB13151,Anti-inhibitor coagulant complex,,P02671,Fibrinogen alpha chain,FGA,cleavage,B02BD03
DB13151,Anti-inhibitor coagulant complex,,P02675,Fibrinogen beta chain,FGB,cleavage,B02BD03
DB13151,Anti-inhibitor coagulant complex,,P00488,Coagulation factor XIII A chain,F13A1,agonist,B02BD03
DB13151,Anti-inhibitor coagulant complex,,P12259,Coagulation factor V,F5,agonist,B02BD03
DB13151,Anti-inhibitor coagulant complex,,P00451,Coagulation factor VIII,F8,agonist,B02BD03
DB13151,Anti-inhibitor coagulant complex,,P08709,Coagulation factor VII,F7,agonist,B02BD03
DB13152,Coagulation Factor IX Human,,P00742,Coagulation factor X,F10,activator,B02BD04;B02BD01
DB13152,Coagulation Factor IX Human,,P03951,Coagulation factor XI,F11,ligand,B02BD04;B02BD01
DB13152,Coagulation Factor IX Human,,P08709,Coagulation factor VII,F7,ligand,B02BD04;B02BD01
DB13152,Coagulation Factor IX Human,,P00451,Coagulation factor VIII,F8,cofactor,B02BD04;B02BD01
DB13152,Coagulation Factor IX Human,,P00734,Prothrombin,F2,,B02BD04;B02BD01
DB13152,Coagulation Factor IX Human,,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,,B02BD04;B02BD01
DB13152,Coagulation Factor IX Human,,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,,B02BD04;B02BD01
DB13154,Parachlorophenol,,P35499,Sodium channel protein type 4 subunit alpha,SCN4A,,
DB13155,Esculin,,P10275,Androgen receptor,AR,agonist,
DB13158,Clobetasone,,P04150,Glucocorticoid receptor,NR3C1,agonist,D07AB01;S01CA11;S01BA09
DB13161,Nusinersen,,B4DP61,Survival motor neuron protein,SMN2,antisense oligonucleotide,M09AX07
DB13164,Olmutinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,L01EB06
DB13165,Ripasudil,,Q13464,Rho-associated protein kinase 1,ROCK1,inhibitor,S01EX07
DB13165,Ripasudil,,O75116,Rho-associated protein kinase 2,ROCK2,inhibitor,S01EX07
DB13166,Zofenopril,,P12821,Angiotensin-converting enzyme,ACE,inhibitor,C09BA15;C09AA15
DB13167,Alclofenac,,P35354,Prostaglandin G/H synthase 2,PTGS2,antagonist,M01AB06
DB13170,Plecanatide,,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,agonist,A06AX07
DB13173,Cerliponase alfa,,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,ligand,A16AB17
DB13174,Rhein,,Q13133,Oxysterols receptor LXR-alpha,NR1H3,inhibitor,
DB13174,Rhein,,P55055,Oxysterols receptor LXR-beta,NR1H2,inhibitor,
DB13174,Rhein,,,Arylamine N-acetyltransferase,,inhibitor,
DB13174,Rhein,,P09917,Arachidonate 5-lipoxygenase,ALOX5,inhibitor,
DB13179,Troleandomycin,,P49228,50S ribosomal protein L32,rpmF,inhibitor,J01FA08
DB13179,Troleandomycin,,P60723,50S ribosomal protein L4,rplD,inhibitor,J01FA08
DB13179,Troleandomycin,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,activator,J01FA08
DB13191,Phosphocreatine,,Q14353,Guanidinoacetate N-methyltransferase,GAMT,product of,C01EB06
DB13191,Phosphocreatine,,P48029,Sodium- and chloride-dependent creatine transporter 1,SLC6A8,,C01EB06
DB13191,Phosphocreatine,,P06732,Creatine kinase M-type,CKM,ligand,C01EB06
DB13191,Phosphocreatine,,P12532,"Creatine kinase U-type, mitochondrial",CKMT1A,ligand,C01EB06
DB13191,Phosphocreatine,,P17540,"Creatine kinase S-type, mitochondrial",CKMT2,ligand,C01EB06
DB13191,Phosphocreatine,,P12277,Creatine kinase B-type,CKB,ligand,C01EB06
DB13192,Antihemophilic factor human,,P00740,Coagulation factor IX,F9,activator,B02BD02
DB13192,Antihemophilic factor human,,P00742,Coagulation factor X,F10,activator,B02BD02
DB13200,Lipegfilgrastim,,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,agonist,L03AA14
DB13242,Bucladesine,,P05121,Plasminogen activator inhibitor 1,SERPINE1,inhibitor,C01CE04
DB13257,Ferrous sulfate anhydrous,,P69905,Hemoglobin subunit alpha,HBA1,binder,
DB13257,Ferrous sulfate anhydrous,,P02786,Transferrin receptor,TFRC,substrate,
DB13269,Dichlorobenzyl alcohol,,P35498,Sodium channel protein,SCN1A,antagonist,R02AA03
DB13310,Ormeloxifene,,P03372,Estrogen receptor alpha,ESR1,modulator,G03XC04
DB13310,Ormeloxifene,,Q92731,Estrogen receptor beta,ESR2,modulator,G03XC04
DB13335,Pinazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA14
DB13335,Pinazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA14
DB13345,Dihydroergocristine,,P08908,Serotonin Receptors,HTR1A,antagonist,C04AE54;C04AE04
DB13345,Dihydroergocristine,,P08588,Beta adrenergic receptor,ADRB1,antagonist,C04AE54;C04AE04
DB13345,Dihydroergocristine,,P08588,Beta adrenergic receptor,ADRB1,agonist,C04AE54;C04AE04
DB13345,Dihydroergocristine,,P35348,Alpha adrenergic receptor,ADRA1A,antagonist,C04AE54;C04AE04
DB13345,Dihydroergocristine,,P35348,Alpha adrenergic receptor,ADRA1A,agonist,C04AE54;C04AE04
DB13345,Dihydroergocristine,,P21728,Dopamine receptor,DRD1,antagonist,C04AE54;C04AE04
DB13345,Dihydroergocristine,,P21728,Dopamine receptor,DRD1,agonist,C04AE54;C04AE04
DB13346,Bufexamac,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,M01AB17;M02AA09
DB13346,Bufexamac,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,M01AB17;M02AA09
DB13346,Bufexamac,,Q9UBN7,Histone deacetylase 6,HDAC6,inhibitor,M01AB17;M02AA09
DB13346,Bufexamac,,Q969S8,Histone deacetylase 10,HDAC10,inhibitor,M01AB17;M02AA09
DB13421,Edoxudine,,Q91CQ6,DNA polymerase,DNApol,inhibitor,D06BB09
DB13437,Medazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA03
DB13437,Medazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA03
DB13501,Bendazac,,,Free radicals,,blocker,M02AA11;S01BC07
DB13501,Bendazac,,P23219,Prostaglandin G/H synthase 1,PTGS1,,M02AA11;S01BC07
DB13501,Bendazac,,P35354,Prostaglandin G/H synthase 2,PTGS2,,M02AA11;S01BC07
DB13503,Tyrothricin,,,Phospholipid membrane,,disruptor,S01AA05;R02AB02;D06AX08
DB13503,Tyrothricin,,P22303,Acetylcholinesterase,ACHE,inhibitor,S01AA05;R02AB02;D06AX08
DB13503,Tyrothricin,,P00722,Beta-galactosidase,lacZ,inhibitor,S01AA05;R02AB02;D06AX08
DB13520,Metergoline,,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,inhibitor,G02CB05
DB13581,Rociverine,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,antagonist,A03AA06
DB13581,Rociverine,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,antagonist,A03AA06
DB13581,Rociverine,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03AA06
DB13581,Rociverine,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,antagonist,A03AA06
DB13581,Rociverine,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,antagonist,A03AA06
DB13615,Mifamurtide,,O00206,Toll-like receptor 4,TLR4,ligand,L03AX15
DB13615,Mifamurtide,,Q9HC29,Nucleotide-binding oligomerization domain-containing protein 2,NOD2,ligand,L03AX15
DB13624,Methoxyphenamine,,P07550,Beta-2 adrenergic receptor,ADRB2,regulator,R03CB02
DB13643,Loprazolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD11
DB13643,Loprazolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD11
DB13720,Diphemanil,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,antagonist,A03CA08;A03AB15
DB13729,Camostat,,P07477,Trypsin-1,PRSS1,inhibitor,B02AB04
DB13729,Camostat,,O15393,Transmembrane protease serine 2,TMPRSS2,inhibitor,B02AB04
DB13729,Camostat,,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,ST14,inhibitor,B02AB04
DB13729,Camostat,,P06307,Cholecystokinin,CCK,inhibitor,B02AB04
DB13746,Bioallethrin,,Q86DI9,Sodium channel protein,,modulator,P03AC52;P03AC02
DB13746,Bioallethrin,,P35498,Voltage-gated sodium channel alpha subunit,SCN1A,modulator,P03AC52;P03AC02
DB13746,Bioallethrin,,Q06432,Voltage-dependent calcium channel,CACNG1,agonist,P03AC52;P03AC02
DB13746,Bioallethrin,,O43497,Voltage-dependent T-type calcium channel,CACNA1G,blocker,P03AC52;P03AC02
DB13746,Bioallethrin,,O00555,Voltage-dependent P/Q-type calcium channel,CACNA1A,blocker,P03AC52;P03AC02
DB13746,Bioallethrin,,Q13936,Voltage-dependent L-type calcium channel,CACNA1C,blocker,P03AC52;P03AC02
DB13751,Glycyrrhizic acid,,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,antagonist,A05BA08
DB13751,Glycyrrhizic acid,,P01375,Tumor necrosis factor,TNF,antagonist,A05BA08
DB13751,Glycyrrhizic acid,,P42574,Caspase-3,CASP3,antagonist,A05BA08
DB13751,Glycyrrhizic acid,,Q00653,Nuclear factor NF-kappa-B,NFKB2,translocation inhibitor,A05BA08
DB13751,Glycyrrhizic acid,,P06858,Lipoprotein lipase,LPL,inducer,A05BA08
DB13760,Niperotidine,,P25021,Histamine H2 receptor,HRH2,antagonist,A02BA05
DB13761,Tilactase,,,Lactose,,cleavage,A09AA04
DB13781,Xamoterol,,P08588,Beta-1 adrenergic receptor,ADRB1,partial agonist,C01CX07
DB13783,Acemetacin,,P23219,Prostaglandin G/H synthase 1,PTGS1,antagonist,M01AB11
DB13783,Acemetacin,,P35354,Prostaglandin G/H synthase 2,PTGS2,antagonist,M01AB11
DB13800,Calcium levulinate,,P0DP23,Calmodulin,CALM1,agonist,A12AA30
DB13800,Calcium levulinate,,P31415,Calsequestrin-1,CASQ1,agonist,A12AA30
DB13800,Calcium levulinate,,P22676,Calretinin,CALB2,agonist,A12AA30
DB13837,Doxefazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD12
DB13837,Doxefazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD12
DB13857,Demegestone,,P06401,Progesterone receptor,PGR,agonist,G03DB05
DB13867,Fluticasone,,P04150,Glucocorticoid receptor,NR3C1,agonist,R03BA05;D07AC17;R03AK11;R03AK06;R01AD08;R01AD58
DB13867,Fluticasone,,P06401,Progesterone receptor,PGR,agonist,R03BA05;D07AC17;R03AK11;R03AK06;R01AD08;R01AD58
DB13867,Fluticasone,,P47712,Cytosolic phospholipase A2,PLA2G4A,inhibitor,R03BA05;D07AC17;R03AK11;R03AK06;R01AD08;R01AD58
DB13867,Fluticasone,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,R03BA05;D07AC17;R03AK11;R03AK06;R01AD08;R01AD58
DB13868,Adefovir,,P24024,DNA polymerase/reverse transcriptase,P,inhibitor,
DB13869,2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol,,Q92731,Estrogen receptor beta,ESR2,,
DB13869,2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol,,P03372,Estrogen receptor alpha,ESR1,,
DB13872,Lormetazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05CD06
DB13872,Lormetazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05CD06
DB13873,Fenofibric acid,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,agonist,C10AB11
DB13873,Fenofibric acid,,Q9NPA2,Matrix metalloproteinase-25,MMP25,unknown,C10AB11
DB13873,Fenofibric acid,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,C10AB11
DB13873,Fenofibric acid,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,unknown,C10AB11
DB13873,Fenofibric acid,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,partial agonist,C10AB11
DB13874,Enasidenib,,P48735,"Isocitrate dehydrogenase [NADP], mitochondrial",IDH2,inhibitor,L01XX59
DB13875,Harmaline,,P50135,Histamine N-methyltransferase,HNMT,inhibitor,
DB13876,Brofaromine,,P21397,Amine oxidase [flavin-containing] A,MAOA,inhibitor,
DB13877,Iniparib,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,
DB13878,Pibrentasvir,,Q5L478,Nonstructural protein 5A,NS5A,inhibitor,J05AP57
DB13879,Glecaprevir,,Q91RS4,NS3 protease,,inhibitor,J05AP57
DB13879,Glecaprevir,,B0B3C9,NS3/4A protein,NS3/4A,inhibitor,J05AP57
DB13881,Tisagenlecleucel,,P15391,B-lymphocyte antigen CD19,CD19,antibody,L01XL04
DB13884,Albutrepenonacog alfa,,P00742,Coagulation factor X,F10,activator,
DB13893,Crotalus adamanteus antivenin,,O15496,Group 10 secretory phospholipase A2,PLA2G10,antagonist,
DB13894,Agkistrodon piscivorus antivenin,,O15496,Group 10 secretory phospholipase A2,PLA2G10,antagonist,
DB13896,Talimogene laherparepvec,,,Heparan sulfate,,,L01XL02
DB13896,Talimogene laherparepvec,,P04293,DNA polymerase catalytic subunit,,activator,L01XL02
DB13896,Talimogene laherparepvec,,P09252,DNA polymerase catalytic subunit,,activator,L01XL02
DB13897,Equine Botulinum Neurotoxin E Immune FAB2,,Q00496,Botulinum neurotoxin type E,,antibody,
DB13898,Equine Botulinum Neurotoxin C Immune FAB2,,P18640,Botulinum neurotoxin type C1,,antibody,
DB13899,Equine Botulinum Neurotoxin G Immune FAB2,,Q60393,Botulinum neurotoxin type G,botG,antibody,
DB13900,Equine Botulinum Neurotoxin A Immune FAB2,,P10845,Botulinum neurotoxin type A,botA,antibody,
DB13901,Equine Botulinum Neurotoxin F Immune FAB2,,P30996,Botulinum neurotoxin type F,botF,antibody,
DB13902,Equine Botulinum Neurotoxin D Immune FAB2,,P19321,Botulinum neurotoxin type D,botD,antibody,
DB13903,Equine Botulinum Neurotoxin B Immune FAB2,,P10844,Botulinum neurotoxin type B,botB,antibody,
DB13906,Aloe vera leaf,,,Free radicals,,chelator,
DB13908,Amylmetacresol,,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,antagonist,
DB13914,Volixibat,,Q12908,Ileal sodium/bile acid cotransporter,SLC10A2,inhibitor,
DB13915,Axicabtagene ciloleucel,,P15391,B-lymphocyte antigen CD19,CD19,antibody,L01XL03
DB13919,Candesartan,,P30556,Type-1 angiotensin II receptor,AGTR1,antagonist,C09DA06;C09DB07;C09DX06;C09CA06;C10BX19
DB13923,Emicizumab,,P00740,Coagulation factor IX,F9,cofactor,B02BX06
DB13923,Emicizumab,,P00742,Coagulation factor X,F10,activator,B02BX06
DB13925,Dotatate gallium Ga-68,,P30874,Somatostatin receptor type 2,SSTR2,binder,
DB13926,Cenegermin,,P04629,High affinity nerve growth factor receptor,NTRK1,stimulator,S01XA24
DB13926,Cenegermin,,P08138,Tumor necrosis factor receptor superfamily member 16,NGFR,stimulator,S01XA24
DB13928,Semaglutide,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,A10BJ06
DB13929,Relcovaptan,,P30559,Oxytocin receptor,OXTR,antagonist,
DB13929,Relcovaptan,,P37288,Vasopressin V1a receptor,AVPR1A,antagonist,
DB13930,Ulixertinib,,P27361,Mitogen-activated protein kinase 3,MAPK3,inhibitor,
DB13930,Ulixertinib,,P28482,Mitogen-activated protein kinase 1,MAPK1,inhibitor,
DB13931,Netarsudil,,Q13464,Rho-associated protein kinase 1,ROCK1,inhibitor,S01EE51;S01EX05
DB13931,Netarsudil,,O75116,Rho-associated protein kinase 2,ROCK2,inhibitor,S01EE51;S01EX05
DB13931,Netarsudil,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,S01EE51;S01EX05
DB13932,Voretigene neparvovec,,Q16518,Retinoid isomerohydrolase,RPE65,gene replacement,S01XA27
DB13933,Nonacog beta pegol,,P08709,Coagulation factor VII,F7,cofactor,
DB13933,Nonacog beta pegol,,P00451,Coagulation factor VIII,F8,cofactor,
DB13933,Nonacog beta pegol,,P00742,Coagulation factor X,F10,agonist,
DB13934,Ligandrol,,P10275,Androgen receptor,AR,antagonist,
DB13934,Ligandrol,,P10275,Androgen receptor,AR,agonist,
DB13940,"2,5-Dimethoxy-4-ethylthioamphetamine",,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,
DB13940,"2,5-Dimethoxy-4-ethylthioamphetamine",,P28335,5-hydroxytryptamine receptor 2C,HTR2C,agonist,
DB13943,Testosterone cypionate,,P10275,Androgen receptor,AR,agonist,
DB13943,Testosterone cypionate,,P03372,Estrogen receptor alpha,ESR1,,
DB13943,Testosterone cypionate,,P08235,Mineralocorticoid receptor,NR3C2,,
DB13944,Testosterone enanthate,,P10275,Androgen receptor,AR,agonist,
DB13944,Testosterone enanthate,,P03372,Estrogen receptor alpha,ESR1,,
DB13944,Testosterone enanthate,,P08235,Mineralocorticoid receptor,NR3C2,,
DB13946,Testosterone undecanoate,,P10275,Androgen receptor,AR,agonist,
DB13948,"N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine",,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,
DB13949,Ferric cation,,P02786,Transferrin receptor protein 1,TFRC,agonist,
DB13949,Ferric cation,,P07822,Iron(3+)-hydroxamate-binding protein FhuD,fhuD,binder,
DB13951,Stanolone acetate,,P10275,Androgen receptor,AR,,
DB13951,Stanolone acetate,,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,,
DB13951,Stanolone acetate,,P03372,Estrogen receptor alpha,ESR1,,
DB13951,Stanolone acetate,,P08235,Mineralocorticoid receptor,NR3C2,,
DB13952,Estradiol acetate,,P03372,Estrogen receptor alpha,ESR1,agonist,
DB13952,Estradiol acetate,,Q92731,Estrogen receptor beta,ESR2,agonist,
DB13952,Estradiol acetate,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB13952,Estradiol acetate,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,
DB13952,Estradiol acetate,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB13952,Estradiol acetate,,Q99527,G-protein coupled estrogen receptor 1,GPER1,,
DB13952,Estradiol acetate,,P00846,ATP synthase subunit a,MT-ATP6,,
DB13952,Estradiol acetate,,Q14457,Beclin-1,BECN1,,
DB13952,Estradiol acetate,,P37059,Estradiol 17-beta-dehydrogenase 2,HSD17B2,,
DB13952,Estradiol acetate,,P62508,Estrogen-related receptor gamma,ESRRG,ligand,
DB13953,Estradiol benzoate,,P03372,Estrogen receptor alpha,ESR1,agonist,
DB13953,Estradiol benzoate,,Q92731,Estrogen receptor beta,ESR2,agonist,
DB13953,Estradiol benzoate,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB13953,Estradiol benzoate,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,
DB13953,Estradiol benzoate,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB13953,Estradiol benzoate,,Q99527,G-protein coupled estrogen receptor 1,GPER1,,
DB13953,Estradiol benzoate,,P00846,ATP synthase subunit a,MT-ATP6,,
DB13953,Estradiol benzoate,,Q14457,Beclin-1,BECN1,,
DB13953,Estradiol benzoate,,P37059,Estradiol 17-beta-dehydrogenase 2,HSD17B2,,
DB13953,Estradiol benzoate,,P62508,Estrogen-related receptor gamma,ESRRG,ligand,
DB13954,Estradiol cypionate,,P03372,Estrogen receptor alpha,ESR1,agonist,
DB13954,Estradiol cypionate,,Q92731,Estrogen receptor beta,ESR2,agonist,
DB13954,Estradiol cypionate,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB13954,Estradiol cypionate,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,
DB13954,Estradiol cypionate,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB13954,Estradiol cypionate,,Q99527,G-protein coupled estrogen receptor 1,GPER1,,
DB13954,Estradiol cypionate,,P00846,ATP synthase subunit a,MT-ATP6,,
DB13954,Estradiol cypionate,,Q14457,Beclin-1,BECN1,,
DB13954,Estradiol cypionate,,P37059,Estradiol 17-beta-dehydrogenase 2,HSD17B2,,
DB13954,Estradiol cypionate,,P62508,Estrogen-related receptor gamma,ESRRG,ligand,
DB13955,Estradiol dienanthate,,P03372,Estrogen receptor alpha,ESR1,agonist,
DB13955,Estradiol dienanthate,,Q92731,Estrogen receptor beta,ESR2,agonist,
DB13955,Estradiol dienanthate,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB13955,Estradiol dienanthate,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,
DB13955,Estradiol dienanthate,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB13955,Estradiol dienanthate,,Q99527,G-protein coupled estrogen receptor 1,GPER1,,
DB13955,Estradiol dienanthate,,P00846,ATP synthase subunit a,MT-ATP6,,
DB13955,Estradiol dienanthate,,Q14457,Beclin-1,BECN1,,
DB13955,Estradiol dienanthate,,P37059,Estradiol 17-beta-dehydrogenase 2,HSD17B2,,
DB13955,Estradiol dienanthate,,P62508,Estrogen-related receptor gamma,ESRRG,ligand,
DB13956,Estradiol valerate,,P03372,Estrogen receptor alpha,ESR1,agonist,
DB13956,Estradiol valerate,,Q92731,Estrogen receptor beta,ESR2,agonist,
DB13956,Estradiol valerate,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB13956,Estradiol valerate,,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,,
DB13956,Estradiol valerate,,Q15596,Nuclear receptor coactivator 2,NCOA2,,
DB13956,Estradiol valerate,,Q99527,G-protein coupled estrogen receptor 1,GPER1,,
DB13956,Estradiol valerate,,P00846,ATP synthase subunit a,MT-ATP6,,
DB13956,Estradiol valerate,,Q14457,Beclin-1,BECN1,,
DB13956,Estradiol valerate,,P37059,Estradiol 17-beta-dehydrogenase 2,HSD17B2,,
DB13956,Estradiol valerate,,P62508,Estrogen-related receptor gamma,ESRRG,ligand,
DB13960,Bronopol,,,Thiol groups,,oxidizer,
DB13961,Fish oil,,Q96PD7,Diacylglycerol O-acyltransferase 2,DGAT2,agonist,
DB13961,Fish oil,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB13961,Fish oil,,Q5NUL3,Free fatty acid receptor 4,FFAR4,agonist,
DB13961,Fish oil,,Q5NUL3,Free fatty acid receptor 4,FFAR4,inhibits downstream inflammation cascades,
DB13961,Fish oil,,Q13936,Voltage gated L-type calcium channel,CACNA1C,inhibitor,
DB13961,Fish oil,,P35498,Sodium channel protein,SCN1A,inhibitor,
DB13961,Fish oil,,,Free radicals,,,
DB13961,Fish oil,,Q00653,Nuclear factor NF-kappa-B,NFKB2,regulator,
DB13961,Fish oil,,P36956,Sterol regulatory element-binding protein 1,SREBF1,regulator,
DB13961,Fish oil,,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,regulator,
DB13961,Fish oil,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB13961,Fish oil,,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,regulator,
DB13967,Patent Blue,,P02768,Serum albumin,ALB,binder,V04CX09
DB13978,Selisistat,,Q96EB6,NAD-dependent protein deacetylase sirtuin-1,SIRT1,inhibitor,
DB13979,Besilesomab,,Q14081,Carcinoembryonic antigen,,,
DB13983,"5,7,2′-trihydroxy-6,8-dimethoxyflavone",,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,
DB13985,Lutetium Lu 177 dotatate,,P30874,Somatostatin receptor type 2,SSTR2,agonist,
DB13985,Lutetium Lu 177 dotatate,,P30872,Somatostatin receptor type 1,SSTR1,agonist,
DB13985,Lutetium Lu 177 dotatate,,P32745,Somatostatin receptor type 3,SSTR3,agonist,
DB13985,Lutetium Lu 177 dotatate,,P31391,Somatostatin receptor type 4,SSTR4,agonist,
DB13985,Lutetium Lu 177 dotatate,,P35346,Somatostatin receptor type 5,SSTR5,agonist,
DB13988,SB-269970,,P34969,5-hydroxytryptamine receptor 7,HTR7,antagonist,
DB13994,AZD-7325,,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,positive allosteric modulator,
DB13994,AZD-7325,,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,positive allosteric modulator,
DB13995,Ferric pyrophosphate citrate,,P02792,Ferritin light chain,FTL,binder,
DB13995,Ferric pyrophosphate citrate,,P02794,Ferritin heavy chain,FTH1,binder,
DB13995,Ferric pyrophosphate citrate,,P69905,Hemoglobin subunit alpha,HBA1,binder,
DB13995,Ferric pyrophosphate citrate,,P68871,Hemoglobin subunit beta,HBB,binder,
DB13996,Magnesium acetate,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,,
DB13997,Baloxavir marboxil,,P03433,Polymerase acidic protein,PA,inhibitor,J05AX25
DB13998,Lonoctocog alfa,,P00742,Coagulation factor X,F10,activator,
DB13998,Lonoctocog alfa,,P00740,Coagulation factor IX,F9,cofactor,
DB13998,Lonoctocog alfa,,P04275,von Willebrand factor,VWF,binder,
DB13998,Lonoctocog alfa,,O14832,"Phytanoyl-CoA dioxygenase, peroxisomal",PHYH,antagonist,
DB13998,Lonoctocog alfa,,P07307,Asialoglycoprotein receptor 2,ASGR2,binder,
DB13998,Lonoctocog alfa,,P11021,78 kDa glucose-regulated protein,HSPA5,chaperone,
DB13998,Lonoctocog alfa,,P27797,Calreticulin,CALR,chaperone,
DB13998,Lonoctocog alfa,,P27824,Calnexin,CANX,chaperone,
DB13998,Lonoctocog alfa,,P49257,Protein ERGIC-53,LMAN1,chaperone,
DB13998,Lonoctocog alfa,,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,modulator,
DB13998,Lonoctocog alfa,,Q8NI22,Multiple coagulation factor deficiency protein 2,MCFD2,modulator,
DB13999,Moroctocog alfa,,P00742,Coagulation factor X,F10,activator,
DB13999,Moroctocog alfa,,P00740,Coagulation factor IX,F9,cofactor,
DB13999,Moroctocog alfa,,P04275,von Willebrand factor,VWF,binder,
DB13999,Moroctocog alfa,,O14832,"Phytanoyl-CoA dioxygenase, peroxisomal",PHYH,antagonist,
DB13999,Moroctocog alfa,,P07307,Asialoglycoprotein receptor 2,ASGR2,binder,
DB13999,Moroctocog alfa,,P11021,78 kDa glucose-regulated protein,HSPA5,chaperone,
DB13999,Moroctocog alfa,,P27797,Calreticulin,CALR,chaperone,
DB13999,Moroctocog alfa,,P27824,Calnexin,CANX,chaperone,
DB13999,Moroctocog alfa,,P49257,Protein ERGIC-53,LMAN1,chaperone,
DB13999,Moroctocog alfa,,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,modulator,
DB13999,Moroctocog alfa,,Q8NI22,Multiple coagulation factor deficiency protein 2,MCFD2,modulator,
DB14001,alpha-Tocopherol succinate,,Q9UDX4,SEC14-like protein 3,SEC14L3,,
DB14001,alpha-Tocopherol succinate,,O76054,SEC14-like protein 2,SEC14L2,,
DB14001,alpha-Tocopherol succinate,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB14001,alpha-Tocopherol succinate,,P05771,Protein kinase C beta type,PRKCB,,
DB14001,alpha-Tocopherol succinate,,P09917,Arachidonate 5-lipoxygenase,ALOX5,,
DB14001,alpha-Tocopherol succinate,,P17252,Protein kinase C alpha type,PRKCA,,
DB14001,alpha-Tocopherol succinate,,P23743,Diacylglycerol kinase,DGKA,,
DB14001,alpha-Tocopherol succinate,,,Lung epithelial cells,,,
DB14002,D-alpha-Tocopherol acetate,,Q9UDX4,SEC14-like protein 3,SEC14L3,,
DB14002,D-alpha-Tocopherol acetate,,O76054,SEC14-like protein 2,SEC14L2,,
DB14002,D-alpha-Tocopherol acetate,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,,
DB14002,D-alpha-Tocopherol acetate,,P05771,Protein kinase C beta type,PRKCB,,
DB14002,D-alpha-Tocopherol acetate,,P09917,Arachidonate 5-lipoxygenase,ALOX5,,
DB14002,D-alpha-Tocopherol acetate,,P17252,Protein kinase C alpha type,PRKCA,,
DB14003,alpha-Tocopherol acetate,,,Free radicals,,binder,
DB14004,Tildrakizumab,,P29460,Interleukin-23,IL12B,antagonist,L04AC17
DB14006,Choline salicylate,,Q9Y5K3,Choline-phosphate cytidylyltransferase B,PCYT1B,product of,N02BA03
DB14006,Choline salicylate,,P22303,Acetylcholinesterase,ACHE,product of,N02BA03
DB14006,Choline salicylate,,P49585,Choline-phosphate cytidylyltransferase A,PCYT1A,product of,N02BA03
DB14006,Choline salicylate,,O14939,Phospholipase D2,PLD2,product of,N02BA03
DB14006,Choline salicylate,,P06276,Cholinesterase,BCHE,product of,N02BA03
DB14006,Choline salicylate,,Q13393,Phospholipase D1,PLD1,product of,N02BA03
DB14006,Choline salicylate,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,N02BA03
DB14007,Pentetic acid,,,Transuranium elements,,chelator,
DB14009,Medical Cannabis,,P21554,Cannabinoid receptor 1,CNR1,negative modulator,
DB14009,Medical Cannabis,,P34972,Cannabinoid receptor 2,CNR2,,
DB14009,Medical Cannabis,,P47775,G-protein coupled receptor 12,GPR12,inverse agonist,
DB14009,Medical Cannabis,,P23415,Glycine receptor subunit alpha-1,GLRA1,,
DB14009,Medical Cannabis,,P23415,Glycine receptor (alpha-1/beta),GLRA1,,
DB14009,Medical Cannabis,,O75311,Glycine receptor subunit alpha-3,GLRA3,,
DB14009,Medical Cannabis,,Q14330,N-arachidonyl glycine receptor,GPR18,,
DB14009,Medical Cannabis,,Q9Y2T6,G-protein coupled receptor 55,GPR55,,
DB14009,Medical Cannabis,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB14009,Medical Cannabis,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB14009,Medical Cannabis,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,
DB14009,Medical Cannabis,,P41143,Delta-type opioid receptor,OPRD1,,
DB14009,Medical Cannabis,,P35372,Mu-type opioid receptor,OPRM1,,
DB14009,Medical Cannabis,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB14009,Medical Cannabis,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,,
DB14009,Medical Cannabis,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,,
DB14009,Medical Cannabis,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,,
DB14009,Medical Cannabis,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,,
DB14009,Medical Cannabis,,O75762,Transient receptor potential cation channel subfamily A member 1,TRPA1,,
DB14009,Medical Cannabis,,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,TRPM8,,
DB14009,Medical Cannabis,,Q9Y5S1,Transient receptor potential cation channel subfamily V member 2,TRPV2,,
DB14009,Medical Cannabis,,Q8NET8,Transient receptor potential cation channel subfamily V member 3,TRPV3,,
DB14009,Medical Cannabis,,Q9HBA0,Transient receptor potential cation channel subfamily V member 4,TRPV4,,
DB14009,Medical Cannabis,,P21796,Voltage-dependent anion-selective channel protein 1,VDAC1,,
DB14009,Medical Cannabis,,Q6IQ20,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D,NAPEPLD,inhibitor,
DB14009,Medical Cannabis,,Q02083,N-acylethanolamine-hydrolyzing acid amidase,NAAA,inhibitor,
DB14009,Medical Cannabis,,Q16613,Serotonin N-acetyltransferase,AANAT,inhibitor,
DB14009,Medical Cannabis,,P04054,Phospholipase A2,PLA2G1B,inhibitor,
DB14009,Medical Cannabis,,P04054,Phospholipase A2,PLA2G1B,inducer,
DB14009,Medical Cannabis,,P00441,Superoxide dismutase [Cu-Zn],SOD1,inhibitor,
DB14009,Medical Cannabis,,O00519,Fatty-acid amide hydrolase 1,FAAH,inhibitor,
DB14009,Medical Cannabis,,P04040,Catalase,CAT,inhibitor,
DB14009,Medical Cannabis,,Q08257,Quinone oxidoreductase,CRYZ,inhibitor,
DB14009,Medical Cannabis,,P17405,Sphingomyelin phosphodiesterase,SMPD1,inducer,
DB14009,Medical Cannabis,,P07203,Glutathione peroxidase 1,GPX1,inducer,
DB14009,Medical Cannabis,,P00390,"Glutathione reductase, mitochondrial",GSR,inducer,
DB14009,Medical Cannabis,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,inducer,
DB14009,Medical Cannabis,,P14902,"Indoleamine 2,3-dioxygenase 1",IDO1,inhibitor,
DB14009,Medical Cannabis,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB14009,Medical Cannabis,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB14009,Medical Cannabis,,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,inhibitor,
DB14009,Medical Cannabis,,P24752,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,inhibitor,
DB14010,"5-methoxy-N,N-dimethyltryptamine",,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,
DB14010,"5-methoxy-N,N-dimethyltryptamine",,P28223,5-hydroxytryptamine receptor 2A,HTR2A,agonist,
DB14011,Nabiximols,,P21554,Cannabinoid receptor 1,CNR1,,
DB14011,Nabiximols,,P34972,Cannabinoid receptor 2,CNR2,,
DB14011,Nabiximols,,P47775,G-protein coupled receptor 12,GPR12,inverse agonist,
DB14011,Nabiximols,,P23415,Glycine receptor subunit alpha-1,GLRA1,,
DB14011,Nabiximols,,P23415,Glycine receptor (alpha-1/beta),GLRA1,,
DB14011,Nabiximols,,O75311,Glycine receptor subunit alpha-3,GLRA3,,
DB14011,Nabiximols,,Q14330,N-arachidonyl glycine receptor,GPR18,,
DB14011,Nabiximols,,Q9Y2T6,G-protein coupled receptor 55,GPR55,,
DB14011,Nabiximols,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,,
DB14011,Nabiximols,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,,
DB14011,Nabiximols,,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,,
DB14011,Nabiximols,,P41143,Delta-type opioid receptor,OPRD1,,
DB14011,Nabiximols,,P35372,Mu-type opioid receptor,OPRM1,,
DB14011,Nabiximols,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB14011,Nabiximols,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,,
DB14011,Nabiximols,,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,,
DB14011,Nabiximols,,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,,
DB14011,Nabiximols,,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,,
DB14011,Nabiximols,,O75762,Transient receptor potential cation channel subfamily A member 1,TRPA1,,
DB14011,Nabiximols,,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,TRPM8,,
DB14011,Nabiximols,,Q9Y5S1,Transient receptor potential cation channel subfamily V member 2,TRPV2,,
DB14011,Nabiximols,,Q8NET8,Transient receptor potential cation channel subfamily V member 3,TRPV3,,
DB14011,Nabiximols,,Q9HBA0,Transient receptor potential cation channel subfamily V member 4,TRPV4,,
DB14011,Nabiximols,,P21796,Voltage-dependent anion-selective channel protein 1,VDAC1,,
DB14011,Nabiximols,,P23219,Prostaglandin G/H synthase 1,PTGS1,inhibitor,
DB14011,Nabiximols,,P35354,Prostaglandin G/H synthase 2,PTGS2,inhibitor,
DB14011,Nabiximols,,P24752,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,inhibitor,
DB14011,Nabiximols,,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,inhibitor,
DB14011,Nabiximols,,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,stimulator,
DB14011,Nabiximols,,P00390,"Glutathione reductase, mitochondrial",GSR,stimulator,
DB14011,Nabiximols,,P07203,Glutathione peroxidase 1,GPX1,stimulator,
DB14011,Nabiximols,,P14902,"Indoleamine 2,3-dioxygenase 1",IDO1,inhibitor,
DB14011,Nabiximols,,Q16613,Serotonin N-acetyltransferase,AANAT,inhibitor,
DB14011,Nabiximols,,Q16678,Cytochrome P450 1B1,CYP1B1,inhibitor,
DB14011,Nabiximols,,P20815,Cytochrome P450 3A5,CYP3A5,inhibitor,
DB14011,Nabiximols,,P10635,Cytochrome P450 2D6,CYP2D6,substrate,
DB14011,Nabiximols,,P10635,Cytochrome P450 2D6,CYP2D6,inhibitor,
DB14011,Nabiximols,,P05177,Cytochrome P450 1A2,CYP1A2,inhibitor,
DB14011,Nabiximols,,P04798,Cytochrome P450 1A1,CYP1A1,inhibitor,
DB14011,Nabiximols,,P24462,Cytochrome P450 3A7,CYP3A7,inhibitor,
DB14011,Nabiximols,,Q08257,Quinone oxidoreductase,CRYZ,inhibitor,
DB14011,Nabiximols,,P04040,Catalase,CAT,inhibitor,
DB14011,Nabiximols,,O00519,Fatty-acid amide hydrolase 1,FAAH,inhibitor,
DB14011,Nabiximols,,O00519,Fatty-acid amide hydrolase 1,FAAH,inducer,
DB14011,Nabiximols,,P00441,Superoxide dismutase [Cu-Zn],SOD1,inhibitor,
DB14011,Nabiximols,,Q02083,N-acylethanolamine-hydrolyzing acid amidase,NAAA,inhibitor,
DB14012,Burosumab,,Q7Z4T2,Fibroblast growth factor 23,FGF23,antagonist,M05BX05
DB14013,SR-9009,,P20393,Nuclear receptor subfamily 1 group D member 1,NR1D1,agonist,
DB14013,SR-9009,,Q14995,Nuclear receptor subfamily 1 group D member 2,NR1D2,agonist,
DB14014,SR-9011,,Q14995,Nuclear receptor subfamily 1 group D member 2,NR1D2,agonist,
DB14014,SR-9011,,P20393,Nuclear receptor subfamily 1 group D member 1,NR1D1,agonist,
DB14017,H3B-8800,,O75533,Splicing factor 3B subunit 1,SF3B1,inhibitor,
DB14019,Fosnetupitant,,P25103,Neurokinin 1 receptor,TACR1,antagonist,
DB14027,Taspoglutide,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,
DB14028,Nordazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA16
DB14028,Nordazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA16
DB14033,Acetyl sulfisoxazole,,P0AC13,Dihydropteroate synthase,folP,inhibitor,G01AE10
DB14034,Darglitazone,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,agonist,
DB14039,Erenumab,,Q16602,Calcitonin gene-related peptide type 1 receptor,CALCRL,,N02CD01
DB14040,Eptinezumab,,P06881,Calcitonin gene-related peptide 1,CALCA,binder,N02CD05
DB14040,Eptinezumab,,P06881,Calcitonin gene-related peptide 1,CALCA,antibody,N02CD05
DB14040,Eptinezumab,,P10092,Calcitonin gene-related peptide 2,CALCB,binder,N02CD05
DB14040,Eptinezumab,,P10092,Calcitonin gene-related peptide 2,CALCB,antibody,N02CD05
DB14041,Fremanezumab,,P06881,Calcitonin gene-related peptide 1,CALCA,binder,N02CD03
DB14041,Fremanezumab,,P06881,Calcitonin gene-related peptide 1,CALCA,antibody,N02CD03
DB14041,Fremanezumab,,P10092,Calcitonin gene-related peptide 2,CALCB,binder,N02CD03
DB14041,Fremanezumab,,P10092,Calcitonin gene-related peptide 2,CALCB,antibody,N02CD03
DB14042,Galcanezumab,,P06881,Calcitonin gene-related peptide 1,CALCA,antibody,N02CD02
DB14042,Galcanezumab,,P10092,Calcitonin gene-related peptide 2,CALCB,antibody,N02CD02
DB14048,Sodium zirconium cyclosilicate,,,Potassium,,binder,V03AE10
DB14050,Cannabidivarin,,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,agonist,
DB14050,Cannabidivarin,,Q9Y5S1,Transient receptor potential cation channel subfamily V member 2,TRPV2,agonist,
DB14050,Cannabidivarin,,O75762,Transient receptor potential cation channel subfamily A member 1,TRPA1,agonist,
DB14050,Cannabidivarin,,F5GY58,Sn1-specific diacylglycerol lipase alpha,DAGLA,inhibitor,
DB14051,Malacidin A,,,NAM/NAG peptide subunits of peptidoglycan,,ligand,
DB14052,Malacidin B,,,NAM/NAG peptide subunits of peptidoglycan,,ligand,
DB14058,Basifungin,,O13332,Inositol phosphorylceramide synthase,AUR1,inhibitor,
DB14059,SC-236,,Q8SPQ9,Cyclooxygenase 2,PTGS2,inhibitor,
DB14059,SC-236,,Q00653,Nuclear factor NF-kappa-B complex,NFKB2,inhibitor,
DB14060,NS-398,,Q8SPQ9,Cyclooxygenase 2,PTGS2,inhibitor,
DB14061,Hycanthone,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14062,Concanamycin A,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14063,Dexverapamil,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14064,Emopamil,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14065,Lomerizine,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14066,Tetrandrine,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14067,Dofequidar,,Q2M3G0,ATP-binding cassette sub-family B member 5,ABCB5,inhibitor,
DB14067,Dofequidar,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14068,Dexniguldipine,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14069,ONT-093,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14070,HM-30181,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14071,Desmethylsertraline,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14072,Reversin 121,,P08183,P-glycoprotein 1,ABCB1,inhibitor,
DB14074,Icaridin,,Q8T6S0,Odorant binding protein,OBP-1,ligand,
DB14083,Bisphenol A diglycidyl ether,,Q8NEC5,Cation channel sperm-associated protein 1,CATSPER1,activator,
DB14089,Dimercaptosuccinic acid,,,Mercury,,chelator,
DB14089,Dimercaptosuccinic acid,,,Arsenic,,chelator,
DB14109,alpha-Arbutin,,P10253,Lysosomal alpha-glucosidase,GAA,substrate,
DB14109,alpha-Arbutin,,P10253,Lysosomal alpha-glucosidase,GAA,regulator,
DB14123,Menthol,,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,TRPM8,agonist,
DB14126,Tenofovir,,Q72547,Reverse transcriptase/RNaseH,pol,inhibitor,
DB14126,Tenofovir,,Q3MS49,Reverse transcriptase,rt,inhibitor,
DB14126,Tenofovir,,I6TLU5,DNA polymerase,,inhibitor,
DB14132,8-chlorotheophylline,,P29274,Adenosine receptor A2a,ADORA2A,antagonist,
DB14146,Loxicodegol,,P35372,Mu-type opioid receptor,OPRM1,agonist,
DB14146,Loxicodegol,,P41143,Delta-type opioid receptor,OPRD1,agonist,
DB14146,Loxicodegol,,P41145,Kappa-type opioid receptor,OPRK1,agonist,
DB14185,Aripiprazole lauroxil,,P14416,Dopamine D2 receptor,DRD2,partial agonist,
DB14185,Aripiprazole lauroxil,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,partial agonist,
DB14185,Aripiprazole lauroxil,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,
DB14185,Aripiprazole lauroxil,,P28222,5-hydroxytryptamine receptor 1B,HTR1B,,
DB14185,Aripiprazole lauroxil,,P28221,5-hydroxytryptamine receptor 1D,HTR1D,,
DB14185,Aripiprazole lauroxil,,P28566,5-hydroxytryptamine receptor 1E,HTR1E,,
DB14185,Aripiprazole lauroxil,,P21728,Dopamine D1 receptor,DRD1,,
DB14185,Aripiprazole lauroxil,,P21918,Dopamine D5 receptor,DRD5,,
DB14185,Aripiprazole lauroxil,,P35462,Dopamine D3 receptor,DRD3,,
DB14185,Aripiprazole lauroxil,,P21917,Dopamine D4 receptor,DRD4,,
DB14185,Aripiprazole lauroxil,,P28335,5-hydroxytryptamine receptor 2C,HTR2C,,
DB14185,Aripiprazole lauroxil,,P46098,5-hydroxytryptamine receptor 3A,HTR3A,,
DB14185,Aripiprazole lauroxil,,P50406,5-hydroxytryptamine receptor 6,HTR6,,
DB14185,Aripiprazole lauroxil,,P34969,5-hydroxytryptamine receptor 7,HTR7,,
DB14185,Aripiprazole lauroxil,,P35367,Histamine H1 receptor,HRH1,antagonist,
DB14185,Aripiprazole lauroxil,,P35348,Alpha-1A adrenergic receptor,ADRA1A,antagonist,
DB14185,Aripiprazole lauroxil,,P35368,Alpha-1B adrenergic receptor,ADRA1B,antagonist,
DB14185,Aripiprazole lauroxil,,P08913,Alpha-2A adrenergic receptor,ADRA2A,,
DB14185,Aripiprazole lauroxil,,P18089,Alpha-2B adrenergic receptor,ADRA2B,,
DB14185,Aripiprazole lauroxil,,P18825,Alpha-2C adrenergic receptor,ADRA2C,,
DB14185,Aripiprazole lauroxil,,P11229,Muscarinic acetylcholine receptor M1,CHRM1,,
DB14185,Aripiprazole lauroxil,,P08172,Muscarinic acetylcholine receptor M2,CHRM2,,
DB14185,Aripiprazole lauroxil,,P20309,Muscarinic acetylcholine receptor M3,CHRM3,,
DB14185,Aripiprazole lauroxil,,P08173,Muscarinic acetylcholine receptor M4,CHRM4,,
DB14185,Aripiprazole lauroxil,,P08912,Muscarinic acetylcholine receptor M5,CHRM5,,
DB14481,Calcium phosphate dihydrate,,P41180,Extracellular calcium-sensing receptor,CASR,,
DB14481,Calcium phosphate dihydrate,,P27797,Calreticulin,CALR,,
DB14481,Calcium phosphate dihydrate,,Q99828,Calcium and integrin-binding protein 1,CIB1,,
DB14481,Calcium phosphate dihydrate,,O75340,Programmed cell death protein 6,PDCD6,,
DB14481,Calcium phosphate dihydrate,,P30626,Sorcin,SRI,,
DB14481,Calcium phosphate dihydrate,,Q99653,Calcineurin B homologous protein 1,CHP1,,
DB14481,Calcium phosphate dihydrate,,P09486,SPARC,SPARC,,
DB14481,Calcium phosphate dihydrate,,P27824,Calnexin,CANX,,
DB14481,Calcium phosphate dihydrate,,P35556,Fibrillin-2,FBN2,,
DB14481,Calcium phosphate dihydrate,,P04271,Protein S100-B,S100B,,
DB14481,Calcium phosphate dihydrate,,O14958,Calsequestrin-2,CASQ2,,
DB14481,Calcium phosphate dihydrate,,Q15493,Regucalcin,RGN,,
DB14481,Calcium phosphate dihydrate,,Q9UBV8,Peflin,PEF1,,
DB14481,Calcium phosphate dihydrate,,P06703,Protein S100-A6,S100A6,,
DB14481,Calcium phosphate dihydrate,,P13693,Translationally-controlled tumor protein,TPT1,,
DB14481,Calcium phosphate dihydrate,,O75838,Calcium and integrin-binding family member 2,CIB2,,
DB14481,Calcium phosphate dihydrate,,Q99584,Protein S100-A13,S100A13,,
DB14481,Calcium phosphate dihydrate,,P31415,Calsequestrin-1,CASQ1,,
DB14481,Calcium phosphate dihydrate,,Q02818,Nucleobindin-1,NUCB1,,
DB14481,Calcium phosphate dihydrate,,P80303,Nucleobindin-2,NUCB2,,
DB14481,Calcium phosphate dihydrate,,P0DP23,Calmodulin,CALM1,,
DB14481,Calcium phosphate dihydrate,,Q75N90,Fibrillin-3,FBN3,,
DB14481,Calcium phosphate dihydrate,,P28676,Grancalcin,GCA,,
DB14481,Calcium phosphate dihydrate,,Q9ULU8,Calcium-dependent secretion activator 1,CADPS,,
DB14481,Calcium phosphate dihydrate,,P0DP24,Calmodulin-2,CALM2,,
DB14481,Calcium phosphate dihydrate,,P0DP25,Calmodulin-3,CALM3,,
DB14481,Calcium phosphate dihydrate,,Q96FQ6,Protein S100-A16,S100A16,,
DB14481,Calcium phosphate dihydrate,,P22676,Calretinin,CALB2,,
DB14481,Calcium phosphate dihydrate,,Q13938,Calcyphosin,CAPS,,
DB14481,Calcium phosphate dihydrate,,Q86UW7,Calcium-dependent secretion activator 2,CADPS2,,
DB14481,Calcium phosphate dihydrate,,Q96L12,Calreticulin-3,CALR3,,
DB14481,Calcium phosphate dihydrate,,Q9ULB1,Neurexin-1,NRXN1,,
DB14481,Calcium phosphate dihydrate,,P62166,Neuronal calcium sensor 1,NCS1,,
DB14487,Zinc acetate,,P46663,B1 bradykinin receptor,BDKRB1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,,C05AX04;A16AX05
DB14487,Zinc acetate,,P04075,Fructose-bisphosphate aldolase A,ALDOA,,C05AX04;A16AX05
DB14487,Zinc acetate,,P68104,Elongation factor 1-alpha 1,EEF1A1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P06733,Alpha-enolase,ENO1,,C05AX04;A16AX05
DB14487,Zinc acetate,,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,,C05AX04;A16AX05
DB14487,Zinc acetate,,P15531,Nucleoside diphosphate kinase A,NME1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P07237,Protein disulfide-isomerase,P4HB,,C05AX04;A16AX05
DB14487,Zinc acetate,,P30101,Protein disulfide-isomerase A3,PDIA3,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q06830,Peroxiredoxin-1,PRDX1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P78330,Phosphoserine phosphatase,PSPH,,C05AX04;A16AX05
DB14487,Zinc acetate,,P60174,Triosephosphate isomerase,TPI1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P49411,"Elongation factor Tu, mitochondrial",TUFM,,C05AX04;A16AX05
DB14487,Zinc acetate,,P03372,Estrogen receptor alpha,ESR1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P08700,Interleukin-3,IL3,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02795,Metallothionein-2,MT2A,,C05AX04;A16AX05
DB14487,Zinc acetate,,O14618,Copper chaperone for superoxide dismutase,CCS,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q13547,Histone deacetylase 1,HDAC1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P56524,Histone deacetylase 4,HDAC4,,C05AX04;A16AX05
DB14487,Zinc acetate,,P29372,DNA-3-methyladenine glycosylase,MPG,,C05AX04;A16AX05
DB14487,Zinc acetate,,P04279,Semenogelin-1,SEMG1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P00441,Superoxide dismutase [Cu-Zn],SOD1,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q9BY41,Histone deacetylase 8,HDAC8,,C05AX04;A16AX05
DB14487,Zinc acetate,,O15304,Apoptosis regulatory protein Siva,SIVA1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P23415,Glycine receptor subunit alpha-1,GLRA1,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q00987,E3 ubiquitin-protein ligase Mdm2,MDM2,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01308,Insulin,INS,,C05AX04;A16AX05
DB14487,Zinc acetate,,P46939,Utrophin,UTRN,,C05AX04;A16AX05
DB14487,Zinc acetate,,P45381,Aspartoacylase,ASPA,,C05AX04;A16AX05
DB14487,Zinc acetate,,P05109,Protein S100-A8,S100A8,,C05AX04;A16AX05
DB14487,Zinc acetate,,P06702,Protein S100-A9,S100A9,,C05AX04;A16AX05
DB14487,Zinc acetate,,P14780,Matrix metalloproteinase-9,MMP9,,C05AX04;A16AX05
DB14487,Zinc acetate,,O15350,Tumor protein p73,TP73,,C05AX04;A16AX05
DB14487,Zinc acetate,,P29034,Protein S100-A2,S100A2,,C05AX04;A16AX05
DB14487,Zinc acetate,,P04637,Cellular tumor antigen p53,TP53,,C05AX04;A16AX05
DB14487,Zinc acetate,,P25713,Metallothionein-3,MT3,,C05AX04;A16AX05
DB14487,Zinc acetate,,O75340,Programmed cell death protein 6,PDCD6,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q8N907,DAN domain family member 5,DAND5,,C05AX04;A16AX05
DB14487,Zinc acetate,,P04731,Metallothionein-1A,MT1A,,C05AX04;A16AX05
DB14487,Zinc acetate,,P04217,Alpha-1B-glycoprotein,A1BG,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01023,Alpha-2-macroglobulin,A2M,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01019,Angiotensinogen,AGT,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02765,Alpha-2-HS-glycoprotein,AHSG,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02743,Serum amyloid P-component,APCS,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02647,Apolipoprotein A-I,APOA1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02652,Apolipoprotein A-II,APOA2,,C05AX04;A16AX05
DB14487,Zinc acetate,,P06727,Apolipoprotein A-IV,APOA4,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q0VD83,Apolipoprotein B receptor,APOBR,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02649,Apolipoprotein E,APOE,,C05AX04;A16AX05
DB14487,Zinc acetate,,O14791,Apolipoprotein L1,APOL1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02746,Complement C1q subcomponent subunit B,C1QB,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02747,Complement C1q subcomponent subunit C,C1QC,,C05AX04;A16AX05
DB14487,Zinc acetate,,P00736,Complement C1r subcomponent,C1R,,C05AX04;A16AX05
DB14487,Zinc acetate,,P09871,Complement C1s subcomponent,C1S,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01024,Complement C3,C3,,C05AX04;A16AX05
DB14487,Zinc acetate,,P0C0L5,Complement C4-B,C4B,,C05AX04;A16AX05
DB14487,Zinc acetate,,P04003,C4b-binding protein alpha chain,C4BPA,,C05AX04;A16AX05
DB14487,Zinc acetate,,P20851,C4b-binding protein beta chain,C4BPB,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01031,Complement C5,C5,,C05AX04;A16AX05
DB14487,Zinc acetate,,P46736,Lys-63-specific deubiquitinase BRCC36,BRCC3,,C05AX04;A16AX05
DB14487,Zinc acetate,,P07357,Complement component C8 alpha chain,C8A,,C05AX04;A16AX05
DB14487,Zinc acetate,,P07358,Complement component C8 beta chain,C8B,,C05AX04;A16AX05
DB14487,Zinc acetate,,P07360,Complement component C8 gamma chain,C8G,,C05AX04;A16AX05
DB14487,Zinc acetate,,P00751,Complement factor B,CFB,,C05AX04;A16AX05
DB14487,Zinc acetate,,P08603,Complement factor H,CFH,,C05AX04;A16AX05
DB14487,Zinc acetate,,P05156,Complement factor I,CFI,,C05AX04;A16AX05
DB14487,Zinc acetate,,P10909,Clusterin,CLU,,C05AX04;A16AX05
DB14487,Zinc acetate,,P00450,Ceruloplasmin,CP,,C05AX04;A16AX05
DB14487,Zinc acetate,,P15169,Carboxypeptidase N catalytic chain,CPN1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P22792,Carboxypeptidase N subunit 2,CPN2,,C05AX04;A16AX05
DB14487,Zinc acetate,,P81605,Dermcidin,DCD,,C05AX04;A16AX05
DB14487,Zinc acetate,,P15924,Desmoplakin,DSP,,C05AX04;A16AX05
DB14487,Zinc acetate,,P00748,Coagulation factor XII,F12,,C05AX04;A16AX05
DB14487,Zinc acetate,,P05160,Coagulation factor XIII B chain,F13B,,C05AX04;A16AX05
DB14487,Zinc acetate,,P00734,Prothrombin,F2,,C05AX04;A16AX05
DB14487,Zinc acetate,,O75636,Ficolin-3,FCN3,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02671,Fibrinogen alpha chain,FGA,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02751,Fibronectin,FN1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P06396,Gelsolin,GSN,,C05AX04;A16AX05
DB14487,Zinc acetate,,P69905,Hemoglobin subunit alpha,HBA1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P68871,Hemoglobin subunit beta,HBB,,C05AX04;A16AX05
DB14487,Zinc acetate,,P00739,Haptoglobin-related protein,HPR,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q86YZ3,Hornerin,HRNR,,C05AX04;A16AX05
DB14487,Zinc acetate,,P35858,Insulin-like growth factor-binding protein complex acid labile subunit,IGFALS,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01876,Ig alpha-1 chain C region,IGHA1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01871,Ig mu chain C region,IGHM,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01599,Immunoglobulin kappa variable 1-17,IGKV1-17,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01619,Ig kappa chain V-III region GOL,,,C05AX04;A16AX05
DB14487,Zinc acetate,,P80748,Immunoglobulin lambda variable 3-21,IGLV3-21,,C05AX04;A16AX05
DB14487,Zinc acetate,,P19827,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P19823,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q06033,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q14624,Inter-alpha-trypsin inhibitor heavy chain H4,ITIH4,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01591,Immunoglobulin J chain,JCHAIN,,C05AX04;A16AX05
DB14487,Zinc acetate,,P14923,Junction plakoglobin,JUP,,C05AX04;A16AX05
DB14487,Zinc acetate,,P03952,Plasma kallikrein,KLKB1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01042,Kininogen-1,KNG1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P04264,"Keratin, type II cytoskeletal 1",KRT1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P13645,"Keratin, type I cytoskeletal 10",KRT10,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02533,"Keratin, type I cytoskeletal 14",KRT14,,C05AX04;A16AX05
DB14487,Zinc acetate,,P08779,"Keratin, type I cytoskeletal 16",KRT16,,C05AX04;A16AX05
DB14487,Zinc acetate,,P35908,"Keratin, type II cytoskeletal 2 epidermal",KRT2,,C05AX04;A16AX05
DB14487,Zinc acetate,,P13647,"Keratin, type II cytoskeletal 5",KRT5,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02538,"Keratin, type II cytoskeletal 6A",KRT6A,,C05AX04;A16AX05
DB14487,Zinc acetate,,P35527,"Keratin, type I cytoskeletal 9",KRT9,,C05AX04;A16AX05
DB14487,Zinc acetate,,P19652,Alpha-1-acid glycoprotein 2,ORM2,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q96PD5,N-acetylmuramoyl-L-alanine amidase,PGLYRP2,,C05AX04;A16AX05
DB14487,Zinc acetate,,P27169,Serum paraoxonase/arylesterase 1,PON1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P20742,Pregnancy zone protein,PZP,,C05AX04;A16AX05
DB14487,Zinc acetate,,P31151,Protein S100-A7,S100A7,,C05AX04;A16AX05
DB14487,Zinc acetate,,P49908,Selenoprotein P,SEPP1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01009,Alpha-1-antitrypsin,SERPINA1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P01011,Alpha-1-antichymotrypsin,SERPINA3,,C05AX04;A16AX05
DB14487,Zinc acetate,,P29622,Kallistatin,SERPINA4,,C05AX04;A16AX05
DB14487,Zinc acetate,,P08185,Corticosteroid-binding globulin,SERPINA6,,C05AX04;A16AX05
DB14487,Zinc acetate,,P05546,Heparin cofactor 2,SERPIND1,,C05AX04;A16AX05
DB14487,Zinc acetate,,P04278,Sex hormone-binding globulin,SHBG,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02787,Serotransferrin,TF,,C05AX04;A16AX05
DB14487,Zinc acetate,,P02766,Transthyretin,TTR,,C05AX04;A16AX05
DB14487,Zinc acetate,,P04004,Vitronectin,VTN,,C05AX04;A16AX05
DB14487,Zinc acetate,,P51693,Amyloid-like protein 1,APLP1,,C05AX04;A16AX05
DB14487,Zinc acetate,,Q06481,Amyloid-like protein 2,APLP2,,C05AX04;A16AX05
DB14487,Zinc acetate,,P05067,Amyloid beta A4 protein,APP,,C05AX04;A16AX05
DB14487,Zinc acetate,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,,C05AX04;A16AX05
DB14488,Ferrous gluconate,,P02786,Transferrin receptor protein 1,TFRC,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,Q9GZT9,Egl nine homolog 1,EGLN1,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,Q9BY41,Histone deacetylase 8,HDAC8,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,Q9NZD4,Alpha-hemoglobin-stabilizing protein,AHSP,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,P69905,Hemoglobin subunit alpha,HBA1,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,Q16595,"Frataxin, mitochondrial",FXN,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,P02794,Ferritin heavy chain,FTH1,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,P39748,Flap endonuclease 1,FEN1,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,Q96FI4,Endonuclease 8-like 1,NEIL1,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,Q969S2,Endonuclease 8-like 2,NEIL2,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,P06746,DNA polymerase beta,POLB,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,P00450,Ceruloplasmin,CP,,B03AD05;B03AA03
DB14488,Ferrous gluconate,,P02787,Serotransferrin,TF,,B03AD05;B03AA03
DB14489,Ferrous succinate,,P02786,Transferrin receptor protein 1,TFRC,,B03AA06
DB14489,Ferrous succinate,,Q9GZT9,Egl nine homolog 1,EGLN1,,B03AA06
DB14489,Ferrous succinate,,Q9BY41,Histone deacetylase 8,HDAC8,,B03AA06
DB14489,Ferrous succinate,,Q9NZD4,Alpha-hemoglobin-stabilizing protein,AHSP,,B03AA06
DB14489,Ferrous succinate,,P69905,Hemoglobin subunit alpha,HBA1,,B03AA06
DB14489,Ferrous succinate,,Q16595,"Frataxin, mitochondrial",FXN,,B03AA06
DB14489,Ferrous succinate,,P02794,Ferritin heavy chain,FTH1,,B03AA06
DB14489,Ferrous succinate,,P39748,Flap endonuclease 1,FEN1,,B03AA06
DB14489,Ferrous succinate,,Q96FI4,Endonuclease 8-like 1,NEIL1,,B03AA06
DB14489,Ferrous succinate,,Q969S2,Endonuclease 8-like 2,NEIL2,,B03AA06
DB14489,Ferrous succinate,,P06746,DNA polymerase beta,POLB,,B03AA06
DB14489,Ferrous succinate,,P00450,Ceruloplasmin,CP,,B03AA06
DB14489,Ferrous succinate,,P02787,Serotransferrin,TF,,B03AA06
DB14490,Ferrous ascorbate,,P02786,Transferrin receptor protein 1,TFRC,,B03AA10
DB14490,Ferrous ascorbate,,Q9GZT9,Egl nine homolog 1,EGLN1,,B03AA10
DB14490,Ferrous ascorbate,,Q9BY41,Histone deacetylase 8,HDAC8,,B03AA10
DB14490,Ferrous ascorbate,,Q9NZD4,Alpha-hemoglobin-stabilizing protein,AHSP,,B03AA10
DB14490,Ferrous ascorbate,,P69905,Hemoglobin subunit alpha,HBA1,,B03AA10
DB14490,Ferrous ascorbate,,Q16595,"Frataxin, mitochondrial",FXN,,B03AA10
DB14490,Ferrous ascorbate,,P02794,Ferritin heavy chain,FTH1,,B03AA10
DB14490,Ferrous ascorbate,,P39748,Flap endonuclease 1,FEN1,,B03AA10
DB14490,Ferrous ascorbate,,Q96FI4,Endonuclease 8-like 1,NEIL1,,B03AA10
DB14490,Ferrous ascorbate,,Q969S2,Endonuclease 8-like 2,NEIL2,,B03AA10
DB14490,Ferrous ascorbate,,P06746,DNA polymerase beta,POLB,,B03AA10
DB14490,Ferrous ascorbate,,P00450,Ceruloplasmin,CP,,B03AA10
DB14490,Ferrous ascorbate,,P02787,Serotransferrin,TF,,B03AA10
DB14491,Ferrous fumarate,,P02786,Transferrin receptor protein 1,TFRC,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,Q9GZT9,Egl nine homolog 1,EGLN1,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,Q9BY41,Histone deacetylase 8,HDAC8,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,Q9NZD4,Alpha-hemoglobin-stabilizing protein,AHSP,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,P69905,Hemoglobin subunit alpha,HBA1,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,Q16595,"Frataxin, mitochondrial",FXN,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,P02794,Ferritin heavy chain,FTH1,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,P39748,Flap endonuclease 1,FEN1,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,Q96FI4,Endonuclease 8-like 1,NEIL1,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,Q969S2,Endonuclease 8-like 2,NEIL2,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,P06746,DNA polymerase beta,POLB,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,P00450,Ceruloplasmin,CP,,B03AA02;B03AD02
DB14491,Ferrous fumarate,,P02787,Serotransferrin,TF,,B03AA02;B03AD02
DB14498,Potassium acetate,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,,B05XA17
DB14499,Potassium sulfate,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,,
DB14500,Potassium,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,regulator,C03AB03;C03BB07;C03BB02;C03BB04;C03AB01;C03BB05;C03AB04;C03AB08;C03AB07;C03BB03;C03AB05;C03CB01;C03AB09;C03AB02;C03CB02;C03AB06
DB14501,Ferrous glycine sulfate,,P02786,Transferrin receptor protein 1,TFRC,,B03AA01
DB14501,Ferrous glycine sulfate,,Q9GZT9,Egl nine homolog 1,EGLN1,,B03AA01
DB14501,Ferrous glycine sulfate,,Q9BY41,Histone deacetylase 8,HDAC8,,B03AA01
DB14501,Ferrous glycine sulfate,,Q9NZD4,Alpha-hemoglobin-stabilizing protein,AHSP,,B03AA01
DB14501,Ferrous glycine sulfate,,P69905,Hemoglobin subunit alpha,HBA1,,B03AA01
DB14501,Ferrous glycine sulfate,,Q16595,"Frataxin, mitochondrial",FXN,,B03AA01
DB14501,Ferrous glycine sulfate,,P02794,Ferritin heavy chain,FTH1,,B03AA01
DB14501,Ferrous glycine sulfate,,P39748,Flap endonuclease 1,FEN1,,B03AA01
DB14501,Ferrous glycine sulfate,,Q96FI4,Endonuclease 8-like 1,NEIL1,,B03AA01
DB14501,Ferrous glycine sulfate,,Q969S2,Endonuclease 8-like 2,NEIL2,,B03AA01
DB14501,Ferrous glycine sulfate,,P06746,DNA polymerase beta,POLB,,B03AA01
DB14501,Ferrous glycine sulfate,,P00450,Ceruloplasmin,CP,,B03AA01
DB14501,Ferrous glycine sulfate,,P02787,Serotransferrin,TF,,B03AA01
DB14507,Lithium citrate,,O14732,Inositol monophosphatase 2,IMPA2,,
DB14507,Lithium citrate,,P29218,Inositol monophosphatase 1,IMPA1,,
DB14507,Lithium citrate,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB14507,Lithium citrate,,P42263,Glutamate receptor 3,GRIA3,,
DB14508,Lithium succinate,,O14732,Inositol monophosphatase 2,IMPA2,,D11AX04
DB14508,Lithium succinate,,P29218,Inositol monophosphatase 1,IMPA1,,D11AX04
DB14508,Lithium succinate,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,D11AX04
DB14508,Lithium succinate,,P42263,Glutamate receptor 3,GRIA3,,D11AX04
DB14509,Lithium carbonate,,O14732,Inositol monophosphatase 2,IMPA2,,
DB14509,Lithium carbonate,,P29218,Inositol monophosphatase 1,IMPA1,,
DB14509,Lithium carbonate,,P49841,Glycogen synthase kinase-3 beta,GSK3B,,
DB14509,Lithium carbonate,,P42263,Glutamate receptor 3,GRIA3,,
DB14512,Mometasone furoate,,P04150,Glucocorticoid receptor,NR3C1,,D07AC13;R03BA07;D07XC03;R01AD09;R03AK09
DB14512,Mometasone furoate,,P06401,Progesterone receptor,PGR,,D07AC13;R03BA07;D07XC03;R01AD09;R03AK09
DB14514,Magnesium levulinate,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,,A12CC07
DB14515,Magnesium lactate,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,,A12CC06
DB14517,Aluminium phosphate,,P02787,Serotransferrin,TF,,A02AB03
DB14517,Aluminium phosphate,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,,A02AB03
DB14517,Aluminium phosphate,,P06870,Kallikrein-1,KLK1,,A02AB03
DB14517,Aluminium phosphate,,P05067,Amyloid beta A4 protein,APP,,A02AB03
DB14518,Aluminum acetate,,P02787,Serotransferrin,TF,,
DB14518,Aluminum acetate,,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,,
DB14518,Aluminum acetate,,P06870,Kallikrein-1,KLK1,,
DB14518,Aluminum acetate,,P05067,Amyloid beta A4 protein,APP,,
DB14520,Tetraferric tricitrate decahydrate,,P02786,Transferrin receptor protein 1,TFRC,ligand,V03AE08
DB14520,Tetraferric tricitrate decahydrate,,P07822,Iron(3+)-hydroxamate-binding protein FhuD,fhuD,binder,V03AE08
DB14526,Chromic citrate,,P00167,Cytochrome b5,CYB5A,,
DB14527,Chromic nitrate,,P00167,Cytochrome b5,CYB5A,,
DB14528,Chromium gluconate,,P00167,Cytochrome b5,CYB5A,,
DB14529,Chromium nicotinate,,P00167,Cytochrome b5,CYB5A,,
DB14530,Chromous sulfate,,P00167,Cytochrome b5,CYB5A,,
DB14533,Zinc chloride,,P46663,B1 bradykinin receptor,BDKRB1,agonist,C05AX04;B05XA12
DB14533,Zinc chloride,,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,stabilization,C05AX04;B05XA12
DB14533,Zinc chloride,,P04075,Fructose-bisphosphate aldolase A,ALDOA,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P68104,Elongation factor 1-alpha 1,EEF1A1,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P06733,Alpha-enolase,ENO1,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P15531,Nucleoside diphosphate kinase A,NME1,inhibitor,C05AX04;B05XA12
DB14533,Zinc chloride,,P07237,Protein disulfide-isomerase,P4HB,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P30101,Protein disulfide-isomerase A3,PDIA3,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,Q06830,Peroxiredoxin-1,PRDX1,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P78330,Phosphoserine phosphatase,PSPH,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P60174,Triosephosphate isomerase,TPI1,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P49411,"Elongation factor Tu, mitochondrial",TUFM,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P03372,Estrogen receptor alpha,ESR1,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P08700,Interleukin-3,IL3,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P02795,Metallothionein-2,MT2A,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,O14618,Copper chaperone for superoxide dismutase,CCS,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,Q13547,Histone deacetylase 1,HDAC1,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P56524,Histone deacetylase 4,HDAC4,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P29372,DNA-3-methyladenine glycosylase,MPG,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P04279,Semenogelin-1,SEMG1,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P00441,Superoxide dismutase [Cu-Zn],SOD1,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,Q9BY41,Histone deacetylase 8,HDAC8,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,O15304,Apoptosis regulatory protein Siva,SIVA1,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P23415,Glycine receptor subunit alpha-1,GLRA1,inhibitor,C05AX04;B05XA12
DB14533,Zinc chloride,,Q00987,E3 ubiquitin-protein ligase Mdm2,MDM2,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P01308,Insulin,INS,stabilization,C05AX04;B05XA12
DB14533,Zinc chloride,,P46939,Utrophin,UTRN,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P45381,Aspartoacylase,ASPA,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P05109,Protein S100-A8,S100A8,regulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P06702,Protein S100-A9,S100A9,regulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P14780,Matrix metalloproteinase-9,MMP9,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,O15350,Tumor protein p73,TP73,chaperone,C05AX04;B05XA12
DB14533,Zinc chloride,,P29034,Protein S100-A2,S100A2,inactivator,C05AX04;B05XA12
DB14533,Zinc chloride,,P29034,Protein S100-A2,S100A2,regulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P04637,Cellular tumor antigen p53,TP53,chaperone,C05AX04;B05XA12
DB14533,Zinc chloride,,P25713,Metallothionein-3,MT3,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P04731,Metallothionein-1A,MT1A,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P01023,Alpha-2-macroglobulin,A2M,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P02765,Alpha-2-HS-glycoprotein,AHSG,chelator,C05AX04;B05XA12
DB14533,Zinc chloride,,P02647,Apolipoprotein A-I,APOA1,inducer,C05AX04;B05XA12
DB14533,Zinc chloride,,P02647,Apolipoprotein A-I,APOA1,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,Q0VD83,Apolipoprotein B receptor,APOBR,inducer,C05AX04;B05XA12
DB14533,Zinc chloride,,P02649,Apolipoprotein E,APOE,antagonist,C05AX04;B05XA12
DB14533,Zinc chloride,,O14791,Apolipoprotein L1,APOL1,inhibitor,C05AX04;B05XA12
DB14533,Zinc chloride,,P02746,Complement C1q subcomponent subunit B,C1QB,modulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P02747,Complement C1q subcomponent subunit C,C1QC,modulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P00736,Complement C1r subcomponent,C1R,modulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P09871,Complement C1s subcomponent,C1S,modulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P01024,Complement C3,C3,inhibitor,C05AX04;B05XA12
DB14533,Zinc chloride,,P01024,Complement C3,C3,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P0C0L5,Complement C4-B,C4B,modulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P04003,C4b-binding protein alpha chain,C4BPA,modulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P20851,C4b-binding protein beta chain,C4BPB,modulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P01031,Complement C5,C5,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P46736,Lys-63-specific deubiquitinase BRCC36,BRCC3,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P08603,Complement factor H,CFH,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P10909,Clusterin,CLU,inducer,C05AX04;B05XA12
DB14533,Zinc chloride,,P00450,Ceruloplasmin,CP,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P15169,Carboxypeptidase N catalytic chain,CPN1,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P22792,Carboxypeptidase N subunit 2,CPN2,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P81605,Dermcidin,DCD,stabilization,C05AX04;B05XA12
DB14533,Zinc chloride,,P02671,Fibrinogen alpha chain,FGA,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P02751,Fibronectin,FN1,modulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P02751,Fibronectin,FN1,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P69905,Hemoglobin subunit alpha,HBA1,inducer,C05AX04;B05XA12
DB14533,Zinc chloride,,P68871,Hemoglobin subunit beta,HBB,inducer,C05AX04;B05XA12
DB14533,Zinc chloride,,P00738,Haptoglobin,HP,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P35858,Insulin-like growth factor-binding protein complex acid labile subunit,IGFALS,inducer,C05AX04;B05XA12
DB14533,Zinc chloride,,P19827,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P19823,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,Q06033,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,Q14624,Inter-alpha-trypsin inhibitor heavy chain H4,ITIH4,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P01591,Immunoglobulin J chain,JCHAIN,component of,C05AX04;B05XA12
DB14533,Zinc chloride,,P03952,Plasma kallikrein,KLKB1,inhibitor,C05AX04;B05XA12
DB14533,Zinc chloride,,P01042,Kininogen-1,KNG1,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P35527,"Keratin, type I cytoskeletal 9",KRT9,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P19652,Alpha-1-acid glycoprotein 2,ORM2,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,Q96PD5,N-acetylmuramoyl-L-alanine amidase,PGLYRP2,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P27169,Serum paraoxonase/arylesterase 1,PON1,inducer,C05AX04;B05XA12
DB14533,Zinc chloride,,P20742,Pregnancy zone protein,PZP,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P31151,Protein S100-A7,S100A7,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P49908,Selenoprotein P,SEPP1,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P01009,Alpha-1-antitrypsin,SERPINA1,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P01011,Alpha-1-antichymotrypsin,SERPINA3,binder,C05AX04;B05XA12
DB14533,Zinc chloride,,P08185,Corticosteroid-binding globulin,SERPINA6,modulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P05546,Heparin cofactor 2,SERPIND1,agonist,C05AX04;B05XA12
DB14533,Zinc chloride,,P04278,Sex hormone-binding globulin,SHBG,modulator,C05AX04;B05XA12
DB14533,Zinc chloride,,P02787,Serotransferrin,TF,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P02766,Transthyretin,TTR,inducer,C05AX04;B05XA12
DB14533,Zinc chloride,,P04004,Vitronectin,VTN,inducer,C05AX04;B05XA12
DB14533,Zinc chloride,,P51693,Amyloid-like protein 1,APLP1,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,Q06481,Amyloid-like protein 2,APLP2,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P05067,Amyloid beta A4 protein,APP,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P09874,Poly [ADP-ribose] polymerase 1,PARP1,component of,C05AX04;B05XA12
DB14533,Zinc chloride,,P04114,Apolipoprotein B-100,APOB,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P02790,Hemopexin,HPX,ligand,C05AX04;B05XA12
DB14533,Zinc chloride,,P04196,Histidine-rich glycoprotein,HRG,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P03951,Coagulation factor XI,F11,activator,C05AX04;B05XA12
DB14533,Zinc chloride,,P41238,C->U-editing enzyme APOBEC-1,APOBEC1,cofactor,C05AX04;B05XA12
DB14533,Zinc chloride,,P41238,C->U-editing enzyme APOBEC-1,APOBEC1,chelator,C05AX04;B05XA12
DB14533,Zinc chloride,,Q02383,Semenogelin-2,SEMG2,cofactor,C05AX04;B05XA12
DB14538,Hydrocortisone aceponate,,P04083,Annexin A1,ANXA1,,D07AC16
DB14538,Hydrocortisone aceponate,,P04150,Glucocorticoid receptor,NR3C1,,D07AC16
DB14538,Hydrocortisone aceponate,,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,,D07AC16
DB14538,Hydrocortisone aceponate,,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,,D07AC16
DB14539,Hydrocortisone acetate,,P04083,Annexin A1,ANXA1,,
DB14539,Hydrocortisone acetate,,P04150,Glucocorticoid receptor,NR3C1,,
DB14539,Hydrocortisone acetate,,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,,
DB14539,Hydrocortisone acetate,,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,,
DB14540,Hydrocortisone butyrate,,P04083,Annexin A1,ANXA1,,D07AB02;D07BB04
DB14540,Hydrocortisone butyrate,,P04150,Glucocorticoid receptor,NR3C1,,D07AB02;D07BB04
DB14540,Hydrocortisone butyrate,,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,,D07AB02;D07BB04
DB14540,Hydrocortisone butyrate,,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,,D07AB02;D07BB04
DB14541,Hydrocortisone cypionate,,P04083,Annexin A1,ANXA1,,
DB14541,Hydrocortisone cypionate,,P04150,Glucocorticoid receptor,NR3C1,,
DB14541,Hydrocortisone cypionate,,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,,
DB14541,Hydrocortisone cypionate,,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,,
DB14542,Hydrocortisone phosphate,,P04083,Annexin A1,ANXA1,,
DB14542,Hydrocortisone phosphate,,P04150,Glucocorticoid receptor,NR3C1,,
DB14542,Hydrocortisone phosphate,,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,,
DB14542,Hydrocortisone phosphate,,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,,
DB14543,Hydrocortisone probutate,,P04083,Annexin A1,ANXA1,,D07AB11
DB14543,Hydrocortisone probutate,,P04150,Glucocorticoid receptor,NR3C1,,D07AB11
DB14543,Hydrocortisone probutate,,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,,D07AB11
DB14543,Hydrocortisone probutate,,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,,D07AB11
DB14544,Hydrocortisone valerate,,P04083,Annexin A1,ANXA1,,
DB14544,Hydrocortisone valerate,,P04150,Glucocorticoid receptor,NR3C1,,
DB14544,Hydrocortisone valerate,,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,,
DB14544,Hydrocortisone valerate,,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,,
DB14548,"Zinc sulfate, unspecified form",,P46663,B1 bradykinin receptor,BDKRB1,agonist,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,stabilization,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P04075,Fructose-bisphosphate aldolase A,ALDOA,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P68104,Elongation factor 1-alpha 1,EEF1A1,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P06733,Alpha-enolase,ENO1,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P15531,Nucleoside diphosphate kinase A,NME1,inhibitor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P07237,Protein disulfide-isomerase,P4HB,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P30101,Protein disulfide-isomerase A3,PDIA3,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,Q06830,Peroxiredoxin-1,PRDX1,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P78330,Phosphoserine phosphatase,PSPH,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P60174,Triosephosphate isomerase,TPI1,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P49411,"Elongation factor Tu, mitochondrial",TUFM,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P03372,Estrogen receptor alpha,ESR1,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P08700,Interleukin-3,IL3,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02795,Metallothionein-2,MT2A,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,O14618,Copper chaperone for superoxide dismutase,CCS,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,Q13547,Histone deacetylase 1,HDAC1,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P56524,Histone deacetylase 4,HDAC4,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P29372,DNA-3-methyladenine glycosylase,MPG,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P04279,Semenogelin-1,SEMG1,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P00441,Superoxide dismutase [Cu-Zn],SOD1,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,Q9BY41,Histone deacetylase 8,HDAC8,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,O15304,Apoptosis regulatory protein Siva,SIVA1,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P23415,Glycine receptor subunit alpha-1,GLRA1,inhibitor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,Q00987,E3 ubiquitin-protein ligase Mdm2,MDM2,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P01308,Insulin,INS,stabilization,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P46939,Utrophin,UTRN,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P45381,Aspartoacylase,ASPA,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P05109,Protein S100-A8,S100A8,regulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P06702,Protein S100-A9,S100A9,regulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P14780,Matrix metalloproteinase-9,MMP9,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,O15350,Tumor protein p73,TP73,chaperone,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P29034,Protein S100-A2,S100A2,inactivator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P29034,Protein S100-A2,S100A2,regulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P04637,Cellular tumor antigen p53,TP53,chaperone,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P25713,Metallothionein-3,MT3,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P04731,Metallothionein-1A,MT1A,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P01023,Alpha-2-macroglobulin,A2M,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02765,Alpha-2-HS-glycoprotein,AHSG,chelator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02647,Apolipoprotein A-I,APOA1,inducer,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02647,Apolipoprotein A-I,APOA1,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,Q0VD83,Apolipoprotein B receptor,APOBR,inducer,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02649,Apolipoprotein E,APOE,antagonist,C05AX04
DB14548,"Zinc sulfate, unspecified form",,O14791,Apolipoprotein L1,APOL1,inhibitor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02746,Complement C1q subcomponent subunit B,C1QB,modulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02747,Complement C1q subcomponent subunit C,C1QC,modulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P00736,Complement C1r subcomponent,C1R,modulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P09871,Complement C1s subcomponent,C1S,modulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P01024,Complement C3,C3,inhibitor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P01024,Complement C3,C3,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P0C0L5,Complement C4-B,C4B,modulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P04003,C4b-binding protein alpha chain,C4BPA,modulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P20851,C4b-binding protein beta chain,C4BPB,modulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P01031,Complement C5,C5,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P46736,Lys-63-specific deubiquitinase BRCC36,BRCC3,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P08603,Complement factor H,CFH,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P10909,Clusterin,CLU,inducer,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P00450,Ceruloplasmin,CP,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P15169,Carboxypeptidase N catalytic chain,CPN1,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P22792,Carboxypeptidase N subunit 2,CPN2,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P81605,Dermcidin,DCD,stabilization,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02671,Fibrinogen alpha chain,FGA,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02751,Fibronectin,FN1,modulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02751,Fibronectin,FN1,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P69905,Hemoglobin subunit alpha,HBA1,inducer,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P68871,Hemoglobin subunit beta,HBB,inducer,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P00738,Haptoglobin,HP,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P35858,Insulin-like growth factor-binding protein complex acid labile subunit,IGFALS,inducer,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P19827,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P19823,Inter-alpha-trypsin inhibitor heavy chain H2,ITIH2,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,Q06033,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,Q14624,Inter-alpha-trypsin inhibitor heavy chain H4,ITIH4,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P01591,Immunoglobulin J chain,JCHAIN,component of,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P03952,Plasma kallikrein,KLKB1,inhibitor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P01042,Kininogen-1,KNG1,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P35527,"Keratin, type I cytoskeletal 9",KRT9,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P19652,Alpha-1-acid glycoprotein 2,ORM2,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,Q96PD5,N-acetylmuramoyl-L-alanine amidase,PGLYRP2,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P27169,Serum paraoxonase/arylesterase 1,PON1,inducer,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P20742,Pregnancy zone protein,PZP,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P31151,Protein S100-A7,S100A7,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P49908,Selenoprotein P,SEPP1,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P01009,Alpha-1-antitrypsin,SERPINA1,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P01011,Alpha-1-antichymotrypsin,SERPINA3,binder,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P08185,Corticosteroid-binding globulin,SERPINA6,modulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P05546,Heparin cofactor 2,SERPIND1,agonist,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P04278,Sex hormone-binding globulin,SHBG,modulator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02787,Serotransferrin,TF,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02766,Transthyretin,TTR,inducer,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P04004,Vitronectin,VTN,inducer,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P51693,Amyloid-like protein 1,APLP1,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,Q06481,Amyloid-like protein 2,APLP2,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P05067,Amyloid beta A4 protein,APP,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P09874,Poly [ADP-ribose] polymerase 1,PARP1,component of,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P04114,Apolipoprotein B-100,APOB,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P02790,Hemopexin,HPX,ligand,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P04196,Histidine-rich glycoprotein,HRG,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P03951,Coagulation factor XI,F11,activator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P41238,C->U-editing enzyme APOBEC-1,APOBEC1,cofactor,C05AX04
DB14548,"Zinc sulfate, unspecified form",,P41238,C->U-editing enzyme APOBEC-1,APOBEC1,chelator,C05AX04
DB14548,"Zinc sulfate, unspecified form",,Q02383,Semenogelin-2,SEMG2,cofactor,C05AX04
DB14562,Andexanet alfa,,P10646,Tissue factor pathway inhibitor,TFPI,inhibitor,V03AB38
DB14568,Ivosidenib,,O75874,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,inhibitor,L01XX62
DB14569,Tedizolid,,,23S ribosomal RNA,,inhibitor,J01XX11
DB14575,Eslicarbazepine,,Q99571,P2X purinoceptor 4,P2RX4,,N03AF04
DB14580,Lecanemab,,P05067,Amyloid beta A4 protein,APP,binder,
DB14581,CPI-1205,,Q15910,Histone-lysine N-methyltransferase EZH2,EZH2,inhibitor,
DB14582,Patisiran,,,Transthyretin mRNA,,antisense oligonucleotide,N07XX12
DB14583,Segesterone acetate,,P06401,Progesterone receptor,PGR,agonist,
DB14583,Segesterone acetate,,P06401,Progesterone receptor,PGR,activator,
DB14583,Segesterone acetate,,P10275,Androgen receptor,AR,agonist,
DB14583,Segesterone acetate,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB14597,Lanadelumab,,P03952,Plasma kallikrein,KLKB1,inhibitor,B06AC05
DB14597,Lanadelumab,,P03952,Plasma kallikrein,KLKB1,regulator,B06AC05
DB14598,Edetate calcium disodium anhydrous,,,Lead,,chelator,
DB14598,Edetate calcium disodium anhydrous,,,Iron,,chelator,
DB14598,Edetate calcium disodium anhydrous,,,Manganese cation,,chelator,
DB14600,Edetate disodium anhydrous,,,Lead,,chelator,
DB14600,Edetate disodium anhydrous,,,Iron,,chelator,
DB14600,Edetate disodium anhydrous,,,Manganese cation,,chelator,
DB14631,Prednisolone phosphate,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB14631,Prednisolone phosphate,,P04083,Annexin A1,ANXA1,ligand,
DB14635,Curcumin sulfate,,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,,
DB14635,Curcumin sulfate,,P11473,Vitamin D3 receptor,VDR,,
DB14635,Curcumin sulfate,,O15440,Multidrug resistance-associated protein 5,ABCC5,,
DB14635,Curcumin sulfate,,P16152,Carbonyl reductase [NADPH] 1,CBR1,,
DB14635,Curcumin sulfate,,P09211,Glutathione S-transferase P,GSTP1,,
DB14639,Boldenone undecylenate,,P10275,Androgen receptor,AR,,
DB14641,Estriol tripropionate,,P03372,Estrogen receptor alpha,ESR1,,
DB14641,Estriol tripropionate,,Q92731,Estrogen receptor beta,ESR2,,
DB14641,Estriol tripropionate,,P04278,Sex hormone-binding globulin,SHBG,,
DB14642,Lypressin,,P37288,Vasopressin V1a receptor,AVPR1A,,H01BA03
DB14642,Lypressin,,P30518,Vasopressin V2 receptor,AVPR2,,H01BA03
DB14642,Lypressin,,P47901,Vasopressin V1b receptor,AVPR1B,,H01BA03
DB14649,Dexamethasone acetate,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB14649,Dexamethasone acetate,,P04083,Annexin A1,ANXA1,agonist,
DB14649,Dexamethasone acetate,,P35228,"Nitric oxide synthase, inducible",NOS2,negative modulator,
DB14649,Dexamethasone acetate,,P51843,Nuclear receptor subfamily 0 group B member 1,NR0B1,stimulator,
DB14649,Dexamethasone acetate,,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,agonist,
DB14669,Betamethasone phosphate,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB14669,Betamethasone phosphate,,P04083,Annexin A1,ANXA1,agonist,
DB14672,Oxazepam acetate,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,
DB14672,Oxazepam acetate,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,
DB14700,Damoctocog alfa pegol,,P00451,Coagulation factor VIII,F8,binder,
DB14707,Cemiplimab,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,L01FF06
DB14707,Cemiplimab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,L01FF06
DB14712,Elapegademase,,,Adenosine,,metabolizer,L03AX21
DB14713,Inotersen,,,Transthyretin mRNA,,antisense oligonucleotide,N07XX15
DB14715,Cinazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,
DB14715,Cinazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,
DB14719,Bentazepam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA24
DB14719,Bentazepam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA24
DB14723,Larotrectinib,,P04629,High affinity nerve growth factor receptor,NTRK1,inhibitor,L01EX12
DB14723,Larotrectinib,,Q16620,BDNF/NT-3 growth factors receptor,NTRK2,inhibitor,L01EX12
DB14723,Larotrectinib,,Q16288,NT-3 growth factor receptor,NTRK3,inhibitor,L01EX12
DB14724,Emapalumab,,P01579,Interferon gamma,IFNG,neutralizer,L04AA39
DB14730,Calaspargase pegol,,,L-asparagine,,degradation,
DB14731,Tagraxofusp,,P26951,Interleukin-3 receptor subunit alpha,IL3RA,ligand,L01XX67
DB14738,Turoctocog alfa pegol,,P00740,Coagulation factor IX,F9,activator,
DB14738,Turoctocog alfa pegol,,P00742,Coagulation factor X,F10,activator,
DB14738,Turoctocog alfa pegol,,P00734,Prothrombin,F2,binder,
DB14738,Turoctocog alfa pegol,,P04275,von Willebrand factor,VWF,binder,
DB14740,Hyaluronidase,,,Hyaluronic acid,,modulator,B06AA03
DB14740,Hyaluronidase,,,Hyaluronic acid,,metabolizer,B06AA03
DB14740,Hyaluronidase,,P01137,Transforming growth factor beta-1,TGFB1,inhibitor,B06AA03
DB00781,Polymyxin B,,,Bacterial outer membrane,,incorporation into and destabilization,S02AA11;S03AA03;J01XB02;A07AA05;S01AA18
DB14751,Mecasermin rinfabate,,P08069,Insulin-like growth factor 1 receptor,IGF1R,agonist,H01AC05
DB14751,Mecasermin rinfabate,,P06213,Insulin receptor,INSR,,H01AC05
DB14751,Mecasermin rinfabate,,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,,H01AC05
DB14753,Hydroxystilbamidine,,,DNA,,other/unknown,
DB14754,Solriamfetol,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,,N06BA14
DB14754,Solriamfetol,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,,N06BA14
DB14761,Remdesivir,,P0DTD1,Replicase polyprotein 1ab,rep,inhibitor,J05AB16
DB14761,Remdesivir,,P0C6X7,Replicase polyprotein 1ab,rep,inhibitor,J05AB16
DB14761,Remdesivir,,K9N7C7,Replicase polyprotein 1ab,rep,inhibitor,J05AB16
DB14761,Remdesivir,,Q05318,RNA-directed RNA polymerase L,L,inhibitor,J05AB16
DB14762,Risankizumab,,P29460,Interleukin-23,IL12B,inhibitor,L04AC18
DB14766,Etrasimod,,P21453,Sphingosine 1-phosphate receptor 1,S1PR1,modulator,
DB14766,Etrasimod,,O95977,Sphingosine 1-phosphate receptor 4,S1PR4,modulator,
DB14766,Etrasimod,,Q9H228,Sphingosine 1-phosphate receptor 5,S1PR5,modulator,
DB14776,Camrelizumab,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,
DB14776,Camrelizumab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,
DB14776,Camrelizumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,
DB14776,Camrelizumab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,antibody,
DB14782,Tofersen,,,Superoxide dismutase 1 (SOD1),,antisense oligonucleotide,
DB14783,Diroximel fumarate,,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,agonist,L04AX09
DB14785,Fenebrutinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB14805,Piflufolastat F 18,,Q04609,Glutamate carboxypeptidase 2,FOLH1,binder,
DB14811,Isatuximab,,P28907,ADP-ribosyl cyclase 1,CD38,binder,L01FC02
DB14811,Isatuximab,,P28907,ADP-ribosyl cyclase 1,CD38,antibody,L01FC02
DB14840,Ripretinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,L01EX19
DB14840,Ripretinib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,L01EX19
DB14840,Ripretinib,,Q02763,Angiopoietin-1 receptor,TEK,inhibitor,L01EX19
DB14840,Ripretinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EX19
DB14840,Ripretinib,,P15056,Serine/threonine-protein kinase B-raf,BRAF,inhibitor,L01EX19
DB14840,Ripretinib,,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,inhibitor,L01EX19
DB14845,Filgotinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,L04AA45
DB14851,Relatlimab,,P18627,Lymphocyte activation gene 3 protein,LAG3,antibody,L01XY03
DB14864,Brolucizumab,,P15692,Vascular endothelial growth factor A,VEGFA,inhibitor,S01LA06
DB14879,Cefiderocol,,Q51504,Penicillin-binding protein 3,pbpB,inhibitor,J01DI04
DB14879,Cefiderocol,,Q07806,Penicillin-binding protein 1A,mrcA,inhibitor,J01DI04
DB14879,Cefiderocol,,Q9X6W0,Penicillin-binding protein 1B,ponB,inhibitor,J01DI04
DB14879,Cefiderocol,,Q9X6V3,Penicillin-binding protein 2,pbpA,inhibitor,J01DI04
DB14879,Cefiderocol,,P24228,D-alanyl-D-alanine carboxypeptidase DacB,dacB,inhibitor,J01DI04
DB14881,Oliceridine,,P35372,Mu-type opioid receptor,OPRM1,agonist,N02AX07
DB14892,Spartalizumab,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,
DB14892,Spartalizumab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,
DB14895,Vibegron,,P13945,Beta-3 adrenergic receptor,ADRB3,agonist,
DB14901,Inclisiran,,Q8NBP7,Proprotein convertase subtilisin/kexin type 9,PCSK9,antisense oligonucleotide,C10AX16
DB14904,Pimasertib,,Q02750,Mitogen-activated protein kinase kinase (MAPKK),MAP2K1,inhibitor,
DB14910,Mirikizumab,,Q9NPF7,Interleukin-23 subunit alpha,IL23A,binder,
DB14910,Mirikizumab,,Q9NPF7,Interleukin-23 subunit alpha,IL23A,antibody,
DB14914,Flortaucipir F-18,,P10636,Microtubule-associated protein tau,MAPT,binder,V09AX07
DB14914,Flortaucipir F-18,,P21397,Amine oxidase [flavin-containing] A,MAOA,binder,V09AX07
DB14914,Flortaucipir F-18,,P27338,Amine oxidase [flavin-containing] B,MAOB,binder,V09AX07
DB14917,Ceralasertib,,Q13535,Serine/threonine-protein kinase ATR,ATR,inhibitor,
DB14919,Rozanolixizumab,,P55899,IgG receptor FcRn large subunit p51,FCGRT,antibody,
DB14921,Mavacamten,,P12883,Myosin-7,MYH7,inhibitory allosteric modulator,C01EB24
DB14922,Tislelizumab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,L01FF09
DB14924,Ritlecitinib,,P52333,Tyrosine-protein kinase JAK3,JAK3,inhibitor,
DB14924,Ritlecitinib,,P42680,Tyrosine-protein kinase Tec,TEC,inhibitor,
DB14924,Ritlecitinib,,Q08881,Tyrosine-protein kinase ITK/TSK,ITK,inhibitor,
DB14924,Ritlecitinib,,P42681,Tyrosine-protein kinase TXK,TXK,inhibitor,
DB14924,Ritlecitinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB14924,Ritlecitinib,,P51813,Cytoplasmic tyrosine-protein kinase BMX,BMX,inhibitor,
DB14939,Motixafortide,,P61073,C-X-C chemokine receptor type 4,CXCR4,inhibitor,
DB14960,Somatrogon,,P10912,Growth hormone receptor,GHR,binder,H01AC08
DB14962,Trastuzumab deruxtecan,,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,antibody,L01FD04
DB14962,Trastuzumab deruxtecan,,P11387,DNA topoisomerase 1,TOP1,inhibitor,L01FD04
DB14967,Margetuximab,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,antagonist,L01FD06
DB14973,Abrocitinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,D11AH08
DB14973,Abrocitinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,D11AH08
DB14973,Abrocitinib,,P52333,Tyrosine-protein kinase JAK3,JAK3,inhibitor,D11AH08
DB14973,Abrocitinib,,P29597,Non-receptor tyrosine-protein kinase TYK2,TYK2,inhibitor,D11AH08
DB14975,Voxelotor,,P69905,Hemoglobin subunit alpha,HBA1,binder,B06AX03
DB14984,Casimersen,,,DMD gene (exon 45 casimersen target site),,binder,M09AX13
DB14989,Umbralisib,,P49674,Casein kinase I isoform epsilon,CSNK1E,inhibitor,L01EX25
DB14989,Umbralisib,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,inhibitor,L01EX25
DB14989,Umbralisib,,P00519,Tyrosine-protein kinase ABL1,ABL1,inhibitor,L01EX25
DB14992,Pegunigalsidase alfa,,,Globotriaosylceramide,,metabolizer,A16AB20
DB14992,Pegunigalsidase alfa,,,Globotriaosylceramide,,ligand,A16AB20
DB14996,Sutimlimab,,P09871,Complement C1s subcomponent,C1S,inhibitor,L04AA55
DB14996,Sutimlimab,,P09871,Complement C1s subcomponent,C1S,antibody,L04AA55
DB14999,Human interferon beta,,P17181,Interferon alpha/beta receptor 1,IFNAR1,binder,
DB15001,Eflapegrastim,,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,ligand,
DB15005,Viltolarsen,,,DMD gene (exon 53 viltolarsen target site),,binder,M09AX12
DB15011,Avacopan,,P21730,C5a anaphylatoxin chemotactic receptor 1,C5AR1,antagonist,L04AA59
DB15031,Daridorexant,,O43613,Orexin receptor type 1,HCRTR1,antagonist,
DB15031,Daridorexant,,O43614,Orexin receptor type 2,HCRTR2,antagonist,
DB15035,Zanubrutinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,L01EL03
DB15035,Zanubrutinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,L01EL03
DB15035,Zanubrutinib,,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,inhibitor,L01EL03
DB15035,Zanubrutinib,,Q15303,Receptor tyrosine-protein kinase erbB-4,ERBB4,inhibitor,L01EL03
DB15035,Zanubrutinib,,Q08881,Tyrosine-protein kinase ITK/TSK,ITK,inhibitor,L01EL03
DB15035,Zanubrutinib,,P51813,Cytoplasmic tyrosine-protein kinase BMX,BMX,inhibitor,L01EL03
DB15035,Zanubrutinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,L01EL03
DB15035,Zanubrutinib,,P42680,Tyrosine-protein kinase Tec,TEC,inhibitor,L01EL03
DB15035,Zanubrutinib,,P51451,Tyrosine-protein kinase Blk,BLK,inhibitor,L01EL03
DB15035,Zanubrutinib,,P52333,Tyrosine-protein kinase JAK3,JAK3,inhibitor,L01EL03
DB15035,Zanubrutinib,,Q13882,Protein-tyrosine kinase 6,PTK6,inhibitor,L01EL03
DB15035,Zanubrutinib,,P09769,Tyrosine-protein kinase Fgr,FGR,inhibitor,L01EL03
DB15035,Zanubrutinib,,P42685,Tyrosine-protein kinase FRK,FRK,inhibitor,L01EL03
DB15035,Zanubrutinib,,P06239,Tyrosine-protein kinase Lck,LCK,inhibitor,L01EL03
DB15035,Zanubrutinib,,P42681,Tyrosine-protein kinase TXK,TXK,inhibitor,L01EL03
DB15043,Toripalimab,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,
DB15043,Toripalimab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,
DB15044,Tafasitamab,,P15391,B-lymphocyte antigen CD19,CD19,binder,L01FX12
DB15044,Tafasitamab,,P15391,B-lymphocyte antigen CD19,CD19,antibody,L01FX12
DB15066,Givosiran,,,ALAS1 mRNA,,cleavage,A16AX16
DB15067,Volanesorsen,,P02656,Apolipoprotein C-III,APOC3,inhibitor,C10AX18
DB15067,Volanesorsen,,P02656,Apolipoprotein C-III,APOC3,antisense oligonucleotide,C10AX18
DB15071,Omidenepag isopropyl,,P43116,Prostaglandin E2 receptor EP2 subtype,PTGER2,agonist,G01AE10
DB15071,Omidenepag isopropyl,,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,agonist,G01AE10
DB15090,Tezepelumab,,Q969D9,Thymic stromal lymphopoietin,TSLP,binder,R03DX11
DB15090,Tezepelumab,,Q969D9,Thymic stromal lymphopoietin,TSLP,antibody,R03DX11
DB15091,Upadacitinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,L04AA44
DB15093,Somapacitan,,P10912,Growth hormone receptor,GHR,agonist,H01AC07
DB15097,Gefapixant,,P56373,P2X purinoceptor 3,P2RX3,antagonist,R05DB29;G01AE10
DB15097,Gefapixant,,Q9UBL9,P2X purinoceptor 2,P2RX2,antagonist,R05DB29;G01AE10
DB15100,Cusatuzumab,,P32970,CD70 antigen,CD70,antibody,
DB15102,Pemigatinib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EN02
DB15102,Pemigatinib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,L01EN02
DB15102,Pemigatinib,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,L01EN02
DB15102,Pemigatinib,,P22455,Fibroblast growth factor receptor 4,FGFR4,inhibitor,L01EN02
DB15114,Vamorolone,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB15114,Vamorolone,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,
DB15119,Ropeginterferon alfa-2b,,P17181,Interferon alpha/beta receptor (IFNAR),IFNAR1,binder,L03AB15
DB15133,Tepotinib,,P08581,Hepatocyte growth factor receptor,MET,inhibitor,L01EX21
DB15133,Tepotinib,,Q9Y2I1,Nischarin,NISCH,inhibitor,L01EX21
DB15133,Tepotinib,,P49286,Melatonin receptor type 1B,MTNR1B,inhibitor,L01EX21
DB15149,Futibatinib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EN04
DB15149,Futibatinib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,L01EN04
DB15149,Futibatinib,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,L01EN04
DB15149,Futibatinib,,P22455,Fibroblast growth factor receptor 4,FGFR4,inhibitor,L01EN04
DB15163,Selatogrel,,Q9H244,P2Y purinoceptor 12,P2RY12,antagonist,
DB15164,Apadamtase alfa,,P04275,von Willebrand factor,VWF,cleavage,
DB15165,Avacincaptad pegol,,P01031,Complement C5,C5,inhibitor,
DB15170,Evobrutinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB15171,Tirzepatide,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,A10BX16
DB15171,Tirzepatide,,P09681,Gastric inhibitory polypeptide,GIP,agonist,A10BX16
DB15218,Pozelimab,,P01031,Complement C5,C5,antibody,
DB15226,Dasiglucagon,,P47871,Glucagon receptor,GCGR,agonist,H04AA02
DB15227,Tirabrutinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB15233,Avapritinib,,,Platelet derived growth factor receptor alpha,,inhibitor,L01EX18
DB15233,Avapritinib,,P10721,Mast/stem cell growth factor receptor Kit,KIT,inhibitor,L01EX18
DB15248,Bulevirtide,,Q14973,Sodium/bile acid cotransporter,SLC10A1,inhibitor,J05AX28
DB15250,Vercirnon,,P51686,C-C chemokine receptor type 9,CCR9,,
DB15258,Imlifidase,,P01857,IgG heavy chain,IGHG1,cleavage,L04AA41
DB15270,Efgartigimod alfa,,P55899,IgG receptor FcRn large subunit p51,FCGRT,binder,L04AA58
DB15271,Crizanlizumab,,P16109,P-selectin,SELP,inhibitor,B06AX01
DB15283,Tebentafusp,,P40967,Melanocyte protein PMEL,PMEL,binder,L01XX75
DB15303,Faricimab,,P15692,Vascular endothelial growth factor A,VEGFA,antagonist,S01LA09
DB15303,Faricimab,,O15123,Angiopoietin-2,ANGPT2,antagonist,S01LA09
DB15327,Abivertinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,
DB15327,Abivertinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB15328,Ubrogepant,,Q16602,Calcitonin gene-related peptide type 1 receptor,CALCRL,antagonist,N02CD04
DB15347,Branebrutinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB15354,Evinacumab,,Q9Y5C1,Angiopoietin-related protein 3,ANGPTL3,inhibitor,C10AX17
DB15354,Evinacumab,,Q9Y5C1,Angiopoietin-related protein 3,ANGPTL3,binder,C10AX17
DB15354,Evinacumab,,Q9Y5C1,Angiopoietin-related protein 3,ANGPTL3,antibody,C10AX17
DB15395,Elranatamab,,Q02223,Tumor necrosis factor receptor superfamily member 17,TNFRSF17,antibody,
DB15395,Elranatamab,,P04234,T-cell surface glycoprotein CD3,CD3D,antibody,
DB15399,BMS-754807,,P08069,Insulin-like growth factor 1 receptor,IGF1R,inhibitor,
DB15399,BMS-754807,,P06213,Insulin receptor,INSR,inhibitor,
DB15406,GLPG-0974,,O15552,Free fatty acid receptor 2,FFAR2,antagonist,
DB15413,Pafolacianine,,P15328,Folate receptor alpha,FOLR1,ligand,V04CX10
DB15434,Mosunetuzumab,,P11836,B-lymphocyte antigen CD20,MS4A1,binder,
DB15434,Mosunetuzumab,,P07766,T-cell surface glycoprotein CD3 epsilon chain,CD3E,binder,
DB15442,Trilaciclib,,P11802,Cyclin-dependent kinase 4,CDK4,inhibitor,V03AF12
DB15442,Trilaciclib,,Q00534,Cyclin-dependent kinase 6,CDK6,inhibitor,V03AF12
DB15442,Trilaciclib,,P50750,Cyclin-dependent kinase 9,CDK9,inhibitor,V03AF12
DB15442,Trilaciclib,,P24941,Cyclin-dependent kinase 2,CDK2,inhibitor,V03AF12
DB15442,Trilaciclib,,Q00535,Cyclin-dependent kinase 5,CDK5,inhibitor,V03AF12
DB15442,Trilaciclib,,P50613,Cyclin-dependent kinase 7,CDK7,inhibitor,V03AF12
DB15444,Elexacaftor,,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,positive allosteric modulator,R07AX32
DB15456,Vericiguat,,Q02153,Guanylate cyclase soluble subunit beta-1,GUCY1B1,stimulator,C01DX22
DB15463,Belzutifan,,Q99814,Endothelial PAS domain-containing protein 1,EPAS1,inhibitor,L01XX74
DB15466,Tallimustine,,,DNA,,binder,
DB15488,Echinacoside,,Q92847,Growth hormone secretagogue receptor type 1,GHSR,agonist,
DB15488,Echinacoside,,P10275,Androgen receptor,AR,agonist,
DB15489,Mexazolam,,P14867,GABA(A) Receptor Benzodiazepine Binding Site,GABRA1,ligand,N05BA25
DB15489,Mexazolam,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,N05BA25
DB15490,Zuranolone,,P14867,GABA(A) Receptor,GABRA1,positive allosteric modulator,
DB15493,Cambinol,,Q96EB6,NAD-dependent protein deacetylase sirtuin-1,SIRT1,inhibitor,
DB15493,Cambinol,,Q8IXJ6,NAD-dependent protein deacetylase sirtuin-2,SIRT2,inhibitor,
DB15493,Cambinol,,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,inhibitor,
DB15494,Edotreotide gallium Ga-68,,P30874,Somatostatin receptor type 2,SSTR2,ligand,V09IX09
DB15494,Edotreotide gallium Ga-68,,P35346,Somatostatin receptor type 5,SSTR5,ligand,V09IX09
DB15494,Edotreotide gallium Ga-68,,P32745,Somatostatin receptor type 3,SSTR3,ligand,V09IX09
DB15494,Edotreotide gallium Ga-68,,P30872,Somatostatin receptor type 1,SSTR1,ligand,V09IX09
DB15495,Rocaglamide,,P35232,Prohibitin,PHB,inhibitor,
DB15495,Rocaglamide,,Q99623,Prohibitin-2,PHB2,inhibitor,
DB15496,Didesmethylrocaglamide,,P35232,Prohibitin,PHB,inhibitor,
DB15496,Didesmethylrocaglamide,,Q99623,Prohibitin-2,PHB2,inhibitor,
DB15498,BOS172722,,P33981,Dual specificity protein kinase TTK,TTK,inhibitor,
DB15534,Colchiceine,,P07437,Tubulin beta chain,TUBB,binder,
DB15534,Colchiceine,,Q71U36,Tubulin alpha-1A chain,TUBA1A,binder,
DB15561,Valoctocogene roxaparvovec,,,Coagulation factor VIII (F8),,gene replacement,
DB15565,Cilazaprilat,,P12821,Angiotensin-converting enzyme,ACE,,
DB15566,Prednisolone acetate,,P04150,Glucocorticoid receptor,NR3C1,agonist,
DB15568,Adagrasib,,P01116,GTPase KRas,KRAS,inhibitor,L01XX77
DB15569,Sotorasib,,P01116,GTPase KRas,KRAS,inhibitor,L01XX73
DB15570,FLX475,,P51679,C-C chemokine receptor type 4,CCR4,antagonist,
DB15588,Ursolic acid,,P01112,GTPase HRas,HRAS,regulator,
DB15588,Ursolic acid,,P08246,Neutrophil elastase,ELANE,inhibitor,
DB15593,Golodirsen,,P11532,Dystrophin,DMD,inducer,M09AX08
DB15594,Brilliant blue G,,,Internal limiting membrane (ILM),,binder,
DB15598,Ferric maltol,,P05106,Integrin beta-3,ITGB3,substrate,B03AB10
DB15598,Ferric maltol,,P49281,Natural resistance-associated macrophage protein 2,SLC11A2,substrate,B03AB10
DB15599,MIV-711,,P43235,Cathepsin K,CTSK,inhibitor,
DB15617,Ferric derisomaltose,,P69905,Hemoglobin subunit alpha,HBA1,binder,
DB15617,Ferric derisomaltose,,P02786,Transferrin receptor,TFRC,binder,
DB15623,TMC-310911,,O90777,HIV-1 protease,HIV-1 protease,inhibitor,
DB15624,Halicin,,P53779,c-Jun N-terminal kinases,MAPK10,inhibitor,
DB15626,Spesolimab,,Q9HB29,Interleukin-1 receptor-like 2,IL1RL2,antagonist,L04AC22
DB15627,Dostarlimab,,Q15116,Programmed cell death protein 1,PDCD1,binder,L01FF07
DB15627,Dostarlimab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,L01FF07
DB15628,Inolimomab,,P01589,Interleukin-2 receptor subunit alpha,IL2RA,antibody,
DB15635,Omburtamab,,Q5ZPR3,CD276 antigen,CD276,binder,
DB15636,Zilucoplan,,P01031,Complement C5,C5,inhibitor,
DB15643,N-(2-Aminoethyl)-1-aziridineethanamine,,Q9BYF1,Angiotensin-converting enzyme 2,ACE2,inhibitor,
DB15647,Ketodarolutamide,,P10275,Androgen receptor,AR,antagonist,
DB15650,Efpeglenatide,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,
DB15665,SEP-363856,,Q96RJ0,Trace amine-associated receptor 1,TAAR1,agonist,
DB15665,SEP-363856,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,
DB15669,Fezolinetant,,P29371,Neuromedin-K receptor,TACR3,antagonist,G02CX06
DB15673,Lenacapavir,,P04585,Gag-Pol polyprotein,gag-pol,inhibitor,J05AX31
DB15685,Selpercatinib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,inhibitor,L01EX22
DB15685,Selpercatinib,,P17948,Vascular endothelial growth factor receptor 1,FLT1,inhibitor,L01EX22
DB15685,Selpercatinib,,P35916,Vascular endothelial growth factor receptor 3,FLT4,inhibitor,L01EX22
DB15685,Selpercatinib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EX22
DB15685,Selpercatinib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,L01EX22
DB15685,Selpercatinib,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,L01EX22
DB15686,GS-441524,,P0C6X7,Replicase polyprotein 1ab,rep,inhibitor,
DB15686,GS-441524,,Q05318,RNA-directed RNA polymerase L,L,inhibitor,
DB15688,Zavegepant,,Q16602,Calcitonin gene-related peptide type 1 receptor,CALCRL,antagonist,
DB15690,Fluoroestradiol F-18,,P03372,Estrogen receptor alpha,ESR1,binder,
DB15690,Fluoroestradiol F-18,,Q92731,Estrogen receptor beta,ESR2,binder,
DB15691,Anti-SARS-CoV-2 REGN-COV2,,P0DTC2,Spike glycoprotein,S,binder,
DB15694,Cedazuridine,,P32320,Cytidine deaminase,CDA,inhibitor,
DB15699,Brexucabtagene autoleucel,,P15391,B-lymphocyte antigen CD19,CD19,binder,L01XL06
DB15718,Bamlanivimab,,P0DTC2,Spike glycoprotein,S,antagonist,
DB15719,Belantamab mafodotin,,Q02223,Tumor necrosis factor receptor superfamily member 17,TNFRSF17,binder,L01FX15
DB15762,Satralizumab,,P08887,Interleukin-6 receptor subunit alpha,IL6R,binder,L04AC19
DB15762,Satralizumab,,P08887,Interleukin-6 receptor subunit alpha,IL6R,antibody,L04AC19
DB15765,Sintilimab,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,
DB15765,Sintilimab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,
DB15766,Retifanlimab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,L01FF10
DB15766,Retifanlimab,,Q15116,Programmed cell death protein 1,PDCD1,blocker,L01FF10
DB15767,AMP-224,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,
DB15767,AMP-224,,Q15116,Programmed cell death protein 1,PDCD1,antibody,
DB15768,MEDI0680,,Q15116,Programmed cell death protein 1,PDCD1,inhibitor,
DB15768,MEDI0680,,Q15116,Programmed cell death protein 1,PDCD1,antibody,
DB15769,Envafolimab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,
DB15769,Envafolimab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,antibody,
DB15770,Cosibelimab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,
DB15770,Cosibelimab,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,antibody,
DB15771,AUNP-12,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,
DB15771,AUNP-12,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,antibody,
DB15772,CA-170,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,
DB15773,anti-OX40 antibody BMS 986178,,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,inhibitor,
DB15791,MK-0668,,P13612,VLA-4 (very late antigen-4),ITGA4,,
DB15796,GC-376 free acid,,P0DTD1,Replicase polyprotein 1ab,rep,inhibitor,
DB15796,GC-376 free acid,,P0DTC1,Replicase polyprotein 1a,,inhibitor,
DB15796,GC-376 free acid,,Q98VG9,Replicase polyprotein 1ab,rep,inhibitor,
DB15796,GC-376 free acid,,K9N638,Replicase polyprotein 1a,,,
DB15796,GC-376 free acid,,K9N7C7,Replicase polyprotein 1ab,rep,,
DB15797,GC-373,,K9N7C7,Replicase polyprotein 1ab,rep,inhibitor,
DB15797,GC-373,,K9N638,Replicase polyprotein 1a,,inhibitor,
DB15797,GC-373,,P0DTD1,Replicase polyprotein 1ab,rep,inhibitor,
DB15797,GC-373,,P0DTC1,Replicase polyprotein 1a,,inhibitor,
DB15797,GC-373,,Q98VG9,Replicase polyprotein 1ab,rep,inhibitor,
DB15822,Pralsetinib,,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,inhibitor,L01EX23
DB15822,Pralsetinib,,Q08345,Epithelial discoidin domain-containing receptor 1,DDR1,inhibitor,L01EX23
DB15822,Pralsetinib,,Q16288,NT-3 growth factor receptor,NTRK3,inhibitor,L01EX23
DB15822,Pralsetinib,,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,inhibitor,L01EX23
DB15822,Pralsetinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,L01EX23
DB15822,Pralsetinib,,O60674,Tyrosine-protein kinase JAK2,JAK2,inhibitor,L01EX23
DB15822,Pralsetinib,,P04629,High affinity nerve growth factor receptor,NTRK1,inhibitor,L01EX23
DB15822,Pralsetinib,,P35968,Vascular endothelial growth factor receptor 2,KDR,inhibitor,L01EX23
DB15822,Pralsetinib,,P09619,Platelet-derived growth factor receptor beta,PDGFRB,inhibitor,L01EX23
DB15822,Pralsetinib,,P11362,Fibroblast growth factor receptor 1,FGFR1,inhibitor,L01EX23
DB15822,Pralsetinib,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,L01EX23
DB15873,Copper oxodotreotide Cu-64,,P30874,Somatostatin receptor type 2,SSTR2,binder,
DB15874,Agalsidase alfa,,,Globotriaosylceramide,,metabolizer,A16AB03
DB15874,Agalsidase alfa,,,Globotriaosylceramide,,ligand,A16AB03
DB15897,Etesevimab,,P0DTC2,Spike glycoprotein,S,binder,
DB15898,Atoltivimab,,Q05320,Envelope glycoprotein,GP,antagonist,
DB15899,Maftivimab,,Q05320,Envelope glycoprotein,GP,antagonist,
DB15900,Odesivimab,,Q05320,Envelope glycoprotein,GP,antagonist,
DB15935,Lumasiran,,Q9UJM8,Hydroxyacid oxidase 1,HAO1,antisense oligonucleotide,A16AX18
DB15940,Imdevimab,,P0DTC2,Spike glycoprotein,S,binder,J06BD07
DB15941,Casirivimab,,P0DTC2,Spike glycoprotein,S,binder,J06BD07
DB15965,Naxitamab,,,GD2 disialoganglioside,,binder,L01FX21
DB15965,Naxitamab,,,GD2 disialoganglioside,,antibody,L01FX21
DB15982,Berotralstat,,P03952,Plasma kallikrein,KLKB1,inhibitor,B06AC06
DB16007,Rurioctocog alfa pegol,,P04275,von Willebrand factor,VWF,binder,
DB16007,Rurioctocog alfa pegol,,P00451,Coagulation factor VIII,F8,regulator,
DB16019,Gallium Ga-68 gozetotide,,P07288,Prostate-specific antigen,KLK3,binder,V09IX14
DB16098,Atogepant,,Q16602,Calcitonin gene-related peptide type 1 receptor,CALCRL,antagonist,N02CD07
DB16099,Avalglucosidase alfa,,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,ligand,A16AB22
DB16165,Finerenone,,P08235,Mineralocorticoid receptor,NR3C2,antagonist,C03DA05
DB16199,Eplontersen,,,Transthyretin mRNA,,antisense oligonucleotide,
DB16200,Iptacopan,,P00751,Complement factor B,CFB,inhibitor,
DB16217,Leniolisib,,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,inhibitor,
DB16220,Lonapegsomatropin,,P10912,Growth hormone receptor,GHR,ligand,H01AC09
DB16220,Lonapegsomatropin,,P16471,Prolactin receptor,PRLR,ligand,H01AC09
DB16222,Loncastuximab tesirine,,P15391,B-lymphocyte antigen CD19,CD19,binder,L01FX22
DB16226,Maralixibat,,Q12908,Ileal sodium/bile acid cotransporter,SLC10A2,inhibitor,A05AX04
DB16236,Mitapivat,,P30613,Pyruvate kinase PKLR,PKLR,activator,G01AE10;B06AX04
DB16236,Mitapivat,,P11511,Cytochrome P450 19A1,CYP19A1,inhibitor,G01AE10;B06AX04
DB16255,Nidufexor,,Q96RI1,Bile acid receptor,NR1H4,agonist,
DB16258,Nirsevimab,,P13843,Fusion glycoprotein F0,F,antibody,J06BD08
DB16258,Nirsevimab,,P03420,Fusion glycoprotein F0,F,antibody,J06BD08
DB16258,Nirsevimab,,P11209,Fusion glycoprotein F0,F,antibody,J06BD08
DB16261,Odevixibat,,Q12908,Ileal sodium/bile acid cotransporter,SLC10A2,inhibitor,A05AX05
DB16265,Olinvacimab,,P35968,Vascular endothelial growth factor receptor 2,KDR,antibody,
DB16265,Olinvacimab,,P35968,Vascular endothelial growth factor receptor 2,KDR,regulator,
DB16266,Olodanrigan,,P50052,Type-2 angiotensin II receptor,AGTR2,antagonist,
DB16267,Olutasidenib,,O75874,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,inhibitor,
DB16275,Otlertuzumab,,P11049,Leukocyte antigen CD37,CD37,antibody,
DB16275,Otlertuzumab,,P11049,Leukocyte antigen CD37,CD37,regulator,
DB16279,Pecavaptan,,P37288,Vasopressin V1a receptor,AVPR1A,antagonist,
DB16279,Pecavaptan,,P30518,Vasopressin V2 receptor,AVPR2,antagonist,
DB16309,Revusiran,,P02766,Transthyretin,TTR,regulator,
DB16310,Rezafungin,,A2QLK4,"1,3-beta-glucan synthase component FKS1",fksA,inhibitor,
DB16310,Rezafungin,,P40989,"1,3-beta-glucan synthase component GSC2",GSC2,inhibitor,
DB16315,Rivenprost,,P35408,Prostaglandin E2 receptor EP4 subtype,PTGER4,agonist,
DB16315,Rivenprost,,P34995,Prostaglandin E2 Receptors,PTGER1,agonist,
DB16318,Romilkimab,,P35225,Interleukin-13,IL13,inhibitor,
DB16318,Romilkimab,,P05112,Interleukin-4,IL4,inhibitor,
DB16321,S-777469,,P34972,Cannabinoid receptor 2,CNR2,agonist,
DB16324,Selgantolimod,,Q9NR97,Toll-like receptor 8,TLR8,agonist,
DB16341,Tilsotolimod,,Q9NR96,Toll-like receptor 9,TLR9,agonist,
DB16343,Tropifexor,,Q96RI1,Bile acid receptor,NR1H4,agonist,
DB16343,Tropifexor,,Q96RI1,Bile acid receptor,NR1H4,binder,
DB16346,Veliflapon,,P20292,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,inhibitor,
DB16349,Vicagrel,,Q9H244,P2Y purinoceptor 12,P2RY12,antagonist,
DB16349,Vicagrel,,Q9H244,P2Y purinoceptor 12,P2RY12,inhibitor,
DB16351,Volinanserin,,P28223,5-hydroxytryptamine receptor 2A,HTR2A,antagonist,
DB16353,Razuprotafib,,P23467,Receptor-type tyrosine-protein phosphatase beta,PTPRB,inhibitor,
DB16355,Sotrovimab,,P0DTC2,Spike glycoprotein,S,binder,J06BD05
DB16370,Mezagitamab,,P28907,ADP-ribosyl cyclase 1,CD38,inhibitor,
DB16371,Glofitamab,,P11836,B-lymphocyte antigen CD20,MS4A1,binder,
DB16371,Glofitamab,,P11836,B-lymphocyte antigen CD20,MS4A1,antibody,
DB16371,Glofitamab,,P04234,T-cell surface glycoprotein CD3,CD3D,binder,
DB16371,Glofitamab,,P04234,T-cell surface glycoprotein CD3,CD3D,antibody,
DB16379,Garetosmab,,P08476,Inhibin beta A chain,INHBA,binder,
DB16385,Ansuvimab,,Q05320,Envelope glycoprotein,GP,antagonist,J06BD04
DB16390,Mobocertinib,,P00533,Epidermal growth factor receptor,EGFR,inhibitor,L01EB10
DB16393,Cilgavimab,,P0DTC2,Spike glycoprotein,S,binder,J06BD03
DB16394,Tixagevimab,,P0DTC2,Spike glycoprotein,S,binder,J06BD03
DB16405,Regdanvimab,,P0DTC2,Spike glycoprotein,S,antibody,J06BD06
DB16407,Azvudine,,Q9UNQ0,ATP-binding cassette sub-family G member 2,ABCG2,regulator,
DB16407,Azvudine,,Q92887,Canalicular multispecific organic anion transporter 1,ABCC2,regulator,
DB16407,Azvudine,,P08183,P-glycoprotein 1,ABCB1,activator,
DB16407,Azvudine,,P08183,P-glycoprotein 1,ABCB1,regulator,
DB16411,Camidanlumab tesirine,,P01589,Interleukin-2 receptor subunit alpha,IL2RA,antibody,
DB16411,Camidanlumab tesirine,,P01589,Interleukin-2 receptor subunit alpha,IL2RA,regulator,
DB16416,Vilobelimab,,P01031,Complement C5,C5,inhibitor,
DB16417,Geptanolimab,,Q15116,Programmed cell death protein 1,PDCD1,regulator,
DB16418,Narsoplimab,,O00187,Mannan-binding lectin serine protease 2,MASP2,antagonist,
DB16446,Vafidemstat,,P27338,Amine oxidase [flavin-containing] B,MAOB,inhibitor,
DB16446,Vafidemstat,,O60341,Lysine-specific histone demethylase 1A,KDM1A,inhibitor,
DB16446,Vafidemstat,,O60341,Lysine-specific histone demethylase 1A,KDM1A,binder,
DB16446,Vafidemstat,,O60341,Lysine-specific histone demethylase 1A,KDM1A,modulator,
DB16453,Efzofitimod,,O60462,Neuropilin-2,NRP2,modulator,
DB16474,Pam2csk4,,Q9Y2C9,Toll-like receptor 6,TLR6,agonist,
DB16474,Pam2csk4,,O60603,Toll-like receptor 2,TLR2,agonist,
DB16514,PF-07304814,,P0DTD1,Replicase polyprotein 1ab,rep,inhibitor,
DB16515,PLN-74809,,P06756,Integrin alpha-V,ITGAV,,
DB16515,PLN-74809,,P05556,Integrin beta-1,ITGB1,,
DB16515,PLN-74809,,P18564,Integrin beta-6,ITGB6,,
DB16547,Furvina,,,30S ribosomal protein,,antagonist,
DB16580,Afimetoran,,Q9NYK1,Toll-like receptor 7,TLR7,antagonist,
DB16580,Afimetoran,,Q9NR97,Toll-like receptor 8,TLR8,antagonist,
DB16582,Lisocabtagene maraleucel,,P15391,B-lymphocyte antigen CD19,CD19,binder,
DB16627,Melphalan flufenamide,,,DNA,,cross-linking/alkylation,L01AA10
DB16628,Fosdenopterin,,O96007,Molybdopterin synthase catalytic subunit,MOCS2,substrate,A16AX19
DB16629,Serdexmethylphenidate,,Q01959,Sodium-dependent dopamine transporter,SLC6A3,inhibitor,N06BA15
DB16629,Serdexmethylphenidate,,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,inhibitor,N06BA15
DB16629,Serdexmethylphenidate,,P08908,5-hydroxytryptamine receptor 1A,HTR1A,agonist,N06BA15
DB16630,OPB-111077,,P40763,Signal transducer and activator of transcription 3,STAT3,inhibitor,
DB16637,KW-2450 free base,,P06213,Insulin receptor,INSR,inhibitor,
DB16637,KW-2450 free base,,P08069,Insulin-like growth factor 1 receptor,IGF1R,inhibitor,
DB16640,Almonertinib,,Q504U8,Receptor protein-tyrosine kinase,EGFR,inhibitor,
DB16650,Deucravacitinib,,P29597,Non-receptor tyrosine-protein kinase TYK2,TYK2,inhibitor,L04AA56
DB16652,Avotaciclib,,P06493,Cyclin-dependent kinase 1,CDK1,inhibitor,
DB16655,Teclistamab,,P04234,T-cell surface glycoprotein CD3,CD3D,antibody,
DB16655,Teclistamab,,Q02223,Tumor necrosis factor receptor superfamily member 17,TNFRSF17,antibody,
DB16656,Zotiraciclib,,P50750,Cyclin-dependent kinase 9,CDK9,inhibitor,
DB16656,Zotiraciclib,,P06241,Tyrosine-protein kinase Fyn,FYN,inhibitor,
DB16656,Zotiraciclib,,P06239,Tyrosine-protein kinase Lck,LCK,inhibitor,
DB16657,Vecabrutinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB16662,Efanesoctocog alfa,,P00740,Coagulation factor IX,F9,binder,
DB16662,Efanesoctocog alfa,,P00742,Coagulation factor X,F10,binder,
DB16662,Efanesoctocog alfa,,P98164,Low-density lipoprotein receptor-related protein 2,LRP2,binder,
DB16662,Efanesoctocog alfa,,P98160,Basement membrane-specific heparan sulfate proteoglycan core protein,HSPG2,binder,
DB16665,Idecabtagene vicleucel,,Q02223,Tumor necrosis factor receptor superfamily member 17,TNFRSF17,binder,L01XL07
DB16668,Budigalimab,,Q15116,Programmed cell death protein 1,PDCD1,regulator,
DB16672,Epcoritamab,,P11836,B-lymphocyte antigen CD20,MS4A1,binder,
DB16672,Epcoritamab,,P11836,B-lymphocyte antigen CD20,MS4A1,antibody,
DB16672,Epcoritamab,,P07766,T-cell surface glycoprotein CD3 epsilon chain,CD3E,binder,
DB16672,Epcoritamab,,P07766,T-cell surface glycoprotein CD3 epsilon chain,CD3E,antibody,
DB16678,Talquetamab,,P04234,T-cell surface glycoprotein CD3,CD3D,antibody,
DB16678,Talquetamab,,Q9NZD1,G-protein coupled receptor family C group 5 member D,GPRC5D,antibody,
DB16684,Odronextamab,,P11836,B-lymphocyte antigen CD20,MS4A1,binder,
DB16684,Odronextamab,,P04234,T-cell surface glycoprotein CD3,CD3D,binder,
DB16690,Tegoprazan,,P05023,Sodium/Potassium Transporting ATPase,ATP1A1,inhibitor,A02BC09
DB16691,Nirmatrelvir,,P0DTD1,Replicase polyprotein 1ab,rep,inhibitor,J05AE30
DB16694,Pegcetacoplan,,P01024,Complement C3,C3,binder,L04AA54
DB16694,Pegcetacoplan,,P01024,Complement C3,C3,regulator,L04AA54
DB16695,Amivantamab,,P00533,Epidermal growth factor receptor,EGFR,antibody,L01FX18
DB16695,Amivantamab,,P00533,Epidermal growth factor receptor,EGFR,downregulator,L01FX18
DB16695,Amivantamab,,P08581,Hepatocyte growth factor receptor,MET,antagonist,L01FX18
DB16695,Amivantamab,,P08581,Hepatocyte growth factor receptor,MET,antibody,L01FX18
DB16695,Amivantamab,,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,inducer,L01FX18
DB16697,Glutazumab,,P43220,Glucagon-like peptide 1 receptor,GLP1R,agonist,
DB16698,Neihulizumab,,Q14242,P-selectin glycoprotein ligand 1,SELPLG,agonist,
DB16699,Vutrisiran,,,Transthyretin mRNA,,antisense oligonucleotide,N07XX18
DB16703,Belumosudil,,O75116,Rho-associated protein kinase 2,ROCK2,inhibitor,L04AA48
DB16703,Belumosudil,,Q13464,Rho-associated protein kinase 1,ROCK1,inhibitor,L04AA48
DB16707,Gavorestat,,P15121,Aldose reductase,AKR1B1,inhibitor,
DB16708,Cipaglucosidase alfa,,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,ligand,A16AB23
DB16708,Cipaglucosidase alfa,,,Alpha glucosidase (GAA),,gene replacement,A16AB23
DB16732,Tisotumab vedotin,,P13726,Tissue factor,F3,antibody,L01FX23
DB16733,Rimtuzalcap,,Q92952,Small conductance calcium-activated potassium channel protein 1,KCNN1,positive allosteric modulator,
DB16733,Rimtuzalcap,,Q9H2S1,Small conductance calcium-activated potassium channel protein 2,KCNN2,positive allosteric modulator,
DB16733,Rimtuzalcap,,Q9UGI6,Small conductance calcium-activated potassium channel protein 3,KCNN3,positive allosteric modulator,
DB16737,MM3122,,O15393,Transmembrane protease serine 2,TMPRSS2,inhibitor,
DB16738,Ciltacabtagene autoleucel,,Q02223,Tumor necrosis factor receptor superfamily member 17,TNFRSF17,binder,L01XL05
DB16739,MK-886,,P20292,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,inhibitor,
DB16740,Prolgolimab,,Q15116,Programmed cell death protein 1,PDCD1,antibody,L01FF08
DB16754,TPMPA,,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,antagonist,
DB16754,TPMPA,,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,antagonist,
DB16754,TPMPA,,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,antagonist,
DB16755,Bebtelovimab,,P0DTC2,Spike glycoprotein,S,antibody,
DB16756,Ivarmacitinib,,P23458,Tyrosine-protein kinase JAK1,JAK1,inhibitor,
DB16778,Lutetium Lu-177 vipivotide tetraxetan,,P07288,Prostate-specific antigen,KLK3,binder,
DB16820,Letibotulinumtoxina,,P60880,Synaptosomal-associated protein 25,SNAP25,cleavage,
DB16826,Repotrectinib,,P08922,Proto-oncogene tyrosine-protein kinase ROS,ROS1,inhibitor,
DB16826,Repotrectinib,,P04629,High affinity nerve growth factor receptor,NTRK1,inhibitor,
DB16826,Repotrectinib,,Q16620,BDNF/NT-3 growth factors receptor,NTRK2,inhibitor,
DB16826,Repotrectinib,,Q16288,NT-3 growth factor receptor,NTRK3,inhibitor,
DB16862,Indigo,,P35869,Aryl hydrocarbon receptor,AHR,binder,
DB16900,Betibeglogene autotemcel,,V9H1D9,Alpha globin,,binder,B06AX02
DB17080,KW-6356,,P29274,Adenosine receptor A2a,ADORA2A,antagonist,
DB17083,Linzagolix,,P30968,Gonadotropin-releasing hormone receptor,GNRHR,antagonist,H01CC04
DB17087,JNJ-17216498,,Q9Y5N1,Histamine H3 receptor,HRH3,antagonist,
DB17096,UCB7362,,Q8IAS0,Plasmepsin X,PMX,inhibitor,
DB17096,UCB7362,,Q8IAS0,Plasmepsin X,PMX,binder,
DB17096,UCB7362,,W7JWW5,Plasmepsin X,PMX,inhibitor,
DB17096,UCB7362,,W7JWW5,Plasmepsin X,PMX,binder,
DB17449,Anacaulase,,P01011,Alpha-1-antichymotrypsin,SERPINA3,binder,
DB17449,Anacaulase,,P01023,Alpha-2-macroglobulin,A2M,binder,
DB17472,Pirtobrutinib,,Q06187,Tyrosine-protein kinase BTK,BTK,inhibitor,
DB17493,Bioymifi,,O14763,Tumor necrosis factor receptor superfamily member 10B,TNFRSF10B,binder,
DB17538,Atidarsagene autotemcel,,,Human Arylsulfatase A mRNA,,gene replacement,A16AB21
DB17587,KIN-3248,,P21802,Fibroblast growth factor receptor 2,FGFR2,inhibitor,
DB17587,KIN-3248,,P22607,Fibroblast growth factor receptor 3,FGFR3,inhibitor,
DB17635,Nedosiran,,P00338,L-lactate dehydrogenase A chain,LDHA,antisense oligonucleotide,
DB17851,Flotufolastat F-18,,Q04609,Glutamate carboxypeptidase 2,FOLH1,binder,
DB17992,Lotilaner,,E0W492,"Gaba-gated chloride channel, putative",8239847,antagonist,
DB18236,(R)-9b,,Q07912,Activated CDC42 kinase 1,TNK2,inhibitor,
DB18680,Lovotibeglogene autotemcel,,,Hemoglobin subunit beta,,gene replacement,
DB18704,Efbemalenograstim alfa,,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,stimulator,L03AA18
DB18716,Enmetazobactam,,P37321,Extended-spectrum beta-lactamase PER-1,per1,inhibitor,
